Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ABCA6 EST155051 ENSG00000154262 "ATP binding cassette subfamily A member 6" Q8N139 17 69078702-69141888 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 53.9" "Group enriched" "Detected in many" 4 "Fibroblasts: 27.1;Hepatocytes: 95.4;Leydig cells: 47.5" "Cancer enriched" "Detected in some" 7 "liver cancer: 4.8" "Group enriched" "Detected in many" 5 "basal ganglia: 6.6;midbrain: 10.9;pons and medulla: 11.2;thalamus: 9.3" "Cell type enhanced" "Detected in some" "classical monocyte: 1.0;plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 20.7;ASC TERT1: 30.0;HSkMC: 13.1;HUVEC TERT2: 27.9;RT4: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA064878, HPA067180" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064878: AB_2685380, HPA067180: AB_2685797" "unprognostic (7.76e-2)" "unprognostic (6.80e-2)" "unprognostic (2.12e-1)" "unprognostic (8.01e-2)" "unprognostic (8.47e-2)" "unprognostic (9.82e-3)" "prognostic favorable (3.29e-4)" "unprognostic (1.35e-1)" "unprognostic (6.60e-2)" "unprognostic (3.00e-2)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (7.96e-4)" "unprognostic (1.61e-4)" "unprognostic (2.10e-2)" "unprognostic (3.03e-2)" "unprognostic (1.69e-1)" 31.4 4.3 1.4 2.0 6.6 0.4 12.1 0.7 1.9 12.3 9.9 4.7 2.9 1.8 7.9 6.9 10.5 4.9 7.2 13.2 1.5 0.9 3.0 53.9 9.3 3.6 10.9 0.2 22.0 1.9 1.1 6.0 1.8 11.2 8.0 3.4 4.2 7.1 1.9 6.6 5.0 3.9 9.8 21.0 1.8 4.4 5.0 9.3 0.0 6.7 6.6 2.5 16.6 11.7 0.0 1.2 0.0 1.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 20.7 30.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 13.1 0.0 1.6 0.4 0.8 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.2 1.2 0.0 0.3 1.4 6.6 0.7 1.9 1.5 0.9 10.9 0.2 11.2 9.3 0.0 0.0 2.7 0.9 2.7 13.9 4.8 0.0 0.0 1.2 3.5 5.9 0.0 0.0 0.2 2.9 2.2 0.5 0.0 0.2 0.0 27.1 0.1 0.0 95.4 1.2 0.0 2.4 2.5 1.8 2.2 47.5 2.8 5.0 1.0 0.1 3.9 0.5 0.0 11.3 0.6 13.8 0.0 1.7 0.9 1.0 2.5 0.0 0.0 0.0 0.3 ABHD16B "C20orf135, dJ591C20.1" ENSG00000183260 "Abhydrolase domain containing 16B" Q9H3Z7 20 63861498-63862988 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 58 "Early spermatids: 120.3;Late spermatids: 172.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 6.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 13.6;PC-3: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA059272, HPA075886" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059272: AB_2683963, HPA075886: " 4.3 3.6 3.0 5.3 3.8 2.0 1.1 0.6 3.0 1.3 1.9 4.1 2.3 0.0 2.9 2.2 0.9 2.2 1.9 2.0 2.6 2.0 2.2 3.4 1.5 2.3 4.8 0.0 3.2 1.3 2.9 0.0 3.6 0.0 3.1 2.4 3.4 0.0 1.2 7.4 5.0 9.0 2.0 0.0 1.4 1.5 1.8 1.6 6.3 1.8 0.4 2.0 1.6 4.1 2.7 0.5 1.1 0.0 0.0 6.3 4.9 0.0 0.0 0.0 13.6 5.4 3.8 4.0 0.0 1.2 10.6 0.0 0.0 0.0 2.6 3.3 2.4 4.7 9.8 0.0 1.4 6.9 0.0 0.0 0.0 0.0 0.2 0.0 2.9 4.6 4.5 0.0 7.1 2.2 4.0 1.2 0.5 16.3 4.8 0.6 1.4 0.0 2.8 2.0 1.6 4.6 2.7 0.6 0.2 5.4 0.6 1.7 2.9 5.1 1.5 2.0 3.7 2.1 2.5 2.1 1.5 2.1 0.3 1.8 6.3 1.9 1.2 1.2 0.8 0.7 1.5 1.5 1.8 1.5 1.1 0.8 0.4 0.8 1.6 2.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 172.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 ABL1 "ABL, c-ABL, JTK7, p150" ENSG00000097007 "ABL proto-oncogene 1, non-receptor tyrosine kinase" P00519 9 130713946-130887675 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis" "DNA-binding, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002686, HPA027251, HPA027280, HPA028409" Supported Enhanced "Nucleoplasm,Nuclear bodies" Yes No Nucleoplasm "Nuclear bodies" "CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011" "unprognostic (4.82e-2)" "unprognostic (3.99e-2)" "unprognostic (5.55e-2)" "unprognostic (4.72e-2)" "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (3.75e-3)" "unprognostic (1.89e-3)" "unprognostic (2.34e-1)" "unprognostic (2.54e-2)" "unprognostic (1.09e-2)" "unprognostic (1.48e-1)" "unprognostic (3.96e-3)" "unprognostic (1.10e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" 20.1 11.6 12.4 15.0 18.1 10.7 22.0 6.7 16.0 28.9 34.3 29.1 12.1 11.9 26.6 16.9 21.4 20.8 30.9 14.2 10.3 8.4 9.9 6.7 13.8 8.7 24.1 9.4 24.2 12.2 27.7 14.5 13.6 17.1 27.3 15.8 19.4 14.6 18.0 10.8 14.2 17.0 66.6 14.3 10.8 21.9 9.8 21.2 5.8 19.5 11.4 9.1 35.8 31.9 3.1 3.1 1.1 5.0 2.4 2.6 1.6 7.2 16.1 17.2 20.8 25.3 30.9 6.3 12.7 19.9 14.9 12.6 12.6 9.4 11.9 7.3 16.8 15.3 14.0 8.7 11.7 11.0 7.4 5.4 7.8 27.4 10.7 17.3 11.9 10.9 22.5 12.9 26.6 16.5 20.8 20.6 15.4 43.5 9.5 18.1 13.7 15.1 9.8 19.1 11.3 11.9 17.5 22.3 12.8 15.1 8.5 16.1 20.1 21.3 8.3 10.2 10.5 16.2 11.0 23.6 57.2 14.8 21.8 19.9 2.9 6.8 15.9 23.5 9.9 18.1 0.2 2.1 1.1 2.0 1.2 2.6 3.1 2.0 1.9 2.0 1.4 1.9 1.7 0.2 2.4 5.0 3.1 0.9 1.6 12.4 18.1 6.7 16.0 10.3 8.4 24.1 9.4 17.1 21.2 8.9 9.9 4.2 6.4 8.1 6.2 5.8 12.7 5.3 5.7 14.0 11.8 11.3 1.7 12.6 3.1 14.3 15.4 0.0 9.5 3.5 27.8 8.1 2.3 13.4 13.7 9.5 21.2 20.3 13.7 7.4 25.9 6.5 5.0 3.6 15.7 15.7 14.3 20.3 24.1 8.4 9.7 19.4 21.0 11.9 13.6 5.9 12.7 7.9 19.1 6.4 AC118549.1 ENSG00000036549 "ZZ-type zinc finger-containing protein 3 " Q8IYH5 1 77562416-77683419 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 19.0;Proximal tubular cells: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053663, HPA054913, HPA066197" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA053663: AB_2682222, HPA054913: AB_2682640, HPA066197: AB_2685635" "unprognostic (1.30e-1)" "unprognostic (4.78e-2)" "unprognostic (2.73e-2)" "unprognostic (2.13e-3)" "unprognostic (5.38e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (6.96e-5)" "unprognostic (2.91e-1)" "unprognostic (9.67e-2)" "unprognostic (1.35e-1)" "unprognostic (2.83e-1)" "unprognostic (1.91e-1)" "unprognostic (1.71e-1)" "unprognostic (3.96e-1)" "unprognostic (1.95e-1)" "unprognostic (3.05e-2)" "unprognostic (1.43e-1)" 17.8 17.4 20.8 14.1 23.6 11.6 21.6 20.4 20.3 18.1 16.2 16.1 18.3 12.1 18.3 14.3 14.5 15.3 12.1 13.7 16.9 11.7 18.8 20.0 12.3 15.8 24.1 17.8 24.1 14.5 19.0 28.2 13.9 14.4 16.0 13.0 10.5 15.2 16.8 19.0 16.9 12.4 17.0 16.2 11.5 13.5 9.9 23.6 17.9 26.5 8.6 16.0 20.1 14.9 7.9 7.4 5.6 5.1 7.4 10.4 5.0 13.4 6.9 12.7 9.7 11.1 17.7 13.4 17.2 15.9 15.9 17.5 7.7 7.2 17.6 15.5 14.4 18.0 12.4 16.7 11.1 24.1 13.8 13.2 21.8 13.9 9.5 17.1 22.5 6.2 13.5 17.2 17.6 34.4 15.4 16.1 12.2 21.1 13.7 15.4 6.3 11.2 7.0 18.8 7.4 15.7 13.2 21.7 9.0 11.1 14.3 15.9 13.4 10.3 11.8 30.3 9.1 7.1 12.4 13.2 13.8 17.0 22.3 22.1 10.3 14.4 18.7 13.6 19.7 10.5 0.1 4.6 5.6 6.9 5.1 10.4 7.9 8.2 8.1 7.4 7.9 10.2 9.2 0.9 7.4 4.7 5.0 10.4 5.0 20.8 23.6 20.4 20.3 16.9 11.7 24.1 17.8 14.4 23.6 11.9 19.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 12.5 10.4 0.0 11.4 10.0 13.1 0.0 0.0 0.0 0.0 11.1 10.1 0.0 0.0 5.8 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 13.6 0.0 0.0 11.8 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 ACTL6A "Actl6, Arp4, BAF53A, INO80K" ENSG00000136518 "Actin like 6A" O96019 3 179562880-179588408 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 197.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012188, HPA018671, HPA063149" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: " "unprognostic (2.13e-1)" "unprognostic (5.33e-2)" "unprognostic (1.54e-2)" "unprognostic (2.24e-3)" "unprognostic (7.79e-3)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.89e-5)" "unprognostic (3.36e-2)" "unprognostic (1.09e-3)" "unprognostic (2.13e-2)" "prognostic unfavorable (5.44e-5)" "unprognostic (1.03e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (4.21e-2)" "unprognostic (1.96e-1)" "unprognostic (4.21e-3)" "unprognostic (5.20e-2)" 18.8 17.9 9.9 23.4 16.8 8.7 21.3 8.7 9.6 16.8 21.3 15.3 15.6 14.5 24.8 16.4 23.2 16.3 14.9 24.2 8.7 7.4 19.6 18.6 14.6 17.4 16.7 5.4 24.8 20.9 13.7 23.4 20.1 13.7 17.7 23.5 10.4 19.0 17.4 12.8 19.4 19.8 16.1 14.8 19.3 16.7 47.5 17.0 46.1 21.9 20.4 23.8 18.7 22.7 17.5 19.8 8.0 16.1 14.5 22.4 13.8 46.2 14.0 34.9 18.4 13.4 14.7 27.4 18.7 14.6 34.9 29.6 31.6 22.8 36.2 33.6 17.5 40.6 21.4 30.5 23.0 43.5 35.8 25.4 29.6 15.5 23.9 15.3 36.7 18.6 10.2 23.6 22.5 19.0 11.0 19.8 21.9 23.0 20.7 25.1 31.6 32.1 22.7 31.0 42.0 31.4 30.2 29.2 66.9 27.6 18.7 28.7 20.5 28.8 28.8 28.8 18.2 56.2 30.3 14.9 24.9 21.5 25.5 56.3 13.5 20.1 55.5 13.8 39.1 27.4 3.3 11.3 8.0 15.1 14.3 20.0 17.5 17.5 17.4 19.8 13.7 19.2 19.4 1.5 14.5 16.1 11.2 22.4 13.8 9.9 16.8 8.7 9.6 8.7 7.4 16.7 5.4 13.7 17.0 20.8 23.9 24.3 37.3 41.9 4.8 6.0 28.1 30.8 23.9 26.2 7.9 42.0 29.9 42.1 15.5 20.7 13.0 0.0 39.2 57.0 28.9 28.3 13.9 14.0 30.6 0.0 29.2 12.3 18.6 11.4 30.0 16.7 28.7 33.3 24.6 16.3 32.2 17.5 28.3 17.9 12.3 25.8 23.6 197.2 97.8 40.1 25.6 19.2 36.2 35.1 ADAR "ADAR1, G1P1, IFI4" ENSG00000160710 "Adenosine deaminase, RNA specific" P55265 1 154582062-154627999 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing" "DNA-binding, Hydrolase, RNA-binding" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003890, HPA051519, CAB056157" Enhanced Enhanced Nucleoplasm,Nucleoli No No Nucleoli Nucleoplasm "CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520" "unprognostic (3.46e-1)" "unprognostic (8.11e-2)" "unprognostic (1.42e-1)" "unprognostic (1.83e-2)" "unprognostic (2.38e-1)" "unprognostic (9.37e-2)" "unprognostic (2.07e-2)" "unprognostic (6.97e-2)" "unprognostic (2.03e-1)" "unprognostic (2.90e-1)" "unprognostic (4.13e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.30e-5)" "unprognostic (3.44e-1)" "unprognostic (1.49e-1)" "unprognostic (9.00e-2)" "unprognostic (3.94e-2)" 36.1 33.1 30.3 36.6 44.4 43.1 29.7 41.4 50.8 30.7 28.2 33.3 19.9 31.4 38.0 26.5 27.7 32.9 28.9 24.0 25.7 38.1 31.5 36.0 34.7 41.3 27.3 32.6 39.2 29.5 46.2 38.4 33.9 39.8 28.8 31.1 32.2 36.7 30.2 14.0 27.0 40.6 36.3 24.4 47.7 29.1 21.9 26.9 57.6 32.8 16.7 41.9 29.7 27.6 7.8 6.1 25.1 8.6 6.4 9.7 5.6 26.6 30.9 26.5 32.6 26.8 27.8 31.5 18.4 36.9 61.6 53.5 26.6 26.2 48.0 29.7 29.3 34.2 25.9 33.8 34.9 31.4 46.6 16.9 25.0 21.9 15.0 29.2 35.3 27.8 27.0 25.5 31.5 32.3 25.2 31.5 34.7 23.6 37.0 21.5 32.5 42.6 18.2 43.7 35.7 23.3 40.8 21.8 38.6 21.1 29.7 26.4 31.5 31.7 51.3 37.6 41.3 34.5 43.5 28.7 22.1 21.8 18.2 21.2 43.8 48.0 51.6 21.5 23.3 24.9 6.9 6.6 12.0 9.4 8.3 8.8 7.8 9.4 9.7 6.1 6.2 8.8 8.6 25.1 6.4 8.6 5.5 7.1 5.6 30.3 44.4 41.4 50.8 25.7 38.1 27.3 32.6 39.8 26.9 77.4 46.4 72.2 33.2 29.7 90.3 15.5 33.1 41.5 43.3 45.4 90.3 33.7 8.3 43.8 3.6 83.1 68.1 23.3 58.0 42.0 39.5 47.9 61.1 78.8 46.9 158.9 60.6 78.0 80.2 9.5 68.1 57.4 18.6 68.5 54.5 46.8 58.0 53.7 55.5 36.0 81.7 51.8 36.9 11.7 23.2 35.3 26.3 58.3 48.2 41.3 ADD1 ENSG00000087274 "Adducin 1" P35611 4 2843857-2930076 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 379.0;Rod photoreceptor cells: 557.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009794, HPA035873, HPA035874" Enhanced Enhanced "Nucleoplasm,Plasma membrane" NA NA 1400000 "Plasma membrane" Nucleoplasm "CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "unprognostic (1.66e-2)" "unprognostic (5.40e-3)" "unprognostic (1.90e-1)" "unprognostic (2.66e-2)" "unprognostic (5.07e-3)" "unprognostic (1.68e-2)" "unprognostic (3.52e-1)" "unprognostic (2.50e-1)" "prognostic favorable (3.94e-4)" "unprognostic (5.22e-2)" "prognostic favorable (1.29e-7)" "unprognostic (2.61e-2)" "unprognostic (1.12e-1)" "unprognostic (7.38e-2)" "unprognostic (4.03e-3)" 44.0 31.7 43.1 27.9 52.1 26.7 35.6 46.3 66.6 37.5 43.3 47.2 27.3 30.8 47.9 29.2 35.1 43.0 33.1 41.1 39.5 34.1 36.8 23.4 38.0 27.9 40.5 46.7 65.3 25.0 31.3 28.4 31.2 44.7 43.1 30.7 36.3 26.2 54.9 69.5 25.5 33.6 58.1 33.8 34.9 32.6 25.2 37.0 25.5 27.9 19.6 28.5 45.3 34.9 21.3 16.2 21.5 6.5 16.4 12.9 9.1 18.5 15.6 37.1 19.1 55.0 41.2 13.9 31.5 37.9 32.9 27.9 22.9 23.6 9.7 16.6 54.0 38.6 11.9 27.7 26.5 27.6 12.4 12.7 27.5 13.5 22.0 26.9 16.3 19.6 40.6 24.9 28.9 11.6 34.3 40.9 18.5 28.5 23.6 37.5 10.9 50.2 22.8 20.8 17.1 22.2 22.3 20.6 11.4 24.1 41.3 22.2 28.9 22.8 9.3 19.5 29.4 21.8 15.5 49.4 27.0 13.9 22.1 26.0 19.0 15.4 12.4 26.0 20.3 26.0 11.0 4.8 21.5 12.9 4.5 11.8 16.1 7.2 10.8 7.5 21.3 6.8 8.1 6.7 16.4 6.5 16.2 9.2 9.1 43.1 52.1 46.3 66.6 39.5 34.1 40.5 46.7 44.7 37.0 65.5 42.1 48.2 25.8 23.9 91.0 71.2 40.8 34.8 51.2 57.6 379.0 29.9 13.3 33.6 44.3 61.8 38.1 0.0 39.8 26.5 52.3 36.5 35.9 41.0 35.3 104.9 55.5 59.5 43.4 29.2 71.9 38.1 33.7 57.7 42.6 228.9 44.9 31.6 114.5 36.3 557.2 97.0 52.0 40.7 36.8 32.0 30.6 55.8 35.2 27.7 ADI1 "APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL" ENSG00000182551 "Acireductone dioxygenase 1" Q9BV57 2 3497361-3519736 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 127.7" "Cell type enhanced" "Detected in all" 7 "Distal tubular cells: 752.7;Hepatocytes: 1079.9;Proximal tubular cells: 1041.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035403, HPA035404" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA035403: AB_10603576, HPA035404: AB_2674611" "unprognostic (2.19e-2)" "unprognostic (1.68e-2)" "unprognostic (2.60e-2)" "unprognostic (1.75e-1)" "unprognostic (3.65e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-3)" "unprognostic (4.23e-3)" "unprognostic (2.36e-3)" "unprognostic (4.00e-3)" "unprognostic (2.97e-2)" "unprognostic (1.50e-1)" "unprognostic (1.90e-2)" "unprognostic (1.56e-1)" "unprognostic (9.94e-2)" "unprognostic (6.76e-2)" "unprognostic (8.74e-2)" 13.5 19.1 10.8 9.0 11.5 6.4 15.1 5.2 9.2 12.5 60.6 9.3 29.9 27.3 11.7 17.8 16.3 11.4 35.5 49.5 9.0 7.9 42.6 127.7 10.8 12.4 11.3 9.4 12.8 14.7 9.2 8.4 18.7 9.6 24.5 11.8 10.7 22.7 27.0 43.1 7.9 38.9 17.3 11.7 16.6 18.3 8.0 7.9 4.9 12.9 18.9 10.4 14.7 17.9 14.2 37.8 64.7 26.5 10.1 17.7 32.2 12.0 14.7 13.3 10.6 46.7 22.8 24.9 25.2 32.6 27.4 19.9 20.9 13.8 5.7 39.9 26.7 4.6 11.0 15.7 11.8 14.1 10.2 35.1 17.6 9.5 33.8 39.1 18.2 39.5 25.2 15.7 12.8 16.0 9.7 17.2 8.4 13.1 10.0 21.5 27.1 6.1 32.1 11.6 27.4 23.0 6.5 8.5 32.4 19.0 18.0 14.9 15.0 13.9 14.7 9.6 8.2 15.6 19.3 14.3 18.9 7.7 9.2 14.1 9.9 23.9 23.4 13.9 28.3 9.9 14.2 26.5 64.7 6.3 25.2 6.8 14.2 14.9 5.9 25.6 11.2 17.7 5.9 12.3 10.1 22.0 37.8 13.8 32.2 10.8 11.5 5.2 9.2 9.0 7.9 11.3 9.4 9.6 7.9 62.5 87.9 109.0 118.8 67.5 8.0 255.0 285.3 33.5 56.9 144.8 13.7 343.4 752.7 121.5 6.7 56.4 182.2 46.7 76.6 194.2 104.6 159.8 40.5 1079.9 211.6 7.9 54.8 164.5 143.1 16.8 126.8 60.1 194.0 117.2 123.2 123.6 76.7 181.4 197.7 1041.1 13.1 161.7 119.7 4.6 8.9 67.1 319.0 55.1 135.6 117.6 ADPRHL2 "ARH3, FLJ20446" ENSG00000116863 "ADP-ribosylhydrolase like 2" Q9NX46 1 36088875-36093932 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" Hydrolase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026641, HPA027104, HPA027141" Approved Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA026641: , HPA027104: AB_10601330, HPA027141: AB_1844619" "unprognostic (3.22e-3)" "unprognostic (5.10e-2)" "unprognostic (2.95e-2)" "unprognostic (1.61e-2)" "unprognostic (5.98e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (2.10e-7)" "unprognostic (3.71e-2)" "unprognostic (2.63e-1)" "unprognostic (5.34e-2)" "unprognostic (3.17e-2)" "unprognostic (7.80e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (4.37e-2)" "unprognostic (9.31e-2)" "unprognostic (3.65e-2)" "unprognostic (4.74e-2)" 15.5 27.6 17.4 15.2 17.4 16.9 20.0 16.5 22.7 15.9 17.3 30.3 17.7 15.6 14.3 17.8 26.3 28.4 13.5 15.1 19.1 18.9 19.8 16.5 20.7 19.1 25.8 18.5 19.7 27.6 15.1 14.0 20.9 19.7 16.6 12.9 12.2 21.9 20.2 26.4 24.4 17.7 22.2 23.5 18.0 14.1 25.1 20.0 21.2 21.2 22.3 19.7 16.1 15.9 27.7 38.9 34.1 38.8 23.5 29.3 29.2 25.7 10.9 13.0 18.3 12.0 8.8 18.6 19.2 16.2 31.1 30.7 12.9 23.4 18.4 18.8 19.1 16.1 16.1 16.4 29.5 18.7 13.1 20.6 16.7 13.2 17.3 22.7 19.0 9.9 10.3 22.6 28.1 12.3 23.7 19.6 17.8 14.4 15.3 14.5 12.4 19.2 28.8 28.0 15.3 22.7 15.7 13.7 18.5 27.8 21.2 16.0 25.4 14.1 14.8 31.3 18.0 15.2 16.5 13.4 18.0 18.6 24.9 25.4 19.9 19.0 16.3 26.0 18.9 11.0 18.2 32.4 34.1 25.5 38.7 24.0 23.6 27.9 29.3 38.9 27.7 28.3 24.0 31.4 23.5 38.8 24.6 22.8 29.2 17.4 17.4 16.5 22.7 19.1 18.9 25.8 18.5 19.7 20.0 29.8 10.0 22.9 24.4 34.9 17.7 7.3 15.3 30.8 14.8 21.0 5.9 67.9 29.9 47.4 6.6 17.1 20.1 0.0 30.7 33.5 19.7 18.0 14.9 6.0 46.0 9.5 16.7 11.1 11.2 7.9 15.3 22.0 25.3 45.1 12.5 24.3 38.3 15.0 17.0 36.1 15.8 25.8 17.9 24.4 46.2 35.8 59.0 19.2 19.8 22.7 AEBP2 MGC17922 ENSG00000139154 "AE binding protein 2" Q6ZN18 12 19404045-19720801 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020893, HPA022282" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA020893: AB_2670528, HPA022282: AB_2670931" "unprognostic (3.28e-1)" "unprognostic (1.77e-1)" "unprognostic (2.29e-1)" "unprognostic (3.16e-2)" "unprognostic (2.74e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (3.24e-4)" "unprognostic (9.15e-2)" "unprognostic (4.56e-2)" "unprognostic (5.19e-3)" "unprognostic (1.87e-1)" "unprognostic (3.45e-2)" "unprognostic (1.68e-1)" "unprognostic (7.92e-2)" "unprognostic (1.71e-1)" "unprognostic (3.02e-1)" "unprognostic (1.47e-1)" 20.9 27.6 26.8 23.6 24.0 13.8 19.1 31.9 32.4 28.2 19.6 13.3 14.6 11.8 25.7 16.2 27.0 20.4 20.2 16.9 21.4 13.5 21.1 14.8 16.3 19.0 14.1 25.0 26.5 14.2 30.5 19.0 40.2 15.6 25.1 15.9 18.2 21.8 24.5 15.8 28.7 15.8 25.2 16.6 16.4 15.3 15.8 19.2 19.6 23.7 11.5 22.5 28.9 28.7 5.2 4.0 6.0 4.4 9.6 9.9 1.9 9.3 12.3 12.7 6.6 9.7 12.3 33.8 8.8 10.8 13.6 14.5 14.1 17.0 15.4 7.3 11.9 8.9 11.7 27.7 10.6 21.5 43.5 10.5 13.9 18.1 9.4 11.9 17.3 9.6 10.8 11.6 11.2 16.7 16.3 11.0 10.9 7.7 0.7 12.8 10.9 19.0 25.3 26.6 7.9 5.8 15.2 27.2 10.5 10.0 19.9 3.3 7.6 18.5 7.3 9.2 30.5 10.2 11.1 12.0 12.8 9.8 3.9 13.2 4.2 7.7 33.0 9.6 7.9 9.4 6.0 4.4 4.0 7.3 4.3 7.3 3.7 7.3 6.3 3.1 5.2 6.4 9.9 5.0 9.6 3.3 4.0 7.0 1.9 26.8 24.0 31.9 32.4 21.4 13.5 14.1 25.0 15.6 19.2 23.8 11.0 14.3 21.7 66.7 28.8 19.8 10.2 25.4 28.4 12.2 41.2 51.8 14.9 10.5 1.1 20.4 7.9 0.0 10.4 21.2 32.2 20.9 26.6 11.4 13.3 49.3 21.8 13.5 19.0 1.4 22.7 10.5 27.0 15.4 10.2 17.4 9.7 8.6 27.3 14.6 15.6 19.4 61.4 11.7 23.0 66.5 69.5 17.9 10.8 23.7 AHDC1 "DJ159A19.3, RP1-159A19.1" ENSG00000126705 "AT-hook DNA binding motif containing 1" Q5TGY3 1 27534035-27604431 "Disease related genes, Predicted intracellular proteins" DNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028648, HPA028685, HPA028691" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028648: AB_10599276, HPA028685: , HPA028691: AB_10601781" "unprognostic (1.96e-1)" "unprognostic (1.73e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (4.43e-1)" "prognostic favorable (2.68e-4)" "unprognostic (9.20e-2)" "unprognostic (3.05e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (5.21e-3)" "unprognostic (3.96e-1)" "unprognostic (1.76e-1)" "unprognostic (1.46e-1)" "unprognostic (2.30e-1)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" 10.2 17.6 16.9 6.7 12.9 4.6 7.7 40.3 21.7 15.3 8.7 5.8 6.7 5.2 16.8 6.6 20.4 13.5 7.5 9.9 15.2 7.4 7.2 5.6 6.6 5.7 8.2 12.7 19.0 7.5 4.3 16.0 8.4 13.7 8.0 3.0 8.8 15.4 13.1 41.5 21.3 5.6 11.0 14.6 18.2 9.3 8.9 12.9 9.1 12.8 10.9 10.6 9.8 14.0 0.6 1.6 0.9 0.7 2.0 1.4 0.7 7.6 7.0 9.9 5.3 3.2 5.3 10.1 7.2 5.2 5.0 4.2 2.7 7.2 1.1 5.3 4.8 3.0 7.7 1.0 9.4 1.4 2.8 3.8 6.0 6.3 3.6 3.0 1.6 3.1 5.0 3.9 3.5 2.2 5.1 2.6 3.6 7.2 0.9 8.3 3.7 5.1 8.6 7.3 1.9 8.7 22.9 11.9 0.6 3.3 1.0 17.1 6.5 5.0 8.3 2.0 3.5 4.1 1.3 4.8 8.7 7.2 6.4 2.2 2.5 1.7 1.2 7.4 4.8 4.9 0.9 0.4 0.5 1.2 0.6 0.7 0.5 1.0 1.2 0.4 0.6 1.4 1.0 0.7 2.0 0.7 1.6 1.1 0.7 16.9 12.9 40.3 21.7 15.2 7.4 8.2 12.7 13.7 12.9 6.0 6.9 8.2 7.7 44.0 32.7 14.2 2.5 5.3 9.1 17.4 0.0 9.1 3.3 9.3 0.6 11.9 5.6 0.0 11.8 4.0 19.6 9.7 0.0 9.7 11.2 33.4 9.4 14.7 2.1 1.9 48.1 4.1 15.1 2.8 6.1 11.7 12.9 5.8 59.8 4.4 1.8 38.8 15.6 2.6 4.3 49.1 4.7 4.5 6.3 11.3 AK9 "AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954" ENSG00000155085 "Adenylate kinase 9" Q5TCS8 6 109492856-109691217 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 165.9;Spermatocytes: 116.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711" Enhanced Enhanced "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265" "unprognostic (9.68e-3)" "unprognostic (2.15e-1)" "unprognostic (1.66e-2)" "unprognostic (2.36e-2)" "unprognostic (3.42e-1)" "unprognostic (7.28e-2)" "unprognostic (1.41e-3)" "unprognostic (6.76e-3)" "unprognostic (1.89e-1)" "unprognostic (3.50e-2)" "unprognostic (1.67e-4)" "unprognostic (2.58e-1)" "unprognostic (2.98e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (8.39e-2)" "unprognostic (5.56e-2)" 4.6 4.7 7.7 5.6 8.4 4.7 8.3 13.5 8.7 5.0 6.5 8.5 4.1 5.0 6.3 11.1 6.2 11.3 5.2 6.9 9.1 10.3 7.6 4.5 6.7 5.5 9.4 4.9 6.7 4.6 15.4 33.3 4.4 11.5 5.9 6.7 3.7 7.0 6.3 6.1 5.5 6.2 5.7 11.7 6.5 6.1 22.0 7.7 20.5 11.4 4.1 5.0 5.9 4.4 11.2 2.9 15.1 4.1 4.9 6.4 1.6 2.5 1.8 7.6 13.5 7.1 4.5 5.7 4.0 5.0 4.2 5.7 2.9 5.3 5.5 2.1 3.7 9.2 4.5 2.2 4.3 8.9 11.7 4.7 4.2 4.4 2.9 5.8 5.3 2.6 3.6 8.4 7.7 10.1 10.3 5.5 8.4 3.9 4.6 3.1 5.2 4.6 3.5 1.7 5.8 2.9 6.1 4.2 5.1 6.1 5.0 9.2 7.9 4.8 4.6 6.6 4.5 6.0 6.4 5.8 4.0 2.7 5.8 2.6 2.4 2.1 3.2 8.1 6.7 2.2 15.1 2.8 6.5 5.1 1.5 4.4 10.5 5.1 6.1 2.0 11.2 6.4 5.5 5.4 4.9 4.1 2.9 3.6 1.6 7.7 8.4 13.5 8.7 9.1 10.3 9.4 4.9 11.5 7.7 26.8 18.8 6.6 7.7 2.4 14.6 16.1 2.5 165.9 18.2 8.7 13.7 3.3 0.0 7.0 55.8 11.3 10.5 0.0 3.9 1.2 3.5 4.8 20.9 1.8 3.0 19.1 19.0 5.5 4.6 32.1 6.9 5.3 5.0 1.8 14.3 15.2 6.1 7.8 6.0 5.6 48.9 25.8 5.2 116.9 28.5 2.3 4.7 12.8 9.9 7.5 ALKBH2 "ABH2, MGC90512" ENSG00000189046 "AlkB homolog 2, alpha-ketoglutarate dependent dioxygenase" Q6NS38 12 109088188-109093631 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011198, HPA045392, HPA051976" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB011198: AB_261971, HPA045392: AB_2679309, HPA051976: AB_2681680" "prognostic favorable (6.67e-5)" "unprognostic (3.66e-3)" "unprognostic (1.08e-1)" "unprognostic (4.64e-2)" "unprognostic (4.55e-2)" "unprognostic (4.71e-2)" "unprognostic (1.69e-1)" "unprognostic (9.60e-2)" "unprognostic (3.63e-1)" "unprognostic (1.85e-1)" "unprognostic (6.39e-2)" "unprognostic (6.43e-3)" "prognostic unfavorable (1.41e-5)" "unprognostic (1.01e-2)" "unprognostic (7.88e-2)" "unprognostic (6.24e-2)" "prognostic favorable (8.67e-4)" 16.1 12.3 13.6 16.9 13.4 8.2 22.3 12.7 20.5 12.9 11.7 15.2 14.6 9.0 18.0 14.2 14.1 18.3 12.2 12.3 13.5 12.3 12.0 25.6 9.8 17.0 14.3 8.9 23.1 18.5 7.1 7.8 8.1 15.7 15.0 10.7 10.8 18.9 18.5 20.0 25.0 10.7 15.9 15.4 12.3 12.6 14.3 13.5 11.3 13.9 19.7 16.5 15.5 13.8 16.9 13.1 1.1 6.7 9.0 18.2 6.9 13.0 22.4 12.8 28.6 9.0 12.3 20.4 8.7 5.8 9.2 10.3 23.5 9.4 20.1 8.7 5.0 4.3 9.5 21.5 8.7 5.4 17.9 19.2 10.0 12.7 21.4 12.0 13.8 9.4 12.6 19.0 8.7 22.4 11.4 3.5 19.4 14.8 12.0 6.1 23.0 12.7 27.8 17.7 13.8 22.8 11.3 12.5 21.6 12.2 18.2 13.2 22.8 9.2 30.0 18.2 5.0 18.4 8.5 3.6 10.3 11.2 9.7 12.8 16.9 19.6 43.8 8.8 12.0 16.4 1.1 5.1 0.7 8.0 6.7 14.1 16.2 12.1 11.2 5.1 16.9 18.2 10.7 0.9 9.0 4.3 13.1 9.0 6.9 13.6 13.4 12.7 20.5 13.5 12.3 14.3 8.9 15.7 13.5 8.9 4.6 11.9 40.0 45.2 4.3 5.9 10.2 13.4 18.2 8.7 2.0 14.2 13.3 16.1 10.1 14.7 2.6 0.0 20.7 22.0 18.8 11.8 5.8 19.2 9.1 4.8 8.1 4.9 7.1 4.9 24.7 7.4 25.3 3.6 10.2 10.0 18.9 2.9 16.3 14.6 6.4 0.0 27.8 8.8 28.1 52.4 4.2 11.5 14.5 23.5 ALKBH3 DEPC-1 ENSG00000166199 "AlkB homolog 3, alpha-ketoglutaratedependent dioxygenase" Q96Q83 11 43880811-43920266 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 78.8;Late spermatids: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA009674, HPA046489" Approved Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA009674: AB_1850460, HPA046489: AB_2679671" "unprognostic (3.53e-1)" "unprognostic (2.41e-1)" "unprognostic (7.43e-3)" "unprognostic (4.70e-2)" "unprognostic (6.94e-3)" "unprognostic (1.89e-1)" "unprognostic (7.71e-2)" "unprognostic (5.42e-2)" "unprognostic (8.56e-2)" "unprognostic (4.62e-1)" "unprognostic (5.87e-2)" "unprognostic (7.02e-2)" "unprognostic (2.09e-2)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (2.76e-1)" "unprognostic (1.35e-2)" 17.6 14.2 14.3 13.2 16.7 8.6 26.5 21.2 22.7 19.1 15.7 19.5 12.8 13.2 22.6 31.2 16.2 20.0 16.4 12.5 14.3 13.4 15.6 25.8 15.1 17.3 15.0 14.4 21.8 23.5 22.1 16.6 9.1 15.6 19.1 16.6 19.5 25.5 19.1 29.1 20.2 15.0 18.3 14.8 17.8 17.0 17.3 12.1 14.5 16.4 21.4 22.2 15.2 17.4 14.9 18.5 21.2 21.0 17.1 21.3 13.8 7.4 13.0 5.2 0.0 10.1 13.0 0.0 9.1 20.2 18.3 18.0 6.1 5.8 1.1 5.8 13.7 9.9 10.2 7.1 15.7 17.0 0.0 24.9 10.9 8.8 12.8 25.1 20.0 14.6 13.7 27.3 8.1 39.4 7.6 13.1 21.5 15.4 11.9 9.0 8.9 17.9 10.3 9.5 7.9 19.1 5.2 11.2 14.0 11.0 11.7 9.7 7.8 7.0 11.1 16.7 4.8 16.1 12.3 9.2 10.4 5.8 17.0 13.0 10.8 11.3 12.1 15.5 8.5 8.5 21.2 12.9 7.1 17.0 14.1 16.2 14.4 17.4 15.1 18.5 14.9 21.3 18.9 2.3 17.1 21.0 16.3 16.2 13.8 14.3 16.7 21.2 22.7 14.3 13.4 15.0 14.4 15.6 12.1 14.9 10.4 11.1 9.1 9.2 10.0 5.6 12.7 16.0 10.3 15.7 3.9 3.1 26.6 17.0 78.8 13.7 9.2 0.0 28.4 4.0 9.7 6.6 7.0 11.3 16.7 9.5 9.1 14.7 10.7 69.5 15.0 13.1 16.9 15.4 12.7 17.2 23.0 7.0 9.9 14.1 10.5 6.5 19.6 18.7 9.5 6.1 1.8 14.9 13.1 5.0 ANAPC11 "APC11, Apc11p, HSPC214, MGC882" ENSG00000141552 "Anaphase promoting complex subunit 11" Q9NYG5 17 81890790-81900991 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 944.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA021989, HPA027838" Approved Enhanced Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA021989: AB_1844915, HPA027838: AB_10600978" "unprognostic (9.00e-3)" "unprognostic (1.24e-2)" "unprognostic (3.76e-1)" "unprognostic (4.93e-2)" "unprognostic (8.76e-2)" "unprognostic (1.67e-1)" "unprognostic (5.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.65e-1)" "unprognostic (2.17e-3)" "unprognostic (2.22e-2)" "unprognostic (1.08e-1)" "unprognostic (4.76e-2)" "unprognostic (8.07e-2)" "unprognostic (9.08e-2)" "unprognostic (2.51e-2)" "unprognostic (3.16e-1)" 29.3 26.1 44.9 21.9 34.1 39.6 27.2 19.5 31.8 19.4 26.3 14.8 30.3 26.1 19.2 27.5 31.7 24.6 26.0 63.6 32.9 26.7 25.9 38.4 18.5 26.7 35.2 31.8 17.2 40.3 12.6 20.6 25.7 29.8 25.4 12.2 18.1 48.8 24.0 94.2 21.6 24.8 25.4 27.6 18.9 25.9 42.2 27.3 18.5 32.5 45.7 17.0 23.5 25.5 54.9 107.5 74.0 80.1 43.1 52.8 80.4 41.4 97.5 23.2 34.3 18.5 21.1 26.6 20.1 15.8 18.3 20.9 40.0 36.6 13.1 22.5 17.7 20.2 24.2 9.3 25.7 6.6 19.2 70.6 19.6 43.3 60.3 20.8 14.6 17.4 23.4 23.5 18.7 15.3 11.9 29.3 17.9 26.7 38.2 18.9 74.7 35.5 24.2 21.9 40.3 72.8 14.8 22.1 26.3 16.7 37.3 29.2 47.4 21.7 34.3 39.4 16.7 41.9 35.6 17.4 35.6 28.5 38.1 37.7 18.7 7.8 16.5 37.4 22.3 28.4 70.1 80.1 74.0 45.3 63.7 42.8 54.9 46.4 49.5 64.6 51.6 45.2 43.5 40.5 43.1 59.3 107.5 52.8 80.4 44.9 34.1 19.5 31.8 32.9 26.7 35.2 31.8 29.8 27.3 119.1 121.6 108.7 168.5 132.0 55.6 277.3 203.8 155.2 153.6 188.5 19.6 436.4 442.7 236.1 329.1 152.3 247.2 186.9 293.4 435.1 217.2 291.4 105.2 427.2 386.6 31.8 182.7 139.3 155.4 944.1 168.2 179.2 248.0 315.6 205.6 112.3 274.1 235.0 154.9 400.2 53.7 103.5 220.7 379.1 245.5 163.2 425.4 121.6 237.2 254.5 ANAPC2 "APC2, KIAA1406" ENSG00000176248 "Anaphase promoting complex subunit 2" Q9UJX6 9 137174784-137188549 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018692, HPA066539" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB018692: AB_2258285, HPA066539: AB_2685688" "unprognostic (5.20e-2)" "unprognostic (8.86e-3)" "unprognostic (1.43e-2)" "prognostic favorable (8.91e-5)" "unprognostic (2.29e-1)" "unprognostic (2.38e-2)" "unprognostic (4.46e-1)" "unprognostic (4.84e-2)" "unprognostic (1.07e-1)" "unprognostic (3.36e-1)" "prognostic favorable (1.07e-7)" "unprognostic (7.41e-2)" "prognostic favorable (3.67e-4)" "prognostic favorable (2.87e-4)" "unprognostic (1.35e-1)" "unprognostic (8.46e-2)" "unprognostic (9.88e-2)" 14.6 15.5 13.3 15.3 17.9 19.0 14.1 21.8 26.9 12.2 11.8 28.5 17.7 17.1 15.1 12.3 13.6 13.8 16.4 14.1 12.5 10.2 12.3 19.1 13.1 19.1 22.4 14.5 15.4 23.7 10.6 12.6 11.0 16.2 15.2 5.0 15.5 25.7 14.5 20.0 25.0 16.2 9.4 13.3 19.3 16.2 31.6 13.4 14.0 14.4 11.7 15.2 13.2 11.7 1.4 2.3 0.6 3.2 1.1 2.4 3.3 10.2 22.8 5.5 9.1 6.7 4.0 17.4 9.2 5.9 8.8 6.8 13.7 10.7 11.1 10.9 6.1 8.2 21.2 6.6 7.1 1.3 14.1 11.3 6.6 26.6 12.4 7.9 10.1 11.6 8.0 5.7 5.9 3.2 4.4 10.7 10.3 9.7 13.7 4.1 28.9 12.1 14.3 11.2 13.7 17.4 14.5 13.6 20.6 6.8 9.1 7.3 11.0 14.0 19.1 5.8 2.8 20.3 13.9 11.2 13.1 10.4 15.5 8.3 6.7 9.8 12.0 10.5 7.0 9.4 0.3 2.3 0.4 2.4 2.4 1.4 1.4 1.2 1.9 1.9 1.4 1.4 1.5 0.6 1.1 3.2 2.3 1.2 3.3 13.3 17.9 21.8 26.9 12.5 10.2 22.4 14.5 16.2 13.4 0.0 0.3 6.5 7.4 8.2 4.7 3.1 7.6 0.0 1.2 10.4 3.9 22.6 11.6 9.4 31.6 5.7 18.6 0.0 9.4 9.5 8.5 6.4 11.5 10.4 13.6 1.6 9.8 12.3 9.5 40.9 10.3 6.6 13.5 16.2 14.6 3.5 6.9 7.0 8.9 13.4 4.3 0.0 9.9 30.0 24.3 8.3 20.5 10.2 11.3 6.3 ANKRA2 ENSG00000164331 "Ankyrin repeat family A member 2" Q9H9E1 5 73552335-73565686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003968, HPA065263" Approved Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA003968: , HPA065263: AB_2685449" "unprognostic (1.75e-1)" "unprognostic (5.78e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-1)" "unprognostic (3.31e-1)" "unprognostic (3.89e-2)" "unprognostic (5.68e-2)" "unprognostic (6.19e-2)" "unprognostic (3.47e-2)" "unprognostic (1.09e-1)" "unprognostic (1.06e-2)" "unprognostic (1.79e-1)" "unprognostic (9.80e-3)" "unprognostic (3.36e-1)" "unprognostic (3.31e-1)" "unprognostic (6.65e-2)" "unprognostic (1.13e-3)" 13.0 19.4 11.9 9.2 17.1 18.7 20.9 22.8 18.3 15.7 13.5 16.6 13.1 15.0 20.0 21.0 13.3 18.5 15.0 12.2 18.1 15.8 9.6 15.9 20.7 13.9 20.6 12.3 23.3 19.7 11.4 30.2 15.4 23.1 19.8 16.4 17.5 19.0 14.3 14.5 13.4 15.3 17.8 30.7 13.0 16.2 10.3 15.8 18.1 22.2 4.5 14.7 14.9 13.3 10.7 5.9 16.9 7.4 7.0 15.5 7.3 5.1 3.9 5.8 6.1 10.6 16.2 17.7 7.1 10.6 6.2 9.3 1.2 8.0 4.8 5.7 7.0 7.0 3.7 2.7 12.6 8.9 10.1 4.8 4.2 3.0 5.5 8.3 2.5 8.3 16.7 17.1 7.4 7.7 11.6 6.9 6.4 4.1 8.1 7.1 3.1 4.3 6.5 3.1 1.9 2.9 2.6 6.2 6.6 4.8 6.4 7.8 6.1 5.4 4.3 8.4 9.3 6.5 4.2 8.6 2.5 3.0 4.0 5.1 16.0 11.5 4.1 6.2 4.1 7.2 16.9 5.7 11.3 8.7 4.6 10.5 10.7 10.2 12.1 4.9 8.4 15.5 14.2 9.0 7.0 7.4 5.9 11.7 7.3 11.9 17.1 22.8 18.3 18.1 15.8 20.6 12.3 23.1 15.8 3.0 8.6 26.7 25.9 14.1 25.6 7.7 35.7 16.0 12.5 17.4 9.8 22.6 23.2 10.6 0.9 12.1 16.1 23.3 14.6 18.8 13.1 25.9 18.5 19.5 9.2 22.3 23.2 16.0 16.2 1.7 30.2 11.1 11.8 12.6 19.4 15.6 14.7 18.4 27.3 14.0 21.5 25.8 14.4 23.0 15.1 10.8 40.8 18.1 16.2 31.3 ANKRD11 "LZ16, T13" ENSG00000167522 "Ankyrin repeat domain 11" Q6UB99 16 89267619-89490561 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019288, HPA041593, HPA049470" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB019288: , HPA041593: AB_2677567, HPA049470: AB_2680780" "unprognostic (7.31e-2)" "unprognostic (6.35e-2)" "unprognostic (1.85e-1)" "unprognostic (3.53e-3)" "unprognostic (1.82e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (6.39e-4)" "unprognostic (1.81e-1)" "unprognostic (1.83e-2)" "unprognostic (1.78e-1)" "unprognostic (4.81e-2)" "prognostic unfavorable (7.67e-4)" "unprognostic (1.56e-3)" "unprognostic (1.79e-1)" "unprognostic (7.93e-2)" "unprognostic (5.78e-3)" "unprognostic (2.16e-1)" 24.2 23.3 22.8 25.6 23.1 48.7 41.4 32.3 31.7 22.0 24.1 22.9 22.0 22.4 26.9 18.9 25.0 23.4 23.4 22.2 24.6 20.0 17.8 15.1 32.3 33.8 20.8 21.0 32.6 27.9 33.7 31.5 18.8 19.3 20.5 14.9 23.3 21.4 25.8 27.0 35.8 24.1 26.7 20.3 26.1 22.6 21.3 22.1 26.1 21.6 19.3 19.6 23.4 34.4 4.2 7.2 11.7 5.9 9.8 4.5 1.8 21.9 27.5 27.7 21.2 17.1 17.7 26.8 25.1 16.9 15.2 10.8 32.0 23.6 20.4 17.4 18.2 17.1 22.3 18.9 23.1 17.2 10.1 22.6 16.1 19.1 25.6 25.9 11.8 18.3 19.6 23.5 19.9 25.8 22.1 18.2 34.3 34.5 16.3 19.0 20.8 19.5 29.8 24.3 11.4 25.4 40.4 32.0 17.0 15.8 18.5 16.3 20.0 36.2 7.6 26.0 14.7 17.8 18.6 33.6 32.1 30.0 17.7 27.5 29.8 10.4 25.4 25.8 19.6 17.3 7.5 3.9 3.7 3.8 4.0 4.3 3.1 4.3 4.5 2.1 4.2 3.8 3.5 11.7 9.8 5.9 7.2 4.2 1.8 22.8 23.1 32.3 31.7 24.6 20.0 20.8 21.0 19.3 22.1 122.1 96.0 57.0 118.7 103.5 174.0 224.2 89.2 33.5 56.9 68.0 149.2 36.4 26.6 65.7 85.7 83.9 67.5 46.7 62.6 29.3 87.3 94.1 53.2 57.8 42.6 147.8 102.5 75.5 58.0 27.9 96.1 74.6 45.5 95.6 51.2 90.0 94.9 50.7 99.7 28.0 102.5 38.8 89.3 78.8 102.6 106.9 32.4 71.0 51.7 144.5 ANKRD61 ENSG00000157999 "Ankyrin repeat domain 61" A6NGH8 7 6031376-6036386 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "bone marrow: 8.7;testis: 9.1" "Group enriched" "Detected in some" 19 "Early spermatids: 44.1;Late spermatids: 19.5" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 12.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029511, HPA050732" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029511: AB_10602430, HPA050732: " "unprognostic (1.40e-1)" "unprognostic (1.03e-3)" "unprognostic (9.32e-2)" "unprognostic (5.67e-2)" "unprognostic (1.73e-1)" "unprognostic (2.56e-2)" "unprognostic (6.76e-2)" "unprognostic (2.65e-1)" "unprognostic (8.44e-2)" "unprognostic (8.46e-2)" "unprognostic (1.98e-1)" "unprognostic (6.68e-2)" "unprognostic (2.73e-2)" "unprognostic (5.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.55e-2)" "unprognostic (2.63e-1)" 0.5 0.5 0.0 0.7 0.2 8.7 0.7 0.5 0.9 0.4 0.3 0.6 0.6 0.0 0.4 0.5 0.2 0.6 0.1 0.1 0.3 0.5 0.5 1.1 0.0 0.8 1.0 0.1 0.5 0.4 0.4 0.0 0.9 0.0 0.6 2.1 0.8 0.0 0.2 0.9 0.9 9.1 0.9 0.0 0.5 0.5 0.6 1.5 0.9 1.1 0.0 0.8 0.3 2.2 6.0 1.8 2.8 0.3 0.3 2.6 1.4 0.4 0.6 0.6 3.0 5.6 1.1 0.6 0.2 2.6 2.2 1.0 0.0 0.7 0.3 0.8 1.5 12.7 0.4 0.2 1.7 2.6 0.4 1.2 0.5 1.1 1.3 0.5 1.7 2.0 1.8 0.7 3.8 0.3 1.8 0.9 0.4 0.7 1.6 0.5 0.3 0.5 2.9 1.4 2.5 1.4 1.6 0.2 2.9 3.0 1.1 1.2 2.4 4.9 2.9 1.8 1.6 1.8 0.9 0.7 1.4 1.5 0.9 1.1 0.0 0.1 1.1 0.0 0.0 0.0 0.8 1.5 0.6 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 ANKRD7 TSA806 ENSG00000106013 "Ankyrin repeat domain 7" Q92527 7 118214669-118496171 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "testis: 184.1" "Group enriched" "Detected in some" 4 "Early spermatids: 2368.8;Spermatocytes: 2786.2" "Cancer enhanced" "Detected in some" "testis cancer: 1.9" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 5.2;JURKAT: 5.8;SCLC-21H: 9.8;U-266/70: 12.7;WM-115: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043489, HPA052941" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043489: AB_10959304, HPA052941: " "unprognostic (1.29e-1)" "unprognostic (7.22e-4)" "unprognostic (3.13e-3)" "unprognostic (6.16e-2)" "unprognostic (8.49e-2)" "unprognostic (1.69e-1)" "unprognostic (5.51e-1)" "unprognostic (9.46e-2)" "unprognostic (1.44e-1)" "unprognostic (2.63e-3)" "unprognostic (1.45e-2)" "unprognostic (1.55e-2)" "unprognostic (3.35e-2)" "unprognostic (3.57e-4)" "unprognostic (3.32e-2)" 0.1 0.1 0.5 0.0 0.8 0.0 0.1 0.1 1.0 0.1 0.1 0.0 0.0 0.1 0.1 1.3 0.1 0.1 0.0 0.1 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.9 0.0 1.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 184.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 3.1 0.4 1.0 0.0 0.0 0.8 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.2 1.6 0.0 3.1 0.0 0.1 0.3 0.1 1.4 1.0 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.4 0.7 0.0 0.4 0.0 5.8 0.0 2.2 1.4 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 2.4 0.0 0.0 1.9 0.0 0.0 1.2 0.4 0.0 1.1 0.3 0.0 12.7 0.6 0.5 1.8 0.0 4.0 0.0 0.0 1.0 0.4 0.0 0.3 3.1 0.2 0.6 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.4 0.0 0.1 0.5 0.8 0.1 1.0 0.4 0.1 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.4 2.5 0.0 0.0 0.0 0.0 0.1 5.0 0.1 2368.8 0.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 3.2 0.0 0.0 0.0 635.0 36.5 0.0 1.7 0.0 0.0 1.2 0.1 0.0 27.6 1.4 0.0 25.8 0.1 2786.2 17.7 0.1 0.0 0.0 0.0 0.0 ANLN "ANILLIN, scra, Scraps" ENSG00000011426 "Anillin actin binding protein" Q9NQW6 7 36389806-36453791 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.4;lymphoid tissue: 32.7" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 106.8;Late spermatids: 41.2;Spermatocytes: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HBF TERT88: 100.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005680, CAB033902, HPA050556, CAB062547, CAB068175" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes Nucleoplasm Midbody "CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175" "unprognostic (4.23e-2)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.67e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (5.97e-7)" "prognostic unfavorable (6.99e-5)" "unprognostic (2.69e-2)" "unprognostic (3.66e-2)" "prognostic unfavorable (2.00e-6)" "unprognostic (3.13e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.29e-2)" "unprognostic (1.34e-1)" "unprognostic (2.94e-2)" "unprognostic (4.04e-3)" 1.7 0.6 13.9 7.2 10.5 20.9 1.3 1.8 36.7 1.9 3.9 1.6 0.0 2.9 1.3 2.4 12.8 0.6 1.4 0.6 24.0 12.1 0.7 0.8 3.3 4.2 30.5 2.5 0.9 0.4 0.3 0.3 12.9 9.7 0.7 5.5 0.0 0.9 0.3 0.4 8.9 3.4 9.4 63.4 1.6 3.3 9.2 12.5 32.7 0.6 17.7 6.7 2.6 1.3 0.0 0.3 0.6 0.9 0.0 1.7 2.0 68.4 14.4 12.0 9.1 1.6 4.2 12.9 43.2 25.3 52.2 39.2 9.8 21.2 3.4 12.5 21.8 27.8 35.3 9.4 25.2 100.3 2.3 6.8 4.7 16.2 8.1 0.2 6.7 5.5 0.9 1.1 34.0 22.4 6.2 16.2 4.6 9.8 7.3 42.5 10.3 5.7 7.8 13.3 10.5 15.2 4.2 36.0 2.3 11.5 11.2 5.1 6.0 22.7 26.4 3.9 17.4 17.8 7.7 15.3 32.7 36.8 19.2 50.4 3.0 4.8 6.4 11.1 10.9 68.6 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.9 0.5 0.3 0.0 0.6 0.0 0.6 0.0 0.3 0.2 1.7 2.0 13.9 10.5 1.8 7.7 24.0 12.1 30.5 2.5 9.7 12.5 0.0 0.6 0.0 1.0 12.6 0.0 0.6 0.0 2.7 1.2 0.0 0.0 2.5 0.0 0.5 106.8 0.1 0.9 0.0 0.2 20.2 3.5 1.3 0.0 0.0 8.0 0.0 0.0 1.8 1.5 41.2 1.1 2.6 0.0 0.0 2.2 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.4 20.9 14.9 8.2 2.4 1.5 1.6 1.4 ANP32A "C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32" ENSG00000140350 "Acidic nuclear phosphoprotein 32 family member A" P39687 15 68778535-68820897 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005231, HPA063133, HPA067561" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 740000 "Nucleoplasm, Centrosome" Cytosol "CAB005231: AB_2289588, HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (1.41e-2)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (3.03e-1)" "unprognostic (6.96e-2)" "unprognostic (2.29e-2)" "unprognostic (1.04e-2)" "unprognostic (4.44e-2)" "unprognostic (4.00e-2)" "unprognostic (3.74e-2)" "unprognostic (1.20e-1)" "unprognostic (7.83e-2)" "unprognostic (4.16e-2)" "unprognostic (3.24e-2)" "unprognostic (2.38e-2)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" 25.8 20.4 32.7 32.0 40.1 46.0 28.2 50.7 33.7 24.5 30.7 40.5 16.0 27.0 26.8 21.7 28.8 30.0 23.4 47.8 32.3 23.6 30.0 29.6 27.2 55.0 33.9 30.0 26.7 25.6 24.2 18.3 38.6 26.6 30.4 35.4 27.2 23.6 27.8 41.7 18.9 28.9 30.5 42.7 40.1 29.8 9.4 36.7 75.0 29.0 18.5 52.4 35.7 27.6 12.7 19.8 27.7 19.9 18.1 12.3 9.6 26.4 32.5 42.8 36.9 15.0 13.2 28.4 14.0 18.7 27.4 23.2 26.8 49.9 85.9 26.2 15.7 16.2 38.9 98.9 28.6 33.0 38.7 33.7 65.0 27.5 33.5 9.3 51.1 35.2 10.5 20.2 15.0 30.0 18.0 39.8 41.7 47.2 33.6 23.5 18.5 51.3 42.0 37.9 26.2 16.5 72.0 39.7 51.0 24.1 41.9 56.8 35.2 21.3 24.0 39.3 44.7 31.9 67.1 17.8 28.5 45.3 19.6 37.3 20.4 56.6 99.5 18.9 86.1 26.0 8.1 17.6 27.7 11.9 19.9 10.0 12.7 9.8 12.3 19.8 12.7 12.1 10.6 18.1 18.1 16.8 17.6 11.2 9.6 32.7 40.1 50.7 33.7 32.3 23.6 33.9 30.0 26.6 36.7 101.3 93.6 54.3 58.8 57.6 85.2 68.1 48.4 129.8 100.1 66.3 33.4 225.4 91.2 95.6 3.6 76.3 57.2 70.0 83.9 137.0 53.5 48.8 89.1 75.9 163.6 62.0 75.3 58.3 145.4 4.0 32.2 112.8 74.2 132.6 83.9 86.2 70.3 56.1 28.0 115.7 65.9 25.8 68.0 7.7 13.8 30.6 194.4 102.2 82.6 46.3 ANP32B "APRIL, PHAPI2, SSP29" ENSG00000136938 "Acidic nuclear phosphoprotein 32 family member B" Q92688 9 97983361-98015943 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063133, HPA067561, HPA069657" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 290000 Nucleoplasm "Centrosome, Cytosol" "HPA063133: AB_2684947, HPA067561: AB_2685861, HPA069657: " "unprognostic (2.82e-1)" "unprognostic (2.05e-2)" "unprognostic (4.57e-2)" "unprognostic (6.74e-2)" "unprognostic (1.85e-1)" "unprognostic (5.52e-2)" "prognostic unfavorable (1.98e-7)" "unprognostic (6.76e-3)" "unprognostic (5.70e-2)" "unprognostic (7.16e-2)" "unprognostic (3.50e-1)" "unprognostic (6.39e-2)" "unprognostic (9.22e-3)" "unprognostic (5.20e-2)" "unprognostic (2.36e-1)" "unprognostic (3.67e-2)" "unprognostic (1.78e-2)" 43.0 24.6 37.9 46.5 55.5 105.7 37.7 15.6 30.1 43.2 38.9 81.0 24.6 32.7 46.3 38.4 40.4 28.4 39.2 27.0 41.8 32.0 26.0 35.9 35.0 70.4 55.7 21.7 51.1 46.0 29.3 20.7 37.5 41.8 38.9 42.3 26.2 32.5 29.7 29.4 38.6 34.9 45.3 88.3 38.6 36.7 19.0 47.6 85.9 37.0 31.9 81.8 64.5 58.6 34.8 32.6 36.8 44.6 22.7 51.3 25.1 71.5 38.7 43.2 36.0 24.3 43.0 39.4 37.2 33.0 40.0 33.7 48.5 35.2 87.8 22.3 24.9 30.5 47.4 58.1 42.0 45.9 56.9 32.8 76.0 33.2 52.3 31.3 130.1 44.3 32.5 30.7 32.1 66.3 32.6 34.7 78.8 146.1 62.2 30.8 95.5 98.2 115.7 16.8 70.3 38.5 58.7 67.3 41.7 26.1 30.0 34.9 30.5 43.6 42.7 38.1 22.2 24.1 48.7 42.0 26.1 42.3 32.8 39.0 56.5 63.8 53.0 24.2 52.3 48.6 23.1 27.2 36.8 22.7 30.9 31.3 34.8 42.7 31.9 32.6 29.6 51.3 38.7 11.3 22.7 44.6 31.8 50.8 25.1 37.9 55.5 15.6 30.1 41.8 32.0 55.7 21.7 41.8 47.6 80.4 91.7 174.3 178.4 160.5 57.6 74.9 101.9 53.5 93.3 71.5 23.6 273.1 82.9 105.6 102.1 109.0 128.4 327.1 148.0 437.2 99.8 129.7 116.6 84.4 250.6 112.8 144.0 112.3 244.5 70.6 135.4 174.1 121.4 164.1 222.6 53.5 126.7 126.7 136.5 75.6 33.5 148.8 133.5 138.6 318.8 134.8 278.6 173.4 278.8 183.9 ANP32D PP32R2 ENSG00000139223 "Acidic nuclear phosphoprotein 32 family member D" O95626 12 48472665-48473624 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.3;REH: 1.2" "HPA063133, HPA067561" Uncertain Enhanced Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (2.20e-1)" "unprognostic (3.75e-1)" "unprognostic (3.18e-1)" "unprognostic (3.23e-2)" "unprognostic (5.11e-2)" "unprognostic (1.72e-3)" "unprognostic (2.30e-2)" "unprognostic (3.62e-3)" "unprognostic (2.76e-2)" "unprognostic (3.48e-1)" 0.1 0.9 0.3 0.0 0.2 0.1 0.2 0.2 0.6 0.0 0.5 0.0 0.6 0.8 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.7 0.0 0.2 1.1 0.1 0.0 0.2 0.5 0.3 0.2 0.4 0.3 0.2 0.0 0.1 0.2 0.2 0.5 0.2 0.9 0.8 0.0 0.4 0.1 0.1 0.1 0.6 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.4 0.4 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ANP32E "LANP-L, LANPL, MGC5350" ENSG00000143401 "Acidic nuclear phosphoprotein 32 family member E" Q9BTT0 1 150218417-150236156 "Predicted intracellular proteins" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021114, HPA063133, HPA067561" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 18000 "Nucleoplasm, Centrosome" Cytosol "CAB021114: AB_10057407, HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (1.04e-1)" "unprognostic (2.40e-1)" "unprognostic (2.51e-1)" "unprognostic (8.95e-2)" "unprognostic (1.69e-2)" "unprognostic (1.47e-3)" "prognostic unfavorable (4.50e-5)" "unprognostic (1.64e-1)" "unprognostic (6.58e-2)" "unprognostic (3.91e-2)" "unprognostic (7.73e-3)" "unprognostic (2.47e-1)" "prognostic unfavorable (3.82e-8)" "unprognostic (1.76e-2)" "unprognostic (1.60e-1)" "unprognostic (1.77e-1)" "unprognostic (3.52e-1)" 11.5 18.3 31.2 21.0 30.9 38.4 10.6 50.3 20.6 14.3 11.3 18.3 13.5 12.9 16.5 21.0 12.8 12.8 11.9 19.8 22.9 25.9 18.6 16.8 13.3 38.4 26.5 19.5 19.1 6.9 20.1 14.7 12.3 21.2 14.2 10.9 20.1 9.2 20.9 25.5 12.5 14.5 25.2 32.7 20.3 9.9 6.0 17.8 52.2 18.1 13.6 34.7 20.6 12.1 24.5 8.2 20.7 10.5 14.6 27.0 15.7 34.3 22.2 46.4 23.0 3.6 5.4 17.7 18.5 10.5 17.9 17.2 16.4 24.4 62.6 16.5 10.6 10.6 12.0 26.1 11.5 25.7 71.6 15.8 43.3 27.6 23.6 3.4 87.0 22.0 4.4 1.8 16.7 15.4 8.8 13.2 30.5 41.4 37.1 16.3 35.6 35.5 22.7 46.8 11.2 10.2 37.8 25.8 32.9 12.7 13.8 15.2 26.2 38.6 6.2 10.8 21.5 16.8 44.5 13.6 9.2 25.9 9.4 36.9 47.9 48.1 61.3 10.4 62.8 16.7 20.7 10.5 16.3 18.0 7.3 27.0 24.5 24.2 19.7 8.2 17.0 17.4 21.6 7.2 14.6 8.8 5.7 25.7 15.7 31.2 30.9 50.3 20.6 22.9 25.9 26.5 19.5 21.2 17.8 11.9 78.4 61.4 38.4 86.4 117.9 90.4 22.9 60.2 30.7 69.8 31.4 37.5 72.9 27.5 1.1 45.4 12.3 140.2 23.2 113.7 65.8 16.5 60.2 48.9 46.0 60.4 13.8 39.9 41.9 1.4 28.1 57.2 64.1 62.3 11.5 131.8 20.8 17.5 31.5 44.8 110.8 25.8 85.5 9.3 21.8 86.1 34.0 89.3 28.0 19.3 ANXA1 "ANX1, LPC1" ENSG00000135046 "Annexin A1" P04083 9 73151757-73170393 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Phospholipase A2 inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 432.6;tongue: 235.4" "Cell type enhanced" "Detected in many" 10 "granulocytes: 2387.0;Syncytiotrophoblasts: 5914.0;Urothelial cells: 4139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011271, HPA011272, CAB013023, CAB035987, CAB058693" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA Yes 77000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884" "unprognostic (2.53e-2)" "unprognostic (1.31e-1)" "unprognostic (9.08e-2)" "prognostic favorable (5.71e-5)" "unprognostic (1.53e-2)" "unprognostic (4.28e-2)" "unprognostic (1.82e-2)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.54e-3)" "unprognostic (1.47e-1)" "unprognostic (9.82e-3)" "unprognostic (1.13e-1)" "unprognostic (8.55e-2)" "prognostic favorable (4.57e-5)" "prognostic unfavorable (6.19e-6)" 52.7 3.5 2.7 11.5 3.3 81.4 45.9 0.9 2.5 61.5 8.5 3.6 5.5 2.4 6.9 11.2 432.6 11.9 14.9 8.9 3.2 2.5 9.1 2.1 37.3 7.6 4.3 1.9 11.7 2.4 0.5 6.3 149.5 13.5 12.9 4.4 6.4 93.0 7.2 7.9 11.6 6.4 12.3 6.5 5.9 5.9 5.6 3.1 3.9 21.7 235.4 153.3 18.0 83.1 0.7 98.9 146.2 79.1 27.3 52.5 102.8 66.2 104.7 4.7 4.9 66.8 63.6 0.3 114.8 71.8 47.5 32.2 3.0 59.9 0.1 38.0 100.1 105.0 81.6 10.1 69.5 37.7 37.5 0.7 5.1 31.1 0.1 53.3 11.0 2.5 36.6 57.6 48.0 94.4 44.0 67.3 6.0 21.0 2.8 58.5 0.2 19.5 6.0 5.9 26.5 42.6 0.0 26.7 0.2 106.8 14.0 0.0 0.0 39.5 1.0 26.5 65.5 0.2 1.7 83.1 55.7 35.1 76.5 58.9 0.4 0.1 0.2 128.7 10.3 83.8 146.2 79.1 141.1 52.2 21.5 52.5 0.7 47.0 45.9 98.9 0.2 13.7 25.4 8.6 27.3 19.3 3.5 8.3 102.8 2.7 3.3 0.9 2.5 3.2 2.5 4.3 1.9 13.5 3.1 541.9 512.9 7.3 2232.0 752.1 0.0 11.9 17.8 1060.0 889.5 59.3 0.0 1215.0 0.0 156.6 6.3 398.1 0.8 0.0 20.0 1352.9 735.1 1709.3 2387.0 2.5 570.9 0.0 5.1 113.5 449.6 2.3 206.0 1058.5 291.8 475.3 1.8 0.2 431.7 0.0 8.9 3.1 0.0 64.7 275.6 0.7 2.9 522.6 5914.0 282.4 0.5 4139.3 AP5S1 "C20orf29, FLJ11168" ENSG00000125843 "Adaptor related protein complex 5 sigma 1 subunit" Q9NUS5 20 3820524-3828837 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034200, HPA043533, HPA048244" Uncertain Enhanced Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "CAB034200: AB_1564201, HPA043533: AB_2732507, HPA048244: AB_2680328" "unprognostic (1.07e-2)" "unprognostic (1.43e-1)" "unprognostic (8.52e-2)" "unprognostic (2.74e-2)" "unprognostic (1.34e-1)" "unprognostic (2.05e-2)" "unprognostic (5.49e-2)" "unprognostic (7.76e-2)" "unprognostic (1.33e-1)" "unprognostic (8.91e-2)" "unprognostic (5.15e-3)" "unprognostic (8.17e-2)" "prognostic favorable (5.53e-5)" "unprognostic (2.92e-1)" "unprognostic (1.62e-1)" "unprognostic (6.09e-3)" "unprognostic (5.08e-2)" 9.4 14.9 10.1 8.6 13.4 10.7 6.8 7.9 15.3 6.7 10.6 12.0 13.9 10.4 7.1 11.8 8.5 8.2 10.6 13.2 10.2 9.3 12.4 18.9 7.9 19.3 8.9 10.7 8.1 16.9 12.1 9.4 13.0 7.1 8.2 7.5 13.4 13.8 7.0 27.2 7.3 9.9 6.7 8.2 10.2 9.9 19.9 6.3 11.2 13.2 11.2 8.3 7.0 5.8 7.8 10.8 4.7 12.9 6.5 11.9 6.6 11.0 21.2 3.0 2.0 4.1 5.3 3.6 6.7 5.5 6.7 5.3 17.9 11.9 6.4 7.3 7.1 12.7 9.9 2.5 10.9 2.3 3.5 7.0 10.6 6.2 15.4 7.0 7.3 6.5 9.0 6.2 8.3 6.6 4.5 7.8 7.8 7.5 12.6 8.8 18.1 16.9 6.4 2.6 8.0 17.3 7.2 5.0 6.6 7.5 9.0 9.1 3.6 6.7 20.5 11.1 2.1 10.1 3.7 10.6 14.1 6.7 7.2 12.7 6.8 7.5 3.5 4.9 6.6 12.0 1.7 8.3 4.7 11.9 12.9 9.2 6.1 10.1 9.9 10.8 7.8 9.4 8.7 2.1 6.5 7.0 8.7 10.3 6.6 10.1 13.4 7.9 15.3 10.2 9.3 8.9 10.7 7.1 6.3 0.0 8.8 3.7 4.0 1.4 14.4 10.1 10.2 5.3 4.5 3.5 9.8 17.2 10.0 8.7 2.6 6.7 8.5 0.0 11.0 12.0 4.2 4.0 13.9 7.4 13.6 23.8 12.1 6.7 5.1 2.5 5.5 6.2 5.0 13.6 5.9 12.3 9.1 7.4 3.9 6.2 19.6 12.9 3.9 14.9 8.5 0.9 15.4 4.9 5.2 2.7 AQR "fSAP164, IBP160, KIAA0560" ENSG00000021776 "Aquarius intron-binding spliceosomal factor" O60306 15 34851782-34969839 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 108.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040624, HPA055647" Enhanced Nucleoplasm No No Nucleoplasm "HPA040624: AB_2677050, HPA055647: AB_2682874" "unprognostic (1.73e-1)" "unprognostic (3.71e-2)" "unprognostic (2.97e-1)" "unprognostic (1.32e-2)" "unprognostic (1.03e-1)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-2)" "unprognostic (2.65e-1)" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "prognostic favorable (4.83e-4)" "unprognostic (2.97e-1)" "unprognostic (2.47e-1)" "unprognostic (3.84e-1)" "unprognostic (3.13e-2)" 15.5 15.8 8.0 14.0 12.4 9.7 16.1 11.2 14.3 16.6 11.2 11.8 8.7 9.2 18.5 11.8 18.3 12.3 8.7 9.9 8.4 7.5 14.4 11.2 10.7 12.6 8.7 6.9 15.5 13.6 16.8 13.2 15.3 13.2 12.0 11.8 12.4 15.1 11.3 8.7 14.2 13.0 14.3 8.3 16.8 12.9 15.8 9.2 27.9 14.8 8.5 16.5 15.7 14.9 5.9 5.5 7.1 5.1 4.5 6.5 2.9 5.0 13.1 8.7 9.1 11.8 11.0 4.5 6.2 7.9 8.3 7.5 5.9 3.1 4.1 4.0 10.5 5.5 8.0 14.6 8.9 9.2 5.8 5.9 13.2 11.6 5.4 6.7 10.7 6.2 8.5 5.9 6.5 6.9 7.8 7.0 3.3 9.3 4.1 8.2 3.4 6.2 7.2 8.6 11.7 5.4 8.5 15.0 4.1 8.4 8.9 9.5 7.4 10.1 9.7 2.2 8.0 6.8 8.4 9.1 6.2 3.4 4.2 5.5 5.0 6.1 8.4 7.7 9.3 6.2 7.1 4.7 2.7 6.5 5.1 5.7 4.0 5.7 6.2 3.8 5.9 5.8 6.4 2.3 4.5 3.0 5.5 4.6 2.9 8.0 12.4 11.2 13.4 8.4 7.5 8.7 6.9 13.2 9.2 11.9 27.0 11.9 11.9 8.5 25.3 14.6 20.4 29.4 36.4 14.0 108.0 13.3 3.3 11.5 36.0 17.9 15.5 0.0 12.3 12.0 10.6 12.5 23.1 17.1 13.1 23.8 12.7 31.9 17.0 6.9 19.2 12.7 15.1 13.6 17.7 17.4 15.9 14.0 17.3 10.3 38.7 6.5 9.8 19.3 20.1 8.4 11.1 20.8 19.1 11.2 ARFGEF1 "ARFGEP1, BIG1, DKFZP434L057, p200" ENSG00000066777 "ADP ribosylation factor guanine nucleotide exchange factor 1" Q9Y6D6 8 67173511-67343677 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 131.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023399, HPA023822" Supported Supported Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA023399: AB_1844981, HPA023822: AB_1844982" "prognostic unfavorable (8.76e-4)" "unprognostic (1.62e-1)" "unprognostic (4.60e-2)" "unprognostic (1.01e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (4.52e-1)" "unprognostic (5.38e-2)" "unprognostic (4.67e-2)" "unprognostic (2.13e-3)" "unprognostic (1.31e-1)" "prognostic favorable (2.48e-4)" "unprognostic (1.13e-1)" "unprognostic (2.84e-1)" "unprognostic (1.62e-1)" "unprognostic (1.61e-2)" 17.0 17.1 14.5 24.3 15.6 24.9 14.0 20.4 16.3 17.7 24.7 9.5 24.7 16.8 15.4 20.3 23.8 13.1 16.0 12.0 11.3 11.7 23.9 15.3 18.6 22.7 11.4 9.5 15.1 21.4 38.6 21.8 17.4 16.7 15.8 17.7 13.2 20.7 29.4 20.9 18.4 26.9 13.8 12.0 20.1 19.5 27.1 12.6 36.7 22.9 15.7 16.8 22.9 17.7 2.1 3.7 8.4 3.7 3.7 6.1 1.3 15.8 10.3 10.1 3.7 11.7 16.0 11.9 11.2 12.5 11.4 11.6 6.3 15.5 12.0 4.9 14.0 13.9 11.4 12.1 15.7 14.0 15.4 8.5 20.2 6.3 6.8 10.1 10.3 20.2 9.8 11.3 10.2 17.5 11.8 16.2 12.7 12.4 13.1 13.1 3.5 24.2 4.9 22.1 17.4 9.5 11.9 7.2 2.4 18.9 29.5 4.0 7.8 7.2 17.5 9.8 16.1 30.2 9.2 19.7 7.9 10.5 10.3 8.3 11.5 12.5 9.0 12.4 10.6 7.3 8.0 2.6 6.6 4.8 3.7 6.1 2.1 3.2 3.9 2.6 2.1 5.3 4.5 8.4 3.7 1.5 3.7 5.9 1.3 14.5 15.6 20.4 16.3 11.3 11.7 11.4 9.5 16.7 12.6 41.7 17.2 18.8 23.7 21.1 35.4 28.2 20.4 30.8 26.1 36.6 131.6 16.1 10.0 24.5 19.5 24.8 32.5 0.0 22.1 13.2 15.8 30.7 15.0 17.8 14.2 41.3 28.3 22.1 29.5 23.4 37.2 23.8 16.9 27.9 29.9 21.4 31.5 23.0 28.3 21.0 94.9 6.5 17.5 49.4 48.5 25.7 20.8 23.0 22.7 61.6 ARGLU1 FLJ10154 ENSG00000134884 "Arginine and glutamate rich 1" Q9NWB6 13 106541673-106568164 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 91.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034962, HPA056792" Supported Enhanced Nucleoplasm,Mitochondria,Cytosol No No Nucleoplasm "Mitochondria, Cytosol" "HPA034962: AB_10611676, HPA056792: AB_2683236" "unprognostic (1.66e-2)" "unprognostic (3.10e-2)" "unprognostic (2.24e-1)" "unprognostic (2.82e-1)" "unprognostic (3.97e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (3.21e-2)" "unprognostic (9.00e-2)" "unprognostic (1.52e-1)" "prognostic favorable (3.92e-5)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (2.91e-3)" "unprognostic (2.65e-1)" "unprognostic (2.87e-1)" "prognostic favorable (7.34e-5)" 43.5 31.8 59.1 46.5 63.6 67.5 46.1 82.1 72.8 37.9 41.7 44.9 33.5 35.2 62.2 50.9 38.1 50.2 55.0 40.4 55.7 20.6 30.5 24.4 65.3 75.7 62.5 44.5 65.2 34.1 24.0 61.1 48.3 44.0 38.9 48.6 35.5 46.8 48.2 34.1 53.0 54.3 43.3 51.8 50.4 42.8 25.9 67.2 40.2 45.5 22.0 61.0 44.0 44.9 23.7 23.2 34.7 18.0 16.5 18.6 10.9 26.6 14.8 67.4 15.1 10.7 18.6 15.0 29.7 9.0 10.0 15.2 30.2 38.8 32.4 10.2 11.6 11.7 30.2 14.2 12.2 18.8 42.1 15.1 37.2 91.5 15.5 9.5 60.0 24.8 16.6 16.1 9.1 12.3 25.0 12.7 22.5 13.4 25.2 12.8 9.4 23.7 31.9 17.8 19.6 5.6 40.9 16.9 15.4 11.2 31.1 17.6 25.3 14.0 22.5 6.7 27.9 17.7 31.1 23.0 13.4 13.4 14.9 16.6 28.3 23.3 38.8 27.7 38.5 15.3 34.7 18.0 16.7 18.6 14.6 17.2 20.7 13.8 11.6 14.4 23.7 15.8 13.8 30.3 16.5 13.4 23.2 15.5 10.9 59.1 63.6 82.1 72.8 55.7 20.6 62.5 44.5 44.0 67.2 131.0 200.7 147.3 175.2 232.4 221.8 78.3 101.9 224.9 215.0 108.2 127.6 118.5 84.6 100.9 28.5 282.9 157.6 93.5 97.9 120.4 173.1 219.9 158.9 69.6 87.5 287.6 180.1 188.4 85.6 18.1 236.2 133.0 121.4 162.3 134.2 304.1 112.4 133.3 204.7 39.4 283.1 213.4 189.5 194.6 112.8 229.2 154.9 147.4 126.3 268.6 ARID1A "B120, BAF250, BAF250a, C10rf4, C1orf4, P270, SMARCF1" ENSG00000117713 "AT-rich interaction domain 1A" O14497 1 26693236-26782110 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005456, CAB016334" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB016334: AB_673396, HPA005456: AB_1078205" "unprognostic (2.83e-1)" "unprognostic (1.81e-1)" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (2.44e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (4.18e-4)" "unprognostic (3.02e-1)" "unprognostic (3.66e-2)" "unprognostic (1.34e-1)" "unprognostic (9.69e-2)" "unprognostic (7.76e-2)" "unprognostic (1.01e-2)" "unprognostic (1.62e-2)" "unprognostic (6.05e-2)" "unprognostic (2.66e-1)" "unprognostic (6.54e-2)" 18.6 18.4 17.4 24.9 17.0 33.8 27.8 23.6 19.1 20.3 23.7 21.7 23.9 15.8 24.1 17.3 23.2 20.6 21.9 15.5 14.8 12.8 13.7 15.9 18.8 35.6 20.3 19.2 24.1 23.9 27.5 15.8 19.3 17.2 16.5 16.4 18.9 21.4 23.1 22.6 20.6 20.7 18.4 15.4 25.9 19.5 16.5 19.8 57.3 24.8 14.2 24.5 24.4 20.4 4.3 5.3 7.4 3.3 4.7 5.1 3.5 19.2 18.3 25.9 27.0 7.5 7.2 12.2 9.0 7.9 12.4 8.8 13.3 13.0 27.2 7.9 11.7 7.8 11.7 22.5 10.0 14.5 33.6 8.8 23.1 11.9 8.9 6.2 34.2 7.4 8.3 7.1 14.6 10.5 6.9 10.6 19.7 27.6 30.5 8.0 9.1 28.8 13.3 27.4 12.5 8.5 30.1 17.1 15.4 7.7 13.0 24.3 20.0 15.8 13.4 10.9 15.0 3.9 19.4 18.7 13.3 12.9 12.4 14.6 14.5 19.1 12.5 8.1 21.9 11.7 0.4 3.3 2.9 4.0 2.9 5.1 4.3 3.2 4.9 3.1 4.3 4.0 4.4 7.4 4.7 2.8 5.3 1.5 3.5 17.4 17.0 23.6 19.1 14.8 12.8 20.3 19.2 17.2 19.8 56.6 36.8 33.6 18.1 65.3 60.2 31.1 28.1 25.4 28.4 36.6 49.1 31.8 1.7 31.8 14.2 37.2 28.4 0.0 32.5 32.1 42.6 39.3 56.9 53.9 43.0 69.9 45.7 51.0 93.5 7.5 35.6 45.4 38.8 34.3 56.1 31.2 40.3 31.6 39.3 14.5 37.1 51.8 27.2 46.0 55.3 82.4 30.7 41.2 46.0 27.7 ARID5A "MRF-1, RP11-363D14" ENSG00000196843 "AT-rich interaction domain 5A" Q03989 2 96536743-96552638 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Smooth muscle cells: 294.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "HDLM-2: 73.1;RPMI-8226: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002860, HPA023879" Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA002860: , HPA023879: AB_1845014" "prognostic favorable (2.05e-6)" "unprognostic (1.08e-3)" "unprognostic (1.69e-2)" "unprognostic (3.89e-3)" "unprognostic (1.90e-2)" "unprognostic (3.38e-2)" "unprognostic (3.03e-1)" "unprognostic (1.17e-1)" "unprognostic (1.24e-3)" "unprognostic (2.46e-1)" "unprognostic (1.56e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (4.24e-8)" "unprognostic (2.74e-2)" "unprognostic (9.79e-2)" "unprognostic (1.06e-1)" "unprognostic (5.13e-2)" 20.1 4.1 6.8 24.5 8.7 14.6 26.2 3.1 8.8 10.5 14.6 4.9 4.1 7.2 17.5 16.1 9.1 11.5 16.8 17.8 7.0 5.5 5.4 7.2 26.0 29.0 10.7 3.1 11.4 9.8 3.8 6.6 13.0 17.4 14.7 3.7 11.4 8.2 5.1 26.1 7.3 12.3 33.1 13.6 14.9 10.1 5.4 6.2 12.4 8.2 7.7 15.7 19.5 12.0 5.2 12.8 21.4 5.3 17.7 11.5 8.8 0.8 0.3 0.4 1.5 0.8 0.9 2.2 1.4 4.9 1.7 1.5 0.8 0.2 0.2 1.0 0.8 2.6 1.3 0.4 0.0 0.5 73.1 1.1 1.8 0.3 1.7 1.0 1.2 1.4 0.6 1.6 1.4 0.2 1.5 1.5 2.2 1.5 11.1 0.6 0.8 2.4 4.3 0.9 0.4 0.0 3.3 3.0 32.2 0.2 0.7 0.6 0.3 0.1 0.1 1.1 0.4 0.0 2.7 1.4 1.5 1.9 1.7 1.2 6.8 5.3 0.9 0.8 3.0 1.4 7.2 5.3 21.4 11.5 4.8 11.1 4.4 9.7 10.7 7.1 5.2 10.8 10.5 15.3 17.7 3.3 12.8 11.0 8.8 6.8 8.7 3.1 8.8 7.0 5.5 10.7 3.1 17.4 6.2 3.0 28.9 11.8 34.4 46.5 17.4 12.2 5.1 10.7 11.4 3.5 29.5 3.6 3.3 29.9 14.9 43.6 3.2 0.0 27.0 7.0 17.5 22.9 58.0 22.2 62.8 0.0 0.0 22.1 29.8 23.3 3.4 64.4 55.6 95.6 5.4 6.2 24.8 5.3 6.0 5.0 24.7 45.3 294.5 2.7 17.6 28.4 3.3 91.4 2.6 17.8 ARIH2 TRIAD1 ENSG00000177479 "Ariadne RBR E3 ubiquitin protein ligase 2" O95376 3 48918821-48986382 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067381, HPA069715, HPA070963" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA067381: AB_2685827, HPA069715: AB_2686182, HPA070963: AB_2686329" "unprognostic (7.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.26e-1)" "unprognostic (2.74e-1)" "unprognostic (2.55e-1)" "unprognostic (4.79e-3)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.90e-2)" "unprognostic (4.01e-2)" "unprognostic (5.01e-2)" "prognostic favorable (7.31e-4)" "unprognostic (5.01e-3)" "prognostic favorable (6.60e-4)" "unprognostic (1.15e-1)" "unprognostic (7.04e-2)" "unprognostic (1.27e-2)" "unprognostic (1.39e-2)" 15.0 16.2 14.1 12.8 20.6 16.0 19.2 22.7 22.5 14.1 18.6 25.4 13.9 10.0 18.7 29.2 14.9 16.2 12.8 38.5 15.8 14.9 14.3 17.2 14.5 17.8 24.7 18.3 18.3 20.5 23.1 19.8 15.3 19.7 16.5 15.5 19.2 13.2 19.5 71.3 11.4 14.4 23.0 18.8 17.5 15.7 27.5 21.4 17.7 18.7 15.2 17.2 16.4 14.1 20.6 21.7 27.6 24.5 15.8 32.6 25.3 14.3 14.5 14.0 19.8 20.7 11.4 19.0 16.9 19.8 21.2 23.5 15.2 12.8 29.3 7.9 18.1 30.8 8.6 28.8 17.3 26.0 19.7 17.5 30.2 19.1 12.4 18.8 22.3 14.6 12.2 26.2 26.4 35.9 12.1 15.9 14.1 23.8 20.1 18.7 9.9 22.5 9.2 23.8 15.5 22.0 8.4 16.0 24.4 12.4 19.4 6.1 16.6 16.6 20.9 16.2 17.3 10.6 15.9 15.1 12.9 18.7 19.2 26.5 26.3 50.8 37.1 14.1 18.7 16.1 27.6 24.5 26.2 32.6 21.6 22.1 19.5 20.9 26.7 21.7 20.6 21.6 27.8 17.2 15.8 13.5 18.7 22.9 25.3 14.1 20.6 22.7 22.5 15.8 14.9 24.7 18.3 19.7 21.4 32.8 22.3 31.1 35.9 45.2 56.4 60.0 30.6 37.5 58.0 27.9 82.5 31.2 24.9 23.6 8.2 33.8 20.3 23.3 37.3 30.6 28.0 46.9 42.9 36.5 23.8 54.0 16.0 35.0 26.4 4.7 38.6 33.2 28.7 41.5 22.9 39.7 33.1 22.9 40.7 25.6 73.6 25.8 35.4 140.0 77.3 47.2 44.6 50.1 26.5 58.6 ASF1A "CIA, DKFZP547E2110" ENSG00000111875 "Anti-silencing function 1A histone chaperone" Q9Y294 6 118894220-118909167 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030502, HPA071495" Enhanced Nucleoplasm No No Nucleoplasm "HPA030502: AB_2673504, HPA071495: AB_2686404" "unprognostic (7.09e-2)" "unprognostic (1.33e-1)" "unprognostic (4.78e-2)" "unprognostic (1.35e-1)" "unprognostic (3.95e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (5.02e-7)" "unprognostic (8.28e-2)" "unprognostic (8.42e-2)" "unprognostic (8.37e-3)" "unprognostic (3.28e-2)" "unprognostic (4.95e-1)" "unprognostic (9.07e-3)" "unprognostic (2.90e-2)" "unprognostic (7.37e-2)" "unprognostic (1.42e-2)" "unprognostic (5.09e-3)" 7.8 14.1 21.5 9.1 23.8 7.9 14.4 20.3 17.5 12.9 10.4 12.6 16.1 8.5 12.3 15.6 13.7 12.3 9.0 14.6 18.1 19.2 14.4 13.3 15.0 16.3 21.6 14.9 20.9 10.8 25.7 12.9 9.5 15.2 12.0 12.5 9.1 11.6 15.4 16.6 12.9 11.7 11.6 21.4 15.2 11.8 10.5 14.8 36.9 20.2 14.9 16.4 13.3 12.2 13.4 12.8 12.2 7.9 12.1 30.8 17.6 6.0 3.9 13.8 9.2 11.9 7.0 11.1 8.3 8.3 10.9 12.3 4.8 5.3 10.2 13.7 5.9 9.5 6.7 11.9 10.6 13.9 7.3 11.0 15.0 9.4 30.9 8.3 25.3 7.8 6.1 10.8 9.4 14.4 14.6 14.4 32.7 23.2 27.4 12.8 6.4 29.5 20.0 5.7 9.1 13.5 16.2 5.6 12.7 14.5 7.9 8.9 6.8 8.4 8.5 9.7 4.5 4.9 23.7 12.3 5.1 7.5 7.0 12.7 8.5 14.1 14.9 13.3 20.2 10.9 6.6 6.0 12.2 16.3 6.3 22.7 13.4 26.6 20.9 12.8 8.1 29.1 23.8 1.0 12.1 7.9 9.7 30.8 17.6 21.5 23.8 20.3 17.5 18.1 19.2 21.6 14.9 15.2 14.8 14.9 19.9 35.3 13.8 26.2 15.4 23.4 12.7 24.1 15.9 8.7 3.9 59.8 53.0 28.9 26.4 23.7 8.5 116.8 20.7 67.2 19.7 9.5 22.0 13.9 21.7 23.8 28.4 14.1 16.8 7.8 23.6 19.0 15.1 26.2 10.5 22.6 19.3 10.5 21.9 22.6 12.5 12.9 29.7 26.5 40.0 28.9 39.0 47.3 16.7 11.1 ASNA1 "ARSA-I, GET3, TRC40" ENSG00000198356 "ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)" O43681 19 12737139-12748323 "Predicted intracellular proteins, Transporters" Transport Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045951, HPA048087" Approved Enhanced Nucleoplasm,Nucleoli NA NA 52000 Nucleoli Nucleoplasm "HPA045951: AB_2679511, HPA048087: AB_2680258" "unprognostic (2.87e-1)" "prognostic favorable (9.53e-4)" "unprognostic (1.01e-1)" "unprognostic (2.16e-1)" "unprognostic (2.05e-2)" "unprognostic (5.70e-2)" "unprognostic (2.01e-2)" "unprognostic (1.33e-2)" "unprognostic (3.34e-1)" "unprognostic (3.08e-2)" "unprognostic (1.85e-1)" "unprognostic (4.39e-2)" "prognostic favorable (4.27e-5)" "unprognostic (6.11e-2)" "unprognostic (5.77e-2)" "unprognostic (2.32e-3)" "prognostic unfavorable (8.47e-4)" 22.3 33.9 32.3 23.1 32.8 35.1 22.2 28.2 51.9 23.5 27.2 26.1 23.6 24.7 24.8 30.3 33.3 30.7 28.9 48.0 30.5 27.9 46.9 28.5 21.2 26.6 29.2 26.5 24.2 30.3 23.8 25.2 32.0 27.3 21.8 18.3 30.9 26.7 21.5 35.7 28.9 24.7 21.3 24.5 26.5 24.2 30.9 18.5 25.8 40.7 28.0 23.5 28.7 20.6 12.5 27.1 16.0 26.9 9.3 20.2 19.4 33.6 27.8 14.9 32.1 29.7 18.3 18.4 17.5 24.2 34.0 26.8 21.7 16.8 15.5 27.4 22.7 39.0 18.1 20.6 23.4 16.3 23.8 32.3 13.4 21.0 24.6 31.8 19.8 26.1 21.1 20.6 27.4 16.3 22.0 24.0 18.4 16.6 21.1 26.5 75.3 26.1 15.9 37.7 21.7 52.4 19.4 23.2 30.3 31.7 28.8 27.7 23.5 23.7 31.9 28.0 13.3 26.3 19.1 20.4 48.1 16.3 53.2 40.6 38.0 63.9 14.3 33.7 32.4 26.4 16.0 26.9 15.0 16.1 20.4 13.7 12.5 14.4 14.2 27.1 10.6 10.4 12.8 9.6 9.3 23.7 17.8 20.2 19.4 32.3 32.8 28.2 51.9 30.5 27.9 29.2 26.5 27.3 18.5 3.0 6.5 44.7 52.5 61.4 33.5 7.4 66.2 9.4 5.7 52.4 15.7 89.1 112.7 135.7 88.0 42.9 87.6 46.7 116.1 66.8 58.1 46.3 34.5 24.5 125.2 27.0 53.9 36.8 50.0 143.9 44.5 54.1 77.6 138.9 56.6 59.9 93.6 94.7 53.0 177.7 23.1 32.3 54.5 52.9 128.0 69.5 92.6 59.8 57.4 54.0 ASXL2 "ASXH2, FLJ10898, KIAA1685" ENSG00000143970 "Additional sex combs like 2, transcriptional regulator" Q76L83 2 25733753-25878516 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034646, HPA058040" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA034646: AB_2674261, HPA058040: AB_2683586" "unprognostic (4.78e-2)" "unprognostic (3.41e-2)" "unprognostic (2.23e-2)" "unprognostic (1.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.88e-2)" "unprognostic (2.98e-2)" "unprognostic (2.80e-1)" "unprognostic (2.68e-3)" "unprognostic (3.17e-2)" "unprognostic (1.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.33e-3)" "unprognostic (1.82e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-1)" "unprognostic (3.75e-2)" 15.0 14.9 14.5 14.1 16.5 10.4 13.1 23.0 16.1 14.4 13.9 15.7 13.0 9.8 14.7 9.9 17.5 12.1 10.0 14.2 15.2 8.9 14.7 10.2 13.1 15.3 14.3 8.5 11.4 12.1 28.0 17.4 17.4 13.9 10.5 14.2 12.6 15.3 14.1 20.5 14.2 12.9 13.3 12.3 15.4 12.1 20.7 18.0 26.2 16.5 10.7 17.0 16.7 13.5 3.0 3.7 4.7 2.7 1.8 4.5 1.3 15.7 9.5 7.3 5.2 7.3 10.3 9.4 8.7 13.6 8.5 7.7 10.5 8.6 9.8 5.1 9.8 10.0 9.8 14.4 10.6 12.3 9.8 6.6 17.4 8.5 11.5 6.2 19.2 17.4 5.1 11.1 13.0 10.3 7.6 10.9 6.2 15.1 7.9 9.0 6.4 9.0 6.4 10.3 9.2 6.7 10.1 25.0 7.9 7.9 10.7 8.0 9.0 10.5 10.0 8.8 7.5 5.6 8.2 14.4 12.1 13.8 10.4 12.5 16.1 15.8 20.5 11.3 16.2 8.6 2.1 2.4 3.7 4.5 2.7 3.6 2.7 3.5 3.9 2.3 3.0 3.0 3.6 4.7 1.8 2.4 3.7 2.5 1.3 14.5 16.5 23.0 16.1 15.2 8.9 14.3 8.5 13.9 18.0 23.8 17.9 16.0 8.0 28.7 21.5 25.8 10.2 38.8 15.9 8.7 23.6 9.0 13.3 13.9 36.9 22.2 10.5 0.0 12.4 7.4 14.5 11.0 23.1 13.9 16.0 23.8 9.9 26.4 25.3 19.7 18.1 21.6 21.9 15.4 16.7 13.6 14.9 14.0 12.4 12.9 24.1 38.8 11.0 30.5 24.7 35.9 12.2 28.8 15.6 13.8 ATAD2 "ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000" ENSG00000156802 "ATPase family, AAA domain containing 2" Q6PL18 8 123319850-123416350 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 53.8" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 74.6;Spermatogonia: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 75.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029424, CAB056158" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB056158: AB_2665580, HPA029424: AB_10611680" "unprognostic (1.56e-1)" "unprognostic (4.55e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.08e-1)" "unprognostic (4.44e-2)" "unprognostic (2.98e-2)" "unprognostic (2.74e-3)" "unprognostic (2.02e-3)" "unprognostic (5.62e-2)" "unprognostic (1.19e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (8.33e-15)" "unprognostic (1.15e-2)" "unprognostic (1.82e-1)" "unprognostic (4.84e-2)" "unprognostic (6.17e-2)" 4.1 4.9 4.6 12.6 9.2 22.8 7.2 5.6 6.9 14.0 8.6 1.5 13.4 5.3 4.7 5.0 10.7 4.7 3.5 13.7 4.2 6.3 2.2 10.1 9.8 13.7 4.0 4.3 9.9 3.9 3.5 18.7 5.2 4.0 11.4 7.5 2.4 6.8 15.4 13.8 7.2 6.6 5.5 4.1 8.8 6.9 20.2 3.4 53.8 4.8 6.3 12.7 9.9 5.9 4.3 2.3 7.2 2.8 4.0 7.4 1.8 25.5 9.9 14.2 4.8 2.5 3.2 6.2 20.0 6.9 17.3 19.3 7.5 11.1 16.7 6.1 6.3 6.8 12.2 18.9 6.4 27.8 23.2 10.1 30.0 10.7 15.2 1.0 10.9 14.9 1.0 1.0 16.4 5.4 3.7 5.2 9.8 14.0 17.0 12.8 26.4 31.4 8.2 2.5 19.3 9.9 16.4 16.9 9.0 6.1 11.7 18.2 7.9 29.0 75.6 5.1 6.0 15.4 10.4 3.2 13.1 18.1 10.3 24.0 5.5 9.8 15.5 8.6 18.4 10.2 7.2 1.5 5.4 2.9 1.3 4.0 4.3 4.2 4.8 2.3 2.8 2.8 3.0 0.4 4.0 2.8 0.3 7.4 1.8 4.6 9.2 5.6 6.9 4.2 6.3 4.0 4.3 4.0 3.4 6.0 8.3 14.2 19.9 14.1 2.5 22.9 2.5 5.3 11.4 3.5 3.9 8.2 1.7 2.4 46.2 6.7 2.2 23.3 1.9 21.2 7.3 19.9 13.9 14.0 9.7 1.6 1.2 9.2 11.1 17.9 6.9 6.6 1.7 5.4 4.4 5.2 2.7 3.5 13.1 0.9 2.1 0.0 8.6 74.6 90.7 10.7 11.3 15.3 12.8 24.8 ATF1 TREB36 ENSG00000123268 "Activating transcription factor 1" P18846 12 50763710-50821122 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016222, HPA055069, HPA055406" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016222: AB_2290030, HPA055069: AB_2682688, HPA055406: AB_2682807" "unprognostic (1.71e-1)" "unprognostic (1.50e-3)" "unprognostic (1.50e-1)" "unprognostic (9.05e-2)" "unprognostic (6.68e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (1.53e-5)" "unprognostic (3.65e-1)" "unprognostic (8.17e-3)" "unprognostic (5.94e-2)" "unprognostic (4.31e-3)" "unprognostic (5.52e-2)" "unprognostic (1.73e-1)" "unprognostic (2.74e-2)" "unprognostic (2.46e-1)" "unprognostic (2.27e-1)" "unprognostic (8.75e-2)" 24.4 20.7 9.8 13.7 9.5 10.2 16.2 28.1 10.6 22.4 19.7 8.1 14.6 12.3 19.2 14.2 16.2 15.5 13.4 20.0 10.8 8.0 17.7 19.8 15.1 15.8 12.2 6.0 24.7 11.8 18.1 15.2 36.1 11.9 20.7 15.1 12.5 16.3 14.2 37.9 12.9 18.8 13.4 12.3 22.9 12.7 9.3 13.9 34.4 30.8 16.3 16.2 21.6 20.0 13.3 13.6 26.3 12.3 12.2 18.8 11.6 13.5 9.8 10.4 10.6 15.0 16.0 25.9 14.4 24.8 22.8 18.0 20.1 21.5 18.7 23.8 16.6 10.0 11.3 12.3 14.8 24.4 18.4 12.7 20.6 22.2 10.7 28.8 29.6 19.8 17.0 23.5 16.3 26.8 23.8 11.0 13.2 25.1 18.1 16.9 20.1 18.6 18.8 15.1 15.7 15.7 17.9 16.2 22.1 17.3 9.3 14.0 7.6 30.5 13.3 21.7 14.9 18.5 18.1 7.6 16.1 19.5 13.5 11.4 10.0 11.8 29.9 15.5 16.7 7.6 4.2 11.5 26.3 13.9 12.3 15.8 13.0 15.1 16.4 13.6 13.3 18.8 14.3 7.3 12.2 7.7 6.2 17.9 11.6 9.8 9.5 28.1 10.6 10.8 8.0 12.2 6.0 11.9 13.9 50.6 14.4 34.4 42.6 66.9 12.0 12.9 10.2 18.7 23.9 12.2 0.0 27.2 44.7 20.3 6.5 18.6 17.3 70.0 18.5 60.0 36.0 33.7 9.3 15.7 24.6 12.7 5.8 15.4 21.9 4.9 29.7 29.4 21.9 18.0 13.9 12.9 18.2 14.0 26.2 25.4 6.9 38.8 32.0 9.3 10.2 47.7 67.4 30.9 21.2 30.7 ATF2 "CRE-BP1, CREB2, HB16, TREB7" ENSG00000115966 "Activating transcription factor 2" P15336 2 175072250-175168382 "Enzymes, Predicted intracellular proteins, Transcription factors" "DNA damage, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 100.8;Late spermatids: 111.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003769, HPA022134" Supported Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB003769: AB_562241, HPA022134: AB_1845138" "unprognostic (1.11e-1)" "unprognostic (2.01e-1)" "unprognostic (9.81e-2)" "unprognostic (1.93e-1)" "unprognostic (9.29e-3)" "unprognostic (2.56e-1)" "prognostic unfavorable (7.08e-5)" "unprognostic (2.28e-2)" "unprognostic (3.70e-2)" "unprognostic (6.47e-2)" "unprognostic (7.17e-2)" "unprognostic (4.02e-2)" "unprognostic (4.40e-3)" "unprognostic (1.15e-2)" "unprognostic (1.50e-1)" "unprognostic (7.21e-3)" "unprognostic (6.70e-2)" 25.3 21.0 25.3 14.3 29.3 14.3 19.7 39.6 33.4 27.5 15.9 18.0 15.7 12.8 22.4 22.6 16.0 19.5 17.9 14.1 25.1 28.0 23.0 26.8 15.2 17.6 23.2 18.4 27.3 19.0 24.0 33.0 19.9 29.6 19.0 16.0 14.9 16.8 19.1 13.9 10.1 13.2 18.3 22.9 17.5 13.8 19.9 18.9 34.6 32.6 10.2 20.1 21.7 16.7 15.0 18.7 24.2 14.8 15.3 22.0 14.3 7.3 6.5 19.4 12.5 17.3 18.5 8.9 12.1 20.8 14.7 21.4 14.0 13.8 11.1 13.3 14.2 17.4 7.2 14.7 7.4 23.1 13.8 8.5 15.7 11.9 30.5 19.4 14.5 16.5 13.8 16.5 18.9 22.6 19.5 20.2 10.5 12.7 17.4 16.4 5.6 23.4 18.1 18.0 12.6 14.8 20.4 8.9 17.2 21.5 6.5 16.1 13.3 15.2 4.7 17.8 16.3 10.5 16.2 12.7 17.2 9.0 9.1 7.2 16.6 25.0 14.2 13.5 13.9 11.6 24.2 14.4 16.8 18.2 12.8 22.0 15.0 15.7 18.8 18.7 12.7 18.3 19.9 9.3 15.3 14.8 10.5 19.8 14.3 25.3 29.3 39.6 33.4 25.1 28.0 23.2 18.4 29.6 18.9 14.9 10.4 18.4 14.2 29.3 20.8 18.7 20.4 21.4 14.8 22.7 9.8 11.7 11.6 12.1 100.8 23.3 13.2 0.0 6.1 9.9 28.8 16.7 28.9 24.6 16.4 38.1 15.6 18.4 26.8 111.2 30.2 20.4 28.7 10.0 14.8 24.9 12.5 8.6 26.9 14.9 24.6 12.9 38.1 32.4 11.7 22.1 5.3 24.5 13.6 9.5 ATF7IP "FLJ10688, p621" ENSG00000171681 "Activating transcription factor 7 interacting protein" Q6VMQ6 12 14365632-14502935 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016578, HPA023505" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA016578: AB_1845147, HPA023505: AB_1845148" "unprognostic (2.06e-2)" "unprognostic (3.12e-2)" "unprognostic (1.25e-1)" "unprognostic (6.25e-3)" "unprognostic (1.20e-3)" "unprognostic (2.48e-2)" "unprognostic (5.84e-2)" "unprognostic (8.56e-3)" "unprognostic (7.36e-2)" "unprognostic (3.05e-2)" "unprognostic (3.62e-2)" "unprognostic (1.86e-1)" "unprognostic (7.90e-3)" "unprognostic (2.88e-1)" "unprognostic (7.64e-2)" "unprognostic (1.14e-2)" "unprognostic (3.78e-2)" 17.5 15.0 11.1 36.4 15.3 25.2 16.6 29.4 12.7 18.0 12.9 14.1 16.0 7.3 16.1 14.5 20.2 13.0 15.2 18.3 11.7 8.3 11.3 14.0 16.2 25.2 13.8 10.7 19.5 13.0 23.3 23.3 22.4 11.9 15.7 12.3 14.4 21.7 18.0 25.4 15.6 16.6 15.4 12.3 23.9 12.5 30.1 13.6 38.8 20.2 12.6 24.5 17.2 27.3 25.0 9.9 15.9 9.7 8.6 13.4 6.6 10.9 6.5 27.1 15.7 14.3 18.3 5.9 11.5 6.7 9.3 14.4 15.0 11.8 18.3 8.1 8.1 17.1 11.1 16.8 10.9 21.2 13.1 9.8 12.3 11.2 3.2 8.4 8.3 7.3 9.8 9.1 11.5 12.0 14.8 20.3 6.7 7.2 10.0 14.7 10.4 11.9 7.3 17.3 5.7 6.2 24.9 29.9 9.9 8.1 21.6 8.7 7.2 13.5 7.9 7.6 23.0 8.0 9.8 9.3 13.2 8.5 7.5 9.8 6.5 6.3 26.0 8.4 7.9 14.1 15.9 8.1 13.6 12.9 6.3 13.4 16.9 11.0 12.5 7.2 25.0 8.9 12.2 13.5 8.6 9.7 9.9 13.4 6.6 11.1 15.3 29.4 12.7 11.7 8.3 13.8 10.7 11.9 13.6 62.5 34.4 42.4 10.8 6.0 51.5 58.1 15.3 32.1 38.7 33.2 64.8 13.8 6.6 13.0 53.7 33.7 9.3 23.3 10.6 7.7 14.3 12.4 24.4 25.9 17.2 60.4 27.0 27.6 42.9 13.3 27.0 26.9 5.0 26.2 21.6 26.7 13.6 10.5 27.6 14.0 38.8 12.9 11.3 42.6 23.5 5.8 12.9 45.7 19.5 9.1 ATG16L2 "ATG16B, FLJ00012, WDR80" ENSG00000168010 "Autophagy related 16 like 2" Q8NAA4 11 72814308-72843674 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 60.9;lymphoid tissue: 52.0" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 45.9;Macrophages: 38.5;Paneth cells: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 28.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045444, HPA050312" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045444: AB_2679324, HPA050312: AB_2681082" "unprognostic (7.20e-3)" "unprognostic (1.16e-1)" "unprognostic (1.54e-1)" "unprognostic (4.26e-2)" "unprognostic (2.12e-1)" "unprognostic (1.31e-3)" "unprognostic (1.61e-2)" "unprognostic (4.74e-3)" "unprognostic (1.89e-1)" "unprognostic (1.90e-1)" "prognostic favorable (7.06e-4)" "unprognostic (2.49e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (1.74e-1)" "unprognostic (4.38e-2)" "unprognostic (1.08e-1)" "unprognostic (4.83e-2)" 7.8 6.6 7.1 20.7 8.0 60.9 7.2 7.4 6.2 9.5 9.7 10.5 7.6 5.5 11.9 7.5 10.2 8.3 11.6 5.8 7.4 4.8 7.2 6.5 16.3 16.4 10.7 7.0 10.1 8.0 5.7 11.5 5.2 8.6 7.3 8.9 11.3 10.1 5.5 3.6 35.7 13.1 10.4 7.9 52.0 6.6 2.6 8.3 3.2 6.5 8.0 19.6 8.5 8.5 2.0 4.7 28.5 7.1 2.4 2.6 1.4 1.4 1.3 4.1 3.2 4.9 4.0 2.6 3.2 3.2 1.6 2.5 1.6 3.5 9.6 2.1 4.1 2.9 2.9 0.5 10.8 2.8 7.6 1.6 7.5 6.9 2.7 3.6 9.8 31.3 3.9 1.5 3.6 4.5 17.9 4.9 17.6 1.0 13.2 1.8 4.7 11.3 16.9 0.6 6.4 1.5 5.6 2.9 4.2 5.3 4.9 3.1 2.4 1.3 7.2 3.0 3.4 3.6 13.5 6.8 4.4 1.6 7.9 2.5 6.0 1.5 4.2 1.9 8.8 2.4 2.4 7.1 18.1 1.3 3.9 1.3 1.2 1.9 2.6 4.7 2.0 1.0 1.2 28.5 2.4 4.7 0.8 1.7 1.4 7.1 8.0 7.4 6.2 7.4 4.8 10.7 7.0 8.6 8.3 6.0 18.4 16.7 5.1 14.8 2.6 4.4 5.1 6.7 3.4 5.2 2.0 6.8 0.0 3.7 0.5 7.9 8.0 0.0 0.9 3.1 5.6 2.8 23.0 2.9 15.2 4.8 12.6 12.9 45.9 0.4 9.5 38.5 3.3 16.2 9.0 4.0 2.3 43.6 7.4 1.6 3.7 0.0 6.6 1.6 7.7 15.2 10.3 23.5 10.4 4.2 ATG2B "C14orf103, FLJ10242" ENSG00000066739 "Autophagy related 2B" Q96BY7 14 96279202-96363870 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000880, HPA001427, HPA019665" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000880: AB_1078888, HPA001427: AB_1845551, HPA019665: AB_2274278" "unprognostic (9.39e-2)" "unprognostic (1.01e-1)" "unprognostic (7.28e-2)" "unprognostic (1.07e-1)" "unprognostic (1.02e-1)" "unprognostic (6.01e-2)" "unprognostic (3.19e-1)" "unprognostic (9.29e-3)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (3.75e-3)" "unprognostic (1.45e-2)" "unprognostic (7.60e-3)" "unprognostic (6.66e-2)" "unprognostic (3.08e-1)" "unprognostic (3.90e-2)" "unprognostic (8.49e-2)" 3.6 3.4 2.6 2.5 4.1 4.4 5.2 9.2 4.5 3.9 3.2 3.1 4.9 4.4 2.9 4.0 3.0 2.7 3.2 3.3 4.5 6.0 3.4 3.1 3.0 5.1 8.1 9.7 4.1 2.7 4.0 3.2 3.1 3.1 5.2 9.3 4.3 3.8 2.7 3.9 3.6 6.5 4.9 3.5 3.3 3.6 1.5 1.6 2.1 1.0 2.5 3.0 0.7 4.1 5.2 6.5 5.1 11.3 10.5 5.2 6.1 8.7 6.7 7.6 2.8 2.8 9.2 5.8 9.9 4.5 5.7 8.8 6.0 10.8 8.5 4.5 4.0 5.7 2.5 7.4 7.3 4.4 8.8 6.1 9.0 7.2 7.1 8.4 7.0 4.6 8.3 5.3 6.6 6.6 6.3 3.1 4.8 5.4 6.1 14.6 6.2 7.5 5.1 6.4 7.2 9.2 3.8 4.4 7.0 6.0 4.2 11.2 3.7 1.7 9.0 3.9 8.4 6.9 8.6 7.6 5.1 3.6 0.6 1.0 1.7 1.6 0.6 3.0 1.5 1.8 1.7 1.3 1.5 1.9 2.0 2.1 2.5 1.0 1.6 2.7 0.7 11.9 10.5 7.5 2.8 12.2 24.5 11.2 7.6 2.7 6.8 8.7 25.5 4.4 3.3 5.2 31.1 9.8 8.2 0.0 5.2 2.7 7.8 11.1 6.9 23.2 3.6 30.2 7.9 13.5 10.5 36.0 11.8 8.9 1.7 3.6 11.8 8.5 4.9 10.5 9.9 6.8 19.0 6.5 8.5 15.6 13.8 24.6 13.2 6.5 8.7 3.1 ATM "ATA, ATC, ATD, ATDC, TEL1, TELO1" ENSG00000149311 "ATM serine/threonine kinase" Q13315 11 108222484-108369102 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Neurodegeneration, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 196.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000102, HPA067142" Supported Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB000102: , HPA067142: AB_2685789" "unprognostic (9.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.04e-1)" "unprognostic (2.36e-1)" "unprognostic (5.70e-2)" "unprognostic (2.86e-2)" "unprognostic (6.32e-3)" "unprognostic (1.05e-1)" "unprognostic (8.19e-2)" "unprognostic (1.63e-1)" "unprognostic (7.68e-2)" "unprognostic (6.16e-2)" "unprognostic (2.17e-3)" "unprognostic (3.10e-1)" "unprognostic (7.87e-2)" "unprognostic (1.21e-1)" "unprognostic (2.81e-1)" 8.3 10.9 12.7 26.5 19.3 16.8 9.4 17.7 14.4 10.9 8.5 10.9 8.8 6.0 11.2 11.4 6.9 9.5 9.2 9.6 12.4 8.5 7.7 9.5 10.1 33.4 19.6 6.7 20.5 20.7 15.7 29.2 8.8 14.5 9.1 7.9 7.2 15.1 9.8 6.2 8.4 16.5 10.6 23.4 22.6 8.9 6.1 17.9 19.5 10.7 5.1 26.9 10.7 10.7 13.7 6.1 13.5 12.5 7.6 18.5 4.4 2.7 3.9 7.7 4.1 10.0 14.6 2.0 6.1 6.8 3.5 5.9 4.8 6.5 9.6 9.1 4.9 5.6 4.1 5.8 5.1 5.5 7.7 3.4 8.7 4.8 4.8 5.3 10.5 9.4 9.4 3.2 5.4 10.4 7.7 7.4 8.2 8.4 6.6 6.9 2.0 7.1 9.7 6.3 4.1 3.9 5.6 5.3 15.1 4.0 5.5 5.2 6.4 7.1 3.3 10.5 7.1 5.0 5.9 11.5 8.8 4.9 5.0 5.7 4.4 4.6 48.5 5.8 11.5 9.8 13.5 5.7 3.8 14.9 5.3 10.4 11.1 10.5 11.3 2.7 13.7 18.5 17.9 10.8 7.6 12.5 6.1 5.3 4.4 12.7 19.3 17.7 14.4 12.4 8.5 19.6 6.7 14.5 17.9 35.7 21.0 122.7 17.4 11.2 101.7 35.4 10.2 13.4 19.4 21.0 198.3 14.8 5.0 7.7 12.8 18.8 4.9 0.0 10.6 10.5 26.4 9.5 12.7 21.2 26.0 57.2 19.5 36.8 82.2 2.7 36.5 48.1 25.3 9.0 15.9 35.9 7.6 10.5 26.2 10.3 196.6 25.8 17.3 18.7 33.6 10.8 3.5 111.7 11.7 9.9 ATN1 "B37, D12S755E, DRPLA" ENSG00000111676 "Atrophin 1" P54259 12 6924463-6942321 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031619 Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031619: AB_10601667" "unprognostic (3.86e-3)" "unprognostic (2.07e-1)" "unprognostic (1.80e-3)" "unprognostic (5.82e-2)" "unprognostic (1.37e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (7.20e-4)" "unprognostic (1.44e-1)" "unprognostic (6.90e-2)" "unprognostic (8.42e-3)" "unprognostic (1.86e-2)" "unprognostic (3.19e-1)" "unprognostic (7.43e-2)" "unprognostic (5.46e-2)" "unprognostic (9.49e-2)" "unprognostic (3.95e-1)" "unprognostic (7.35e-2)" 37.6 38.6 34.6 20.1 28.1 4.3 25.9 57.5 45.5 33.7 30.5 27.0 38.3 22.8 35.7 17.2 21.2 34.7 28.0 25.6 32.8 22.4 21.6 8.8 26.3 11.9 24.4 33.8 72.0 28.7 37.4 43.8 27.6 29.2 28.9 14.2 29.2 44.0 40.9 26.5 28.3 20.5 33.4 29.5 19.3 22.3 8.8 29.4 2.3 42.0 7.3 9.1 30.0 57.6 2.6 2.1 2.5 0.5 0.5 2.5 0.7 15.5 20.3 22.0 44.2 20.8 18.8 36.7 18.6 16.0 19.1 13.6 20.5 18.6 4.2 5.9 22.9 15.7 10.4 13.4 18.2 10.1 49.4 13.3 19.8 18.8 9.7 32.2 4.0 30.2 30.4 13.4 23.9 18.8 33.0 18.7 6.4 16.7 8.6 16.9 22.3 8.7 3.7 45.0 7.2 8.6 18.2 11.9 3.1 14.0 22.0 6.8 21.9 19.0 22.2 13.3 22.5 8.4 11.2 24.2 22.5 29.0 17.7 28.4 6.6 2.2 2.9 17.5 5.2 23.5 1.9 0.5 2.5 2.5 0.3 2.2 2.6 1.1 1.4 0.6 2.3 1.4 1.9 0.0 0.5 0.1 2.1 1.2 0.7 34.6 28.1 57.5 45.5 32.8 22.4 24.4 33.8 29.2 29.4 14.9 18.8 2.4 11.1 26.9 27.8 12.2 15.3 10.7 21.6 27.9 17.7 23.4 13.3 16.4 1.7 28.0 25.9 0.0 26.2 12.8 25.2 15.6 9.3 7.2 10.2 23.8 20.8 27.6 11.9 2.6 59.0 9.4 20.3 7.2 23.5 15.7 23.6 19.8 49.5 9.9 25.4 19.4 22.1 5.8 7.1 21.8 31.0 7.2 18.8 15.2 ATXN1L BOAT1 ENSG00000224470 "Ataxin 1 like" P0C7T5 16 71845991-71885268 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 197.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062596, HPA062789" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA062596: AB_2684802, HPA062789: AB_2684868" "unprognostic (1.51e-1)" "unprognostic (1.73e-2)" "unprognostic (1.39e-1)" "unprognostic (1.67e-1)" "unprognostic (3.01e-2)" "unprognostic (1.01e-1)" "unprognostic (1.68e-1)" "unprognostic (1.14e-1)" "unprognostic (1.00e-1)" "unprognostic (1.04e-1)" "unprognostic (8.13e-2)" "unprognostic (1.99e-1)" "prognostic favorable (5.33e-8)" "unprognostic (1.61e-1)" "unprognostic (1.42e-1)" "unprognostic (5.30e-2)" "prognostic unfavorable (8.42e-4)" 19.2 12.0 17.1 14.2 15.9 41.3 16.2 11.9 20.9 15.0 15.4 22.7 9.1 10.2 19.4 9.8 14.7 14.2 14.5 11.9 13.5 10.9 23.4 10.0 14.9 11.4 14.7 13.1 16.7 16.3 29.3 10.3 14.6 14.7 14.4 11.9 14.2 14.4 14.0 15.9 18.6 14.9 16.3 14.5 13.8 16.0 25.3 16.9 10.9 15.1 8.2 12.9 16.2 18.5 1.8 1.3 3.2 2.1 2.0 3.0 1.4 8.5 11.6 11.8 8.6 13.9 6.9 13.9 7.2 8.1 13.2 10.1 16.5 9.6 9.6 11.4 11.3 6.0 15.1 10.0 11.0 14.4 2.6 8.8 7.0 12.1 11.5 10.4 8.5 14.4 9.9 14.1 14.9 10.8 8.7 11.9 12.7 7.9 7.7 7.7 24.3 14.3 8.4 10.8 6.7 5.5 15.4 12.0 11.4 9.1 12.0 6.3 10.8 14.4 7.7 8.8 13.0 11.9 9.1 14.3 14.5 15.3 9.1 9.7 17.4 14.6 22.9 9.0 5.8 12.2 3.2 1.5 1.7 2.3 2.1 1.6 1.8 1.7 2.0 1.3 1.5 3.0 2.7 2.2 2.0 0.9 0.8 3.0 1.4 17.1 15.9 11.9 20.9 13.5 10.9 14.7 13.1 14.7 16.9 0.0 8.8 10.7 13.3 20.3 11.2 11.0 7.6 5.3 5.7 14.0 13.7 7.2 14.9 10.6 37.1 15.7 13.6 0.0 10.3 6.3 10.5 13.0 12.7 10.6 7.5 14.3 7.5 13.5 8.8 197.6 13.8 11.3 11.8 15.4 7.5 8.0 12.2 16.4 12.0 14.0 15.5 12.9 14.4 20.4 17.9 21.8 9.6 23.5 8.5 23.8 AURKB "Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5" ENSG00000178999 "Aurora kinase B" Q96GD4 17 8204733-8210600 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.7;lymphoid tissue: 59.9" "Group enriched" "Detected in many" 6 "Erythroid cells: 46.7;Extravillous trophoblasts: 76.2;Hofbauer cells: 23.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Lineage enriched" "Detected in many" 5 "T-cells: 10.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB005862, HPA037708" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes Nucleoplasm Midbody "CAB005862: AB_449204, HPA037708: AB_2675623" "unprognostic (4.76e-2)" "unprognostic (3.61e-3)" "unprognostic (2.25e-1)" "unprognostic (3.14e-2)" "unprognostic (2.27e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.99e-3)" "unprognostic (9.41e-3)" "unprognostic (3.47e-2)" "unprognostic (4.61e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.77e-2)" "unprognostic (2.93e-1)" "unprognostic (6.76e-2)" "unprognostic (3.77e-1)" 1.2 1.3 0.4 22.1 0.6 19.7 2.0 0.6 0.6 2.6 5.8 0.5 0.9 5.9 0.9 1.3 17.1 0.3 2.2 1.0 0.4 0.2 1.4 1.8 2.4 17.8 0.4 0.4 0.8 0.6 0.0 0.4 3.8 0.8 0.9 5.5 0.7 2.7 0.4 2.1 5.0 8.1 1.3 0.7 11.2 4.2 1.2 0.4 59.9 0.5 8.0 19.1 2.1 5.0 2.3 0.8 1.2 0.6 0.5 10.9 1.4 41.6 28.6 42.7 20.5 0.9 1.4 16.4 20.0 10.8 41.5 38.3 37.0 12.6 41.6 10.4 7.9 17.3 30.7 30.9 13.7 34.3 18.2 50.8 24.8 16.4 31.2 0.1 13.0 24.4 0.7 0.6 24.3 15.2 4.1 19.0 27.4 15.4 16.1 18.1 19.8 47.5 18.6 26.5 13.7 12.7 32.2 39.3 17.2 9.0 8.2 9.3 13.2 17.8 8.0 13.6 13.3 14.0 8.8 7.4 16.6 17.1 14.9 52.0 11.8 7.8 31.3 8.0 19.9 33.6 0.0 0.6 0.9 0.6 0.4 0.2 1.6 1.9 3.1 0.8 2.3 0.2 1.0 1.2 0.5 0.3 0.2 10.9 1.4 0.4 0.6 0.6 0.6 0.4 0.2 0.4 0.4 0.8 0.4 0.0 0.3 2.2 0.3 3.9 0.0 1.1 0.0 0.0 3.4 0.0 0.0 5.1 0.0 0.2 0.0 0.0 1.4 46.7 0.0 76.2 4.7 0.4 4.6 0.6 23.9 0.0 0.0 4.9 6.3 0.0 0.6 4.4 1.7 0.0 4.2 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.3 0.7 2.0 2.0 7.6 2.5 6.3 1.4 BABAM1 "C19orf62, FLJ20571, HSPC142, MERIT40, NBA1" ENSG00000105393 "BRISC and BRCA1 A complex member 1" Q9NWV8 19 17267350-17281249 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA054386, HPA068786, HPA077609" Approved Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA054386: AB_2682471, HPA068786: AB_2686034, HPA077609: " "unprognostic (5.60e-2)" "unprognostic (1.08e-3)" "unprognostic (6.77e-2)" "unprognostic (1.06e-1)" "unprognostic (1.44e-1)" "unprognostic (2.18e-2)" "unprognostic (9.45e-3)" "unprognostic (2.05e-2)" "unprognostic (7.30e-2)" "unprognostic (2.03e-2)" "unprognostic (5.12e-2)" "unprognostic (7.21e-2)" "unprognostic (3.31e-3)" "unprognostic (1.74e-2)" "unprognostic (1.63e-1)" "unprognostic (3.79e-1)" "unprognostic (5.74e-2)" 23.2 26.7 39.8 24.2 33.6 37.3 23.7 32.5 50.0 25.6 25.6 24.5 18.7 25.5 24.9 20.5 26.3 22.0 26.8 36.8 35.2 33.3 24.0 31.2 21.6 30.7 34.4 33.8 23.6 29.2 22.2 15.7 31.9 25.8 22.7 23.8 20.8 30.5 25.5 72.7 25.0 23.4 23.9 23.3 29.1 24.5 24.6 22.2 34.5 19.2 33.5 31.3 21.4 19.8 44.7 51.6 51.6 50.1 33.2 55.2 59.7 35.4 19.9 20.1 19.1 22.5 16.0 45.9 21.3 28.4 43.1 43.0 22.8 42.5 25.2 50.9 29.5 19.2 17.7 23.6 29.5 27.7 36.1 37.6 22.1 26.4 27.6 18.3 39.7 28.3 24.2 20.6 28.5 17.0 23.6 36.2 36.1 36.8 29.6 31.1 29.0 39.9 37.7 52.6 29.9 42.9 26.9 26.6 33.2 31.6 17.5 19.5 35.4 25.8 27.0 23.3 24.1 23.7 32.1 26.0 26.2 16.6 32.0 35.4 39.7 47.5 33.1 37.2 52.6 24.6 50.0 50.1 51.6 45.4 46.0 43.4 44.7 42.0 43.8 51.6 43.3 39.2 38.6 12.6 33.2 43.4 42.8 55.2 59.7 39.8 33.6 32.5 50.0 35.2 33.3 34.4 33.8 25.8 22.2 11.9 33.8 59.1 31.8 31.0 19.2 29.8 35.7 16.0 21.6 33.2 13.7 144.3 86.2 64.8 47.6 38.0 52.1 23.3 63.0 136.2 53.0 40.9 45.1 42.0 86.6 15.9 42.1 35.6 36.2 68.8 33.9 46.9 62.4 98.2 53.3 27.8 60.0 57.5 41.8 72.1 12.0 38.8 52.6 40.7 69.5 36.1 132.2 58.6 59.6 34.3 BAG6 "BAT3, D6S52E, G3" ENSG00000204463 "BCL2 associated athanogene 6" P46379 6 31639028-31652705 "Predicted intracellular proteins" "Apoptosis, Differentiation, Immunity, Spermatogenesis, Transport" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 339.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020704, HPA045116, HPA053291" Enhanced Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 2000000 "Nucleoplasm, Cytosol" "CAB020704: , HPA045116: AB_2679220, HPA053291: AB_2682103" "unprognostic (7.32e-2)" "unprognostic (2.96e-2)" "unprognostic (3.43e-1)" "unprognostic (7.67e-3)" "unprognostic (2.61e-1)" "unprognostic (6.00e-2)" "unprognostic (1.07e-3)" "unprognostic (2.14e-1)" "unprognostic (4.46e-1)" "unprognostic (1.34e-1)" "unprognostic (2.88e-2)" "unprognostic (9.98e-2)" "unprognostic (1.08e-3)" "unprognostic (2.04e-1)" "unprognostic (1.82e-2)" "unprognostic (6.05e-2)" "unprognostic (8.16e-2)" 20.8 30.1 16.1 18.4 21.7 16.9 18.1 22.1 31.2 23.9 23.8 22.3 17.9 38.2 25.1 38.6 19.9 23.8 21.4 25.5 15.1 14.1 20.6 41.8 25.7 18.1 15.9 15.6 22.0 22.2 6.6 20.7 27.0 17.5 20.5 30.7 24.4 20.9 19.6 50.5 22.3 31.0 17.3 13.2 23.7 26.1 101.8 16.2 39.9 22.9 30.4 27.1 18.3 19.3 4.8 8.4 8.2 7.5 3.2 6.3 3.1 1.9 14.4 16.8 3.4 8.4 13.0 3.8 3.4 2.7 3.3 3.6 35.8 1.6 2.5 26.0 27.8 20.7 2.4 2.0 29.5 5.4 4.1 39.5 11.1 1.8 22.7 12.6 3.3 33.0 10.4 11.9 2.9 3.9 15.0 9.7 20.4 21.0 11.6 24.1 5.6 2.0 19.6 2.1 3.2 2.6 4.9 2.3 4.6 14.4 5.2 2.4 4.5 1.3 4.1 3.3 4.3 30.2 27.7 1.9 11.4 8.7 2.0 3.3 15.2 20.0 22.1 15.5 2.7 3.6 8.2 5.7 6.6 6.3 7.5 5.0 4.4 4.4 4.1 4.5 4.8 3.5 4.2 5.8 3.2 6.8 8.4 3.0 3.1 16.1 21.7 22.1 31.2 15.1 14.1 15.9 15.6 17.5 16.2 44.7 36.5 27.4 30.3 28.5 26.7 70.2 43.3 36.1 39.8 34.9 17.7 53.0 26.6 57.4 195.1 37.0 85.3 23.3 43.3 57.5 32.9 30.2 48.4 36.0 49.4 47.7 73.6 38.1 38.8 339.6 30.8 35.7 27.0 30.7 49.7 29.6 55.0 57.5 37.1 40.2 39.7 38.8 37.2 93.9 52.8 31.0 99.9 35.4 49.8 33.1 BAP1 "hucep-6, KIAA0272, UCHL2" ENSG00000163930 "BRCA1 associated protein 1" Q92560 3 52401013-52410350 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Chromatin regulator, Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004322, HPA028814, HPA028815, HPA055560" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: AB_2672785, HPA055560: AB_2682850" "unprognostic (1.52e-1)" "unprognostic (7.96e-2)" "unprognostic (1.96e-2)" "unprognostic (6.04e-2)" "unprognostic (1.74e-1)" "unprognostic (2.55e-2)" "unprognostic (9.41e-3)" "unprognostic (8.53e-3)" "unprognostic (1.33e-1)" "unprognostic (3.15e-1)" "unprognostic (4.64e-3)" "unprognostic (3.30e-3)" "prognostic favorable (3.29e-7)" "unprognostic (6.37e-2)" "unprognostic (1.91e-1)" "unprognostic (5.54e-2)" "unprognostic (2.92e-1)" 13.8 17.6 35.6 14.7 33.3 37.3 13.5 21.8 50.4 12.5 17.0 16.3 11.5 12.4 14.7 14.6 21.2 12.1 15.7 16.4 41.5 15.5 16.6 19.0 14.9 15.2 19.4 27.6 16.9 16.3 30.0 11.1 14.8 19.6 14.4 14.9 15.6 17.9 14.6 24.8 40.5 13.9 14.5 10.0 16.1 13.3 37.3 14.7 18.6 15.3 12.9 16.0 14.1 11.7 5.5 8.4 11.3 5.0 3.0 8.5 3.9 14.8 16.9 20.6 17.4 19.9 12.8 23.2 14.7 19.1 24.0 18.6 20.5 13.9 21.4 7.4 20.5 27.1 12.1 21.6 23.8 15.3 21.1 20.5 26.4 35.8 21.2 18.5 24.8 23.5 19.1 31.9 26.5 14.2 13.2 19.1 41.2 22.6 18.9 18.0 12.9 29.4 34.0 23.2 11.8 20.6 12.7 16.7 21.1 14.8 24.1 7.8 25.3 18.1 5.3 21.5 12.1 14.8 34.3 20.4 21.7 20.0 26.0 27.3 28.7 37.7 30.6 23.7 26.2 25.6 3.4 5.0 7.4 8.5 3.9 4.0 5.0 6.8 6.9 3.3 5.5 4.9 6.4 11.3 3.0 3.1 8.4 6.0 3.9 35.6 33.3 21.8 50.4 41.5 15.5 19.4 27.6 19.6 14.7 0.0 13.6 15.0 8.8 28.0 15.3 19.3 10.2 5.3 9.1 24.4 0.0 12.2 10.0 12.0 81.1 12.4 17.6 0.0 14.3 13.1 11.8 9.7 20.7 25.8 11.0 9.5 10.4 15.4 19.3 32.6 9.5 10.2 11.8 11.8 12.9 9.9 12.6 15.3 11.0 14.6 11.3 19.4 13.2 30.9 12.4 20.6 10.1 11.3 16.4 8.5 BATF "B-ATF, BATF1, SFA-2" ENSG00000156127 "Basic leucine zipper ATF-like transcription factor" Q16520 14 75522425-75547015 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.1;lymphoid tissue: 26.6" "Cell type enhanced" "Detected in many" 18 "granulocytes: 226.5;T-cells: 75.6;Urothelial cells: 57.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "T-cells: 41.1" "Cell line enhanced" "Detected in some" "HDLM-2: 82.7;MCF7: 31.1;RT4: 19.5;SK-BR-3: 15.9;U-937: 23.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA059588, HPA064962" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059588: AB_2684074, HPA064962: AB_2685392" "unprognostic (3.33e-3)" "unprognostic (4.87e-3)" "prognostic unfavorable (8.30e-4)" "prognostic favorable (5.35e-6)" "unprognostic (3.02e-2)" "prognostic favorable (7.91e-5)" "unprognostic (1.14e-2)" "unprognostic (1.39e-1)" "unprognostic (2.94e-1)" "unprognostic (6.72e-2)" "unprognostic (7.17e-2)" "unprognostic (8.90e-2)" "prognostic unfavorable (3.74e-9)" "unprognostic (4.74e-2)" "unprognostic (1.90e-1)" "unprognostic (1.41e-1)" "prognostic favorable (4.30e-4)" 4.9 1.3 0.9 15.8 4.7 13.8 7.6 0.2 1.9 2.8 2.8 0.2 1.0 2.0 1.3 1.4 2.6 1.9 7.0 3.1 1.0 0.7 1.9 3.0 7.9 20.2 2.1 0.2 1.6 1.6 0.5 1.2 3.7 1.9 5.2 1.1 1.0 6.0 8.3 0.9 2.8 8.0 2.6 2.7 26.6 5.7 0.7 1.9 6.2 2.7 3.4 23.1 10.4 7.3 7.1 9.0 5.0 8.9 6.4 41.1 8.4 1.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.7 0.0 1.8 0.0 0.3 2.7 2.2 8.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.4 2.4 0.0 31.1 1.0 6.7 0.0 13.0 0.0 0.2 0.0 1.4 0.0 19.5 0.0 0.0 0.0 15.9 0.6 0.0 1.4 4.3 0.0 0.0 0.0 1.0 0.0 7.7 8.2 0.0 0.0 23.0 0.0 1.2 8.9 2.7 19.6 4.9 15.4 7.1 21.4 25.1 9.0 5.2 8.6 18.1 5.0 6.4 4.2 1.0 41.1 8.4 0.9 4.7 0.2 1.9 1.0 0.7 2.1 0.2 1.9 1.9 8.9 43.8 23.6 46.3 4.7 0.0 0.2 2.5 9.4 13.6 3.5 0.0 0.3 0.0 0.3 0.5 0.7 0.0 0.0 2.3 0.2 3.3 20.8 226.5 0.8 49.2 0.0 0.0 3.1 16.0 0.2 0.0 19.3 5.0 9.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.0 0.9 75.6 0.0 57.9 BBX "HBP2, HSPC339, MDS001" ENSG00000114439 "BBX, HMG-box containing" Q8WY36 3 107522936-107811324 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 761.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006049, HPA050646" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006049: AB_2667504, HPA050646: AB_2681200" "unprognostic (7.57e-3)" "unprognostic (1.49e-2)" "unprognostic (8.73e-2)" "unprognostic (3.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.49e-1)" "unprognostic (2.32e-2)" "unprognostic (2.12e-2)" "unprognostic (1.91e-1)" "unprognostic (9.84e-2)" "unprognostic (4.81e-2)" "unprognostic (8.62e-2)" "unprognostic (1.11e-3)" "unprognostic (7.22e-2)" "unprognostic (2.24e-1)" "unprognostic (3.28e-1)" "unprognostic (3.02e-1)" 10.6 22.6 13.1 11.0 20.6 11.2 10.8 12.8 15.1 14.3 13.2 15.4 27.8 6.7 15.1 28.3 10.2 13.2 12.7 11.5 14.8 11.6 14.9 7.3 10.8 10.4 24.5 9.0 21.0 9.0 35.7 39.6 17.8 17.5 17.4 7.3 9.1 11.8 25.1 8.5 7.5 9.4 14.0 26.7 14.1 9.6 43.9 25.5 13.5 19.3 8.0 10.1 15.9 15.6 33.7 16.3 25.2 17.5 25.2 26.1 11.4 18.6 17.3 14.9 22.3 13.3 19.4 12.2 17.7 18.3 16.1 17.9 1.9 15.2 9.7 22.2 11.2 18.4 13.0 16.7 21.5 24.4 12.5 7.8 14.5 14.0 4.1 15.8 19.9 9.0 16.2 15.8 16.2 32.6 22.7 13.5 11.7 6.7 14.6 13.6 6.2 11.2 2.0 7.3 0.2 14.7 15.9 14.1 11.0 10.2 14.1 10.7 10.9 31.3 3.1 15.4 16.0 12.4 4.5 17.7 19.8 14.7 7.3 12.6 6.2 4.1 11.0 17.9 10.3 11.5 25.2 9.1 21.6 22.6 9.2 26.1 32.8 20.3 22.8 12.7 33.7 25.7 21.1 14.9 25.2 17.5 16.3 13.4 11.4 13.1 20.6 12.8 15.1 14.8 11.6 24.5 9.0 17.5 25.5 59.6 69.7 91.3 125.6 75.7 90.3 93.6 76.5 44.2 45.5 90.7 60.9 172.5 41.4 69.4 761.4 73.0 16.6 46.7 65.1 74.7 80.3 95.3 31.2 27.6 41.9 162.1 63.8 57.1 54.0 372.5 144.7 68.9 64.1 36.1 33.3 141.5 56.6 43.5 193.7 88.0 61.1 142.3 128.8 73.5 118.0 66.0 165.9 68.7 36.0 108.0 BCL9L DLNB11 ENSG00000186174 "B cell CLL/lymphoma 9 like" Q86UU0 11 118893875-118925608 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049370, HPA053421" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049370: AB_2680732, HPA053421: AB_2682145" "unprognostic (1.67e-2)" "unprognostic (1.48e-2)" "unprognostic (1.20e-1)" "unprognostic (2.71e-1)" "unprognostic (2.87e-1)" "unprognostic (1.90e-1)" "unprognostic (6.61e-3)" "unprognostic (1.17e-3)" "unprognostic (1.03e-1)" "unprognostic (4.61e-2)" "unprognostic (4.66e-3)" "unprognostic (1.39e-1)" "unprognostic (2.83e-3)" "unprognostic (4.85e-3)" "unprognostic (2.24e-2)" "unprognostic (2.14e-1)" "unprognostic (2.90e-3)" 18.4 18.9 10.2 17.2 10.0 13.3 23.8 31.7 9.9 27.4 16.4 6.7 15.8 13.2 22.3 12.8 18.9 22.2 21.2 15.6 9.0 4.1 10.9 9.0 17.1 13.8 9.5 7.7 22.2 16.4 9.0 6.5 31.9 9.1 16.1 4.1 14.5 21.5 14.7 19.1 19.9 14.6 22.8 7.9 13.9 14.0 9.0 8.6 13.0 12.2 11.9 16.7 21.9 25.6 0.6 0.6 1.1 0.5 0.7 2.2 0.8 12.3 22.5 3.2 5.9 10.5 10.2 20.7 17.1 13.2 5.4 3.2 23.9 24.7 3.4 22.9 17.9 22.2 24.0 1.5 31.4 1.4 4.1 0.8 3.3 12.6 8.2 11.9 1.1 3.2 12.9 19.6 6.5 13.1 10.5 4.8 2.0 4.3 3.9 3.7 20.8 2.5 0.9 3.8 7.4 13.0 5.3 1.4 2.3 5.7 8.6 1.7 2.6 24.1 36.6 3.4 6.0 28.8 1.4 16.0 17.5 13.3 5.2 14.5 0.8 0.0 1.0 9.4 3.9 9.9 0.0 0.5 0.0 2.2 0.0 1.5 0.3 1.2 1.3 0.1 0.6 1.9 1.5 1.1 0.7 0.0 0.6 0.2 0.8 10.2 10.0 31.7 9.9 9.0 4.1 9.5 7.7 9.1 8.6 14.9 11.5 2.4 8.8 34.5 18.4 2.0 15.3 4.0 11.4 7.0 3.9 9.8 0.0 11.8 0.1 10.1 8.0 0.0 12.7 7.0 11.6 18.2 2.3 10.0 3.8 12.7 5.2 11.1 5.2 0.0 13.6 2.6 6.8 19.8 5.0 6.9 20.3 7.0 13.4 2.2 2.8 25.8 14.7 0.5 1.0 39.5 29.6 11.8 6.3 9.1 BCOR "FLJ20285, KIAA1575" ENSG00000183337 "BCL6 corepressor" Q6W2J9 X 40049815-40177329 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056308, HPA073591" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA056308: AB_2683095, HPA073591: AB_2732227" "unprognostic (2.75e-2)" "unprognostic (2.83e-1)" "unprognostic (2.45e-1)" "unprognostic (9.26e-2)" "unprognostic (1.55e-1)" "unprognostic (9.80e-3)" "prognostic unfavorable (1.30e-5)" "unprognostic (3.82e-3)" "unprognostic (6.86e-2)" "unprognostic (1.86e-1)" "unprognostic (4.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.91e-3)" "unprognostic (6.83e-2)" "unprognostic (9.57e-2)" "unprognostic (2.63e-1)" "unprognostic (1.55e-1)" 9.1 12.8 8.7 8.7 10.5 20.6 13.3 11.5 12.0 10.0 12.6 22.7 11.9 7.8 11.1 13.9 13.6 10.4 8.6 13.0 7.1 5.4 11.2 13.3 11.4 15.2 12.9 8.4 19.8 13.6 19.7 11.9 12.5 10.7 13.2 8.2 13.7 11.1 16.5 28.8 13.6 10.3 12.9 8.6 11.4 11.5 9.8 15.8 18.4 16.0 11.4 13.5 13.8 25.5 6.5 7.3 7.6 7.1 8.2 6.8 11.8 13.1 8.7 17.8 21.7 2.0 1.6 3.1 4.5 7.1 5.7 4.7 3.7 5.3 12.0 5.3 8.3 3.7 12.4 29.0 3.8 5.1 20.9 26.4 13.4 13.4 14.4 3.4 10.8 7.7 2.6 5.6 6.3 3.6 8.4 7.7 7.9 34.3 29.0 7.0 8.4 24.4 22.6 17.5 6.2 13.6 11.9 18.4 13.5 10.5 8.3 12.8 23.1 9.4 8.3 7.0 9.1 8.9 23.8 6.4 6.2 7.8 9.1 5.0 17.2 13.3 12.5 5.4 9.9 9.5 7.6 5.0 4.5 6.8 6.1 4.3 6.5 4.7 3.9 7.3 5.5 4.7 4.8 1.1 8.2 7.1 3.1 5.5 11.8 8.7 10.5 11.5 12.0 7.1 5.4 12.9 8.4 10.7 15.8 20.8 23.2 12.3 3.2 13.1 34.2 7.6 10.2 6.7 5.7 10.4 11.8 3.7 1.7 4.5 2.1 17.4 4.9 0.0 9.1 5.5 13.6 7.9 23.2 9.5 6.4 14.3 15.6 19.0 11.0 2.1 9.8 8.6 5.0 7.2 11.7 7.7 6.6 0.0 7.4 4.0 22.0 0.0 26.4 1.1 13.5 12.2 1.7 7.5 7.6 2.6 BDP1 "HSA238520, KIAA1241, KIAA1689, TAF3B1, TFC5, TFIIIB150, TFIIIB90, TFNR" ENSG00000145734 "B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB" A6H8Y1 5 71455615-71567820 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 7.3;TIME: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064166, HPA077984" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064166: , HPA077984: " "unprognostic (4.96e-2)" "unprognostic (2.19e-1)" "unprognostic (6.65e-2)" "unprognostic (3.01e-1)" "unprognostic (3.47e-2)" "unprognostic (1.44e-2)" "unprognostic (7.72e-2)" "unprognostic (2.02e-1)" "unprognostic (9.59e-3)" "unprognostic (8.20e-2)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "unprognostic (3.86e-2)" "unprognostic (1.52e-1)" "unprognostic (7.83e-2)" "unprognostic (2.50e-2)" "unprognostic (5.86e-2)" 7.8 8.7 6.1 4.4 9.0 3.3 7.9 13.1 9.8 5.9 4.4 2.5 3.3 1.5 6.1 3.3 5.0 7.8 5.2 4.0 6.6 3.4 6.5 4.2 3.7 3.5 6.3 5.6 5.0 10.7 1.5 10.0 3.7 5.7 4.9 4.1 1.9 4.9 6.1 10.0 6.5 4.1 6.1 4.1 4.7 3.6 4.9 7.5 6.7 7.9 2.5 3.0 5.7 3.7 2.5 1.4 1.8 0.4 1.9 1.3 0.1 0.2 2.3 4.4 1.1 0.1 0.5 4.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.3 1.6 5.0 0.0 0.1 0.0 3.5 0.0 0.0 0.1 5.6 1.0 2.7 0.6 0.0 0.0 0.0 0.0 0.7 2.4 4.1 0.0 7.3 0.0 1.8 2.4 0.0 0.4 0.0 0.3 4.8 4.7 0.0 4.0 1.9 1.7 0.0 6.1 0.0 0.9 3.6 2.6 0.0 0.0 9.7 4.7 0.1 1.6 0.0 1.5 3.8 0.0 0.0 0.4 5.2 0.0 0.1 1.8 1.3 0.4 0.6 0.9 0.6 0.5 0.6 2.5 1.3 0.9 0.5 1.9 0.0 1.4 0.4 0.1 6.1 9.0 13.1 9.8 6.6 3.4 6.3 5.6 5.7 7.5 56.6 88.2 43.6 51.4 39.5 73.1 98.6 45.9 57.6 83.0 33.2 96.2 32.1 1.7 38.7 21.8 53.7 20.2 46.7 31.3 41.0 40.7 42.1 55.6 24.1 27.5 89.0 56.2 22.1 17.5 16.8 54.4 37.3 27.0 55.1 25.9 46.5 39.7 23.0 51.2 8.2 121.3 51.8 48.6 64.7 53.0 37.9 40.3 55.4 32.3 59.9 BHLHE41 "BHLHB3, bHLHe41, DEC2, SHARP-1, SHARP1" ENSG00000123095 "Basic helix-loop-helix family member e41" Q9C0J9 12 26120026-26125127 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.9" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 333.3;Cone photoreceptor cells: 172.8;Horizontal cells: 236.8;Muller glia cells: 283.4;Rod photoreceptor cells: 289.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 35 "memory B-cell: 5.3;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 54 "B-cells: 5.3" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 33.8;Karpas-707: 14.3;RT4: 44.7;U-266/70: 19.2;U-87 MG: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056035, HPA077617" Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA056035: AB_2683017, HPA077617: " "unprognostic (1.57e-3)" "unprognostic (1.57e-2)" "unprognostic (2.32e-2)" "unprognostic (6.62e-2)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" "unprognostic (5.86e-2)" "unprognostic (2.59e-1)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.96e-2)" "prognostic unfavorable (8.73e-5)" "unprognostic (5.23e-2)" "unprognostic (1.65e-1)" "unprognostic (5.61e-3)" "prognostic favorable (1.09e-4)" 7.0 11.7 23.8 5.8 32.3 1.2 10.7 22.9 26.9 30.6 7.6 33.3 3.0 2.8 6.9 15.6 3.2 34.5 14.1 14.7 25.9 19.6 3.8 1.4 9.1 6.0 38.9 14.0 10.9 6.4 6.2 11.2 8.3 28.3 8.2 9.1 19.0 13.4 11.7 58.9 3.8 4.3 4.3 49.6 6.2 4.4 4.0 44.0 0.9 43.6 6.4 13.3 16.5 6.7 5.3 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.0 7.6 3.5 1.7 0.8 1.3 0.1 0.5 0.0 4.8 0.0 0.7 1.5 11.4 4.0 0.1 0.6 0.4 0.0 0.6 0.3 0.0 0.0 0.3 1.9 0.1 0.5 0.4 2.8 5.5 33.8 0.0 0.0 0.0 14.3 0.8 0.4 0.0 1.3 3.7 1.3 2.8 0.0 0.6 10.9 1.8 44.7 0.0 0.0 0.5 0.2 10.1 0.2 0.0 0.0 2.3 2.6 3.1 0.3 2.0 19.2 11.0 0.0 16.5 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 32.3 22.9 26.9 25.9 19.6 38.9 14.0 28.3 44.0 0.0 0.6 22.9 50.0 5.4 333.3 33.5 33.1 42.8 10.3 27.9 172.8 22.2 0.0 35.8 0.2 4.8 10.8 0.0 19.8 2.4 18.8 38.9 5.7 0.0 71.2 236.8 12.6 3.1 2.7 0.4 27.9 35.2 13.5 47.7 3.0 283.4 13.9 5.7 25.1 2.1 289.4 6.5 6.6 0.5 0.4 2.9 5.9 0.0 3.3 52.5 BIRC7 "KIAP, ML-IAP, mliap, RNF50" ENSG00000101197 "Baculoviral IAP repeat containing 7" Q96CA5 20 63235883-63240507 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.4;placenta: 13.6;retina: 21.1" "Group enriched" "Detected in some" 5 "Hofbauer cells: 56.9;Melanocytes: 25.3;Muller glia cells: 46.0" "Cancer enriched" "Detected in many" 10 "melanoma: 73.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 9 "T-cells: 2.0" "Cell line enriched" "Detected in some" 4 "SK-MEL-30: 63.7" "Not detected" "Not detected" "HPA047850, HPA061283" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA047850: AB_2680181, HPA061283: " "unprognostic (3.60e-1)" "unprognostic (7.94e-2)" "unprognostic (2.70e-2)" "unprognostic (1.78e-3)" "unprognostic (1.15e-1)" "unprognostic (8.11e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.62e-3)" "unprognostic (1.24e-2)" "unprognostic (6.90e-2)" "unprognostic (2.27e-1)" "unprognostic (8.82e-3)" "unprognostic (1.22e-2)" "unprognostic (4.77e-2)" "unprognostic (2.55e-2)" "unprognostic (4.84e-2)" 1.6 1.3 1.0 0.7 1.0 0.3 0.7 0.1 2.2 3.0 1.3 0.5 0.1 0.4 0.8 14.4 0.3 0.3 0.5 2.8 0.9 1.1 2.6 0.8 2.3 2.2 4.9 1.0 0.2 0.1 0.1 0.6 13.6 1.5 0.4 0.3 21.1 0.8 0.1 0.1 4.9 0.3 0.2 4.3 1.6 0.3 0.4 0.3 0.3 0.3 1.0 0.5 0.4 1.8 0.0 0.0 0.0 0.2 0.0 2.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 2.2 0.4 0.0 6.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 63.7 1.6 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 1.0 0.1 2.2 0.9 1.1 4.9 1.0 1.5 0.3 0.0 0.6 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 1.8 0.0 1.4 0.0 0.6 0.1 0.0 0.0 0.0 0.6 8.2 0.5 0.0 2.3 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 46.0 2.3 0.0 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 BIVM-ERCC5 ENSG00000270181 "BIVM-ERCC5 readthrough" 13 102799110-102875994 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 10.6" "Group enriched" "Detected in some" 28 "Alveolar cells type 2: 2.9;Ciliated cells: 1.4;Club cells: 4.5;granulocytes: 2.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "MAIT T-cell: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 3.0;HEK 293: 12.2;HeLa: 5.2;PC-3: 6.7;SCLC-21H: 3.4" "HPA045845, HPA050126, HPA050374" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045845: AB_2679471, HPA050126: AB_2681027, HPA050374: AB_2681106" "unprognostic (6.01e-2)" 1.0 1.0 2.7 3.7 4.5 1.1 1.4 10.6 5.7 1.0 2.9 1.3 2.6 1.0 2.1 1.1 1.0 2.6 1.0 1.9 2.7 3.2 2.4 2.3 1.5 2.2 2.7 1.0 1.9 1.0 2.7 1.3 2.6 2.0 1.0 1.1 1.0 2.7 1.0 1.0 1.0 2.6 0.6 1.8 2.6 1.2 2.3 0.3 1.7 1.5 1.0 1.0 1.0 0.0 2.8 0.0 1.4 1.3 2.9 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.7 0.0 0.1 0.6 0.0 3.0 0.3 0.0 0.0 0.0 12.2 0.0 5.2 0.0 0.5 2.5 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.4 0.1 3.4 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 0.6 2.9 0.0 0.7 1.0 2.8 0.0 0.2 0.1 0.0 1.3 0.0 0.0 0.3 1.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BMS1 "BMS1L, KIAA0187" ENSG00000165733 "BMS1, ribosome biogenesis factor" Q14692 10 42782801-42834937 "Disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036589, HPA043081" Uncertain Enhanced "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli, Mitotic chromosome" "HPA036589: AB_10601460, HPA043081: AB_2678305" "unprognostic (1.46e-2)" "unprognostic (4.31e-1)" "unprognostic (7.09e-2)" "unprognostic (3.56e-2)" "unprognostic (3.11e-2)" "unprognostic (7.25e-3)" "prognostic unfavorable (1.06e-6)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.89e-2)" "unprognostic (3.81e-3)" "unprognostic (1.32e-2)" "unprognostic (2.16e-3)" "unprognostic (7.03e-2)" "unprognostic (1.80e-1)" "unprognostic (3.43e-1)" "unprognostic (4.82e-2)" 17.8 15.3 10.4 15.8 19.7 17.4 16.2 22.5 20.6 15.5 12.9 13.7 11.2 11.8 23.1 13.4 17.8 14.0 10.0 14.4 10.8 13.3 17.8 16.8 14.1 17.2 12.6 15.4 17.5 16.2 24.7 28.0 15.3 22.8 14.1 15.4 12.3 18.8 14.0 29.9 18.1 13.8 14.7 15.0 18.3 13.5 14.8 13.4 20.7 14.0 17.2 19.2 14.4 15.9 9.8 8.4 3.4 9.1 6.2 11.6 5.6 16.8 14.4 14.0 15.9 10.6 8.8 13.6 14.2 15.0 16.8 14.5 19.8 13.3 9.0 10.1 12.2 9.4 14.8 22.8 18.3 22.1 13.1 16.0 12.0 11.2 16.8 9.2 32.4 11.4 7.9 9.4 18.1 17.6 9.4 12.7 10.5 21.0 9.7 11.9 14.2 18.0 10.7 17.7 11.7 15.3 16.6 14.7 9.6 9.3 14.9 10.7 11.4 12.3 13.8 11.7 15.3 16.7 9.4 15.3 7.9 28.3 15.7 23.0 7.8 9.6 26.3 11.5 24.0 6.0 3.4 5.1 2.9 8.6 9.1 10.2 9.8 10.6 9.3 8.4 7.4 11.6 10.0 0.7 6.2 7.4 4.4 7.5 5.6 10.4 19.7 22.5 20.6 10.8 13.3 12.6 15.4 22.8 13.4 29.8 24.9 24.6 24.5 20.4 21.0 41.4 22.9 68.3 44.3 22.7 9.8 24.5 18.3 25.0 12.0 26.4 7.9 0.0 30.5 25.1 21.9 17.4 20.9 17.1 17.5 20.6 16.1 23.9 18.6 8.1 21.9 21.0 32.1 41.5 10.4 11.4 29.2 7.0 15.6 23.2 25.6 19.4 20.3 35.2 53.5 22.2 20.8 20.0 16.8 36.0 BNC1 "BNC, HsT19447" ENSG00000169594 "Basonuclin 1" Q01954 15 83255903-83284714 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 13.4;testis: 27.5;tongue: 20.2" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 78.8;Early spermatids: 37.3;Late spermatids: 74.8;Suprabasal keratinocytes: 51.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 16.3;HBEC3-KT: 37.1;hTCEpi: 41.7;hTERT-HME1: 40.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063183, HPA066947, HPA077428" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063183: AB_2684957, HPA066947: AB_2685752, HPA077428: AB_2732345" "unprognostic (1.86e-3)" "unprognostic (1.08e-1)" "unprognostic (7.89e-3)" "unprognostic (5.55e-2)" "unprognostic (4.06e-2)" "unprognostic (2.47e-2)" "unprognostic (2.45e-2)" "unprognostic (7.91e-2)" "unprognostic (8.89e-4)" "unprognostic (6.94e-2)" "unprognostic (4.13e-1)" "unprognostic (3.85e-3)" "unprognostic (8.46e-3)" "unprognostic (2.20e-1)" "unprognostic (2.95e-3)" "unprognostic (1.01e-2)" 12.7 0.1 0.0 1.6 0.1 0.0 0.9 0.0 0.4 2.7 1.5 0.1 0.0 0.0 0.4 10.8 13.4 0.8 0.1 1.4 0.1 0.0 0.1 0.1 0.7 1.3 0.2 0.2 0.6 0.0 0.0 0.0 1.9 0.5 0.4 0.0 0.7 1.7 0.2 0.1 7.9 0.2 0.3 0.3 0.1 0.0 27.5 0.0 6.0 0.2 20.2 3.7 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 1.4 2.1 0.0 0.6 0.1 7.1 10.0 0.0 0.1 0.0 0.3 4.3 0.0 16.3 0.8 37.1 12.9 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 1.8 41.7 6.3 40.7 1.5 6.9 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.7 0.0 0.0 4.8 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.0 9.7 78.8 0.0 0.4 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 37.3 0.5 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.0 0.1 0.0 0.0 1.3 0.0 74.8 0.6 0.5 8.5 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.2 16.3 5.9 51.1 0.0 0.0 0.0 4.6 BOD1L1 "BOD1L, FAM44A, FLJ33215, KIAA1327" ENSG00000038219 "Biorientation of chromosomes in cell division 1 like 1" Q8NFC6 4 13568738-13627723 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Rod photoreceptor cells: 187.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 12.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036943, HPA037362, HPA041290" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036943: AB_2675397, HPA037362: AB_10670380, HPA041290: AB_2677393" "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (7.73e-2)" "unprognostic (2.29e-2)" "unprognostic (5.94e-2)" "unprognostic (6.15e-2)" "unprognostic (6.39e-2)" "unprognostic (2.10e-1)" "unprognostic (2.13e-2)" "unprognostic (3.19e-1)" "unprognostic (9.02e-2)" "unprognostic (1.72e-1)" "prognostic favorable (3.48e-6)" "unprognostic (2.03e-1)" "unprognostic (1.16e-1)" "unprognostic (1.02e-2)" "unprognostic (6.60e-2)" 17.5 12.6 18.9 23.8 24.3 40.2 18.3 30.4 34.9 21.5 16.8 10.4 18.2 12.1 20.5 19.8 15.2 16.9 14.1 13.6 18.4 12.4 14.2 12.6 22.8 22.0 20.1 21.7 26.8 16.0 28.6 16.0 18.3 21.1 15.4 14.5 7.1 17.1 27.3 13.2 19.5 20.9 18.2 21.1 26.9 16.1 18.0 21.6 23.4 16.4 11.7 22.3 16.5 16.2 2.2 2.5 12.2 1.4 0.7 1.6 0.5 10.2 13.8 13.8 9.9 16.8 17.8 10.6 11.9 12.6 9.9 11.2 10.3 11.2 13.8 5.4 13.0 18.5 7.0 11.2 11.8 19.2 9.5 6.5 19.4 17.4 12.6 10.4 29.1 16.1 14.2 13.5 20.5 15.9 13.7 10.2 9.8 13.6 16.6 12.4 6.1 15.0 19.5 17.7 6.6 12.0 11.5 20.5 5.5 18.5 10.4 8.2 15.1 13.1 4.6 10.6 15.5 5.4 11.3 23.1 15.4 8.1 9.5 15.6 19.7 11.5 17.5 15.2 13.8 12.2 2.5 1.4 2.8 1.6 1.4 1.3 1.7 1.0 1.1 0.9 2.2 1.5 1.1 12.2 0.7 0.9 2.5 0.9 0.5 18.9 24.3 30.4 34.9 18.4 12.4 20.1 21.7 21.1 21.6 77.4 85.8 51.3 16.8 23.4 156.0 80.3 53.5 52.2 75.1 34.9 84.4 13.6 3.3 26.0 15.3 42.2 24.0 23.3 21.8 14.9 25.9 20.4 60.2 30.4 18.6 152.6 33.4 33.7 36.5 13.5 46.6 34.3 23.6 21.6 26.0 103.2 26.0 21.0 54.5 4.5 187.0 45.3 24.0 75.4 15.2 25.2 15.6 37.3 21.0 22.8 BOP1 KIAA0124 ENSG00000261236 "Block of proliferation 1" Q14137 8 144262102-144291370 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 60.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 67.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047869, HPA066764" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA047869: AB_2680193, HPA066764: AB_2685716" "unprognostic (6.92e-2)" "unprognostic (5.03e-3)" "unprognostic (6.78e-2)" "unprognostic (2.06e-3)" "unprognostic (3.32e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (3.35e-5)" "unprognostic (2.25e-2)" "unprognostic (4.14e-1)" "unprognostic (3.31e-1)" "unprognostic (2.26e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (2.23e-7)" "unprognostic (7.83e-2)" "unprognostic (4.33e-1)" "unprognostic (8.49e-2)" "unprognostic (4.06e-3)" 4.8 4.3 5.7 7.7 5.9 7.8 6.4 6.3 6.9 2.0 3.9 1.6 2.0 5.1 2.7 1.5 6.8 2.6 4.8 5.1 5.5 2.8 6.2 2.3 6.6 4.1 6.7 2.7 17.5 5.1 2.2 3.2 4.3 2.9 1.5 1.5 5.8 3.0 19.0 7.4 4.5 4.9 2.0 4.8 4.4 8.3 3.3 6.3 3.9 6.7 4.5 3.5 6.9 5.2 6.4 2.5 4.7 3.5 5.7 2.5 12.5 24.6 3.4 14.5 2.0 2.3 12.6 8.7 1.8 8.8 5.5 18.6 7.3 15.3 14.9 3.3 3.3 10.1 6.2 10.3 2.0 13.4 24.8 19.2 14.9 14.1 4.6 8.5 10.6 4.5 5.1 7.4 6.7 1.7 5.5 14.2 19.3 5.1 3.4 32.0 22.8 10.9 8.3 12.9 67.8 17.5 5.1 23.3 3.6 8.4 19.1 7.6 9.3 12.1 5.9 1.7 8.9 8.1 10.3 8.1 25.0 10.9 24.9 4.9 3.1 12.8 6.0 13.8 10.6 0.0 4.7 2.5 4.4 4.7 4.8 5.2 4.9 5.7 6.4 4.5 4.4 4.1 0.2 3.5 4.0 4.1 4.2 2.5 8.9 6.1 13.4 13.8 0.5 10.2 6.7 10.2 2.7 6.8 10.4 0.0 21.5 5.0 24.4 8.9 8.7 7.0 0.0 18.7 35.1 9.3 10.0 10.3 13.1 19.1 14.3 25.8 3.7 6.4 15.5 9.8 7.5 0.0 11.8 9.2 13.7 20.3 8.6 9.2 13.6 4.2 12.9 4.3 10.4 60.5 0.1 14.9 8.7 21.6 11.6 BPTF "FAC1, FALZ, NURF301" ENSG00000171634 "Bromodomain PHD finger transcription factor" Q12830 17 67825524-67984378 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029069, HPA048289" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029069: AB_10602597, HPA048289: AB_2680342" "unprognostic (1.22e-1)" "unprognostic (6.53e-2)" "unprognostic (2.41e-2)" "unprognostic (3.74e-2)" "unprognostic (4.43e-2)" "unprognostic (1.10e-1)" "unprognostic (1.02e-2)" "unprognostic (2.30e-1)" "unprognostic (8.97e-2)" "unprognostic (1.54e-1)" "unprognostic (4.07e-2)" "unprognostic (9.24e-2)" "prognostic favorable (8.46e-4)" "unprognostic (1.05e-1)" "unprognostic (2.85e-1)" "unprognostic (3.01e-2)" "unprognostic (1.56e-1)" 16.1 16.2 28.0 28.6 28.7 22.3 19.5 61.9 35.3 20.7 18.5 18.9 17.0 12.1 20.1 24.0 17.9 17.8 17.4 13.9 26.6 17.7 17.1 14.7 24.1 31.7 31.6 22.2 27.1 16.3 31.3 29.7 17.2 26.0 17.3 18.0 14.5 16.9 18.4 17.9 29.5 18.2 16.5 18.4 21.1 17.4 23.6 33.5 41.4 19.0 12.3 30.1 16.7 32.5 12.6 10.4 15.1 4.8 9.7 7.3 1.4 13.3 17.5 25.7 13.0 14.3 13.7 14.1 10.5 9.8 12.6 11.0 16.1 9.6 54.9 7.8 11.7 10.0 10.5 25.1 11.3 20.6 7.7 24.2 21.1 16.8 22.0 6.8 30.7 17.0 10.0 12.8 12.6 9.6 11.5 23.6 17.6 23.8 15.8 10.9 20.5 31.3 15.3 19.6 12.5 16.0 22.6 31.1 10.8 11.1 16.8 19.4 22.2 14.4 38.9 14.8 32.6 16.4 17.8 16.5 19.3 15.1 7.0 12.9 13.0 13.0 32.6 9.1 14.9 7.4 15.1 3.9 7.5 7.3 2.2 5.9 5.7 5.9 5.7 2.8 12.6 6.2 6.4 8.9 9.7 4.8 10.4 4.2 1.4 28.0 28.7 61.9 35.3 26.6 17.7 31.6 22.2 26.0 33.5 107.2 124.1 51.4 47.2 66.7 204.4 114.1 56.0 96.4 130.8 55.8 135.5 32.0 6.6 51.8 19.7 85.7 44.6 46.7 54.5 27.7 63.0 50.8 115.8 38.4 36.7 187.5 121.0 64.4 50.9 14.5 100.7 50.8 60.8 45.1 58.7 132.3 54.5 60.4 104.7 15.3 196.3 64.7 58.2 135.4 80.7 66.0 32.4 81.2 68.6 50.4 BRD4 "CAP, HUNK1, HUNKI, MCAP" ENSG00000141867 "Bromodomain containing 4" O60885 19 15235519-15332545 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015055, HPA061646, CAB068177, CAB068178" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB068177: AB_2665685, CAB068178: AB_2665686, HPA015055: AB_1845435, HPA061646: AB_2684575" "unprognostic (2.83e-3)" "unprognostic (2.39e-2)" "unprognostic (6.37e-3)" "unprognostic (3.38e-2)" "unprognostic (2.15e-1)" "unprognostic (9.53e-3)" "unprognostic (3.03e-3)" "unprognostic (6.13e-2)" "unprognostic (7.63e-2)" "unprognostic (2.72e-2)" "unprognostic (3.98e-2)" "unprognostic (5.26e-2)" "unprognostic (1.83e-3)" "unprognostic (2.43e-1)" "unprognostic (2.73e-1)" "unprognostic (1.28e-1)" "unprognostic (1.22e-1)" 23.0 20.7 27.8 25.6 30.1 25.2 20.4 32.1 29.9 20.8 19.6 17.2 18.9 17.6 23.4 12.5 22.9 18.6 15.8 21.3 20.3 12.4 18.1 25.3 22.5 22.7 14.8 17.6 27.3 31.3 19.1 18.8 34.0 17.6 20.8 10.7 18.9 22.0 19.3 47.7 27.3 21.0 20.3 13.9 26.8 20.2 20.1 16.8 34.2 21.5 11.6 23.7 20.9 24.8 6.9 4.3 11.6 4.4 4.9 3.5 2.0 20.4 20.7 12.9 24.3 12.3 8.7 15.6 15.1 12.3 11.9 12.6 21.8 30.9 25.7 25.0 16.4 11.7 20.5 15.0 14.2 10.4 25.7 9.9 24.3 18.1 19.0 18.8 24.0 27.1 12.8 14.7 14.8 29.2 7.9 11.5 17.3 41.1 26.1 7.6 26.5 22.5 17.3 26.3 9.4 24.3 28.3 13.6 16.1 9.5 22.1 15.6 14.1 19.9 14.6 17.0 11.0 14.6 16.4 18.3 31.2 14.9 27.7 23.7 21.3 18.8 13.1 17.2 19.5 24.2 5.2 3.6 3.9 3.5 4.4 2.7 5.4 3.1 2.9 2.1 6.9 3.1 2.9 11.6 4.9 3.9 4.3 2.2 2.0 27.8 30.1 32.1 29.9 20.3 12.4 14.8 17.6 17.6 16.8 59.6 53.2 59.1 104.0 104.5 62.2 73.0 56.0 22.7 28.4 24.4 78.5 177.3 21.6 46.6 107.0 73.3 66.9 93.5 57.8 59.0 72.1 110.7 34.8 77.4 51.9 74.7 109.2 55.3 67.7 148.2 71.7 51.2 42.2 43.3 47.3 38.6 55.1 44.4 75.0 28.3 85.9 71.1 85.8 52.5 37.5 125.2 212.7 56.7 51.5 128.6 BRD7 "BP75, CELTIX1" ENSG00000166164 "Bromodomain containing 7" Q9NPI1 16 50313487-50368934 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042389, CAB046458, HPA060171" Enhanced Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB046458: AB_2066024, HPA042389: AB_2677974, HPA060171: AB_2684214" "unprognostic (2.10e-2)" "unprognostic (9.52e-3)" "unprognostic (7.06e-2)" "unprognostic (3.39e-2)" "unprognostic (7.27e-2)" "unprognostic (1.62e-1)" "unprognostic (4.85e-3)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.38e-4)" "unprognostic (2.15e-1)" "unprognostic (8.97e-2)" "unprognostic (9.46e-2)" "prognostic favorable (1.55e-4)" "unprognostic (1.13e-1)" "unprognostic (4.38e-2)" "unprognostic (3.59e-2)" "unprognostic (6.34e-2)" 23.5 26.9 38.8 33.7 39.0 42.2 39.1 34.5 35.9 24.5 30.7 32.4 26.4 23.4 29.0 38.1 37.3 27.1 24.4 41.2 35.3 31.9 29.9 22.9 27.9 32.1 38.4 26.9 26.8 36.5 53.3 35.1 37.9 42.6 29.5 30.3 22.2 26.9 30.7 37.9 31.2 31.1 27.2 48.1 32.1 29.0 41.5 36.4 46.1 31.2 26.5 36.4 24.5 40.0 8.8 11.2 9.6 6.8 12.3 12.1 3.7 22.3 19.7 34.7 20.6 14.7 14.6 22.9 18.4 18.2 29.1 13.2 33.1 22.8 33.4 19.3 16.3 18.1 20.7 31.7 18.5 33.6 15.1 26.3 22.6 15.8 45.7 17.3 31.1 25.0 10.6 27.9 14.9 25.8 17.7 19.3 33.2 32.6 10.7 17.7 14.5 35.2 42.0 27.2 23.6 18.8 43.4 32.6 24.2 25.4 15.8 27.0 21.9 22.3 21.7 15.0 31.0 13.0 28.3 19.4 18.5 22.5 15.2 17.8 5.1 1.9 57.1 14.5 22.7 18.3 8.2 6.8 9.6 8.8 5.7 6.8 8.0 8.9 8.1 5.4 8.8 10.1 12.1 4.0 12.3 5.1 11.2 8.5 3.7 38.8 39.0 34.5 35.9 35.3 31.9 38.4 26.9 42.6 36.4 35.7 59.7 42.5 27.5 45.1 90.5 31.9 48.4 50.9 36.4 47.1 62.8 63.5 91.2 20.0 32.8 31.4 37.2 46.7 19.9 40.7 28.7 42.0 15.0 35.5 26.0 85.8 34.5 23.9 27.0 15.6 30.2 35.5 25.3 14.4 38.2 74.8 20.8 37.0 26.5 46.0 113.1 51.8 22.1 155.1 163.9 55.3 60.5 24.9 35.5 64.3 BRD9 FLJ13441 ENSG00000028310 "Bromodomain containing 9" Q9H8M2 5 850291-892824 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021465, HPA023197" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021465: AB_1845441, HPA023197: AB_2671106" "unprognostic (3.10e-2)" "unprognostic (1.76e-1)" "unprognostic (1.45e-3)" "unprognostic (4.61e-2)" "unprognostic (5.89e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (5.88e-7)" "unprognostic (6.28e-2)" "unprognostic (7.53e-3)" "unprognostic (3.84e-2)" "unprognostic (8.82e-2)" "unprognostic (2.28e-2)" "prognostic unfavorable (2.37e-6)" "unprognostic (6.64e-2)" "unprognostic (1.07e-1)" "unprognostic (6.62e-3)" "unprognostic (1.02e-2)" 13.7 12.3 14.5 15.2 23.8 12.7 12.9 31.8 22.0 13.0 13.0 16.1 10.9 11.7 17.9 10.0 12.8 14.9 9.1 15.3 16.2 10.9 9.1 8.5 11.9 14.3 15.1 15.0 16.3 14.6 13.2 18.2 10.9 14.4 11.2 11.1 11.1 14.7 14.7 25.8 13.1 12.5 12.7 13.9 12.5 13.6 18.5 21.1 16.8 13.3 12.0 15.9 15.6 14.4 6.5 3.1 6.2 4.7 2.7 4.8 1.1 6.2 3.8 12.0 11.9 4.3 8.8 13.7 12.5 7.3 12.5 9.2 7.9 8.5 8.0 19.3 11.8 13.3 5.8 8.1 11.3 10.5 43.9 5.5 10.4 13.8 3.9 9.4 15.0 8.9 6.6 3.3 8.8 7.7 8.8 12.2 14.3 12.7 5.7 9.4 6.4 17.3 8.6 7.2 5.7 6.5 11.0 7.3 6.8 6.3 8.2 7.1 12.6 23.9 8.4 4.4 6.6 7.5 13.2 12.1 11.2 7.5 5.8 12.1 9.2 4.2 14.2 9.4 14.4 13.6 6.2 4.7 5.4 3.5 2.4 4.6 6.5 4.2 4.8 3.1 4.9 4.8 3.0 4.1 2.7 3.1 1.8 4.5 1.1 14.5 23.8 31.8 22.0 16.2 10.9 15.1 15.0 14.4 21.1 17.9 15.6 25.2 12.1 22.6 66.5 21.2 25.5 2.7 14.8 22.7 43.2 15.1 19.9 21.0 76.4 21.8 20.0 0.0 17.1 26.0 16.9 10.8 18.5 18.4 18.2 95.3 15.6 33.7 23.0 43.5 21.0 16.9 13.5 24.4 24.0 25.2 23.6 21.6 18.4 12.6 85.2 25.8 16.5 33.9 61.3 17.8 16.5 29.9 21.8 11.5 BUD13 "Cwc26, fSAP71, MGC13125" ENSG00000137656 "BUD13 homolog" Q9BRD0 11 116748170-116772988 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038340, HPA038341" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038340: AB_2675967, HPA038341: AB_10671528" "unprognostic (1.89e-1)" "unprognostic (1.73e-1)" "unprognostic (1.01e-2)" "unprognostic (2.77e-2)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (5.07e-5)" "unprognostic (1.77e-1)" "unprognostic (8.39e-2)" "unprognostic (1.46e-1)" "unprognostic (4.23e-2)" "unprognostic (9.10e-2)" "unprognostic (1.81e-1)" "unprognostic (4.53e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.63e-1)" 15.1 10.0 9.7 20.4 12.4 12.9 16.1 19.0 15.5 21.2 20.6 16.1 11.6 12.8 19.4 13.8 16.3 16.8 13.7 13.2 9.5 9.4 12.4 11.3 14.4 17.5 10.8 7.8 20.4 13.8 15.7 13.3 18.0 11.0 17.1 16.3 13.5 14.7 13.4 18.5 15.1 20.8 15.5 12.4 18.1 14.7 29.8 11.9 37.9 18.1 14.0 21.2 16.6 22.6 10.8 8.5 20.1 8.7 7.1 11.9 5.7 11.0 6.1 17.2 10.3 5.5 6.6 8.6 10.9 12.2 12.6 12.3 14.3 16.8 23.5 13.9 9.0 13.2 15.6 13.8 8.5 13.9 13.7 5.6 27.4 4.4 10.8 6.7 23.0 16.4 6.0 10.0 10.6 10.9 8.1 12.2 23.4 17.5 11.7 10.3 8.7 28.0 20.4 10.3 15.8 9.7 21.2 14.8 18.1 8.9 12.8 10.2 13.6 12.8 9.4 5.0 11.4 12.9 15.3 6.9 14.5 9.2 7.3 14.5 4.8 6.0 19.4 4.7 21.3 12.8 14.3 7.8 20.1 10.9 7.8 11.9 10.8 9.4 8.6 8.5 8.8 10.8 8.8 9.5 7.1 8.7 7.5 8.0 5.7 9.7 12.4 19.0 15.5 9.5 9.4 10.8 7.8 11.0 11.9 8.9 3.5 6.9 10.0 6.8 6.6 3.7 2.5 12.0 5.7 8.7 11.8 7.2 6.6 6.8 7.7 6.6 10.2 23.3 7.2 9.4 5.1 5.1 10.5 5.4 7.0 3.2 9.2 6.7 7.9 3.2 8.3 8.1 6.8 4.6 6.4 6.9 5.1 6.8 10.3 3.9 6.5 6.5 3.6 33.2 21.3 4.3 8.2 10.0 9.7 5.8 BYSL Enp1 ENSG00000112578 "Bystin like" Q13895 6 41921188-41933046 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031217, HPA031219" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA031217: AB_10599488, HPA031219: AB_10601989" "unprognostic (6.12e-3)" "unprognostic (6.97e-2)" "unprognostic (2.90e-1)" "unprognostic (2.33e-3)" "unprognostic (4.38e-2)" "unprognostic (2.73e-3)" "prognostic unfavorable (6.43e-4)" "unprognostic (2.09e-2)" "unprognostic (2.51e-1)" "unprognostic (6.38e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (2.15e-8)" "unprognostic (4.39e-2)" "unprognostic (2.18e-1)" "unprognostic (2.79e-3)" "unprognostic (5.99e-2)" 11.5 13.4 6.0 11.5 7.2 6.0 17.5 5.0 8.9 7.8 7.9 4.6 5.3 4.0 11.0 5.4 11.7 9.3 10.0 17.6 5.9 6.8 8.0 18.6 7.1 7.4 5.8 6.5 11.8 15.9 10.6 5.4 11.3 7.4 8.0 6.8 4.8 9.6 7.9 31.7 9.2 5.0 12.6 6.3 9.9 7.3 8.9 4.6 20.1 7.1 11.9 12.9 7.3 10.1 4.0 9.3 0.9 3.4 4.5 5.5 2.2 11.9 14.8 8.2 11.6 6.1 6.9 16.8 12.2 6.4 19.3 14.1 20.4 3.1 22.0 11.1 9.1 13.2 7.9 24.9 17.8 15.2 7.9 27.1 20.5 10.4 22.9 10.6 14.6 9.0 8.9 11.6 18.0 16.4 4.2 13.2 12.9 26.0 4.9 12.7 20.4 15.3 14.7 6.4 37.3 15.6 18.3 11.2 14.0 10.7 10.2 16.5 10.0 8.1 7.4 14.2 6.6 8.6 12.9 10.2 11.2 13.3 7.6 17.7 5.7 7.4 47.6 3.8 14.8 11.7 0.0 3.4 0.9 3.9 3.4 5.5 3.8 2.5 3.1 5.4 4.0 1.3 3.0 0.3 4.5 3.1 9.3 3.1 2.2 6.0 7.2 5.0 8.9 5.9 6.8 5.8 6.5 7.4 4.6 0.0 3.8 8.9 21.5 27.5 2.5 2.5 5.1 4.0 5.7 1.8 3.9 19.5 3.3 20.9 6.2 7.1 1.4 0.0 14.8 19.5 10.6 9.6 2.3 6.6 10.6 0.0 5.2 4.3 1.0 3.4 7.5 5.3 8.5 7.2 5.5 3.4 18.6 0.0 6.7 8.4 2.8 6.5 17.3 6.5 26.9 22.1 24.4 5.0 9.9 23.5 C11orf1 FLJ23499 ENSG00000137720 "Chromosome 11 open reading frame 1" Q9H5F2 11 111878935-111885975 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 16 "Early spermatids: 375.8;Late spermatids: 825.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038410, HPA057519" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038410: AB_10672591, HPA057519: AB_2683454" "unprognostic (1.33e-2)" "unprognostic (1.61e-1)" "unprognostic (1.96e-1)" "prognostic favorable (9.32e-4)" "unprognostic (1.30e-1)" "unprognostic (1.42e-2)" "unprognostic (1.10e-1)" "unprognostic (1.14e-1)" "unprognostic (9.26e-2)" "unprognostic (3.23e-2)" "unprognostic (1.41e-2)" "unprognostic (2.86e-2)" "prognostic favorable (1.39e-4)" "unprognostic (3.76e-2)" "unprognostic (2.12e-1)" "unprognostic (1.97e-1)" "unprognostic (2.08e-1)" 11.5 21.2 20.3 12.5 34.8 8.9 29.2 8.3 13.9 12.6 15.8 11.2 21.0 11.8 10.4 39.3 17.7 17.0 19.8 20.8 16.6 18.2 40.1 31.2 15.8 12.4 20.2 12.0 17.1 47.6 19.9 18.9 8.3 14.3 16.6 15.8 12.7 22.6 29.5 8.3 16.9 15.5 10.2 17.4 10.0 15.6 31.4 12.2 10.6 24.2 15.0 10.2 14.2 9.5 14.8 19.0 5.0 8.2 9.5 22.0 6.3 8.0 10.4 13.6 15.0 15.7 12.1 14.1 4.5 11.5 3.7 4.7 17.3 15.1 29.6 21.5 7.6 10.6 9.5 5.4 16.5 5.8 13.1 7.7 10.0 2.2 13.4 9.9 14.6 7.1 22.1 26.0 13.1 25.3 16.6 4.5 31.9 14.3 22.4 12.4 7.9 19.7 23.0 15.5 28.2 15.9 10.2 14.1 41.2 22.9 14.9 12.2 11.7 2.8 10.6 9.6 13.6 21.2 10.3 3.9 13.7 9.8 6.0 6.2 13.1 19.1 44.2 7.0 17.4 8.3 3.3 4.4 5.0 8.2 8.2 15.4 14.8 13.7 10.4 6.4 10.2 22.0 16.4 1.1 9.5 5.5 19.0 9.7 6.3 20.3 34.8 8.3 13.9 16.6 18.2 20.2 12.0 14.3 12.2 23.8 17.5 18.4 55.8 21.1 6.9 48.4 20.4 42.8 31.8 33.2 5.9 24.6 170.8 16.9 375.8 13.5 15.8 46.7 23.8 20.6 13.9 36.9 28.8 31.0 21.2 14.3 25.3 9.2 7.3 825.1 25.3 19.0 23.6 19.0 36.6 26.8 21.3 17.5 23.0 138.3 12.9 19.4 12.7 47.1 30.9 25.7 17.6 12.7 46.6 52.8 C11orf71 FLJ20010 ENSG00000180425 "Chromosome 11 open reading frame 71" Q6IPW1 11 114391443-114400511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "testis: 83.2" "Group enriched" "Detected in many" 15 "Early spermatids: 502.7;Late spermatids: 1567.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA063943, HPA074787" Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA063943: AB_2685157, HPA074787: AB_2686712" "unprognostic (1.24e-1)" "unprognostic (2.53e-2)" "unprognostic (1.42e-2)" "prognostic favorable (6.94e-4)" "unprognostic (7.35e-2)" "unprognostic (4.53e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-3)" "unprognostic (1.58e-1)" "unprognostic (3.04e-3)" "unprognostic (1.39e-2)" "unprognostic (2.85e-2)" "prognostic favorable (7.01e-9)" "unprognostic (5.68e-2)" "unprognostic (5.43e-2)" "unprognostic (1.87e-1)" "unprognostic (1.17e-2)" 3.9 7.3 5.7 3.4 12.1 2.2 5.7 4.1 8.1 4.2 4.9 10.2 5.6 5.5 3.7 18.0 3.2 5.4 3.9 5.4 6.9 6.1 10.6 15.0 3.9 4.3 10.3 4.7 5.0 6.9 8.7 6.9 2.5 6.7 5.6 4.6 5.7 7.2 5.0 9.9 5.6 5.1 2.1 5.7 5.4 5.2 83.2 12.2 6.4 9.5 4.7 3.2 3.1 3.1 10.5 13.6 14.5 17.7 13.2 11.9 11.3 1.2 3.3 3.5 11.1 5.3 3.1 2.5 0.5 1.4 1.4 1.3 2.7 19.9 5.3 7.1 0.8 6.9 5.1 2.3 2.3 1.7 6.1 1.4 4.0 2.4 5.3 5.0 2.3 4.5 5.0 2.6 1.8 5.6 1.6 1.7 8.9 4.1 5.0 2.6 4.5 4.2 3.5 1.8 4.4 2.1 3.1 2.8 13.6 3.1 2.4 9.6 3.8 12.5 1.4 1.9 3.8 9.4 1.3 1.7 0.3 5.2 3.9 0.9 4.9 7.9 4.1 0.7 5.5 1.4 11.7 17.7 11.1 10.3 11.1 6.3 7.0 7.0 7.1 10.6 10.5 11.4 11.9 14.5 13.2 12.2 13.6 7.7 11.3 5.7 12.1 4.1 8.1 6.9 6.1 10.3 4.7 6.7 12.2 3.0 11.2 1.5 13.8 2.4 9.8 18.7 0.0 24.1 5.7 5.2 3.9 14.3 69.6 12.0 502.7 7.0 13.5 0.0 16.8 2.2 3.7 14.4 5.8 0.0 10.1 12.7 17.4 0.0 0.0 1567.4 12.0 9.1 5.0 10.0 19.0 23.4 11.0 17.5 8.5 59.7 12.5 6.5 4.1 23.4 8.8 2.3 12.2 1.7 15.1 9.5 C19orf47 FLJ36888 ENSG00000160392 "Chromosome 19 open reading frame 47" Q8N9M1 19 40319536-40348527 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 35.4;skeletal muscle: 118.0" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 20.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 20.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041843, HPA046309" Enhanced Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA041843: AB_10959886, HPA046309: AB_10960266" "prognostic favorable (6.50e-4)" "unprognostic (1.35e-3)" "unprognostic (1.80e-1)" "prognostic unfavorable (7.10e-5)" "unprognostic (2.75e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (2.26e-1)" "unprognostic (1.59e-1)" "unprognostic (1.63e-1)" "unprognostic (1.47e-2)" "unprognostic (3.25e-2)" "unprognostic (6.23e-2)" "unprognostic (1.62e-2)" "unprognostic (5.28e-2)" "unprognostic (2.77e-1)" "unprognostic (3.28e-2)" 3.2 2.9 4.5 4.2 5.7 4.7 4.4 5.8 9.1 3.5 3.3 9.2 3.6 3.8 3.8 3.1 7.4 2.8 3.5 35.4 4.2 3.8 2.9 4.4 3.4 4.5 6.2 5.0 3.6 3.8 3.7 3.7 4.8 5.6 4.5 2.5 3.6 4.9 4.6 118.0 5.2 3.6 3.7 4.8 3.7 3.0 10.0 5.3 5.0 3.8 6.4 4.7 4.1 5.0 2.1 1.6 20.2 1.6 1.7 2.3 1.3 12.9 19.9 8.4 9.1 5.0 4.5 11.6 13.4 6.2 12.7 15.4 16.5 5.4 15.1 7.5 6.3 6.7 6.5 10.2 12.3 5.3 18.5 12.5 12.3 12.4 12.5 3.7 12.4 8.0 4.5 7.3 17.1 6.1 3.4 7.7 14.1 15.0 8.9 10.7 12.6 18.5 7.0 5.4 10.4 7.6 18.4 13.8 7.6 4.1 11.4 10.8 8.8 14.4 13.6 5.2 5.2 8.1 10.3 10.1 16.0 11.2 10.8 18.3 10.7 14.7 15.0 6.8 11.9 11.0 20.2 1.6 4.7 1.3 1.4 1.6 1.6 2.3 2.1 1.6 2.1 1.6 1.2 5.7 1.7 1.6 1.6 1.6 1.3 4.5 5.7 5.8 9.1 4.2 3.8 6.2 5.0 5.6 5.3 3.0 3.2 0.0 2.4 4.2 2.9 39.1 2.5 1.4 2.3 0.0 2.0 9.1 0.0 3.2 8.0 3.7 2.9 0.0 3.9 11.7 4.7 1.6 4.6 3.8 5.8 3.2 3.5 5.5 5.6 17.1 1.7 2.6 5.0 2.8 2.8 2.9 3.3 0.0 6.3 2.4 1.8 6.5 2.1 14.9 5.5 6.0 13.3 2.2 2.3 1.4 C1orf174 RP13-531C17.2 ENSG00000198912 "Chromosome 1 open reading frame 174" Q8IYL3 1 3889125-3900293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 104.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008270, HPA065778" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA008270: AB_1845633, HPA065778: AB_2685557" "unprognostic (4.91e-3)" "unprognostic (1.13e-1)" "unprognostic (1.62e-1)" "unprognostic (1.75e-1)" "unprognostic (3.38e-1)" "unprognostic (1.49e-2)" "prognostic unfavorable (5.84e-4)" "unprognostic (2.52e-1)" "prognostic unfavorable (7.62e-4)" "unprognostic (7.24e-2)" "unprognostic (5.36e-2)" "unprognostic (7.02e-2)" "prognostic unfavorable (2.73e-6)" "unprognostic (3.71e-2)" "unprognostic (3.95e-1)" "unprognostic (8.05e-2)" "unprognostic (1.46e-2)" 17.6 17.4 15.0 18.8 16.5 24.0 17.8 16.3 19.2 15.4 16.9 21.3 11.6 15.6 19.4 20.1 19.3 19.7 21.1 13.4 15.3 15.4 18.1 24.8 14.5 20.2 15.8 17.1 19.6 20.0 5.4 13.3 24.4 16.7 18.9 15.6 16.5 15.9 17.2 22.9 15.6 16.5 20.1 13.7 22.4 16.5 18.9 15.3 26.9 21.9 19.7 22.4 19.5 15.0 16.5 18.7 30.4 28.8 16.1 27.6 13.6 14.3 8.4 13.3 11.2 11.2 7.0 9.4 13.2 7.4 11.8 12.1 12.2 22.8 11.4 14.9 9.7 16.5 13.9 14.0 9.0 13.3 19.3 13.6 29.4 8.6 17.9 6.9 20.9 15.3 7.4 5.9 12.4 10.0 9.2 9.4 14.1 22.9 11.7 8.2 10.7 21.6 16.1 15.1 19.2 17.8 16.4 22.2 10.7 8.0 8.7 12.8 10.6 12.0 18.0 18.1 12.8 7.5 12.8 10.2 17.1 12.8 28.3 12.5 4.5 4.3 21.9 8.3 23.3 5.6 27.7 16.1 30.4 27.6 28.8 24.0 16.5 18.7 20.9 18.7 15.2 17.9 22.7 13.3 16.1 18.8 10.3 19.3 13.6 15.0 16.5 16.3 19.2 15.3 15.4 15.8 17.1 16.7 15.3 8.9 4.8 14.9 10.8 19.5 9.8 3.4 7.6 12.0 14.8 5.2 7.9 52.5 23.2 19.2 104.9 12.3 10.9 0.0 16.9 53.1 17.4 9.5 36.8 11.6 27.7 11.1 10.9 9.8 14.0 14.5 15.8 18.9 13.5 16.2 13.6 11.7 14.8 14.0 18.0 17.2 10.5 12.9 12.3 20.1 26.0 15.4 22.3 24.5 15.6 9.9 C1orf52 "FLJ44982, gm117" ENSG00000162642 "Chromosome 1 open reading frame 52" Q8N6N3 1 85249953-85259672 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036072, HPA061790" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036072: AB_10602696, HPA061790: AB_2684610" "unprognostic (1.59e-1)" "unprognostic (2.30e-1)" "unprognostic (5.97e-2)" "unprognostic (1.13e-2)" "unprognostic (4.06e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (5.37e-5)" "unprognostic (6.67e-3)" "unprognostic (2.95e-2)" "unprognostic (3.73e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (4.93e-4)" "prognostic unfavorable (1.17e-7)" "unprognostic (8.01e-2)" "unprognostic (2.54e-1)" "unprognostic (4.14e-1)" "unprognostic (2.05e-2)" 14.4 13.5 22.4 13.4 30.1 42.9 17.4 13.8 25.8 11.8 12.3 19.1 9.4 11.3 14.2 16.9 12.0 11.3 12.2 13.0 25.4 19.3 9.9 13.3 14.6 20.3 20.6 19.9 13.9 14.2 11.0 15.6 21.0 17.9 13.1 11.9 8.8 11.5 11.8 18.0 19.8 10.7 12.0 18.7 14.1 12.0 17.0 20.3 12.4 11.4 8.8 14.3 11.2 12.3 27.3 20.8 25.6 21.4 15.5 23.6 16.7 13.4 6.1 11.9 9.9 13.0 9.9 20.7 13.7 8.3 15.1 14.8 8.7 7.2 12.4 12.9 12.0 13.5 9.0 24.0 7.8 15.2 12.8 15.0 16.7 10.7 10.9 11.5 17.2 7.8 7.9 11.1 13.2 10.1 10.6 9.5 18.7 19.7 13.7 8.8 3.7 13.1 14.0 36.7 6.5 8.8 14.5 13.8 5.3 15.0 8.4 7.3 11.4 3.8 10.7 20.2 15.7 6.1 28.0 9.1 8.3 12.4 15.2 16.8 13.0 21.7 18.9 4.9 13.2 9.3 25.6 15.1 22.8 16.4 21.4 17.6 27.3 15.6 14.2 19.4 16.7 23.6 22.9 23.6 15.5 17.6 20.8 12.9 16.7 22.4 30.1 13.8 25.8 25.4 19.3 20.6 19.9 17.9 20.3 41.7 26.4 35.3 50.1 129.1 22.6 21.3 7.6 30.8 33.0 15.7 21.6 54.0 16.6 32.5 28.7 43.0 21.5 23.3 24.1 49.7 56.0 31.9 49.7 14.7 32.0 14.3 37.2 25.8 27.0 8.0 33.9 37.1 30.4 16.2 18.9 25.6 27.3 23.5 23.0 17.3 25.6 38.8 54.2 91.6 55.3 112.7 56.8 36.3 22.0 60.4 C2orf42 FLJ20558 ENSG00000115998 "Chromosome 2 open reading frame 42" Q9NWW7 2 70149880-70248615 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.2" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 194.1;Late spermatids: 86.2;Spermatocytes: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031840, HPA031841, HPA031842" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031840: AB_2674066, HPA031841: AB_10601124, HPA031842: AB_2674068" "unprognostic (8.49e-2)" "unprognostic (2.09e-1)" "unprognostic (2.52e-1)" "unprognostic (1.03e-1)" "unprognostic (1.51e-1)" "unprognostic (3.41e-1)" "unprognostic (1.92e-1)" "unprognostic (2.20e-3)" "unprognostic (2.26e-1)" "unprognostic (3.73e-1)" "prognostic favorable (5.94e-5)" "unprognostic (4.66e-2)" "unprognostic (9.41e-2)" "unprognostic (2.11e-2)" "unprognostic (1.43e-1)" "unprognostic (2.84e-1)" "unprognostic (2.49e-3)" 6.2 5.9 6.2 4.3 8.7 3.1 6.8 10.7 11.8 6.4 4.5 11.5 6.6 3.2 6.6 8.5 5.0 8.7 5.7 4.2 7.2 6.4 6.3 11.2 4.5 8.2 7.3 6.2 8.3 5.0 8.6 8.2 5.9 6.7 5.0 4.0 7.4 4.6 5.8 4.8 4.9 4.6 5.8 6.1 6.7 4.4 41.2 8.2 9.7 6.2 2.1 8.3 6.2 7.5 12.8 6.6 8.0 6.6 17.9 14.2 9.0 4.9 8.4 8.0 7.2 15.9 9.8 9.0 12.0 8.0 10.1 8.4 6.4 4.6 6.2 7.0 7.5 16.1 7.0 8.1 6.8 10.7 11.0 7.2 7.5 5.9 6.4 14.2 6.2 7.6 11.6 13.0 9.2 11.9 10.5 9.3 8.2 6.3 24.8 12.7 4.7 8.0 8.8 5.6 8.4 9.0 7.7 10.7 11.5 8.2 6.0 6.6 6.6 6.4 11.0 12.1 5.7 4.7 7.5 7.2 8.8 6.1 8.1 9.6 13.3 13.2 6.4 7.2 10.0 7.7 1.9 6.6 8.0 11.2 6.1 14.2 12.8 11.4 13.4 6.6 11.5 13.2 13.7 7.0 17.9 6.1 6.0 12.6 9.0 6.2 8.7 10.7 11.8 7.2 6.4 7.3 6.2 6.7 8.2 0.0 2.1 11.8 2.6 2.3 6.6 2.4 0.0 5.3 1.2 5.2 0.0 7.4 6.6 3.1 194.1 2.6 2.9 0.0 2.1 3.0 4.0 2.7 2.3 5.8 3.8 0.0 1.2 5.5 3.5 86.2 6.9 2.7 3.3 1.0 2.2 7.0 1.7 2.9 7.4 5.4 3.9 0.0 3.1 42.3 11.7 3.8 8.0 6.4 2.1 1.8 C5orf51 LOC285636 ENSG00000205765 "Chromosome 5 open reading frame 51" A6NDU8 5 41904188-41921636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043779, HPA063816" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043779: AB_2678666, HPA063816: AB_2685130" "unprognostic (6.64e-2)" "unprognostic (2.24e-2)" "unprognostic (9.92e-2)" "unprognostic (6.92e-3)" "unprognostic (3.93e-2)" "unprognostic (3.41e-2)" "prognostic unfavorable (1.90e-4)" "unprognostic (4.98e-2)" "unprognostic (1.59e-1)" "unprognostic (4.90e-3)" "unprognostic (2.10e-2)" "unprognostic (4.58e-2)" "unprognostic (1.01e-1)" "unprognostic (3.97e-1)" "unprognostic (3.75e-1)" "unprognostic (2.30e-2)" "unprognostic (1.67e-2)" 16.6 12.4 15.9 12.7 21.5 3.4 15.9 20.5 21.3 14.7 12.5 23.5 12.6 10.5 14.9 21.9 16.2 11.4 12.2 12.8 16.0 17.5 15.3 14.0 10.7 13.1 20.6 12.3 22.1 11.9 24.1 18.6 17.2 25.1 16.5 12.6 13.2 12.9 15.4 7.2 14.1 11.9 16.8 22.1 12.8 11.5 9.4 18.5 16.2 19.0 6.9 14.0 18.9 13.5 5.6 6.8 21.0 7.4 5.6 7.4 7.9 7.4 5.7 11.7 24.4 24.0 18.9 12.8 8.8 15.3 12.5 13.4 5.7 7.7 8.0 10.9 9.8 21.8 4.8 15.4 8.3 18.1 10.7 4.7 7.7 17.3 8.5 29.1 9.8 5.9 18.4 12.1 14.6 16.9 8.0 10.7 9.7 13.7 13.8 13.2 7.7 9.2 10.1 11.6 4.5 3.1 8.1 16.2 12.4 8.3 7.2 7.1 11.1 28.1 13.5 14.5 10.9 15.0 10.1 7.7 14.9 8.9 11.2 8.5 7.0 11.3 8.2 16.5 17.3 10.5 21.0 6.9 6.6 4.7 5.6 6.0 5.1 5.5 5.0 6.8 5.6 7.4 4.9 4.7 5.6 7.4 4.1 3.9 7.9 15.9 21.5 20.5 21.3 16.0 17.5 20.6 12.3 25.1 18.5 29.8 8.6 14.5 7.4 8.9 9.2 13.4 12.7 10.7 9.1 14.0 5.9 11.0 8.3 9.8 9.1 9.0 5.1 0.0 6.7 10.7 9.3 9.4 4.7 16.3 12.5 7.9 10.4 8.6 16.1 8.9 8.3 6.7 6.8 10.8 9.2 14.5 7.3 5.8 7.4 10.8 9.0 12.9 11.3 6.6 7.8 11.5 14.1 5.0 7.4 9.1 C8orf44 FLJ11267 ENSG00000213865 "Chromosome 8 open reading frame 44" Q96CB5 8 66667615-66685564 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043660, HPA054753" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043660: AB_10794889, HPA054753: AB_2682592" "unprognostic (6.19e-2)" "unprognostic (7.50e-2)" "unprognostic (3.09e-2)" "unprognostic (1.05e-2)" "unprognostic (1.99e-1)" "unprognostic (2.53e-1)" "unprognostic (8.61e-3)" "unprognostic (8.20e-3)" "unprognostic (4.42e-2)" "unprognostic (2.73e-2)" "prognostic favorable (4.21e-4)" "unprognostic (7.35e-2)" "prognostic unfavorable (1.08e-7)" "unprognostic (4.01e-2)" "unprognostic (9.35e-2)" "unprognostic (1.49e-1)" "prognostic favorable (2.68e-6)" 5.8 4.5 15.8 6.1 18.1 8.6 9.6 16.6 14.9 6.6 5.3 10.4 7.2 4.3 8.4 27.7 4.2 7.7 5.6 5.8 10.6 7.7 5.9 4.0 4.7 10.1 11.4 9.0 10.2 4.6 6.8 14.6 5.8 8.6 6.8 8.3 8.9 7.7 7.0 11.6 12.4 5.3 5.9 9.2 7.5 6.4 15.3 11.5 9.4 10.8 3.0 8.0 6.8 6.0 5.8 4.4 5.7 3.1 0.6 3.8 1.5 8.7 3.4 5.8 4.1 3.5 6.9 3.2 2.4 2.3 3.3 3.9 3.5 9.9 9.8 1.6 4.1 4.7 6.0 5.5 2.1 4.6 7.3 5.3 8.3 10.5 7.2 2.8 3.7 5.9 5.8 4.9 4.4 4.8 6.5 4.1 10.9 9.4 6.5 3.3 3.2 4.1 5.1 5.0 6.5 4.3 4.0 1.9 2.0 4.8 1.8 4.7 3.8 2.6 1.7 3.1 4.3 5.8 2.4 5.9 3.5 4.7 3.4 1.5 7.7 2.6 4.0 5.7 4.0 1.8 5.7 3.1 4.0 1.9 2.5 1.4 5.8 2.4 2.2 2.6 4.8 3.8 2.8 3.6 0.6 1.3 4.4 3.4 1.5 15.8 18.1 16.6 14.9 10.6 7.7 11.4 9.0 8.6 11.5 3.0 3.4 3.7 5.3 0.6 8.6 26.0 0.0 5.3 4.5 7.0 7.9 2.7 10.0 2.0 0.9 3.8 2.6 0.0 3.4 1.6 4.4 4.8 3.5 2.4 2.6 1.6 6.3 3.7 4.4 1.3 8.6 4.9 1.7 1.8 3.6 7.0 2.4 4.3 8.5 3.3 6.0 12.9 3.9 16.4 5.7 1.4 1.4 2.9 3.3 3.4 C8orf59 ENSG00000176731 "Chromosome 8 open reading frame 59" Q8N0T1 8 85214076-85220421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044805, HPA071903" Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA044805: AB_2679095, HPA071903: AB_2686469" "unprognostic (1.61e-2)" "unprognostic (2.98e-1)" "unprognostic (4.51e-1)" "unprognostic (1.63e-3)" "unprognostic (2.19e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-3)" "unprognostic (1.63e-1)" "unprognostic (1.69e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (2.29e-1)" "unprognostic (3.84e-3)" 28.1 28.2 25.3 25.3 21.9 33.0 46.1 18.9 26.5 33.0 38.4 12.6 36.3 28.1 32.0 45.5 44.8 28.7 25.8 41.5 20.6 24.1 32.3 47.1 20.8 30.7 26.3 27.2 45.1 35.1 19.5 36.0 27.7 24.4 35.5 27.7 14.7 37.8 36.2 43.9 24.8 37.1 33.7 27.0 32.2 36.9 16.7 25.7 39.1 43.5 53.6 32.0 39.1 35.2 33.3 42.7 21.3 25.3 36.5 38.0 23.9 38.9 19.9 29.6 19.2 18.4 35.7 23.2 26.0 25.0 30.4 30.0 23.2 33.8 9.7 21.5 17.2 28.5 27.2 20.5 28.5 34.3 27.4 22.4 57.6 18.8 34.2 21.8 21.6 26.1 30.2 33.9 19.6 24.8 33.1 25.8 35.0 25.8 24.0 25.2 30.7 47.7 40.6 8.5 88.2 34.8 20.4 24.8 44.2 29.5 25.0 10.0 21.5 19.7 32.4 35.7 37.3 37.3 32.3 19.7 19.4 40.7 21.5 24.6 27.9 32.7 45.8 38.7 27.7 21.5 21.3 20.5 13.4 24.7 25.3 29.5 33.3 32.7 30.1 34.8 29.9 38.0 36.3 5.1 36.5 21.5 42.7 32.1 23.9 25.3 21.9 18.9 26.5 20.6 24.1 26.3 27.2 24.4 25.7 80.4 65.2 124.2 47.1 48.2 25.9 26.3 86.6 147.2 103.5 34.9 9.8 86.5 56.3 152.0 93.6 67.1 76.6 46.7 240.4 102.1 84.3 40.2 75.1 136.0 90.6 22.3 36.9 108.6 132.2 20.6 173.2 92.3 54.0 180.3 112.7 58.4 213.9 84.2 122.0 90.6 33.5 155.2 88.6 128.1 91.8 40.0 64.3 104.7 101.8 39.3 C9orf78 "HCA59, HSPC220" ENSG00000136819 "Chromosome 9 open reading frame 78" Q9NZ63 9 129827290-129835863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021216, HPA021232, HPA021242" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "HPA021216: AB_1845836, HPA021232: AB_1845837, HPA021242: AB_1845838" "unprognostic (1.00e-1)" "unprognostic (4.23e-3)" "unprognostic (1.03e-2)" "unprognostic (1.83e-1)" "unprognostic (3.35e-2)" "unprognostic (7.03e-2)" "unprognostic (3.50e-2)" "unprognostic (6.02e-3)" "unprognostic (1.27e-1)" "unprognostic (1.26e-1)" "unprognostic (1.13e-2)" "unprognostic (1.43e-2)" "prognostic favorable (3.49e-7)" "unprognostic (5.34e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" 23.9 29.0 42.7 24.5 44.0 73.8 28.0 37.0 34.5 24.0 24.7 27.6 25.5 21.8 24.1 28.9 26.2 21.5 24.8 28.7 40.3 39.6 44.8 41.7 21.8 35.7 39.5 30.8 31.1 26.3 20.9 26.6 24.5 29.3 27.5 27.6 18.0 26.7 26.4 45.8 27.8 25.9 28.9 38.7 28.1 22.5 32.3 32.8 42.0 33.6 23.5 34.0 32.4 31.3 28.5 22.9 57.6 43.6 37.8 52.8 34.4 9.3 9.3 10.0 15.6 17.9 12.1 12.4 13.6 11.0 12.2 8.9 9.7 9.9 14.6 11.0 15.5 19.2 20.1 13.7 11.6 10.2 14.3 9.8 23.3 16.6 10.2 11.9 33.8 24.1 11.0 20.6 14.9 12.7 12.3 11.1 62.7 58.3 17.9 14.8 22.4 43.3 43.5 14.8 38.1 22.3 12.5 15.4 30.9 12.2 6.4 8.3 15.8 20.5 19.1 16.3 9.9 16.7 23.9 12.5 18.2 13.8 17.8 17.1 8.0 23.2 23.8 15.1 27.5 14.9 36.4 23.3 57.6 44.4 35.3 43.9 28.5 46.4 48.0 19.2 28.1 52.8 48.2 18.0 37.8 43.6 22.9 48.9 34.4 42.7 44.0 37.0 34.5 40.3 39.6 39.5 30.8 29.3 32.8 83.4 75.8 65.1 59.9 69.4 38.3 50.4 61.1 103.1 105.8 54.1 35.3 62.3 106.1 56.0 34.8 56.1 58.8 186.9 78.2 64.8 51.4 57.1 128.5 71.9 59.9 30.2 81.0 35.6 56.4 11.6 54.7 75.9 69.2 90.2 53.5 48.4 55.0 38.6 57.3 121.7 34.8 77.6 67.6 82.1 101.3 74.3 56.5 139.4 52.1 49.2 CACYBP "S100A6BP, SIP" ENSG00000116161 "Calcyclin binding protein" Q9HB71 1 174999163-175011715 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 117.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025753, HPA057038" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 360000 Cytosol Nucleoplasm "HPA025753: AB_1845878, HPA057038: AB_2683318" "unprognostic (4.70e-3)" "unprognostic (9.92e-2)" "unprognostic (5.55e-2)" "unprognostic (2.22e-1)" "unprognostic (1.25e-1)" "unprognostic (8.96e-3)" "prognostic unfavorable (1.12e-6)" "unprognostic (1.50e-2)" "unprognostic (2.03e-2)" "prognostic favorable (1.39e-5)" "unprognostic (4.55e-2)" "unprognostic (1.87e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.41e-1)" "unprognostic (4.44e-2)" "unprognostic (1.97e-1)" "unprognostic (6.79e-2)" 15.1 15.9 38.3 20.3 39.7 24.6 36.2 36.1 46.5 16.0 16.7 10.7 12.5 13.3 14.0 22.5 13.9 15.6 12.7 13.0 36.9 39.1 23.4 18.5 13.3 25.2 33.8 22.8 26.5 10.1 21.4 17.2 19.1 33.1 17.0 18.6 7.9 11.8 17.2 29.8 12.6 14.0 14.4 29.0 13.3 11.7 23.3 27.5 16.2 19.1 12.6 23.9 16.6 117.2 26.7 20.1 17.3 30.2 25.3 29.0 25.8 30.3 21.0 30.9 13.2 10.3 11.6 19.9 23.3 13.8 30.2 22.1 21.6 19.0 32.0 24.3 16.5 21.7 16.6 38.5 17.0 31.3 16.9 23.5 24.0 20.7 23.1 7.8 32.2 15.1 7.8 10.5 24.8 15.0 15.6 21.2 28.8 48.0 18.0 21.7 11.3 49.5 29.5 29.4 45.8 9.8 22.4 22.0 36.9 21.5 24.3 21.3 20.5 15.8 27.7 24.0 43.6 21.5 28.2 10.9 17.2 18.4 24.0 37.3 17.4 50.0 71.0 14.4 28.3 19.9 17.3 16.1 15.9 19.0 24.4 22.1 26.7 27.5 23.0 20.1 20.4 29.0 25.7 8.7 25.3 30.2 16.6 28.5 25.8 38.3 39.7 36.1 46.5 36.9 39.1 33.8 22.8 33.1 27.5 80.4 34.1 105.0 107.7 103.9 56.2 89.6 38.2 80.3 52.4 33.2 58.9 184.6 129.3 83.6 75.6 64.3 63.7 23.3 82.6 245.4 120.8 92.6 91.1 35.8 172.4 28.6 114.6 40.5 47.3 21.9 79.7 120.6 102.9 341.8 42.9 55.2 88.9 53.2 69.3 119.5 79.1 32.3 106.6 100.9 149.2 74.9 120.0 115.4 82.3 81.3 CAMTA2 KIAA0909 ENSG00000108509 "Calmodulin binding transcription activator 2" O94983 17 4967992-4987652 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027835, HPA051147" Supported "Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol" NA NA Nucleoplasm "Vesicles, Actin filaments, Mitochondria, Cytosol" "HPA027835: , HPA051147: AB_2681362" "unprognostic (2.82e-1)" "unprognostic (3.06e-1)" "unprognostic (1.11e-2)" "unprognostic (1.01e-3)" "unprognostic (1.10e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (4.71e-2)" "unprognostic (2.78e-2)" "unprognostic (7.08e-2)" "prognostic favorable (6.00e-8)" "unprognostic (3.42e-2)" "unprognostic (9.02e-2)" "unprognostic (3.73e-2)" "unprognostic (1.20e-1)" "unprognostic (4.56e-2)" "unprognostic (1.19e-1)" 9.8 6.4 27.0 9.2 25.2 6.4 5.4 63.6 44.9 6.2 8.0 6.4 3.8 7.3 6.2 3.1 8.4 6.8 6.1 8.0 33.8 17.4 5.5 4.2 8.8 6.2 11.7 19.1 6.7 11.7 14.8 21.3 5.1 18.5 6.8 8.0 5.5 8.7 9.1 20.1 8.6 9.0 10.5 6.5 8.7 8.0 9.0 8.8 2.7 6.5 2.9 6.5 6.5 4.7 1.3 2.2 5.7 8.1 1.1 2.7 2.1 8.0 14.4 2.7 3.8 18.1 12.6 5.6 7.8 8.7 7.4 6.6 3.6 2.2 9.5 7.6 12.2 6.3 8.2 10.2 12.2 4.2 13.3 13.2 6.0 7.8 4.0 10.4 3.5 25.8 8.7 15.3 7.0 11.0 9.0 12.3 7.4 9.7 8.7 6.9 5.3 6.2 2.2 0.4 9.6 6.0 5.4 3.0 3.7 8.4 8.5 3.7 3.2 4.9 9.0 2.4 4.8 7.9 3.5 16.3 5.9 3.5 6.2 12.7 4.4 4.7 3.4 14.4 7.0 5.7 1.0 2.2 1.8 2.7 3.0 2.1 1.3 1.2 2.5 1.4 0.9 1.8 2.0 5.7 1.1 8.1 2.2 1.1 2.1 27.0 25.2 63.6 44.9 33.8 17.4 11.7 19.1 18.5 8.8 3.0 13.7 8.3 3.5 6.2 12.1 5.9 15.3 5.3 3.4 10.4 9.8 5.2 1.7 6.8 29.0 6.9 16.3 0.0 9.8 6.8 6.8 5.5 12.7 11.9 7.7 33.4 10.9 14.1 9.2 39.5 9.5 8.0 3.3 8.2 13.1 4.3 9.1 12.4 8.9 10.5 9.6 12.9 12.3 5.2 7.6 9.2 10.4 10.2 9.5 3.4 CAND1 "DKFZp434M1414, KIAA0829, TIP120, TIP120A" ENSG00000111530 "Cullin associated and neddylation dissociated 1" Q86VP6 12 67269281-67319951 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055748, HPA062833, HPA069053" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No 4200000 "Nucleoplasm, Golgi apparatus, Cytosol" "HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074" "unprognostic (1.50e-2)" "unprognostic (1.60e-1)" "unprognostic (1.39e-3)" "unprognostic (2.31e-1)" "unprognostic (2.19e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (2.02e-2)" "unprognostic (2.17e-2)" "unprognostic (3.02e-1)" "unprognostic (3.38e-3)" "unprognostic (1.66e-1)" "unprognostic (2.54e-2)" "unprognostic (2.88e-1)" "unprognostic (1.58e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" 21.3 26.7 28.7 19.1 38.3 19.6 27.0 34.6 32.6 23.9 20.0 17.5 17.0 19.7 22.8 29.9 26.6 20.6 19.0 15.2 24.8 27.0 25.4 27.7 18.7 25.4 23.3 29.0 29.0 22.1 33.2 27.1 23.3 33.2 24.1 21.7 15.8 19.6 22.0 11.1 29.5 19.5 22.4 21.5 20.2 19.3 26.9 23.8 39.4 27.0 17.0 30.2 21.1 22.1 11.9 7.8 6.1 10.1 14.7 15.2 4.3 22.5 23.2 35.4 25.1 27.2 21.3 23.8 22.4 19.4 23.7 20.9 21.5 12.9 48.7 19.6 22.4 14.9 21.6 38.0 25.5 27.2 18.4 22.8 27.4 18.7 20.3 17.8 32.3 15.6 20.1 19.4 21.6 20.0 29.1 22.0 23.9 21.7 27.3 25.5 22.1 29.2 21.9 37.4 17.4 16.2 28.6 30.4 20.6 21.8 38.5 36.4 18.1 27.9 25.7 18.1 31.1 27.6 14.9 18.7 18.8 12.2 12.9 16.9 9.0 11.0 41.5 22.4 19.2 19.3 6.1 5.0 5.5 11.6 5.9 14.1 8.6 14.2 12.7 7.8 11.9 15.2 12.7 2.2 14.7 10.1 6.6 14.7 4.3 28.7 38.3 34.6 31.8 24.8 27.0 23.3 29.0 33.2 23.8 56.6 27.6 42.6 43.5 51.6 88.5 14.7 45.9 34.8 29.6 41.8 110.0 31.5 11.6 27.1 2.8 38.6 46.3 0.0 24.9 36.0 41.4 44.6 7.0 41.5 27.1 82.6 43.6 38.1 40.0 7.7 63.9 30.4 32.1 52.3 46.0 63.0 29.9 24.6 57.3 27.3 106.8 25.8 34.2 72.7 42.4 55.8 37.3 47.9 38.5 52.1 CAPG "AFCP, MCP" ENSG00000042493 "Capping actin protein, gelsolin like" P40121 2 85394748-85418432 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 121.1" "Cell type enhanced" "Detected in many" 10 "granulocytes: 535.8;Hofbauer cells: 1102.8;monocytes: 603.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 79.0;classical monocyte: 97.4;eosinophil: 58.2;intermediate monocyte: 36.4;memory B-cell: 50.1;myeloid DC: 121.1;naive B-cell: 37.1;NK-cell: 48.3;plasmacytoid DC: 84.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 81.3;HMC-1: 116.7;SK-MEL-30: 84.8;U-937: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018843, HPA019080, HPA019092" Enhanced Enhanced Nucleoplasm "Intracellular and membrane" Yes No 6700000 Nucleoplasm "HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980" "unprognostic (2.82e-2)" "unprognostic (1.37e-1)" "unprognostic (8.80e-2)" "unprognostic (1.28e-2)" "unprognostic (4.37e-2)" "unprognostic (7.52e-2)" "prognostic unfavorable (3.22e-5)" "unprognostic (8.83e-2)" "unprognostic (3.22e-2)" "unprognostic (1.54e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-1)" "prognostic favorable (2.96e-4)" "unprognostic (1.45e-1)" "unprognostic (7.68e-2)" "unprognostic (5.30e-3)" "unprognostic (7.89e-3)" 44.3 4.9 10.1 18.3 10.8 32.4 17.6 3.3 7.6 19.9 13.8 17.6 17.7 6.8 14.0 16.0 52.3 12.9 25.2 4.1 8.5 6.5 35.4 2.9 44.3 26.9 14.7 4.8 10.6 8.9 40.3 5.2 15.6 11.9 15.0 11.0 7.6 22.5 19.3 2.6 39.2 11.5 9.9 17.6 10.9 25.9 8.4 10.0 21.2 31.5 28.1 40.2 27.0 31.1 50.1 121.1 79.0 97.4 48.3 9.7 67.5 22.8 11.0 0.0 1.0 7.8 17.0 11.8 8.7 0.9 8.6 8.5 1.3 81.3 2.9 12.4 16.3 9.1 26.7 0.0 17.1 3.7 17.6 0.6 8.2 20.2 4.8 6.1 4.6 116.7 14.7 13.2 7.8 9.7 0.4 5.6 16.9 0.9 6.8 5.9 19.3 12.3 54.3 3.4 17.1 14.6 12.3 1.3 1.3 32.6 11.4 0.1 0.1 10.9 14.7 84.8 6.3 6.1 58.0 21.6 18.4 4.0 0.6 0.3 0.1 0.6 1.2 41.7 61.9 0.2 79.0 97.4 58.2 1.1 36.4 3.4 50.1 9.7 3.7 121.1 37.1 2.8 1.3 14.1 48.3 10.3 84.1 9.6 67.5 10.1 10.8 3.3 7.6 8.5 6.5 14.7 4.8 11.9 10.0 17.9 29.8 86.2 131.0 107.6 0.5 1.1 63.7 9.4 23.9 300.1 0.0 25.0 179.1 90.0 3.2 5.8 101.1 0.0 81.2 260.0 55.7 64.5 535.8 0.9 1102.8 1.6 27.6 3.1 175.5 12.5 43.4 306.0 140.0 603.3 55.7 37.8 257.6 119.4 21.2 88.5 1.1 12.9 23.5 6.3 40.4 148.2 29.9 59.9 86.5 209.1 CARM1 PRMT4 ENSG00000142453 "Coactivator associated arginine methyltransferase 1" Q86X55 19 10871513-10923070 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 64.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032961, HPA043561, HPA048073, HPA069313" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: AB_2680250, HPA069313: " "unprognostic (9.46e-2)" "unprognostic (3.61e-1)" "unprognostic (2.94e-2)" "unprognostic (2.23e-1)" "unprognostic (2.69e-2)" "unprognostic (3.13e-2)" "unprognostic (1.66e-3)" "unprognostic (3.76e-2)" "unprognostic (7.81e-2)" "unprognostic (6.18e-2)" "unprognostic (9.31e-2)" "unprognostic (7.25e-2)" "prognostic unfavorable (7.88e-6)" "unprognostic (1.71e-2)" "unprognostic (6.26e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (8.37e-4)" 12.2 8.8 12.3 12.6 16.1 13.2 9.6 12.5 17.7 15.8 14.0 9.3 9.0 11.5 19.6 9.1 20.5 14.8 12.4 14.7 11.2 7.2 9.3 14.5 8.9 12.4 7.8 10.2 13.0 16.9 8.2 6.9 15.3 9.5 12.6 10.2 12.0 11.4 13.2 64.3 12.5 12.0 15.6 6.6 9.8 11.1 17.5 8.6 9.4 10.0 12.7 15.6 15.8 15.9 1.3 1.6 0.3 1.4 0.1 2.6 0.4 22.6 16.9 24.2 32.8 20.2 27.7 23.2 16.3 28.3 24.2 23.3 26.0 8.3 31.2 19.6 28.4 12.2 21.7 24.7 24.5 15.3 34.9 20.1 9.6 11.0 31.5 17.3 14.4 12.5 18.9 16.0 16.5 20.0 13.8 30.6 24.9 22.9 28.1 14.2 40.9 25.1 12.4 29.9 15.2 28.1 35.1 12.4 36.3 14.6 11.7 17.6 16.9 11.6 14.1 15.7 12.6 14.1 12.4 18.3 29.2 16.5 27.7 19.0 27.4 21.6 27.3 19.2 23.2 12.6 0.0 1.4 0.2 1.2 1.4 0.5 1.3 0.9 2.6 1.3 1.3 1.0 0.9 0.3 0.1 0.7 1.6 0.8 0.4 12.3 16.1 12.5 17.7 11.2 7.2 7.8 10.2 9.5 8.6 8.9 13.5 11.5 4.9 6.9 31.0 0.8 17.8 8.1 6.8 8.7 49.1 16.3 6.6 11.8 25.6 5.7 28.0 46.7 16.9 26.3 10.3 10.9 1.1 23.7 22.3 42.9 26.5 11.1 17.8 13.0 26.2 7.5 5.0 28.9 25.6 10.2 20.3 25.9 18.0 7.3 19.9 6.5 9.2 25.8 16.4 6.0 10.1 4.1 21.2 9.0 CBFA2T3 "ETO2, MTG16, MTGR2, RUNX1T3, ZMYND4" ENSG00000129993 "CBFA2/RUNX1 translocation partner 3" O75081 16 88874858-88977204 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 75.9" "Cell type enhanced" "Detected in many" 7 "B-cells: 11.5;Mucus-secreting cells: 13.5;Sertoli cells: 19.4;Smooth muscle cells: 11.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 26.0" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 21.4;K-562: 37.4;MCF7: 17.3;MOLT-4: 19.0;NB-4: 23.1;REH: 37.6;T-47d: 17.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA059931, HPA062423, HPA065890" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059931: AB_2684168, HPA062423: AB_2684758, HPA065890: AB_2685575" "unprognostic (2.47e-1)" "unprognostic (2.03e-2)" "unprognostic (9.24e-3)" "unprognostic (2.62e-1)" "unprognostic (1.98e-1)" "prognostic favorable (3.95e-4)" "unprognostic (1.13e-3)" "unprognostic (1.69e-2)" "unprognostic (1.25e-1)" "unprognostic (2.10e-1)" "unprognostic (7.30e-3)" "unprognostic (2.38e-1)" "unprognostic (7.04e-5)" "unprognostic (2.18e-1)" "unprognostic (4.08e-2)" "unprognostic (4.62e-2)" "unprognostic (9.35e-3)" 10.0 1.7 3.6 11.3 7.4 8.2 6.1 26.0 5.4 2.3 3.9 1.3 1.4 3.9 3.2 2.1 2.1 1.9 2.5 6.2 3.0 3.0 0.7 2.0 6.4 9.5 2.0 3.8 0.9 24.9 0.7 2.7 3.8 2.3 3.7 1.5 3.1 4.5 2.9 14.2 2.6 5.5 1.5 1.2 14.7 3.5 3.2 2.2 75.9 2.4 2.0 10.3 3.6 4.8 3.7 11.6 3.6 4.9 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 21.4 0.0 0.0 0.0 5.6 10.6 0.0 0.0 0.0 0.0 0.0 0.0 10.3 37.4 0.2 0.0 17.3 19.0 23.1 0.4 0.0 0.0 37.6 0.3 3.7 0.0 0.0 7.4 1.6 0.8 0.1 0.1 0.1 17.1 6.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 12.4 0.0 6.5 0.0 1.1 2.7 2.7 0.0 3.2 0.0 3.7 0.0 0.0 7.1 2.1 0.0 0.0 3.6 0.1 4.9 11.6 0.0 1.7 3.6 7.4 26.0 5.4 3.0 3.0 2.0 3.8 2.3 2.2 0.0 1.4 11.5 5.1 2.3 7.7 1.6 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.2 0.0 3.6 0.9 0.0 2.4 0.1 1.6 2.5 5.8 5.7 2.4 0.0 3.5 2.5 2.8 0.0 2.0 6.4 0.0 1.0 13.5 0.1 1.4 0.0 0.7 0.5 1.2 19.4 11.2 0.2 4.5 1.9 0.2 1.0 0.8 3.8 CBX4 "hPC2, NBP16, PC2" ENSG00000141582 "Chromobox 4" O00257 17 79833156-79839429 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 109.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 39.0;SK-MEL-30: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008228, HPA012021" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA008228: AB_1078413, HPA012021: AB_2668603" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-2)" "unprognostic (1.86e-1)" "unprognostic (3.97e-2)" "unprognostic (8.80e-2)" "unprognostic (5.39e-3)" "unprognostic (1.49e-1)" "unprognostic (2.55e-1)" "unprognostic (1.40e-2)" "unprognostic (7.62e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (8.72e-8)" "unprognostic (7.49e-2)" "unprognostic (2.87e-1)" "unprognostic (3.99e-2)" "unprognostic (1.07e-1)" 7.1 9.9 11.6 11.3 14.8 109.1 7.0 9.0 22.5 5.9 6.2 20.4 6.3 8.3 5.9 6.3 14.8 6.7 10.3 12.0 12.9 12.9 6.5 15.3 9.0 13.9 15.4 10.8 9.3 16.8 16.2 14.8 17.0 13.9 8.9 4.8 14.5 12.9 6.9 3.8 20.6 8.5 5.2 12.6 16.3 10.8 5.5 13.1 29.2 8.3 6.7 19.2 8.6 7.1 3.6 4.2 5.2 1.7 1.0 3.8 1.3 10.8 9.7 3.0 12.7 1.9 1.7 8.3 4.9 2.9 1.8 1.9 7.0 6.1 4.2 7.0 1.9 4.0 5.6 3.2 3.2 1.3 4.5 6.2 2.3 9.3 13.0 9.2 12.4 18.6 2.3 19.3 1.6 3.0 3.0 1.5 12.4 7.2 23.7 1.9 7.8 17.0 12.7 1.6 11.3 9.8 17.7 3.0 18.8 2.5 5.2 3.1 5.9 7.4 39.0 43.4 1.3 9.2 19.9 3.8 10.6 9.4 6.5 6.3 20.5 10.4 11.8 6.7 10.8 14.0 3.9 1.4 4.1 2.4 1.5 1.8 3.3 3.1 3.3 0.9 3.6 3.8 3.5 5.2 1.0 1.7 4.2 0.5 1.3 11.6 14.8 9.0 22.5 12.9 12.9 15.4 10.8 13.9 13.1 3.0 14.9 15.9 2.2 20.7 30.6 37.0 12.7 9.4 9.1 1.8 21.6 27.3 0.0 7.5 0.1 13.5 11.5 23.3 6.4 3.3 11.4 6.6 6.9 13.5 11.7 19.1 50.6 20.3 20.6 0.6 4.0 10.2 16.9 4.6 38.4 26.1 7.5 15.9 5.3 2.6 40.4 6.5 11.0 0.0 2.5 26.8 7.2 16.0 26.7 4.8 CBX5 "HP1, HP1-ALPHA, HP1Hs-alpha" ENSG00000094916 "Chromobox 5" P45973 12 54230940-54280133 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016699, CAB017548" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB017548: AB_2071368, HPA016699: AB_1850627" "unprognostic (1.58e-2)" "unprognostic (7.99e-2)" "unprognostic (1.15e-2)" "unprognostic (5.05e-3)" "unprognostic (3.80e-1)" "unprognostic (4.59e-3)" "unprognostic (2.97e-3)" "unprognostic (6.39e-3)" "unprognostic (2.57e-2)" "unprognostic (1.41e-1)" "unprognostic (4.47e-2)" "unprognostic (1.96e-1)" "unprognostic (2.34e-1)" "unprognostic (1.70e-1)" "unprognostic (1.08e-1)" "unprognostic (6.26e-2)" "unprognostic (8.64e-2)" 9.7 18.2 26.3 16.3 28.4 17.3 16.0 22.3 32.3 13.8 12.0 25.3 10.4 8.7 11.7 18.0 11.2 18.9 10.6 22.0 22.1 28.4 20.8 10.1 11.6 19.8 22.4 18.8 22.2 12.2 42.5 26.8 13.9 20.4 13.9 13.0 19.5 10.5 16.0 14.1 19.5 10.4 12.6 25.3 11.7 11.8 26.8 20.3 37.0 27.4 9.0 23.4 10.0 11.6 11.3 18.4 3.7 6.1 6.2 8.2 3.6 8.8 26.4 41.4 19.1 5.5 12.0 9.6 13.7 9.9 11.6 12.1 10.2 28.4 24.5 18.5 13.5 13.9 7.5 29.3 8.5 19.9 38.8 6.4 21.6 30.0 3.6 4.3 11.4 9.2 5.9 5.8 19.9 17.6 13.2 12.8 22.8 24.5 24.3 19.1 15.3 36.2 11.9 33.1 3.7 3.2 35.9 23.2 13.6 12.1 8.1 20.8 32.1 25.7 5.8 3.0 17.0 22.4 19.3 16.8 19.7 17.0 7.4 16.2 6.1 6.8 47.1 12.5 11.7 20.5 0.8 4.7 3.7 6.2 4.9 5.0 9.4 6.7 5.7 7.8 11.3 6.6 6.1 0.7 6.2 6.1 18.4 8.2 3.6 26.3 28.4 22.3 27.2 22.1 28.4 22.4 18.8 20.4 20.3 35.7 44.5 47.7 38.8 41.1 105.7 135.1 56.0 92.3 52.4 78.5 43.2 45.4 89.5 54.0 84.3 46.6 14.0 70.0 51.5 49.9 48.3 35.9 29.0 27.7 32.9 173.2 25.9 32.5 22.5 38.8 59.8 30.8 33.7 55.1 34.8 65.1 38.7 7.0 75.7 47.7 56.4 32.3 42.9 202.7 89.2 28.5 21.9 35.2 33.3 23.0 CBX8 "HPC3, PC3, RC1" ENSG00000141570 "Chromobox 8" Q9HC52 17 79792132-79801683 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031462 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031462: AB_10601252" "unprognostic (4.77e-2)" "unprognostic (2.24e-1)" "unprognostic (1.34e-1)" "unprognostic (8.81e-2)" "unprognostic (3.26e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.94e-6)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (6.26e-2)" "prognostic favorable (3.84e-5)" "unprognostic (4.74e-1)" "prognostic unfavorable (5.39e-7)" "unprognostic (6.99e-3)" "unprognostic (7.18e-2)" "unprognostic (4.51e-1)" "unprognostic (5.99e-2)" 5.0 4.6 6.3 7.5 4.3 3.6 4.6 4.4 7.2 3.8 4.3 5.1 3.9 5.4 3.6 20.5 3.9 13.9 7.3 4.8 5.6 2.7 6.9 7.8 6.2 5.0 4.5 5.0 3.2 7.9 10.0 11.0 4.7 4.7 3.6 1.6 5.9 4.8 6.9 3.9 4.2 4.1 2.2 3.3 4.3 5.5 13.6 5.5 12.8 4.4 1.7 4.0 2.6 2.5 4.9 5.7 14.6 6.8 3.0 3.4 2.1 7.8 16.1 4.3 15.5 2.4 1.5 5.2 4.0 2.9 3.5 2.4 8.8 4.0 5.8 11.4 2.2 3.1 7.4 5.5 1.2 1.5 4.4 7.7 2.1 8.5 9.3 2.8 8.6 18.2 1.3 2.5 2.2 0.7 3.4 0.7 6.9 5.1 2.6 1.0 9.6 9.8 12.8 1.7 5.7 8.8 9.2 3.8 10.6 2.6 5.4 6.3 12.7 5.8 18.5 9.2 1.5 9.7 11.3 1.8 7.3 10.1 2.9 6.3 7.5 2.9 3.7 4.5 8.6 4.0 1.0 5.2 14.6 3.4 6.5 1.2 4.9 1.9 2.0 5.7 2.1 1.9 1.8 6.5 3.0 6.8 4.6 1.9 2.1 6.3 4.3 4.4 7.2 5.6 2.7 4.5 5.0 4.7 5.5 0.0 0.3 1.3 0.7 1.5 5.2 2.1 10.2 1.4 0.0 3.5 7.9 6.1 0.0 4.1 2.7 1.2 3.2 0.0 4.8 2.4 1.5 0.8 5.7 2.6 4.2 7.9 8.7 0.6 2.8 0.0 0.9 1.1 1.7 1.0 6.3 6.8 3.7 4.0 2.1 1.9 10.8 0.0 2.8 0.5 11.4 1.0 2.1 3.8 3.7 0.3 CCAR2 "DBC-1, DBC1, KIAA1967, NET35" ENSG00000158941 "Cell cycle and apoptosis regulator 2" Q8N163 8 22604632-22621514 "Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, DNA damage, mRNA processing, mRNA splicing, Transcription, Transcription regulation, Wnt signaling pathway" "Activator, Metalloenzyme inhibitor, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019907, HPA019943, CAB072827, CAB072828" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA 5300 "Nucleoplasm, Nuclear bodies" "CAB072827: , CAB072828: , HPA019907: AB_1852452, HPA019943: AB_1852454" "unprognostic (3.42e-2)" "unprognostic (5.78e-3)" "unprognostic (2.46e-3)" "unprognostic (1.33e-2)" "unprognostic (6.87e-2)" "unprognostic (2.23e-2)" "unprognostic (5.13e-2)" "unprognostic (8.56e-2)" "unprognostic (2.97e-1)" "unprognostic (1.77e-1)" "unprognostic (2.32e-2)" "unprognostic (1.54e-2)" "prognostic favorable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (2.46e-1)" "unprognostic (7.54e-2)" "unprognostic (1.77e-1)" 28.6 32.7 27.8 35.4 38.3 63.1 29.9 45.0 59.1 26.7 33.0 38.4 28.0 25.7 37.3 24.6 31.7 32.8 30.0 21.9 24.6 25.0 25.2 28.1 29.7 39.7 24.8 36.3 37.8 28.0 34.5 31.5 32.3 33.2 28.8 23.4 27.2 29.1 25.4 44.4 39.8 30.9 25.2 22.4 41.2 29.7 62.4 25.0 63.5 29.4 23.3 37.0 30.6 26.2 13.3 10.7 14.4 21.0 12.2 24.3 14.3 26.7 50.1 48.5 25.2 19.2 16.2 32.3 26.3 26.0 38.9 34.8 44.9 22.2 44.3 33.2 28.7 35.8 33.6 44.5 31.2 28.2 17.9 26.6 52.3 38.7 34.8 17.8 28.6 44.8 16.7 28.1 30.9 19.1 22.6 27.9 40.3 54.6 28.2 28.7 32.0 86.1 30.2 70.6 29.0 18.3 57.7 40.1 23.7 20.1 63.8 24.3 56.7 29.6 34.1 22.7 24.5 31.0 27.1 45.0 28.9 38.3 34.7 34.6 20.8 25.8 52.2 32.5 25.2 44.8 12.9 10.1 14.4 24.3 17.4 20.7 13.3 18.2 18.3 10.7 13.2 18.3 19.0 3.7 12.2 21.0 10.1 20.9 14.3 27.8 38.3 45.0 59.1 24.6 25.0 24.8 36.3 33.2 25.0 14.9 3.4 11.0 8.0 12.4 11.5 7.1 7.6 14.7 5.7 15.7 15.7 21.1 8.3 16.3 3.9 8.7 18.0 0.0 15.6 18.8 9.5 9.9 8.1 10.5 13.4 9.5 21.4 9.8 10.8 5.6 13.8 8.6 11.8 10.8 17.8 14.3 17.7 11.5 11.3 7.7 11.8 19.4 12.2 30.0 21.7 13.4 19.8 14.9 18.3 8.6 CCDC174 "C3orf19, FLJ33839" ENSG00000154781 "Coiled-coil domain containing 174" Q6PII3 3 14651746-14672659 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043468, HPA060129" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043468: AB_2678493, HPA060129: AB_2684208" "unprognostic (6.10e-2)" "unprognostic (7.96e-2)" "unprognostic (2.92e-1)" "unprognostic (3.26e-2)" "unprognostic (6.58e-3)" "unprognostic (5.06e-2)" "unprognostic (6.48e-3)" "unprognostic (1.13e-1)" "unprognostic (1.52e-1)" "unprognostic (5.29e-2)" "unprognostic (3.86e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.15e-2)" "unprognostic (2.30e-3)" "unprognostic (2.04e-1)" "unprognostic (2.64e-1)" "prognostic favorable (3.81e-5)" 16.8 12.9 15.7 13.4 17.5 27.1 17.1 22.3 18.2 19.2 18.5 17.8 15.2 16.8 24.0 14.5 16.1 15.5 12.9 14.4 13.1 10.9 17.9 15.3 13.0 15.7 17.9 14.8 28.0 18.6 15.7 29.9 15.6 16.9 17.7 13.7 12.6 16.1 15.7 26.9 17.4 20.6 14.9 18.7 20.2 18.2 15.3 19.2 23.1 17.5 9.8 18.4 19.0 17.6 14.7 9.5 21.0 9.9 15.4 16.7 8.4 5.1 5.7 8.8 9.3 12.2 10.1 22.3 7.0 10.0 8.8 6.9 6.4 6.1 10.8 5.1 6.1 6.0 4.6 6.3 5.8 6.9 8.1 7.7 11.0 6.8 6.8 17.7 10.7 12.8 11.6 15.0 11.8 14.6 12.4 7.5 11.6 10.9 9.9 6.5 9.1 11.2 9.5 11.8 8.6 9.4 8.4 8.2 8.8 9.0 9.2 4.3 11.6 8.1 6.4 11.2 10.7 9.7 15.3 6.9 7.1 6.9 6.5 8.0 13.2 11.7 12.6 7.1 8.3 9.6 21.0 9.5 18.4 12.1 9.7 14.1 14.7 15.1 13.9 8.4 13.3 16.7 13.3 18.4 15.4 9.9 9.5 10.3 8.4 15.7 17.5 22.3 18.2 13.1 10.9 17.9 14.8 16.9 19.2 8.9 34.6 52.9 25.1 14.3 31.2 32.7 28.1 36.1 34.2 12.2 19.6 26.1 48.0 29.4 124.0 26.9 26.2 70.0 30.5 21.0 25.8 23.3 50.8 26.6 23.1 14.3 17.7 27.6 22.9 39.8 31.1 28.8 13.5 55.1 21.6 23.3 32.0 31.7 37.8 29.8 23.3 32.3 21.7 47.7 31.1 11.8 54.9 42.1 21.1 27.8 CCDC86 MGC2574 ENSG00000110104 "Coiled-coil domain containing 86" Q9H6F5 11 60842071-60851081 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 200.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041117, HPA041540" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA041117: AB_10794984, HPA041540: AB_10794299" "unprognostic (2.93e-1)" "unprognostic (6.59e-2)" "unprognostic (2.38e-1)" "unprognostic (1.47e-3)" "unprognostic (3.64e-1)" "prognostic unfavorable (7.36e-5)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.65e-3)" "unprognostic (9.52e-2)" "unprognostic (1.25e-2)" "unprognostic (6.12e-2)" "unprognostic (4.47e-1)" "unprognostic (3.76e-2)" "unprognostic (7.54e-3)" "unprognostic (2.90e-1)" "unprognostic (2.16e-1)" "unprognostic (6.25e-2)" 13.5 12.4 7.3 8.6 11.0 6.1 11.2 3.3 11.2 5.8 6.7 7.9 3.4 7.4 8.4 5.0 9.3 7.4 8.3 9.3 6.7 6.4 8.1 11.4 5.4 8.2 10.0 6.0 11.3 13.6 200.8 12.7 7.3 8.5 11.9 4.7 6.7 6.4 6.2 20.2 10.4 6.2 7.3 6.7 9.3 7.7 47.8 8.7 10.2 7.9 12.6 6.5 8.6 6.5 6.9 20.0 5.0 19.5 4.2 8.5 6.7 21.0 28.7 7.1 20.5 5.8 9.6 9.7 14.2 11.1 26.1 14.0 24.4 14.2 25.8 27.2 7.7 18.6 19.8 24.0 17.1 12.0 9.1 26.6 13.1 12.7 34.0 19.2 20.5 22.5 10.9 13.0 24.1 15.3 3.8 19.3 14.2 41.9 13.3 12.7 24.9 30.8 31.3 28.7 12.5 41.3 21.0 10.7 64.9 9.1 9.0 16.1 10.4 9.1 21.1 16.6 4.7 21.3 8.2 12.6 26.0 16.0 35.3 30.7 11.2 16.5 27.9 21.3 22.2 31.4 2.6 9.1 5.0 6.5 19.5 6.9 6.9 6.9 6.0 20.0 6.5 8.5 7.4 0.7 4.2 6.3 11.2 6.2 6.7 7.3 11.0 3.3 11.2 6.7 6.4 10.0 6.0 8.5 8.7 0.0 2.1 3.0 15.4 32.7 9.3 0.4 2.5 0.0 4.5 1.8 7.9 15.9 6.6 20.4 19.7 6.8 2.6 0.0 10.4 14.1 9.5 18.2 4.7 2.4 16.0 3.2 6.9 3.7 2.8 10.6 10.6 7.9 15.1 4.6 4.9 3.6 13.7 3.5 5.6 5.4 7.9 19.4 20.2 37.1 19.1 27.0 6.9 6.1 9.7 15.5 CCNA2 "CCN1, CCNA" ENSG00000145386 "Cyclin A2" P20248 4 121816444-121823933 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 122.3" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 70.0;Extravillous trophoblasts: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 6.8" "Group enriched" "Detected in many" 5 "NK-cells: 1.7;T-cells: 6.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB000114, HPA020626" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes "Nucleoplasm, Cytosol" "CAB000114: AB_563675, HPA020626: AB_1847376" "unprognostic (4.02e-2)" "unprognostic (1.93e-1)" "unprognostic (7.66e-3)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.25e-1)" "unprognostic (1.67e-2)" "prognostic unfavorable (9.17e-5)" "prognostic unfavorable (4.27e-4)" "unprognostic (3.92e-3)" "unprognostic (2.65e-2)" "prognostic unfavorable (4.43e-6)" "unprognostic (8.38e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (6.07e-2)" "unprognostic (1.59e-1)" 3.2 1.5 1.3 18.6 1.7 21.6 1.8 5.1 1.2 2.5 6.3 1.0 0.8 6.6 2.2 2.1 11.7 1.7 2.4 3.2 1.8 1.8 1.7 1.6 3.4 15.6 1.6 0.8 4.5 0.9 0.5 3.2 12.0 1.3 2.2 7.8 1.0 2.1 0.8 1.1 4.2 7.4 2.4 1.8 8.9 2.9 8.4 0.8 122.3 1.4 18.8 18.4 2.5 5.1 0.3 0.9 0.6 0.3 1.7 6.8 1.9 38.7 10.1 27.7 11.8 1.5 3.8 22.7 27.1 11.9 36.0 26.8 22.0 24.1 35.7 7.3 14.2 12.7 13.1 34.8 15.9 29.7 17.1 16.1 28.6 13.4 21.3 0.3 43.1 20.3 1.0 1.2 14.9 8.9 5.7 21.5 19.0 40.7 35.9 28.5 13.9 54.9 25.0 21.8 24.3 11.3 25.2 53.7 17.4 10.2 7.7 11.8 12.5 14.2 17.4 7.5 21.7 14.5 18.3 12.7 16.9 25.7 17.8 25.8 22.8 24.1 40.9 9.7 43.9 18.7 0.0 0.3 0.6 0.2 0.1 0.1 0.3 2.0 1.4 0.9 0.1 0.0 0.5 0.3 1.7 0.3 0.1 6.8 1.9 1.3 1.7 5.1 1.2 1.8 1.8 1.6 0.8 1.3 0.8 0.0 0.6 0.0 0.7 2.5 1.1 0.7 0.0 2.7 1.2 0.0 11.8 5.7 0.0 0.3 4.8 0.7 1.5 70.0 0.2 72.3 3.3 1.1 0.0 1.5 21.0 0.0 1.2 2.5 7.5 1.5 0.9 2.9 1.7 0.0 3.1 1.3 0.4 1.5 1.1 0.0 14.2 0.0 0.9 6.1 7.9 1.1 7.1 3.2 6.4 1.3 CCND2 ENSG00000118971 "Cyclin D2" P30279 12 4273772-4305350 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 305.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 32.3;HBEC3-KT: 29.5;HDLM-2: 49.7;Karpas-707: 71.8;RH-30: 47.0;SuSa: 37.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049138, HPA054196" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA049138: AB_2680650, HPA054196: AB_2682412" "unprognostic (2.98e-3)" "unprognostic (1.15e-1)" "unprognostic (7.21e-2)" "unprognostic (1.65e-2)" "unprognostic (1.70e-2)" "unprognostic (4.82e-2)" "unprognostic (4.94e-2)" "unprognostic (2.01e-3)" "unprognostic (3.16e-2)" "unprognostic (1.66e-2)" "prognostic favorable (2.52e-4)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (8.23e-2)" "unprognostic (4.52e-1)" "prognostic favorable (9.76e-5)" "unprognostic (7.06e-2)" 13.7 39.3 20.8 12.0 15.9 23.6 10.4 6.1 22.3 14.4 28.3 8.1 24.3 18.5 21.9 41.9 12.2 16.5 9.1 36.9 17.5 7.3 6.0 5.7 12.8 24.5 7.9 17.0 11.6 18.4 8.3 19.2 23.5 9.3 16.4 24.2 14.1 8.3 22.4 2.0 9.2 19.6 45.5 14.0 16.5 11.1 5.2 8.6 6.2 18.5 6.9 13.6 22.3 16.3 3.9 2.1 4.6 1.0 9.1 14.8 5.4 0.0 0.0 32.3 0.0 5.6 0.8 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.2 0.0 0.0 4.1 0.9 29.5 0.0 49.7 0.8 0.3 0.0 0.2 0.1 12.6 2.7 10.8 4.9 0.0 22.3 0.2 0.0 0.9 3.4 71.8 6.3 0.0 0.0 16.6 13.3 0.2 0.0 0.0 47.0 23.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.1 2.3 0.0 9.4 0.0 0.0 1.2 12.2 0.0 0.1 9.1 0.0 4.1 1.0 4.6 9.1 0.2 13.7 3.9 13.0 11.0 2.1 1.5 8.2 9.8 1.5 9.1 0.1 1.0 14.8 5.4 20.8 15.9 6.1 22.3 17.5 7.3 7.9 17.0 9.3 8.6 56.6 49.3 25.1 24.4 94.8 6.8 305.9 0.0 9.4 43.3 12.2 0.0 2.6 0.0 2.5 0.7 38.4 26.9 46.7 59.7 1.7 135.6 5.7 54.3 0.8 12.0 3.2 62.3 17.8 13.3 0.9 48.6 38.9 37.1 6.4 146.6 155.3 32.6 35.1 116.7 1.0 3.7 25.8 50.5 0.7 3.6 34.6 5.3 61.2 109.0 7.0 CCNDBP1 "DIP1, GCIP, HHM" ENSG00000166946 "Cyclin D1 binding protein 1" O95273 15 43185118-43197176 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 55.4" "Cell type enhanced" "Detected in all" 12 "Cytotrophoblasts: 313.6;Syncytiotrophoblasts: 883.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 8 "HEL: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020664, HPA041065" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB020664: , HPA041065: AB_2677282" "unprognostic (4.48e-1)" "unprognostic (3.98e-2)" "unprognostic (5.00e-2)" "unprognostic (2.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-2)" "unprognostic (2.95e-1)" "unprognostic (7.75e-2)" "unprognostic (2.13e-1)" "unprognostic (4.94e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.40e-2)" "unprognostic (1.87e-1)" "unprognostic (7.95e-2)" "unprognostic (1.68e-2)" 15.6 10.9 3.4 12.6 5.3 55.4 17.5 10.8 9.5 8.8 9.4 5.6 11.5 7.6 11.3 10.7 18.3 10.4 9.6 14.1 3.9 6.9 8.2 8.4 11.6 23.6 6.1 5.6 5.6 13.4 5.2 9.6 24.1 9.3 8.8 9.0 7.7 11.3 12.8 21.1 12.0 12.9 8.2 6.0 12.8 11.8 5.9 5.4 8.3 15.6 5.9 11.0 15.9 11.7 5.4 2.9 16.9 8.0 4.6 7.6 1.6 0.3 0.4 0.6 0.3 1.6 1.1 0.6 0.4 2.0 0.4 0.4 0.5 0.4 0.6 0.5 1.4 0.2 0.6 1.4 0.6 0.3 0.9 1.4 16.9 0.8 0.6 1.2 0.8 1.0 2.0 1.6 0.2 0.6 1.7 1.3 0.3 1.0 0.6 0.6 0.0 0.5 1.9 1.2 0.7 0.5 0.5 0.6 1.5 2.2 0.7 0.8 1.3 0.6 0.5 0.4 0.7 0.1 1.6 1.6 0.5 0.2 1.3 0.3 2.0 0.7 0.3 1.7 1.8 0.5 16.9 1.9 4.9 5.2 3.3 5.4 4.4 5.6 5.1 1.6 5.4 5.9 6.1 6.1 4.6 8.0 2.9 7.6 1.6 3.4 5.3 10.8 9.5 3.9 6.9 6.1 5.6 9.3 5.4 44.7 55.2 77.3 44.9 30.8 27.2 52.0 35.7 92.3 50.0 27.9 19.6 313.6 76.3 59.3 11.5 45.0 55.7 140.2 52.3 67.6 49.5 41.5 54.4 28.2 77.3 42.9 44.4 47.9 82.6 10.0 43.7 59.8 60.8 151.5 49.4 52.2 58.5 56.1 27.6 38.5 63.1 45.3 48.9 65.4 36.8 35.3 883.1 83.0 45.2 73.2 CCNE1 CCNE ENSG00000105173 "Cyclin E1" P24864 19 29811898-29824308 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.3;placenta: 46.7" "Cell type enriched" "Detected in many" 14 "Extravillous trophoblasts: 1526.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 81.6" "Low region specificity" "Detected in all" "CAB000308, CAB016682, HPA018169" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384" "unprognostic (2.90e-3)" "unprognostic (1.33e-2)" "unprognostic (1.47e-3)" "prognostic unfavorable (6.35e-6)" "unprognostic (5.78e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (3.89e-5)" "unprognostic (1.26e-3)" "unprognostic (3.14e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (3.29e-2)" "unprognostic (7.07e-2)" "unprognostic (1.11e-16)" "unprognostic (5.61e-2)" "unprognostic (1.92e-1)" "unprognostic (6.63e-2)" "unprognostic (1.46e-1)" 1.6 6.8 2.4 4.5 2.9 23.3 0.6 6.3 3.3 0.8 3.0 1.7 1.1 2.3 1.2 0.6 4.7 0.7 2.2 4.4 2.3 2.8 1.2 0.7 1.1 4.6 1.9 1.9 0.9 1.4 1.7 1.0 46.7 2.8 1.1 3.8 1.5 3.2 1.2 2.2 4.4 2.5 3.0 1.7 4.6 2.0 12.3 1.6 4.1 1.6 2.1 5.9 2.7 2.5 2.7 1.6 1.6 1.9 0.0 1.4 0.5 4.1 8.6 6.6 9.4 1.4 1.6 81.6 6.6 1.4 2.9 3.6 8.7 8.4 3.5 15.7 2.9 3.8 1.3 7.8 3.4 4.2 11.1 4.8 2.9 8.4 9.1 1.1 11.5 7.9 1.7 1.9 4.0 0.5 0.9 3.5 3.5 11.8 1.6 4.4 6.2 6.3 3.3 11.0 9.4 2.0 9.5 7.7 2.6 2.2 6.6 5.6 4.7 9.5 11.7 1.0 10.1 2.6 8.6 2.0 6.9 25.9 4.1 4.4 6.6 4.6 23.9 3.9 1.4 3.7 0.0 0.1 0.0 0.6 1.9 1.1 2.7 0.5 0.4 1.6 0.2 0.1 0.9 1.6 0.0 1.9 0.0 1.4 0.5 2.4 2.9 6.3 3.3 2.3 2.8 1.9 1.9 2.8 1.6 0.0 1.1 0.8 1.0 4.2 2.4 2.8 0.0 0.0 2.3 0.0 0.0 112.5 0.0 0.4 7.1 1.1 1.7 0.0 0.6 1526.8 4.8 1.9 0.0 0.0 37.5 3.2 2.9 1.3 0.3 2.6 1.1 1.1 1.7 0.0 2.7 1.8 1.0 2.9 2.1 0.2 0.8 6.5 3.1 14.1 19.5 5.3 96.8 2.2 3.8 2.4 CCNK CPR4 ENSG00000090061 "Cyclin K" O75909 14 99481169-99535044 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" Cyclin "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000645, HPA077073" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000645: AB_1078606, HPA077073: AB_2732331" "unprognostic (8.07e-2)" "unprognostic (9.32e-3)" "unprognostic (9.52e-2)" "unprognostic (1.52e-2)" "unprognostic (5.83e-2)" "unprognostic (6.71e-2)" "unprognostic (9.22e-4)" "unprognostic (1.50e-2)" "unprognostic (2.06e-1)" "unprognostic (1.64e-1)" "unprognostic (4.78e-3)" "unprognostic (8.94e-3)" "unprognostic (7.74e-2)" "unprognostic (3.93e-1)" "unprognostic (2.73e-1)" "unprognostic (1.06e-1)" "unprognostic (6.21e-2)" 21.9 18.4 16.1 20.3 20.6 70.4 16.9 25.0 17.6 20.4 21.0 26.2 15.3 20.4 20.2 16.6 25.2 18.6 15.8 18.4 17.0 13.2 18.7 16.5 21.5 21.4 18.9 11.0 26.0 16.9 12.6 28.7 21.0 16.7 16.2 23.2 20.6 21.6 16.2 36.3 20.6 22.5 16.9 19.0 23.1 20.1 50.5 22.4 35.9 19.1 21.0 29.7 21.0 18.5 6.8 6.0 15.6 7.0 6.0 9.3 3.9 16.3 18.4 19.0 15.9 15.5 16.2 34.9 21.8 19.6 22.8 26.6 26.7 21.9 25.9 15.3 23.5 17.0 18.8 20.2 28.1 32.1 25.3 10.6 23.9 12.5 22.9 20.4 33.6 27.4 17.5 21.8 22.7 26.2 10.9 17.1 26.0 21.6 23.1 19.8 35.2 25.8 13.6 18.7 20.4 16.4 23.3 25.6 13.6 12.7 31.4 15.7 11.7 19.6 10.1 9.0 19.3 27.6 15.3 20.7 8.2 13.2 71.9 19.5 19.7 25.6 31.7 21.1 15.7 16.8 5.8 6.5 13.9 9.3 7.0 8.1 6.8 7.2 8.0 5.6 6.6 8.4 7.6 15.6 6.0 6.8 6.0 7.3 3.9 16.1 20.6 25.0 17.6 17.0 13.2 18.9 11.0 16.7 22.4 11.9 35.2 21.7 34.4 32.6 15.9 8.7 17.8 45.5 42.1 21.0 19.6 20.8 11.6 16.6 34.3 20.7 27.5 23.3 21.3 23.6 19.9 39.1 19.7 17.0 21.5 17.5 18.9 27.6 29.1 13.7 20.8 24.0 16.9 27.1 32.0 14.6 24.2 28.5 17.0 13.7 29.9 0.0 15.1 70.7 62.3 39.5 22.8 28.7 29.2 60.7 CCNT1 "CCNT, CYCT1, HIVE1" ENSG00000129315 "Cyclin T1" O60563 12 48688458-48716998 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 95.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004892, CAB009016, HPA072012" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009016: AB_2073888, HPA004892: AB_1078607, HPA072012: " "unprognostic (1.76e-3)" "unprognostic (3.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.36e-2)" "unprognostic (1.71e-2)" "unprognostic (3.76e-1)" "unprognostic (1.93e-3)" "unprognostic (1.38e-1)" "unprognostic (5.78e-3)" "unprognostic (1.86e-1)" "unprognostic (2.80e-1)" "unprognostic (1.28e-1)" "unprognostic (3.13e-1)" "unprognostic (3.22e-1)" "unprognostic (3.43e-2)" "unprognostic (4.50e-2)" "unprognostic (1.92e-1)" 16.6 14.9 13.1 12.9 17.4 38.1 15.7 20.9 17.7 13.4 12.6 16.5 10.9 9.9 19.9 13.0 13.8 15.8 10.5 11.8 13.5 8.5 13.0 14.1 15.6 14.9 14.3 13.2 21.5 15.9 18.4 19.6 18.5 14.5 12.8 12.4 12.8 12.6 11.2 18.8 16.4 14.6 13.3 12.1 16.8 13.8 22.6 15.7 22.4 16.5 10.9 15.9 15.3 13.2 5.5 4.4 14.8 2.8 3.7 4.9 0.9 7.6 10.6 10.5 10.4 8.4 9.8 12.8 10.3 8.1 7.8 6.4 13.1 9.4 20.8 13.5 6.6 5.6 9.6 16.7 7.3 11.6 11.6 10.7 21.6 17.1 5.9 9.9 23.8 11.0 7.8 10.9 9.8 13.5 11.3 6.4 12.3 20.7 9.0 9.4 4.9 11.1 11.1 11.4 4.6 8.7 10.8 16.8 8.9 7.8 14.0 11.2 12.7 15.8 8.6 12.6 8.7 11.4 13.7 6.5 9.0 9.2 6.4 9.0 13.9 18.7 18.6 10.2 33.9 5.2 6.8 2.8 7.9 3.6 1.8 4.9 4.3 3.1 3.5 1.7 5.5 4.5 4.0 14.8 3.7 2.0 4.4 1.8 0.9 13.1 17.4 20.9 17.7 13.5 8.5 14.3 13.2 14.5 15.7 14.9 17.6 17.9 16.5 34.2 20.2 11.3 15.3 24.1 14.8 12.2 21.6 11.3 3.3 7.0 95.2 23.3 11.2 0.0 6.0 11.3 13.4 16.0 28.9 12.9 8.8 36.5 11.5 22.7 18.0 21.0 15.5 16.2 20.3 5.4 14.3 16.7 6.5 10.5 13.8 7.9 13.0 6.5 23.7 16.1 13.2 39.3 14.5 24.5 10.9 27.8 CD3EAP "ASE-1, CAST, PAF49" ENSG00000117877 "CD3e molecule associated protein" O15446 19 45406209-45410766 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 109.3;Suprabasal keratinocytes: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-251 MG: 65.8" "Low region specificity" "Detected in all" "HPA041664, HPA041734" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoplasm, Nucleoli fibrillar center" Mitochondria "HPA041664: AB_10795693, HPA041734: AB_10794489" "unprognostic (1.03e-1)" "unprognostic (8.98e-2)" "unprognostic (9.28e-2)" "unprognostic (1.37e-3)" "unprognostic (2.46e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (4.79e-9)" "unprognostic (1.62e-3)" "unprognostic (3.21e-1)" "unprognostic (5.01e-2)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (6.29e-9)" "unprognostic (1.02e-1)" "unprognostic (2.81e-1)" "unprognostic (1.38e-2)" "unprognostic (4.53e-2)" 7.3 5.9 7.7 8.4 9.7 4.0 7.1 14.9 9.0 5.6 5.5 6.5 2.9 4.9 6.4 3.0 9.9 7.1 6.4 6.7 7.1 6.4 5.2 6.8 4.5 7.2 8.1 6.0 8.7 18.3 6.6 7.3 5.1 8.0 5.2 4.9 3.1 7.2 4.6 14.2 8.4 4.3 6.6 5.6 5.8 4.3 5.2 9.3 3.6 6.1 7.8 8.5 5.5 5.8 3.5 15.9 1.3 3.7 3.2 4.1 2.1 10.4 10.8 1.7 7.9 2.6 2.1 7.0 5.0 1.7 8.9 5.2 10.6 7.5 16.3 5.3 3.7 7.2 10.1 15.6 14.3 6.3 8.0 10.1 9.0 4.1 7.8 4.4 9.1 3.2 3.2 9.2 12.9 7.1 2.2 6.4 6.0 20.5 3.3 8.6 12.3 6.9 2.6 12.7 11.6 9.1 9.4 6.9 10.7 3.5 7.8 10.8 4.0 10.7 14.3 2.3 3.8 7.2 5.5 6.2 12.7 13.3 7.3 65.8 5.9 23.4 17.3 6.3 13.0 9.1 0.9 2.8 0.3 1.7 3.7 3.4 2.8 2.2 2.4 5.0 3.5 3.1 4.1 1.3 3.2 3.3 15.9 1.2 2.1 7.7 9.7 14.9 9.0 7.1 6.4 8.1 6.0 8.0 9.3 6.0 12.8 10.0 23.3 109.3 4.5 1.2 7.6 6.7 12.5 1.8 9.8 13.7 1.7 15.9 0.2 9.0 1.7 0.0 5.8 19.4 6.6 7.7 5.7 4.2 10.0 11.1 4.6 4.9 2.6 0.5 8.9 7.0 11.8 2.8 4.3 3.5 11.0 0.0 10.6 6.1 5.8 0.0 8.9 0.5 18.9 96.7 6.4 0.0 9.5 11.5 CDC20 "CDC20A, p55CDC" ENSG00000117399 "Cell division cycle 20" Q12834 1 43358955-43363203 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 42.0;testis: 73.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 97.6;Erythroid cells: 70.0;Extravillous trophoblasts: 127.9;Spermatocytes: 74.9;Spermatogonia: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2" "Group enriched" "Detected in many" 9 "B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "CAB004525, HPA045842, HPA055288" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes "Nucleoplasm, Cytosol" "CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773" "unprognostic (1.66e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-2)" "unprognostic (2.14e-3)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.00e-8)" "unprognostic (9.06e-3)" "unprognostic (1.17e-2)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (8.55e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.29e-2)" 1.3 1.2 0.6 16.6 1.1 20.2 1.8 0.8 1.3 2.1 6.2 2.8 0.4 5.8 1.1 1.6 17.8 0.4 1.9 1.2 0.9 0.5 2.2 1.2 1.8 13.4 1.1 0.7 0.9 0.5 0.0 0.4 3.9 1.2 0.8 7.0 0.4 2.9 0.4 0.6 4.6 6.4 2.8 1.2 7.8 4.4 73.2 0.7 42.0 1.2 11.7 21.7 1.9 4.2 4.5 0.9 0.8 0.1 9.8 11.2 2.7 52.6 25.7 35.9 23.4 1.2 3.2 34.4 24.4 21.9 71.2 38.0 40.3 43.8 30.5 14.3 22.4 25.1 37.1 39.2 46.6 59.5 23.9 29.0 44.6 25.4 24.9 0.3 31.1 16.3 1.0 2.2 49.4 44.8 6.2 30.1 29.3 20.1 21.0 32.2 20.4 29.9 19.1 45.4 25.1 34.6 43.5 49.3 19.3 17.3 14.0 21.2 10.4 43.1 29.2 13.5 28.8 20.5 39.4 15.6 21.3 50.0 23.6 75.6 16.1 14.3 31.6 15.3 38.8 31.7 0.0 0.1 0.0 0.4 0.0 0.0 4.5 3.3 3.6 0.9 0.9 0.1 0.3 0.8 9.8 0.0 0.2 11.2 2.7 0.6 1.1 0.8 1.3 0.9 0.5 1.1 0.7 1.2 0.7 0.0 0.6 16.2 2.0 9.3 0.0 0.7 0.0 2.7 1.2 0.0 0.0 13.4 0.0 2.1 97.6 0.7 3.2 70.0 0.3 127.9 4.1 2.0 0.0 1.0 30.9 0.0 0.0 8.0 5.0 7.0 2.6 5.2 0.0 2.8 2.9 0.2 0.7 0.0 1.8 2.1 2.6 0.0 1.4 74.9 48.1 7.3 8.9 1.3 15.5 2.6 CDC27 "ANAPC3, APC3, D0S1430E, D17S978E, NUC2" ENSG00000004897 "Cell division cycle 27" P30260 17 47117703-47189422 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Erythroid cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016315, HPA028129, HPA052399, HPA065835" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB016315: AB_627228, HPA028129: AB_10603559, HPA052399: AB_2681814, HPA065835: " "unprognostic (2.34e-2)" "unprognostic (8.83e-3)" "prognostic favorable (1.77e-4)" "unprognostic (4.26e-2)" "unprognostic (7.99e-2)" "unprognostic (8.93e-3)" "prognostic unfavorable (4.38e-4)" "prognostic unfavorable (8.15e-4)" "unprognostic (1.98e-1)" "unprognostic (1.45e-1)" "unprognostic (4.05e-3)" "unprognostic (6.17e-2)" "prognostic unfavorable (6.39e-5)" "unprognostic (2.64e-1)" "unprognostic (1.58e-1)" "unprognostic (7.95e-2)" "unprognostic (3.66e-2)" 29.2 18.9 19.4 18.7 25.2 23.0 23.3 26.0 33.0 23.7 17.2 14.8 13.8 14.4 23.2 19.6 17.6 17.6 18.6 22.8 18.3 22.6 16.8 23.8 20.4 21.3 19.4 23.9 19.5 14.3 27.8 26.8 25.0 31.5 17.6 18.2 14.6 15.7 16.5 31.6 15.5 15.3 24.4 17.7 24.2 16.1 23.5 17.4 25.2 42.8 15.5 22.9 23.6 17.3 9.0 7.7 9.6 10.3 12.8 11.6 5.4 23.6 25.4 21.3 17.1 14.4 22.9 12.7 33.5 30.2 32.0 32.8 16.2 12.5 31.9 22.6 28.0 20.5 11.4 22.9 18.9 44.2 45.8 23.5 37.1 26.8 14.4 15.6 21.7 16.9 16.6 9.3 28.8 22.8 15.5 33.0 18.7 29.5 17.8 26.0 20.1 26.7 9.9 10.1 13.4 20.7 14.4 54.7 14.1 19.3 15.0 14.2 17.3 16.8 5.9 18.6 19.0 17.9 15.4 35.1 33.5 29.1 21.1 24.7 18.2 31.5 28.9 18.5 13.0 23.1 9.6 4.4 6.2 8.1 10.3 7.8 6.0 6.8 8.5 6.0 9.0 6.7 7.6 5.7 12.8 7.4 7.7 11.6 5.4 19.4 25.2 26.0 33.0 18.3 22.6 19.4 23.9 31.5 17.4 8.9 22.9 28.9 16.0 23.1 20.2 34.3 22.9 10.7 28.4 19.2 15.7 24.5 13.3 23.9 23.6 38.7 10.6 163.5 23.1 29.3 36.3 14.9 25.5 25.2 24.1 33.4 13.3 37.4 24.8 22.5 26.2 19.8 6.8 31.5 13.5 19.5 24.1 10.5 28.0 17.4 13.9 19.4 33.0 88.5 35.1 23.5 9.6 21.0 14.3 13.1 CDCA5 ENSG00000146670 "Cell division cycle associated 5" Q96FF9 11 65066300-65084164 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 39.9;testis: 27.9" "Group enriched" "Detected in many" 5 "Early spermatids: 41.6;Extravillous trophoblasts: 30.6;Late spermatids: 84.2;Spermatocytes: 40.4;Spermatogonia: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "NK-cell: 5.8;T-reg: 4.2" "Group enriched" "Detected in many" 4 "NK-cells: 5.8;T-cells: 4.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023691, HPA076007" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA023691: AB_1846392, HPA076007: " "unprognostic (3.14e-2)" "unprognostic (4.20e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.15e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.21e-6)" "unprognostic (1.41e-3)" "unprognostic (7.55e-3)" "unprognostic (6.93e-2)" "prognostic unfavorable (8.72e-6)" "unprognostic (2.16e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.55e-3)" "unprognostic (1.86e-1)" "unprognostic (1.35e-1)" "unprognostic (8.97e-2)" 1.3 1.3 1.1 12.3 1.1 27.4 4.3 1.0 2.8 1.6 3.8 0.6 0.0 3.3 0.9 1.4 7.9 0.7 1.4 1.3 1.1 0.9 1.3 1.3 1.9 9.5 1.1 0.5 0.8 0.7 0.2 0.7 5.5 1.3 0.9 4.7 0.1 1.5 0.1 0.7 2.4 3.6 1.7 0.7 5.7 2.1 27.9 0.2 39.9 0.7 6.6 9.9 1.5 2.3 1.2 0.8 0.3 0.5 5.8 4.2 1.4 30.7 17.6 16.9 14.3 1.1 1.8 14.1 22.0 9.2 25.8 20.6 18.0 18.7 28.0 12.7 7.1 30.4 21.3 27.3 12.1 25.2 28.0 11.9 25.2 12.8 15.1 0.1 26.8 20.4 0.6 1.1 24.1 11.2 2.7 7.8 33.6 28.5 51.8 15.7 25.5 37.8 27.7 26.6 15.2 21.4 33.2 18.7 26.7 5.3 11.8 22.0 16.5 14.1 20.2 14.9 11.0 26.0 13.2 4.9 23.4 24.2 24.6 24.4 26.2 41.5 45.6 9.4 16.6 24.1 0.0 0.2 0.3 0.8 0.0 0.1 0.7 1.1 0.6 0.8 1.2 0.1 0.8 0.1 5.8 0.5 0.7 4.2 1.4 1.1 1.1 1.0 2.8 1.1 0.9 1.1 0.5 1.3 0.2 0.0 0.3 0.8 0.8 3.4 0.8 0.8 0.0 0.0 1.2 0.0 2.0 3.7 1.7 0.9 41.6 0.9 0.9 0.0 0.7 30.6 1.8 0.4 3.5 0.0 9.5 1.6 0.0 1.3 2.8 84.2 2.6 1.9 0.0 3.6 2.3 0.8 0.5 0.0 1.4 0.3 0.2 0.0 0.3 40.4 22.0 0.9 3.1 1.9 2.8 1.0 CDK12 "CRK7, CRKR, CRKRS, KIAA0904" ENSG00000167258 "Cyclin dependent kinase 12" Q9NYV4 17 39461511-39564907 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 87.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008038, HPA073305" Supported Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA008038: AB_1078570, HPA073305: " "unprognostic (2.02e-1)" "unprognostic (1.80e-1)" "unprognostic (2.61e-2)" "unprognostic (7.56e-2)" "unprognostic (1.05e-1)" "unprognostic (3.19e-1)" "unprognostic (2.56e-3)" "unprognostic (2.37e-2)" "unprognostic (3.86e-2)" "unprognostic (3.00e-3)" "unprognostic (6.87e-3)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "unprognostic (9.10e-2)" "unprognostic (1.24e-1)" "unprognostic (2.22e-2)" "unprognostic (5.32e-1)" 16.0 13.1 12.4 17.4 9.2 32.4 14.0 23.4 17.8 18.2 17.6 9.6 15.7 11.1 15.7 12.0 16.9 12.2 12.5 11.0 10.1 6.7 10.2 18.5 13.5 15.2 10.9 14.3 17.4 11.3 19.0 12.2 18.4 9.5 12.7 11.7 10.4 15.6 11.1 11.1 17.0 16.5 11.0 10.6 16.3 11.8 18.9 8.3 29.0 15.0 5.4 17.3 16.3 20.5 5.1 4.0 10.4 2.9 6.6 4.0 0.9 8.9 11.1 6.7 6.2 4.9 5.5 6.2 8.1 6.9 11.1 8.3 13.6 5.5 12.7 7.1 8.5 11.3 14.6 13.3 10.2 10.8 8.3 11.4 13.7 7.5 10.5 4.8 18.7 9.6 5.9 7.1 13.5 10.7 4.6 6.7 7.7 23.2 8.4 6.3 4.2 15.3 4.8 7.0 4.4 5.0 10.1 14.4 7.2 4.2 10.7 7.2 4.6 10.3 87.5 7.0 10.1 11.2 8.1 7.2 10.1 8.1 7.0 10.4 6.9 4.9 17.9 7.2 7.9 6.6 10.4 2.9 4.1 4.0 2.2 3.0 2.9 2.5 2.7 1.8 5.1 2.9 2.7 9.7 6.6 1.8 4.0 2.0 0.9 12.4 9.2 23.4 17.8 10.1 6.7 10.9 14.3 9.5 8.3 23.8 26.1 37.7 45.0 57.5 45.4 12.1 35.7 29.4 40.9 36.6 60.9 27.7 11.6 24.4 15.9 29.6 32.0 23.3 23.8 24.7 35.7 62.9 27.8 38.9 23.9 33.4 29.9 27.6 37.0 14.0 34.5 34.5 25.3 27.9 26.9 31.5 36.1 31.6 31.8 12.9 67.7 32.3 33.0 113.1 90.5 60.3 48.7 42.9 28.8 77.9 CDK2 ENSG00000123374 "Cyclin dependent kinase 2" P24941 12 55966769-55972784 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 78.7;Extravillous trophoblasts: 67.5;Melanocytes: 82.7;Syncytiotrophoblasts: 142.8" "Cancer enhanced" "Detected in all" "melanoma: 88.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 107.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013115, HPA066915" Enhanced Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "CAB013115: AB_2536375, HPA066915: AB_2685748" "unprognostic (2.36e-2)" "unprognostic (2.60e-1)" "unprognostic (3.71e-2)" "unprognostic (1.83e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.94e-4)" "prognostic unfavorable (8.61e-5)" "unprognostic (3.48e-2)" "unprognostic (1.31e-1)" "unprognostic (4.67e-2)" "unprognostic (5.38e-3)" "unprognostic (4.69e-3)" "prognostic unfavorable (1.46e-10)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (6.75e-2)" 10.7 7.6 4.5 20.8 6.5 18.7 11.5 4.2 4.3 12.6 11.6 3.5 6.0 6.1 10.7 6.4 13.6 10.8 12.6 10.1 5.4 2.2 8.3 16.7 19.5 12.2 6.0 2.0 14.2 8.3 5.2 4.2 49.0 7.3 10.8 9.1 51.2 9.3 9.9 10.8 14.6 9.3 11.8 5.0 12.5 10.1 7.8 5.1 39.3 9.5 10.7 14.7 16.7 10.1 9.3 10.8 5.2 3.9 4.5 7.6 4.3 16.8 9.1 20.1 11.1 4.1 5.3 37.0 21.0 11.0 26.2 24.5 19.2 16.3 16.1 15.8 7.8 10.5 10.8 15.3 9.2 26.6 18.9 15.0 18.5 15.1 7.3 1.3 14.6 13.4 2.8 2.3 17.7 6.1 7.6 13.2 16.7 17.5 14.7 18.1 13.0 30.3 12.4 8.0 11.5 13.6 29.6 19.3 12.1 7.6 16.6 8.3 10.7 24.0 8.8 107.8 12.0 19.0 10.7 7.3 18.1 17.5 13.9 15.3 8.3 9.6 20.0 10.3 10.7 15.6 5.2 3.6 3.1 7.0 3.9 7.0 9.3 3.2 5.0 2.7 6.1 3.0 5.3 1.7 4.5 1.6 10.8 7.6 4.3 4.5 6.5 4.2 4.3 5.4 2.2 6.0 2.0 7.3 5.1 14.9 3.7 5.2 20.1 24.8 0.0 2.6 12.7 5.3 9.1 1.8 0.0 78.7 1.7 10.5 0.4 15.0 2.1 0.0 5.0 67.5 17.6 10.9 10.4 8.9 11.6 1.6 5.2 8.6 4.8 0.2 13.8 6.3 82.7 47.7 6.3 3.8 9.0 0.0 4.2 3.8 3.4 0.0 14.4 2.9 7.7 27.5 142.8 5.7 6.8 18.0 CDKL1 KKIALRE ENSG00000100490 "Cyclin dependent kinase like 1" Q00532 14 50329404-50416461 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 17.9;Ciliated cells: 34.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059605, HPA065919" Uncertain Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059605: AB_2684080, HPA065919: AB_2685578" "unprognostic (4.12e-3)" "unprognostic (3.22e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.02e-1)" "unprognostic (3.23e-3)" "unprognostic (9.36e-3)" "unprognostic (2.63e-1)" "unprognostic (9.99e-2)" "unprognostic (1.20e-1)" "unprognostic (9.36e-2)" "unprognostic (5.53e-8)" "unprognostic (1.21e-1)" "unprognostic (7.96e-2)" "unprognostic (9.39e-3)" "unprognostic (3.31e-3)" 7.1 2.1 7.5 1.8 5.1 0.9 3.0 2.7 20.2 14.1 5.9 1.6 2.5 8.4 12.1 2.3 2.6 16.4 2.6 2.9 7.1 2.4 18.8 1.1 4.3 3.0 2.0 12.3 10.5 2.0 1.4 1.4 4.9 2.9 4.0 5.7 1.6 2.5 8.4 1.7 3.0 3.0 7.7 3.1 3.7 2.0 1.9 1.4 1.3 5.0 6.1 2.1 7.0 5.6 5.7 1.3 6.0 2.5 3.8 6.7 2.6 6.1 4.9 0.6 2.4 6.5 7.9 0.3 2.1 3.9 2.2 2.6 2.0 5.8 0.4 2.6 4.6 2.2 4.2 0.9 0.6 2.5 6.7 2.4 6.5 2.1 1.7 7.4 5.9 3.5 1.7 3.6 4.6 10.1 1.8 8.5 6.2 2.7 2.6 1.0 0.3 1.9 3.1 0.7 1.6 2.3 0.7 2.8 1.9 6.9 2.3 1.1 1.3 2.5 16.7 0.6 0.1 0.2 5.0 2.7 5.7 2.9 5.7 4.7 0.9 0.4 0.4 1.0 6.2 7.0 6.0 2.5 4.4 6.3 2.3 6.2 4.6 4.4 6.7 1.3 5.7 3.4 3.7 1.4 3.8 0.3 1.2 4.1 2.6 7.5 5.1 2.7 20.2 7.1 2.4 2.0 12.3 2.9 1.4 17.9 6.9 1.3 3.2 2.7 0.4 0.4 0.0 34.8 4.5 10.4 0.0 0.1 5.0 0.9 0.3 2.1 4.7 0.0 1.6 0.1 4.7 1.2 1.1 0.2 0.3 0.0 1.7 6.7 1.9 0.9 8.3 1.1 0.0 0.0 2.3 0.8 1.2 3.7 3.2 5.5 0.7 0.0 1.3 0.0 0.2 2.4 0.2 2.5 3.4 1.4 CDKN2AIP "CARF, FLJ20036" ENSG00000168564 "CDKN2A interacting protein" Q9NXV6 4 183444591-183448198 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 103.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 60.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041397, HPA062142" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA041397: AB_10794297, HPA062142: AB_2684696" "unprognostic (9.00e-2)" "unprognostic (1.14e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.56e-1)" "unprognostic (7.20e-2)" "unprognostic (1.52e-2)" "unprognostic (7.65e-3)" "unprognostic (6.70e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "prognostic favorable (3.00e-5)" "unprognostic (2.93e-2)" "unprognostic (4.69e-2)" "unprognostic (2.25e-3)" "unprognostic (2.23e-2)" 14.2 14.3 13.9 13.6 15.6 32.3 15.9 20.8 13.8 18.1 18.1 15.0 10.1 18.7 17.1 13.2 27.7 13.0 13.3 15.0 13.0 12.9 18.1 17.2 17.8 17.8 15.4 10.7 24.0 18.4 15.9 21.9 16.4 14.0 21.5 14.2 13.0 15.9 15.2 11.1 14.2 18.0 14.8 13.7 16.0 17.2 20.1 12.2 24.7 23.4 20.6 27.3 16.6 24.1 8.3 4.6 28.5 5.9 8.1 14.7 8.4 5.1 2.9 8.7 6.2 7.3 5.3 6.5 8.7 7.3 9.0 6.0 4.3 5.0 17.3 1.8 5.9 3.7 4.1 7.9 6.4 9.5 7.0 4.7 17.9 14.0 5.5 5.8 13.1 7.2 6.3 6.0 5.3 7.0 4.8 7.1 6.6 8.9 18.7 6.2 2.7 14.8 10.7 6.3 1.9 6.0 12.8 4.2 6.9 60.3 4.9 8.9 7.6 6.3 26.6 10.4 5.9 3.9 11.4 4.0 3.2 4.5 2.9 7.0 9.1 3.7 8.9 5.0 11.3 5.1 28.5 4.8 10.4 9.0 5.6 9.4 7.4 11.1 9.7 4.6 8.3 14.7 13.3 5.7 8.1 5.9 3.1 10.9 8.4 13.9 15.6 20.8 13.8 13.0 12.9 15.4 10.7 14.0 12.2 14.9 30.7 18.2 22.6 31.9 21.9 15.7 22.9 33.5 27.3 15.7 9.8 20.1 14.9 11.0 103.2 21.8 25.7 0.0 13.7 12.2 23.7 35.9 61.1 12.8 13.7 20.6 29.1 17.8 8.8 51.4 19.5 18.9 20.3 11.8 19.1 18.8 13.2 20.1 16.3 10.5 19.8 12.9 21.1 32.3 36.3 34.8 15.7 34.1 17.5 48.5 CDX2 CDX3 ENSG00000165556 "Caudal type homeobox 2" Q99626 13 27962137-27971139 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "intestine: 21.2" "Group enriched" "Detected in some" 7 "Enterocytes: 190.4;Intestinal endocrine cells: 60.0;Mucus-secreting cells: 200.2;Paneth cells: 129.8;Undifferentiated cells: 183.4" "Cancer enriched" "Detected in many" 6 "colorectal cancer: 63.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 14.7;CAPAN-2: 4.9;HEK 293: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002221, HPA045669, HPA049580" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002221: AB_563649, HPA045669: AB_2679413, HPA049580: AB_2680823" "unprognostic (1.42e-1)" "unprognostic (2.41e-1)" "unprognostic (2.92e-1)" "unprognostic (8.11e-3)" "unprognostic (4.19e-6)" "unprognostic (1.73e-4)" "unprognostic (1.71e-1)" "unprognostic (1.58e-1)" "unprognostic (5.51e-2)" "unprognostic (6.07e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 21.2 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 14.3 0.0 0.0 0.0 0.0 16.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.7 4.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 8.1 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 20.8 0.0 0.0 190.4 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.4 0.0 60.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 200.2 0.0 1.1 129.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 183.4 0.1 CEBPB "C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5" ENSG00000172216 "CCAAT/enhancer binding protein beta" P17676 20 50190734-50192689 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 121.9" "Cell type enhanced" "Detected in many" 7 "Smooth muscle cells: 658.6;Suprabasal keratinocytes: 699.3;Syncytiotrophoblasts: 1179.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.6" "Group enriched" "Detected in many" 8 "granulocytes: 13.6;monocytes: 6.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 45.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB004213, HPA061355, HPA062267" Supported Enhanced Nucleoplasm Yes No Nucleoplasm "CAB004213: AB_626772, HPA061355: AB_2684487, HPA062267: AB_2684731" "unprognostic (2.30e-2)" "unprognostic (2.64e-1)" "unprognostic (1.24e-2)" "unprognostic (1.09e-2)" "unprognostic (9.48e-2)" "unprognostic (2.24e-2)" "unprognostic (1.32e-1)" "unprognostic (1.40e-3)" "unprognostic (1.79e-2)" "unprognostic (9.85e-3)" "unprognostic (9.26e-3)" "unprognostic (6.55e-2)" "prognostic unfavorable (2.44e-12)" "unprognostic (7.29e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-2)" "unprognostic (7.63e-2)" 56.9 54.7 7.0 35.9 9.9 21.1 34.4 1.8 6.2 22.8 25.2 6.4 8.0 8.0 19.4 11.2 19.2 21.7 20.2 33.6 8.4 4.4 15.3 92.5 51.3 20.4 9.5 3.0 33.6 18.6 4.1 7.4 75.1 7.7 21.1 5.0 14.0 14.6 11.7 121.9 23.9 19.4 12.6 9.5 40.3 15.3 14.3 8.1 1.5 46.1 25.3 10.7 30.8 30.6 0.4 1.2 13.6 6.1 0.4 0.5 0.5 7.4 3.4 0.3 4.1 19.3 7.6 33.5 10.1 16.0 7.0 6.2 3.4 6.9 4.9 19.4 4.1 34.4 10.2 1.0 9.9 4.7 3.5 2.5 1.5 4.4 5.0 23.8 2.4 9.8 8.1 26.3 8.9 15.8 14.6 0.9 5.1 7.1 9.1 4.3 2.8 1.1 5.3 2.1 7.1 9.9 3.5 1.0 5.5 2.3 1.8 2.0 1.3 8.4 20.9 45.0 2.3 5.5 13.8 1.3 14.6 11.1 12.4 9.7 19.4 8.0 4.3 26.6 5.6 6.3 5.9 3.0 9.1 0.4 5.3 0.1 0.4 0.4 0.5 1.2 0.3 0.3 0.2 13.6 0.4 6.1 0.0 0.2 0.5 7.0 9.9 1.8 6.2 8.4 4.4 9.5 3.0 7.7 8.1 32.8 78.5 51.8 281.2 643.3 2.2 40.0 84.1 21.4 31.8 43.6 0.0 157.2 26.6 27.6 4.6 30.6 66.5 0.0 11.5 550.7 468.0 220.5 50.7 350.5 326.4 3.2 64.1 81.0 362.0 5.0 120.0 403.2 205.8 1.8 77.9 46.2 16.6 52.6 90.5 50.0 3.3 155.2 658.6 0.7 9.1 699.3 1179.1 63.8 45.7 245.2 CELF1 "BRUNOL2, CUG-BP, CUGBP, CUGBP1, EDEN-BP, hNab50, NAB50, NAPOR" ENSG00000149187 "CUGBP Elav-like family member 1" Q92879 11 47465933-47565569 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016114, HPA044597, CAB069989" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016114: AB_627319, CAB069989: AB_2086153, HPA044597: AB_2679012" "unprognostic (1.05e-1)" "unprognostic (7.54e-2)" "unprognostic (3.24e-2)" "unprognostic (7.64e-2)" "unprognostic (2.69e-1)" "unprognostic (4.08e-2)" "prognostic unfavorable (7.55e-4)" "unprognostic (3.84e-2)" "unprognostic (3.41e-2)" "unprognostic (1.59e-1)" "unprognostic (2.75e-1)" "unprognostic (4.24e-2)" "unprognostic (1.24e-1)" "unprognostic (4.81e-2)" "unprognostic (2.68e-1)" "unprognostic (9.58e-2)" "unprognostic (3.34e-2)" 18.4 22.8 28.3 19.9 30.8 25.8 22.7 49.5 29.8 17.8 20.7 16.6 22.9 14.7 22.9 20.1 21.5 19.0 16.5 19.3 18.7 14.1 18.5 36.5 21.0 24.0 12.8 20.2 18.9 19.2 54.3 19.6 18.2 14.6 16.3 17.7 18.4 18.0 19.7 45.4 20.1 20.1 31.4 11.9 22.3 17.9 20.4 17.7 15.8 19.5 17.0 24.6 20.6 23.8 15.4 12.4 20.6 15.5 7.0 16.1 8.0 17.9 32.0 26.6 27.3 20.9 22.4 22.7 19.3 20.1 24.4 25.6 27.1 21.4 47.5 13.5 20.8 29.5 26.9 41.1 27.4 41.2 19.8 17.9 14.6 42.0 19.4 20.4 22.8 16.2 17.1 16.9 26.5 32.3 17.3 22.2 20.6 27.3 19.4 15.6 24.0 23.5 18.3 37.2 22.4 18.9 24.3 21.3 18.6 21.0 32.2 25.0 21.1 25.7 23.9 15.7 28.5 33.7 15.1 25.5 28.0 27.6 26.7 26.1 16.7 15.1 37.9 22.6 10.9 22.7 10.9 10.8 20.6 12.8 9.6 16.1 14.6 13.5 14.5 12.4 15.4 14.7 12.1 14.6 7.0 15.5 7.7 9.2 8.0 28.3 30.8 49.5 29.8 18.7 14.1 12.8 20.2 14.6 17.7 50.6 34.1 56.8 64.7 95.7 73.0 45.8 86.6 37.5 29.6 75.0 90.3 45.7 18.3 52.0 15.0 60.9 41.1 46.7 48.3 42.8 47.4 90.8 20.8 179.6 61.2 120.8 82.1 87.2 102.7 7.0 48.9 83.5 40.5 34.3 52.3 66.2 69.1 45.6 51.9 31.8 44.1 51.8 57.1 53.7 63.4 95.4 30.1 57.3 64.3 86.4 CENPB ENSG00000125817 "Centromere protein B" P07199 20 3783851-3786690 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011626, HPA053507, HPA054405" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "CAB011626: AB_726801, HPA053507: AB_2682173, HPA054405: AB_2682477" "unprognostic (2.01e-1)" "unprognostic (8.47e-3)" "unprognostic (2.61e-1)" "unprognostic (1.12e-2)" "unprognostic (1.75e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.09e-4)" "unprognostic (2.40e-2)" "unprognostic (3.27e-2)" "unprognostic (3.57e-1)" "unprognostic (1.48e-3)" "unprognostic (7.93e-2)" "unprognostic (2.78e-2)" "unprognostic (1.39e-1)" "unprognostic (2.68e-1)" "unprognostic (1.34e-1)" "unprognostic (2.46e-1)" 30.4 18.9 41.2 18.0 41.6 11.9 22.9 13.0 28.9 22.4 23.0 41.1 18.7 19.6 18.4 19.8 22.3 18.1 27.3 26.9 41.9 29.1 19.8 20.3 20.0 16.0 48.0 14.7 25.0 23.9 22.7 12.1 15.2 22.0 18.6 12.3 13.0 27.6 24.3 58.3 32.6 19.9 20.1 55.8 19.8 21.9 9.0 21.9 19.6 21.7 26.4 14.9 20.7 28.0 3.7 4.2 1.4 4.5 3.9 5.0 2.5 32.0 41.4 8.1 17.3 17.3 13.8 5.2 23.1 16.9 14.9 12.1 16.8 23.2 11.2 7.2 21.4 23.3 26.0 6.4 26.3 7.5 15.9 11.0 23.8 14.9 14.8 20.2 7.7 8.0 15.6 14.1 21.3 13.7 11.7 12.7 14.6 15.3 7.1 12.6 52.9 23.0 17.8 10.2 18.2 49.4 19.2 1.0 8.2 15.5 19.9 20.0 14.9 19.1 26.9 18.0 3.8 16.9 17.2 21.5 25.9 14.0 22.3 35.2 8.6 12.4 6.6 9.0 27.8 16.9 0.1 4.5 1.4 5.0 4.0 3.5 2.5 3.6 3.1 3.2 3.7 3.3 3.8 0.6 3.9 2.6 4.2 1.0 2.5 41.2 41.6 13.0 28.9 41.9 29.1 48.0 14.7 22.0 21.9 6.0 17.9 1.5 4.7 12.4 16.8 13.6 33.1 10.7 10.3 14.0 9.8 4.5 3.3 16.2 0.8 17.9 29.0 0.0 25.4 6.4 12.7 10.4 7.0 22.2 19.3 20.6 19.7 17.8 20.8 3.9 20.1 13.0 16.9 10.8 24.3 28.3 24.5 20.4 24.4 6.5 12.2 12.9 13.7 1.2 1.3 12.3 3.8 6.4 21.0 6.2 CENPQ "C6orf139, CENP-Q, FLJ10545" ENSG00000031691 "Centromere protein Q" Q7L2Z9 6 49463378-49493107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029043, HPA046634, HPA054965" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA029043: AB_2672881, HPA046634: AB_2679728, HPA054965: AB_2682653" "unprognostic (7.39e-2)" "unprognostic (7.33e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (2.49e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (2.21e-5)" "unprognostic (1.36e-1)" "unprognostic (1.76e-2)" "prognostic favorable (6.26e-4)" "unprognostic (2.89e-1)" "unprognostic (8.19e-2)" "unprognostic (1.48e-3)" "unprognostic (8.93e-2)" "unprognostic (7.47e-2)" "unprognostic (2.74e-3)" "unprognostic (2.56e-1)" 7.2 7.6 10.4 11.2 15.4 6.4 8.7 10.9 11.4 6.6 5.8 6.4 5.8 4.2 7.5 7.1 12.1 6.4 5.4 10.0 11.5 9.3 7.6 6.8 5.8 10.0 19.8 7.7 10.4 4.8 4.6 8.9 9.1 15.3 7.4 7.5 2.7 5.5 5.4 6.9 6.1 5.1 7.0 18.7 8.8 5.6 8.8 18.3 15.1 6.0 9.1 12.7 9.5 6.4 7.8 5.0 7.2 3.1 4.4 5.6 2.3 16.4 4.6 14.7 9.1 4.0 6.3 13.0 21.4 12.3 20.6 29.0 5.6 6.7 11.2 10.7 6.0 16.1 6.0 7.6 7.7 30.5 12.1 10.7 8.2 7.4 9.0 1.7 17.4 10.4 2.8 4.3 25.2 8.8 5.3 7.5 9.8 12.6 11.2 15.2 4.7 12.2 8.2 9.1 14.4 4.2 8.8 17.4 12.1 6.0 6.8 7.9 7.9 10.0 6.0 11.2 15.2 7.7 16.0 4.4 16.0 12.4 12.5 19.0 5.1 13.2 10.0 10.8 13.1 15.4 4.1 2.2 7.2 4.0 2.7 4.2 7.6 4.3 4.6 2.5 7.8 4.7 4.5 1.6 4.4 3.1 5.0 5.6 2.3 10.4 15.4 10.9 11.4 11.5 9.3 19.8 7.7 15.3 18.3 0.0 2.4 6.7 8.9 7.7 5.4 5.1 7.6 10.7 3.4 7.0 2.0 12.0 6.6 7.0 1.0 6.3 1.6 0.0 6.9 23.5 8.4 4.8 4.6 2.8 8.8 6.4 2.4 13.5 10.8 1.9 8.1 5.5 3.3 7.2 2.7 12.4 6.0 3.6 10.3 3.1 5.0 6.5 5.1 16.8 28.6 6.0 10.4 6.4 4.5 5.4 CFAP45 "CCDC19, NESG1" ENSG00000213085 "Cilia and flagella associated protein 45" Q9UL16 1 159872364-159900163 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 35.5;testis: 29.7" "Group enriched" "Detected in many" 5 "Ciliated cells: 306.5;Early spermatids: 187.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 10.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "eosinophil: 6.0;neutrophil: 4.9" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.0" "Cell line enhanced" "Detected in many" "BEWO: 11.2;HEL: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042204, HPA043618" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042204: AB_10966555, HPA043618: AB_10959305" "unprognostic (1.88e-1)" "unprognostic (4.15e-2)" "unprognostic (3.95e-1)" "unprognostic (5.18e-3)" "unprognostic (4.78e-3)" "unprognostic (1.49e-1)" "unprognostic (8.80e-4)" "unprognostic (2.57e-1)" "unprognostic (1.76e-1)" "unprognostic (5.21e-2)" "unprognostic (1.43e-1)" "unprognostic (1.92e-1)" "unprognostic (1.08e-12)" "unprognostic (2.95e-1)" "unprognostic (1.87e-1)" "unprognostic (3.83e-3)" "unprognostic (1.65e-1)" 0.3 0.3 2.0 0.4 7.5 0.6 0.5 0.0 0.2 2.5 0.2 11.9 0.0 0.4 1.3 10.5 0.4 35.5 0.2 0.5 3.1 2.8 0.3 0.2 6.1 0.3 0.1 0.1 7.3 0.1 0.1 0.2 3.3 12.5 0.2 0.2 0.0 0.2 0.5 0.2 0.3 0.2 0.4 0.5 0.5 0.6 29.7 3.4 0.0 0.7 0.0 0.3 0.4 0.1 0.7 0.3 6.0 0.3 0.2 0.5 0.2 2.5 0.6 0.0 0.0 0.1 0.3 11.2 1.3 1.6 2.4 1.0 1.9 3.3 1.1 0.5 0.6 1.3 1.6 0.3 0.3 1.4 0.6 0.3 14.5 0.6 0.1 0.7 1.2 0.5 1.0 0.8 2.6 0.9 3.4 1.7 0.4 1.5 0.5 0.4 3.5 0.2 1.1 0.6 2.1 1.2 0.0 1.2 0.5 0.4 0.6 1.0 0.2 1.3 3.9 0.4 3.4 3.8 0.2 2.2 1.0 3.0 2.0 2.4 1.2 0.0 0.4 5.4 0.5 0.8 0.0 0.3 6.0 0.0 0.3 0.0 0.5 0.3 0.5 0.3 0.7 0.0 0.5 4.9 0.2 0.0 0.3 0.0 0.2 2.0 7.5 0.0 0.1 3.1 2.8 0.1 0.1 12.5 3.4 0.0 3.7 0.0 0.7 0.0 0.0 0.8 0.0 306.5 54.6 5.2 0.0 1.5 0.0 1.4 187.0 2.3 0.0 0.0 2.0 6.4 0.4 0.9 3.5 0.0 0.4 0.0 0.0 1.3 1.6 33.1 2.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 1.4 0.4 0.0 0.0 0.4 19.0 2.3 0.0 0.7 0.0 0.0 1.1 CGGBP1 "CGGBP, p20-CGGBP" ENSG00000163320 "CGG triplet repeat binding protein 1" Q9UFW8 3 88051944-88149885 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 111.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035568, HPA037017" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035568: AB_10670022, HPA037017: AB_2675433" "unprognostic (2.87e-1)" "unprognostic (2.86e-1)" "unprognostic (2.43e-2)" "unprognostic (4.89e-2)" "unprognostic (1.30e-2)" "unprognostic (2.96e-2)" "unprognostic (6.76e-2)" "unprognostic (2.95e-2)" "unprognostic (8.30e-2)" "unprognostic (3.63e-1)" "unprognostic (1.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" "unprognostic (3.35e-2)" "unprognostic (3.00e-1)" "prognostic favorable (7.79e-4)" 29.6 23.9 26.1 27.5 28.6 38.5 80.0 33.3 36.9 28.7 28.3 19.4 23.7 23.1 30.7 23.6 23.5 24.2 23.6 33.8 23.1 21.6 28.4 30.8 29.1 39.4 24.4 26.4 37.1 25.9 40.6 33.2 26.4 21.2 27.3 26.0 23.7 25.2 24.9 30.8 19.2 30.0 29.7 28.9 33.9 25.1 22.4 22.0 76.0 32.7 16.7 37.4 27.7 30.9 24.8 19.9 41.6 23.0 20.8 25.1 19.8 8.0 13.8 23.0 16.4 20.3 18.1 7.4 16.1 14.6 17.0 20.2 10.1 11.9 17.6 10.9 14.4 13.3 6.4 18.1 12.2 21.0 26.6 10.0 26.9 12.1 9.0 18.1 17.8 19.2 16.3 12.7 18.7 24.2 21.0 17.3 20.1 12.7 18.4 19.2 12.8 26.7 12.7 12.6 13.5 11.6 17.3 21.6 12.6 12.7 12.3 4.5 15.1 13.6 7.8 38.0 16.9 11.8 21.6 16.7 20.6 15.2 111.3 16.8 13.5 16.3 19.3 15.7 17.4 17.6 41.6 21.2 39.4 23.3 21.7 22.7 22.5 20.7 23.9 19.9 24.8 25.1 20.5 39.8 20.8 23.0 17.9 23.0 19.8 26.1 28.6 33.3 36.9 23.1 21.6 24.4 26.4 21.2 22.0 47.6 40.0 45.5 57.2 47.3 33.0 39.5 35.7 16.0 46.6 38.4 15.7 48.1 56.3 34.4 15.7 65.2 42.3 23.3 36.4 51.7 55.0 57.7 45.1 49.4 36.3 63.5 40.2 61.4 45.7 28.6 64.5 53.4 38.8 34.3 30.1 61.7 41.1 34.9 47.0 52.9 30.4 64.7 68.9 82.4 49.4 43.7 70.1 69.0 31.8 57.8 CHAMP1 "C13orf8, CAMP, CHAMP, ZNF828" ENSG00000198824 "Chromosome alignment maintaining phosphoprotein 1" Q96JM3 13 114314335-114337626 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006623, HPA008900" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Midbody ring" Yes No Nucleoplasm "Nuclear bodies, Midbody ring" "HPA006623: AB_1845548, HPA008900: AB_1845547" "unprognostic (6.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (1.67e-1)" "unprognostic (3.89e-3)" "unprognostic (2.07e-1)" "unprognostic (9.43e-2)" "unprognostic (1.13e-1)" "unprognostic (4.38e-2)" "unprognostic (1.13e-2)" "unprognostic (4.40e-2)" "unprognostic (3.50e-2)" "unprognostic (3.67e-1)" "unprognostic (4.62e-2)" "unprognostic (2.40e-1)" 13.7 16.8 11.8 12.7 18.5 16.5 13.3 25.2 19.8 12.4 13.3 15.9 10.9 13.7 16.7 11.7 12.6 16.7 10.7 10.3 11.6 12.2 12.7 20.6 12.3 19.9 12.5 12.4 17.8 20.8 12.8 9.5 13.5 16.6 14.5 14.3 12.4 13.2 14.7 16.1 12.6 16.4 14.2 11.4 16.8 16.3 11.6 11.9 35.0 15.2 9.8 23.1 14.3 11.2 7.9 14.5 7.0 6.8 3.7 5.7 2.5 15.4 6.7 24.9 10.5 8.9 13.9 10.7 16.4 13.8 15.6 17.5 9.9 9.4 31.9 6.7 12.8 9.8 9.9 18.1 13.1 23.3 12.3 22.3 20.9 9.7 8.7 10.1 30.4 12.5 13.6 8.2 12.3 12.1 5.5 7.5 11.1 13.2 8.8 19.9 6.1 20.2 8.9 18.7 19.0 8.8 20.3 11.7 11.0 11.8 9.6 12.1 14.4 9.4 21.4 15.5 18.1 12.3 25.7 8.2 8.6 13.8 9.1 10.0 11.3 11.5 34.7 17.1 18.0 16.4 7.0 4.0 5.2 4.7 4.6 5.7 6.8 4.3 4.5 4.5 7.9 3.5 3.9 1.0 3.7 6.8 14.5 2.8 2.5 11.8 18.5 25.2 19.8 11.6 12.2 12.5 12.4 16.6 11.9 8.9 8.1 18.2 6.1 3.0 10.9 5.3 15.3 9.4 1.2 12.2 3.9 11.4 11.6 10.4 0.8 8.6 9.6 0.0 9.9 14.5 8.3 14.3 9.3 18.8 18.9 14.3 10.4 10.4 17.7 1.0 10.9 12.0 11.8 14.4 12.5 8.1 10.8 8.0 10.6 14.0 9.6 6.5 6.2 8.8 20.5 3.3 6.6 8.2 10.4 3.0 CHD2 "DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614" ENSG00000173575 "Chromodomain helicase DNA binding protein 2" O14647 15 92900189-93028005 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060744, HPA060960" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA060744: AB_2684353, HPA060960: AB_2684398" "unprognostic (1.65e-2)" "unprognostic (2.43e-1)" "unprognostic (2.14e-2)" "unprognostic (5.98e-2)" "unprognostic (2.12e-2)" "unprognostic (3.10e-2)" "unprognostic (2.67e-2)" "unprognostic (7.85e-2)" "unprognostic (7.51e-3)" "unprognostic (1.14e-1)" "unprognostic (2.84e-1)" "unprognostic (1.79e-2)" "unprognostic (4.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.58e-1)" "unprognostic (3.15e-1)" "unprognostic (1.70e-2)" 23.7 16.6 18.7 23.6 21.1 66.7 21.8 35.1 22.8 24.1 19.9 19.7 17.6 15.7 26.1 31.9 20.3 18.4 16.8 15.3 18.5 15.7 17.7 17.6 30.4 25.2 22.1 13.9 26.3 20.9 27.5 41.9 33.1 19.1 22.4 16.1 22.1 21.2 19.9 24.3 25.2 24.3 20.3 30.8 26.9 20.8 20.4 22.4 39.5 28.8 11.3 37.4 34.7 19.0 25.5 17.2 34.5 6.3 8.0 17.5 4.6 10.7 5.9 16.0 7.0 10.0 24.6 12.3 10.1 10.4 6.8 8.5 7.5 14.2 2.6 8.5 8.8 11.7 16.1 9.3 10.0 9.6 0.0 5.5 12.8 11.8 6.4 13.4 13.5 10.1 15.5 12.3 8.1 16.6 14.2 11.6 19.1 13.3 30.4 10.3 6.6 7.0 7.0 10.1 5.3 6.6 10.1 14.6 14.5 7.1 14.5 8.9 9.5 17.6 6.5 13.2 16.8 7.3 11.4 18.4 5.6 7.4 4.8 6.4 29.0 11.6 11.1 8.6 8.1 4.9 14.9 6.3 15.0 12.9 3.3 11.8 25.5 12.6 10.1 3.3 23.4 17.5 12.5 34.5 8.0 5.8 17.2 12.3 4.6 18.7 21.1 35.1 22.8 18.5 15.7 22.1 13.9 19.1 22.4 65.5 165.7 52.5 97.7 146.0 66.2 34.7 25.5 105.7 153.6 43.6 86.4 24.4 3.3 30.1 45.6 46.5 39.7 23.3 32.9 20.4 79.4 107.2 94.9 29.8 22.2 54.0 56.9 23.4 43.8 28.3 32.2 70.9 91.1 47.7 34.3 34.1 46.6 37.7 35.3 8.7 80.7 32.3 55.9 14.4 10.0 158.0 50.6 94.7 35.1 111.1 CHD4 "Mi-2b, Mi2-BETA" ENSG00000111642 "Chromodomain helicase DNA binding protein 4" Q14839 12 6570082-6614524 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012008 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA012008: AB_1846633" "unprognostic (6.11e-2)" "unprognostic (2.26e-2)" "unprognostic (1.71e-2)" "unprognostic (6.40e-3)" "unprognostic (8.99e-2)" "unprognostic (3.36e-3)" "prognostic unfavorable (6.03e-6)" "unprognostic (2.66e-2)" "unprognostic (1.05e-1)" "unprognostic (6.85e-2)" "unprognostic (3.15e-1)" "unprognostic (3.94e-1)" "unprognostic (2.06e-1)" "unprognostic (3.33e-1)" "unprognostic (1.82e-1)" "unprognostic (9.84e-2)" "unprognostic (1.66e-1)" 23.5 34.9 21.9 50.0 33.5 27.2 25.9 29.4 25.1 28.1 29.5 29.3 38.5 18.6 37.2 35.4 29.1 28.0 40.3 52.8 23.5 19.2 29.5 25.0 25.5 30.9 33.6 19.4 34.6 27.4 58.4 25.3 29.5 27.2 21.5 26.0 26.5 24.8 46.2 33.7 31.1 24.4 36.6 30.3 29.4 27.2 29.7 28.9 75.7 38.4 33.7 38.4 34.7 24.3 12.6 16.8 12.8 9.1 13.5 16.7 5.8 20.4 18.7 46.4 17.4 19.0 21.4 27.3 22.7 22.2 25.1 23.2 31.2 15.9 44.1 9.0 25.7 16.4 18.3 43.5 25.0 33.9 33.0 22.4 61.6 29.1 19.4 16.5 48.3 29.6 20.7 12.4 24.3 17.0 31.7 29.3 24.7 48.4 22.0 23.8 25.6 45.8 15.8 44.4 19.0 17.7 39.3 28.5 24.1 15.9 24.2 22.0 28.3 29.2 32.6 22.6 53.2 14.9 27.5 27.2 25.7 54.7 18.8 26.5 35.7 21.2 56.3 17.0 29.5 18.7 9.0 7.7 9.2 12.2 9.1 12.0 10.5 10.3 11.1 7.9 12.6 13.0 12.3 12.8 13.5 8.1 16.8 16.7 5.8 21.9 33.5 29.4 25.1 23.5 19.2 33.6 19.4 27.2 28.9 56.6 102.0 59.1 45.6 60.9 103.2 110.8 66.2 96.4 79.6 83.7 66.8 38.6 11.6 71.4 71.8 70.5 43.4 23.3 62.1 41.7 66.9 40.2 81.1 60.6 61.2 131.9 93.2 49.7 44.2 45.3 60.9 57.6 45.5 56.9 59.2 71.6 76.6 24.6 70.0 30.3 60.2 51.8 73.5 97.0 107.1 59.1 56.9 61.8 61.8 37.3 CHD8 "DUPLIN, HELSNF1, KIAA1564" ENSG00000100888 "Chromodomain helicase DNA binding protein 8" Q9HCK8 14 21385194-21456126 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor" "Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052186, HPA076133" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052186: AB_2681754, HPA076133: " "unprognostic (3.45e-1)" "unprognostic (9.71e-2)" "unprognostic (3.31e-1)" "unprognostic (2.67e-1)" "unprognostic (1.14e-1)" "unprognostic (3.43e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (7.31e-2)" "unprognostic (9.22e-2)" "prognostic favorable (8.35e-4)" "unprognostic (1.64e-1)" "unprognostic (2.63e-2)" "unprognostic (2.54e-3)" "unprognostic (2.88e-1)" "unprognostic (9.24e-2)" "unprognostic (2.51e-1)" "unprognostic (8.07e-3)" 13.9 14.5 13.0 14.8 21.5 34.8 17.0 28.9 25.7 15.8 14.4 26.6 14.1 11.1 18.3 13.4 17.4 15.9 11.7 12.3 13.5 13.3 14.0 11.2 15.5 18.5 15.4 15.2 20.7 19.0 34.7 25.3 15.2 20.3 16.3 14.6 19.3 15.7 14.9 16.9 24.5 16.4 17.2 13.1 19.2 16.1 15.2 18.1 29.9 17.4 10.4 24.8 16.6 14.5 12.3 7.8 12.8 7.4 8.7 8.6 3.0 16.5 21.7 24.1 11.2 15.4 13.3 13.6 13.2 15.2 20.1 20.1 18.8 14.4 27.4 8.3 17.6 15.9 20.3 29.4 18.5 25.4 20.9 13.4 24.0 14.5 22.8 14.3 33.2 22.9 17.9 15.1 22.5 16.2 15.6 17.8 21.7 16.7 14.7 15.1 17.8 23.8 13.6 18.4 16.1 18.4 22.4 18.2 9.2 14.9 30.6 17.6 16.9 20.6 16.1 11.4 22.7 11.3 16.1 20.9 16.7 12.8 9.8 15.6 16.7 19.9 27.4 6.7 12.3 16.6 12.8 4.8 12.1 7.7 5.0 8.6 5.8 6.8 7.5 3.3 12.3 7.4 6.4 11.0 8.7 7.4 7.8 5.7 3.0 13.0 21.5 28.9 25.7 13.5 13.3 15.4 15.2 20.3 18.1 35.7 52.5 15.1 10.4 11.2 32.4 18.1 20.4 36.1 43.3 31.4 25.5 12.2 1.7 19.0 1.6 18.0 11.3 23.3 20.2 10.1 9.9 12.1 26.7 12.4 15.0 22.3 26.0 14.1 20.9 2.5 15.0 13.0 10.1 19.8 16.3 19.2 21.3 14.0 16.6 6.3 22.9 0.0 13.3 26.2 22.4 14.4 10.3 22.3 14.7 11.1 CHTF8 "CTF8, DERPC, FLJ20400" ENSG00000168802 "Chromosome transmission fidelity factor 8" "P0CG12, P0CG13" 16 69118010-69132584 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051872, HPA065522" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051872: AB_2681647, HPA065522: AB_2685503" "unprognostic (7.86e-3)" "unprognostic (1.99e-2)" "unprognostic (2.59e-2)" "unprognostic (2.46e-2)" "unprognostic (6.44e-2)" "unprognostic (1.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.86e-3)" "unprognostic (9.88e-2)" "unprognostic (7.45e-2)" "unprognostic (2.96e-1)" "unprognostic (1.02e-1)" "prognostic favorable (3.59e-9)" "unprognostic (3.74e-2)" "unprognostic (1.85e-1)" "unprognostic (3.75e-2)" "unprognostic (1.45e-1)" 27.8 29.9 20.5 25.1 26.8 12.7 34.3 18.5 24.4 29.3 27.8 18.8 36.3 18.4 33.5 40.5 33.1 38.5 26.0 25.7 18.5 15.5 42.0 46.8 27.2 32.2 24.8 23.0 30.9 60.8 37.0 27.6 38.0 17.6 31.4 26.7 31.4 38.7 30.2 22.9 30.4 30.3 30.0 18.7 37.9 30.9 32.1 20.6 51.5 56.9 23.2 37.1 27.8 32.4 35.7 32.5 46.9 35.7 26.3 32.9 32.2 34.2 31.7 42.7 27.3 35.0 34.0 33.4 30.7 29.5 49.2 41.0 34.9 48.9 35.7 40.0 28.3 27.9 41.7 45.4 52.7 41.6 24.4 24.3 36.6 23.2 20.4 29.3 36.0 37.4 29.5 36.2 38.6 28.2 34.9 50.0 28.3 40.3 15.0 41.3 30.0 41.4 35.4 41.1 45.5 24.8 59.1 22.6 46.9 40.1 26.5 36.3 29.4 43.9 19.4 35.9 37.6 34.6 45.1 31.6 30.5 28.8 17.9 27.4 29.2 37.9 53.6 27.6 25.2 34.1 46.9 32.5 28.6 27.1 35.7 30.8 30.5 27.8 31.5 32.5 35.7 28.6 27.2 18.1 26.3 34.9 29.3 32.9 32.2 20.5 26.8 18.5 24.4 18.5 15.5 24.8 23.0 17.6 20.6 14.9 13.9 29.5 17.9 12.8 11.5 12.2 25.5 13.4 7.9 22.7 3.9 56.7 51.4 34.5 5.0 19.0 27.1 0.0 41.8 56.3 18.4 24.1 6.9 34.5 37.5 6.4 27.1 29.4 28.0 14.3 19.8 22.2 11.8 45.9 27.7 18.0 36.9 23.0 25.5 53.5 7.9 6.5 14.7 22.1 41.9 15.1 55.7 20.1 28.1 16.0 CIITA "C2TA, MHC2TA, NLRA" ENSG00000179583 "Class II major histocompatibility complex transactivator" P33076 16 10866222-10943021 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, Kinase, Transferase" "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.2" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 17.9;Macrophages: 36.9;monocytes: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 23.3;REH: 40.9;U-266/70: 8.6;U-698: 12.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016084, HPA054757" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB016084: AB_627261, HPA054757: " "unprognostic (1.45e-3)" "unprognostic (1.38e-2)" "unprognostic (8.22e-3)" "unprognostic (1.12e-2)" "unprognostic (5.66e-2)" "unprognostic (2.88e-3)" "unprognostic (2.92e-2)" "unprognostic (1.55e-2)" "unprognostic (1.15e-2)" "unprognostic (1.85e-1)" "unprognostic (1.23e-1)" "unprognostic (3.72e-1)" "unprognostic (1.64e-2)" "unprognostic (2.72e-2)" "unprognostic (6.33e-3)" "unprognostic (2.74e-1)" "unprognostic (1.05e-2)" 8.0 5.9 4.6 47.7 7.1 4.3 6.8 1.5 5.5 6.3 3.7 10.6 4.2 10.4 8.1 10.4 4.8 5.2 8.1 4.9 4.7 3.5 8.8 2.9 15.0 27.0 9.4 1.1 2.5 3.5 1.9 4.0 1.2 6.6 5.5 4.3 5.5 13.3 4.3 2.9 4.4 17.4 3.7 15.6 25.9 6.2 1.5 7.4 12.6 6.1 5.2 67.2 6.3 6.8 27.3 19.0 6.5 11.9 0.7 0.5 1.7 0.1 0.2 0.3 0.3 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.3 5.6 5.1 0.8 0.0 0.9 0.9 0.0 0.0 0.1 23.3 0.3 2.9 1.1 0.6 0.0 0.5 0.4 1.0 0.0 0.1 0.0 0.9 0.0 0.3 0.3 2.0 0.1 0.3 0.2 0.4 0.1 0.2 0.1 40.9 0.3 3.6 0.0 1.7 0.9 0.1 0.9 0.3 0.9 0.3 0.5 1.7 0.3 2.1 0.3 0.6 0.2 8.6 0.6 12.1 7.7 0.5 6.9 0.2 11.9 6.5 0.3 9.5 0.1 17.9 0.1 0.5 17.7 27.3 0.1 0.2 2.8 0.7 10.0 19.0 0.4 1.7 4.6 7.1 1.5 5.5 4.7 3.5 9.4 1.1 6.6 7.4 6.0 17.9 12.3 0.3 2.1 0.6 2.8 2.5 2.7 1.2 3.5 0.0 0.1 0.0 2.5 0.6 4.2 3.4 0.0 1.7 0.2 1.0 0.3 10.4 1.0 9.1 0.0 2.4 2.5 15.6 0.0 0.6 36.9 6.8 58.7 0.7 0.4 1.7 0.0 0.0 3.3 0.9 0.0 0.9 0.0 0.0 2.5 0.1 1.0 0.4 0.3 CIZ1 "LSFR1, ZNF356" ENSG00000148337 "CDKN1A interacting zinc finger protein 1" Q9ULV3 9 128166064-128204383 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020380, HPA020387" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA020380: , HPA020387: AB_2670425" "unprognostic (1.28e-1)" "unprognostic (5.77e-2)" "unprognostic (2.81e-2)" "unprognostic (3.33e-1)" "unprognostic (1.69e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.43e-4)" "unprognostic (6.14e-2)" "unprognostic (1.63e-1)" "unprognostic (7.49e-3)" "unprognostic (3.13e-3)" "unprognostic (8.05e-3)" "unprognostic (2.30e-2)" "unprognostic (1.54e-1)" "unprognostic (2.11e-1)" "unprognostic (3.24e-1)" "unprognostic (8.47e-3)" 31.9 24.3 33.6 23.8 36.0 36.7 36.7 39.4 40.4 31.5 35.7 28.0 21.3 26.8 33.6 20.9 30.3 33.5 26.7 25.5 30.5 19.9 19.7 12.1 22.2 24.8 29.4 27.5 56.3 41.7 23.1 21.1 21.9 23.4 30.1 21.8 23.3 31.3 28.8 51.4 49.6 26.1 40.0 27.3 22.5 28.9 35.4 37.0 30.3 22.8 24.2 27.0 35.2 39.3 6.7 4.6 4.9 5.8 8.1 8.3 3.2 23.0 27.9 23.9 22.5 24.7 29.9 23.4 18.2 27.4 33.5 19.0 25.5 20.3 27.1 15.5 30.7 27.9 33.6 18.4 19.6 18.3 24.6 21.0 25.9 35.0 16.4 28.5 24.0 30.9 28.9 35.1 36.7 31.3 24.4 22.6 17.4 62.6 23.5 20.1 53.9 31.4 24.4 20.7 31.2 28.7 26.7 25.2 27.9 15.1 15.9 29.8 23.1 40.5 28.7 24.0 11.1 29.9 31.3 23.9 35.8 25.5 40.6 34.1 27.3 30.8 26.2 25.3 16.1 38.3 4.6 4.3 4.9 5.0 5.8 4.5 5.7 6.1 6.4 4.6 6.7 6.1 5.5 0.7 8.1 4.3 4.6 8.3 3.2 33.6 36.0 39.4 40.4 30.5 19.9 29.4 27.5 23.4 37.0 3.0 11.7 14.1 19.6 20.6 21.1 8.7 12.7 5.3 9.1 17.4 27.5 19.0 11.6 22.6 63.0 13.4 23.6 0.0 38.7 23.5 21.6 14.9 9.2 4.7 19.4 15.9 21.9 14.7 16.7 60.3 32.2 14.9 18.6 20.8 17.7 17.7 26.4 14.0 29.4 14.6 23.8 12.9 20.8 24.4 24.7 21.8 17.4 17.9 25.5 13.3 CLASRP "CLASP, SFRS16, SWAP2" ENSG00000104859 "CLK4 associating serine/arginine rich protein" Q8N2M8 19 45039040-45070956 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA060469, HPA062455" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA060469: AB_2684289, HPA062455: AB_2684770" "unprognostic (2.99e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (9.77e-4)" "unprognostic (9.03e-2)" "unprognostic (1.37e-1)" "unprognostic (2.76e-3)" "unprognostic (1.58e-2)" "unprognostic (2.62e-1)" "unprognostic (8.52e-2)" "unprognostic (4.01e-2)" "unprognostic (1.76e-3)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.69e-8)" "unprognostic (2.19e-1)" "unprognostic (1.74e-2)" "unprognostic (3.36e-1)" "prognostic favorable (1.02e-5)" 14.5 12.2 14.1 16.5 24.6 40.4 13.6 19.0 25.7 12.0 14.5 27.4 13.0 17.6 14.4 14.5 14.7 13.8 13.4 9.6 16.2 12.2 11.6 11.6 13.9 17.7 26.8 16.2 18.3 28.6 13.7 19.8 12.0 18.4 14.7 9.4 10.7 16.8 17.2 21.5 17.0 20.6 14.6 22.1 18.5 18.3 14.3 22.4 7.8 14.7 9.9 14.1 11.7 15.3 7.1 5.1 9.2 3.6 2.7 4.1 2.0 11.0 15.9 6.5 4.8 2.1 3.4 14.5 9.6 3.6 7.4 7.4 7.3 10.6 17.4 7.3 3.8 2.9 12.2 9.9 7.3 3.3 8.6 14.7 10.3 8.5 9.2 4.9 6.9 14.2 4.2 4.0 5.0 8.9 3.5 5.0 11.8 16.3 9.9 2.5 11.1 18.4 23.0 9.0 7.3 9.3 14.7 7.3 13.2 4.9 11.1 7.5 11.7 7.7 7.4 7.0 3.7 9.5 15.1 7.5 7.3 9.1 6.1 14.5 14.4 11.6 15.6 5.1 11.2 5.9 0.7 3.6 5.5 3.8 2.6 3.5 7.1 2.3 4.1 3.2 6.4 3.3 2.9 9.2 2.7 3.0 5.1 1.9 2.0 14.1 24.6 19.0 25.7 16.2 12.2 26.8 16.2 18.4 22.4 3.0 2.7 25.1 23.5 20.7 25.6 3.6 20.4 2.7 3.4 15.7 15.7 20.7 5.0 9.7 15.9 13.5 27.2 0.0 13.0 24.6 15.0 15.3 12.7 13.9 15.2 19.1 9.2 14.7 17.4 4.6 20.1 18.1 3.3 19.8 22.5 22.0 12.7 21.0 16.6 6.5 28.8 32.3 16.5 61.4 27.7 18.9 30.3 20.0 17.9 18.2 CLK2 clk2 ENSG00000176444 "CDC like kinase 2" P49760 1 155262868-155278491 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055366, HPA059507" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA055366: AB_2682795, HPA059507: AB_2684044" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.84e-2)" "unprognostic (3.16e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.82e-4)" "unprognostic (2.38e-1)" "unprognostic (2.36e-1)" "unprognostic (1.36e-2)" "unprognostic (7.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (2.95e-9)" "unprognostic (1.70e-1)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "prognostic favorable (5.43e-4)" 15.3 16.6 14.6 15.0 19.0 12.9 17.1 33.1 20.2 22.3 18.0 18.7 18.1 14.5 22.6 19.9 15.5 18.2 13.9 11.8 17.1 7.3 17.3 18.2 14.7 22.2 16.9 16.9 24.7 15.9 29.2 21.6 19.2 13.5 22.1 13.5 16.1 16.4 18.2 10.4 21.4 15.6 17.0 13.5 27.0 13.7 13.7 20.3 18.1 22.9 8.0 22.2 16.7 20.1 2.8 1.9 4.8 1.7 0.7 4.1 1.1 5.9 5.1 18.7 5.7 9.4 5.1 16.0 5.3 6.5 4.1 4.2 5.4 4.3 13.0 7.4 3.6 2.2 8.6 9.3 6.9 3.9 9.4 7.3 10.3 5.4 6.9 8.1 12.8 10.4 4.1 6.4 6.0 12.2 11.9 7.2 11.1 14.5 9.0 6.2 10.3 8.7 7.6 12.2 15.0 7.3 9.7 11.3 13.9 10.5 13.4 8.9 12.7 2.0 6.4 4.9 14.7 9.8 15.7 4.7 2.5 6.8 4.6 4.4 17.2 14.7 11.8 5.1 9.2 2.9 4.8 1.7 3.4 2.0 0.8 2.9 2.8 3.4 1.8 1.8 2.4 3.4 4.1 2.1 0.7 0.8 1.9 1.7 1.1 14.6 19.0 33.1 20.2 17.1 7.3 16.9 16.9 13.5 20.3 14.9 22.4 4.8 4.8 4.0 5.8 13.3 12.7 4.0 18.2 7.0 3.9 6.8 0.0 5.2 6.3 8.3 4.3 0.0 3.8 7.3 7.2 3.9 9.3 5.8 6.0 4.8 6.4 8.0 10.5 5.4 7.2 5.8 3.3 7.2 7.9 5.4 4.4 3.5 2.8 2.8 5.7 6.5 3.3 8.3 3.8 4.0 10.4 4.4 6.3 4.3 CLOCK "bHLHe8, KAT13D, KIAA0334" ENSG00000134852 "Clock circadian regulator" O15516 4 55427903-55547138 "Enzymes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, Transcription, Transcription regulation" "Activator, Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001867, HPA027565" Supported Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA001867: AB_1078537, HPA027565: AB_1846975" "unprognostic (1.30e-2)" "unprognostic (9.02e-2)" "unprognostic (4.25e-3)" "unprognostic (2.48e-1)" "unprognostic (3.94e-2)" "unprognostic (2.00e-2)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.32e-2)" "unprognostic (3.01e-2)" "unprognostic (5.96e-2)" "unprognostic (4.07e-2)" "unprognostic (8.31e-2)" "unprognostic (1.69e-1)" "unprognostic (5.18e-2)" "unprognostic (7.16e-2)" 9.3 9.2 7.8 5.8 11.7 1.7 8.4 16.2 14.3 12.5 9.5 5.2 9.2 7.1 10.5 8.4 13.9 8.1 6.7 10.5 7.9 7.9 12.4 9.1 8.2 9.4 7.0 9.8 11.7 8.6 18.7 21.9 8.5 8.4 9.7 8.4 5.6 8.2 9.2 16.1 9.4 12.6 13.8 8.3 9.1 9.6 18.5 5.0 4.0 14.7 5.9 5.2 8.4 17.1 2.5 3.6 0.6 3.0 2.9 4.7 1.4 13.6 5.9 5.4 8.4 8.1 8.2 2.7 14.1 11.6 9.9 9.1 3.7 10.9 3.7 7.3 16.4 7.4 11.4 6.9 10.9 16.7 4.5 2.5 2.9 6.3 4.6 7.2 4.7 3.4 4.8 10.9 13.6 13.4 7.4 9.2 3.1 6.7 7.5 14.8 7.5 2.6 2.7 3.9 11.2 6.9 1.7 6.2 2.4 7.6 7.4 5.3 4.7 10.2 12.6 6.4 4.7 4.2 2.6 12.7 13.4 14.4 4.4 18.9 6.8 4.9 2.3 11.9 4.2 10.6 0.0 3.0 0.6 2.8 3.0 4.7 1.4 3.2 2.5 3.6 2.5 1.9 2.4 0.6 2.9 2.7 2.1 3.1 1.4 7.8 11.7 16.2 14.3 7.9 7.9 7.0 9.8 8.4 5.0 38.7 23.0 9.8 18.1 27.6 61.3 50.4 12.7 12.0 13.6 14.0 41.2 9.5 1.7 11.5 25.0 28.9 20.3 0.0 14.4 5.7 30.8 25.1 3.5 25.9 10.1 31.8 38.2 28.8 12.7 12.1 22.2 14.3 10.1 8.2 19.3 29.6 19.8 15.3 33.9 17.0 39.4 12.9 30.8 56.9 73.3 32.9 4.3 10.2 14.9 46.9 CLSPN ENSG00000092853 Claspin Q9HAW4 1 35720218-35769967 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 12.6;lymphoid tissue: 30.4;testis: 10.0" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 33.9;Rod photoreceptor cells: 96.1;Spermatocytes: 71.5;Spermatogonia: 133.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 12 "basal ganglia: 7.0" "Low region specificity" "Detected in all" "HPA026305, HPA026312" Enhanced "Nucleoplasm,Golgi apparatus" Yes Yes "Nucleoplasm, Golgi apparatus" "HPA026305: AB_2671833, HPA026312: AB_2671837" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-3)" "unprognostic (3.54e-2)" "unprognostic (6.82e-2)" "unprognostic (1.62e-2)" "unprognostic (1.18e-6)" "unprognostic (3.99e-3)" "unprognostic (2.08e-3)" "unprognostic (1.63e-2)" "unprognostic (8.71e-6)" "unprognostic (3.23e-2)" "unprognostic (7.61e-6)" "prognostic favorable (4.92e-4)" "unprognostic (5.12e-1)" "unprognostic (1.73e-1)" "unprognostic (1.29e-1)" 1.5 0.8 0.9 11.5 1.0 12.6 1.7 0.3 3.6 0.9 2.1 0.1 0.0 1.0 0.5 0.9 2.9 0.5 2.8 0.6 1.1 0.6 1.0 0.7 1.9 6.0 0.6 0.1 0.5 0.5 0.3 0.4 4.3 0.7 0.5 2.7 1.9 1.0 0.0 0.4 1.2 3.4 1.0 0.8 4.4 1.1 10.0 0.5 30.4 0.5 4.2 6.6 0.9 1.2 0.9 0.9 3.4 1.1 1.3 1.6 1.1 8.7 7.3 15.9 8.4 1.1 2.1 5.9 18.0 5.0 13.2 17.7 11.5 8.2 18.7 5.8 4.8 9.6 8.8 15.5 6.2 20.7 12.8 7.0 26.3 15.9 5.1 0.0 21.5 15.5 0.4 0.2 22.7 1.6 1.5 7.1 11.2 17.7 13.0 12.6 5.7 22.6 4.9 15.0 6.0 5.2 14.4 24.1 5.6 2.7 14.5 5.9 6.9 15.6 4.8 3.1 11.2 4.1 8.5 5.1 19.0 14.4 11.6 20.0 4.7 11.4 19.7 6.0 15.4 15.3 1.6 1.1 1.1 1.6 0.5 0.5 0.4 1.0 0.8 0.9 0.9 0.4 0.8 3.4 1.3 0.7 0.8 1.3 1.1 0.9 1.0 0.3 3.6 1.1 0.6 0.6 0.1 0.7 0.5 0.0 0.3 1.5 4.6 4.9 7.9 1.1 2.5 0.0 3.4 0.0 11.8 5.5 0.0 1.3 6.2 1.9 0.4 0.0 0.6 33.9 3.9 1.4 1.1 0.0 14.0 1.6 1.2 3.7 3.2 4.9 2.3 6.5 3.3 15.4 1.6 6.6 0.9 1.9 0.4 0.0 96.1 6.5 2.5 71.5 133.3 1.8 8.7 5.1 4.1 2.6 CMTR1 "FTSJD2, ISG95, KIAA0082, MTr1" ENSG00000137200 "Cap methyltransferase 1" Q8N1G2 6 37433219-37482827 "Enzymes, Predicted intracellular proteins" "mRNA capping, mRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 77.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029954, HPA029979, HPA029980" Enhanced Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094" "unprognostic (1.33e-1)" "unprognostic (2.12e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.00e-1)" "unprognostic (3.72e-1)" "unprognostic (1.68e-2)" "unprognostic (6.43e-3)" "unprognostic (2.95e-2)" "unprognostic (9.17e-2)" "unprognostic (5.24e-3)" "unprognostic (1.50e-3)" "unprognostic (3.00e-3)" "unprognostic (3.27e-2)" "unprognostic (9.72e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-2)" 14.4 17.4 23.1 17.3 17.7 22.4 14.6 25.0 25.0 14.5 18.0 15.5 21.3 15.0 19.5 19.4 12.6 16.9 15.0 18.8 17.6 16.1 13.9 16.6 15.2 19.2 16.0 22.7 22.6 18.4 24.4 20.2 20.6 16.9 16.3 13.1 17.1 17.6 17.9 28.9 16.6 16.5 17.6 12.5 21.7 15.9 63.9 17.8 18.4 15.7 14.1 20.7 16.2 14.8 11.1 9.8 8.1 13.2 9.7 11.5 7.8 7.0 6.7 9.7 15.8 11.0 10.1 11.8 8.4 11.7 21.5 24.1 10.1 4.7 14.7 9.6 12.4 20.2 7.9 12.3 8.7 16.5 10.1 10.9 8.1 7.8 11.2 8.5 11.6 5.5 8.7 6.5 11.8 8.5 11.3 10.0 13.7 17.9 10.8 11.2 11.5 14.7 10.4 4.8 4.7 6.4 11.7 11.5 8.4 6.9 8.6 10.7 8.1 9.5 7.3 12.1 7.3 12.4 9.0 9.2 12.9 9.7 5.1 9.4 12.4 6.4 77.6 5.1 12.2 14.1 8.1 10.2 6.4 10.1 13.2 8.5 11.1 8.9 10.7 9.8 8.1 9.9 8.0 6.6 9.7 9.9 8.2 11.5 7.8 23.1 17.7 25.0 25.0 17.6 16.1 16.0 22.7 16.9 17.8 8.9 8.6 7.3 3.4 3.2 13.3 7.9 7.6 13.4 15.9 7.0 31.4 14.0 0.0 4.0 20.1 9.0 4.2 23.3 7.4 6.2 6.4 3.4 3.5 7.4 6.6 11.1 8.1 9.2 5.9 8.3 7.2 7.5 3.3 13.6 7.5 10.1 6.4 3.5 6.3 3.5 10.9 6.5 4.9 14.4 9.9 4.1 17.4 8.7 5.4 2.8 CNDP2 "CN2, CPGL, FLJ10830, HsT2298, PEPA" ENSG00000133313 "Carnosine dipeptidase 2" Q96KP4 18 74495816-74523454 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 371.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 76.6;RPMI-8226: 98.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026196, HPA036898, HPA036899" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 2400000 "Nucleoplasm, Cytosol" "CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371" "unprognostic (2.81e-2)" "unprognostic (9.96e-2)" "unprognostic (3.28e-1)" "unprognostic (1.19e-3)" "unprognostic (2.57e-2)" "unprognostic (5.06e-2)" "unprognostic (2.84e-2)" "unprognostic (5.35e-2)" "unprognostic (1.49e-1)" "unprognostic (9.31e-2)" "unprognostic (1.56e-3)" "unprognostic (1.15e-1)" "prognostic favorable (3.50e-6)" "unprognostic (2.37e-3)" "unprognostic (4.65e-3)" "unprognostic (1.51e-1)" "unprognostic (1.34e-1)" 19.0 11.5 31.0 19.1 36.0 6.1 16.9 10.4 33.0 39.4 37.6 45.2 27.0 51.3 12.5 35.3 20.4 38.9 25.9 11.6 31.1 26.4 89.0 66.4 22.1 23.0 36.1 24.1 11.4 27.6 15.7 13.7 28.8 27.2 34.7 22.2 14.1 16.9 32.7 7.5 11.8 71.1 10.4 39.4 39.2 27.2 6.5 32.5 10.9 43.9 11.6 21.4 28.4 12.0 29.6 49.0 12.5 44.4 31.4 23.9 30.3 10.2 13.9 10.1 9.5 12.3 7.3 42.4 10.8 10.2 14.8 14.8 8.0 11.1 13.0 13.7 11.7 11.6 15.6 15.3 20.5 10.6 19.4 6.0 12.9 7.0 12.8 18.0 25.2 20.1 11.0 15.8 12.8 23.1 8.4 12.9 15.6 13.6 76.6 9.8 11.5 13.4 12.1 15.2 6.8 8.3 14.6 11.6 98.6 58.2 43.1 11.0 5.8 8.4 60.2 14.4 25.2 25.2 10.4 13.5 15.9 13.5 3.5 7.2 14.3 58.7 17.3 10.8 18.4 13.2 7.8 30.0 12.5 21.8 44.4 23.8 28.9 17.6 20.3 49.0 29.6 19.1 20.7 4.4 31.4 43.1 43.0 23.9 30.3 31.0 36.0 10.4 33.0 31.1 26.4 36.1 24.1 27.2 32.5 68.5 54.2 53.8 35.3 8.1 33.7 22.9 91.7 60.2 38.7 113.4 15.7 128.9 159.2 142.6 2.2 45.9 105.2 0.0 136.1 106.3 20.6 56.1 11.5 102.8 184.6 41.3 62.7 36.8 86.2 3.2 17.3 82.3 16.9 112.8 71.7 80.3 99.7 74.1 15.6 371.2 24.6 12.9 15.9 4.8 7.3 8.4 91.2 36.3 82.5 47.4 COL4A3BP "CERT, GPBP, STARD11" ENSG00000113163 "Collagen type IV alpha 3 binding protein" Q9Y5P4 5 75356345-75512138 "Disease related genes, Predicted intracellular proteins" "Lipid transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 52.0;WM-115: 45.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035645, HPA042608" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA035645: AB_10600700, HPA042608: AB_2678075" "unprognostic (2.45e-1)" "unprognostic (7.16e-2)" "unprognostic (6.56e-3)" "unprognostic (1.53e-2)" "unprognostic (2.44e-1)" "unprognostic (9.29e-2)" "unprognostic (4.06e-2)" "unprognostic (3.22e-1)" "unprognostic (2.51e-1)" "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "unprognostic (4.29e-2)" "prognostic favorable (1.24e-5)" "unprognostic (9.12e-2)" "unprognostic (2.29e-1)" "unprognostic (2.83e-1)" "unprognostic (2.91e-1)" 30.0 25.5 16.5 17.1 21.9 17.9 21.4 34.4 21.2 26.9 19.9 14.9 21.5 13.5 20.5 11.6 21.9 17.1 17.4 14.9 15.2 16.3 21.1 22.7 19.6 13.4 22.5 12.4 17.9 12.4 24.6 25.9 17.8 18.2 19.0 14.6 14.8 17.5 16.1 33.4 14.2 19.3 18.9 16.6 17.2 17.0 21.3 20.7 17.8 37.4 14.3 15.9 21.8 19.1 6.4 9.8 20.9 16.6 5.1 8.8 5.7 16.6 8.6 8.3 7.2 52.0 14.5 11.1 9.4 11.6 7.2 9.6 12.9 9.6 8.1 20.3 9.9 10.0 10.1 12.6 12.9 11.1 9.9 5.8 6.7 9.5 6.8 13.2 6.6 7.8 10.9 9.2 8.5 9.7 11.8 8.3 10.7 12.1 12.2 9.5 8.8 7.9 5.0 10.7 3.8 6.4 6.7 11.0 7.4 11.8 20.2 6.4 6.4 11.8 8.3 11.6 18.3 8.1 11.4 11.3 4.9 5.9 8.8 7.7 11.3 14.9 9.4 8.5 11.4 45.0 5.0 13.9 10.6 6.0 15.6 5.6 6.0 6.2 5.6 9.8 6.4 5.9 5.8 20.9 5.1 16.6 5.7 8.8 5.7 16.5 21.9 34.4 21.2 15.2 16.3 22.5 12.4 18.2 20.7 56.6 58.5 6.4 28.0 16.7 30.7 32.7 22.9 71.0 75.1 17.4 21.6 13.6 18.3 19.6 83.3 28.1 19.2 0.0 19.2 13.9 20.9 36.3 47.5 17.9 31.6 41.3 26.4 55.9 33.0 73.0 32.2 37.4 49.0 19.8 15.6 31.1 21.5 13.1 39.3 22.3 33.1 19.4 19.6 41.5 31.5 23.3 23.2 21.3 14.3 38.3 COPS5 "CSN5, JAB1, MOV-34, SGN5" ENSG00000121022 "COP9 signalosome subunit 5" Q92905 8 67043079-67083783 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 275.9;Late spermatids: 320.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004242, HPA004845, HPA051531" Supported Enhanced Nucleoplasm NA NA 27000 Nucleoplasm "CAB004242: AB_627835, HPA004845: AB_1078557, HPA051531: AB_2681522" "unprognostic (1.90e-3)" "unprognostic (1.35e-1)" "unprognostic (1.61e-1)" "unprognostic (2.85e-3)" "unprognostic (2.53e-1)" "unprognostic (4.16e-2)" "unprognostic (2.04e-3)" "unprognostic (1.39e-1)" "unprognostic (2.15e-2)" "unprognostic (4.48e-2)" "unprognostic (4.74e-3)" "unprognostic (1.96e-2)" "unprognostic (1.90e-3)" "unprognostic (2.88e-2)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.18e-2)" 20.2 26.3 29.4 19.6 28.6 16.2 28.1 28.5 40.3 18.0 21.7 15.6 20.2 22.0 17.6 21.7 24.0 17.7 15.5 46.8 27.6 27.5 27.4 33.7 16.8 17.5 31.8 29.9 17.0 20.7 23.3 21.7 24.3 33.7 18.3 25.5 9.9 19.6 18.9 64.0 16.8 22.5 23.3 39.2 16.1 20.7 27.4 31.3 19.6 18.5 29.2 22.4 18.3 16.5 20.7 35.1 33.7 30.0 26.5 28.1 22.3 28.8 27.4 23.3 21.3 24.5 26.2 18.5 25.4 20.9 35.3 31.9 17.7 35.6 26.8 11.7 26.2 25.5 24.2 31.2 28.0 39.0 25.7 26.9 38.1 27.5 23.8 23.8 24.0 23.1 23.8 36.0 28.8 37.2 27.3 34.4 28.3 45.0 18.6 31.6 26.8 42.3 42.2 30.9 60.8 31.5 27.2 16.6 21.1 37.4 25.7 14.1 19.5 14.6 28.3 24.6 21.5 46.6 24.8 25.4 18.0 22.2 21.7 19.9 23.4 29.8 35.7 26.2 27.4 24.5 26.0 28.6 33.7 20.8 30.0 21.7 20.7 20.1 23.1 35.1 17.5 21.6 19.1 21.2 26.5 28.3 18.4 28.1 22.3 29.4 28.6 28.5 40.3 27.6 27.5 31.8 29.9 33.7 31.3 20.8 21.3 38.7 36.8 43.8 32.5 99.1 43.3 26.8 29.6 29.6 31.4 115.4 74.6 65.8 275.9 33.7 37.6 0.0 52.3 84.4 39.7 44.8 34.7 33.9 69.9 23.8 32.8 31.9 28.8 320.8 40.0 37.7 27.0 55.9 34.2 45.4 48.3 45.6 48.1 56.1 44.9 32.3 31.6 126.7 59.2 41.5 106.9 39.5 48.7 48.1 CPSF1 CPSF160 ENSG00000071894 "Cleavage and polyadenylation specific factor 1" Q10570 8 144393229-144409349 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065167, HPA068906" Enhanced Nucleoplasm No No Nucleoplasm "HPA065167: AB_2685426, HPA068906: AB_2686055" "unprognostic (6.37e-2)" "unprognostic (7.72e-2)" "unprognostic (2.41e-2)" "unprognostic (1.21e-1)" "unprognostic (2.93e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (1.05e-1)" "unprognostic (2.00e-3)" "unprognostic (6.45e-2)" "unprognostic (7.54e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (6.54e-5)" "unprognostic (2.40e-1)" "unprognostic (1.91e-1)" "unprognostic (7.90e-2)" "unprognostic (9.66e-3)" 11.9 13.5 13.4 18.6 17.2 27.0 14.3 28.5 18.0 11.7 15.1 16.3 14.9 40.7 17.8 8.9 13.0 16.2 14.3 10.3 13.0 8.2 13.0 15.0 13.7 17.4 16.6 11.5 19.8 22.4 7.3 21.6 11.1 15.4 18.4 7.6 14.9 26.9 13.8 14.7 25.2 29.8 11.7 11.0 21.2 16.3 27.9 16.1 27.1 17.7 10.6 16.0 13.1 13.4 7.5 8.8 4.9 9.3 5.7 10.0 5.8 9.4 13.3 12.1 12.6 6.5 5.2 11.9 8.9 5.6 7.3 7.6 13.4 12.2 10.9 8.7 6.6 4.9 8.6 6.8 7.5 2.0 9.8 19.7 21.4 14.9 21.4 5.5 8.1 13.3 5.7 3.2 6.7 3.9 4.4 9.7 18.2 17.9 9.3 3.6 40.3 21.2 17.1 7.3 7.9 18.8 15.3 4.9 8.7 7.7 14.0 9.9 9.8 11.5 7.2 6.5 3.6 12.7 9.1 8.3 5.0 19.4 11.0 9.8 5.6 4.4 10.3 6.8 13.8 5.9 4.9 7.8 4.9 8.0 9.3 8.4 6.9 8.5 8.4 8.8 7.5 7.5 7.1 1.5 5.7 8.6 4.1 10.0 5.8 13.4 17.2 28.5 18.0 13.0 8.2 16.6 11.5 15.4 16.1 14.9 22.7 3.0 3.6 9.0 10.3 8.3 15.3 8.1 11.4 8.7 11.8 8.9 1.7 7.8 15.6 11.1 19.5 0.0 9.9 9.4 9.3 3.4 13.9 7.2 13.0 7.9 12.6 9.2 8.3 30.3 13.0 13.0 13.5 8.2 23.9 4.3 9.8 11.5 15.2 4.6 13.8 6.5 8.0 24.2 22.0 10.8 6.1 10.4 24.2 3.3 CPSF6 "CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7" ENSG00000111605 "Cleavage and polyadenylation specific factor 6" Q16630 12 69239537-69274358 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039973 Supported Enhanced "Nucleoplasm,Nuclear speckles" No No 500000 "Nucleoplasm, Nuclear speckles" "HPA039973: AB_10795242" "unprognostic (1.50e-1)" "unprognostic (3.33e-2)" "unprognostic (4.37e-3)" "unprognostic (5.47e-2)" "unprognostic (4.24e-2)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.91e-6)" "unprognostic (6.82e-2)" "unprognostic (2.91e-3)" "unprognostic (8.57e-2)" "unprognostic (1.52e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.20e-1)" "unprognostic (7.63e-2)" "unprognostic (2.05e-1)" "unprognostic (7.41e-2)" 22.3 26.4 29.4 28.1 32.6 52.0 23.1 49.1 32.2 24.8 20.7 24.3 21.3 21.8 27.4 34.5 27.1 23.2 17.0 21.8 24.3 16.4 20.0 19.7 21.6 36.1 23.6 26.8 42.2 23.5 28.6 36.4 21.0 24.9 21.5 21.5 22.2 25.6 21.4 25.4 23.3 23.1 22.3 20.7 24.7 21.9 22.1 25.8 42.8 25.5 10.5 32.9 21.3 24.2 22.0 25.5 21.0 21.5 19.3 30.2 12.4 28.7 24.2 35.8 25.1 13.9 15.9 27.0 19.0 22.7 27.1 25.7 25.2 19.8 45.9 19.6 19.2 15.1 27.2 35.1 22.4 29.0 29.9 23.9 37.0 25.0 28.8 20.8 49.9 27.1 19.0 17.8 21.8 9.0 18.2 20.8 27.7 38.0 49.3 22.4 33.5 46.7 32.7 34.6 24.0 20.7 47.5 28.4 32.1 21.3 34.3 30.2 26.6 25.5 23.9 25.9 22.4 28.7 35.4 23.9 20.5 25.1 19.3 31.0 31.7 25.6 57.4 16.6 29.3 26.3 21.0 17.1 18.7 19.7 21.5 20.9 22.0 22.0 20.2 25.5 19.0 17.0 20.1 5.2 19.3 17.8 18.3 30.2 12.4 29.4 32.6 49.1 32.2 24.3 16.4 23.6 26.8 24.9 25.8 11.9 19.8 32.8 39.9 67.5 52.9 29.0 22.9 21.4 25.0 17.4 35.3 55.0 31.5 46.3 14.2 31.0 20.8 0.0 49.2 71.9 38.1 25.5 34.6 18.7 34.7 84.2 50.4 17.2 27.8 13.5 52.6 28.0 23.6 55.9 26.2 35.0 48.6 21.0 49.8 20.2 42.9 38.8 30.4 71.1 72.7 51.7 42.8 35.2 31.1 46.0 CREB1 ENSG00000118260 "CAMP responsive element binding protein 1" P16220 2 207529737-207603431 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "Early spermatids: 355.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003803, HPA019150" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB003803: AB_562092, HPA019150: AB_1847220" "unprognostic (1.20e-1)" "unprognostic (3.15e-1)" "unprognostic (3.30e-2)" "unprognostic (2.69e-2)" "unprognostic (3.16e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.77e-5)" "unprognostic (8.41e-2)" "unprognostic (1.04e-2)" "unprognostic (2.53e-1)" "unprognostic (9.58e-2)" "unprognostic (1.74e-2)" "unprognostic (4.82e-3)" "unprognostic (5.53e-3)" "unprognostic (1.06e-1)" "unprognostic (1.77e-1)" "unprognostic (8.45e-2)" 21.2 12.9 19.4 24.8 17.0 22.9 16.7 25.5 18.7 17.6 15.7 14.3 14.7 12.6 19.3 14.9 17.9 15.4 15.5 14.4 15.4 14.5 14.6 13.1 17.7 21.7 15.8 17.7 20.5 12.9 19.8 20.0 19.8 16.1 16.3 16.2 11.2 16.2 14.9 11.6 14.3 15.2 19.5 19.8 19.0 13.3 39.2 18.5 38.4 19.7 13.3 27.7 16.1 23.6 22.1 20.7 34.8 19.1 28.4 22.5 14.5 15.3 13.8 25.5 9.8 15.0 15.4 14.6 9.9 14.8 17.2 18.1 13.9 15.6 10.0 13.3 14.5 20.2 13.4 23.1 13.5 25.3 15.9 8.3 18.3 12.3 14.2 12.6 17.3 13.5 11.1 10.0 14.2 21.1 17.2 24.1 18.7 12.8 14.6 21.2 10.6 26.2 10.2 18.2 15.4 8.4 20.5 13.9 13.1 15.4 15.9 17.6 15.3 13.7 10.1 11.9 25.5 11.3 18.9 11.5 14.1 15.1 14.7 12.6 13.2 16.7 23.0 17.3 15.9 14.7 16.9 17.0 16.8 17.3 18.0 15.4 22.1 16.6 16.7 20.7 20.2 19.9 13.5 34.8 28.4 19.1 11.3 22.5 14.5 19.4 17.0 25.5 18.7 15.4 14.5 15.8 17.7 16.1 18.5 17.9 12.8 45.4 39.6 63.0 36.1 22.1 12.7 9.4 25.0 12.2 31.4 24.5 19.9 20.2 355.9 44.6 20.0 0.0 17.9 21.7 32.3 41.9 42.7 14.3 25.7 38.1 31.2 31.3 43.4 27.4 24.2 38.0 42.2 36.9 24.2 40.0 21.9 23.5 27.6 15.6 36.9 38.8 34.1 24.7 27.5 50.6 15.6 31.9 23.0 54.8 CREBBP "CBP, KAT3A, RSTS, RTS" ENSG00000005339 "CREB binding protein" Q92793 16 3725054-3880726 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004212, HPA055861" Supported Enhanced "Nucleoplasm,Nuclear bodies" No No Nucleoplasm "Nuclear bodies" "CAB004212: AB_626817, HPA055861: AB_2682948" "unprognostic (1.17e-1)" "unprognostic (8.51e-2)" "unprognostic (1.60e-1)" "unprognostic (1.63e-1)" "unprognostic (1.49e-1)" "unprognostic (5.09e-2)" "unprognostic (9.59e-3)" "unprognostic (6.98e-2)" "unprognostic (8.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.76e-1)" "unprognostic (2.84e-1)" "prognostic favorable (6.24e-5)" "unprognostic (1.47e-1)" "unprognostic (1.74e-1)" "unprognostic (3.97e-2)" "unprognostic (8.23e-2)" 18.5 10.9 17.2 22.8 17.5 37.0 17.4 42.6 18.8 20.1 17.2 16.8 17.1 9.9 25.1 15.2 14.1 18.9 21.3 14.5 17.1 8.7 11.1 12.3 16.9 14.4 20.5 12.0 31.6 23.4 24.3 13.0 13.3 15.8 18.4 11.6 14.6 14.9 16.7 28.2 20.4 16.4 17.0 13.6 17.4 14.7 29.1 20.2 29.6 19.5 13.8 16.1 19.0 29.9 4.7 2.3 10.6 3.8 2.0 2.7 1.1 5.6 14.5 18.8 8.3 11.5 11.4 9.8 8.1 13.7 14.0 13.7 13.1 10.6 15.6 9.7 15.5 9.0 10.9 21.6 6.7 16.0 26.3 8.7 12.2 13.4 8.3 12.8 12.2 17.6 10.1 6.8 15.6 18.9 8.7 10.5 8.0 13.9 21.4 7.6 19.3 8.1 5.9 15.4 5.4 6.0 38.3 14.9 11.9 5.4 7.6 15.7 10.3 13.9 13.7 8.2 12.7 12.2 12.0 16.3 17.2 17.2 8.8 7.4 10.0 10.8 30.3 3.5 7.3 12.1 2.9 1.7 1.3 2.7 2.2 1.4 4.7 1.3 2.0 1.0 3.3 1.4 1.7 10.6 2.0 3.8 2.3 1.3 1.1 17.2 17.5 42.6 18.8 17.1 8.7 20.5 12.0 15.8 20.2 41.7 45.9 13.8 25.5 49.9 31.9 37.0 43.3 32.1 33.0 10.4 23.6 14.6 5.0 17.4 38.0 35.3 24.0 0.0 17.7 9.4 24.3 32.2 30.0 25.1 17.8 27.0 14.5 32.5 38.7 57.1 52.3 33.5 16.9 27.9 22.4 31.4 22.7 17.3 48.1 10.7 15.8 45.3 36.0 33.1 46.0 51.4 25.7 35.9 23.8 31.6 CRKL ENSG00000099942 "CRK like proto-oncogene, adaptor protein" P46109 22 20917426-20953749 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 89.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000532, HPA001100" Uncertain Enhanced Nucleoplasm,Cytosol NA NA 1500000 Nucleoplasm Cytosol "HPA000532: AB_2666019, HPA001100: AB_1078569" "unprognostic (5.54e-2)" "unprognostic (2.66e-1)" "unprognostic (5.87e-2)" "unprognostic (2.40e-2)" "unprognostic (3.06e-2)" "unprognostic (1.59e-1)" "unprognostic (1.92e-2)" "unprognostic (6.51e-2)" "unprognostic (2.35e-2)" "unprognostic (4.60e-1)" "unprognostic (2.71e-1)" "unprognostic (5.99e-2)" "prognostic unfavorable (8.82e-6)" "unprognostic (8.40e-2)" "unprognostic (1.43e-1)" "unprognostic (9.52e-2)" "unprognostic (1.61e-2)" 16.4 15.2 25.0 18.1 24.1 41.9 18.4 34.0 31.7 17.8 19.9 26.4 12.3 20.2 18.9 12.8 25.2 19.9 13.6 22.6 22.6 23.8 16.4 24.9 19.0 21.3 24.6 26.1 26.9 21.7 22.2 17.9 25.1 20.7 18.8 18.7 16.7 14.5 19.1 48.1 22.7 19.1 18.6 23.6 19.6 14.3 12.6 19.8 35.7 16.6 17.8 24.7 17.7 24.6 11.7 14.8 19.2 21.5 11.0 19.7 16.8 11.5 6.9 15.6 12.2 10.5 6.8 16.8 7.8 9.6 12.1 13.7 11.4 5.2 14.8 6.3 8.2 8.3 14.8 18.2 12.5 14.4 12.5 17.8 20.5 7.5 12.5 10.5 21.8 10.5 6.8 16.6 10.5 18.0 9.9 10.6 12.0 89.5 12.2 9.7 10.8 12.7 10.2 12.2 12.0 7.5 16.5 24.7 3.5 8.0 10.1 10.1 12.9 13.1 11.6 9.5 19.5 9.9 12.2 8.5 19.2 21.9 7.2 9.8 11.8 11.3 17.3 14.2 9.3 11.7 13.4 13.0 19.2 17.5 12.5 18.9 11.6 15.8 17.5 14.8 11.7 19.7 18.4 14.1 11.0 21.5 7.4 12.8 16.8 25.0 24.1 34.0 31.7 22.6 23.8 24.6 26.1 20.7 19.8 8.9 16.2 15.6 11.6 48.1 16.8 20.3 10.2 10.7 10.3 5.2 13.7 17.3 1.7 6.8 20.7 14.3 12.4 23.3 7.3 32.0 16.2 13.4 1.1 21.2 15.0 17.5 19.5 18.4 13.7 43.2 14.1 11.1 23.6 10.8 21.5 16.0 9.1 8.6 14.5 8.4 12.7 12.9 11.1 11.6 11.3 52.8 22.8 10.0 14.5 17.4 CRTC2 TORC2 ENSG00000160741 "CREB regulated transcription coactivator 2" Q53ET0 1 153947669-153958625 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028454, HPA028465" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA028454: AB_10599617, HPA028465: AB_10601991" "unprognostic (4.91e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (4.32e-3)" "unprognostic (2.86e-1)" "unprognostic (4.63e-3)" "unprognostic (1.54e-3)" "unprognostic (1.20e-2)" "unprognostic (1.07e-1)" "unprognostic (2.24e-2)" "unprognostic (2.17e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (1.35e-7)" "unprognostic (7.90e-2)" "unprognostic (2.59e-1)" "unprognostic (3.35e-1)" "prognostic favorable (6.12e-5)" 22.4 19.7 21.0 23.1 26.6 28.7 21.1 31.8 22.8 21.5 18.9 29.5 15.6 13.3 24.3 20.2 17.7 22.7 18.4 17.4 20.4 11.3 21.4 22.9 26.0 31.1 25.7 16.3 32.3 20.6 22.7 19.7 24.2 18.6 20.1 15.9 21.9 20.1 22.1 24.6 24.0 23.5 21.5 19.2 39.4 18.9 18.1 28.1 22.1 23.6 10.9 29.7 23.4 21.0 6.1 4.6 10.1 5.9 4.6 5.0 1.8 14.8 11.2 10.9 12.3 18.0 13.1 16.7 8.4 17.4 16.1 13.3 11.5 15.0 14.3 13.4 14.5 10.9 17.0 13.0 16.9 9.0 18.7 17.0 7.3 11.4 8.8 18.2 11.8 12.2 17.2 16.5 17.7 14.5 12.8 14.9 8.2 11.7 17.3 11.5 23.6 12.8 19.8 8.5 16.2 13.9 9.5 7.5 12.0 17.0 12.1 9.2 15.1 13.5 27.6 20.9 11.2 13.3 23.2 11.0 13.0 11.8 13.9 14.2 28.3 18.3 9.8 12.0 10.1 9.6 5.2 3.9 8.4 4.6 5.9 3.8 4.5 4.7 5.0 3.4 6.1 3.2 3.8 10.1 4.6 4.7 4.6 3.1 1.8 21.0 26.6 31.8 22.8 20.4 11.3 25.7 16.3 18.6 28.1 6.0 10.6 4.8 7.1 21.9 5.2 5.6 10.2 2.7 4.5 12.2 3.9 8.3 1.7 8.1 1.1 11.7 10.9 0.0 8.9 8.2 11.2 9.1 8.1 10.6 9.5 1.6 15.4 10.4 10.5 1.1 11.2 12.0 3.3 11.8 12.1 4.5 11.7 2.9 14.2 2.8 6.9 6.5 11.7 11.5 11.5 19.7 10.2 12.9 7.6 9.6 CRTC3 FLJ21868 ENSG00000140577 "CREB regulated transcription coactivator 3" Q6UUV7 15 90529925-90645345 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 16.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 40.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043735, HPA063691" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043735: AB_10794286, HPA063691: AB_2685092" "unprognostic (7.60e-2)" "unprognostic (6.13e-2)" "unprognostic (1.35e-1)" "unprognostic (2.31e-2)" "unprognostic (5.12e-2)" "unprognostic (3.51e-1)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (6.48e-2)" "unprognostic (3.60e-1)" "unprognostic (1.47e-1)" "unprognostic (2.23e-1)" "unprognostic (5.22e-3)" "unprognostic (4.67e-2)" "unprognostic (9.32e-2)" "unprognostic (9.51e-2)" "unprognostic (2.30e-1)" 22.3 14.0 13.7 17.0 20.9 11.4 26.6 15.0 16.2 21.2 22.2 27.5 15.3 8.9 23.9 14.5 15.1 19.4 21.5 17.2 14.0 9.7 10.7 11.7 19.2 21.7 24.1 10.9 45.9 13.9 17.1 9.6 20.2 15.7 18.2 11.7 17.4 19.9 22.0 16.1 15.8 13.7 31.8 20.3 13.1 14.2 15.3 23.6 12.8 22.7 9.2 18.1 24.0 29.6 5.3 2.1 16.0 2.5 3.3 6.6 3.0 4.8 8.0 5.5 8.9 11.9 8.8 25.1 6.2 9.0 9.8 9.3 6.6 4.9 0.1 4.5 12.8 8.1 8.2 8.8 5.4 7.7 8.4 10.2 12.3 40.0 3.0 13.5 3.2 21.1 9.9 8.7 8.1 10.9 7.2 7.0 5.5 6.5 2.8 7.2 5.6 1.3 4.6 2.0 1.4 3.7 4.2 8.8 0.2 3.5 10.3 10.1 8.9 18.1 6.0 10.1 6.0 6.0 6.0 8.6 10.9 8.0 10.0 7.1 3.8 5.1 3.7 4.5 6.4 5.2 16.0 2.5 1.4 3.7 0.8 4.2 3.1 4.5 4.0 1.6 5.3 6.6 4.1 0.5 3.3 0.3 2.1 4.2 3.0 13.7 20.9 15.0 16.2 14.0 9.7 24.1 10.9 15.7 23.6 6.0 8.6 37.4 23.2 20.9 21.6 13.4 17.8 0.0 4.5 12.2 25.5 12.1 1.7 12.0 22.9 18.0 6.4 0.0 9.4 36.5 23.1 23.5 23.1 13.5 13.5 54.0 15.0 20.9 19.7 14.7 24.7 21.3 16.9 8.2 10.0 20.4 9.0 10.5 41.1 8.4 55.7 45.3 38.4 7.7 16.5 21.0 14.9 30.5 11.3 31.1 CSE1L "CAS, CSE1, XPO2" ENSG00000124207 "Chromosome segregation 1 like" P55060 20 49046246-49096960 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 153.6;Spermatogonia: 127.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002140, HPA038059, HPA038060" Enhanced Enhanced Nucleoplasm,Cytosol No No 64000 Nucleoplasm Cytosol "CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812" "unprognostic (4.01e-2)" "unprognostic (3.15e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.91e-5)" "unprognostic (4.86e-1)" "unprognostic (4.91e-2)" "prognostic unfavorable (2.42e-8)" "unprognostic (3.44e-2)" "unprognostic (1.45e-2)" "unprognostic (2.63e-2)" "unprognostic (2.72e-3)" "unprognostic (2.54e-2)" "prognostic unfavorable (1.89e-4)" "unprognostic (2.59e-1)" "unprognostic (4.84e-1)" "unprognostic (5.71e-1)" "prognostic unfavorable (6.91e-4)" 15.7 18.9 19.5 18.7 23.7 13.7 21.2 24.9 31.3 17.5 14.2 13.4 14.0 12.0 19.5 15.5 25.5 17.3 11.8 17.8 20.0 17.7 18.8 18.7 12.8 24.0 27.3 19.4 18.7 17.3 23.2 16.8 23.1 24.2 16.7 18.4 8.4 15.5 17.0 34.3 20.9 12.4 21.7 31.3 12.6 17.1 50.9 21.0 27.0 14.7 28.1 25.3 18.3 17.5 12.8 14.8 9.4 15.9 16.8 18.0 12.8 36.2 25.2 30.9 23.7 12.0 15.5 33.4 28.6 15.2 90.0 38.2 82.4 29.3 37.1 38.4 18.1 36.5 42.0 45.3 53.7 86.0 6.0 22.0 25.7 29.7 39.9 7.3 28.3 14.2 8.6 20.2 44.0 25.5 12.4 29.7 20.7 36.3 14.7 33.7 12.4 34.1 14.6 25.9 30.3 37.6 21.7 50.8 28.9 19.8 25.3 27.2 15.8 45.7 49.5 16.2 24.5 41.3 18.5 19.1 48.0 40.3 28.2 40.5 8.6 20.8 34.8 28.6 22.9 25.5 9.4 11.8 2.7 11.0 15.2 16.5 12.8 16.8 13.4 14.8 10.4 18.0 15.3 3.3 16.8 15.9 6.6 14.4 12.8 19.5 23.7 24.9 31.3 20.0 17.7 27.3 19.4 24.2 21.0 6.0 23.2 18.2 20.7 26.9 14.3 23.5 35.7 21.4 18.2 26.2 9.8 56.3 11.6 28.2 61.2 21.5 7.8 0.0 23.0 50.5 21.6 15.7 4.6 23.2 26.0 14.3 5.2 20.9 15.1 39.7 23.6 19.3 25.3 29.7 9.1 21.8 23.6 10.5 29.7 17.0 11.9 38.8 19.1 153.6 127.3 30.2 60.8 16.6 18.2 20.0 CSPG4 "HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2" ENSG00000173546 "Chondroitin sulfate proteoglycan 4" Q6UVK1 15 75674322-75712848 "Predicted membrane proteins" "Angiogenesis, Differentiation, Tissue remodeling" "Developmental protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Sertoli cells: 116.4;Smooth muscle cells: 29.5" "Cancer enhanced" "Detected in all" "melanoma: 74.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "NK-cell: 1.9" "Lineage enriched" "Detected in single" 11 "NK-cells: 1.9" "Cell line enhanced" "Detected in many" "BJ: 20.1;SK-MEL-30: 45.8;U-138 MG: 29.6;WM-115: 43.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001933, HPA002951, CAB016189, HPA042785, HPA050008" Approved Enhanced "Nucleoplasm,Plasma membrane" NA NA 28000000 "Plasma membrane" Nucleoplasm "CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: AB_2680991" "unprognostic (5.21e-2)" "unprognostic (2.17e-3)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.56e-2)" "unprognostic (3.58e-1)" "unprognostic (1.09e-2)" "unprognostic (2.11e-2)" "unprognostic (1.07e-1)" "unprognostic (5.00e-2)" "unprognostic (1.63e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (7.60e-6)" "unprognostic (1.23e-2)" "unprognostic (2.04e-2)" "unprognostic (3.21e-2)" "prognostic unfavorable (4.93e-5)" 36.1 3.1 8.3 10.0 7.9 1.0 19.5 1.6 7.8 15.3 29.2 7.2 6.9 4.6 21.3 14.9 19.9 9.4 18.2 9.2 6.5 5.2 3.5 1.5 10.9 1.4 6.6 5.2 7.0 3.8 3.0 1.6 20.9 6.6 11.4 3.9 10.0 3.4 16.7 25.7 8.0 9.1 37.9 5.4 3.8 14.0 2.5 6.3 0.0 4.7 6.0 1.3 30.3 10.9 0.0 0.1 0.0 0.0 1.9 0.0 0.0 3.6 0.0 0.3 2.2 0.5 3.2 0.0 20.1 9.0 14.1 9.2 0.0 14.0 0.0 0.5 14.0 1.9 0.2 0.0 0.1 4.3 0.1 0.0 0.0 5.9 0.0 3.2 0.0 0.0 1.5 0.0 4.2 0.5 5.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 45.8 0.4 0.3 0.3 0.0 29.6 5.8 1.1 0.2 0.0 0.0 0.0 6.5 0.1 43.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 8.3 7.9 1.6 5.9 6.5 5.2 6.6 5.2 6.6 6.3 0.0 0.0 0.0 0.6 2.5 0.0 9.8 0.0 1.4 1.2 1.8 0.0 0.1 0.0 0.0 0.6 2.8 0.0 0.0 0.0 0.2 6.5 0.6 0.0 0.0 1.1 0.0 0.0 1.3 0.0 0.0 0.3 0.8 11.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 116.4 29.5 0.0 1.3 1.6 0.2 0.0 0.0 0.3 CSRNP1 "AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1" ENSG00000144655 "Cysteine and serine rich nuclear protein 1" Q96S65 3 39141855-39154562 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Smooth muscle cells: 150.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045207, HPA058463" Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA045207: AB_10967202, HPA058463: AB_2683726" "unprognostic (2.90e-2)" "unprognostic (6.89e-2)" "unprognostic (3.00e-1)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (1.46e-1)" "unprognostic (3.78e-2)" "unprognostic (1.90e-2)" "unprognostic (1.81e-2)" "unprognostic (1.34e-1)" "unprognostic (3.46e-1)" "unprognostic (1.39e-1)" "prognostic favorable (1.07e-4)" "prognostic unfavorable (6.47e-4)" "unprognostic (2.42e-2)" "unprognostic (1.98e-1)" "unprognostic (1.51e-1)" 33.5 24.9 5.9 16.4 11.5 70.1 20.4 4.9 8.6 16.2 14.4 11.4 13.9 5.1 12.9 9.6 25.9 35.8 28.7 19.7 5.4 5.3 9.6 33.3 35.7 7.9 8.8 3.3 24.9 16.3 11.7 17.6 30.9 15.3 15.8 6.8 9.7 10.9 50.1 22.4 19.9 21.0 26.9 11.9 9.2 20.3 11.4 7.5 8.9 14.5 14.6 7.8 21.4 16.9 3.6 3.9 15.9 9.2 2.2 2.5 1.9 2.3 5.3 1.4 2.7 2.7 2.8 4.4 8.7 12.3 7.3 6.0 7.5 2.2 7.8 1.9 6.6 5.3 2.7 1.6 11.6 3.6 11.6 2.2 8.9 4.3 5.6 3.3 2.2 8.9 1.3 6.3 11.5 1.8 6.6 9.9 2.1 6.7 13.9 6.0 7.5 0.4 3.6 6.4 4.0 4.5 3.6 5.8 12.7 5.8 8.7 3.9 0.6 4.8 36.2 2.9 8.6 4.0 4.1 4.9 3.7 16.0 3.1 6.4 3.6 3.0 3.6 8.2 2.8 4.6 0.1 2.7 3.2 1.7 5.6 2.1 3.6 1.6 1.9 3.0 3.6 2.0 1.3 15.9 2.2 9.2 3.9 2.5 1.9 5.9 11.5 4.9 8.6 5.4 5.3 8.8 3.3 15.3 7.5 44.7 66.0 21.2 65.0 91.8 1.4 12.9 17.8 9.4 17.0 10.4 0.0 13.0 8.3 30.2 47.7 63.8 51.3 23.3 34.0 40.3 70.9 58.0 96.7 34.8 35.2 0.0 56.9 49.7 35.1 34.1 1.4 49.4 65.8 20.8 34.8 4.3 37.1 28.1 3.9 4.8 1.6 12.9 150.2 0.2 3.2 69.5 75.9 27.7 25.5 32.3 CSTF1 ENSG00000101138 "Cleavage stimulation factor subunit 1" Q05048 20 56392371-56406369 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019270, HPA047275, HPA065000" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB019270: , HPA047275: AB_2680008, HPA065000: AB_2685400" "unprognostic (2.51e-1)" "unprognostic (1.74e-1)" "unprognostic (1.54e-3)" "unprognostic (1.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.50e-1)" "unprognostic (8.57e-3)" "unprognostic (3.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.62e-1)" "unprognostic (1.03e-1)" "unprognostic (4.05e-2)" "unprognostic (3.91e-2)" "unprognostic (2.87e-1)" "unprognostic (2.67e-1)" "unprognostic (1.29e-1)" "unprognostic (3.60e-1)" 14.3 16.6 9.7 15.0 15.9 6.8 17.1 14.8 14.9 13.2 11.9 14.5 9.1 8.1 17.5 12.6 16.4 15.2 12.0 11.9 10.2 9.6 18.1 27.5 12.8 17.2 12.9 9.4 20.1 18.4 20.1 19.0 14.1 12.2 14.1 12.7 14.6 22.8 11.7 18.7 16.9 13.6 13.6 10.5 17.1 14.1 28.2 11.4 32.5 15.8 15.8 21.9 14.9 12.1 15.1 15.7 9.4 11.6 21.0 22.6 12.9 8.6 8.2 10.4 7.2 10.8 9.8 11.4 11.8 13.1 23.6 17.7 17.8 12.6 17.8 12.8 8.6 15.1 14.6 16.7 20.1 27.8 5.6 5.9 17.4 14.7 10.7 6.5 14.5 11.3 9.4 11.7 13.2 11.4 9.0 14.1 11.3 14.7 8.7 14.2 20.2 16.1 7.5 9.6 17.0 10.8 12.0 22.4 15.7 11.4 8.9 11.6 8.0 15.9 43.8 11.7 12.6 17.5 10.1 7.7 19.2 12.3 7.9 11.3 6.1 9.5 19.4 15.1 9.6 9.1 7.5 11.6 9.0 14.9 10.1 19.0 14.8 19.1 16.8 14.9 15.1 21.1 18.4 9.4 21.0 8.2 15.7 22.6 12.9 9.7 15.9 14.8 14.9 10.2 9.6 12.9 9.4 12.2 11.4 8.9 13.3 9.3 10.1 8.1 8.5 8.1 15.3 12.0 7.9 17.4 13.7 26.5 16.6 14.9 11.5 10.5 6.9 0.0 12.9 17.1 7.4 9.9 17.3 19.1 13.4 4.8 4.7 13.5 20.3 4.2 12.7 6.6 5.0 17.2 9.3 12.0 10.7 12.7 12.0 15.9 11.1 19.4 6.2 17.7 36.6 7.8 17.6 15.4 10.7 8.0 CSTF2 CstF-64 ENSG00000101811 "Cleavage stimulation factor subunit 2" P33240 X 100820359-100840932 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000427, CAB004680" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB004680: AB_425385, HPA000427: AB_1078580" "unprognostic (2.02e-2)" "unprognostic (8.70e-3)" "unprognostic (3.50e-1)" "unprognostic (3.43e-1)" "unprognostic (7.00e-2)" "unprognostic (1.09e-2)" "prognostic unfavorable (8.23e-6)" "unprognostic (2.02e-1)" "unprognostic (4.82e-2)" "unprognostic (2.08e-3)" "unprognostic (5.98e-3)" "unprognostic (2.75e-1)" "prognostic favorable (1.12e-4)" "unprognostic (1.75e-2)" "unprognostic (2.90e-2)" "unprognostic (8.75e-2)" "unprognostic (2.89e-1)" 8.6 11.1 10.1 14.1 14.6 12.2 10.5 18.8 14.5 10.0 14.9 9.1 15.8 11.4 11.9 11.8 30.1 11.3 8.8 7.8 12.7 10.5 10.3 7.9 9.1 14.7 11.2 11.6 9.8 8.1 11.9 12.7 9.5 10.8 10.3 16.5 9.7 13.0 16.8 7.2 11.8 12.7 10.7 12.5 11.8 9.1 18.9 11.2 20.6 9.0 9.4 24.2 11.3 12.8 15.8 19.6 14.6 20.9 19.1 21.2 12.7 16.8 19.9 12.6 12.4 7.3 6.2 18.5 13.5 12.0 22.4 33.7 21.8 15.0 16.6 16.6 8.7 30.7 17.4 31.1 17.0 25.5 15.5 20.0 15.0 18.8 14.9 10.3 19.8 16.9 5.9 8.4 24.2 15.2 6.3 13.5 15.2 24.0 16.6 13.2 20.4 16.5 15.2 36.6 26.3 19.6 17.3 21.9 19.8 8.8 15.5 11.5 14.7 21.5 10.0 9.4 12.8 10.1 11.1 11.1 13.3 21.6 17.1 17.3 10.7 21.9 20.4 11.4 24.0 16.0 14.6 14.6 10.1 21.2 16.5 16.6 15.8 18.7 20.0 19.6 13.4 16.4 16.2 2.4 19.1 20.9 13.5 20.3 12.7 10.1 14.6 18.8 14.5 12.7 10.5 11.2 11.6 10.8 11.2 3.0 0.6 6.0 3.4 3.8 2.0 3.2 0.0 4.0 2.3 0.0 2.0 15.4 5.0 10.9 5.8 3.6 5.1 0.0 7.4 15.4 3.3 1.8 3.5 1.5 9.2 3.2 4.1 2.5 2.1 1.9 4.4 3.2 1.7 7.2 3.5 3.7 10.4 5.7 3.9 3.1 2.4 6.5 3.1 7.6 23.4 3.6 6.4 5.3 6.0 4.8 CSTF2T "CstF-64T, DKFZp434C1013, KIAA0689, tauCstF-64" ENSG00000177613 "Cleavage stimulation factor subunit 2 tau variant" Q9H0L4 10 51695487-51699591 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039216, HPA062021" Approved Enhanced Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "HPA039216: AB_10795462, HPA062021: AB_2684662" "unprognostic (2.60e-2)" "unprognostic (3.75e-2)" "unprognostic (2.93e-2)" "unprognostic (2.17e-1)" "unprognostic (8.59e-2)" "unprognostic (1.06e-1)" "unprognostic (4.06e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (3.42e-1)" "unprognostic (5.92e-2)" "unprognostic (5.36e-2)" "unprognostic (7.63e-2)" "unprognostic (5.19e-2)" "unprognostic (2.22e-1)" "unprognostic (3.31e-1)" "unprognostic (1.96e-1)" 20.2 23.5 16.5 20.0 21.6 14.0 15.2 16.2 24.0 14.8 13.5 29.6 9.9 14.3 16.8 13.4 13.1 19.0 12.7 17.4 18.4 16.6 15.5 15.4 11.9 21.7 21.3 16.5 23.3 16.3 30.2 14.1 14.6 23.5 15.8 13.5 12.6 13.4 12.5 25.0 13.3 16.8 16.8 28.0 24.6 17.7 11.6 20.1 31.9 17.0 12.6 22.9 17.0 13.2 4.6 5.5 5.5 5.1 13.9 6.8 3.2 8.5 10.1 15.3 16.0 21.7 14.9 1.0 12.1 11.3 14.0 13.7 13.5 12.5 24.6 7.0 10.5 8.5 13.4 11.5 12.7 12.8 14.2 13.0 14.2 10.8 2.5 10.5 5.4 13.0 21.4 9.9 12.3 14.4 8.9 10.5 14.5 15.2 14.0 12.1 7.3 22.2 8.8 5.6 10.4 21.9 17.7 30.9 5.2 10.7 7.1 12.9 16.6 10.1 10.6 10.8 16.7 19.7 10.1 11.1 9.0 12.3 8.3 15.0 17.9 6.6 17.7 18.7 12.8 7.7 3.7 5.0 5.5 4.9 5.1 6.8 2.3 3.6 3.8 5.5 4.6 6.2 5.3 1.5 13.9 3.4 3.5 5.7 3.2 16.5 21.6 16.2 24.0 18.4 16.6 21.3 16.5 23.5 20.1 8.9 6.9 15.9 6.1 8.0 14.6 11.4 10.2 17.4 6.8 8.7 7.9 20.3 19.9 13.7 0.7 16.5 6.4 0.0 13.3 13.9 9.3 3.3 19.7 13.7 13.1 19.1 5.8 17.2 15.6 2.1 22.2 12.0 0.0 22.6 6.6 11.8 11.2 6.5 18.7 10.7 12.8 6.5 11.4 36.7 13.8 5.6 5.1 21.5 10.0 4.8 CSTF3 CstF-77 ENSG00000176102 "Cleavage stimulation factor subunit 3" Q12996 11 33077188-33162371 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039743, HPA040168" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039743: AB_10795682, HPA040168: AB_10794025" "unprognostic (2.38e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.63e-4)" "unprognostic (3.77e-1)" "unprognostic (4.04e-2)" "unprognostic (4.35e-2)" "prognostic unfavorable (8.20e-6)" "unprognostic (1.47e-1)" "unprognostic (1.67e-2)" "unprognostic (6.42e-3)" "unprognostic (9.73e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (4.64e-2)" "unprognostic (1.86e-2)" "unprognostic (1.15e-2)" "unprognostic (1.01e-3)" 9.6 16.0 27.4 16.4 38.2 11.2 16.0 30.7 35.5 12.1 13.2 11.2 14.4 16.0 16.2 50.9 16.2 13.0 13.2 11.9 24.9 23.4 15.0 19.5 12.7 20.0 17.7 22.2 17.0 12.8 21.3 45.2 15.6 17.4 18.7 16.9 12.7 13.5 13.3 12.3 21.7 14.6 12.8 20.4 15.9 15.7 21.8 19.1 20.9 19.4 15.1 16.8 13.3 15.2 9.2 11.3 9.4 11.8 9.3 13.3 5.3 18.3 18.3 34.0 22.6 8.9 15.8 25.5 18.7 11.6 20.2 27.2 14.0 15.0 19.9 12.8 11.3 13.6 24.0 29.8 17.1 32.1 20.3 50.5 20.5 39.7 22.9 10.4 26.6 12.7 11.8 12.2 15.2 15.2 16.4 25.9 15.8 27.0 14.6 26.4 13.9 25.0 13.9 16.6 13.4 22.4 20.3 33.7 15.3 21.6 26.1 26.0 14.9 21.2 12.4 14.2 22.5 22.2 17.1 16.0 16.5 21.1 27.4 23.9 13.6 19.1 17.4 20.5 26.4 16.1 5.4 7.9 9.4 9.6 9.9 11.0 9.2 11.4 9.2 11.3 8.3 12.3 12.2 4.3 9.3 11.8 8.6 13.3 5.3 27.4 38.2 30.7 35.5 24.9 23.4 17.7 22.2 17.4 19.1 17.9 16.0 27.9 37.5 16.8 33.5 18.5 25.5 72.3 43.3 55.8 5.9 56.0 53.0 20.9 31.0 22.9 14.4 23.3 14.5 25.8 32.3 29.2 13.9 51.6 24.7 12.7 30.6 12.3 21.3 9.8 27.6 20.7 27.0 28.9 26.0 29.9 17.7 14.4 28.0 36.5 25.0 25.8 21.7 72.7 51.5 16.9 28.3 20.8 31.1 52.5 CTAG2 "CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803" ENSG00000126890 "Cancer/testis antigen 2" O75638 X 154651972-154653579 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 8.5;skeletal muscle: 5.7;testis: 11.9" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 72.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 22.0;K-562: 27.8;OE19: 41.0;RPMI-8226: 61.9;SK-BR-3: 40.5;U-266/84: 70.1" "HPA071467, HPA076586" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA071467: AB_2686402, HPA076586: " "prognostic unfavorable (2.35e-4)" "unprognostic (3.87e-1)" "unprognostic (1.00e-1)" "unprognostic (1.25e-2)" 0.2 1.0 0.4 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.2 0.0 0.0 0.0 1.0 2.9 0.0 8.5 0.0 0.0 0.1 0.8 0.2 0.0 0.2 0.8 3.6 0.0 0.4 4.4 0.2 0.0 0.1 0.0 5.7 0.2 0.0 0.0 0.0 0.3 0.6 11.9 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.6 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 40.5 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.0 0.5 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 3.3 0.0 0.1 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 16.8 72.0 0.0 0.9 0.0 0.0 0.0 CTBP1 BARS ENSG00000159692 "C-terminal binding protein 1" Q13363 4 1211448-1249953 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Oxidoreductase, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004217, HPA018987, HPA044971" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161" "unprognostic (6.19e-2)" "unprognostic (4.78e-2)" "unprognostic (9.14e-2)" "prognostic favorable (4.03e-4)" "unprognostic (3.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.52e-2)" "unprognostic (1.04e-2)" "unprognostic (9.65e-2)" "unprognostic (2.24e-2)" "unprognostic (6.35e-3)" "unprognostic (3.58e-2)" "unprognostic (3.36e-1)" "unprognostic (2.46e-2)" "unprognostic (3.00e-1)" "unprognostic (3.22e-2)" "prognostic favorable (8.94e-4)" 32.3 35.8 42.4 39.8 44.4 31.3 54.6 70.7 56.1 27.6 29.4 29.2 29.0 44.9 35.8 30.8 31.9 38.2 37.6 41.2 41.5 45.7 29.3 36.0 28.5 48.4 38.0 41.2 35.4 62.2 28.4 48.1 27.2 30.2 32.6 21.6 28.2 44.9 27.9 74.2 33.9 43.6 29.7 29.3 47.0 33.5 16.7 27.2 44.9 29.4 30.5 30.2 32.2 38.6 15.6 25.0 11.6 16.2 16.1 24.5 10.3 22.8 33.9 26.2 32.1 18.4 13.3 22.5 18.1 16.9 22.5 23.0 29.0 55.6 28.1 21.0 21.0 34.9 18.4 15.8 23.8 6.8 21.3 19.1 25.4 38.3 37.0 30.7 22.8 36.3 22.9 18.3 19.1 11.1 21.9 16.8 32.1 28.8 48.3 12.4 37.8 73.3 71.9 31.0 18.7 32.8 51.9 15.8 36.6 14.4 29.2 49.3 30.9 17.3 18.7 23.9 16.5 40.9 35.2 21.4 37.7 21.3 21.6 38.7 35.2 33.5 32.5 29.8 35.6 29.5 8.6 11.9 11.6 24.5 16.2 18.4 15.3 17.2 20.8 14.7 15.6 13.5 19.5 9.3 16.1 15.8 25.0 14.6 10.3 42.4 44.4 70.7 56.1 41.5 45.7 38.0 41.2 30.2 27.2 38.7 35.8 50.6 18.9 30.3 28.2 46.2 45.9 24.1 19.4 34.9 3.9 21.5 10.0 27.3 2.7 34.3 46.6 46.7 35.0 26.5 27.8 33.2 23.1 79.0 37.1 38.1 44.3 48.5 64.1 3.6 41.7 35.1 43.9 24.4 42.4 41.9 38.2 31.6 33.6 29.3 15.7 6.5 27.0 6.0 15.1 33.1 16.6 39.6 51.0 23.8 CTNNBL1 "C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L" ENSG00000132792 "Catenin beta like 1" Q8WYA6 20 37693955-37872129 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 296.8;granulocytes: 250.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 76.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004742, HPA027906, HPA027907" Approved Enhanced Nucleoplasm,Centrosome,Cytosol No No Nucleoplasm "Centrosome, Cytosol" "HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362" "unprognostic (2.81e-1)" "unprognostic (3.42e-1)" "unprognostic (8.80e-2)" "unprognostic (1.88e-3)" "unprognostic (1.93e-1)" "unprognostic (2.55e-2)" "unprognostic (1.44e-1)" "unprognostic (5.11e-2)" "unprognostic (1.02e-1)" "unprognostic (3.79e-2)" "unprognostic (2.56e-1)" "unprognostic (1.43e-1)" "unprognostic (2.06e-3)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (2.81e-1)" "unprognostic (5.31e-2)" 21.0 14.7 19.6 25.8 21.4 27.3 18.9 20.9 21.3 20.3 23.5 18.4 31.7 16.1 25.4 25.2 18.9 21.0 17.7 25.6 17.5 15.8 19.3 35.3 19.3 26.9 17.9 14.7 21.7 14.6 14.5 22.6 22.4 17.5 19.4 18.1 16.1 15.5 34.3 27.3 20.1 19.7 23.8 16.6 49.5 25.9 35.5 20.6 31.0 15.9 15.5 29.7 22.2 29.3 24.9 31.4 60.3 29.1 21.7 18.2 18.4 15.6 14.4 13.8 10.8 10.0 8.3 21.9 10.0 10.5 24.1 21.3 53.9 12.7 17.4 14.7 10.1 23.3 16.8 18.6 23.7 26.0 8.4 9.2 57.1 7.9 26.3 10.4 18.0 76.0 8.7 14.1 13.6 13.6 8.4 14.3 25.0 15.4 7.2 12.8 12.9 29.2 24.0 12.5 17.6 21.0 20.6 26.8 13.1 10.5 13.1 11.1 13.3 17.4 24.9 17.6 13.4 12.3 14.5 10.6 24.1 14.4 15.8 16.2 8.4 10.6 20.3 17.0 11.3 12.7 60.3 22.3 27.9 15.8 29.1 15.0 24.9 15.4 16.2 31.4 23.4 15.5 16.6 4.9 21.7 28.7 24.7 18.2 18.4 19.6 21.4 20.9 21.3 17.5 15.8 17.9 14.7 17.5 20.6 26.8 26.6 37.0 27.7 20.3 25.3 35.5 20.4 21.4 31.8 17.4 17.7 122.6 31.5 25.9 296.8 26.1 24.4 0.0 30.3 56.0 26.8 18.9 250.2 39.2 44.0 17.5 20.1 31.3 29.7 86.0 31.7 43.3 25.3 129.0 23.0 28.3 25.6 19.8 31.5 32.3 21.0 19.4 40.1 76.5 43.0 19.6 44.3 32.4 19.5 18.6 CTR9 "KIAA0155, p150TSP, SH2BP1, TSBP" ENSG00000198730 "CTR9 homolog, Paf1/RNA polymerase II complex component" Q6PD62 11 10750987-10801625 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061027, HPA068122" Supported Enhanced Nucleoplasm No No Nucleoplasm "HPA061027: AB_2684418, HPA068122: AB_2685959" "unprognostic (1.92e-1)" "unprognostic (1.82e-1)" "unprognostic (2.89e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.58e-1)" "unprognostic (6.27e-2)" "unprognostic (2.42e-1)" "unprognostic (5.26e-2)" "unprognostic (2.80e-1)" "unprognostic (2.63e-1)" "unprognostic (7.27e-2)" "prognostic favorable (3.65e-6)" "unprognostic (6.88e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" 16.7 26.7 15.9 19.9 17.4 18.4 26.1 17.5 17.1 21.5 15.8 13.0 20.3 14.2 21.4 44.1 23.7 17.7 13.7 24.2 18.8 14.8 20.5 35.0 15.6 23.8 14.3 14.0 25.4 18.8 36.5 31.4 26.7 16.0 17.5 16.4 14.0 19.1 20.2 24.0 18.3 19.2 16.6 15.7 26.6 17.6 24.4 15.8 39.1 20.9 13.1 21.9 19.6 21.1 11.9 11.9 27.2 12.1 17.5 18.5 9.5 13.0 10.2 14.7 13.9 32.2 12.9 7.2 14.6 9.7 11.8 12.5 16.8 28.1 11.9 8.0 12.0 14.4 13.6 18.0 11.9 19.3 18.3 21.6 60.8 10.8 9.5 10.3 23.8 33.8 11.9 9.8 7.5 10.3 10.9 13.5 11.6 24.5 14.6 14.2 5.9 15.2 9.3 12.2 15.8 12.8 14.1 17.9 8.2 10.2 18.0 6.7 16.1 13.2 13.1 10.2 14.7 11.6 10.5 13.2 10.0 10.3 17.5 7.8 8.0 18.8 13.1 10.7 16.1 10.2 27.2 10.0 19.8 14.1 12.1 18.5 11.6 14.9 13.6 11.9 11.9 14.7 13.8 7.5 17.5 11.2 6.0 12.4 9.5 15.9 17.4 17.5 17.1 18.8 14.8 14.3 14.0 16.0 15.8 53.6 45.6 25.3 36.7 77.4 33.6 39.1 22.9 36.1 45.5 24.4 53.0 31.1 16.6 23.4 13.7 23.9 23.8 0.0 21.3 20.2 22.3 24.0 80.1 34.2 25.0 60.4 25.8 26.4 28.9 6.8 31.1 22.9 11.8 22.6 34.5 29.0 21.5 20.3 29.4 15.6 45.5 25.8 23.6 72.8 63.9 70.9 38.2 33.1 21.5 27.6 CUEDC2 "C10orf66, MGC2491" ENSG00000107874 "CUE domain containing 2" Q9H467 10 102423245-102432661 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036544, HPA041829" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036544: AB_10670111, HPA041829: AB_2677694" "unprognostic (2.10e-1)" "unprognostic (2.80e-2)" "unprognostic (7.31e-2)" "unprognostic (4.24e-2)" "unprognostic (9.78e-2)" "unprognostic (3.09e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (1.06e-1)" "unprognostic (4.98e-2)" "unprognostic (1.88e-1)" "unprognostic (2.24e-2)" "unprognostic (1.32e-1)" "unprognostic (3.48e-3)" "unprognostic (4.34e-1)" "unprognostic (1.67e-1)" "unprognostic (8.38e-2)" "unprognostic (1.58e-2)" 18.8 26.2 29.9 14.9 28.5 13.0 16.2 22.0 49.7 19.8 20.3 19.0 18.5 10.8 19.6 20.8 17.1 25.1 22.7 38.7 25.5 22.3 20.1 18.2 14.9 15.3 27.5 29.5 27.9 23.3 24.4 16.7 14.6 25.4 20.7 12.6 17.5 21.5 22.4 61.6 13.2 11.2 23.6 23.6 15.1 16.3 13.5 18.2 16.5 20.0 25.5 15.8 17.1 14.9 37.4 50.1 35.5 50.5 38.2 36.1 36.0 15.1 17.4 27.2 32.0 22.7 29.2 10.2 12.8 41.3 27.5 21.1 5.4 15.3 25.3 27.3 21.4 12.5 15.0 17.6 27.7 13.6 22.5 17.9 15.6 14.8 5.4 38.4 11.9 10.6 34.4 25.8 26.8 26.7 53.0 28.3 31.6 12.1 25.3 30.8 16.3 27.8 26.6 9.3 11.7 10.9 32.3 33.3 13.0 27.9 7.0 13.5 32.3 8.6 8.5 26.1 11.7 25.9 19.0 16.2 13.7 13.0 17.4 17.1 31.3 25.3 16.8 24.8 41.7 10.9 34.1 50.5 35.5 32.3 39.7 36.1 34.8 32.1 33.7 50.1 37.4 32.0 30.7 19.2 38.2 24.6 43.3 35.7 36.0 29.9 28.5 22.0 49.7 25.5 22.3 27.5 29.5 25.4 18.2 29.8 21.6 30.6 36.9 28.2 50.1 49.7 40.8 20.1 20.5 43.6 23.6 56.6 68.0 58.9 15.1 40.5 20.8 23.3 40.9 25.8 56.9 34.1 50.7 37.6 66.4 63.5 53.5 53.4 50.0 29.8 52.9 44.6 49.0 116.4 32.4 74.4 42.9 31.6 56.6 125.1 35.9 38.8 58.4 59.4 29.7 29.5 38.1 34.6 33.3 28.6 CUL2 ENSG00000108094 "Cullin 2" Q13617 10 35008551-35090642 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 245.9;Late spermatids: 133.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002677, HPA024578" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002677: , HPA024578: AB_1847338" "unprognostic (8.11e-3)" "unprognostic (1.12e-1)" "unprognostic (9.77e-2)" "unprognostic (1.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (8.24e-6)" "unprognostic (2.18e-1)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (4.70e-2)" "unprognostic (6.94e-2)" "prognostic unfavorable (9.32e-5)" "unprognostic (2.26e-2)" "unprognostic (2.31e-1)" "unprognostic (3.70e-1)" "unprognostic (2.29e-1)" 16.2 14.9 17.2 12.6 22.6 14.3 13.6 16.8 20.9 11.6 14.3 9.0 18.1 11.9 13.6 9.5 14.3 12.1 10.1 15.7 15.4 15.1 12.2 17.2 11.9 15.4 14.3 20.8 12.9 17.7 21.4 19.3 21.9 17.3 13.3 13.0 7.0 12.8 14.1 33.7 14.2 12.4 16.1 14.0 15.1 14.5 27.9 15.4 20.3 13.7 14.4 16.6 15.6 12.3 11.4 11.9 10.0 13.7 11.3 17.4 7.7 20.0 11.9 15.7 13.5 18.0 19.9 16.7 23.8 13.3 23.6 23.8 15.9 19.3 16.0 13.2 25.1 17.3 18.6 22.8 21.9 27.1 18.8 14.9 20.9 12.9 14.0 19.8 11.3 13.8 19.1 18.3 25.8 9.0 18.2 26.2 17.1 23.9 14.6 25.7 13.7 18.8 6.3 5.7 13.9 48.8 15.9 25.5 10.0 21.6 15.8 7.7 10.3 13.3 16.8 18.7 18.3 12.7 13.0 24.0 14.6 16.3 24.9 15.5 6.1 8.3 19.3 28.1 25.7 10.2 9.6 9.3 10.0 12.3 13.7 17.4 10.8 14.0 14.7 11.9 11.4 16.7 15.5 4.4 11.3 13.3 5.4 16.6 7.7 17.2 22.6 16.8 20.9 15.4 15.1 14.3 20.8 17.3 15.4 20.8 9.3 10.7 8.3 10.6 12.2 23.2 7.6 22.7 22.7 8.7 9.8 21.0 13.3 16.2 245.9 19.5 10.6 0.0 15.5 16.7 11.8 7.8 19.7 17.9 17.5 22.3 10.3 12.9 19.7 133.1 13.0 19.8 10.1 24.4 9.5 15.3 15.9 7.0 11.0 11.5 13.0 0.0 14.1 33.9 31.3 11.4 31.0 18.1 11.5 8.1 CUL4B ENSG00000158290 "Cullin 4B" Q13620 X 120524609-120575794 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Ubl conjugation pathway" "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 78.2;Late spermatids: 113.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003046, HPA011880, CAB017786, HPA058979" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB017786: , HPA003046: , HPA011880: AB_1847340, HPA058979: AB_2683868" "unprognostic (2.34e-2)" "unprognostic (2.74e-2)" "unprognostic (2.69e-2)" "unprognostic (7.73e-3)" "unprognostic (9.66e-2)" "unprognostic (3.91e-1)" "unprognostic (3.88e-3)" "unprognostic (8.99e-2)" "unprognostic (8.12e-3)" "unprognostic (3.20e-2)" "unprognostic (1.07e-1)" "unprognostic (1.90e-1)" "unprognostic (2.87e-3)" "unprognostic (3.83e-2)" "unprognostic (1.35e-1)" "unprognostic (6.82e-2)" "unprognostic (2.84e-1)" 20.9 24.0 19.0 19.2 28.1 12.2 25.3 28.9 25.7 32.6 20.5 12.1 25.7 14.0 24.2 47.2 29.3 19.6 18.5 19.4 18.5 20.2 19.1 20.4 23.8 23.5 17.3 20.4 30.1 18.8 34.4 48.3 17.0 18.4 30.8 17.2 15.7 17.3 27.3 10.8 17.7 16.3 36.0 20.5 19.9 17.0 34.0 17.3 29.8 18.8 13.9 24.1 40.4 22.5 7.6 12.5 15.4 4.3 5.5 8.3 4.9 11.8 10.0 8.4 8.9 36.9 18.8 6.7 26.9 32.3 22.3 23.3 9.0 33.7 11.9 9.2 61.9 39.5 8.8 17.1 7.9 25.4 6.9 8.9 5.8 14.6 6.4 16.0 6.2 8.3 20.9 6.0 12.8 11.1 40.3 39.8 6.4 8.9 9.3 21.5 6.3 8.1 6.5 12.7 13.4 10.2 6.9 8.3 12.1 7.4 5.9 9.5 8.0 19.9 9.8 9.8 10.9 8.3 5.7 52.4 16.0 8.9 21.4 24.1 5.9 10.3 14.8 17.4 8.5 14.4 5.8 4.3 9.0 7.2 3.8 7.7 7.6 7.0 6.6 5.1 5.7 7.9 8.3 15.4 5.5 2.7 12.5 8.2 4.9 19.0 28.1 28.9 25.7 18.5 20.2 17.3 20.4 18.4 17.3 20.8 11.8 6.0 8.4 13.5 15.6 14.3 7.6 17.4 9.1 14.0 13.7 8.8 11.6 8.5 78.2 15.7 9.9 0.0 7.7 19.0 13.1 10.1 13.9 13.5 14.7 23.8 23.6 43.0 28.3 113.1 19.8 13.7 11.8 8.2 16.6 13.0 13.8 3.5 20.1 9.8 12.9 12.9 13.4 11.3 12.1 12.0 8.4 12.9 13.0 8.3 CUTC CGI-32 ENSG00000119929 "CutC copper transporter" Q9NTM9 10 99702558-99756134 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.1" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038619, HPA058231" Enhanced Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Cytosol" Nucleoli "HPA038619: AB_10672649, HPA058231: " "unprognostic (1.25e-2)" "unprognostic (5.92e-2)" "unprognostic (2.70e-1)" "unprognostic (8.66e-2)" "unprognostic (7.39e-2)" "unprognostic (1.39e-1)" "unprognostic (3.55e-3)" "unprognostic (8.67e-2)" "unprognostic (5.36e-2)" "unprognostic (1.81e-1)" "unprognostic (5.87e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.81e-7)" "unprognostic (1.00e-1)" "unprognostic (3.42e-2)" "unprognostic (2.41e-1)" "unprognostic (3.97e-1)" 11.6 4.9 5.7 9.8 8.7 7.9 9.8 3.5 6.5 5.3 5.9 7.2 3.5 4.4 4.9 8.0 6.2 5.1 5.8 13.2 5.9 4.7 5.3 11.0 5.1 7.9 8.6 6.6 4.6 4.5 3.5 3.6 4.5 5.5 6.0 6.4 6.9 5.7 5.4 122.1 5.8 6.2 11.6 7.4 9.2 6.0 14.1 8.3 9.2 4.3 25.1 7.3 13.5 11.4 32.8 24.2 47.1 19.4 25.5 36.3 19.3 9.5 20.5 7.2 21.9 26.8 12.3 3.9 7.8 10.1 7.9 8.9 9.4 7.3 34.7 7.0 13.3 3.9 8.2 14.7 13.0 8.8 10.2 14.0 11.5 9.2 14.8 12.4 21.3 5.6 12.7 8.1 12.6 26.2 9.8 13.5 20.2 10.1 7.7 5.9 6.6 19.1 22.0 7.2 9.7 7.7 13.0 8.5 13.3 8.3 3.9 2.4 5.4 3.6 5.7 9.8 10.4 9.1 12.2 7.5 3.3 4.4 3.6 10.3 12.7 16.5 24.3 10.8 45.8 2.9 26.5 19.4 47.1 27.2 15.2 28.3 32.8 25.9 25.9 21.0 29.0 36.3 27.8 30.8 25.5 18.5 24.2 24.7 19.3 5.7 8.7 3.5 6.5 5.9 4.7 8.6 6.6 5.5 8.3 8.9 12.2 21.9 13.0 10.8 16.5 35.8 10.2 20.1 10.3 5.2 7.9 15.9 18.3 14.6 8.1 21.5 4.9 0.0 15.0 10.7 15.3 11.4 30.0 20.2 18.3 11.1 11.6 22.7 17.8 6.8 12.0 15.9 28.7 27.9 7.8 17.8 10.1 10.1 15.2 24.5 27.1 19.4 15.6 105.8 35.1 9.5 11.3 20.1 9.7 10.7 CWC27 "NY-CO-10, SDCCAG-10, SDCCAG10" ENSG00000153015 "CWC27 spliceosome associated protein homolog" Q6UX04 5 64768930-65018763 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Disease mutation, Dwarfism, Mental retardation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 197.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020344, HPA024149, HPA065809" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: AB_2685561" "unprognostic (1.71e-1)" "unprognostic (6.47e-3)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (8.91e-2)" "unprognostic (4.00e-3)" "prognostic unfavorable (5.27e-6)" "unprognostic (1.58e-2)" "unprognostic (3.43e-2)" "unprognostic (1.21e-1)" "unprognostic (1.48e-2)" "unprognostic (2.04e-1)" "unprognostic (2.07e-1)" "unprognostic (2.46e-1)" "unprognostic (2.05e-1)" "unprognostic (2.74e-1)" "unprognostic (7.45e-3)" 15.6 16.4 22.0 14.9 30.4 21.7 16.4 30.1 25.6 16.5 17.5 13.8 14.0 11.8 19.4 15.7 17.3 14.9 13.8 22.1 20.6 19.9 17.5 12.1 12.8 17.0 22.3 20.7 23.3 10.9 21.4 28.8 17.5 26.2 18.6 18.7 11.4 13.3 16.0 24.0 13.8 15.9 24.7 23.3 15.0 13.9 19.6 23.6 22.5 17.2 18.2 18.6 18.6 20.0 15.1 14.6 8.6 11.5 17.0 15.9 9.0 15.2 10.2 18.4 34.0 15.8 19.3 20.5 16.1 13.4 18.0 19.0 17.0 19.4 22.7 28.2 16.7 20.3 9.7 19.2 29.1 32.9 18.9 15.7 17.0 17.2 14.1 24.2 17.8 11.6 12.8 22.4 22.7 28.9 16.0 19.0 26.0 16.5 15.0 17.8 15.2 24.7 16.1 14.9 8.0 12.4 23.0 24.7 23.6 17.1 13.3 21.9 9.7 19.6 8.0 18.1 18.3 17.4 26.2 15.8 10.6 18.7 16.9 25.6 11.7 15.2 22.3 19.9 31.3 18.8 8.6 11.5 7.9 12.8 11.3 15.5 15.1 14.2 15.9 14.6 11.9 15.4 15.9 2.5 17.0 8.5 12.0 15.1 9.0 22.0 30.4 30.1 25.6 20.6 19.9 22.3 20.7 26.2 23.6 8.9 25.8 20.1 22.0 14.5 30.0 55.8 20.4 33.5 14.8 14.0 13.7 36.6 18.3 35.9 197.3 26.9 10.5 23.3 28.8 45.9 24.6 20.8 18.5 10.5 28.6 19.1 28.7 14.1 17.2 37.1 35.6 23.8 13.5 29.7 16.0 31.3 33.5 10.5 33.9 21.9 53.9 32.3 28.4 43.0 28.9 17.6 25.7 23.6 26.6 17.4 CXorf67 ENSG00000187690 "Chromosome X open reading frame 67" Q86X51 X 51406915-51408843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 14.3;testis: 21.4" "Group enriched" "Detected in some" 5 "Sertoli cells: 6.5;Spermatocytes: 4.9;Spermatogonia: 15.6" "Cancer enriched" "Detected in some" 6 "testis cancer: 11.4" "Region enriched" "Detected in single" 5 "cerebellum: 2.8" "Cell type enhanced" "Detected in some" "memory B-cell: 1.1;naive CD4 T-cell: 1.2" "Group enriched" "Detected in many" 11 "B-cells: 1.1;T-cells: 1.2" "Cell line enriched" "Detected in single" 46 "U-2 OS: 27.7" "HPA004003, HPA006128" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA004003: AB_2667113, HPA006128: AB_2667517" "unprognostic (4.21e-2)" "unprognostic (6.36e-2)" "unprognostic (3.37e-2)" "unprognostic (8.58e-3)" "unprognostic (3.57e-4)" "unprognostic (1.47e-6)" "unprognostic (4.55e-2)" "unprognostic (3.06e-2)" "unprognostic (4.26e-1)" 0.1 0.2 0.3 0.2 0.6 0.1 0.1 2.8 0.4 0.1 0.1 0.1 0.1 0.0 0.3 0.4 0.1 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.2 0.2 0.2 0.1 0.7 0.1 0.0 1.5 14.3 0.1 0.4 0.1 0.1 0.9 0.2 0.1 0.2 0.2 0.1 0.4 0.7 0.1 21.4 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.1 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.7 1.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.6 2.8 0.4 0.3 0.5 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 6.5 0.0 4.9 15.6 0.0 1.6 0.0 0.0 0.0 CXXC1 "CFP1, CGBP, hCGBP, HsT2645, PCCX1, PHF18, SPP1, ZCGPC1" ENSG00000154832 "CXXC finger protein 1" Q9P0U4 18 50282343-50288304 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044511 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044511: AB_10963081" "unprognostic (4.47e-2)" "unprognostic (1.83e-2)" "unprognostic (1.69e-2)" "unprognostic (1.36e-2)" "unprognostic (1.99e-1)" "unprognostic (1.49e-2)" "prognostic unfavorable (4.18e-6)" "unprognostic (3.82e-1)" "unprognostic (3.24e-1)" "unprognostic (5.08e-2)" "prognostic favorable (2.60e-4)" "unprognostic (1.10e-2)" "unprognostic (1.00e-1)" "unprognostic (3.83e-2)" "unprognostic (2.07e-1)" "unprognostic (2.12e-1)" "unprognostic (2.41e-2)" 12.1 16.9 17.5 20.0 20.3 40.3 12.4 42.4 23.1 15.7 15.2 15.7 18.7 18.3 16.8 10.2 15.5 19.8 17.5 13.6 18.2 12.2 16.5 14.9 13.9 23.6 22.6 13.1 23.6 32.8 13.7 14.3 22.4 18.7 15.6 9.1 14.1 24.7 19.4 12.1 17.2 15.1 17.7 11.7 19.3 17.3 15.5 20.3 25.8 15.5 14.0 18.6 17.5 20.1 22.0 16.6 24.5 16.9 16.0 21.1 15.0 8.3 11.3 8.6 16.2 7.0 4.9 17.8 11.0 7.6 11.0 9.7 8.3 6.3 23.7 5.7 5.0 6.5 13.7 14.3 10.4 3.1 19.4 12.7 19.1 12.4 13.1 5.0 44.7 20.8 4.8 8.1 12.0 6.2 4.0 7.4 18.7 11.8 20.3 5.5 11.8 26.5 22.0 18.9 4.2 7.6 26.7 8.9 19.1 5.9 5.0 18.1 17.4 8.6 5.6 6.9 5.1 7.1 18.9 11.2 15.4 9.8 6.8 9.3 35.0 24.6 19.5 9.7 16.6 13.1 17.7 14.1 24.5 19.2 16.9 21.1 22.0 17.7 19.3 16.6 21.7 19.6 16.2 6.2 16.0 13.1 12.1 19.6 15.0 17.5 20.3 42.4 23.1 18.2 12.2 22.6 13.1 18.7 20.3 17.9 27.2 14.9 11.2 23.8 13.6 6.3 12.7 13.4 20.5 17.4 13.7 32.2 11.6 16.2 12.1 17.9 26.6 0.0 19.0 32.2 14.6 10.7 8.1 12.8 19.3 7.9 33.9 16.0 17.5 7.0 18.4 21.2 8.5 16.2 22.0 17.1 18.2 22.4 18.4 10.6 11.7 6.5 16.4 48.7 18.1 26.3 31.0 27.4 23.1 9.4 CYB5RL LOC606495 ENSG00000215883 "Cytochrome b5 reductase like" Q6IPT4 1 54169651-54200036 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 9.4" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042671, HPA060463" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042671: AB_2678107, HPA060463: AB_2684286" "unprognostic (2.03e-1)" "unprognostic (1.36e-1)" "unprognostic (1.72e-2)" "unprognostic (1.84e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-3)" "unprognostic (1.90e-4)" "unprognostic (6.45e-3)" "unprognostic (9.75e-2)" "unprognostic (2.04e-1)" "unprognostic (5.93e-2)" "unprognostic (2.58e-1)" "unprognostic (2.35e-1)" "unprognostic (1.80e-2)" "unprognostic (5.08e-2)" "unprognostic (5.74e-2)" "unprognostic (2.86e-1)" 1.7 4.9 1.9 0.8 1.9 1.6 2.4 1.3 1.7 2.5 2.2 2.6 2.5 2.3 2.1 2.9 2.0 3.5 2.1 1.7 2.7 2.6 1.5 2.1 2.3 5.0 4.1 1.8 4.2 1.1 2.1 2.7 3.2 1.4 3.7 3.9 1.5 2.4 1.8 2.5 2.8 1.2 3.1 2.2 2.8 1.8 1.4 1.8 2.6 3.5 3.1 1.5 1.2 3.9 5.3 7.3 7.5 5.9 5.7 2.5 3.1 4.5 6.1 6.6 4.9 4.3 6.6 3.7 2.1 13.9 3.6 11.3 3.3 6.9 7.4 4.6 7.5 8.5 5.0 4.4 6.3 3.8 3.0 4.4 7.2 3.3 4.3 5.3 6.0 8.0 3.1 4.4 4.8 6.3 3.5 7.2 4.5 4.2 10.2 8.9 6.0 2.7 4.5 10.7 5.3 2.1 7.2 6.3 6.1 5.0 4.9 2.4 4.7 3.8 6.9 5.5 4.7 7.5 9.7 5.2 13.6 7.1 2.2 1.8 1.6 1.0 3.5 0.8 1.1 1.5 0.6 1.6 1.4 1.2 1.2 2.6 3.1 0.8 1.8 0.5 1.2 0.0 7.4 0.9 1.0 0.1 3.7 4.2 0.0 9.4 4.5 3.5 3.9 1.5 6.6 2.4 0.0 3.6 0.9 0.0 3.6 1.7 1.5 1.1 2.3 2.1 4.6 0.0 2.4 3.1 1.0 0.6 1.4 1.4 0.0 1.0 0.7 2.0 1.3 0.0 1.8 2.2 3.1 0.0 1.4 0.9 5.3 0.6 0.2 0.5 2.4 0.8 CYHR1 "CHRP, KIAA0496, MGC13010" ENSG00000187954 "Cysteine and histidine rich 1" Q6ZMK1 8 144449582-144465677 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053653, HPA059543" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053653: AB_2682219, HPA059543: AB_2684056" "unprognostic (1.04e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.58e-2)" "unprognostic (8.28e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.90e-4)" "unprognostic (4.02e-2)" "unprognostic (2.63e-1)" "unprognostic (2.13e-1)" "unprognostic (7.08e-3)" "unprognostic (1.46e-1)" "unprognostic (5.33e-2)" "unprognostic (1.07e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (1.54e-2)" 18.7 26.9 30.3 10.9 30.2 10.3 15.8 49.5 29.5 19.4 16.6 21.4 40.6 14.7 17.1 25.3 15.3 24.3 17.2 33.4 26.4 20.3 16.4 17.2 14.1 13.9 22.0 21.5 19.3 40.2 29.1 28.2 11.2 22.3 28.3 9.5 16.9 40.4 41.6 35.3 22.9 14.5 17.2 16.1 14.7 16.3 26.9 25.6 10.1 19.5 13.8 11.7 19.6 15.8 10.1 19.1 4.8 8.7 3.3 17.4 7.0 11.4 14.8 9.5 12.1 17.0 11.9 12.3 8.4 8.5 7.9 10.6 6.5 16.3 5.3 17.1 12.5 10.3 17.6 7.8 12.7 3.2 12.7 13.1 11.8 17.3 11.3 24.7 3.1 6.5 20.9 16.3 10.2 12.7 17.2 9.3 14.8 17.9 14.6 7.8 27.4 14.9 8.6 6.4 17.9 30.2 14.4 4.0 13.9 12.1 10.6 14.3 8.6 17.8 14.2 18.7 7.8 19.5 12.8 10.8 10.4 11.4 11.3 8.5 7.4 4.9 4.2 14.8 10.8 7.8 2.1 8.7 4.8 7.2 5.6 11.6 9.7 8.9 5.9 9.0 10.1 17.4 9.6 4.4 3.3 6.2 19.1 3.5 7.0 30.3 30.2 49.5 29.5 26.4 20.3 22.0 21.5 22.3 25.6 32.8 21.6 16.6 38.3 27.1 79.2 16.5 38.2 34.8 27.3 55.8 23.6 26.6 36.5 23.2 7.8 28.7 37.7 0.0 24.8 16.3 32.4 46.0 4.7 42.0 22.3 85.8 32.4 36.8 20.6 29.7 46.9 19.0 25.3 32.5 43.9 110.9 24.4 42.1 37.4 30.5 50.8 38.8 24.7 39.5 25.6 33.9 14.0 19.5 43.5 27.8 DAXX DAP6 ENSG00000204209 "Death domain associated protein" Q9UER7 6 33318558-33323016 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Transcription, Transcription regulation" "Chaperone, Chromatin regulator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002224, HPA008736, HPA008797, CAB025546, HPA065779" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB002224: AB_563688, CAB025546: , HPA008736: AB_1078625, HPA008797: AB_2797218, HPA065779: AB_2685558" "prognostic favorable (6.05e-4)" "unprognostic (2.90e-1)" "unprognostic (9.66e-2)" "unprognostic (4.04e-2)" "unprognostic (8.55e-2)" "unprognostic (1.36e-1)" "unprognostic (1.46e-3)" "unprognostic (3.48e-1)" "unprognostic (1.92e-1)" "unprognostic (8.58e-3)" "unprognostic (1.34e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (6.32e-7)" "unprognostic (2.43e-1)" "unprognostic (5.37e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 10.4 14.3 10.7 13.5 11.9 8.8 10.8 11.3 14.8 11.8 12.2 9.4 7.3 11.2 13.2 43.7 13.5 12.6 12.1 9.1 9.7 7.3 9.2 12.0 10.3 18.3 10.2 8.5 13.8 18.6 24.4 10.4 11.6 11.6 13.0 14.1 7.3 10.7 15.2 14.8 11.6 12.7 15.5 8.1 20.4 10.5 20.2 11.5 25.0 16.1 6.8 30.9 11.5 10.9 17.0 5.9 12.6 11.2 15.3 18.2 21.8 2.1 0.0 7.1 2.8 1.2 2.3 4.7 7.0 22.9 17.9 13.2 0.8 2.4 6.9 2.5 5.4 20.5 1.3 0.1 5.7 16.6 8.2 15.6 9.0 12.4 11.1 3.9 9.6 2.6 6.0 8.5 2.0 5.3 5.3 0.5 4.5 5.0 4.5 5.5 5.2 3.8 21.3 0.4 0.1 3.3 5.9 0.1 7.7 1.4 0.7 8.5 2.2 0.0 0.4 3.7 3.5 2.2 0.2 5.9 4.4 5.6 0.2 0.1 7.8 16.2 14.9 3.3 4.4 4.7 7.8 7.5 12.6 16.3 8.0 18.2 16.6 15.4 15.8 5.9 17.0 13.9 14.1 7.4 15.3 11.2 5.9 17.1 21.8 10.7 11.9 11.3 14.8 9.7 7.3 10.2 8.5 11.6 11.5 6.0 21.4 27.0 17.6 52.0 17.3 7.5 15.3 14.7 25.0 12.2 17.7 21.7 19.9 29.4 9.8 20.6 18.0 0.0 33.3 29.5 26.3 21.9 35.9 13.5 21.9 14.3 20.2 11.6 13.7 4.7 16.4 20.8 23.6 60.5 19.5 17.7 46.9 21.0 21.9 11.9 73.3 12.9 23.7 48.8 34.9 53.2 20.7 51.7 20.9 30.2 DAZAP1 MGC19907 ENSG00000071626 "DAZ associated protein 1" Q96EP5 19 1407569-1435687 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004201, HPA004631" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 1700000 Nucleoplasm Cytosol "HPA004201: AB_1078627, HPA004631: AB_1078626" "unprognostic (1.50e-1)" "unprognostic (3.19e-2)" "unprognostic (7.69e-2)" "unprognostic (2.29e-1)" "unprognostic (7.31e-3)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.86e-4)" "unprognostic (1.83e-1)" "unprognostic (2.30e-1)" "unprognostic (6.13e-2)" "unprognostic (1.09e-1)" "unprognostic (8.11e-3)" "unprognostic (2.72e-3)" "unprognostic (2.40e-3)" "unprognostic (8.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.21e-3)" 22.1 15.0 11.4 33.1 14.2 37.1 32.9 16.1 19.4 15.2 21.4 22.2 17.2 28.3 17.8 11.0 30.9 16.0 13.5 26.7 11.5 9.2 17.1 38.1 18.7 29.2 16.8 12.4 20.7 28.3 11.9 11.4 22.2 13.3 15.9 15.6 16.8 17.0 12.0 31.4 20.2 28.7 17.7 10.9 28.5 22.0 46.8 15.0 43.8 15.9 22.6 21.0 21.4 27.7 7.1 6.1 4.3 7.5 6.5 7.1 3.1 53.2 19.4 13.0 23.7 5.8 7.1 37.4 24.0 12.0 19.7 16.2 19.3 26.4 62.8 14.8 11.7 9.6 30.1 17.2 22.9 16.7 43.9 27.2 32.3 18.6 19.6 13.5 39.1 27.8 7.0 15.1 13.4 24.6 8.4 17.2 26.7 48.1 33.2 12.3 21.8 68.5 34.8 40.2 19.6 19.6 49.4 20.8 38.7 14.8 18.1 25.9 23.3 15.9 25.0 28.9 17.7 22.7 52.2 18.6 16.2 22.0 28.3 52.5 39.3 40.3 49.8 19.6 38.1 24.8 3.2 5.5 4.3 6.5 7.5 7.1 7.1 6.0 6.9 4.9 5.5 6.0 6.4 2.4 6.5 5.2 6.1 6.1 3.1 11.4 14.2 16.1 19.4 11.5 9.2 16.8 12.4 13.3 15.0 8.9 25.1 51.6 76.4 61.6 49.4 34.3 33.1 10.7 18.2 24.4 33.4 33.1 19.9 45.8 41.0 31.5 47.0 23.3 47.1 91.4 34.5 63.8 26.5 38.1 42.1 25.4 31.8 30.7 39.5 45.6 25.9 40.6 38.8 24.4 62.3 27.0 52.0 42.1 22.3 37.7 38.4 25.8 48.4 128.2 37.5 65.5 57.7 39.8 68.9 92.5 DBR1 ENSG00000138231 "Debranching RNA lariats 1" Q9UK59 3 138161012-138174949 "Predicted intracellular proteins" "mRNA processing" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035365 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035365: AB_10611956" "unprognostic (1.20e-1)" "unprognostic (3.72e-2)" "unprognostic (8.48e-3)" "unprognostic (2.04e-2)" "unprognostic (2.83e-1)" "unprognostic (9.40e-2)" "prognostic unfavorable (1.36e-4)" "unprognostic (2.33e-1)" "unprognostic (5.24e-2)" "unprognostic (9.99e-2)" "unprognostic (2.60e-1)" "unprognostic (3.33e-2)" "prognostic favorable (1.36e-4)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (5.35e-2)" "unprognostic (4.79e-2)" 11.8 13.5 9.3 10.0 10.5 20.7 12.2 12.5 10.5 13.3 10.1 14.4 12.8 8.3 15.8 13.6 12.3 11.8 12.4 9.3 9.3 8.9 13.4 12.2 15.3 12.6 11.0 10.5 13.7 15.5 13.1 16.1 9.1 10.0 12.3 10.1 12.7 12.8 10.7 10.8 11.9 12.4 11.6 10.9 17.0 18.3 5.8 12.0 22.3 13.2 7.7 13.6 11.0 12.7 8.3 9.8 14.3 11.2 9.2 13.3 7.0 14.9 6.2 11.3 12.5 6.3 5.9 11.7 8.9 6.5 9.6 11.8 10.4 6.7 13.7 17.0 8.0 14.6 11.1 13.0 4.4 12.7 11.7 10.7 14.8 8.1 8.6 7.7 19.1 13.1 8.1 7.4 8.9 8.4 5.7 7.9 12.0 9.6 3.0 9.7 11.5 18.7 11.3 13.0 11.6 7.3 11.8 12.8 12.5 8.3 14.6 10.9 14.1 23.7 8.3 12.7 9.6 15.6 15.7 7.4 8.2 5.7 15.0 10.2 4.5 6.2 28.7 5.3 13.8 10.5 4.8 8.1 14.3 10.4 11.2 13.3 8.3 11.8 9.9 9.8 8.0 12.1 13.1 3.5 9.2 9.0 6.0 9.5 7.0 9.3 10.5 12.5 10.5 9.3 8.9 11.0 10.5 10.0 12.0 6.0 11.7 7.5 3.0 4.6 5.4 4.3 10.2 5.3 5.7 8.7 0.0 9.2 8.3 9.5 0.0 5.3 3.8 0.0 7.7 8.3 6.9 3.6 5.7 6.4 9.2 6.4 5.8 6.7 16.1 0.0 8.1 5.6 3.3 8.2 5.6 8.9 6.1 5.5 7.8 5.1 4.8 0.0 4.2 4.4 2.1 3.6 3.8 10.1 6.6 2.6 DCAF11 "GL014, PRO2389, WDR23" ENSG00000100897 "DDB1 and CUL4 associated factor 11" Q8TEB1 14 24114195-24125242 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003583, HPA031157" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003583: AB_2667001, HPA031157: AB_10603002" "unprognostic (1.50e-1)" "unprognostic (4.72e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (1.01e-1)" "unprognostic (9.58e-2)" "unprognostic (1.91e-3)" "unprognostic (1.48e-3)" "unprognostic (3.23e-2)" "unprognostic (4.08e-1)" "unprognostic (1.19e-1)" "unprognostic (2.01e-1)" "prognostic favorable (3.50e-13)" "unprognostic (2.58e-1)" "unprognostic (3.48e-1)" "unprognostic (6.80e-2)" "unprognostic (1.68e-1)" 7.6 20.8 14.4 12.1 15.4 21.7 10.3 14.2 23.0 8.1 14.0 11.5 18.7 23.7 8.8 14.1 13.5 10.5 13.6 13.9 14.1 10.9 15.3 56.2 9.8 13.1 12.3 15.5 11.8 42.5 21.1 12.6 8.6 10.4 11.6 11.3 12.3 18.3 19.4 26.8 8.9 25.2 9.5 9.7 14.2 14.4 13.4 9.4 13.1 17.1 13.2 10.5 10.6 7.3 12.8 18.0 20.9 16.5 23.9 17.2 14.8 6.2 10.5 5.1 4.8 5.9 4.7 9.3 5.1 7.8 9.5 8.9 6.6 10.5 11.0 4.9 6.6 6.3 9.1 8.7 7.4 6.4 11.2 5.2 10.5 11.2 33.5 8.0 13.0 14.6 5.2 8.6 4.9 9.6 6.3 6.9 14.5 6.9 11.2 5.5 19.7 12.9 11.3 3.1 17.1 9.5 12.1 9.5 13.0 6.9 16.0 10.9 7.3 4.4 15.2 7.7 5.8 8.9 11.1 3.9 7.1 5.9 5.7 6.1 17.2 16.2 13.4 5.4 10.5 7.9 15.1 15.3 20.9 15.8 16.5 13.7 12.8 14.2 14.4 18.0 12.5 14.7 13.7 13.2 23.9 13.1 9.3 17.2 14.8 14.4 15.4 14.2 23.0 14.1 10.9 12.3 15.5 10.4 9.4 26.8 50.8 26.1 16.7 7.8 34.9 33.5 33.1 20.1 22.7 36.6 45.2 27.4 39.7 34.6 15.9 12.7 79.6 93.5 40.4 26.6 14.9 21.0 11.6 112.5 32.6 15.9 27.7 18.4 19.3 20.4 8.3 16.1 16.9 40.5 34.2 28.5 29.3 33.2 13.8 39.6 26.0 25.8 13.3 12.6 10.2 9.9 42.2 37.0 39.4 17.0 DDB1 ENSG00000167986 "Damage specific DNA binding protein 1" Q16531 11 61299451-61342596 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 331.8;Rod photoreceptor cells: 442.7;Syncytiotrophoblasts: 325.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032821, HPA045174, HPA068456" Approved Enhanced Nucleoplasm NA NA 170000 Nucleoplasm "CAB032821: AB_639050, HPA045174: AB_2679242, HPA068456: AB_2685992" "unprognostic (3.45e-1)" "unprognostic (8.38e-2)" "prognostic favorable (7.09e-4)" "unprognostic (1.21e-1)" "unprognostic (6.56e-2)" "unprognostic (1.19e-2)" "unprognostic (1.11e-2)" "unprognostic (9.33e-2)" "unprognostic (9.74e-3)" "unprognostic (1.09e-1)" "unprognostic (7.42e-3)" "unprognostic (3.11e-1)" "prognostic favorable (1.51e-8)" "unprognostic (3.44e-1)" "unprognostic (1.58e-1)" "unprognostic (7.30e-2)" "unprognostic (1.25e-3)" 19.3 83.3 19.9 14.1 24.9 16.1 19.7 22.9 33.8 21.3 16.2 24.9 33.3 18.4 23.9 30.6 19.8 26.2 17.4 21.1 18.1 20.8 21.7 26.8 16.0 21.7 18.3 23.4 31.1 23.5 107.3 22.0 80.3 27.3 19.4 17.8 33.0 23.9 27.2 57.1 24.1 19.7 20.7 16.7 17.5 19.7 36.1 14.4 33.3 22.1 20.4 21.0 22.6 17.9 19.6 30.5 17.8 23.5 22.0 32.5 23.8 39.3 42.5 41.2 36.1 39.3 37.1 62.0 37.0 47.9 45.0 34.1 45.9 33.3 59.6 33.0 50.6 26.9 36.8 60.5 44.1 48.6 30.1 32.8 34.2 40.7 47.4 27.6 48.8 29.7 43.7 30.3 44.4 38.4 31.4 48.3 25.5 68.7 32.6 39.5 47.8 60.2 23.0 54.7 24.8 36.7 49.7 52.3 62.3 31.4 43.7 36.8 37.5 40.0 46.8 36.8 38.4 58.0 20.7 39.8 32.0 30.2 36.5 26.2 37.6 39.7 52.9 35.3 26.1 30.9 17.8 20.9 17.7 24.8 23.5 32.5 19.6 22.4 24.8 30.5 17.9 20.7 23.1 2.5 22.0 21.0 16.8 24.4 23.8 19.9 24.9 22.9 33.8 18.1 20.8 18.3 23.4 27.3 14.4 26.8 65.3 45.5 43.2 46.8 67.6 79.5 38.2 42.8 48.9 50.6 331.8 218.9 14.9 38.9 12.5 47.4 47.5 0.0 36.5 109.7 39.2 49.2 29.0 61.1 65.3 82.6 71.2 47.3 39.9 13.6 78.9 30.6 40.5 42.3 50.3 62.6 44.2 28.1 58.4 41.7 442.7 32.3 39.2 87.4 115.3 52.2 325.6 38.3 51.6 46.7 DDI2 MGC14844 ENSG00000197312 "DNA damage inducible 1 homolog 2" Q5TDH0 1 15617500-15669044 "Plasma proteins, Predicted intracellular proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043119, HPA043225" Approved Enhanced Nucleoplasm,Cytosol NA NA 170000 "Nucleoplasm, Cytosol" "HPA043119: AB_2678326, HPA043225: AB_2678369" "unprognostic (1.93e-1)" "unprognostic (8.03e-2)" "unprognostic (1.26e-1)" "unprognostic (3.38e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-3)" "unprognostic (3.04e-2)" "unprognostic (1.63e-2)" "unprognostic (3.31e-3)" "unprognostic (8.31e-3)" "unprognostic (1.02e-3)" "unprognostic (2.24e-1)" "unprognostic (1.51e-3)" "unprognostic (7.56e-2)" "unprognostic (1.84e-1)" "unprognostic (7.63e-2)" "unprognostic (3.77e-2)" 14.8 8.1 5.1 10.5 7.1 10.5 15.0 8.7 8.4 8.7 10.8 8.2 9.8 9.0 12.3 9.6 19.4 7.7 8.3 12.5 5.8 4.7 10.4 24.9 10.2 9.1 6.7 5.2 8.3 9.4 14.8 8.0 11.5 7.5 12.1 7.9 11.5 13.5 13.8 54.8 13.3 9.2 8.0 6.5 9.9 6.9 4.3 6.0 11.1 7.6 11.7 16.4 12.1 12.3 3.8 5.4 0.8 2.3 2.0 3.5 1.4 7.5 4.4 8.0 8.3 11.0 8.7 7.8 4.7 3.6 4.2 3.6 10.7 6.9 19.0 5.6 5.2 3.1 8.0 17.4 7.6 7.1 8.7 11.6 14.8 7.4 10.5 4.7 19.6 7.5 8.6 9.1 7.8 8.4 5.2 8.5 12.4 23.8 7.0 5.1 5.1 11.3 6.5 7.6 11.2 3.6 10.7 11.3 11.2 5.9 6.3 9.8 5.4 8.8 14.4 13.1 9.4 7.5 5.1 7.4 6.0 5.2 6.8 5.8 6.6 8.0 15.4 4.7 14.3 4.7 0.7 2.3 0.4 3.3 2.1 2.9 2.6 2.5 2.6 2.3 3.8 2.8 3.5 0.8 2.0 1.6 5.4 2.3 1.4 5.1 7.1 8.7 8.4 5.8 4.7 6.7 5.2 7.5 6.0 8.9 15.2 11.9 12.2 13.6 23.7 23.0 12.7 29.4 22.7 3.5 13.7 17.5 1.7 6.8 1.5 12.1 15.1 46.7 6.6 16.1 13.9 22.6 1.1 54.8 13.2 33.4 14.5 16.0 21.2 0.4 11.8 12.5 15.1 6.4 22.4 8.0 12.5 3.5 6.3 16.5 36.7 6.5 12.3 10.0 7.8 17.7 33.6 12.7 20.1 12.7 DDX21 "GURDB, RH-II/GU" ENSG00000165732 "DExD-box helicase 21" Q9NR30 10 68956128-68985073 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Suprabasal keratinocytes: 515.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036592, HPA036593" Enhanced Enhanced "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No 14000 "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA036592: AB_10673625, HPA036593: AB_2675208" "unprognostic (3.04e-1)" "unprognostic (6.81e-3)" "unprognostic (1.13e-2)" "unprognostic (1.21e-2)" "unprognostic (1.75e-2)" "unprognostic (6.71e-3)" "unprognostic (1.34e-2)" "unprognostic (1.99e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (3.12e-4)" "unprognostic (1.64e-1)" "unprognostic (1.39e-2)" "unprognostic (9.33e-2)" "unprognostic (5.41e-2)" "unprognostic (1.24e-2)" "unprognostic (5.74e-3)" 37.5 16.0 10.0 26.6 13.3 46.8 24.4 8.0 11.8 18.5 20.1 7.2 16.2 13.3 18.7 13.7 28.3 20.1 17.6 19.1 11.4 8.0 25.1 48.0 25.9 24.4 14.9 7.2 30.2 27.9 15.6 20.7 22.8 18.3 14.0 17.6 5.9 18.0 17.8 61.2 22.5 18.5 19.0 20.4 43.5 19.0 12.9 13.3 27.1 18.1 24.1 25.8 33.2 22.4 12.6 11.5 17.1 17.3 7.7 15.0 6.2 33.1 19.7 11.5 35.6 10.4 13.8 24.4 22.8 18.4 29.5 25.1 63.7 22.8 50.0 14.1 18.9 13.9 29.6 44.3 28.4 39.6 15.5 31.2 35.0 14.0 26.4 22.3 83.2 33.3 14.1 37.0 35.2 59.0 13.7 21.4 18.8 66.6 25.0 20.7 15.1 32.6 18.1 31.5 15.8 42.1 29.2 18.9 24.6 19.6 17.9 23.9 25.6 20.5 45.5 26.6 14.5 25.8 17.5 22.0 17.3 24.6 23.2 40.0 28.9 38.2 73.9 14.4 63.2 11.7 5.0 9.7 17.1 8.4 15.0 15.0 12.6 10.9 11.0 11.5 10.4 10.3 11.3 4.5 7.7 17.3 10.8 7.9 6.2 10.0 13.3 8.0 11.8 11.4 8.0 14.9 7.2 18.3 13.3 95.3 139.8 208.1 223.1 488.7 27.0 59.4 112.1 83.0 195.7 68.0 39.3 72.5 61.3 111.8 41.5 139.6 52.0 23.3 160.6 118.9 142.8 222.8 164.0 182.5 102.7 23.8 83.2 113.5 149.3 13.6 82.8 170.5 118.1 66.7 97.0 22.8 171.9 92.1 72.5 73.0 27.4 25.8 155.6 101.9 142.2 515.4 115.0 93.8 113.1 301.9 DDX55 KIAA1595 ENSG00000111364 "DEAD-box helicase 55" Q8NHQ9 12 123602077-123620941 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039962, HPA044101" Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA039962: AB_2676774, HPA044101: AB_2678810" "unprognostic (1.14e-1)" "unprognostic (2.30e-2)" "unprognostic (2.29e-1)" "unprognostic (3.71e-3)" "unprognostic (1.92e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (2.11e-9)" "unprognostic (1.60e-1)" "unprognostic (4.49e-2)" "unprognostic (7.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.67e-3)" "prognostic unfavorable (8.97e-12)" "unprognostic (9.15e-3)" "unprognostic (2.94e-1)" "unprognostic (3.47e-2)" "unprognostic (1.23e-3)" 15.0 13.5 12.3 16.4 14.0 27.7 16.3 21.4 13.9 13.0 13.2 15.7 16.2 12.0 14.7 13.2 14.2 15.0 11.8 8.8 11.4 10.9 10.2 17.8 11.2 19.9 15.6 10.3 17.5 25.9 13.8 20.3 12.3 14.4 14.4 14.5 11.9 15.2 12.6 12.6 21.4 12.9 11.9 10.5 18.8 11.6 11.2 14.8 16.9 12.2 12.5 16.5 11.9 23.1 13.4 12.8 7.3 10.0 12.2 15.7 8.5 10.1 14.5 11.1 11.2 9.6 7.6 16.8 12.6 4.6 11.3 7.8 16.4 7.5 15.1 10.1 5.5 10.2 12.6 16.9 9.4 13.2 11.3 15.3 20.4 16.0 12.1 7.3 25.0 16.1 6.4 10.0 13.4 15.5 8.8 8.1 12.3 20.8 8.0 7.9 10.5 24.5 34.1 17.2 11.8 14.4 18.5 11.9 9.8 7.9 17.7 13.2 11.0 10.3 13.4 17.2 9.7 23.8 16.2 8.3 9.8 12.9 15.9 15.6 14.8 18.3 27.4 9.3 18.0 16.6 2.8 9.2 7.3 12.0 10.0 12.7 13.4 11.6 12.5 7.5 11.3 15.7 14.7 5.6 12.2 5.9 12.8 9.1 8.5 12.3 14.0 21.4 13.9 11.4 10.9 15.6 10.3 14.4 14.8 20.8 11.5 9.0 8.3 9.7 18.5 2.2 7.6 13.4 10.3 7.0 21.6 11.2 6.6 9.6 42.5 10.5 5.1 46.7 10.4 13.9 10.1 8.4 24.3 8.5 12.6 14.3 6.9 6.2 6.6 50.7 15.8 7.9 6.8 4.6 10.5 15.6 11.6 7.0 13.8 5.4 25.4 6.5 8.5 17.9 19.6 14.8 6.4 10.2 8.3 7.8 DEF6 "IBP, SLAT, SWAP70L" ENSG00000023892 "DEF6, guanine nucleotide exchange factor" Q9H4E7 6 35297852-35321771 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.5;lymphoid tissue: 51.7" "Cell type enhanced" "Detected in many" 10 "Hofbauer cells: 76.8;Late spermatids: 127.4;T-cells: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 27.3;MOLT-4: 23.7;NB-4: 31.6;REH: 21.9;THP-1: 25.3;U-937: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038975, HPA038976" Enhanced Enhanced Nucleoplasm Yes NA Nucleoplasm "HPA038975: AB_10697544, HPA038976: AB_10673409" "prognostic favorable (3.02e-6)" "prognostic favorable (1.08e-4)" "prognostic unfavorable (1.71e-4)" "prognostic favorable (2.37e-4)" "unprognostic (1.93e-1)" "unprognostic (3.63e-3)" "unprognostic (2.24e-1)" "unprognostic (1.53e-2)" "unprognostic (1.64e-1)" "unprognostic (2.12e-1)" "unprognostic (2.14e-1)" "unprognostic (6.21e-3)" "prognostic unfavorable (1.02e-8)" "unprognostic (1.78e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (1.45e-3)" 2.9 2.0 4.5 34.8 4.6 30.3 3.4 0.9 3.1 4.3 4.7 6.9 4.7 5.3 3.1 11.1 15.3 2.7 6.8 2.6 3.8 2.7 3.1 2.5 7.5 42.7 5.3 1.0 2.0 16.5 0.7 5.1 4.2 4.8 10.6 4.0 2.9 14.1 6.7 0.9 14.4 15.2 2.4 7.1 32.6 8.3 6.7 5.0 42.6 4.7 9.3 51.7 6.7 8.6 13.9 21.0 43.5 13.8 25.9 31.5 20.7 7.5 0.0 0.2 0.2 0.0 0.1 9.6 0.8 1.2 0.2 0.2 0.4 3.2 9.0 2.7 0.4 0.0 5.0 0.0 6.4 0.1 0.3 0.3 10.1 0.1 4.0 0.2 18.2 13.3 1.5 8.2 0.1 7.4 0.0 0.0 27.3 4.5 21.7 0.0 3.9 23.7 31.6 0.4 0.9 0.9 21.9 0.2 12.1 0.8 5.7 0.1 0.0 0.6 1.9 1.7 0.4 5.2 25.3 1.2 0.1 0.2 0.0 0.1 12.4 11.4 7.5 0.0 37.9 0.0 16.3 13.8 43.5 31.5 11.0 25.8 13.9 25.7 31.0 21.0 12.5 27.1 26.1 26.7 25.9 9.9 13.9 26.9 20.7 4.5 4.6 0.9 3.1 3.8 2.7 5.3 1.0 4.8 5.0 6.0 10.1 30.6 16.6 10.5 2.3 0.5 5.1 2.7 6.8 5.2 0.0 20.5 0.0 0.7 44.9 1.7 2.9 0.0 8.6 14.6 1.5 5.8 17.3 0.5 76.8 3.2 4.1 3.7 28.3 127.4 2.6 28.4 6.8 7.2 8.5 0.8 5.8 10.5 1.8 0.2 1.6 0.0 1.2 4.2 0.7 10.3 10.5 75.9 7.2 12.7 DEK D6S231E ENSG00000124795 "DEK proto-oncogene" P35659 6 18223868-18264823 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB015226, HPA054505, HPA057799" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB015226: , HPA054505: AB_2682508, HPA057799: AB_2683530" "unprognostic (6.35e-2)" "unprognostic (6.11e-2)" "unprognostic (5.04e-3)" "unprognostic (1.40e-2)" "unprognostic (3.66e-1)" "unprognostic (5.02e-3)" "prognostic unfavorable (9.65e-4)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (1.61e-3)" "unprognostic (6.49e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (3.45e-4)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (2.31e-1)" "unprognostic (3.78e-1)" 30.9 20.0 22.9 41.8 29.5 50.8 28.9 41.5 30.2 31.0 35.8 11.4 24.0 28.2 32.9 19.7 31.0 23.8 19.2 33.5 26.8 14.1 19.3 23.8 29.2 42.7 30.7 17.6 28.3 19.3 20.5 27.8 24.3 27.7 33.9 29.9 11.0 26.8 21.4 40.2 23.2 35.9 51.3 28.1 29.8 24.2 12.6 32.9 58.8 44.9 33.9 38.4 45.1 43.3 40.0 40.2 57.7 49.3 34.0 46.3 35.0 60.9 18.0 47.6 39.7 9.6 16.7 27.7 56.2 31.0 50.7 68.8 29.4 22.9 69.4 59.6 25.3 40.8 36.6 35.2 27.9 85.4 46.7 33.6 42.9 32.3 34.2 9.3 65.3 34.9 8.2 13.9 35.0 27.7 24.0 24.2 25.6 52.1 0.0 32.3 21.9 47.1 29.3 29.2 24.3 20.1 62.8 63.2 40.7 24.4 35.3 29.2 26.8 50.7 44.1 30.6 32.6 39.6 26.9 24.6 59.5 33.0 33.1 69.9 4.2 10.2 73.2 14.2 33.3 55.1 51.1 49.3 21.9 41.4 39.3 46.3 40.0 42.1 42.5 40.2 33.2 33.5 32.0 57.7 34.0 43.9 31.0 40.6 35.0 22.9 29.5 41.5 30.2 26.8 14.1 30.7 17.6 27.7 32.9 113.2 133.1 112.0 157.1 241.0 64.8 174.2 152.8 109.7 146.7 75.0 76.6 208.5 69.6 136.5 15.9 140.0 115.1 443.9 150.2 201.0 139.1 206.8 105.4 107.1 166.8 25.4 84.9 75.5 163.3 15.6 175.4 212.2 96.2 259.7 117.1 119.5 110.8 110.4 180.0 82.7 127.2 207.0 187.2 63.1 177.2 204.1 90.8 150.3 203.5 166.1 DENND2C "dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1" ENSG00000175984 "DENN domain containing 2C" Q68D51 1 114582848-114670422 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.7;skeletal muscle: 31.1" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 99.0;Basal keratinocytes: 97.0;Suprabasal keratinocytes: 150.2;Urothelial cells: 270.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 6.1;eosinophil: 2.1" "Lineage enriched" "Detected in single" 9 "granulocytes: 6.1" "Cell line enhanced" "Detected in many" "U-2197: 10.3;U-266/70: 22.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA029935, HPA054955" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029935: AB_10601208, HPA054955: AB_2682648" "unprognostic (2.25e-1)" "unprognostic (1.08e-1)" "unprognostic (9.97e-2)" "unprognostic (4.89e-4)" "unprognostic (1.52e-1)" "unprognostic (2.46e-1)" "unprognostic (2.53e-1)" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (6.61e-2)" "unprognostic (2.20e-2)" "unprognostic (7.43e-2)" "unprognostic (2.77e-2)" "unprognostic (2.24e-2)" "unprognostic (6.11e-2)" "unprognostic (3.64e-2)" "unprognostic (1.57e-2)" 1.9 0.7 1.5 0.7 1.5 0.8 1.7 1.4 1.1 8.6 1.1 0.5 0.8 0.6 4.2 1.7 28.7 1.0 1.1 1.5 1.3 0.5 0.8 2.1 1.7 1.7 0.6 0.3 1.1 4.0 2.4 3.6 0.3 1.9 2.5 0.6 1.6 3.0 1.4 31.1 10.6 0.6 2.4 0.6 0.5 0.8 4.5 0.2 0.0 1.3 16.0 10.4 6.2 6.6 0.6 0.1 6.1 0.2 0.3 0.5 0.3 1.7 0.0 0.1 1.2 1.5 1.7 0.3 0.5 0.9 0.6 0.9 0.2 0.0 0.0 0.8 3.5 1.2 6.5 1.2 4.0 0.6 0.0 1.6 1.0 0.4 0.1 0.5 0.0 1.6 1.7 3.9 2.4 2.0 0.1 0.2 0.4 0.1 0.3 2.1 5.1 0.2 0.1 0.8 0.0 0.9 0.0 5.5 0.1 0.1 4.9 0.0 0.0 3.9 0.1 0.4 1.1 0.8 0.3 0.2 0.9 1.3 10.3 0.1 22.5 4.0 0.0 0.9 0.0 0.7 6.1 0.2 2.1 0.5 0.0 0.5 0.6 0.1 0.4 0.0 0.4 0.3 0.2 0.5 0.3 0.1 0.1 0.2 0.3 1.5 1.5 1.4 1.1 1.3 0.5 0.6 0.3 1.9 0.2 26.8 2.1 0.0 99.0 97.0 21.6 6.9 12.7 20.1 4.5 7.0 19.6 0.1 0.0 5.6 23.7 8.7 0.0 0.0 6.4 0.0 5.3 46.7 2.3 11.0 0.2 0.0 0.0 13.5 3.4 9.1 4.6 1.6 6.8 1.0 0.8 2.0 20.3 0.0 2.1 0.6 8.7 0.0 8.5 23.4 49.0 150.2 0.0 0.7 0.5 270.3 DIS3 "dis3p, EXOSC11, KIAA1008, RRP44" ENSG00000083520 "DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease" Q9Y2L1 13 72752169-72782096 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "rRNA processing" "Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 123.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039281, HPA058762" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039281: AB_10795583, HPA058762: AB_2683810" "unprognostic (1.61e-1)" "unprognostic (1.52e-1)" "unprognostic (1.18e-1)" "unprognostic (8.97e-2)" "unprognostic (8.14e-2)" "unprognostic (1.51e-2)" "unprognostic (1.49e-1)" "unprognostic (2.84e-1)" "unprognostic (6.38e-2)" "unprognostic (8.68e-2)" "unprognostic (1.32e-3)" "unprognostic (3.35e-3)" "unprognostic (1.02e-1)" "unprognostic (2.37e-2)" "unprognostic (3.69e-2)" "unprognostic (7.88e-2)" "unprognostic (1.03e-1)" 25.5 14.7 11.7 17.6 24.8 23.8 22.4 23.4 19.4 20.3 18.8 11.6 17.0 11.8 18.0 19.3 23.1 17.8 16.0 21.6 12.4 13.6 20.2 25.6 19.3 22.2 13.9 17.0 23.4 15.3 15.8 22.8 26.3 18.7 18.0 15.6 9.8 17.4 19.3 19.9 17.3 17.9 17.5 12.9 22.8 16.2 27.7 14.6 23.7 21.3 19.1 23.0 26.7 19.3 6.9 6.8 11.1 9.7 10.3 10.0 5.0 15.7 7.4 14.5 12.2 15.5 18.5 9.6 14.1 17.2 14.4 17.7 11.2 13.2 19.2 12.3 14.4 9.1 13.1 19.8 16.2 23.4 15.7 14.6 22.5 15.8 10.1 19.3 38.0 13.1 19.3 11.4 16.3 21.6 14.4 15.4 14.7 15.0 8.1 17.5 5.5 16.1 18.7 13.6 24.1 8.7 13.0 11.1 8.7 14.4 12.7 13.1 17.3 11.5 9.7 13.6 15.8 9.3 17.4 14.3 8.7 7.1 9.8 14.8 15.6 17.5 15.4 24.4 18.1 12.6 11.1 5.5 7.8 6.5 9.7 9.4 6.9 8.5 7.3 6.8 6.0 8.1 7.6 3.4 10.3 7.6 4.3 10.0 5.0 11.7 24.8 23.4 19.4 12.4 13.6 13.9 17.0 18.7 14.6 32.8 30.4 16.8 29.7 22.7 38.6 24.2 25.5 37.5 45.5 8.7 27.5 20.7 19.9 16.8 123.4 38.3 15.1 0.0 17.3 19.4 13.5 23.6 32.4 21.2 12.8 30.2 29.2 25.2 16.2 100.0 26.7 13.6 11.8 31.5 15.2 20.6 18.9 2.9 26.5 13.6 39.7 6.5 19.6 23.7 35.3 27.4 18.9 21.0 18.6 45.4 DNAJB4 HLJ1 ENSG00000162616 "DnaJ heat shock protein family (Hsp40) member B4" Q9UDY4 1 77979175-78017964 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 89.8" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 151.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 28.6;HUVEC TERT2: 43.5;LHCN-M2: 73.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004995, HPA028383, HPA028385" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944" "unprognostic (1.21e-1)" "unprognostic (4.36e-2)" "unprognostic (2.19e-1)" "unprognostic (5.50e-3)" "unprognostic (3.40e-2)" "unprognostic (4.76e-3)" "unprognostic (4.32e-3)" "unprognostic (3.93e-3)" "unprognostic (1.53e-1)" "unprognostic (2.16e-1)" "unprognostic (2.00e-1)" "unprognostic (3.22e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.60e-2)" "unprognostic (1.51e-1)" "unprognostic (7.12e-3)" "unprognostic (1.01e-2)" 23.3 39.0 19.2 8.4 20.7 4.9 16.6 22.7 24.1 21.3 12.7 7.2 9.3 5.4 20.8 10.1 25.0 11.7 25.2 42.0 18.0 16.8 16.0 15.5 21.7 7.0 25.7 9.1 15.3 18.5 16.4 19.1 19.5 23.8 19.4 9.4 5.1 7.0 12.2 33.3 7.6 8.8 23.0 29.5 30.3 11.9 7.8 22.5 2.8 35.1 29.4 5.1 22.1 89.8 3.6 5.0 4.5 1.9 3.1 7.2 2.6 1.4 2.8 3.5 2.1 15.3 28.6 1.6 27.8 7.1 12.4 14.0 0.9 1.8 2.1 4.7 13.2 5.1 2.1 4.5 2.4 21.2 2.3 1.2 1.0 8.3 6.7 20.8 0.5 0.5 11.8 6.7 16.0 4.6 6.9 43.5 0.7 4.5 1.5 73.8 0.1 0.6 1.5 2.2 0.4 1.3 1.1 6.2 1.3 2.9 0.7 2.5 0.8 3.2 2.3 2.6 3.8 0.9 0.9 20.7 17.5 4.3 12.4 3.6 1.3 0.4 1.8 2.3 1.2 3.0 4.5 1.7 2.7 2.6 1.7 4.4 3.6 3.2 3.1 1.7 3.0 7.2 5.1 0.4 3.1 1.9 5.0 4.2 2.6 19.2 20.7 22.7 24.1 18.0 16.8 25.7 9.1 23.8 22.5 56.6 4.6 13.3 77.1 37.1 28.0 82.6 10.2 30.8 20.5 17.4 64.8 46.9 31.5 10.5 126.4 66.1 19.8 23.3 12.8 18.9 83.6 23.4 57.5 18.1 15.9 28.6 20.5 33.2 21.3 48.4 22.7 19.0 62.4 6.4 4.0 35.7 14.8 17.5 32.9 22.8 56.8 25.8 119.1 21.1 13.2 34.4 151.4 15.2 6.5 27.1 DNAJB6 "LGMD1D, MRJ" ENSG00000105993 "DnaJ heat shock protein family (Hsp40) member B6" O75190 7 157335381-157417439 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Suprabasal keratinocytes: 839.6;Urothelial cells: 816.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004670, HPA024258, HPA058593" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: AB_2683767" "unprognostic (4.37e-1)" "unprognostic (1.62e-2)" "unprognostic (3.22e-2)" "unprognostic (9.26e-3)" "unprognostic (6.66e-3)" "unprognostic (4.68e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.01e-2)" "unprognostic (8.41e-2)" "unprognostic (3.19e-1)" "unprognostic (6.33e-2)" "unprognostic (2.24e-1)" "unprognostic (1.54e-1)" "unprognostic (6.45e-2)" "unprognostic (1.52e-1)" 24.0 23.1 38.0 17.9 35.0 51.3 40.5 42.2 41.3 17.1 25.5 21.7 19.1 14.5 23.3 38.8 33.2 20.9 17.3 37.0 31.7 32.2 24.5 16.7 19.4 16.4 37.6 32.2 22.8 18.8 17.2 20.2 24.4 37.7 19.5 17.2 15.3 20.1 25.6 96.9 34.2 15.6 31.7 33.9 17.2 16.8 38.3 35.2 12.2 17.9 23.5 21.9 23.4 51.9 32.7 30.4 74.3 48.1 35.5 42.1 55.0 37.8 23.0 28.0 28.3 28.4 25.8 25.9 42.6 34.9 39.7 43.6 31.3 38.3 14.6 80.3 31.5 36.1 24.3 19.0 29.8 61.6 29.2 26.0 26.1 13.9 22.1 26.2 19.3 22.0 22.6 28.9 30.0 14.3 39.9 29.5 15.7 42.3 14.6 50.8 25.7 48.2 38.1 56.0 26.8 30.7 26.0 20.2 20.3 32.7 23.2 16.9 44.7 33.3 26.1 31.1 60.4 19.0 27.4 36.7 25.1 19.1 59.7 36.6 28.0 39.9 17.1 35.7 44.5 31.7 70.6 41.5 48.8 36.2 41.6 36.1 32.7 33.2 37.2 30.4 28.1 42.1 39.3 74.3 35.5 48.1 27.6 38.9 55.0 38.0 35.0 42.2 41.3 31.7 32.2 37.6 32.2 37.7 35.2 44.7 57.9 61.6 535.0 672.2 87.1 103.2 40.8 135.1 83.0 92.5 76.6 239.3 164.2 120.8 82.9 125.4 92.1 46.7 61.0 198.1 160.4 315.0 212.0 42.7 149.9 89.0 185.4 94.5 124.0 94.1 139.8 162.9 268.2 444.6 63.2 102.0 105.0 73.7 190.2 165.4 87.6 97.0 208.1 297.0 373.7 839.6 425.0 152.3 79.1 816.5 DNAJC8 SPF31 ENSG00000126698 "DnaJ heat shock protein family (Hsp40) member C8" O75937 1 28199456-28233025 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026275, HPA026283" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA026275: AB_2671823, HPA026283: AB_10600907" "unprognostic (1.42e-1)" "unprognostic (2.44e-2)" "unprognostic (5.71e-2)" "prognostic favorable (6.95e-5)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (4.71e-4)" "unprognostic (2.54e-1)" "unprognostic (3.07e-3)" "unprognostic (9.57e-2)" "unprognostic (3.93e-1)" "unprognostic (1.65e-1)" "unprognostic (1.23e-1)" "unprognostic (1.72e-1)" "unprognostic (5.50e-2)" "prognostic favorable (2.39e-4)" "unprognostic (4.84e-2)" 27.3 26.9 35.9 27.8 40.1 27.5 27.7 33.6 40.7 26.3 27.2 33.6 15.8 22.6 33.1 25.9 24.5 23.6 22.5 30.5 31.2 31.7 29.0 29.1 23.4 38.5 34.2 32.5 32.0 15.0 20.0 23.8 32.4 38.2 30.0 25.4 21.4 20.7 26.1 26.4 21.8 21.8 36.0 33.0 30.3 22.3 15.7 36.0 30.8 35.1 19.9 42.8 29.6 27.7 31.9 34.8 29.6 30.8 29.6 37.0 44.0 24.9 12.9 20.4 23.4 24.7 20.3 18.2 20.8 26.0 42.0 38.6 13.5 20.4 28.7 21.6 23.1 20.8 15.5 29.9 20.4 44.6 22.5 22.2 36.8 19.8 23.9 22.3 36.2 30.4 15.5 18.3 26.5 14.0 19.8 27.8 23.9 34.3 20.2 30.6 14.5 27.5 25.4 36.9 15.6 15.0 31.3 30.2 27.5 26.7 20.6 7.4 19.1 27.3 11.7 24.6 15.8 16.8 29.6 21.3 18.8 20.4 41.9 30.9 19.2 25.1 45.1 25.2 44.3 25.4 29.6 30.5 27.8 37.0 29.3 37.0 31.9 33.5 36.1 33.1 30.7 33.6 34.1 16.2 29.6 30.8 34.8 35.1 44.0 35.9 40.1 33.6 40.7 31.2 31.7 34.2 32.5 38.2 36.0 71.5 77.9 119.9 114.0 115.2 95.1 130.7 76.5 89.7 100.1 101.2 23.6 164.5 228.8 122.3 29.6 126.6 51.6 70.0 85.7 129.7 132.6 93.6 134.3 64.5 156.1 65.2 44.2 86.5 68.5 31.5 111.7 136.1 97.8 171.3 45.8 156.0 94.7 57.5 135.4 133.6 90.4 84.1 106.1 126.5 83.5 96.4 187.4 117.7 62.3 94.7 DOCK1 "ced5, DOCK180" ENSG00000150760 "Dedicator of cytokinesis 1" Q14185 10 126905409-127452517 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 1.5;plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004378, HPA048692, HPA053277" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004378: AB_2094604, HPA048692: AB_2680495, HPA053277: AB_2682097" "unprognostic (4.27e-2)" "unprognostic (4.22e-3)" "unprognostic (1.49e-3)" "unprognostic (8.98e-3)" "unprognostic (2.57e-2)" "unprognostic (3.31e-1)" "unprognostic (4.12e-1)" "unprognostic (4.80e-2)" "unprognostic (6.85e-2)" "unprognostic (1.55e-1)" "unprognostic (2.75e-2)" "unprognostic (2.42e-1)" "unprognostic (2.61e-3)" "unprognostic (1.87e-1)" "unprognostic (3.85e-2)" "unprognostic (1.18e-1)" "unprognostic (4.83e-2)" 17.1 7.7 27.4 8.1 36.8 1.0 17.4 6.9 25.4 23.5 12.5 27.4 14.3 12.2 18.3 18.0 13.8 17.6 16.2 12.9 24.4 17.8 18.9 9.0 12.8 8.0 34.5 11.4 24.2 12.1 38.6 5.3 17.9 25.0 16.1 13.0 9.4 15.4 18.3 9.7 30.0 13.6 21.2 25.4 8.7 11.0 6.6 32.3 2.2 25.1 9.1 5.5 14.5 18.5 0.0 2.3 0.0 0.7 0.8 0.0 0.0 6.4 12.3 24.0 17.0 12.3 16.6 5.3 12.9 27.3 9.2 9.8 7.6 7.4 0.0 4.3 19.0 8.4 7.3 7.6 9.6 10.8 0.1 7.3 4.0 8.1 8.9 12.1 0.0 6.0 13.4 2.9 9.5 20.7 22.0 21.1 0.0 0.0 0.0 13.8 6.4 0.0 0.0 5.9 4.9 5.5 0.0 15.7 0.1 9.1 7.1 1.4 10.2 13.5 7.6 12.0 17.7 1.9 0.0 22.0 16.6 6.6 4.2 12.3 0.0 0.0 0.0 13.3 0.0 10.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 0.0 2.3 0.0 0.0 27.4 36.8 6.9 25.4 24.4 17.8 34.5 11.4 25.0 32.3 29.8 16.9 0.0 12.4 15.2 0.0 10.1 7.6 25.4 23.9 21.0 0.0 12.0 0.0 11.0 9.3 21.5 15.7 0.0 6.2 10.1 12.7 11.5 0.0 7.3 4.9 0.0 5.2 27.0 4.5 18.9 30.2 4.9 6.8 3.6 14.8 7.1 11.6 7.0 34.3 7.8 1.3 12.9 13.4 1.8 7.9 14.2 10.5 0.5 11.7 8.8 DOK7 "C4orf25, Dok-7, FLJ33718, FLJ39137" ENSG00000175920 "Docking protein 7" Q18PE1 4 3463311-3501473 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 19.1;skeletal muscle: 17.0" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 11.9;Collecting duct cells: 5.2;Early spermatids: 5.5;Intestinal endocrine cells: 5.8;Late spermatids: 4.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.0" "Group enriched" "Detected in some" 8 "cerebellum: 8.7;pons and medulla: 2.5" "Group enriched" "Detected in some" 14 "memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2" "Group enriched" "Detected in many" 15 "B-cells: 6.3;NK-cells: 3.2" "Cell line enriched" "Detected in some" 4 "MCF7: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059449, HPA062780" Approved Enhanced Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA059449: AB_2684023, HPA062780: AB_2732688" "prognostic favorable (8.45e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-2)" "prognostic favorable (2.19e-4)" "unprognostic (5.96e-2)" "unprognostic (6.80e-3)" "unprognostic (1.05e-2)" "unprognostic (9.54e-2)" "unprognostic (1.12e-2)" "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-4)" "unprognostic (4.61e-3)" "unprognostic (5.09e-1)" "unprognostic (3.16e-2)" "prognostic favorable (1.28e-4)" 1.2 0.5 0.1 0.2 0.2 0.2 0.5 8.7 0.7 1.5 0.3 1.4 0.1 0.1 1.3 4.7 1.1 5.0 3.7 19.1 0.4 0.6 1.4 0.4 1.7 0.7 0.1 0.1 1.3 4.3 0.0 9.7 0.1 2.5 0.7 0.1 2.4 2.0 6.4 17.0 0.3 0.1 0.7 0.1 0.6 2.2 5.3 0.4 0.1 0.6 1.8 0.6 0.6 0.1 6.3 0.0 0.0 0.0 3.2 0.3 0.2 2.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.9 0.0 0.1 1.0 0.0 3.5 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 27.8 0.0 1.1 0.2 1.2 0.1 0.0 5.4 0.2 1.8 2.4 0.5 0.1 2.3 0.0 0.0 0.0 6.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.3 0.0 3.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.2 0.1 0.2 8.7 0.7 0.4 0.6 0.1 0.1 2.5 0.4 0.0 1.0 0.0 3.2 0.0 0.2 11.9 0.0 1.4 4.5 5.2 0.0 0.0 0.0 1.9 5.5 0.0 0.0 0.0 3.8 0.0 0.3 1.8 0.0 0.0 0.1 0.0 5.8 0.0 0.0 4.8 0.9 0.0 0.0 0.0 2.1 0.0 1.3 0.0 0.0 0.4 0.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.7 DOT1L "DOT1, KIAA1814, KMT4" ENSG00000104885 "DOT1 like histone lysine methyltransferase" Q8TEK3 19 2164149-2232578 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.7" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011875, HPA071217, HPA074977" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA011875: AB_2668552, HPA071217: AB_2686364, HPA074977: " "unprognostic (1.41e-2)" "unprognostic (1.44e-1)" "unprognostic (2.26e-1)" "prognostic favorable (1.69e-4)" "unprognostic (1.08e-1)" "prognostic favorable (6.00e-4)" "unprognostic (2.53e-3)" "unprognostic (2.21e-1)" "unprognostic (1.57e-2)" "unprognostic (1.67e-2)" "unprognostic (5.25e-3)" "unprognostic (8.18e-3)" "unprognostic (2.56e-1)" "unprognostic (1.73e-3)" "unprognostic (1.43e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" 7.3 8.8 7.0 10.7 11.7 20.1 5.1 20.6 11.7 4.5 7.9 9.8 6.0 13.5 6.4 4.9 8.3 5.4 6.9 5.7 7.0 3.6 9.5 8.5 10.0 8.4 11.9 5.3 6.5 10.8 3.6 8.3 11.6 7.1 5.7 4.9 9.5 6.1 7.4 9.8 9.9 13.0 4.2 6.7 10.4 13.3 64.7 9.7 10.5 9.2 7.0 9.1 4.8 5.3 0.7 1.0 3.0 0.9 2.8 1.4 0.6 12.2 6.6 22.4 12.2 1.7 2.5 29.5 7.0 1.5 3.8 3.1 8.4 4.6 14.4 3.4 4.5 3.3 11.0 7.4 3.9 1.8 7.3 9.3 13.2 10.8 8.2 2.7 18.9 24.4 2.4 2.9 7.4 3.8 3.1 3.1 8.2 16.0 15.1 3.0 7.0 15.1 20.9 17.3 7.8 11.8 15.6 6.3 9.9 2.1 5.8 15.0 11.6 4.9 14.6 9.2 6.2 6.7 14.5 4.4 10.7 9.8 15.8 13.4 14.0 18.3 10.0 10.6 13.1 6.2 0.5 0.7 3.0 0.9 0.3 1.4 0.7 0.8 0.2 0.9 0.7 0.5 0.3 0.3 2.8 0.9 1.0 0.1 0.6 7.0 11.7 20.6 11.7 7.0 3.6 11.9 5.3 7.1 9.7 29.8 18.9 9.9 9.3 15.8 25.0 5.2 20.4 6.7 6.8 8.7 62.8 5.3 3.3 10.1 25.8 7.1 25.4 0.0 10.4 11.3 11.0 12.4 5.8 13.1 9.3 12.7 20.0 6.7 11.9 11.9 2.8 14.6 11.8 5.4 10.8 7.3 14.1 14.0 3.2 2.2 26.6 0.0 8.1 28.3 23.5 17.3 13.6 4.9 11.7 14.2 DPF3 "BAF45c, cer-d4, Cerd4, FLJ14079" ENSG00000205683 "Double PHD fingers 3" Q92784 14 72619296-72894116 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.3;skeletal muscle: 28.4" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 33.3;Cone photoreceptor cells: 102.1;Early spermatids: 36.1;Rod photoreceptor cells: 86.0" "Cancer enhanced" "Detected in some" "glioma: 3.2" "Region enriched" "Detected in all" 5 "cerebellum: 56.3" "Cell type enhanced" "Detected in some" "memory B-cell: 1.1;naive B-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 13.7;BJ hTERT+ SV40 Large T+: 9.4;HEL: 23.3;Karpas-707: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA066790, HPA070601" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA066790: AB_2685724, HPA070601: AB_2686284" "unprognostic (2.38e-2)" "unprognostic (2.96e-1)" "unprognostic (3.25e-1)" "unprognostic (1.56e-2)" "unprognostic (1.55e-1)" "unprognostic (9.98e-2)" "unprognostic (4.80e-2)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (3.54e-2)" "unprognostic (9.71e-3)" "unprognostic (1.02e-1)" "unprognostic (2.02e-1)" "unprognostic (3.85e-3)" "unprognostic (4.08e-2)" "unprognostic (4.80e-2)" "unprognostic (1.96e-1)" 0.7 2.2 6.2 1.1 10.3 3.2 0.8 56.3 7.6 0.9 2.7 8.4 0.0 0.8 0.8 0.5 1.2 0.7 1.0 16.8 6.4 2.5 2.2 4.3 0.8 1.5 8.9 4.5 17.8 0.7 8.4 0.9 0.9 10.4 0.7 2.4 3.4 0.8 0.7 28.4 1.1 1.7 1.2 10.1 1.4 1.1 6.6 10.7 0.0 0.8 6.3 1.8 0.8 0.7 1.9 0.0 0.0 0.3 0.4 0.8 0.2 1.5 0.0 1.2 0.1 0.2 2.3 13.7 4.1 3.9 9.4 3.6 0.0 0.1 0.2 0.2 1.2 0.2 0.1 1.3 0.6 5.8 0.2 0.5 23.3 0.1 0.0 0.3 0.1 0.4 0.6 0.2 2.2 1.6 1.6 3.0 2.5 2.0 9.5 3.0 0.1 1.9 0.2 0.0 0.0 1.3 5.1 0.6 0.3 1.6 0.0 0.9 0.5 0.0 0.1 0.0 0.4 0.0 0.0 6.5 4.6 0.0 1.7 0.5 3.4 0.9 0.3 0.4 0.9 0.1 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.2 6.2 10.3 56.3 7.6 6.4 2.5 8.9 4.5 10.4 10.7 0.0 0.0 0.9 0.0 0.6 4.7 33.3 0.0 0.0 0.0 0.0 102.1 2.2 1.7 0.0 36.1 1.8 3.9 23.3 0.3 1.2 0.8 0.1 4.6 4.2 0.4 6.4 0.0 0.6 1.5 22.2 0.3 0.9 0.0 0.0 3.3 8.1 0.5 4.0 4.6 9.9 86.0 0.0 0.8 1.7 0.7 0.3 0.1 2.5 6.3 0.0 DPH6 "ATPBD4, MGC14798" ENSG00000134146 "Diphthamine biosynthesis 6" Q7L8W6 15 35217345-35546193 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042976, HPA055496" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA042976: AB_10964890, HPA055496: AB_2682835" "unprognostic (9.78e-2)" "unprognostic (1.45e-1)" "unprognostic (1.92e-1)" "unprognostic (1.14e-1)" "unprognostic (1.82e-1)" "unprognostic (1.45e-2)" "unprognostic (1.60e-1)" "unprognostic (9.94e-2)" "unprognostic (1.76e-1)" "unprognostic (1.49e-3)" "unprognostic (7.92e-3)" "unprognostic (1.13e-1)" "unprognostic (4.65e-6)" "unprognostic (9.70e-2)" "unprognostic (5.61e-2)" "unprognostic (2.18e-2)" "unprognostic (7.44e-2)" 13.3 12.7 8.0 6.8 16.1 6.4 15.3 11.6 15.8 14.7 9.2 15.5 10.8 8.5 23.9 17.1 14.7 11.5 10.5 14.4 7.8 7.2 14.7 11.2 8.7 9.3 9.7 12.0 16.7 19.5 15.8 31.7 11.1 13.4 8.5 10.2 14.6 11.5 14.7 24.9 15.2 8.7 16.8 11.1 8.3 9.6 11.3 10.6 7.1 15.3 16.5 10.0 11.0 11.3 8.4 6.3 0.3 6.5 13.2 10.8 4.4 10.5 5.7 9.6 8.1 1.7 7.9 9.4 4.0 7.0 9.7 5.1 7.6 9.9 3.3 9.8 3.7 11.8 12.2 11.1 11.5 11.6 2.6 7.0 12.3 6.5 12.0 10.3 6.5 8.0 6.6 14.6 3.9 18.9 6.0 9.3 7.1 13.5 13.4 8.9 4.1 8.0 6.1 8.5 16.1 5.3 10.0 9.0 4.5 8.4 13.5 7.0 6.9 7.5 8.4 6.4 5.9 29.0 9.1 2.8 9.5 9.2 9.4 6.3 12.0 19.0 8.3 8.2 11.3 9.0 0.0 6.5 0.3 6.2 6.0 7.7 8.4 8.3 8.6 6.3 6.5 10.8 9.5 0.3 13.2 5.6 5.4 5.4 4.4 8.0 16.1 11.6 15.8 7.8 7.2 9.7 12.0 13.4 10.6 14.9 6.9 12.6 16.6 27.5 31.5 11.0 17.8 5.3 17.0 8.7 37.3 22.9 11.6 12.0 2.1 9.5 10.1 23.3 21.1 18.8 11.6 7.6 3.5 7.3 15.0 17.5 5.2 6.7 10.0 1.6 13.0 10.9 15.1 15.4 6.0 16.6 15.1 7.0 6.3 16.4 22.2 0.0 11.3 8.3 15.1 20.3 18.9 5.0 9.2 11.1 DVL2 ENSG00000004975 "Dishevelled segment polarity protein 2" O14641 17 7225341-7234545 "Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009312, HPA021611, HPA022914, HPA064732" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB009312: AB_639776, HPA021611: AB_2670776, HPA022914: AB_1847683, HPA064732: AB_2685338" "unprognostic (7.63e-3)" "unprognostic (6.84e-2)" "unprognostic (1.20e-1)" "unprognostic (1.60e-1)" "unprognostic (1.44e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (4.34e-6)" "unprognostic (5.66e-2)" "unprognostic (8.01e-2)" "unprognostic (8.97e-2)" "prognostic favorable (3.85e-4)" "unprognostic (8.90e-2)" "unprognostic (1.28e-1)" "unprognostic (3.23e-1)" "unprognostic (2.30e-1)" "unprognostic (2.80e-1)" "unprognostic (5.45e-2)" 14.6 16.7 16.9 11.0 24.6 12.5 14.2 22.3 16.2 20.2 15.7 20.0 12.3 12.6 24.3 12.3 22.6 18.0 15.3 12.8 14.5 8.2 13.2 7.8 12.2 14.8 16.7 12.3 30.6 12.7 15.7 26.3 14.9 12.5 18.9 8.6 18.9 14.4 19.3 11.9 21.2 12.9 18.2 10.9 12.7 11.4 14.5 17.0 24.6 16.1 9.5 16.3 16.7 19.7 11.7 7.8 11.6 5.4 7.2 12.1 6.9 13.1 19.2 23.1 23.0 17.7 16.0 10.0 9.2 16.8 22.3 28.6 16.3 11.2 18.8 14.0 10.2 17.4 19.0 19.1 12.4 8.5 18.5 22.0 12.2 20.4 17.1 31.1 6.8 10.6 24.0 21.4 21.1 11.5 15.6 9.2 22.0 10.3 8.9 13.3 12.3 25.9 6.8 7.9 8.8 7.4 38.2 15.0 11.4 12.2 11.7 10.2 20.8 16.7 8.4 20.1 11.0 12.1 9.5 7.6 12.6 11.4 23.5 17.0 13.9 11.6 8.6 14.7 10.3 19.5 11.6 4.7 10.7 12.1 5.4 10.1 10.4 8.3 10.7 5.6 11.7 9.9 10.1 2.1 7.2 5.1 7.8 5.0 6.9 16.9 24.6 22.3 16.2 14.5 8.2 16.7 12.3 12.5 17.0 8.9 8.9 5.7 20.2 15.5 14.9 5.6 7.6 5.3 9.1 17.4 23.6 17.9 5.0 9.3 0.7 9.0 9.3 0.0 9.0 13.9 17.8 13.7 14.9 4.3 12.2 9.5 12.7 7.4 8.2 1.5 24.2 7.4 10.1 12.6 13.0 12.8 6.9 10.5 20.8 4.2 30.2 12.9 11.3 18.9 30.6 16.8 30.6 10.0 20.8 12.0 E4F1 E4F ENSG00000167967 "E4F transcription factor 1" Q66K89 16 2223566-2235742 "Enzymes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, Growth regulation, Host-virus interaction, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052042, HPA069007, HPA071325, HPA072309" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052042: AB_2681705, HPA069007: , HPA071325: AB_2686390, HPA072309: " "unprognostic (3.05e-1)" "prognostic favorable (9.13e-4)" "unprognostic (7.31e-2)" "unprognostic (4.57e-3)" "unprognostic (2.89e-1)" "prognostic favorable (1.10e-4)" "unprognostic (9.16e-2)" "unprognostic (4.23e-2)" "unprognostic (3.08e-1)" "unprognostic (1.87e-1)" "unprognostic (1.29e-2)" "unprognostic (8.49e-3)" "prognostic unfavorable (5.50e-4)" "unprognostic (1.85e-1)" "unprognostic (1.03e-1)" "unprognostic (5.12e-1)" "unprognostic (8.93e-3)" 12.4 12.8 18.1 13.8 15.4 21.0 21.0 26.1 18.9 10.8 10.7 11.9 9.3 13.4 14.8 10.4 11.4 10.9 13.5 9.8 14.3 10.7 11.7 12.9 10.0 13.4 16.7 16.4 13.8 17.0 11.6 14.8 12.0 12.8 15.5 5.0 8.7 20.7 13.7 26.7 23.2 14.7 10.3 9.8 18.8 15.9 14.6 17.2 13.3 17.3 9.3 10.6 10.5 13.4 11.5 11.6 15.2 14.2 8.5 14.7 9.3 6.1 11.8 5.0 9.7 2.9 2.7 11.9 8.6 4.0 6.0 4.0 18.9 9.5 9.0 9.3 3.3 3.3 8.4 4.1 4.4 1.1 9.7 14.6 6.4 19.0 10.2 5.7 8.1 11.3 4.0 5.1 5.4 2.5 3.4 4.0 7.9 14.9 6.3 2.2 17.1 10.6 17.3 11.1 3.8 11.0 19.7 5.4 15.5 3.7 4.4 12.6 9.2 10.5 13.1 6.0 1.9 11.4 11.6 7.1 7.1 9.4 7.1 7.2 12.3 5.9 18.2 3.0 5.8 7.2 7.5 10.7 14.6 14.7 13.1 12.5 11.5 12.0 13.6 11.6 11.5 13.2 11.9 15.2 8.5 14.2 7.0 14.1 9.3 18.1 15.4 26.1 18.9 14.3 10.7 16.7 16.4 12.8 17.2 14.9 8.0 14.5 6.7 6.4 13.9 3.5 5.1 4.0 12.5 10.4 35.3 16.5 10.0 9.5 11.4 7.8 14.4 0.0 9.1 14.7 8.0 8.1 2.3 8.9 11.0 28.6 24.8 6.7 6.1 3.3 10.6 7.6 6.8 9.0 15.3 9.1 9.7 10.5 15.2 6.8 14.0 12.9 9.2 14.8 15.2 7.9 11.2 8.7 11.8 6.0 EAF1 ENSG00000144597 "ELL associated factor 1" Q96JC9 3 15427355-15450635 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 55.7" "Group enriched" "Detected in many" 6 "Early spermatids: 229.6;Late spermatids: 321.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 56.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059516, HPA060569, HPA069538" Supported Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Nucleoplasm, Nuclear bodies" Vesicles "HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147" "unprognostic (1.26e-1)" "unprognostic (1.61e-2)" "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (3.22e-1)" "unprognostic (3.16e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (2.06e-2)" "unprognostic (5.17e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" 15.6 11.5 13.9 12.2 20.0 55.7 11.4 18.1 19.1 9.8 11.7 13.3 11.5 12.7 10.1 9.9 13.1 9.4 12.9 7.6 14.3 18.1 13.7 22.2 12.0 12.4 14.7 13.0 8.0 11.8 13.0 17.6 18.9 18.6 12.7 12.4 9.6 9.5 15.4 8.6 15.9 12.5 10.4 13.7 15.1 13.7 9.7 10.1 14.0 13.0 9.1 12.9 11.9 9.0 5.1 9.9 7.1 7.4 8.1 15.4 4.3 4.0 6.6 7.0 7.1 4.1 3.5 56.2 5.9 4.2 6.8 6.7 9.0 4.5 11.3 3.8 4.3 4.5 3.4 9.0 5.2 7.9 9.2 6.5 9.7 6.0 8.1 9.2 9.1 7.9 4.6 9.3 9.9 6.7 5.2 6.8 9.3 10.3 8.3 5.6 8.3 9.0 5.1 12.4 7.6 6.8 8.3 5.8 6.2 5.9 7.1 7.2 12.6 7.2 6.8 6.9 9.4 10.1 7.3 6.6 7.2 5.3 6.3 8.5 11.0 22.1 11.9 7.0 10.9 8.5 7.1 7.4 4.5 12.0 5.4 15.4 5.1 10.1 9.3 4.3 3.8 6.0 9.8 6.7 8.1 6.5 9.9 10.5 4.3 13.9 20.0 18.1 19.1 14.3 18.1 14.7 13.0 18.6 10.1 8.9 12.9 2.9 7.7 41.7 6.8 4.5 7.6 6.7 10.3 12.2 5.9 7.2 8.3 7.8 229.6 11.7 13.6 0.0 7.0 11.7 16.0 15.1 10.3 27.0 14.1 20.6 33.0 11.6 21.8 321.2 10.6 14.6 21.9 5.4 11.2 4.8 11.8 10.5 11.3 18.9 6.0 25.8 11.3 18.6 11.5 47.4 30.0 20.4 10.9 14.5 ECT2 ARHGEF31 ENSG00000114346 "Epithelial cell transforming 2" Q9H8V3 3 172750682-172821474 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport" "Guanine-nucleotide releasing factor" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.8" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 60.9;Erythroid cells: 70.0;Spermatogonia: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA036363, HPA053261" Enhanced Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA036363: AB_2732472, HPA053261: AB_2682094" "unprognostic (3.83e-2)" "unprognostic (4.34e-1)" "unprognostic (1.27e-2)" "unprognostic (4.22e-3)" "unprognostic (4.49e-2)" "unprognostic (5.02e-3)" "prognostic unfavorable (6.82e-6)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.82e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.24e-5)" "unprognostic (2.44e-2)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.08e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" "unprognostic (1.33e-1)" 6.4 6.0 5.4 9.9 7.2 16.3 7.4 11.1 7.6 9.0 11.0 2.6 2.1 9.1 4.6 2.8 14.9 3.2 6.6 4.2 5.4 5.0 10.1 4.3 8.9 9.6 6.7 5.8 3.2 4.1 4.0 6.1 11.1 10.2 4.1 16.1 2.4 9.0 2.7 2.9 7.0 7.6 7.2 8.4 8.7 9.2 14.7 6.8 50.8 5.7 9.3 10.8 8.0 6.5 2.8 2.6 10.4 3.2 1.3 3.6 1.0 46.2 33.0 26.1 13.5 2.7 5.6 13.0 20.5 16.8 30.8 30.0 18.3 49.1 11.5 31.2 12.0 29.5 20.4 21.0 13.1 42.1 16.4 11.6 7.2 18.1 9.3 1.2 11.1 8.3 1.8 2.2 18.3 18.7 8.7 13.2 17.1 7.4 16.9 24.3 16.3 11.3 8.3 21.2 38.3 18.0 8.1 25.6 14.8 23.4 10.8 17.4 11.2 25.9 29.5 10.4 13.7 49.1 8.3 11.4 15.0 14.4 20.1 42.6 8.3 11.1 21.7 13.2 9.7 19.5 6.8 3.2 1.3 1.8 2.8 1.9 2.2 2.4 1.6 2.4 2.8 1.2 1.8 10.4 1.3 1.2 2.6 3.6 1.0 5.4 7.2 11.1 7.6 5.4 5.0 6.7 5.8 10.2 6.8 6.0 2.7 9.0 4.3 17.3 3.4 3.1 7.6 10.7 4.5 3.5 60.9 4.9 0.0 9.0 2.7 6.4 3.2 70.0 7.9 13.0 7.0 8.8 0.0 1.5 6.1 0.0 4.6 5.5 3.1 2.3 0.9 5.1 6.8 1.8 10.8 2.9 14.3 3.5 1.4 1.9 13.4 0.0 3.3 33.1 37.4 11.2 3.2 1.5 6.2 7.8 EFCAB13 "C17orf57, FLJ40342" ENSG00000178852 "EF-hand calcium binding domain 13" Q8IY85 17 47323290-47441312 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "vagina: 29.9" "Group enriched" "Detected in many" 4 "Early spermatids: 161.3;Late spermatids: 143.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "CAB002501, HPA021633, HPA023249, HPA026561" Uncertain Enhanced "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear speckles" "CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596" "unprognostic (1.66e-1)" "unprognostic (3.48e-1)" "unprognostic (1.24e-2)" "unprognostic (2.40e-2)" "unprognostic (6.71e-2)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.40e-1)" "unprognostic (7.43e-2)" "unprognostic (8.79e-3)" "unprognostic (8.75e-2)" "unprognostic (1.75e-2)" "unprognostic (1.46e-5)" "unprognostic (1.68e-1)" "unprognostic (1.61e-1)" "unprognostic (8.10e-2)" "unprognostic (1.90e-3)" 4.1 2.8 2.9 12.2 3.4 3.4 6.5 2.8 3.8 6.5 4.7 2.3 3.5 4.8 8.9 4.4 2.4 4.2 4.1 3.5 2.3 1.5 7.5 4.0 3.1 4.3 3.6 0.4 5.5 2.8 8.4 7.6 5.4 3.2 9.3 3.4 2.6 5.4 2.0 1.3 2.2 6.3 9.9 3.5 4.6 3.5 20.0 2.7 2.4 14.9 0.7 4.3 5.5 29.9 5.6 1.0 5.3 2.1 0.8 2.6 0.8 0.9 4.0 1.7 0.2 2.1 7.3 3.1 2.2 0.5 0.7 1.2 1.7 5.6 0.3 6.6 0.8 0.0 1.1 0.0 0.4 4.0 0.2 0.6 5.2 3.3 0.5 2.1 4.0 0.6 1.3 1.9 2.7 0.0 5.0 4.5 4.1 1.5 9.9 2.4 0.1 1.7 2.3 0.9 2.8 3.2 4.7 1.3 1.8 9.2 3.2 1.2 0.6 1.2 0.1 2.6 1.3 6.6 4.7 1.6 0.3 1.3 0.4 1.1 10.2 7.0 0.9 6.3 7.8 4.3 5.3 2.1 0.6 1.1 1.2 0.9 4.3 0.9 0.6 1.0 5.6 2.6 1.2 0.0 0.8 0.7 0.4 0.1 0.8 2.9 3.4 2.8 3.8 2.3 1.5 3.6 0.4 3.2 2.7 8.9 2.1 2.0 1.7 0.7 2.3 3.8 0.0 5.3 1.2 0.0 0.0 0.2 0.0 0.7 161.3 6.3 0.5 0.0 0.7 0.2 1.3 1.0 5.8 0.8 1.7 3.2 2.9 3.7 2.1 143.2 1.7 1.3 0.0 1.8 0.2 1.1 1.2 0.0 3.5 0.8 2.6 0.0 2.3 34.1 7.9 0.5 0.0 0.0 0.6 1.0 EFTUD2 "SNRNP116, Snrp116, Snu114, U5-116KD" ENSG00000108883 "Elongation factor Tu GTP binding domain containing 2" Q15029 17 44849943-44899662 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022021 Supported Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA022021: AB_1848032" "unprognostic (4.28e-2)" "unprognostic (4.12e-2)" "unprognostic (1.98e-3)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (4.98e-2)" "prognostic unfavorable (2.71e-6)" "unprognostic (6.94e-2)" "unprognostic (4.52e-1)" "unprognostic (2.37e-1)" "unprognostic (4.11e-3)" "unprognostic (5.19e-2)" "unprognostic (5.48e-3)" "unprognostic (1.62e-2)" "unprognostic (5.30e-2)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" 22.5 26.5 16.0 23.1 27.0 25.0 17.7 13.4 34.9 14.8 20.3 22.0 10.4 16.6 22.1 15.4 27.0 20.2 12.7 22.6 16.6 16.7 21.5 27.7 17.3 25.2 15.8 19.8 15.3 20.0 21.2 15.3 27.5 22.6 14.9 23.2 19.1 27.2 15.7 49.6 22.0 20.3 18.5 15.7 25.9 18.5 30.2 13.1 36.9 18.6 17.9 34.9 18.6 16.0 12.8 31.8 31.6 31.5 15.6 16.9 23.3 22.7 45.6 22.3 36.0 17.1 16.9 26.2 18.1 24.3 45.8 39.8 35.1 19.6 39.4 21.4 22.8 35.3 26.1 48.3 31.7 53.6 39.6 40.1 39.1 28.5 37.3 18.9 46.0 29.1 18.3 18.2 42.4 23.1 17.7 39.6 35.7 48.1 15.4 26.1 22.7 46.1 30.4 22.9 53.8 38.2 32.5 45.3 34.2 26.1 25.6 36.7 21.9 17.8 13.2 18.8 34.1 35.0 29.1 24.0 34.5 26.6 20.8 45.6 16.3 20.4 39.6 27.7 25.7 35.1 12.3 31.5 31.6 15.2 31.0 16.9 12.8 13.5 14.6 31.8 12.5 12.0 13.3 5.1 15.6 29.7 13.7 13.2 23.3 16.0 27.0 13.4 34.9 16.6 16.7 15.8 19.8 22.6 13.1 0.0 12.3 16.4 10.8 10.4 13.9 15.9 28.1 14.7 12.5 17.4 31.4 30.5 3.3 25.5 9.7 16.3 14.6 0.0 23.3 26.0 12.2 9.3 19.6 18.4 34.2 25.4 10.4 17.2 31.7 4.9 11.8 22.3 5.0 49.5 12.0 14.3 21.4 10.5 8.5 10.1 16.1 19.4 9.2 24.7 36.5 12.8 22.8 13.1 20.5 10.3 EGR1 "AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225" ENSG00000120738 "Early growth response 1" P18146 5 138465490-138469315 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 923.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.5;intermediate monocyte: 5.1;neutrophil: 9.9" "Group enriched" "Detected in many" 8 "granulocytes: 9.9;monocytes: 5.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 39.7;hTCEpi: 57.8;U-266/84: 87.2" "Group enriched" "Detected in all" 6 "amygdala: 88.4;basal ganglia: 148.1;cerebral cortex: 237.4;hippocampal formation: 138.8;olfactory region: 126.1" "Low region specificity" "Detected in all" "CAB019427, HPA029937, HPA029938" Supported Enhanced Nucleoplasm No No Nucleoplasm "CAB019427: AB_2097038, HPA029937: AB_2673258, HPA029938: AB_2673259" "unprognostic (5.47e-2)" "unprognostic (4.09e-1)" "unprognostic (1.57e-1)" "unprognostic (7.74e-2)" "unprognostic (6.32e-2)" "unprognostic (2.66e-1)" "unprognostic (1.80e-1)" "unprognostic (2.96e-1)" "unprognostic (7.36e-2)" "unprognostic (2.97e-3)" "unprognostic (1.75e-1)" "unprognostic (2.94e-2)" "unprognostic (3.51e-3)" "unprognostic (3.57e-2)" "unprognostic (1.03e-1)" "unprognostic (1.67e-1)" "unprognostic (1.98e-3)" 78.7 47.9 5.5 114.3 23.3 18.3 28.7 23.7 25.0 61.8 40.5 31.6 8.0 6.8 51.7 15.6 47.2 187.3 158.4 42.9 7.0 8.1 22.0 68.8 39.7 18.6 4.9 7.0 130.9 23.0 15.8 43.3 24.3 17.8 45.2 21.7 56.1 18.7 100.5 19.4 54.2 29.8 60.8 4.4 8.8 46.1 14.7 2.8 19.4 76.6 67.5 26.6 43.2 20.3 0.9 0.9 9.9 5.1 0.1 0.2 0.4 4.1 0.1 9.0 13.4 24.5 39.7 1.0 7.2 4.5 9.7 7.9 5.1 3.7 0.2 1.1 15.6 33.4 1.9 0.5 14.6 4.5 0.2 0.6 0.5 1.7 1.4 3.1 1.5 11.6 3.1 57.8 8.6 1.9 7.6 0.8 10.6 21.2 5.1 2.8 20.8 0.6 6.5 0.8 15.5 0.0 0.1 1.3 0.7 7.4 2.5 11.3 1.3 8.7 24.2 18.7 9.1 0.3 1.2 0.3 3.5 4.6 1.7 2.7 12.1 87.2 1.7 4.1 19.8 1.0 0.0 3.5 0.4 0.2 5.1 0.0 0.9 0.1 0.1 0.9 0.3 0.2 0.2 9.9 0.1 1.4 0.0 0.2 0.4 5.5 23.3 23.7 25.0 7.0 8.1 4.9 7.0 17.8 2.8 256.1 658.4 51.0 240.2 161.5 44.6 590.3 183.4 53.5 87.6 27.9 60.9 127.7 6.6 145.2 1.2 175.3 431.9 0.0 86.9 88.6 317.5 418.7 343.2 161.3 107.4 3.2 923.5 169.4 153.0 1.8 152.5 134.7 101.3 10.0 629.1 114.5 132.3 391.8 49.8 5.0 87.7 219.9 490.3 2.3 1.9 175.0 108.5 55.8 355.8 76.3 ELAC2 "FLJ10530, HPC2" ENSG00000006744 "ElaC ribonuclease Z 2" Q9BQ52 17 12992391-13018187 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Endonuclease, Hydrolase, Nuclease" "Disease mutation, Primary mitochondrial disease, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 96.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019535 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA019535: AB_1848106" "unprognostic (4.24e-3)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "prognostic favorable (3.24e-6)" "unprognostic (8.64e-2)" "unprognostic (1.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.47e-1)" "unprognostic (2.22e-1)" "unprognostic (3.98e-1)" "unprognostic (5.31e-3)" "unprognostic (3.09e-1)" "unprognostic (5.31e-3)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (8.09e-2)" "unprognostic (3.70e-2)" 20.3 35.9 15.2 17.2 23.5 13.8 18.6 16.9 30.0 17.5 21.2 24.6 17.9 15.8 22.1 13.1 25.9 19.5 19.6 28.1 14.2 14.3 23.5 34.8 14.2 19.4 18.2 19.5 20.3 24.5 27.5 14.0 21.2 20.5 20.7 25.1 19.4 19.1 26.2 49.2 20.7 18.7 26.6 15.6 25.5 22.8 29.5 17.1 28.1 20.7 20.1 25.9 23.0 16.3 19.9 23.5 9.4 20.4 24.0 25.1 20.9 14.7 23.6 16.3 18.2 13.1 12.8 9.9 16.2 13.0 26.5 17.9 18.9 7.9 26.8 17.7 15.4 10.0 20.0 29.6 18.8 26.6 13.9 29.9 15.7 18.4 12.4 9.7 13.4 21.7 11.4 16.0 20.6 19.2 11.9 18.5 15.9 21.4 8.2 20.1 13.1 23.6 13.4 13.5 28.3 15.8 16.6 28.0 16.8 15.0 13.3 8.4 12.3 20.6 13.4 8.3 96.8 13.3 5.8 18.0 32.8 10.9 13.0 23.8 5.1 9.5 10.8 13.0 14.3 11.9 9.4 14.7 9.3 21.4 20.1 23.0 19.9 20.7 21.3 23.5 17.4 21.5 19.2 2.2 24.0 20.4 13.3 25.1 20.9 15.2 23.5 16.9 30.0 14.2 14.3 18.2 19.5 20.5 17.1 6.0 13.3 13.7 8.6 9.2 10.1 22.9 15.3 10.7 5.7 15.7 2.0 52.4 16.6 22.1 5.2 12.0 10.9 0.0 22.4 24.6 15.4 8.8 9.2 21.8 24.4 11.1 8.1 12.3 14.6 4.2 9.8 10.2 13.5 18.0 10.0 13.8 23.0 16.1 20.1 15.6 10.9 51.8 13.3 25.0 27.4 12.7 28.0 13.8 16.6 7.1 ELF3 "EPR-1, ERT, ESE-1, ESX" ENSG00000163435 "E74 like ETS transcription factor 3" P78545 1 202007945-202017188 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Inflammatory response, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 100.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 1511.9;Glandular cells: 1015.6;Paneth cells: 1043.9;Urothelial cells: 1629.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 40.5;CAPAN-2: 57.8;OE19: 37.3;RT4: 41.5;SK-BR-3: 80.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003316, HPA003479" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003316: AB_1078757, HPA003479: AB_1078756" "unprognostic (9.90e-3)" "unprognostic (1.72e-1)" "unprognostic (7.50e-2)" "unprognostic (1.12e-1)" "unprognostic (2.96e-3)" "unprognostic (3.88e-2)" "unprognostic (1.38e-2)" "unprognostic (1.83e-1)" "unprognostic (1.69e-1)" "unprognostic (5.05e-3)" "unprognostic (7.67e-3)" "unprognostic (7.07e-2)" "unprognostic (9.92e-3)" "unprognostic (4.03e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-1)" "unprognostic (3.37e-3)" 0.3 0.1 0.1 16.0 0.2 0.0 34.0 0.2 0.2 13.2 80.7 0.2 12.5 34.4 3.8 8.9 59.3 8.6 67.7 1.1 0.1 0.1 38.1 33.3 24.6 0.1 0.1 0.1 5.8 38.4 1.1 1.7 16.7 0.3 39.9 31.3 0.7 37.9 11.3 0.7 3.5 100.8 9.5 0.3 0.2 29.9 1.9 0.1 0.6 5.7 25.5 43.5 44.7 22.7 0.3 0.8 2.0 0.3 0.2 0.3 0.0 10.6 40.5 0.0 0.0 0.0 0.0 12.6 0.0 1.5 0.0 0.0 9.0 57.8 0.0 4.8 0.0 0.3 10.5 0.0 0.0 0.0 1.2 0.0 0.0 7.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.1 0.6 37.3 3.4 0.0 0.0 0.5 15.4 41.5 0.0 0.0 0.4 80.2 0.0 1.9 5.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.8 0.3 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.8 0.3 0.2 0.1 2.0 0.2 0.3 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.3 0.1 273.9 377.1 5.4 575.3 4.5 1.7 1.2 448.4 586.2 343.5 312.3 17.7 60.7 34.9 553.5 0.0 1.1 1511.9 0.0 565.5 107.5 4.2 1015.6 40.3 30.4 7.8 0.0 434.4 0.6 1.3 0.0 0.0 12.0 8.5 25.2 963.0 2.0 453.3 1043.9 0.0 114.1 63.9 0.0 0.4 0.0 0.2 7.3 215.1 2.2 773.6 1629.9 ELK1 ENSG00000126767 "ELK1, ETS transcription factor" P19419 X 47635521-47650604 "Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003808, HPA036084, HPA064381" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB003808: AB_562282, HPA036084: AB_2674931, HPA064381: AB_2685250" "unprognostic (2.25e-1)" "unprognostic (1.83e-2)" "unprognostic (4.77e-2)" "unprognostic (1.40e-2)" "unprognostic (2.31e-1)" "unprognostic (2.73e-1)" "unprognostic (1.16e-2)" "unprognostic (1.69e-1)" "unprognostic (1.47e-1)" "unprognostic (2.59e-3)" "unprognostic (1.17e-1)" "unprognostic (8.39e-2)" "prognostic unfavorable (3.25e-5)" "unprognostic (1.02e-1)" "unprognostic (2.03e-1)" "unprognostic (1.79e-2)" "unprognostic (1.67e-2)" 12.1 20.9 37.2 10.8 52.2 11.5 8.2 32.6 32.9 11.1 9.4 4.9 14.6 8.1 11.4 17.5 8.5 13.1 9.9 12.4 23.3 11.6 7.7 19.0 8.9 10.4 5.7 22.7 37.7 9.8 12.0 7.5 13.7 6.7 9.3 9.8 7.4 9.8 11.3 17.9 8.6 8.5 10.8 4.4 14.3 7.5 19.1 11.2 8.7 6.9 8.3 11.5 8.9 6.7 7.4 11.7 3.9 9.5 4.2 12.7 6.3 17.2 13.6 7.0 19.4 12.1 14.7 9.7 14.5 17.3 17.8 18.5 9.5 13.1 13.6 8.0 15.7 28.8 10.5 18.4 15.5 16.9 15.1 17.5 11.3 12.5 8.5 26.9 12.3 19.9 14.1 14.1 28.5 19.2 14.9 10.2 19.4 23.4 16.1 14.5 22.8 13.0 14.1 16.2 8.5 28.8 14.2 17.6 21.3 9.5 7.5 15.1 12.6 24.4 8.7 20.5 16.6 22.1 7.9 8.1 20.4 21.2 26.5 13.5 26.7 36.7 14.2 22.6 22.4 12.7 2.0 8.1 3.4 7.4 9.5 8.6 7.4 9.5 8.6 11.7 6.7 8.4 6.8 3.9 4.2 7.8 8.2 12.7 6.3 37.2 52.2 32.6 32.9 23.3 11.6 5.7 22.7 6.7 11.2 0.0 7.0 7.4 10.8 14.9 13.3 7.5 5.1 1.4 4.5 7.0 3.9 6.8 5.0 6.9 2.9 8.0 4.5 0.0 6.4 8.2 8.2 10.6 8.1 11.9 9.0 4.8 9.8 18.4 6.5 0.9 13.0 9.0 6.8 20.8 7.7 8.2 6.0 3.5 28.0 4.4 6.8 6.5 11.3 1.9 7.8 13.9 7.4 7.2 10.5 9.5 ELMSAN1 "C14orf117, C14orf43, LSR68" ENSG00000156030 "ELM2 and Myb/SANT domain containing 1" Q6PJG2 14 73715122-73790285 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003111 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003111: AB_1078329" "unprognostic (1.54e-3)" "unprognostic (2.69e-1)" "unprognostic (2.83e-1)" "unprognostic (9.69e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.03e-2)" "unprognostic (1.12e-1)" "unprognostic (8.55e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (2.02e-1)" "unprognostic (2.89e-1)" "unprognostic (3.36e-3)" "unprognostic (7.35e-2)" "unprognostic (2.44e-1)" "unprognostic (1.11e-1)" "unprognostic (1.96e-1)" 17.8 8.1 11.2 18.7 10.1 18.8 17.4 17.8 9.9 17.3 13.7 14.5 9.7 11.2 16.8 11.1 14.0 12.7 15.8 11.2 8.3 6.3 7.7 7.8 13.9 12.9 7.6 8.2 18.6 8.7 21.4 7.6 12.8 9.4 14.2 6.0 16.8 13.1 13.1 13.4 26.1 14.1 13.9 7.6 18.8 12.6 8.2 11.8 8.8 11.0 9.5 20.0 16.1 15.0 2.9 4.4 3.1 1.9 2.1 1.8 1.3 6.8 7.7 2.8 5.2 2.6 4.5 5.4 2.8 4.8 3.9 3.5 6.7 8.2 10.0 3.2 3.8 4.1 10.6 4.6 7.9 1.6 13.2 2.8 16.0 6.6 2.4 4.3 2.7 34.9 5.9 4.9 3.4 4.3 3.4 6.2 3.5 8.2 9.3 1.9 16.0 6.3 4.4 0.9 3.4 6.4 7.4 15.2 2.6 5.9 7.4 3.6 3.0 10.6 14.7 5.9 1.6 11.3 5.9 12.3 8.1 9.4 6.0 3.0 7.3 3.4 11.1 6.6 3.4 9.4 2.1 1.9 0.7 1.2 0.9 1.8 1.8 0.6 1.3 2.1 2.9 0.7 0.8 3.1 2.1 1.1 4.4 1.4 1.3 11.2 10.1 17.8 9.9 8.3 6.3 7.6 8.2 9.4 11.8 23.8 22.4 64.8 25.5 78.6 20.9 18.6 20.4 13.4 10.3 17.4 49.1 32.2 13.3 17.8 1.6 26.4 41.7 0.0 14.9 23.4 29.6 22.2 22.0 17.1 23.3 11.1 39.2 43.6 34.2 2.2 25.0 22.4 69.2 28.9 30.4 17.8 17.2 28.8 29.4 12.9 33.8 32.3 25.0 1.1 18.8 54.5 24.6 26.7 20.2 5.8 EP300 "KAT3B, p300" ENSG00000100393 "E1A binding protein p300" Q09472 22 41091786-41180079 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000146, HPA003128, HPA004112" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000146: AB_2533138, HPA003128: AB_1078745, HPA004112: AB_1078746" "unprognostic (7.67e-2)" "unprognostic (5.56e-2)" "unprognostic (2.29e-1)" "unprognostic (2.52e-1)" "unprognostic (6.10e-3)" "unprognostic (1.66e-1)" "unprognostic (2.21e-2)" "unprognostic (2.13e-1)" "unprognostic (1.54e-1)" "unprognostic (8.97e-2)" "unprognostic (1.74e-2)" "unprognostic (8.54e-2)" "prognostic favorable (7.45e-5)" "unprognostic (7.97e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-1)" "unprognostic (8.66e-2)" 16.8 14.8 19.1 13.9 15.5 45.3 14.5 33.0 20.6 14.8 16.8 15.6 18.9 11.1 18.1 11.6 16.8 15.7 16.5 10.7 16.6 8.3 11.5 12.2 14.1 12.9 16.9 12.7 20.2 15.7 26.4 14.5 27.7 13.8 13.2 12.2 12.3 15.3 17.9 19.5 18.2 17.4 13.8 12.7 15.9 14.7 20.6 18.6 29.3 16.9 10.9 14.1 18.7 22.5 4.3 4.4 9.8 3.9 5.7 3.9 2.3 15.7 11.3 19.2 11.9 12.2 13.2 17.2 7.6 11.0 11.4 11.0 14.4 5.8 16.4 6.7 15.0 10.5 12.7 27.7 10.4 12.7 15.9 18.4 12.3 13.0 11.2 13.9 29.2 13.9 12.9 10.9 16.5 13.8 10.0 12.6 9.5 13.0 22.6 9.0 5.8 8.4 9.1 13.8 19.8 7.9 17.3 9.0 10.2 10.8 20.9 6.1 6.5 26.9 13.7 13.1 16.7 9.7 17.0 16.3 11.4 13.8 8.1 10.8 15.5 7.3 25.6 8.4 9.0 10.8 5.0 3.2 3.0 3.7 3.9 3.2 4.3 3.6 3.9 4.4 2.9 3.1 2.6 9.8 5.7 2.1 3.0 2.6 2.3 19.1 15.5 33.0 20.6 16.6 8.3 16.9 12.7 13.8 18.6 62.5 45.1 44.7 19.0 21.9 43.6 25.4 53.5 29.4 18.2 24.4 33.4 15.3 3.3 13.2 12.6 27.2 22.2 46.7 16.0 15.4 23.4 24.1 24.3 24.1 15.9 23.8 23.7 34.4 59.8 3.4 26.7 31.6 8.5 20.8 23.1 31.8 20.2 26.6 28.7 9.2 31.1 25.8 15.6 20.6 29.9 22.6 25.3 26.6 20.3 30.6 EPAS1 "bHLHe73, HIF2A, HLF, MOP2, PASD2" ENSG00000116016 "Endothelial PAS domain protein 1" Q99814 2 46293667-46386703 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Congenital erythrocytosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 200.8" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 341.0;Ito cells: 438.9;Smooth muscle cells: 281.4;Syncytiotrophoblasts: 292.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "basophil: 14.9;eosinophil: 7.1" "Lineage enriched" "Detected in single" 21 "granulocytes: 14.9" "Cell line enhanced" "Detected in many" "BEWO: 46.9;BJ hTERT+: 46.2;HHSteC: 58.7;RT4: 58.1;TIME: 58.0;U-138 MG: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031200, HPA069697" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031200: AB_2673785, HPA069697: AB_2732139" "unprognostic (1.74e-1)" "unprognostic (9.47e-2)" "unprognostic (1.29e-2)" "unprognostic (2.74e-1)" "unprognostic (5.25e-2)" "unprognostic (1.75e-1)" "unprognostic (2.22e-2)" "unprognostic (8.67e-2)" "unprognostic (6.00e-2)" "unprognostic (9.72e-2)" "unprognostic (1.55e-2)" "unprognostic (9.29e-2)" "prognostic favorable (2.63e-4)" "unprognostic (6.66e-3)" "unprognostic (7.75e-2)" "unprognostic (7.56e-2)" "unprognostic (1.36e-1)" 71.2 14.2 12.5 17.1 15.7 0.8 101.7 5.3 13.9 24.9 20.9 8.9 11.3 12.0 28.8 13.0 21.6 24.8 35.2 40.0 12.8 11.0 35.2 31.2 200.8 27.2 14.3 11.1 20.2 15.5 18.1 9.4 119.6 18.4 20.7 11.5 41.2 13.3 18.7 25.2 13.0 15.6 19.2 12.5 20.5 12.8 13.8 8.0 1.1 43.8 15.2 10.3 32.2 39.3 0.0 0.0 14.9 0.1 0.7 0.1 0.1 5.3 5.7 0.3 0.4 27.6 17.8 46.9 16.9 46.2 9.7 10.6 1.0 0.9 0.0 4.2 32.2 9.7 2.6 0.1 13.5 7.3 0.1 0.2 0.0 1.8 12.0 58.7 0.0 3.4 26.0 18.7 19.0 13.4 7.2 33.4 0.1 0.5 0.0 5.9 4.6 0.1 0.1 0.2 3.7 3.2 0.1 0.6 1.7 6.0 58.1 0.2 12.0 13.3 30.6 3.6 12.5 2.0 2.3 58.0 50.4 1.4 6.7 1.4 0.0 0.0 0.0 36.7 0.9 1.2 14.9 0.1 7.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 12.5 15.7 5.3 12.6 12.8 11.0 14.3 11.1 18.4 8.0 71.5 137.9 8.1 61.5 42.7 3.5 58.5 50.9 30.8 96.7 3.5 9.8 93.6 1.7 15.5 12.6 341.0 66.4 0.0 45.9 256.0 104.5 46.7 40.4 77.4 47.9 0.0 4.1 438.9 58.4 41.8 11.5 23.9 27.0 0.0 13.6 89.1 25.9 40.4 6.0 24.0 57.7 278.1 281.4 1.2 1.7 29.1 292.5 9.6 11.6 58.0 EPHA6 FLJ35246 ENSG00000080224 "EPH receptor A6" Q9UF33 3 96814581-97752460 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.9;ovary: 13.2;testis: 15.5" "Group enriched" "Detected in some" 67 "Early spermatids: 305.1;Late spermatids: 156.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEK 293: 8.2;U-266/70: 24.9" "Low region specificity" "Detected in many" "HPA007397, HPA058047" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA007397: AB_2667821, HPA058047: AB_2683588" "unprognostic (9.87e-2)" "unprognostic (1.67e-2)" "unprognostic (3.42e-4)" "unprognostic (7.21e-5)" "unprognostic (8.51e-2)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (3.14e-1)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (1.71e-4)" "unprognostic (1.93e-3)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (7.14e-3)" 0.8 0.5 8.7 0.5 9.8 0.3 0.8 27.9 9.9 2.2 5.8 1.1 0.3 0.6 2.2 1.0 2.1 4.2 2.1 1.1 15.4 1.3 1.3 0.5 0.5 0.4 1.1 6.8 13.2 1.4 0.7 0.6 0.5 5.7 2.5 1.8 0.2 0.6 1.7 0.4 0.5 1.1 3.2 0.8 0.4 1.7 15.5 2.8 0.0 4.3 0.0 0.5 2.1 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 8.2 0.0 2.1 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.8 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 2.1 0.0 0.8 24.9 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 9.8 27.9 9.9 15.4 1.3 1.1 6.8 5.7 2.8 0.0 0.0 0.0 0.1 0.2 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 305.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 156.3 2.8 0.0 0.0 0.0 0.0 0.9 0.1 0.0 1.4 0.6 0.2 0.0 0.1 3.4 2.3 0.0 0.1 0.0 0.0 0.0 EPM2A "LD, LDE" ENSG00000112425 "EPM2A, laforin glucan phosphatase" O95278 6 145382535-145736023 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Carbohydrate metabolism, Glycogen metabolism" "Hydrolase, Protein phosphatase" "Disease mutation, Epilepsy, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.9" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 23.5;Early spermatids: 28.2;Horizontal cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 20.3" "Low region specificity" "Detected in all" "HPA053643, HPA055468" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053643: AB_2797247, HPA055468: AB_2797252" "unprognostic (2.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" "unprognostic (3.34e-3)" "unprognostic (2.92e-3)" "unprognostic (1.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.63e-1)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" "unprognostic (1.52e-4)" "unprognostic (2.28e-1)" "prognostic favorable (4.08e-7)" "unprognostic (4.12e-4)" "unprognostic (2.17e-1)" "unprognostic (2.99e-3)" "unprognostic (1.23e-1)" 5.4 6.0 8.8 1.9 9.0 2.2 3.6 4.0 8.9 3.9 11.1 8.6 2.5 3.4 4.8 4.8 8.9 4.3 3.9 19.4 9.6 8.7 8.0 5.7 3.5 3.4 11.9 5.5 5.9 2.9 5.5 3.3 2.0 9.6 6.2 3.4 5.6 3.1 9.2 60.9 2.4 3.3 13.9 13.6 2.5 4.6 3.3 7.1 3.7 4.2 15.7 2.9 10.4 6.0 1.4 1.0 0.3 1.4 5.4 2.4 1.0 1.1 1.7 3.3 6.3 8.2 2.5 1.4 3.0 3.5 2.8 3.4 1.5 1.7 20.3 2.5 3.5 3.4 1.8 1.2 1.3 2.5 7.9 1.7 3.3 2.4 2.5 5.0 11.3 2.0 2.1 6.8 1.7 0.6 3.7 2.0 4.8 1.4 5.2 3.5 2.6 7.5 2.4 3.4 3.0 1.7 4.3 3.0 5.9 2.5 1.7 6.1 6.1 5.3 3.2 7.0 3.1 1.8 6.5 4.3 2.8 1.4 2.6 2.3 3.8 3.8 8.2 2.4 2.7 4.4 0.0 0.1 0.1 0.4 1.4 1.1 1.3 1.1 0.9 1.0 1.4 1.2 2.4 0.3 5.4 0.3 0.9 0.2 1.0 8.8 9.0 4.0 8.9 9.6 8.7 11.9 5.5 9.6 7.1 6.0 1.0 3.2 0.8 0.8 7.9 23.5 5.1 2.7 3.4 1.8 5.9 0.7 10.0 0.9 28.2 1.5 0.3 0.0 2.0 0.6 1.2 1.3 2.3 5.8 2.0 28.6 1.2 1.3 1.5 14.1 2.8 3.1 6.8 0.0 1.5 7.5 1.1 1.1 2.1 6.3 6.7 0.0 2.0 1.6 1.3 0.4 0.3 0.0 1.0 0.3 ERCC1 RAD10 ENSG00000012061 "ERCC excision repair 1, endonuclease non-catalytic subunit" P07992 19 45407333-45478828 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cataract" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004390, HPA029773, HPA050182, CAB072859, CAB072860" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004390: AB_2278023, CAB072859: AB_2665703, CAB072860: AB_2665704, HPA029773: AB_10602129, HPA050182: AB_2681044" "unprognostic (1.54e-3)" "unprognostic (5.99e-2)" "unprognostic (1.58e-1)" "unprognostic (1.34e-1)" "unprognostic (1.41e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (9.69e-4)" "unprognostic (2.57e-1)" "unprognostic (5.80e-2)" "unprognostic (7.37e-2)" "unprognostic (1.93e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (9.00e-5)" "unprognostic (6.19e-2)" "unprognostic (1.96e-1)" "unprognostic (1.60e-1)" "unprognostic (1.43e-1)" 25.0 28.2 25.9 20.2 27.5 20.8 30.6 28.4 34.8 26.4 21.5 35.4 20.6 20.8 27.4 34.6 28.6 30.9 24.0 63.5 24.7 24.4 22.9 24.2 21.3 26.3 28.3 25.0 37.6 42.9 31.6 32.0 20.3 27.4 29.1 17.1 29.1 53.8 24.4 43.3 43.5 20.4 26.1 23.5 24.3 22.4 21.6 26.7 22.6 28.4 25.7 25.1 22.0 26.0 16.6 69.0 5.3 29.7 12.6 14.2 17.9 13.9 24.1 20.5 29.9 14.1 26.8 6.5 21.0 28.1 25.5 34.0 2.6 13.7 8.3 5.9 22.3 13.6 10.8 6.5 66.9 15.8 18.0 6.6 12.3 9.2 8.2 29.4 12.4 23.2 19.9 14.4 26.6 24.1 22.3 27.7 9.6 7.5 16.6 40.0 9.4 11.7 10.0 4.8 12.7 9.6 17.7 9.6 11.1 18.7 8.9 8.8 18.5 13.3 11.4 18.3 7.1 13.8 23.8 15.9 23.0 22.0 14.0 21.1 12.3 9.9 8.9 26.5 10.7 69.4 4.7 29.2 5.3 14.2 29.7 9.6 16.4 8.7 11.0 29.3 16.6 7.0 11.3 4.0 12.6 21.8 69.0 10.2 17.9 25.9 27.5 28.4 34.8 24.7 24.4 28.3 25.0 27.4 26.7 20.8 37.2 34.7 96.6 63.0 0.0 31.4 35.7 49.5 35.2 19.2 0.0 32.3 76.3 41.3 22.9 40.9 32.2 0.0 57.1 27.9 72.1 73.7 48.5 24.1 86.0 0.0 38.1 33.2 64.8 84.9 73.4 73.4 64.1 25.2 36.0 0.0 64.4 35.1 53.7 53.0 0.0 45.3 61.7 21.5 39.8 46.2 29.7 37.4 38.3 82.3 ERCC3 "BTF2, GTF2H, RAD25, TFIIH, XPB" ENSG00000163161 "ERCC excision repair 3, TFIIH core complex helicase subunit" P19447 2 127257290-127294176 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037153, HPA046077" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB037153: AB_796181, HPA046077: AB_2679527" "unprognostic (2.31e-1)" "unprognostic (1.15e-1)" "unprognostic (3.03e-2)" "unprognostic (1.07e-3)" "unprognostic (1.05e-1)" "unprognostic (8.85e-2)" "prognostic unfavorable (1.62e-7)" "unprognostic (2.74e-1)" "unprognostic (9.13e-3)" "unprognostic (9.25e-2)" "unprognostic (1.25e-1)" "unprognostic (2.46e-2)" "prognostic unfavorable (4.30e-6)" "unprognostic (3.71e-1)" "unprognostic (8.50e-2)" "unprognostic (5.73e-2)" "unprognostic (3.92e-2)" 17.4 20.0 26.1 23.8 28.9 20.5 21.0 35.9 32.0 22.1 19.4 19.7 17.1 11.5 21.6 15.7 19.1 23.6 20.4 20.4 23.2 18.8 17.5 17.4 19.4 23.1 19.7 25.8 23.3 22.4 32.0 26.4 16.3 21.5 20.1 17.1 18.3 18.0 21.8 30.1 19.7 17.3 26.1 16.0 24.5 17.4 39.5 20.1 24.1 19.3 15.8 25.9 22.4 20.8 11.8 13.9 7.2 9.7 18.8 16.2 11.7 22.2 15.3 19.0 20.1 21.1 14.5 23.5 20.5 26.6 33.2 32.2 23.4 16.3 16.9 17.0 18.7 21.5 20.0 28.9 21.6 28.9 26.4 25.9 21.2 18.7 24.6 15.7 18.4 23.1 15.0 20.3 38.3 16.4 21.2 21.3 22.2 20.6 11.1 20.9 22.0 26.2 19.8 27.6 14.5 23.9 21.6 21.8 14.0 18.5 20.8 23.0 24.8 17.5 26.7 26.8 22.7 14.4 21.1 16.9 20.0 22.9 18.1 24.3 19.9 38.8 26.5 17.7 8.9 21.3 6.6 9.5 7.2 16.0 9.7 16.2 11.5 11.8 13.5 13.9 11.8 15.8 10.9 3.1 18.8 7.9 11.3 16.1 11.7 26.1 28.9 35.9 32.0 23.2 18.8 19.7 25.8 21.5 20.1 20.8 13.4 8.2 8.1 6.8 0.0 10.5 5.1 32.1 22.7 7.0 0.0 15.9 1.7 12.0 3.5 14.3 4.9 0.0 13.1 10.3 12.0 6.2 9.3 7.8 12.5 0.0 5.8 12.3 12.6 3.1 15.3 9.2 8.5 12.6 8.2 0.0 12.9 5.8 12.0 7.0 0.0 12.9 8.5 34.7 27.5 8.3 12.2 13.8 9.9 5.6 ERCC5 "ERCM2, XPGC" ENSG00000134899 "ERCC excision repair 5, endonuclease" P28715 13 102807146-102876001 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 44.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045845, HPA050126, HPA050374" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045845: AB_2679471, HPA050126: AB_2681027, HPA050374: AB_2681106" "unprognostic (1.28e-3)" "unprognostic (1.32e-3)" "unprognostic (1.86e-2)" "unprognostic (9.28e-3)" "unprognostic (6.19e-2)" "unprognostic (8.73e-2)" "unprognostic (1.23e-1)" "unprognostic (8.72e-2)" "unprognostic (2.52e-1)" "unprognostic (2.55e-1)" "unprognostic (7.77e-3)" "unprognostic (5.76e-3)" "prognostic unfavorable (2.96e-6)" "unprognostic (3.56e-2)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "prognostic favorable (6.82e-4)" 22.3 19.1 15.9 16.1 17.8 23.7 20.1 26.4 20.8 19.7 27.0 17.9 27.0 25.0 22.1 25.7 21.0 15.1 21.1 15.4 14.6 13.1 18.7 28.1 19.9 26.4 17.1 16.2 22.9 22.3 15.7 25.6 17.9 19.0 20.1 23.1 15.9 20.5 24.7 14.6 25.8 31.1 17.0 19.4 30.6 21.9 14.0 17.8 40.8 21.8 16.6 26.0 22.4 19.6 10.1 10.8 23.4 17.4 17.7 17.5 12.0 14.8 5.4 10.8 6.8 21.7 20.4 6.6 15.1 20.0 8.7 11.4 8.3 20.8 9.3 7.6 15.2 6.1 15.5 9.6 13.8 9.1 14.1 5.4 13.9 15.7 7.2 10.6 28.3 18.2 19.4 13.3 10.1 15.7 13.8 15.2 19.7 6.5 8.5 15.3 4.0 15.2 19.6 4.7 17.9 7.6 8.3 8.1 9.4 18.0 8.3 7.3 10.8 7.9 13.3 8.0 8.7 11.9 26.4 15.3 6.8 3.4 5.7 9.4 12.5 3.8 4.7 26.4 11.5 8.4 23.4 9.8 18.3 16.7 12.3 15.5 9.6 15.5 17.5 10.8 10.1 16.6 16.1 7.2 17.7 17.4 7.7 16.6 12.0 15.9 17.8 26.4 20.8 14.6 13.1 17.1 16.2 19.0 17.8 3.0 7.4 14.6 5.7 6.4 0.0 25.5 7.6 6.7 13.6 0.0 0.0 7.7 0.0 1.0 44.4 9.0 18.4 0.0 1.1 6.6 8.2 3.7 18.5 17.1 9.3 0.0 4.7 10.4 14.3 23.3 20.4 9.9 6.8 1.0 19.0 0.0 1.4 16.4 14.9 1.2 0.0 19.4 6.1 10.6 6.4 6.0 4.8 25.4 16.6 4.3 ERF "PE-2, PE2" ENSG00000105722 "ETS2 repressor factor" P50548 19 42247572-42255157 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 139.4;Suprabasal keratinocytes: 95.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058532, HPA067952" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA058532: AB_2683744, HPA067952: AB_2685932" "prognostic favorable (8.07e-4)" "unprognostic (2.86e-1)" "unprognostic (1.47e-2)" "unprognostic (9.07e-2)" "unprognostic (5.21e-2)" "unprognostic (6.66e-2)" "unprognostic (2.21e-1)" "unprognostic (7.27e-3)" "unprognostic (3.61e-2)" "unprognostic (2.20e-1)" "unprognostic (8.63e-3)" "unprognostic (3.24e-1)" "unprognostic (6.41e-2)" "unprognostic (1.63e-1)" "unprognostic (2.85e-1)" "unprognostic (1.91e-2)" "unprognostic (1.54e-2)" 29.0 18.1 17.8 17.5 22.0 11.2 20.4 8.3 29.6 27.0 23.5 48.3 14.9 28.4 29.8 15.5 18.4 34.6 42.1 21.5 17.6 12.0 20.2 27.2 22.8 15.2 26.7 13.7 41.0 24.1 14.1 25.0 15.5 22.7 21.0 8.8 23.7 15.2 15.7 10.1 23.3 28.1 17.4 17.7 19.0 17.5 20.8 25.2 18.0 22.9 18.4 16.2 25.0 18.1 0.6 1.0 3.1 0.2 0.0 0.5 0.1 18.4 44.9 19.4 21.8 4.3 11.2 5.4 17.5 12.5 18.1 18.4 20.3 21.6 15.3 11.1 16.1 16.2 20.3 14.0 40.9 13.3 7.5 9.6 9.2 25.2 25.8 11.8 10.6 15.3 12.6 13.9 13.9 15.4 23.6 15.0 12.5 19.5 12.8 9.8 37.4 12.0 8.0 16.2 17.6 9.7 15.0 7.0 6.4 11.1 16.0 8.9 18.3 19.6 14.5 20.2 13.8 14.5 19.1 17.8 26.7 38.5 9.2 32.2 14.6 16.3 12.2 26.0 11.4 36.0 0.0 0.2 1.7 0.2 0.1 0.2 0.0 0.1 0.1 1.0 0.6 0.3 0.3 3.1 0.0 0.0 0.1 0.5 0.1 17.8 22.0 8.3 29.6 17.6 12.0 26.7 13.7 22.7 25.2 3.0 1.7 8.3 24.0 139.4 14.4 6.5 25.5 1.4 1.2 8.7 21.6 6.2 6.6 16.4 8.0 29.2 22.0 0.0 13.8 4.2 11.4 20.6 11.5 25.3 10.2 9.5 25.3 41.7 13.2 3.1 10.3 15.5 52.3 2.8 21.1 23.4 12.4 25.8 9.6 19.2 11.9 12.9 30.3 2.6 15.6 95.9 12.4 14.9 19.1 12.2 ESCO2 "EFO2, RBS" ENSG00000171320 "Establishment of sister chromatid cohesion N-acetyltransferase 2" Q56NI9 8 27771949-27812640 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3" "Group enriched" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 30.1;Spermatogonia: 77.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027243, HPA053679" Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes Yes "Nucleoplasm, Golgi apparatus" "Cell Junctions" "HPA027243: AB_2672175, HPA053679: AB_2682227" "unprognostic (7.86e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.04e-4)" "unprognostic (5.13e-3)" "unprognostic (9.50e-2)" "unprognostic (8.67e-3)" "unprognostic (7.30e-4)" "unprognostic (5.24e-3)" "unprognostic (2.24e-2)" "unprognostic (2.54e-2)" "unprognostic (7.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.65e-14)" "unprognostic (6.65e-3)" "unprognostic (5.32e-1)" "unprognostic (5.85e-2)" "unprognostic (4.06e-1)" 1.0 1.7 0.5 7.1 0.5 5.5 1.0 0.4 0.6 1.2 9.6 0.1 0.5 11.9 0.6 1.0 5.0 0.3 1.8 1.1 0.7 0.5 1.6 1.4 1.1 4.2 0.5 0.6 0.6 1.0 0.3 0.3 1.5 0.5 0.5 4.5 0.1 1.4 1.4 0.4 1.1 23.2 0.4 0.8 4.7 2.4 10.3 0.2 39.8 0.5 5.3 5.7 1.0 1.8 1.3 1.9 0.8 1.5 0.9 4.6 0.8 25.1 19.1 8.6 10.4 1.1 1.8 4.8 15.1 6.4 14.1 16.1 6.7 5.0 9.3 8.0 3.9 11.8 13.9 10.4 4.1 21.4 7.2 4.4 11.0 8.6 7.1 0.1 5.6 10.3 0.3 0.4 8.2 2.1 1.4 5.2 7.2 8.8 14.2 8.1 4.9 22.6 2.5 5.8 13.8 6.4 10.0 25.7 6.8 4.6 15.2 3.7 5.5 7.6 9.2 3.8 3.3 6.3 6.2 2.3 8.7 18.0 17.5 11.8 1.9 5.0 11.5 4.8 9.4 12.0 0.1 0.7 0.4 0.3 1.5 0.1 1.3 0.7 1.0 1.9 0.1 0.5 0.4 0.8 0.9 0.4 0.2 4.6 0.8 0.5 0.5 0.4 0.6 0.7 0.5 0.5 0.6 0.5 0.2 0.0 6.6 2.2 0.7 2.1 1.5 1.1 0.0 2.7 5.7 0.0 3.9 1.0 0.0 0.3 3.9 0.1 5.3 70.0 0.0 5.5 0.9 0.2 1.1 1.1 4.5 0.0 1.2 0.6 4.1 0.4 1.7 3.5 0.0 0.0 2.3 0.0 0.1 0.8 0.0 0.0 1.8 6.5 0.3 30.1 77.3 0.5 0.8 2.9 4.0 0.9 ESRP1 "FLJ20171, RBM35A" ENSG00000104413 "Epithelial splicing regulatory protein 1" Q6NXG1 8 94641074-94707466 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 65.1" "Cell type enhanced" "Detected in many" 6 "Mucus-secreting cells: 101.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "MAIT T-cell: 1.9" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "A-431: 33.3;BEWO: 25.6;CAPAN-2: 35.1;HaCaT: 20.4;hTCEpi: 57.4;OE19: 34.8;RT4: 24.4;T-47d: 27.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA023719, HPA023720, HPA067104" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Nuclear bodies" Nucleoplasm "HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779" "prognostic unfavorable (9.28e-4)" "unprognostic (7.12e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (4.12e-1)" "unprognostic (6.99e-3)" "unprognostic (2.70e-1)" "unprognostic (2.61e-2)" "unprognostic (5.19e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (4.48e-2)" "prognostic favorable (1.96e-8)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (4.96e-2)" "unprognostic (1.29e-1)" 0.6 0.5 0.5 15.1 0.5 0.0 7.6 0.5 0.6 9.7 18.1 0.2 18.7 7.7 3.3 21.3 43.1 6.6 14.5 0.6 0.5 0.5 6.4 0.7 15.5 0.8 0.5 0.2 1.8 65.1 11.8 10.1 18.5 0.3 8.9 20.8 0.2 38.2 15.1 0.5 24.8 12.7 1.9 0.5 0.5 12.1 1.0 0.2 1.4 20.2 30.4 28.9 9.0 16.8 0.0 0.0 0.0 0.0 0.0 1.9 0.0 33.3 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 10.9 35.1 0.0 0.9 0.0 0.0 20.4 0.9 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.4 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 16.2 0.4 0.1 3.1 34.8 0.8 0.0 0.0 4.4 4.4 24.4 8.9 0.0 0.0 5.2 3.3 5.6 27.1 0.2 0.0 0.0 0.0 0.0 0.0 3.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.6 0.5 0.5 0.5 0.2 0.3 0.2 35.7 23.4 0.5 19.5 39.6 0.0 0.7 20.4 30.8 22.7 26.2 0.0 45.8 11.6 18.7 5.9 0.0 53.4 0.0 24.0 54.1 2.0 25.5 1.1 0.0 5.1 0.0 31.9 0.0 0.0 6.8 0.0 0.6 23.6 1.0 101.9 0.0 21.5 42.1 0.7 0.3 0.0 0.0 0.9 0.2 0.7 69.3 51.9 0.0 68.9 33.0 ESRP2 "FLJ21918, RBM35B" ENSG00000103067 "Epithelial splicing regulatory protein 2" Q9H6T0 16 68229111-68238102 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.2;pancreas: 41.5" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 63.6;Syncytiotrophoblasts: 48.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 18.4;MCF7: 36.1;RT4: 19.4;SK-BR-3: 19.4;T-47d: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040751, HPA048597, HPA048618" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040751: AB_2677115, HPA048597: AB_2680458, HPA048618: AB_2680463" "unprognostic (3.55e-2)" "unprognostic (1.18e-1)" "unprognostic (1.19e-1)" "unprognostic (3.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.62e-2)" "unprognostic (1.54e-1)" "unprognostic (1.33e-1)" "unprognostic (1.50e-1)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "unprognostic (8.80e-2)" "prognostic favorable (1.30e-6)" "unprognostic (1.24e-1)" "unprognostic (3.16e-1)" "unprognostic (9.04e-3)" "unprognostic (8.75e-3)" 0.4 0.2 0.2 7.6 0.5 0.0 3.9 0.6 0.3 4.7 8.0 0.6 4.1 4.6 1.2 10.2 30.1 2.1 12.4 0.6 0.3 0.1 13.4 45.2 15.6 0.2 0.2 0.2 1.3 41.5 7.0 2.5 11.3 0.7 6.6 5.6 0.8 17.3 5.0 0.3 17.6 8.5 0.6 0.2 0.2 12.8 7.0 0.3 3.0 18.4 25.7 17.1 6.4 9.4 0.0 0.0 0.0 0.8 0.0 0.8 0.0 12.4 0.0 0.0 0.0 0.0 0.0 18.4 0.1 0.0 0.0 0.1 11.7 6.2 0.0 0.5 0.0 0.0 12.9 0.0 9.6 0.0 0.0 8.5 0.0 3.5 9.3 0.2 0.0 0.1 0.0 13.6 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 1.3 9.3 4.2 0.0 0.0 0.0 4.8 19.4 1.3 0.0 6.2 19.4 0.0 1.6 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.6 0.3 0.3 0.1 0.2 0.2 0.7 0.3 17.9 12.1 0.0 4.0 5.7 0.5 1.0 15.3 2.7 10.3 22.7 0.0 27.4 0.0 10.0 23.1 0.4 10.3 0.0 12.2 3.2 0.8 6.9 0.0 28.2 2.4 0.0 8.1 0.0 1.5 63.6 0.9 0.0 1.7 1.0 23.1 0.2 11.0 7.0 0.0 3.5 0.2 0.0 0.3 5.7 1.5 7.4 48.9 0.0 15.1 7.1 ETS1 "ETS-1, EWSR2, FLJ10768" ENSG00000134954 "ETS proto-oncogene 1, transcription factor" P14921 11 128458761-128587558 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Immunity, Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 122.5" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 159.3;Ito cells: 228.3;T-cells: 181.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 59.4;JURKAT: 62.5;U-698: 79.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002575, HPA063230" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002575: AB_563721, HPA063230: AB_2684965" "unprognostic (1.76e-2)" "unprognostic (2.49e-1)" "unprognostic (3.18e-3)" "unprognostic (6.22e-2)" "unprognostic (3.07e-1)" "unprognostic (2.56e-1)" "unprognostic (1.24e-2)" "unprognostic (1.57e-1)" "unprognostic (1.35e-2)" "unprognostic (7.17e-2)" "unprognostic (2.46e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.30e-5)" "unprognostic (2.02e-1)" "unprognostic (3.08e-2)" "unprognostic (1.38e-1)" "unprognostic (5.48e-3)" 33.2 6.3 4.1 45.9 4.7 6.4 24.0 1.6 3.3 13.3 15.0 3.1 4.9 5.3 18.0 9.3 12.6 8.1 13.6 19.1 4.2 3.7 12.4 9.9 36.7 53.9 4.7 2.9 14.1 6.2 6.7 4.1 11.6 4.2 11.7 6.6 12.7 11.7 5.7 12.9 7.5 19.1 7.9 4.3 68.0 8.8 6.0 2.3 122.5 16.7 9.2 51.4 17.5 18.8 6.0 3.0 20.5 0.4 12.5 17.3 4.7 14.5 2.6 12.7 0.0 5.5 8.9 0.0 11.3 24.2 14.2 13.7 0.8 15.8 52.7 11.6 18.6 32.6 5.1 1.2 32.6 30.0 11.1 0.2 59.4 1.1 0.0 14.8 6.1 0.7 17.4 2.6 12.2 44.7 8.1 11.7 62.5 0.1 11.0 17.0 0.0 30.6 4.5 4.7 1.3 9.5 8.4 20.8 4.1 11.2 16.3 0.1 0.8 5.9 0.1 12.5 8.9 0.0 3.0 21.5 32.0 10.0 6.2 18.5 8.2 1.4 79.5 5.7 11.5 28.0 20.5 0.0 3.0 10.4 0.1 14.6 6.0 14.0 12.6 0.1 4.9 17.3 13.5 0.5 12.5 0.4 3.0 15.5 4.7 4.1 4.7 1.6 3.3 4.2 3.7 4.7 2.9 4.2 2.3 23.8 31.1 40.2 29.1 102.1 0.0 6.2 2.5 2.7 35.2 10.4 0.0 0.2 0.0 33.5 2.0 159.3 6.7 0.0 19.5 0.3 45.7 17.2 18.5 3.8 5.6 0.0 14.9 228.3 20.9 0.9 13.0 5.0 65.8 10.0 13.3 0.1 65.1 5.8 14.5 2.9 0.0 103.5 62.6 0.9 1.5 55.3 0.3 181.5 4.0 30.3 ETS2 ENSG00000157557 "ETS proto-oncogene 2, transcription factor" P15036 21 38805307-38824955 "Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 580.2;Suprabasal keratinocytes: 425.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 16.5;granulocytes: 18.5;monocytes: 14.9" "Cell line enhanced" "Detected in many" "HEL: 60.5;hTCEpi: 55.4;hTERT-HME1: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003176 Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA003176: AB_2666824" "unprognostic (2.06e-1)" "unprognostic (5.91e-2)" "unprognostic (9.16e-3)" "unprognostic (5.33e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.88e-3)" "unprognostic (7.36e-2)" "unprognostic (8.99e-3)" "unprognostic (3.66e-2)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-2)" "unprognostic (2.12e-1)" "unprognostic (1.89e-1)" "unprognostic (8.10e-2)" "unprognostic (7.10e-2)" 33.6 10.4 25.8 29.6 12.8 44.7 28.5 5.5 36.5 28.4 38.1 7.3 13.7 39.7 27.0 20.3 30.1 21.8 42.6 42.9 16.2 10.8 21.2 75.5 58.3 56.9 13.8 18.2 23.6 11.7 20.0 19.7 23.2 14.2 31.4 50.6 12.9 17.6 17.4 64.2 72.4 59.0 43.3 13.6 68.7 25.8 8.3 11.0 7.2 21.5 28.4 13.7 40.8 35.5 0.2 16.5 18.5 14.9 0.1 2.5 3.6 23.4 5.0 3.5 1.1 4.0 13.6 9.4 5.5 32.0 7.3 9.7 4.4 6.7 5.1 2.7 4.9 10.7 7.0 5.9 14.7 14.0 4.7 2.3 60.5 30.4 11.0 41.2 3.7 5.9 8.0 55.4 10.3 45.2 4.7 5.8 3.4 6.2 0.0 3.2 3.4 11.2 4.0 11.3 7.8 3.3 36.8 2.2 4.7 10.3 15.2 2.7 3.6 15.6 6.4 1.2 1.3 0.3 6.9 6.2 17.6 2.5 11.2 12.0 0.1 0.0 5.1 4.2 12.5 14.6 10.1 9.2 3.3 1.7 12.3 2.0 0.2 1.6 2.5 16.5 0.2 1.6 1.6 18.5 0.1 14.9 4.0 0.1 3.6 25.8 12.8 5.5 36.5 16.2 10.8 13.8 18.2 14.2 11.0 47.6 133.7 24.2 580.2 379.6 2.1 25.0 45.9 141.8 183.1 48.8 0.0 42.0 10.0 60.7 3.0 196.3 148.0 23.3 94.2 94.1 55.2 133.5 49.7 211.1 50.3 0.0 88.0 256.6 144.5 1.7 16.7 174.6 64.1 29.7 182.6 1.0 94.1 98.2 23.3 27.9 1.1 51.8 93.5 0.6 2.9 425.2 148.5 18.1 194.6 292.4 EWSR1 EWS ENSG00000182944 "EWS RNA binding protein 1" Q01844 22 29268009-29300525 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Calmodulin-binding, Repressor, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004230, HPA051771, HPA062953" Enhanced Enhanced "Nucleoplasm,Nucleoli rim" No No Nucleoplasm "Nucleoli rim" "CAB004230: AB_675526, HPA051771: AB_2681602, HPA062953: AB_2684910" "unprognostic (1.96e-1)" "unprognostic (6.39e-3)" "unprognostic (1.32e-1)" "unprognostic (3.93e-2)" "unprognostic (3.59e-1)" "unprognostic (3.15e-2)" "prognostic unfavorable (1.27e-6)" "unprognostic (1.33e-1)" "unprognostic (1.09e-2)" "unprognostic (2.71e-2)" "unprognostic (7.04e-2)" "unprognostic (9.30e-2)" "prognostic unfavorable (1.21e-5)" "unprognostic (7.33e-3)" "unprognostic (1.79e-1)" "unprognostic (3.67e-2)" "unprognostic (1.50e-3)" 35.3 43.2 45.3 41.3 51.3 67.5 32.1 58.2 48.6 32.4 39.8 43.2 31.3 41.0 45.1 38.5 40.8 37.6 25.9 40.7 40.1 32.8 33.0 48.5 33.4 50.5 32.7 49.9 38.4 32.0 47.2 44.3 34.0 41.7 35.0 39.9 41.5 32.3 38.2 52.8 34.8 36.6 40.5 33.8 44.1 34.5 85.6 32.5 39.9 32.5 30.9 55.4 36.4 34.5 52.0 65.8 50.6 81.1 58.4 67.8 76.1 57.2 44.6 61.4 47.7 31.3 26.0 42.2 34.9 55.8 57.9 49.7 50.8 29.8 78.3 22.1 53.5 44.0 45.0 87.4 71.4 59.7 53.3 62.3 59.1 39.5 48.6 46.9 90.9 42.3 39.7 30.1 48.3 78.4 27.8 44.8 37.5 44.2 35.4 42.8 57.5 91.2 34.8 43.1 47.4 34.0 64.1 59.1 47.3 53.2 60.9 50.3 48.1 43.4 50.9 37.6 42.2 32.7 49.5 45.7 35.4 39.3 22.2 50.6 46.0 36.9 72.6 33.7 40.5 43.0 48.4 57.9 50.6 60.2 81.1 60.7 50.4 56.6 59.6 65.8 52.0 55.8 53.6 43.3 58.4 78.6 35.3 67.8 76.1 45.3 51.3 58.2 48.6 40.1 32.8 32.7 49.9 41.7 32.5 95.3 103.6 96.6 120.0 61.7 71.3 60.0 89.2 124.5 102.4 61.1 70.7 120.3 56.3 106.1 87.5 78.6 71.5 70.0 93.8 108.0 78.0 80.7 117.8 64.2 85.5 77.9 77.7 82.3 69.0 21.4 57.0 89.6 77.6 112.8 73.3 66.1 95.4 94.7 58.4 59.1 77.8 51.8 86.8 180.0 109.0 51.2 127.5 88.0 89.6 101.6 EXO1 "HEX1, hExoI" ENSG00000174371 "Exonuclease 1" Q9UQ84 1 241847967-241895148 "Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, Immunity, Meiosis" "DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.6;lymphoid tissue: 31.3;testis: 14.8" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 4.7;Extravillous trophoblasts: 14.1;Spermatocytes: 9.8;Spermatogonia: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053079, HPA069738" Enhanced "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA053079: AB_2682037, HPA069738: AB_2732140" "unprognostic (6.33e-3)" "unprognostic (8.54e-3)" "unprognostic (9.47e-3)" "prognostic unfavorable (8.21e-4)" "unprognostic (2.43e-1)" "unprognostic (6.34e-2)" "prognostic unfavorable (6.94e-7)" "unprognostic (1.84e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.40e-2)" "unprognostic (4.81e-3)" "unprognostic (9.40e-2)" "unprognostic (0.00e+0)" "unprognostic (6.72e-2)" "unprognostic (2.29e-1)" "unprognostic (1.75e-1)" "unprognostic (3.57e-1)" 2.1 1.0 0.9 10.3 1.0 15.6 1.0 0.3 1.3 1.3 3.1 0.3 0.1 2.9 0.7 0.8 6.2 0.4 1.3 1.5 0.7 0.6 0.9 1.3 1.5 5.6 0.6 0.3 1.3 1.3 1.8 0.4 4.6 0.7 0.7 3.9 0.3 1.4 0.1 1.0 1.7 4.2 1.0 0.6 5.7 1.5 14.8 0.1 31.3 0.6 4.0 8.1 1.6 2.0 1.4 0.6 2.9 0.7 0.9 3.3 1.0 15.1 10.1 16.7 11.0 1.0 2.7 14.1 20.2 6.8 18.1 19.8 12.6 8.6 16.6 9.9 4.7 9.5 15.1 21.1 8.4 21.5 25.6 18.5 15.4 10.8 6.4 0.3 21.9 11.5 0.6 0.4 18.0 4.9 2.2 5.6 16.3 30.8 21.9 14.4 7.0 23.6 12.4 22.8 18.5 10.0 17.1 15.6 17.7 3.7 9.6 18.7 23.7 13.2 10.7 7.1 8.2 9.9 13.6 2.0 17.6 15.5 16.5 27.2 16.1 21.3 26.7 6.1 17.9 20.9 2.9 0.7 0.0 1.1 0.0 0.0 1.4 1.1 1.1 0.6 1.3 0.6 0.2 0.3 0.9 0.0 0.1 3.3 1.0 0.9 1.0 0.3 1.3 0.7 0.6 0.6 0.3 0.7 0.1 0.0 0.0 0.0 0.1 0.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 4.7 0.0 0.0 0.0 0.0 14.1 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 9.8 6.9 0.1 3.3 0.7 0.6 0.1 FAHD1 "C16orf36, DKFZP566J2046" ENSG00000180185 "Fumarylacetoacetate hydrolase domain containing 1" Q6P587 16 1826941-1840207 "Enzymes, Predicted intracellular proteins" "Hydrolase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Proximal tubular cells: 175.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025530, HPA043226, HPA043534" Enhanced Enhanced Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535" "unprognostic (3.71e-1)" "unprognostic (1.25e-2)" "prognostic favorable (8.27e-4)" "unprognostic (1.99e-1)" "unprognostic (6.74e-2)" "unprognostic (1.01e-3)" "unprognostic (2.89e-2)" "unprognostic (4.32e-1)" "unprognostic (1.13e-1)" "unprognostic (5.36e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "prognostic favorable (2.80e-14)" "unprognostic (1.02e-1)" "unprognostic (1.66e-1)" "unprognostic (1.26e-1)" "unprognostic (3.31e-2)" 10.4 17.0 10.4 6.7 9.9 6.5 9.2 8.6 12.7 6.8 21.7 9.3 8.2 26.7 9.8 10.9 14.8 5.8 10.2 15.8 10.9 11.4 46.8 43.6 5.6 5.2 10.1 9.4 7.9 17.4 9.0 11.1 10.4 9.9 8.1 11.1 8.5 9.1 9.8 20.2 12.4 24.8 6.9 8.8 6.3 14.9 6.9 9.5 4.7 12.5 19.0 5.7 9.9 7.9 18.5 23.1 8.6 27.5 19.6 16.0 13.7 8.4 19.1 9.1 16.1 12.1 8.8 5.7 13.9 6.9 9.3 10.2 12.2 8.8 5.4 11.7 8.6 14.4 17.4 7.1 11.2 8.4 8.2 16.9 4.8 16.5 28.1 11.8 8.3 9.4 11.6 14.7 8.5 5.7 7.9 12.1 6.6 5.0 5.7 11.6 38.7 4.5 12.6 5.4 7.8 14.3 10.4 12.4 15.2 33.4 10.6 17.8 14.8 18.2 14.7 21.8 6.4 21.5 5.7 17.6 15.3 10.9 9.0 7.5 8.2 17.2 6.4 9.7 6.1 6.5 6.5 23.5 8.6 14.4 27.5 13.0 18.5 14.5 15.7 23.1 16.9 16.0 14.9 2.0 19.6 19.1 17.9 14.7 13.7 10.4 9.9 8.6 12.7 10.9 11.4 10.1 9.4 9.9 9.5 23.8 16.0 12.3 12.4 12.5 20.0 37.0 22.9 17.4 17.0 40.1 25.5 18.6 43.1 43.5 88.6 14.7 72.1 23.3 34.0 12.3 14.7 9.4 4.7 30.5 26.4 17.5 28.2 8.0 8.1 38.9 13.6 18.2 15.1 23.4 22.1 16.9 34.9 30.9 14.5 175.3 22.4 12.9 14.1 7.0 8.3 21.0 12.8 10.7 41.2 8.1 FAM114A1 Noxp20 ENSG00000197712 "Family with sequence similarity 114 member A1" Q8IWE2 4 38867677-38945739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 102.6;Peritubular cells: 109.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 5.1;intermediate monocyte: 6.3;myeloid DC: 4.3;neutrophil: 3.8;non-classical monocyte: 2.2" "Group enriched" "Detected in many" 6 "dendritic cells: 4.3;granulocytes: 3.8;monocytes: 6.3" "Cell line enhanced" "Detected in many" "ASC diff: 42.5;ASC TERT1: 44.4;BJ hTERT+: 50.7;fHDF/TERT166: 56.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA067948, HPA069104, HPA069701" Uncertain Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No "Golgi apparatus, Cytosol" Nucleoplasm "HPA067948: AB_2685931, HPA069104: AB_2686087, HPA069701: AB_2686175" "unprognostic (2.13e-3)" "unprognostic (4.68e-2)" "unprognostic (1.94e-1)" "unprognostic (4.66e-2)" "unprognostic (9.40e-3)" "unprognostic (6.77e-2)" "unprognostic (2.54e-1)" "unprognostic (2.31e-2)" "unprognostic (4.88e-2)" "unprognostic (1.55e-1)" "unprognostic (3.06e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.63e-6)" "unprognostic (1.31e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (3.44e-3)" 15.8 27.3 4.4 11.8 7.3 0.3 17.9 2.5 5.1 23.3 18.9 8.0 17.1 9.0 34.1 23.5 19.9 11.4 24.1 14.1 7.0 4.2 9.6 31.8 14.5 6.1 5.8 5.0 21.7 33.4 8.8 18.7 19.1 6.5 22.0 14.0 13.0 59.9 12.6 9.3 10.1 15.8 36.7 6.2 6.3 13.9 10.8 5.8 1.5 11.5 16.7 15.1 29.1 17.8 0.7 4.3 3.8 6.3 0.1 0.2 1.3 8.7 6.3 3.8 4.5 42.5 44.4 1.2 34.6 50.7 14.7 22.5 1.6 6.8 0.0 4.8 56.0 25.1 2.4 0.0 11.0 17.0 0.0 0.9 0.6 6.7 8.1 15.2 0.0 1.2 26.2 3.5 21.3 4.9 33.4 21.0 0.0 0.6 0.0 21.4 2.2 0.0 0.4 0.8 3.7 3.2 0.1 19.1 0.6 4.9 1.7 0.1 1.9 6.9 0.1 7.1 9.4 4.3 0.7 32.0 16.0 7.5 20.0 8.0 0.1 0.0 0.0 26.2 0.6 13.0 0.8 5.1 0.1 0.2 6.3 0.1 0.7 0.2 0.1 4.3 0.3 0.2 0.2 3.8 0.1 2.2 0.5 0.1 1.3 4.4 7.3 2.5 5.1 7.0 4.2 5.8 5.0 6.5 5.8 14.9 10.4 0.0 39.8 10.9 0.1 14.4 10.2 40.2 23.9 7.0 0.0 1.5 8.3 41.1 0.9 28.7 35.9 0.0 54.0 35.9 79.4 79.1 1.1 66.9 14.7 0.0 15.1 30.1 6.7 2.2 102.6 9.9 20.3 5.4 70.8 10.6 41.7 35.1 109.3 8.4 1.0 19.4 25.7 0.5 1.1 8.9 2.9 2.5 27.3 53.6 FAM131B KIAA0773 ENSG00000159784 "Family with sequence similarity 131 member B" Q86XD5 7 143353400-143362770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 47.1" "Cell type enhanced" "Detected in some" 13 "Distal tubular cells: 1.7;Intestinal endocrine cells: 2.4;Late spermatids: 2.9" "Cancer enriched" "Detected in many" 11 "glioma: 14.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 10.3;hTERT-RPE1: 6.5;NTERA-2: 16.8;PC-3: 16.1;SCLC-21H: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021371, HPA029992" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021371: AB_1852341, HPA029992: " "unprognostic (1.70e-1)" "unprognostic (7.26e-2)" "unprognostic (1.29e-1)" "unprognostic (5.61e-2)" "unprognostic (5.97e-2)" "unprognostic (2.54e-2)" "unprognostic (9.99e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.00e-1)" "unprognostic (7.99e-5)" "unprognostic (1.31e-2)" "unprognostic (1.66e-1)" "unprognostic (1.02e-2)" "unprognostic (3.53e-2)" 1.5 2.1 10.0 2.0 12.4 0.9 1.2 37.2 47.1 2.7 2.0 15.1 0.0 1.7 4.4 1.0 1.7 1.6 1.4 1.1 9.1 6.8 1.1 0.9 1.5 1.3 14.6 12.3 1.0 0.9 6.4 0.4 0.9 13.8 1.0 2.2 0.0 0.9 1.0 7.7 0.8 2.1 5.6 18.6 1.1 1.4 1.2 11.3 0.0 0.9 0.0 1.1 1.2 0.5 0.0 0.2 0.0 0.5 0.1 2.1 0.2 0.0 0.1 5.0 0.0 4.1 5.2 0.0 0.2 1.2 0.8 0.2 10.3 0.0 0.0 0.0 0.3 0.0 0.2 2.0 0.4 0.7 2.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 6.5 0.9 0.1 0.0 0.0 0.7 0.0 0.0 0.3 16.8 0.0 16.1 0.0 0.0 0.0 0.0 0.0 16.4 0.5 0.2 1.2 0.0 1.1 0.0 0.0 0.7 0.3 1.6 0.1 0.0 0.0 0.0 0.0 0.1 3.3 0.1 0.0 0.3 0.0 2.1 0.5 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.2 0.0 0.0 0.2 10.0 12.4 37.2 25.0 9.1 6.8 14.6 12.3 13.8 11.3 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 2.4 0.6 0.3 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 FAM133B MGC40405 ENSG00000234545 "Family with sequence similarity 133 member B" Q5BKY9 7 92560793-92590394 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA066175: AB_2685629, HPA069513: AB_2686143" "unprognostic (5.54e-2)" "unprognostic (4.42e-1)" "unprognostic (1.07e-1)" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (6.70e-2)" "unprognostic (2.42e-2)" "unprognostic (1.54e-2)" "unprognostic (2.87e-3)" "unprognostic (8.56e-3)" "unprognostic (1.11e-1)" "unprognostic (8.85e-2)" "unprognostic (2.73e-3)" "unprognostic (9.01e-3)" "unprognostic (3.16e-1)" "unprognostic (1.87e-1)" "unprognostic (2.38e-2)" 10.5 11.7 18.5 11.1 23.6 32.1 15.1 25.7 23.3 13.6 10.4 8.2 12.0 11.9 13.0 22.5 11.4 10.4 9.2 9.2 13.8 9.1 11.2 14.3 11.2 14.1 15.3 13.2 15.1 13.6 13.4 21.3 12.9 18.0 12.0 11.7 7.5 11.4 10.5 17.1 12.8 10.8 15.7 18.5 12.1 10.6 7.3 17.3 15.9 12.5 7.5 12.8 10.6 12.0 22.5 23.2 9.8 11.7 10.7 17.0 5.9 13.1 6.8 19.2 29.4 11.3 12.0 11.5 14.9 16.1 14.6 17.8 10.9 14.6 21.5 14.5 10.1 12.7 10.6 15.1 9.4 22.4 12.1 19.7 17.4 10.0 21.8 11.8 19.1 15.1 8.0 9.9 11.2 14.0 11.5 8.6 16.8 22.9 27.3 15.6 16.0 30.0 29.9 26.2 12.0 8.8 21.8 19.3 17.8 14.5 14.1 18.6 18.0 12.8 16.3 17.3 18.8 15.1 14.1 9.9 16.8 26.7 19.5 16.7 7.1 7.5 38.5 10.1 25.2 21.6 9.5 11.7 9.8 10.7 10.5 13.9 22.5 13.6 13.2 9.6 18.8 17.0 14.4 4.9 10.7 7.8 23.2 14.3 5.9 18.5 23.6 25.7 23.3 13.8 9.1 15.3 13.2 18.0 17.3 53.6 65.5 102.1 185.5 101.5 81.2 25.7 180.9 38.8 62.6 83.7 70.7 55.8 84.6 78.1 31.4 87.5 92.6 163.5 75.9 52.0 92.4 103.6 86.4 97.3 62.9 52.4 131.6 108.1 107.2 13.2 95.0 114.5 72.6 69.5 83.4 83.5 72.6 112.3 83.4 48.4 75.1 51.8 103.0 97.0 117.4 91.7 59.0 97.2 97.8 127.1 FAM193B "FLJ10404, IRIZIO, KIAA1931" ENSG00000146067 "Family with sequence similarity 193 member B" Q96PV7 5 177519788-177554541 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035847, HPA035848" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA035847: , HPA035848: AB_10601320" "unprognostic (6.58e-3)" "unprognostic (1.07e-1)" "unprognostic (8.95e-3)" "unprognostic (2.94e-1)" "unprognostic (1.81e-1)" "unprognostic (1.15e-3)" "unprognostic (4.07e-2)" "unprognostic (1.48e-2)" "unprognostic (1.91e-1)" "unprognostic (2.24e-1)" "unprognostic (1.71e-3)" "unprognostic (2.78e-2)" "prognostic unfavorable (3.71e-8)" "unprognostic (1.08e-1)" "unprognostic (1.35e-1)" "unprognostic (3.15e-1)" "prognostic favorable (1.30e-5)" 13.5 9.5 18.5 16.5 17.2 35.6 15.8 37.9 20.4 18.1 13.5 13.6 17.2 15.4 19.8 11.6 13.8 13.3 12.3 9.1 18.4 8.0 16.3 18.5 17.0 20.5 17.3 18.3 22.1 22.1 10.3 15.2 15.2 17.0 19.0 11.6 17.1 14.3 14.6 11.6 34.9 18.7 12.7 10.9 27.8 14.9 14.0 16.2 11.7 16.9 9.5 15.3 13.7 23.1 1.3 1.6 2.9 1.8 2.0 2.8 0.9 5.3 7.1 15.8 13.8 7.8 7.6 34.3 4.9 5.2 8.1 7.7 19.1 10.4 10.2 7.5 4.7 10.2 9.3 7.2 10.2 6.0 22.4 7.5 7.2 11.2 9.1 4.6 7.0 14.8 7.5 11.4 6.8 7.5 14.5 8.1 16.2 6.9 10.1 5.7 17.9 12.7 20.4 11.0 4.7 5.7 20.8 3.5 8.6 7.7 15.3 14.7 9.4 5.6 16.3 4.8 12.5 15.9 9.7 10.0 9.0 7.4 5.8 5.7 11.1 4.6 8.2 7.2 11.4 7.4 0.0 1.8 0.7 2.8 0.2 1.8 0.7 1.4 2.0 1.1 1.3 0.7 1.0 2.9 2.0 1.1 1.6 0.9 0.9 18.5 17.2 37.9 20.4 18.4 8.0 17.3 18.3 17.0 16.2 17.9 29.0 6.0 5.1 7.7 10.9 6.4 22.9 8.1 13.6 10.4 17.7 4.3 0.0 5.4 5.1 9.2 9.1 0.0 7.6 6.8 7.8 7.9 4.7 10.4 4.2 11.1 8.1 14.1 7.6 7.4 9.2 7.8 8.5 3.6 13.9 9.1 5.5 5.8 4.9 2.2 12.4 6.5 9.9 10.6 12.9 11.3 3.8 7.9 10.3 5.4 FAM208A "C3orf63, KIAA1105, RAP140, se89-1, TASOR" ENSG00000163946 "Family with sequence similarity 208 member A" Q9UK61 3 56620133-56683237 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006735, HPA017142" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006735: AB_1852384, HPA017142: AB_1852382" "unprognostic (1.46e-1)" "unprognostic (7.97e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-1)" "unprognostic (2.51e-2)" "unprognostic (2.30e-3)" "unprognostic (9.31e-2)" "unprognostic (3.91e-2)" "unprognostic (5.93e-2)" "unprognostic (1.51e-1)" "unprognostic (8.84e-2)" "unprognostic (1.73e-1)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (1.67e-1)" "unprognostic (2.74e-1)" 10.3 11.6 11.4 10.9 14.7 8.0 9.8 13.8 11.6 9.9 10.1 14.3 10.5 7.3 12.6 5.8 11.2 11.1 9.0 9.9 9.2 5.4 8.1 5.8 8.5 14.6 15.2 7.1 11.9 12.6 22.9 19.2 7.0 10.5 7.6 9.6 8.6 11.4 7.6 7.4 8.2 10.4 16.9 11.6 10.5 10.2 21.1 13.0 13.8 14.6 4.1 14.2 14.3 12.9 4.1 3.3 3.7 2.6 2.9 4.4 2.0 23.1 9.2 14.4 11.3 7.8 13.7 7.2 10.4 10.7 10.0 10.5 7.6 17.4 36.8 3.9 10.4 16.8 9.3 14.3 12.2 14.6 18.1 7.2 14.4 13.5 3.4 5.5 15.1 22.9 6.5 10.3 9.7 17.6 11.8 12.9 14.0 13.9 21.3 12.7 8.1 18.5 3.0 8.0 12.3 14.2 9.9 14.3 12.2 9.6 17.1 9.6 11.9 22.7 9.1 11.4 8.6 15.0 17.5 13.8 13.0 12.0 11.7 15.8 19.4 27.0 18.7 15.0 22.4 17.1 1.8 2.6 3.7 4.3 2.0 2.8 2.8 3.8 4.4 3.3 4.1 4.1 4.2 0.8 2.9 2.3 2.5 3.3 2.0 11.4 14.7 13.8 11.6 9.2 5.4 15.2 7.1 10.5 13.0 14.9 33.1 18.2 14.9 17.5 31.9 22.6 28.1 33.5 21.6 14.0 21.6 11.6 8.3 12.5 13.8 28.2 12.7 23.3 14.7 7.4 19.2 13.4 17.4 13.0 18.1 35.0 17.9 31.3 45.6 6.3 34.5 23.3 13.5 17.2 17.4 26.0 14.8 10.5 21.5 14.1 25.8 45.3 22.9 72.1 46.0 20.3 7.7 26.1 17.2 10.9 FAM208B "bA318E3.2, C10orf18, FLJ20360, KIAA2006" ENSG00000108021 "Family with sequence similarity 208 member B" Q5VWN6 10 5684838-5763740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038042, HPA038043, HPA061547" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038042: AB_10673038, HPA038043: AB_10672402, HPA061547: AB_2684558" "unprognostic (3.69e-2)" "unprognostic (3.13e-2)" "unprognostic (9.25e-2)" "unprognostic (8.83e-2)" "unprognostic (8.12e-3)" "unprognostic (4.84e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.39e-1)" "unprognostic (9.21e-2)" "unprognostic (8.36e-2)" "unprognostic (8.85e-2)" "unprognostic (4.88e-3)" "unprognostic (2.90e-3)" "unprognostic (2.98e-1)" "unprognostic (3.50e-1)" "unprognostic (7.79e-3)" "unprognostic (5.23e-2)" 15.4 15.5 10.1 22.9 13.6 16.1 16.4 18.9 13.4 18.7 15.0 11.8 13.6 8.6 21.2 20.7 14.6 19.6 13.4 16.9 12.0 9.3 13.6 15.9 15.1 20.5 15.0 10.6 23.8 19.4 26.2 24.3 16.0 12.6 15.9 15.8 12.9 15.6 17.0 26.9 12.7 16.4 17.4 12.8 16.7 15.7 29.7 14.0 19.5 22.6 14.1 21.1 17.4 22.0 4.3 2.2 1.8 2.4 8.6 3.2 0.8 17.5 14.9 9.6 16.3 12.4 14.8 13.5 15.0 9.6 12.9 16.4 15.7 10.4 35.9 9.6 14.7 8.2 13.9 27.4 15.4 21.0 7.0 18.4 16.7 11.6 10.5 12.4 12.3 10.0 11.3 17.3 21.0 17.9 8.7 14.9 14.0 26.9 8.4 14.4 11.8 15.9 4.4 11.7 11.4 9.7 11.9 13.4 12.5 7.8 16.0 11.8 13.3 14.9 13.6 10.7 11.3 17.8 9.7 14.9 16.4 17.7 31.5 20.4 10.3 9.8 32.1 8.1 12.2 8.6 1.4 2.4 0.5 2.4 2.3 2.2 2.1 1.8 2.3 1.4 4.3 1.8 3.2 1.8 8.6 0.9 2.2 2.4 0.8 10.1 13.6 18.9 13.4 12.0 9.3 15.0 10.6 12.6 14.0 23.8 20.2 21.5 15.6 30.7 32.0 24.6 20.4 12.0 38.7 10.4 35.3 9.2 1.7 13.8 20.4 26.3 9.8 0.0 9.8 8.6 27.3 25.1 3.5 14.3 8.9 20.6 13.2 21.5 13.5 6.2 25.0 14.4 20.3 16.2 15.4 14.3 13.9 11.5 26.9 8.1 36.0 25.8 25.9 60.2 44.9 36.6 6.1 20.8 19.4 27.5 FAM217B "C20orf177, dJ551D2.5" ENSG00000196227 "Family with sequence similarity 217 member B" Q9NTX9 20 59933764-59948680 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041021, HPA056698" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA041021: AB_10959734, HPA056698: AB_2683212" "unprognostic (1.78e-1)" "unprognostic (2.92e-2)" "unprognostic (2.88e-2)" "unprognostic (1.32e-2)" "unprognostic (9.43e-2)" "unprognostic (5.05e-2)" "unprognostic (9.04e-8)" "unprognostic (2.78e-3)" "unprognostic (4.51e-2)" "unprognostic (1.56e-1)" "unprognostic (1.17e-1)" "unprognostic (9.89e-2)" "unprognostic (1.13e-2)" "unprognostic (5.51e-2)" "unprognostic (1.55e-1)" "unprognostic (1.76e-1)" "unprognostic (2.63e-2)" 5.5 5.2 17.7 7.2 18.2 14.7 6.2 18.7 29.6 6.4 5.4 10.7 5.0 6.2 8.6 7.3 5.9 7.2 5.1 11.7 15.5 14.3 6.8 2.8 6.5 10.3 14.4 19.1 13.7 4.0 5.9 14.3 7.7 14.1 9.6 4.6 4.7 5.8 11.8 16.5 4.3 7.1 5.8 10.7 7.4 5.6 10.8 11.6 8.5 8.5 4.9 10.4 7.0 6.8 7.2 8.0 13.8 7.0 9.3 13.5 6.9 5.3 3.7 8.6 5.9 4.1 6.2 6.9 7.7 6.6 8.5 6.2 19.1 11.8 11.9 13.0 3.2 6.8 13.3 9.3 6.4 8.4 6.5 5.8 11.1 9.2 10.9 2.7 17.6 15.1 3.6 7.9 6.2 2.0 3.5 2.5 14.4 7.9 5.1 5.5 9.8 30.7 9.7 8.4 5.0 7.6 7.5 8.5 11.6 3.3 8.4 8.8 10.5 10.3 13.4 11.3 8.4 12.9 12.6 3.5 7.1 8.3 7.3 4.0 8.6 14.6 14.1 9.9 11.6 4.6 9.6 7.0 9.5 11.0 4.6 13.5 6.6 10.6 10.0 8.0 7.2 11.0 11.6 13.8 9.3 4.3 6.4 9.1 6.9 17.7 18.2 18.7 29.6 15.5 14.3 14.4 19.1 14.1 11.6 14.9 14.2 20.3 4.0 4.7 30.9 27.4 10.2 16.0 10.3 10.4 21.6 18.9 14.9 4.7 19.0 13.4 14.2 0.0 7.0 8.9 11.7 8.1 27.8 4.9 15.8 57.2 8.1 13.5 31.8 16.0 16.1 16.4 11.8 10.0 6.2 23.6 7.1 5.8 9.6 11.8 29.6 32.3 16.5 51.9 14.7 4.6 5.7 22.4 9.2 4.3 FAM222B "C17orf63, FLJ10700" ENSG00000173065 "Family with sequence similarity 222 member B" Q8WU58 17 28755978-28855232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051840, HPA062239" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051840: AB_2681633, HPA062239: AB_2684722" "unprognostic (4.11e-2)" "unprognostic (9.72e-2)" "unprognostic (9.12e-2)" "unprognostic (2.40e-3)" "unprognostic (1.57e-1)" "unprognostic (2.12e-2)" "prognostic unfavorable (3.45e-4)" "unprognostic (1.18e-2)" "unprognostic (1.05e-1)" "unprognostic (8.28e-3)" "unprognostic (1.63e-1)" "unprognostic (1.79e-1)" "unprognostic (3.70e-2)" "unprognostic (2.37e-2)" "unprognostic (1.46e-1)" "unprognostic (3.61e-2)" "unprognostic (7.18e-2)" 9.6 7.6 12.0 11.5 13.4 7.9 9.4 25.4 15.3 10.6 14.0 12.3 9.2 15.3 9.7 10.5 13.9 9.4 11.1 10.6 11.6 9.5 11.6 8.7 9.3 7.6 11.5 10.3 11.4 9.2 15.0 15.2 12.4 13.9 10.5 13.0 16.4 16.8 12.2 42.4 8.5 13.4 9.7 9.5 7.8 10.5 39.4 10.9 10.1 11.1 4.4 9.2 13.3 12.5 7.8 5.7 13.6 8.5 4.1 10.2 4.2 7.7 15.4 13.1 15.2 11.4 8.0 14.4 5.6 5.3 7.9 8.0 19.7 7.7 7.9 11.2 6.2 9.8 10.0 11.0 12.6 6.6 11.0 14.5 8.9 7.7 14.9 13.1 5.6 14.5 8.3 12.5 11.2 10.0 7.9 15.6 9.3 16.7 5.7 16.7 9.9 9.9 4.7 15.0 10.4 5.8 4.7 12.5 8.0 14.0 10.0 14.5 10.1 7.7 15.0 19.6 29.0 11.7 5.5 17.4 5.2 10.8 5.7 8.7 11.6 14.1 5.1 7.2 4.0 9.4 13.6 4.2 11.1 8.2 5.9 10.2 7.8 6.8 8.3 5.6 6.4 9.6 7.9 6.1 4.1 8.5 5.7 5.9 4.2 12.0 13.4 25.4 15.3 11.6 9.5 11.5 10.3 13.9 10.9 3.0 8.2 7.3 7.0 8.4 13.6 11.4 25.5 4.0 5.7 7.0 25.5 6.9 3.3 16.7 45.8 13.1 17.3 46.7 11.5 8.3 7.2 11.3 9.3 11.0 7.6 23.8 24.9 32.5 6.9 35.2 11.5 6.6 6.8 8.2 21.2 5.6 17.4 10.5 7.4 7.8 7.2 0.0 5.6 40.0 32.9 5.8 5.0 5.1 18.4 8.7 FAM50A "9F, DXS9928E, HXC-26, XAP5" ENSG00000071859 "Family with sequence similarity 50 member A" Q14320 X 154444126-154450654 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003585 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003585: AB_1080603" "unprognostic (1.95e-1)" "prognostic favorable (2.05e-4)" "prognostic unfavorable (9.52e-5)" "unprognostic (5.39e-2)" "unprognostic (4.73e-2)" "unprognostic (3.32e-1)" "prognostic unfavorable (3.15e-5)" "unprognostic (2.56e-1)" "unprognostic (4.62e-2)" "unprognostic (1.40e-1)" "unprognostic (3.64e-3)" "unprognostic (6.35e-2)" "unprognostic (3.28e-2)" "unprognostic (9.78e-2)" "unprognostic (1.18e-1)" "unprognostic (1.97e-2)" "unprognostic (4.14e-1)" 33.0 29.9 31.4 23.3 46.1 21.7 22.6 42.7 45.3 23.0 27.0 25.6 22.2 24.8 22.2 38.1 18.9 16.4 17.4 31.9 32.6 23.5 24.7 23.2 23.1 16.6 43.5 29.5 20.3 25.1 32.1 41.3 30.5 35.6 23.1 20.2 24.3 27.9 26.6 54.7 16.1 22.9 26.5 31.4 24.1 23.1 7.0 42.9 11.7 25.6 12.4 16.9 24.8 39.9 16.5 24.5 19.4 35.1 19.6 30.3 14.6 26.0 32.5 10.8 15.5 40.6 29.3 21.5 33.9 30.8 33.2 50.8 29.6 12.3 1.3 35.3 35.8 48.5 10.3 25.6 23.7 25.8 19.0 16.3 8.3 39.0 18.6 59.4 7.5 24.9 33.5 17.1 51.1 26.3 24.0 27.2 10.0 10.8 21.3 32.2 17.8 8.9 10.0 7.3 23.1 20.4 13.1 27.3 18.8 21.0 26.4 19.6 13.9 12.3 20.0 40.6 19.5 17.4 14.8 33.0 22.9 18.8 37.5 41.5 49.5 28.4 9.3 31.0 26.5 25.5 14.2 26.6 19.4 22.5 33.9 30.3 16.5 23.4 21.5 24.5 14.0 13.2 18.0 14.4 19.6 35.1 18.8 24.9 14.6 31.4 46.1 42.7 45.3 32.6 23.5 43.5 29.5 35.6 42.9 32.8 52.0 32.9 35.3 23.1 61.4 79.5 50.9 10.7 15.9 27.9 25.5 56.8 48.0 42.2 0.8 43.0 99.3 93.5 58.5 92.1 57.0 45.1 47.2 37.6 125.0 44.5 60.7 39.9 53.7 2.6 72.2 73.5 30.4 61.3 64.6 70.3 63.3 77.2 75.0 89.7 62.4 32.3 59.0 7.2 15.7 22.6 101.7 53.3 49.8 41.4 FAM50B "D6S2654E, X5L" ENSG00000145945 "Family with sequence similarity 50 member B" Q9Y247 6 3849386-3851317 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 42.6;MCF7: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA064111, HPA067817" Approved Enhanced "Nucleoplasm,Cytokinetic bridge,Midbody" Yes NA Nucleoplasm "Cytokinetic bridge, Midbody" "HPA064111: AB_2685191, HPA067817: AB_2685904" "unprognostic (1.15e-1)" "unprognostic (7.76e-2)" "unprognostic (4.28e-2)" "unprognostic (4.43e-2)" "unprognostic (2.12e-3)" "unprognostic (2.69e-1)" "unprognostic (2.38e-2)" "unprognostic (7.13e-2)" "unprognostic (1.60e-1)" "unprognostic (1.79e-1)" "unprognostic (2.15e-1)" "unprognostic (2.90e-1)" "prognostic favorable (4.01e-6)" "unprognostic (1.60e-1)" "unprognostic (3.22e-1)" "unprognostic (1.34e-1)" "unprognostic (9.39e-2)" 7.2 9.5 13.4 5.7 20.6 3.1 5.7 18.7 16.7 6.7 6.8 11.0 8.4 10.1 8.3 6.7 5.5 11.2 8.1 16.0 12.8 14.2 12.9 12.0 6.2 7.1 11.4 14.9 14.4 12.7 5.8 7.7 3.4 9.7 8.2 3.0 5.9 15.2 9.8 41.1 7.9 6.9 10.2 10.8 7.7 7.9 10.2 9.9 5.8 11.8 5.7 5.5 7.5 13.3 14.9 10.1 3.4 9.1 19.4 20.5 5.6 3.1 4.3 0.0 0.0 2.6 2.4 0.2 3.8 1.8 2.6 3.3 0.0 5.9 3.4 4.1 2.7 1.0 2.4 0.0 1.5 1.9 42.6 2.3 0.0 10.2 0.0 2.7 0.0 0.0 2.7 3.0 2.0 0.6 0.8 2.6 0.0 0.0 0.0 2.3 13.4 0.0 4.7 0.9 2.0 2.0 0.0 0.0 0.0 1.2 0.0 6.0 5.3 6.2 3.9 0.2 0.0 4.2 3.8 3.5 0.0 0.4 5.1 0.0 0.0 9.2 0.0 1.4 0.3 7.1 3.4 4.7 2.4 7.1 6.1 16.8 14.9 13.6 9.2 6.1 12.9 11.3 7.1 1.9 19.4 9.1 10.1 20.5 5.6 13.4 20.6 18.7 16.7 12.8 14.2 11.4 14.9 9.7 9.9 14.9 6.5 6.5 5.9 5.7 17.4 15.7 5.1 4.0 7.9 12.2 3.9 3.3 28.2 10.7 24.9 4.1 2.2 0.0 9.9 4.8 5.8 2.7 3.5 18.8 8.7 14.3 1.2 8.6 4.1 25.0 7.8 4.0 11.8 10.0 3.3 19.1 7.9 3.6 10.3 32.6 12.6 0.0 7.9 34.4 39.6 5.8 0.8 4.5 3.3 1.6 FANCI "FLJ10719, KIAA1794" ENSG00000140525 "Fanconi anemia complementation group I" Q9NVI1 15 89243949-89317261 "Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 44.4;testis: 28.3" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 46.7;Spermatocytes: 45.0;Spermatogonia: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039972, HPA040379" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039972: AB_10673265, HPA040379: AB_2676951" "unprognostic (6.88e-2)" "unprognostic (1.37e-2)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (2.99e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (1.11e-4)" "unprognostic (6.82e-3)" "unprognostic (1.15e-2)" "unprognostic (4.59e-3)" "prognostic unfavorable (3.59e-4)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.71e-13)" "unprognostic (2.40e-2)" "unprognostic (2.72e-1)" "unprognostic (1.27e-1)" "unprognostic (2.12e-1)" 3.7 3.2 1.7 11.1 3.3 16.5 3.3 1.8 5.6 3.8 5.9 3.0 2.7 3.3 3.3 3.3 10.7 2.1 1.8 2.8 2.5 1.5 2.4 2.0 3.5 13.4 5.0 2.6 3.1 2.3 1.8 1.5 7.1 2.9 2.8 7.6 2.3 4.0 1.7 1.3 5.4 4.9 3.8 2.8 6.7 4.6 28.3 3.2 44.4 1.7 9.2 15.4 3.9 4.6 3.8 3.9 17.7 3.8 4.6 10.6 3.0 24.5 28.2 30.2 20.3 2.7 3.9 18.7 23.6 13.6 29.6 36.2 22.3 22.4 45.5 12.8 7.8 18.9 33.7 46.1 16.0 27.9 29.0 28.8 45.1 41.5 10.4 0.4 32.5 23.0 2.1 1.6 20.8 10.6 4.3 12.0 28.1 31.1 33.6 19.7 14.0 33.9 11.2 23.7 16.1 10.4 29.5 44.0 19.5 6.8 45.4 22.5 19.3 24.4 17.3 11.0 21.3 19.1 14.8 8.2 24.6 25.1 22.5 35.8 22.3 46.3 35.1 9.2 29.0 24.6 17.7 2.4 2.8 5.2 3.0 2.9 3.5 5.0 6.8 2.1 3.8 4.1 6.0 3.7 4.6 3.8 3.9 10.6 3.0 1.7 3.3 1.8 5.6 2.5 1.5 5.0 2.6 2.9 3.2 3.0 1.0 3.7 1.8 3.8 2.1 2.7 0.0 8.1 4.5 1.8 0.0 8.3 0.0 1.7 5.9 1.6 1.3 46.7 2.5 15.5 2.7 1.4 2.3 0.8 6.8 1.6 1.2 9.2 3.1 5.3 3.1 4.3 1.7 3.6 4.5 9.5 2.2 0.0 1.4 1.0 1.7 6.5 1.9 45.0 68.0 2.0 10.4 5.2 4.4 1.7 FBXO32 "ATROGIN1, Fbx32, MAFbx" ENSG00000156804 "F-box protein 32" Q969P5 8 123497889-123541206 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 200.5" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 172.4;Cardiomyocytes: 242.3;Glandular cells: 165.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 2.9;gdT-cell: 3.7;MAIT T-cell: 3.6;memory CD4 T-cell: 5.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 6.0;naive CD8 T-cell: 7.6;NK-cell: 4.4;T-reg: 4.5" "Group enriched" "Detected in many" 7 "granulocytes: 2.9;NK-cells: 4.4;T-cells: 7.6" "Cell line enhanced" "Detected in some" "GAMG: 17.4;HDLM-2: 59.1;hTERT-RPE1: 20.6;U-251 MG: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA058955, HPA065209" Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA058955: , HPA065209: AB_2685433" "unprognostic (2.55e-1)" "unprognostic (3.62e-1)" "unprognostic (1.80e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.11e-2)" "unprognostic (1.23e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (8.58e-3)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (7.97e-3)" 3.5 1.5 2.4 4.9 5.1 0.8 13.2 1.0 3.8 5.6 31.1 8.9 14.4 2.6 25.3 5.8 8.1 15.8 16.6 26.1 2.9 2.1 1.5 1.0 1.7 4.1 10.2 2.5 9.5 2.0 0.9 5.6 4.9 7.3 19.7 8.0 4.2 8.0 23.1 200.5 3.7 6.5 36.9 8.8 1.7 10.8 3.5 7.6 0.2 9.0 15.1 3.1 24.8 16.1 0.6 0.2 2.9 0.3 4.4 7.6 1.4 1.7 0.3 0.0 0.0 3.8 0.9 0.6 0.3 3.9 0.2 0.4 0.0 1.0 0.0 1.1 2.9 17.4 0.1 0.0 0.3 0.3 59.1 1.3 0.0 2.0 0.0 5.2 0.0 0.2 7.6 2.6 0.9 1.1 20.6 0.2 0.8 0.1 0.5 0.2 0.4 0.2 0.0 0.0 0.7 0.3 0.0 0.0 0.3 0.6 0.5 0.1 0.3 0.4 6.7 6.8 0.4 6.6 0.1 0.2 1.1 0.3 0.3 17.7 6.1 0.8 0.1 4.5 0.0 0.8 2.9 0.3 0.0 3.7 0.2 3.6 0.6 5.1 5.4 0.2 0.6 6.0 7.6 0.2 4.4 0.2 0.1 4.5 1.4 2.4 5.1 1.0 3.8 2.9 2.1 10.2 2.5 7.3 7.6 0.0 3.0 0.9 172.4 10.2 7.9 242.3 2.5 2.7 20.5 7.0 33.4 13.8 8.3 11.6 2.6 7.7 43.7 23.3 26.4 10.2 11.3 165.2 0.0 1.5 4.9 20.6 98.1 0.6 3.2 2.7 36.8 2.9 42.2 1.0 40.8 51.7 39.4 23.2 57.7 3.3 92.8 19.4 73.6 5.4 1.3 5.5 91.3 21.0 19.3 65.2 FCHO1 KIAA0290 ENSG00000130475 "FCH domain only 1" O14526 19 17747718-17788568 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 25.7;bone marrow: 18.9;brain: 30.2;lymphoid tissue: 22.6;skin 1: 13.4" "Cell type enhanced" "Detected in many" 6 "B-cells: 10.4;granulocytes: 9.2;Kupffer cells: 12.6;Macrophages: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 28.2;RPMI-8226: 19.4;U-937: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041653, HPA062981" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041653: AB_10795641, HPA062981: AB_2684915" "unprognostic (3.02e-1)" "unprognostic (9.52e-2)" "unprognostic (1.80e-1)" "unprognostic (4.54e-3)" "unprognostic (3.62e-2)" "unprognostic (5.63e-2)" "unprognostic (3.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.84e-1)" "unprognostic (2.16e-1)" "unprognostic (6.93e-2)" "unprognostic (5.48e-3)" "unprognostic (1.72e-9)" "unprognostic (3.76e-3)" "unprognostic (1.18e-1)" "unprognostic (2.21e-1)" "unprognostic (9.77e-3)" 2.2 2.3 13.6 13.7 18.9 18.9 1.9 11.4 15.2 1.1 2.7 30.2 0.0 3.7 1.8 1.8 1.5 1.9 4.5 1.1 17.8 11.7 1.0 2.7 3.4 22.6 23.0 10.0 2.2 0.9 0.8 2.6 1.4 10.8 1.4 2.6 0.6 2.7 1.2 0.9 13.4 4.0 2.1 15.9 13.7 3.5 4.3 23.3 16.4 1.2 0.0 17.3 5.1 1.0 9.9 10.4 25.7 9.5 4.1 5.7 4.4 0.4 5.4 3.5 2.5 0.1 0.1 3.5 0.5 0.1 0.1 0.2 0.7 0.6 28.2 8.1 0.2 0.6 1.1 1.7 1.0 0.1 12.4 0.9 2.2 0.7 2.8 0.3 6.9 4.8 0.0 0.1 0.1 0.2 0.2 0.7 14.0 11.0 13.5 0.0 7.8 16.0 12.5 1.7 6.6 13.4 13.6 0.1 19.4 0.1 0.5 0.6 1.3 0.1 2.8 0.4 0.4 2.7 7.0 0.5 0.1 2.0 0.5 0.2 8.6 3.9 15.2 0.4 17.4 0.3 6.9 6.6 6.5 5.2 9.5 4.5 8.8 5.7 4.5 9.7 9.9 5.5 4.4 25.7 4.1 7.2 10.4 5.2 4.4 13.6 18.9 11.4 15.2 17.8 11.7 23.0 10.0 10.8 23.3 0.0 1.0 10.4 0.4 0.0 6.7 0.8 2.5 0.0 0.0 1.8 0.0 2.7 0.0 0.4 1.0 0.8 0.8 0.0 0.0 3.7 0.4 0.2 9.2 0.0 6.5 0.0 1.2 3.7 12.6 0.0 2.3 11.9 1.7 4.6 1.4 0.2 1.4 0.0 8.1 0.0 0.7 0.0 0.4 0.7 1.7 0.5 0.7 5.4 1.0 0.1 FEM1C "EUROIMAGE686608, EUROIMAGE783647, FEM1A, KIAA1785" ENSG00000145780 "Fem-1 homolog C" Q96JP0 5 115520908-115544894 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 58.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059919, HPA060977" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059919: AB_2684161, HPA060977: AB_2684402" "unprognostic (1.14e-2)" "unprognostic (3.02e-1)" "prognostic favorable (1.83e-4)" "unprognostic (1.28e-1)" "unprognostic (3.31e-1)" "unprognostic (7.56e-2)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (4.67e-2)" "unprognostic (5.52e-3)" "unprognostic (1.99e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.64e-1)" "unprognostic (3.37e-1)" "unprognostic (1.37e-2)" "unprognostic (1.05e-2)" 18.2 6.8 15.9 8.6 19.4 58.5 14.6 21.1 19.6 15.1 14.2 12.2 10.7 12.1 11.3 7.5 16.4 8.7 13.8 28.6 13.9 8.6 8.7 16.8 15.3 7.3 12.9 17.1 10.7 12.1 6.9 8.2 7.2 14.9 11.5 13.7 6.4 8.5 9.9 24.3 13.1 17.4 12.2 15.3 9.0 14.2 14.1 14.5 4.1 9.5 15.4 7.4 16.5 10.2 3.3 6.1 6.4 10.9 3.0 5.5 3.6 8.3 5.0 7.3 11.3 13.1 18.5 5.9 13.3 10.6 10.0 11.7 5.5 7.5 8.6 9.1 9.7 11.6 6.6 5.8 11.1 14.8 13.2 5.5 4.5 7.2 4.2 8.7 3.0 6.1 12.1 9.4 12.5 11.4 9.4 9.8 7.2 2.8 11.3 15.1 3.6 7.7 5.0 5.1 5.3 6.4 6.6 13.3 9.3 11.2 15.9 6.0 4.8 8.6 6.0 14.3 6.1 7.8 6.0 17.2 17.3 9.0 15.8 11.8 9.0 6.5 6.9 10.1 8.4 6.9 2.5 6.1 6.4 3.8 9.4 5.5 3.3 4.0 2.8 6.1 1.9 4.6 3.7 6.4 3.0 10.9 1.6 4.4 3.6 15.9 19.4 21.1 19.6 13.9 8.6 12.9 17.1 14.9 14.5 20.8 9.9 10.7 13.5 23.6 14.9 28.2 20.4 13.4 11.4 10.4 19.6 3.5 5.0 10.4 38.8 19.0 31.9 46.7 7.2 6.7 26.4 18.1 12.7 36.5 6.8 4.8 16.0 17.2 16.7 59.6 8.1 16.4 28.7 5.4 24.9 18.7 16.0 17.6 6.3 9.1 26.4 0.0 24.7 6.9 6.1 21.7 4.2 6.9 17.8 26.6 FEN1 "FEN-1, MF1, RAD2" ENSG00000168496 "Flap structure-specific endonuclease 1" P39748 11 61792637-61797244 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.3" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 61.7;Spermatogonia: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002262, HPA006748" Enhanced Enhanced Nucleoplasm,Nucleoli NA Yes 38000 Nucleoplasm Nucleoli "CAB002262: AB_563729, HPA006748: AB_1848494" "unprognostic (1.82e-1)" "unprognostic (2.71e-2)" "unprognostic (3.76e-2)" "unprognostic (2.77e-1)" "unprognostic (1.26e-1)" "unprognostic (6.45e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (1.50e-2)" "unprognostic (9.82e-2)" "prognostic favorable (7.85e-4)" "unprognostic (2.82e-3)" "unprognostic (5.86e-2)" "prognostic unfavorable (5.73e-6)" "prognostic favorable (9.46e-4)" "unprognostic (1.10e-1)" "unprognostic (4.49e-3)" "unprognostic (4.04e-2)" 4.8 9.6 7.9 14.6 8.5 23.9 7.4 16.9 14.9 4.9 11.0 8.5 5.0 8.1 5.0 6.6 13.3 4.2 7.0 4.6 8.6 8.5 4.9 9.3 5.0 22.5 8.3 9.8 3.9 6.3 5.2 7.9 11.2 12.6 4.7 12.0 7.3 9.3 4.6 11.2 6.8 8.2 6.4 7.1 12.3 7.2 16.2 5.9 36.3 3.5 10.6 25.5 6.1 4.2 11.5 18.1 14.5 9.4 13.3 18.0 7.3 31.2 28.8 31.6 17.0 3.1 3.9 20.1 27.7 15.8 33.9 38.6 25.1 23.6 45.1 21.6 11.7 32.0 33.1 44.4 24.2 34.8 23.7 24.5 23.8 39.3 25.6 2.4 37.0 24.7 2.7 3.3 31.3 8.3 5.0 13.2 25.5 36.0 32.7 28.1 39.4 51.6 33.3 34.7 24.6 28.2 35.4 36.6 46.6 13.5 29.6 36.0 29.9 18.5 24.2 15.9 15.5 35.1 26.0 8.8 30.2 38.2 38.4 27.8 25.9 40.2 46.9 21.1 24.8 26.0 14.5 5.0 10.2 12.4 9.4 13.1 11.5 10.0 11.8 5.8 11.5 11.2 11.3 2.1 13.3 8.8 18.1 18.0 7.3 7.9 8.5 16.9 14.9 8.6 8.5 8.3 9.8 12.6 5.9 0.0 2.1 12.6 4.8 9.2 21.1 4.0 5.1 6.7 3.4 0.0 11.8 28.6 6.6 11.6 16.8 2.7 3.1 23.3 10.5 61.7 7.6 4.4 0.0 6.8 21.8 14.3 4.6 1.3 5.1 9.8 5.2 7.1 5.0 19.0 5.3 29.9 9.3 6.0 6.7 4.7 20.5 0.0 4.2 33.0 63.4 5.4 25.9 14.1 13.0 3.7 FIP1L1 "DKFZp586K0717, FIP1" ENSG00000145216 "Factor interacting with PAPOLA and CPSF1" Q6UN15 4 53377643-53460861 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "mRNA processing" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037475, HPA058202" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037475: AB_10696933, HPA058202: AB_2683636" "unprognostic (3.80e-1)" "unprognostic (5.46e-2)" "unprognostic (5.60e-3)" "unprognostic (1.40e-1)" "unprognostic (7.18e-2)" "unprognostic (4.71e-2)" "prognostic unfavorable (1.51e-4)" "unprognostic (1.87e-1)" "unprognostic (9.00e-3)" "unprognostic (1.14e-2)" "unprognostic (5.48e-2)" "unprognostic (1.42e-1)" "unprognostic (4.07e-1)" "unprognostic (1.10e-1)" "unprognostic (8.66e-3)" "unprognostic (3.10e-2)" "unprognostic (1.39e-1)" 25.7 24.4 20.2 27.6 25.8 35.8 24.0 23.0 25.1 24.5 18.0 19.4 16.1 16.0 27.4 17.7 23.4 22.4 16.2 19.7 17.1 16.6 19.7 19.0 20.3 24.5 20.1 26.0 32.2 16.9 26.6 26.6 28.2 20.9 21.7 21.0 16.2 21.5 18.0 33.9 24.5 20.0 23.5 19.4 24.5 20.4 40.2 22.4 42.4 22.7 17.8 29.2 26.6 22.6 26.5 32.7 36.5 24.0 33.7 32.4 21.3 18.3 12.1 22.2 13.3 16.8 17.1 28.4 23.3 29.3 19.0 14.7 17.6 17.1 33.7 18.1 24.8 17.8 11.6 24.1 17.3 24.7 11.7 13.1 26.6 10.0 16.2 26.7 39.5 22.8 19.6 15.8 24.0 24.6 18.4 14.0 20.4 30.6 15.8 14.9 13.5 35.6 18.2 14.6 23.5 11.9 32.0 10.1 14.8 15.4 16.6 17.3 18.7 16.3 18.8 26.7 21.8 10.7 14.7 14.7 19.5 17.0 18.1 27.9 19.8 11.5 42.6 16.9 24.8 34.7 25.8 16.9 36.5 25.7 17.8 29.2 26.5 25.8 25.1 22.6 24.2 28.9 25.4 20.7 33.7 24.0 32.7 32.4 21.3 20.2 25.8 23.0 25.1 17.1 16.6 20.1 26.0 20.9 22.4 23.8 20.1 45.5 37.4 34.5 40.5 13.1 17.8 45.5 27.3 26.2 17.7 52.0 31.5 34.1 7.4 26.3 21.3 0.0 30.6 43.6 38.6 25.4 47.4 18.7 28.6 73.1 35.2 33.2 19.4 8.8 61.9 27.7 30.4 46.9 24.6 45.2 30.3 31.7 50.2 19.6 28.8 38.8 24.7 112.4 78.8 29.7 72.2 41.5 25.5 30.3 FKBP4 "FKBP52, FKBP59" ENSG00000004478 "FK506 binding protein 4" Q02790 12 2794953-2805423 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Chaperone, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "vagina: 209.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006148, CAB017441, HPA062857" Supported Enhanced Nucleoplasm,Cytosol NA NA 110000 Cytosol Nucleoplasm "CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: AB_2684883" "unprognostic (1.46e-2)" "unprognostic (1.73e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (7.65e-4)" "unprognostic (1.97e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.12e-5)" "prognostic unfavorable (1.44e-4)" "unprognostic (3.43e-1)" "unprognostic (3.25e-2)" "unprognostic (1.72e-1)" "unprognostic (3.14e-1)" "unprognostic (3.89e-2)" "unprognostic (1.59e-2)" "unprognostic (1.76e-1)" "unprognostic (1.59e-1)" "unprognostic (2.22e-1)" 16.2 21.6 26.0 13.7 30.7 13.3 40.7 50.4 31.9 19.9 22.6 22.8 36.2 13.1 20.1 30.7 34.2 25.7 16.4 20.4 25.0 32.5 31.6 31.3 15.8 11.7 44.7 23.4 23.9 30.3 30.1 19.5 32.0 39.4 30.2 25.3 11.5 30.1 31.6 33.5 25.3 16.1 26.4 25.2 11.5 25.3 36.0 42.1 15.6 47.1 16.5 18.5 17.4 209.6 13.8 6.0 10.9 13.7 8.4 14.0 9.9 15.3 34.2 9.9 16.6 12.3 7.3 47.5 15.1 5.4 25.0 16.9 34.0 18.8 20.5 4.3 9.7 17.4 21.1 61.5 20.5 30.1 37.5 39.4 22.6 25.1 12.0 9.5 17.6 6.2 6.6 18.8 29.5 29.6 14.9 14.5 20.8 20.7 29.3 10.0 44.1 30.9 16.0 84.3 45.3 24.7 18.6 17.4 12.3 21.0 19.6 14.3 20.5 17.5 47.8 7.6 64.7 64.4 12.0 7.7 12.3 38.7 13.8 38.0 7.3 11.2 30.3 10.9 26.4 12.5 10.9 10.8 5.9 12.5 9.8 14.0 13.3 11.1 11.8 6.0 13.8 11.8 13.7 1.5 8.4 13.7 5.3 10.1 9.9 26.0 30.7 50.4 31.9 25.0 32.5 44.7 23.4 39.4 42.1 6.0 8.6 47.9 182.5 127.9 60.2 11.7 40.8 16.0 12.5 50.6 70.7 148.6 131.0 77.3 90.2 33.8 86.8 0.0 22.4 85.7 62.6 189.3 39.1 41.9 54.7 92.2 101.7 12.3 15.0 26.1 32.2 42.7 87.7 52.3 61.6 41.8 62.2 84.2 36.4 112.7 51.3 84.1 88.6 179.1 92.0 116.1 186.7 20.2 77.5 121.3 FKBP5 "FKBP51, FKBP54, P54, PPIase, Ptg-10" ENSG00000096060 "FK506 binding protein 5" Q13451 6 35573585-35728583 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Chaperone, Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 277.2" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 325.8;Peritubular cells: 205.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 103.4;ASC TERT1: 64.4;HHSteC: 81.0;HSkMC: 97.8;hTCEpi: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009315, HPA031092, HPA031093, HPA031095" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734" "unprognostic (2.09e-3)" "unprognostic (1.70e-1)" "unprognostic (1.44e-2)" "unprognostic (1.17e-2)" "unprognostic (1.02e-1)" "unprognostic (1.93e-1)" "unprognostic (4.72e-1)" "unprognostic (6.30e-3)" "unprognostic (3.70e-3)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "unprognostic (1.73e-1)" "unprognostic (7.48e-3)" "unprognostic (2.18e-3)" "unprognostic (8.31e-2)" "unprognostic (4.22e-2)" "unprognostic (6.90e-3)" 78.8 20.7 9.5 14.2 15.6 4.9 36.7 2.4 10.9 16.5 29.0 5.1 29.8 2.2 18.6 16.9 29.2 19.4 17.9 26.3 10.6 4.2 44.9 30.7 19.7 55.9 15.7 3.6 27.2 43.7 8.6 33.8 6.0 13.1 18.3 8.2 11.8 30.4 25.1 277.2 20.2 36.7 18.6 18.2 32.3 25.0 14.3 12.4 20.1 24.2 9.8 16.8 22.5 18.4 4.0 30.6 24.9 31.2 11.8 42.3 39.9 5.0 2.2 9.7 14.4 103.4 64.4 0.1 2.7 0.1 1.8 4.1 3.8 0.9 25.0 2.6 0.5 1.5 0.0 5.7 12.1 4.3 9.8 5.5 10.7 1.9 5.3 81.0 6.7 1.1 97.8 49.2 3.1 29.7 1.9 10.5 5.0 11.4 10.2 19.0 3.2 27.9 12.6 2.5 1.1 1.6 12.4 2.5 12.2 8.0 3.0 3.7 2.2 2.2 2.6 0.5 2.2 14.3 7.9 23.2 2.6 2.3 0.3 3.8 4.6 5.3 31.7 0.8 13.2 1.0 13.7 31.2 19.4 20.0 27.0 23.8 3.0 28.2 20.8 30.6 4.0 42.3 30.2 24.9 11.8 12.0 9.2 10.3 39.9 9.5 15.6 2.4 10.9 10.6 4.2 15.7 3.6 13.1 12.4 11.9 9.9 41.7 52.1 15.7 1.7 110.1 79.0 21.4 13.6 5.2 0.0 0.6 19.9 0.5 8.8 66.1 19.7 163.5 6.9 0.9 22.2 38.7 36.0 165.7 28.8 0.0 20.1 130.8 325.8 11.8 149.0 56.5 6.8 91.0 17.5 3.7 3.3 9.3 205.4 16.3 18.2 142.3 28.8 11.6 19.2 18.6 0.3 117.1 19.5 19.5 FLII "FLI, Fli1, FLIL, MGC39265" ENSG00000177731 "FLII, actin remodeling protein" Q13045 17 18244836-18258916 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Actin-binding, Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007084, HPA008903, CAB016132" Approved Enhanced "Nucleoplasm,Centriolar satellite,Cytosol" NA NA 1800000 "Nucleoplasm, Centriolar satellite, Cytosol" "CAB016132: AB_627613, HPA007084: AB_1848638, HPA008903: AB_1848640" "unprognostic (8.09e-2)" "unprognostic (1.09e-2)" "unprognostic (6.89e-2)" "unprognostic (2.53e-2)" "unprognostic (4.22e-2)" "unprognostic (4.78e-2)" "unprognostic (1.88e-2)" "unprognostic (1.23e-2)" "unprognostic (4.91e-2)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (2.47e-3)" "unprognostic (4.03e-2)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (2.06e-1)" "unprognostic (3.39e-2)" 21.2 16.8 8.6 16.9 12.4 16.6 21.7 11.7 11.4 17.5 18.5 12.8 14.3 14.6 17.3 16.3 25.9 13.7 15.6 28.3 9.3 7.4 19.0 18.8 17.3 13.4 15.0 6.1 15.3 20.0 15.4 13.5 15.8 13.6 17.2 10.7 11.0 21.3 17.0 78.4 14.4 18.9 19.1 11.1 20.0 15.4 15.6 11.9 21.2 15.1 25.4 17.5 21.5 16.3 5.3 16.0 12.9 24.9 5.2 7.2 10.3 58.1 21.0 6.0 9.1 13.8 12.5 9.0 16.2 19.6 18.3 11.4 26.8 13.3 11.4 17.0 18.5 10.6 26.0 8.0 26.9 10.7 9.5 12.5 6.2 15.5 10.6 15.6 6.9 13.2 11.3 16.4 14.9 22.5 11.7 17.6 10.6 5.0 4.6 10.7 17.3 10.2 5.8 6.2 25.7 11.0 10.0 26.8 14.1 13.6 16.5 2.1 3.1 18.8 16.1 8.7 39.0 27.4 5.4 21.7 16.3 16.8 31.3 19.0 4.8 3.5 3.4 15.4 6.7 8.8 4.8 13.6 12.9 7.0 21.4 7.2 5.3 5.8 7.2 16.0 3.6 4.3 4.6 12.0 5.2 24.9 4.7 6.6 10.3 8.6 12.4 11.7 11.4 9.3 7.4 15.0 6.1 13.6 11.9 56.6 34.6 18.1 20.3 20.1 16.0 33.1 25.5 45.5 44.3 24.4 17.7 22.0 13.3 53.5 34.8 28.6 52.0 0.0 48.6 24.9 20.8 27.1 45.1 16.9 44.4 25.4 23.0 27.0 42.1 5.3 30.0 48.8 15.1 55.1 23.3 10.6 95.0 43.3 32.9 17.6 11.3 32.3 21.1 39.6 18.8 17.1 21.3 28.0 32.6 31.1 FOSL2 "FLJ23306, FRA2" ENSG00000075426 "FOS like 2, AP-1 transcription factor subunit" P15408 2 28392448-28417312 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Smooth muscle cells: 255.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 23.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004817, CAB013460, HPA061417" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013460: , HPA004817: AB_1849014, HPA061417: AB_2684509" "unprognostic (1.21e-1)" "unprognostic (3.60e-1)" "unprognostic (1.21e-1)" "unprognostic (8.55e-2)" "unprognostic (1.28e-3)" "unprognostic (3.41e-2)" "unprognostic (7.24e-2)" "unprognostic (3.78e-3)" "unprognostic (1.08e-1)" "unprognostic (7.73e-3)" "unprognostic (1.40e-2)" "unprognostic (2.08e-1)" "unprognostic (2.38e-1)" "unprognostic (2.38e-1)" "unprognostic (1.72e-2)" "unprognostic (1.99e-2)" "unprognostic (2.79e-2)" 62.8 66.9 7.3 24.6 11.2 74.5 22.5 5.4 11.9 34.4 35.4 7.0 15.0 11.4 43.8 16.3 49.6 26.6 42.0 30.3 12.0 4.7 17.2 12.6 32.2 4.4 10.2 3.6 62.0 14.1 4.1 14.2 20.8 15.9 36.4 15.9 11.4 16.2 22.1 56.3 31.1 37.2 40.8 20.0 20.4 25.4 13.8 8.0 2.1 13.6 16.2 14.5 47.1 79.7 0.0 2.5 23.0 6.2 2.7 5.1 2.8 12.5 8.6 0.5 6.7 7.1 12.6 18.2 10.8 11.0 17.3 15.1 10.2 10.0 0.0 15.9 13.8 17.6 12.1 0.7 14.2 15.6 2.9 0.9 1.3 16.1 1.7 11.2 2.2 5.5 20.0 36.4 20.2 17.9 14.6 9.0 0.4 0.1 3.6 11.5 2.0 0.2 6.8 1.0 12.8 4.3 0.5 16.8 1.2 27.7 43.6 4.6 0.6 17.5 10.3 3.1 5.2 1.1 10.1 26.9 36.4 24.6 21.1 15.6 5.6 2.0 0.0 24.1 12.3 6.2 8.8 6.2 5.4 5.1 4.7 5.0 0.0 1.1 2.5 2.5 0.0 0.3 1.7 23.0 2.7 3.8 0.8 0.7 2.8 7.3 11.2 5.4 11.9 12.0 4.7 10.2 3.6 15.9 8.0 29.8 69.6 2.4 72.6 127.2 0.5 23.8 50.9 13.4 25.0 158.7 0.0 19.1 16.6 56.4 1.1 60.9 113.3 0.0 51.5 108.4 60.6 59.1 105.2 12.4 34.3 0.0 26.9 49.7 65.1 2.2 20.8 81.0 81.0 38.7 56.3 0.5 55.4 66.6 23.0 25.4 1.0 25.8 255.1 1.7 2.5 131.7 42.0 34.6 44.8 118.3 FOXO3 "AF6q21, FKHRL1, FOXO2, FOXO3A" ENSG00000118689 "Forkhead box O3" O43524 6 108559835-108684774 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Erythroid cells: 210.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004074, HPA063104" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004074: AB_2106672, HPA063104: AB_2684941" "unprognostic (3.42e-2)" "unprognostic (3.76e-2)" "unprognostic (4.28e-2)" "unprognostic (1.96e-2)" "unprognostic (6.68e-2)" "unprognostic (4.63e-2)" "unprognostic (4.08e-3)" "unprognostic (1.73e-1)" "unprognostic (3.81e-2)" "unprognostic (5.18e-2)" "unprognostic (1.98e-2)" "unprognostic (1.75e-1)" "unprognostic (2.54e-2)" "unprognostic (9.09e-2)" "unprognostic (1.13e-1)" "unprognostic (5.81e-2)" "unprognostic (5.68e-2)" 29.6 7.7 11.5 12.2 12.6 36.7 35.4 28.0 18.1 19.9 16.1 12.6 9.8 7.8 17.4 16.1 22.3 16.5 18.0 12.9 9.7 7.7 10.7 14.0 21.1 16.8 12.4 14.0 28.8 52.3 14.3 8.8 13.1 10.3 13.8 11.0 14.3 21.2 10.5 54.7 20.3 11.3 13.9 7.9 14.2 14.8 13.1 13.2 11.6 13.1 12.7 10.2 17.1 20.3 1.8 2.7 15.7 4.6 3.4 4.0 1.0 9.1 3.3 6.0 9.7 18.6 22.3 7.5 7.6 8.0 6.7 9.2 5.9 8.3 5.9 6.5 8.9 9.8 6.7 6.2 9.3 10.0 5.3 9.0 14.7 2.9 4.4 21.7 3.5 10.8 25.4 18.8 13.7 18.8 9.3 5.0 5.4 9.8 40.1 12.1 5.2 4.9 5.4 3.9 4.4 5.0 5.7 17.1 19.7 13.3 7.0 10.6 27.6 6.5 5.3 7.6 11.0 5.8 11.7 8.0 11.4 6.4 7.0 9.8 0.7 6.9 5.6 6.2 7.1 7.8 6.7 2.9 5.7 3.6 1.5 4.0 1.0 1.9 3.0 1.7 1.8 1.7 2.3 15.7 3.4 4.6 2.7 1.8 1.0 11.5 12.6 28.0 18.1 9.7 7.7 12.4 14.0 10.3 13.2 41.7 39.5 22.4 61.6 60.1 55.0 28.2 73.9 44.2 46.6 24.4 66.8 19.2 14.9 43.0 12.5 63.2 36.2 210.2 26.5 31.0 67.9 115.8 15.0 60.6 39.1 49.3 64.2 66.9 66.3 12.1 98.7 35.8 54.0 43.3 49.3 89.6 53.0 33.6 94.4 15.9 67.1 32.3 89.8 7.2 18.1 40.7 34.4 35.5 29.9 108.9 FOXP1 "12CC4, hFKH1B, HSPC215, QRF1" ENSG00000114861 "Forkhead box P1" Q9H334 3 70952817-71583993 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 40.2" "HPA003876, CAB011501" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB011501: AB_732428, HPA003876: AB_1078907" "unprognostic (2.31e-1)" "unprognostic (4.35e-3)" "unprognostic (2.09e-2)" "unprognostic (3.54e-2)" "unprognostic (2.69e-1)" "unprognostic (2.81e-3)" "unprognostic (1.68e-1)" "unprognostic (1.00e-1)" "unprognostic (1.23e-1)" "unprognostic (2.03e-1)" "unprognostic (4.38e-3)" "unprognostic (3.40e-1)" "unprognostic (6.14e-2)" "unprognostic (1.05e-1)" "unprognostic (8.65e-2)" "unprognostic (1.27e-1)" "unprognostic (6.05e-2)" 24.6 5.1 7.0 30.2 19.2 32.7 21.9 7.2 13.1 16.3 29.3 8.7 10.3 10.1 19.8 9.9 19.6 13.1 19.3 15.5 8.4 5.9 7.6 12.9 26.1 34.0 7.6 10.2 30.3 14.7 7.2 25.7 11.4 7.4 21.6 21.6 11.3 24.6 11.2 12.7 12.2 16.7 34.3 7.9 18.6 20.4 11.7 10.1 38.1 19.8 13.1 27.0 28.5 31.8 29.9 8.4 14.4 9.9 9.2 29.6 11.2 3.8 2.9 7.1 4.8 3.3 9.6 3.4 11.4 13.1 10.0 7.3 21.3 4.5 10.3 1.7 5.1 7.2 2.6 13.1 9.8 16.9 3.1 5.4 5.3 7.1 20.0 8.3 9.9 13.1 9.8 4.0 40.2 17.8 7.0 14.9 6.1 5.3 15.1 4.5 16.8 4.9 3.9 8.7 2.7 18.6 14.9 12.3 1.8 8.2 12.1 6.0 10.9 11.9 3.3 0.7 7.1 2.3 7.3 18.8 13.9 6.0 19.3 15.7 3.8 2.8 14.6 8.8 12.7 2.9 14.4 5.7 6.0 8.3 5.7 9.3 25.8 18.3 10.3 5.3 29.9 29.6 18.9 8.3 9.2 9.9 8.4 15.9 11.2 7.0 19.2 7.2 13.1 8.4 5.9 7.6 10.2 7.4 10.1 68.5 106.7 181.2 154.9 162.6 27.9 38.3 114.7 87.0 93.3 31.4 17.7 37.3 26.6 65.8 141.2 159.5 75.9 70.0 81.8 13.6 54.0 219.0 213.7 53.9 43.0 6.4 260.7 120.9 97.8 57.5 38.9 86.3 35.4 111.0 226.3 20.3 98.8 101.7 23.3 15.6 38.0 90.5 74.6 10.8 6.4 88.7 43.8 126.3 146.7 116.8 FOXP2 "CAGH44, SPCH1, TNRC10" ENSG00000128573 "Forkhead box P2" O15409 7 114086327-114693772 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 48.4;urinary bladder: 31.5" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 27.2;Muller glia cells: 42.1;Suprabasal keratinocytes: 22.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 15.0;RH-30: 27.6;THP-1: 8.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000382, HPA000383, HPA001679" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000382: AB_1078908, HPA000383: AB_1078909, HPA001679: AB_2666415" "unprognostic (1.21e-1)" "unprognostic (7.85e-2)" "unprognostic (4.89e-2)" "unprognostic (8.83e-3)" "unprognostic (4.66e-1)" "unprognostic (3.69e-4)" "unprognostic (2.04e-2)" "unprognostic (6.22e-2)" "unprognostic (2.17e-1)" "unprognostic (6.70e-3)" "unprognostic (1.22e-1)" "unprognostic (1.77e-1)" "unprognostic (8.04e-2)" "unprognostic (4.16e-3)" "unprognostic (2.84e-1)" "unprognostic (9.81e-2)" "unprognostic (4.19e-2)" 1.7 1.5 0.9 9.4 2.9 0.0 2.0 0.6 2.8 9.4 20.4 0.7 3.6 2.7 18.1 2.1 12.4 3.5 7.7 1.2 0.7 2.9 1.5 2.9 1.4 0.6 2.0 1.0 11.1 4.5 0.0 0.9 0.7 1.8 13.3 5.7 1.4 2.8 1.5 4.6 3.3 4.2 48.4 0.9 0.6 4.6 0.9 0.9 0.6 5.3 3.2 1.2 31.5 5.4 9.4 16.5 11.1 7.2 6.3 10.3 16.3 0.2 2.2 15.0 0.0 3.5 4.7 0.9 2.4 2.6 0.5 0.3 1.0 0.2 0.2 0.6 0.8 0.1 0.3 0.6 0.0 0.1 0.1 5.1 5.6 3.4 4.6 0.0 0.3 0.3 1.2 0.6 0.0 0.0 0.9 0.6 0.0 1.2 2.1 0.5 1.1 1.2 0.8 0.8 0.2 0.7 0.4 27.6 5.3 0.3 6.0 3.9 1.6 0.0 0.9 0.7 1.0 0.7 8.2 1.1 1.0 0.4 1.4 0.4 5.4 0.4 0.6 1.1 0.5 0.4 7.5 5.2 11.1 6.2 7.2 6.3 9.4 7.0 6.8 6.8 7.3 7.2 8.1 5.6 6.3 5.9 16.5 10.3 16.3 0.9 2.9 0.6 2.7 0.7 2.9 2.0 1.0 1.8 0.9 0.0 5.1 0.0 1.7 27.2 0.0 1.4 7.6 12.0 7.9 3.5 2.0 0.1 0.0 0.0 8.1 2.2 4.3 0.0 4.8 0.0 7.2 3.1 0.0 10.6 0.2 12.7 4.1 9.8 1.9 4.5 4.9 0.7 3.3 0.0 11.9 42.1 2.0 16.1 0.7 2.2 1.0 0.0 1.0 0.1 0.2 22.3 0.2 0.0 12.1 2.4 FUBP1 "FBP, FUBP" ENSG00000162613 "Far upstream element binding protein 1" Q96AE4 1 77944055-77979110 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006149 Supported Enhanced Nucleoplasm NA NA 200000 Nucleoplasm "HPA006149: AB_1849172" "unprognostic (4.17e-2)" "unprognostic (2.83e-2)" "unprognostic (3.35e-3)" "unprognostic (3.89e-2)" "unprognostic (3.77e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (9.83e-9)" "unprognostic (2.32e-2)" "unprognostic (2.16e-1)" "unprognostic (1.69e-1)" "unprognostic (3.31e-3)" "unprognostic (9.80e-3)" "unprognostic (9.02e-3)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (6.24e-2)" "unprognostic (9.46e-2)" 23.9 35.5 21.8 42.4 26.9 56.8 27.0 34.0 31.8 24.3 19.6 18.1 23.0 21.8 29.4 35.0 23.5 25.2 18.4 27.5 22.0 22.3 26.6 16.3 27.2 37.6 17.5 28.8 44.4 31.6 36.0 41.5 27.3 26.3 22.4 28.3 22.0 28.2 35.6 27.4 21.3 24.0 22.7 31.3 28.6 22.6 17.6 19.9 64.9 35.0 26.2 40.3 24.0 29.1 16.1 11.3 10.8 16.1 23.5 22.2 12.8 22.3 19.7 46.6 18.5 7.2 9.1 38.2 23.1 13.8 22.2 16.2 19.9 25.0 40.0 10.8 17.1 26.3 22.3 31.2 25.4 29.7 44.0 15.9 25.6 32.7 29.2 15.7 43.8 10.8 11.9 21.0 23.7 18.9 18.2 17.7 27.0 29.3 17.8 17.5 22.5 34.7 21.2 36.4 22.0 14.1 42.7 36.9 15.3 23.0 22.0 24.6 23.2 21.5 20.4 18.2 26.0 24.8 15.9 22.7 21.5 31.3 6.1 27.6 17.1 18.4 51.9 9.3 19.3 21.9 3.8 9.6 10.8 18.7 15.7 22.2 16.1 18.3 19.4 8.7 13.1 17.9 20.9 4.0 23.5 16.1 11.3 21.3 12.8 21.8 26.9 34.0 31.8 22.0 22.3 17.5 28.8 26.3 19.9 68.5 47.3 43.1 67.8 75.3 41.1 65.5 30.6 96.4 89.9 31.4 39.3 42.2 36.5 50.0 27.8 42.8 20.6 0.0 62.7 54.9 40.0 39.3 75.2 20.7 29.1 17.5 52.9 33.7 27.2 15.1 44.5 34.8 37.1 55.9 32.7 36.4 54.2 30.6 28.3 19.7 37.0 32.3 42.4 33.8 40.6 55.2 29.9 54.8 35.4 54.0 FUS "ALS6, FUS1, hnRNP-P2, HNRNPP2, TLS" ENSG00000089280 "FUS RNA binding protein" P35637 16 31180110-31194871 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008784, CAB033036, CAB058691" Supported Enhanced Nucleoplasm NA NA 190000 Nucleoplasm "CAB033036: AB_2105208, CAB058691: AB_2665583, HPA008784: AB_1849181" "unprognostic (3.06e-2)" "unprognostic (2.53e-1)" "unprognostic (1.86e-2)" "unprognostic (8.68e-2)" "unprognostic (1.44e-1)" "unprognostic (8.03e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (5.22e-3)" "unprognostic (1.01e-1)" "unprognostic (1.01e-3)" "unprognostic (1.12e-3)" "unprognostic (1.87e-1)" "unprognostic (5.27e-1)" "unprognostic (1.66e-1)" "unprognostic (1.49e-2)" 44.0 24.2 35.0 47.1 43.3 41.7 29.9 64.1 59.0 39.7 32.4 48.6 22.6 28.0 54.5 44.7 29.6 48.6 35.9 32.0 32.7 34.6 30.3 24.4 27.7 51.3 31.1 39.0 66.7 28.8 41.7 24.8 44.1 39.2 29.1 30.2 39.3 27.6 30.5 43.6 24.3 28.7 46.5 33.7 36.2 27.7 40.7 30.7 66.3 29.1 40.1 49.6 30.3 31.4 16.4 22.3 24.2 29.0 14.2 24.8 9.4 48.3 42.0 55.3 35.9 13.6 11.6 58.9 65.2 23.7 29.8 22.8 56.6 32.6 74.6 46.5 32.9 36.9 21.1 55.1 42.2 28.5 44.3 35.8 63.0 31.7 57.0 22.8 67.0 43.4 23.5 11.6 43.0 29.2 14.3 28.4 44.4 66.8 25.4 37.0 59.2 48.6 59.3 84.2 29.4 46.1 79.9 73.7 42.7 33.3 35.5 36.1 64.8 42.8 30.2 32.3 36.7 36.4 74.6 35.2 47.8 48.0 31.5 68.8 23.6 45.2 105.0 26.7 45.6 57.7 5.6 17.5 24.2 24.8 29.0 24.0 12.8 17.4 21.8 19.3 16.4 20.3 21.1 14.9 14.2 25.1 22.3 13.9 9.4 35.0 43.3 64.1 59.0 32.7 34.6 31.1 39.0 39.2 30.7 95.3 108.8 163.2 313.8 128.6 263.0 87.0 94.3 111.1 129.7 99.5 123.7 234.5 58.0 142.1 94.6 197.5 188.3 46.7 133.2 323.0 212.4 178.2 227.1 52.9 180.4 190.7 203.5 174.3 132.4 22.8 284.5 176.9 156.9 172.3 132.7 214.0 132.4 175.4 202.6 57.5 247.1 161.7 222.6 158.2 225.3 134.9 246.8 262.6 169.5 255.7 FZD10 CD350 ENSG00000111432 "Frizzled class receptor 10" Q9ULW2 12 130162459-130165740 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 26.9;lymphoid tissue: 18.6" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 3.9;Basal keratinocytes: 7.4;Smooth muscle cells: 14.4;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 8.6;BEWO: 9.9;hTCEpi: 5.7;RPTEC TERT1: 3.0;RT4: 4.8" "Region enhanced" "Detected in some" "thalamus: 7.6" "Low region specificity" "Detected in many" "HPA014484, HPA014485" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA014484: AB_1849132, HPA014485: AB_1849134" "unprognostic (2.41e-3)" "unprognostic (3.29e-1)" "unprognostic (4.74e-2)" "prognostic favorable (5.05e-7)" "unprognostic (2.81e-2)" "unprognostic (4.63e-2)" "unprognostic (8.62e-3)" "unprognostic (6.33e-2)" "unprognostic (5.41e-2)" "unprognostic (3.77e-2)" "unprognostic (2.70e-1)" "unprognostic (2.24e-3)" "unprognostic (2.66e-9)" "unprognostic (2.18e-1)" "unprognostic (3.07e-1)" "unprognostic (1.49e-2)" "unprognostic (1.07e-1)" 1.1 0.4 1.0 0.5 1.9 0.2 1.5 5.4 2.1 11.6 0.6 2.1 1.6 0.4 5.1 3.4 26.9 2.2 7.1 0.5 1.0 1.0 0.4 0.2 2.0 0.9 1.6 1.2 3.4 1.1 0.2 1.4 9.2 1.9 3.7 0.6 3.0 5.4 3.1 1.2 10.2 0.7 0.9 1.2 0.3 1.0 0.7 2.0 0.6 1.7 9.0 18.6 5.1 7.2 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 8.6 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 1.5 0.7 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 3.0 4.8 0.1 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.0 1.9 5.4 2.1 1.0 1.0 1.6 1.2 1.9 2.0 0.0 0.3 0.0 3.9 7.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 1.1 0.0 0.0 0.2 0.3 2.5 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 14.4 0.0 0.4 7.4 0.7 0.0 0.0 1.1 GABPA "E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A" ENSG00000154727 "GA binding protein transcription factor alpha subunit" Q06546 21 25734570-25772460 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003258, CAB004411, HPA028791" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004411: AB_627648, HPA003258: AB_1078928, HPA028791: AB_10602598" "unprognostic (5.50e-2)" "unprognostic (2.40e-1)" "unprognostic (3.74e-2)" "unprognostic (2.68e-1)" "unprognostic (3.98e-2)" "unprognostic (1.17e-2)" "unprognostic (3.01e-1)" "unprognostic (2.73e-1)" "unprognostic (2.56e-2)" "unprognostic (1.76e-1)" "unprognostic (4.07e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (3.97e-5)" "unprognostic (1.62e-1)" "unprognostic (1.77e-1)" "unprognostic (5.70e-2)" "unprognostic (2.73e-3)" 25.3 15.2 11.6 17.0 16.9 13.6 18.3 15.9 15.4 17.6 17.1 11.4 18.8 12.7 19.5 15.9 15.1 15.4 13.6 18.6 12.5 9.5 14.6 18.8 13.3 18.8 12.9 9.0 20.4 13.3 19.4 20.3 34.5 12.5 18.0 14.2 10.8 14.2 15.4 18.2 11.5 17.0 15.8 18.4 20.0 12.3 19.5 16.3 37.7 27.3 10.3 19.0 18.4 35.3 8.9 6.6 12.0 8.2 10.8 10.3 6.1 12.8 5.3 15.8 11.2 16.2 22.0 12.2 10.3 11.6 8.6 8.5 6.7 11.0 27.6 8.2 11.9 8.3 5.9 17.5 10.5 14.3 15.6 16.2 19.2 7.2 6.4 11.0 20.4 13.0 16.0 10.3 11.4 10.8 14.1 15.8 15.1 17.5 16.7 14.3 6.4 22.0 8.9 21.8 14.0 7.4 18.4 22.7 16.9 10.0 8.6 9.7 13.1 18.5 11.8 12.6 10.0 10.5 15.8 15.5 10.4 9.6 11.3 8.5 13.4 11.5 24.5 10.8 15.7 12.5 12.0 6.8 11.5 7.4 8.2 9.9 8.9 8.6 8.7 6.6 8.4 10.3 8.7 8.7 10.8 6.0 3.4 8.6 6.1 11.6 16.9 15.9 15.4 12.5 9.5 12.9 9.0 12.5 16.3 8.9 11.8 14.7 10.4 10.3 6.6 6.7 15.3 6.7 13.6 21.0 0.0 14.8 3.3 6.9 5.5 20.4 9.0 0.0 7.0 10.8 11.7 9.2 5.8 17.5 10.8 12.7 8.6 22.7 19.7 2.1 16.4 11.5 6.8 7.2 13.3 20.9 7.5 8.6 20.8 8.5 9.4 19.4 12.0 27.7 17.4 11.0 21.1 13.1 11.2 11.6 GATAD1 "FLJ22489, ODAG, RG083M05.2" ENSG00000157259 "GATA zinc finger domain containing 1" Q8WUU5 7 92447448-92459432 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 125.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006105, HPA072785" Enhanced Nucleoplasm Yes No Nucleoplasm "HPA006105: AB_1078956, HPA072785: AB_2686556" "unprognostic (8.37e-2)" "unprognostic (1.01e-1)" "unprognostic (7.31e-3)" "unprognostic (6.24e-2)" "unprognostic (6.03e-2)" "unprognostic (1.36e-1)" "unprognostic (8.65e-3)" "unprognostic (6.43e-2)" "unprognostic (5.16e-2)" "unprognostic (4.30e-2)" "unprognostic (2.18e-1)" "unprognostic (2.16e-1)" "unprognostic (9.91e-2)" "unprognostic (2.93e-1)" "unprognostic (1.36e-1)" "unprognostic (3.44e-2)" "unprognostic (1.98e-3)" 20.1 20.9 14.7 13.7 32.1 8.7 21.1 19.5 23.5 23.1 18.2 32.9 20.8 17.6 23.2 29.8 13.7 21.7 20.0 14.9 18.3 13.4 21.5 17.5 22.5 12.4 37.7 21.4 32.9 27.3 19.7 22.5 19.3 22.1 21.7 18.3 19.5 17.0 21.2 10.4 15.3 16.9 22.2 28.9 18.9 21.1 11.5 31.8 6.5 28.1 8.0 11.3 21.4 18.7 4.5 3.8 7.3 3.8 3.1 3.0 1.1 8.6 5.5 11.3 11.8 14.7 17.0 9.1 8.7 13.0 9.2 12.7 6.0 13.5 6.5 12.1 6.4 21.6 10.4 7.7 5.9 9.8 11.3 8.4 8.3 5.5 8.3 20.5 9.9 22.5 12.8 14.2 7.0 20.6 16.6 10.3 4.8 16.8 14.0 10.0 12.5 3.8 14.1 15.2 14.0 10.6 5.1 13.4 8.5 9.9 9.8 10.1 16.0 11.4 12.1 16.3 14.7 6.8 13.4 9.4 14.8 11.3 22.3 11.1 11.3 3.9 7.2 12.4 6.5 20.2 7.3 3.8 3.4 2.6 2.3 2.5 2.8 2.0 1.6 2.0 4.5 2.1 3.0 3.9 3.1 2.5 3.8 2.0 1.1 14.7 32.1 19.5 23.5 18.3 13.4 37.7 21.4 22.1 31.8 44.7 54.7 23.8 32.5 11.7 77.4 13.2 20.4 45.5 33.0 45.4 66.8 21.8 3.3 18.5 3.3 25.3 24.9 0.0 19.1 19.7 20.3 33.0 50.9 19.5 21.7 58.8 16.1 30.1 26.3 3.4 42.0 29.9 20.3 10.8 35.4 86.9 22.4 33.6 32.9 13.5 125.5 19.4 26.7 10.7 7.0 15.6 17.3 18.5 29.9 26.0 GATAD2A p66alpha ENSG00000167491 "GATA zinc finger domain containing 2A" Q86YP4 19 19385826-19508931 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006759, HPA024373" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006759: AB_1079549, HPA024373: AB_1849522" "unprognostic (1.07e-1)" "unprognostic (2.79e-2)" "unprognostic (1.40e-1)" "unprognostic (5.64e-3)" "unprognostic (3.41e-1)" "unprognostic (1.86e-1)" "unprognostic (9.04e-3)" "unprognostic (9.53e-2)" "unprognostic (2.12e-1)" "unprognostic (2.58e-2)" "unprognostic (6.62e-3)" "unprognostic (4.69e-2)" "unprognostic (3.06e-3)" "unprognostic (4.50e-2)" "unprognostic (2.43e-1)" "unprognostic (3.30e-2)" "unprognostic (9.84e-2)" 19.2 16.1 14.7 24.4 15.3 30.5 25.9 11.1 14.2 12.9 22.2 12.2 20.4 24.8 16.7 16.1 23.3 13.1 17.4 16.3 16.2 11.3 21.2 28.7 22.3 29.9 12.8 10.1 16.0 28.5 13.8 16.2 26.9 15.3 11.7 13.0 18.1 16.7 20.2 17.9 29.9 26.4 13.1 14.8 28.1 19.5 42.0 11.4 34.1 16.1 15.3 24.6 16.3 23.0 3.2 4.9 12.3 4.9 3.7 5.2 2.7 18.7 16.1 15.0 22.2 6.2 6.5 31.6 14.8 10.1 15.5 14.8 29.1 19.9 36.8 22.6 14.8 10.3 15.7 14.0 13.1 9.0 12.5 15.2 27.0 16.1 16.0 15.3 29.9 23.4 10.3 9.7 16.1 13.1 5.1 15.4 21.3 43.0 11.9 8.9 21.2 35.3 11.9 31.6 17.4 14.7 37.7 15.1 17.1 8.0 24.8 28.5 15.9 12.8 15.6 18.7 10.2 14.1 12.6 30.0 29.5 14.2 34.4 27.6 14.9 18.7 39.4 18.4 25.3 17.1 5.6 4.9 4.5 5.2 2.3 3.1 3.1 3.1 4.2 2.1 3.2 2.3 2.6 12.3 3.7 4.5 4.9 2.1 2.7 14.7 15.3 11.1 14.2 16.2 11.3 12.8 10.1 15.3 11.4 11.9 16.3 12.4 16.8 49.5 14.4 10.6 10.2 9.4 12.5 14.0 17.7 20.2 11.6 19.7 14.7 28.5 34.2 0.0 26.2 27.9 19.3 19.6 16.2 25.1 23.4 22.3 15.0 25.2 24.1 13.3 14.4 19.3 30.4 16.2 28.2 17.4 36.9 32.3 13.1 22.5 18.5 19.4 21.7 12.1 33.7 48.6 30.7 35.5 26.9 23.0 GATAD2B P66beta ENSG00000143614 "GATA zinc finger domain containing 2B" Q8WXI9 1 153789030-153923360 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017015 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA017015: AB_1854905" "unprognostic (1.90e-1)" "unprognostic (5.02e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.43e-2)" "unprognostic (2.59e-3)" "unprognostic (1.07e-1)" "unprognostic (3.79e-2)" "unprognostic (4.37e-2)" "unprognostic (2.02e-2)" "unprognostic (3.29e-1)" "unprognostic (1.28e-1)" "unprognostic (6.40e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.53e-1)" "unprognostic (1.92e-1)" "unprognostic (2.51e-1)" "unprognostic (5.17e-2)" 12.9 9.6 16.5 16.2 19.8 22.2 13.6 33.2 24.4 12.0 12.4 22.2 10.5 10.7 15.7 9.0 14.6 13.1 9.6 19.3 16.3 11.0 8.8 10.5 15.9 18.4 15.1 12.3 17.1 16.0 19.4 11.1 14.4 14.7 10.8 9.6 12.3 10.7 14.6 20.2 17.2 11.9 17.6 13.9 14.6 11.6 24.6 17.9 29.5 19.1 7.6 17.7 12.1 14.4 1.3 2.9 6.7 1.1 1.5 1.4 0.7 4.8 9.2 8.2 9.0 1.7 5.4 4.9 3.0 7.3 9.6 11.3 4.4 7.6 9.5 7.2 6.8 5.1 9.8 11.4 5.9 7.9 8.6 7.9 9.3 10.0 1.8 5.6 5.6 13.3 4.2 4.2 10.7 21.3 4.6 9.1 13.4 6.9 13.1 1.9 9.0 20.1 1.5 3.6 3.8 4.5 20.5 4.1 10.4 1.9 6.8 9.5 10.0 11.2 13.8 5.9 6.3 12.7 4.8 8.1 9.4 8.4 5.2 6.4 17.8 12.0 14.6 5.3 3.7 8.1 6.7 1.1 0.9 1.3 0.5 1.3 0.7 0.6 1.4 0.3 1.3 0.5 0.6 6.4 1.5 0.5 2.9 1.1 0.7 16.5 19.8 33.2 24.4 16.3 11.0 15.1 12.3 14.7 17.9 8.9 11.8 11.8 11.6 38.9 43.4 14.5 22.9 12.0 9.1 24.4 37.3 8.2 6.6 10.9 12.5 23.4 7.9 23.3 12.3 5.5 12.9 16.7 24.3 19.5 11.9 33.4 22.8 24.5 27.8 5.2 25.0 17.4 13.5 34.3 19.5 18.6 14.4 20.9 32.9 7.9 35.5 6.5 19.8 25.5 19.8 41.5 8.2 24.5 14.0 16.0 GET4 "C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35" ENSG00000239857 "Golgi to ER traffic protein 4" Q7L5D6 7 876552-896436 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Cone photoreceptor cells: 3.9;Horizontal cells: 7.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019765 Uncertain Enhanced "Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol" Yes No "Nucleoplasm, Cytosol" "Nucleoli, Mitotic chromosome" "HPA019765: AB_1845750" "unprognostic (2.80e-2)" "unprognostic (2.40e-2)" "unprognostic (2.10e-2)" "unprognostic (9.66e-4)" "unprognostic (9.86e-2)" "unprognostic (8.64e-2)" "unprognostic (4.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.59e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-1)" "unprognostic (1.21e-1)" "unprognostic (7.65e-2)" "unprognostic (8.18e-2)" "unprognostic (1.26e-1)" "unprognostic (5.93e-2)" "unprognostic (9.47e-2)" 13.7 39.8 22.4 14.8 21.4 28.5 15.3 22.1 23.5 10.3 15.5 20.9 19.0 21.8 12.3 23.8 18.8 14.6 12.8 18.7 16.4 15.4 27.8 37.5 12.2 15.1 22.9 21.5 16.5 32.6 11.3 32.9 21.7 18.9 16.8 9.9 15.2 25.0 21.9 53.7 29.7 20.9 12.6 18.9 16.9 22.2 32.0 22.7 12.5 16.0 21.8 12.5 14.3 17.3 23.3 31.5 28.9 30.7 24.9 27.3 21.9 26.3 13.0 9.1 13.4 4.7 3.3 28.9 7.3 5.2 9.4 9.4 35.3 33.0 9.7 7.7 4.2 26.2 16.8 10.2 8.0 4.1 3.9 17.5 5.3 10.2 19.9 10.4 9.1 9.9 4.9 9.7 8.2 5.4 7.1 7.4 11.3 34.5 9.0 5.2 20.0 6.9 21.9 32.7 15.6 19.5 14.5 1.6 10.4 8.3 15.6 16.5 17.8 6.7 24.9 10.6 11.6 18.9 16.2 7.4 6.9 15.6 16.0 10.0 13.6 8.5 12.5 7.1 15.7 17.5 16.8 27.4 28.9 24.2 24.7 23.7 23.3 26.5 24.0 27.7 23.2 26.0 27.3 21.1 24.9 30.7 31.5 24.5 21.9 22.4 21.4 22.1 23.5 16.4 15.4 22.9 21.5 18.9 22.7 0.0 1.9 0.0 0.2 0.9 0.8 0.4 0.0 2.7 3.4 0.0 3.9 0.9 0.0 0.6 3.6 0.1 1.6 0.0 0.6 0.6 0.3 0.4 1.1 0.0 0.6 7.9 0.0 0.0 0.3 1.5 0.0 2.5 0.0 0.0 1.9 0.2 0.8 0.0 0.0 0.6 1.1 0.0 0.2 0.5 1.0 0.9 1.4 0.9 1.7 0.8 GINS3 "FLJ13912, PSF3" ENSG00000181938 "GINS complex subunit 3" Q9BRX5 16 58295080-58406144 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-698: 53.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041216, HPA048209" Uncertain Enhanced Nucleoplasm No No Nucleoplasm "HPA041216: AB_10794989, HPA048209: AB_2680314" "unprognostic (3.12e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-3)" "unprognostic (6.34e-2)" "unprognostic (4.70e-2)" "unprognostic (2.82e-1)" "unprognostic (1.75e-4)" "unprognostic (7.76e-2)" "unprognostic (1.76e-3)" "unprognostic (7.19e-2)" "unprognostic (4.50e-2)" "unprognostic (2.67e-3)" "unprognostic (1.14e-7)" "unprognostic (9.76e-3)" "unprognostic (5.34e-2)" "unprognostic (8.23e-2)" "unprognostic (1.07e-2)" 5.5 10.6 3.3 5.6 11.4 9.9 4.4 20.4 4.7 5.9 6.6 3.2 13.2 4.3 5.6 5.5 11.5 3.4 3.3 8.2 3.5 3.6 5.3 4.2 6.1 10.0 5.8 1.5 2.8 2.3 6.0 4.2 6.3 4.5 3.5 6.0 3.3 4.8 10.0 3.9 5.4 5.0 5.1 4.1 11.9 3.4 8.0 4.9 17.5 4.9 14.3 13.1 3.8 7.9 4.7 10.9 0.5 2.4 5.0 4.1 2.1 7.3 8.3 10.0 5.4 1.1 1.4 5.0 8.4 3.7 13.4 10.2 6.1 7.4 12.8 6.7 2.8 10.1 7.0 9.2 7.0 15.2 7.1 11.3 7.5 4.7 7.4 0.6 9.5 12.9 1.6 1.3 6.9 2.4 3.0 9.1 10.7 11.9 5.5 5.6 7.5 17.3 8.7 9.4 6.3 17.1 30.1 11.1 16.3 4.9 4.7 11.6 7.7 13.9 9.2 4.6 4.2 4.8 7.8 3.8 9.1 10.6 5.4 10.4 5.5 7.1 53.9 6.3 9.6 11.0 0.2 2.4 0.2 2.9 2.2 2.1 3.5 2.4 4.1 5.5 4.7 2.3 3.6 0.5 5.0 1.2 10.9 3.2 2.1 3.3 11.4 20.4 4.3 3.5 3.6 5.8 1.5 4.5 4.9 0.0 1.6 5.2 3.9 1.5 1.3 3.0 0.0 1.4 1.2 0.0 2.0 4.9 0.0 3.1 15.8 2.8 0.5 0.0 1.8 6.7 1.0 1.5 1.1 0.8 2.4 4.8 0.0 2.5 2.1 7.1 1.4 1.1 1.7 2.8 0.6 1.5 1.5 0.0 1.1 0.4 1.8 6.5 1.5 4.2 8.1 2.0 2.6 2.5 2.2 5.4 GLI1 GLI ENSG00000111087 "GLI family zinc finger 1" P08151 12 57460135-57472262 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 21 "Leydig cells: 27.3;Peritubular cells: 40.3;Sertoli cells: 12.9" "Cancer enhanced" "Detected in many" "testis cancer: 7.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 5.2" "Cell line enhanced" "Detected in many" "AN3-CA: 12.2;BJ hTERT+: 7.8;NTERA-2: 7.9;RH-30: 35.9;U-266/70: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009460, HPA065172, HPA068903" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009460: AB_2111764, HPA065172: AB_2685427, HPA068903: AB_2732122" "unprognostic (4.97e-4)" "unprognostic (5.53e-2)" "unprognostic (1.26e-1)" "unprognostic (5.58e-3)" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (9.00e-2)" "unprognostic (1.88e-1)" "unprognostic (1.43e-1)" "unprognostic (8.52e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-8)" "unprognostic (4.59e-3)" "unprognostic (2.98e-2)" "unprognostic (2.78e-2)" "unprognostic (1.04e-2)" 3.2 1.7 4.0 2.1 2.5 0.6 2.1 8.2 4.4 14.4 3.5 0.0 3.0 3.7 12.8 8.3 0.7 4.7 8.3 2.7 2.9 1.9 3.2 1.8 2.0 1.3 1.5 2.0 4.7 1.0 0.1 1.2 0.6 3.3 5.6 4.9 9.6 2.9 4.3 3.1 2.4 3.7 3.8 2.8 1.2 2.4 6.2 2.5 0.6 3.3 3.4 1.4 4.8 4.6 0.9 0.4 5.2 0.2 0.1 0.5 0.1 0.0 5.6 1.7 12.2 0.2 0.0 0.2 0.7 7.8 1.3 1.4 0.2 0.4 1.9 0.0 0.3 1.4 1.0 1.0 0.7 0.2 2.1 0.1 0.0 0.6 0.1 1.3 0.3 0.6 0.5 0.2 1.3 0.4 2.5 0.2 1.2 0.4 4.1 0.6 0.0 0.4 0.2 7.9 0.4 0.5 0.6 35.9 0.8 1.5 0.0 0.0 0.1 0.1 0.0 0.2 1.4 0.0 0.1 0.0 1.4 4.5 0.4 0.2 10.0 0.4 3.2 1.2 0.8 2.2 2.2 0.2 0.9 0.1 0.0 0.0 0.9 0.2 0.0 0.0 0.4 0.4 0.3 5.2 0.1 0.1 0.4 0.5 0.1 4.0 2.5 8.2 4.4 2.9 1.9 1.5 2.0 3.3 2.5 0.0 0.0 0.5 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 27.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 40.3 1.0 0.0 12.9 0.5 0.3 0.8 0.5 0.1 0.0 0.0 0.1 GLIS2 NPHP7 ENSG00000126603 "GLIS family zinc finger 2" Q9BZE0 16 4314761-4339597 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Ciliopathy, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 31.8;Smooth muscle cells: 30.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062755, HPA065406" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA062755: , HPA065406: " "unprognostic (2.86e-1)" "unprognostic (3.27e-2)" "unprognostic (5.96e-2)" "prognostic unfavorable (1.59e-5)" "unprognostic (3.76e-1)" "unprognostic (5.15e-2)" "unprognostic (8.13e-2)" "unprognostic (6.65e-2)" "unprognostic (3.94e-1)" "unprognostic (2.37e-3)" "unprognostic (3.59e-1)" "unprognostic (2.48e-1)" "prognostic favorable (8.06e-6)" "unprognostic (1.59e-3)" "unprognostic (3.18e-2)" "unprognostic (1.24e-2)" "unprognostic (4.40e-3)" 3.6 6.0 1.5 2.3 1.6 0.0 2.4 4.3 2.4 5.0 4.4 1.2 5.8 1.0 1.2 4.3 7.4 8.4 0.9 1.2 11.5 0.3 7.8 1.4 1.4 8.0 3.2 2.2 5.3 5.7 5.6 0.2 3.0 5.8 1.1 1.5 1.2 4.3 0.2 0.8 2.7 1.9 5.3 0.5 5.6 2.7 0.3 0.0 0.2 0.0 0.0 0.1 0.0 4.0 10.6 1.7 3.9 1.4 5.7 3.6 4.5 4.3 1.6 1.2 2.9 3.0 0.0 7.9 4.9 1.9 2.6 1.0 4.5 0.1 4.7 0.0 0.0 8.1 1.5 6.2 0.0 0.8 3.3 1.1 1.5 0.7 2.3 1.5 0.1 0.3 1.8 1.1 2.6 0.1 0.9 3.8 0.6 1.8 6.8 2.3 4.8 0.0 0.1 0.8 3.7 5.2 2.2 1.0 0.6 6.3 0.7 3.4 2.4 3.9 28.0 1.4 0.8 0.5 1.3 0.9 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.9 9.8 0.0 6.2 4.9 10.4 4.9 20.4 2.7 4.5 12.2 3.9 0.1 16.6 10.0 0.1 6.0 0.0 0.0 7.4 0.9 20.7 2.6 0.0 0.6 0.3 6.4 0.0 5.5 0.0 0.4 20.4 1.2 3.3 1.8 0.0 9.4 7.6 0.0 31.8 19.5 6.5 0.0 30.9 0.0 3.4 2.5 0.9 0.0 0.0 1.7 GLRX2 "bA101E13.1, GRX2" ENSG00000023572 "Glutaredoxin 2" Q9NS18 1 193090866-193106114 "Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 19 "Early spermatids: 789.5;Late spermatids: 1440.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 69.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023087, HPA057224" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA023087: AB_1849778, HPA057224: AB_2683373" "unprognostic (4.80e-2)" "unprognostic (3.77e-2)" "unprognostic (8.04e-2)" "unprognostic (2.33e-1)" "unprognostic (1.13e-1)" "unprognostic (4.99e-2)" "unprognostic (2.40e-3)" "unprognostic (5.11e-2)" "unprognostic (3.21e-2)" "unprognostic (2.38e-2)" "unprognostic (1.10e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (3.30e-7)" "unprognostic (6.23e-2)" "unprognostic (1.73e-1)" "unprognostic (6.21e-2)" "unprognostic (4.48e-2)" 14.1 17.9 13.8 9.7 12.2 10.7 16.3 7.4 22.0 7.8 14.9 6.6 7.4 14.7 6.7 14.5 13.1 5.1 8.8 23.5 13.0 13.3 14.3 28.2 7.8 6.1 16.5 13.1 5.4 10.4 4.6 9.9 9.5 22.3 21.8 11.7 7.4 8.6 11.6 28.5 8.9 12.7 10.9 12.3 7.6 10.3 27.9 8.7 2.3 7.7 11.6 9.0 9.6 10.2 10.8 17.4 19.6 21.4 11.6 14.1 10.9 13.9 17.2 4.4 9.8 16.3 10.6 7.8 20.5 8.9 17.0 14.1 10.6 13.4 6.2 11.5 8.5 20.7 13.6 5.2 11.7 17.4 13.7 9.7 12.0 11.6 12.3 17.4 9.8 12.1 7.1 10.2 23.3 11.8 6.6 10.7 4.1 17.7 6.6 20.5 19.3 7.8 18.0 5.1 22.3 12.6 7.1 7.1 14.2 16.3 9.2 4.2 3.8 8.3 24.6 69.6 6.8 10.7 11.1 6.5 13.3 3.4 28.9 21.1 13.3 13.7 11.9 12.7 11.3 18.4 7.8 15.2 19.6 10.8 17.9 11.9 10.8 11.3 9.7 17.4 8.2 10.2 11.4 7.6 11.6 21.4 7.3 14.1 10.9 13.8 12.2 7.4 22.0 13.0 13.3 16.5 13.1 22.3 8.7 8.9 8.5 18.7 19.2 16.3 7.1 57.9 15.3 8.1 7.9 15.7 5.9 33.7 24.9 36.1 789.5 17.5 28.0 0.0 35.9 32.5 22.1 28.9 45.1 29.9 40.5 1.6 13.3 10.4 12.1 1440.5 16.1 26.5 25.3 24.4 19.0 6.6 33.9 28.1 17.0 53.0 11.2 6.5 24.5 10.8 26.4 17.3 20.7 13.8 20.9 15.9 GLYR1 "BM045, HIBDL, N-PAC, NP60" ENSG00000140632 "Glyoxylate reductase 1 homolog" Q49A26 16 4803203-4847342 "Predicted intracellular proteins" "DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017022, HPA048226, HPA050136" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028" "unprognostic (4.72e-1)" "unprognostic (1.65e-1)" "unprognostic (3.19e-2)" "unprognostic (8.20e-2)" "unprognostic (2.77e-1)" "unprognostic (1.97e-2)" "unprognostic (3.86e-2)" "unprognostic (3.18e-2)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" "unprognostic (1.41e-1)" "unprognostic (8.47e-3)" "prognostic favorable (8.74e-7)" "unprognostic (3.34e-1)" "unprognostic (4.38e-2)" "unprognostic (1.77e-1)" "unprognostic (2.86e-1)" 24.1 33.2 39.1 29.4 37.4 27.5 22.5 26.3 44.8 24.8 32.6 31.0 32.8 30.7 30.0 20.6 32.1 33.9 26.1 28.3 29.8 24.8 39.0 30.5 24.5 27.6 27.0 33.1 22.2 27.4 53.4 34.7 24.1 37.1 30.4 32.3 28.5 29.9 29.4 41.6 24.3 29.9 30.1 27.3 30.7 33.9 17.4 26.0 27.6 29.6 17.2 30.0 35.3 22.7 7.6 8.3 22.2 14.5 5.2 7.5 5.5 13.1 14.7 24.3 15.1 21.4 17.2 23.3 24.9 18.6 19.1 16.4 20.7 23.5 21.5 23.8 22.9 15.7 14.6 30.4 20.9 17.3 34.9 18.3 22.1 17.7 14.5 12.1 35.7 41.2 16.3 16.6 18.0 13.3 18.4 24.2 20.3 37.0 18.6 20.7 21.4 29.0 19.8 28.8 19.8 11.1 37.5 19.1 26.4 23.5 19.8 29.7 15.1 27.0 25.3 11.5 27.9 28.4 37.8 26.8 13.1 14.7 59.1 15.5 15.5 21.6 45.0 9.4 17.8 26.8 6.3 10.9 5.7 7.5 9.8 6.5 5.1 4.9 7.1 7.3 7.6 5.2 4.6 22.2 5.2 14.5 8.3 4.9 5.5 39.1 37.4 26.3 44.8 29.8 24.8 27.0 33.1 37.1 26.0 35.7 45.5 25.1 16.3 16.9 31.8 36.2 30.6 93.7 46.6 29.6 27.5 23.2 56.3 20.8 7.9 26.3 37.1 0.0 16.8 26.4 21.1 25.4 30.1 47.3 28.0 42.9 44.5 25.8 38.6 8.0 22.5 29.5 20.3 44.1 38.4 22.8 24.2 37.4 15.2 42.9 40.9 19.4 16.9 20.9 24.5 21.1 29.9 17.5 33.2 17.0 GMEB1 "P96PIF, PIF96" ENSG00000162419 "Glucocorticoid modulatory element binding protein 1" Q9Y692 1 28668732-28719353 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044811, HPA052975" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044811: AB_10959666, HPA052975: AB_2682003" "unprognostic (1.52e-1)" "unprognostic (3.55e-2)" "unprognostic (2.49e-2)" "prognostic favorable (1.94e-4)" "unprognostic (2.71e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.91e-7)" "unprognostic (1.42e-2)" "unprognostic (1.41e-1)" "unprognostic (6.88e-2)" "unprognostic (1.39e-1)" "unprognostic (3.38e-2)" "unprognostic (8.41e-2)" "unprognostic (4.79e-3)" "unprognostic (3.44e-1)" "unprognostic (1.75e-1)" "unprognostic (1.13e-2)" 8.3 6.6 8.0 14.0 6.5 21.1 8.7 13.5 9.0 8.8 8.0 8.4 6.4 5.4 10.9 8.0 10.4 8.5 8.0 6.8 7.8 4.9 6.6 7.3 8.7 11.3 5.8 7.0 12.1 7.5 8.6 8.8 16.4 5.8 7.2 8.4 8.0 7.4 6.8 10.3 9.3 8.6 9.1 6.3 11.5 7.4 11.4 6.4 25.3 7.5 7.0 14.1 7.9 12.4 10.8 9.7 14.4 12.7 10.6 12.8 6.3 9.3 6.8 11.6 10.4 3.8 7.1 8.2 10.0 7.3 6.5 9.7 2.1 7.6 17.3 5.3 9.3 3.9 3.7 10.3 7.8 8.5 19.7 6.3 16.1 7.1 4.1 5.8 13.3 8.3 5.7 5.6 15.7 10.2 5.7 8.9 8.7 9.6 13.9 7.8 8.2 8.3 4.4 15.4 6.3 4.6 5.6 7.9 8.0 4.9 7.7 8.5 7.0 9.5 6.5 6.5 8.1 4.9 6.9 9.0 4.5 10.8 7.6 13.5 6.2 10.5 9.7 5.4 12.5 7.0 10.0 8.2 14.4 11.1 10.2 8.4 6.6 10.6 12.8 9.7 10.8 8.8 9.3 11.8 10.6 12.7 7.2 8.9 6.3 8.0 6.5 13.5 9.0 7.8 4.9 5.8 7.0 5.8 6.4 6.0 24.8 13.5 13.9 15.0 22.8 4.2 5.1 5.3 12.5 14.0 11.8 11.6 5.0 9.2 8.0 10.6 9.6 23.3 9.5 13.6 7.3 9.8 27.7 5.6 9.4 23.8 7.5 17.8 12.9 2.2 8.9 11.7 1.7 8.2 11.1 17.5 9.5 10.4 7.4 4.9 23.9 19.4 7.6 14.4 27.4 14.6 27.0 15.9 9.2 15.6 GMEB2 "KIAA1269, P79PIF, PIF79" ENSG00000101216 "Glucocorticoid modulatory element binding protein 2" Q9UKD1 20 63587602-63627041 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009706, HPA067455" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA009706: AB_1078996, HPA067455: AB_2685845" "unprognostic (4.55e-1)" "unprognostic (5.65e-2)" "unprognostic (3.16e-1)" "unprognostic (1.38e-3)" "unprognostic (1.36e-1)" "unprognostic (4.85e-2)" "unprognostic (2.77e-3)" "unprognostic (2.04e-1)" "unprognostic (5.47e-2)" "unprognostic (5.43e-2)" "unprognostic (2.01e-2)" "unprognostic (2.04e-2)" "unprognostic (6.86e-3)" "unprognostic (2.82e-2)" "unprognostic (3.84e-1)" "unprognostic (3.46e-1)" "unprognostic (2.29e-1)" 9.3 8.2 7.4 9.0 9.8 29.8 8.4 13.5 11.5 8.7 10.5 7.7 6.9 9.6 10.6 6.1 10.0 11.0 9.5 7.4 8.1 6.2 7.7 9.3 8.7 11.5 6.0 6.5 11.5 17.6 9.6 9.5 14.5 7.2 9.9 5.1 9.8 16.0 7.5 10.1 10.0 11.0 10.3 7.1 12.1 8.8 18.8 5.7 24.7 18.0 9.5 10.4 9.2 13.8 3.0 2.6 4.4 5.6 1.9 4.5 2.2 10.8 6.6 8.1 7.0 4.0 3.7 10.8 7.5 4.8 12.1 6.4 20.5 8.1 8.6 7.9 6.5 8.8 15.5 6.3 11.1 5.4 4.6 7.1 6.6 9.7 9.8 5.3 6.3 11.1 5.2 10.6 7.8 9.8 5.1 5.3 11.0 9.8 6.3 4.2 11.6 15.4 13.9 5.8 12.9 10.7 16.8 8.3 7.9 5.0 9.6 12.2 10.0 13.6 12.0 7.8 3.9 14.7 10.4 6.6 13.4 7.3 7.9 8.3 12.0 9.8 13.7 8.0 5.9 8.6 0.0 1.9 3.2 4.5 2.6 4.3 2.1 4.0 3.9 2.1 3.0 4.5 3.9 4.4 1.9 5.6 2.6 2.7 2.2 7.4 9.8 13.5 11.5 8.1 6.2 6.0 6.5 7.2 5.7 3.0 6.4 2.2 10.1 5.4 5.1 2.8 7.6 1.4 4.5 3.5 0.0 3.7 1.7 3.9 18.0 4.7 5.1 0.0 4.6 5.3 3.0 11.1 2.3 5.7 3.8 7.9 9.2 4.3 2.8 5.1 3.7 2.6 1.7 1.0 7.9 1.7 5.0 7.0 5.3 3.0 4.7 6.5 3.7 14.9 9.7 4.6 9.6 4.3 5.3 10.3 GMIP ARHGAP46 ENSG00000089639 "GEM interacting protein" Q9P107 19 19629476-19643667 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 32.7;bone marrow: 31.0;lymphoid tissue: 40.0" "Cell type enhanced" "Detected in many" 8 "Hofbauer cells: 20.7;Kupffer cells: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042484, HPA045481" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042484: AB_2678018, HPA045481: AB_2679343" "unprognostic (7.54e-2)" "unprognostic (5.35e-3)" "unprognostic (3.10e-3)" "unprognostic (4.54e-3)" "unprognostic (1.44e-1)" "unprognostic (1.24e-3)" "unprognostic (1.23e-2)" "unprognostic (4.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.85e-2)" "unprognostic (6.75e-3)" "prognostic unfavorable (3.97e-5)" "prognostic favorable (3.03e-4)" "unprognostic (4.92e-2)" "unprognostic (2.54e-1)" "prognostic favorable (5.15e-4)" 6.1 2.8 3.5 20.3 4.9 31.0 4.0 0.9 4.1 2.9 6.9 4.3 2.7 7.0 2.7 3.2 6.2 4.4 7.9 3.3 4.3 3.4 4.2 3.9 11.7 28.0 4.2 2.5 2.4 4.6 10.6 3.0 3.9 3.4 4.1 4.6 2.7 6.0 4.5 1.5 4.9 15.3 2.9 4.9 40.0 11.1 2.2 3.1 26.8 6.2 2.7 23.2 6.1 4.5 6.6 6.7 32.7 13.9 4.2 6.4 4.6 4.4 2.1 2.8 3.0 3.1 1.6 11.2 2.8 2.5 1.7 1.6 1.7 6.1 11.0 5.8 2.0 2.2 5.4 1.8 3.1 1.1 3.8 2.8 3.5 3.3 1.8 0.9 9.8 43.8 2.0 2.1 1.8 1.0 2.0 3.8 9.9 2.3 4.0 1.8 6.6 6.1 16.2 1.6 5.8 3.8 10.6 1.2 6.3 3.2 10.7 2.4 7.2 3.9 4.1 1.6 2.2 3.8 14.1 7.0 3.2 1.8 3.6 2.1 2.0 0.8 9.1 2.0 12.9 2.1 2.9 8.3 21.5 6.4 10.6 5.9 5.9 4.0 5.7 6.7 6.6 4.5 4.6 32.7 4.2 13.9 6.1 4.5 4.6 3.5 4.9 0.9 4.1 4.3 3.4 4.2 2.5 3.4 3.1 0.0 15.1 15.6 1.1 1.0 0.0 0.6 2.5 1.4 2.3 0.0 0.0 0.5 0.0 3.8 0.1 1.4 13.3 0.0 4.2 4.6 0.9 1.6 6.9 0.9 20.7 0.0 0.0 2.5 34.3 0.0 0.6 16.5 1.7 17.2 6.3 0.2 9.4 12.2 0.7 0.6 0.0 0.0 0.9 0.1 1.5 1.0 0.7 15.9 5.8 2.6 GMNN Gem ENSG00000112312 "Geminin, DNA replication inhibitor" O75496 6 24774931-24786099 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "DNA replication inhibitor" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 95.0" "Cell type enhanced" "Detected in many" 8 "Paneth cells: 272.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011458, CAB047327, CAB047328, HPA049977, HPA054597" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538" "unprognostic (1.37e-1)" "unprognostic (3.43e-3)" "unprognostic (3.91e-3)" "unprognostic (1.52e-2)" "unprognostic (1.28e-1)" "unprognostic (4.37e-2)" "unprognostic (2.90e-3)" "unprognostic (8.29e-2)" "unprognostic (1.23e-3)" "prognostic favorable (4.13e-4)" "prognostic unfavorable (9.77e-4)" "unprognostic (1.33e-2)" "prognostic unfavorable (7.82e-5)" "unprognostic (2.25e-1)" "unprognostic (7.92e-2)" "unprognostic (3.63e-2)" "unprognostic (5.90e-3)" 4.5 3.9 10.7 11.2 19.0 24.1 10.7 15.6 9.4 4.9 17.1 3.2 9.7 7.6 5.3 6.3 8.0 7.3 4.7 3.7 11.0 10.2 10.8 8.4 4.4 12.0 13.6 9.8 7.2 95.0 2.6 7.5 7.9 10.7 18.4 18.9 3.4 4.2 11.6 3.7 17.3 7.4 5.7 7.9 12.6 9.7 19.6 11.9 26.1 13.2 11.0 9.7 15.2 7.4 8.5 9.2 15.8 6.7 5.3 15.2 5.6 24.9 14.8 37.6 15.5 5.3 5.7 25.1 24.5 13.0 29.5 32.4 28.7 9.0 25.1 31.3 7.9 21.7 14.7 32.5 18.1 31.8 9.3 34.0 34.4 26.4 47.0 5.0 26.7 12.6 4.6 5.9 17.9 7.0 6.1 14.5 19.6 43.2 13.4 20.8 19.5 50.1 28.9 20.5 20.4 11.7 29.2 29.4 32.2 12.4 21.8 30.2 18.6 11.0 18.2 21.6 22.1 19.1 16.4 7.1 18.1 18.3 20.8 41.5 14.9 45.7 47.1 5.5 50.4 25.9 5.3 5.3 15.8 4.6 6.7 5.8 8.5 8.9 7.1 7.4 4.5 6.6 7.3 3.0 5.3 4.7 9.2 15.2 5.6 10.7 19.0 15.6 9.4 11.0 10.2 13.6 9.8 10.7 11.9 6.0 14.1 15.7 25.3 29.3 8.9 9.4 15.3 33.5 52.4 41.8 2.0 52.0 8.3 78.3 58.9 14.3 21.2 0.0 100.1 110.5 15.8 27.7 12.7 15.3 45.0 11.1 24.9 9.8 9.2 17.5 8.9 12.4 21.9 19.8 24.9 29.4 43.9 272.7 10.3 14.6 12.1 19.4 12.3 132.2 59.4 55.6 40.7 17.5 87.0 19.7 GON4L "FLJ20203, GON-4, GON4, YARP" ENSG00000116580 "Gon-4 like" Q3T8J9 1 155749662-155859400 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 123.7;Rod photoreceptor cells: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA006986, HPA057305, HPA074504" Uncertain Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA006986: AB_1080620, HPA057305: AB_2683408, HPA074504: AB_2686696" "unprognostic (3.16e-2)" "unprognostic (9.26e-3)" "unprognostic (1.68e-1)" "prognostic unfavorable (4.19e-4)" "unprognostic (9.85e-3)" "unprognostic (5.21e-2)" "unprognostic (1.83e-2)" "unprognostic (1.15e-1)" "unprognostic (7.49e-2)" "unprognostic (7.50e-2)" "unprognostic (1.69e-1)" "unprognostic (1.94e-1)" "unprognostic (5.12e-3)" "unprognostic (3.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.26e-2)" "unprognostic (5.83e-2)" 17.4 12.5 13.5 16.1 18.9 13.6 18.3 30.1 21.6 17.6 15.7 14.4 18.7 11.8 25.8 18.3 13.7 15.9 12.0 14.0 14.8 10.2 14.9 12.7 16.7 18.3 14.8 13.0 17.2 16.3 26.0 22.3 15.9 15.3 16.1 15.4 16.3 15.2 15.8 18.8 17.8 17.5 18.3 16.5 21.1 15.1 14.1 16.0 25.1 18.8 11.4 24.8 16.9 16.0 7.0 5.2 10.2 4.7 8.4 6.6 2.5 11.4 9.5 18.4 11.3 11.6 14.6 11.6 10.4 12.9 13.5 13.2 11.3 10.5 13.2 11.4 13.6 6.8 13.3 13.6 12.1 15.7 12.3 9.6 13.2 11.7 6.3 11.0 15.5 12.3 12.9 10.7 14.9 14.2 13.9 15.9 14.7 16.8 5.1 11.3 11.7 13.4 9.4 20.3 14.4 10.9 12.4 11.7 14.7 9.9 13.8 10.3 17.3 12.7 12.9 10.0 19.4 14.1 18.6 17.8 11.0 9.1 11.2 12.9 20.7 13.8 22.2 9.6 9.3 12.1 5.0 4.7 4.0 6.6 3.7 4.4 3.7 4.3 4.6 4.7 7.0 4.5 4.1 10.2 8.4 3.1 5.2 4.2 2.5 13.5 18.9 30.1 21.6 14.8 10.2 14.8 13.0 15.3 16.0 14.9 32.6 21.4 18.8 10.8 69.8 18.6 15.3 16.0 34.2 19.2 123.7 20.5 8.3 19.9 17.3 35.0 19.8 0.0 15.7 19.3 20.6 22.5 38.0 11.0 17.2 73.1 31.2 23.4 16.3 8.5 32.5 21.6 15.1 34.3 17.7 44.4 18.7 20.1 25.8 10.1 164.4 38.8 17.6 49.5 37.5 15.3 37.6 34.6 19.6 19.5 GORAB "FLJ11752, GO, NTKL-BP1, SCYL1BP1" ENSG00000120370 "Golgin, RAB6 interacting" Q5T7V8 1 170532129-170553446 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027208, HPA027250, HPA027746" Approved Enhanced "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Nucleoli" "HPA027208: AB_10599622, HPA027250: AB_10611253, HPA027746: " "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (4.75e-3)" "prognostic favorable (1.39e-4)" "prognostic unfavorable (5.26e-4)" "unprognostic (8.48e-3)" "unprognostic (2.94e-2)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.77e-2)" "prognostic unfavorable (7.83e-12)" "unprognostic (2.52e-2)" "unprognostic (2.83e-1)" "unprognostic (7.71e-2)" "unprognostic (1.70e-1)" 7.7 14.7 8.4 9.4 9.2 0.5 10.6 8.7 9.5 10.7 9.4 4.8 7.0 4.8 8.8 10.5 6.3 6.8 6.7 8.2 7.4 7.8 7.2 11.1 6.8 9.6 6.3 8.1 12.6 9.7 6.5 20.6 9.4 8.7 11.1 10.4 6.3 8.8 13.1 3.3 6.5 7.0 6.4 11.1 10.4 5.6 8.6 7.3 8.7 10.5 4.2 9.7 10.4 10.0 6.2 7.3 1.2 7.4 7.9 9.4 5.5 5.1 5.0 9.6 3.6 12.9 9.6 6.3 7.8 12.1 6.9 7.2 3.2 8.8 7.5 9.0 7.9 4.5 6.5 9.5 4.6 9.2 8.0 2.9 5.0 6.5 4.0 8.7 6.6 5.1 8.3 4.5 7.4 6.9 8.6 5.4 4.3 6.8 3.7 7.3 1.2 9.5 6.0 8.5 11.6 6.3 5.7 6.4 10.0 6.2 3.8 2.5 5.3 6.5 7.9 18.2 6.4 5.0 11.7 6.9 11.0 5.8 4.3 10.8 6.7 7.3 6.6 9.2 6.0 9.8 1.0 7.4 0.0 4.7 7.4 7.4 6.1 8.3 7.2 7.3 6.2 7.3 6.2 1.2 7.9 5.7 4.6 9.4 5.5 8.4 9.2 8.7 9.5 7.4 7.8 6.3 8.1 8.7 7.3 0.0 10.7 6.0 2.9 2.5 3.9 6.7 7.6 1.4 6.8 5.2 2.0 5.2 3.3 9.4 1.6 7.4 5.1 0.0 5.3 5.6 10.4 4.1 12.8 5.8 6.3 4.8 0.0 3.7 6.3 2.6 13.0 3.9 3.3 10.0 6.4 3.4 5.8 7.0 6.0 4.4 7.2 6.5 8.5 13.1 7.7 1.4 4.7 5.7 6.0 2.7 GPATCH4 "DKFZP434F1735, FLJ20249, GPATC4" ENSG00000160818 "G-patch domain containing 4" 1 156594487-156601496 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028323, HPA054319" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA028323: AB_10601017, HPA054319: AB_2682447" "unprognostic (2.80e-2)" "unprognostic (4.61e-2)" "unprognostic (3.45e-1)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (3.17e-5)" "unprognostic (2.40e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-3)" "unprognostic (9.60e-2)" "unprognostic (6.39e-3)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.07e-1)" "unprognostic (1.71e-1)" "unprognostic (6.03e-2)" "unprognostic (6.80e-2)" 18.2 13.3 14.7 16.9 27.7 9.4 15.1 6.9 22.5 10.0 12.1 8.3 3.9 9.7 13.8 10.0 14.0 11.6 7.2 11.9 12.6 12.1 18.0 23.1 10.0 15.7 15.3 12.4 15.3 12.9 19.6 16.2 10.0 24.2 12.6 14.6 5.7 11.5 11.9 47.1 10.9 10.0 15.1 10.2 16.6 12.5 8.8 13.2 8.0 10.3 19.0 19.1 12.5 10.1 16.6 10.1 0.3 11.2 10.7 15.9 7.6 17.1 23.7 10.0 14.4 9.2 7.1 13.0 21.3 8.5 16.7 9.8 24.2 13.0 41.4 17.7 14.9 10.8 12.0 22.7 18.8 18.5 12.3 22.5 24.7 23.2 18.5 8.3 55.1 16.0 8.0 15.9 31.6 28.0 4.7 11.7 13.5 40.4 10.4 13.5 32.0 22.6 13.3 43.8 29.9 25.0 22.6 17.1 28.7 11.5 20.4 15.8 23.8 20.4 44.9 13.1 11.4 14.7 26.8 17.8 15.9 21.7 16.5 38.1 19.1 21.0 53.4 14.4 28.6 24.0 0.0 5.4 0.1 13.3 10.5 13.4 16.6 13.5 14.7 10.1 16.6 15.4 15.9 0.3 10.7 11.2 6.4 8.5 7.6 14.7 27.7 6.9 22.5 12.6 12.1 15.3 12.4 24.2 13.2 29.8 34.7 41.0 38.8 65.5 7.1 24.8 28.1 16.0 40.9 15.7 7.9 31.9 21.6 38.5 7.6 30.2 8.5 23.3 48.9 40.5 22.6 43.6 56.6 37.8 33.7 7.9 35.5 14.7 10.7 7.4 24.7 22.6 21.9 19.8 19.7 4.3 44.1 14.0 25.1 25.9 5.9 32.3 59.0 37.1 39.9 54.7 12.9 29.7 28.3 36.6 GPKOW "GPATC5, GPATCH5, Spp2, T54" ENSG00000068394 "G-patch domain and KOW motifs" Q92917 X 49113389-49123801 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000287, HPA001894" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000287: AB_1079015, HPA001894: AB_1079014" "unprognostic (3.34e-2)" "unprognostic (9.54e-3)" "unprognostic (8.95e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (1.19e-1)" "unprognostic (2.03e-3)" "unprognostic (1.02e-1)" "unprognostic (9.29e-2)" "unprognostic (7.96e-2)" "unprognostic (4.32e-1)" "unprognostic (7.08e-2)" "unprognostic (1.14e-2)" "unprognostic (3.17e-1)" "unprognostic (2.73e-1)" "unprognostic (1.59e-1)" "unprognostic (1.89e-2)" 14.9 14.6 20.1 11.8 23.1 15.0 13.8 24.3 25.3 14.5 14.8 22.6 11.7 15.3 15.5 13.4 14.7 17.0 11.3 17.0 17.6 20.1 12.3 15.8 12.8 14.1 22.9 28.9 14.3 11.5 22.4 15.8 14.7 20.0 13.8 13.9 12.1 13.4 19.3 31.9 16.9 14.1 15.3 20.3 14.0 13.5 8.0 22.3 15.7 14.2 9.0 14.9 14.8 12.1 21.3 17.0 20.7 24.8 17.8 29.5 14.6 20.5 21.9 14.7 12.3 13.0 11.3 16.0 13.4 15.1 21.3 22.7 15.9 20.7 8.6 10.3 16.4 21.9 14.6 16.2 15.8 14.0 18.1 17.3 9.0 18.4 11.2 15.6 10.6 19.1 12.3 20.2 17.0 17.4 12.6 15.9 17.5 11.0 13.6 13.8 33.5 14.5 17.7 10.4 11.1 17.5 18.2 16.2 23.4 10.9 26.3 12.3 14.3 15.5 14.8 14.3 16.2 28.4 13.9 17.7 12.4 18.8 17.9 12.6 21.0 14.3 11.7 15.9 17.7 19.0 19.3 16.8 20.7 29.5 23.1 24.0 15.4 23.2 22.0 17.0 21.3 19.7 18.5 13.3 17.8 24.8 15.5 22.7 14.6 20.1 23.1 24.3 25.3 17.6 20.1 22.9 28.9 20.0 22.3 17.9 8.3 11.7 11.1 7.1 14.9 10.4 28.1 6.7 17.0 7.0 3.9 23.1 13.3 22.4 0.8 10.8 14.9 23.3 22.2 16.9 13.4 9.1 11.5 13.0 14.5 4.8 7.5 9.8 7.0 1.3 14.4 10.8 5.0 15.4 10.8 15.8 21.4 21.0 14.2 17.0 11.7 38.8 14.4 5.2 17.9 8.7 36.6 14.4 10.7 10.8 GPS1 "COPS1, CSN1" ENSG00000169727 "G protein pathway suppressor 1" Q13098 17 82050691-82057470 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047448, HPA052848" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047448: , HPA052848: " "unprognostic (1.96e-1)" "unprognostic (5.89e-2)" "unprognostic (1.50e-1)" "unprognostic (9.65e-2)" "unprognostic (3.41e-1)" "unprognostic (2.19e-1)" "unprognostic (4.75e-3)" "unprognostic (2.18e-2)" "unprognostic (3.17e-1)" "prognostic favorable (3.06e-4)" "unprognostic (1.18e-3)" "unprognostic (1.92e-1)" "unprognostic (4.96e-3)" "unprognostic (4.07e-1)" "unprognostic (8.90e-2)" "unprognostic (1.45e-1)" "unprognostic (2.15e-1)" 23.5 23.9 27.2 19.3 28.2 23.6 18.8 27.7 47.2 20.5 18.7 33.3 19.8 22.4 21.5 21.1 22.2 24.5 19.2 33.4 28.7 26.7 29.6 39.9 17.2 21.6 28.7 25.9 25.3 34.4 23.2 22.3 20.8 28.0 23.2 12.0 25.1 37.1 28.9 67.1 26.5 19.7 16.8 23.7 20.7 21.9 36.0 18.2 32.3 25.3 29.8 20.6 19.5 17.0 26.1 37.3 25.2 34.5 29.7 44.0 36.0 27.1 50.8 18.9 24.7 13.4 12.9 26.8 18.3 14.7 29.1 24.1 44.4 17.0 13.5 16.5 18.3 21.2 20.7 18.0 23.4 9.9 8.9 64.3 22.8 28.5 49.2 22.3 24.8 22.1 18.5 17.2 25.7 15.4 11.7 30.3 23.4 21.3 15.6 16.1 53.7 42.2 28.2 24.0 26.2 38.0 26.0 26.0 21.9 17.9 28.4 32.5 50.9 18.6 34.5 27.0 15.1 39.1 22.5 17.2 29.1 34.5 22.4 29.3 28.7 12.0 14.2 22.7 16.0 26.1 19.6 34.5 25.2 33.0 31.7 34.5 26.1 34.8 33.0 37.3 24.5 25.0 31.2 5.4 29.7 28.6 25.7 44.0 36.0 27.2 28.2 27.7 47.2 28.7 26.7 28.7 25.9 28.0 18.2 11.9 21.9 21.6 19.7 22.2 28.4 50.0 28.1 32.1 18.2 19.2 23.6 60.9 51.4 48.6 24.6 27.5 66.9 23.3 60.4 58.8 33.4 21.0 24.3 47.8 53.5 46.1 39.6 30.7 32.4 58.5 27.9 36.5 32.1 45.9 33.5 36.5 43.4 45.6 29.7 84.8 24.9 6.5 35.6 48.3 48.5 26.2 45.2 25.8 42.2 17.0 GRWD1 "GRWD, RRB1, WDR28" ENSG00000105447 "Glutamate rich WD repeat containing 1" Q9BQ67 19 48445773-48457022 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042643, HPA055680" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA042643: AB_10795510, HPA055680: AB_2682884" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (4.99e-2)" "unprognostic (1.00e-1)" "unprognostic (3.46e-1)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.71e-2)" "unprognostic (5.68e-2)" "unprognostic (2.69e-2)" "unprognostic (7.70e-2)" "unprognostic (2.83e-2)" "unprognostic (8.10e-2)" "unprognostic (1.78e-1)" "unprognostic (3.09e-1)" "unprognostic (2.02e-1)" "unprognostic (5.07e-2)" 16.9 15.5 9.2 15.7 11.1 14.8 15.5 12.9 14.1 13.6 14.1 10.4 11.9 15.6 18.7 12.8 20.0 15.0 16.2 16.9 7.8 8.6 13.0 26.3 12.5 17.5 11.0 10.3 19.3 35.5 16.5 10.3 14.7 9.5 13.8 8.0 12.0 18.6 14.4 29.1 18.3 11.5 13.3 8.2 19.4 14.7 13.1 10.9 18.6 17.3 19.0 17.3 14.1 18.0 21.1 18.4 1.4 17.8 17.4 22.6 16.5 17.0 45.1 7.7 14.4 6.3 6.2 6.6 13.3 6.4 19.2 16.1 25.3 12.7 24.4 11.6 8.3 10.8 14.6 19.1 20.6 7.6 18.2 25.8 22.2 15.3 18.0 7.3 20.9 14.3 7.4 11.4 18.1 9.2 4.3 9.5 13.4 31.0 15.4 8.0 17.7 22.0 52.6 20.9 18.2 13.2 27.4 8.6 17.5 8.0 21.1 17.3 9.6 15.0 21.3 6.6 4.8 10.5 10.6 10.1 17.9 15.1 7.8 31.6 15.7 35.9 22.8 6.0 18.9 20.8 0.1 11.0 1.4 19.6 17.8 22.6 21.1 18.1 19.5 18.4 20.4 21.3 19.7 0.8 17.4 13.5 13.6 15.6 16.5 9.2 11.1 12.9 14.1 7.8 8.6 11.0 10.3 9.5 10.9 3.0 17.4 22.9 20.9 41.1 12.6 6.5 15.3 18.7 14.8 12.2 0.0 35.6 19.9 28.0 1.7 18.0 7.3 0.0 15.7 30.6 18.6 13.5 19.6 14.7 21.5 20.6 18.4 11.6 10.7 14.6 15.8 12.4 27.0 35.1 9.0 5.3 18.5 7.0 11.7 15.3 13.0 19.4 20.2 6.1 34.7 35.5 29.3 20.0 13.4 17.6 GTF2E1 "FE, TFIIE-A" ENSG00000153767 "General transcription factor IIE subunit 1" P29083 3 120742637-120783069 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009884, HPA056359, HPA066881" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009884: AB_2279381, HPA056359: AB_2683106, HPA066881: AB_2685740" "unprognostic (3.19e-1)" "unprognostic (1.40e-1)" "unprognostic (2.05e-1)" "unprognostic (1.05e-2)" "unprognostic (8.94e-2)" "unprognostic (3.23e-1)" "unprognostic (4.36e-3)" "unprognostic (2.62e-1)" "unprognostic (2.64e-2)" "unprognostic (1.59e-1)" "unprognostic (4.38e-2)" "unprognostic (9.34e-3)" "unprognostic (5.10e-2)" "unprognostic (8.29e-3)" "unprognostic (4.94e-1)" "unprognostic (3.19e-2)" "unprognostic (2.97e-1)" 11.1 18.0 8.6 10.7 9.9 6.6 10.0 9.1 9.9 9.2 8.5 11.6 7.3 7.8 13.3 8.1 9.4 7.6 6.4 8.5 8.8 8.3 12.9 12.7 8.4 14.0 9.3 7.6 10.5 14.5 8.4 12.9 11.9 9.1 8.2 10.4 7.9 18.7 10.2 12.8 7.8 9.8 10.0 11.9 14.0 7.8 16.3 8.9 25.6 9.6 10.0 14.9 9.2 9.5 10.9 10.5 16.8 12.9 11.9 12.0 8.7 9.2 13.0 16.3 9.9 12.3 5.7 14.2 6.2 5.7 9.8 10.6 15.5 6.7 15.2 11.0 4.6 7.6 11.2 15.0 8.2 13.8 10.5 3.5 19.6 9.5 12.9 9.6 17.6 11.9 7.5 8.9 7.3 10.4 6.7 15.0 13.1 13.6 8.0 10.3 10.6 14.5 8.9 15.5 9.0 12.1 12.0 19.2 11.3 9.7 6.0 3.5 10.8 9.4 8.2 8.4 15.4 10.4 13.6 13.1 9.2 10.1 2.9 7.0 7.1 7.7 21.8 9.7 17.9 8.8 16.8 8.5 13.0 8.5 12.9 11.1 10.9 10.1 12.0 10.5 9.1 11.1 10.7 6.2 11.9 11.7 4.9 11.4 8.7 8.6 9.9 9.1 9.9 8.8 8.3 9.3 7.6 9.1 8.9 3.0 4.1 11.0 2.7 1.6 4.5 4.5 10.2 2.7 6.8 7.0 0.0 7.7 5.0 4.5 5.6 3.6 2.6 0.0 3.9 7.0 3.1 2.6 12.7 3.8 8.1 15.9 1.2 6.2 6.5 2.0 2.0 6.3 3.3 12.6 3.2 5.2 4.3 0.0 4.6 4.8 4.1 0.0 1.9 12.6 21.5 2.3 7.3 5.0 3.5 2.8 GTF2E2 "FE, TF2E2, TFIIE-B" ENSG00000197265 "General transcription factor IIE subunit 2" P29084 8 30578318-30658251 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004816, CAB009603, HPA025065" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009603: AB_2114537, HPA004816: AB_2667252, HPA025065: AB_10601658" "unprognostic (4.84e-2)" "unprognostic (7.38e-3)" "unprognostic (6.20e-3)" "unprognostic (9.09e-2)" "unprognostic (6.30e-2)" "unprognostic (4.38e-1)" "unprognostic (6.05e-3)" "unprognostic (8.69e-2)" "unprognostic (2.29e-1)" "unprognostic (4.72e-2)" "unprognostic (1.57e-2)" "unprognostic (4.09e-2)" "prognostic unfavorable (5.82e-7)" "unprognostic (8.25e-2)" "unprognostic (1.72e-1)" "unprognostic (1.05e-3)" "unprognostic (1.24e-1)" 19.0 21.9 11.4 16.2 17.0 7.5 26.7 21.2 13.1 16.4 19.1 10.7 15.1 16.8 17.7 15.8 20.0 12.3 11.7 12.7 11.1 10.9 14.7 21.1 13.4 20.3 11.6 12.2 24.2 44.6 14.1 22.5 14.5 11.9 14.2 14.4 12.1 12.6 13.8 9.9 14.8 26.2 16.3 11.6 17.2 20.9 31.0 11.7 21.4 17.2 10.6 22.0 16.9 27.5 16.4 8.0 5.6 4.2 8.7 7.9 2.6 21.7 17.6 12.2 12.8 32.9 29.4 9.2 23.6 21.4 19.4 24.8 10.5 15.6 28.1 20.1 21.0 28.1 15.4 20.0 22.0 25.9 12.5 11.8 14.0 12.3 24.9 32.0 6.7 12.4 21.5 29.2 20.8 21.2 19.4 26.7 21.0 26.9 17.3 30.4 14.7 32.8 16.9 13.7 26.3 21.2 17.3 13.2 14.0 21.0 14.9 9.4 12.2 13.1 8.8 18.4 16.8 8.5 8.3 20.3 12.8 13.3 10.8 16.0 17.7 24.0 30.4 20.2 11.6 16.9 3.0 4.2 5.6 3.9 3.3 4.2 16.4 6.0 7.9 7.2 9.3 5.9 5.9 2.2 8.7 3.3 8.0 6.7 2.6 11.4 17.0 21.2 13.1 11.1 10.9 11.6 12.2 11.9 11.7 0.0 9.6 39.5 36.7 42.6 8.9 7.8 17.8 21.4 11.4 14.0 9.8 36.2 16.6 26.8 61.8 21.5 30.5 0.0 29.1 39.9 29.8 60.5 11.5 25.6 31.1 4.8 12.7 27.6 20.2 43.8 36.5 28.3 20.3 76.7 19.8 7.3 37.7 23.2 66.4 35.1 13.8 25.8 30.9 56.0 82.0 40.7 51.9 30.9 21.8 88.4 GTF2F1 "BTF4, RAP74, TF2F1, TFIIF" ENSG00000125651 "General transcription factor IIF subunit 1" P35269 19 6379569-6393981 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 199.3;Late spermatids: 301.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022793, HPA028707, HPA070752" Supported Enhanced "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA022793: AB_1857946, HPA028707: AB_2672745, HPA070752: AB_2732163" "unprognostic (1.30e-2)" "unprognostic (6.05e-3)" "unprognostic (2.00e-1)" "prognostic favorable (8.39e-4)" "unprognostic (3.18e-1)" "unprognostic (8.46e-2)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.99e-2)" "unprognostic (6.45e-3)" "unprognostic (6.96e-2)" "prognostic favorable (9.80e-4)" "unprognostic (1.34e-2)" "unprognostic (7.02e-2)" "unprognostic (9.92e-2)" "unprognostic (4.25e-1)" 24.9 26.0 32.5 26.6 33.1 41.1 22.6 60.7 47.3 25.5 24.7 18.8 26.1 35.2 31.7 22.6 30.8 29.9 26.5 22.9 28.9 25.9 24.4 21.7 19.8 34.9 23.9 36.3 59.8 40.7 31.8 33.4 19.9 26.6 24.6 16.3 22.3 33.9 24.4 25.6 21.8 31.9 27.6 26.4 26.7 26.4 39.4 23.1 23.6 36.4 19.7 22.2 26.0 39.8 24.4 21.5 28.4 21.4 19.0 23.8 14.1 38.3 28.3 20.6 32.7 13.9 22.6 16.3 27.0 25.3 33.7 32.2 29.6 15.2 23.4 38.0 17.7 24.2 35.0 19.3 17.1 16.6 35.7 24.6 32.5 21.1 26.3 24.2 37.6 26.4 23.7 22.9 24.0 18.4 28.6 19.8 23.2 39.6 31.8 18.6 26.7 37.3 21.4 37.3 17.8 36.1 34.6 22.8 29.9 18.8 22.0 25.3 34.8 27.9 21.4 29.8 13.0 27.2 30.0 28.0 26.5 22.3 45.7 38.0 56.5 63.4 25.3 33.0 39.5 29.6 7.0 21.4 14.0 20.5 20.6 23.8 24.4 18.4 19.5 16.9 23.3 21.7 18.8 28.4 19.0 19.1 21.5 17.6 14.1 32.5 33.1 60.7 47.3 28.9 25.9 23.9 36.3 26.6 23.1 44.7 44.6 45.7 42.2 21.6 25.9 26.2 20.4 115.1 78.5 24.4 7.9 38.5 18.3 42.3 199.3 33.5 64.5 23.3 44.2 36.6 30.1 27.3 60.3 23.7 51.8 23.8 29.2 52.8 50.9 301.8 41.1 31.9 32.1 62.3 38.4 32.6 42.6 35.9 46.7 29.3 28.8 32.3 43.2 51.5 36.8 18.3 45.2 56.5 40.9 36.7 GTF2H1 "BTF2, P62, TFIIH" ENSG00000110768 "General transcription factor IIH subunit 1" P32780 11 18322295-18367044 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004637, HPA046660" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004637: AB_425470, HPA046660: AB_2679743" "unprognostic (2.25e-1)" "unprognostic (2.33e-1)" "unprognostic (9.78e-2)" "unprognostic (2.38e-1)" "unprognostic (2.63e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (5.98e-9)" "unprognostic (7.71e-2)" "unprognostic (4.24e-2)" "unprognostic (2.81e-1)" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (7.42e-3)" "unprognostic (8.31e-2)" "unprognostic (1.24e-1)" "unprognostic (7.90e-2)" "unprognostic (2.94e-1)" 27.1 26.4 24.1 18.2 28.8 10.5 33.0 32.6 35.7 21.5 21.6 19.3 24.1 18.0 23.5 23.1 26.2 18.6 22.9 21.4 24.1 20.4 25.9 25.0 19.1 23.7 19.6 22.2 27.2 24.3 27.1 32.4 24.3 27.4 22.5 20.9 21.2 25.8 26.0 20.8 32.4 21.7 20.6 21.1 23.4 20.5 38.5 23.3 22.7 29.3 21.7 25.7 22.9 22.2 12.0 11.8 20.3 12.1 15.9 13.9 8.8 12.3 11.4 9.6 13.7 22.1 17.6 12.1 18.5 20.0 16.5 19.0 11.9 4.9 20.7 7.4 19.0 23.8 17.2 15.8 17.0 21.4 9.1 15.6 13.4 11.7 12.0 31.5 25.7 14.6 19.8 20.4 10.2 32.4 13.6 14.5 11.0 20.5 11.0 23.7 11.5 12.9 20.5 8.4 20.8 16.5 13.3 20.5 9.6 13.6 17.0 11.0 11.9 15.3 14.8 22.8 8.7 7.7 15.1 10.7 22.3 10.8 39.8 15.0 5.6 13.3 15.2 19.2 20.2 21.1 20.3 10.9 11.3 9.1 11.0 9.8 11.7 11.5 10.1 11.8 12.0 13.9 11.1 7.9 15.9 12.1 6.5 11.0 8.8 24.1 28.8 32.6 35.7 24.1 20.4 19.6 22.2 27.4 23.3 14.9 12.8 15.4 18.2 42.8 16.7 22.8 22.9 28.1 22.7 10.4 19.6 21.2 6.6 19.7 33.7 20.4 13.9 0.0 26.5 23.5 19.3 19.1 17.4 11.4 21.7 20.6 7.5 21.5 18.0 32.8 15.8 23.4 21.9 24.4 11.2 20.1 23.7 8.6 15.2 18.8 19.3 6.5 26.4 48.3 30.1 45.2 23.6 15.3 15.5 21.4 GTF2I "BAP-135, BTKAP1, DIWS, IB291, SPIN, TFII-I, WBSCR6" ENSG00000263001 "General transcription factor IIi" P78347 7 74657667-74760692 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004595, HPA026638" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004595: AB_628345, HPA026638: AB_1857959" "unprognostic (3.47e-1)" "unprognostic (2.26e-2)" "unprognostic (3.63e-1)" "unprognostic (1.61e-1)" "unprognostic (3.21e-1)" "unprognostic (1.11e-1)" "unprognostic (7.08e-2)" "unprognostic (2.53e-2)" "unprognostic (1.15e-2)" "unprognostic (1.63e-1)" "unprognostic (8.80e-3)" "unprognostic (1.28e-1)" "prognostic favorable (6.35e-6)" "unprognostic (7.70e-2)" "unprognostic (1.60e-1)" "unprognostic (1.19e-1)" "unprognostic (5.88e-2)" 10.2 14.3 12.6 10.2 14.3 4.0 11.5 13.1 15.2 11.3 8.6 15.4 6.0 9.1 10.5 9.6 9.9 12.5 10.8 8.6 12.8 13.5 10.2 10.2 8.8 18.1 9.7 12.1 8.5 29.0 12.4 9.8 12.9 12.1 6.9 12.1 11.7 10.3 13.4 10.9 7.9 11.1 8.8 7.5 12.0 4.3 16.0 21.2 22.3 6.3 11.6 10.3 7.1 16.8 14.8 10.9 6.9 14.2 13.2 5.8 29.6 24.5 50.8 49.8 28.1 25.0 10.6 18.8 17.3 20.8 20.7 17.0 36.2 35.8 7.6 23.0 27.7 26.1 49.7 22.6 26.9 26.9 26.3 18.2 29.1 23.6 16.9 34.5 27.3 23.1 19.5 15.7 16.2 30.5 27.8 12.1 35.5 17.1 25.0 27.6 28.7 30.9 54.4 63.3 15.3 31.6 17.6 29.3 27.3 51.7 42.6 54.4 34.2 51.5 17.2 44.6 26.3 22.9 24.8 28.6 15.4 14.3 23.9 20.2 17.8 56.9 16.3 20.9 28.5 5.1 6.9 10.9 8.3 5.1 13.2 14.6 11.3 12.9 10.5 16.8 13.1 12.9 2.8 14.2 4.2 14.8 5.7 5.8 74.5 52.9 73.0 73.2 53.3 262.6 25.7 193.6 52.2 54.6 113.4 267.0 84.7 48.0 123.3 33.9 79.4 49.7 0.0 72.6 51.4 66.4 111.8 12.7 84.7 68.3 236.8 108.4 117.2 104.4 29.3 141.5 49.6 52.3 67.7 67.6 192.8 108.5 76.4 181.4 83.8 173.7 84.1 49.5 22.3 38.3 80.4 60.4 45.7 63.2 92.7 GTF3C5 "TFiiiC2-63, TFIIIC63, TFIIICepsilon" ENSG00000148308 "General transcription factor IIIC subunit 5" Q9Y5Q8 9 133030675-133058503 "Predicted intracellular proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067063, HPA069805" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA067063: AB_2685773, HPA069805: AB_2686201" "unprognostic (1.07e-2)" "unprognostic (1.78e-3)" "unprognostic (5.58e-2)" "unprognostic (2.35e-1)" "unprognostic (1.62e-1)" "unprognostic (1.27e-1)" "unprognostic (7.97e-3)" "unprognostic (4.01e-2)" "unprognostic (1.54e-1)" "unprognostic (1.22e-1)" "unprognostic (1.10e-2)" "unprognostic (1.58e-2)" "unprognostic (1.45e-3)" "unprognostic (4.55e-3)" "unprognostic (1.13e-2)" "unprognostic (1.33e-1)" "unprognostic (8.73e-2)" 21.2 24.6 20.1 18.2 30.4 33.3 21.8 38.7 30.6 21.9 25.0 39.6 20.6 24.7 23.1 21.9 28.0 25.7 16.2 24.5 20.8 17.3 20.9 25.1 18.8 23.1 31.9 19.9 41.3 24.6 24.4 26.0 24.9 22.7 24.0 18.5 21.3 26.4 20.1 36.7 31.2 23.6 20.6 23.0 23.9 20.4 24.2 30.8 43.5 22.1 29.3 29.2 19.5 22.5 11.2 12.0 28.4 13.2 13.8 17.0 11.5 11.7 22.0 19.2 17.9 10.5 9.1 25.6 11.5 13.0 22.2 15.7 23.1 19.6 19.8 10.9 12.7 17.9 28.8 22.9 20.8 12.6 20.1 19.0 22.6 25.2 21.3 16.1 18.4 48.7 12.8 13.9 23.3 16.2 10.9 19.5 65.7 29.2 19.5 11.5 39.3 29.4 25.6 24.9 27.4 22.1 31.2 19.2 25.0 14.6 13.8 23.0 17.0 19.0 21.1 12.1 12.2 27.0 26.3 11.9 26.7 20.7 16.4 19.0 7.5 15.2 21.5 13.3 13.6 18.0 28.4 11.0 14.9 11.8 13.2 17.0 11.2 12.2 15.3 12.0 10.8 14.0 12.4 6.6 13.8 10.7 11.6 13.4 11.5 20.1 30.4 38.7 30.6 20.8 17.3 31.9 19.9 22.7 30.8 8.9 14.7 20.4 14.8 11.0 14.4 27.1 7.6 10.7 13.6 15.7 7.9 34.8 24.9 20.8 3.0 14.3 26.2 23.3 26.2 32.0 16.6 10.9 16.1 15.3 19.8 14.3 13.8 20.9 15.5 3.6 16.1 10.8 15.1 16.2 14.6 20.6 22.9 23.0 20.1 10.2 17.1 45.3 15.6 17.2 28.4 14.4 34.8 19.1 21.2 15.3 H1FX "H1X, MGC15959, MGC8350" ENSG00000184897 "H1 histone family member X" Q92522 3 129314771-129316277 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "bone marrow: 381.6;lymphoid tissue: 238.6" "Cell type enhanced" "Detected in all" 6 "Basal glandular cells: 485.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 139.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB012235, HPA040099, HPA068431" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB012235: , HPA040099: AB_2676846, HPA068431: " "unprognostic (1.01e-2)" "unprognostic (1.12e-2)" "unprognostic (4.13e-2)" "unprognostic (8.48e-2)" "unprognostic (6.94e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.46e-2)" "unprognostic (1.16e-1)" "unprognostic (5.51e-2)" "unprognostic (5.28e-3)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (3.24e-1)" "unprognostic (2.50e-2)" 23.1 13.1 11.9 19.0 14.5 381.6 33.7 29.0 22.9 30.9 21.0 9.6 13.4 21.1 26.0 19.6 34.5 25.1 24.0 27.5 11.3 11.2 12.9 24.9 30.9 44.2 6.7 16.3 39.0 22.4 18.4 20.5 15.0 6.9 26.2 7.8 18.4 32.3 16.3 30.8 40.5 26.0 19.1 9.6 29.9 29.0 14.2 6.3 238.6 21.9 18.1 20.5 35.6 25.0 5.7 10.8 15.9 5.3 4.8 8.3 2.2 19.9 10.6 20.1 8.7 2.0 2.4 19.1 8.8 6.4 10.5 11.1 6.3 11.0 2.5 9.7 3.1 7.0 20.1 8.4 5.6 1.6 18.3 16.3 7.6 8.2 8.6 8.7 8.8 2.0 4.9 7.7 4.2 9.7 4.7 6.0 35.4 11.7 45.5 1.4 20.9 40.7 17.5 18.8 3.6 12.0 29.4 8.6 23.7 3.2 4.2 32.1 37.2 9.3 4.6 26.6 4.0 18.2 17.8 5.9 8.1 42.6 7.9 7.3 139.5 53.3 21.5 6.6 8.4 8.9 0.4 5.3 15.9 4.3 3.7 4.0 4.4 6.7 5.1 7.4 5.7 8.3 4.3 1.2 4.8 3.3 10.8 5.1 2.2 11.9 14.5 29.0 22.9 11.3 11.2 6.7 16.3 6.9 6.3 14.9 12.8 95.3 485.3 89.5 119.1 25.5 63.7 2.7 3.4 89.0 29.5 60.0 94.5 42.6 7.4 89.9 34.4 70.0 71.0 93.0 97.3 173.5 5.7 38.5 77.7 138.2 153.1 85.3 93.5 8.0 92.0 75.7 118.1 25.2 86.3 209.9 59.2 48.9 48.8 25.1 84.3 122.9 82.1 13.2 36.5 96.0 57.2 72.6 52.5 312.3 H3F3B H3.3B ENSG00000132475 "H3 histone family member 3B" P84243 17 75776434-75785893 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 570.8;bone marrow: 441.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 570.8" "Lineage enriched" "Detected in all" 6 "granulocytes: 570.8" "Low cell line specificity" "Detected in all" "CAB037166, CAB037187, CAB037221, HPA042570" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB037166: AB_2115285, CAB037187: AB_477069, CAB037221: AB_477076, HPA042570: AB_2678056" "unprognostic (1.66e-1)" "unprognostic (8.42e-3)" "unprognostic (3.42e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.95e-1)" "unprognostic (2.41e-1)" "unprognostic (2.43e-3)" "unprognostic (3.37e-2)" "unprognostic (1.64e-1)" "unprognostic (5.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.26e-3)" "unprognostic (9.20e-2)" "unprognostic (4.81e-2)" "unprognostic (2.33e-1)" "unprognostic (1.99e-1)" 57.2 41.2 38.1 58.9 48.6 441.9 71.4 60.2 47.0 86.6 44.6 65.9 42.7 37.9 60.5 77.7 93.2 70.2 75.8 35.1 38.5 33.9 42.8 48.1 64.2 62.3 50.4 41.2 141.0 90.9 33.0 41.5 58.5 42.7 60.5 26.6 65.8 58.4 55.4 71.1 114.0 58.0 63.7 51.8 65.9 45.1 66.9 46.2 78.6 58.9 69.1 55.7 78.5 71.9 78.9 88.1 570.8 98.4 80.0 77.2 203.5 117.9 104.8 43.8 43.2 25.0 39.2 60.6 55.9 49.5 68.7 55.2 112.2 84.0 59.1 53.4 32.5 48.6 46.5 34.6 77.3 39.1 32.2 78.0 52.7 55.9 94.9 56.5 87.5 67.9 42.8 47.9 70.4 90.8 30.6 51.6 38.6 74.6 106.3 35.3 173.6 125.6 73.5 35.1 38.2 117.1 93.6 80.2 64.4 54.2 70.1 88.9 98.7 56.7 83.2 120.0 24.4 65.2 94.6 48.1 123.3 109.1 53.2 148.0 128.6 76.0 71.0 65.2 83.5 67.2 182.8 98.4 259.3 74.4 86.9 70.2 78.9 71.8 70.5 86.7 65.3 77.2 64.5 570.8 80.0 78.9 88.1 76.0 203.5 38.1 48.6 60.2 47.0 38.5 33.9 50.4 41.2 42.7 46.2 851.6 868.5 887.7 3350.2 2457.1 1722.8 361.5 690.4 1184.5 958.9 922.9 382.9 1428.6 1080.9 1926.0 2467.5 1156.8 1059.1 327.1 1563.3 1285.8 1898.2 1719.4 1592.3 352.8 1655.2 575.2 1610.5 672.8 901.1 452.7 934.0 1810.8 1808.5 1233.6 1221.5 2460.8 1745.6 1627.3 545.9 699.9 1161.2 983.1 2751.1 2035.3 943.0 3026.0 2929.8 1269.9 852.2 2611.9 HDAC1 "GON-10, HD1, RPD3L1" ENSG00000116478 "Histone deacetylase 1" Q13547 1 32292086-32333635 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005017, HPA029693, CAB068191" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB005017: AB_2248344, CAB068191: AB_2665664, HPA029693: AB_10601659" "unprognostic (2.51e-2)" "unprognostic (9.10e-2)" "unprognostic (2.92e-1)" "unprognostic (2.98e-1)" "unprognostic (9.15e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (5.76e-7)" "unprognostic (9.57e-2)" "unprognostic (5.02e-2)" "unprognostic (3.47e-2)" "unprognostic (7.06e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (1.04e-5)" "unprognostic (6.86e-2)" "unprognostic (3.78e-1)" "unprognostic (7.16e-2)" "unprognostic (1.72e-1)" 13.8 22.8 12.8 33.5 14.8 15.0 21.1 5.1 13.0 21.9 35.7 16.0 34.8 22.2 24.6 17.5 40.6 21.0 43.8 12.4 12.5 8.5 21.1 21.5 17.2 33.3 14.7 8.6 27.7 20.5 17.2 27.1 24.4 12.2 25.2 33.9 18.0 27.8 31.3 6.6 16.9 32.7 22.1 13.3 32.6 27.8 20.0 16.7 59.4 36.8 21.2 51.1 26.0 25.1 47.7 32.1 59.8 44.6 42.4 49.2 54.7 29.4 18.0 11.6 23.0 6.8 8.1 24.1 20.9 23.4 28.0 25.9 32.9 53.1 45.4 38.8 23.0 28.5 34.4 35.5 28.4 31.1 42.4 35.3 31.3 21.6 25.2 16.0 55.4 45.4 14.6 15.6 21.7 14.4 22.0 21.2 59.5 41.0 18.1 12.3 22.4 63.1 31.2 26.8 35.2 46.1 43.6 27.5 20.2 30.3 42.6 9.1 11.5 34.8 23.5 43.8 47.7 27.7 43.1 24.5 18.7 21.9 5.7 50.8 11.0 23.7 62.3 15.4 46.0 24.2 37.0 27.7 59.8 43.2 35.5 35.4 47.7 42.4 46.1 32.1 44.3 49.2 45.7 19.9 42.4 44.6 20.1 42.5 54.7 12.8 14.8 5.1 13.0 12.5 8.5 14.7 8.6 12.2 16.7 23.8 38.4 50.1 48.1 22.0 15.5 18.2 56.0 80.3 48.9 64.6 15.7 81.3 81.2 57.2 10.0 40.9 97.1 0.0 65.1 93.0 21.5 29.1 29.0 28.2 38.0 11.1 82.9 63.8 40.8 5.9 38.0 31.0 27.0 42.3 101.3 32.1 65.7 108.7 41.8 25.9 13.9 58.2 37.7 45.1 76.2 22.2 78.1 50.7 115.8 49.8 HDGF HMG1L2 ENSG00000143321 "Heparin binding growth factor" P51858 1 156742107-156766925 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Growth factor, Heparin-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026035, HPA048728, HPA053422" Enhanced Enhanced Nucleoplasm NA NA 300000 Nucleoplasm "CAB026035: , HPA048728: AB_2680503, HPA053422: AB_2682146" "unprognostic (2.80e-1)" "unprognostic (9.63e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (9.06e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (2.43e-8)" "unprognostic (9.80e-3)" "unprognostic (2.34e-2)" "prognostic favorable (9.84e-4)" "unprognostic (2.45e-3)" "unprognostic (3.67e-2)" "unprognostic (1.40e-3)" "unprognostic (8.66e-3)" "unprognostic (2.14e-1)" "unprognostic (2.06e-1)" "unprognostic (3.86e-2)" 27.6 24.0 24.4 26.4 24.6 78.7 51.5 26.7 22.1 29.7 57.9 22.4 23.9 40.6 22.1 22.9 53.0 34.9 38.1 41.7 23.5 18.3 64.5 92.6 38.0 32.6 23.7 12.9 29.0 35.3 25.6 19.0 49.1 20.4 21.3 37.5 15.9 26.5 30.6 57.2 39.2 83.1 21.7 25.5 30.0 25.6 11.8 22.4 79.0 38.3 64.8 44.0 30.9 29.6 7.5 14.5 10.4 12.3 6.1 9.7 7.8 72.9 36.2 41.6 19.8 24.1 33.2 46.0 24.2 61.9 56.8 37.2 40.9 78.0 49.4 47.9 48.2 25.3 51.7 61.9 54.4 56.6 40.0 43.9 42.2 52.6 35.7 32.1 61.8 35.7 23.8 52.2 44.4 86.8 45.3 41.8 39.1 55.2 41.4 46.2 53.7 50.9 68.5 73.5 117.0 51.4 57.5 24.9 65.9 62.4 24.7 62.2 67.6 57.8 76.5 29.1 53.8 61.1 96.1 36.9 28.8 44.7 36.4 61.4 55.9 69.4 86.0 38.3 49.2 36.6 6.0 12.3 10.4 8.5 10.4 6.3 6.7 7.3 7.5 14.1 7.5 6.6 6.2 7.1 6.1 11.4 14.5 9.7 7.8 24.4 24.6 26.7 22.1 23.5 18.3 23.7 12.9 20.4 22.4 65.5 86.4 36.5 146.2 130.9 60.7 81.8 79.0 123.1 80.8 68.0 25.5 38.8 68.0 89.5 37.7 46.6 109.5 70.0 112.1 90.8 73.3 173.1 30.0 144.0 46.2 50.9 119.7 27.6 33.2 33.1 37.7 55.8 37.1 37.9 83.0 56.2 134.0 51.8 43.2 94.2 31.4 19.4 48.5 28.7 24.6 139.4 45.9 41.5 82.1 206.9 HDGFL2 "Hdgfrp2, HRP2" ENSG00000167674 "HDGF like 2" Q7Z4V5 19 4472287-4502211 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.1" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 31.1;Ductal cells: 22.5;Extravillous trophoblasts: 24.9;Hofbauer cells: 21.7;monocytes: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042559, HPA044208" Enhanced Supported Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA042559: AB_2678049, HPA044208: AB_2678858" "unprognostic (1.33e-1)" "unprognostic (2.38e-2)" "unprognostic (5.47e-3)" "unprognostic (6.57e-3)" "unprognostic (6.80e-2)" "unprognostic (1.96e-2)" "unprognostic (1.52e-2)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (1.97e-1)" "prognostic favorable (6.57e-4)" "unprognostic (2.12e-2)" "unprognostic (1.36e-1)" "unprognostic (9.73e-3)" "unprognostic (4.75e-1)" "unprognostic (1.58e-1)" "unprognostic (2.05e-1)" 10.3 9.6 15.4 10.0 13.6 8.1 10.3 15.3 21.0 9.7 8.8 9.0 8.0 10.1 12.3 10.4 6.6 10.2 9.9 8.5 16.6 13.5 9.8 9.9 7.3 10.2 11.9 13.2 15.9 10.6 8.3 10.2 9.6 10.5 10.1 5.0 7.8 11.3 16.8 39.4 10.9 9.2 12.0 8.8 10.3 9.2 49.1 9.5 13.6 7.3 6.2 7.4 7.7 9.0 7.0 2.2 3.6 1.8 2.3 2.4 0.8 27.7 16.4 28.5 26.4 12.4 12.7 19.9 22.4 12.1 24.7 22.0 18.7 12.1 24.5 13.1 16.4 13.0 15.9 18.9 20.4 14.5 27.3 30.0 15.0 12.3 24.6 16.1 14.8 21.5 18.1 11.1 16.9 8.3 17.6 22.5 23.2 17.2 30.9 11.9 19.7 33.4 29.7 32.6 11.2 29.5 33.3 23.5 15.7 15.3 14.2 31.5 31.1 21.8 12.5 18.1 16.3 12.3 23.6 29.7 15.6 21.4 29.3 21.1 38.4 20.0 17.2 21.9 23.9 16.4 0.0 1.8 3.6 1.4 1.1 0.4 1.1 1.5 1.1 1.6 7.0 2.4 0.9 0.5 2.3 0.6 2.2 1.8 0.8 15.4 13.6 15.3 21.0 16.6 13.5 11.9 13.2 10.5 9.5 6.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 17.4 9.1 12.2 0.0 31.1 16.6 22.5 0.0 0.0 0.0 0.0 17.5 24.9 0.0 0.0 1.1 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 26.2 0.0 0.0 19.1 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 HEATR3 FLJ20718 ENSG00000155393 "HEAT repeat containing 3" Q7Z4Q2 16 50065941-50106387 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041990, HPA058579" Uncertain Enhanced Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA041990: AB_10793940, HPA058579: AB_2683762" "unprognostic (7.36e-3)" "unprognostic (2.72e-1)" "unprognostic (2.01e-3)" "unprognostic (1.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.80e-3)" "prognostic unfavorable (4.11e-5)" "unprognostic (7.68e-2)" "unprognostic (5.11e-2)" "unprognostic (8.79e-2)" "unprognostic (4.96e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (5.16e-6)" "unprognostic (2.26e-1)" "unprognostic (1.76e-1)" "unprognostic (1.86e-1)" "unprognostic (3.17e-2)" 14.7 13.6 8.8 17.8 16.1 10.1 9.3 19.5 14.0 10.2 11.5 12.4 11.1 10.1 9.2 10.3 13.0 8.5 9.4 9.9 9.4 9.6 10.7 20.7 10.5 14.6 10.9 8.1 7.1 19.2 14.8 13.3 12.1 8.7 8.4 13.8 7.8 12.4 7.8 19.6 13.3 10.9 11.3 10.5 21.6 11.4 15.6 11.1 14.5 6.4 10.7 12.9 9.2 8.0 2.4 4.2 2.2 7.0 2.0 2.9 2.2 10.8 11.1 10.3 16.3 6.4 8.6 11.1 13.2 8.8 13.3 5.3 13.6 8.3 20.5 9.6 12.6 5.0 13.0 12.4 9.9 15.5 5.2 13.3 10.1 7.8 17.2 9.2 17.5 20.6 6.7 6.8 9.4 5.7 5.8 10.7 10.9 12.8 3.6 13.0 6.7 13.4 22.0 12.1 13.2 11.6 14.9 14.0 16.6 7.4 8.9 13.4 7.1 12.8 16.6 8.3 8.3 7.5 12.8 13.9 10.7 7.2 8.2 10.1 8.7 6.9 18.4 10.6 17.7 10.5 1.3 6.2 1.4 2.6 7.0 2.8 1.6 1.6 2.9 4.2 2.4 2.3 2.4 2.2 2.0 6.1 3.7 2.6 2.2 8.8 16.1 19.5 14.0 9.4 9.6 10.9 8.1 8.7 11.1 3.0 4.3 2.7 0.7 2.9 7.2 5.2 5.1 2.7 1.2 1.8 15.7 3.0 6.6 2.2 9.3 3.6 3.8 0.0 2.6 2.9 2.6 1.9 1.1 6.7 8.3 1.6 3.4 2.5 25.3 13.3 3.1 7.0 1.7 3.6 3.3 1.9 2.6 2.9 2.1 3.4 7.3 0.0 2.1 4.8 4.5 1.5 0.8 4.4 4.9 1.4 HECTD1 KIAA1131 ENSG00000092148 "HECT domain E3 ubiquitin protein ligase 1" Q9ULT8 14 31100112-31207804 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Urothelial cells: 267.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002929, HPA054461" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA002929: AB_1850574, HPA054461: AB_2682496" "unprognostic (6.71e-2)" "unprognostic (4.86e-2)" "unprognostic (5.31e-2)" "unprognostic (1.25e-1)" "unprognostic (1.64e-1)" "unprognostic (6.99e-2)" "unprognostic (1.32e-1)" "unprognostic (7.03e-2)" "unprognostic (2.29e-2)" "unprognostic (3.13e-2)" "unprognostic (3.60e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.20e-6)" "unprognostic (6.53e-2)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (9.91e-3)" 22.0 22.3 14.2 21.0 16.8 22.0 18.5 22.3 18.9 19.4 17.9 15.2 20.2 11.5 17.6 15.7 30.4 16.1 15.2 26.2 13.5 14.3 18.0 35.2 15.0 14.1 14.5 14.5 18.2 15.1 34.8 20.5 27.0 18.8 16.8 15.5 16.8 18.9 16.4 88.5 24.3 16.3 15.6 13.7 16.4 18.8 18.9 14.4 16.7 24.8 23.0 18.6 18.6 22.3 10.6 9.3 12.6 8.6 8.9 8.1 3.3 28.8 18.1 15.9 9.9 50.4 26.4 15.2 17.7 17.9 15.8 13.7 13.5 15.7 22.7 18.8 32.3 11.3 19.6 21.2 16.0 24.1 13.9 8.7 23.2 14.9 54.0 23.5 24.1 17.0 23.2 22.1 17.8 28.0 22.0 29.1 13.5 16.6 10.5 24.6 23.7 9.3 10.3 12.1 25.3 16.5 17.3 18.4 9.9 24.7 30.0 11.8 13.9 25.9 18.0 15.7 20.2 18.9 15.6 29.1 18.4 14.4 13.2 15.0 11.5 16.4 25.6 8.7 12.2 15.5 12.6 8.6 11.3 7.1 7.1 8.1 7.2 8.0 6.3 9.3 10.6 6.7 6.6 4.4 8.9 5.3 7.8 8.0 3.3 14.2 16.8 22.3 18.9 13.5 14.3 14.5 14.5 18.8 14.4 44.7 63.3 37.1 68.0 76.9 78.2 103.0 22.9 155.2 84.2 68.0 92.3 53.4 10.0 37.6 2.9 56.2 38.8 23.3 31.4 36.2 49.1 82.9 31.3 79.7 25.8 62.0 46.8 39.9 39.7 6.7 63.9 34.4 32.1 29.7 30.4 36.8 41.9 28.1 70.0 20.0 175.8 45.3 41.2 53.4 107.2 100.5 117.1 37.4 37.3 267.3 HEMGN "CT155, EDAG, NDR" ENSG00000136929 Hemogen Q9BXL5 9 97926791-97944856 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 71.1;placenta: 20.2;testis: 32.5" "Group enriched" "Detected in some" 149 "Early spermatids: 1388.7;Erythroid cells: 724.2;Late spermatids: 1114.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.2" "Group enriched" "Detected in many" 27 "granulocytes: 2.1;NK-cells: 2.9;T-cells: 8.2" "Cell line enriched" "Detected in some" 4 "K-562: 77.0" "Region enriched" "Detected in all" 5 "cerebellum: 55.9" "HPA019572, HPA019604, HPA019606" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (2.50e-2)" "unprognostic (9.00e-3)" "unprognostic (2.12e-3)" "unprognostic (2.48e-1)" "unprognostic (6.45e-4)" "unprognostic (2.77e-1)" "unprognostic (5.74e-2)" "unprognostic (2.25e-1)" 0.3 0.2 0.2 0.4 0.2 71.1 0.2 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.3 1.0 0.2 0.2 0.3 0.9 5.4 0.5 0.2 0.0 0.6 0.2 0.0 0.3 20.2 1.1 0.2 0.0 0.1 0.2 0.0 0.2 0.2 0.2 0.0 0.3 2.8 0.2 32.5 0.0 17.1 0.3 0.2 0.5 1.4 4.8 0.0 0.1 2.1 0.1 2.9 8.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 77.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 2.1 0.1 0.0 0.4 0.1 0.8 0.0 2.3 1.1 0.1 0.0 8.2 3.3 1.0 2.9 0.0 0.0 1.2 4.4 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 1388.7 0.0 0.0 724.2 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.3 1114.5 5.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 6.5 0.0 7.2 3.3 0.0 0.5 0.0 0.0 0.0 HEXIM1 "CLP-1, EDG1, HIS1, MAQ1" ENSG00000186834 "Hexamethylene bisacetamide inducible 1" O94992 17 45148502-45152101 "Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Syncytiotrophoblasts: 390.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008926, CAB011625" Supported Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB011625: AB_2233058, HPA008926: AB_1079048" "unprognostic (2.82e-2)" "unprognostic (1.08e-1)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (2.39e-1)" "unprognostic (2.27e-1)" "unprognostic (1.10e-1)" "unprognostic (1.34e-2)" "unprognostic (4.74e-2)" "unprognostic (1.44e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.83e-2)" "unprognostic (2.77e-1)" "unprognostic (1.58e-1)" "unprognostic (2.89e-3)" "unprognostic (1.26e-2)" 14.8 25.3 30.0 12.6 25.3 30.4 13.7 41.4 37.4 16.2 21.0 10.7 18.5 17.8 17.0 17.2 18.6 18.2 18.6 16.0 31.1 15.6 20.9 19.0 15.8 11.8 24.9 19.2 14.8 15.6 12.2 24.4 56.7 27.5 19.9 10.8 12.6 16.4 25.2 29.7 22.6 20.2 19.5 31.4 20.7 17.3 17.1 21.7 8.9 17.2 14.3 12.3 17.8 30.6 3.7 3.4 15.9 6.7 3.8 4.6 2.3 13.0 41.6 8.7 12.5 14.4 7.7 21.3 11.6 10.5 9.6 10.8 19.5 18.6 5.7 35.9 12.2 4.6 10.6 5.2 11.4 7.8 11.8 12.4 17.7 22.9 23.8 12.6 11.0 23.6 9.0 9.8 7.1 3.1 24.2 4.8 10.1 7.8 13.9 7.2 17.5 11.5 12.8 8.0 12.1 12.6 4.8 7.6 7.0 25.3 23.2 4.7 3.5 17.5 19.8 18.7 9.2 20.6 8.7 9.1 9.7 13.5 5.5 21.5 12.7 4.0 3.7 8.9 10.4 11.0 15.9 4.3 6.6 4.5 6.1 2.7 3.3 4.6 4.0 3.3 3.7 4.2 4.4 10.5 3.8 6.7 3.4 3.9 2.3 30.0 25.3 41.4 37.4 31.1 15.6 24.9 19.2 27.5 21.7 68.5 92.7 29.4 49.2 75.1 23.7 46.8 86.6 41.5 59.1 24.4 21.6 110.7 6.6 30.0 2.1 58.5 171.5 23.3 20.3 55.9 57.3 53.6 120.4 33.6 37.7 14.3 50.7 41.1 29.4 2.1 32.5 51.4 50.6 42.3 63.9 24.3 22.5 108.7 41.1 40.3 26.5 25.8 75.9 2.1 6.4 62.5 390.9 55.4 47.5 30.7 HIF1A "bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8" ENSG00000100644 "Hypoxia inducible factor 1 alpha subunit" Q16665 14 61695513-61748259 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 47.8" "Lineage enriched" "Detected in all" 6 "granulocytes: 47.8" "Cell line enhanced" "Detected in many" "LHCN-M2: 119.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000907, HPA001275, CAB017442" Approved Enhanced "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "CAB017442: AB_10621732, HPA000907: AB_2666139, HPA001275: AB_1079057" "unprognostic (1.07e-2)" "unprognostic (1.13e-3)" "unprognostic (9.41e-2)" "unprognostic (1.07e-1)" "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (2.94e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.77e-2)" "unprognostic (8.39e-2)" "unprognostic (1.24e-1)" "unprognostic (3.23e-2)" "unprognostic (3.58e-1)" "unprognostic (7.35e-2)" "unprognostic (3.88e-2)" 31.9 62.0 15.6 45.2 17.8 125.2 24.9 22.7 18.5 45.7 15.3 12.3 23.5 10.8 17.7 31.3 31.2 21.7 50.0 19.4 17.5 16.5 76.4 42.7 42.8 27.3 18.3 11.0 34.5 12.7 13.7 26.8 24.2 25.1 17.6 13.9 14.0 24.6 36.2 8.0 17.4 16.9 18.7 27.2 57.3 16.0 21.1 12.4 24.7 26.9 18.4 28.8 37.8 21.5 6.6 6.0 47.8 6.8 6.2 7.9 5.1 38.0 15.2 15.3 43.7 24.3 39.2 20.7 31.7 38.2 39.9 36.0 6.6 12.6 9.3 23.9 39.1 11.4 9.0 9.8 52.0 50.0 4.0 5.1 5.7 14.0 11.4 54.2 2.4 6.2 68.3 16.5 29.3 31.4 53.9 25.1 5.4 3.8 0.0 119.1 7.9 7.4 2.9 13.8 6.0 20.1 0.5 34.3 2.7 51.5 25.3 12.9 14.3 59.4 8.5 20.9 21.8 8.9 4.5 14.9 90.7 20.3 30.0 26.6 5.0 7.2 10.6 47.8 4.7 24.5 11.2 6.8 47.8 3.8 5.5 4.9 6.5 5.0 4.4 6.0 6.6 7.9 5.1 18.2 6.2 5.6 2.9 3.4 5.1 15.6 17.8 22.7 13.2 17.5 16.5 18.3 11.0 25.1 12.4 65.5 115.1 54.6 71.5 94.4 49.4 37.3 86.6 33.5 69.4 247.7 47.1 22.6 87.9 226.7 3.1 113.7 30.7 0.0 216.2 57.6 82.5 54.8 217.2 23.7 123.2 147.8 63.8 177.4 143.9 3.6 22.5 156.8 97.8 76.7 36.5 141.2 213.6 23.0 45.6 116.2 52.0 51.8 129.7 27.4 24.9 76.9 21.3 60.6 34.8 75.6 HIRA "DGCR1, TUP1, TUPLE1" ENSG00000100084 "Histone cell cycle regulator" P54198 22 19330698-19447450 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 50.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 74.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB039243, CAB039244, HPA050714, HPA052902" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB039243: , CAB039244: , HPA050714: AB_2681219, HPA052902: AB_2681984" "unprognostic (1.32e-1)" "unprognostic (1.74e-3)" "unprognostic (2.45e-3)" "unprognostic (1.11e-1)" "unprognostic (4.59e-2)" "unprognostic (2.46e-1)" "unprognostic (2.42e-2)" "unprognostic (2.17e-2)" "unprognostic (2.50e-1)" "prognostic favorable (8.11e-4)" "prognostic favorable (3.97e-4)" "unprognostic (9.05e-2)" "prognostic favorable (5.18e-6)" "unprognostic (4.84e-2)" "unprognostic (8.57e-2)" "unprognostic (6.36e-2)" "unprognostic (1.32e-3)" 9.9 9.8 14.8 10.0 13.6 19.9 7.4 16.7 16.3 8.0 11.7 10.9 9.4 12.4 11.9 8.4 9.7 11.5 10.0 9.2 13.4 11.6 12.8 15.0 9.1 11.4 11.3 10.0 10.8 11.3 25.6 11.4 7.6 9.8 7.6 9.4 8.9 8.6 8.7 15.3 10.8 12.1 10.3 8.3 10.2 10.1 10.5 10.6 20.3 50.0 4.6 10.0 8.9 18.2 8.2 2.9 6.1 1.2 3.6 2.4 1.2 8.1 7.1 10.1 10.4 9.9 6.5 7.1 6.8 7.9 11.3 11.2 16.2 4.7 15.7 3.4 8.8 6.8 9.6 14.3 8.6 7.3 9.8 16.6 14.6 7.7 14.8 10.8 33.7 10.8 7.9 8.4 8.8 8.7 6.1 8.1 15.9 74.9 8.4 6.4 10.0 16.5 12.0 9.2 19.2 7.2 13.2 14.4 4.6 6.5 9.0 14.8 9.9 7.8 7.9 9.4 5.3 5.0 11.8 9.4 7.8 11.6 7.9 8.0 9.0 8.9 16.5 9.0 10.9 6.4 6.1 1.2 5.0 2.3 1.2 2.4 3.7 1.3 2.3 1.5 8.2 0.6 1.7 2.2 3.6 0.6 2.9 0.6 1.2 14.8 13.6 16.7 16.3 13.4 11.6 11.3 10.0 9.8 10.6 6.0 0.3 6.9 1.9 8.1 8.5 2.0 5.1 0.0 0.0 5.2 2.0 3.2 5.0 5.3 5.7 3.6 7.0 0.0 7.7 3.0 4.1 3.8 0.0 18.1 5.6 15.9 2.4 7.4 10.8 1.6 4.6 2.5 10.1 3.6 8.5 4.5 6.6 10.8 6.3 9.3 4.0 6.5 4.2 7.1 7.5 9.3 2.5 3.3 13.3 1.8 HIRIP3 ENSG00000149929 "HIRA interacting protein 3" Q9BW71 16 29992321-29996436 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 94.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051897, HPA063205" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA051897: AB_2681655, HPA063205: AB_2684963" "unprognostic (6.99e-2)" "prognostic favorable (2.74e-5)" "unprognostic (4.75e-2)" "unprognostic (2.83e-1)" "unprognostic (1.08e-1)" "unprognostic (4.48e-2)" "unprognostic (9.55e-2)" "unprognostic (1.80e-2)" "unprognostic (3.58e-2)" "unprognostic (8.53e-3)" "unprognostic (3.85e-2)" "unprognostic (2.07e-1)" "unprognostic (4.26e-3)" "unprognostic (5.22e-2)" "unprognostic (1.69e-1)" "unprognostic (1.97e-2)" "unprognostic (2.35e-2)" 9.4 11.3 16.8 9.2 26.8 15.0 10.0 23.4 17.9 10.9 11.3 20.7 10.0 9.6 11.3 10.8 9.5 12.5 9.0 17.6 16.4 14.6 10.6 13.6 12.8 12.7 22.9 13.6 18.2 11.4 20.0 14.2 8.4 15.3 10.1 7.5 11.5 12.8 15.5 29.0 13.3 9.2 13.3 20.1 10.8 8.5 34.0 23.9 21.0 11.8 9.0 11.9 10.3 12.4 13.9 14.6 10.8 13.9 9.7 16.6 8.3 11.0 11.8 18.2 12.3 5.8 6.3 6.3 8.8 7.2 9.6 8.1 9.9 12.1 19.6 18.6 5.8 6.5 8.3 11.9 10.8 6.3 19.4 14.3 21.0 15.7 11.1 5.4 18.6 18.5 3.4 8.2 9.1 13.6 5.1 5.5 22.6 10.9 25.0 5.0 8.1 26.9 11.8 6.0 7.2 7.5 29.4 20.3 22.5 6.1 4.8 13.2 15.8 8.4 7.5 6.2 4.6 10.6 13.3 5.4 12.9 9.6 9.0 8.6 17.3 12.1 13.4 11.9 17.5 17.3 3.5 5.9 10.8 13.4 9.2 9.3 13.9 15.3 12.4 4.9 11.7 16.1 14.9 2.7 9.7 13.9 14.6 16.6 8.3 16.8 26.8 23.4 17.9 16.4 14.6 22.9 13.6 15.3 23.9 62.5 22.9 6.7 16.0 11.3 36.1 27.0 10.2 26.8 20.5 8.7 13.7 21.2 24.9 8.4 13.9 14.6 13.6 0.0 10.7 25.6 12.2 5.7 30.1 12.3 16.1 14.3 9.2 8.6 9.9 8.2 19.0 13.5 5.0 10.0 9.1 34.7 6.1 10.5 21.2 15.3 39.9 12.9 19.6 94.0 51.7 9.9 9.6 19.2 13.3 4.2 HJURP "DKFZp762E1312, FAKTS, hFLEG1, URLC9" ENSG00000123485 "Holliday junction recognition protein" Q8NCD3 2 233833416-233854566 "Predicted intracellular proteins" "Cell cycle" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 12.4;Erythroid cells: 46.7;Extravillous trophoblasts: 13.7;Spermatocytes: 18.4;Spermatogonia: 12.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.2" "Group enriched" "Detected in many" 4 "granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA008436, HPA027261" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria" Yes Yes "Nucleoplasm, Nucleoli, Nucleoli rim" Mitochondria "HPA008436: AB_1850757, HPA027261: AB_2672184" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.87e-1)" "unprognostic (1.44e-3)" "unprognostic (3.62e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.37e-5)" "prognostic unfavorable (2.46e-4)" "prognostic unfavorable (6.49e-4)" "unprognostic (9.48e-2)" "prognostic unfavorable (7.72e-5)" "unprognostic (7.60e-2)" "unprognostic (0.00e+0)" "unprognostic (7.42e-2)" "unprognostic (5.58e-2)" "unprognostic (1.89e-2)" "unprognostic (5.74e-2)" 1.4 0.9 0.1 12.2 0.4 27.4 2.2 0.1 0.7 1.1 3.7 0.3 0.1 2.6 0.6 1.8 8.0 0.3 0.7 1.1 0.1 0.2 1.0 1.2 2.0 8.1 0.2 0.1 0.6 0.4 0.0 0.2 3.1 0.2 0.7 3.6 0.3 1.5 1.0 0.2 2.6 4.8 1.1 0.4 5.8 2.4 20.9 0.1 51.1 0.4 3.0 11.6 1.0 2.8 0.5 0.3 1.2 1.3 0.5 4.2 1.7 17.0 23.1 22.6 10.6 0.8 1.8 14.1 25.6 12.3 18.3 20.0 16.2 18.7 5.3 2.9 10.1 32.6 20.0 18.0 13.3 24.4 12.5 6.8 20.6 18.6 15.7 0.1 16.9 14.2 0.6 0.5 14.9 10.3 5.2 11.4 16.5 17.4 13.3 33.6 17.2 23.7 18.7 19.3 13.4 16.0 18.4 33.9 9.5 9.4 10.3 13.0 8.1 14.8 11.2 10.5 10.8 8.4 13.1 8.3 19.8 21.6 14.5 27.7 12.7 10.0 21.4 11.9 12.5 49.3 0.6 0.2 0.2 0.3 0.2 0.2 0.4 0.7 0.6 0.3 0.5 0.3 0.5 1.2 0.5 1.3 0.2 4.2 1.7 0.1 0.4 0.1 0.7 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.3 0.8 0.4 1.1 0.0 0.8 0.0 0.0 3.4 0.0 0.0 1.1 0.0 0.0 12.4 0.1 0.9 46.7 0.0 13.7 0.3 0.4 0.0 0.0 5.7 0.0 0.0 2.5 2.4 7.4 0.6 2.1 0.0 0.0 0.7 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.3 18.4 12.9 0.6 1.3 1.3 1.2 0.6 HLF MGC33822 ENSG00000108924 "HLF, PAR bZIP transcription factor" Q16534 17 55265012-55325065 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 78.8" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 122.6;Hepatocytes: 152.5;Horizontal cells: 87.4" "Cancer enhanced" "Detected in many" "liver cancer: 13.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 2.4;T-reg: 2.1" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enriched" "Detected in some" 6 "Hep G2: 60.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068156, HPA071210" Enhanced Nucleoplasm Yes NA Nucleoplasm "HPA068156: AB_2685963, HPA071210: AB_2686361" "unprognostic (1.24e-1)" "unprognostic (1.19e-3)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (3.30e-1)" "prognostic favorable (1.88e-4)" "unprognostic (5.30e-3)" "prognostic favorable (2.71e-7)" "unprognostic (1.42e-1)" "unprognostic (3.44e-2)" "unprognostic (1.24e-3)" "unprognostic (2.19e-1)" "prognostic favorable (3.55e-6)" "unprognostic (8.47e-2)" "unprognostic (1.64e-1)" "unprognostic (6.85e-2)" "unprognostic (1.60e-2)" 9.5 15.2 13.3 2.0 26.2 1.0 10.8 15.2 38.0 10.5 10.6 6.4 2.4 1.7 10.3 8.5 18.1 9.3 6.1 15.9 12.6 6.9 9.2 78.8 9.5 2.1 6.6 24.5 34.6 2.7 2.8 8.0 1.5 12.3 9.9 3.1 23.7 15.9 9.5 5.3 11.6 3.0 14.3 5.5 5.7 4.7 3.4 6.3 0.0 23.4 7.1 5.6 9.2 5.2 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 10.0 0.2 0.0 0.0 60.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.9 0.0 0.1 0.1 5.0 0.0 4.2 0.2 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 1.9 1.7 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 13.3 26.2 15.2 38.0 12.6 6.9 6.6 24.5 12.3 6.3 3.0 36.8 0.0 4.7 19.8 122.6 31.9 15.3 1.4 11.4 7.0 9.8 0.1 10.0 1.5 0.9 8.6 0.0 0.0 0.8 0.0 6.0 1.2 0.0 152.5 0.1 87.4 2.9 4.9 4.1 2.7 26.2 1.0 10.1 0.0 0.1 54.5 0.3 0.0 36.7 18.9 13.0 12.9 6.2 0.3 2.7 24.1 1.0 2.2 0.0 0.5 HLTF "HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3" ENSG00000071794 "Helicase like transcription factor" Q14527 3 149030127-149086554 "Enzymes, Predicted intracellular proteins" "Transcription, Ubl conjugation pathway" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 88.3;Spermatocytes: 110.2;Spermatogonia: 89.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015284, HPA049001" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015284: AB_1857263, HPA049001: AB_2680594" "unprognostic (3.21e-2)" "unprognostic (3.46e-2)" "unprognostic (6.81e-2)" "unprognostic (1.95e-3)" "unprognostic (4.29e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (3.01e-2)" "unprognostic (2.13e-2)" "unprognostic (2.27e-1)" "unprognostic (4.78e-2)" "unprognostic (9.00e-3)" "unprognostic (1.39e-1)" "unprognostic (2.94e-1)" "unprognostic (3.42e-1)" "unprognostic (2.83e-2)" "unprognostic (1.07e-2)" 10.2 22.1 12.6 8.4 17.6 9.0 12.4 29.3 23.8 11.1 11.0 12.4 6.2 4.8 12.4 9.6 7.1 10.8 8.6 16.5 15.8 16.6 15.6 16.3 7.1 9.8 15.7 19.0 17.6 12.0 16.5 25.1 7.3 29.9 14.7 7.0 11.3 9.3 11.1 9.7 5.1 6.6 12.7 19.0 7.5 8.7 37.7 14.0 17.1 19.0 4.8 9.6 10.0 7.8 8.4 9.2 8.8 2.3 5.4 10.4 3.5 24.6 12.0 17.2 13.4 11.5 14.9 1.7 16.7 10.0 12.4 14.5 9.7 17.2 15.9 20.5 7.7 24.3 0.7 23.0 6.6 20.8 8.8 11.2 38.2 9.4 3.9 7.2 10.0 15.9 9.4 3.6 9.2 5.4 19.0 7.1 26.0 13.3 10.4 16.9 12.4 20.5 15.4 12.9 12.5 15.1 23.8 19.3 2.5 10.2 8.0 17.0 10.0 25.4 11.8 23.0 9.5 35.2 9.8 5.0 14.6 8.8 20.5 18.2 15.4 8.6 20.8 14.3 13.7 5.6 8.8 1.3 4.0 5.6 2.1 10.4 8.4 4.9 7.2 3.9 5.4 7.2 7.4 0.2 5.4 2.3 9.2 4.4 3.5 12.6 17.6 29.3 23.8 15.8 16.6 15.7 19.0 29.9 14.0 23.8 14.8 13.8 7.6 4.9 88.3 34.8 17.8 30.8 21.6 29.6 39.3 6.6 29.9 7.9 9.5 10.8 1.3 0.0 7.3 8.2 10.6 11.9 53.2 14.9 7.6 44.5 4.7 15.4 4.0 5.8 31.4 7.5 5.0 3.6 6.2 35.2 6.8 2.8 30.4 15.6 75.2 12.9 14.1 110.2 89.0 3.8 1.4 13.8 6.6 4.3 HMG20B "BRAF25, BRAF35, HMGX2, HMGXB2, SMARCE1r, SOXL" ENSG00000064961 "High mobility group 20B" Q9P0W2 19 3572777-3579088 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 228.6;Melanocytes: 217.6;Syncytiotrophoblasts: 254.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 81.6;WM-115: 84.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050220, HPA053157, HPA069832" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA050220: AB_2681056, HPA053157: AB_2682061, HPA069832: AB_2686210" "unprognostic (2.97e-1)" "unprognostic (1.84e-2)" "unprognostic (2.57e-1)" "prognostic favorable (1.72e-7)" "unprognostic (2.18e-2)" "unprognostic (1.77e-2)" "unprognostic (1.12e-1)" "unprognostic (2.97e-1)" "unprognostic (1.66e-1)" "unprognostic (4.62e-2)" "unprognostic (3.19e-2)" "unprognostic (1.43e-2)" "unprognostic (1.71e-1)" "unprognostic (1.91e-3)" "unprognostic (2.78e-2)" "unprognostic (1.84e-1)" "prognostic favorable (2.89e-5)" 22.2 19.0 14.4 19.2 17.1 18.7 22.8 7.1 15.0 23.7 24.5 18.5 28.3 20.4 27.0 22.6 26.0 20.6 28.9 17.4 16.3 8.2 25.0 23.3 17.4 13.0 20.3 9.9 19.0 21.7 19.3 9.8 35.2 14.8 33.6 12.9 18.8 36.6 23.5 12.5 25.9 24.6 22.6 14.6 18.6 24.2 19.0 16.2 44.8 29.4 14.0 25.0 24.0 24.4 18.6 32.7 31.1 35.2 27.7 22.9 24.8 18.6 8.0 7.2 17.3 9.1 8.2 13.3 12.1 8.8 11.0 8.4 2.9 6.8 10.2 11.4 8.7 10.0 9.1 4.2 8.2 6.6 9.0 9.6 5.0 26.2 7.6 5.8 6.8 24.7 7.0 9.9 6.3 4.2 11.3 11.1 9.2 8.3 17.0 7.2 25.3 12.7 12.3 8.3 16.0 16.2 8.5 12.7 13.9 8.2 12.0 4.5 13.8 16.9 29.4 81.6 7.2 22.2 18.4 15.9 5.9 13.3 20.8 10.2 16.0 8.4 7.1 15.3 17.3 84.1 19.1 34.5 31.1 21.2 33.6 18.9 18.6 18.3 22.9 32.7 15.9 19.7 18.9 19.0 27.7 35.2 29.5 19.9 24.8 14.4 17.1 7.1 15.0 16.3 8.2 20.3 9.9 14.8 16.2 26.8 17.1 34.9 44.6 62.6 3.3 5.9 22.9 17.4 19.4 17.4 9.8 97.1 77.9 53.0 20.8 36.2 53.8 0.0 39.7 228.6 45.8 57.3 38.0 17.4 72.0 7.9 64.1 27.0 24.0 36.4 34.5 48.2 217.6 123.6 117.2 30.7 48.6 54.6 42.1 56.9 17.4 32.3 56.2 38.7 15.6 69.8 254.0 28.8 59.7 56.3 HNF4G NR2A2 ENSG00000164749 "Hepatocyte nuclear factor 4 gamma" Q14541 8 75407914-75566843 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 139.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 53.6;Mucus-secreting cells: 31.7;Paneth cells: 41.9;Undifferentiated cells: 25.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "gdT-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "A549: 4.5;CAPAN-2: 16.8;Karpas-707: 4.7;OE19: 10.3;PC-3: 5.1;THP-1: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005438, HPA010610" Enhanced Enhanced "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA005438: AB_1850822, HPA010610: AB_2668318" "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.77e-2)" "unprognostic (9.44e-2)" "unprognostic (5.60e-2)" "unprognostic (4.65e-2)" "unprognostic (5.26e-2)" "unprognostic (1.27e-2)" "unprognostic (3.92e-1)" "unprognostic (8.09e-2)" "unprognostic (3.68e-2)" "unprognostic (1.83e-2)" "unprognostic (6.93e-3)" "unprognostic (1.67e-2)" "unprognostic (2.11e-1)" "unprognostic (4.22e-2)" "unprognostic (2.47e-2)" 0.2 0.2 0.5 5.0 0.5 0.0 0.3 0.3 0.3 0.6 56.2 0.1 0.3 35.9 0.4 1.1 0.4 0.3 12.6 0.2 0.3 0.3 6.1 12.1 0.4 0.0 0.4 0.2 0.2 10.9 0.0 0.2 0.0 0.3 0.6 6.9 0.2 0.4 0.6 0.2 0.2 139.6 0.2 0.3 0.2 2.6 0.9 0.1 0.1 0.2 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.1 4.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.3 16.8 0.0 2.4 0.0 2.0 0.0 2.1 0.0 0.0 0.0 1.9 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.5 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.3 0.3 10.3 5.1 0.0 0.0 0.3 2.9 0.1 0.3 1.7 0.3 0.1 0.0 0.2 0.3 5.6 0.0 0.3 0.1 0.1 0.0 1.2 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.3 0.3 0.3 0.4 0.2 0.3 0.1 0.0 0.6 0.5 0.6 0.0 0.0 0.2 17.8 9.4 1.2 3.5 0.0 0.0 5.0 2.2 1.7 0.0 53.6 0.0 3.7 0.0 0.0 1.1 0.0 9.0 0.0 0.0 15.6 0.0 0.0 4.5 0.0 0.0 0.0 0.0 31.7 0.0 5.6 41.9 0.0 13.6 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 25.9 2.8 HNRNPA0 "hnRNPA0, HNRPA0" ENSG00000177733 "Heterogeneous nuclear ribonucleoprotein A0" Q13151 5 137745651-137754376 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036569, HPA059404" Enhanced Enhanced Nucleoplasm No No 110000 Nucleoplasm "HPA036569: AB_10670840, HPA059404: AB_2684004" "unprognostic (5.51e-2)" "unprognostic (4.86e-2)" "unprognostic (2.00e-2)" "unprognostic (3.78e-1)" "unprognostic (8.99e-2)" "unprognostic (2.52e-1)" "unprognostic (2.65e-3)" "unprognostic (1.06e-1)" "unprognostic (1.77e-1)" "unprognostic (1.23e-1)" "prognostic favorable (3.74e-4)" "unprognostic (6.86e-2)" "prognostic favorable (1.99e-4)" "unprognostic (2.34e-1)" "unprognostic (4.57e-1)" "unprognostic (2.66e-2)" "unprognostic (7.39e-2)" 25.6 30.9 18.1 31.8 21.4 40.7 62.9 35.2 43.8 27.0 21.2 11.5 17.2 21.0 38.1 26.3 25.7 29.3 29.5 29.1 15.7 18.0 17.4 18.5 40.4 61.2 16.5 22.5 42.7 34.8 15.1 20.4 30.7 16.6 22.1 17.2 20.0 18.6 20.8 38.1 23.2 23.1 33.4 16.8 24.2 24.3 25.7 13.6 50.1 26.2 22.5 21.6 24.8 24.2 5.2 6.1 8.0 4.4 7.8 7.1 1.5 14.4 14.5 28.2 28.4 13.9 8.9 29.0 11.1 9.2 10.0 11.6 27.0 11.4 26.3 16.1 9.5 11.0 13.3 15.2 17.3 12.2 13.2 21.2 17.0 9.3 16.3 12.8 15.5 18.1 14.3 12.2 7.9 9.2 11.0 13.8 23.9 13.8 17.7 10.0 18.8 29.0 20.9 22.0 6.9 10.6 34.9 20.6 13.2 9.8 16.7 35.8 29.1 14.3 10.0 18.8 32.3 12.7 18.0 13.4 16.0 13.7 8.8 21.1 17.9 14.4 18.7 10.4 18.0 15.8 4.2 2.4 8.0 5.9 4.1 7.1 4.2 5.6 5.9 4.2 5.2 6.1 6.0 2.6 7.8 4.4 6.1 3.2 1.5 18.1 21.4 35.2 43.8 15.7 18.0 16.5 22.5 16.6 13.6 80.4 53.0 188.3 346.9 489.4 73.3 31.1 99.3 37.5 62.6 96.0 35.3 296.0 145.9 218.1 24.7 188.8 85.5 70.0 128.8 402.7 254.2 247.7 94.6 65.2 171.4 79.4 226.9 148.0 122.8 31.9 146.2 137.9 266.6 273.3 165.1 127.6 167.3 162.1 141.8 99.3 53.7 84.1 348.8 141.2 79.6 423.3 305.8 240.4 208.3 323.0 HNRNPA1 "ALS20, hnRNP-A1, hnRNPA1, HNRPA1" ENSG00000135486 "Heterogeneous nuclear ribonucleoprotein A1" P09651 12 54280193-54287088 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport" "Ribonucleoprotein, RNA-binding" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001609, HPA001666, HPA005812, HPA007185, CAB010894" Supported Enhanced Nucleoplasm NA NA 10000000 Nucleoplasm "CAB010894: AB_261962, HPA001609: AB_2666383, HPA001666: AB_1850836, HPA005812: AB_2667441, HPA007185: AB_2667768" "unprognostic (1.38e-3)" "unprognostic (1.90e-1)" "unprognostic (1.59e-2)" "unprognostic (5.98e-3)" "unprognostic (2.82e-2)" "unprognostic (2.46e-1)" "unprognostic (1.22e-2)" "unprognostic (9.71e-2)" "unprognostic (3.34e-2)" "unprognostic (2.91e-2)" "unprognostic (3.72e-2)" "unprognostic (3.51e-2)" "unprognostic (6.88e-3)" "unprognostic (2.32e-2)" "unprognostic (1.14e-1)" "unprognostic (1.48e-1)" "unprognostic (9.54e-3)" 36.4 33.3 31.7 55.6 37.4 99.5 45.1 48.3 43.0 52.2 38.9 38.4 33.9 35.2 54.1 41.6 41.3 39.5 20.4 31.9 29.7 28.5 40.5 76.2 29.7 51.7 33.1 23.1 123.6 46.1 34.4 36.7 49.9 42.6 35.3 38.7 28.1 33.4 31.5 40.5 37.3 35.6 34.9 40.1 59.5 34.1 69.6 33.3 88.7 42.1 62.0 62.7 37.5 45.8 61.6 72.5 17.9 51.1 86.6 98.1 105.8 84.3 77.7 166.2 131.5 51.4 82.2 90.4 77.8 89.3 86.3 73.2 116.3 93.1 222.9 76.5 53.9 27.9 76.2 111.0 111.6 104.9 87.1 84.5 123.7 111.5 200.3 27.3 175.9 81.5 73.2 43.2 57.0 85.0 82.0 94.4 100.5 136.9 94.0 71.9 109.4 191.5 190.3 175.1 58.7 55.2 186.9 132.7 108.5 93.5 127.5 93.3 128.0 57.7 118.8 86.2 92.3 74.2 110.4 79.7 64.4 86.5 64.9 99.6 84.4 85.3 149.4 42.2 111.0 56.3 12.0 39.5 17.9 61.9 51.1 96.1 61.6 82.7 72.3 72.5 55.2 98.1 89.4 4.2 86.6 41.3 55.9 70.9 105.8 31.7 37.4 48.3 43.0 29.7 28.5 33.1 23.1 42.6 33.3 282.9 416.9 979.2 866.3 1257.9 240.2 144.8 512.1 277.1 532.3 279.2 88.4 1846.9 626.6 1015.4 131.7 691.4 446.7 116.8 1834.6 2353.9 905.7 556.1 513.1 175.1 878.1 103.3 791.7 392.3 666.2 95.5 972.8 726.1 558.5 1333.7 1093.4 203.6 1143.2 522.5 697.3 587.0 150.2 446.3 924.5 196.6 318.3 1103.1 1822.1 976.0 1319.8 750.5 HNRNPA2B1 HNRPA2B1 ENSG00000122566 "Heterogeneous nuclear ribonucleoprotein A2/B1" P22626 7 26189927-26201529 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport" "Ribonucleoprotein, RNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001666, HPA005812, CAB012403, HPA065537" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA 11000000 Nucleoplasm "CAB012403: , HPA001666: AB_1850836, HPA005812: AB_2667441, HPA065537: AB_2685507" "unprognostic (1.19e-1)" "unprognostic (4.45e-1)" "unprognostic (2.33e-1)" "unprognostic (6.39e-2)" "unprognostic (5.64e-2)" "unprognostic (8.04e-3)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.25e-2)" "unprognostic (9.12e-3)" "unprognostic (4.35e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (5.12e-4)" "prognostic unfavorable (8.01e-5)" "unprognostic (6.74e-2)" "unprognostic (3.36e-2)" "unprognostic (2.02e-1)" "unprognostic (1.56e-2)" 82.2 97.4 85.1 105.3 106.3 90.9 74.4 123.3 87.4 77.1 85.7 89.4 68.7 87.5 92.6 71.9 90.4 75.1 51.7 87.9 82.4 71.8 113.4 103.7 76.2 127.7 118.6 57.0 121.0 75.7 107.2 121.2 100.7 96.3 75.5 98.6 64.4 71.4 66.5 167.2 58.7 94.8 73.7 139.7 116.5 74.1 73.1 135.4 180.3 81.9 104.4 140.7 74.2 128.8 33.7 46.5 35.1 52.4 32.1 42.5 36.0 124.0 105.9 154.2 115.6 39.7 36.3 71.4 79.6 62.1 88.0 79.7 97.8 90.4 226.9 76.1 73.8 105.0 86.6 164.9 104.0 124.0 70.5 100.5 137.5 127.8 116.9 33.3 148.0 94.2 34.3 54.5 83.7 76.4 46.4 90.8 104.9 161.7 74.2 88.8 100.4 158.3 173.1 136.6 95.1 81.7 147.2 125.3 95.0 101.6 108.6 90.1 110.5 95.7 94.3 58.1 98.3 105.7 128.9 78.4 49.5 102.5 67.0 135.8 98.6 195.4 215.9 63.8 168.7 93.2 17.4 38.7 35.1 42.5 52.4 38.6 33.7 35.5 36.6 46.5 29.2 35.6 35.6 13.0 32.1 48.4 43.6 36.1 36.0 85.1 106.3 123.3 87.4 82.4 71.8 118.6 57.0 96.3 135.4 452.6 512.0 456.4 620.8 656.0 459.5 635.5 267.5 721.4 702.9 326.2 280.8 790.3 391.3 484.7 96.5 561.1 396.4 280.4 392.8 789.3 528.7 417.7 617.9 353.4 530.6 295.6 471.8 332.7 355.7 124.0 380.5 569.8 372.8 501.4 392.2 570.4 369.1 357.7 366.7 366.6 518.1 433.4 564.3 596.8 448.9 524.9 905.5 489.7 465.4 566.2 HNRNPA3 HNRPA3 ENSG00000170144 "Heterogeneous nuclear ribonucleoprotein A3" P51991 2 177212563-177223958 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001666, HPA005812, HPA066381" Supported Enhanced Nucleoplasm NA NA 1500000 Nucleoplasm "HPA001666: AB_1850836, HPA005812: AB_2667441, HPA066381: AB_2685666" "unprognostic (2.85e-2)" "prognostic favorable (4.87e-4)" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (2.14e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.95e-5)" "unprognostic (2.46e-1)" "unprognostic (3.15e-3)" "unprognostic (2.80e-3)" "unprognostic (3.65e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (9.57e-7)" "unprognostic (6.95e-2)" "unprognostic (3.04e-1)" "unprognostic (4.55e-2)" "unprognostic (1.10e-2)" 22.9 17.6 24.7 29.5 28.0 29.8 19.5 22.3 29.3 24.3 24.8 16.1 13.7 18.0 26.5 26.9 33.8 20.8 20.9 16.7 20.8 14.2 23.9 20.3 23.7 29.9 40.4 17.7 35.6 19.3 20.6 20.1 27.0 26.5 19.0 28.7 14.9 20.0 28.4 28.0 23.2 23.5 23.4 35.0 24.8 19.7 22.2 27.3 23.0 30.7 18.4 40.6 20.5 28.2 15.2 26.4 7.4 15.8 15.6 18.7 9.3 63.7 43.0 94.5 48.2 25.0 22.3 72.5 48.9 23.0 38.5 36.7 85.5 33.0 128.6 37.3 37.7 51.6 36.8 93.3 61.1 72.5 59.0 56.9 95.8 65.2 169.2 26.9 102.9 59.7 24.8 27.4 57.3 42.7 21.4 52.5 57.2 68.4 44.3 48.8 85.9 71.7 41.5 51.6 73.5 40.5 91.9 80.2 40.2 53.7 126.1 55.4 49.9 72.7 22.7 29.5 71.3 32.8 64.7 58.1 49.4 55.1 34.3 70.4 40.3 71.5 110.0 29.4 68.4 31.9 4.9 15.3 7.4 18.7 15.8 15.0 13.9 15.0 16.5 16.4 15.2 13.8 13.9 6.6 15.6 14.9 26.4 17.3 9.3 24.7 28.0 22.3 29.3 20.8 14.2 40.4 17.7 26.5 27.3 154.9 215.2 221.2 361.3 312.4 188.7 56.1 86.6 283.7 291.2 151.8 92.3 425.0 102.8 195.6 26.3 270.9 149.7 46.7 236.9 457.8 255.4 219.8 270.4 155.4 295.4 139.8 263.9 182.3 180.4 26.3 189.6 227.7 182.2 276.9 212.7 161.7 237.6 169.9 197.0 126.2 152.7 148.8 302.8 280.0 218.2 288.8 414.8 248.4 249.1 343.8 HNRNPAB "ABBP1, FLJ40338, HNRPAB" ENSG00000197451 "Heterogeneous nuclear ribonucleoprotein A/B" Q99729 5 178204507-178211163 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046688 Approved Enhanced Nucleoplasm NA NA 380000 Nucleoplasm "HPA046688: AB_10964924" "unprognostic (2.23e-1)" "unprognostic (6.21e-2)" "unprognostic (2.61e-2)" "unprognostic (1.96e-2)" "unprognostic (8.69e-2)" "unprognostic (1.17e-1)" "unprognostic (1.22e-3)" "unprognostic (4.09e-2)" "unprognostic (6.17e-3)" "prognostic favorable (9.79e-4)" "unprognostic (9.12e-3)" "unprognostic (4.23e-2)" "prognostic unfavorable (1.35e-7)" "unprognostic (3.47e-2)" "unprognostic (1.82e-1)" "unprognostic (3.53e-1)" "unprognostic (2.08e-1)" 34.9 41.7 16.5 47.8 18.4 44.6 32.5 17.9 19.1 30.0 54.0 20.4 24.9 37.0 33.9 23.0 50.9 27.3 38.6 44.4 15.4 17.8 50.0 72.4 29.8 36.5 20.6 12.4 39.1 39.1 25.5 20.5 36.7 16.8 26.8 47.1 19.4 31.3 26.7 53.3 43.4 55.0 38.7 18.9 53.5 31.9 26.5 15.9 75.6 34.6 46.3 41.3 38.7 36.8 5.9 11.4 15.1 7.2 5.7 6.6 2.2 46.1 38.5 59.4 57.4 22.0 19.4 85.9 52.0 24.1 41.6 44.9 70.9 34.7 74.8 48.0 27.8 50.8 30.6 51.4 70.6 51.7 115.6 60.6 47.0 31.0 43.3 22.0 59.4 40.1 19.1 33.4 37.3 37.6 17.2 37.2 30.0 38.3 34.2 41.7 124.3 71.6 57.4 54.4 47.6 55.5 58.5 35.8 44.3 35.1 49.5 54.7 42.6 40.5 56.6 36.6 38.8 33.9 36.4 33.3 50.9 43.0 35.8 71.0 40.1 46.8 88.0 20.6 65.8 41.2 2.8 4.8 15.1 5.5 7.2 6.2 5.9 4.6 6.6 4.6 5.0 4.5 5.3 0.9 5.7 7.1 11.4 4.8 2.2 16.5 18.4 17.9 19.1 15.4 17.8 20.6 12.4 16.8 15.9 29.8 43.7 80.2 123.5 250.0 24.2 39.9 48.4 25.4 44.3 47.1 17.7 71.8 43.1 103.9 4.5 77.1 177.1 93.5 130.6 169.9 80.3 113.7 44.9 96.2 90.6 15.9 114.3 57.1 60.6 7.9 68.4 88.9 64.1 41.5 155.2 31.3 147.7 149.7 82.7 85.7 26.4 77.6 138.6 57.6 139.0 297.1 95.7 42.1 166.2 201.2 HNRNPC "hnRNPC, HNRPC" ENSG00000092199 "Heterogeneous nuclear ribonucleoprotein C (C1/C2)" P07910 14 21209136-21269494 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005223, HPA051075, CAB075755, CAB075756" Supported Enhanced Nucleoplasm NA NA 1400000 Nucleoplasm "CAB005223: AB_2117508, CAB075755: AB_2665761, CAB075756: AB_2665762, HPA051075: AB_2681335" "unprognostic (1.92e-3)" "unprognostic (1.02e-2)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (1.42e-2)" "unprognostic (5.21e-3)" "prognostic unfavorable (7.72e-5)" "unprognostic (8.66e-3)" "unprognostic (5.96e-3)" "prognostic favorable (1.19e-4)" "unprognostic (3.31e-3)" "unprognostic (5.30e-3)" "prognostic unfavorable (7.29e-5)" "unprognostic (7.36e-2)" "unprognostic (3.73e-3)" "unprognostic (2.28e-3)" "unprognostic (5.42e-2)" 41.1 53.9 51.8 51.1 64.0 71.6 55.1 72.1 65.5 49.6 41.9 45.3 47.3 35.3 51.0 51.1 53.4 54.3 38.0 41.1 47.9 45.1 50.0 51.9 43.0 76.7 54.8 42.1 72.8 57.8 38.3 63.3 54.7 43.7 45.2 47.8 43.9 36.0 44.5 44.5 39.8 39.5 57.6 54.8 55.8 37.4 62.4 52.4 49.3 53.0 37.9 75.6 45.3 45.9 78.3 104.6 119.0 73.3 64.8 89.1 142.9 94.7 79.3 119.5 68.1 79.4 73.5 84.2 60.5 73.6 102.2 87.3 74.7 72.0 168.5 38.5 76.1 66.5 71.7 164.3 102.5 139.5 109.7 87.7 84.5 62.6 111.4 90.3 129.2 70.6 76.1 83.8 75.4 180.2 89.4 107.3 95.6 129.7 72.0 80.8 91.1 154.1 122.9 124.3 95.0 73.9 123.6 95.3 83.0 109.0 86.1 66.3 61.6 73.5 71.0 67.0 110.2 66.7 116.1 69.4 36.8 66.4 43.6 86.9 65.3 97.8 164.4 34.3 105.3 72.0 57.8 73.3 71.2 65.9 63.5 86.1 78.3 78.0 70.2 104.6 68.7 89.1 75.0 119.0 64.8 59.7 67.5 80.3 142.9 51.8 64.0 72.1 65.5 47.9 45.1 54.8 42.1 43.7 52.4 142.9 216.7 293.4 537.0 476.4 166.6 113.3 191.1 426.9 343.5 261.7 186.5 541.0 240.4 270.5 104.5 231.5 115.2 93.5 187.7 622.0 348.5 363.8 401.3 193.0 344.7 109.7 214.8 160.2 259.6 47.1 249.9 333.4 197.4 316.6 194.2 147.6 213.3 119.3 217.1 276.6 280.5 148.8 296.7 355.3 259.1 471.9 731.7 329.0 278.1 447.5 HNRNPD "AUF1, HNRPD" ENSG00000138668 "Heterogeneous nuclear ribonucleoprotein D" Q14103 4 82352498-82374503 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004911 Supported Enhanced Nucleoplasm NA NA 550000 Nucleoplasm "HPA004911: AB_1078250" "unprognostic (9.60e-3)" "unprognostic (1.01e-2)" "unprognostic (9.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.74e-1)" "unprognostic (1.77e-1)" "unprognostic (1.03e-3)" "unprognostic (1.75e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-2)" "unprognostic (1.40e-2)" "unprognostic (5.93e-2)" "unprognostic (1.08e-1)" "unprognostic (2.81e-1)" "unprognostic (1.31e-2)" 45.5 40.0 35.4 58.8 46.1 88.0 49.4 49.1 40.6 55.2 49.8 37.2 40.5 45.1 56.2 39.1 55.5 47.9 48.5 40.8 28.4 27.4 36.4 40.6 43.2 72.2 26.5 37.1 64.5 48.9 51.6 38.7 51.9 32.9 44.9 45.8 41.5 52.9 48.6 51.6 49.5 49.9 53.1 27.9 61.4 46.7 30.4 30.7 136.1 41.5 53.7 80.4 58.2 49.9 17.8 21.8 18.0 11.9 12.4 17.5 5.9 60.1 23.9 103.1 32.7 13.6 17.8 48.7 47.4 36.6 54.7 47.2 42.7 53.5 123.3 34.4 32.1 29.1 29.8 81.9 35.5 86.0 22.9 42.3 88.3 32.9 57.8 27.8 117.0 45.5 21.7 15.9 44.1 44.7 28.1 49.4 60.3 97.1 42.7 46.4 23.2 142.4 81.3 85.7 45.1 22.2 105.5 104.8 51.1 45.6 36.9 52.1 56.2 46.7 40.7 23.6 50.2 30.4 46.7 41.7 42.3 57.7 32.5 60.9 45.3 35.6 143.5 32.5 60.5 48.1 18.0 10.8 10.8 13.2 11.3 14.5 17.8 15.9 16.5 12.3 14.4 17.5 14.5 13.1 12.4 11.9 21.8 17.2 5.9 35.4 46.1 49.1 40.6 28.4 27.4 26.5 37.1 32.9 30.7 95.3 129.9 97.5 173.8 232.1 125.8 176.6 81.5 117.8 162.7 106.4 58.9 238.7 59.7 146.2 21.6 142.9 61.9 93.5 181.6 291.7 117.2 144.5 88.0 106.3 135.9 101.7 140.7 111.1 121.5 16.8 115.6 129.0 86.0 133.5 128.6 156.0 133.5 42.1 96.2 65.2 99.6 109.9 139.4 99.7 128.2 200.9 227.5 109.0 142.2 181.5 HNRNPDL "HNRPDL, JKTBP, laAUF1" ENSG00000152795 "Heterogeneous nuclear ribonucleoprotein D like" O14979 4 82422564-82430408 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056820, HPA063147" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA056820: AB_2683246, HPA063147: AB_2684950" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (1.38e-1)" "unprognostic (3.29e-3)" "unprognostic (1.11e-1)" "unprognostic (3.13e-1)" "unprognostic (6.30e-3)" "unprognostic (7.19e-2)" "unprognostic (4.05e-2)" "unprognostic (3.59e-1)" "unprognostic (3.46e-1)" "unprognostic (5.56e-3)" "unprognostic (4.07e-2)" "unprognostic (1.72e-1)" "unprognostic (2.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.03e-2)" 60.5 43.9 52.0 58.8 82.9 98.2 58.8 67.6 79.7 50.1 51.9 60.4 42.9 41.8 73.7 57.8 45.3 53.5 42.4 47.7 49.0 44.7 43.0 37.4 52.9 64.4 86.9 74.2 101.7 66.0 43.5 41.0 46.2 79.0 49.8 44.5 31.6 46.4 52.3 89.7 46.0 47.8 60.6 69.4 55.7 51.1 32.8 80.8 48.3 49.0 59.2 51.3 44.9 51.5 27.7 20.3 14.4 31.1 17.6 35.6 19.9 52.6 27.9 104.1 20.6 39.1 21.4 34.2 57.1 62.1 50.9 48.5 38.3 43.7 98.3 36.4 61.8 26.3 41.1 78.4 52.7 59.8 21.6 56.8 56.9 45.2 68.6 18.4 96.7 42.4 37.7 15.3 56.9 51.0 40.3 40.3 62.8 73.7 40.8 49.3 22.0 90.3 67.9 71.4 47.8 33.0 81.1 84.1 44.9 59.3 34.5 44.3 76.6 35.5 45.9 33.5 49.0 48.0 55.0 33.8 51.4 63.5 33.6 68.1 48.0 45.9 108.2 45.0 56.6 43.2 14.4 15.7 13.2 28.5 25.7 23.3 27.7 25.5 26.0 12.6 26.8 35.6 30.6 6.7 17.6 31.1 20.3 19.4 19.9 52.0 82.9 67.6 79.7 49.0 44.7 86.9 74.2 79.0 80.8 253.1 256.3 276.8 560.8 585.3 217.8 173.8 101.9 365.4 381.1 144.8 100.1 445.7 252.0 241.5 42.1 260.0 120.7 23.3 220.9 513.8 334.8 344.9 370.4 124.1 286.8 166.8 226.5 117.9 193.0 32.1 196.8 307.6 295.3 348.1 161.4 241.5 205.1 122.8 190.6 215.4 158.8 161.7 311.0 158.6 399.4 484.4 435.7 307.9 180.7 425.7 HNRNPF HNRPF ENSG00000169813 "Heterogeneous nuclear ribonucleoprotein F" P52597 10 43385617-43409166 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016884, HPA069667" Supported Enhanced Nucleoplasm NA NA 2500000 Nucleoplasm "HPA016884: AB_1856444, HPA069667: AB_2686166" "unprognostic (9.93e-2)" "unprognostic (2.26e-2)" "unprognostic (1.81e-1)" "unprognostic (3.65e-2)" "unprognostic (6.39e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (5.85e-4)" "unprognostic (1.51e-2)" "unprognostic (6.37e-2)" "unprognostic (6.33e-3)" "unprognostic (4.89e-3)" "unprognostic (1.07e-2)" "unprognostic (1.95e-2)" "unprognostic (3.77e-3)" "unprognostic (3.35e-1)" "unprognostic (3.71e-1)" "unprognostic (2.22e-1)" 48.1 34.0 19.9 41.2 34.9 43.3 56.1 23.2 22.3 31.1 44.5 31.6 26.9 41.1 34.9 32.6 50.4 39.2 35.7 26.2 21.7 18.3 42.3 68.3 40.4 55.9 33.7 13.9 54.2 39.7 22.5 28.1 37.5 32.5 35.4 37.8 26.2 36.9 25.0 40.0 40.6 57.5 41.6 27.5 58.7 39.2 66.4 31.2 77.5 40.6 42.3 56.9 46.2 57.4 58.3 59.7 52.0 62.5 63.2 75.8 89.4 46.3 49.3 30.7 46.4 37.6 41.3 45.0 36.4 61.2 51.2 60.6 46.1 64.9 93.5 23.4 39.3 30.1 65.8 81.9 59.4 42.2 39.1 49.0 59.5 30.7 59.2 46.5 87.2 60.5 50.1 47.2 39.7 73.3 29.8 43.9 46.2 60.1 42.5 38.6 72.4 85.2 47.8 23.1 70.6 41.7 71.7 28.8 44.3 52.3 71.9 37.9 38.1 37.0 68.1 55.1 34.9 75.8 42.7 32.7 23.6 44.9 38.6 57.4 38.3 64.5 56.7 38.3 83.9 23.0 38.5 54.4 52.0 62.3 62.5 75.8 58.3 65.5 68.6 59.7 48.1 55.7 52.5 36.5 63.2 55.5 33.4 72.6 89.4 19.9 34.9 23.2 22.3 21.7 18.3 33.7 13.9 32.5 31.2 125.0 101.0 151.2 286.6 298.4 46.3 53.4 129.9 188.7 104.6 106.4 45.2 238.4 149.2 179.9 260.2 132.4 146.6 93.5 123.9 343.0 154.8 203.1 114.2 201.4 197.1 46.1 121.7 118.4 187.9 81.6 135.2 151.7 94.5 200.2 160.4 105.7 142.1 149.4 110.7 162.5 134.4 97.0 151.4 223.4 171.5 288.8 176.0 209.8 206.2 283.8 HNRNPH1 "hnRNPH, HNRPH1" ENSG00000169045 "Heterogeneous nuclear ribonucleoprotein H1" P31943 5 179614178-179634784 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Basal keratinocytes: 688.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000914, HPA001359, HPA016884, CAB032820" Supported Enhanced Nucleoplasm NA NA 2100000 Nucleoplasm "CAB032820: AB_2248257, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444" "unprognostic (9.01e-2)" "unprognostic (3.83e-1)" "unprognostic (3.45e-3)" "unprognostic (8.82e-2)" "unprognostic (1.01e-1)" "prognostic favorable (7.85e-4)" "prognostic unfavorable (3.29e-7)" "unprognostic (7.99e-2)" "unprognostic (6.22e-3)" "unprognostic (1.56e-1)" "unprognostic (8.65e-3)" "unprognostic (8.64e-3)" "prognostic unfavorable (3.46e-4)" "unprognostic (1.40e-2)" "unprognostic (1.54e-1)" "unprognostic (2.40e-3)" "unprognostic (1.72e-3)" 40.1 36.2 26.8 86.3 31.0 90.5 45.4 73.4 33.2 55.6 38.2 26.6 54.7 30.2 52.4 44.3 41.7 37.7 45.3 30.3 25.6 23.3 36.5 42.3 37.0 59.8 33.0 30.3 60.1 41.3 24.4 46.1 43.6 28.9 40.8 34.7 34.4 53.5 60.3 51.3 44.3 43.0 61.6 31.3 65.2 34.4 42.5 34.3 113.2 47.5 61.5 62.0 57.3 54.4 26.3 34.7 18.4 27.7 24.3 36.8 13.8 51.6 39.4 62.4 40.8 22.4 12.3 50.5 30.8 16.0 40.3 26.6 53.4 34.4 86.0 27.9 22.4 34.2 33.1 58.1 36.3 36.2 72.0 41.7 46.8 65.0 67.0 26.3 61.1 45.1 12.9 26.4 39.3 24.8 25.1 21.9 36.5 58.7 45.5 23.9 35.4 93.0 56.9 72.3 28.9 29.0 82.9 71.0 51.0 20.7 61.6 59.6 50.7 59.8 40.9 53.8 34.7 38.9 79.3 35.9 59.1 42.0 26.9 69.6 37.4 80.9 90.1 32.0 58.5 69.0 18.4 18.0 17.5 26.0 27.7 34.3 26.3 27.8 27.9 26.6 22.7 35.5 36.8 3.5 24.3 20.8 34.7 31.7 13.8 26.8 31.0 73.4 33.2 25.6 23.3 33.0 30.3 28.9 34.3 107.2 244.9 156.8 156.9 688.7 112.1 115.5 160.5 113.8 153.6 148.3 123.7 142.0 66.3 86.3 122.9 189.6 133.1 303.7 106.4 163.6 207.4 153.7 235.1 192.4 96.7 66.7 245.0 179.2 181.7 67.9 103.3 177.8 317.2 101.0 168.3 82.9 89.4 147.3 110.3 55.5 160.3 181.1 190.5 157.9 116.9 627.7 161.0 200.5 170.7 155.5 HNRNPH2 "FTP3, hnRNPH', HNRPH', HNRPH2" ENSG00000126945 "Heterogeneous nuclear ribonucleoprotein H2" P55795 X 101408295-101414133 "Disease related genes, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 253.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000914, HPA001359, CAB004436, HPA016884" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004436: AB_627737, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444" "unprognostic (1.00e-1)" "unprognostic (5.57e-2)" "unprognostic (2.10e-1)" "unprognostic (2.70e-1)" "unprognostic (5.48e-2)" "unprognostic (1.71e-2)" "unprognostic (3.83e-2)" "unprognostic (1.47e-2)" "unprognostic (3.88e-1)" "unprognostic (3.04e-1)" "unprognostic (2.22e-1)" "unprognostic (2.99e-1)" "prognostic favorable (7.37e-4)" "unprognostic (8.09e-2)" "unprognostic (1.04e-2)" "unprognostic (3.66e-1)" "unprognostic (6.68e-2)" 49.5 44.2 43.4 34.6 51.9 38.3 42.7 49.1 53.9 37.0 32.2 33.8 33.3 34.1 36.6 39.7 36.7 32.7 28.2 35.9 40.3 42.4 49.8 46.1 34.5 30.1 37.1 46.4 47.8 28.4 77.5 50.0 44.9 48.8 37.9 35.9 25.0 30.4 45.2 54.8 40.0 43.6 39.7 36.7 42.2 30.6 18.9 34.2 44.0 44.1 39.9 39.9 41.7 34.4 16.7 28.8 65.9 32.1 22.1 19.4 22.6 31.1 21.7 42.6 25.5 37.6 32.8 20.4 26.7 37.2 25.2 51.6 18.3 28.0 32.1 27.3 37.3 34.7 28.7 48.5 36.9 34.6 31.2 23.8 23.8 52.7 24.8 32.2 29.5 23.4 33.3 34.0 24.9 24.5 30.5 34.2 17.7 24.1 46.5 38.2 39.9 24.2 26.0 26.8 51.0 21.3 23.2 45.4 31.2 54.3 41.6 19.6 35.8 39.8 19.0 30.1 31.5 24.2 28.2 37.1 14.1 25.9 40.1 10.9 15.7 22.5 22.7 29.0 34.3 17.5 29.3 29.4 43.2 18.1 32.1 19.4 16.7 17.7 18.2 28.8 15.6 18.7 19.2 65.9 22.1 30.4 12.1 16.3 22.6 43.4 51.9 49.1 53.9 40.3 42.4 37.1 46.4 48.8 34.2 26.8 63.6 43.1 84.4 63.0 39.8 45.6 33.1 44.2 47.8 85.5 11.8 120.9 84.6 83.4 2.9 54.0 50.2 23.3 64.4 53.5 57.5 42.3 80.8 70.6 73.2 15.9 58.3 47.3 65.5 4.3 51.2 73.1 65.8 105.6 41.2 38.4 56.0 48.0 55.5 110.9 28.7 77.6 49.5 8.0 21.3 63.0 253.0 48.5 42.5 60.2 HNRNPK "CSBP, HNRPK, TUNP" ENSG00000165119 "Heterogeneous nuclear ribonucleoprotein K" P61978 9 83968083-83980616 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004435, HPA007644, CAB016225, HPA044105" Supported Enhanced Nucleoplasm NA NA 5000000 Nucleoplasm "CAB004435: AB_627734, CAB016225: , HPA007644: AB_1079077, HPA044105: AB_2678812" "unprognostic (4.84e-2)" "unprognostic (4.69e-1)" "unprognostic (1.15e-2)" "unprognostic (8.42e-3)" "unprognostic (2.78e-2)" "unprognostic (9.83e-3)" "prognostic unfavorable (6.68e-5)" "unprognostic (3.46e-3)" "unprognostic (8.11e-2)" "unprognostic (1.47e-1)" "unprognostic (8.85e-3)" "unprognostic (2.81e-2)" "unprognostic (2.76e-3)" "unprognostic (2.23e-3)" "unprognostic (6.50e-2)" "unprognostic (4.59e-1)" "unprognostic (2.82e-1)" 79.0 92.0 70.0 80.7 81.7 146.9 97.2 88.0 104.8 77.9 70.0 68.8 80.9 74.5 96.3 69.0 95.8 79.6 67.5 80.4 68.2 71.5 76.0 90.9 77.7 125.0 80.9 72.9 96.5 102.8 91.4 74.5 92.3 67.3 69.4 75.2 58.6 76.5 104.6 101.4 78.7 76.7 100.9 86.3 96.1 72.5 60.3 78.6 162.5 79.9 80.8 106.9 81.0 77.1 59.7 76.1 92.7 71.0 75.6 73.2 136.4 122.3 84.6 145.5 86.1 69.9 77.5 116.9 86.6 107.7 108.5 102.2 70.8 87.7 145.4 59.6 90.6 94.1 94.1 145.4 105.1 132.5 99.9 85.6 102.0 74.2 100.3 92.6 126.4 101.3 78.8 80.4 92.5 123.1 81.8 110.4 82.7 103.7 74.7 106.7 107.3 156.7 86.7 129.2 124.4 82.4 136.9 116.0 96.9 105.1 101.0 94.4 112.1 91.1 97.2 86.3 105.3 96.2 107.5 90.3 75.6 89.1 76.6 112.8 78.7 103.0 105.6 72.2 102.4 106.8 77.4 71.0 90.1 53.9 69.2 67.3 59.7 62.5 61.2 76.1 56.8 65.1 59.3 92.7 75.6 65.8 45.2 73.2 136.4 70.0 81.7 88.0 104.8 68.2 71.5 80.9 72.9 67.3 78.6 190.6 233.2 308.4 456.1 449.4 175.4 171.5 206.4 338.6 282.1 249.5 84.4 518.7 334.9 379.2 22.5 338.4 245.6 163.5 321.8 621.5 373.1 281.2 324.9 300.6 341.5 147.8 371.7 237.6 349.5 31.1 309.8 311.8 310.4 423.8 309.1 344.3 335.2 270.0 301.9 310.5 156.5 271.7 398.2 345.1 248.3 392.2 609.3 308.9 346.3 397.3 HNRNPL HNRPL ENSG00000104824 "Heterogeneous nuclear ribonucleoprotein L" P14866 19 38836388-38852347 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016326, HPA051748, HPA052661" Supported Enhanced Nucleoplasm NA NA 130000 Nucleoplasm "CAB016326: AB_627736, HPA051748: AB_2681588, HPA052661: AB_2681905" "unprognostic (5.33e-2)" "unprognostic (4.58e-2)" "unprognostic (2.27e-1)" "unprognostic (9.67e-3)" "unprognostic (8.99e-3)" "unprognostic (4.90e-3)" "prognostic unfavorable (3.25e-6)" "unprognostic (1.45e-1)" "unprognostic (8.85e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (9.69e-4)" "unprognostic (1.57e-2)" "prognostic unfavorable (1.96e-11)" "unprognostic (2.17e-2)" "unprognostic (4.23e-2)" "unprognostic (1.58e-2)" "unprognostic (4.39e-2)" 44.1 43.3 32.8 47.1 37.1 102.7 40.6 48.9 47.6 38.9 46.2 42.5 35.9 43.7 47.8 34.8 50.1 36.2 42.0 39.7 31.8 31.9 39.9 52.9 43.2 48.0 36.2 32.5 41.6 41.6 36.1 28.1 47.9 34.7 34.6 49.1 35.6 37.5 39.8 44.7 50.7 48.1 49.4 34.3 44.8 38.2 34.9 39.4 102.8 53.0 36.8 67.6 37.9 40.5 3.1 6.2 3.5 3.8 2.2 3.6 1.9 46.2 36.6 46.5 29.9 18.5 21.8 43.9 38.5 26.6 35.8 34.1 39.2 35.6 73.5 31.5 24.7 27.2 28.4 57.3 43.2 53.3 56.6 31.1 60.7 23.3 34.9 19.7 56.0 41.1 23.7 20.5 36.1 35.7 20.5 39.5 32.5 58.8 38.1 37.3 36.6 57.9 34.6 54.7 32.5 25.4 75.3 53.2 46.2 40.1 34.8 39.0 36.2 38.7 30.4 15.5 33.8 39.8 31.2 35.3 35.9 40.9 31.5 55.3 36.6 49.1 82.7 23.1 49.6 39.2 1.1 2.6 1.7 3.5 3.8 2.7 2.2 2.5 2.1 3.5 3.1 2.7 2.2 3.5 2.2 2.8 6.2 3.6 1.9 32.8 37.1 48.9 47.6 31.8 31.9 36.2 32.5 34.7 39.4 20.8 57.5 59.4 53.2 31.5 76.3 16.1 20.4 25.4 36.4 21.0 60.9 36.1 6.6 30.0 12.1 37.0 50.9 0.0 38.1 29.7 32.6 50.4 38.1 62.1 23.8 31.8 60.4 42.4 60.8 8.9 26.2 37.5 25.3 31.5 62.4 41.8 34.9 35.1 21.2 17.8 69.2 19.4 36.3 19.1 19.6 41.5 43.7 49.8 62.6 36.9 HNRNPM "CEAR, HNRNPM4, HNRPM, HNRPM4, HTGR1, NAGR1" ENSG00000099783 "Heterogeneous nuclear ribonucleoprotein M" P52272 19 8444767-8489114 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016113, HPA024344" Supported Enhanced Nucleoplasm NA NA 170000 Nucleoplasm "CAB016113: AB_627739, HPA024344: AB_1850879" "unprognostic (2.12e-1)" "unprognostic (8.59e-2)" "unprognostic (2.51e-2)" "unprognostic (2.06e-2)" "unprognostic (1.27e-1)" "unprognostic (1.52e-3)" "prognostic unfavorable (1.80e-6)" "unprognostic (2.44e-1)" "unprognostic (2.59e-2)" "unprognostic (6.91e-3)" "unprognostic (4.70e-3)" "unprognostic (7.34e-2)" "unprognostic (3.62e-2)" "unprognostic (1.22e-3)" "unprognostic (1.02e-1)" "unprognostic (2.17e-1)" "unprognostic (1.73e-1)" 41.1 38.3 43.2 57.1 44.8 83.6 39.3 66.1 56.7 41.0 45.8 32.8 45.7 42.0 51.5 35.5 54.5 40.7 41.2 38.3 40.4 29.0 38.9 53.9 37.9 55.7 36.4 35.5 56.3 36.0 57.6 42.2 44.8 37.5 37.9 41.1 35.7 40.4 52.4 98.8 43.4 40.8 48.7 39.6 50.1 38.3 41.0 45.4 91.7 41.4 40.0 64.7 37.9 64.3 26.0 32.4 16.5 35.0 30.6 36.6 28.2 61.8 42.0 79.8 31.9 18.3 20.4 50.8 37.4 28.1 46.6 35.5 59.8 19.0 91.4 49.9 33.7 33.5 38.2 81.3 46.7 58.7 57.0 67.1 81.1 42.7 57.2 19.0 82.8 43.4 21.0 23.7 39.5 16.5 13.7 41.7 34.4 81.3 26.3 36.9 42.1 79.5 71.8 68.6 34.1 51.2 89.7 69.2 43.2 24.5 60.0 43.9 48.8 62.8 33.9 35.0 39.8 40.3 49.4 48.4 40.7 49.3 42.7 69.7 38.6 71.1 106.1 30.5 67.6 44.2 6.9 28.2 16.5 36.0 35.0 36.6 26.0 31.4 35.9 32.2 24.6 34.0 33.0 7.7 30.6 25.7 32.4 31.6 28.2 43.2 44.8 66.1 56.7 40.4 29.0 36.4 35.5 37.5 45.4 119.1 188.2 159.3 181.9 147.8 207.0 80.6 96.8 250.3 285.5 111.7 66.8 237.5 82.9 166.9 9.2 145.2 70.1 116.8 237.4 247.6 125.5 75.8 253.7 134.1 152.1 130.3 182.7 108.6 128.8 17.2 105.0 125.4 104.6 223.6 109.3 163.0 169.0 103.7 133.7 73.2 167.9 207.0 191.9 152.3 129.3 119.7 219.3 156.9 140.9 130.8 HNRNPR "hnRNP-R, HNRPR" ENSG00000125944 "Heterogeneous nuclear ribonucleoprotein R" O43390 1 23303771-23344336 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011687, HPA026092" Supported Enhanced Nucleoplasm NA NA 50000 Nucleoplasm "CAB011687: AB_2295532, HPA026092: AB_1850885" "unprognostic (1.86e-1)" "unprognostic (2.12e-1)" "unprognostic (1.45e-2)" "unprognostic (1.17e-1)" "unprognostic (1.92e-1)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.29e-2)" "unprognostic (1.67e-2)" "unprognostic (3.01e-1)" "unprognostic (1.15e-3)" "unprognostic (3.28e-2)" "unprognostic (7.65e-2)" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (4.14e-2)" "unprognostic (4.12e-1)" 27.1 30.4 31.2 36.1 34.7 33.8 31.2 41.0 32.2 32.4 27.4 34.3 29.5 26.5 42.2 23.7 33.2 32.7 20.3 25.6 29.1 27.9 25.1 25.1 28.1 39.6 35.0 27.9 44.3 32.8 40.5 40.9 40.9 27.5 27.3 31.3 26.5 28.1 27.7 31.1 27.8 26.8 41.0 34.1 28.8 24.9 20.3 40.0 68.3 29.9 29.7 40.9 29.0 29.4 21.9 23.6 20.8 23.2 26.1 28.5 19.8 36.7 22.9 47.0 27.8 16.8 16.8 22.2 25.0 25.5 35.3 25.5 15.7 25.5 45.0 12.3 30.3 21.3 21.2 48.5 32.4 46.3 31.2 32.9 43.0 30.3 28.3 17.0 53.2 29.0 18.7 20.0 33.1 26.8 18.0 26.2 34.8 38.6 31.4 27.1 21.1 60.7 15.5 26.5 25.4 21.1 43.5 45.9 31.7 23.8 18.0 30.0 31.3 32.8 27.8 20.2 27.0 22.3 23.8 26.5 23.7 32.4 29.0 29.6 19.9 29.6 60.7 17.9 45.5 25.8 8.7 18.5 20.8 25.4 22.5 27.7 21.9 24.3 25.2 23.6 20.1 26.3 24.4 6.6 26.1 23.2 13.9 28.5 19.8 31.2 34.7 41.0 32.2 29.1 27.9 35.0 27.9 27.5 40.0 110.2 90.3 90.8 156.4 113.3 122.1 64.1 76.5 147.2 144.5 83.7 41.2 198.0 77.9 84.8 12.3 105.1 51.1 23.3 109.3 227.4 125.2 131.2 163.3 64.4 93.4 119.2 111.7 58.3 74.5 13.1 111.9 91.5 79.2 159.7 84.5 155.0 99.5 59.6 109.6 54.2 110.8 84.1 129.6 143.8 153.0 113.4 172.9 111.0 103.7 158.3 HNRNPU "C1orf199, FLJ30202, FLJ37978, hnRNPU, HNRNPU-AS1, HNRPU, NCRNA00201, SAF-A" ENSG00000153187 "Heterogeneous nuclear ribonucleoprotein U" Q00839 1 244840638-244864560 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Cell division, Differentiation, Host-virus interaction, Mitosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011532, HPA041057, HPA058707" Supported Enhanced Nucleoplasm NA NA 840000 Nucleoplasm "CAB011532: AB_732983, HPA041057: AB_2677278, HPA058707: AB_2683796" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (1.31e-2)" "unprognostic (1.99e-1)" "unprognostic (3.63e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.88e-5)" "unprognostic (2.26e-2)" "unprognostic (4.09e-3)" "unprognostic (1.87e-2)" "unprognostic (6.59e-2)" "unprognostic (1.12e-2)" "unprognostic (7.45e-2)" "unprognostic (1.21e-1)" "unprognostic (3.01e-2)" "unprognostic (2.98e-1)" "unprognostic (4.62e-1)" 55.6 57.5 55.3 55.3 68.1 87.3 60.9 80.2 61.7 53.4 47.9 57.7 49.6 38.9 61.4 74.9 53.3 55.9 48.0 47.4 53.3 51.5 68.5 61.2 45.1 52.2 60.5 51.8 76.0 51.7 85.9 48.6 55.4 47.2 56.5 51.1 43.9 49.0 54.3 69.7 43.9 50.3 58.0 55.4 62.3 49.4 47.8 64.5 121.5 61.7 41.5 64.3 57.5 97.9 17.3 25.1 17.0 11.7 15.1 21.7 7.3 47.9 38.6 51.3 40.2 26.9 23.3 50.4 34.4 22.2 31.6 28.2 36.9 32.0 75.9 32.3 29.0 30.3 37.8 68.6 39.0 50.3 31.9 46.0 65.4 34.2 56.3 28.3 74.8 39.8 26.2 23.6 34.4 36.6 28.4 32.3 47.9 85.1 28.2 42.6 34.3 79.6 77.8 89.0 36.0 35.2 79.9 64.0 41.2 50.9 35.4 42.9 42.3 54.2 35.9 41.6 39.1 49.4 84.4 38.9 31.7 46.7 33.7 60.7 46.6 50.8 74.0 26.0 64.2 45.3 14.1 11.7 15.5 15.3 10.1 16.2 17.3 18.6 18.4 12.4 17.0 21.7 18.3 17.0 15.1 11.0 25.1 15.8 7.3 55.3 68.1 80.2 50.4 53.3 51.5 60.5 51.8 47.2 64.5 303.7 307.6 169.4 272.6 241.0 145.0 162.6 101.9 311.8 396.9 183.2 172.8 181.9 82.9 177.3 334.5 193.4 127.0 0.0 156.7 227.3 175.2 162.2 346.3 111.1 161.8 133.5 190.1 114.8 193.9 392.9 142.4 255.5 116.4 215.6 139.7 150.4 156.6 124.3 134.0 103.9 204.8 142.3 205.0 166.3 161.8 209.2 211.3 200.3 159.5 244.9 HNRNPUL1 "E1B-AP5, E1BAP5, FLJ12944, HNRPUL1" ENSG00000105323 "Heterogeneous nuclear ribonucleoprotein U like 1" Q9BUJ2 19 41262496-41307598 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046290, CAB046477, HPA049475" Enhanced Enhanced Nucleoplasm NA NA 20000 Nucleoplasm "CAB046477: AB_2120664, HPA046290: AB_2679616, HPA049475: AB_2680783" "unprognostic (5.52e-2)" "unprognostic (6.37e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.39e-1)" "unprognostic (4.29e-2)" "unprognostic (3.45e-3)" "unprognostic (1.94e-1)" "unprognostic (6.08e-2)" "unprognostic (2.86e-1)" "unprognostic (1.76e-1)" "unprognostic (3.59e-2)" "unprognostic (5.78e-2)" "unprognostic (2.32e-1)" "unprognostic (1.66e-1)" "unprognostic (8.05e-2)" "unprognostic (2.39e-1)" 44.8 37.1 31.0 40.7 32.2 72.3 40.4 35.9 40.3 48.9 48.0 47.3 38.1 38.6 50.3 33.3 43.6 41.4 43.6 52.9 28.9 24.6 29.1 28.4 39.0 45.5 30.8 26.7 58.8 44.9 34.3 33.7 27.9 28.8 38.3 35.8 40.8 45.4 44.7 50.9 48.4 40.1 55.5 29.7 41.2 39.6 54.3 34.5 85.2 39.6 45.9 50.2 52.7 44.1 9.4 13.0 13.2 6.7 11.5 19.3 4.8 58.1 77.5 46.0 42.4 22.7 27.1 17.6 35.6 40.8 44.3 40.6 45.1 44.8 52.2 24.3 42.5 24.8 19.2 43.4 40.1 50.3 51.0 37.7 57.7 35.8 35.0 26.5 53.8 53.6 29.0 25.3 39.5 36.7 39.8 41.1 39.4 41.1 49.4 39.1 44.4 68.4 31.6 35.1 55.6 28.3 44.7 37.4 29.0 32.4 61.6 36.8 33.6 78.4 45.1 20.2 32.9 34.6 59.9 40.8 49.9 48.6 22.7 65.8 58.2 37.4 49.1 31.6 43.9 65.7 9.0 5.9 9.4 12.3 6.2 19.3 8.6 14.9 12.6 6.7 9.4 10.1 8.0 13.2 11.5 6.7 13.0 9.8 4.8 31.0 32.2 35.9 40.3 28.9 24.6 30.8 26.7 28.8 34.5 74.5 69.5 91.1 39.9 49.9 61.0 56.5 33.1 53.5 34.2 29.6 68.7 44.1 38.1 50.3 36.2 49.6 41.7 93.5 54.0 50.7 57.7 39.1 56.7 37.5 55.7 46.1 73.6 58.9 80.2 56.6 80.0 61.8 33.7 61.3 60.4 65.5 55.5 31.6 67.1 24.6 98.2 77.6 60.1 100.8 116.2 52.7 44.6 105.4 68.9 37.6 HNRNPUL2 "DKFZp762N1910, HNRPUL2" ENSG00000214753 "Heterogeneous nuclear ribonucleoprotein U like 2" Q1KMD3 11 62712630-62727349 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041632, HPA056696, HPA067699" Supported Enhanced Nucleoplasm NA NA 23000 Nucleoplasm "HPA041632: AB_10960896, HPA056696: AB_2683211, HPA067699: AB_2685891" "unprognostic (3.06e-3)" "unprognostic (2.31e-1)" "unprognostic (7.48e-2)" "unprognostic (9.27e-3)" "unprognostic (4.38e-2)" "unprognostic (1.95e-1)" "unprognostic (1.91e-2)" "unprognostic (2.21e-1)" "unprognostic (2.83e-1)" "unprognostic (4.99e-3)" "unprognostic (2.35e-1)" "unprognostic (6.43e-2)" "unprognostic (2.50e-1)" "unprognostic (3.92e-2)" "unprognostic (2.17e-1)" "unprognostic (2.33e-2)" "unprognostic (6.45e-2)" 26.6 17.3 35.3 24.5 42.1 22.1 25.8 52.1 42.3 28.1 32.2 23.5 22.9 26.8 27.6 37.0 28.5 23.7 27.2 23.7 31.9 29.6 24.2 19.5 24.0 30.1 32.8 35.2 26.3 25.3 33.1 19.5 26.9 27.7 26.3 27.8 21.6 28.0 31.2 38.8 35.1 28.6 34.2 26.7 29.5 24.0 17.1 28.4 36.6 20.8 14.8 34.6 26.6 31.3 4.0 5.0 4.4 3.8 2.6 5.1 1.7 35.9 17.1 28.9 17.3 16.3 20.0 4.8 23.2 14.3 18.6 14.4 11.8 12.6 42.4 11.9 19.8 15.7 20.3 18.0 22.9 25.0 17.9 9.3 39.8 22.2 13.3 14.5 41.6 26.7 15.5 18.1 17.5 21.9 14.4 22.6 11.0 15.0 16.2 21.3 21.6 41.3 37.8 13.6 13.7 13.8 29.1 26.4 20.2 23.2 22.6 17.1 19.1 24.0 20.4 24.4 14.5 14.9 18.1 24.5 21.6 9.5 26.7 24.4 20.3 16.8 42.0 19.4 20.1 19.7 3.2 2.9 4.4 5.1 1.9 3.7 3.4 3.7 4.3 1.7 4.0 2.9 3.6 3.8 2.6 3.8 5.0 3.3 1.7 35.3 42.1 52.1 42.3 31.9 29.6 32.8 35.2 27.7 28.4 26.8 8.9 31.2 12.6 26.2 27.8 37.2 33.1 8.1 13.6 50.6 9.8 21.3 5.0 24.6 5.7 28.7 53.9 0.0 31.1 22.2 25.3 20.4 15.0 34.6 32.7 39.7 36.9 39.3 58.6 5.2 38.9 27.8 13.5 22.6 52.8 16.6 29.1 47.2 43.2 21.9 17.9 32.3 27.8 12.9 20.1 28.1 21.1 24.9 53.4 15.9 HOXA9 "HOX1, HOX1G" ENSG00000078399 "Homeobox A9" P31269 7 27162435-27175180 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 35.1" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 46.4;Intestinal endocrine cells: 37.7;Proximal tubular cells: 60.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basophil: 5.4;myeloid DC: 6.0;NK-cell: 11.7" "Group enriched" "Detected in many" 5 "dendritic cells: 6.0;granulocytes: 5.4;NK-cells: 11.7" "Cell line enhanced" "Detected in some" "HEK 293: 43.6;PC-3: 15.2;RPTEC TERT1: 15.0;SCLC-21H: 40.5;U-937: 14.5" "HPA061982, HPA076200" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA061982: AB_2684651, HPA076200: " "unprognostic (4.72e-1)" "unprognostic (1.23e-2)" "unprognostic (2.86e-1)" "unprognostic (5.24e-3)" "unprognostic (2.36e-1)" "unprognostic (2.02e-1)" "unprognostic (8.35e-2)" "unprognostic (8.44e-3)" "unprognostic (5.50e-2)" "unprognostic (5.71e-2)" "unprognostic (9.87e-3)" "unprognostic (4.42e-2)" "unprognostic (2.80e-3)" "unprognostic (6.45e-2)" "unprognostic (7.58e-2)" "unprognostic (1.92e-2)" "unprognostic (1.35e-1)" 3.2 3.4 0.2 8.8 0.1 2.4 8.7 0.1 0.2 15.5 12.8 0.2 4.1 0.0 10.4 16.8 1.4 12.2 0.3 0.1 0.1 0.0 35.1 0.1 0.8 0.7 0.1 0.1 2.0 0.1 0.0 0.1 1.4 0.4 16.6 4.5 0.2 0.5 5.6 21.0 13.3 8.2 13.1 0.7 1.0 0.0 2.4 0.1 2.6 0.3 0.3 0.3 16.2 11.4 0.5 6.0 5.4 1.0 11.7 1.5 0.5 12.7 0.0 0.0 6.4 2.1 1.6 0.0 5.1 4.1 0.4 0.4 0.8 0.5 0.1 0.5 2.7 0.0 11.9 8.2 0.0 0.4 0.0 43.6 0.1 0.3 0.0 0.2 0.0 0.1 2.2 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 15.2 2.7 0.0 0.0 15.0 0.2 40.5 0.0 5.4 0.0 0.1 0.2 0.0 10.7 0.4 0.0 4.0 4.9 0.0 0.0 0.0 0.0 0.0 14.5 0.0 5.4 1.0 0.0 1.5 0.2 0.2 0.2 0.0 0.1 6.0 0.5 0.3 0.1 0.9 11.7 0.4 1.9 0.2 0.5 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.8 10.6 22.2 0.0 0.6 0.0 0.0 0.0 17.4 0.0 0.3 46.4 0.0 0.0 0.2 7.9 0.0 0.0 0.3 10.8 14.2 0.0 0.0 0.3 0.0 37.7 0.0 4.8 0.0 0.0 1.6 5.0 0.0 19.1 0.0 0.0 18.4 0.0 60.8 0.0 0.0 3.6 0.0 0.6 24.1 0.2 4.4 19.4 11.5 HOXB13 ENSG00000159184 "Homeobox B13" Q92826 17 48724763-48729178 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 18.6;prostate: 38.3" "Cell type enhanced" "Detected in some" 17 "Glandular cells: 62.7;Intestinal endocrine cells: 187.8;Mucus-secreting cells: 92.1;Paneth cells: 66.2;Undifferentiated cells: 64.4" "Cancer enriched" "Detected in many" 17 "prostate cancer: 187.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.3" "Cell line enriched" "Detected in some" 13 "PC-3: 59.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004438, HPA062852, HPA065019" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004438: AB_627744, HPA062852: AB_2684880, HPA065019: AB_2685406" "unprognostic (4.81e-2)" "unprognostic (2.57e-2)" "unprognostic (4.40e-2)" "unprognostic (1.33e-2)" "unprognostic (5.85e-3)" "unprognostic (1.88e-2)" "unprognostic (1.19e-2)" "unprognostic (3.19e-2)" "unprognostic (1.17e-2)" "unprognostic (6.65e-2)" "unprognostic (1.74e-1)" "unprognostic (4.27e-2)" "unprognostic (4.73e-11)" "unprognostic (1.39e-2)" "unprognostic (4.50e-2)" "unprognostic (1.12e-1)" 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 2.4 10.8 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.4 0.1 38.3 18.6 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 3.6 2.4 0.1 0.2 1.3 0.1 0.1 0.1 0.0 0.6 2.0 0.0 4.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.9 1.0 0.0 1.0 0.0 0.5 0.0 3.0 0.0 0.0 0.3 1.4 0.9 0.6 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.2 0.1 0.0 0.1 0.0 0.7 59.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.9 0.0 1.4 0.2 0.0 0.2 0.0 0.2 1.7 1.7 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 37.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 40.4 0.0 0.0 0.2 0.3 62.7 0.0 0.0 0.1 0.0 187.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 92.1 0.0 0.0 66.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 64.4 6.4 HOXC9 "HOX3, HOX3B" ENSG00000180806 "Homeobox C9" P31274 12 53994895-54003337 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 18.9;skeletal muscle: 28.3" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 34.9;Fibroblasts: 20.8;Melanocytes: 37.1;Proximal tubular cells: 16.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 14.7;HDLM-2: 18.7;HEK 293: 22.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063965, HPA072160" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063965: AB_2685162, HPA072160: AB_2686491" "unprognostic (2.38e-1)" "unprognostic (1.03e-1)" "unprognostic (3.19e-5)" "unprognostic (1.23e-1)" "unprognostic (4.09e-3)" "unprognostic (7.12e-2)" "unprognostic (6.92e-3)" "unprognostic (1.06e-3)" "unprognostic (4.32e-1)" "unprognostic (1.58e-2)" "unprognostic (7.38e-2)" "unprognostic (4.08e-2)" "unprognostic (9.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.01e-1)" "unprognostic (2.74e-2)" "unprognostic (1.53e-1)" 18.9 2.5 0.0 1.2 0.0 0.1 12.8 0.0 0.1 0.5 0.2 0.0 0.4 0.1 1.7 7.8 0.3 6.3 0.1 0.1 0.0 0.0 12.2 0.1 0.1 4.3 0.0 0.0 5.6 1.0 0.1 0.0 2.0 0.0 0.9 0.1 0.0 0.5 0.2 28.3 5.7 4.4 1.2 0.5 0.1 0.1 4.3 0.0 0.1 0.2 0.2 0.3 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 2.2 0.0 14.7 5.9 4.9 1.0 1.5 1.4 1.9 1.3 0.6 2.2 0.0 1.1 5.8 0.3 2.6 0.3 1.5 1.7 18.7 22.8 0.4 3.3 0.5 0.6 0.0 3.4 5.5 2.5 2.8 1.3 0.0 1.8 0.1 4.6 0.0 3.9 1.6 0.0 1.3 0.0 1.1 0.2 0.2 2.8 0.0 4.4 1.4 0.0 4.3 5.3 2.8 5.8 0.4 4.4 0.2 0.0 3.5 6.3 1.0 1.8 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.3 34.9 0.0 3.4 0.1 0.0 0.0 0.3 10.4 20.8 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.6 4.4 0.3 37.1 0.0 0.0 0.0 0.3 0.0 7.4 16.7 0.0 6.5 2.5 7.6 8.9 8.3 0.3 0.0 0.0 0.0 HOXD1 "HOX4, HOX4G" ENSG00000128645 "Homeobox D1" Q9GZZ0 2 176188579-176190907 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9;epididymis: 14.1;seminal vesicle: 20.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 21.0;Distal tubular cells: 21.6;Enterocytes: 18.8;Mucus-secreting cells: 16.6;Undifferentiated cells: 20.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 6.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.9;Hep G2: 6.0;RPTEC TERT1: 18.8;RT4: 14.4;SCLC-21H: 5.0" "Region enriched" "Detected in single" 5 "pons and medulla: 1.2" "Low region specificity" "Detected in many" "HPA040062, HPA056900" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040062: AB_2676826, HPA056900: AB_2683270" "unprognostic (8.78e-2)" "unprognostic (9.97e-2)" "unprognostic (7.11e-3)" "unprognostic (1.06e-3)" "unprognostic (2.70e-1)" "unprognostic (3.19e-2)" "unprognostic (7.33e-2)" "unprognostic (4.10e-2)" "unprognostic (2.85e-1)" "unprognostic (2.44e-1)" "unprognostic (9.64e-2)" "unprognostic (4.02e-1)" "unprognostic (1.54e-5)" "unprognostic (4.33e-3)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.32e-1)" 2.4 0.6 1.5 1.1 3.5 0.3 2.0 0.6 3.9 0.5 5.2 18.8 11.8 0.7 0.8 14.1 0.9 8.8 1.4 0.3 4.1 2.2 6.8 0.2 5.7 0.9 9.8 1.3 1.2 0.5 0.2 0.2 0.3 15.5 1.7 3.7 0.3 1.0 20.4 0.3 1.2 4.4 0.9 18.9 1.5 0.7 2.2 6.3 0.0 0.4 0.0 0.5 4.6 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 5.9 0.3 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 6.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 18.8 14.4 5.0 0.9 0.0 0.0 0.9 0.8 0.0 0.0 3.3 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.5 0.6 3.2 4.1 2.2 9.8 1.3 15.5 6.3 3.0 21.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 4.5 7.0 0.0 0.0 21.6 0.0 0.0 2.9 18.8 0.0 0.0 0.0 0.1 0.5 2.3 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 3.3 0.0 16.6 0.0 0.1 11.5 0.4 2.9 0.0 0.0 0.1 2.6 6.4 2.3 0.0 0.0 20.6 1.8 HSPH1 "HSP105A, HSP105B, KIAA0201, NY-CO-25" ENSG00000120694 "Heat shock protein family H (Hsp110) member 1" Q92598 13 31134974-31162388 "Cancer-related genes, Predicted intracellular proteins" "Stress response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "vagina: 286.1" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 738.6;Urothelial cells: 485.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002060, HPA028675, HPA031569" Uncertain Enhanced Nucleoplasm,Cytosol No Yes 820000 Cytosol Nucleoplasm "CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938" "unprognostic (1.10e-2)" "unprognostic (4.94e-2)" "unprognostic (5.44e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.90e-4)" "prognostic unfavorable (1.41e-5)" "unprognostic (5.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (1.53e-1)" "unprognostic (3.13e-1)" "unprognostic (7.45e-3)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (2.04e-1)" "unprognostic (7.89e-2)" 13.7 19.8 36.6 12.2 57.1 9.8 33.7 11.7 44.0 14.7 10.6 9.8 13.0 6.1 13.3 21.7 13.9 31.0 18.1 14.2 34.8 40.3 16.6 14.8 15.9 17.4 36.5 16.3 13.4 10.1 15.1 24.1 19.8 32.7 14.5 14.5 3.6 7.0 17.3 10.5 11.0 6.4 15.7 34.8 9.0 12.2 35.0 34.6 12.1 22.5 7.8 23.8 17.0 286.1 9.0 6.8 2.1 14.6 13.7 12.8 5.5 13.7 26.5 21.8 2.1 21.0 11.9 14.5 23.9 21.3 37.2 17.3 31.1 21.5 35.8 15.0 16.6 52.9 26.8 84.1 21.2 48.1 28.0 10.6 31.0 14.6 27.4 6.9 21.5 24.8 7.5 49.2 24.8 14.3 19.5 21.5 12.6 25.9 5.7 26.1 18.8 30.8 24.6 31.0 67.6 19.8 24.3 17.9 11.8 28.1 16.8 22.6 18.8 21.8 21.4 11.0 34.9 7.2 21.0 13.1 12.8 16.3 18.4 26.4 4.5 14.7 30.7 10.7 26.1 21.4 1.0 3.9 2.1 6.6 9.6 8.1 9.0 8.4 10.0 6.8 7.8 12.8 11.9 0.4 13.7 14.6 5.3 5.3 5.5 36.6 57.1 11.7 44.0 34.8 40.3 36.5 16.3 32.7 34.6 122.1 81.5 33.2 738.6 190.6 38.7 130.6 17.8 302.5 185.4 43.6 392.7 17.7 24.9 44.8 71.1 92.6 26.2 0.0 31.1 55.8 207.2 407.7 251.8 21.5 79.0 28.6 217.9 24.5 27.7 22.4 31.4 113.0 155.3 47.7 22.5 16.6 37.1 45.6 36.7 22.8 57.7 38.8 156.8 128.9 138.0 125.3 35.6 28.0 26.7 485.8 HTATSF1 TAT-SF1 ENSG00000102241 "HIV-1 Tat specific factor 1" O43719 X 136497079-136512346 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000504 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000504: AB_10752094" "unprognostic (3.56e-2)" "prognostic favorable (3.78e-4)" "unprognostic (1.72e-1)" "unprognostic (2.56e-2)" "unprognostic (6.72e-2)" "unprognostic (3.70e-1)" "unprognostic (3.32e-3)" "unprognostic (3.27e-1)" "unprognostic (2.09e-2)" "unprognostic (1.49e-1)" "unprognostic (1.73e-2)" "unprognostic (3.37e-2)" "prognostic favorable (8.13e-8)" "unprognostic (7.12e-2)" "unprognostic (2.67e-2)" "unprognostic (2.25e-2)" "unprognostic (4.05e-1)" 14.5 40.9 26.2 11.8 24.7 18.3 19.6 29.5 22.2 15.2 13.4 19.4 12.9 9.6 15.9 24.7 12.3 14.5 11.5 25.2 23.8 29.9 17.5 12.7 10.4 12.1 26.9 17.6 25.5 10.9 25.6 71.7 21.2 21.4 15.1 14.2 11.9 10.6 16.6 72.2 13.6 9.8 14.4 28.1 10.2 12.4 15.8 19.0 14.5 19.4 22.6 13.3 12.7 12.9 17.1 14.1 19.2 16.1 23.6 24.9 13.1 42.0 22.5 28.5 20.2 21.3 16.1 25.2 19.5 17.4 16.7 16.3 13.3 18.9 31.6 47.5 18.9 19.4 18.2 34.5 14.6 21.7 24.1 29.3 19.7 28.5 16.3 11.8 37.0 16.0 14.2 19.1 18.3 11.3 11.7 16.9 47.6 18.1 23.4 21.4 31.3 36.8 31.9 16.4 37.9 33.5 29.1 35.5 28.8 17.9 29.8 20.2 31.4 18.5 15.5 15.3 25.2 11.5 26.7 16.3 20.4 15.4 23.1 34.9 13.7 18.8 26.3 13.0 52.9 14.3 19.2 10.1 16.4 21.9 10.5 24.4 17.1 24.1 22.2 14.1 15.9 24.9 22.2 3.4 23.6 16.1 10.3 24.0 13.1 26.2 24.7 29.5 22.2 23.8 29.9 26.9 17.6 21.4 19.0 47.6 40.5 17.9 31.9 26.3 49.7 142.2 15.3 58.9 68.2 47.1 9.8 79.5 41.4 30.5 4.9 27.0 20.7 0.0 29.6 57.8 33.4 28.5 33.5 20.4 33.5 39.7 77.9 10.4 19.3 9.9 41.7 26.7 30.4 26.2 34.6 55.0 26.0 14.0 50.5 24.8 43.9 45.3 33.5 21.8 87.9 23.2 97.7 40.6 29.3 30.6 HUWE1 "Ib772, KIAA0312, UREB1" ENSG00000086758 "HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase" Q7Z6Z7 X 53532096-53686729 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002548, CAB022718" Approved Enhanced Nucleoplasm,Cytosol NA NA 3400 "Nucleoplasm, Cytosol" "CAB022718: , HPA002548: AB_1080489" "unprognostic (4.73e-2)" "unprognostic (9.06e-2)" "unprognostic (1.31e-1)" "unprognostic (1.59e-2)" "unprognostic (6.64e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (2.21e-1)" "unprognostic (3.56e-1)" "unprognostic (5.51e-2)" "unprognostic (1.33e-1)" "unprognostic (8.89e-2)" "unprognostic (8.10e-3)" "unprognostic (2.17e-1)" "unprognostic (1.32e-1)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" 24.6 28.2 27.7 23.8 43.3 22.4 28.0 37.0 41.1 31.8 25.9 34.3 26.6 17.1 31.9 52.4 27.4 26.5 23.1 27.1 28.0 31.8 30.3 26.2 20.3 23.1 30.0 30.2 43.3 27.8 59.8 34.2 27.2 34.6 27.3 22.7 25.6 26.4 29.6 59.1 50.1 22.1 33.9 23.9 26.6 25.7 28.4 27.7 32.4 27.6 20.7 28.6 27.0 22.9 5.1 7.2 8.2 7.0 6.9 8.9 3.5 50.2 31.0 20.2 14.2 35.4 21.2 24.9 15.1 19.5 16.0 16.7 23.6 16.2 26.4 10.3 27.5 28.8 24.2 45.6 25.3 21.9 38.0 20.2 21.0 27.8 18.3 32.5 31.4 12.9 20.2 19.0 38.3 44.1 15.8 27.6 20.7 20.9 17.1 20.7 31.0 17.0 17.6 27.6 13.8 22.3 15.7 27.8 16.0 26.5 34.9 16.9 12.2 42.7 19.1 13.6 39.5 27.3 15.3 35.1 14.7 21.1 21.0 19.2 15.0 14.8 23.0 15.7 30.8 21.1 4.0 4.7 8.2 7.2 3.8 8.9 5.1 6.9 7.6 6.7 5.1 4.9 4.9 4.2 6.9 7.0 7.2 5.7 3.5 27.7 43.3 37.0 41.1 28.0 31.8 30.0 30.2 34.6 27.7 47.6 43.2 23.8 25.3 26.8 53.1 98.6 45.9 37.5 36.4 38.4 47.1 26.9 1.7 35.4 22.3 29.2 24.7 0.0 30.4 29.3 24.4 33.4 20.9 43.1 21.9 77.9 45.8 31.3 25.6 21.6 26.2 26.1 25.3 40.5 28.4 20.9 40.0 17.3 36.7 12.2 31.9 12.9 33.0 17.1 43.7 36.4 31.7 37.1 29.2 40.4 ID1 "bHLHb24, dJ857M17.1.2" ENSG00000125968 "Inhibitor of DNA binding 1, HLH protein" P41134 20 31605283-31606515 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 163.1" "Cell type enhanced" "Detected in many" 8 "Ito cells: 1636.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 3.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.9" "Cell line enhanced" "Detected in many" "EFO-21: 75.9;HaCaT: 72.3;PC-3: 75.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025915, HPA051456, HPA058518" Approved Enhanced Nucleoplasm "Intracellular and membrane" Yes No Nucleoplasm "CAB025915: , HPA051456: AB_2681492, HPA058518: AB_2683740" "unprognostic (3.89e-2)" "unprognostic (3.45e-2)" "unprognostic (2.62e-2)" "unprognostic (3.19e-2)" "unprognostic (1.27e-2)" "unprognostic (1.74e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (4.85e-4)" "unprognostic (2.29e-1)" "unprognostic (1.58e-1)" "unprognostic (2.14e-2)" "unprognostic (7.83e-2)" "unprognostic (1.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.97e-1)" "unprognostic (6.17e-3)" "unprognostic (3.41e-3)" 28.6 12.3 8.2 15.2 9.1 4.4 33.2 5.6 13.8 36.3 33.3 15.4 38.5 36.4 25.9 11.6 78.0 25.1 19.0 33.5 8.7 8.4 22.3 23.4 57.4 17.9 10.0 7.9 12.3 5.8 4.0 25.7 22.1 14.3 56.4 13.1 34.9 10.5 163.1 23.0 16.5 40.6 16.9 8.1 15.3 48.6 7.8 4.0 2.4 78.8 36.2 21.0 80.0 26.4 0.4 0.7 3.9 0.7 0.3 0.5 0.5 10.7 35.5 0.4 7.2 4.7 2.1 27.7 45.5 1.8 8.4 0.9 18.7 16.2 0.0 75.9 12.1 9.9 72.3 5.9 2.5 1.3 0.8 3.7 5.9 30.8 60.2 6.4 0.1 0.3 8.7 10.4 0.0 0.6 14.0 5.1 4.0 13.0 0.3 16.1 14.0 1.6 0.2 25.5 48.0 75.7 0.1 29.7 0.5 1.6 29.7 13.8 12.9 37.8 13.6 0.3 20.1 8.3 1.0 27.1 22.6 44.0 7.2 30.5 0.8 0.8 0.6 26.3 5.6 3.0 0.0 0.6 0.9 0.1 0.2 0.0 0.1 0.1 0.0 0.7 0.4 0.0 0.5 3.9 0.3 0.7 0.0 0.0 0.5 8.2 9.1 5.6 13.8 8.7 8.4 10.0 7.9 14.3 4.0 220.3 143.7 26.8 631.9 90.9 1.0 20.7 76.5 89.7 271.8 216.3 3.9 104.2 31.5 429.0 5.6 483.5 528.2 0.0 472.2 442.0 137.2 501.4 21.9 90.9 22.4 0.0 550.7 1636.4 76.9 5.9 26.4 25.7 86.0 13.6 450.7 80.6 190.0 770.0 0.4 2.7 4.0 12.9 193.3 1.9 2.2 76.9 74.5 24.9 241.9 477.9 IDO1 "IDO, INDO" ENSG00000131203 "Indoleamine 2,3-dioxygenase 1" P14902 8 39902275-39928444 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.7;placenta: 33.2" "Cell type enriched" "Detected in some" 552 "monocytes: 4555.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 17 "eosinophil: 77.7" "Lineage enriched" "Detected in many" 17 "granulocytes: 77.7" "Cell line enriched" "Detected in some" 7 "EFO-21: 36.6" "Region enriched" "Detected in single" 13 "basal ganglia: 30.5" "Low region specificity" "Detected in all" "HPA023072, HPA023149, HPA027772, CAB072820" Enhanced Supported Nucleoplasm,Vesicles,Mitochondria,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles, Mitochondria" "CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222" "unprognostic (1.68e-2)" "unprognostic (1.71e-2)" "unprognostic (4.08e-3)" "unprognostic (7.21e-3)" "unprognostic (1.90e-1)" "unprognostic (1.09e-2)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "prognostic favorable (5.27e-4)" "prognostic favorable (3.32e-4)" "unprognostic (3.59e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (1.12e-7)" "unprognostic (4.18e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.97e-2)" 8.7 0.2 0.9 11.2 0.9 0.0 1.4 0.9 0.9 4.0 1.5 0.9 0.9 2.6 2.6 0.9 1.2 0.6 1.3 1.0 0.9 0.0 0.9 0.9 16.8 14.1 0.9 0.9 0.9 0.9 0.0 0.9 33.2 0.9 1.6 2.1 1.9 0.9 0.9 2.5 0.3 5.9 0.9 2.0 6.2 2.2 0.9 0.9 0.9 7.2 0.9 8.9 2.3 0.9 0.0 4.6 77.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.5 2.6 0.1 0.3 0.0 36.6 0.0 1.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.2 0.0 0.1 0.0 0.1 0.0 4.5 0.1 77.7 0.0 0.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.9 0.9 0.9 0.9 0.9 0.0 0.9 0.9 0.9 0.9 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.0 0.0 2.5 2.6 0.9 0.0 0.0 6.7 0.0 0.2 0.4 0.0 0.0 0.8 0.0 0.0 0.0 8.2 1.3 0.0 6.0 0.0 4555.6 0.0 3.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.4 IER2 ETR101 ENSG00000160888 "Immediate early response 2" Q9BTL4 19 13150415-13154908 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 120.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 57.5;U-266/84: 73.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055387, HPA060574" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055387: AB_2682802, HPA060574: AB_2684324" "unprognostic (3.09e-2)" "unprognostic (1.78e-1)" "unprognostic (1.99e-1)" "unprognostic (4.86e-2)" "unprognostic (3.86e-2)" "unprognostic (2.47e-2)" "unprognostic (2.10e-1)" "unprognostic (3.31e-1)" "unprognostic (2.35e-2)" "unprognostic (7.05e-2)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (5.69e-2)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" "unprognostic (2.86e-1)" "unprognostic (1.01e-1)" 34.1 24.4 11.5 13.4 16.1 68.2 19.1 13.3 16.8 16.4 20.3 10.1 28.7 12.6 20.3 13.0 22.3 66.8 16.4 16.2 14.1 5.9 16.8 19.9 25.4 14.0 19.2 13.7 33.9 21.6 15.1 17.0 19.9 14.9 26.4 10.0 11.6 34.4 27.1 4.2 45.6 13.7 24.1 15.3 17.1 25.3 7.0 14.2 6.7 29.0 6.7 11.9 18.3 26.4 23.8 14.3 120.1 27.5 28.4 38.4 30.3 14.0 8.4 6.6 10.0 4.4 5.9 14.6 10.9 5.9 7.5 4.4 7.1 8.5 8.3 11.1 7.9 12.7 9.5 3.0 6.3 3.8 4.9 5.7 10.9 14.3 5.9 5.4 13.7 12.2 3.0 15.7 8.1 5.1 9.2 8.8 8.7 27.5 11.2 2.9 23.0 8.2 57.5 12.6 15.2 36.4 16.0 6.7 9.9 6.8 8.3 8.2 11.8 12.2 37.7 24.7 5.4 4.4 8.3 15.8 16.0 10.9 13.2 31.4 33.1 73.6 8.6 8.6 27.4 12.3 40.5 23.4 37.6 38.4 27.5 33.1 21.3 27.0 30.7 14.3 23.8 18.1 22.7 120.1 28.4 24.7 6.5 25.3 30.3 11.5 16.1 13.3 16.8 14.1 5.9 19.2 13.7 14.9 14.2 163.8 583.5 268.0 446.3 283.3 80.9 53.2 336.3 91.0 145.6 90.7 33.4 412.8 44.7 562.1 8.3 433.3 636.2 23.3 334.1 457.3 546.3 696.8 470.7 72.3 507.9 14.3 939.8 260.9 263.5 8.1 127.8 482.9 224.4 162.3 744.6 230.0 421.9 589.0 36.4 32.7 128.3 633.8 468.1 4.5 8.9 386.1 765.7 449.7 550.7 402.2 ILF3 "DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1" ENSG00000129351 "Interleukin enhancer binding factor 3" Q12906 19 10654261-10692417 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001897 Supported Enhanced Nucleoplasm,Nucleoli,Mitochondria No No 1100000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA001897: AB_1078703" "unprognostic (2.39e-1)" "unprognostic (9.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (5.55e-3)" "unprognostic (1.11e-3)" "unprognostic (2.96e-1)" "prognostic unfavorable (1.57e-4)" "unprognostic (3.45e-2)" "unprognostic (1.04e-1)" "unprognostic (4.38e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (7.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.03e-1)" "unprognostic (6.20e-2)" 31.0 39.0 29.6 45.5 26.8 88.2 34.5 48.3 35.2 34.2 30.2 30.8 35.2 30.3 45.4 31.7 40.5 41.9 32.5 34.0 25.5 20.0 28.1 25.6 34.1 44.9 24.7 27.8 52.8 36.8 34.9 34.9 31.8 32.3 34.9 27.3 35.5 35.1 46.2 50.1 37.7 37.2 33.2 33.3 44.5 32.6 54.3 28.0 58.6 43.4 32.4 41.1 38.5 32.1 18.7 18.7 11.5 14.3 15.4 19.4 8.0 45.7 37.3 60.4 55.2 13.1 18.0 35.2 29.3 24.9 49.2 38.6 42.7 26.6 57.2 29.1 26.3 30.1 41.0 65.2 39.6 44.4 36.5 58.0 74.2 32.9 39.8 18.8 53.4 37.1 17.0 17.7 39.0 43.8 18.8 42.0 33.4 63.3 45.0 28.6 37.7 88.5 85.8 72.5 24.2 41.0 65.2 57.5 39.5 19.6 48.6 66.7 48.5 37.7 30.0 21.8 28.6 25.4 34.3 33.7 40.4 38.4 41.8 57.7 38.6 52.8 69.4 22.6 57.1 43.5 11.5 13.4 7.1 19.4 10.4 16.1 14.7 15.9 17.3 16.8 18.7 15.7 16.0 2.1 15.4 14.3 18.7 15.0 8.0 29.6 26.8 48.3 35.2 25.5 20.0 24.7 27.8 32.3 28.0 92.3 128.4 63.8 84.3 76.5 92.4 59.0 50.9 96.4 131.9 40.1 80.5 65.6 23.2 66.6 12.8 60.9 40.0 46.7 69.0 90.4 57.8 80.9 92.6 46.1 63.0 89.0 109.3 33.7 53.5 14.4 70.8 66.0 37.1 46.9 68.0 70.5 72.3 56.1 58.7 38.2 92.6 32.3 67.0 108.6 117.8 67.2 59.3 68.2 82.6 87.0 IMP3 "BRMS2, C15orf12, FLJ10968, MRPS4" ENSG00000177971 "IMP3, U3 small nucleolar ribonucleoprotein" Q9NV31 15 75639085-75648706 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060955, HPA061177" Enhanced Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA060955: AB_2684397, HPA061177: AB_2684445" "unprognostic (6.01e-2)" "unprognostic (5.40e-3)" "unprognostic (7.04e-2)" "unprognostic (7.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.22e-1)" "unprognostic (8.44e-2)" "unprognostic (4.51e-2)" "unprognostic (2.69e-3)" "unprognostic (1.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.14e-1)" "unprognostic (1.25e-1)" "unprognostic (8.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.23e-1)" "unprognostic (3.22e-2)" 21.2 28.4 21.9 23.0 24.0 18.9 34.3 20.1 28.8 19.4 31.0 15.4 17.5 27.5 14.7 24.5 35.6 20.1 25.2 21.7 21.1 19.7 28.2 49.7 21.1 28.5 17.6 19.6 23.0 29.1 12.6 17.3 16.9 16.7 23.3 19.2 17.5 28.3 25.4 37.6 29.3 31.5 11.0 15.5 28.5 25.9 12.4 13.3 33.7 30.0 37.5 27.9 19.6 21.8 40.7 34.0 23.0 31.1 33.3 47.2 48.1 20.4 23.2 11.3 19.5 20.1 11.5 16.7 17.3 13.8 14.2 16.4 17.8 18.1 24.5 18.9 9.0 15.7 34.0 37.1 28.0 12.6 18.4 44.5 25.7 19.1 30.8 14.8 26.0 17.9 10.5 23.2 11.4 14.1 10.6 9.3 20.1 33.1 20.0 12.8 24.6 20.6 63.7 30.3 20.9 24.5 22.5 13.8 26.9 19.2 27.9 19.3 19.9 14.6 25.6 31.4 17.1 22.3 24.3 10.5 18.5 14.9 13.2 23.3 27.4 50.4 27.5 20.4 42.3 12.1 18.5 31.1 23.0 42.0 23.9 45.1 40.7 40.5 40.4 33.4 38.7 47.2 44.5 4.0 33.3 23.0 34.0 38.7 48.1 21.9 24.0 20.1 28.8 21.1 19.7 17.6 19.6 16.7 13.3 35.7 34.5 89.1 67.5 203.1 22.0 11.4 66.2 52.2 52.4 38.4 13.7 88.6 122.7 81.1 1.3 74.4 52.6 23.3 93.2 83.2 66.4 58.7 46.3 101.8 81.8 20.6 42.2 68.2 45.6 4.1 56.4 60.5 92.8 116.4 61.3 53.7 92.0 59.6 41.4 158.4 20.3 25.8 71.8 14.0 43.8 207.5 45.9 74.0 84.6 70.1 ING3 "Eaf4, FLJ20089, MEAF4, p47ING3" ENSG00000071243 "Inhibitor of growth family member 3" Q9NXR8 7 120950749-120977216 "Disease related genes, Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004762, HPA067388, HPA067575" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA004762: , HPA067388: AB_2685831, HPA067575: AB_2685863" "unprognostic (1.35e-1)" "unprognostic (6.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.78e-1)" "unprognostic (3.03e-1)" "unprognostic (1.39e-2)" "unprognostic (4.26e-2)" "unprognostic (7.09e-3)" "unprognostic (4.07e-2)" "unprognostic (5.18e-2)" "unprognostic (8.04e-3)" "unprognostic (2.86e-1)" "unprognostic (6.90e-2)" "unprognostic (3.96e-2)" "unprognostic (1.52e-1)" "unprognostic (1.72e-1)" "unprognostic (5.64e-2)" 9.6 9.1 7.4 8.8 9.9 57.7 9.6 21.5 13.8 9.0 9.6 5.5 11.1 7.3 11.1 9.7 8.0 9.7 7.7 7.6 7.3 7.3 8.8 8.4 12.3 11.9 7.6 12.2 11.9 12.1 7.9 17.7 13.0 11.1 9.5 10.6 6.7 10.0 11.5 7.7 6.1 12.9 11.4 8.8 16.4 10.4 8.6 9.6 19.0 12.6 10.4 11.2 8.3 8.4 15.8 15.0 32.7 19.5 18.5 16.9 9.8 9.3 2.8 12.7 7.1 4.8 3.8 4.3 6.4 5.1 9.3 10.9 3.6 10.9 15.2 2.9 5.6 9.8 4.6 12.2 5.0 10.7 10.6 21.4 11.0 10.6 2.1 6.6 21.2 13.1 2.8 2.6 8.2 5.8 4.5 14.5 9.6 24.6 24.7 8.9 3.2 17.4 12.7 15.3 5.3 5.2 8.6 9.1 12.6 9.4 9.7 11.5 12.5 6.6 13.7 6.9 8.2 3.1 8.3 5.1 9.5 3.5 20.4 11.6 11.3 7.2 22.9 4.8 14.3 7.9 22.3 19.1 16.5 13.9 19.5 13.4 14.4 14.1 12.6 15.0 15.8 14.4 13.1 32.7 18.5 19.1 11.2 16.9 9.8 7.4 9.9 21.5 13.8 7.3 7.3 7.6 12.2 11.1 9.6 17.9 13.6 22.2 20.2 6.8 20.4 12.6 7.6 13.4 7.9 7.0 3.9 33.3 18.3 10.3 4.0 18.5 17.3 23.3 15.7 21.2 19.3 14.2 33.4 11.1 15.3 25.4 11.5 19.6 26.6 3.9 12.7 19.0 15.1 15.4 14.0 17.3 12.9 14.8 9.2 9.7 17.2 19.4 22.6 15.0 13.9 9.8 38.2 21.8 12.4 13.9 INTS13 "ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30" ENSG00000064102 "Integrator complex subunit 13" Q9NVM9 12 26905181-26938326 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 20.8;Extravillous trophoblasts: 13.8;Hofbauer cells: 13.1;Pancreatic endocrine cells: 13.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039543, HPA040109, HPA073020" Uncertain Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Vesicles" "HPA039543: AB_10795150, HPA040109: , HPA073020: " "unprognostic (2.09e-1)" "unprognostic (8.48e-3)" "unprognostic (2.75e-2)" "unprognostic (1.40e-3)" "unprognostic (3.94e-2)" "unprognostic (3.01e-2)" "prognostic unfavorable (1.17e-10)" "unprognostic (5.22e-3)" "unprognostic (5.28e-2)" "unprognostic (1.67e-2)" "unprognostic (1.78e-3)" "unprognostic (3.75e-3)" "prognostic unfavorable (3.16e-6)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (4.37e-2)" "unprognostic (4.78e-2)" 10.0 20.9 10.5 11.5 14.7 15.3 11.5 11.4 11.4 10.5 10.0 22.3 4.6 9.0 10.6 10.4 14.1 8.1 7.5 10.2 12.3 9.8 12.6 14.3 8.0 14.1 18.8 7.4 9.2 11.9 9.3 17.6 9.2 22.4 10.1 10.4 8.9 9.4 6.6 16.9 11.4 8.5 11.6 30.2 17.9 14.1 10.9 14.1 26.6 10.7 11.6 15.1 16.9 9.6 7.4 6.8 5.1 5.4 16.4 18.7 7.1 9.4 10.5 6.4 13.6 9.2 14.8 9.1 13.2 8.0 12.5 14.2 15.7 12.6 24.0 13.9 7.3 12.4 13.6 15.6 12.4 21.3 11.0 9.6 18.7 13.0 12.9 16.5 31.7 11.6 8.1 9.6 20.4 43.4 16.6 16.2 10.6 19.8 9.5 13.7 10.9 16.6 58.3 27.8 13.0 18.9 11.7 18.7 32.1 10.7 8.7 5.1 4.9 11.6 9.2 13.3 23.2 12.5 6.9 10.6 14.9 11.0 24.9 16.0 4.9 5.6 35.1 9.9 22.0 10.4 4.2 5.4 5.1 10.5 3.7 15.5 6.8 13.1 12.9 6.8 7.4 9.4 11.5 1.8 16.4 3.2 4.6 18.7 7.1 10.5 14.7 11.4 11.4 12.3 9.8 18.8 7.4 22.4 14.1 20.8 8.5 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.5 5.2 0.0 10.1 3.3 12.3 0.0 0.0 0.0 0.0 10.4 13.8 0.0 0.0 7.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 10.0 0.0 0.0 13.3 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 INTS9 "CPSF2L, FLJ10871, RC-74" ENSG00000104299 "Integrator complex subunit 9" Q9NV88 8 28767661-28890242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051615, HPA066822" Enhanced Nucleoplasm Yes No Nucleoplasm "HPA051615: AB_2681552, HPA066822: AB_2685729" "unprognostic (2.19e-2)" "unprognostic (1.45e-2)" "unprognostic (1.79e-2)" "prognostic favorable (9.45e-4)" "unprognostic (2.46e-1)" "unprognostic (1.56e-3)" "unprognostic (6.91e-3)" "prognostic favorable (7.71e-4)" "unprognostic (3.64e-2)" "unprognostic (5.01e-2)" "unprognostic (4.72e-2)" "unprognostic (2.48e-3)" "prognostic favorable (1.91e-5)" "unprognostic (2.51e-2)" "unprognostic (2.73e-1)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" 10.8 28.8 10.5 14.1 13.4 8.1 11.0 14.2 16.5 11.3 11.7 15.5 7.7 9.3 16.4 16.1 14.1 13.7 9.1 13.0 9.5 7.6 12.8 9.3 11.4 17.9 15.2 8.1 11.4 12.5 13.4 24.0 11.4 12.1 11.6 12.9 17.9 15.5 10.6 14.1 12.4 11.9 12.8 13.5 20.4 11.7 15.2 13.3 28.4 17.2 8.5 23.1 13.2 11.2 17.6 24.3 15.5 19.3 19.9 17.0 9.3 13.2 9.4 11.3 12.0 14.0 6.6 5.0 6.1 8.4 10.7 11.9 6.5 7.5 13.2 8.6 6.2 9.6 11.1 21.8 12.5 15.0 5.5 8.9 13.2 5.3 11.3 10.2 6.6 10.3 7.5 9.0 12.9 9.3 5.8 13.2 19.1 27.8 7.7 7.1 7.3 30.5 12.0 15.3 15.6 6.1 19.7 13.1 6.9 7.5 9.2 8.2 15.0 6.3 8.3 11.1 9.5 8.0 7.5 7.7 6.2 16.0 10.5 7.7 4.0 2.7 16.4 9.6 11.1 8.8 12.1 17.7 15.5 15.4 19.3 14.3 15.4 13.7 17.0 24.3 17.6 12.5 13.1 7.2 19.9 13.7 12.8 16.3 9.3 10.5 13.4 14.2 16.5 9.5 7.6 15.2 8.1 12.1 13.3 6.0 3.4 4.7 2.4 2.1 2.1 4.6 7.6 1.4 2.3 3.5 5.9 6.7 1.7 3.0 6.1 2.9 2.3 0.0 4.5 3.8 3.8 1.4 0.0 1.6 6.7 1.6 5.8 2.5 4.1 3.3 7.2 2.9 3.3 4.6 4.0 2.0 4.7 0.0 4.2 3.3 5.5 0.0 2.8 3.0 3.3 2.6 4.0 3.2 3.3 1.4 IPMK ENSG00000151151 "Inositol polyphosphate multikinase" Q8NFU5 10 58191517-58267934 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 48.0;Suprabasal keratinocytes: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.4" "Group enriched" "Detected in many" 4 "granulocytes: 6.4;monocytes: 2.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037837, HPA057542" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037837: AB_10670166, HPA057542: AB_2683460" "unprognostic (4.52e-2)" "unprognostic (3.29e-2)" "unprognostic (4.22e-3)" "unprognostic (6.85e-2)" "unprognostic (2.41e-2)" "unprognostic (1.99e-1)" "unprognostic (1.39e-3)" "unprognostic (2.10e-1)" "unprognostic (9.39e-2)" "unprognostic (2.23e-1)" "unprognostic (1.55e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (9.96e-7)" "unprognostic (1.79e-1)" "unprognostic (4.33e-1)" "unprognostic (1.27e-3)" "unprognostic (9.02e-3)" 12.2 4.1 5.4 6.8 5.6 2.8 6.7 8.7 5.6 5.9 19.4 3.5 2.1 9.5 3.2 5.6 10.8 3.8 8.6 7.4 5.2 5.5 5.3 21.3 11.0 13.8 4.9 3.3 4.8 6.0 22.5 6.1 13.8 4.3 4.4 7.5 4.8 6.4 4.4 9.8 9.0 28.1 4.9 6.0 14.1 4.4 2.9 3.8 11.7 5.9 4.9 5.9 10.4 12.3 0.7 1.0 6.4 2.1 0.4 0.9 0.4 14.7 3.8 5.6 5.4 5.5 6.5 4.9 3.9 8.4 3.4 6.8 7.6 9.5 11.8 8.0 4.6 3.2 4.6 4.7 5.2 10.8 5.4 3.6 2.9 3.8 7.2 3.3 4.6 6.7 7.1 4.7 5.7 11.5 3.8 7.2 3.5 1.9 6.1 5.9 3.7 6.2 8.9 3.5 6.0 3.6 0.4 12.1 5.5 6.2 3.8 3.9 6.8 5.1 13.6 3.9 9.6 11.3 5.6 6.2 3.7 7.1 7.7 4.9 13.1 7.7 9.4 6.9 4.9 1.4 2.3 1.5 3.3 0.4 1.6 0.4 0.7 0.4 0.2 1.0 0.4 0.9 0.3 6.4 0.4 2.1 0.4 0.1 0.4 5.4 5.6 8.7 5.6 5.2 5.5 4.9 3.3 4.3 3.8 6.0 3.4 9.7 9.1 48.0 9.1 2.4 5.1 17.4 7.9 1.8 5.9 8.5 3.3 3.2 1.9 3.2 22.2 0.0 4.2 17.8 16.0 7.8 6.9 11.4 9.0 12.7 8.1 8.6 27.1 1.0 2.6 17.3 25.3 1.0 11.7 3.7 6.2 16.4 1.8 7.3 5.4 6.5 12.2 9.8 4.3 50.7 7.9 4.3 9.0 14.3 IRF2 ENSG00000168310 "Interferon regulatory factor 2" P14316 4 184387713-184474580 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 173.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 50.9;Karpas-707: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030813, CAB032306, HPA057327" Supported Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410" "prognostic favorable (6.95e-5)" "unprognostic (1.69e-3)" "unprognostic (5.43e-2)" "unprognostic (1.59e-3)" "unprognostic (2.70e-2)" "unprognostic (1.46e-1)" "unprognostic (2.48e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-3)" "unprognostic (2.90e-2)" "unprognostic (4.00e-2)" "unprognostic (2.35e-1)" "unprognostic (6.87e-3)" "unprognostic (8.55e-3)" "unprognostic (5.25e-2)" "prognostic favorable (8.34e-5)" "unprognostic (1.31e-3)" 27.5 30.6 15.2 31.0 19.3 11.3 21.0 21.5 16.4 21.5 23.7 28.8 16.6 21.2 19.8 16.5 20.5 18.1 17.3 16.1 15.3 12.1 15.3 26.1 24.0 38.7 22.8 9.7 28.0 14.9 12.4 24.5 19.7 17.8 20.5 20.4 16.8 22.1 16.1 21.9 18.1 27.7 21.2 22.4 39.4 21.3 8.4 22.0 36.1 24.0 12.6 34.5 28.8 26.4 22.2 16.2 83.9 27.5 18.1 21.9 17.2 6.1 4.5 5.6 3.7 12.3 12.7 3.3 4.5 14.2 11.1 11.7 1.3 11.9 3.8 2.4 6.7 9.1 5.7 3.8 8.6 7.2 50.9 2.1 10.5 2.5 8.2 12.2 6.4 8.9 13.6 7.9 6.3 16.5 9.6 8.4 4.6 2.0 53.1 4.6 4.3 12.3 7.8 1.2 5.6 3.3 16.2 2.1 16.9 8.5 9.5 2.4 3.7 6.4 5.3 9.3 2.4 4.1 5.8 6.9 3.2 3.5 3.6 3.9 15.2 12.1 3.3 6.7 6.3 5.6 17.7 19.4 34.5 16.4 25.3 16.9 21.2 16.3 17.6 16.2 22.2 17.5 17.3 83.9 18.1 27.5 4.1 21.9 17.2 15.2 19.3 21.5 16.4 15.3 12.1 22.8 9.7 17.8 22.0 35.7 23.2 51.9 43.4 43.6 11.8 19.6 28.1 64.3 26.1 24.4 5.9 27.6 31.5 24.5 0.1 35.9 32.5 23.3 26.4 13.4 30.4 57.1 26.5 32.6 42.8 19.1 29.4 37.4 73.6 1.3 34.5 47.6 18.6 173.1 25.9 25.5 27.3 37.4 49.8 23.7 7.8 38.8 24.7 0.2 1.1 38.9 22.3 58.6 20.9 59.3 IRF2BP2 IRF-2BP2 ENSG00000168264 "Interferon regulatory factor 2 binding protein 2" Q7Z5L9 1 234604269-234609525 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 396.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 75.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027815, HPA062269" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027815: AB_10609994, HPA062269: AB_2684732" "unprognostic (1.15e-3)" "unprognostic (1.02e-1)" "unprognostic (3.90e-1)" "unprognostic (2.13e-1)" "unprognostic (3.41e-3)" "unprognostic (1.69e-1)" "unprognostic (1.74e-3)" "unprognostic (1.97e-2)" "unprognostic (8.77e-2)" "unprognostic (2.19e-1)" "unprognostic (3.69e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (1.25e-1)" "unprognostic (2.70e-1)" "unprognostic (3.14e-1)" "unprognostic (3.77e-1)" 17.9 14.5 11.3 21.1 12.9 48.0 29.9 16.5 17.6 19.8 19.3 13.8 10.9 13.9 20.3 13.1 17.3 17.1 31.6 19.6 12.7 11.5 12.3 20.4 35.0 30.3 11.1 10.6 25.3 22.6 15.9 10.8 11.1 13.9 18.5 18.1 16.8 19.6 12.9 18.8 25.2 20.0 11.6 15.0 16.2 17.0 23.9 11.3 28.6 21.1 14.6 19.5 17.4 19.4 4.0 17.4 8.9 4.5 2.8 5.1 2.3 7.5 11.7 8.4 12.9 17.7 14.1 10.1 6.1 5.2 3.7 4.1 6.7 9.4 0.0 14.4 5.8 12.3 10.5 4.5 8.0 5.7 12.4 10.6 7.3 9.2 19.8 14.4 26.9 25.7 16.5 18.6 8.1 15.3 21.0 9.1 6.9 6.3 15.6 9.3 2.2 6.8 28.7 7.6 17.8 4.5 13.4 3.9 17.9 7.0 6.3 16.9 11.9 9.8 13.1 19.1 8.7 12.6 75.3 10.2 13.1 5.5 9.7 11.4 34.7 9.0 2.5 6.5 24.6 17.7 8.9 4.5 7.6 4.1 3.4 4.2 4.0 5.0 4.8 4.5 3.9 5.1 4.3 2.3 2.8 1.8 17.4 3.7 2.3 11.3 12.9 16.5 17.6 12.7 11.5 11.1 10.6 13.9 11.3 125.0 159.6 51.3 373.3 289.5 29.7 48.7 129.9 73.6 138.8 48.8 9.8 34.2 11.6 50.2 20.2 107.9 65.6 70.0 43.0 37.5 72.0 119.8 103.0 148.0 75.7 55.6 139.8 102.5 119.4 18.0 64.5 110.8 104.6 13.6 101.3 95.4 59.9 66.6 76.4 35.8 18.6 77.6 123.6 20.5 17.0 346.3 66.4 45.8 141.3 396.8 IRF2BPL "C14orf4, EAP1, KIAA1865" ENSG00000119669 "Interferon regulatory factor 2 binding protein like" Q9H1B7 14 77024543-77028699 "Plasma proteins, Predicted intracellular proteins" Transferase "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050862, HPA061333" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA050862: AB_2681258, HPA061333: AB_2684481" "unprognostic (5.58e-2)" "unprognostic (6.48e-2)" "unprognostic (1.99e-3)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.78e-3)" "unprognostic (1.57e-2)" "unprognostic (2.70e-1)" "unprognostic (1.81e-1)" "unprognostic (5.74e-2)" "unprognostic (2.53e-2)" "unprognostic (2.51e-3)" "unprognostic (5.39e-2)" "unprognostic (1.03e-3)" "unprognostic (2.55e-1)" "unprognostic (9.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" 24.2 21.6 12.7 13.7 13.0 7.9 24.4 20.3 17.9 21.0 21.0 9.8 18.2 11.0 19.3 13.3 16.3 26.3 23.4 21.3 12.9 12.3 19.7 16.3 15.6 12.7 13.8 7.4 36.9 18.2 35.8 17.2 13.7 15.7 20.2 6.0 19.7 26.2 20.2 15.9 17.0 11.1 18.4 13.5 18.4 13.9 15.3 13.4 27.4 27.6 7.1 9.8 21.8 24.6 2.1 12.2 9.9 2.4 6.5 3.4 0.7 6.8 6.0 14.9 16.7 4.5 4.2 21.3 7.2 5.9 2.0 2.7 2.8 11.3 2.4 5.3 6.1 5.8 10.7 2.5 5.3 1.7 11.4 8.8 3.0 5.9 3.8 5.9 0.8 13.8 5.6 4.2 3.6 3.2 16.3 2.7 5.0 4.5 27.4 2.6 18.7 9.2 6.4 6.7 2.9 31.3 1.9 4.2 5.6 7.1 10.1 11.6 16.8 10.2 10.7 17.8 4.2 7.4 1.5 4.7 9.5 9.3 3.1 4.6 10.6 11.3 4.1 14.7 2.1 11.8 1.5 1.6 1.4 3.4 2.2 3.2 1.7 3.0 3.1 1.4 2.1 2.5 2.6 9.9 6.5 2.4 12.2 2.9 0.7 12.7 13.0 20.3 14.1 12.9 12.3 13.8 7.4 15.7 13.4 20.8 14.7 25.3 28.2 65.5 56.8 14.7 38.2 8.1 9.1 61.1 27.5 17.1 31.5 19.5 1.2 24.8 5.6 0.0 16.4 44.6 44.5 25.7 25.5 42.3 28.3 9.5 45.8 48.5 47.9 2.7 27.9 17.0 33.7 0.0 13.5 45.5 16.0 3.5 32.2 19.3 10.0 38.8 33.3 1.7 28.8 44.3 38.4 25.5 11.9 17.6 IRF8 "ICSBP, ICSBP1, IRF-8" ENSG00000140968 "Interferon regulatory factor 8" Q02556 16 85898803-85922609 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Autophagy, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 197.4;lymphoid tissue: 64.4" "Cell type enhanced" "Detected in many" 13 "B-cells: 159.1;Hofbauer cells: 61.3;Kupffer cells: 76.1;Macrophages: 82.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 197.4" "Lineage enriched" "Detected in many" 6 "dendritic cells: 197.4" "Cell line enhanced" "Detected in some" "Daudi: 35.6;THP-1: 60.1;U-698: 140.9;U-937: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002267, HPA002531, CAB013480" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904" "unprognostic (2.09e-3)" "unprognostic (7.51e-2)" "unprognostic (5.16e-2)" "unprognostic (1.19e-1)" "unprognostic (7.54e-2)" "unprognostic (3.46e-3)" "unprognostic (3.19e-2)" "unprognostic (5.31e-3)" "unprognostic (1.23e-1)" "unprognostic (1.20e-1)" "unprognostic (1.66e-1)" "unprognostic (5.31e-2)" "unprognostic (3.14e-3)" "unprognostic (3.97e-2)" "unprognostic (9.66e-3)" "unprognostic (4.04e-1)" "unprognostic (1.10e-2)" 12.4 4.0 6.8 36.1 8.8 19.2 6.7 2.6 5.3 2.3 7.8 8.3 6.8 12.3 2.3 3.0 3.7 2.9 5.6 2.9 5.8 3.3 5.6 9.9 11.7 60.4 9.3 3.1 2.1 3.1 0.2 2.2 2.7 6.7 3.3 10.0 2.2 6.1 8.9 1.5 2.6 36.4 3.6 10.9 64.4 6.5 2.2 8.8 18.4 3.6 2.3 63.3 8.3 2.1 31.8 197.4 0.7 10.8 8.9 0.3 9.8 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 3.8 0.0 35.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 3.2 0.0 1.1 0.1 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 60.1 0.0 0.0 1.6 0.0 0.1 0.0 0.0 140.9 0.0 19.9 0.0 0.5 10.7 0.2 0.2 10.8 0.3 29.3 0.1 0.1 23.7 31.8 0.3 0.2 0.7 8.9 7.2 197.4 0.0 9.8 6.8 8.8 2.6 5.3 5.8 3.3 9.3 3.1 6.7 8.8 0.0 6.2 159.1 1.1 9.3 0.0 1.2 2.5 0.0 2.3 0.0 0.0 0.5 1.7 0.4 1.4 3.9 16.1 0.0 1.2 4.7 6.4 0.9 2.3 5.6 61.3 0.0 27.5 3.1 76.1 3.7 0.3 82.3 42.2 7.2 5.8 0.4 0.2 11.9 0.0 2.2 0.0 6.5 4.4 0.5 5.5 8.2 0.9 13.8 19.3 2.5 ITCH AIP4 ENSG00000078747 "Itchy E3 ubiquitin protein ligase" Q96J02 20 34363235-34511393 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021126, HPA049032, CAB072824, CAB072825" Supported Enhanced Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: AB_2680607" "unprognostic (2.51e-1)" "unprognostic (6.95e-2)" "unprognostic (1.25e-3)" "unprognostic (3.22e-2)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (2.78e-1)" "unprognostic (9.29e-3)" "unprognostic (1.94e-1)" "unprognostic (3.89e-3)" "unprognostic (1.28e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (1.30e-1)" "unprognostic (2.24e-1)" "unprognostic (3.23e-2)" "unprognostic (2.21e-1)" 20.7 16.7 18.9 15.4 26.9 20.5 17.5 19.8 26.7 23.9 18.2 37.9 15.2 16.9 18.4 15.1 35.9 14.5 14.5 17.9 20.4 15.9 21.1 46.5 18.5 16.8 29.2 16.5 19.3 17.1 21.6 26.3 26.9 29.0 17.5 20.4 16.7 20.1 18.4 24.0 19.2 20.3 19.8 30.4 17.3 17.3 34.8 32.3 22.3 22.7 13.0 23.6 19.6 21.0 7.3 11.4 19.6 6.2 6.2 11.4 2.7 20.2 13.4 13.7 9.8 15.1 21.6 16.4 16.5 18.9 20.7 20.2 37.6 31.3 9.9 16.0 21.0 28.2 25.7 20.8 33.3 25.2 7.4 6.7 28.8 11.4 22.5 15.8 11.8 13.0 11.0 17.0 17.4 27.4 18.7 15.5 14.4 16.3 17.2 16.1 10.1 17.2 6.2 6.6 12.5 15.9 14.5 28.9 22.9 12.3 35.3 8.4 6.1 30.8 12.1 18.5 14.1 14.5 10.7 15.0 24.7 14.8 16.1 12.2 13.7 14.3 14.5 15.3 7.6 14.4 3.6 5.8 6.1 10.8 6.2 11.4 7.3 3.8 5.7 4.5 6.9 3.3 4.9 19.6 6.2 3.8 11.4 4.8 2.7 18.9 26.9 19.8 26.7 20.4 15.9 29.2 16.5 29.0 32.3 11.9 17.9 13.3 15.9 13.4 19.6 20.1 7.6 28.1 33.0 29.6 23.6 15.1 5.0 11.7 46.0 17.5 21.6 0.0 14.1 17.6 16.0 23.0 18.5 43.1 14.0 14.3 11.5 16.5 22.8 102.3 20.8 21.2 25.3 23.4 15.8 34.3 16.6 21.0 14.5 18.0 26.8 12.9 17.8 25.7 21.5 14.2 39.2 20.6 9.9 38.9 IWS1 "DKFZp761G0123, FLJ10006, FLJ14655, FLJ32319" ENSG00000163166 "IWS1, SUPT6H interacting protein" Q96ST2 2 127436207-127526886 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035719, HPA061866" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035719: AB_10669527, HPA061866: AB_2684628" "unprognostic (3.11e-2)" "unprognostic (1.31e-1)" "unprognostic (1.80e-2)" "unprognostic (3.07e-2)" "unprognostic (1.44e-1)" "unprognostic (1.17e-2)" "unprognostic (8.49e-2)" "unprognostic (1.05e-1)" "unprognostic (4.27e-2)" "unprognostic (2.25e-1)" "unprognostic (4.32e-2)" "unprognostic (9.96e-2)" "unprognostic (1.42e-2)" "unprognostic (1.50e-1)" "unprognostic (9.10e-2)" "unprognostic (9.01e-2)" "unprognostic (9.81e-2)" 18.6 16.5 21.7 24.5 30.8 25.4 22.9 32.7 25.3 19.6 18.6 23.6 19.1 21.2 21.7 23.1 19.6 18.3 17.8 30.8 24.3 21.4 18.9 27.0 19.1 24.2 32.4 21.8 16.7 18.8 26.8 30.6 35.6 24.9 21.1 22.6 13.4 19.9 19.1 40.5 17.2 20.1 21.0 27.9 23.4 18.4 20.3 32.3 31.4 18.8 24.8 25.2 19.1 23.0 15.7 13.6 18.3 16.4 15.0 13.2 9.2 21.9 15.0 30.3 19.7 23.3 19.4 31.7 32.1 22.0 29.9 25.2 35.0 16.9 20.7 17.0 25.6 22.8 18.1 29.0 25.1 35.7 21.4 19.7 29.0 21.7 38.8 27.4 32.6 24.1 19.0 19.3 31.6 28.6 15.9 25.4 26.1 30.5 16.4 28.3 20.4 32.2 26.7 40.5 18.3 20.2 29.2 23.8 19.0 30.0 26.8 23.7 15.4 23.0 28.9 25.3 34.2 12.9 22.8 28.9 29.7 22.5 17.9 18.8 12.7 13.9 28.2 16.5 23.2 19.6 3.8 13.8 18.3 11.2 14.9 13.2 12.0 12.5 13.0 13.6 15.7 11.8 12.3 14.5 15.0 16.4 12.2 11.1 9.2 21.7 30.8 32.7 25.3 24.3 21.4 32.4 21.8 24.9 32.3 104.2 66.6 34.3 45.4 14.0 26.6 62.9 25.5 52.2 72.8 15.7 25.5 33.4 16.6 32.9 6.5 24.3 27.5 0.0 22.1 44.1 25.5 45.0 39.5 22.2 23.7 20.6 27.0 20.3 16.5 6.2 36.2 28.8 10.1 35.1 19.7 28.4 33.6 21.5 29.7 17.7 43.7 32.3 38.3 56.6 54.1 14.9 77.6 32.4 22.5 80.0 JADE2 "JADE-2, KIAA0239, PHF15" ENSG00000043143 "Jade family PHD finger 2" Q9NQC1 5 134524312-134583230 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025959, HPA055789" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA025959: AB_1855289, HPA055789: AB_2682922" "unprognostic (8.98e-2)" "unprognostic (1.38e-1)" "unprognostic (1.10e-2)" "unprognostic (1.29e-1)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (7.69e-2)" "unprognostic (5.56e-2)" "unprognostic (8.25e-2)" "prognostic unfavorable (4.42e-4)" "unprognostic (1.58e-2)" "unprognostic (3.49e-2)" "prognostic favorable (5.36e-6)" "unprognostic (3.73e-1)" "unprognostic (1.76e-3)" "unprognostic (2.68e-1)" "unprognostic (2.87e-2)" 15.6 19.8 16.7 16.1 22.0 9.7 13.9 22.8 21.7 16.0 13.4 15.3 9.2 12.7 13.9 8.4 11.8 20.6 13.2 13.4 17.8 14.5 14.8 4.7 15.0 25.8 30.8 16.0 28.4 14.0 30.9 14.4 8.5 20.1 12.8 8.2 16.4 15.0 16.9 12.0 11.5 17.8 13.0 16.8 22.9 12.9 8.1 30.8 13.0 20.6 6.0 19.2 20.0 22.7 7.3 2.0 6.8 3.0 3.1 6.2 2.4 28.7 20.5 0.6 0.8 7.2 8.7 9.4 5.2 13.7 9.6 11.3 15.6 22.4 31.7 11.6 6.7 9.7 6.1 3.6 27.5 4.8 19.1 1.4 7.4 14.3 4.2 7.2 8.1 1.1 5.8 13.3 11.7 14.8 7.6 7.2 9.5 4.6 11.9 5.8 10.3 14.0 7.3 6.8 8.8 10.7 12.6 0.6 12.4 9.0 8.0 4.4 2.9 12.8 0.4 18.4 5.8 5.6 10.1 10.1 6.8 6.1 19.1 12.9 5.5 23.0 29.3 10.5 14.6 9.5 6.8 1.2 4.4 6.2 1.1 6.0 7.3 5.7 5.6 2.0 5.5 5.6 5.6 1.3 3.1 3.0 1.2 5.8 2.4 16.7 22.0 22.8 21.7 17.8 14.5 30.8 16.0 20.1 30.8 8.9 9.1 20.8 6.1 3.8 21.4 10.1 10.2 6.7 4.5 7.0 33.4 6.4 6.6 4.6 0.2 9.2 8.4 0.0 14.6 8.4 8.1 4.3 2.3 3.0 4.0 9.5 11.1 15.4 30.1 0.0 19.0 8.0 1.7 22.6 9.7 6.0 8.8 3.5 18.0 9.1 21.8 0.0 10.8 0.2 1.5 3.1 6.1 20.2 11.9 3.4 JPH1 JP-1 ENSG00000104369 "Junctophilin 1" Q9HDC5 8 74234700-74321328 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 97.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 35.7;Basal glandular cells: 27.1;Cardiomyocytes: 31.6;Glandular cells: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 10.1;OE19: 12.1;SK-BR-3: 24.2;T-47d: 17.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008996, HPA009413, CAB013461" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163" "unprognostic (2.91e-3)" "unprognostic (3.01e-1)" "unprognostic (8.85e-2)" "unprognostic (8.73e-6)" "unprognostic (2.07e-1)" "unprognostic (1.86e-1)" "unprognostic (3.63e-2)" "prognostic favorable (5.77e-5)" "unprognostic (8.97e-2)" "unprognostic (1.30e-1)" "unprognostic (2.38e-1)" "unprognostic (5.99e-2)" "unprognostic (9.80e-2)" "unprognostic (6.87e-2)" "unprognostic (3.03e-1)" "unprognostic (4.88e-2)" "unprognostic (1.08e-2)" 1.7 0.6 1.8 0.7 5.7 0.5 0.8 13.7 3.1 0.8 1.9 0.8 0.4 0.8 1.5 1.7 1.8 0.6 0.6 3.3 2.1 0.7 0.8 0.5 2.2 0.5 1.0 4.2 0.5 3.5 1.1 0.4 1.1 2.4 1.8 2.8 0.0 1.3 0.8 97.2 0.7 0.9 1.4 2.4 0.5 0.9 0.9 2.3 2.4 1.2 21.5 1.4 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.4 0.1 3.1 0.0 1.0 0.0 0.7 4.5 3.9 3.1 1.0 0.0 5.9 0.0 3.6 0.0 0.5 2.0 0.2 0.6 2.6 0.0 2.9 0.0 0.0 7.8 0.5 0.0 0.2 2.8 10.1 0.0 6.8 12.1 2.0 5.1 3.9 0.0 0.1 9.0 5.2 0.7 0.0 24.2 1.2 1.2 17.2 0.1 0.0 1.2 1.7 0.4 1.0 0.0 0.0 0.0 2.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 5.7 13.7 3.1 2.1 0.7 1.0 4.2 2.4 2.3 35.7 8.0 0.0 27.1 2.5 0.0 31.6 0.0 8.1 15.9 1.8 5.9 0.0 0.0 0.2 2.1 0.4 1.3 0.0 1.2 0.0 2.1 24.9 0.0 0.0 0.1 0.0 12.1 0.0 0.0 0.4 0.9 0.2 1.7 0.0 10.1 0.2 3.4 8.0 0.0 0.7 0.0 0.0 2.3 0.1 3.6 1.8 0.0 0.0 5.6 16.6 JUN "AP-1, c-Jun" ENSG00000177606 "Jun proto-oncogene, AP-1 transcription factor subunit" P05412 1 58780788-58784327 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 71.6" "Low region specificity" "Detected in all" "CAB003801, CAB007780, HPA031174, HPA059474" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "CAB003801: AB_365485, CAB007780: AB_562268, HPA031174: , HPA059474: AB_2684030" "unprognostic (2.06e-2)" "unprognostic (1.76e-2)" "unprognostic (1.34e-1)" "unprognostic (7.85e-2)" "unprognostic (1.60e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" "unprognostic (5.21e-2)" "unprognostic (1.24e-1)" "unprognostic (5.00e-2)" "unprognostic (2.14e-1)" "unprognostic (2.82e-1)" "unprognostic (5.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.83e-1)" "unprognostic (2.37e-1)" "unprognostic (2.81e-3)" 64.5 29.4 26.7 33.7 17.2 68.4 61.7 19.5 20.6 60.0 32.7 30.8 28.4 13.3 40.5 21.8 34.1 72.6 48.5 31.3 20.2 12.4 21.2 39.3 55.1 14.3 15.3 12.0 49.8 48.7 15.0 16.7 21.6 24.1 48.6 16.7 40.5 59.4 39.3 32.2 51.3 28.6 40.7 17.6 22.9 47.0 18.2 18.1 9.0 61.0 35.2 23.3 41.5 33.1 7.4 1.3 4.0 5.1 3.2 2.5 1.2 16.1 2.3 5.2 1.0 8.3 9.5 0.1 20.6 7.5 14.6 8.9 4.2 1.2 0.6 9.9 12.8 31.6 5.6 0.4 6.7 9.3 12.8 37.5 0.2 0.9 4.7 6.9 1.1 3.7 10.2 17.3 18.8 7.9 6.6 10.9 0.7 5.7 9.4 5.6 3.0 1.0 9.0 4.2 7.8 14.7 0.4 71.6 3.2 13.7 1.5 14.5 4.2 14.3 15.0 6.0 5.9 5.3 0.6 19.1 33.3 15.1 12.0 25.8 20.9 3.3 1.2 34.8 2.1 9.5 1.2 5.1 2.0 2.4 1.1 1.3 4.1 1.2 2.5 1.3 7.4 0.3 1.7 4.0 3.2 0.4 0.2 0.9 1.2 26.7 17.2 19.5 20.6 20.2 12.4 15.3 12.0 24.1 18.1 500.2 627.8 505.0 717.3 1097.5 107.5 1349.5 494.3 76.3 282.1 99.5 247.4 529.1 43.1 569.2 40.2 960.8 1411.6 46.7 449.9 86.5 867.7 1920.0 529.9 118.4 560.4 82.6 1440.1 352.4 430.2 18.1 1136.5 481.3 718.7 237.2 1907.1 688.6 543.7 1520.1 243.3 25.0 400.6 1513.4 1714.3 15.6 13.8 843.0 347.6 518.9 938.7 449.9 KAT2B "GCN5, GCN5L, P/CAF, PCAF" ENSG00000114166 "Lysine acetyltransferase 2B" Q92831 3 20040023-20154404 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002470, CAB004526, HPA055839, HPA073897" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: " "unprognostic (2.91e-2)" "unprognostic (6.85e-3)" "unprognostic (9.05e-2)" "unprognostic (2.25e-1)" "unprognostic (2.66e-2)" "unprognostic (3.01e-3)" "unprognostic (2.44e-1)" "unprognostic (3.83e-3)" "unprognostic (2.44e-2)" "unprognostic (1.03e-1)" "unprognostic (5.23e-3)" "unprognostic (7.13e-2)" "unprognostic (7.03e-2)" "unprognostic (2.26e-2)" "unprognostic (1.59e-1)" "unprognostic (5.16e-2)" "unprognostic (4.63e-2)" 10.6 6.6 30.1 9.4 27.5 24.9 6.8 22.0 20.1 10.2 9.4 27.6 7.9 10.9 7.8 5.4 17.3 7.7 8.0 21.9 24.7 18.0 10.8 24.0 10.1 12.7 26.8 15.9 18.2 11.6 38.1 8.7 8.5 24.2 9.5 8.1 10.7 20.9 9.2 33.4 8.9 13.0 8.7 21.4 11.7 9.0 1.8 31.1 8.7 10.0 7.4 12.0 8.7 11.0 2.1 2.7 5.5 1.5 1.1 4.8 0.8 1.5 4.0 2.2 3.6 9.1 8.6 5.2 5.1 7.6 5.4 7.9 1.2 2.6 13.7 2.1 9.6 6.8 1.1 5.5 1.6 4.5 12.4 5.2 12.0 6.3 0.4 4.3 1.8 15.6 3.7 3.0 4.7 3.0 9.5 5.1 3.4 7.7 19.4 7.6 1.9 3.9 3.6 0.9 3.8 3.9 5.1 4.2 2.9 7.3 8.1 1.1 2.4 2.8 4.6 17.3 3.6 4.8 8.1 4.9 9.1 3.7 3.4 5.8 7.4 15.4 3.3 8.3 7.9 19.2 1.3 1.1 2.8 3.6 1.5 3.4 1.0 3.1 2.5 0.9 2.1 1.1 2.1 5.5 1.1 1.1 2.7 4.8 0.8 30.1 27.5 22.0 20.1 24.7 18.0 26.8 15.9 24.2 31.1 29.8 17.3 4.7 10.0 7.6 11.9 56.5 2.5 17.4 14.8 5.2 3.9 5.4 10.0 2.8 2.3 10.5 13.6 23.3 3.8 1.1 9.3 10.0 10.4 26.1 6.5 14.3 11.1 18.4 21.9 1.3 6.1 15.7 16.9 5.4 5.7 12.6 3.7 0.0 4.9 5.3 11.2 6.5 9.9 0.9 0.9 11.3 8.2 13.8 3.1 7.1 KDM3A "JHMD2A, JMJD1, JMJD1A, KIAA0742, TSGA" ENSG00000115548 "Lysine demethylase 3A" Q9Y4C1 2 86440647-86492716 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055543, HPA065162" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055543: AB_2682842, HPA065162: AB_2685424" "unprognostic (1.97e-2)" "unprognostic (3.03e-3)" "unprognostic (1.32e-2)" "unprognostic (4.04e-2)" "unprognostic (5.06e-2)" "unprognostic (5.24e-2)" "prognostic unfavorable (2.15e-6)" "unprognostic (2.01e-1)" "unprognostic (3.35e-3)" "unprognostic (9.50e-3)" "unprognostic (4.44e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (2.17e-1)" "unprognostic (2.24e-1)" "unprognostic (1.24e-1)" "unprognostic (2.66e-2)" 21.5 12.5 21.5 14.6 27.2 52.9 18.5 17.2 18.7 18.9 25.9 19.6 17.3 17.0 21.2 24.8 20.3 16.8 14.7 21.3 22.7 11.4 13.2 11.9 17.2 14.8 17.8 15.2 20.6 15.7 16.3 20.3 19.5 17.8 19.7 14.9 14.6 19.2 19.1 20.7 34.7 19.1 21.0 22.1 15.7 14.5 42.9 23.6 30.1 18.6 12.8 17.3 29.0 22.1 4.8 4.9 14.4 3.4 4.9 9.1 4.1 18.4 7.4 17.6 4.6 9.1 9.3 16.5 9.0 8.9 8.5 10.5 9.4 7.9 10.8 17.1 7.5 17.5 11.8 13.1 9.0 16.6 14.5 10.9 17.4 6.8 13.3 6.8 13.8 11.1 10.2 13.7 7.6 14.1 29.3 10.4 10.2 11.1 17.8 8.9 4.7 19.2 19.4 15.8 11.1 11.3 13.1 23.8 23.3 7.6 10.5 13.7 14.5 11.9 8.6 16.4 16.2 5.0 9.1 11.6 17.3 7.2 17.8 10.2 18.6 17.5 16.1 21.9 14.4 21.1 11.9 3.2 5.9 7.6 3.4 8.0 4.8 8.4 7.3 4.9 4.1 9.1 7.8 14.4 4.9 2.3 4.4 8.6 4.1 21.5 27.2 17.2 18.7 22.7 11.4 17.8 15.2 17.8 23.6 32.8 13.4 6.9 20.9 27.1 22.7 22.6 10.2 36.1 23.9 5.2 49.1 3.7 0.0 12.1 58.0 19.8 15.9 23.3 8.6 5.9 16.9 16.0 37.0 6.8 9.0 52.4 15.0 14.7 11.3 20.1 16.1 15.1 20.3 5.4 11.4 35.1 10.0 9.7 16.3 4.2 33.6 6.5 14.4 32.1 10.2 35.0 9.7 17.0 9.3 11.7 KDM3B "C5orf7, JMJD1B, KIAA1082, NET22" ENSG00000120733 "Lysine demethylase 3B" Q7LBC6 5 138352596-138437028 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016610, HPA057202" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA016610: AB_1852004, HPA057202: AB_2683367" "unprognostic (1.21e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-3)" "unprognostic (1.34e-1)" "unprognostic (6.72e-2)" "unprognostic (1.72e-1)" "unprognostic (5.21e-2)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (4.68e-2)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "prognostic favorable (6.67e-4)" "unprognostic (1.73e-1)" "unprognostic (3.05e-1)" "unprognostic (1.43e-1)" "unprognostic (7.60e-2)" 13.5 12.8 10.0 10.9 12.6 12.2 14.9 20.2 14.9 14.0 14.2 18.4 13.5 9.9 20.0 18.0 13.0 14.7 12.5 11.8 14.7 8.6 12.8 8.4 11.4 11.5 12.0 9.6 19.8 17.4 27.9 15.1 11.7 11.3 13.6 14.4 18.5 16.3 16.3 29.6 16.5 14.0 21.5 10.7 13.3 12.6 10.4 12.2 25.2 16.1 9.0 16.4 21.9 19.4 4.1 5.1 9.3 4.6 7.4 5.7 2.2 10.6 15.0 28.3 25.9 13.1 10.9 21.9 7.4 12.0 13.2 14.8 16.7 11.8 21.3 13.4 14.0 18.1 11.0 23.0 16.5 15.1 14.0 14.1 18.3 13.3 12.6 11.7 14.7 20.0 13.0 18.0 10.2 12.2 10.4 15.7 12.4 14.3 11.4 15.8 13.7 19.2 18.2 14.0 14.5 6.2 23.4 21.8 13.9 18.9 14.8 15.0 16.4 12.6 12.4 10.9 43.9 11.8 18.6 15.1 7.9 8.2 8.3 12.8 15.8 7.5 18.9 5.2 20.8 11.2 0.3 4.6 6.5 4.2 3.6 5.7 4.1 5.0 5.2 4.1 3.9 4.4 4.2 9.3 7.4 3.6 5.1 2.8 2.2 10.0 12.6 20.2 14.9 14.7 8.6 12.0 9.6 11.3 12.2 14.9 14.9 8.8 12.1 14.2 19.4 29.7 25.5 10.7 13.6 21.0 27.5 10.5 0.0 12.9 5.9 12.7 15.8 0.0 14.4 8.0 12.8 16.3 12.7 18.3 15.1 22.3 20.2 17.8 45.4 2.2 19.5 16.7 15.1 17.2 28.8 20.6 16.4 26.8 21.5 12.6 29.9 25.8 12.7 12.3 13.9 18.9 9.2 11.4 23.0 17.3 KDM5C "DXS1272E, JARID1C, MRX13, SMCX, XE169" ENSG00000126012 "Lysine demethylase 5C" P41229 X 53191321-53225422 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038244, HPA046147" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038244: AB_2675911, HPA046147: AB_2679555" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (1.56e-2)" "unprognostic (7.10e-2)" "unprognostic (9.75e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.08e-2)" "unprognostic (2.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.45e-2)" "unprognostic (1.58e-2)" "unprognostic (5.05e-3)" "unprognostic (1.96e-2)" "unprognostic (6.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.00e-1)" 19.5 22.9 22.4 22.6 24.7 26.3 17.9 43.0 31.7 25.9 19.5 23.4 16.7 22.2 29.2 13.3 26.9 24.8 15.2 17.6 21.6 15.3 17.0 18.8 20.6 25.8 24.6 21.8 33.1 22.5 37.7 31.8 34.0 22.8 18.7 13.5 17.0 25.6 17.1 36.6 28.4 22.2 23.6 16.0 25.0 19.4 10.6 26.2 29.0 22.2 11.3 24.5 21.5 26.4 4.5 4.3 4.8 4.0 2.8 6.1 3.8 16.9 23.1 24.8 19.0 17.2 15.7 17.6 10.6 12.4 14.4 13.4 15.6 11.1 15.8 13.8 13.9 40.6 15.2 28.0 22.7 11.0 11.8 41.4 15.3 24.7 11.0 21.2 18.1 30.6 12.4 16.7 28.1 34.7 20.6 21.2 13.2 29.7 10.5 10.5 21.7 13.2 20.4 21.0 8.8 21.7 15.0 14.8 17.1 9.1 16.3 18.7 24.1 32.2 29.9 12.1 23.8 20.9 16.0 14.5 16.1 13.9 14.4 10.3 15.3 12.4 12.0 20.9 21.5 11.9 3.0 3.8 2.7 6.1 3.6 5.1 4.5 3.7 5.7 3.1 3.2 4.5 2.9 4.8 2.8 4.0 4.3 4.3 3.8 22.4 24.7 43.0 31.7 21.6 15.3 24.6 21.8 22.8 26.2 11.9 12.2 11.9 9.7 10.8 25.0 7.7 17.8 12.0 12.5 7.0 23.6 10.6 3.3 13.4 0.6 14.3 21.7 0.0 18.7 11.4 11.3 12.4 12.7 19.8 12.4 23.8 30.0 18.4 14.6 1.7 13.6 9.4 13.5 10.0 27.8 10.9 20.8 24.6 14.9 4.2 16.1 0.0 10.3 7.0 14.6 13.9 17.4 10.2 15.6 15.9 KHDRBS1 "FLJ34027, p62, Sam68" ENSG00000121774 "KH RNA binding domain containing, signal transduction associated 1" Q07666 1 32013829-32060850 "Predicted intracellular proteins" "Cell cycle, mRNA processing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005355, HPA051280, HPA056813" Supported Enhanced Nucleoplasm NA NA 20000 Nucleoplasm "CAB005355: AB_631869, HPA051280: AB_2681417, HPA056813: AB_2683240" "unprognostic (1.31e-1)" "unprognostic (3.01e-2)" "unprognostic (1.22e-2)" "unprognostic (1.55e-1)" "unprognostic (2.09e-1)" "unprognostic (6.55e-2)" "prognostic unfavorable (3.68e-5)" "unprognostic (5.01e-2)" "unprognostic (2.51e-3)" "unprognostic (4.03e-2)" "unprognostic (2.17e-2)" "unprognostic (1.91e-3)" "prognostic unfavorable (9.32e-4)" "unprognostic (1.08e-1)" "unprognostic (1.45e-1)" "unprognostic (1.26e-1)" "unprognostic (7.03e-2)" 34.5 31.7 31.1 49.7 34.2 42.0 35.9 56.6 41.5 42.0 38.8 35.1 30.1 33.3 51.5 37.8 37.0 39.5 51.2 34.9 29.7 30.1 30.0 30.9 38.3 52.5 27.3 35.9 63.2 31.3 40.4 29.5 33.9 25.9 36.5 31.7 32.2 31.1 35.5 39.0 30.6 32.4 44.2 31.4 36.0 31.0 42.7 23.7 69.9 35.1 41.0 50.0 40.2 34.4 11.4 10.2 6.4 10.2 8.2 14.4 3.5 44.4 27.1 62.1 45.6 21.6 27.2 36.5 27.0 34.4 50.8 42.9 30.1 40.0 66.7 30.3 34.1 29.5 31.2 50.0 37.0 52.1 39.7 42.7 42.0 26.7 41.0 28.5 55.6 28.3 29.8 21.2 38.6 30.7 33.4 47.9 41.1 54.1 30.6 38.9 29.0 81.8 47.6 63.0 28.1 32.6 65.7 52.6 56.3 35.4 45.2 42.5 55.6 39.3 33.7 33.9 46.2 40.1 40.5 35.9 33.1 35.9 35.3 45.1 32.2 34.8 65.6 34.4 44.5 25.2 4.6 6.7 6.4 9.6 10.2 14.4 11.4 11.5 9.9 9.0 9.3 12.5 11.8 5.9 8.2 8.2 10.2 10.3 3.5 31.1 34.2 56.6 41.5 29.7 30.1 27.3 35.9 25.9 23.7 35.7 61.9 121.1 181.3 131.1 88.3 92.4 79.0 108.4 116.0 66.3 47.1 161.4 71.3 89.2 18.7 98.3 69.3 23.3 88.7 198.7 113.7 105.9 126.8 57.1 105.8 60.4 113.1 87.8 125.1 11.5 102.9 123.6 102.9 84.8 92.4 126.7 86.6 57.5 116.7 98.2 71.0 90.5 113.7 152.3 117.7 114.2 145.1 101.2 124.2 156.2 KHSRP "FBP2, FUBP2, KSRP" ENSG00000088247 "KH-type splicing regulatory protein" Q92945 19 6413348-6424794 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034739, HPA056518" Supported Enhanced Nucleoplasm NA NA 740000 Nucleoplasm "HPA034739: AB_10601582, HPA056518: AB_2683162" "unprognostic (2.16e-1)" "unprognostic (3.98e-2)" "unprognostic (2.41e-1)" "unprognostic (4.27e-1)" "unprognostic (4.57e-2)" "unprognostic (1.77e-2)" "unprognostic (2.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.25e-1)" "unprognostic (7.12e-2)" "unprognostic (1.74e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.45e-2)" "unprognostic (1.50e-1)" "unprognostic (9.38e-2)" "unprognostic (2.84e-2)" 40.3 34.3 31.4 34.5 37.2 49.9 27.6 53.8 54.2 38.9 35.6 51.4 23.9 49.5 48.0 27.5 41.5 39.2 33.3 27.4 31.3 27.7 31.0 49.2 27.0 39.3 31.7 29.8 51.0 45.3 18.4 31.4 43.4 28.1 35.0 25.6 39.2 44.4 35.9 43.7 41.8 44.8 30.3 30.3 37.9 36.1 56.3 29.2 73.9 37.8 35.0 33.4 37.7 33.7 8.9 11.5 4.9 7.6 3.1 6.3 3.5 72.0 36.3 34.7 33.7 15.1 16.5 60.4 29.7 19.6 35.2 36.3 73.6 19.7 71.5 46.5 17.2 21.1 39.0 39.5 28.0 28.1 0.3 74.1 46.1 22.5 50.9 26.4 51.6 44.5 21.3 12.7 28.9 23.7 14.6 27.3 33.0 85.6 30.3 21.2 46.0 63.3 51.0 67.5 17.9 51.3 66.9 34.0 45.8 16.3 37.1 41.1 45.5 36.5 25.4 32.2 24.2 30.3 48.2 29.7 28.9 36.2 61.1 58.2 60.6 47.1 54.6 25.4 73.5 33.9 3.2 6.9 4.5 5.7 7.6 6.0 5.9 6.0 6.3 6.4 8.9 4.2 4.5 4.9 3.1 6.3 11.5 4.1 3.5 31.4 37.2 53.8 54.2 31.3 27.7 31.7 29.8 28.1 29.2 8.9 20.3 40.4 19.2 52.2 42.6 12.6 40.8 12.0 25.0 29.6 47.1 31.6 5.0 24.6 57.0 30.1 34.2 23.3 26.5 36.8 31.4 26.2 18.4 39.5 33.0 47.7 55.3 38.1 29.9 19.6 46.9 22.9 25.3 16.2 44.5 35.1 29.9 24.6 43.5 20.3 58.4 25.8 22.3 68.6 52.6 63.2 33.4 16.0 55.7 28.8 KIAA1143 ENSG00000163807 KIAA1143 Q96AT1 3 44737661-44761662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 149.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045018, HPA061799" Approved Enhanced "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA045018: AB_10964578, HPA061799: AB_2684614" "unprognostic (1.31e-1)" "unprognostic (2.74e-1)" "prognostic favorable (3.65e-4)" "unprognostic (2.25e-1)" "unprognostic (6.00e-2)" "unprognostic (3.01e-3)" "unprognostic (2.23e-3)" "unprognostic (6.17e-2)" "unprognostic (6.42e-2)" "unprognostic (1.57e-3)" "unprognostic (3.71e-1)" "unprognostic (4.08e-2)" "prognostic favorable (3.26e-6)" "unprognostic (1.82e-1)" "unprognostic (1.85e-1)" "unprognostic (3.19e-2)" "unprognostic (6.46e-2)" 21.7 14.6 19.8 13.2 16.9 9.0 18.8 17.2 21.7 18.9 15.7 13.6 11.9 10.4 19.9 13.3 17.9 16.5 12.8 22.0 19.9 17.9 16.2 11.4 13.6 13.8 21.4 12.7 26.0 16.2 22.2 15.2 14.5 18.8 20.9 12.2 9.1 13.3 15.3 28.9 16.0 14.2 17.9 21.7 16.7 12.7 9.4 16.7 25.0 19.4 16.5 15.8 23.3 17.8 6.6 5.5 9.5 8.7 7.6 7.4 4.5 6.6 4.3 12.4 8.6 8.4 13.2 6.2 7.7 10.8 9.9 10.1 4.4 5.9 16.4 5.9 8.0 4.7 4.7 14.5 8.1 13.1 9.0 4.9 11.9 8.1 5.3 5.8 14.9 8.4 9.4 9.9 10.1 9.6 11.0 8.2 10.2 16.8 9.0 9.6 3.8 16.5 10.5 11.6 7.1 5.6 6.8 11.8 9.2 6.3 5.7 6.2 10.6 8.9 7.0 6.1 8.6 11.6 12.8 9.4 5.5 5.0 14.4 8.7 5.8 16.5 10.0 10.2 14.5 8.0 5.3 5.7 9.5 7.4 6.3 6.5 6.6 6.4 5.9 5.5 6.3 6.8 6.2 5.7 7.6 8.7 3.7 5.3 4.5 19.8 16.9 17.2 21.7 19.9 17.9 21.4 12.7 18.8 16.7 35.7 29.6 39.6 25.1 30.7 17.4 23.8 30.6 32.1 45.5 22.7 7.9 37.2 58.0 37.7 149.2 31.5 17.6 0.0 53.7 48.7 27.7 35.1 37.0 22.9 30.8 14.3 15.0 30.7 39.1 61.4 34.8 35.6 13.5 26.2 22.9 41.7 40.6 23.5 46.3 29.3 12.2 0.0 25.5 46.8 40.9 24.3 47.8 34.8 24.1 36.6 KIF20A RAB6KIFL ENSG00000112984 "Kinesin family member 20A" O95235 5 138178719-138187715 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.7;testis: 18.2" "Cell type enhanced" "Detected in some" 23 "Erythroid cells: 46.7;Extravillous trophoblasts: 10.5;Spermatocytes: 17.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "NK-cell: 10.0;T-reg: 3.2" "Group enriched" "Detected in many" 64 "NK-cells: 10.0;T-cells: 3.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA036909, HPA036910" Approved Enhanced "Nucleoplasm,Cytokinetic bridge,Cleavage furrow" Yes Yes "Nucleoplasm, Cleavage furrow" "Cytokinetic bridge" "HPA036909: AB_10670245, HPA036910: AB_10671716" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (1.39e-3)" "unprognostic (1.21e-2)" "unprognostic (3.47e-2)" "unprognostic (2.60e-2)" "prognostic unfavorable (2.14e-12)" "prognostic unfavorable (6.79e-4)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (9.73e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (9.05e-2)" "unprognostic (2.61e-1)" "unprognostic (1.09e-1)" "unprognostic (3.16e-1)" 2.3 1.7 0.3 3.6 0.4 10.4 0.7 0.3 0.7 1.7 2.7 0.4 0.3 2.7 1.6 2.2 10.7 0.3 0.3 0.8 0.3 0.3 1.2 1.2 2.3 6.7 0.6 0.4 0.8 0.5 0.0 0.3 6.6 0.5 1.0 4.2 0.4 2.0 0.3 0.5 3.5 2.7 4.4 0.5 3.8 2.1 18.2 0.3 47.7 0.5 6.1 11.7 1.8 3.0 0.1 0.0 0.0 0.0 10.0 3.2 0.4 22.2 15.0 33.2 22.0 1.7 3.3 14.3 19.3 17.7 42.1 31.8 28.2 20.8 9.6 10.4 24.3 15.8 22.1 31.1 36.1 42.2 14.0 14.7 14.2 26.8 17.9 0.1 6.9 6.6 1.2 0.6 22.4 12.9 7.1 27.2 13.7 5.9 18.4 29.1 20.4 11.6 6.8 21.0 13.1 16.4 12.8 33.3 9.9 11.5 11.0 9.9 9.8 36.5 12.4 8.5 44.5 15.8 7.2 12.9 11.0 16.4 9.9 32.2 9.5 9.1 10.7 7.1 20.5 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 3.2 0.4 0.3 0.4 0.3 0.7 0.3 0.3 0.6 0.4 0.5 0.3 0.0 1.7 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.0 0.4 46.7 0.0 10.5 0.4 0.1 4.6 0.0 4.9 0.0 0.0 3.7 1.0 1.0 0.3 0.6 0.0 0.0 0.1 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 17.9 4.6 0.4 0.8 0.0 1.6 0.0 KIF23 "KNSL5, MKLP-1, MKLP1" ENSG00000137807 "Kinesin family member 23" Q02241 15 69414246-69448427 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.8;testis: 20.4" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 31.4;Spermatocytes: 47.9;Spermatogonia: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "eosinophil: 7.7" "Group enriched" "Detected in many" 12 "granulocytes: 7.7;monocytes: 2.2;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB010414, HPA045208, HPA068831" Uncertain Enhanced "Nucleoplasm,Midbody ring,Mitotic spindle" Yes Yes Nucleoplasm "Midbody ring, Mitotic spindle" "CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045" "unprognostic (1.29e-1)" "unprognostic (2.40e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.86e-1)" "unprognostic (7.99e-3)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.43e-3)" "unprognostic (4.25e-3)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (5.85e-3)" "unprognostic (0.00e+0)" "unprognostic (1.15e-2)" "unprognostic (2.59e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" 1.8 2.6 1.8 12.7 1.3 16.3 3.2 0.3 0.9 2.2 3.3 0.3 1.4 3.5 3.3 1.2 8.8 1.8 2.4 2.2 0.7 0.5 4.9 0.8 2.5 6.7 0.9 0.5 1.6 0.9 0.0 0.3 10.8 1.3 1.9 4.3 0.6 2.1 0.9 0.3 3.0 3.9 3.4 1.4 4.5 3.1 20.4 0.2 41.8 0.6 6.3 8.8 1.8 3.3 0.3 0.1 7.7 2.2 0.1 2.1 0.6 25.2 22.0 16.3 15.6 1.0 1.9 9.9 27.7 15.0 40.2 31.3 13.3 19.8 14.8 8.4 14.3 21.4 29.2 33.6 10.3 40.9 13.7 15.7 13.9 20.6 8.2 0.6 14.3 12.9 0.9 1.1 19.2 16.2 5.1 13.6 12.0 9.2 18.5 25.2 11.1 8.0 7.7 20.2 9.4 8.8 9.1 36.3 8.2 10.6 13.1 8.3 6.9 32.2 14.2 12.1 21.4 13.5 6.5 8.8 24.3 32.4 16.8 40.7 7.2 19.5 13.3 8.6 19.3 21.4 0.0 2.2 7.7 0.0 1.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.1 1.0 0.1 2.1 0.6 1.8 1.3 0.3 0.9 0.7 0.5 0.9 0.5 1.3 0.2 0.0 0.3 0.0 2.6 1.6 0.2 0.8 7.6 1.4 6.8 7.0 2.0 5.9 3.3 1.8 6.3 0.1 1.1 0.0 0.0 31.4 3.1 0.5 2.3 0.0 6.8 0.0 1.7 6.2 3.2 3.2 0.9 2.9 0.0 10.0 2.2 0.1 0.4 0.0 1.8 0.5 0.0 6.5 2.3 47.9 18.3 0.9 2.1 0.8 2.3 1.0 KIF2A "HK2, KIF2" ENSG00000068796 "Kinesin family member 2A" O00139 5 62306162-62537249 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Motor protein" "Cancer-related genes, Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004715, HPA004716" Approved Enhanced Nucleoplasm,Nucleoli,Centrosome Yes No 2100000 "Nucleoplasm, Nucleoli, Centrosome" "HPA004715: AB_2667215, HPA004716: AB_1079211" "unprognostic (2.40e-2)" "unprognostic (3.43e-1)" "prognostic favorable (1.70e-4)" "unprognostic (2.74e-2)" "unprognostic (1.43e-1)" "prognostic favorable (5.45e-4)" "prognostic unfavorable (3.17e-6)" "unprognostic (8.77e-3)" "unprognostic (4.69e-2)" "unprognostic (9.10e-2)" "unprognostic (1.85e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (3.81e-5)" "unprognostic (3.53e-2)" "unprognostic (2.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.58e-1)" 11.3 9.3 25.4 21.9 26.4 12.4 15.5 15.4 40.1 19.7 13.5 19.4 8.0 10.3 12.9 7.6 14.3 17.5 13.7 7.2 26.2 24.1 8.2 5.8 10.6 29.4 24.9 24.6 13.0 12.3 15.2 14.3 27.8 37.0 10.2 14.5 6.8 10.7 11.9 7.4 7.9 15.8 13.5 34.3 17.4 9.6 39.2 26.4 28.7 13.0 5.6 26.7 17.4 14.8 9.0 8.4 7.1 3.0 15.8 25.4 9.7 17.3 17.4 29.1 25.8 11.0 15.5 23.8 18.6 15.4 20.3 25.8 18.7 19.1 43.1 20.6 16.4 24.0 11.0 22.0 14.9 27.1 43.2 15.4 43.2 16.3 10.2 13.0 23.5 16.5 12.8 9.9 19.7 17.9 11.9 18.5 24.9 30.6 26.3 16.9 13.1 39.4 11.7 16.9 4.2 11.0 29.0 23.0 23.8 9.1 21.1 26.1 21.7 25.3 10.6 13.1 22.5 13.9 13.3 16.0 12.1 20.0 14.0 18.5 24.9 35.9 45.5 14.0 28.4 14.8 7.1 3.0 3.4 20.2 2.6 22.8 9.0 20.3 20.6 4.0 7.8 17.9 18.4 5.3 15.8 1.8 8.4 25.4 9.7 25.4 26.4 15.4 31.2 26.2 24.1 24.9 24.6 37.0 26.4 14.9 13.1 22.3 22.3 14.9 41.8 7.0 7.6 71.0 25.0 19.2 98.2 16.2 11.6 30.0 88.3 17.5 11.4 0.0 27.0 18.7 10.4 29.9 16.3 3.4 13.1 49.3 20.2 14.7 10.2 90.3 12.0 18.7 11.8 152.3 5.1 22.4 23.3 7.4 12.4 13.5 88.2 25.8 13.3 80.2 42.1 8.3 36.7 39.6 9.5 40.0 KIN "KIN17, Rts2" ENSG00000151657 "Kin17 DNA and RNA binding protein" O60870 10 7750962-7787981 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication, Host-virus interaction, mRNA processing, Stress response" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016339, HPA038700" Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016339: AB_627860, HPA038700: AB_2676159" "unprognostic (4.33e-3)" "unprognostic (1.24e-2)" "unprognostic (1.66e-2)" "unprognostic (1.40e-2)" "unprognostic (2.94e-2)" "unprognostic (1.31e-1)" "unprognostic (3.17e-3)" "unprognostic (1.30e-2)" "unprognostic (2.58e-1)" "unprognostic (5.59e-2)" "unprognostic (1.11e-1)" "unprognostic (5.40e-3)" "prognostic unfavorable (1.44e-7)" "unprognostic (3.98e-2)" "unprognostic (1.17e-1)" "unprognostic (4.65e-1)" "prognostic favorable (3.23e-5)" 8.5 8.6 9.0 8.2 9.7 9.4 9.0 19.8 11.9 9.5 7.0 10.2 9.1 7.8 11.3 9.9 6.5 8.1 7.2 8.6 7.5 7.8 10.1 12.9 7.4 10.4 9.7 8.2 10.8 10.2 7.7 15.5 10.0 10.6 10.0 7.7 8.4 8.4 8.6 9.1 11.5 10.0 9.1 9.0 10.8 8.1 6.9 9.7 13.6 11.1 7.7 9.7 8.8 8.3 7.0 6.9 13.8 5.1 5.9 5.0 1.8 6.9 4.4 6.8 4.3 5.6 6.8 5.5 6.2 2.8 7.5 8.1 8.5 7.0 5.4 3.3 3.8 2.3 6.7 5.7 3.8 8.7 6.1 6.6 8.5 4.5 8.1 8.0 3.0 6.9 5.6 4.3 5.7 3.8 6.3 5.6 6.9 8.4 5.2 5.8 6.2 6.0 4.7 6.6 7.2 2.7 7.7 4.9 4.9 6.3 3.9 3.0 6.4 4.9 5.0 9.9 6.8 9.1 6.1 4.0 4.9 5.5 8.6 5.0 6.8 7.3 6.7 6.2 4.7 3.3 13.8 4.8 8.0 4.7 5.1 4.7 6.5 4.2 3.9 3.6 7.0 4.8 5.0 10.8 5.9 4.6 6.9 3.4 1.8 9.0 9.7 19.8 11.9 7.5 7.8 9.7 8.2 10.6 9.7 32.8 25.6 13.0 13.7 15.3 52.4 11.1 22.9 30.8 18.2 17.4 37.3 31.0 11.6 26.4 4.2 24.1 15.8 23.3 18.7 21.8 20.6 11.9 15.1 12.4 27.3 60.4 22.3 24.5 18.0 4.3 25.6 22.4 15.1 19.0 17.1 29.5 18.4 20.1 29.0 14.6 53.1 12.9 17.6 28.6 16.7 12.5 32.2 25.4 13.3 13.3 KLF3 BKLF ENSG00000109787 "Kruppel like factor 3" P57682 4 38664196-38701042 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 244.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049512, HPA065054" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049512: AB_2680799, HPA065054: AB_2685415" "unprognostic (4.20e-1)" "unprognostic (2.08e-2)" "unprognostic (4.70e-3)" "unprognostic (3.77e-2)" "unprognostic (1.36e-1)" "unprognostic (3.02e-2)" "unprognostic (3.20e-2)" "unprognostic (2.33e-1)" "unprognostic (2.57e-2)" "unprognostic (2.15e-1)" "unprognostic (1.02e-3)" "unprognostic (4.10e-2)" "prognostic favorable (4.36e-4)" "unprognostic (9.01e-2)" "unprognostic (1.70e-1)" "unprognostic (1.99e-1)" "unprognostic (3.10e-3)" 23.0 14.3 11.1 14.7 14.4 41.7 25.6 8.9 13.7 20.2 31.2 21.7 10.4 21.0 20.0 14.1 51.9 14.6 39.3 12.0 11.9 8.1 13.2 25.2 21.4 16.6 16.2 8.2 36.1 18.6 21.6 11.4 20.4 13.8 19.0 27.6 12.4 24.0 17.6 12.5 43.1 40.3 18.7 16.7 22.3 25.6 7.9 18.2 6.5 16.4 25.7 34.9 26.1 28.3 4.0 3.1 14.3 10.9 2.7 9.4 2.1 9.5 6.6 25.0 5.0 11.5 17.2 7.9 5.3 15.5 3.6 4.5 6.2 17.7 0.0 7.5 11.5 10.4 10.5 7.1 9.3 5.8 0.1 5.2 9.1 9.7 13.0 11.8 2.2 0.0 15.5 25.8 5.2 9.7 6.8 13.8 3.6 25.9 4.5 5.7 2.2 2.4 4.0 5.8 19.8 4.8 3.2 12.1 10.4 12.8 23.1 7.2 9.3 5.8 4.6 11.1 10.5 2.8 3.2 21.8 12.0 6.8 20.3 5.7 6.3 2.0 0.0 4.9 6.9 5.1 8.8 4.0 14.3 6.3 6.9 4.3 3.7 7.0 5.6 3.1 4.0 9.4 5.6 12.8 2.7 10.9 0.7 7.2 2.1 11.1 14.4 8.9 13.7 11.9 8.1 16.2 8.2 13.8 18.2 20.8 25.6 15.7 113.6 107.8 41.2 15.3 63.7 21.4 23.9 29.6 29.5 23.5 10.0 75.6 0.6 80.0 132.1 140.2 75.2 17.8 67.1 127.0 19.6 48.4 47.0 33.4 83.1 51.0 71.6 1.9 48.1 51.1 47.2 34.3 132.6 51.1 83.4 132.3 45.3 18.4 36.2 25.8 29.9 0.7 0.9 194.5 22.9 35.8 87.7 244.9 KLHDC3 "dJ20C7.3, hPeas, PEAS" ENSG00000124702 "Kelch domain containing 3" Q9BQ90 6 43014103-43021298 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.7" "Group enriched" "Detected in all" 9 "Early spermatids: 436.9;Late spermatids: 1305.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030131, HPA030132, HPA030133, HPA030134" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350" "unprognostic (3.85e-2)" "prognostic favorable (9.15e-4)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.52e-4)" "unprognostic (9.97e-3)" "unprognostic (2.80e-1)" "unprognostic (2.09e-3)" "unprognostic (1.05e-2)" "unprognostic (5.09e-2)" "unprognostic (1.58e-3)" "prognostic favorable (9.08e-4)" "unprognostic (6.34e-2)" "unprognostic (2.88e-2)" "unprognostic (8.73e-2)" "unprognostic (9.78e-2)" "unprognostic (2.88e-1)" "unprognostic (1.52e-1)" 16.1 19.0 37.2 11.6 41.6 14.7 17.6 38.0 68.2 15.2 16.7 14.6 15.4 14.4 12.8 21.2 16.1 19.9 13.6 34.0 34.2 25.7 14.8 20.2 14.4 14.4 26.7 41.6 20.3 15.2 15.6 17.6 20.9 29.6 16.3 15.0 13.5 21.3 18.5 122.7 15.1 14.7 15.9 14.6 14.1 15.4 47.0 15.3 17.4 19.3 17.6 15.6 13.7 11.2 19.5 39.4 41.6 36.3 21.6 31.5 29.8 26.4 8.2 27.3 45.6 18.8 14.2 19.6 12.0 15.5 23.5 25.8 23.5 13.9 26.3 13.7 17.5 8.8 14.1 29.0 15.5 16.1 14.0 39.5 32.7 23.6 24.4 18.5 19.2 23.4 22.8 15.6 18.1 10.6 18.3 22.7 30.1 39.7 18.8 8.8 32.9 31.4 33.1 35.5 66.8 8.8 30.6 20.0 31.5 14.4 15.4 50.6 39.5 12.7 14.6 20.4 18.5 25.4 55.7 13.4 10.7 20.0 11.8 11.8 20.6 25.8 38.2 4.7 27.6 9.0 14.9 36.3 41.6 28.5 33.8 24.0 19.2 23.8 25.8 39.4 19.5 31.5 24.5 17.7 21.6 25.8 21.8 25.1 29.8 37.2 41.6 38.0 68.2 34.2 25.7 26.7 41.6 29.6 15.3 11.9 17.1 31.9 30.7 16.7 29.1 32.5 30.6 5.3 6.8 17.4 13.7 84.7 72.9 52.9 436.9 20.2 33.8 23.3 48.1 97.9 40.2 39.5 13.8 24.5 56.1 30.2 50.3 24.5 35.6 1305.6 41.4 26.0 32.1 61.3 43.7 33.2 40.4 43.6 55.5 45.1 21.9 51.8 26.8 102.4 30.2 18.1 89.5 30.2 50.7 28.0 KLHL7 "KLHL6, RP42, SBBI26" ENSG00000122550 "Kelch like family member 7" Q8IXQ5 7 23105758-23177914 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 452.0;Late spermatids: 236.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029491, HPA029492" Uncertain Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029491: AB_10599605, HPA029492: AB_10600881" "unprognostic (1.24e-2)" "unprognostic (4.45e-1)" "unprognostic (1.77e-1)" "unprognostic (4.55e-2)" "unprognostic (1.29e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (3.78e-1)" "unprognostic (6.10e-2)" "unprognostic (6.41e-3)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "prognostic favorable (8.98e-5)" "unprognostic (2.46e-2)" "unprognostic (3.55e-3)" "unprognostic (3.23e-2)" "unprognostic (2.27e-2)" 7.5 14.6 9.2 5.6 13.0 8.2 10.3 12.6 15.1 8.8 5.7 7.9 4.7 5.9 9.1 9.9 7.7 7.4 7.6 37.1 8.1 8.7 9.2 7.7 6.4 5.8 8.3 9.7 9.6 5.9 7.1 6.1 6.5 15.9 8.1 6.3 8.6 7.2 6.8 7.4 8.6 5.8 8.1 10.6 5.8 5.2 40.7 6.2 9.6 7.2 5.1 6.7 6.9 7.1 5.5 5.5 32.0 8.7 4.2 8.0 6.0 10.9 9.4 25.9 30.6 12.7 11.1 9.5 9.7 14.4 14.3 16.7 11.4 8.0 10.8 7.9 11.8 23.7 11.9 9.9 6.8 12.1 2.8 7.1 7.1 8.1 14.6 9.5 14.3 5.6 9.8 8.9 16.4 13.5 11.4 18.2 13.4 12.4 11.8 23.3 12.6 11.9 22.8 35.7 7.5 11.2 10.6 14.5 9.8 13.4 9.5 15.6 15.3 21.1 10.5 9.9 16.6 8.7 7.5 7.7 12.1 12.6 26.5 11.5 18.6 15.2 25.7 8.0 15.2 14.4 18.7 7.8 32.0 6.8 8.7 7.1 4.5 7.3 6.4 5.5 5.5 5.5 5.4 7.4 4.2 7.5 4.0 8.0 6.0 9.2 13.0 12.6 15.1 8.1 8.7 8.3 9.7 15.9 6.2 20.8 5.6 13.3 15.2 20.9 19.9 85.8 5.1 16.0 9.1 8.7 27.5 18.6 10.0 15.7 452.0 14.1 4.9 0.0 15.3 24.1 17.0 11.5 20.8 5.9 16.7 35.0 10.4 14.1 15.3 236.4 15.5 14.1 11.8 12.6 7.6 23.5 14.7 0.0 19.4 9.8 15.0 6.5 19.1 94.0 10.6 29.5 19.8 15.2 6.4 22.7 KLHL8 KIAA1378 ENSG00000145332 "Kelch like family member 8" Q9P2G9 4 87160103-87240314 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 56.2" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 205.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013856, HPA017762" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA013856: AB_1852594, HPA017762: AB_2669660" "unprognostic (2.93e-2)" "unprognostic (4.91e-3)" "unprognostic (3.44e-2)" "unprognostic (4.66e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (2.12e-1)" "unprognostic (4.46e-3)" "unprognostic (3.27e-2)" "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (3.46e-1)" "prognostic favorable (1.53e-5)" "unprognostic (4.24e-3)" "unprognostic (3.05e-1)" "unprognostic (3.57e-3)" "unprognostic (1.57e-3)" 6.8 7.3 6.9 5.6 8.1 3.0 12.0 10.0 10.7 9.2 7.5 5.3 3.8 7.3 8.3 56.2 5.3 5.4 5.0 7.4 7.7 7.2 11.4 10.3 9.0 8.1 6.3 5.6 6.1 6.3 7.1 14.2 6.6 7.3 5.7 8.5 4.6 6.5 7.7 23.4 4.8 8.2 6.6 8.0 6.9 5.5 4.2 6.5 7.0 17.3 2.9 4.7 6.8 10.9 3.8 10.3 8.6 12.1 8.7 4.9 5.0 6.5 5.8 10.5 4.7 9.6 7.0 5.6 8.4 4.5 5.6 6.6 9.2 5.0 9.5 6.8 6.2 4.6 2.8 11.1 8.3 12.2 9.1 7.0 11.6 4.4 5.4 8.2 19.0 7.3 8.8 6.0 8.6 8.7 5.5 6.7 7.3 14.9 8.7 5.8 7.2 22.7 9.6 2.6 14.8 2.3 8.6 9.0 5.8 9.5 6.8 22.0 7.7 5.5 13.5 6.2 4.1 4.7 14.1 6.2 7.2 8.8 7.6 7.0 13.1 8.5 16.9 5.4 9.1 7.8 1.9 12.1 7.3 3.0 9.2 4.9 3.3 2.4 2.5 10.3 3.8 4.4 4.3 8.6 8.7 9.0 2.7 0.9 5.0 6.9 8.1 10.0 10.7 7.7 7.2 6.3 5.6 7.3 6.5 3.0 18.5 11.3 9.5 12.2 18.4 11.7 5.1 6.7 10.3 41.8 39.3 3.2 10.0 4.5 2.8 9.5 12.2 0.0 3.9 4.6 8.6 10.5 7.0 17.1 8.6 22.3 8.6 5.5 30.8 2.4 8.9 13.4 10.1 2.8 12.0 205.6 5.0 8.6 7.8 16.5 44.7 12.9 9.2 11.2 19.4 12.9 19.9 7.7 13.3 9.8 KNL1 "AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7" ENSG00000137812 "Kinetochore scaffold 1" Q8NG31 15 40594020-40664342 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "lymphoid tissue: 54.7;testis: 35.6" "Cell type enhanced" "Detected in some" 12 "Club cells: 3.4;Extravillous trophoblasts: 9.3;Hofbauer cells: 5.6;Proximal tubular cells: 8.4;Syncytiotrophoblasts: 3.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA026624, HPA049647" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Yes Yes Nucleoplasm "Nuclear bodies" "HPA026624: AB_10601696, HPA049647: AB_2680840" "unprognostic (5.35e-2)" "unprognostic (1.01e-1)" "unprognostic (5.59e-3)" "unprognostic (4.22e-2)" "unprognostic (1.59e-2)" "unprognostic (5.66e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.20e-4)" "unprognostic (2.22e-2)" "unprognostic (1.93e-12)" "unprognostic (3.07e-2)" "unprognostic (3.08e-1)" "unprognostic (8.45e-2)" "unprognostic (7.36e-2)" 0.7 0.5 0.3 7.1 0.4 5.4 0.7 0.3 0.3 0.6 4.0 0.1 0.0 1.5 0.4 0.8 3.9 0.4 0.9 0.5 0.4 0.4 0.9 1.0 1.3 4.7 0.3 0.0 0.5 0.5 0.0 0.4 2.8 0.1 0.5 1.5 0.0 0.8 0.0 0.4 0.8 3.9 0.5 0.4 3.3 0.8 35.6 0.0 54.7 0.5 4.1 3.7 0.7 0.9 2.9 1.2 0.7 0.5 0.7 2.5 0.0 10.9 5.6 11.5 8.3 0.3 1.7 5.1 12.8 5.2 10.0 8.5 6.9 4.4 7.3 4.1 5.5 7.6 13.7 10.8 6.0 10.6 12.6 3.0 21.4 9.6 2.0 0.0 16.3 10.8 0.3 0.2 6.7 4.2 1.3 8.5 13.0 13.7 12.2 11.7 3.7 13.9 3.3 5.6 6.6 6.0 12.7 16.5 3.6 1.5 9.7 9.9 4.6 11.1 6.3 1.3 3.8 6.8 5.0 7.9 11.7 10.4 13.4 7.1 4.7 15.9 14.2 4.7 11.1 11.1 0.4 0.2 0.1 0.1 0.1 0.0 2.9 1.1 0.1 1.2 2.2 0.0 0.7 0.7 0.7 0.5 0.1 2.5 0.0 0.3 0.4 0.3 0.3 0.4 0.4 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.4 1.8 0.0 2.4 1.7 0.2 0.0 0.0 0.0 0.0 0.5 9.3 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 KPNA1 "IPOA5, NPI-1, RCH2, SRP1" ENSG00000114030 "Karyopherin subunit alpha 1" P52294 3 122421949-122514945 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.4" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 145.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053627, HPA063426" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053627: AB_2682211, HPA063426: AB_2685013" "unprognostic (6.23e-2)" "unprognostic (3.83e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" "unprognostic (4.02e-3)" "unprognostic (2.86e-1)" "unprognostic (1.40e-1)" "unprognostic (6.77e-3)" "unprognostic (7.89e-3)" "unprognostic (5.22e-2)" "unprognostic (9.09e-2)" "unprognostic (5.43e-1)" "unprognostic (4.02e-1)" "unprognostic (4.77e-1)" 15.4 16.9 15.1 14.4 15.5 7.6 17.8 14.6 19.3 11.8 13.6 12.0 9.0 9.9 14.4 12.3 17.2 10.8 9.6 18.7 13.9 11.6 13.1 24.6 12.5 11.2 14.4 16.8 10.8 14.5 19.6 13.8 13.6 16.5 12.3 12.3 8.6 13.2 15.1 89.4 13.1 11.3 17.7 15.8 10.9 12.3 15.2 13.5 12.4 14.1 10.9 15.3 14.5 13.6 11.4 17.3 29.3 18.2 13.5 13.9 10.9 29.9 17.8 30.7 15.5 20.0 22.1 9.7 23.2 19.7 25.5 23.1 21.4 14.7 21.9 21.4 25.5 20.2 15.8 24.0 19.8 37.7 5.9 9.1 26.9 16.0 11.9 11.7 23.8 12.4 15.3 25.8 18.3 25.8 12.5 27.8 11.9 18.8 12.7 23.1 14.0 17.2 5.7 13.3 21.2 19.2 17.7 25.5 14.0 11.1 21.1 21.2 12.8 24.9 13.6 20.2 25.1 18.0 14.1 23.7 16.0 17.6 7.8 17.9 12.2 12.3 40.7 22.4 16.7 16.2 15.7 13.1 12.5 12.6 13.4 13.5 11.4 11.2 13.9 17.3 8.8 11.6 11.8 29.3 13.5 18.2 5.5 11.8 10.9 15.1 15.5 14.6 16.7 13.9 11.6 14.4 16.8 16.5 13.5 14.9 28.5 15.2 21.0 36.9 27.4 26.5 25.5 46.8 42.1 14.0 29.5 18.8 11.6 21.1 89.9 29.2 15.5 46.7 28.8 20.9 21.6 27.0 38.1 43.9 20.5 19.1 15.6 26.4 29.7 145.2 20.8 25.2 16.9 25.2 17.0 23.9 27.4 17.5 23.3 16.7 47.9 12.9 33.5 30.1 16.6 39.6 20.8 27.3 10.7 24.2 KPNA2 "IPOA1, QIP2, RCH1, SRP1alpha" ENSG00000182481 "Karyopherin subunit alpha 2" P52292 17 68035519-68046842 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 103.9" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 663.6;Spermatocytes: 296.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015460, HPA041270" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes 38000 Nucleoplasm Cytosol "CAB015460: AB_831493, HPA041270: AB_2677385" "unprognostic (2.78e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.83e-4)" "unprognostic (2.14e-2)" "unprognostic (1.64e-1)" "unprognostic (5.16e-3)" "prognostic unfavorable (2.12e-10)" "prognostic unfavorable (5.77e-4)" "unprognostic (3.34e-2)" "unprognostic (7.59e-2)" "unprognostic (3.72e-3)" "unprognostic (3.08e-2)" "prognostic unfavorable (1.26e-13)" "unprognostic (3.07e-2)" "unprognostic (1.78e-1)" "unprognostic (9.50e-2)" "prognostic unfavorable (2.19e-4)" 10.6 8.3 10.2 19.5 12.0 38.6 11.9 6.1 13.2 7.4 11.5 6.6 4.3 10.1 8.3 10.4 21.1 6.3 7.9 8.9 11.6 13.2 10.9 11.8 9.1 25.5 10.3 10.3 5.3 4.7 4.5 8.4 16.4 11.4 4.6 14.5 4.0 8.2 4.7 7.2 8.7 10.2 13.2 8.5 14.8 9.7 103.9 9.0 56.6 5.9 20.3 36.8 10.0 8.3 24.6 28.1 16.4 22.6 20.3 17.7 15.0 62.2 81.9 78.2 31.3 11.6 11.3 49.7 55.0 42.7 88.9 69.4 56.3 29.2 58.5 17.4 31.7 44.3 34.5 86.4 42.9 102.4 23.5 50.9 51.8 39.6 53.7 12.2 44.5 35.7 7.0 8.1 51.1 31.5 12.5 85.5 25.0 41.1 42.3 78.8 58.1 55.5 28.7 52.8 50.8 42.5 30.7 71.4 32.0 35.0 29.2 31.1 34.6 30.9 99.8 32.3 74.7 58.1 22.4 33.3 49.3 61.0 34.7 73.9 35.1 50.2 58.4 24.0 38.3 52.9 16.4 16.1 6.6 14.1 22.6 10.9 24.6 10.3 14.4 28.1 19.7 7.9 12.3 1.2 20.3 18.9 21.4 17.7 15.0 10.2 12.0 6.1 13.2 11.6 13.2 10.3 10.3 11.4 9.0 11.9 32.3 47.6 33.0 97.4 19.1 12.6 7.6 8.1 18.2 17.4 7.9 59.0 13.3 31.3 663.6 49.2 9.8 70.0 22.3 244.0 94.4 18.1 43.8 15.3 104.7 30.2 41.1 16.0 36.5 186.9 17.8 52.4 50.6 104.6 9.7 29.4 18.3 10.5 13.8 26.9 17.8 32.3 72.6 296.7 211.0 77.3 99.4 34.5 15.8 20.4 KPNA4 "IPOA3, MGC12217, MGC26703, QIP1, SRP3" ENSG00000186432 "Karyopherin subunit alpha 4" O00629 3 160494995-160565588 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034336, HPA043154, HPA045500" Enhanced Enhanced Nucleoplasm NA NA 250000 Nucleoplasm "CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351" "unprognostic (1.58e-1)" "unprognostic (7.65e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (8.59e-4)" "unprognostic (7.56e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (6.24e-7)" "unprognostic (7.71e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.20e-1)" "unprognostic (1.21e-1)" "unprognostic (3.98e-2)" "unprognostic (2.21e-1)" "unprognostic (2.17e-3)" "unprognostic (1.48e-1)" 18.0 9.4 12.6 12.9 12.7 15.2 25.1 13.1 14.1 14.8 14.4 8.6 11.1 7.3 13.1 10.8 22.1 8.9 13.9 45.0 12.0 12.1 11.0 12.6 11.4 12.4 11.6 10.8 15.0 10.7 12.5 6.9 17.5 11.1 11.0 9.7 7.1 10.9 13.1 66.1 10.6 9.5 20.4 10.4 12.1 10.8 13.5 6.3 13.8 11.4 22.2 10.2 21.8 25.2 2.9 2.9 6.8 11.5 8.3 5.6 3.2 33.8 12.0 12.4 16.7 14.3 13.2 16.3 21.1 15.1 15.5 13.2 15.3 17.8 18.0 25.3 21.6 23.2 15.8 13.9 13.6 23.4 22.3 7.8 15.2 10.7 9.1 18.6 21.2 13.7 13.5 14.4 15.0 30.6 12.5 20.4 8.9 11.4 14.6 22.0 9.5 19.1 8.8 25.2 15.3 11.2 12.8 18.5 18.2 12.5 13.0 10.1 9.8 20.4 20.5 29.3 14.4 17.8 11.6 22.7 17.8 15.3 17.7 33.9 26.8 17.7 41.3 16.2 22.2 15.7 6.8 3.6 6.0 3.1 6.7 5.6 2.9 4.5 4.5 2.7 2.5 3.6 4.7 5.4 8.3 11.5 2.9 4.2 3.2 12.6 12.7 13.1 13.3 12.0 12.1 11.6 10.8 11.1 6.3 35.7 24.3 27.5 63.0 109.9 56.4 153.2 20.4 40.2 43.3 10.4 74.6 22.7 29.9 33.3 19.9 45.0 51.2 0.0 32.4 20.6 50.3 69.0 30.1 26.1 35.0 50.9 27.5 29.4 41.9 14.3 31.4 45.8 42.2 26.2 29.9 52.1 57.1 33.4 32.5 31.4 60.8 32.3 42.2 40.3 21.8 110.2 34.0 29.9 30.5 94.6 KPNB1 "IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97" ENSG00000108424 "Karyopherin subunit beta 1" Q14974 17 47649476-47685505 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 28.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 28.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029878, CAB034449, HPA050302" Supported Enhanced "Nucleoplasm,Nuclear membrane,Cytosol" Yes No 5500000 "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079" "unprognostic (2.57e-1)" "unprognostic (1.15e-1)" "unprognostic (4.33e-3)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (8.15e-2)" "prognostic unfavorable (2.55e-7)" "unprognostic (7.18e-3)" "unprognostic (9.52e-2)" "unprognostic (5.47e-3)" "unprognostic (4.37e-2)" "unprognostic (8.41e-3)" "prognostic unfavorable (8.43e-6)" "unprognostic (1.34e-2)" "unprognostic (1.20e-1)" "unprognostic (1.41e-2)" "unprognostic (3.44e-2)" 38.0 42.1 31.9 46.1 30.7 22.1 33.3 32.9 33.5 37.6 37.9 29.7 39.9 24.5 39.3 35.4 51.2 33.1 35.0 43.5 28.1 30.5 33.8 48.8 35.8 50.5 31.6 35.3 47.2 32.3 42.3 29.4 34.6 34.9 36.1 39.3 23.7 35.2 45.9 74.6 31.7 32.1 40.7 36.6 50.3 35.7 62.4 34.8 47.6 37.0 34.3 62.8 50.8 47.5 5.4 4.0 28.2 3.9 3.7 6.3 2.8 43.7 74.6 47.5 43.1 23.0 40.0 47.7 52.2 46.8 68.5 53.9 130.2 26.1 56.5 35.7 48.7 48.3 31.0 85.7 48.1 104.1 34.7 52.3 62.4 60.2 40.7 23.7 70.6 41.1 32.4 21.2 78.6 77.1 29.2 45.1 31.5 70.5 38.7 52.9 47.6 65.4 21.2 45.2 29.9 47.2 40.6 84.0 32.9 28.1 62.7 41.8 38.8 35.7 19.2 30.2 59.2 41.5 27.3 37.5 74.9 46.5 38.9 63.2 47.4 54.7 81.0 31.9 34.2 54.9 4.3 3.5 7.1 4.9 3.6 6.3 5.4 5.5 5.5 2.1 5.1 5.2 4.9 28.2 3.7 3.9 4.0 4.0 2.8 31.9 30.7 32.9 33.3 28.1 30.5 31.6 35.3 34.9 34.8 119.1 66.6 108.8 81.6 111.6 93.4 119.7 66.2 52.2 73.9 41.8 64.8 98.4 34.9 106.8 32.0 100.4 53.1 46.7 102.8 118.0 87.0 86.2 75.0 80.5 109.7 76.3 118.8 122.8 99.2 31.1 89.8 89.3 57.3 151.5 71.7 76.6 115.8 60.4 114.2 42.9 82.7 97.0 78.3 276.1 166.5 125.5 132.3 92.4 98.1 114.9 KRR1 "HRB2, RIP-1" ENSG00000111615 "KRR1, small subunit processome component homolog" Q13601 12 75490861-75511636 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043433, HPA051690" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA043433: AB_10960988, HPA051690: AB_2681574" "unprognostic (2.77e-1)" "unprognostic (1.02e-1)" "unprognostic (8.21e-2)" "unprognostic (1.71e-1)" "unprognostic (2.02e-1)" "unprognostic (4.71e-2)" "unprognostic (6.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.00e-1)" "unprognostic (1.38e-1)" "unprognostic (5.85e-2)" "unprognostic (1.88e-1)" "unprognostic (2.32e-2)" "unprognostic (1.69e-1)" "unprognostic (1.61e-1)" "unprognostic (3.26e-1)" "unprognostic (1.12e-2)" 22.5 18.4 14.2 15.1 22.0 38.0 17.8 29.1 23.3 21.2 14.3 6.7 14.6 12.6 18.3 15.2 24.2 14.7 10.5 12.5 12.6 10.8 23.7 25.0 13.5 18.2 12.8 16.4 21.7 15.0 17.8 33.5 21.4 19.8 20.9 11.8 6.3 20.7 14.2 28.8 16.6 15.2 15.7 16.1 19.8 15.1 12.3 17.3 24.3 20.5 22.4 18.1 19.6 16.4 15.8 10.8 8.9 4.6 8.6 14.7 5.6 25.4 21.1 13.3 11.8 10.5 9.6 24.3 22.3 14.2 17.6 11.3 15.4 13.4 27.1 18.2 11.0 17.6 13.4 17.8 19.6 19.9 22.3 18.1 26.2 11.7 17.9 12.7 46.1 16.6 9.9 16.8 20.2 19.3 17.8 12.0 25.9 28.9 8.7 17.2 16.8 26.8 13.1 19.6 14.1 19.3 21.3 25.6 16.3 19.6 32.2 16.0 13.3 21.1 15.0 26.3 13.3 24.9 18.8 14.9 16.3 10.8 16.8 23.1 17.4 21.8 17.0 8.8 16.3 29.3 7.7 2.4 8.9 10.1 4.6 12.4 15.8 14.1 11.4 3.9 14.4 14.7 13.8 1.1 8.6 3.7 10.8 12.5 5.6 14.2 22.0 29.1 23.3 12.6 10.8 12.8 16.4 19.8 17.3 65.5 42.2 31.8 91.0 43.6 53.3 22.4 15.3 48.2 54.6 38.4 31.4 56.6 49.7 37.5 4.0 32.2 15.1 0.0 42.7 45.8 41.4 40.8 36.9 36.7 26.1 69.9 17.2 22.1 18.8 5.3 48.6 29.3 11.8 32.5 23.2 65.0 33.7 27.9 50.2 37.3 53.6 12.9 36.3 55.6 54.8 38.8 58.9 48.4 29.3 62.9 LCOR "C10orf12, DKFZP564P1916, FLJ13022, FLJ38026, KIAA1795, MLR2" ENSG00000196233 "Ligand dependent nuclear receptor corepressor" Q96JN0 10 96832282-96995959 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031429, HPA057621, HPA077000" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031429: AB_2673879, HPA057621: AB_2732616, HPA077000: AB_2686824" "unprognostic (5.61e-2)" "unprognostic (1.59e-1)" "unprognostic (2.11e-1)" "unprognostic (2.23e-1)" "unprognostic (1.49e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-3)" "unprognostic (2.19e-1)" "unprognostic (2.40e-1)" "unprognostic (1.54e-1)" "unprognostic (4.93e-2)" "unprognostic (5.61e-3)" "unprognostic (1.20e-1)" "unprognostic (1.96e-2)" "unprognostic (4.40e-2)" "unprognostic (1.24e-1)" "prognostic favorable (2.16e-4)" 7.5 6.4 9.9 9.2 11.6 35.5 8.6 25.7 10.5 7.8 13.8 12.6 9.4 17.4 8.9 8.1 12.9 8.3 8.3 7.8 7.3 6.9 9.1 10.0 9.4 9.7 13.6 7.5 13.1 16.9 10.3 20.3 25.9 10.8 8.7 14.1 9.5 12.1 7.4 11.9 7.1 24.2 9.4 11.4 9.9 10.9 7.6 11.7 13.2 10.5 6.6 13.2 12.5 9.7 6.8 4.8 12.2 4.2 3.4 5.4 1.9 11.2 7.4 13.0 6.0 3.7 4.2 6.7 5.7 5.0 6.5 7.1 10.0 7.8 11.9 6.0 5.5 5.5 6.5 12.6 6.9 11.5 5.6 6.5 12.2 4.3 11.8 7.3 11.5 7.1 3.8 5.9 9.6 16.7 6.5 7.0 6.4 10.2 6.2 9.5 5.4 6.7 6.1 4.3 5.8 3.4 9.1 10.3 3.5 6.5 25.1 6.0 5.2 5.5 3.4 7.3 6.2 7.4 5.1 9.7 5.3 10.7 4.2 9.3 5.9 5.1 13.9 5.1 11.9 2.4 2.1 3.8 6.4 4.8 4.2 4.6 3.8 4.0 5.4 3.1 6.8 4.7 4.7 12.2 3.4 2.5 4.8 2.4 1.9 9.9 11.6 25.7 10.5 7.3 6.9 13.6 7.5 10.8 11.7 17.9 23.2 11.8 15.3 13.7 43.1 12.4 48.4 50.9 29.6 29.6 72.6 11.6 10.0 25.1 0.8 17.3 59.9 0.0 29.4 6.5 12.3 29.5 25.5 19.5 12.0 38.1 45.1 24.5 25.9 1.1 9.5 27.5 20.3 19.0 30.3 10.3 34.4 42.1 13.1 21.3 55.5 19.4 20.8 19.2 25.0 11.3 32.3 23.0 29.6 29.7 LEO1 ENSG00000166477 "LEO1 homolog, Paf1/RNA polymerase II complex component" Q8WVC0 15 51938025-51971806 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "granulocytes: 262.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040741, HPA040941" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Centrosome" No No "Nucleoplasm, Nucleoli fibrillar center" Centrosome "HPA040741: AB_10794859, HPA040941: AB_10805832" "unprognostic (2.76e-2)" "unprognostic (2.14e-2)" "unprognostic (2.44e-1)" "unprognostic (1.81e-3)" "unprognostic (2.85e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-2)" "unprognostic (1.04e-2)" "unprognostic (1.83e-2)" "unprognostic (2.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.02e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (8.48e-2)" "unprognostic (2.10e-2)" "unprognostic (1.08e-1)" 10.7 15.2 15.0 15.3 27.9 8.3 17.0 42.6 24.4 13.4 17.8 14.1 9.7 13.9 12.6 11.2 24.4 9.7 14.2 10.6 14.0 14.0 21.4 27.8 10.2 17.2 14.8 14.9 10.6 10.3 25.2 22.4 12.7 22.7 13.8 21.0 9.1 21.2 12.5 13.5 21.8 19.8 12.6 15.3 14.3 13.9 9.8 18.5 23.4 12.0 9.4 18.2 16.9 15.7 12.3 15.3 9.6 15.3 18.9 19.7 10.0 9.6 22.6 14.6 11.7 15.1 13.1 10.5 15.8 13.1 13.6 12.4 15.6 6.4 19.6 9.3 16.2 15.1 19.0 19.4 14.1 13.1 13.0 8.8 30.9 18.4 27.3 11.9 27.8 43.2 14.0 11.1 10.6 13.8 12.9 13.2 16.6 18.7 10.8 16.1 41.2 14.7 21.1 6.3 28.9 9.7 16.5 25.3 20.5 11.9 27.2 10.4 15.9 12.0 18.5 12.3 16.7 15.4 25.4 15.7 13.5 9.3 12.4 18.8 8.5 26.5 18.1 11.8 39.9 14.3 5.4 9.4 9.6 18.7 14.6 17.5 12.3 18.7 15.2 15.3 10.1 19.5 17.5 2.3 18.9 15.3 11.5 19.7 10.0 15.0 27.9 42.6 24.4 14.0 14.0 14.8 14.9 22.7 18.5 32.8 27.7 10.4 12.9 23.2 35.2 17.1 20.4 45.5 39.8 7.0 9.8 21.3 13.3 21.4 1.6 15.0 19.3 0.0 21.0 22.3 16.2 9.1 262.5 12.3 16.9 25.4 7.5 8.6 12.3 2.1 7.5 7.8 3.3 14.4 16.3 20.9 17.2 14.0 12.7 17.9 20.8 6.5 9.2 15.6 9.0 21.7 14.8 15.4 13.9 20.1 LMO2 "RBTN2, RBTNL1, RHOM2, TTG2" ENSG00000135363 "LIM domain only 2" P25791 11 33858576-33892289 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 121.0;Erythroid cells: 46.7;Ito cells: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 1.5;classical monocyte: 1.1;eosinophil: 3.0;intermediate monocyte: 3.1;myeloid DC: 4.3;neutrophil: 1.6;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 7 "dendritic cells: 4.3;granulocytes: 3.0;monocytes: 3.6" "Cell line enhanced" "Detected in some" "HEL: 23.3;HL-60: 23.2;K-562: 23.6;NB-4: 9.9;THP-1: 30.8;U-937: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016258, HPA029285, HPA070901, HPA070910" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016258: AB_2136572, HPA029285: AB_2672978, HPA070901: , HPA070910: " "unprognostic (1.60e-1)" "unprognostic (1.47e-2)" "unprognostic (6.03e-2)" "unprognostic (1.71e-3)" "unprognostic (1.89e-1)" "unprognostic (1.14e-3)" "prognostic favorable (3.12e-4)" "unprognostic (1.73e-3)" "unprognostic (8.95e-2)" "unprognostic (5.76e-2)" "unprognostic (7.86e-3)" "unprognostic (3.69e-1)" "unprognostic (7.10e-2)" "unprognostic (9.65e-2)" "unprognostic (3.90e-1)" "unprognostic (1.45e-1)" "unprognostic (4.46e-2)" 18.2 6.1 13.8 13.6 15.6 28.8 14.5 5.2 18.4 9.4 5.5 10.3 6.4 6.2 9.7 9.9 6.9 8.6 9.1 6.4 15.8 12.2 12.9 5.5 15.9 22.2 14.2 7.2 5.1 3.9 4.2 8.3 8.5 11.9 8.3 2.7 14.6 4.5 4.0 25.0 4.2 5.5 6.6 13.9 22.0 4.4 3.6 11.1 1.0 10.7 8.1 13.3 11.1 14.8 0.5 4.3 3.0 3.6 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.9 0.5 5.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 23.3 0.0 0.0 0.1 23.2 8.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 23.6 0.0 0.0 0.1 2.1 9.9 0.4 0.0 0.0 6.6 0.3 0.0 0.0 0.3 1.9 0.0 0.1 0.2 0.0 0.1 0.0 30.8 0.3 0.0 0.1 0.7 0.0 0.0 0.1 0.2 2.1 10.9 0.1 1.5 1.1 3.0 0.0 3.1 0.1 0.5 0.0 0.0 4.3 0.0 0.0 0.0 1.6 0.0 3.6 0.3 0.0 0.5 13.8 15.6 5.2 9.5 15.8 12.2 14.2 7.2 11.9 11.1 3.0 10.3 7.6 7.8 7.4 1.4 1.7 7.6 5.3 0.0 5.2 2.0 0.3 0.0 2.9 0.2 121.0 0.0 46.7 1.7 1.7 8.4 4.1 7.0 1.0 33.2 0.0 0.0 110.5 41.7 0.7 3.7 42.5 10.1 0.0 0.0 1.0 0.9 0.0 0.0 5.6 1.9 0.0 2.8 0.2 2.7 5.3 18.0 0.5 0.4 19.5 LONP1 "hLON, LonHS, PIM1, PRSS15" ENSG00000196365 "Lon peptidase 1, mitochondrial" P36776 19 5691834-5720572 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Hydrolase, Protease, Serine protease" "Cataract, Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002034, HPA002192" Supported Enhanced Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA002034: AB_2756304, HPA002192: AB_1079695" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (2.43e-1)" "unprognostic (2.43e-2)" "unprognostic (2.84e-1)" "unprognostic (2.38e-1)" "unprognostic (1.66e-3)" "unprognostic (5.56e-2)" "unprognostic (2.71e-1)" "unprognostic (7.57e-2)" "unprognostic (4.04e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-2)" "unprognostic (1.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" 15.8 78.3 16.4 12.8 19.8 12.5 13.9 16.1 22.8 11.3 13.6 15.8 13.3 13.7 10.5 13.8 12.7 12.7 15.7 27.3 15.4 15.3 19.9 49.6 10.3 14.5 17.7 14.9 15.5 17.7 17.6 16.8 16.6 16.2 11.7 8.5 12.7 18.5 14.7 38.0 14.7 13.9 11.5 12.7 15.5 13.5 9.8 13.3 13.8 21.2 15.3 11.8 14.7 12.5 6.7 6.5 6.0 6.2 4.0 7.2 3.0 23.0 23.9 7.9 25.3 9.4 6.7 24.7 14.7 11.7 15.9 19.5 20.4 8.3 28.9 20.6 15.4 15.3 9.8 20.4 17.8 7.7 17.1 16.8 16.0 20.9 26.7 43.7 36.4 16.8 12.6 25.6 15.1 29.9 7.7 12.7 40.6 42.3 57.8 7.3 15.3 18.0 21.7 28.3 9.4 31.6 19.0 11.4 31.2 8.8 13.7 21.1 21.1 12.9 18.9 51.6 5.8 11.1 45.7 8.9 8.1 8.9 22.5 21.4 60.9 37.5 25.7 36.5 39.9 14.6 6.0 4.1 0.8 6.4 6.2 4.1 6.0 5.6 6.1 4.3 6.7 7.2 4.8 0.5 4.0 2.4 6.5 4.0 3.0 16.4 19.8 16.1 22.8 15.4 15.3 17.7 14.9 16.2 13.3 6.0 13.3 13.7 8.7 7.3 24.7 17.9 15.3 9.4 10.3 26.2 5.9 24.8 39.7 28.3 5.3 9.8 24.8 0.0 23.9 27.0 10.5 12.9 5.7 44.0 28.2 20.6 10.9 14.1 11.3 4.0 11.8 15.2 13.5 24.4 21.6 20.9 25.6 14.4 16.3 36.0 22.0 19.4 10.3 9.1 13.4 9.4 29.3 9.2 22.2 9.4 LOXL2 "LOR, WS9-14" ENSG00000134013 "Lysyl oxidase like 2" Q9Y4K0 8 23297189-23425328 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Transcription, Transcription regulation" "Chromatin regulator, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Endothelial cells: 15.5;Extravillous trophoblasts: 20.1;Fibroblasts: 16.6;Ito cells: 23.4;Sertoli cells: 25.8;Smooth muscle cells: 22.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 8 "pons and medulla: 22.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 109.9;BJ hTERT+ SV40 Large T+ RasG12V: 63.6;fHDF/TERT166: 71.2;TIME: 59.3;U-87 MG: 110.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025848, HPA036257, HPA056542" Approved Enhanced Nucleoplasm "Secreted to extracellular matrix" NA NA Nucleoplasm "CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168" "unprognostic (9.48e-2)" "prognostic unfavorable (9.83e-6)" "unprognostic (2.03e-1)" "unprognostic (2.81e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (5.55e-2)" "unprognostic (1.42e-2)" "prognostic unfavorable (1.46e-7)" "unprognostic (2.91e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (9.05e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.91e-7)" "unprognostic (1.51e-2)" "unprognostic (7.07e-2)" "unprognostic (4.93e-2)" "unprognostic (3.68e-3)" 37.8 2.7 1.2 14.5 1.6 0.6 22.4 2.9 1.6 16.9 18.4 1.0 12.2 5.8 11.8 9.1 11.5 4.1 5.4 7.2 1.2 1.3 4.3 4.1 6.2 7.5 1.9 0.7 15.6 4.4 1.3 2.2 38.0 22.7 8.4 3.8 1.6 5.6 9.7 6.2 4.3 10.7 27.3 10.9 8.3 7.7 4.1 0.7 1.6 4.3 8.0 8.6 19.1 6.4 1.9 1.3 3.0 0.7 2.1 2.8 0.7 6.3 17.0 5.1 4.1 14.0 23.1 2.2 109.9 35.6 50.4 63.6 0.1 0.4 1.2 0.8 71.2 23.4 5.3 0.2 9.4 26.7 0.2 0.9 0.0 2.3 0.1 28.3 0.0 0.4 20.4 0.4 18.8 2.5 33.6 42.1 0.2 0.0 0.2 16.6 3.4 0.0 0.1 3.3 0.0 2.6 0.2 4.2 0.0 14.6 0.0 0.1 1.4 13.7 0.7 1.0 16.8 0.1 0.1 59.3 46.9 12.4 19.1 14.4 0.4 0.0 3.3 110.2 0.1 48.8 1.9 0.7 3.0 1.6 0.3 0.8 1.9 0.6 1.3 0.5 0.9 0.8 2.8 1.6 2.1 0.6 1.3 0.2 0.7 1.2 1.6 2.9 1.0 1.2 1.3 1.9 0.7 22.7 0.7 0.0 4.0 0.5 0.4 2.3 1.7 1.7 0.0 1.4 0.0 0.0 0.0 2.0 0.0 1.5 0.5 15.5 0.0 0.0 1.3 20.1 16.6 0.5 0.0 0.0 1.1 1.6 0.0 23.4 0.3 0.0 0.9 0.5 3.3 0.0 0.0 0.8 3.4 0.0 0.4 0.0 3.1 25.8 22.6 0.9 0.9 2.8 0.8 0.0 0.0 0.1 LRRC32 "D11S833E, GARP" ENSG00000137507 "Leucine rich repeat containing 32" Q14392 11 76657524-76670747 "Predicted intracellular proteins, Predicted membrane proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endothelial cells: 91.0;Extravillous trophoblasts: 149.6;Fibroblasts: 48.9;Ito cells: 70.6;Sertoli cells: 38.8;Smooth muscle cells: 74.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "neutrophil: 1.0;T-reg: 3.1" "Group enriched" "Detected in many" 7 "granulocytes: 1.0;T-cells: 3.1" "Group enriched" "Detected in some" 6 "ASC diff: 42.0;ASC TERT1: 25.9;HSkMC: 16.1;HUVEC TERT2: 18.2;U-2197: 38.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA055775, HPA058434" Enhanced Nucleoplasm "Intracellular and membrane" NA NA 19000 Nucleoplasm "HPA055775: AB_2732600, HPA058434: AB_2732622" "unprognostic (3.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (4.19e-3)" "unprognostic (1.16e-1)" "unprognostic (8.84e-2)" "unprognostic (1.39e-2)" "unprognostic (2.24e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.58e-1)" "unprognostic (9.86e-2)" "prognostic unfavorable (3.93e-5)" "unprognostic (7.99e-3)" "unprognostic (1.15e-2)" "unprognostic (5.22e-3)" "prognostic unfavorable (2.64e-4)" 50.5 16.5 5.4 8.0 11.3 1.9 35.1 4.6 9.1 19.8 12.4 4.4 3.5 7.0 15.2 10.4 11.1 10.8 22.6 18.0 7.6 3.5 19.5 8.5 51.8 4.7 10.2 4.3 19.9 8.7 7.9 7.0 40.5 10.1 12.6 5.1 16.6 5.2 9.4 29.0 9.9 7.7 13.0 5.7 21.2 8.1 8.6 8.7 0.6 16.6 9.7 2.1 19.8 25.1 0.2 0.0 1.0 0.0 0.0 3.1 9.6 0.0 0.0 0.4 0.0 42.0 25.9 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.2 0.0 0.8 0.0 0.0 16.1 0.0 1.4 0.0 0.3 18.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 4.8 2.7 0.3 38.6 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 3.1 9.6 5.4 11.3 4.6 9.1 7.6 3.5 10.2 4.3 10.1 8.7 0.0 7.0 3.4 0.2 12.9 0.0 3.4 0.0 1.4 2.3 0.0 0.0 1.3 0.0 0.1 1.3 91.0 0.0 0.0 0.0 149.6 48.9 1.2 2.3 0.8 3.3 0.0 0.0 70.6 4.4 1.1 8.3 5.2 16.9 0.0 0.2 0.4 0.0 2.9 8.5 0.1 0.0 38.8 74.8 0.5 2.7 10.9 7.0 1.3 0.0 1.1 LRRC42 MGC8974 ENSG00000116212 "Leucine rich repeat containing 42" Q9Y546 1 53946077-53968168 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047458, HPA050537, HPA064581" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA047458: , HPA050537: AB_2681161, HPA064581: AB_2685292" "unprognostic (3.13e-1)" "unprognostic (1.32e-1)" "unprognostic (5.88e-2)" "unprognostic (9.97e-3)" "unprognostic (4.01e-2)" "unprognostic (7.95e-3)" "prognostic unfavorable (3.88e-5)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (1.11e-1)" "unprognostic (1.13e-1)" "unprognostic (2.24e-2)" "unprognostic (9.08e-2)" "unprognostic (7.36e-3)" "unprognostic (1.67e-2)" 12.0 27.1 11.8 9.8 14.7 8.7 20.3 8.8 10.5 15.1 13.1 7.9 18.5 10.7 17.5 19.4 18.8 15.1 16.6 14.0 9.1 8.3 16.1 23.1 13.1 12.9 7.7 10.0 17.9 11.5 12.4 23.1 32.3 10.5 15.8 11.9 17.9 15.0 21.2 14.9 18.0 10.2 16.1 13.6 10.2 14.4 24.0 9.9 16.6 21.8 14.9 13.1 18.3 17.8 6.5 10.5 7.6 4.5 6.4 8.9 4.1 25.3 9.5 24.0 14.1 12.6 17.2 16.3 20.1 28.2 26.9 36.8 31.2 17.2 14.2 16.2 24.7 32.0 22.5 20.3 28.8 31.5 11.3 12.2 13.2 15.2 20.2 23.0 8.2 12.7 15.5 40.1 23.2 25.7 19.9 17.1 13.4 16.5 3.9 26.1 8.8 15.1 11.5 20.4 18.8 14.8 26.2 25.4 10.0 19.4 19.2 14.4 15.4 26.9 15.4 22.1 39.6 22.7 9.9 13.8 20.6 26.3 18.2 12.5 10.7 12.3 21.4 20.0 8.6 10.9 0.1 4.5 7.6 7.6 4.4 6.4 6.5 6.5 8.9 5.6 4.1 6.9 5.0 6.8 6.4 3.3 10.5 7.0 4.1 11.8 14.7 8.8 10.5 9.1 8.3 7.7 10.0 10.5 9.9 11.9 4.3 5.6 28.2 45.8 3.6 8.3 20.4 12.0 11.4 10.4 3.9 38.1 16.6 32.6 2.2 8.7 8.5 0.0 14.7 26.4 20.6 35.2 0.0 11.9 15.2 9.5 65.5 8.6 5.6 2.7 22.2 8.6 10.1 10.8 8.5 20.7 26.6 13.5 16.6 12.2 3.2 12.9 14.1 24.6 45.1 34.3 48.1 6.5 13.6 35.8 LSM2 "C6orf28, G7b, YBL026W" ENSG00000204392 "LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated" Q9Y333 6 31797396-31806984 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052805, HPA066718" Supported Enhanced Nucleoplasm NA NA 26000 Nucleoplasm "HPA052805: , HPA066718: AB_2685710" "unprognostic (1.69e-1)" "unprognostic (7.78e-2)" "unprognostic (5.65e-2)" "unprognostic (1.24e-1)" "unprognostic (5.10e-2)" "unprognostic (1.50e-1)" "unprognostic (1.36e-3)" "unprognostic (6.14e-2)" "unprognostic (1.03e-1)" "unprognostic (2.34e-3)" "unprognostic (1.51e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (5.59e-9)" "unprognostic (2.23e-1)" "unprognostic (8.48e-2)" "unprognostic (4.49e-2)" "unprognostic (9.59e-2)" 20.3 17.4 15.7 21.7 19.4 21.0 18.7 14.4 17.7 21.1 19.5 14.0 11.8 17.9 23.6 15.2 21.8 21.5 20.7 17.5 14.4 12.8 17.5 15.1 18.0 33.5 20.7 17.5 19.4 20.3 9.6 15.1 17.9 20.3 19.7 21.3 10.8 12.8 14.0 19.5 17.1 15.3 21.5 26.7 22.1 16.7 16.5 19.4 51.8 23.4 19.5 26.9 21.8 20.9 18.2 10.8 8.7 5.7 12.3 15.3 10.1 10.2 5.0 8.8 11.3 5.0 6.9 9.3 6.4 4.1 9.2 8.2 5.7 3.9 10.9 9.0 5.3 8.5 4.1 11.6 10.9 8.3 11.5 14.9 12.5 3.1 5.8 6.1 12.4 4.5 5.2 5.0 8.5 8.8 4.3 9.6 11.2 16.3 7.1 6.5 7.4 14.9 28.4 8.1 7.7 10.9 9.2 7.0 16.0 7.6 3.0 8.9 7.7 6.9 6.2 12.5 4.8 6.8 9.9 5.0 5.5 9.6 6.3 10.3 7.4 12.6 13.9 2.8 14.8 8.5 8.7 5.7 3.6 9.4 5.2 12.4 18.2 10.1 10.6 9.5 16.1 9.7 11.9 1.2 12.3 4.4 10.8 15.3 10.1 15.7 19.4 14.4 17.7 14.4 12.8 20.7 17.5 20.3 19.4 20.8 23.4 106.9 62.3 51.7 30.5 12.2 40.8 18.7 22.7 52.4 5.9 114.2 96.2 89.8 18.3 82.4 26.4 70.0 118.6 172.4 68.7 55.0 82.9 52.9 122.6 28.6 51.9 62.0 59.2 20.0 46.1 69.2 87.7 110.0 89.7 34.6 82.0 49.1 46.3 86.4 26.4 45.3 57.7 49.6 178.0 56.1 57.7 108.4 103.8 39.9 LTV1 "C6orf93, dJ468K18.4, FLJ14909" ENSG00000135521 "LTV1 ribosome biogenesis factor" Q96GA3 6 143843344-143863812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA030159, HPA030160, HPA030161" Approved Enhanced Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA030159: AB_10600770, HPA030160: AB_10600056, HPA030161: AB_10602001" "unprognostic (2.26e-2)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" "unprognostic (5.45e-2)" "unprognostic (1.11e-1)" "unprognostic (1.99e-2)" "prognostic unfavorable (4.95e-5)" "unprognostic (7.09e-2)" "unprognostic (2.16e-1)" "unprognostic (1.55e-2)" "unprognostic (1.26e-1)" "unprognostic (4.70e-2)" "prognostic unfavorable (6.01e-13)" "unprognostic (2.94e-1)" "unprognostic (6.83e-2)" "unprognostic (8.62e-3)" "unprognostic (1.41e-1)" 20.0 20.6 15.6 19.5 26.2 39.3 26.7 19.4 26.0 14.6 16.5 11.1 17.9 13.8 21.2 14.7 21.2 18.0 11.3 15.7 25.1 10.9 14.4 29.0 18.9 21.2 21.0 17.1 20.6 20.9 13.3 19.7 17.3 17.4 16.3 18.9 8.0 16.6 18.5 52.0 23.5 17.2 20.7 18.5 20.8 18.3 17.5 18.1 15.0 16.1 26.4 21.8 16.6 25.5 17.3 18.4 4.1 12.9 21.2 16.1 8.3 11.7 11.0 13.1 29.1 9.7 11.9 15.2 18.3 13.5 20.3 16.2 17.8 6.1 24.8 14.8 16.5 22.3 13.3 21.8 17.9 28.4 14.2 21.3 49.0 12.6 27.3 17.2 60.2 28.5 13.3 13.2 22.5 24.8 8.4 14.0 14.5 46.5 16.5 15.6 19.8 20.5 25.7 15.5 13.5 12.2 17.8 24.8 11.1 15.0 16.4 11.6 14.0 18.7 15.5 17.0 12.5 8.7 38.6 12.6 13.0 15.0 28.9 33.5 20.6 25.3 33.7 13.0 31.6 18.2 1.2 10.1 4.1 12.1 12.9 13.1 17.3 12.7 13.0 15.2 14.3 14.1 16.1 0.3 21.2 11.0 18.4 10.9 8.3 15.6 26.2 19.4 26.0 25.1 10.9 21.0 17.1 17.4 18.1 6.0 28.5 25.1 16.5 22.8 9.2 21.2 10.2 29.4 30.7 7.0 2.0 22.4 11.6 22.5 19.1 16.8 7.4 0.0 24.9 25.7 22.1 9.1 24.3 17.3 24.9 11.1 18.9 11.1 11.1 6.2 23.9 21.1 5.0 37.9 11.7 9.9 24.3 8.6 25.8 12.4 8.7 6.5 15.6 50.2 65.1 28.1 13.6 16.6 16.4 15.6 LYAR "ZC2HC2, ZLYAR" ENSG00000145220 "Ly1 antibody reactive" Q9NX58 4 4267701-4290169 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.2" "Cell type enhanced" "Detected in many" 12 "Spermatocytes: 435.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035880, HPA035881" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA035880: , HPA035881: AB_10669980" "unprognostic (2.81e-1)" "unprognostic (3.79e-1)" "unprognostic (2.64e-2)" "unprognostic (6.22e-3)" "unprognostic (1.44e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (3.20e-5)" "unprognostic (1.08e-3)" "unprognostic (2.92e-2)" "prognostic favorable (8.82e-4)" "unprognostic (5.05e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (4.36e-10)" "unprognostic (4.94e-2)" "unprognostic (1.61e-1)" "unprognostic (5.90e-2)" "unprognostic (2.72e-1)" 11.1 5.7 6.8 11.9 10.1 10.9 8.2 7.3 8.0 6.6 6.9 4.3 4.1 5.7 6.9 5.5 11.2 7.1 5.4 10.1 7.0 4.6 5.0 9.9 7.7 13.8 10.9 4.5 11.1 6.3 4.4 15.6 7.1 8.4 7.8 6.8 3.7 5.4 6.4 15.1 5.9 6.2 9.1 7.9 18.2 5.8 60.2 12.0 10.0 6.3 11.9 10.9 10.1 10.4 7.3 7.1 8.9 12.9 10.7 32.8 10.3 13.3 7.0 6.3 9.2 5.5 6.3 10.8 12.2 4.2 12.7 8.8 22.0 17.6 35.9 8.8 5.2 20.5 8.5 23.5 12.7 16.7 6.4 17.3 36.0 6.7 24.6 9.4 41.5 9.8 4.9 8.1 14.6 24.9 3.3 10.9 20.5 48.1 12.0 8.8 13.5 14.1 53.5 31.3 14.2 23.0 21.7 11.5 17.3 5.7 9.3 15.0 6.4 6.6 7.3 12.4 8.4 7.5 12.4 10.2 12.7 10.1 16.5 38.4 8.5 12.8 57.4 8.6 35.1 10.2 8.9 9.7 8.5 28.6 9.6 32.8 7.3 18.9 30.8 7.1 5.7 8.9 19.0 2.8 10.7 12.9 5.3 8.8 10.3 6.8 10.1 7.3 8.0 7.0 4.6 10.9 4.5 8.4 12.0 14.9 30.0 19.7 34.4 106.7 9.4 21.6 12.7 26.8 36.4 1.8 7.9 43.0 8.3 15.1 74.2 29.5 2.8 0.0 17.0 43.6 29.4 25.4 20.8 10.6 32.5 14.3 10.3 8.6 30.8 61.9 31.7 32.1 20.3 19.0 16.0 9.6 22.6 13.9 25.1 5.1 28.7 38.8 35.0 435.9 39.2 101.3 16.9 130.7 24.0 62.3 LYSMD1 "MGC35223, RP11-68I18.5, SB145" ENSG00000163155 "LysM domain containing 1" Q96S90 1 151159748-151165948 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028055, HPA064537" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA028055: AB_10601912, HPA064537: AB_2685281" "unprognostic (1.71e-1)" "unprognostic (1.45e-2)" "unprognostic (1.19e-2)" "unprognostic (3.60e-3)" "unprognostic (2.59e-3)" "unprognostic (8.26e-2)" "unprognostic (7.24e-3)" "unprognostic (7.31e-3)" "unprognostic (1.77e-1)" "unprognostic (1.53e-2)" "unprognostic (1.88e-1)" "unprognostic (2.24e-2)" "unprognostic (8.72e-3)" "unprognostic (1.80e-1)" "unprognostic (2.07e-1)" "unprognostic (8.47e-3)" "unprognostic (6.33e-2)" 8.2 11.2 9.0 4.7 11.2 2.1 10.0 20.8 13.4 11.0 9.3 13.0 10.7 10.6 12.1 7.9 8.6 11.4 8.7 13.2 8.8 9.1 9.4 9.3 5.9 5.2 8.5 9.9 19.8 10.9 13.8 14.8 13.2 11.0 10.6 9.8 11.1 9.0 15.4 20.6 9.2 8.7 12.4 9.3 6.3 8.2 7.3 10.6 8.2 11.1 6.4 5.7 10.0 8.8 3.6 3.3 7.2 2.1 3.1 3.5 0.7 4.1 4.5 9.7 7.6 5.7 6.4 7.6 6.1 5.3 7.2 6.5 2.8 5.0 5.5 7.4 3.9 3.7 7.3 7.6 4.2 5.3 10.5 8.4 3.1 7.4 3.0 9.0 3.2 5.1 8.9 9.4 6.7 9.7 9.8 3.0 12.6 6.2 5.3 5.0 6.6 8.3 4.1 6.2 4.2 5.8 6.0 7.1 3.2 5.3 1.9 11.8 14.4 4.5 13.9 7.8 12.9 8.5 11.2 3.0 5.6 3.1 3.5 7.8 16.9 12.9 2.6 4.8 1.3 5.2 3.8 2.1 3.0 2.1 1.3 2.4 1.7 2.5 1.4 1.6 3.6 3.3 3.5 7.2 3.1 1.7 3.3 3.3 0.7 9.0 11.2 20.8 13.2 8.8 9.1 8.5 9.9 11.0 10.6 0.0 0.3 0.0 0.8 0.8 4.1 7.5 0.0 4.0 4.5 5.2 5.9 3.4 3.3 1.8 0.3 0.9 3.4 0.0 0.5 2.3 2.7 1.0 0.0 3.2 0.5 1.6 4.1 2.5 0.0 0.0 4.0 0.0 1.7 0.0 1.9 3.4 1.9 0.0 5.6 4.3 7.9 0.0 3.0 1.6 2.5 1.0 2.4 0.0 2.7 0.9 LYST "CHS, CHS1" ENSG00000143669 "Lysosomal trafficking regulator" Q99698 1 235661041-235883640 "Disease related genes, Predicted intracellular proteins" "Phagocytosis, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.8" "Cell type enhanced" "Detected in many" 6 "monocytes: 236.3;Rod photoreceptor cells: 167.4" "Cancer enhanced" "Detected in all" "melanoma: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Group enriched" "Detected in all" 5 "granulocytes: 13.0;monocytes: 5.9" "Cell line enhanced" "Detected in many" "HDLM-2: 13.7;SK-MEL-30: 12.7;THP-1: 44.9;U-937: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053366, HPA055725" Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" Yes No Nucleoplasm "Plasma membrane, Centriolar satellite" "HPA053366: AB_2682129, HPA055725: AB_2682898" "unprognostic (1.56e-2)" "unprognostic (1.54e-1)" "unprognostic (9.92e-2)" "unprognostic (8.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.32e-2)" "unprognostic (4.11e-2)" "unprognostic (7.79e-2)" "unprognostic (4.08e-2)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.27e-5)" "unprognostic (1.59e-1)" "unprognostic (1.54e-1)" "unprognostic (6.29e-2)" "unprognostic (1.99e-1)" 10.3 5.2 6.4 9.0 8.8 31.3 10.6 10.5 7.1 8.8 5.3 3.8 3.4 3.4 6.8 4.3 6.6 5.6 5.8 4.7 4.3 2.4 5.0 6.1 10.9 7.8 4.2 6.0 6.2 5.0 9.1 12.6 5.5 5.3 6.0 5.0 9.6 8.2 4.8 3.9 11.7 6.3 9.8 9.2 11.3 8.4 6.4 6.3 38.8 8.5 4.0 7.6 9.3 10.6 1.6 1.7 13.0 5.9 1.7 1.0 0.7 3.8 0.9 0.4 0.9 6.0 6.9 0.6 1.4 5.7 1.5 1.4 0.0 1.0 0.5 0.6 3.1 3.6 1.8 0.5 0.7 1.3 13.7 1.2 1.2 0.8 0.3 1.1 1.8 1.7 2.3 3.6 1.9 4.7 2.2 1.2 0.6 0.1 0.8 1.2 0.2 2.3 3.9 0.1 0.7 0.4 0.1 0.5 0.0 4.4 4.2 2.5 0.5 1.5 0.0 12.7 0.5 0.5 44.9 2.6 1.1 0.5 1.3 1.2 0.9 0.0 0.0 1.9 17.2 3.2 0.4 3.1 5.7 0.6 3.5 1.0 1.1 0.3 0.7 1.7 1.6 0.2 0.5 13.0 1.7 5.9 0.2 0.2 0.7 6.4 8.8 10.5 7.1 4.3 2.4 4.2 6.0 5.3 6.3 17.9 50.4 48.0 71.9 63.1 61.8 9.2 10.2 24.1 39.8 10.4 88.4 5.4 10.0 5.6 9.9 41.7 11.5 0.0 10.7 4.0 23.9 49.0 106.6 14.5 28.2 49.3 9.2 15.4 73.1 13.4 25.9 70.4 114.7 236.3 11.3 23.7 24.4 14.2 20.5 9.0 167.4 12.9 28.6 79.6 22.6 57.0 7.3 65.4 6.3 82.9 MAB21L2 ENSG00000181541 "Mab-21 like 2" Q9Y586 4 150581922-150584693 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.2;intestine: 59.8;smooth muscle: 15.2" "Cell type enhanced" "Detected in some" 24 "Cholangiocytes: 12.7;Horizontal cells: 23.8;Muller glia cells: 5.1" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.3" "Region enriched" "Detected in some" 18 "pons and medulla: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "hTERT-RPE1: 46.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049324, HPA059864" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049324: AB_2680712, HPA059864: AB_2684147" "unprognostic (1.12e-1)" "unprognostic (3.67e-2)" "unprognostic (4.03e-2)" "unprognostic (2.63e-1)" "unprognostic (2.32e-1)" "unprognostic (3.85e-2)" "unprognostic (8.99e-2)" "unprognostic (2.76e-2)" "unprognostic (2.75e-1)" "unprognostic (6.60e-2)" "unprognostic (4.78e-3)" "unprognostic (1.18e-1)" "unprognostic (6.81e-2)" "unprognostic (1.68e-1)" 0.6 3.1 0.2 8.6 0.4 0.0 0.1 0.2 0.2 0.2 59.8 0.1 0.0 6.8 0.1 0.9 0.9 0.2 0.5 0.7 0.2 0.6 0.1 0.5 0.1 0.6 1.0 0.0 0.1 0.2 0.0 0.3 0.0 19.2 0.2 8.1 9.0 2.2 0.0 0.3 0.2 14.7 15.2 4.5 0.1 0.3 0.1 0.0 0.2 1.4 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.0 0.0 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 0.6 1.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.8 12.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MAEA "EMP, GID9" ENSG00000090316 "Macrophage erythroblast attacher" Q7L5Y9 4 1289851-1340147 "Predicted intracellular proteins" "Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway" "Actin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036886, HPA058185" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA036886: , HPA058185: AB_2683633" "unprognostic (2.70e-2)" "unprognostic (1.52e-1)" "unprognostic (1.78e-2)" "unprognostic (1.11e-1)" "unprognostic (2.03e-2)" "prognostic favorable (5.34e-4)" "unprognostic (3.10e-3)" "unprognostic (3.89e-2)" "unprognostic (1.78e-1)" "unprognostic (2.50e-1)" "unprognostic (6.94e-3)" "unprognostic (4.65e-3)" "prognostic favorable (1.90e-4)" "unprognostic (1.17e-2)" "unprognostic (2.49e-1)" "unprognostic (1.97e-1)" "unprognostic (4.51e-2)" 23.6 35.4 25.5 26.3 28.4 19.5 20.9 34.0 35.8 24.4 33.3 21.7 26.8 39.9 27.3 23.8 34.7 26.0 29.2 36.6 23.7 33.1 33.2 27.9 19.1 26.1 23.3 32.0 33.4 32.0 21.9 30.3 27.6 34.0 23.6 17.2 22.3 36.7 28.0 27.3 29.0 38.2 20.9 17.7 31.0 30.3 23.3 26.7 26.5 26.1 28.5 26.5 26.3 25.4 19.7 18.9 48.2 28.0 17.0 35.8 21.9 22.7 27.0 19.2 19.0 12.8 12.8 25.0 23.3 12.2 18.8 17.3 28.0 29.3 20.7 18.2 16.7 34.9 16.9 18.4 28.5 7.8 16.6 20.5 19.5 29.8 26.7 15.3 21.9 21.0 15.9 15.6 15.2 9.6 13.1 15.2 20.0 27.1 16.6 16.5 24.1 32.5 33.6 25.3 24.7 29.1 31.7 15.4 18.7 20.1 27.5 34.5 24.1 20.8 15.7 15.8 11.2 29.0 19.1 21.3 35.1 15.1 16.0 38.5 20.9 32.0 22.8 24.5 20.2 19.3 23.9 20.2 27.2 25.5 20.7 35.8 19.7 20.5 24.1 18.9 16.5 18.3 18.8 48.2 17.0 28.0 13.3 23.1 21.9 25.5 28.4 34.0 35.8 23.7 33.1 23.3 32.0 34.0 26.7 17.9 23.5 19.1 12.9 16.7 25.9 30.8 12.7 14.7 21.6 15.7 19.6 42.4 39.7 39.2 5.8 20.4 33.8 0.0 26.5 43.0 21.1 18.9 10.4 15.3 34.2 20.6 19.5 18.4 22.3 8.2 32.8 16.9 27.0 55.9 30.8 20.6 33.1 32.0 35.0 28.1 18.6 12.9 16.5 25.9 41.2 17.3 79.6 27.4 32.9 18.6 MAFK "NFE2U, P18" ENSG00000198517 "MAF bZIP transcription factor K" O60675 7 1530714-1543043 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 62.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2 OS: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026820, HPA060841" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "CAB026820: , HPA060841: AB_2684377" "unprognostic (6.82e-2)" "unprognostic (3.71e-3)" "unprognostic (1.49e-2)" "unprognostic (2.55e-1)" "unprognostic (6.44e-3)" "unprognostic (1.19e-1)" "unprognostic (9.44e-2)" "unprognostic (2.28e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-2)" "unprognostic (2.81e-1)" "unprognostic (1.40e-1)" "unprognostic (2.83e-2)" "unprognostic (1.08e-2)" "unprognostic (1.24e-1)" "unprognostic (5.59e-2)" "unprognostic (2.14e-1)" 15.7 14.3 12.6 12.4 20.1 16.3 13.0 4.2 12.5 9.3 18.0 13.5 6.7 18.2 14.7 5.0 10.1 10.2 12.7 30.9 13.2 11.8 10.5 10.9 18.7 8.7 19.7 11.0 7.2 34.9 6.0 8.7 62.4 14.5 16.1 5.1 6.7 11.0 12.0 26.8 12.8 16.8 26.1 12.1 11.3 13.2 4.1 13.1 22.8 9.1 9.7 7.5 13.7 19.0 1.9 5.1 3.6 1.7 1.5 2.6 1.4 20.0 14.4 0.5 2.1 1.6 2.0 11.0 13.3 7.6 3.2 2.3 10.3 5.5 4.7 4.9 3.3 21.9 15.6 1.2 3.8 1.4 7.2 10.5 2.7 18.4 7.5 3.7 6.4 8.7 2.0 5.0 5.4 4.1 4.0 2.9 14.8 7.0 2.6 1.5 13.2 7.2 23.1 4.6 4.9 14.6 10.9 0.5 7.9 3.0 8.3 6.2 2.3 8.0 23.8 5.8 3.3 9.2 8.6 6.9 5.0 34.8 25.0 7.2 5.0 1.5 7.8 6.6 8.9 7.0 1.7 1.6 3.6 2.1 0.8 2.3 1.4 1.2 2.5 0.7 1.9 2.6 2.0 2.2 1.5 1.7 5.1 2.2 1.4 12.6 20.1 4.2 12.5 13.2 11.8 19.7 11.0 14.5 13.1 38.7 21.2 5.1 38.8 56.7 1.8 2.4 12.7 9.4 15.9 29.6 2.0 7.9 1.7 12.6 2.8 17.5 32.5 0.0 12.9 7.1 20.6 51.3 9.2 11.6 9.5 11.1 22.2 10.4 16.3 3.8 4.4 14.9 18.6 5.4 21.7 7.5 30.7 26.8 2.8 2.1 0.6 12.9 22.7 0.5 4.7 50.4 65.2 8.6 13.4 64.3 MAGED2 "11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386" ENSG00000102316 "MAGE family member D2" Q9UNF1 X 54807599-54816012 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Bartter syndrome, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 301.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031572, HPA031573" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli, Cytosol" "HPA031572: AB_10599819, HPA031573: AB_10602181" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.32e-1)" "unprognostic (1.69e-3)" "unprognostic (4.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.41e-3)" "unprognostic (1.39e-1)" "unprognostic (2.97e-1)" "prognostic favorable (2.88e-4)" "prognostic favorable (2.82e-4)" "unprognostic (6.34e-2)" "unprognostic (3.55e-3)" "prognostic unfavorable (9.43e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" "unprognostic (3.58e-1)" 22.1 38.4 26.9 14.8 26.5 8.2 50.2 24.4 43.0 55.7 27.3 27.8 21.4 16.2 41.1 31.8 21.9 45.9 28.5 40.7 23.8 38.2 42.7 17.3 24.0 13.5 30.3 36.0 79.7 23.5 34.5 57.6 58.6 57.1 63.9 16.4 43.1 32.0 53.7 25.6 16.5 17.6 41.6 24.7 17.5 22.5 21.8 18.3 23.4 45.1 17.3 22.0 31.9 29.2 17.1 11.7 43.1 37.0 28.5 35.5 32.5 5.4 10.0 60.2 18.3 28.7 39.1 11.1 22.5 40.2 17.9 31.8 10.0 13.9 7.6 59.1 45.3 14.7 7.4 17.1 17.0 12.9 13.5 14.2 15.7 11.9 19.5 24.6 4.0 12.1 51.1 7.1 18.1 9.2 36.9 33.9 8.9 3.8 9.3 34.1 15.0 8.9 6.7 22.2 9.5 12.0 5.9 21.6 10.8 24.5 4.1 9.5 24.5 8.9 10.4 52.0 73.5 42.9 6.8 29.2 15.3 23.8 22.7 6.3 6.0 5.0 5.4 22.3 10.6 77.7 43.1 9.1 35.5 35.5 22.4 27.3 16.3 29.4 33.1 11.7 17.1 29.7 34.1 3.4 28.5 37.0 7.2 29.2 32.5 26.9 26.5 24.4 43.0 23.8 38.2 30.3 36.0 57.1 18.3 41.7 33.9 29.8 80.0 37.7 72.3 51.6 53.5 66.9 30.7 73.3 27.5 185.2 208.9 88.2 2.4 76.6 14.7 0.0 47.8 117.1 94.0 95.1 100.4 13.2 60.7 130.3 56.0 66.9 12.9 8.5 216.0 36.3 150.1 64.9 42.6 178.6 48.5 32.3 301.2 111.7 49.9 155.2 150.8 13.5 12.4 30.6 141.5 45.4 24.9 55.9 MAN2C1 "MANA, MANA1" ENSG00000140400 "Mannosidase alpha class 2C member 1" Q9NTJ4 15 75355207-75368630 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040627, HPA067407" Uncertain Enhanced Nucleoplasm NA NA 9000 Nucleoplasm "HPA040627: AB_10795490, HPA067407: AB_2685834" "unprognostic (4.68e-2)" "unprognostic (1.95e-1)" "unprognostic (3.84e-3)" "unprognostic (3.48e-2)" "unprognostic (3.85e-1)" "unprognostic (3.00e-2)" "unprognostic (1.26e-2)" "unprognostic (6.26e-2)" "unprognostic (2.47e-1)" "unprognostic (5.02e-2)" "unprognostic (1.06e-2)" "unprognostic (3.40e-2)" "unprognostic (4.87e-3)" "unprognostic (9.56e-2)" "unprognostic (1.33e-1)" "unprognostic (2.91e-1)" "unprognostic (1.39e-3)" 29.9 28.8 22.6 20.4 26.0 30.0 24.6 27.5 25.5 25.1 25.1 26.8 23.8 22.9 27.8 27.5 20.2 24.2 23.3 28.2 18.3 12.9 22.9 21.4 25.2 17.0 23.0 28.3 32.8 22.3 28.2 30.6 22.4 18.3 24.9 14.2 30.8 25.6 20.2 37.9 30.9 27.7 20.0 15.0 28.1 23.0 28.8 19.9 21.0 34.7 15.3 19.5 21.1 21.3 2.3 15.7 2.6 16.2 3.9 7.3 8.5 5.5 13.3 11.1 8.0 12.7 11.0 13.8 12.9 12.2 6.8 5.7 9.2 19.1 2.7 7.6 9.4 6.2 17.2 6.1 8.7 4.4 15.2 13.4 17.5 25.2 9.1 18.8 11.2 2.8 13.1 8.8 6.4 8.1 14.4 15.8 8.0 10.0 14.4 5.5 10.8 5.5 12.7 4.7 6.6 5.6 7.8 5.6 16.6 8.9 25.9 6.6 12.0 8.2 12.5 5.8 8.3 12.4 13.1 30.9 14.3 10.0 9.9 12.7 14.4 3.5 4.4 9.2 12.9 14.2 2.6 13.3 2.0 7.2 16.2 6.8 2.3 5.3 5.2 15.7 2.0 7.3 5.1 1.4 3.9 12.4 6.4 7.0 8.5 22.6 26.0 27.5 25.5 18.3 12.9 23.0 28.3 18.3 19.9 20.8 52.5 12.9 13.4 11.9 32.1 2.0 5.1 16.0 18.2 8.7 51.1 14.5 3.3 9.4 8.2 17.2 21.3 0.0 7.7 8.8 15.0 13.8 31.1 21.5 17.5 27.0 32.8 33.2 37.8 10.6 21.6 24.1 15.1 19.8 21.0 18.6 9.2 14.4 11.7 12.3 52.0 25.8 10.4 18.6 10.9 7.4 17.7 12.7 20.7 11.9 MAPK7 "BMK1, ERK5, PRKM7" ENSG00000166484 "Mitogen-activated protein kinase 7" Q13164 17 19377721-19383544 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Differentiation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 25.8;Spermatocytes: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 24.1;SuSa: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018561, HPA031031" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB018561: AB_2140544, HPA031031: AB_2673706" "unprognostic (1.63e-1)" "unprognostic (2.75e-2)" "unprognostic (1.72e-1)" "unprognostic (2.90e-2)" "unprognostic (4.38e-2)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (5.67e-3)" "unprognostic (1.62e-2)" "unprognostic (1.16e-1)" "unprognostic (1.83e-2)" "unprognostic (4.75e-2)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (5.71e-1)" "unprognostic (1.55e-1)" "unprognostic (3.78e-2)" 11.5 15.0 6.4 7.3 7.6 9.2 11.8 12.5 7.9 13.4 15.3 7.2 6.0 9.2 13.1 14.1 17.3 9.4 11.8 8.2 5.9 4.7 10.8 4.8 9.9 9.2 8.2 5.2 25.4 5.7 7.3 7.5 12.5 6.7 14.0 6.9 10.5 7.8 12.3 7.5 13.1 11.2 13.8 7.1 13.2 8.0 13.3 7.5 4.5 8.6 11.3 10.6 12.7 15.9 2.2 2.6 11.5 7.4 5.5 4.7 3.0 3.6 5.8 4.8 3.7 24.1 10.1 5.6 5.0 4.6 6.9 6.4 6.7 0.6 2.2 4.0 8.6 5.1 4.1 5.6 4.6 4.3 3.8 4.3 1.0 4.1 2.9 10.4 0.9 3.7 10.6 3.2 10.5 3.7 6.0 5.1 4.3 1.9 0.8 6.9 2.4 7.4 3.9 5.5 3.7 3.8 4.0 7.0 1.5 2.3 2.0 2.2 6.4 5.1 0.5 2.5 29.6 3.1 1.2 2.8 7.4 5.5 8.2 3.4 1.4 2.1 0.6 8.6 0.9 4.5 1.0 3.6 11.5 4.7 7.4 2.5 2.2 2.2 4.1 2.6 1.4 2.1 2.6 1.3 5.5 6.5 1.7 1.0 3.0 6.4 7.6 12.5 7.9 5.9 4.7 8.2 5.2 6.7 7.5 6.0 3.5 6.2 5.5 4.8 2.0 1.7 0.0 1.4 2.3 5.2 2.0 4.8 5.0 7.1 6.3 7.1 9.0 0.0 5.3 6.9 8.3 5.5 2.3 1.3 6.7 0.0 10.3 6.7 6.7 5.9 10.6 6.3 3.3 2.8 5.7 14.5 6.2 13.5 11.0 3.0 2.0 25.8 8.6 31.4 10.6 3.8 4.2 4.4 6.1 5.2 MASP1 "CRARF, MASP, PRSS5" ENSG00000127241 "Mannan binding lectin serine peptidase 1" P48740 3 187217285-187292022 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement activation lectin pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 43.4;liver: 80.1" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 32.5;Cholangiocytes: 28.1;Hepatocytes: 57.1;Ito cells: 30.7" "Group enriched" "Detected in some" 9 "glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BJ: 27.1;BJ hTERT+: 103.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001617, HPA009641" Supported Enhanced Nucleoplasm,Cytosol "Secreted to blood" No NA 8670000000 1800000000 "Nucleoplasm, Cytosol" "HPA001617: AB_1079314, HPA009641: AB_1079313" "unprognostic (1.67e-1)" "unprognostic (1.02e-2)" "unprognostic (1.99e-1)" "unprognostic (5.20e-2)" "unprognostic (1.02e-2)" "unprognostic (1.25e-6)" "prognostic favorable (2.20e-4)" "unprognostic (9.92e-2)" "unprognostic (3.22e-1)" "unprognostic (2.29e-1)" "unprognostic (4.18e-1)" "unprognostic (1.29e-1)" "unprognostic (2.82e-3)" "unprognostic (3.56e-3)" "unprognostic (1.97e-1)" "unprognostic (7.85e-2)" "unprognostic (4.29e-1)" 2.1 1.4 3.6 1.2 3.8 0.1 1.2 1.9 10.2 43.4 19.1 14.8 2.4 0.8 34.9 7.1 4.1 6.7 3.3 39.6 6.1 2.5 1.6 80.1 2.2 0.4 6.4 3.0 1.7 0.2 0.2 0.5 3.2 13.0 17.4 2.1 0.1 0.9 19.4 12.2 2.5 2.6 17.1 21.8 0.4 0.6 1.5 6.7 0.0 1.3 6.3 3.5 4.4 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 3.7 0.0 27.1 103.4 0.4 0.1 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.8 1.9 3.5 6.1 2.5 6.4 3.0 13.0 6.7 0.0 2.6 0.0 0.1 2.6 0.0 32.5 28.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.6 0.7 0.0 0.0 0.0 0.2 11.0 0.0 0.0 57.1 0.4 0.0 0.0 30.7 2.4 3.8 2.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.0 5.9 0.0 0.0 1.5 0.1 0.5 0.0 0.1 MASTL "FLJ14813, Gwl, THC2" ENSG00000120539 "Microtubule associated serine/threonine kinase like" Q96GX5 10 27154824-27186924 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 20.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027175, HPA054273" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA027175: AB_1853591, HPA054273: AB_2682433" "unprognostic (4.10e-2)" "unprognostic (6.89e-2)" "unprognostic (1.22e-2)" "unprognostic (3.14e-3)" "unprognostic (3.67e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.52e-6)" "unprognostic (2.19e-2)" "unprognostic (4.00e-2)" "unprognostic (4.05e-2)" "prognostic unfavorable (4.81e-5)" "unprognostic (3.78e-2)" "prognostic unfavorable (1.71e-6)" "unprognostic (1.55e-3)" "unprognostic (2.27e-1)" "unprognostic (2.66e-1)" "unprognostic (1.79e-1)" 9.1 7.0 3.6 8.9 6.1 21.1 8.3 4.0 7.5 7.4 7.6 3.8 5.7 5.7 6.0 6.7 12.3 5.4 5.3 5.6 6.8 4.5 6.5 7.1 10.2 14.8 5.4 5.7 7.0 12.7 6.7 6.3 14.2 6.7 5.5 7.1 5.6 8.0 4.7 4.0 10.1 10.0 6.1 5.6 8.7 6.2 11.3 2.3 21.1 6.5 4.3 12.3 8.7 7.5 3.9 2.6 5.6 4.9 2.3 4.0 1.8 11.9 9.6 18.4 6.8 2.8 4.2 10.9 17.9 7.5 29.7 36.6 11.6 12.0 9.6 6.8 7.5 14.4 11.6 11.7 7.1 21.1 8.1 11.3 11.3 6.7 6.7 1.6 4.3 8.5 2.5 3.2 17.9 3.5 3.9 6.4 7.8 8.6 21.6 18.0 7.9 14.0 4.7 13.7 6.7 3.9 9.0 30.7 7.9 7.3 4.5 8.2 11.8 11.3 7.6 7.9 12.7 7.6 9.1 5.5 7.4 15.6 18.9 15.7 2.6 4.2 14.1 8.1 13.1 6.1 0.1 4.4 3.8 2.0 4.3 3.0 2.6 2.5 1.8 2.5 3.9 2.5 2.3 5.6 2.3 4.9 2.6 4.0 1.8 3.6 6.1 4.0 7.5 6.8 4.5 5.4 5.7 6.7 2.3 6.0 8.5 7.2 4.0 9.7 1.9 1.6 0.0 4.0 9.1 1.8 0.0 3.3 0.0 3.2 1.7 3.6 3.0 0.0 2.2 20.7 5.8 3.3 12.7 1.7 5.1 3.2 4.1 2.5 12.0 1.5 2.8 5.6 0.0 1.8 3.4 1.5 3.6 1.9 2.5 1.4 0.9 0.0 5.9 11.2 16.4 8.7 5.1 8.7 3.5 5.9 MAZ "Pur-1, ZF87, Zif87, ZNF801" ENSG00000103495 "MYC associated zinc finger protein" P56270 16 29806106-29811164 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Intestinal endocrine cells: 128.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048315, HPA059495, HPA065930" Approved Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA048315: AB_2680353, HPA059495: AB_2684039, HPA065930: AB_2685579" "unprognostic (1.05e-1)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" "unprognostic (3.83e-1)" "unprognostic (3.25e-3)" "unprognostic (6.16e-2)" "unprognostic (1.27e-1)" "unprognostic (5.12e-2)" "unprognostic (2.00e-1)" "unprognostic (6.39e-3)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.20e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.22e-4)" "unprognostic (7.08e-2)" 23.9 32.2 49.3 34.0 37.9 86.3 62.2 57.3 49.0 31.7 51.5 25.5 30.8 34.8 33.1 26.5 31.1 34.9 31.4 21.3 43.3 30.1 22.8 33.0 31.3 52.5 30.5 32.4 38.4 39.8 44.5 30.2 24.2 22.1 48.1 38.8 29.0 32.3 31.2 41.0 35.8 34.6 29.1 22.9 34.5 28.7 28.4 25.4 141.5 30.2 26.7 40.8 30.6 39.4 5.7 8.4 9.5 9.9 16.4 28.6 8.7 28.1 37.6 38.9 42.3 21.1 20.1 35.1 20.6 16.9 32.2 23.4 48.0 40.7 50.6 26.9 40.2 15.9 25.7 63.8 26.9 11.5 41.2 102.1 33.5 81.7 65.4 29.7 82.8 41.8 21.4 38.1 27.0 30.6 30.1 32.1 71.6 49.0 44.6 15.2 116.4 79.3 70.6 39.4 30.9 29.4 78.5 36.7 58.9 26.2 30.7 59.8 46.6 19.7 42.8 25.8 26.1 36.8 80.0 22.0 35.5 28.6 13.5 32.0 32.6 41.0 55.9 17.4 54.8 29.3 6.8 6.3 9.5 26.1 9.9 28.6 5.7 17.5 24.8 8.0 4.2 14.6 21.4 5.0 16.4 6.2 8.4 18.4 8.7 49.3 37.9 57.3 49.0 43.3 30.1 30.5 32.4 22.1 25.4 6.0 4.8 31.8 14.3 29.2 60.4 0.3 33.1 9.4 6.8 10.4 11.8 21.0 24.9 29.7 2.1 30.0 41.1 0.0 35.5 46.9 42.8 30.2 33.4 34.2 49.7 44.5 128.1 28.8 32.4 3.4 25.9 25.0 43.9 13.6 101.5 21.1 32.8 59.6 34.6 17.0 30.3 32.3 47.4 17.7 20.5 31.0 14.0 40.1 104.1 11.3 MBD1 "CXXC3, PCM1" ENSG00000141644 "Methyl-CpG binding domain protein 1" Q9UIS9 18 50266882-50281774 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009017, CAB036003, HPA068850" Approved Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB009017: AB_2095559, CAB036003: , HPA068850: AB_2732121" "unprognostic (2.12e-2)" "unprognostic (5.05e-2)" "unprognostic (6.88e-2)" "unprognostic (5.01e-3)" "unprognostic (9.20e-2)" "unprognostic (6.85e-2)" "prognostic unfavorable (5.08e-6)" "unprognostic (5.91e-2)" "unprognostic (2.61e-2)" "unprognostic (4.65e-2)" "unprognostic (1.96e-3)" "prognostic unfavorable (1.70e-6)" "unprognostic (7.06e-3)" "unprognostic (7.70e-2)" "unprognostic (7.05e-2)" "unprognostic (4.61e-2)" "unprognostic (1.31e-1)" 14.7 21.7 18.0 18.8 20.8 29.4 15.7 27.1 29.4 15.3 17.2 18.8 16.2 18.7 18.4 16.6 21.1 16.4 16.8 19.7 19.2 14.0 17.4 18.9 16.0 20.9 21.8 23.1 20.7 19.7 28.2 24.2 19.4 18.2 18.0 13.9 15.0 19.6 19.5 25.9 24.2 18.3 18.3 15.2 22.6 18.0 72.3 21.5 19.1 19.9 20.0 18.2 19.1 20.0 13.1 11.7 22.2 11.6 14.3 17.4 12.1 10.4 9.9 11.1 12.6 12.0 9.8 12.0 12.6 14.5 17.5 13.5 7.4 8.3 16.6 9.2 12.2 10.2 18.9 12.7 22.0 10.2 18.5 8.1 10.4 14.0 7.8 23.2 25.2 22.1 11.4 35.6 19.9 45.7 11.1 14.3 16.6 13.1 26.0 13.4 9.7 21.1 13.2 10.5 5.5 7.9 19.6 8.2 18.0 8.6 4.7 14.8 14.0 9.3 9.0 11.5 9.4 11.4 23.1 15.5 19.0 8.7 6.1 12.7 48.3 20.4 17.4 12.3 19.4 17.1 15.2 11.6 22.2 17.4 10.1 16.4 13.0 15.2 14.4 11.7 13.1 15.9 12.8 15.6 14.3 7.9 10.7 13.9 12.1 18.0 20.8 27.1 29.4 19.2 14.0 21.8 23.1 18.2 21.5 8.9 24.0 8.2 12.0 20.1 15.2 24.2 12.7 13.4 19.4 15.7 17.7 24.4 11.6 13.0 58.6 18.8 17.5 0.0 11.9 19.1 14.4 10.8 8.1 16.3 16.1 14.3 12.5 14.7 14.3 75.6 14.4 15.2 15.1 12.6 19.9 16.3 16.7 17.0 18.0 8.4 19.0 12.9 17.6 96.5 17.9 25.6 43.0 14.6 17.1 15.6 MBD2 ENSG00000134046 "Methyl-CpG binding domain protein 2" Q9UBB5 18 54151601-54224788 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Kupffer cells: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 8.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037282, HPA067582, HPA067615" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB037282: AB_477234, HPA067582: AB_2685866, HPA067615: AB_2685872" "unprognostic (4.86e-2)" "unprognostic (7.21e-2)" "prognostic favorable (6.49e-4)" "unprognostic (1.19e-1)" "unprognostic (3.36e-2)" "unprognostic (2.47e-1)" "unprognostic (2.38e-3)" "unprognostic (2.35e-2)" "unprognostic (2.71e-2)" "unprognostic (2.36e-3)" "unprognostic (8.04e-3)" "unprognostic (1.10e-2)" "unprognostic (1.08e-1)" "unprognostic (8.70e-2)" "unprognostic (1.67e-1)" "unprognostic (2.51e-3)" "unprognostic (5.19e-2)" 29.8 11.9 8.5 27.9 9.8 15.3 24.0 9.9 9.0 17.5 22.5 7.4 20.1 10.5 12.5 14.8 33.1 11.3 18.7 17.9 7.9 8.1 23.3 23.2 21.3 33.7 10.0 5.3 15.3 19.3 13.1 12.5 38.1 8.6 18.3 15.0 12.1 23.3 17.3 13.9 24.1 26.7 15.7 11.7 36.9 12.5 26.1 9.4 31.0 31.0 25.4 32.2 22.8 27.1 2.0 1.5 2.2 8.2 0.4 2.6 0.8 12.7 5.8 10.8 5.3 12.7 10.8 10.6 12.1 15.2 14.0 12.3 3.7 7.1 30.2 6.2 18.6 6.2 20.5 9.1 16.3 15.4 22.5 5.0 4.4 9.1 8.0 13.2 14.1 8.2 9.4 18.4 10.7 15.7 9.3 16.1 9.3 3.4 28.1 12.6 6.1 14.2 7.9 11.3 5.0 7.8 9.6 6.3 12.2 20.1 13.2 11.8 5.0 9.4 9.5 6.3 14.9 4.9 7.2 13.9 14.3 6.6 4.9 10.7 30.5 16.6 23.3 12.6 12.0 8.5 0.1 2.6 1.2 1.2 4.6 1.6 1.4 1.3 1.9 1.5 2.0 0.7 1.2 2.2 0.4 8.2 1.2 2.6 0.8 8.5 9.8 9.9 9.0 7.9 8.1 10.0 5.3 8.6 9.4 26.8 16.0 24.2 25.1 43.8 17.7 28.8 20.4 24.1 20.5 31.4 15.7 11.3 6.6 23.6 1.7 25.3 29.7 23.3 49.8 45.1 20.5 42.9 8.1 17.9 28.1 20.6 15.6 24.5 111.1 3.3 23.3 44.3 25.3 33.3 38.0 36.6 44.0 20.1 24.8 19.0 23.2 25.8 18.1 5.2 4.3 54.6 15.3 17.5 33.1 78.0 MBD6 KIAA1887 ENSG00000166987 "Methyl-CpG binding domain protein 6" Q96DN6 12 57520710-57530148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "neutrophil: 14.7" "Lineage enriched" "Detected in many" 10 "granulocytes: 14.7" "Cell line enhanced" "Detected in all" "RH-30: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038948, HPA038949" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038948: AB_2676285, HPA038949: AB_10671868" "unprognostic (2.56e-1)" "unprognostic (4.15e-2)" "unprognostic (1.64e-2)" "unprognostic (3.12e-2)" "unprognostic (1.13e-1)" "unprognostic (2.84e-1)" "unprognostic (2.84e-2)" "unprognostic (6.96e-2)" "unprognostic (2.74e-2)" "unprognostic (3.19e-1)" "unprognostic (1.83e-2)" "unprognostic (6.65e-2)" "unprognostic (1.28e-3)" "unprognostic (1.13e-1)" "unprognostic (1.73e-1)" "unprognostic (2.24e-1)" "unprognostic (1.01e-2)" 16.0 21.1 15.2 22.1 18.4 35.0 18.7 20.2 15.2 22.3 22.1 19.6 35.2 27.9 24.9 22.6 18.0 21.7 25.2 13.1 15.2 7.6 21.0 21.6 17.6 16.3 18.0 11.1 24.3 22.4 24.2 60.6 35.1 14.0 19.9 14.3 34.8 23.7 37.0 22.5 25.1 22.8 14.6 16.1 34.4 28.6 31.1 18.7 16.1 48.2 14.0 21.9 19.0 20.3 1.4 0.5 14.7 1.1 0.7 1.3 0.6 8.7 12.5 9.7 10.3 6.7 4.8 13.6 10.1 6.1 6.5 4.9 12.9 13.9 8.8 7.8 5.4 6.5 12.3 8.8 7.6 4.6 17.4 8.9 15.5 12.1 8.7 8.2 9.2 40.2 8.4 13.4 7.0 10.0 10.2 8.7 7.5 9.8 23.4 5.2 9.0 9.5 9.2 9.3 6.4 9.2 9.5 46.8 6.7 5.6 17.3 13.4 8.1 8.1 16.2 9.9 6.1 18.2 14.9 8.6 7.2 11.9 7.3 6.8 24.4 8.2 6.1 9.4 5.8 12.1 0.0 1.1 0.4 1.3 0.9 0.6 1.4 0.2 0.4 0.5 1.0 0.6 0.6 14.7 0.7 0.4 0.4 0.2 0.6 15.2 18.4 20.2 15.2 15.2 7.6 18.0 11.1 14.0 18.7 6.0 16.2 6.7 12.6 9.7 56.0 5.2 33.1 12.0 10.3 8.7 25.5 9.5 5.0 7.2 6.7 12.7 14.9 0.0 10.4 6.7 8.2 11.5 18.5 24.3 12.2 23.8 15.0 15.4 20.2 7.8 13.6 15.0 11.8 1.0 19.5 28.3 8.8 17.5 12.0 3.7 67.0 19.4 7.6 39.1 29.6 10.8 18.9 13.1 15.7 14.9 MBNL1 "EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL" ENSG00000152601 "Muscleblind like splicing regulator 1" Q9NR56 3 152243828-152465780 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016398, HPA035098" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016398: AB_784435, HPA035098: AB_2674461" "unprognostic (5.46e-3)" "unprognostic (6.01e-3)" "unprognostic (1.94e-3)" "unprognostic (1.99e-1)" "unprognostic (3.44e-2)" "unprognostic (5.82e-3)" "unprognostic (2.75e-2)" "unprognostic (9.49e-3)" "unprognostic (5.18e-2)" "unprognostic (1.70e-2)" "unprognostic (2.78e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.90e-7)" "unprognostic (7.53e-3)" "unprognostic (6.15e-2)" "unprognostic (1.77e-1)" "unprognostic (2.98e-1)" 55.9 17.5 14.5 50.8 17.0 28.5 43.8 11.8 14.5 46.4 44.0 10.8 18.0 15.2 41.1 23.6 33.3 22.3 27.5 29.9 14.3 12.9 18.6 16.5 39.6 45.6 18.0 9.1 30.5 12.5 12.5 16.0 10.4 12.6 30.5 26.0 12.7 18.3 25.1 87.6 22.8 29.5 59.8 22.1 39.6 23.1 14.6 17.4 71.9 18.5 34.5 46.0 64.4 29.3 25.0 30.7 38.2 27.4 33.6 39.9 40.2 27.8 23.0 3.7 8.4 29.6 30.6 2.8 35.0 28.4 23.1 19.4 10.1 16.4 28.7 17.9 49.0 7.2 12.8 6.9 20.2 34.3 22.3 9.4 31.3 11.7 4.7 16.5 37.4 22.9 14.2 11.0 26.6 20.8 17.8 47.4 11.6 15.9 39.2 22.4 9.6 34.8 13.7 1.5 8.2 18.4 35.7 11.6 35.9 11.7 14.1 3.0 3.4 15.2 8.3 14.8 1.4 11.5 57.1 39.8 31.7 12.2 21.0 30.1 41.0 23.4 33.0 18.5 46.8 17.0 32.6 22.7 38.2 37.2 27.4 39.9 25.0 30.5 30.9 30.7 24.1 38.9 33.3 35.4 33.6 22.8 11.1 27.0 40.2 14.5 17.0 11.8 14.5 14.3 12.9 18.0 9.1 12.6 17.4 140.0 156.6 98.0 41.0 189.8 25.7 160.6 45.9 78.9 139.9 36.6 60.9 20.0 18.3 32.5 2.1 146.2 138.0 70.0 54.4 8.3 91.5 50.3 155.2 83.5 55.2 30.2 45.4 75.5 193.7 5.9 82.8 171.1 97.8 129.0 61.7 16.0 47.0 71.9 67.1 29.9 84.3 97.0 113.3 4.9 10.9 213.0 12.4 228.4 54.7 46.0 MCM2 "BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030" ENSG00000073111 "Minichromosome maintenance complex component 2" P49736 3 127598223-127622436 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 69.9" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 45.7;Extravillous trophoblasts: 22.4;Spermatogonia: 27.1;Syncytiotrophoblasts: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000303, HPA031450, HPA031495, HPA031496" Enhanced Enhanced Nucleoplasm Yes Yes 8600 Nucleoplasm "CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905" "unprognostic (2.43e-1)" "prognostic favorable (4.66e-4)" "unprognostic (4.44e-2)" "unprognostic (3.12e-3)" "unprognostic (1.68e-1)" "unprognostic (2.25e-2)" "prognostic unfavorable (1.51e-7)" "unprognostic (8.43e-3)" "unprognostic (1.92e-2)" "unprognostic (1.79e-1)" "unprognostic (1.41e-3)" "unprognostic (1.21e-2)" "unprognostic (1.16e-2)" "unprognostic (8.16e-3)" "unprognostic (1.56e-1)" "unprognostic (3.29e-2)" "unprognostic (2.82e-1)" 2.9 3.7 2.1 24.3 4.0 32.5 3.5 6.7 3.2 4.7 7.1 3.3 2.2 4.7 4.7 5.9 11.2 4.8 5.4 3.6 2.0 2.3 3.9 3.4 3.4 14.6 2.2 3.5 5.1 3.0 2.4 2.4 26.4 3.0 3.2 6.0 2.5 4.7 1.9 7.0 6.0 7.1 2.9 2.9 13.3 3.8 20.3 3.9 69.9 4.1 16.6 20.7 3.4 5.1 10.4 3.6 0.9 1.4 5.8 10.6 3.4 25.1 21.4 23.5 20.5 1.4 3.0 23.0 13.2 8.5 26.6 29.0 35.5 16.7 27.1 12.9 6.5 22.8 20.3 41.9 15.2 16.6 22.4 26.2 44.9 28.7 25.8 0.9 41.9 19.6 1.6 1.7 18.0 2.7 3.2 8.3 29.6 22.3 24.9 9.8 33.3 38.8 30.7 34.4 21.6 18.9 43.6 33.7 38.8 5.5 19.5 29.3 22.2 33.9 10.1 3.5 9.9 21.7 32.9 4.2 20.7 17.7 25.5 17.8 25.8 29.2 67.4 14.3 31.7 7.9 0.0 0.6 0.2 4.7 1.4 5.9 10.4 4.1 5.5 2.8 9.2 3.9 5.0 0.9 5.8 0.3 3.6 10.6 3.4 2.1 4.0 6.7 3.2 2.0 2.3 2.2 3.5 3.0 3.9 3.0 1.3 6.7 1.7 4.0 2.2 7.6 0.0 10.7 5.7 0.0 0.0 45.7 0.0 4.1 0.7 1.7 1.0 0.0 1.6 22.4 3.3 0.7 1.1 1.7 15.2 0.0 3.5 1.3 1.6 0.7 1.7 1.6 1.7 15.4 5.1 1.5 1.7 0.0 1.4 0.5 1.7 0.0 2.8 6.2 27.1 2.6 28.0 3.2 12.0 0.6 MCM4 "CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21" ENSG00000104738 "Minichromosome maintenance complex component 4" P33991 8 47960185-47978160 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 56.6" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 117.9;Late spermatids: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004497, HPA004873, HPA031052" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712" "unprognostic (4.55e-2)" "unprognostic (3.16e-3)" "prognostic favorable (2.19e-4)" "prognostic unfavorable (2.84e-5)" "unprognostic (7.71e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.12e-3)" "prognostic unfavorable (1.15e-4)" "unprognostic (2.65e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (5.16e-2)" "prognostic unfavorable (2.61e-4)" "unprognostic (3.53e-2)" "unprognostic (2.90e-1)" "unprognostic (1.70e-2)" "unprognostic (1.40e-1)" 4.9 8.7 6.7 18.4 12.6 33.1 9.3 13.9 14.8 6.7 11.9 6.9 3.6 8.3 4.7 7.8 21.6 5.9 6.8 8.3 6.6 7.1 8.0 6.6 4.4 20.3 5.9 7.7 5.3 5.5 4.3 4.1 29.2 7.7 4.2 13.2 5.3 9.0 3.1 8.7 16.2 10.3 5.9 6.4 10.1 6.3 39.0 4.1 56.6 4.0 21.8 23.7 8.0 9.5 5.1 4.9 3.4 4.3 4.9 12.9 4.5 34.5 21.5 39.9 14.6 3.9 6.9 17.6 26.4 17.3 33.3 37.7 22.8 31.5 37.5 14.8 13.1 25.0 25.5 50.3 21.4 37.6 11.8 33.2 64.3 25.8 25.3 1.1 34.3 14.1 4.1 4.3 26.5 9.5 5.1 11.7 25.3 35.4 31.2 22.9 21.4 75.8 25.0 43.3 41.1 9.3 48.2 31.3 24.4 12.0 31.0 38.4 18.4 53.4 22.3 7.9 23.8 26.6 18.1 7.8 25.4 24.7 28.5 24.2 10.3 24.6 76.5 20.4 31.9 22.7 3.4 2.1 1.5 5.5 3.7 2.7 5.1 5.0 6.8 4.9 2.1 4.6 3.4 0.1 4.9 4.3 1.7 12.9 4.5 6.7 12.6 13.9 14.8 6.6 7.1 5.9 7.7 7.7 4.1 0.0 4.6 3.0 9.5 19.3 11.6 22.4 0.0 17.4 10.3 5.2 9.8 26.7 3.3 6.0 117.9 5.2 5.0 46.7 5.2 33.9 7.4 4.3 1.1 3.4 10.4 15.9 6.4 1.3 3.5 57.7 4.9 9.9 3.3 2.8 9.6 6.5 4.1 3.5 2.8 2.2 15.3 0.0 8.0 45.2 31.3 16.7 24.9 3.8 20.2 8.2 MCM5 CDC46 ENSG00000100297 "Minichromosome maintenance complex component 5" P33992 22 35400063-35425430 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.0;lymphoid tissue: 60.6" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 115.2;monocytes: 225.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000101, HPA000845, HPA052880" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979" "unprognostic (6.71e-2)" "prognostic favorable (2.81e-6)" "unprognostic (5.29e-3)" "unprognostic (7.94e-2)" "unprognostic (1.83e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.78e-4)" "prognostic unfavorable (3.95e-4)" "unprognostic (1.29e-1)" "unprognostic (3.34e-2)" "unprognostic (1.37e-1)" "unprognostic (8.07e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (3.26e-2)" "unprognostic (1.01e-1)" "unprognostic (1.77e-3)" "unprognostic (1.53e-1)" 12.1 4.9 6.1 27.5 9.0 57.0 9.1 6.7 5.7 10.4 11.5 12.3 5.0 9.5 10.8 10.8 15.8 8.7 9.4 5.2 4.4 3.4 6.8 8.0 9.3 31.1 8.8 3.7 17.9 10.8 6.2 3.6 19.3 5.8 7.2 8.3 6.5 8.9 5.1 8.8 10.3 16.7 6.0 7.8 31.2 8.4 16.4 8.8 60.6 9.0 17.7 33.0 8.7 9.6 46.8 30.9 19.0 26.0 21.3 32.9 24.0 39.3 28.6 22.6 23.0 2.2 4.5 19.9 26.3 14.0 39.4 37.5 19.0 19.7 26.1 15.3 13.4 16.3 19.7 22.6 20.9 12.6 21.0 41.5 37.2 28.7 38.0 0.8 76.8 33.7 2.4 1.9 23.5 6.4 3.6 17.4 23.9 23.0 39.0 14.9 32.5 62.5 25.6 30.1 26.9 17.0 70.8 32.1 32.8 7.7 22.9 17.5 18.6 36.2 14.5 8.1 12.4 15.2 29.4 10.3 39.8 30.2 24.7 27.1 21.7 26.8 49.1 25.8 29.1 30.3 19.0 20.7 14.5 18.4 24.1 13.1 46.8 16.1 19.4 27.1 37.0 13.1 14.8 9.9 21.3 26.0 30.9 32.9 24.0 6.1 9.0 6.7 5.7 4.4 3.4 8.8 3.7 5.8 8.8 6.0 8.2 53.6 8.0 9.4 1.5 3.4 12.7 5.3 4.5 7.0 0.0 115.2 5.0 14.8 1.9 7.5 3.8 70.0 11.1 61.5 6.2 3.3 15.0 5.1 47.1 1.6 3.4 13.5 21.1 3.6 10.0 25.5 6.8 225.4 9.2 4.5 9.4 7.0 5.6 3.7 3.2 19.4 6.4 11.2 52.2 5.5 68.8 20.8 32.2 4.7 MCM6 Mis5 ENSG00000076003 "Minichromosome maintenance complex component 6" Q14566 2 135839626-135876426 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 66.3" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 46.7;Spermatogonia: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004818, CAB009577" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB009577: AB_2266309, HPA004818: AB_1079339" "unprognostic (6.73e-2)" "unprognostic (6.68e-3)" "unprognostic (1.22e-3)" "unprognostic (3.60e-3)" "unprognostic (8.98e-2)" "unprognostic (4.34e-2)" "prognostic unfavorable (5.70e-7)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (2.36e-2)" "unprognostic (1.36e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (8.29e-12)" "unprognostic (2.84e-1)" "unprognostic (9.02e-2)" "unprognostic (7.42e-2)" "unprognostic (1.68e-1)" 11.3 6.3 7.2 17.7 8.4 23.1 9.5 12.3 9.4 9.1 11.9 5.1 2.9 8.7 10.4 8.8 12.6 8.7 7.6 6.0 5.0 5.5 6.8 7.0 8.5 23.9 4.9 8.0 10.9 4.3 6.2 3.4 10.9 5.9 8.6 12.2 6.2 6.9 6.7 8.2 8.9 16.7 10.4 7.2 14.1 8.0 13.2 3.7 66.3 5.1 11.4 27.5 10.8 9.8 5.5 9.4 5.3 4.0 7.0 13.9 5.6 23.3 14.3 31.3 19.9 6.7 8.8 12.3 17.0 12.9 19.8 22.1 29.3 17.9 40.8 12.5 12.3 8.7 13.9 31.6 15.5 21.2 20.9 21.8 40.5 21.3 9.2 3.1 48.5 18.1 5.2 2.0 14.4 4.4 4.0 13.4 32.2 28.9 34.5 14.5 23.8 59.2 35.7 28.2 20.6 14.4 29.4 37.5 37.3 9.9 20.6 19.7 16.8 22.4 10.7 10.7 23.4 12.3 30.6 6.6 13.8 11.5 14.8 12.8 20.7 33.7 53.7 19.3 37.2 16.4 5.3 1.4 0.9 7.6 4.0 7.1 5.5 10.5 9.2 4.6 3.2 9.6 11.8 0.8 7.0 3.6 9.4 13.9 5.6 7.2 8.4 12.3 9.4 5.0 5.5 4.9 8.0 5.9 3.7 0.0 2.4 2.2 3.8 6.0 2.2 3.2 2.5 4.0 6.8 3.5 0.0 26.1 0.0 4.4 2.1 7.1 1.3 46.7 5.8 20.9 11.3 1.5 9.2 3.0 20.4 3.2 2.4 9.8 4.0 1.6 8.6 5.8 5.0 3.6 9.2 2.3 2.8 3.5 15.9 1.0 0.5 0.0 4.2 15.6 41.4 3.6 8.9 17.5 9.7 1.0 MCM7 "CDC47, MCM2, PPP1R104" ENSG00000166508 "Minichromosome maintenance complex component 7" P33993 7 100092728-100101940 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002163, HPA003898, CAB016312" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632" "unprognostic (1.87e-1)" "prognostic favorable (1.28e-4)" "unprognostic (1.36e-1)" "unprognostic (5.20e-2)" "unprognostic (1.94e-1)" "unprognostic (7.03e-2)" "prognostic unfavorable (2.18e-4)" "unprognostic (2.08e-2)" "unprognostic (5.79e-3)" "unprognostic (2.16e-2)" "unprognostic (2.42e-1)" "unprognostic (9.34e-3)" "unprognostic (3.83e-2)" "unprognostic (5.41e-2)" "unprognostic (1.76e-1)" "unprognostic (1.32e-2)" "unprognostic (2.38e-1)" 8.6 5.2 17.5 13.6 21.7 37.3 11.2 20.0 20.6 8.2 14.2 19.2 15.0 10.4 16.0 6.3 10.7 8.6 9.9 5.1 18.1 12.4 5.5 8.5 7.4 22.4 23.7 9.5 12.6 13.1 7.5 10.3 10.7 15.5 10.0 15.7 7.2 9.2 9.2 11.5 10.1 10.3 11.7 23.5 10.7 7.8 14.9 22.3 7.5 9.4 4.1 28.2 10.3 10.0 7.3 5.7 1.9 5.7 7.6 9.0 6.0 24.9 28.8 31.8 24.0 3.1 4.1 16.3 15.2 18.4 42.5 45.3 22.0 26.4 42.3 14.5 10.8 27.1 19.8 46.7 22.1 35.9 21.6 39.9 26.9 16.2 15.2 1.7 45.7 17.5 2.8 4.2 31.1 18.7 5.4 16.1 24.4 51.5 34.7 21.5 53.3 77.6 18.7 27.9 23.2 20.9 41.8 46.7 51.6 8.2 15.1 20.8 31.7 24.0 22.3 7.5 18.6 10.2 19.2 6.8 16.0 29.1 31.4 30.1 14.5 24.8 76.1 11.1 36.7 28.6 1.8 2.5 1.9 8.1 4.1 6.2 5.3 5.7 7.9 5.5 7.3 5.9 5.7 1.6 7.6 5.7 5.7 9.0 6.0 17.5 21.7 20.0 20.6 18.1 12.4 23.7 9.5 15.5 22.3 8.9 17.0 23.7 20.7 41.4 8.7 7.9 15.3 24.1 9.1 3.5 13.7 90.8 8.3 17.6 40.0 14.5 15.8 70.0 22.4 78.1 17.3 11.3 24.2 10.4 34.4 6.4 16.7 8.0 10.8 22.7 19.5 16.5 18.6 17.2 34.7 10.1 16.0 20.1 14.5 9.1 11.9 12.9 22.7 83.2 67.3 30.9 60.2 28.7 60.9 12.3 MCMBP "C10orf119, FLJ13081, MCM-BP" ENSG00000197771 "Minichromosome maintenance complex binding protein" Q9BTE3 10 119829404-119892556 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013792, HPA038481" Uncertain Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "CAB013792: , HPA038481: AB_10794620" "unprognostic (1.26e-1)" "unprognostic (7.92e-2)" "unprognostic (4.62e-2)" "unprognostic (2.31e-2)" "unprognostic (1.72e-2)" "unprognostic (4.64e-2)" "unprognostic (1.31e-3)" "unprognostic (5.61e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (7.32e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (2.23e-2)" "unprognostic (8.24e-2)" "unprognostic (2.51e-1)" "unprognostic (4.87e-2)" 33.6 15.3 11.7 23.2 13.8 14.6 35.5 17.2 13.8 27.0 26.3 16.9 11.4 15.5 28.0 14.9 26.4 23.0 18.7 26.3 12.0 10.2 18.7 23.7 28.5 38.6 17.4 8.5 29.2 18.2 23.2 17.6 35.4 14.2 22.5 21.4 15.7 21.0 17.4 30.1 23.8 20.7 26.0 16.8 26.0 20.7 15.4 15.5 38.0 24.5 28.2 24.7 32.5 28.6 4.5 6.9 12.1 9.7 4.1 5.1 2.4 31.0 22.1 31.0 21.4 15.7 19.3 18.2 28.8 31.6 36.7 38.0 28.8 25.5 36.2 13.3 23.0 16.7 29.0 37.0 29.0 43.0 26.5 27.3 18.6 17.6 22.0 24.4 34.3 45.0 15.8 16.4 33.2 43.8 20.2 25.1 23.7 17.1 27.3 24.0 23.0 43.0 20.7 15.6 23.1 16.0 27.2 60.0 18.4 15.7 21.4 13.4 17.2 21.0 17.5 24.0 24.3 11.9 24.5 19.4 18.1 17.8 18.3 34.3 19.7 21.9 40.1 21.6 23.1 11.1 12.1 5.3 3.6 4.2 9.7 5.1 4.5 3.9 4.4 6.9 1.8 4.2 3.8 6.4 4.1 6.1 3.5 3.9 2.4 11.7 13.8 17.2 13.8 12.0 10.2 17.4 8.5 14.2 15.5 14.9 13.9 20.1 27.2 38.0 10.0 16.2 12.7 10.7 18.2 19.2 3.9 30.7 11.6 9.6 3.3 32.4 15.1 0.0 11.5 42.5 26.3 18.7 17.4 23.1 33.4 30.2 10.4 30.1 35.7 4.9 27.9 31.3 21.9 8.2 18.5 16.9 12.8 7.0 21.2 17.5 17.1 19.4 29.9 27.6 61.5 37.4 33.2 27.4 26.9 24.5 MCTP2 "FLJ11175, FLJ33303" ENSG00000140563 "Multiple C2 and transmembrane domain containing 2" Q6DN12 15 94231538-94483952 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.6" "Cell type enhanced" "Detected in many" 5 "granulocytes: 35.7;Mucus-secreting cells: 42.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 21.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 14.5;HMC-1: 12.0;U-698: 15.9;U-87 MG: 18.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA051176, HPA070541" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051176: AB_2681373, HPA070541: AB_2686277" "unprognostic (1.70e-2)" "unprognostic (4.32e-2)" "unprognostic (5.63e-2)" "unprognostic (7.15e-4)" "unprognostic (3.57e-2)" "unprognostic (2.66e-3)" "unprognostic (3.45e-2)" "unprognostic (3.68e-3)" "unprognostic (2.83e-1)" "unprognostic (1.45e-1)" "unprognostic (2.97e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (2.18e-5)" "unprognostic (5.87e-2)" "unprognostic (4.36e-1)" "unprognostic (1.76e-3)" "unprognostic (9.41e-2)" 5.3 4.1 0.8 19.7 1.7 12.6 2.7 0.7 1.5 5.4 12.3 0.0 6.9 5.6 4.0 9.5 5.7 4.5 10.3 4.6 1.0 2.2 3.6 2.3 12.4 18.4 2.5 0.8 3.8 10.0 5.3 24.4 17.1 0.6 6.8 10.2 2.5 16.8 9.6 0.8 4.0 10.9 4.0 0.9 41.6 3.7 1.7 0.4 3.0 8.7 4.1 12.9 6.2 14.8 2.7 0.1 21.2 0.5 6.8 4.4 1.1 2.5 0.0 0.0 0.0 0.0 0.0 1.8 1.3 0.8 0.2 0.1 1.7 3.1 7.3 0.3 0.0 0.0 5.7 0.1 4.7 0.0 1.4 0.5 14.5 2.0 0.8 1.0 3.0 12.0 0.8 5.8 0.1 6.0 0.0 0.0 2.5 0.5 4.1 0.0 0.0 1.4 8.0 0.6 2.4 2.6 3.3 0.1 2.7 0.3 7.6 1.4 0.3 0.1 2.4 0.9 0.5 0.0 0.2 0.0 0.0 1.2 0.0 0.0 8.7 0.1 15.9 18.0 7.9 0.9 3.2 0.5 7.7 4.4 0.1 2.1 2.2 1.2 1.9 0.0 2.7 0.5 1.9 21.2 6.8 0.5 0.1 0.0 1.1 0.8 1.7 0.7 1.5 1.0 2.2 2.5 0.8 0.6 0.4 3.0 24.7 20.4 10.8 3.8 0.8 0.8 5.1 5.3 15.9 3.5 0.0 13.2 0.0 2.7 3.2 2.1 18.6 0.0 4.1 5.9 7.2 13.7 35.7 1.3 7.5 0.0 15.0 1.3 12.7 3.9 0.3 2.1 1.7 0.0 42.4 0.2 4.0 21.0 0.0 1.7 0.5 0.0 0.8 0.1 2.0 1.9 20.5 19.7 18.7 14.9 MED10 "L6, MGC5309, NUT2, TRG20" ENSG00000133398 "Mediator complex subunit 10" Q9BTT4 5 6371881-6378594 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042795, HPA054188" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042795: AB_10796679, HPA054188: AB_2682410" "unprognostic (2.33e-3)" "unprognostic (3.31e-1)" "unprognostic (1.50e-2)" "unprognostic (1.06e-3)" "prognostic unfavorable (2.65e-5)" "unprognostic (3.38e-2)" "prognostic unfavorable (1.62e-6)" "unprognostic (3.26e-1)" "unprognostic (5.16e-2)" "unprognostic (4.92e-3)" "unprognostic (4.32e-2)" "unprognostic (2.16e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (3.85e-2)" "unprognostic (3.78e-2)" "unprognostic (3.11e-1)" "unprognostic (2.14e-1)" 19.8 15.8 28.8 16.9 23.2 37.2 16.2 20.6 31.4 13.9 22.7 19.3 17.1 15.8 15.1 20.3 22.2 16.7 16.6 24.6 29.9 31.2 14.7 17.2 16.2 25.1 27.7 21.1 17.7 31.4 10.6 13.8 16.5 23.9 15.9 10.4 13.7 17.1 19.6 21.5 21.3 18.7 24.0 26.6 17.4 16.9 21.1 17.5 15.1 16.4 12.3 21.6 19.6 22.9 34.4 24.4 37.4 17.2 24.9 40.0 35.2 17.5 19.5 7.8 14.4 12.4 13.7 22.2 22.2 20.0 23.6 17.3 29.5 14.1 22.7 18.0 18.5 34.2 13.1 13.4 16.4 21.2 37.6 15.6 15.0 30.5 14.7 38.3 18.0 13.3 15.6 21.6 22.4 32.1 14.5 18.7 13.1 22.0 13.5 18.0 22.0 26.2 27.2 13.3 12.2 51.3 15.1 13.8 9.5 16.0 18.5 14.9 22.2 42.3 17.5 33.6 10.1 12.2 16.2 20.6 23.6 26.1 21.6 23.4 22.0 21.7 32.6 21.2 28.5 17.5 37.4 15.8 33.1 28.7 16.4 35.2 34.4 36.2 30.9 13.3 31.5 40.0 33.6 11.4 24.9 17.2 24.4 31.8 35.2 28.8 23.2 20.6 31.4 29.9 31.2 27.7 21.1 23.9 17.5 20.8 20.0 57.8 71.8 81.7 63.0 37.5 28.1 26.8 20.5 43.6 27.5 70.4 49.7 97.6 4.0 72.4 44.3 23.3 79.7 67.2 66.6 65.2 50.7 21.5 57.0 69.9 42.4 66.9 26.4 8.0 65.0 44.9 59.1 114.6 40.5 50.4 108.8 43.2 42.5 39.7 47.1 32.3 76.8 57.9 89.6 61.6 66.4 95.9 40.4 66.0 MED6 NY-REN-28 ENSG00000133997 "Mediator complex subunit 6" O75586 14 70581257-70600690 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030764, HPA069039" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030764: AB_2673601, HPA069039: AB_2686070" "unprognostic (1.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (2.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-1)" "unprognostic (6.93e-2)" "unprognostic (2.86e-1)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (3.15e-2)" 16.7 19.7 20.3 16.5 30.7 22.7 21.9 42.0 30.4 17.6 15.7 19.3 16.6 14.2 23.6 22.9 24.5 19.7 14.8 17.1 20.1 19.5 14.7 20.2 15.5 26.9 17.4 23.0 25.7 15.6 13.5 30.0 22.9 21.9 15.2 16.5 20.5 17.4 17.4 29.9 24.1 16.2 18.9 19.6 21.6 16.4 16.6 20.5 21.0 19.4 18.9 30.2 18.5 18.8 19.9 18.5 23.5 21.1 21.3 24.8 14.2 36.9 20.7 26.8 11.6 14.7 15.5 21.4 18.8 19.9 28.9 28.3 20.3 23.0 28.4 11.1 15.9 17.3 17.9 31.3 18.9 31.2 19.8 16.6 20.6 16.0 27.4 18.0 18.0 16.6 17.6 22.2 20.7 19.2 12.8 22.1 21.7 18.9 18.0 20.9 27.6 25.7 24.4 19.9 26.3 25.2 21.5 25.0 14.7 18.0 19.8 18.3 19.8 19.6 21.0 21.8 16.3 32.8 22.7 17.5 23.8 34.6 12.0 17.2 19.1 28.4 39.8 20.8 15.7 16.5 17.4 16.2 23.5 18.7 18.2 22.2 18.9 24.8 21.3 18.5 19.9 23.1 23.3 15.8 21.3 21.1 13.9 23.1 14.2 20.3 30.7 42.0 30.4 20.1 19.5 17.4 23.0 21.9 20.5 17.9 21.7 37.3 31.2 17.2 71.1 5.6 10.2 25.4 18.2 17.4 74.6 34.1 5.0 27.0 5.8 22.4 13.9 23.3 20.3 35.6 20.0 28.9 45.1 12.5 22.6 25.4 21.2 26.4 19.2 4.4 25.0 20.6 16.9 27.1 10.5 47.4 22.6 17.6 27.6 12.5 92.2 25.8 18.6 20.6 39.9 17.6 41.0 40.8 14.6 27.6 MEF2D ENSG00000116604 "Myocyte enhancer factor 2D" Q14814 1 156463727-156500828 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 97.8" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 163.0;Sertoli cells: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 55.0;U-266/70: 48.3;U-266/84: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004807, HPA007114" Enhanced Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA004807: AB_1079354, HPA007114: AB_1079353" "unprognostic (3.17e-2)" "unprognostic (7.31e-2)" "unprognostic (3.35e-2)" "unprognostic (3.45e-2)" "unprognostic (1.95e-1)" "unprognostic (8.99e-2)" "unprognostic (2.02e-1)" "unprognostic (1.29e-1)" "unprognostic (9.96e-2)" "unprognostic (1.96e-2)" "unprognostic (1.97e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (7.53e-4)" "unprognostic (9.27e-2)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.45e-1)" 18.1 19.6 14.9 15.7 27.5 47.6 15.5 27.0 40.3 23.8 21.1 12.1 10.5 11.0 28.6 12.9 13.8 19.5 16.6 26.3 11.8 9.6 10.4 10.6 20.0 13.9 8.6 21.1 26.7 22.4 21.4 15.0 16.2 11.6 17.2 10.6 22.3 11.3 18.8 97.8 17.5 14.8 22.0 8.4 17.2 16.1 9.9 9.9 17.2 14.7 19.4 15.6 21.9 19.3 1.7 8.5 8.1 2.0 1.5 2.3 0.8 4.6 8.6 1.8 2.8 4.4 6.1 2.8 6.1 8.0 3.2 3.5 2.7 6.3 10.8 7.1 8.2 3.2 4.6 2.1 3.5 1.9 14.7 2.8 2.6 10.7 1.5 5.4 6.3 8.6 6.8 5.9 5.6 7.7 6.8 6.1 3.4 1.9 19.1 5.1 4.4 4.2 14.6 2.6 2.6 4.4 20.8 3.9 12.4 2.8 2.3 3.0 4.7 5.9 12.9 10.2 3.7 3.5 55.0 10.2 7.7 7.2 5.6 4.5 48.3 49.9 20.7 6.5 5.0 4.1 1.3 2.0 2.3 1.9 1.1 2.3 1.7 1.4 1.7 1.4 1.7 0.7 1.3 8.1 1.5 1.9 8.5 1.6 0.8 14.9 27.5 27.0 40.3 11.8 9.6 8.6 21.1 11.6 9.9 6.0 18.1 14.4 10.3 33.1 78.1 35.2 20.4 2.7 15.9 1.8 163.0 3.9 0.0 7.0 1.3 21.1 33.9 0.0 9.7 4.3 21.3 16.3 3.5 11.3 15.8 66.7 20.6 18.4 22.5 4.6 29.1 18.3 13.5 10.0 29.7 16.8 18.5 28.1 30.4 2.6 80.6 97.0 38.1 5.1 9.8 33.2 12.8 12.9 11.0 14.9 METTL1 "C12orf1, TRM8, TRMT8" ENSG00000037897 "Methyltransferase like 1" Q9UBP6 12 57768471-57772793 "Enzymes, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in all" 6 "RH-30: 78.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020914, HPA050450" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA020914: AB_1853830, HPA050450: AB_2681130" "unprognostic (5.24e-2)" "unprognostic (2.60e-1)" "unprognostic (9.43e-2)" "unprognostic (3.46e-1)" "unprognostic (9.01e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (4.25e-6)" "unprognostic (5.67e-2)" "unprognostic (6.19e-2)" "unprognostic (1.14e-3)" "unprognostic (1.78e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (3.55e-6)" "unprognostic (7.75e-2)" "unprognostic (1.96e-1)" "unprognostic (5.01e-2)" "unprognostic (2.22e-1)" 12.2 16.6 6.7 13.8 8.8 8.4 12.3 2.2 6.9 7.6 7.6 4.5 10.8 3.3 9.4 21.2 10.3 9.0 10.7 8.1 5.8 5.0 20.9 15.3 7.7 8.8 7.4 4.6 17.6 34.9 10.9 10.6 8.3 6.5 11.0 10.3 5.3 17.9 17.2 20.4 8.5 5.7 10.5 5.0 8.2 7.3 11.4 5.4 4.5 15.1 15.6 9.8 8.8 7.8 6.1 12.6 0.7 6.7 7.3 18.6 5.1 6.1 11.2 4.7 4.3 6.4 4.4 6.4 6.6 6.0 11.1 6.0 7.8 8.6 7.4 12.3 8.0 6.3 7.3 7.2 10.2 10.8 4.4 8.4 8.6 4.3 9.5 4.5 9.3 4.5 3.9 9.3 12.4 8.7 5.4 5.9 4.8 7.9 7.4 5.6 11.9 6.5 11.1 11.1 8.2 11.3 5.8 78.7 10.9 9.7 7.7 5.0 4.5 6.9 7.6 6.1 4.9 10.0 8.8 4.4 4.5 5.0 7.9 8.7 3.4 2.5 9.0 6.4 6.7 9.3 0.0 4.7 0.0 5.3 6.7 18.6 4.7 6.9 6.5 10.3 6.1 9.5 9.2 0.7 7.3 1.1 12.6 3.3 5.1 6.7 8.8 2.2 6.9 5.8 5.0 7.4 4.6 6.5 5.4 8.9 3.5 8.9 11.4 9.3 2.9 3.6 2.5 1.4 17.0 5.2 0.0 15.0 21.6 15.2 11.3 7.1 1.3 0.0 20.6 19.6 12.0 7.7 12.7 9.0 22.2 3.2 6.3 4.3 1.0 8.6 10.3 9.0 6.8 27.1 5.6 1.6 12.8 0.0 4.6 53.6 5.5 0.0 14.7 4.8 14.7 9.2 8.1 4.3 9.1 10.5 METTL17 "FLJ20859, METT11D1" ENSG00000165792 "Methyltransferase like 17" Q9H7H0 14 20989770-20997035 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002955, HPA059802" Uncertain Enhanced Nucleoplasm "Intracellular and membrane" No No Nucleoplasm "HPA002955: AB_2144183, HPA059802: AB_2684129" "unprognostic (1.90e-2)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (2.88e-1)" "unprognostic (1.28e-1)" "unprognostic (1.00e-2)" "unprognostic (2.23e-3)" "unprognostic (1.90e-1)" "unprognostic (1.33e-1)" "unprognostic (1.39e-1)" "unprognostic (4.02e-2)" "unprognostic (3.06e-2)" "unprognostic (1.39e-2)" "unprognostic (1.35e-1)" "unprognostic (2.11e-1)" "unprognostic (3.29e-2)" 11.4 35.7 15.8 15.8 18.4 25.4 14.4 24.9 16.6 16.4 22.1 14.2 25.6 19.7 14.9 15.8 23.4 15.2 12.2 20.6 17.3 10.0 20.7 20.4 17.5 18.5 21.1 11.8 15.6 19.8 11.6 18.9 16.0 16.1 13.4 25.0 14.2 23.1 26.1 20.2 16.0 21.6 21.0 16.3 25.0 17.6 21.9 20.2 17.9 15.1 22.1 22.3 12.7 15.2 7.9 10.3 17.6 5.3 6.2 9.2 4.3 14.4 17.9 18.8 7.1 11.6 5.2 14.5 9.6 13.5 29.3 24.2 14.1 18.9 31.0 9.8 12.5 18.1 24.2 23.8 18.8 21.2 10.9 19.7 16.2 13.2 18.4 10.9 27.1 18.8 10.8 16.6 15.0 11.2 10.4 11.7 27.8 14.9 14.9 13.9 10.7 18.0 28.2 18.7 23.1 22.7 23.1 16.5 20.4 15.6 14.2 13.5 15.9 12.7 16.7 9.6 14.4 11.6 23.9 6.5 10.2 29.9 9.9 13.1 12.9 20.9 22.1 5.9 19.5 12.3 17.6 5.3 5.0 8.6 4.9 4.8 7.3 9.1 8.4 10.3 7.9 8.9 9.2 0.0 6.2 3.2 6.2 7.1 4.3 15.8 18.4 24.9 16.6 17.3 10.0 21.1 11.8 16.1 20.2 8.9 12.4 26.4 18.4 16.8 36.1 4.8 17.8 24.1 12.5 10.4 41.2 27.0 5.0 17.2 37.8 9.0 22.4 0.0 13.4 14.1 13.0 10.5 27.8 22.7 16.0 20.6 11.7 12.3 9.9 5.6 31.1 17.5 3.3 19.8 20.1 26.1 13.4 30.0 20.1 13.6 49.5 12.9 13.9 18.2 14.0 15.6 10.6 18.7 30.4 24.6 MGLL "HU-K5, MGL" ENSG00000074416 "Monoglyceride lipase" Q99685 3 127689062-127823250 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 404.8;Pancreatic endocrine cells: 322.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.6;intermediate monocyte: 28.5;non-classical monocyte: 18.3;plasmacytoid DC: 30.4" "Group enriched" "Detected in many" 13 "dendritic cells: 30.4;granulocytes: 11.6;monocytes: 28.5" "Cell line enhanced" "Detected in many" "BJ: 46.5;BJ hTERT+: 53.6;LHCN-M2: 42.8;RPTEC TERT1: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011348, HPA011993, HPA011994" Enhanced Enhanced Nucleoplasm NA NA 4300000 Nucleoplasm "HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916" "unprognostic (1.84e-2)" "unprognostic (1.80e-2)" "unprognostic (2.14e-1)" "unprognostic (8.19e-2)" "unprognostic (1.15e-2)" "unprognostic (1.69e-1)" "unprognostic (5.83e-2)" "unprognostic (3.61e-2)" "unprognostic (1.45e-1)" "unprognostic (8.83e-2)" "prognostic unfavorable (6.41e-4)" "unprognostic (7.63e-3)" "unprognostic (1.44e-1)" "unprognostic (1.68e-1)" "unprognostic (1.90e-2)" "unprognostic (2.51e-1)" "unprognostic (2.11e-3)" 72.2 6.7 29.4 22.6 29.7 7.5 39.0 32.8 36.9 13.3 36.3 8.3 8.4 16.5 8.7 10.8 63.8 16.3 24.1 35.5 23.6 10.2 22.6 32.1 32.4 6.0 15.4 17.8 3.9 3.6 1.7 5.0 18.9 10.2 10.6 27.6 10.0 31.4 13.6 40.9 11.9 22.3 13.6 12.2 19.2 17.5 3.2 15.5 2.4 6.4 33.4 19.7 14.4 14.5 1.8 30.4 11.6 28.5 0.6 0.9 6.0 11.2 10.1 0.0 0.0 17.8 21.0 1.3 46.5 53.6 10.3 16.6 0.3 4.6 2.9 12.9 15.7 3.1 0.4 0.0 6.1 5.7 5.0 0.1 0.3 7.2 0.0 6.4 0.0 0.3 7.8 3.6 19.3 21.1 5.8 21.8 0.1 0.0 0.5 42.8 1.1 0.0 0.1 0.0 7.3 16.0 0.0 5.5 23.8 38.6 1.2 6.0 0.4 8.0 15.8 2.7 0.4 0.7 0.4 27.9 11.3 3.3 27.2 6.3 0.0 0.0 9.5 23.4 0.6 35.0 4.2 2.8 11.6 0.2 28.5 0.9 1.8 0.2 0.3 3.1 0.2 0.0 0.0 0.5 0.6 18.3 30.4 0.0 6.0 29.4 29.7 32.8 36.9 23.6 10.2 15.4 17.8 10.2 15.5 181.7 90.0 5.2 8.0 20.3 16.7 42.0 119.8 56.2 34.2 40.1 0.0 68.4 142.6 90.3 3.6 101.2 167.0 23.3 144.8 129.8 47.2 9.2 8.1 126.2 122.7 0.0 85.0 14.7 24.4 4.0 30.2 33.6 20.3 404.8 177.1 46.3 322.3 129.8 65.4 60.0 6.1 84.1 176.1 0.2 1.1 19.4 60.8 10.2 49.8 4.2 MGMT ENSG00000170430 "O-6-methylguanine-DNA methyltransferase" P16455 10 129467184-129768007 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Hepatocytes: 419.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002786, HPA032135, HPA032136, HPA069497, CAB069881" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002786: , CAB069881: AB_10002128, HPA032135: AB_2674171, HPA032136: AB_2674172, HPA069497: AB_2732134" "unprognostic (1.10e-1)" "prognostic favorable (9.42e-4)" "unprognostic (1.48e-1)" "unprognostic (5.81e-2)" "unprognostic (7.84e-3)" "unprognostic (1.67e-1)" "prognostic favorable (1.54e-4)" "unprognostic (6.54e-3)" "unprognostic (4.71e-2)" "unprognostic (2.03e-1)" "unprognostic (1.26e-1)" "unprognostic (6.32e-1)" "unprognostic (4.89e-1)" "unprognostic (2.75e-1)" "unprognostic (1.95e-1)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" 11.7 11.3 7.4 15.5 7.6 7.1 11.3 3.5 9.1 8.3 12.2 10.0 19.6 10.8 15.3 17.1 9.9 15.2 14.1 10.5 7.1 7.1 12.6 45.6 7.5 11.6 8.6 6.6 12.3 16.5 5.7 5.8 4.5 9.2 11.2 3.4 11.8 14.9 24.5 14.4 9.2 9.6 10.9 8.1 8.6 9.9 11.7 3.9 16.0 10.2 14.9 14.7 12.6 13.0 20.3 17.7 6.5 15.3 18.2 21.2 16.6 0.0 2.5 2.7 13.0 5.7 11.8 10.2 5.7 6.4 4.2 4.1 15.8 16.9 11.8 9.2 7.4 0.0 7.7 1.7 6.1 1.9 0.0 1.0 2.3 5.8 10.1 8.8 0.2 6.8 7.5 0.0 2.4 0.0 0.0 0.0 20.0 0.0 8.3 5.1 21.3 9.3 12.1 0.6 10.9 10.2 10.8 0.0 4.6 7.8 5.8 2.7 6.8 6.9 2.8 0.0 2.2 11.2 9.2 0.0 5.5 2.8 0.0 0.0 0.0 0.0 6.0 0.0 3.8 0.0 2.6 15.3 6.5 19.1 14.8 18.6 20.3 17.5 17.8 15.8 19.9 17.6 18.9 1.8 18.2 13.7 17.7 21.2 16.6 7.4 7.6 3.5 9.1 7.1 7.1 8.6 6.6 9.2 3.9 11.9 14.7 57.0 56.4 45.4 15.7 37.8 86.6 57.6 15.9 97.7 7.9 41.1 107.8 40.8 70.9 48.0 68.8 23.3 51.1 53.2 48.9 49.8 64.5 419.1 76.3 14.3 52.4 98.2 75.3 90.6 62.5 39.9 62.4 45.9 56.4 33.9 74.4 47.0 51.9 227.8 39.0 45.3 55.7 43.1 97.3 37.3 22.4 67.1 59.6 48.8 MICAL3 KIAA0819 ENSG00000243156 "Microtubule associated monooxygenase, calponin and LIM domain containing 3" Q7RTP6 22 17787649-18024559 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Exocytosis" "Actin-binding, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Muller glia cells: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 10.0;memory B-cell: 3.3;naive B-cell: 5.2" "Group enriched" "Detected in many" 6 "B-cells: 5.2;granulocytes: 10.0" "Cell line enhanced" "Detected in many" "WM-115: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000639, HPA003421, HPA034882" Approved Supported "Nucleoplasm,Plasma membrane,Midbody ring,Cytosol" Yes No "Nucleoplasm, Midbody ring" "Plasma membrane, Cytosol" "HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: AB_2674371" "unprognostic (1.65e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-2)" "unprognostic (2.00e-2)" "unprognostic (7.68e-2)" "unprognostic (2.06e-1)" "unprognostic (4.71e-2)" "unprognostic (3.07e-3)" "unprognostic (3.41e-1)" "unprognostic (1.01e-1)" "unprognostic (4.58e-1)" "unprognostic (3.82e-1)" "unprognostic (8.86e-3)" "unprognostic (1.36e-2)" "unprognostic (1.23e-1)" "unprognostic (2.03e-2)" "unprognostic (6.64e-2)" 10.1 9.0 15.4 20.7 19.2 10.2 9.6 62.2 25.0 12.8 22.4 30.0 8.8 8.3 30.3 14.0 13.8 28.6 9.5 23.7 15.4 13.8 8.7 16.8 6.1 15.2 21.6 15.6 20.2 10.2 30.4 11.0 11.9 19.4 11.8 16.5 14.2 8.0 14.8 28.0 14.7 13.2 26.1 20.9 12.2 11.1 15.7 22.6 3.0 10.4 7.8 20.8 14.7 15.1 5.2 0.3 10.0 0.1 1.3 1.1 0.2 13.9 15.4 8.2 13.2 6.1 7.9 9.8 12.3 13.4 17.5 13.8 14.6 2.0 15.6 6.3 16.8 20.1 16.2 12.0 14.2 17.0 15.1 11.4 16.2 16.3 6.1 4.1 7.2 8.7 6.3 11.4 18.3 19.5 11.1 10.1 4.5 17.8 10.1 6.4 12.5 6.8 4.5 5.5 10.3 10.0 9.5 12.2 0.7 14.0 9.9 21.5 8.4 17.4 11.0 26.2 13.0 4.4 3.1 17.8 18.0 11.6 12.3 25.6 6.6 11.7 20.9 15.6 3.2 51.4 10.0 0.0 0.1 0.5 0.1 0.8 3.3 0.6 0.5 0.1 5.2 0.3 0.2 0.2 1.3 0.0 0.3 1.1 0.2 15.4 19.2 62.2 25.0 15.4 13.8 21.6 15.6 19.4 22.6 3.0 15.1 14.3 10.9 10.0 13.4 13.4 12.7 20.1 15.9 12.2 49.1 11.8 0.0 19.8 9.4 14.0 21.9 23.3 8.4 29.4 9.6 10.5 18.5 33.0 2.7 1.6 9.8 6.2 2.7 10.5 3.7 3.7 8.5 8.2 18.5 59.7 22.3 20.1 6.0 3.9 11.6 0.0 9.2 19.3 12.6 10.3 9.4 7.7 15.7 6.7 MIER1 "hMI-ER1, KIAA1610, MI-ER1" ENSG00000198160 "MIER1 transcriptional regulator" Q8N108 1 66924895-66988619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019589, HPA050306" Enhanced Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA019589: AB_1853953, HPA050306: AB_2681080" "unprognostic (3.38e-3)" "unprognostic (1.34e-1)" "prognostic favorable (4.96e-4)" "unprognostic (1.63e-1)" "prognostic favorable (3.44e-8)" "unprognostic (1.61e-1)" "unprognostic (3.15e-3)" "unprognostic (1.32e-1)" "unprognostic (1.05e-1)" "unprognostic (3.92e-3)" "unprognostic (4.48e-3)" "unprognostic (2.57e-2)" "unprognostic (2.81e-2)" "unprognostic (2.25e-2)" "unprognostic (2.73e-1)" "unprognostic (5.15e-2)" "unprognostic (2.45e-2)" 23.5 20.0 13.9 23.2 14.8 70.3 19.9 15.9 14.9 22.2 22.9 10.8 18.8 13.2 19.3 17.9 16.0 15.0 19.0 12.5 13.3 12.9 16.0 20.7 19.4 22.2 14.8 10.9 22.9 11.8 11.2 20.2 18.5 13.3 19.9 20.7 10.8 12.6 22.5 14.0 14.1 22.3 25.6 15.0 23.0 16.1 15.9 13.9 30.4 17.4 13.9 16.3 23.9 34.3 8.5 7.6 24.3 12.2 9.6 14.9 5.3 14.1 8.4 10.3 18.4 21.2 14.6 11.5 15.0 17.0 15.4 16.7 6.8 8.9 14.3 5.7 16.9 13.7 9.5 12.7 16.2 22.0 16.8 9.8 31.4 22.5 10.5 17.2 24.7 18.7 14.5 12.3 17.1 17.8 17.6 16.5 17.9 16.5 13.0 17.6 4.4 35.8 9.0 14.4 6.5 5.4 15.7 24.8 9.9 12.8 16.3 6.2 11.9 22.4 13.8 14.6 10.4 7.4 16.4 19.3 17.6 12.5 17.2 13.8 16.1 14.9 20.9 14.3 10.9 10.6 21.6 7.4 16.6 12.8 8.0 14.9 7.5 11.6 11.3 5.5 8.5 12.0 11.7 24.3 9.6 12.2 7.6 9.5 5.3 13.9 14.8 15.9 14.9 13.3 12.9 14.8 10.9 13.3 13.9 14.9 43.7 34.7 30.9 42.8 36.6 29.9 20.4 36.1 34.2 26.2 23.6 32.0 38.1 31.5 37.6 46.8 73.5 0.0 35.1 21.8 47.2 42.0 89.1 45.1 20.1 38.1 40.5 35.0 36.9 40.6 75.4 43.8 13.5 51.3 46.9 62.0 40.3 63.2 87.7 24.9 46.9 77.6 49.2 49.7 56.8 30.4 28.7 56.8 35.4 56.7 MIER3 "DKFZp686L09111, DKFZp781I1119, FLJ35954" ENSG00000155545 "MIER family member 3" Q7Z3K6 5 56919602-56971675 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058349, HPA065946" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA058349: AB_2683688, HPA065946: AB_2685583" "unprognostic (1.01e-1)" "unprognostic (2.71e-1)" "unprognostic (4.07e-3)" "unprognostic (1.81e-1)" "unprognostic (2.22e-2)" "unprognostic (1.29e-1)" "unprognostic (2.82e-2)" "unprognostic (2.47e-1)" "unprognostic (1.61e-2)" "unprognostic (3.36e-1)" "unprognostic (1.88e-2)" "unprognostic (5.66e-2)" "unprognostic (9.31e-3)" "unprognostic (5.53e-2)" "unprognostic (3.76e-1)" "unprognostic (2.63e-2)" "unprognostic (4.84e-3)" 7.5 7.3 5.6 8.0 7.7 8.0 10.9 23.0 10.7 10.9 25.9 7.7 5.4 19.4 15.3 8.0 7.1 8.4 5.5 6.5 5.9 5.4 6.7 9.5 6.1 6.6 9.2 7.4 13.5 14.7 12.1 12.5 8.7 9.2 8.2 19.5 9.6 7.9 8.7 8.2 6.2 14.1 8.0 8.5 6.4 6.9 15.0 8.1 12.4 8.6 7.7 6.6 7.4 12.2 4.1 4.4 4.4 4.1 3.8 6.0 3.4 6.4 9.4 13.2 24.8 8.8 7.0 18.3 6.1 7.9 11.6 13.0 14.9 5.5 7.0 7.4 7.1 10.5 8.2 16.5 6.5 12.5 3.6 7.6 6.0 11.3 7.1 6.6 8.1 12.4 8.1 8.2 8.6 7.2 7.2 7.5 8.6 7.7 12.1 6.7 7.1 12.2 9.3 10.4 2.9 5.5 20.6 12.4 7.2 5.5 12.9 11.0 17.6 18.5 6.9 9.1 11.0 10.0 7.7 7.2 3.3 10.4 5.9 10.9 7.5 10.1 17.6 6.3 6.3 7.2 0.6 2.4 4.4 3.3 4.1 4.9 4.1 2.6 6.0 3.8 4.0 4.8 3.3 2.3 3.8 3.3 4.4 2.5 3.4 5.6 7.7 23.0 10.7 5.9 5.4 9.2 7.4 9.2 8.1 14.9 4.8 1.9 4.4 11.9 7.1 7.1 10.2 4.0 6.8 3.5 13.7 3.2 5.0 3.5 11.5 5.8 44.2 0.0 5.0 2.9 8.2 7.4 4.6 8.5 3.5 9.5 11.5 8.0 5.1 5.6 5.5 4.8 1.7 7.2 14.2 6.6 6.3 12.7 8.1 4.2 13.2 12.9 6.6 11.7 4.1 8.5 5.7 4.9 8.9 5.4 MINDY1 "FAM63A, FLJ11280, MINDY-1" ENSG00000143409 "MINDY lysine 48 deubiquitinase 1" Q8N5J2 1 150996086-151008375 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 15 "Distal tubular cells: 33.2;Ductal cells: 11.3;Proximal tubular cells: 10.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 26.3;eosinophil: 19.1;neutrophil: 30.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 30.4" "Cell line enhanced" "Detected in many" "T-47d: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028351, HPA028358, HPA061086" Approved Enhanced Nucleoplasm NA NA 240000 Nucleoplasm "HPA028351: AB_10611110, HPA028358: AB_10601102, HPA061086: AB_2684425" "unprognostic (5.73e-2)" "unprognostic (2.86e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-1)" "unprognostic (3.39e-2)" "unprognostic (6.90e-2)" "unprognostic (1.47e-2)" "unprognostic (1.64e-1)" "unprognostic (1.02e-1)" "unprognostic (1.88e-1)" "unprognostic (9.22e-3)" "unprognostic (1.06e-1)" "prognostic favorable (3.43e-8)" "unprognostic (2.30e-1)" "unprognostic (7.95e-2)" "unprognostic (2.50e-2)" "unprognostic (6.06e-2)" 9.2 9.7 14.0 6.7 31.1 5.6 13.0 18.4 21.2 13.1 13.5 53.8 14.8 14.0 14.7 6.5 24.1 14.4 11.8 24.5 17.6 10.1 26.6 12.2 10.9 5.2 37.5 13.5 19.3 37.3 26.2 12.3 5.9 25.0 11.7 14.8 16.9 25.3 21.0 11.9 17.1 12.1 13.7 34.1 10.7 15.9 14.7 35.7 0.9 39.9 7.9 10.3 12.3 13.0 0.6 4.0 30.4 3.2 1.5 2.2 3.4 6.1 4.0 4.3 6.1 7.8 6.5 3.6 2.0 5.1 2.8 4.5 8.6 14.7 0.4 4.8 2.6 0.9 3.1 3.4 3.7 1.3 4.6 5.1 6.0 7.4 7.3 1.7 1.8 2.4 5.3 3.4 5.1 1.4 9.6 7.2 2.1 3.7 15.5 2.9 9.5 0.3 4.0 2.0 1.9 1.4 4.5 0.8 18.9 13.4 12.2 7.5 5.5 3.8 7.0 4.2 2.1 27.9 6.1 6.7 2.4 3.2 1.2 1.7 5.7 5.2 20.6 5.8 4.0 11.4 26.3 3.2 19.1 0.1 1.5 0.1 0.3 1.3 0.3 4.0 0.6 2.2 0.7 30.4 1.5 0.9 0.6 1.6 3.4 14.0 31.1 18.4 21.2 17.6 10.1 37.5 13.5 25.0 35.7 8.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 4.0 6.8 3.5 0.0 3.4 33.2 11.3 0.0 0.0 0.0 0.0 6.1 0.6 0.0 0.0 3.5 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 7.3 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 MINDY2 "FAM63B, KIAA1164" ENSG00000128923 "MINDY lysine 48 deubiquitinase 2" Q8NBR6 15 58771192-58861900 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 137.0;Collecting duct cells: 78.5;Extravillous trophoblasts: 84.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 40.6" "Low region specificity" "Detected in all" "HPA051103, HPA063669" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA051103: AB_2681345, HPA063669: AB_2685082" "unprognostic (4.71e-2)" "unprognostic (8.92e-3)" "unprognostic (4.63e-2)" "unprognostic (4.13e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "unprognostic (8.60e-2)" "unprognostic (7.23e-2)" "unprognostic (7.09e-2)" "unprognostic (2.36e-3)" "unprognostic (4.74e-2)" "prognostic favorable (3.00e-8)" "unprognostic (2.53e-1)" "unprognostic (3.59e-1)" "unprognostic (6.76e-2)" "unprognostic (4.77e-2)" 14.0 9.2 15.5 8.8 14.7 5.6 11.1 41.0 15.4 12.4 8.8 12.4 11.8 5.8 13.0 8.0 11.8 11.7 10.4 16.7 14.6 12.6 16.9 5.8 12.5 6.1 16.2 15.5 11.7 6.4 15.5 12.5 21.9 14.9 15.0 6.6 11.7 7.7 11.8 6.1 11.4 6.5 13.6 16.9 9.4 7.8 6.2 15.8 8.6 15.8 5.4 6.0 13.1 9.1 4.6 2.9 5.5 3.1 1.9 5.5 1.4 5.8 2.9 4.1 2.5 6.2 11.4 6.5 5.4 11.5 1.7 2.4 4.6 2.9 3.0 5.9 6.5 3.0 5.7 7.5 4.3 2.6 3.0 2.7 4.2 3.2 4.1 3.8 3.1 3.9 5.0 7.3 2.0 4.5 6.4 4.1 3.2 7.2 3.4 3.9 0.7 3.9 2.4 8.7 0.8 1.5 1.7 11.8 3.2 5.0 6.6 3.7 2.8 3.9 5.5 9.8 9.1 1.7 6.7 4.8 2.4 2.1 40.6 2.3 3.0 4.3 3.0 5.3 5.2 5.7 5.5 1.8 3.3 3.2 1.6 5.5 2.7 2.8 3.5 0.6 4.6 2.4 3.3 3.9 1.9 3.1 2.9 2.2 1.4 15.5 14.7 41.0 15.4 14.6 12.6 16.2 15.5 14.9 15.8 137.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 52.2 33.0 78.5 0.0 54.4 39.7 36.7 0.0 0.0 0.0 0.0 18.8 84.1 0.0 0.0 10.5 0.0 28.7 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 16.2 0.0 0.0 23.8 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 44.5 0.0 0.0 0.0 MIOS "FLJ20323, MIO, Sea4" ENSG00000164654 "Meiosis regulator for oocyte development" Q9NXC5 7 7566872-7608929 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042928, HPA052223" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042928: AB_10795610, HPA052223: AB_2681768" "unprognostic (8.09e-3)" "unprognostic (1.25e-2)" "unprognostic (6.93e-2)" "prognostic favorable (6.51e-4)" "unprognostic (3.42e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (9.14e-4)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (1.44e-2)" "unprognostic (2.27e-1)" "unprognostic (2.09e-1)" "prognostic favorable (3.28e-6)" "unprognostic (1.03e-1)" "unprognostic (1.10e-2)" "unprognostic (7.67e-3)" "unprognostic (2.72e-1)" 9.9 7.8 6.7 14.4 9.5 10.3 9.6 11.7 10.3 9.9 7.0 7.3 10.3 5.5 8.8 8.7 17.1 8.1 6.4 8.0 7.3 5.6 12.0 11.2 7.4 13.9 5.7 7.2 9.0 16.2 24.6 14.9 11.0 16.8 14.7 8.7 10.9 12.3 14.3 67.7 15.3 8.9 8.0 8.8 15.2 10.6 11.9 7.8 14.0 6.8 14.6 19.0 9.3 12.2 10.5 8.3 8.9 11.0 6.4 7.5 4.2 18.9 8.5 10.3 12.3 8.1 17.5 8.6 14.9 11.9 9.5 9.6 10.5 7.5 16.8 4.7 8.8 25.6 17.2 10.4 10.9 12.7 6.8 9.1 4.1 10.2 7.0 11.4 18.0 4.7 14.5 13.7 8.5 21.4 9.4 8.5 5.7 20.9 13.8 40.2 13.2 4.0 8.2 20.8 9.6 9.1 12.5 15.7 16.1 8.6 9.7 10.8 17.5 7.9 22.7 8.8 19.8 12.3 16.2 7.4 14.9 16.0 8.2 12.6 12.3 13.5 15.0 13.0 10.5 17.3 0.0 5.9 8.9 5.1 11.0 4.3 10.5 5.5 4.7 8.3 9.5 7.5 5.8 0.6 6.4 5.3 5.0 5.4 4.2 6.7 9.5 11.7 10.3 7.3 5.6 5.7 7.2 16.8 7.8 8.9 11.0 15.3 12.4 10.8 7.9 16.5 10.2 12.0 9.1 7.0 11.8 14.7 14.9 11.0 29.5 6.4 6.3 0.0 15.2 7.3 5.7 25.8 9.2 15.1 13.8 11.1 4.1 6.7 20.9 40.8 5.5 13.5 6.8 5.4 8.1 7.8 11.3 9.0 7.1 8.4 15.6 12.9 6.6 24.4 28.0 16.6 17.7 12.5 9.3 16.5 MKI67 "MIB-, PPP1R105" ENSG00000148773 "Marker of proliferation Ki-67" P46013 10 128096659-128126385 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.2;lymphoid tissue: 81.5" "Cell type enhanced" "Detected in many" 19 "Erythroid cells: 163.5;Extravillous trophoblasts: 71.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.4;T-reg: 1.3" "Group enriched" "Detected in many" 13 "NK-cells: 1.1;T-cells: 1.4" "Low cell line specificity" "Detected in many" "CAB000058, HPA000451, HPA001164, CAB068198" Enhanced Enhanced "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes Yes "Nucleoplasm, Nucleoli rim" "Mitotic chromosome" "CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187" "unprognostic (2.54e-1)" "unprognostic (1.29e-1)" "unprognostic (3.37e-1)" "unprognostic (9.92e-3)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.61e-6)" "unprognostic (7.16e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "prognostic unfavorable (9.47e-5)" "unprognostic (2.45e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (4.61e-1)" 1.8 1.2 0.2 9.9 0.5 25.2 1.8 0.3 0.5 1.5 5.0 0.6 0.2 3.6 0.7 1.4 13.4 0.3 1.2 1.3 0.2 0.2 1.2 1.0 1.9 8.8 0.2 0.2 0.5 0.4 0.0 0.4 2.9 0.5 0.7 5.8 0.5 2.2 0.6 0.5 3.9 6.2 1.3 0.8 6.5 3.5 2.5 0.2 81.5 0.4 5.2 10.0 1.3 3.5 0.0 0.0 0.0 0.0 1.1 1.4 0.4 48.1 24.5 25.5 18.0 1.0 2.2 7.9 18.3 13.5 17.4 15.6 20.0 20.0 36.3 5.3 12.5 11.5 29.4 26.7 13.7 26.2 38.2 12.9 31.1 18.1 12.5 0.0 43.6 16.9 0.5 0.6 17.8 18.3 4.3 17.0 16.9 14.2 34.9 17.2 19.1 26.0 13.3 10.1 12.5 11.2 19.4 33.4 4.8 6.3 13.5 8.9 9.6 25.9 9.3 4.4 8.8 7.7 9.3 15.7 9.2 18.5 13.0 49.4 15.9 12.6 44.0 7.7 20.0 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.4 1.0 0.0 1.1 0.0 0.0 1.3 0.4 0.2 0.5 0.3 0.5 0.2 0.2 0.2 0.2 0.5 0.2 0.0 4.8 10.7 0.5 5.7 0.0 1.2 2.5 2.7 7.9 0.0 0.0 2.7 0.0 0.4 2.5 0.0 2.7 163.5 0.0 71.7 3.4 1.4 1.1 1.0 34.1 0.0 6.4 3.7 8.0 0.5 0.3 12.7 3.3 0.0 4.8 0.0 0.1 2.9 0.4 0.0 0.0 0.0 0.4 8.8 14.6 2.6 6.5 13.4 20.7 4.1 MLH1 "COCA2, FCC2, HNPCC, HNPCC2" ENSG00000076242 "MutL homolog 1" P40692 3 36993332-37050918 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013294, HPA052707, HPA060714, CAB070868" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013294: AB_2533406, CAB070868: , HPA052707: AB_2681923, HPA060714: AB_2684348" "unprognostic (1.26e-2)" "unprognostic (3.88e-3)" "unprognostic (2.36e-2)" "unprognostic (1.82e-1)" "unprognostic (3.33e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (8.24e-5)" "unprognostic (3.36e-2)" "unprognostic (2.18e-1)" "unprognostic (1.32e-1)" "unprognostic (8.54e-2)" "unprognostic (8.63e-3)" "unprognostic (2.10e-3)" "unprognostic (4.37e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (8.86e-2)" 16.3 20.7 18.2 19.4 21.4 24.4 18.7 19.7 19.6 15.3 17.3 28.8 19.6 12.4 18.7 23.6 15.1 16.2 14.4 32.0 17.3 17.7 18.8 20.5 17.8 22.8 19.9 16.0 17.6 18.1 26.0 29.4 17.3 19.2 18.5 17.7 16.7 15.6 18.1 46.4 14.2 14.1 21.1 21.6 20.7 16.5 27.6 21.5 29.0 22.2 19.5 24.5 16.9 21.4 12.0 12.9 13.2 23.2 6.7 13.4 9.0 14.2 22.5 28.1 0.0 12.5 15.7 12.6 21.3 17.0 24.8 26.4 17.0 15.9 35.3 10.6 17.3 14.0 9.8 24.2 18.0 26.6 16.0 12.5 24.7 20.8 23.8 13.9 30.3 17.2 11.7 12.7 23.1 28.8 9.8 15.3 23.9 31.6 16.9 25.1 11.5 31.6 12.4 20.6 14.5 12.4 3.1 34.4 14.9 15.7 15.5 6.0 14.2 21.6 23.0 14.2 16.4 33.2 21.6 12.1 19.5 21.0 19.1 25.0 13.4 36.6 33.1 15.1 28.7 17.5 10.9 11.7 13.2 13.4 19.5 9.7 12.0 8.4 10.7 12.9 10.3 9.6 9.7 3.4 6.7 23.2 6.1 12.5 9.0 18.2 21.4 19.7 19.6 17.3 17.7 19.9 16.0 19.2 21.5 23.8 12.0 16.0 10.7 6.4 19.2 37.1 15.3 16.0 13.6 10.4 9.8 27.1 16.6 12.5 20.3 11.2 5.3 0.0 13.0 23.0 13.4 8.0 7.0 14.5 17.5 3.2 5.2 12.3 14.3 9.5 10.3 11.4 8.5 19.8 7.2 14.3 8.6 7.0 13.1 9.2 17.9 12.9 9.5 37.0 25.4 4.8 16.7 13.1 7.6 3.4 MMS19 "hMMS19, MET18, MMS19L" ENSG00000155229 "MMS19 homolog, cytosolic iron-sulfur assembly component" Q96T76 10 97458324-97498794 "Predicted intracellular proteins" "Chromosome partition, DNA damage, DNA repair, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051936, HPA056299" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051936: AB_2681668, HPA056299: AB_2683091" "unprognostic (8.57e-2)" "unprognostic (2.38e-3)" "unprognostic (9.34e-3)" "unprognostic (1.84e-1)" "unprognostic (2.04e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (6.88e-4)" "unprognostic (4.40e-1)" "unprognostic (1.99e-2)" "unprognostic (4.90e-2)" "unprognostic (1.17e-1)" "unprognostic (9.06e-3)" "unprognostic (6.79e-2)" "unprognostic (6.49e-2)" "unprognostic (4.06e-1)" "unprognostic (3.51e-2)" "prognostic unfavorable (3.39e-4)" 17.5 16.4 26.5 16.6 25.5 17.1 23.0 38.0 35.7 18.9 18.2 26.2 17.1 16.8 20.8 23.4 23.1 23.7 15.9 25.6 24.8 18.4 22.8 16.2 20.2 24.2 21.0 24.8 28.3 20.6 19.3 31.4 24.5 22.3 17.3 21.8 23.1 19.5 20.6 26.7 38.2 18.4 22.0 18.6 23.7 17.8 33.7 24.7 27.6 19.2 19.4 26.4 18.0 21.9 8.1 11.0 9.8 8.5 6.7 12.7 7.7 15.2 14.7 17.8 24.8 17.5 21.1 10.7 12.4 25.0 18.9 22.3 19.5 20.1 23.7 13.6 16.8 12.6 17.5 29.1 33.5 17.9 10.2 22.1 12.4 12.2 20.3 13.2 16.4 12.2 17.4 14.6 16.7 35.7 36.8 31.8 17.9 17.7 13.3 18.3 13.9 15.6 30.2 10.0 15.6 12.1 12.6 13.6 10.6 22.4 11.1 7.2 11.9 7.1 9.6 18.4 23.2 19.4 15.0 18.0 8.6 11.0 5.9 13.9 12.0 13.4 13.7 13.0 24.8 7.0 9.8 7.2 5.8 7.5 8.5 12.7 8.1 10.1 9.4 11.0 7.0 12.2 9.5 1.6 6.7 6.5 8.3 10.0 7.7 26.5 25.5 38.0 35.7 24.8 18.4 21.0 24.8 22.3 24.7 20.8 16.5 8.0 5.3 9.3 10.5 15.3 7.6 4.0 5.7 5.2 17.7 11.8 10.0 9.9 7.2 10.8 8.7 0.0 6.9 15.6 8.7 5.0 3.5 12.8 11.1 9.5 9.8 14.7 13.8 6.4 14.4 7.8 13.5 17.2 13.1 5.6 8.4 2.9 10.6 5.5 22.4 12.9 9.2 20.9 29.6 10.0 7.3 7.0 12.0 4.1 MNAT1 "MAT1, RNF66" ENSG00000020426 "MNAT1, CDK activating kinase assembly factor" P51948 14 60734742-60969953 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000701, HPA001154, CAB004495" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004495: AB_670057, HPA000701: AB_1079400, HPA001154: AB_2666212" "unprognostic (4.10e-2)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (6.11e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.17e-2)" "unprognostic (2.73e-1)" "unprognostic (2.62e-2)" "unprognostic (3.52e-2)" "unprognostic (3.48e-2)" "unprognostic (6.34e-2)" "prognostic favorable (3.46e-4)" "unprognostic (2.68e-1)" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "unprognostic (7.14e-3)" 15.3 14.9 14.6 10.1 18.9 9.4 19.6 29.2 20.2 16.9 11.4 11.8 12.2 6.8 17.3 15.0 13.7 18.9 10.8 15.2 14.0 14.2 19.8 17.0 10.7 9.4 13.8 15.4 16.2 10.3 42.8 33.2 13.7 18.7 16.3 9.9 11.6 18.4 12.8 53.0 8.4 7.1 14.6 15.0 9.2 11.5 8.8 11.8 11.8 14.0 15.9 12.5 13.6 12.3 14.7 25.7 11.6 5.1 18.9 10.8 3.9 60.9 11.8 14.7 10.4 17.2 19.0 16.1 22.5 24.3 27.5 22.3 9.4 21.5 14.7 17.1 16.4 14.9 19.5 16.4 25.8 39.6 18.3 17.1 9.9 11.5 13.8 21.4 22.9 5.3 11.5 19.0 17.7 19.7 26.6 26.2 21.5 14.6 14.1 30.6 20.9 14.2 14.4 8.0 11.6 26.4 14.8 40.2 9.2 32.3 28.8 13.2 9.0 17.2 14.5 20.8 17.8 22.5 11.2 19.9 21.2 22.4 9.9 16.8 6.2 5.2 21.1 17.1 3.9 15.3 4.7 3.6 11.6 8.5 4.6 8.8 14.7 9.1 8.9 6.6 11.3 10.8 10.7 0.3 18.9 5.1 25.7 7.5 3.9 14.6 18.9 29.2 20.2 14.0 14.2 13.8 15.4 18.7 11.8 29.8 18.0 15.9 49.9 22.0 39.8 44.5 28.1 66.9 35.2 27.9 29.5 43.5 68.0 30.1 2.7 27.0 2.9 0.0 38.3 30.0 22.1 39.3 31.3 19.1 17.5 22.3 16.7 15.4 4.5 4.9 27.9 11.3 13.5 13.6 13.8 46.7 45.6 11.8 28.7 46.9 58.0 51.8 35.9 54.6 50.7 15.8 30.1 25.5 14.2 38.2 MNT "bHLHd3, MAD6, MXD6, ROX" ENSG00000070444 "MAX network transcriptional repressor" Q99583 17 2384060-2401118 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059532, HPA067578" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059532: AB_2684053, HPA067578: AB_2685864" "unprognostic (3.72e-1)" "unprognostic (3.42e-2)" "unprognostic (1.57e-1)" "unprognostic (2.39e-1)" "unprognostic (1.29e-1)" "unprognostic (5.30e-3)" "unprognostic (1.31e-2)" "unprognostic (4.49e-2)" "unprognostic (1.27e-1)" "unprognostic (4.97e-2)" "unprognostic (3.47e-3)" "unprognostic (2.27e-3)" "unprognostic (1.81e-2)" "unprognostic (3.52e-2)" "unprognostic (5.09e-1)" "unprognostic (9.32e-2)" "unprognostic (1.98e-2)" 18.0 14.7 12.6 15.2 15.2 29.8 11.8 13.3 22.8 17.3 16.8 12.1 9.9 14.9 16.9 11.3 19.5 15.9 14.4 9.0 12.1 11.6 11.2 9.1 11.9 13.2 8.6 13.6 17.9 15.8 14.2 18.9 15.1 12.0 13.8 8.4 15.8 12.4 17.2 10.7 15.3 13.6 13.4 11.4 14.5 13.1 16.2 9.3 14.2 13.3 11.5 14.4 25.5 13.8 1.0 1.1 4.1 1.7 0.6 1.2 0.6 7.2 9.0 7.8 9.9 9.8 11.1 7.1 4.8 6.4 2.7 3.1 5.9 7.1 10.0 5.1 7.4 6.0 11.5 5.6 10.6 2.1 5.4 8.1 7.1 14.8 5.0 6.4 3.0 13.2 17.6 10.0 5.8 7.8 8.8 4.7 8.0 6.0 9.2 3.1 5.2 7.0 5.2 3.7 5.3 5.9 8.1 3.7 6.6 5.1 10.3 8.3 12.0 5.6 5.5 12.9 4.2 4.5 5.8 8.5 6.7 4.6 10.5 3.9 7.9 3.9 4.0 13.6 6.1 4.3 1.5 1.2 2.9 0.6 1.7 1.2 1.0 0.8 1.0 0.5 0.7 1.0 1.0 4.1 0.6 1.3 1.1 0.1 0.6 12.6 15.2 13.3 21.6 12.1 11.6 8.6 13.6 12.0 9.3 6.0 25.0 11.3 14.7 16.6 15.7 5.6 5.1 8.1 15.9 14.0 21.6 5.6 1.7 8.7 6.8 10.5 16.7 0.0 8.9 7.9 12.4 16.5 12.8 8.9 12.2 25.4 19.0 12.9 24.0 12.2 10.3 15.4 10.1 1.8 20.9 10.6 10.9 20.1 12.4 2.4 10.6 6.5 12.2 10.4 19.6 22.5 7.8 12.8 22.3 51.0 MORC3 "KIAA0136, NXP2, ZCW5, ZCWCC3" ENSG00000159256 "MORC family CW-type zinc finger 3" Q14149 21 36320189-36386148 "Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018406, HPA034848" Approved Enhanced Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA018406: AB_1858988, HPA034848: AB_2674359" "unprognostic (4.01e-3)" "unprognostic (4.86e-2)" "unprognostic (4.25e-2)" "unprognostic (1.38e-1)" "unprognostic (1.16e-1)" "unprognostic (6.29e-2)" "unprognostic (6.56e-2)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (2.53e-1)" "unprognostic (6.40e-2)" "unprognostic (8.61e-2)" "unprognostic (1.18e-3)" "unprognostic (1.38e-2)" "unprognostic (3.91e-1)" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" 18.0 11.2 15.6 15.4 16.4 28.0 17.5 30.9 16.3 20.3 15.3 10.1 14.1 10.6 22.5 10.6 23.0 17.9 13.5 12.5 14.6 7.9 11.6 13.0 17.0 20.6 17.5 12.1 29.3 11.3 14.8 25.1 20.6 16.6 16.1 12.1 7.3 20.6 14.2 28.1 20.1 14.8 21.4 21.0 19.1 14.0 10.8 18.2 25.5 15.0 17.6 20.0 22.9 23.5 11.2 7.6 21.9 10.7 8.2 11.9 6.6 12.2 4.7 11.4 7.5 11.8 12.8 16.1 11.6 20.3 13.4 11.1 7.6 8.0 5.9 4.5 13.3 13.3 6.2 8.9 11.6 14.1 11.1 7.0 24.4 5.1 5.6 7.7 12.5 21.8 8.0 14.5 12.8 17.7 14.0 10.7 9.3 19.5 15.1 10.8 4.0 8.0 6.8 9.4 15.0 5.7 9.9 5.7 10.6 5.9 12.8 4.7 12.3 13.5 8.8 13.8 9.2 9.9 10.5 14.3 13.0 3.2 8.7 10.0 6.7 5.9 5.7 8.4 19.9 9.3 21.9 7.5 16.1 8.4 9.4 8.3 10.0 9.2 7.9 7.6 11.2 11.9 8.5 11.7 8.2 10.7 4.9 11.3 6.6 15.6 16.4 30.9 16.3 14.6 7.9 17.5 12.1 16.6 18.2 26.8 20.8 20.5 44.0 60.8 20.0 17.6 12.7 32.1 25.0 21.0 7.9 13.4 3.3 14.1 38.2 20.4 10.1 23.3 10.9 15.8 35.2 39.4 46.2 13.6 15.7 15.9 10.9 12.9 25.7 13.5 17.3 33.9 23.6 21.6 14.7 15.5 17.4 14.4 25.1 5.3 11.9 12.9 20.2 24.7 32.9 71.4 21.1 24.5 9.0 52.9 MORC4 "FLJ11565, ZCW4, ZCWCC2" ENSG00000133131 "MORC family CW-type zinc finger 4" Q8TE76 X 106813871-107000244 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "placenta: 94.5" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 122.1;Alveolar cells type 2: 98.4;Ciliated cells: 111.1;Club cells: 109.2;Cytotrophoblasts: 213.9;granulocytes: 61.5;Syncytiotrophoblasts: 215.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 44.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA000395, HPA015547, HPA050250" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: AB_2681063" "prognostic unfavorable (3.56e-5)" "unprognostic (3.30e-3)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (1.40e-1)" "unprognostic (6.29e-3)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.30e-2)" "unprognostic (5.56e-2)" "unprognostic (8.59e-2)" "unprognostic (1.60e-1)" "unprognostic (1.60e-2)" "unprognostic (6.57e-2)" "unprognostic (4.89e-2)" "unprognostic (8.69e-2)" 8.7 20.0 3.2 6.0 4.8 5.1 6.2 4.9 3.6 8.0 5.3 4.6 12.7 4.6 8.8 8.5 6.8 7.3 6.7 5.3 4.3 2.8 4.9 9.7 6.0 2.2 4.9 2.2 12.3 9.1 6.0 4.9 94.5 5.8 7.7 4.9 4.2 8.7 8.8 9.4 8.6 4.9 7.4 5.4 2.6 5.6 12.5 5.0 2.3 7.6 7.5 5.2 6.3 15.1 6.0 4.6 10.5 3.8 2.8 4.0 0.7 11.0 44.0 4.4 10.1 13.4 15.5 22.9 10.7 11.4 5.4 7.0 23.3 5.0 1.7 5.6 11.0 9.3 8.7 14.7 9.4 6.5 2.5 8.5 2.7 14.9 9.8 9.9 1.9 5.6 8.2 9.1 7.4 10.8 32.3 4.8 1.7 1.5 16.7 12.1 9.7 4.0 2.7 3.9 29.5 16.7 1.9 8.8 1.9 17.5 8.8 3.8 4.8 13.0 12.8 8.4 6.5 7.6 1.9 5.0 8.7 8.8 17.2 5.9 4.7 6.1 4.3 9.3 1.7 6.3 10.5 3.8 3.1 3.7 3.0 3.2 3.3 3.6 2.8 1.6 6.0 4.0 3.4 8.2 2.8 3.6 4.6 2.6 0.7 3.2 4.8 4.9 3.6 4.3 2.8 4.9 2.2 5.8 5.0 122.1 98.4 2.2 12.9 15.5 4.5 2.2 7.6 111.1 109.2 5.2 3.9 213.9 18.3 8.8 0.8 5.0 3.9 0.0 6.4 21.9 23.8 19.4 61.5 16.2 20.2 1.6 1.7 8.6 1.3 0.9 10.3 4.8 11.8 0.0 8.8 5.8 6.7 4.9 11.0 9.0 7.5 25.8 8.6 5.4 24.3 14.1 215.6 6.4 8.4 11.7 MORF4L2 "KIAA0026, MRGX" ENSG00000123562 "Mortality factor 4 like 2" Q15014 X 103675496-103688158 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 931.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031872, HPA054102" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031872: AB_2674081, HPA054102: AB_2682379" "prognostic unfavorable (9.83e-4)" "unprognostic (2.04e-1)" "unprognostic (1.81e-1)" "unprognostic (7.14e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (4.29e-5)" "unprognostic (5.27e-2)" "unprognostic (6.34e-3)" "unprognostic (2.41e-1)" "unprognostic (4.49e-3)" "unprognostic (1.88e-1)" "unprognostic (1.10e-2)" "prognostic unfavorable (7.86e-7)" "unprognostic (8.54e-2)" "unprognostic (2.65e-2)" "unprognostic (1.78e-1)" "unprognostic (4.05e-1)" 33.3 51.4 50.4 26.6 53.5 23.9 51.6 52.8 66.8 76.2 32.9 29.7 62.9 25.8 74.0 63.4 40.2 55.2 39.5 38.5 50.0 71.2 44.0 76.5 34.3 19.3 45.5 48.8 99.8 36.2 38.6 81.8 77.4 63.5 47.4 40.3 23.4 35.2 57.8 44.9 27.4 27.8 93.7 46.1 25.9 31.5 33.5 34.7 21.5 46.8 35.6 29.9 55.5 45.3 21.6 40.7 24.7 24.7 25.4 29.1 21.9 61.5 41.8 56.2 24.8 83.8 63.0 75.5 82.5 72.2 68.6 70.7 42.8 55.5 42.1 67.7 78.4 84.4 41.9 70.3 61.1 86.0 19.3 31.9 22.4 71.9 48.4 91.9 30.6 21.3 68.4 54.5 58.4 77.1 58.7 75.2 21.9 36.7 58.2 83.9 62.3 27.3 30.2 53.4 74.4 47.6 27.7 52.8 44.5 68.5 37.5 53.7 41.8 62.2 46.2 61.5 62.5 30.6 29.8 62.7 40.1 26.9 69.4 44.0 29.0 35.4 37.4 71.7 62.2 60.0 24.7 23.3 18.4 25.4 24.7 29.1 21.6 24.3 23.9 24.3 19.1 26.9 23.1 9.5 25.4 24.6 40.7 19.7 21.9 50.4 53.5 52.8 66.8 50.0 71.2 45.5 48.8 63.5 34.7 116.1 147.5 88.8 414.6 322.8 43.3 119.2 122.3 420.3 177.5 104.7 9.8 369.7 208.9 242.9 24.0 127.8 101.6 93.5 114.3 931.5 289.9 258.5 150.3 162.2 144.9 55.6 171.3 128.3 54.0 17.4 306.3 110.7 178.8 79.4 116.9 105.8 160.2 115.2 540.3 206.2 33.5 142.3 300.8 27.0 40.2 277.8 488.0 71.4 94.4 332.6 MRE11 "ATLD, MRE11A" ENSG00000020922 "MRE11 homolog, double strand break repair nuclease" P49959 11 94415578-94493908 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Meiosis" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes, Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 26.8;Ciliated cells: 21.4;Cytotrophoblasts: 31.8;Syncytiotrophoblasts: 23.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002691, CAB004081" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004081: AB_2145100, HPA002691: AB_1079409" "unprognostic (5.59e-3)" "unprognostic (4.35e-2)" "unprognostic (8.55e-2)" "unprognostic (2.76e-2)" "unprognostic (9.82e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (7.14e-4)" "unprognostic (2.85e-1)" "unprognostic (1.03e-2)" "unprognostic (1.34e-1)" "unprognostic (8.66e-3)" "unprognostic (6.96e-3)" "unprognostic (1.57e-3)" "unprognostic (1.39e-1)" "unprognostic (1.77e-1)" "unprognostic (1.22e-1)" "unprognostic (8.06e-3)" 14.7 11.0 10.7 15.2 12.5 24.0 16.6 21.2 12.0 17.5 11.0 10.8 13.9 8.0 17.4 11.2 13.9 13.2 8.9 9.4 8.7 6.5 8.8 8.9 11.4 13.8 13.3 7.9 16.7 15.5 8.2 12.8 14.2 9.8 12.7 14.1 10.4 14.1 10.8 9.3 18.3 12.8 12.8 13.5 17.2 11.8 9.9 13.0 25.3 12.7 7.4 18.4 14.3 13.3 8.7 14.8 7.9 13.1 10.3 11.8 7.9 10.0 10.3 19.3 2.4 6.6 9.2 11.1 14.2 9.2 12.8 15.2 18.7 20.7 26.4 23.1 7.4 16.0 19.4 16.4 10.6 17.0 17.4 9.7 23.0 14.7 10.7 3.0 15.0 16.6 6.4 6.6 16.6 10.4 5.8 11.2 12.9 16.0 17.1 10.2 7.3 15.2 14.3 6.2 23.4 11.3 13.6 17.3 13.2 8.4 14.1 6.8 9.8 19.6 12.3 3.8 17.1 21.1 9.1 8.1 19.2 14.1 16.6 10.1 4.3 15.2 25.9 5.1 24.0 15.3 5.4 11.1 7.9 11.2 13.1 11.0 8.5 8.4 11.8 14.8 8.7 7.1 11.5 4.8 10.3 9.8 10.5 10.9 7.9 10.7 12.5 21.2 12.0 8.7 6.5 13.3 7.9 9.8 13.0 26.8 14.7 0.0 0.0 0.0 0.0 0.0 0.0 21.4 17.0 8.7 0.0 31.8 3.3 10.1 0.0 0.0 0.0 0.0 6.9 13.1 0.0 0.0 16.3 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 16.2 0.0 0.0 8.6 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 MSL1 "DKFZp686P24239, hMSL1, MSL-1" ENSG00000188895 "Male specific lethal 1 homolog" Q68DK7 17 40122298-40136916 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 11.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 95.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022800, HPA023567" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA022800: AB_1853057, HPA023567: AB_1853059" "unprognostic (1.94e-1)" "unprognostic (6.28e-2)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (4.71e-2)" "unprognostic (5.39e-2)" "unprognostic (2.33e-2)" "unprognostic (1.60e-1)" "unprognostic (1.06e-2)" "unprognostic (2.24e-1)" "unprognostic (3.46e-1)" "unprognostic (7.48e-3)" "prognostic unfavorable (3.06e-6)" "unprognostic (2.92e-2)" "unprognostic (7.91e-2)" "unprognostic (5.80e-2)" "unprognostic (2.61e-2)" 27.2 26.0 31.4 26.6 31.6 29.9 56.5 36.0 45.1 44.6 31.7 25.8 42.7 30.2 39.3 35.1 29.6 38.7 31.9 22.2 31.6 20.3 27.5 21.7 29.3 27.2 31.4 36.7 32.0 28.6 40.5 39.9 28.4 27.2 32.6 28.7 20.3 27.2 32.9 29.2 35.4 28.7 32.5 24.5 43.6 27.0 32.8 33.8 22.1 39.3 23.9 29.4 34.0 52.7 1.7 1.9 11.7 1.3 0.9 2.3 0.8 9.1 10.9 23.5 15.3 21.4 18.6 12.1 16.1 17.2 20.4 18.5 10.9 9.9 20.3 12.4 16.9 13.0 17.1 19.7 10.6 21.1 17.3 15.9 11.2 15.0 12.9 11.2 15.1 21.9 15.5 17.0 15.0 12.5 20.8 18.7 12.4 17.6 16.6 16.2 5.7 24.0 16.8 10.0 10.1 7.2 19.8 13.0 18.3 14.8 10.1 21.8 12.9 15.1 95.0 12.0 22.4 22.2 21.0 15.3 13.8 15.4 10.0 13.5 26.5 14.8 20.3 14.0 11.3 16.0 0.0 1.3 1.0 2.3 0.7 1.2 1.7 1.3 1.8 0.9 1.1 1.3 1.2 11.7 0.9 1.0 1.9 0.8 0.8 31.4 31.6 36.0 45.1 31.6 20.3 31.4 36.7 27.2 33.8 26.8 38.4 15.6 33.7 44.4 55.0 22.6 22.9 26.8 22.7 10.4 11.8 12.6 3.3 16.7 12.4 38.4 28.0 0.0 18.0 11.4 35.5 45.8 3.5 31.4 21.1 49.3 30.0 38.6 33.5 19.8 54.1 27.8 30.4 5.4 31.8 34.6 19.9 23.0 37.4 6.0 28.4 38.8 36.3 69.6 48.1 57.5 14.2 15.2 28.5 42.5 MSRB1 "SelR, SelX, SepR, SEPX1" ENSG00000198736 "Methionine sulfoxide reductase B1" Q9NZV6 16 1938210-1943326 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 195.6;liver: 94.8;pancreas: 107.2" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 236.4;monocytes: 165.9;Proximal tubular cells: 237.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 85.8;neutrophil: 195.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 195.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008650, HPA043463, HPA069557" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153" "unprognostic (3.93e-2)" "unprognostic (3.68e-1)" "unprognostic (1.32e-1)" "unprognostic (9.61e-2)" "unprognostic (1.76e-2)" "unprognostic (1.15e-1)" "unprognostic (2.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.88e-2)" "unprognostic (4.90e-2)" "unprognostic (5.29e-2)" "unprognostic (3.60e-1)" "unprognostic (4.27e-2)" "unprognostic (8.46e-2)" "unprognostic (4.92e-2)" "unprognostic (7.31e-2)" "unprognostic (4.59e-3)" 7.9 4.0 5.2 9.0 6.3 27.3 5.1 3.2 6.1 5.2 13.1 5.6 7.5 8.7 7.9 13.5 16.9 9.6 13.5 13.7 4.7 4.1 24.9 94.8 9.6 15.6 5.5 4.1 7.3 107.2 2.9 3.9 11.6 4.1 11.0 5.1 6.2 4.7 9.4 20.5 8.0 17.0 14.3 4.3 18.2 9.6 8.1 3.6 3.7 5.5 19.8 4.5 14.8 4.8 1.7 10.9 195.6 26.2 2.4 2.8 12.2 6.8 17.3 6.4 15.2 12.0 5.3 11.0 8.4 10.6 12.3 10.7 27.7 7.5 6.6 27.5 9.7 10.8 11.2 10.7 7.4 3.8 37.0 12.2 5.1 6.4 44.1 11.0 14.4 12.2 9.8 6.5 8.9 1.7 3.9 12.3 8.6 8.0 3.7 6.5 37.5 8.1 23.6 8.8 12.3 9.9 11.8 8.9 31.0 19.2 11.4 6.2 8.2 9.5 10.6 5.1 4.3 11.5 25.5 7.3 3.7 10.4 7.4 4.9 9.8 15.5 12.6 3.9 13.6 6.5 26.0 26.2 85.8 2.2 12.0 2.1 1.7 1.8 1.8 10.9 1.7 1.4 1.6 195.6 2.4 10.7 4.6 2.8 12.2 5.2 6.3 3.2 6.1 4.7 4.1 5.5 4.1 4.1 3.6 8.9 14.9 11.5 10.5 5.8 6.0 32.4 38.2 20.1 3.4 31.4 3.9 30.0 79.6 56.2 3.3 12.0 75.5 23.3 97.0 102.6 13.1 12.7 4.6 236.4 55.0 7.9 57.8 19.0 79.6 10.4 8.6 26.2 15.1 165.9 31.9 17.1 66.7 63.3 21.5 237.9 3.0 0.0 19.8 35.7 9.1 8.3 32.3 20.3 27.8 18.7 MTA1 ENSG00000182979 "Metastasis associated 1" Q13330 14 105419820-105470729 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004508, HPA005544" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004508: AB_627969, HPA005544: AB_1079420" "unprognostic (6.79e-3)" "unprognostic (4.22e-2)" "unprognostic (1.06e-1)" "unprognostic (6.36e-2)" "unprognostic (2.91e-2)" "unprognostic (7.74e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (6.59e-2)" "unprognostic (1.47e-1)" "unprognostic (6.72e-3)" "prognostic favorable (9.48e-5)" "unprognostic (4.57e-3)" "unprognostic (1.39e-2)" "unprognostic (2.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.75e-1)" "unprognostic (1.18e-1)" 23.4 20.1 22.4 24.7 24.3 22.0 22.9 33.8 23.4 17.9 18.9 21.9 22.5 22.3 22.1 21.3 14.9 22.5 20.0 27.7 22.1 17.3 14.8 15.1 20.1 22.3 22.8 18.4 31.4 31.1 15.7 26.5 16.1 19.4 21.9 10.6 22.2 28.7 24.8 29.1 20.0 19.8 27.1 15.0 23.6 18.9 31.4 24.1 27.3 21.1 16.1 16.3 19.3 20.5 1.8 3.7 2.8 0.9 1.8 1.8 0.6 13.3 10.7 19.9 19.8 7.6 13.0 17.6 10.7 8.1 10.6 10.2 13.8 18.1 26.2 11.1 7.8 7.5 18.4 14.4 10.2 7.2 17.1 24.2 13.6 9.7 14.1 16.9 17.1 10.5 14.6 12.9 7.5 17.3 14.8 15.0 19.6 15.4 11.4 5.5 24.0 30.8 33.9 28.7 19.1 22.7 29.1 12.1 8.5 8.4 10.5 32.2 33.5 14.4 16.7 15.3 10.6 15.1 16.3 10.8 8.6 9.1 14.1 11.1 23.4 11.2 16.6 10.7 11.6 14.9 0.5 0.9 2.8 1.4 0.9 1.2 1.5 1.2 1.1 1.1 1.8 1.5 1.8 0.2 1.8 0.5 3.7 0.9 0.6 22.4 24.3 33.8 23.4 22.1 17.3 22.8 18.4 19.4 24.1 3.0 13.6 15.6 26.8 13.9 0.0 8.1 15.3 2.7 7.9 33.2 0.0 10.1 14.9 11.4 24.8 18.0 14.8 23.3 17.3 6.9 18.4 25.2 5.7 11.5 9.4 0.0 17.9 12.9 12.5 9.1 33.4 11.0 11.8 8.2 18.6 0.0 14.9 7.0 30.1 7.7 0.0 19.4 23.4 21.9 11.6 16.7 7.8 15.7 21.8 39.4 MTA2 "MTA1-L1, MTA1L1" ENSG00000149480 "Metastasis associated 1 family member 2" O94776 11 62593214-62601840 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005315, HPA006214, CAB017522, HPA072727" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB005315: AB_2146965, CAB017522: AB_831564, HPA006214: AB_1079421, HPA072727: " "unprognostic (5.97e-3)" "unprognostic (1.63e-2)" "unprognostic (1.23e-1)" "unprognostic (3.04e-2)" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" "prognostic unfavorable (4.82e-5)" "unprognostic (3.32e-3)" "unprognostic (1.95e-1)" "unprognostic (5.38e-3)" "unprognostic (3.09e-2)" "unprognostic (1.59e-1)" "unprognostic (1.16e-3)" "unprognostic (3.16e-3)" "unprognostic (9.84e-2)" "unprognostic (2.23e-1)" "unprognostic (2.50e-2)" 26.3 20.4 16.6 28.0 17.9 28.7 20.5 21.6 24.8 23.9 22.0 31.5 15.6 17.1 23.8 16.9 45.1 19.9 23.7 18.8 15.8 12.4 19.0 23.6 21.8 35.5 19.7 12.7 35.0 13.7 22.5 19.8 22.3 20.9 21.9 27.3 21.2 22.3 22.1 12.7 41.1 23.5 25.0 23.8 39.4 19.9 25.7 18.9 64.6 19.3 20.3 49.1 21.7 27.8 12.9 12.0 8.4 13.2 10.4 17.3 4.4 24.8 21.8 34.8 45.5 15.6 14.7 24.0 21.1 29.7 42.4 31.1 20.6 21.8 35.5 22.8 27.7 22.7 33.6 46.9 58.4 36.1 35.1 23.5 37.8 23.6 20.7 24.3 42.6 48.7 16.4 32.9 29.8 44.6 20.2 39.2 37.1 41.7 28.3 30.3 48.3 54.0 54.4 30.0 23.7 25.5 51.9 24.8 41.5 30.0 37.4 27.8 25.5 22.0 31.5 17.8 28.8 36.9 29.3 27.4 23.9 22.0 26.9 24.3 21.2 27.4 50.2 17.4 31.2 23.0 5.6 6.4 8.4 17.3 11.0 14.6 12.9 14.4 12.5 10.2 9.8 13.7 13.5 2.9 10.4 13.2 12.0 11.6 4.4 16.6 17.9 21.6 24.8 15.8 12.4 19.7 12.7 20.9 18.9 3.0 3.8 13.4 3.6 11.8 0.0 3.4 2.5 0.0 5.7 1.8 0.0 11.3 5.0 4.9 0.4 6.2 7.9 23.3 8.1 8.8 6.6 3.3 10.4 8.2 7.3 0.0 11.5 14.1 16.4 0.4 4.6 5.3 1.7 7.2 10.5 0.0 6.9 5.8 3.9 2.1 0.0 0.0 5.7 5.1 5.3 9.8 15.8 7.5 11.5 3.9 MTF2 "M96, PCL2, TDRD19A" ENSG00000143033 "Metal response element binding transcription factor 2" Q9Y483 1 93079235-93139081 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 43.4" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 122.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069047, HPA069066" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA069047: AB_2686073, HPA069066: AB_2686078" "unprognostic (1.84e-2)" "unprognostic (1.45e-1)" "unprognostic (5.56e-2)" "unprognostic (7.88e-3)" "unprognostic (7.12e-2)" "unprognostic (2.26e-3)" "prognostic unfavorable (8.90e-7)" "unprognostic (1.26e-2)" "unprognostic (9.22e-3)" "unprognostic (3.98e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (1.05e-4)" "prognostic unfavorable (2.47e-7)" "unprognostic (7.19e-3)" "unprognostic (2.48e-1)" "unprognostic (2.48e-1)" "unprognostic (1.26e-2)" 6.8 8.0 8.5 19.7 18.4 21.9 10.3 24.3 12.2 9.8 8.0 8.6 4.9 8.0 9.0 8.5 7.2 7.6 7.4 5.3 9.0 8.2 7.6 7.3 8.6 19.9 8.1 9.8 12.0 7.0 6.7 13.9 13.0 9.2 7.0 8.4 6.7 6.7 6.8 7.1 8.1 9.5 6.8 8.5 12.7 7.2 17.3 9.2 43.4 9.6 7.1 19.4 7.9 8.3 11.7 12.0 14.7 10.6 13.0 14.3 6.2 7.4 3.6 12.5 8.2 2.2 2.1 14.5 4.8 3.8 8.3 10.4 6.1 4.1 24.1 8.8 3.0 7.1 4.0 11.5 5.0 12.3 9.3 8.4 16.6 5.5 8.2 3.3 21.6 7.1 2.6 2.7 7.8 4.7 3.8 7.9 18.8 18.7 7.6 5.1 3.1 31.0 18.0 21.3 3.3 4.8 25.2 15.4 6.5 7.7 8.1 7.8 9.5 7.9 9.4 9.6 13.8 5.6 15.3 4.5 5.5 8.2 5.2 7.1 5.9 6.7 42.8 1.1 12.9 3.5 9.4 9.4 14.7 11.3 10.6 12.9 10.0 11.7 14.3 12.0 11.7 13.9 12.4 7.2 13.0 6.3 11.4 12.9 6.2 8.5 18.4 24.3 12.2 9.0 8.2 8.1 9.8 9.2 9.2 26.8 27.2 56.4 25.5 41.3 0.0 11.7 7.6 17.4 28.4 36.6 0.0 60.2 6.6 29.9 3.7 39.3 25.4 23.3 16.9 56.8 29.0 28.2 57.8 13.4 30.0 0.0 30.9 35.0 26.7 5.0 30.2 40.6 16.9 42.3 29.2 0.0 27.2 31.6 22.3 12.9 0.0 38.8 23.6 122.6 74.3 37.8 50.8 48.4 30.8 32.0 MYC "bHLHe39, c-Myc, MYCC" ENSG00000136997 "MYC proto-oncogene, bHLH transcription factor" P01106 8 127735434-127741434 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 812.6;Basal keratinocytes: 900.0;Smooth muscle cells: 529.5;Suprabasal keratinocytes: 935.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 132.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000084, CAB010307, HPA055893, HPA066556" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000084: , CAB010307: AB_631274, HPA055893: AB_2682960, HPA066556: AB_2685691" "unprognostic (1.45e-2)" "unprognostic (4.00e-3)" "unprognostic (3.94e-3)" "unprognostic (2.41e-3)" "unprognostic (8.14e-2)" "unprognostic (3.36e-3)" "unprognostic (5.80e-2)" "unprognostic (4.94e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.52e-4)" "unprognostic (5.19e-3)" "unprognostic (9.86e-3)" "prognostic unfavorable (5.49e-8)" "unprognostic (7.85e-2)" "unprognostic (4.66e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (4.96e-5)" 67.4 20.8 3.2 46.6 7.1 16.3 36.0 1.2 5.0 23.9 23.3 3.8 11.8 11.1 23.8 14.4 47.6 59.5 32.4 23.7 5.8 2.2 11.2 36.6 16.0 40.5 5.8 1.2 38.7 64.6 2.1 7.4 14.9 9.8 20.6 11.3 6.1 14.4 21.8 69.6 78.5 17.2 21.3 12.0 38.3 24.7 16.3 3.8 40.2 9.0 48.4 27.1 28.9 37.3 25.5 8.8 1.0 10.3 20.9 55.2 22.0 7.2 14.0 1.2 12.5 20.4 24.1 3.7 8.7 3.8 10.9 9.1 19.2 19.1 74.3 12.3 5.2 10.7 15.8 65.1 28.3 7.2 17.5 22.7 44.7 23.8 25.0 18.8 31.2 7.2 16.8 62.6 7.3 58.0 8.8 12.5 26.2 66.0 39.3 5.4 20.8 51.0 68.1 3.5 31.3 28.1 28.4 5.3 132.1 9.1 7.5 86.4 8.2 4.0 34.1 22.6 2.1 13.9 20.5 15.2 8.2 9.8 6.3 10.9 0.7 1.2 35.9 7.2 35.0 4.1 0.7 10.3 0.1 8.6 9.1 43.4 25.5 31.1 18.6 8.8 20.6 55.2 34.8 1.0 20.9 6.1 0.3 24.8 22.0 3.2 7.1 1.2 3.6 5.8 2.2 5.8 1.2 9.8 3.8 53.6 68.5 50.1 812.6 900.0 0.0 10.2 28.1 18.7 83.0 12.2 0.0 20.0 1.7 71.3 0.9 89.5 6.3 0.0 37.0 51.5 149.4 176.0 54.4 27.1 25.9 0.0 12.0 96.3 42.9 1.1 91.5 19.1 160.3 3.6 66.1 1.0 60.5 11.5 63.3 5.3 0.2 45.3 529.5 0.5 0.7 935.3 4.9 39.5 82.4 301.8 MYCL "bHLHe38, LMYC, MYCL1" ENSG00000116990 "MYCL proto-oncogene, bHLH transcription factor" P12524 1 39895426-39902256 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 46.4;skin 1: 26.0" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 21.7;Hepatocytes: 21.9;Mucus-secreting cells: 22.7;Urothelial cells: 22.1" "Cancer enhanced" "Detected in all" "urothelial cancer: 28.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 11.5;intermediate monocyte: 5.5;myeloid DC: 12.9;plasmacytoid DC: 15.4" "Group enriched" "Detected in many" 75 "dendritic cells: 15.4;monocytes: 11.5" "Group enriched" "Detected in some" 7 "U-266/70: 96.4;U-266/84: 70.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA063132, HPA074515" Enhanced "Nucleoplasm,Mitotic chromosome" NA NA Nucleoplasm "Mitotic chromosome" "HPA063132: AB_2684946, HPA074515: " "unprognostic (7.45e-2)" "unprognostic (6.91e-2)" "unprognostic (7.36e-2)" "unprognostic (1.83e-3)" "unprognostic (1.61e-2)" "unprognostic (2.92e-3)" "unprognostic (6.72e-3)" "prognostic favorable (4.49e-4)" "unprognostic (1.24e-1)" "unprognostic (1.77e-2)" "unprognostic (5.44e-2)" "unprognostic (1.12e-1)" "unprognostic (5.01e-3)" "unprognostic (2.75e-2)" "unprognostic (5.21e-2)" "unprognostic (1.53e-2)" "unprognostic (5.80e-2)" 0.3 0.3 1.2 4.4 2.1 0.1 1.7 0.8 1.7 3.6 7.5 1.8 8.5 2.6 1.0 4.0 17.8 1.6 2.3 0.7 1.1 0.9 0.8 6.4 1.9 2.9 0.6 1.4 0.5 46.4 0.0 2.1 11.2 1.8 5.3 3.6 1.8 4.6 16.6 0.6 26.0 7.3 1.2 1.1 4.0 3.3 1.5 0.6 6.4 4.2 3.1 6.0 18.4 7.3 0.0 15.4 0.1 11.5 0.0 0.1 3.8 0.2 0.0 2.9 0.7 0.0 0.0 7.1 0.1 0.0 0.2 0.1 0.1 0.1 0.4 0.3 0.0 0.0 0.7 2.0 0.5 0.1 0.4 1.1 0.1 0.0 0.1 0.0 0.0 1.7 0.2 2.4 0.0 0.2 0.0 0.2 1.1 0.7 0.0 0.1 0.2 0.0 0.0 2.8 0.4 0.1 0.2 3.4 0.6 0.2 11.6 0.5 0.7 0.2 0.4 0.1 1.1 0.7 3.7 0.0 0.0 1.1 1.3 0.1 96.4 70.7 0.2 0.0 0.4 0.0 0.0 11.5 0.0 0.0 5.5 0.0 0.0 0.0 0.1 12.9 0.0 0.0 0.0 0.1 0.0 2.3 15.4 0.0 3.8 1.2 2.1 0.8 1.7 1.1 0.9 0.6 1.4 1.8 0.6 0.0 0.6 0.0 9.0 6.0 0.2 3.3 0.0 1.4 4.5 8.7 0.0 21.7 0.0 1.1 0.1 0.5 9.5 0.0 5.1 11.3 0.7 4.8 0.0 21.9 4.9 0.0 16.6 2.5 6.9 0.2 0.0 9.6 1.7 0.0 22.7 1.1 2.4 8.5 0.0 0.0 0.0 0.0 0.3 0.0 0.7 10.3 14.6 0.0 10.5 22.1 MYO6 "DFNA22, DFNB37, KIAA0389" ENSG00000196586 "Myosin VI" Q9UM54 6 75749192-75919537 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Hearing, Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 333.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "gdT-cell: 8.6;MAIT T-cell: 4.0;memory CD4 T-cell: 2.7;memory CD8 T-cell: 4.9;naive CD8 T-cell: 4.8;NK-cell: 3.3" "Group enriched" "Detected in many" 20 "NK-cells: 3.3;T-cells: 8.6" "Cell line enhanced" "Detected in many" "RT4: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010762, HPA035482, HPA035483" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647" "unprognostic (6.29e-2)" "unprognostic (6.34e-2)" "unprognostic (3.63e-3)" "unprognostic (1.30e-1)" "unprognostic (8.98e-2)" "unprognostic (2.73e-2)" "unprognostic (3.41e-3)" "unprognostic (1.23e-2)" "unprognostic (1.23e-2)" "unprognostic (2.66e-2)" "unprognostic (7.78e-2)" "unprognostic (2.78e-2)" "prognostic favorable (1.27e-12)" "unprognostic (1.57e-1)" "unprognostic (1.72e-1)" "unprognostic (1.41e-1)" "unprognostic (2.49e-2)" 8.4 9.1 18.2 9.0 27.0 0.9 26.9 17.1 24.1 16.2 18.9 26.8 28.7 30.0 7.5 25.9 28.1 10.0 23.1 4.9 19.1 12.2 44.0 13.8 20.5 4.5 24.0 17.9 4.6 18.5 42.2 24.2 7.1 19.0 16.0 17.3 11.9 23.3 33.7 4.2 14.1 27.7 8.0 21.2 6.7 23.9 14.3 28.2 0.9 13.4 9.1 10.9 16.1 13.1 0.2 0.0 0.1 0.1 3.3 8.6 1.2 22.7 6.1 4.9 3.5 11.9 9.6 19.6 8.1 8.6 6.0 7.8 9.2 20.5 0.0 7.9 9.1 6.9 18.0 5.8 11.6 6.9 9.6 11.9 6.5 2.0 5.6 10.2 0.0 9.5 6.8 8.4 8.1 6.4 10.0 16.6 3.3 8.5 3.3 6.1 21.9 0.0 0.2 3.3 17.1 1.6 0.4 11.8 0.4 22.3 43.4 10.2 6.7 2.0 20.4 3.5 11.6 8.7 13.3 24.3 6.6 5.7 0.3 7.3 6.9 7.0 0.0 4.1 0.0 2.3 0.1 0.0 0.0 8.6 0.0 4.0 0.2 2.7 4.9 0.0 0.0 0.6 4.8 0.1 3.3 0.1 0.0 0.1 1.2 18.2 27.0 17.1 24.1 19.1 12.2 24.0 17.9 19.0 28.2 131.0 218.3 7.6 88.9 26.8 74.9 7.3 35.7 75.0 79.6 143.1 113.9 27.1 46.4 104.1 3.9 45.8 95.7 0.0 104.0 18.4 24.2 142.1 25.4 28.2 5.5 90.6 81.6 42.4 3.8 5.6 27.9 6.0 28.7 4.6 66.2 333.7 145.6 80.7 40.7 83.4 184.9 12.9 16.9 10.9 13.8 29.7 65.6 12.1 54.2 164.0 MYOD1 "bHLHc1, MYF3, MYOD, PUM" ENSG00000129152 "Myogenic differentiation 1" P15172 11 17719568-17722131 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 31.8" "Cell type enriched" "Detected in single" 7 "Spermatogonia: 3.0" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "RH-30: 103.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055436, HPA078647" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055436: , HPA078647: " "unprognostic (1.07e-3)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.5 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 4.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.0 0.0 0.0 0.0 NAALADL2 ENSG00000177694 "N-acetylated alpha-linked acidic dipeptidase like 2" Q58DX5 3 174438573-175810552 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 29.3" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 60.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.7;BJ hTERT+: 4.2;fHDF/TERT166: 4.9;WM-115: 4.5" "Low region specificity" "Detected in many" "HPA012413, HPA017425, CAB025586" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275" "unprognostic (7.28e-3)" "unprognostic (1.10e-1)" "unprognostic (6.28e-2)" "unprognostic (1.60e-1)" "unprognostic (2.56e-1)" "unprognostic (2.56e-1)" "unprognostic (2.29e-4)" "unprognostic (3.44e-3)" "unprognostic (5.70e-2)" "unprognostic (7.42e-2)" "unprognostic (7.85e-3)" "unprognostic (9.49e-2)" "unprognostic (3.66e-6)" "unprognostic (7.11e-2)" "unprognostic (1.48e-1)" "unprognostic (9.05e-2)" "unprognostic (2.22e-2)" 4.9 2.3 2.2 4.6 3.7 0.8 7.0 1.9 2.7 8.3 8.3 5.4 23.8 2.4 9.7 10.5 2.3 5.0 8.9 5.4 2.5 1.8 7.0 3.7 3.3 1.3 2.3 2.0 5.4 3.9 20.6 3.0 6.4 4.0 9.6 3.3 4.4 17.0 29.3 1.8 3.2 6.6 6.0 3.6 2.6 4.5 1.9 2.9 4.9 3.5 2.6 1.7 8.7 5.0 0.1 1.7 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.2 0.0 3.5 11.7 0.1 2.3 4.2 0.6 0.7 0.2 1.3 0.0 0.5 4.9 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 3.2 0.6 0.1 0.0 3.0 0.4 0.0 0.0 0.1 2.3 0.4 0.2 0.0 0.0 1.6 0.0 0.0 0.2 0.1 1.7 0.2 0.0 0.0 0.2 0.2 0.9 0.3 3.1 0.1 0.5 2.3 0.1 0.1 0.5 0.0 0.0 0.0 1.5 0.0 4.5 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.1 0.0 1.7 0.0 0.0 2.2 3.7 1.9 2.7 2.5 1.8 2.3 2.0 4.0 2.9 0.0 11.5 0.0 7.2 2.1 7.6 2.8 10.2 18.7 6.8 12.2 11.8 16.3 6.6 6.8 60.1 2.1 11.1 0.0 2.3 1.5 7.8 18.3 4.6 2.4 1.6 0.0 8.6 3.1 0.3 28.0 14.1 0.7 3.3 0.0 1.1 7.7 2.5 3.5 11.3 1.7 6.6 0.0 2.3 3.2 1.9 1.6 10.3 0.0 14.9 13.7 NABP1 "DKFZp667M1322, FLJ13624, FLJ22833, hSSB2, MGC111163, OBFC2A, SOSS-B2, SSB2" ENSG00000173559 "Nucleic acid binding protein 1" Q96AH0 2 191678068-191696659 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.0" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 620.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054978, HPA067802" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA054978: AB_2682660, HPA067802: AB_2685899" "unprognostic (5.43e-2)" "unprognostic (5.33e-2)" "unprognostic (2.80e-1)" "unprognostic (4.73e-2)" "unprognostic (1.48e-1)" "unprognostic (6.89e-2)" "unprognostic (8.07e-4)" "unprognostic (1.33e-1)" "unprognostic (2.89e-2)" "unprognostic (2.99e-1)" "unprognostic (2.82e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (8.20e-7)" "unprognostic (5.64e-2)" "unprognostic (7.50e-2)" "unprognostic (1.48e-1)" "unprognostic (6.02e-2)" 20.8 4.9 2.4 26.0 2.3 4.2 22.2 1.1 2.1 4.4 14.1 1.9 1.6 13.3 6.7 9.2 12.1 4.9 8.1 6.9 4.7 2.0 8.8 8.7 18.6 39.6 3.9 1.3 4.9 6.3 0.8 4.4 28.0 6.1 4.7 5.2 2.6 6.2 3.9 3.1 4.3 30.6 4.7 5.3 40.0 4.6 18.4 1.5 7.4 3.6 12.1 23.0 8.7 8.8 3.8 2.2 18.6 7.7 1.6 14.2 1.9 14.8 2.3 0.3 0.4 11.3 13.7 3.9 23.2 19.0 14.4 8.7 12.3 8.4 0.8 18.4 14.0 11.7 4.2 2.1 9.9 16.0 7.7 1.9 7.4 4.7 3.1 8.2 3.4 8.4 18.0 12.5 20.7 14.9 17.2 5.4 2.2 10.4 32.9 22.5 1.2 1.1 4.0 1.3 3.1 11.7 2.5 2.6 7.0 21.6 11.0 0.5 0.1 8.0 2.8 6.5 14.1 0.7 2.2 13.8 12.1 10.2 6.3 14.5 10.9 4.5 3.1 10.0 4.1 2.1 2.5 4.0 1.9 6.4 6.7 8.7 3.8 8.6 6.6 2.2 0.6 2.2 3.8 18.6 1.6 7.7 1.4 14.2 1.9 2.4 2.3 1.1 1.9 4.7 2.0 3.9 1.3 6.1 1.5 199.5 620.7 29.6 104.4 47.2 3.0 6.7 12.7 85.6 168.4 10.4 2.0 20.0 3.3 17.5 161.5 9.3 94.3 0.0 4.6 34.8 18.6 41.1 131.1 6.7 49.8 3.2 4.1 11.6 96.8 54.0 9.5 125.6 38.8 147.9 15.3 1.1 20.2 31.6 3.5 17.7 3.8 6.5 28.6 21.1 18.0 39.5 122.3 52.2 21.7 106.4 NABP2 "hSSB1, MGC2731, OBFC2B, SOSS-B1, SSB1" ENSG00000139579 "Nucleic acid binding protein 2" Q9BQ15 12 56222015-56229854 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 187.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044615, HPA057213" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044615: AB_10795884, HPA057213: AB_2683371" "unprognostic (1.45e-1)" "prognostic favorable (8.35e-6)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (7.44e-6)" "unprognostic (4.00e-1)" "unprognostic (1.11e-1)" "unprognostic (6.96e-3)" "unprognostic (6.52e-2)" "unprognostic (4.72e-2)" "prognostic unfavorable (2.69e-5)" "unprognostic (1.28e-1)" "unprognostic (1.92e-1)" "unprognostic (1.28e-1)" "unprognostic (3.01e-2)" 14.0 26.7 27.7 16.7 33.3 16.2 15.7 23.6 32.6 16.2 19.5 17.6 14.9 22.8 16.3 19.4 15.0 16.0 23.0 16.2 25.8 25.2 21.0 17.7 11.7 18.0 26.4 24.4 23.1 25.8 17.2 17.0 8.6 24.0 15.8 19.9 17.6 15.9 19.6 51.8 14.0 22.4 16.7 20.2 14.9 17.0 18.6 20.5 10.6 20.6 21.7 18.7 15.9 14.7 17.1 13.5 15.3 14.9 25.9 21.0 10.2 25.4 26.4 25.1 27.9 10.9 11.9 4.8 15.4 12.9 22.4 13.4 15.8 23.0 19.6 31.4 14.1 16.0 20.4 23.3 19.4 17.1 36.9 21.9 32.7 18.5 12.1 11.8 23.3 31.9 10.1 15.5 26.7 21.7 19.2 14.3 24.3 16.8 33.8 16.1 23.1 31.5 26.1 18.4 15.2 25.3 28.6 23.5 29.2 10.6 10.6 32.0 23.7 24.7 30.6 20.9 4.1 35.0 20.8 10.1 15.8 15.0 33.1 28.2 22.9 34.9 12.5 29.4 21.8 29.2 15.3 9.9 8.6 17.5 13.8 19.4 17.1 14.7 15.8 13.4 12.6 9.2 15.3 1.9 25.9 14.9 13.5 21.0 10.2 27.7 33.3 23.6 32.6 25.8 25.2 26.4 24.4 24.0 20.5 14.9 17.6 19.2 18.9 16.6 15.5 8.1 12.7 12.0 3.4 22.7 2.0 25.5 41.4 27.1 73.7 17.5 25.1 0.0 61.7 33.3 19.1 11.3 17.3 18.5 27.5 14.3 17.3 16.5 16.1 187.0 21.9 20.4 30.4 36.9 24.4 24.4 31.4 24.6 32.2 28.4 11.8 19.4 19.4 9.9 24.7 14.9 12.7 27.7 34.4 9.3 NACC1 "BEND8, BTBD14B, BTBD30, NAC-1, NAC1" ENSG00000160877 "Nucleus accumbens associated 1" Q96RE7 19 13118103-13141141 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021238, HPA062245, CAB069927" Enhanced Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB069927: AB_1082966, HPA021238: AB_1845475, HPA062245: AB_2684724" "unprognostic (2.19e-1)" "unprognostic (9.20e-3)" "unprognostic (2.67e-2)" "unprognostic (2.84e-2)" "unprognostic (2.62e-1)" "unprognostic (7.75e-2)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.93e-1)" "unprognostic (8.46e-2)" "unprognostic (2.40e-2)" "unprognostic (3.04e-2)" "unprognostic (7.35e-2)" "unprognostic (2.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (9.74e-2)" 12.5 13.7 27.2 18.2 22.3 10.0 6.7 19.8 38.7 10.8 16.6 20.1 11.7 16.6 12.8 10.0 17.9 10.5 9.4 13.2 23.6 14.2 10.8 15.6 11.3 14.9 17.1 14.2 7.8 16.8 10.5 10.6 15.4 16.0 11.9 8.4 7.8 15.3 15.6 17.6 10.9 18.3 9.2 17.2 15.2 16.1 18.8 15.4 10.7 9.8 9.6 9.9 13.2 7.9 0.7 0.9 1.8 0.8 0.6 1.3 0.5 28.3 34.5 8.0 17.8 4.5 5.7 21.8 13.9 10.5 13.5 10.5 34.7 12.1 14.2 31.2 11.6 10.6 14.1 10.3 25.3 5.0 25.1 16.4 9.1 28.2 24.3 10.8 14.2 25.5 8.6 8.4 13.2 7.2 10.6 15.3 12.8 19.7 5.7 6.6 58.5 22.8 11.3 35.7 8.0 31.9 14.0 9.2 14.2 8.2 31.1 17.5 11.0 13.5 19.8 12.3 8.7 17.6 13.1 21.7 28.7 17.9 21.1 24.4 15.7 24.5 11.8 30.7 14.3 17.8 0.1 0.5 0.0 0.8 0.8 0.6 0.7 1.3 0.8 0.9 0.4 0.4 0.7 1.8 0.6 0.6 0.8 0.2 0.5 27.2 22.3 19.8 38.7 23.6 14.2 17.1 14.2 16.0 15.4 0.0 1.7 11.2 5.7 10.8 15.6 2.0 15.3 0.0 2.3 15.7 2.0 16.1 6.6 11.8 1.6 6.8 16.0 0.0 7.5 16.9 5.4 11.3 10.3 14.5 18.9 25.4 4.7 9.8 8.8 1.6 4.0 8.0 5.0 7.2 14.5 8.3 16.0 10.5 8.9 13.6 7.8 6.5 4.2 10.6 14.0 12.2 22.7 12.1 14.3 16.0 NAF1 ENSG00000145414 "Nuclear assembly factor 1 ribonucleoprotein" Q96HR8 4 163110073-163166921 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036241, HPA036242, HPA066090" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036241: AB_2675017, HPA036242: AB_10673616, HPA066090: AB_2685614" "unprognostic (6.24e-2)" "unprognostic (1.20e-2)" "unprognostic (1.20e-2)" "unprognostic (2.58e-1)" "unprognostic (8.99e-2)" "unprognostic (2.00e-2)" "unprognostic (1.18e-2)" "unprognostic (1.56e-2)" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.64e-3)" "unprognostic (1.45e-1)" "unprognostic (8.73e-3)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "unprognostic (3.17e-2)" "unprognostic (3.05e-1)" 13.3 12.3 8.6 9.6 19.8 8.7 11.9 10.7 18.9 12.9 10.6 14.7 6.4 6.2 18.8 8.6 11.0 17.3 10.9 11.7 10.5 7.8 9.5 10.5 10.9 10.7 7.2 9.1 20.1 11.1 15.7 18.7 8.8 10.1 12.0 11.4 13.4 10.4 12.5 36.4 14.3 8.3 12.7 7.4 10.0 11.3 17.2 7.5 12.3 14.0 12.2 12.2 12.5 10.4 2.5 2.4 0.1 1.6 1.2 3.5 1.4 9.1 7.7 10.0 10.2 5.9 9.4 11.7 10.8 7.2 9.5 9.5 8.7 10.9 23.7 3.1 6.6 7.6 7.7 20.2 11.6 12.5 10.4 12.5 25.1 6.9 7.4 10.3 16.2 9.0 8.9 10.4 11.5 9.4 9.9 8.4 7.7 28.1 12.6 12.6 8.9 18.7 9.2 13.0 6.9 7.7 15.6 7.4 12.4 9.4 4.2 10.9 8.2 7.1 13.0 7.7 9.2 7.0 7.1 8.8 11.4 9.8 8.8 12.1 7.9 11.0 18.3 10.8 9.4 11.2 0.0 1.5 0.1 2.2 1.6 0.9 1.9 2.5 3.3 2.4 2.5 3.5 2.3 0.0 1.2 1.5 2.4 0.7 1.4 8.6 19.8 10.7 18.9 10.5 7.8 7.2 9.1 10.1 7.5 6.0 14.7 11.5 15.4 28.7 11.4 3.1 10.2 36.1 7.9 8.7 17.7 12.3 3.3 7.0 37.3 8.5 2.7 0.0 5.9 13.9 10.6 10.3 10.4 4.4 10.8 7.9 18.4 14.1 15.7 16.6 6.4 9.3 8.5 6.4 5.3 9.3 6.7 3.5 4.9 6.9 13.7 32.3 14.4 17.6 14.3 35.9 17.8 10.0 8.4 10.5 NANS SAS ENSG00000095380 "N-acetylneuraminate synthase" Q9NR45 9 98056739-98083075 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019223 Approved Enhanced Nucleoplasm No No 200000 Nucleoplasm "HPA019223: AB_1854298" "unprognostic (2.95e-1)" "unprognostic (5.10e-3)" "unprognostic (2.24e-2)" "prognostic favorable (1.71e-4)" "unprognostic (7.31e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (2.08e-1)" "unprognostic (7.98e-2)" "unprognostic (2.28e-1)" "unprognostic (1.54e-2)" "unprognostic (1.12e-1)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (7.36e-2)" "unprognostic (3.62e-3)" "unprognostic (1.79e-1)" 17.2 10.1 8.8 20.2 11.4 22.2 16.4 7.0 11.7 20.2 47.6 6.4 17.0 19.4 11.0 15.1 18.6 10.4 25.0 20.9 14.4 12.4 15.0 49.6 17.1 20.1 11.5 10.6 14.1 59.2 6.1 16.3 15.8 12.1 37.2 49.6 9.4 80.0 18.3 11.9 10.3 18.9 11.0 9.0 22.2 28.3 11.5 9.8 10.6 19.7 15.2 25.0 15.7 14.8 12.3 41.9 16.4 49.8 7.4 12.1 18.3 73.9 21.9 6.5 18.7 13.1 14.2 14.1 23.7 18.6 19.4 15.9 26.1 10.6 22.8 11.5 26.0 20.5 26.3 12.0 20.3 16.2 18.3 18.0 13.5 24.5 52.1 36.3 15.2 11.1 11.9 13.9 20.6 23.6 22.6 20.6 11.4 24.5 23.8 14.1 50.8 10.2 22.0 11.2 53.6 28.4 19.8 17.8 23.2 15.4 22.7 13.2 6.9 15.2 82.5 20.1 7.5 27.3 16.5 53.6 15.1 14.7 38.7 24.2 22.2 18.4 8.7 17.9 18.5 11.7 5.3 42.1 6.0 8.0 49.8 12.1 12.3 10.5 8.3 41.9 10.1 11.5 7.8 16.4 7.4 43.0 38.4 11.9 18.3 8.8 11.4 7.0 11.7 14.4 12.4 11.5 10.6 12.1 9.8 26.8 52.4 47.0 107.6 62.3 8.1 21.5 53.5 151.3 77.3 21.0 17.7 73.6 59.7 41.8 35.3 57.3 177.1 0.0 89.0 121.2 62.1 166.7 43.8 28.6 139.8 9.5 62.4 25.2 52.6 53.6 30.0 94.4 123.2 58.7 195.9 13.3 63.2 189.8 24.8 47.7 7.0 12.9 96.2 7.2 16.9 54.0 126.1 27.7 245.2 195.9 NASP "DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999" ENSG00000132780 "Nuclear autoantigenic sperm protein" P49321 1 45583846-45618904 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Spermatocytes: 344.6;Spermatogonia: 575.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028136, HPA030518, HPA030520" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510" "unprognostic (5.59e-2)" "unprognostic (1.34e-3)" "unprognostic (5.02e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (5.36e-3)" "prognostic unfavorable (4.96e-6)" "unprognostic (2.59e-1)" "prognostic unfavorable (3.67e-4)" "unprognostic (1.56e-2)" "unprognostic (1.15e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (1.91e-8)" "unprognostic (1.62e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" "unprognostic (5.32e-2)" 20.7 15.2 19.3 33.4 32.0 64.0 21.2 20.1 24.0 22.8 21.9 30.2 26.4 15.9 22.3 19.8 20.1 23.0 12.5 18.1 22.4 17.3 17.5 21.0 17.6 39.0 40.2 17.8 28.3 17.4 21.9 22.9 28.5 24.2 18.9 24.7 12.6 17.8 21.8 14.3 16.1 20.5 21.3 30.3 31.7 17.5 35.8 40.2 49.1 17.7 28.2 43.0 18.5 19.6 16.9 11.8 8.1 9.7 7.3 17.5 6.9 24.6 14.6 70.1 24.8 11.8 6.2 33.0 20.0 14.9 31.1 39.1 26.9 17.9 46.5 14.1 8.6 34.2 23.9 46.7 21.3 39.9 21.2 29.6 60.1 26.3 42.1 4.1 62.7 25.3 7.2 5.2 34.3 11.9 8.1 21.2 39.2 50.5 27.5 21.0 16.8 71.4 57.5 101.9 24.6 12.4 90.3 61.5 44.7 15.4 24.9 26.9 32.6 32.9 18.8 20.3 55.3 13.5 49.1 11.4 14.4 44.2 27.6 32.5 16.9 31.8 80.7 14.7 40.1 14.3 4.9 7.3 8.1 12.3 9.7 14.2 13.5 13.9 14.0 11.5 16.9 12.3 11.8 3.1 7.3 5.7 11.8 17.5 6.9 19.3 32.0 20.1 24.0 22.4 17.3 40.2 17.8 24.2 40.2 53.6 89.6 88.0 115.5 69.4 46.4 46.2 35.7 160.6 146.7 34.9 35.3 265.5 26.6 48.1 12.2 85.7 26.9 23.3 32.6 179.3 75.1 49.2 111.0 32.6 90.0 41.3 49.2 76.1 37.0 19.1 87.8 52.1 38.8 54.1 39.4 64.0 29.7 41.2 73.6 27.1 77.6 84.1 71.5 344.6 575.6 49.8 224.3 87.3 90.3 75.0 NCBP2 "Cbc2, CBP20, NIP1" ENSG00000114503 "Nuclear cap binding protein subunit 2" P52298 3 196935402-196942597 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044850, HPA062483" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044850: AB_10961012, HPA062483: AB_2684779" "unprognostic (1.82e-2)" "unprognostic (1.09e-1)" "unprognostic (4.04e-2)" "unprognostic (5.12e-3)" "unprognostic (3.17e-1)" "unprognostic (5.13e-3)" "prognostic unfavorable (2.37e-7)" "unprognostic (2.86e-2)" "unprognostic (9.63e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.75e-4)" "prognostic unfavorable (2.27e-4)" "unprognostic (3.28e-3)" "unprognostic (6.38e-2)" "unprognostic (1.97e-1)" "unprognostic (4.30e-2)" "unprognostic (5.04e-3)" 27.6 34.5 39.4 26.8 42.1 11.4 35.6 33.4 37.8 28.0 25.4 17.9 25.2 21.8 26.6 32.1 23.1 24.9 22.5 22.6 37.5 33.3 31.9 21.6 20.3 37.6 33.5 28.9 30.8 27.8 28.3 30.4 25.4 31.4 28.3 26.1 18.7 19.8 27.8 41.8 20.1 19.9 33.7 39.0 24.3 21.3 20.4 31.3 24.9 29.8 19.3 30.5 27.5 23.7 26.1 19.1 9.7 20.8 19.6 28.9 17.6 35.7 11.6 26.9 34.0 30.8 27.0 19.3 27.0 20.1 17.1 17.8 25.4 13.0 23.9 60.4 18.8 22.1 21.8 34.5 29.3 26.7 12.6 22.7 31.2 13.5 21.1 27.3 36.4 21.8 21.6 25.3 12.4 35.0 25.6 26.2 26.3 17.6 25.5 28.6 41.6 27.0 22.4 34.3 33.9 37.6 21.3 20.6 22.6 24.8 25.0 15.2 40.3 16.9 32.5 47.1 22.4 72.1 29.0 24.8 17.7 18.8 21.8 48.5 39.3 36.3 41.1 24.1 41.2 26.9 3.8 18.1 9.7 19.2 20.8 28.9 26.1 23.5 22.5 19.1 20.5 27.3 24.4 2.3 19.6 20.1 15.5 20.8 17.6 39.4 42.1 33.4 35.7 37.5 33.3 33.5 28.9 31.4 31.3 23.8 35.0 86.4 59.4 46.6 55.7 35.2 20.4 37.5 50.0 40.1 55.0 50.6 82.9 57.9 91.7 48.0 33.3 0.0 43.2 65.3 43.0 45.0 51.9 29.2 58.3 42.9 43.3 31.9 50.5 46.4 34.8 49.6 30.4 71.3 40.2 72.8 56.6 43.0 48.4 59.3 55.3 25.8 53.0 32.3 58.0 39.1 44.5 49.8 42.2 83.5 NCL "C23, Nsr1" ENSG00000115053 Nucleolin P19338 2 231453531-231483641 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004210, HPA023981, HPA071110" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes Yes 600000 "Nucleoplasm, Nucleoli, Nucleoli rim" "Mitotic chromosome" "CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: " "unprognostic (1.91e-1)" "unprognostic (2.53e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.63e-2)" "unprognostic (2.72e-3)" "prognostic unfavorable (1.41e-6)" "unprognostic (3.74e-2)" "unprognostic (4.31e-3)" "unprognostic (9.78e-2)" "unprognostic (6.70e-3)" "unprognostic (6.07e-2)" "unprognostic (1.66e-2)" "unprognostic (2.57e-2)" "unprognostic (9.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.42e-2)" 71.2 68.2 59.6 67.7 77.0 96.6 71.0 72.8 69.2 72.1 63.0 79.2 46.0 48.1 80.3 63.7 85.2 65.7 45.9 55.9 57.7 53.3 66.7 94.7 55.6 78.4 67.4 51.8 93.9 77.5 94.8 83.4 69.5 79.8 64.6 75.4 47.1 58.1 51.8 120.6 70.3 56.9 70.9 88.4 80.2 59.4 41.7 76.4 118.9 67.8 82.6 105.5 79.9 60.6 40.8 41.3 20.4 36.4 52.6 53.9 40.8 63.3 59.3 71.9 52.7 42.5 46.2 74.0 71.7 48.7 67.7 60.0 97.9 45.6 84.2 61.8 55.3 90.9 62.2 143.9 96.3 116.1 49.2 60.3 140.5 56.3 131.9 46.6 160.1 53.3 43.8 55.9 84.5 89.0 38.9 71.0 76.8 125.1 28.9 59.5 86.2 140.1 99.4 107.1 66.9 42.6 104.6 129.7 73.9 49.7 84.2 62.3 44.4 48.0 55.1 63.3 61.3 41.4 81.1 60.3 54.3 56.2 63.4 94.2 54.8 53.8 181.3 39.5 104.5 56.2 9.5 27.9 20.4 47.4 33.2 53.9 40.8 41.7 42.6 41.3 38.9 46.6 42.1 6.0 52.6 36.4 35.5 34.4 40.8 59.6 77.0 72.8 69.2 57.7 53.3 67.4 51.8 79.8 76.4 271.0 357.6 280.1 370.4 408.5 137.1 290.7 137.6 385.4 589.2 184.9 45.2 333.3 195.6 173.5 15.4 228.8 106.1 210.2 218.7 336.0 249.6 218.4 431.8 217.9 213.5 76.3 191.8 122.8 135.8 18.9 201.0 194.7 156.9 238.1 192.5 194.0 213.8 138.2 150.3 209.2 125.5 148.8 282.2 390.1 563.8 385.9 316.9 226.1 268.8 321.5 NCOA1 "bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1" ENSG00000084676 "Nuclear receptor coactivator 1" Q15788 2 24491914-24770702 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 41.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019402, HPA070213, HPA070520" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" No No Nucleoplasm "Plasma membrane, Cytosol" "CAB019402: AB_2196189, HPA070213: AB_2686235, HPA070520: AB_2686276" "unprognostic (2.73e-1)" "unprognostic (5.82e-2)" "unprognostic (2.46e-2)" "unprognostic (9.89e-3)" "unprognostic (7.60e-2)" "unprognostic (2.36e-2)" "unprognostic (7.06e-3)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" "unprognostic (1.72e-1)" "unprognostic (2.93e-3)" "unprognostic (1.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.15e-2)" "unprognostic (3.08e-1)" "unprognostic (1.29e-1)" "unprognostic (2.92e-2)" 9.8 10.0 15.3 7.3 18.0 8.9 10.5 15.9 17.1 13.7 8.9 13.5 4.9 12.5 13.0 11.5 10.8 10.0 8.3 8.8 20.8 12.2 11.9 8.8 9.4 8.2 10.8 9.9 17.2 10.3 23.9 16.0 10.1 14.2 9.6 10.1 19.9 10.6 13.0 42.5 9.3 10.9 11.6 9.7 9.6 7.6 11.4 10.7 8.5 7.0 12.2 9.3 9.7 10.8 2.5 5.5 14.2 3.5 3.4 4.1 1.8 6.7 5.0 8.9 4.6 9.8 9.0 13.6 3.6 7.3 4.6 4.1 4.7 2.9 4.9 1.5 6.6 8.8 1.6 5.3 3.1 5.0 23.3 7.7 17.6 2.0 1.9 6.2 8.0 14.7 14.3 4.7 4.4 3.6 5.7 4.6 6.4 10.7 8.2 6.9 4.5 7.1 2.9 4.2 4.0 3.4 5.7 41.0 2.5 5.0 9.2 8.1 6.4 8.4 5.1 3.7 4.9 6.1 4.1 5.0 7.7 6.1 5.2 3.6 9.5 8.2 8.6 4.4 5.1 3.8 11.0 3.5 6.9 3.8 2.7 4.1 1.8 3.4 4.1 2.6 2.5 3.3 4.0 14.2 3.4 2.8 5.5 3.7 1.8 15.3 18.0 15.9 17.1 20.8 12.2 10.8 9.9 14.2 10.7 35.7 29.8 13.6 10.7 27.1 97.2 33.1 15.3 20.1 31.8 14.0 49.1 11.2 6.6 12.0 13.1 29.2 24.6 23.3 23.0 14.9 31.2 14.1 18.6 20.3 15.3 58.8 24.2 33.2 25.2 3.8 43.7 26.2 18.6 10.0 22.7 63.8 17.7 35.1 40.7 11.4 67.4 38.8 35.4 32.1 36.8 27.0 4.5 25.4 23.0 14.6 NCOR1 "hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1" ENSG00000141027 "Nuclear receptor corepressor 1" O75376 17 16029157-16218185 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043246, HPA050288, HPA051168, CAB072830" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB072830: , HPA043246: AB_2678386, HPA050288: AB_2681073, HPA051168: AB_2681370" "unprognostic (1.83e-1)" "unprognostic (3.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.10e-1)" "unprognostic (7.38e-2)" "unprognostic (3.59e-2)" "unprognostic (2.55e-2)" "unprognostic (4.27e-2)" "unprognostic (4.87e-2)" "unprognostic (4.06e-2)" "unprognostic (7.07e-2)" "unprognostic (1.52e-2)" "prognostic favorable (7.92e-5)" "unprognostic (4.40e-2)" "unprognostic (2.52e-1)" "unprognostic (1.33e-1)" "unprognostic (5.42e-2)" 19.6 21.2 25.4 24.0 30.8 27.0 25.0 41.8 31.5 24.0 30.6 19.6 18.6 33.2 29.0 19.5 25.0 20.5 21.9 17.8 22.4 17.8 25.6 33.8 20.1 19.5 25.1 19.1 25.9 24.3 39.9 39.8 19.8 21.6 20.8 29.7 17.1 20.9 29.1 43.0 23.8 36.9 29.7 26.4 23.7 29.8 22.1 26.4 38.8 25.3 15.7 23.8 29.6 27.0 43.4 29.9 78.2 24.8 30.4 35.5 19.7 20.4 34.2 24.4 20.3 20.1 15.3 12.2 15.1 17.1 16.6 15.1 18.3 9.4 21.5 10.7 26.3 12.4 15.6 30.0 18.3 24.7 28.6 22.2 21.4 29.6 21.4 19.7 13.4 25.6 15.7 19.2 25.7 30.1 14.2 23.0 30.4 18.6 8.9 16.3 13.3 23.6 8.6 12.1 36.0 9.3 23.6 24.8 10.0 17.2 23.2 8.3 13.9 24.9 10.9 11.8 65.5 10.5 15.3 20.0 17.1 10.1 12.5 20.8 6.1 7.1 12.5 16.3 16.0 14.6 78.2 24.8 52.2 31.3 19.5 25.9 40.7 35.5 34.1 17.5 43.4 34.7 34.8 48.5 30.4 24.0 29.9 31.7 19.7 25.4 30.8 41.8 31.5 22.4 17.8 25.1 19.1 21.6 26.4 74.5 98.7 86.4 91.4 60.2 144.1 78.9 66.2 61.6 72.8 50.6 149.2 79.2 29.9 80.2 53.7 68.9 164.0 93.5 85.1 85.7 74.0 70.9 83.3 105.0 67.5 122.3 84.4 59.5 70.8 35.4 94.0 84.8 35.4 184.0 101.0 81.4 89.5 133.5 114.2 37.3 152.7 90.5 89.5 82.3 75.1 59.6 73.2 110.7 125.6 110.0 NECAB1 EFCBP1 ENSG00000123119 "N-terminal EF-hand calcium binding protein 1" Q8N987 8 90791550-90959408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 56.4" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 54.2;Cardiomyocytes: 55.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 6.1;hTERT-RPE1: 6.4;MOLT-4: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210" Enhanced Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB068208: AB_2665671, CAB068209: AB_2665672, CAB068210: AB_2665673, HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815" "unprognostic (8.09e-3)" "unprognostic (3.78e-1)" "unprognostic (8.17e-3)" "unprognostic (5.96e-5)" "unprognostic (2.51e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-3)" "unprognostic (8.38e-2)" "unprognostic (1.78e-3)" "unprognostic (2.60e-1)" "unprognostic (2.25e-2)" "unprognostic (2.57e-2)" "unprognostic (2.19e-3)" "unprognostic (4.45e-3)" "unprognostic (1.68e-2)" "unprognostic (2.42e-3)" "unprognostic (5.39e-3)" 2.7 4.9 19.7 2.0 27.3 3.2 1.5 0.5 56.4 1.4 3.7 12.1 0.3 1.7 4.1 4.4 3.6 1.6 3.1 10.9 19.5 9.8 3.4 1.1 6.8 1.4 16.0 30.7 3.8 1.3 1.9 1.9 2.8 10.8 2.6 1.1 4.1 2.5 2.0 1.3 1.9 1.8 1.3 18.7 2.4 2.1 5.2 17.4 0.0 2.9 0.0 1.0 4.2 1.2 0.5 1.8 0.3 0.0 0.7 0.9 0.2 0.1 0.1 2.3 0.4 0.0 0.1 0.1 2.5 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.0 2.3 0.0 1.0 0.0 0.1 0.0 4.6 6.1 2.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 6.4 0.0 1.7 4.0 4.4 0.0 4.9 6.3 3.1 0.8 0.0 0.1 0.0 3.9 0.0 0.0 0.0 4.1 4.3 0.1 0.0 2.1 2.9 0.0 0.2 1.5 3.8 3.8 0.0 1.6 6.0 3.6 3.1 3.8 0.0 1.8 0.0 0.0 0.1 0.6 0.0 0.4 0.2 0.4 0.6 0.1 0.5 0.6 0.9 0.3 0.7 0.0 1.8 0.9 0.2 19.7 27.3 0.5 37.1 19.5 9.8 16.0 30.7 10.8 17.4 17.9 54.2 0.0 0.2 0.5 3.9 55.7 0.0 0.0 4.5 12.2 0.0 0.0 0.0 0.0 3.5 0.7 0.0 0.0 0.2 0.0 1.3 0.1 1.1 0.0 0.1 0.0 0.0 0.6 0.0 1.0 2.3 0.7 3.3 0.0 0.0 0.3 0.1 0.0 2.1 5.6 0.5 6.5 2.7 4.3 1.7 0.6 0.0 0.0 0.0 0.0 NEDD8 Nedd-8 ENSG00000129559 "Neural precursor cell expressed, developmentally down-regulated 8" Q15843 14 24216852-24232454 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004082, HPA027583, HPA060254" Uncertain Enhanced Nucleoplasm,Cytosol NA NA 5700000 Nucleoplasm Cytosol "CAB004082: AB_10695300, HPA027583: AB_2732439, HPA060254: AB_2732644" "unprognostic (1.26e-2)" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (3.34e-3)" "unprognostic (1.83e-3)" "unprognostic (9.19e-2)" "unprognostic (4.66e-1)" "unprognostic (1.35e-2)" "unprognostic (2.66e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-3)" "unprognostic (2.76e-2)" "unprognostic (1.31e-1)" "unprognostic (2.79e-2)" "unprognostic (5.25e-3)" 38.2 48.1 55.5 30.7 58.1 34.6 42.2 34.1 62.4 41.0 36.3 26.8 32.6 25.0 32.2 59.9 40.3 34.3 31.3 50.7 47.1 49.5 46.5 48.4 30.5 31.5 49.4 54.6 34.3 33.4 101.1 31.3 39.7 45.5 31.6 40.0 27.4 37.2 40.7 70.7 36.5 28.4 43.0 36.0 34.9 29.9 25.7 34.3 26.9 37.5 44.7 46.8 30.7 32.0 60.2 76.1 90.2 60.1 43.2 64.1 89.9 26.0 45.7 37.1 26.2 42.2 36.9 27.0 35.6 37.8 42.0 38.8 31.5 31.9 22.5 20.9 50.1 35.4 27.5 37.0 55.6 59.1 31.7 22.4 24.0 42.1 107.3 36.6 39.7 25.2 39.2 37.0 35.3 27.8 39.6 50.1 26.4 21.4 26.4 64.7 57.9 31.6 37.7 27.4 48.1 53.5 22.5 29.4 22.9 48.4 49.6 15.7 36.6 30.8 31.4 25.6 39.6 19.0 31.6 37.5 23.9 24.0 30.5 31.5 31.4 47.3 32.6 17.2 22.9 22.6 73.5 57.9 90.2 46.8 60.1 50.7 60.2 54.4 51.9 56.9 51.1 51.2 52.0 62.2 43.2 59.0 76.1 64.1 89.9 55.5 58.1 34.1 62.4 47.1 49.5 49.4 54.6 45.5 34.3 134.0 147.7 239.7 188.0 246.8 91.4 436.0 229.3 136.5 126.3 294.8 45.2 457.7 504.0 309.5 46.7 283.5 261.3 163.5 353.5 526.2 324.5 205.0 213.6 344.7 501.8 100.1 204.1 216.7 303.8 60.6 252.0 280.5 254.8 432.0 208.2 154.8 360.0 256.1 259.2 606.3 68.0 207.0 308.8 113.9 219.0 337.9 350.8 243.7 228.6 222.9 NEIL2 "FLJ31644, MGC2832, MGC4505, NEH2" ENSG00000154328 "Nei like DNA glycosylase 2" Q969S2 8 11769639-11787346 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA073029, HPA073916" Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA073029: AB_2732216, HPA073916: AB_2732245" "unprognostic (1.52e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (9.88e-2)" "unprognostic (2.18e-2)" "unprognostic (5.72e-2)" "unprognostic (2.70e-1)" "unprognostic (2.88e-2)" "unprognostic (5.46e-2)" "unprognostic (6.85e-2)" "unprognostic (1.99e-3)" "unprognostic (1.29e-1)" "unprognostic (1.12e-2)" "unprognostic (5.29e-2)" "unprognostic (1.91e-1)" "unprognostic (2.09e-1)" "unprognostic (4.05e-1)" 10.2 21.8 18.7 6.8 17.7 2.7 10.3 11.8 20.9 11.3 5.6 9.0 7.0 3.6 9.9 15.4 6.5 17.9 6.9 14.2 15.4 20.0 9.3 11.0 7.7 8.4 18.4 16.1 12.6 10.9 7.8 13.2 7.6 20.3 10.5 6.1 9.7 11.5 10.3 24.7 18.1 4.6 10.2 12.3 9.5 5.1 26.8 13.3 1.8 15.5 7.1 7.9 7.4 15.8 14.7 5.5 0.8 2.5 9.1 13.6 4.7 4.9 14.0 8.8 17.2 4.2 7.9 3.9 7.9 6.6 7.7 5.3 4.3 5.5 1.9 3.1 9.5 16.6 4.4 8.4 8.7 10.6 5.8 4.2 6.8 3.3 8.4 3.4 2.9 5.1 6.9 12.9 6.7 6.2 7.5 7.2 2.3 9.6 6.7 9.1 5.2 0.5 3.1 7.9 20.5 7.5 8.7 11.3 5.3 9.0 7.5 13.6 10.7 6.2 3.3 11.3 7.4 5.2 0.5 8.8 8.8 12.7 2.3 11.1 6.3 13.1 3.5 23.2 10.2 17.8 0.4 1.5 0.1 9.1 2.5 12.1 14.7 9.3 10.8 3.0 11.4 13.6 12.0 0.8 9.1 1.1 5.5 5.8 4.7 18.7 17.7 11.8 19.8 15.4 20.0 18.4 16.1 20.3 13.3 0.0 4.3 12.6 14.3 7.6 25.6 17.8 17.8 5.3 6.8 7.0 15.7 15.6 28.2 17.4 0.8 9.3 0.9 0.0 20.5 13.6 10.8 15.1 2.3 21.2 12.1 7.9 9.7 7.4 4.7 2.1 13.0 6.6 13.5 10.0 4.5 27.9 14.2 0.0 23.0 24.7 13.2 6.5 13.2 14.2 45.1 11.2 4.5 7.2 5.0 9.1 NEIL3 "FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3" ENSG00000109674 "Nei like DNA glycosylase 3" Q8TAT5 4 177309836-177362943 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 70.8" "Cell type enhanced" "Detected in some" 8 "Club cells: 2.3;Extravillous trophoblasts: 2.9;Kupffer cells: 2.2;Spermatocytes: 1.9;Spermatogonia: 3.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 26.6;HL-60: 29.0;Karpas-707: 38.1;MOLT-4: 29.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065761 Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA065761: AB_2685555" "unprognostic (6.03e-2)" "unprognostic (5.79e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (5.45e-4)" "unprognostic (4.91e-2)" "unprognostic (2.05e-1)" "unprognostic (3.64e-7)" "prognostic unfavorable (1.16e-4)" "unprognostic (6.09e-3)" "unprognostic (7.67e-2)" "unprognostic (6.51e-4)" "unprognostic (2.82e-3)" "unprognostic (0.00e+0)" "unprognostic (3.25e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (1.04e-2)" 0.5 0.4 0.2 7.4 0.2 9.3 0.7 0.1 0.2 0.8 1.5 0.1 0.1 1.5 0.5 0.1 5.6 0.2 0.3 0.5 0.2 0.2 0.4 0.4 0.9 5.1 0.2 0.1 0.3 0.2 0.0 0.2 1.6 0.2 0.2 2.1 0.2 0.8 0.1 0.2 3.4 1.7 0.5 0.7 1.5 0.8 3.5 0.3 70.8 0.2 1.1 5.0 0.7 1.3 0.2 0.3 0.8 0.0 1.6 1.6 0.2 7.1 5.9 6.3 3.1 0.7 1.3 3.1 8.8 3.3 9.8 5.8 2.1 6.3 7.9 1.3 2.3 9.7 3.3 6.6 3.5 14.3 26.6 4.3 5.4 4.7 5.6 0.2 29.0 3.7 0.1 0.2 10.1 2.2 2.0 3.7 20.5 5.6 38.1 6.3 3.1 29.3 11.1 2.9 2.1 4.4 6.0 4.3 2.5 2.5 0.9 5.0 3.4 4.4 5.1 2.4 2.9 4.2 7.6 1.7 5.9 4.6 3.0 8.9 2.6 1.7 12.5 3.9 10.3 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.0 0.2 0.0 1.1 0.8 1.6 0.0 0.3 1.6 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.6 2.2 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.9 3.0 1.1 0.2 0.5 0.4 0.1 NELFA "NELF-A, WHSC2" ENSG00000185049 "Negative elongation factor complex member A" Q9H3P2 4 1982714-2041903 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009960, HPA039858, HPA043931" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB009960: AB_2288566, HPA039858: AB_2676711, HPA043931: AB_2678737" "unprognostic (1.66e-1)" "unprognostic (2.23e-1)" "unprognostic (3.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.32e-1)" "unprognostic (1.73e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (2.40e-1)" "unprognostic (1.12e-1)" "unprognostic (9.38e-2)" "unprognostic (2.74e-2)" "unprognostic (1.88e-3)" "unprognostic (1.58e-1)" "unprognostic (3.76e-2)" "unprognostic (2.77e-1)" "unprognostic (2.43e-1)" "unprognostic (3.05e-2)" 14.8 13.7 18.3 17.2 19.0 20.0 16.5 36.4 23.2 17.0 15.1 22.5 15.7 21.6 19.5 15.1 26.1 21.0 11.4 10.8 16.8 12.2 14.7 10.9 11.4 15.8 14.1 12.0 26.9 27.0 12.5 19.1 16.8 13.6 15.7 8.3 16.2 28.6 28.4 17.4 23.4 21.2 13.3 11.9 18.4 20.6 26.5 18.3 18.0 16.8 10.9 21.6 18.1 19.5 20.5 14.9 12.0 14.0 13.1 18.5 10.3 10.8 10.0 8.7 16.0 3.6 3.8 17.4 5.8 4.1 7.0 5.6 16.6 18.7 19.2 8.4 3.7 8.8 10.3 8.8 7.3 3.4 9.8 13.7 12.6 7.4 15.6 5.3 13.0 12.9 3.2 6.5 4.7 5.0 5.2 5.3 10.9 23.8 9.2 3.0 12.6 25.2 37.5 25.3 9.3 15.2 23.0 7.6 12.0 5.0 9.1 23.9 14.9 6.7 8.0 9.9 5.7 15.4 9.9 6.0 7.1 8.1 8.2 12.8 19.7 20.3 21.3 8.2 13.7 8.8 6.0 12.3 12.0 14.2 14.0 17.1 14.6 16.3 12.6 11.9 20.5 14.2 11.0 4.7 13.1 11.2 14.9 18.5 10.3 18.3 19.0 36.4 23.2 16.8 12.2 14.1 12.0 13.6 18.3 11.9 14.1 15.2 15.5 29.0 18.7 4.6 10.2 16.0 18.2 12.2 37.3 23.7 8.3 17.3 20.5 9.3 14.7 0.0 12.1 24.1 15.8 15.0 9.2 6.7 14.0 35.0 15.5 10.4 10.3 6.0 14.4 10.4 13.5 19.8 16.5 20.3 13.5 17.8 12.4 6.5 19.5 0.0 10.3 28.3 36.5 33.4 23.8 13.8 18.7 23.7 NELFE "D6S45, NELF-E, RD, RDBP, RDP" ENSG00000204356 "Negative elongation factor complex member E" P18615 6 31952087-31959110 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 512.1;Late spermatids: 1326.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007187, HPA007594, HPA046502" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA007187: AB_1856161, HPA007594: AB_2667867, HPA046502: AB_2679677" "unprognostic (1.09e-1)" "unprognostic (3.28e-1)" "unprognostic (1.45e-1)" "unprognostic (6.33e-3)" "unprognostic (4.43e-2)" "unprognostic (4.25e-2)" "unprognostic (7.71e-3)" "unprognostic (1.34e-1)" "unprognostic (1.95e-1)" "unprognostic (1.46e-2)" "unprognostic (1.97e-1)" "unprognostic (7.78e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (5.21e-2)" "unprognostic (1.07e-1)" "unprognostic (2.21e-1)" "unprognostic (3.68e-2)" 19.4 21.1 18.5 17.6 20.4 18.4 26.8 10.2 18.2 22.8 20.4 19.0 23.5 15.8 20.7 30.2 21.7 30.4 20.4 22.6 18.5 17.0 19.2 13.5 17.0 20.9 18.5 18.7 21.2 46.1 12.4 18.0 23.7 27.5 14.4 17.9 12.7 24.9 22.4 40.4 19.6 18.1 19.5 28.0 16.3 18.1 58.1 18.2 28.3 20.8 16.9 14.7 15.3 18.8 23.6 25.2 28.8 33.4 20.7 22.5 23.4 17.3 12.4 17.4 13.5 6.2 10.2 13.9 12.9 14.0 11.8 6.5 18.7 9.9 13.4 14.5 13.5 29.3 12.7 6.1 6.4 6.9 11.3 13.6 8.0 13.4 23.5 10.2 15.6 9.1 9.1 17.3 10.4 19.5 21.9 10.9 12.1 12.9 16.0 13.4 28.8 22.9 10.2 6.7 21.3 4.3 20.4 13.8 21.0 14.8 16.2 11.1 18.3 10.1 11.2 24.3 12.6 16.8 29.8 10.0 10.8 22.0 11.4 24.0 26.2 27.1 14.9 7.0 9.9 21.0 20.0 25.4 28.8 21.6 30.5 21.8 23.6 22.2 22.5 25.2 23.6 20.1 20.4 14.5 20.7 33.4 18.5 20.5 23.4 18.5 20.4 10.2 18.2 18.5 17.0 18.5 18.7 27.5 18.2 14.9 27.5 38.2 55.6 41.9 14.9 41.2 76.5 119.1 33.0 31.4 11.8 84.5 112.7 75.5 512.1 48.4 82.2 0.0 118.3 93.8 44.0 50.5 43.9 30.6 74.9 11.1 32.8 41.1 50.2 1326.0 65.9 48.4 47.2 80.2 58.5 50.2 89.2 84.2 42.5 78.5 22.9 32.3 48.1 183.6 96.5 36.5 95.7 52.9 62.6 48.2 NFIA "KIAA1439, NFI-L" ENSG00000162599 "Nuclear factor I A" Q12857 1 60865259-61462793 "Disease related genes, Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Leydig cells: 378.6;Peritubular cells: 412.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 37.8;T-47d: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006111, HPA008884" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006111: AB_1854422, HPA008884: AB_1854421" "unprognostic (1.50e-3)" "unprognostic (1.32e-1)" "unprognostic (2.06e-1)" "unprognostic (1.05e-1)" "unprognostic (3.44e-2)" "prognostic favorable (7.30e-4)" "unprognostic (2.55e-1)" "unprognostic (1.22e-2)" "unprognostic (9.12e-2)" "unprognostic (9.38e-2)" "unprognostic (2.85e-2)" "unprognostic (5.20e-2)" "prognostic favorable (7.01e-4)" "unprognostic (2.11e-1)" "unprognostic (1.20e-1)" "unprognostic (2.23e-2)" "prognostic unfavorable (2.03e-4)" 29.1 17.7 21.9 17.0 19.1 15.9 28.5 42.1 16.9 23.1 20.1 17.1 19.2 9.1 17.1 16.3 27.9 20.4 18.7 25.7 18.2 13.7 13.7 48.4 11.3 8.7 16.9 13.0 22.1 17.2 24.5 14.1 6.5 21.9 26.0 12.8 16.4 25.3 26.5 30.8 11.6 12.3 44.0 25.8 11.7 14.9 11.1 15.9 2.9 36.6 14.9 8.8 35.6 30.9 1.3 2.4 5.2 5.0 0.7 5.6 2.8 3.4 3.3 0.4 37.8 15.9 10.5 0.1 0.8 2.6 0.8 1.6 0.2 2.6 5.8 2.7 1.6 0.8 4.5 1.4 9.3 0.4 13.4 3.0 0.3 8.5 2.7 3.6 0.7 1.2 13.2 7.6 3.7 15.4 2.8 9.9 1.8 3.6 10.9 0.7 1.7 0.1 0.1 1.7 3.5 3.3 0.5 3.9 9.6 2.0 6.9 3.7 2.8 2.0 15.9 5.2 0.5 20.1 0.2 9.4 0.6 5.4 8.7 1.6 0.9 1.6 0.0 0.9 0.0 0.8 5.2 5.0 2.3 3.7 3.4 5.5 1.3 4.5 5.6 2.4 0.5 4.4 5.3 0.2 0.7 4.3 1.7 0.1 2.8 21.9 19.1 42.1 16.9 18.2 13.7 16.9 13.0 21.9 15.9 32.8 33.6 5.4 59.0 75.6 33.8 159.5 142.7 66.9 62.6 45.4 2.0 4.7 23.2 26.4 20.8 92.6 15.2 140.2 42.1 1.3 154.1 78.8 26.5 273.8 12.6 39.7 24.2 171.2 52.2 9.9 378.6 13.7 43.9 16.2 43.1 155.3 21.3 31.6 412.3 88.5 5.8 142.3 149.4 6.0 8.1 66.7 1.4 11.4 64.6 44.8 NFRKB "DKFZp547B2013, INO80G" ENSG00000170322 "Nuclear factor related to kappaB binding protein" Q6P4R8 11 129863636-129895590 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007082, HPA007128" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA007082: AB_1079481, HPA007128: AB_1079482" "unprognostic (1.22e-1)" "unprognostic (3.42e-2)" "unprognostic (2.12e-1)" "unprognostic (9.41e-2)" "unprognostic (6.56e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (5.78e-4)" "unprognostic (6.36e-3)" "unprognostic (1.68e-2)" "unprognostic (1.82e-1)" "unprognostic (2.00e-1)" "unprognostic (5.31e-2)" "unprognostic (9.22e-2)" "unprognostic (4.15e-2)" "unprognostic (6.57e-2)" "unprognostic (7.14e-2)" "unprognostic (3.93e-2)" 5.8 7.8 10.1 7.8 13.7 13.4 7.3 17.0 11.2 7.8 9.2 7.6 7.0 8.5 12.7 12.4 8.7 12.5 6.3 4.5 8.4 5.2 7.4 6.6 7.1 8.8 7.5 9.1 14.6 11.4 10.3 10.2 8.4 7.4 9.6 6.7 9.2 9.9 9.6 10.4 14.6 9.0 11.8 5.5 7.0 8.3 27.0 7.0 13.6 18.8 6.6 10.6 10.5 9.5 7.8 8.5 11.1 9.8 3.7 11.5 6.9 7.8 7.5 17.1 9.2 7.3 7.3 10.8 5.4 5.0 6.5 6.4 23.4 13.6 18.8 15.0 4.2 9.6 20.2 16.5 10.7 6.1 7.4 14.4 37.1 13.6 9.7 5.3 9.4 12.6 4.6 11.9 10.7 11.3 7.5 11.2 12.7 21.6 14.4 6.5 7.1 8.0 16.3 8.7 11.6 17.8 11.9 7.4 8.6 8.2 24.8 8.8 9.2 12.3 12.2 3.4 13.3 28.4 8.8 8.8 9.8 9.7 7.2 6.8 4.6 5.6 17.3 4.1 18.7 8.4 11.1 8.4 10.0 10.9 9.8 11.5 5.9 11.1 9.1 8.5 7.8 9.3 7.5 10.0 3.7 8.5 7.7 7.4 6.9 10.1 13.7 17.0 11.2 8.4 5.2 7.5 9.1 7.4 7.0 8.9 15.9 5.2 15.5 26.1 9.3 7.3 7.6 12.0 13.6 7.0 9.8 16.8 6.6 9.6 8.2 7.0 9.7 0.0 8.8 13.2 10.4 9.4 10.4 10.4 9.0 7.9 8.2 8.6 8.1 5.8 13.6 7.3 13.5 10.0 8.8 9.7 8.9 7.0 9.9 6.9 10.6 32.3 8.4 39.3 45.3 30.7 19.5 10.0 10.6 15.4 NFX1 "MGC20369, NFX2, TEG-42, Tex42" ENSG00000086102 "Nuclear transcription factor, X-box binding 1" Q12986 9 33290511-33371157 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056310, HPA061382, HPA073519" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA056310: AB_2683097, HPA061382: AB_2684496, HPA073519: AB_2686614" "unprognostic (3.90e-2)" "unprognostic (6.01e-2)" "unprognostic (1.19e-2)" "unprognostic (1.40e-1)" "unprognostic (3.07e-2)" "unprognostic (2.02e-2)" "unprognostic (9.11e-2)" "unprognostic (1.81e-2)" "unprognostic (8.71e-2)" "prognostic favorable (3.75e-4)" "unprognostic (3.40e-2)" "unprognostic (1.27e-1)" "unprognostic (1.13e-3)" "unprognostic (3.36e-2)" "unprognostic (1.14e-2)" "unprognostic (9.62e-2)" "unprognostic (3.20e-2)" 23.7 19.8 17.6 17.8 26.3 22.5 24.1 33.0 26.7 19.2 24.4 24.7 18.0 19.2 26.3 19.2 22.3 18.6 14.4 26.4 16.2 16.0 17.4 31.3 19.6 23.1 17.8 19.5 26.5 20.9 28.3 30.9 17.7 25.2 20.4 22.4 19.3 22.9 23.6 44.8 31.2 23.0 21.5 18.1 21.0 19.3 14.4 22.0 35.1 26.7 19.1 32.8 24.7 19.8 10.7 12.3 22.9 7.1 6.8 10.1 5.0 15.3 12.5 11.5 10.9 17.2 19.4 11.6 14.5 14.5 16.5 16.5 11.4 6.3 23.8 9.3 16.7 11.1 8.7 20.5 15.7 15.5 17.4 10.3 12.5 30.6 12.7 21.0 22.2 13.9 18.1 26.3 14.0 35.5 14.8 10.0 13.6 19.0 20.8 17.2 10.8 14.3 20.9 18.7 11.3 14.2 15.4 12.6 13.0 11.1 14.7 16.0 11.2 14.5 15.7 8.3 14.2 9.1 22.2 12.5 13.5 11.3 9.7 15.7 11.2 10.1 23.7 14.8 11.3 7.7 22.9 4.2 7.9 8.4 7.1 8.9 10.7 9.0 9.0 7.1 9.1 10.1 9.9 3.0 6.8 5.5 12.3 6.1 5.0 17.6 26.3 33.0 26.7 16.2 16.0 17.8 19.5 25.2 22.0 56.6 43.9 35.8 19.9 7.4 27.8 34.3 28.1 53.5 48.9 26.2 51.1 10.2 6.6 13.9 65.8 11.3 19.0 23.3 11.5 10.2 12.0 21.1 17.4 26.0 12.8 20.6 8.7 16.5 16.7 13.3 17.0 11.5 3.3 13.6 22.8 15.1 11.3 17.6 21.5 6.4 32.6 12.9 11.2 12.1 13.1 9.8 15.1 13.1 16.7 16.1 NMRAL1 "FLJ25918, HSCARG, SDR48A1" ENSG00000153406 "NmrA like redox sensor 1" Q9HBL8 16 4461680-4495763 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041353, HPA062287" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA041353: AB_10796343, HPA062287: AB_2684738" "unprognostic (2.56e-1)" "prognostic favorable (3.33e-7)" "unprognostic (4.16e-1)" "unprognostic (4.04e-3)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (2.20e-1)" "unprognostic (3.90e-1)" "unprognostic (1.28e-1)" "unprognostic (2.86e-1)" "unprognostic (5.52e-2)" "unprognostic (8.48e-2)" "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (5.79e-2)" "unprognostic (2.21e-1)" 10.0 20.6 19.2 8.4 23.3 11.0 17.8 7.0 31.5 16.9 14.1 23.5 19.2 17.1 12.9 18.1 17.0 20.7 17.3 17.0 19.6 16.1 18.1 26.2 12.8 14.8 20.2 23.8 20.1 30.7 14.5 14.2 16.7 17.7 18.9 10.0 14.6 28.7 17.6 3.2 25.3 13.6 12.4 20.1 13.6 19.9 7.0 14.2 14.6 18.1 10.0 12.9 12.4 11.7 13.3 19.5 11.6 19.2 8.9 23.5 17.3 10.2 14.8 2.3 8.2 4.9 4.7 12.4 7.5 2.5 8.5 6.7 15.9 17.4 0.3 15.1 8.2 2.3 11.9 6.6 9.6 3.7 9.2 3.8 9.0 10.9 7.6 11.0 10.7 7.0 7.3 11.5 9.3 3.5 6.7 8.4 32.8 11.5 0.2 3.9 32.7 21.7 10.4 10.3 12.3 13.9 23.7 0.1 12.7 8.9 5.9 3.5 9.6 12.8 21.7 8.2 1.8 20.1 9.7 5.0 5.1 0.3 3.8 0.1 0.3 0.1 18.0 2.3 9.6 9.9 4.7 19.2 2.0 23.5 11.3 18.3 13.3 15.9 22.4 18.2 11.2 17.0 17.7 11.6 8.9 8.7 19.5 14.0 17.3 19.2 23.3 7.0 31.5 19.6 16.1 20.2 23.8 17.7 14.2 23.8 27.0 25.1 32.1 24.3 10.5 20.4 35.7 28.1 29.6 40.1 0.0 90.4 44.7 30.4 11.9 19.4 26.6 0.0 43.3 84.8 27.7 25.0 19.7 67.4 56.7 4.8 19.5 29.4 28.9 21.1 27.0 24.5 33.7 22.6 34.7 36.1 32.0 33.6 28.7 68.0 9.4 25.8 22.8 4.1 40.1 26.7 53.7 27.4 39.1 17.1 NMRK2 "ITGB1BP3, MIBP, NRK2" ENSG00000077009 "Nicotinamide riboside kinase 2" Q9NPI5 19 3933103-3942416 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "heart muscle: 271.6;skeletal muscle: 103.2" "Cell type enriched" "Detected in single" 1346 "Cardiomyocytes: 751.9" "Cancer enhanced" "Detected in some" "renal cancer: 32.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 22.8;NTERA-2: 18.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049909, HPA054792, HPA072450" Approved Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522" "unprognostic (3.61e-1)" "unprognostic (5.92e-2)" "unprognostic (1.18e-2)" "unprognostic (2.54e-1)" "unprognostic (1.03e-1)" "unprognostic (7.61e-2)" "unprognostic (3.30e-2)" "prognostic favorable (1.19e-4)" "unprognostic (1.72e-1)" "unprognostic (3.29e-2)" "unprognostic (5.38e-1)" 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 1.0 0.0 0.0 271.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 1.0 1.9 0.1 103.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 18.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 751.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 NOL4L "C20orf112, C20orf113, dJ1184F4.2, dJ1184F4.4, DKFZP566G1424" ENSG00000197183 "Nucleolar protein 4 like" Q96MY1 20 32443059-32585074 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 78.2;Late spermatids: 112.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 32.2;HEL: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041768, HPA043600" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA041768: AB_10964172, HPA043600: AB_10961001" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (4.03e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.10e-1)" "unprognostic (7.88e-2)" "unprognostic (2.75e-3)" "unprognostic (1.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (1.72e-1)" "unprognostic (3.88e-2)" "unprognostic (9.32e-2)" "unprognostic (3.42e-1)" "unprognostic (6.08e-3)" "prognostic favorable (2.63e-4)" 7.7 8.0 13.1 9.0 14.9 18.9 8.7 19.4 14.8 6.5 16.3 35.6 8.7 19.9 6.5 13.8 2.8 9.9 11.0 5.0 13.9 11.7 9.8 5.7 10.6 8.0 20.5 8.7 3.7 12.1 5.0 19.9 12.1 16.3 7.5 15.0 12.5 11.0 9.8 1.9 3.8 20.7 7.4 17.9 11.3 14.3 33.2 20.1 16.7 8.5 2.6 6.5 10.0 8.7 1.9 2.2 7.2 11.7 8.9 8.7 4.7 3.9 12.1 7.6 5.2 1.6 2.5 1.0 2.5 2.1 3.2 2.2 32.2 9.2 0.2 7.5 3.3 5.0 1.1 2.4 7.0 1.4 0.9 1.9 25.3 5.9 23.0 4.3 0.3 1.5 6.3 1.0 2.3 1.5 7.3 19.2 5.5 7.5 3.4 1.5 2.2 8.2 7.7 4.4 12.0 11.3 3.5 0.9 1.3 5.3 0.7 10.1 8.2 7.9 0.2 4.3 8.2 1.6 7.7 20.1 3.0 10.5 2.7 2.6 2.5 0.8 1.7 3.3 13.7 9.0 3.0 2.2 1.1 6.6 4.9 5.8 1.9 4.4 3.8 2.2 1.4 8.7 7.1 7.2 8.9 11.7 0.3 7.0 4.7 13.1 14.9 19.4 14.8 13.9 11.7 20.5 8.7 16.3 20.1 6.0 3.5 1.7 9.0 0.0 34.0 7.4 5.1 4.0 2.3 12.2 62.8 0.2 8.3 6.4 78.2 21.3 50.9 0.0 6.9 1.6 5.0 14.5 11.5 3.9 8.2 7.9 16.8 26.4 3.0 112.0 5.2 4.7 0.0 5.4 33.1 14.8 10.1 34.5 4.6 17.7 55.8 19.4 6.3 53.6 3.9 0.0 0.3 12.8 28.2 20.1 NOL6 "bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22" ENSG00000165271 "Nucleolar protein 6" Q9H6R4 9 33461441-33473930 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055891, HPA061002" Supported Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA055891: AB_2682959, HPA061002: AB_2684410" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (2.37e-1)" "unprognostic (5.23e-2)" "unprognostic (2.32e-1)" "unprognostic (2.67e-1)" "prognostic unfavorable (4.83e-5)" "unprognostic (7.37e-3)" "unprognostic (8.26e-2)" "unprognostic (3.03e-2)" "unprognostic (2.09e-1)" "unprognostic (4.24e-2)" "unprognostic (2.77e-1)" "unprognostic (2.92e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (9.49e-4)" "unprognostic (4.09e-1)" 15.3 14.9 13.3 17.7 19.7 21.0 14.9 16.8 30.8 16.0 11.4 14.6 9.0 10.3 15.3 11.9 21.1 12.8 18.2 13.1 12.4 10.6 13.8 41.6 13.5 15.8 10.1 11.4 20.5 20.5 22.7 18.2 15.4 19.2 17.5 14.8 12.5 15.5 15.5 23.4 23.5 11.3 17.0 7.3 17.6 13.0 19.0 7.8 13.8 13.2 19.7 20.9 12.4 14.5 4.2 7.1 0.3 8.4 3.9 6.0 3.4 15.6 22.6 8.6 19.5 13.5 9.3 14.8 17.5 13.1 20.5 17.2 24.9 5.8 27.3 8.0 19.6 9.0 11.0 25.0 25.1 21.7 17.3 10.4 14.0 26.3 13.8 13.3 31.9 20.6 10.3 20.8 27.1 26.2 8.5 13.4 10.1 22.8 10.5 16.2 13.8 17.8 32.1 31.2 17.5 20.6 15.4 8.5 14.2 15.8 18.8 10.2 14.1 14.6 18.9 6.2 9.6 7.6 18.6 14.9 12.6 17.0 15.8 30.4 10.0 14.0 23.1 11.2 16.9 14.4 0.0 4.0 0.3 5.4 8.4 6.0 4.2 4.1 5.2 7.1 3.6 5.1 4.8 0.2 3.9 7.9 3.8 4.0 3.4 13.3 19.7 16.8 30.8 12.4 10.6 10.1 11.4 19.2 7.8 3.0 14.6 4.5 5.1 17.7 4.5 5.5 7.6 4.0 11.4 3.5 5.9 3.4 3.3 6.7 17.3 6.0 2.3 0.0 3.4 4.8 4.1 6.5 3.5 6.7 4.4 3.2 9.8 3.7 1.2 17.9 5.5 2.7 5.0 1.8 4.1 4.2 4.9 0.0 5.6 2.1 3.5 0.0 5.1 2.3 6.1 22.6 2.5 5.0 6.8 7.4 NONO "NMT55, NRB54, P54, P54NRB, PPP1R114" ENSG00000147140 "Non-POU domain containing octamer binding" Q15233 X 71283192-71301168 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022069, HPA054094, HPA054559" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles" NA NA 150000 Nucleoplasm "Nucleoli fibrillar center, Nuclear speckles" "CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522" "unprognostic (2.39e-3)" "unprognostic (2.22e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (9.29e-4)" "unprognostic (8.87e-2)" "unprognostic (5.54e-2)" "unprognostic (1.02e-3)" "unprognostic (9.34e-2)" "unprognostic (2.32e-2)" "unprognostic (1.41e-2)" "unprognostic (3.12e-1)" "unprognostic (2.07e-1)" "unprognostic (7.29e-3)" "unprognostic (6.79e-2)" "unprognostic (5.73e-3)" "unprognostic (2.76e-2)" "unprognostic (3.04e-2)" 37.2 55.9 30.2 37.7 30.8 51.2 37.2 54.8 38.6 45.4 33.4 36.0 38.4 29.9 52.4 40.5 41.0 40.5 37.2 30.5 27.5 29.0 40.1 43.3 37.3 45.7 28.8 31.7 69.2 61.0 39.4 48.2 42.4 27.5 40.8 37.5 42.5 39.8 41.4 37.2 38.4 35.2 40.5 38.3 45.9 40.3 34.4 29.0 98.4 51.0 39.1 57.4 43.6 36.8 44.1 47.3 35.3 51.8 45.4 51.8 58.9 59.7 66.1 91.5 50.2 37.3 38.6 50.1 49.0 45.6 66.3 58.6 52.4 44.4 68.0 54.6 45.1 45.8 44.7 136.6 42.6 73.1 51.7 91.2 55.8 69.4 52.2 31.7 78.1 49.0 40.8 30.4 67.1 45.0 55.0 54.5 49.3 71.1 71.3 61.2 53.0 101.1 71.2 114.0 60.3 53.7 90.9 96.0 58.3 50.9 52.9 63.5 78.9 63.5 41.5 56.3 55.5 39.0 50.6 50.0 42.9 64.5 60.0 56.7 41.2 77.9 77.4 32.1 90.9 61.4 35.3 44.8 34.9 45.8 47.6 51.8 43.7 46.6 44.9 47.3 44.1 50.8 50.2 20.8 45.4 51.8 41.2 50.1 58.9 30.2 30.8 54.8 38.6 27.5 29.0 28.8 31.7 27.5 29.0 71.5 74.4 79.8 78.6 112.2 63.2 53.3 94.3 53.5 84.2 41.8 39.3 104.8 48.0 113.5 9.9 89.5 55.4 70.0 96.7 148.6 89.4 78.5 84.5 108.5 99.0 50.9 134.1 70.0 136.1 12.1 98.7 83.7 54.0 104.6 95.9 77.6 111.2 84.2 120.2 93.8 45.1 64.7 107.2 22.8 62.3 107.0 108.8 84.7 122.4 84.4 NOP14 "C4orf9, NOL14, RES4-25, UTP2" ENSG00000087269 "NOP14 nucleolar protein" P78316 4 2937933-2963385 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039596, HPA055652" Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA039596: AB_2676590, HPA055652: AB_2682876" "unprognostic (4.70e-2)" "unprognostic (6.47e-2)" "prognostic favorable (3.93e-5)" "unprognostic (7.32e-2)" "unprognostic (3.28e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (9.10e-4)" "unprognostic (2.41e-2)" "unprognostic (8.62e-2)" "unprognostic (2.09e-1)" "unprognostic (1.30e-1)" "unprognostic (2.55e-3)" "unprognostic (1.16e-1)" "unprognostic (1.27e-3)" "unprognostic (1.44e-1)" "unprognostic (7.15e-2)" "unprognostic (4.77e-2)" 17.3 16.8 9.8 22.4 13.2 19.0 16.2 21.1 15.2 12.0 12.6 9.0 12.6 12.0 14.3 11.7 19.0 12.1 14.7 14.8 8.9 7.1 13.6 34.0 12.9 20.8 10.0 8.7 20.7 26.8 13.9 15.5 12.8 10.6 12.3 12.8 11.1 14.7 14.6 38.6 21.4 13.1 12.4 9.8 18.0 15.1 9.8 11.4 17.9 15.4 16.3 20.9 18.1 18.9 5.2 4.9 1.3 3.8 4.4 8.4 3.0 16.3 13.9 8.3 17.1 11.2 12.7 14.5 15.1 10.8 15.8 13.0 18.1 17.3 46.3 10.7 12.2 11.5 11.3 22.8 19.6 17.0 8.8 21.8 36.8 13.2 16.4 14.8 39.9 16.1 12.8 17.7 17.8 16.3 7.8 13.2 14.3 33.3 16.5 11.8 11.7 42.1 30.1 21.6 15.1 22.8 27.3 12.6 15.4 7.9 26.4 17.2 10.1 12.5 9.3 11.8 7.9 17.8 15.8 16.4 13.2 7.7 16.1 27.7 12.4 19.9 40.0 13.8 29.6 13.7 1.3 3.2 0.6 4.8 3.8 8.4 3.4 5.8 7.0 4.0 5.2 7.0 5.2 0.5 4.4 2.5 4.9 3.8 3.0 9.8 13.2 21.1 15.2 8.9 7.1 10.0 8.7 10.6 11.4 17.9 22.5 10.4 13.9 23.0 9.0 18.2 15.3 17.4 35.2 1.8 13.7 12.7 10.0 12.9 1.7 14.3 3.6 0.0 20.6 13.2 7.6 9.5 19.7 23.1 9.9 19.1 8.6 9.2 3.2 2.1 11.5 11.3 0.0 15.4 9.7 6.0 16.8 8.6 9.2 10.1 7.1 12.9 13.3 9.2 20.6 28.4 9.6 12.5 13.4 14.8 NOP58 "HSPC120, NOP5" ENSG00000055044 "NOP58 ribonucleoprotein" Q9Y2X3 2 202265716-202303666 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018472, HPA021062" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoli fibrillar center" Nucleoplasm "HPA018472: AB_1854564, HPA021062: AB_1854565" "unprognostic (1.56e-2)" "unprognostic (1.61e-1)" "unprognostic (9.20e-2)" "unprognostic (2.15e-3)" "unprognostic (2.39e-1)" "unprognostic (3.94e-2)" "prognostic unfavorable (1.97e-6)" "unprognostic (6.64e-2)" "unprognostic (1.17e-2)" "prognostic favorable (9.86e-4)" "unprognostic (4.52e-3)" "unprognostic (5.20e-2)" "prognostic unfavorable (3.38e-9)" "unprognostic (1.79e-2)" "unprognostic (3.10e-1)" "unprognostic (1.33e-1)" "unprognostic (2.60e-1)" 25.1 26.5 16.7 41.6 24.6 47.1 32.2 30.2 24.2 28.8 21.6 13.7 19.5 20.3 31.0 25.9 31.9 26.4 17.7 21.7 21.4 20.3 23.4 36.2 21.7 40.4 16.9 19.1 32.9 31.5 22.3 47.8 24.0 21.9 26.7 27.0 17.1 25.5 29.5 36.9 22.7 25.2 24.1 19.3 33.0 23.5 17.5 17.8 40.0 24.6 32.8 41.4 31.1 41.3 23.5 22.2 4.3 15.2 21.2 26.7 13.5 26.9 19.2 19.0 23.6 14.2 12.8 45.0 26.0 14.0 20.1 18.8 42.3 24.4 41.8 21.7 15.7 25.1 25.1 37.6 32.0 35.5 16.3 34.5 50.4 28.8 41.6 21.1 49.8 24.3 16.5 19.1 28.0 64.3 10.9 18.0 24.9 55.0 31.9 25.1 28.7 45.4 55.1 47.4 30.1 33.3 38.4 28.7 55.1 23.7 32.7 29.3 21.7 24.1 34.7 29.9 31.8 23.7 39.4 15.5 25.7 30.2 22.9 44.4 26.0 47.4 59.8 19.0 35.5 30.5 4.3 10.2 3.1 16.8 15.2 24.5 23.5 24.0 22.7 15.9 18.7 26.4 26.7 1.0 21.2 10.9 22.2 23.7 13.5 16.7 24.6 30.2 24.2 21.4 20.3 16.9 19.1 21.9 17.8 101.3 103.5 73.0 102.7 76.2 27.1 68.8 38.2 96.4 150.2 38.4 39.3 67.7 24.9 45.7 11.5 57.0 15.0 23.3 58.3 76.0 49.7 70.7 131.9 44.1 43.1 23.8 33.8 29.4 17.4 7.9 40.0 46.4 23.6 73.1 32.3 17.7 45.7 10.5 28.0 32.1 43.5 25.8 81.9 59.1 54.7 65.4 56.9 61.8 56.1 83.8 NOSIP CGI-25 ENSG00000142546 "Nitric oxide synthase interacting protein" Q9Y314 19 49555711-49590262 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 119.4" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 645.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043464, HPA062132" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043464: AB_10794284, HPA062132: AB_2684693" "unprognostic (2.27e-1)" "unprognostic (4.69e-2)" "unprognostic (1.39e-1)" "unprognostic (4.17e-2)" "unprognostic (1.59e-2)" "unprognostic (9.46e-2)" "unprognostic (1.47e-2)" "unprognostic (9.42e-2)" "unprognostic (3.79e-1)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (9.73e-2)" "unprognostic (3.97e-2)" "unprognostic (2.15e-1)" "unprognostic (9.76e-2)" "unprognostic (1.02e-1)" "unprognostic (2.95e-3)" 13.4 13.9 14.2 14.0 14.0 14.3 11.5 12.1 14.2 11.3 15.9 12.3 13.1 17.3 12.5 8.1 12.7 11.1 11.7 14.9 12.3 11.4 13.2 14.5 12.6 24.6 18.3 10.8 12.9 39.7 7.1 13.6 15.6 14.3 11.6 7.9 11.3 19.2 11.4 66.9 11.9 16.5 11.0 13.1 18.0 13.9 40.2 16.3 20.6 15.5 17.6 16.3 11.7 15.0 20.4 21.5 31.8 16.8 29.7 119.4 69.2 66.5 36.1 14.1 31.0 12.6 9.2 13.5 15.7 13.9 26.5 24.4 25.2 11.8 17.9 27.6 13.2 11.1 14.9 13.8 27.6 11.6 20.4 39.9 22.6 20.8 28.0 19.9 18.3 19.1 12.0 19.2 20.1 10.9 10.8 15.9 28.8 25.0 14.3 13.8 17.8 18.6 39.4 19.1 25.0 31.4 24.4 23.4 15.9 12.3 20.1 17.6 22.9 21.2 18.1 15.8 6.7 14.7 19.4 23.5 23.0 19.5 8.0 30.0 26.9 50.8 24.2 8.7 25.2 17.7 28.0 16.8 23.5 35.1 15.7 45.4 20.4 71.4 40.2 16.6 19.8 119.4 65.8 31.8 29.7 14.3 21.5 37.5 69.2 14.2 14.0 12.1 14.2 12.3 11.4 18.3 10.8 14.3 16.3 17.9 37.0 70.7 51.2 64.7 22.7 33.5 58.6 30.8 14.8 48.8 21.6 81.7 72.9 76.5 286.4 75.9 124.9 46.7 245.7 72.4 65.6 38.9 66.9 45.0 63.5 11.1 56.3 82.3 64.5 645.6 66.4 58.6 59.1 85.6 76.3 39.5 185.4 94.7 67.8 92.9 31.4 58.2 62.7 203.6 46.2 66.7 114.0 101.0 98.9 47.7 NPAT "E14, p220" ENSG00000149308 "Nuclear protein, coactivator of histone transcription" Q14207 11 108157215-108222642 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045908, HPA066370" Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA045908: AB_2679493, HPA066370: AB_2685665" "unprognostic (6.93e-2)" "unprognostic (5.81e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (5.37e-2)" "unprognostic (2.60e-2)" "unprognostic (4.89e-2)" "unprognostic (7.38e-2)" "unprognostic (5.03e-3)" "unprognostic (1.26e-1)" "unprognostic (7.04e-2)" "unprognostic (4.14e-2)" "unprognostic (2.76e-3)" "unprognostic (1.97e-1)" "unprognostic (1.86e-1)" "unprognostic (5.76e-2)" "unprognostic (1.93e-1)" 15.7 9.8 8.5 18.6 11.5 7.1 12.0 24.6 12.8 13.1 9.3 7.5 8.9 7.1 12.0 10.7 10.3 10.7 8.2 9.4 7.8 8.7 10.1 9.5 11.5 23.1 10.7 8.9 15.2 9.1 14.6 21.5 18.3 13.1 10.7 11.0 7.9 11.6 8.4 8.8 12.2 12.2 9.0 13.7 17.1 10.0 11.3 11.1 26.7 14.4 7.5 21.6 15.4 10.7 5.2 2.2 7.4 3.1 5.8 11.6 3.6 5.0 4.1 6.4 8.0 8.0 5.9 5.2 7.5 9.6 6.7 10.1 8.4 11.0 8.7 10.2 4.7 7.5 9.5 8.8 7.7 12.1 7.7 3.5 14.4 4.5 4.3 3.4 10.8 9.6 5.5 4.5 11.8 7.6 5.2 9.4 10.2 13.3 4.3 9.3 2.5 13.2 5.8 5.3 8.1 5.7 9.1 9.1 11.9 4.4 7.4 6.9 6.3 9.7 5.8 7.5 7.1 6.6 5.3 7.7 11.7 6.2 6.9 6.8 3.0 3.7 34.0 2.9 8.0 9.0 7.4 1.7 3.2 6.2 3.1 6.9 4.9 7.2 7.8 2.2 5.2 11.6 9.2 2.2 5.8 3.0 1.7 5.2 3.6 8.5 11.5 24.6 12.8 7.8 8.7 10.7 8.9 13.1 11.1 17.9 10.4 14.6 16.1 14.4 16.6 12.5 2.5 10.7 14.8 12.2 27.5 8.3 1.7 7.3 2.6 17.4 5.4 0.0 5.9 7.4 13.6 12.2 18.5 8.5 6.2 9.5 9.9 20.9 11.2 2.6 14.7 12.4 8.5 8.2 8.2 11.4 5.5 7.0 15.9 4.1 17.4 6.5 8.5 24.1 30.6 11.5 11.8 25.3 8.6 11.9 NPM1 "B23, NPM" ENSG00000181163 "Nucleophosmin 1" P06748 5 171387116-171411137 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011384, CAB012983" Supported Enhanced "Nucleoplasm,Nucleoli rim" Yes No 810000 "Nucleoli rim" Nucleoplasm "CAB012983: AB_2533084, HPA011384: AB_1854692" "unprognostic (1.84e-3)" "unprognostic (2.59e-1)" "unprognostic (2.23e-2)" "unprognostic (3.30e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (7.48e-4)" "prognostic unfavorable (4.82e-6)" "unprognostic (1.86e-2)" "unprognostic (5.25e-3)" "unprognostic (1.39e-1)" "unprognostic (2.26e-3)" "unprognostic (1.27e-1)" "prognostic unfavorable (2.89e-6)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.24e-2)" 56.8 44.7 29.9 61.1 33.6 76.0 67.0 37.7 34.6 113.5 57.8 24.8 39.3 36.7 78.2 50.5 81.6 65.0 44.0 48.5 28.8 31.6 64.9 78.8 59.5 128.1 36.1 27.9 177.4 102.0 27.1 57.9 65.2 36.1 87.2 49.3 29.5 47.3 48.2 67.9 42.7 52.8 92.4 43.2 85.9 54.0 56.7 31.3 111.3 112.6 66.5 82.1 116.8 65.7 85.3 54.1 12.3 29.1 59.0 126.6 91.4 119.9 81.3 98.8 139.9 60.4 110.3 147.3 109.2 99.8 148.0 133.3 193.9 84.8 321.2 86.8 63.1 99.7 70.4 137.0 248.2 192.8 100.0 108.7 113.3 79.7 142.8 89.5 228.2 94.0 97.3 87.5 100.4 198.1 116.7 110.3 74.8 137.8 73.9 107.4 149.0 148.9 162.3 123.6 64.0 99.9 133.7 109.0 164.6 126.2 84.6 77.9 62.6 65.2 106.8 197.6 72.0 131.0 101.3 68.9 49.5 109.2 56.9 183.8 59.2 107.6 193.2 74.9 185.8 98.7 12.3 26.9 8.4 45.7 29.1 84.6 85.3 85.1 66.2 54.1 62.8 126.6 99.0 4.0 59.0 23.1 48.7 73.2 91.4 29.9 33.6 37.7 34.6 28.8 31.6 36.1 27.9 36.1 31.3 321.6 347.3 775.5 994.0 1243.7 166.1 228.8 387.3 346.6 597.1 307.1 41.2 1400.5 630.0 839.1 64.3 646.8 150.8 116.8 796.2 1641.6 855.4 473.8 427.8 235.7 952.5 120.8 347.6 298.3 500.7 53.0 902.7 605.7 578.6 960.4 654.2 214.7 840.7 333.1 610.9 657.5 112.2 426.9 861.0 695.1 635.2 890.7 1286.9 674.9 783.2 797.7 NR1H2 "LXR-b, NER, NER-I, RIP15, UNR" ENSG00000131408 "Nuclear receptor subfamily 1 group H member 2" P55055 19 50329653-50382982 "Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005446, HPA056838, HPA070212" Uncertain Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA005446: , HPA056838: AB_2683254, HPA070212: AB_2686234" "unprognostic (1.31e-1)" "unprognostic (5.35e-2)" "prognostic unfavorable (9.86e-4)" "unprognostic (1.34e-3)" "unprognostic (1.68e-1)" "unprognostic (5.24e-3)" "unprognostic (2.26e-2)" "unprognostic (9.69e-2)" "unprognostic (6.45e-2)" "unprognostic (5.23e-2)" "unprognostic (2.40e-1)" "unprognostic (1.88e-1)" "unprognostic (2.69e-2)" "unprognostic (1.86e-1)" "unprognostic (1.35e-1)" "unprognostic (5.12e-2)" "unprognostic (1.69e-3)" 30.1 27.5 24.5 24.7 27.5 98.0 24.4 20.6 33.5 25.1 30.9 23.1 25.2 30.9 31.2 23.1 27.9 26.9 28.7 36.8 23.8 19.4 27.1 31.4 28.3 23.3 31.7 25.9 26.5 37.6 22.0 18.6 30.5 28.1 27.9 10.5 23.2 33.8 33.8 76.2 25.3 30.3 29.9 22.9 29.9 26.7 21.2 29.1 20.4 27.1 24.4 21.7 33.2 27.6 34.1 34.2 63.0 37.7 22.3 28.6 32.5 16.1 42.5 4.1 10.4 12.2 12.9 13.3 22.3 19.0 13.2 15.2 8.8 15.7 10.4 20.0 13.4 10.6 15.1 2.6 12.2 3.2 25.8 22.9 9.9 14.3 9.1 23.4 16.4 27.3 13.5 16.7 13.6 9.2 13.4 12.0 8.3 16.2 21.6 7.4 17.9 11.7 13.5 8.3 10.3 36.5 7.0 10.8 18.0 11.4 18.1 4.6 16.2 14.5 18.0 14.0 2.4 12.4 13.7 15.2 17.8 14.5 18.2 19.8 27.1 22.3 7.6 35.5 10.8 17.9 39.1 35.9 63.0 27.7 35.0 27.0 34.1 27.4 25.9 34.2 34.1 28.6 24.9 55.4 22.3 37.7 29.5 24.4 32.5 24.5 27.5 20.6 33.5 23.8 19.4 31.7 25.9 28.1 29.1 26.8 27.8 34.4 74.6 38.1 39.5 23.4 25.5 9.4 7.9 29.6 13.7 57.0 54.7 54.4 5.2 46.6 78.1 0.0 63.6 44.7 33.4 68.0 50.6 17.4 46.9 35.0 20.0 20.9 26.7 6.8 42.0 44.5 57.3 84.8 39.8 39.5 60.4 87.7 50.2 46.2 21.7 38.8 58.5 32.5 30.0 40.0 117.1 47.8 32.6 81.4 NR1I2 "BXR, ONR1, PAR2, PXR, SXR" ENSG00000144852 "Nuclear receptor subfamily 1 group I member 2" O75469 3 119780484-119818485 "FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 7.1;intestine: 15.4;liver: 22.2" "Group enriched" "Detected in some" 4 "Enterocytes: 29.0;Hepatocytes: 28.7" "Group enriched" "Detected in some" 24 "colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7" "Cell type enriched" "Detected in single" 18 "NK-cell: 7.1" "Lineage enriched" "Detected in single" 18 "NK-cells: 7.1" "Cell line enriched" "Detected in some" 4 "Hep G2: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029309, HPA055121, HPA073926" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643" "unprognostic (6.76e-3)" "unprognostic (2.25e-1)" "unprognostic (5.84e-2)" "unprognostic (1.24e-4)" "unprognostic (4.51e-2)" "unprognostic (4.52e-2)" "unprognostic (4.03e-3)" "unprognostic (3.97e-2)" "unprognostic (5.78e-2)" "unprognostic (5.05e-2)" "unprognostic (5.21e-2)" "unprognostic (3.60e-2)" "unprognostic (5.51e-6)" "unprognostic (4.86e-1)" "unprognostic (6.95e-2)" "unprognostic (3.13e-1)" "unprognostic (6.12e-3)" 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 5.6 15.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.0 22.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 7.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.8 2.5 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.0 0.0 29.0 0.0 0.2 0.0 0.0 0.0 0.0 28.7 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.6 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 NR2C2 "hTAK1, TAK1, TR2R1, TR4" ENSG00000177463 "Nuclear receptor subfamily 2 group C member 2" P49116 3 14947584-15053600 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006313 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006313: AB_1079503" "unprognostic (1.32e-1)" "unprognostic (3.87e-1)" "unprognostic (3.98e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "prognostic favorable (1.51e-5)" "unprognostic (1.03e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-1)" "unprognostic (1.29e-1)" "unprognostic (5.95e-2)" "unprognostic (1.02e-1)" "unprognostic (2.26e-1)" "unprognostic (1.25e-1)" "unprognostic (2.82e-2)" "unprognostic (5.82e-3)" 13.2 13.1 22.5 17.0 17.5 17.1 16.1 30.5 26.4 11.9 14.0 12.8 14.1 18.5 17.8 11.0 13.6 12.6 12.3 14.5 18.3 12.0 12.4 12.6 18.7 16.9 12.6 20.4 18.8 14.2 18.0 23.2 11.9 13.1 12.3 12.2 13.7 13.0 21.5 31.5 19.6 18.1 15.7 13.5 18.8 14.7 29.2 13.3 26.0 19.4 9.0 15.5 15.5 17.8 5.1 4.2 6.2 3.4 2.7 4.9 1.5 10.1 11.5 13.2 10.2 9.4 11.3 30.3 14.7 11.9 11.9 12.4 7.4 10.0 15.7 7.7 13.1 10.5 10.2 12.1 7.5 12.4 20.6 17.2 20.5 24.6 6.6 7.9 15.0 15.9 8.9 10.0 15.0 7.9 10.0 13.4 15.5 14.5 10.8 10.5 9.0 23.0 11.8 8.7 4.8 11.9 18.5 15.7 10.4 5.7 15.4 8.4 21.1 13.3 11.2 13.5 10.9 11.2 15.0 17.3 18.5 22.1 16.8 20.0 16.5 21.3 17.0 13.3 14.4 16.2 6.2 2.5 1.9 4.9 3.4 4.4 2.3 2.7 2.9 2.6 5.1 3.9 3.5 3.5 2.7 3.0 4.2 2.5 1.5 22.5 17.5 30.5 26.4 18.3 12.0 12.6 20.4 13.1 13.3 20.8 9.8 10.9 9.5 3.3 15.5 5.1 12.7 24.1 7.9 7.0 13.7 6.7 5.0 6.1 46.1 6.4 10.7 0.0 6.3 6.3 5.8 13.8 9.2 7.8 6.7 12.7 24.1 20.3 20.9 49.4 17.8 7.7 5.0 7.2 10.7 13.3 9.4 11.8 19.4 5.7 16.3 0.0 4.8 30.9 16.3 2.8 12.5 13.6 10.6 10.7 NR3C1 "GR, GRL" ENSG00000113580 "Nuclear receptor subfamily 3 group C member 1" P04150 5 143277931-143435512 "Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Receptor, RNA-binding" "Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004248, CAB010435" Supported Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "CAB010435: AB_2155784, HPA004248: AB_1078976" "unprognostic (1.38e-1)" "unprognostic (1.93e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.64e-5)" "unprognostic (1.43e-2)" "unprognostic (2.74e-1)" "unprognostic (4.19e-1)" "unprognostic (1.39e-1)" "unprognostic (2.46e-2)" "unprognostic (3.87e-2)" "unprognostic (2.15e-1)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.72e-6)" "unprognostic (9.06e-3)" "unprognostic (1.02e-1)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" 27.7 8.6 13.5 26.1 14.9 29.6 23.5 30.1 19.2 14.9 14.2 17.0 10.5 13.0 14.7 12.9 18.2 13.7 14.7 17.4 13.4 14.1 13.5 27.3 22.0 16.1 18.3 12.8 15.5 12.5 21.9 18.9 31.9 13.6 14.3 10.3 14.2 12.0 15.2 40.4 18.3 14.8 16.8 17.2 17.5 13.4 7.3 18.2 37.1 18.0 15.1 18.2 14.8 32.2 11.1 13.6 33.7 11.8 10.9 9.6 7.3 10.1 20.7 1.5 0.0 13.6 15.2 1.8 15.9 19.1 13.8 15.9 1.5 13.6 9.0 7.3 23.3 16.1 9.6 0.1 12.5 17.1 5.0 7.1 2.3 28.0 4.5 12.8 9.3 7.2 11.0 16.2 22.6 22.1 17.2 5.1 4.1 3.3 34.3 12.1 3.6 5.4 6.6 4.1 1.7 4.4 1.9 14.4 19.1 4.0 0.7 2.7 2.1 27.8 4.0 6.6 1.8 1.8 13.4 12.2 33.4 6.6 15.9 12.0 6.9 6.3 14.1 17.5 9.6 11.6 25.4 9.8 17.9 9.3 11.8 7.7 7.6 9.6 8.9 13.6 11.1 9.2 8.9 33.7 10.9 10.5 12.4 5.8 7.3 13.5 14.9 30.1 19.2 13.4 14.1 18.3 12.8 13.6 18.2 62.5 66.3 52.2 35.5 52.2 11.3 38.3 43.3 45.5 46.6 24.4 15.7 34.4 14.9 27.4 129.9 67.3 15.8 0.0 28.6 30.5 63.9 36.5 86.6 160.0 47.2 35.0 27.0 55.3 56.4 113.7 58.4 78.4 50.6 53.3 2.3 41.2 29.3 21.0 67.1 50.1 55.0 148.8 81.5 18.0 35.6 49.2 30.6 85.5 12.0 12.3 NR6A1 "CT150, GCNF, GCNF1, RTR" ENSG00000148200 "Nuclear receptor subfamily 6 group A member 1" Q15406 9 124517275-124771310 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 28.2" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 112.0;Spermatocytes: 68.9;Spermatogonia: 111.8" "Cancer enriched" "Detected in many" 16 "testis cancer: 27.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.6" "Cell line enhanced" "Detected in many" "BEWO: 47.8;CACO-2: 11.0;Hep G2: 10.7;K-562: 14.1;NTERA-2: 17.0;U-266/84: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031461, HPA045145" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA031461: AB_2673894, HPA045145: AB_2679233" "unprognostic (1.73e-1)" "unprognostic (6.66e-2)" "unprognostic (4.53e-1)" "unprognostic (1.34e-6)" "unprognostic (4.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.52e-5)" "unprognostic (6.31e-2)" "unprognostic (8.01e-3)" "unprognostic (2.71e-2)" "unprognostic (1.58e-2)" "unprognostic (1.63e-1)" "unprognostic (7.26e-2)" "unprognostic (7.20e-3)" "unprognostic (1.71e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-1)" 0.6 1.0 2.9 1.4 3.4 5.5 1.8 5.8 3.5 0.8 7.9 1.2 1.3 2.5 0.9 1.4 2.2 1.0 0.9 1.0 3.3 1.3 1.9 2.8 1.8 0.7 2.1 2.4 0.6 3.3 1.5 2.2 4.2 2.2 1.7 2.3 1.7 1.5 1.4 1.9 2.6 5.3 0.8 2.3 1.1 0.7 28.2 2.8 0.0 7.3 0.8 1.1 1.3 1.4 0.3 1.0 8.6 1.2 0.1 0.0 0.1 0.5 1.2 6.3 0.8 0.1 0.1 47.8 0.1 0.4 0.3 0.5 11.0 1.2 2.1 0.4 0.0 1.6 1.1 0.6 0.5 0.7 0.5 2.0 1.7 1.8 10.7 0.0 1.0 3.1 0.0 0.6 0.5 0.7 0.1 0.1 0.5 14.1 0.3 0.2 0.2 0.0 1.3 17.0 0.5 0.5 0.5 0.6 0.9 0.2 0.8 0.9 0.3 0.0 0.3 0.4 9.8 1.1 0.5 0.0 0.6 1.3 0.4 0.3 1.4 10.3 1.9 0.3 1.0 0.3 0.1 1.2 2.0 0.0 0.9 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.0 8.6 0.1 0.6 0.2 0.0 0.1 2.9 3.4 5.8 3.5 3.3 1.3 2.1 2.4 2.2 2.8 0.0 7.7 0.0 15.1 33.2 2.8 1.4 10.2 4.0 4.5 5.2 27.5 30.8 1.7 7.9 43.0 2.7 13.2 0.0 3.1 112.0 3.0 14.2 1.1 5.5 7.1 1.6 4.6 1.3 1.8 22.4 1.1 4.6 8.5 5.4 6.7 8.0 2.3 7.0 1.8 1.9 10.5 0.0 2.1 68.9 111.8 34.8 25.6 0.0 13.0 11.9 NSA2 "FLJ94393, HCLG1, HUSSY-29, TINP1" ENSG00000164346 "NSA2, ribosome biogenesis homolog" O95478 5 74766991-74780113 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA043487 Approved Enhanced Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA043487: AB_2678507" "unprognostic (4.79e-3)" "unprognostic (1.92e-1)" "unprognostic (5.49e-2)" "unprognostic (7.80e-2)" "unprognostic (1.54e-1)" "unprognostic (4.07e-2)" "unprognostic (6.14e-3)" "unprognostic (4.24e-1)" "unprognostic (2.15e-2)" "unprognostic (9.14e-2)" "unprognostic (8.66e-2)" "unprognostic (1.03e-1)" "unprognostic (4.92e-2)" "unprognostic (3.98e-1)" "unprognostic (1.64e-1)" "unprognostic (2.31e-2)" "unprognostic (1.44e-1)" 25.4 32.6 17.4 26.8 29.3 28.3 24.0 14.0 29.4 31.8 25.8 8.0 18.0 26.2 26.5 22.6 27.9 22.9 13.5 27.7 20.8 13.6 27.4 35.4 27.0 42.5 16.7 19.1 54.2 31.2 13.5 35.4 25.4 20.3 27.8 20.6 10.4 33.8 17.9 51.1 17.3 22.2 23.1 28.5 28.5 24.3 44.5 15.7 26.4 27.2 21.7 26.1 36.7 26.1 17.0 11.1 4.4 11.9 13.1 19.3 6.1 20.6 11.3 14.0 18.8 8.7 16.1 21.4 14.8 7.7 9.5 7.5 18.7 20.3 16.7 31.6 8.2 23.3 12.8 11.0 16.3 13.4 11.4 17.0 8.7 22.0 21.4 8.1 15.2 20.5 10.6 15.4 12.7 9.4 15.5 7.9 15.2 8.6 14.1 10.1 15.7 25.5 38.2 9.3 8.8 9.9 18.3 16.4 31.5 11.9 22.8 15.0 19.6 8.9 17.3 39.9 11.0 16.3 43.3 9.1 7.3 22.1 13.7 42.5 14.1 18.8 27.3 18.3 27.0 10.8 4.4 7.2 4.2 10.5 11.9 15.1 17.0 16.0 15.8 11.1 12.4 19.3 19.1 1.3 13.1 8.8 10.4 15.8 6.1 17.4 29.3 14.0 29.4 20.8 13.6 16.7 19.1 20.3 15.7 74.5 77.0 155.5 140.9 83.6 31.6 79.5 137.6 66.9 104.6 59.3 13.7 119.1 127.6 113.6 331.3 86.4 114.1 116.8 204.5 170.1 84.0 110.5 116.6 184.7 121.5 47.7 134.0 113.5 170.4 102.0 257.7 109.4 79.2 149.7 219.3 47.0 172.0 119.3 161.2 158.4 31.4 135.8 91.0 120.5 95.0 75.2 113.3 107.1 207.0 165.4 NSFL1C "dJ776F14.1, p47, UBX1, UBXD10, UBXN2C" ENSG00000088833 "NSFL1 cofactor" Q9UNZ2 20 1442162-1473842 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047108, HPA050628" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" No No 920000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA047108: AB_2679935, HPA050628: AB_2681194" "unprognostic (7.55e-2)" "unprognostic (5.26e-2)" "unprognostic (2.51e-2)" "unprognostic (2.47e-1)" "unprognostic (5.96e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.10e-2)" "unprognostic (1.59e-1)" "unprognostic (4.67e-2)" "unprognostic (2.58e-1)" "unprognostic (4.97e-2)" "unprognostic (6.90e-2)" "unprognostic (5.46e-2)" "unprognostic (1.54e-1)" "unprognostic (7.44e-2)" "unprognostic (7.50e-3)" 15.7 22.7 20.2 10.2 23.5 15.8 15.3 18.2 26.5 16.6 14.7 17.1 9.3 11.1 17.4 21.2 19.8 19.9 12.2 21.9 16.7 18.2 14.8 19.8 12.7 9.6 17.1 22.4 22.7 10.8 12.4 9.9 21.5 24.2 16.8 13.9 20.1 13.6 21.8 49.7 25.6 12.4 18.9 15.8 12.2 12.6 11.1 15.3 12.8 13.1 14.8 12.4 15.9 13.7 14.5 12.0 32.4 10.9 5.9 11.0 9.4 21.3 24.8 15.9 15.1 14.4 13.4 11.8 10.0 18.0 24.5 18.2 20.9 17.4 11.9 8.1 18.1 23.3 20.3 9.7 26.2 18.9 4.4 10.6 12.0 4.4 24.0 15.2 11.6 7.3 11.4 9.6 25.5 8.5 14.2 17.4 8.6 15.5 10.7 17.1 10.2 12.1 22.2 17.1 16.5 27.5 5.8 19.8 11.6 28.5 15.0 9.2 11.3 12.1 24.1 10.9 9.7 14.7 8.0 16.1 19.0 14.0 11.0 16.3 8.6 15.3 9.9 14.1 16.3 13.4 10.7 8.9 32.4 8.5 10.6 8.5 13.9 9.2 8.3 12.0 14.5 10.5 9.2 29.1 5.9 10.9 9.5 11.0 9.4 20.2 23.5 18.2 26.5 16.7 18.2 17.1 22.4 24.2 15.3 20.8 21.0 25.3 52.2 79.2 58.7 30.5 20.4 25.4 30.7 29.6 21.6 128.5 48.0 77.9 14.8 36.0 52.0 0.0 82.5 121.5 43.5 44.6 39.3 35.8 71.3 66.7 41.9 25.2 37.6 26.4 36.2 39.7 40.5 47.7 29.3 44.2 95.4 52.6 43.5 54.7 37.5 77.6 53.6 80.7 105.4 66.1 126.8 34.5 37.5 81.7 NSMCE4A "bA500G22.3, C10orf86, FLJ20003, NSE4A" ENSG00000107672 "NSE4 homolog A, SMC5-SMC6 complex component" Q9NXX6 10 121957088-121975217 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037459, HPA038412, HPA044872" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037459: AB_10696932, HPA038412: AB_2676005, HPA044872: AB_2679124" "unprognostic (1.16e-3)" "unprognostic (2.86e-2)" "unprognostic (1.56e-1)" "unprognostic (3.73e-2)" "unprognostic (4.09e-3)" "unprognostic (2.18e-2)" "unprognostic (1.64e-1)" "prognostic favorable (2.72e-5)" "unprognostic (3.16e-2)" "unprognostic (7.47e-2)" "unprognostic (1.08e-1)" "unprognostic (6.44e-3)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.64e-1)" "unprognostic (8.13e-2)" "unprognostic (1.35e-1)" "unprognostic (7.01e-3)" 21.8 17.7 11.1 27.1 17.6 16.2 26.0 14.0 12.5 23.7 26.6 14.0 14.3 22.8 20.8 17.1 22.3 18.0 16.7 17.8 11.0 8.2 15.4 23.0 22.3 22.2 18.5 12.6 20.0 24.3 13.3 10.5 15.5 12.2 21.1 20.3 15.2 24.5 23.0 15.9 14.6 26.1 26.9 12.2 20.0 23.7 6.5 16.8 23.3 21.8 15.8 20.6 26.7 16.8 24.0 24.9 8.8 17.6 18.7 22.4 17.2 16.8 20.8 22.3 19.9 7.9 10.4 16.5 9.5 17.1 16.4 22.9 16.0 13.2 22.5 7.4 7.5 9.0 14.7 13.1 10.4 13.0 27.0 30.9 14.8 7.1 29.9 6.7 16.6 10.4 7.0 8.0 9.6 15.7 9.2 17.3 20.7 13.5 16.3 9.1 13.7 30.2 24.5 11.7 12.1 16.4 26.1 17.4 24.2 11.2 14.1 6.1 12.0 10.8 7.4 14.7 9.4 8.1 15.9 14.0 6.5 11.7 10.9 19.6 21.8 23.1 34.7 8.1 22.7 6.9 0.1 15.4 8.8 15.3 17.6 17.7 24.0 20.6 19.8 15.9 21.7 21.8 17.7 1.4 18.7 17.1 24.9 22.4 17.2 11.1 17.6 14.0 12.5 11.0 8.2 18.5 12.6 12.2 16.8 20.8 27.8 29.6 39.9 15.0 20.2 17.1 25.5 17.4 20.5 12.2 31.4 41.8 29.9 24.3 0.3 29.5 27.6 46.7 53.2 31.1 22.0 38.1 11.5 31.4 31.1 25.4 20.7 17.2 18.3 0.4 32.8 19.0 20.3 55.1 31.7 29.1 29.2 37.6 31.5 30.2 36.0 25.8 24.5 6.1 11.7 18.9 55.4 25.8 40.3 43.9 NSUN5 "FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL" ENSG00000130305 "NOP2/Sun RNA methyltransferase family member 5" Q96P11 7 73302517-73308867 "Disease related genes, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020536, HPA045590, HPA046867" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847" "unprognostic (3.94e-1)" "unprognostic (1.12e-1)" "unprognostic (3.79e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.92e-1)" "prognostic unfavorable (3.96e-4)" "unprognostic (3.54e-1)" "unprognostic (2.46e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" "unprognostic (3.21e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-2)" 9.0 7.7 11.2 13.1 12.8 40.9 8.7 12.9 14.4 8.5 10.3 15.0 4.8 12.6 12.3 6.9 10.8 12.0 8.1 9.4 10.8 9.3 9.4 9.8 8.0 16.1 19.4 11.9 10.6 19.6 9.5 8.3 8.3 13.6 9.7 6.2 7.7 13.6 9.7 27.1 11.8 12.1 10.9 11.6 15.8 9.6 14.6 13.6 23.5 10.6 11.2 12.1 10.6 8.9 33.5 21.2 18.7 14.4 16.8 22.3 15.3 12.2 17.0 4.8 10.5 2.0 2.5 18.2 5.9 3.4 9.1 9.8 22.9 9.1 20.2 4.0 2.9 13.4 10.6 9.0 5.9 3.0 13.3 20.9 7.6 12.4 13.1 7.8 16.8 10.4 3.4 9.9 7.8 6.6 2.1 1.2 15.2 24.9 4.8 4.3 29.5 14.2 34.6 19.3 9.0 13.1 17.4 3.6 28.9 3.9 6.1 12.4 20.7 10.3 27.6 13.3 5.4 17.7 13.4 1.9 0.1 13.3 13.2 3.9 19.3 24.9 28.8 0.2 23.6 0.9 14.2 14.4 15.0 14.0 12.5 11.0 21.5 15.9 14.3 16.5 33.5 22.3 18.8 18.7 16.8 9.3 21.2 17.3 15.3 11.2 12.8 12.9 14.4 10.8 9.3 19.4 11.9 13.6 13.6 6.0 6.1 51.6 17.1 15.0 25.1 17.1 25.5 10.7 12.5 34.9 11.8 33.4 31.5 36.0 12.8 7.3 18.6 0.0 28.6 37.8 16.9 12.9 26.5 20.3 30.9 30.2 3.5 6.7 17.4 16.3 27.0 19.4 20.3 46.9 16.4 13.8 24.0 17.5 19.4 19.5 21.4 6.5 14.1 60.6 58.5 18.6 18.2 25.4 19.9 15.5 NTMT1 "AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1" ENSG00000148335 "N-terminal Xaa-Pro-Lys N-methyltransferase 1" Q9BV86 9 129608884-129636131 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 302.3;Late spermatids: 570.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020092, HPA058420" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020092: AB_1853831, HPA058420: AB_2683713" "unprognostic (4.74e-3)" "unprognostic (1.77e-1)" "unprognostic (2.44e-1)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (1.24e-3)" "unprognostic (4.17e-3)" "unprognostic (4.92e-2)" "unprognostic (1.24e-1)" "unprognostic (8.57e-2)" "unprognostic (3.63e-1)" "unprognostic (4.35e-2)" "unprognostic (1.00e-3)" "unprognostic (1.11e-3)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (3.50e-3)" 10.2 25.7 11.9 11.5 13.1 13.8 10.0 13.2 15.3 8.9 10.7 9.0 14.4 11.7 8.8 13.6 10.2 7.8 16.6 31.8 11.5 11.5 11.7 16.8 8.9 11.5 15.7 11.3 8.8 19.5 9.4 10.8 12.1 13.8 10.2 7.4 9.4 13.0 11.4 54.6 10.7 10.2 13.6 10.3 13.1 10.5 56.2 10.7 10.8 12.3 22.1 9.8 12.3 14.5 27.1 28.4 20.3 34.2 14.8 26.6 19.4 16.7 34.8 14.4 24.4 9.2 13.7 15.5 31.9 18.9 32.3 28.0 28.5 22.0 21.6 16.4 22.7 23.3 32.7 30.2 28.1 20.4 16.6 16.2 9.0 31.3 28.7 29.5 18.1 13.7 14.6 14.3 33.8 16.9 10.4 17.6 19.3 33.0 16.2 16.8 55.4 20.4 24.5 18.8 31.2 30.4 19.4 17.0 43.2 13.0 9.6 29.3 15.3 15.7 29.5 21.8 9.6 24.5 9.5 11.9 38.9 19.7 36.0 33.4 12.8 15.2 32.8 17.7 18.8 22.2 15.1 27.3 20.3 25.2 28.7 24.8 23.4 25.5 26.6 26.4 27.1 26.4 22.0 7.6 14.8 34.2 28.4 23.4 19.4 11.9 13.1 13.2 15.3 11.5 11.5 15.7 11.3 13.8 10.7 3.0 11.5 55.2 60.7 88.7 16.0 2.8 20.4 10.7 18.2 21.0 21.6 61.3 82.9 57.5 302.3 31.5 59.1 0.0 48.7 71.0 52.7 55.2 30.0 42.9 59.3 39.7 19.4 20.3 27.3 570.1 32.5 46.3 52.3 28.9 25.6 18.8 57.3 24.6 23.3 72.8 22.1 25.8 84.4 60.3 47.2 86.8 113.4 40.1 37.2 65.8 NUB1 "BS4, NUB1L, NYREN18" ENSG00000013374 "Negative regulator of ubiquitin like proteins 1" Q9Y5A7 7 151341699-151378449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "monocytes: 930.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021220, HPA050722, HPA053648" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA021220: AB_2670630, HPA050722: AB_2681220, HPA053648: AB_2682217" "unprognostic (7.04e-3)" "unprognostic (2.47e-2)" "unprognostic (1.84e-1)" "unprognostic (1.01e-2)" "unprognostic (1.02e-2)" "unprognostic (3.22e-2)" "prognostic unfavorable (8.70e-4)" "unprognostic (1.42e-1)" "unprognostic (2.75e-1)" "unprognostic (2.67e-2)" "unprognostic (2.10e-1)" "unprognostic (8.76e-2)" "unprognostic (2.69e-2)" "unprognostic (9.44e-2)" "unprognostic (1.45e-1)" "unprognostic (2.64e-2)" "unprognostic (5.83e-3)" 20.1 17.3 17.1 22.1 15.5 13.2 20.5 20.5 20.0 22.2 25.0 17.6 17.3 30.9 24.4 17.6 18.1 19.8 17.0 16.5 14.8 12.9 17.1 18.9 21.2 28.7 14.3 15.4 25.4 21.7 28.0 26.4 23.7 18.5 21.6 15.3 16.2 19.8 15.7 30.3 16.9 38.3 20.8 19.8 26.5 17.7 56.0 16.0 32.3 26.5 15.9 19.8 25.3 22.3 21.1 18.9 28.9 24.0 24.5 24.7 17.1 27.0 12.3 16.6 9.8 17.3 21.2 13.8 21.8 20.1 16.6 19.2 12.0 24.0 29.2 28.9 13.6 21.3 13.7 9.9 14.2 10.7 25.8 16.7 10.6 11.7 7.6 24.3 24.6 13.8 13.5 16.7 11.9 11.3 20.6 10.9 14.9 27.7 0.8 13.3 14.5 43.5 18.7 26.0 27.7 16.2 24.2 17.2 4.4 12.3 13.4 15.6 26.0 40.9 17.6 20.8 12.1 12.0 14.2 22.0 14.1 5.0 18.7 20.6 28.5 21.7 25.7 28.5 21.2 23.0 10.4 15.7 20.7 20.9 20.3 24.7 21.1 18.3 21.1 13.6 19.9 20.4 19.0 28.9 24.5 24.0 18.9 14.3 17.1 17.1 15.5 20.5 20.0 14.8 12.9 14.3 15.4 18.5 16.0 68.5 57.3 44.2 28.5 22.0 35.4 51.7 30.6 72.3 71.7 24.4 11.8 39.1 51.4 43.6 181.4 36.0 42.1 0.0 60.6 37.7 28.4 41.4 69.4 33.4 27.3 46.1 28.2 30.7 34.8 15.4 40.9 42.6 15.1 930.6 41.4 52.7 51.5 17.5 38.5 30.5 40.1 25.8 38.7 96.0 12.7 25.3 41.9 48.0 21.9 30.6 NUDT22 MGC13045 ENSG00000149761 "Nudix hydrolase 22" Q9BRQ3 11 64225941-64230686 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039334, HPA053464" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA039334: AB_10795174, HPA053464: AB_2682160" "unprognostic (2.72e-1)" "unprognostic (3.77e-1)" "unprognostic (1.86e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-2)" "unprognostic (9.75e-2)" "unprognostic (1.73e-3)" "unprognostic (1.98e-1)" "unprognostic (1.15e-1)" "unprognostic (1.43e-1)" "unprognostic (7.65e-2)" "unprognostic (6.61e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.76e-2)" "unprognostic (1.50e-1)" "unprognostic (1.71e-1)" "unprognostic (8.54e-2)" 9.2 16.8 8.1 16.0 9.2 14.3 9.8 7.3 12.8 9.2 24.2 9.1 30.9 29.6 9.1 16.9 17.8 9.0 16.7 23.4 8.3 7.0 21.1 30.1 10.2 15.9 10.5 8.4 7.9 26.4 13.8 12.2 14.7 8.6 12.3 8.5 9.0 28.6 35.2 24.9 12.9 23.7 11.4 7.8 20.5 18.5 7.8 7.7 19.5 15.4 15.7 19.6 13.5 9.4 30.0 49.1 20.0 33.9 19.2 25.0 20.1 14.7 9.4 2.4 9.9 3.6 4.4 9.0 6.2 6.5 4.5 4.2 6.1 12.6 7.0 16.5 6.2 6.8 15.5 1.4 9.9 0.6 9.0 4.0 9.4 6.9 6.3 10.8 6.0 15.7 6.8 7.4 4.8 5.1 3.4 7.3 8.4 4.6 7.7 5.3 22.1 8.4 11.2 3.7 9.1 19.9 10.4 4.0 26.0 7.8 8.2 5.5 8.8 5.5 20.9 24.8 0.9 21.3 6.9 6.7 7.6 7.2 23.8 5.3 28.9 11.4 4.4 26.1 7.1 8.8 13.8 28.7 20.0 23.0 33.9 20.5 25.3 20.3 22.4 29.1 30.0 18.0 19.6 17.3 19.2 31.8 49.1 25.0 20.1 8.1 9.2 7.3 12.8 8.3 7.0 10.5 8.4 8.6 7.7 3.0 13.4 41.3 23.3 10.6 12.3 3.1 61.1 4.0 6.8 38.4 11.8 92.1 139.3 53.1 12.7 17.7 92.0 0.0 76.6 42.4 24.2 26.6 14.0 47.8 50.9 28.6 35.7 27.0 50.0 6.5 18.7 38.1 32.1 73.9 66.5 25.6 56.4 92.1 18.4 113.9 16.8 12.9 20.6 4.9 8.3 15.3 56.4 39.2 56.2 28.8 NUFIP1 NUFIP ENSG00000083635 "NUFIP1, FMR1 interacting protein 1" Q9UHK0 13 44939249-44989483 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029958, HPA029959" Approved Enhanced Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA029958: AB_10598911, HPA029959: AB_10602308" "unprognostic (2.01e-1)" "unprognostic (5.32e-3)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (1.70e-2)" "unprognostic (2.98e-3)" "unprognostic (2.32e-1)" "unprognostic (1.45e-2)" "unprognostic (2.91e-2)" "unprognostic (9.74e-3)" "unprognostic (4.52e-1)" "unprognostic (3.95e-2)" "unprognostic (3.73e-2)" "unprognostic (4.04e-2)" "unprognostic (4.89e-2)" "unprognostic (3.31e-1)" "unprognostic (5.24e-2)" 8.9 9.8 10.4 10.7 16.4 17.4 11.6 11.0 17.2 9.8 7.8 10.8 4.8 7.1 11.7 14.4 9.2 9.2 6.3 6.4 12.7 9.6 10.2 13.7 11.2 8.5 8.9 12.6 13.7 11.5 9.3 9.6 7.7 7.9 9.1 7.9 6.3 8.6 8.8 17.0 10.1 6.4 10.3 10.0 8.4 8.6 14.1 8.8 11.4 10.1 6.8 9.3 8.9 8.3 6.6 6.3 1.1 3.7 8.3 6.9 2.5 5.4 4.3 7.3 6.1 5.0 5.3 8.8 6.5 5.6 12.1 7.8 11.6 8.8 16.0 5.5 6.0 7.3 8.6 13.6 9.2 15.8 4.9 10.7 12.2 2.9 10.4 8.4 15.7 5.0 5.5 8.6 8.1 12.4 4.7 6.0 8.3 9.7 2.7 8.5 6.2 12.9 9.9 17.3 14.6 7.1 12.8 7.0 9.8 7.3 4.7 4.0 9.0 5.6 7.6 7.0 7.2 5.8 8.8 4.5 6.2 5.3 7.9 8.9 3.7 5.7 20.2 7.0 11.1 8.7 0.0 3.7 1.1 3.9 3.7 6.9 5.9 4.3 4.1 4.7 6.6 6.8 5.1 0.2 8.3 2.3 6.3 2.4 2.5 10.4 16.4 11.0 17.2 12.7 9.6 8.9 12.6 7.9 8.8 6.0 9.8 6.7 10.1 13.7 7.2 4.0 5.1 5.3 18.2 5.2 11.8 13.3 14.9 11.0 34.3 7.7 2.4 23.3 14.4 12.0 9.3 4.8 17.3 8.1 9.3 7.9 5.2 8.0 4.3 47.9 10.0 7.9 8.5 6.4 4.7 8.2 8.9 0.0 10.6 12.2 6.6 6.5 8.5 26.7 28.3 14.4 7.3 6.2 8.1 7.1 OAZ3 ENSG00000143450 "Ornithine decarboxylase antizyme 3" Q9UMX2 1 151762899-151771334 "Predicted intracellular proteins" "Polyamine biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 102.2" "Cell type enriched" "Detected in many" 4 "Late spermatids: 9340.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030136, HPA045808" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030136: AB_2673331, HPA045808: " "unprognostic (2.12e-1)" "unprognostic (3.86e-1)" "unprognostic (1.53e-1)" "unprognostic (5.44e-3)" "unprognostic (1.71e-1)" "unprognostic (1.01e-2)" "unprognostic (1.48e-3)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (1.01e-4)" "unprognostic (1.57e-2)" "unprognostic (2.89e-1)" "unprognostic (8.05e-6)" "unprognostic (3.94e-2)" "unprognostic (1.32e-1)" "unprognostic (2.50e-2)" "unprognostic (8.36e-2)" 0.4 0.3 0.5 0.7 0.5 0.0 0.6 0.6 0.6 0.3 0.4 0.4 0.7 0.1 0.3 2.0 0.4 0.2 0.3 0.6 0.5 0.5 0.5 0.8 0.6 0.8 0.5 0.5 0.3 0.6 1.4 0.6 0.3 0.4 4.0 0.5 0.3 3.1 0.7 1.0 0.3 0.3 0.5 0.6 0.6 0.2 102.2 0.2 0.3 0.8 0.7 0.4 0.4 0.6 1.4 3.2 2.2 5.0 2.6 2.4 1.6 1.2 2.3 1.4 3.3 1.1 3.3 2.9 2.3 0.6 2.2 1.0 1.3 3.1 1.0 2.0 0.7 1.6 1.2 1.3 2.3 0.7 7.3 6.9 1.1 4.4 1.8 1.3 0.6 1.3 5.1 1.4 2.6 3.5 1.4 3.4 3.0 1.4 3.7 2.3 9.7 0.9 1.6 3.3 4.6 2.5 0.4 1.1 1.7 0.4 2.9 1.5 3.6 1.0 5.2 4.6 3.2 10.4 2.7 3.0 1.3 0.7 2.6 1.3 5.1 9.5 2.6 1.7 1.6 3.5 2.2 3.0 0.6 1.4 1.5 1.3 1.4 1.3 2.4 3.2 1.2 1.5 2.2 2.1 2.6 5.0 1.3 2.2 1.6 0.5 0.5 0.6 0.4 0.5 0.5 0.5 0.5 0.4 0.2 0.0 1.7 0.0 2.1 0.7 0.6 1.2 0.0 2.7 1.2 0.0 2.0 1.4 1.7 1.8 2210.4 2.7 3.0 0.0 2.7 2.3 1.1 27.3 1.1 2.6 4.0 0.0 3.5 1.8 4.0 9340.9 42.6 1.1 1.7 2.8 7.2 1.6 2.5 4.2 40.0 2.8 1.6 0.0 0.8 57.9 27.9 0.5 1.3 0.0 1.8 3.1 OGG1 "HMMH, HOGG1, MUTM, OGH1" ENSG00000114026 "8-oxoguanine DNA glycosylase" O15527 3 9749944-9788219 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027514, CAB047301" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB047301: , HPA027514: AB_10602189" "unprognostic (6.95e-2)" "unprognostic (7.82e-3)" "unprognostic (7.19e-2)" "unprognostic (1.24e-3)" "unprognostic (9.69e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (5.77e-5)" "unprognostic (7.83e-2)" "unprognostic (2.45e-2)" "unprognostic (3.43e-3)" "unprognostic (9.66e-3)" "unprognostic (4.23e-2)" "prognostic favorable (2.65e-4)" "unprognostic (2.06e-2)" "unprognostic (2.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.59e-1)" 10.4 12.9 15.4 28.5 16.2 12.7 11.5 22.0 17.7 16.7 18.8 16.2 10.5 22.0 16.2 13.1 10.0 14.7 12.1 10.7 14.7 10.8 30.1 17.8 9.9 28.5 12.3 14.1 22.5 12.0 5.8 10.2 10.3 15.3 14.4 10.2 14.6 14.3 13.2 7.4 11.5 28.2 12.1 13.6 14.1 10.8 7.3 15.6 19.8 12.2 6.3 25.5 12.2 13.3 12.2 11.9 15.4 8.5 19.4 15.4 8.3 5.7 10.8 10.9 6.8 10.7 12.3 20.2 7.5 7.8 11.6 13.9 10.3 5.7 35.2 5.0 9.5 18.5 5.6 6.4 8.2 4.9 12.5 9.2 17.5 17.4 14.8 11.3 6.8 11.2 12.2 10.6 20.0 8.5 9.4 14.3 5.0 5.5 5.7 11.0 10.8 5.4 6.7 5.8 5.2 15.5 4.0 7.4 11.4 6.5 2.9 4.9 8.6 9.7 7.9 5.8 5.9 12.4 11.6 9.2 11.8 12.4 9.2 12.3 5.7 8.2 18.1 9.5 19.6 7.2 11.3 8.5 15.4 15.1 6.6 14.6 10.4 13.0 12.3 7.6 12.2 10.2 9.6 2.1 19.4 5.3 11.9 15.4 8.3 15.4 16.2 22.0 17.7 14.7 10.8 12.3 14.1 15.3 15.6 0.0 4.3 24.5 8.6 4.8 19.3 2.0 7.6 4.0 2.3 8.7 33.4 5.4 10.0 7.2 0.6 8.3 10.4 23.3 5.9 8.2 9.7 5.0 2.3 8.5 15.7 7.9 17.2 6.7 6.7 0.9 13.3 8.2 6.8 12.6 7.6 10.3 7.1 10.1 12.7 65.4 29.4 25.8 9.0 8.3 15.3 4.0 3.3 13.8 12.2 4.3 PALM KIAA0270 ENSG00000099864 Paralemmin O75781 19 708939-748329 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 47.6;brain: 56.5" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 44.7;Ito cells: 46.6;Leydig cells: 44.8;Muller glia cells: 69.4;Peritubular cells: 42.5;Proximal tubular cells: 43.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "non-classical monocyte: 4.7" "Lineage enriched" "Detected in single" 35 "monocytes: 4.7" "Cell line enhanced" "Detected in many" "AN3-CA: 16.5;EFO-21: 15.3;REH: 27.2;SH-SY5Y: 17.5;U-2197: 14.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041713, HPA049578" Approved Enhanced "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA041713: AB_10794305, HPA049578: AB_2680822" "unprognostic (9.08e-3)" "unprognostic (2.97e-2)" "unprognostic (2.11e-2)" "unprognostic (3.53e-3)" "unprognostic (1.61e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-1)" "unprognostic (8.39e-2)" "unprognostic (7.62e-2)" "unprognostic (1.36e-2)" "prognostic favorable (9.81e-4)" "unprognostic (2.74e-2)" "prognostic favorable (5.44e-4)" "unprognostic (1.24e-2)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (6.00e-2)" 47.6 11.8 49.1 5.1 39.9 2.2 11.3 13.3 56.5 22.7 8.2 12.4 4.2 9.2 10.7 6.7 5.8 17.7 7.2 9.6 37.7 18.9 21.9 3.5 9.0 2.2 19.2 28.1 21.2 2.1 1.2 10.2 17.6 11.9 12.2 2.7 6.1 5.9 18.6 7.0 6.9 7.5 9.0 14.7 10.5 3.6 8.2 12.5 0.0 3.3 3.3 1.9 5.0 8.4 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 4.4 8.6 16.5 1.3 0.1 1.2 1.1 0.0 1.1 0.3 1.0 0.0 0.0 15.3 0.1 0.1 1.5 4.3 0.0 0.2 0.0 8.5 0.0 3.5 5.4 6.0 0.0 0.1 3.9 0.0 0.7 0.0 2.4 0.6 1.9 3.0 0.1 1.1 8.7 0.6 5.1 3.5 0.8 2.4 27.2 0.0 0.1 0.4 0.0 0.9 17.5 4.4 0.0 0.1 2.8 1.5 4.1 0.0 0.0 9.0 14.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 49.1 39.9 13.3 44.4 37.7 18.9 19.2 28.1 11.9 12.5 0.0 1.7 1.4 5.5 6.4 7.6 3.6 0.0 0.0 3.4 5.2 11.8 0.8 44.7 1.6 1.1 26.3 2.1 0.0 0.2 2.5 21.8 8.7 0.0 0.2 0.8 23.8 0.0 46.6 2.2 5.3 44.8 1.6 16.9 0.0 0.0 69.4 0.3 0.3 42.5 43.5 4.2 0.0 13.3 0.9 1.3 6.0 1.6 0.0 0.0 5.0 PAPOLG FLJ12972 ENSG00000115421 "Poly(A) polymerase gamma" Q9BWT3 2 60756230-60802085 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017795, HPA035349, HPA035350" Approved Enhanced Nucleoplasm No No Nucleoplasm "CAB017795: , HPA035349: AB_2674583, HPA035350: AB_2674584" "unprognostic (1.83e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "unprognostic (3.39e-2)" "unprognostic (5.56e-2)" "unprognostic (3.54e-1)" "unprognostic (6.72e-4)" "unprognostic (2.49e-1)" "unprognostic (6.97e-3)" "unprognostic (6.83e-2)" "unprognostic (1.95e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (4.21e-4)" "unprognostic (2.67e-1)" "unprognostic (1.99e-2)" "unprognostic (3.06e-2)" "unprognostic (2.62e-2)" 12.3 9.5 11.6 11.6 11.9 5.8 9.9 19.4 15.3 10.2 8.2 9.8 7.8 6.8 12.1 6.2 10.1 9.0 10.2 8.5 15.1 10.1 8.6 6.9 9.4 14.8 10.9 11.3 17.1 9.9 13.3 18.9 11.8 12.5 9.6 9.2 7.7 11.1 8.7 13.1 11.7 9.7 9.9 21.0 15.0 9.1 14.2 11.0 23.1 27.5 6.6 14.3 10.9 11.1 6.1 3.7 13.2 6.9 9.4 9.7 4.1 5.2 4.9 9.2 7.4 11.8 8.9 8.8 5.8 5.7 5.0 5.3 8.3 4.5 7.5 6.1 4.4 6.6 8.9 13.0 5.5 9.4 13.0 6.9 9.6 4.7 5.8 7.1 10.0 6.6 6.7 6.5 6.0 12.7 7.6 8.0 7.8 9.4 7.2 5.6 4.2 11.5 6.9 14.5 7.7 4.5 9.4 16.3 6.8 5.4 5.0 5.4 7.5 9.3 5.8 5.2 10.7 3.8 6.1 7.5 6.4 7.7 4.8 5.4 7.1 4.2 18.3 5.2 11.4 4.6 13.2 4.1 8.7 6.7 4.3 8.3 5.9 7.2 6.0 3.7 6.1 7.9 7.3 10.6 9.4 6.9 3.3 9.7 4.1 11.6 11.9 19.4 15.3 15.1 10.1 10.9 11.3 12.5 11.0 11.9 9.8 4.5 13.0 11.1 5.7 6.3 5.1 8.1 10.3 8.7 23.6 5.3 3.3 3.9 4.3 9.2 4.3 0.0 3.7 3.5 8.2 12.6 12.7 4.0 6.5 4.8 2.4 10.4 11.6 3.3 6.9 12.4 11.8 7.2 5.1 5.1 3.6 5.8 8.1 2.4 10.1 25.8 8.2 23.3 14.7 13.9 7.3 15.8 3.2 12.0 PARP1 "ADPRT, PARP, PPOL" ENSG00000143799 "Poly(ADP-ribose) polymerase 1" P09874 1 226360691-226408079 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "DNA-binding, Glycosyltransferase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cytotrophoblasts: 400.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727" Supported Supported Enhanced Nucleoplasm,Nucleoli NA NA 39000 Nucleoplasm Nucleoli "CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240" "unprognostic (2.02e-1)" "unprognostic (9.40e-2)" "unprognostic (7.44e-3)" "unprognostic (1.32e-1)" "unprognostic (4.29e-1)" "unprognostic (9.22e-2)" "prognostic unfavorable (3.40e-4)" "unprognostic (2.20e-1)" "unprognostic (3.62e-2)" "unprognostic (1.39e-1)" "unprognostic (2.13e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.35e-5)" "unprognostic (2.38e-2)" "unprognostic (1.82e-1)" "unprognostic (3.14e-2)" "unprognostic (2.64e-1)" 17.3 16.6 31.2 35.7 31.2 14.3 15.3 21.1 29.2 14.3 21.8 37.4 10.3 15.0 18.2 13.0 18.1 15.0 10.8 24.2 27.8 21.9 13.4 24.8 14.1 56.3 40.7 21.8 14.6 28.1 62.6 22.9 28.7 30.4 22.0 19.2 16.3 17.0 24.7 47.3 11.7 19.6 25.5 49.1 32.7 15.9 22.5 34.8 29.5 14.5 16.5 70.2 19.9 13.7 53.0 16.5 9.0 17.5 11.1 21.8 11.5 28.9 15.5 43.2 30.6 11.3 9.4 24.6 19.2 17.1 26.1 21.5 24.7 14.2 84.4 28.7 11.6 11.5 21.8 59.4 18.8 23.1 35.4 82.9 32.6 20.7 16.1 6.8 54.2 15.8 9.2 7.5 21.0 14.9 7.3 20.3 19.6 51.9 43.1 13.5 13.8 17.3 19.6 79.5 40.9 30.8 52.5 74.0 78.0 12.2 20.7 43.5 38.1 25.0 28.0 15.7 31.8 23.5 34.0 15.4 13.9 23.0 18.7 35.9 17.6 29.4 72.5 11.6 18.3 31.1 9.0 6.7 6.9 18.3 11.3 21.6 46.8 19.4 18.0 14.3 53.0 15.2 16.4 1.0 11.1 17.5 16.5 21.8 11.5 31.2 31.2 21.1 28.4 27.8 21.9 40.7 21.8 30.4 34.8 50.6 68.3 130.2 75.6 64.2 94.4 106.4 43.3 75.0 97.8 54.1 133.5 400.4 61.3 77.0 28.3 54.0 16.8 23.3 91.9 75.6 55.5 70.8 116.9 65.7 117.1 85.8 72.1 31.9 42.2 16.3 37.2 45.7 59.1 93.8 46.5 78.6 54.3 24.6 32.9 36.1 102.8 45.3 47.4 92.8 211.4 42.0 115.1 74.0 57.9 42.9 PAX3 "HUP2, WS1" ENSG00000135903 "Paired box 3" P23760 2 222199888-222298996 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Deafness, Disease mutation, Proto-oncogene, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.1;retina: 39.6" "Group enriched" "Detected in some" 8 "Early spermatids: 10.9;Late spermatids: 19.5;Melanocytes: 32.1" "Cancer enriched" "Detected in some" 24 "melanoma: 20.3" "Group enriched" "Detected in some" 6 "cerebellum: 19.1;pons and medulla: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 7.6;BJ hTERT+ SV40 Large T+ RasG12V: 9.1;HBF TERT88: 6.7;RH-30: 13.1;SK-MEL-30: 23.1" "Group enriched" "Detected in some" 7 "cerebellum: 3.9;midbrain: 1.6;pons and medulla: 1.4" "Group enriched" "Detected in many" 5 "cerebellum: 10.0;midbrain: 11.7;pons and medulla: 3.5" "HPA063659, HPA069000" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063659: AB_2685080, HPA069000: AB_2686067" "unprognostic (2.57e-2)" "unprognostic (1.48e-2)" "unprognostic (1.27e-2)" "unprognostic (1.65e-1)" "unprognostic (2.61e-2)" "unprognostic (3.70e-1)" "unprognostic (6.18e-2)" "unprognostic (1.41e-1)" "unprognostic (2.26e-1)" "unprognostic (9.70e-2)" 0.8 0.1 0.0 0.1 0.8 0.1 2.9 19.1 0.2 0.3 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.1 0.1 0.2 2.2 0.0 0.1 0.2 0.1 0.0 0.1 7.8 0.4 0.1 39.6 7.9 0.2 8.6 7.9 0.1 0.1 4.2 0.1 0.2 2.9 0.8 0.0 0.1 3.9 0.5 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 5.2 5.1 7.6 9.1 0.0 0.5 0.0 0.0 3.5 0.1 0.0 0.0 0.0 6.7 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.4 0.1 0.0 0.0 0.0 13.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 23.1 5.9 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.9 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.8 19.1 0.1 0.0 0.2 2.2 0.0 7.8 0.8 0.0 0.0 0.0 0.0 2.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.9 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.3 0.4 0.0 0.0 0.0 0.0 PAX6 "AN, AN2, D11S812E, WAGR" ENSG00000007372 "Paired box 6" P26367 11 31784779-31818062 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.3;retina: 29.4" "Group enriched" "Detected in some" 5 "Horizontal cells: 249.5;Muller glia cells: 410.0" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Region enriched" "Detected in all" 5 "cerebellum: 78.3" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 9.4;AN3-CA: 12.1;HEK 293: 11.3;hTERT-RPE1: 32.3;U-251 MG: 9.9" "Group enriched" "Detected in many" 5 "cerebellum: 61.0;olfactory region: 41.2" "Low region specificity" "Detected in all" "HPA030775, CAB034143" Enhanced Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034143: AB_1127044, HPA030775: AB_10601243" "unprognostic (2.89e-1)" "unprognostic (2.98e-2)" "unprognostic (8.34e-2)" "unprognostic (3.85e-2)" "unprognostic (4.42e-2)" "unprognostic (7.82e-2)" "unprognostic (2.76e-1)" "unprognostic (1.91e-1)" "unprognostic (4.24e-3)" "unprognostic (1.68e-1)" "unprognostic (1.20e-2)" "unprognostic (3.91e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" 0.8 2.0 12.6 0.8 10.4 1.1 1.0 78.3 23.5 0.8 1.1 9.3 0.0 3.5 0.8 1.8 0.8 0.8 0.8 0.8 16.0 3.7 0.9 0.9 0.7 0.9 3.9 9.1 0.8 15.8 0.8 4.6 0.8 10.8 0.8 1.4 29.4 0.8 0.9 1.9 1.6 2.0 0.8 16.1 0.8 19.4 2.8 9.8 0.0 0.8 0.0 1.0 1.1 0.3 0.2 0.2 1.6 0.4 0.4 0.5 0.1 0.0 0.1 9.4 12.1 2.9 4.0 3.6 0.0 0.0 0.1 0.0 0.7 2.2 0.0 3.8 1.2 5.5 0.2 1.0 0.0 0.2 0.0 11.3 5.3 8.8 5.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 32.3 0.0 3.3 4.2 0.0 0.1 0.0 2.2 0.3 0.2 0.0 6.1 0.0 4.4 0.0 0.5 0.3 0.4 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 3.2 0.2 0.0 9.9 0.0 0.1 0.0 5.0 0.0 0.0 1.6 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.2 0.2 0.2 0.3 1.0 0.4 0.4 0.2 0.1 0.1 12.6 10.4 78.3 12.2 16.0 3.7 3.9 9.1 10.8 9.8 0.0 0.0 0.0 0.0 0.5 15.4 4.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 249.5 71.5 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.1 410.0 4.1 0.6 0.0 0.0 27.5 0.0 0.3 3.7 2.9 0.0 0.0 0.0 0.0 0.0 PAX8 ENSG00000125618 "Paired box 8" Q06710 2 113215997-113278950 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 69.3;thyroid gland: 120.5" "Group enriched" "Detected in many" 4 "Collecting duct cells: 233.8;Proximal tubular cells: 100.4" "Group enriched" "Detected in many" 12 "endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "EFO-21: 27.1;GAMG: 16.8;RPTEC TERT1: 63.8" "Region enriched" "Detected in some" 4 "pons and medulla: 5.8" "HPA030062, CAB055097, CAB061888, HPA064554" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283" "unprognostic (2.63e-3)" "unprognostic (3.80e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.75e-5)" "unprognostic (7.24e-2)" "unprognostic (5.16e-5)" "unprognostic (1.56e-2)" "unprognostic (3.29e-2)" "unprognostic (1.03e-1)" "unprognostic (2.16e-1)" "unprognostic (4.13e-2)" "unprognostic (4.00e-2)" "unprognostic (3.37e-2)" "unprognostic (3.27e-1)" "unprognostic (2.37e-1)" "unprognostic (8.93e-3)" "unprognostic (1.02e-1)" 0.9 1.4 1.1 0.5 0.4 0.0 0.6 0.2 0.8 3.8 0.4 0.2 11.7 0.1 2.2 15.2 0.6 9.6 0.8 0.6 0.5 0.5 69.3 0.4 0.5 0.7 0.4 0.3 3.8 0.6 0.1 0.7 0.8 1.5 1.1 0.1 0.5 0.5 10.0 0.3 0.5 0.6 0.4 0.8 0.3 0.4 1.9 0.2 0.4 120.5 0.0 0.2 0.8 1.9 4.4 2.8 1.5 3.4 1.9 2.5 1.1 2.9 0.2 0.1 0.0 0.1 0.0 1.0 0.8 2.7 0.2 0.4 1.8 0.5 0.5 27.1 0.2 16.8 0.0 0.5 0.8 0.2 1.2 0.0 0.4 0.2 1.0 0.3 0.0 0.0 0.7 0.1 0.2 0.6 3.3 0.0 0.0 0.4 2.0 0.8 0.6 0.3 1.2 0.1 0.7 1.8 0.0 0.2 0.6 63.8 4.7 0.5 0.0 3.4 0.0 1.8 0.0 0.0 1.1 0.9 4.6 0.1 0.8 2.3 0.4 1.4 0.1 4.0 0.6 0.0 1.5 3.4 0.0 0.6 1.8 1.5 4.4 1.5 1.1 2.8 1.9 2.5 1.5 0.5 1.9 1.3 1.1 0.8 1.1 1.1 0.4 0.2 0.8 0.5 0.5 0.4 0.3 1.5 0.2 3.0 1.3 0.8 1.7 0.6 0.6 0.8 2.5 0.0 4.5 233.8 0.0 2.1 39.7 9.6 1.5 0.5 5.8 0.0 2.6 2.0 1.9 1.0 0.0 0.0 4.5 0.0 4.6 1.3 1.3 3.1 4.6 2.6 0.0 2.8 2.3 3.3 17.3 7.0 0.4 100.4 0.7 6.5 0.1 4.2 5.8 0.6 0.7 1.0 3.7 1.7 PBRM1 "BAF180, PB1" ENSG00000163939 "Polybromo 1" Q86U86 3 52545352-52685917 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015629, HPA059373" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015629: AB_1855012, HPA059373: AB_2683994" "unprognostic (1.87e-1)" "unprognostic (1.73e-1)" "unprognostic (1.91e-2)" "unprognostic (2.00e-1)" "unprognostic (6.15e-2)" "unprognostic (1.34e-2)" "unprognostic (1.02e-2)" "unprognostic (9.54e-2)" "unprognostic (1.87e-2)" "unprognostic (1.43e-1)" "unprognostic (1.99e-2)" "unprognostic (4.32e-2)" "unprognostic (2.89e-3)" "unprognostic (3.06e-1)" "unprognostic (1.96e-1)" "unprognostic (1.53e-2)" "unprognostic (1.06e-1)" 24.3 14.8 13.8 20.6 15.9 17.2 24.4 19.1 13.8 18.9 18.5 14.0 22.9 12.2 25.9 13.9 19.9 18.9 13.7 15.9 11.1 10.0 11.7 14.5 14.9 16.5 16.5 8.2 25.1 15.4 14.4 30.6 28.0 14.7 16.1 15.3 12.7 17.5 16.2 21.8 17.2 14.3 21.1 15.6 19.1 14.8 13.1 13.7 51.0 22.0 10.5 17.1 22.4 23.0 6.6 10.7 11.1 8.7 4.6 7.4 1.9 12.5 8.1 29.0 14.2 14.3 14.6 20.3 17.3 11.9 20.0 17.6 9.1 8.5 30.4 2.4 20.3 16.6 8.6 25.1 13.1 24.4 32.5 13.5 28.8 15.3 7.0 20.5 24.0 21.9 13.6 15.2 22.4 14.5 15.8 19.3 24.1 16.4 16.7 20.1 4.2 39.5 7.2 17.6 8.5 13.3 20.7 18.2 15.5 8.3 24.5 19.7 21.8 20.8 5.0 16.5 18.4 9.4 13.9 22.2 18.8 14.3 16.2 21.1 12.1 19.0 28.9 11.6 19.5 18.7 10.1 5.0 11.1 4.8 3.2 4.9 3.6 4.8 5.3 4.8 6.6 7.4 4.7 2.7 4.6 8.7 10.7 4.5 1.9 13.8 15.9 19.1 13.8 11.1 10.0 16.5 8.2 14.7 13.7 38.7 54.1 19.5 31.0 35.9 42.0 48.4 28.1 53.5 38.7 22.7 45.2 31.3 16.6 31.4 28.7 40.3 25.3 23.3 40.4 28.9 31.5 35.3 27.8 37.0 45.9 28.6 33.8 35.0 63.3 14.7 31.7 46.6 45.5 50.5 30.6 28.5 42.9 28.1 54.8 13.9 43.3 25.8 45.3 41.9 32.8 45.0 42.6 34.1 34.5 33.3 PBX1 ENSG00000185630 "PBX homeobox 1" P40424 1 164555584-164899296 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.9" "Cell line enhanced" "Detected in many" "HEL: 30.9;NTERA-2: 30.3;SK-BR-3: 62.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003505, HPA003881, CAB018768" Supported Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020" "unprognostic (2.26e-2)" "unprognostic (1.95e-1)" "unprognostic (9.09e-2)" "unprognostic (2.14e-2)" "unprognostic (5.21e-3)" "unprognostic (6.94e-3)" "unprognostic (5.95e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "unprognostic (2.24e-3)" "unprognostic (2.30e-1)" "unprognostic (8.81e-2)" "unprognostic (1.34e-2)" "unprognostic (2.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 13.2 17.3 14.9 8.3 15.0 1.4 16.4 14.1 17.4 73.4 26.3 11.2 15.9 13.6 67.2 15.3 20.8 35.1 25.8 12.6 10.9 9.7 15.4 4.2 10.4 2.3 11.6 14.6 35.2 29.4 21.3 12.4 9.6 8.1 27.6 9.3 10.2 19.6 25.1 16.8 6.0 14.6 56.8 8.0 5.1 13.9 9.7 8.7 2.7 17.4 8.5 6.6 32.2 24.7 0.0 0.1 2.9 0.0 0.3 0.2 2.5 1.1 22.6 22.3 6.0 15.1 7.3 1.3 9.5 6.1 2.6 1.8 4.3 4.0 0.0 2.0 12.9 1.4 7.9 8.8 2.5 1.0 1.1 9.4 30.9 18.2 0.0 10.0 0.0 7.9 7.2 0.0 1.6 0.7 5.6 0.1 0.0 0.0 0.0 0.7 14.9 0.0 0.1 30.3 1.3 1.1 0.0 7.4 9.0 1.8 13.5 0.8 13.2 10.9 62.4 0.0 21.3 23.7 0.0 0.1 1.3 3.1 8.8 2.7 2.8 21.3 0.0 0.1 0.0 0.1 2.9 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.0 0.1 0.0 2.5 14.9 15.0 14.1 17.4 10.9 9.7 11.6 14.6 8.1 8.7 20.8 15.2 0.9 91.3 20.3 27.6 44.2 91.7 25.4 21.6 31.4 104.1 89.0 28.2 41.5 72.1 39.2 28.0 0.0 58.9 4.5 75.2 44.0 71.4 17.3 8.6 4.8 87.2 60.8 1.6 78.2 59.0 6.8 15.1 1.8 35.4 34.9 31.8 59.6 97.6 49.4 28.8 38.8 62.7 0.9 11.5 24.6 87.5 3.2 39.4 82.1 PCBD1 "DCOH, PCBD, PCD" ENSG00000166228 "Pterin-4 alpha-carbinolamine dehydratase 1" P61457 10 70882280-70888784 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation" "Activator, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 99.0" "Cell type enhanced" "Detected in all" 7 "Hepatocytes: 577.2;Proximal tubular cells: 733.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 67.0;Hep G2: 65.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037575, HPA061723" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 210000 Nucleoplasm Cytosol "HPA037575: AB_10671761, HPA061723: AB_2684594" "unprognostic (1.02e-1)" "unprognostic (5.05e-2)" "unprognostic (7.43e-2)" "unprognostic (3.69e-1)" "unprognostic (5.39e-2)" "unprognostic (4.80e-3)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "unprognostic (2.40e-2)" "unprognostic (2.95e-1)" "unprognostic (5.63e-2)" "unprognostic (3.38e-2)" "unprognostic (9.26e-2)" "unprognostic (1.74e-1)" "unprognostic (5.76e-2)" "unprognostic (7.43e-3)" 18.3 25.5 18.1 9.6 15.6 4.3 19.7 13.2 14.8 13.9 18.4 7.8 24.3 12.6 13.9 21.4 26.5 25.6 22.9 32.5 10.8 23.7 38.7 99.0 14.0 7.8 16.7 12.3 18.5 73.0 15.8 15.5 11.7 16.4 26.9 20.3 16.3 16.2 20.7 23.1 5.8 17.2 18.1 14.5 10.2 19.2 7.0 8.7 4.3 36.8 16.2 12.3 22.4 31.8 11.8 20.9 3.5 19.4 8.0 16.9 7.5 20.2 48.2 2.9 29.9 10.9 10.2 3.9 6.6 10.9 10.2 8.2 67.0 36.0 4.1 19.1 7.2 7.9 13.5 18.2 10.5 7.0 10.9 32.8 3.6 7.7 65.8 11.5 3.6 13.5 10.0 11.5 10.1 4.8 15.5 27.4 2.6 7.1 0.3 7.1 33.9 0.4 12.1 4.0 54.9 45.1 1.9 4.0 13.3 42.9 21.0 12.6 21.4 5.4 37.3 14.2 8.4 10.8 7.0 11.3 1.7 14.3 2.5 16.0 0.1 0.8 0.1 9.3 11.8 2.6 0.0 10.7 3.5 8.8 19.4 6.9 11.8 11.6 12.6 20.9 4.1 3.8 7.9 0.6 8.0 13.3 15.3 16.9 7.5 18.1 15.6 13.2 14.8 10.8 23.7 16.7 12.3 16.4 8.7 38.7 59.6 41.0 140.4 44.3 32.7 140.4 142.7 72.3 73.9 177.9 5.9 105.7 384.7 161.2 1.3 33.8 116.6 23.3 147.5 63.7 71.1 169.6 31.1 577.2 160.3 33.4 169.3 32.5 54.4 5.8 62.5 71.4 74.2 90.2 228.3 70.5 157.8 147.3 89.8 733.2 28.5 84.1 57.7 4.9 7.9 40.0 64.9 33.8 199.7 158.3 PCGF1 "MGC10882, NSPC1, RNF68" ENSG00000115289 "Polycomb group ring finger 1" Q9BSM1 2 74505043-74508580 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011356, HPA069156" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA011356: AB_1855063, HPA069156: AB_2686095" "unprognostic (2.41e-1)" "unprognostic (5.97e-2)" "unprognostic (1.11e-3)" "unprognostic (2.71e-2)" "unprognostic (4.25e-2)" "unprognostic (2.73e-2)" "unprognostic (2.32e-2)" "unprognostic (4.18e-3)" "unprognostic (2.26e-1)" "unprognostic (2.14e-1)" "unprognostic (1.57e-1)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.69e-4)" "unprognostic (1.00e-1)" "unprognostic (5.09e-2)" "unprognostic (1.21e-1)" "unprognostic (2.13e-1)" 3.8 3.1 2.5 2.5 6.1 4.8 4.5 5.6 7.4 4.2 4.6 4.1 2.5 4.0 5.2 2.5 3.0 4.4 2.5 2.9 2.5 2.3 3.4 3.3 3.5 4.0 2.5 6.2 5.4 4.1 4.4 4.2 3.1 5.4 3.1 3.4 2.5 3.6 2.5 2.5 4.3 3.2 3.0 5.7 3.1 3.4 5.1 2.5 2.5 5.1 2.5 4.1 2.6 3.4 7.5 8.5 2.9 7.7 4.1 8.1 3.9 4.0 2.9 2.4 3.5 2.2 3.5 4.3 4.5 4.9 4.2 2.5 7.5 2.0 6.0 2.1 4.3 7.5 2.2 4.3 5.8 2.9 5.2 8.4 2.5 3.5 5.5 3.8 7.8 4.2 6.4 4.2 2.5 12.9 5.9 2.4 6.4 7.2 4.3 2.6 6.1 5.7 8.1 3.9 5.8 2.8 4.4 6.1 2.9 5.3 5.4 3.2 10.7 3.7 4.5 6.4 3.1 1.7 7.3 3.1 4.8 4.3 7.8 4.1 3.5 3.1 5.0 4.2 3.9 5.4 1.7 7.7 2.9 5.4 5.5 6.0 7.2 7.0 6.8 8.5 7.5 5.7 5.6 2.7 4.1 6.1 4.8 8.1 3.9 2.5 6.1 5.6 7.4 2.5 2.3 2.5 6.2 5.4 2.5 3.0 2.6 4.2 8.8 11.1 5.1 2.8 12.7 1.4 3.4 3.5 3.9 9.9 26.6 9.7 14.5 5.8 10.3 0.0 9.0 14.2 11.1 8.8 10.3 5.4 12.1 4.8 1.2 6.2 8.7 2.3 7.2 11.0 6.8 13.6 11.7 6.0 10.0 17.3 4.6 13.2 8.7 6.5 8.3 13.5 7.4 16.6 15.3 8.5 8.1 6.4 PCNA ENSG00000132646 "Proliferating cell nuclear antigen" P12004 20 5114953-5126626 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction" DNA-binding "Cancer-related genes, Deafness, Disease mutation, Dwarfism, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 115.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB000148, HPA030521, HPA030522, HPA030523" Enhanced Enhanced Nucleoplasm No Yes Nucleoplasm "CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199" "unprognostic (5.21e-2)" "prognostic favorable (1.86e-5)" "unprognostic (2.96e-2)" "unprognostic (2.43e-1)" "unprognostic (3.17e-1)" "unprognostic (5.60e-3)" "prognostic unfavorable (2.61e-4)" "unprognostic (1.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.89e-2)" "unprognostic (1.01e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (3.03e-6)" "unprognostic (2.12e-2)" "unprognostic (2.29e-1)" "unprognostic (7.11e-3)" "unprognostic (7.46e-2)" 13.9 21.4 11.1 31.8 15.8 87.2 13.7 17.2 14.6 13.7 23.1 15.6 13.7 18.9 15.7 13.7 36.0 12.7 17.5 13.6 11.6 9.8 21.7 14.9 17.8 41.6 18.8 10.8 14.4 14.3 14.0 13.9 24.0 14.3 10.8 26.1 18.7 17.7 15.6 11.0 16.5 20.5 12.8 16.1 24.5 15.7 40.5 17.4 115.8 18.1 40.7 38.7 17.3 17.2 16.9 16.0 8.7 11.6 19.6 24.4 16.9 74.2 58.5 59.3 25.5 14.1 13.2 41.6 48.9 28.8 46.1 65.6 45.6 59.4 75.5 15.9 17.4 40.4 55.8 35.0 58.9 42.3 22.4 38.7 53.0 22.5 106.2 6.0 72.5 23.8 9.6 14.0 39.2 9.3 9.7 26.3 50.4 47.2 63.8 44.9 26.8 138.7 80.3 44.4 58.0 32.4 76.6 52.2 60.9 20.8 43.4 51.0 34.6 34.3 53.0 33.6 22.8 37.4 37.0 17.5 33.3 38.3 46.8 55.8 32.4 92.5 127.9 15.0 69.1 42.6 2.4 11.6 8.7 19.2 10.9 23.8 16.9 24.4 19.3 16.0 13.6 22.4 20.1 3.8 19.6 11.4 14.7 23.3 16.9 11.1 15.8 17.2 14.6 11.6 9.8 18.8 10.8 14.3 17.4 41.7 27.0 42.4 43.7 60.1 36.0 11.2 17.8 34.8 43.3 55.8 25.5 92.8 51.4 37.7 137.5 25.2 25.5 46.7 34.8 161.2 34.6 21.0 20.9 24.7 83.0 30.2 19.1 35.6 27.3 83.6 33.4 41.7 35.4 67.7 35.2 57.6 24.8 21.0 37.8 36.6 74.2 51.8 33.9 133.4 89.3 43.4 55.5 43.6 63.4 25.0 PCNP ENSG00000081154 "PEST proteolytic signal containing nuclear protein" Q8WW12 3 101574095-101594437 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035011, HPA063861" Supported Enhanced "Nucleoplasm,Nuclear bodies" No No Nucleoplasm "Nuclear bodies" "HPA035011: AB_10601386, HPA063861: " "unprognostic (4.34e-2)" "unprognostic (9.65e-2)" "unprognostic (6.74e-2)" "unprognostic (2.08e-3)" "unprognostic (7.67e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.00e-5)" "unprognostic (1.91e-1)" "unprognostic (3.44e-3)" "unprognostic (1.21e-1)" "unprognostic (3.20e-2)" "unprognostic (4.99e-2)" "unprognostic (6.16e-2)" "unprognostic (2.20e-1)" "unprognostic (2.43e-1)" "unprognostic (8.32e-2)" "unprognostic (2.05e-1)" 27.9 30.4 40.0 25.8 48.5 30.7 34.0 48.6 40.2 33.8 32.2 25.0 25.0 24.1 34.1 34.4 30.5 28.3 25.5 35.6 35.1 36.9 32.0 29.7 29.0 32.2 41.1 35.7 45.9 25.2 34.6 32.9 30.7 39.8 36.9 28.6 26.8 25.4 32.8 37.2 24.1 22.8 48.6 32.3 24.3 24.8 17.8 38.0 25.1 38.7 22.4 34.6 40.1 44.3 19.8 15.8 31.0 22.1 23.6 22.9 25.6 39.0 21.5 30.6 24.4 28.8 41.5 34.4 27.0 36.0 27.6 31.3 25.7 21.5 41.5 20.0 28.8 27.4 21.2 41.0 34.3 58.1 30.0 23.3 44.6 26.7 30.7 21.5 40.9 21.7 24.4 33.7 23.3 31.2 39.3 38.1 18.4 41.6 24.4 33.9 16.5 35.1 34.6 49.6 31.9 34.6 20.6 28.8 31.5 36.5 23.1 41.2 32.5 25.1 24.7 36.0 36.3 22.6 31.1 24.4 25.4 35.3 13.2 28.5 18.5 28.6 50.9 25.4 43.7 31.3 31.0 15.1 24.7 15.6 17.7 20.3 19.8 20.5 18.9 15.8 16.0 21.1 19.4 13.7 23.6 22.1 12.5 22.9 25.6 40.0 48.5 48.6 40.2 35.1 36.9 41.1 35.7 39.8 38.0 56.6 85.6 123.1 198.8 206.6 88.0 104.4 40.8 76.3 75.1 61.1 37.3 103.3 225.5 110.5 19.7 119.3 36.9 93.5 83.2 165.8 133.0 159.9 99.4 48.4 81.1 92.2 78.6 69.3 77.9 9.6 121.1 124.6 237.8 140.7 62.5 68.0 98.5 63.1 126.6 113.9 66.7 129.4 228.9 90.0 72.4 208.4 197.3 140.2 67.4 167.6 PDCL3 VIAF1 ENSG00000115539 "Phosducin like 3" Q9H2J4 2 100562690-100576735 "Predicted intracellular proteins" "Angiogenesis, Apoptosis" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 154.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018469, HPA027094" Approved Enhanced Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA018469: AB_1855116, HPA027094: AB_10601387" "unprognostic (1.34e-1)" "unprognostic (8.30e-2)" "unprognostic (2.20e-1)" "unprognostic (3.32e-2)" "unprognostic (5.07e-3)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.07e-5)" "unprognostic (1.44e-1)" "unprognostic (5.46e-2)" "unprognostic (1.66e-2)" "unprognostic (2.18e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (7.94e-2)" "unprognostic (1.78e-1)" "unprognostic (8.22e-2)" "prognostic favorable (4.23e-4)" 12.9 15.9 14.7 16.4 16.2 12.0 18.0 10.7 16.5 12.7 18.8 14.3 15.3 10.5 20.1 23.5 22.5 14.9 13.1 17.6 14.6 15.8 20.9 12.2 13.5 14.0 24.4 15.9 15.4 10.4 10.8 11.4 17.1 17.4 19.6 17.9 10.2 12.0 15.4 35.7 22.0 12.1 49.6 18.3 14.5 13.3 14.0 14.5 13.4 13.0 18.8 19.6 29.9 16.8 26.5 33.4 22.2 43.6 25.6 31.4 23.3 12.8 18.0 19.0 16.4 6.1 8.6 21.1 16.0 9.9 29.0 18.1 22.6 8.0 20.7 24.4 18.7 39.1 10.8 23.4 15.4 23.0 33.3 20.2 21.9 9.7 26.4 16.2 23.1 23.4 9.5 28.3 25.6 16.4 7.6 17.8 16.6 18.1 14.1 21.5 21.9 23.1 35.5 24.8 13.8 26.5 22.6 20.3 14.5 17.7 29.8 17.8 15.7 12.6 17.2 17.6 16.0 13.5 16.0 13.9 18.2 19.4 14.1 22.0 8.5 15.8 21.8 11.3 27.0 14.3 18.6 19.3 22.2 19.4 34.9 22.1 26.5 29.7 21.5 33.4 20.8 31.0 23.8 2.1 25.6 43.6 18.4 31.4 23.3 14.7 16.2 10.7 16.5 14.6 15.8 24.4 15.9 17.4 14.5 17.9 28.0 24.3 30.3 58.3 10.6 33.9 20.4 22.7 33.0 14.0 5.9 56.6 51.4 45.5 25.5 21.8 14.2 0.0 33.9 42.2 26.3 23.8 88.1 14.7 52.5 11.1 19.0 15.4 12.4 11.4 13.6 57.2 33.7 154.1 22.6 13.5 29.8 17.5 31.5 63.2 11.2 51.8 50.5 5.2 45.8 50.3 43.8 40.8 28.7 30.1 PDS5A "KIAA0648, PIG54, SCC-112" ENSG00000121892 "PDS5 cohesin associated factor A" Q29RF7 4 39822863-39977956 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036661, HPA036662" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036661: AB_2675233, HPA036662: AB_10696783" "unprognostic (4.18e-2)" "unprognostic (1.42e-1)" "unprognostic (1.62e-3)" "unprognostic (6.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (9.97e-3)" "unprognostic (2.97e-1)" "unprognostic (6.67e-3)" "unprognostic (3.19e-2)" "unprognostic (2.59e-2)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (1.94e-1)" "unprognostic (1.99e-1)" "unprognostic (2.51e-1)" "unprognostic (3.81e-2)" 24.9 18.7 15.8 34.7 17.3 22.6 44.9 25.9 19.2 20.5 23.8 12.7 22.9 17.5 20.7 19.8 28.3 17.2 17.4 18.3 17.0 16.6 21.1 29.6 26.8 35.1 16.5 13.1 26.3 23.7 34.0 18.7 30.3 15.5 19.9 22.0 12.2 23.2 21.4 22.3 21.6 21.9 18.7 19.3 26.9 18.1 12.1 15.4 61.3 26.0 18.6 29.9 21.3 41.7 5.2 4.6 3.7 3.4 6.3 6.7 2.2 19.6 14.7 18.9 19.9 18.3 18.4 15.1 15.9 15.2 18.9 18.9 14.2 22.3 38.4 17.6 18.8 30.1 10.8 32.2 18.6 27.3 12.8 12.2 26.3 18.5 14.9 18.3 32.1 22.6 12.1 21.1 20.0 29.7 16.8 24.0 23.0 31.1 16.4 19.3 13.8 40.0 28.2 10.7 18.6 9.9 37.4 33.7 14.0 18.1 20.0 26.2 15.5 22.0 15.2 14.1 14.8 15.4 28.5 22.5 21.4 22.3 15.5 26.9 13.9 24.2 41.3 15.3 33.0 16.8 3.7 2.5 3.7 5.2 3.4 6.7 4.5 5.1 5.7 3.8 5.2 6.2 4.7 1.0 6.3 2.2 4.6 4.2 2.2 15.8 17.3 25.9 19.2 17.0 16.6 16.5 13.1 15.5 15.4 80.4 55.3 32.7 32.4 50.4 33.3 34.7 12.7 17.4 53.4 21.0 56.9 26.4 6.6 19.2 7.4 38.6 26.7 0.0 22.5 31.3 29.0 40.9 27.8 51.6 26.8 12.7 29.3 43.0 40.7 5.0 30.5 41.3 43.9 22.6 36.1 14.1 31.8 24.6 31.1 22.3 25.8 32.3 25.8 28.7 44.7 59.6 32.4 34.1 34.7 50.3 PDS5B "APRIN, AS3, CG008, FLJ23236, KIAA0979" ENSG00000083642 "PDS5 cohesin associated factor B" Q9NTI5 13 32586427-32778019 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039513, HPA040015" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039513: AB_10671999, HPA040015: AB_10671047" "unprognostic (3.52e-2)" "unprognostic (1.21e-1)" "unprognostic (4.25e-2)" "unprognostic (6.19e-2)" "unprognostic (2.00e-1)" "unprognostic (2.30e-1)" "unprognostic (8.98e-2)" "unprognostic (3.29e-1)" "unprognostic (4.17e-2)" "unprognostic (1.28e-2)" "unprognostic (3.96e-2)" "unprognostic (6.29e-2)" "unprognostic (5.47e-2)" "unprognostic (9.62e-3)" "unprognostic (2.60e-1)" "unprognostic (1.65e-1)" "unprognostic (3.91e-2)" 14.8 11.2 18.9 11.8 20.5 25.8 17.0 21.2 27.5 21.8 16.2 8.0 10.2 8.1 25.4 18.3 9.8 16.1 10.6 9.8 17.2 16.0 13.6 12.6 14.1 15.9 12.6 22.9 22.0 9.9 15.4 17.8 14.2 14.7 17.7 11.3 8.6 11.3 13.9 14.0 13.6 13.6 16.5 12.5 16.6 12.7 15.3 14.3 29.1 14.0 7.7 13.7 16.9 24.2 9.2 7.7 8.3 6.5 5.6 8.3 3.3 6.2 3.8 17.3 9.2 8.3 6.0 4.8 10.7 7.2 9.1 9.2 5.2 10.5 23.0 3.8 5.2 9.1 8.4 12.4 6.7 10.8 18.3 4.7 20.7 6.9 7.2 4.9 18.9 12.8 4.6 3.4 7.5 6.8 5.9 6.8 9.3 7.1 15.5 8.3 8.0 22.6 14.2 12.7 13.2 4.6 23.1 23.9 7.8 5.8 5.2 4.5 10.9 12.2 12.2 4.5 11.0 11.7 12.7 13.4 8.7 8.5 6.2 6.3 4.8 5.3 19.6 3.7 12.9 12.6 5.8 6.0 8.3 7.2 4.9 8.3 7.8 8.3 7.4 7.7 9.2 8.2 7.9 7.5 5.6 6.5 5.3 5.9 3.3 18.9 20.5 21.2 27.5 17.2 16.0 12.6 22.9 14.7 14.3 14.9 24.6 19.1 19.2 25.6 41.6 22.1 25.5 36.1 31.8 26.2 23.6 19.7 5.0 12.7 12.2 37.9 13.5 0.0 13.6 15.6 29.2 22.6 23.1 24.9 15.6 44.5 30.6 23.4 34.4 9.8 62.2 26.6 33.7 24.4 20.0 17.5 12.0 12.5 58.7 9.6 20.1 71.1 56.1 46.6 59.4 25.6 5.1 28.9 16.3 11.2 PDXK "C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79" ENSG00000160209 "Pyridoxal kinase" O00764 21 43719094-43762307 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 68.9" "Group enriched" "Detected in all" 7 "Early spermatids: 1421.5;Late spermatids: 3146.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030196, HPA030197, HPA030198, CAB033918" Enhanced Enhanced Nucleoplasm NA NA 870000 Nucleoplasm "CAB033918: AB_2162502, HPA030196: AB_10599735, HPA030197: AB_10601792, HPA030198: AB_10603570" "unprognostic (1.01e-1)" "unprognostic (1.99e-1)" "unprognostic (5.88e-2)" "unprognostic (1.87e-1)" "unprognostic (8.29e-2)" "unprognostic (4.31e-3)" "unprognostic (3.64e-3)" "unprognostic (1.32e-1)" "unprognostic (8.66e-2)" "unprognostic (9.34e-2)" "unprognostic (2.10e-1)" "unprognostic (3.54e-1)" "unprognostic (3.70e-2)" "unprognostic (1.31e-3)" "unprognostic (1.10e-1)" "unprognostic (4.78e-2)" "unprognostic (1.51e-3)" 28.1 13.2 37.4 8.7 36.6 13.3 13.3 21.9 38.5 9.7 13.8 11.0 15.7 16.7 9.0 13.2 11.0 12.9 8.8 11.4 26.1 30.4 22.8 17.4 20.4 9.5 24.1 22.7 16.4 17.6 25.7 20.7 12.6 20.3 10.6 11.8 7.8 18.3 13.9 5.8 14.3 22.1 8.8 10.1 7.8 15.2 68.9 10.7 3.9 13.6 7.0 11.0 9.7 8.6 2.7 2.5 1.3 7.7 1.9 3.3 2.4 17.4 21.4 3.4 6.5 8.4 11.9 4.2 6.3 9.9 6.1 5.2 17.4 27.3 5.9 6.7 9.0 8.5 13.2 6.6 17.9 4.1 6.6 5.7 6.0 23.4 12.8 16.5 5.6 8.7 16.8 17.2 6.4 7.2 10.0 2.9 2.6 10.4 13.6 5.8 11.8 0.8 10.1 9.3 17.0 8.2 6.7 2.0 16.3 26.6 21.4 3.3 3.9 26.1 24.2 9.3 1.5 8.0 7.9 5.1 4.5 8.8 6.0 5.8 8.3 3.9 3.4 18.4 16.2 4.3 1.3 4.8 0.2 1.7 4.4 3.3 1.4 1.7 1.9 2.5 2.7 2.0 1.4 1.3 1.9 7.7 1.2 1.5 2.4 37.4 36.6 21.9 38.5 26.1 30.4 24.1 22.7 20.3 10.7 74.5 71.3 17.5 132.2 25.2 41.8 39.3 25.5 21.4 31.8 96.0 21.6 37.3 152.5 146.7 1421.5 25.3 96.0 46.7 174.9 62.9 26.6 143.6 32.2 46.0 193.8 49.3 28.9 18.4 44.0 3146.3 46.3 89.3 40.5 27.1 42.8 10.9 164.5 30.9 50.9 69.5 40.4 6.5 25.8 332.6 27.9 24.8 103.8 22.4 42.8 203.8 PELP1 MNAR ENSG00000141456 "Proline, glutamate and leucine rich protein 1" Q8IZL8 17 4669774-4704337 "Predicted intracellular proteins" Transcription "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053966, HPA056028, HPA060760" Supported Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA053966: AB_2682325, HPA056028: AB_2683013, HPA060760: AB_2684355" "unprognostic (8.81e-2)" "unprognostic (1.22e-2)" "unprognostic (2.81e-3)" "unprognostic (2.24e-1)" "unprognostic (1.39e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (6.44e-4)" "unprognostic (2.72e-1)" "unprognostic (2.76e-1)" "unprognostic (4.31e-2)" "prognostic favorable (4.07e-5)" "unprognostic (2.20e-2)" "unprognostic (4.05e-2)" "unprognostic (1.31e-2)" "unprognostic (3.31e-1)" "unprognostic (8.32e-2)" "unprognostic (5.15e-2)" 14.0 12.3 19.8 13.8 22.0 10.5 10.9 22.9 28.0 12.6 11.8 25.5 8.4 12.9 14.3 9.8 17.4 17.3 11.4 18.2 19.9 18.8 9.6 10.6 11.2 17.2 20.2 18.6 21.0 18.9 18.2 17.0 12.4 18.3 13.8 8.6 13.8 16.5 14.7 38.2 17.2 11.6 12.2 18.7 13.6 12.4 21.3 18.1 17.0 14.5 12.3 13.3 11.2 10.6 3.8 3.5 5.8 3.4 3.8 4.5 1.9 15.9 35.0 13.9 21.9 10.8 8.0 31.2 11.6 8.1 16.1 17.3 34.1 11.8 38.5 17.9 9.1 11.4 24.6 25.8 18.1 9.2 19.9 36.8 17.1 17.6 27.5 14.0 13.8 23.1 9.8 11.3 19.8 16.7 8.3 11.9 20.8 20.6 16.9 8.8 21.9 26.0 16.3 22.8 15.5 11.8 27.5 12.3 18.9 11.2 12.1 14.0 18.7 19.9 14.7 14.9 13.9 17.7 9.4 12.0 12.5 17.7 18.9 22.3 9.1 15.6 16.0 14.1 14.3 16.0 0.9 2.4 5.8 3.1 3.1 3.1 2.6 3.0 2.4 2.4 3.8 3.3 4.5 1.4 3.8 3.4 3.5 2.0 1.9 19.8 22.0 22.9 28.0 19.9 18.8 20.2 18.6 18.3 18.1 20.8 29.6 16.3 12.9 13.2 23.9 19.8 5.1 20.1 19.4 8.7 15.7 24.8 1.7 13.2 47.9 13.2 6.2 0.0 12.6 23.5 14.1 12.3 29.0 9.0 14.7 33.4 12.1 4.9 4.5 17.5 8.6 13.8 10.1 107.4 16.1 12.5 11.1 12.4 18.0 4.1 16.6 6.5 9.9 21.4 71.6 14.3 17.7 13.1 18.8 10.6 PES1 "NOP7, PES" ENSG00000100029 "Pescadillo ribosomal biogenesis factor 1" O00541 22 30576625-30607083 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040210, HPA062439, HPA066670" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes Yes "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700" "unprognostic (1.82e-1)" "unprognostic (5.88e-2)" "unprognostic (5.59e-3)" "unprognostic (4.83e-2)" "unprognostic (1.48e-1)" "unprognostic (3.23e-3)" "prognostic unfavorable (1.84e-9)" "unprognostic (3.29e-2)" "unprognostic (3.40e-1)" "unprognostic (1.73e-1)" "unprognostic (4.79e-2)" "unprognostic (2.46e-2)" "unprognostic (5.65e-2)" "unprognostic (1.27e-3)" "unprognostic (1.65e-1)" "unprognostic (4.56e-2)" "unprognostic (1.42e-1)" 24.4 28.1 26.0 26.1 30.1 28.2 29.6 19.0 31.8 19.7 21.9 27.2 18.1 20.4 28.0 21.3 31.2 28.0 22.7 18.1 26.3 18.5 24.2 34.9 19.8 30.0 27.2 26.6 30.5 49.0 31.3 17.0 20.2 23.6 24.2 19.2 18.6 22.2 22.1 34.1 32.3 19.8 22.9 24.3 26.4 25.2 34.5 27.2 21.2 25.3 23.1 24.9 21.8 22.6 14.4 17.8 3.9 19.4 12.4 16.2 16.3 34.3 39.2 14.5 30.8 16.7 16.4 22.3 22.9 18.8 39.1 30.5 45.4 14.8 46.6 20.5 26.0 30.2 24.0 44.5 40.8 28.8 19.9 42.8 22.6 22.5 39.1 41.7 54.5 23.8 23.1 25.7 40.6 40.9 18.7 25.1 16.7 37.2 19.0 23.6 43.3 26.4 55.3 28.1 33.8 28.8 33.8 25.3 45.6 21.4 23.8 25.1 26.0 22.6 25.8 30.3 12.1 18.1 28.0 19.8 45.9 34.8 23.3 38.2 24.2 20.7 47.6 32.2 25.1 29.3 3.9 15.8 3.9 13.3 19.4 16.2 14.4 12.4 12.7 17.8 13.8 14.2 12.7 0.6 12.4 13.9 15.4 9.5 16.3 26.0 30.1 19.0 31.8 26.3 18.5 27.2 26.6 23.6 27.2 3.0 17.6 13.7 18.1 20.0 6.4 3.4 25.5 26.8 19.4 24.4 7.9 30.6 21.6 36.3 38.4 21.1 24.6 0.0 38.0 33.3 14.9 13.1 17.4 20.7 33.9 3.2 22.5 28.8 29.7 10.4 18.4 20.8 20.3 31.5 19.9 13.1 33.1 14.0 19.1 39.6 8.1 19.4 18.4 23.5 19.3 19.9 23.8 15.0 24.7 12.2 PFKFB2 ENSG00000123836 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2" O60825 1 207034366-207081024 "Enzymes, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 70.2;Late spermatids: 128.8;Rod photoreceptor cells: 111.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "eosinophil: 13.9;plasmacytoid DC: 16.7" "Group enriched" "Detected in many" 8 "dendritic cells: 16.7;granulocytes: 13.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049975, HPA063575" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049975: AB_2680977, HPA063575: AB_2685046" "unprognostic (1.30e-1)" "unprognostic (6.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.75e-2)" "unprognostic (2.27e-1)" "unprognostic (3.76e-2)" "unprognostic (9.96e-3)" "unprognostic (9.74e-2)" "unprognostic (7.27e-2)" "unprognostic (2.27e-2)" "unprognostic (6.01e-2)" "unprognostic (1.30e-1)" "prognostic favorable (3.23e-7)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.63e-4)" "unprognostic (1.86e-2)" 3.3 6.1 9.8 5.8 16.6 15.7 5.1 2.1 14.6 7.3 16.0 19.5 5.3 23.2 4.0 9.1 7.7 4.5 9.1 22.8 14.1 7.7 22.0 3.6 10.9 5.3 13.4 15.1 4.3 11.9 6.2 27.5 3.0 25.3 3.9 18.1 22.4 6.3 3.5 34.9 6.4 18.7 4.0 17.4 12.5 10.7 6.1 15.1 6.5 38.4 8.8 5.0 3.4 3.6 1.6 16.7 13.9 1.9 1.1 0.4 0.4 9.7 4.3 2.8 4.9 5.9 2.9 4.7 1.4 1.7 2.4 1.3 10.5 14.1 1.7 2.2 2.2 7.4 13.9 2.1 5.2 1.4 0.3 2.1 13.8 10.8 3.9 4.9 0.0 9.7 4.1 8.0 2.3 13.2 2.9 0.5 5.8 9.4 0.1 1.3 2.9 2.3 0.4 3.9 4.7 6.5 0.0 0.0 0.2 3.3 10.1 4.5 2.7 9.1 15.4 11.4 3.2 10.6 1.1 0.2 0.0 5.3 7.5 1.3 4.5 4.4 0.9 6.1 0.0 2.6 1.0 0.9 13.9 0.2 1.9 0.3 1.3 0.1 0.3 0.8 1.6 0.3 0.4 2.6 1.1 1.3 16.7 0.0 0.4 9.8 16.6 2.1 14.6 14.1 7.7 13.4 15.1 25.3 15.1 6.0 42.0 4.5 3.4 13.5 7.3 70.2 5.1 14.7 5.7 15.7 0.0 0.5 21.6 4.0 47.4 2.7 43.0 0.0 6.7 0.4 2.5 6.5 9.2 4.9 4.9 3.2 5.8 1.3 11.3 128.8 2.6 6.0 20.3 1.8 18.9 8.1 10.5 27.7 2.8 30.6 111.9 0.0 3.2 3.1 3.3 10.2 1.3 1.0 27.6 11.2 PFKFB3 ENSG00000170525 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3" Q16875 10 6144934-6254644 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 105.6;skeletal muscle: 135.7" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 184.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 20.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 72.7;RPTEC TERT1: 45.9;T-47d: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008266, CAB020795, HPA043889" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717" "unprognostic (1.61e-1)" "unprognostic (5.08e-3)" "unprognostic (2.89e-2)" "unprognostic (6.18e-2)" "unprognostic (2.29e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (1.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.04e-1)" "unprognostic (3.30e-2)" "unprognostic (7.34e-2)" "prognostic unfavorable (1.87e-7)" "unprognostic (1.89e-2)" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.74e-1)" 105.6 9.0 16.4 25.7 17.9 77.0 43.4 8.5 29.4 6.6 8.8 29.1 10.6 7.4 9.4 6.3 13.0 14.4 22.4 5.7 16.6 13.2 22.1 11.2 15.1 12.1 19.2 12.9 8.0 8.1 4.0 10.2 7.5 20.7 5.4 3.8 19.3 9.1 20.0 135.7 11.8 6.9 6.5 36.0 12.4 6.7 4.6 16.8 3.3 2.9 4.7 10.3 10.3 10.1 1.5 3.6 20.5 7.1 0.8 4.7 2.9 5.2 72.7 5.8 4.7 21.9 2.7 3.0 7.7 5.5 5.8 9.0 3.4 19.3 9.0 5.1 3.3 4.5 17.0 6.2 12.3 6.7 10.7 4.3 5.3 3.7 1.2 1.8 5.1 8.1 1.9 4.1 9.9 2.4 14.8 11.1 6.3 3.9 3.4 4.6 8.6 3.6 4.8 5.6 7.5 5.1 8.2 2.8 3.5 45.9 2.7 5.5 2.2 5.6 6.2 11.0 10.4 47.8 6.1 14.0 6.1 5.6 0.7 9.3 7.0 2.4 8.1 16.7 6.0 9.2 2.2 5.6 5.5 1.8 7.1 4.7 1.5 3.4 2.3 3.6 1.4 2.5 2.4 20.5 0.8 4.1 2.2 3.2 2.9 16.4 17.9 8.5 16.9 16.6 13.2 19.2 12.9 20.7 16.8 71.5 75.9 13.7 14.3 91.1 7.8 17.3 15.3 13.4 42.1 184.9 49.1 0.2 0.0 42.7 5.1 29.2 7.4 0.0 22.5 4.6 29.8 4.3 41.7 11.6 19.4 6.4 8.2 9.2 79.2 6.1 2.6 37.7 43.9 23.4 5.2 0.4 46.2 5.8 6.7 2.4 1.6 0.0 21.1 0.7 1.6 55.8 0.8 21.3 5.4 9.9 PGAM2 PGAM-M ENSG00000164708 "Phosphoglycerate mutase 2" P15259 7 44062727-44065587 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0" "Group enriched" "Detected in many" 13 "Early spermatids: 421.0;Late spermatids: 1332.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 39.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA043801, HPA050314, HPA060173" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA 60000000 Nucleoplasm "Nucleoli, Cytosol" "HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215" 1.4 0.8 2.0 0.4 2.2 0.4 0.5 6.9 2.1 0.5 0.5 3.6 0.0 0.6 0.5 9.1 6.1 0.6 0.7 111.6 2.1 3.2 0.8 0.4 0.4 0.4 4.2 1.6 0.5 0.6 0.6 1.3 0.4 2.0 1.9 0.4 2.3 7.6 0.5 379.1 0.4 0.4 0.4 3.2 0.5 0.5 16.7 1.1 4.8 1.5 119.0 4.8 0.4 0.0 0.3 1.3 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 4.3 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 1.3 1.7 0.2 2.0 2.2 6.9 2.1 2.1 3.2 4.2 1.6 2.0 1.1 0.0 0.0 0.5 0.2 1.0 4.3 0.0 0.0 0.0 0.0 0.0 9.8 0.0 68.0 0.0 421.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 22.0 0.0 0.3 1332.7 7.2 0.4 1.7 0.0 0.0 3.8 0.2 0.2 5.6 1.9 4.2 25.8 3.1 30.5 5.6 0.5 0.0 0.0 0.2 0.4 PHACTR3 "C20orf101, PPP1R123" ENSG00000087495 "Phosphatase and actin regulator 3" Q96KR7 20 59577509-59847711 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 56.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 11.9;Bipolar cells: 9.8;Cardiomyocytes: 7.3;Cholangiocytes: 10.2;Club cells: 6.8" "Group enriched" "Detected in some" 5 "glioma: 3.8;lung cancer: 1.6;pancreatic cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 2.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "THP-1: 53.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051834, HPA054847" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051834: AB_2681629, HPA054847: " "unprognostic (7.14e-2)" "unprognostic (1.22e-1)" "unprognostic (3.72e-2)" "unprognostic (1.43e-7)" "unprognostic (1.99e-1)" "unprognostic (2.87e-2)" "unprognostic (5.83e-3)" "unprognostic (8.92e-2)" "unprognostic (5.02e-2)" "unprognostic (2.30e-2)" "unprognostic (7.71e-2)" "unprognostic (7.22e-2)" "unprognostic (1.74e-2)" "unprognostic (1.66e-1)" "unprognostic (5.43e-2)" "unprognostic (2.53e-3)" "unprognostic (1.32e-1)" 1.6 2.7 31.3 1.8 29.2 2.0 1.4 15.9 56.1 1.5 1.9 20.0 0.0 2.1 1.3 2.0 2.8 1.4 3.3 3.0 27.3 14.6 2.0 2.1 5.3 1.4 28.3 19.4 6.9 1.5 1.4 0.5 1.9 21.3 1.4 1.8 0.0 1.3 1.3 1.4 2.6 2.1 1.5 25.4 8.0 1.8 1.8 29.8 0.0 1.4 0.0 1.4 1.6 0.0 0.0 2.5 0.1 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.8 0.0 0.0 0.0 10.4 0.0 0.7 2.7 0.0 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 31.3 29.2 15.9 34.1 27.3 14.6 28.3 19.4 21.3 29.8 11.9 0.3 0.0 1.0 0.6 9.8 7.3 10.2 1.4 6.8 3.5 0.0 0.0 1.7 0.1 0.9 0.1 0.0 0.0 0.0 0.0 1.1 1.9 0.0 0.0 0.2 4.8 1.2 4.3 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.8 1.8 0.0 0.0 0.0 1.6 0.0 0.7 0.0 0.7 0.4 0.0 0.0 0.8 3.0 PHAX "FLJ13193, RNUXA" ENSG00000164902 "Phosphorylated adaptor for RNA export" Q9H814 5 126600268-126627252 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059630, HPA070326" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059630: AB_2684088, HPA070326: AB_2686253" "unprognostic (1.06e-3)" "unprognostic (4.77e-2)" "unprognostic (1.35e-2)" "unprognostic (2.64e-2)" "unprognostic (6.11e-2)" "unprognostic (1.22e-1)" "unprognostic (4.59e-3)" "unprognostic (9.20e-2)" "unprognostic (1.41e-1)" "unprognostic (1.43e-2)" "unprognostic (2.07e-1)" "unprognostic (2.29e-1)" "unprognostic (4.91e-3)" "unprognostic (7.21e-2)" "unprognostic (1.32e-1)" "unprognostic (2.13e-2)" "unprognostic (3.07e-2)" 3.9 4.9 7.9 3.2 7.6 1.5 4.2 8.9 8.2 3.7 3.2 2.1 4.9 3.9 4.8 4.2 3.6 5.0 7.2 6.5 3.8 4.0 3.1 5.2 6.9 6.6 3.5 4.6 3.0 3.5 4.5 3.0 3.5 3.2 5.7 5.7 2.3 4.3 6.6 3.2 2.9 2.5 4.6 5.3 3.8 3.0 10.4 8.2 8.8 7.2 13.1 11.2 6.6 9.6 9.7 8.6 16.9 12.6 12.5 12.3 13.8 10.2 11.3 10.7 13.7 9.8 9.7 12.6 17.5 13.9 7.9 12.2 18.9 16.6 15.8 13.3 8.1 11.4 5.5 7.5 6.6 9.0 12.3 10.6 11.2 10.1 10.6 9.6 5.5 6.5 11.4 17.3 8.3 9.3 8.4 11.0 6.5 8.1 7.6 12.2 8.0 10.5 11.4 11.5 13.1 12.2 10.9 14.1 8.8 14.3 9.4 15.0 19.2 10.8 10.6 20.8 8.9 8.4 11.0 13.7 11.2 13.8 8.8 6.3 8.1 9.6 7.2 10.9 10.4 9.5 9.9 6.2 9.5 10.8 11.2 5.3 13.1 7.2 8.2 8.0 6.6 23.8 31.5 43.5 29.2 25.3 57.1 47.0 15.3 76.3 38.7 33.2 37.3 44.7 63.0 45.9 31.1 34.6 15.3 0.0 29.2 41.6 31.9 25.6 45.1 25.4 26.2 71.5 26.4 21.5 16.8 8.7 38.9 26.7 20.3 55.1 22.5 88.5 34.5 22.8 38.9 39.8 65.9 45.3 24.7 51.1 80.1 22.6 43.0 27.7 23.4 25.1 PHF12 "KIAA1523, PF1" ENSG00000109118 "PHD finger protein 12" Q96QT6 17 28905250-28951771 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 25.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 25.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021410, HPA021452" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021410: AB_1855287, HPA021452: AB_2670708" "unprognostic (9.50e-2)" "unprognostic (2.67e-1)" "unprognostic (2.11e-2)" "unprognostic (1.21e-2)" "unprognostic (2.81e-1)" "unprognostic (1.46e-2)" "unprognostic (1.69e-2)" "unprognostic (3.10e-2)" "unprognostic (8.73e-2)" "unprognostic (5.38e-2)" "unprognostic (1.02e-3)" "unprognostic (6.71e-2)" "prognostic unfavorable (1.24e-5)" "unprognostic (2.16e-2)" "unprognostic (3.11e-1)" "unprognostic (3.24e-1)" "unprognostic (1.08e-3)" 14.0 12.0 16.7 16.5 17.9 38.4 15.6 30.7 18.4 17.1 17.4 18.5 25.4 13.2 21.0 16.4 11.4 18.1 16.1 11.3 13.0 10.5 14.2 14.8 17.2 17.7 18.6 15.2 20.7 20.3 18.6 18.7 12.2 14.0 23.4 12.9 18.9 16.6 24.5 15.6 16.5 18.0 16.2 10.2 25.2 15.4 17.5 18.2 22.1 18.9 7.3 18.0 19.2 16.6 4.5 4.9 25.6 2.7 3.5 4.3 1.5 10.2 16.4 22.5 13.5 13.7 9.8 10.6 10.1 14.9 15.5 14.9 10.9 9.6 11.4 12.6 11.6 12.7 10.6 14.4 8.5 15.1 18.9 15.6 12.0 18.2 8.6 12.4 12.9 15.0 10.8 9.3 14.2 13.1 14.6 11.1 14.9 10.2 11.9 9.7 10.5 24.6 17.5 13.1 22.0 7.3 24.2 18.5 11.3 10.3 12.6 15.3 13.2 15.1 24.1 12.1 12.3 13.1 18.3 6.7 12.9 11.9 12.4 12.0 14.8 13.1 13.4 9.9 10.1 13.2 9.6 2.7 3.9 3.9 2.2 3.9 2.7 3.1 4.3 1.5 4.5 3.0 3.3 25.6 3.5 2.4 4.9 1.7 1.5 16.7 17.9 30.7 18.4 13.0 10.5 18.6 15.2 14.0 18.2 14.9 7.5 13.3 7.2 13.6 20.8 5.9 7.6 4.0 13.6 3.5 13.7 6.2 1.7 7.6 7.2 14.3 7.8 0.0 9.1 6.3 8.7 17.0 13.9 9.6 8.0 23.8 10.3 16.0 11.3 4.1 15.8 11.6 11.8 17.2 15.4 12.3 8.3 7.0 15.6 3.8 21.0 25.8 11.8 14.4 11.1 14.3 5.0 17.5 9.8 11.9 PHF20 "C20orf104, dJ1121G12.1, TDRD20A" ENSG00000025293 "PHD finger protein 20" Q9BVI0 20 35771974-35950381 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 349.5;Late spermatids: 510.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029619, HPA029620, HPA029621" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201" "unprognostic (1.21e-3)" "unprognostic (7.30e-2)" "unprognostic (3.20e-2)" "unprognostic (2.35e-3)" "unprognostic (1.36e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (2.76e-1)" "unprognostic (2.17e-1)" "unprognostic (2.64e-2)" "unprognostic (4.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.92e-2)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (7.23e-2)" "unprognostic (1.01e-2)" 19.1 11.6 14.0 16.8 19.0 14.1 17.2 25.1 19.2 15.9 15.9 16.1 8.1 8.1 19.1 11.6 16.5 14.2 14.8 15.2 14.1 13.8 11.2 11.1 16.5 17.3 14.9 13.0 18.9 9.4 17.9 20.0 15.6 15.0 14.7 11.7 14.7 15.3 15.7 46.6 12.9 12.3 17.2 18.9 20.8 12.7 17.4 15.2 19.4 14.2 14.5 20.8 18.7 21.8 12.0 8.2 23.6 11.9 13.0 12.4 6.5 9.7 7.8 13.7 20.3 10.0 11.5 12.8 11.2 10.7 11.3 9.9 22.8 7.4 16.4 10.2 14.9 13.9 6.1 12.6 15.6 13.8 7.4 5.4 30.5 15.0 8.4 10.0 14.6 11.9 9.0 22.0 11.9 18.4 13.4 12.3 11.7 12.5 10.6 12.9 5.8 14.7 8.5 6.8 6.5 9.8 10.8 20.3 9.7 9.0 6.8 12.5 10.2 20.0 23.2 10.2 13.0 18.3 10.9 17.2 25.1 5.7 13.0 11.4 9.8 11.6 12.0 18.5 10.7 12.8 11.9 8.6 23.6 10.6 9.0 11.3 12.0 10.5 11.9 8.2 9.8 12.0 12.4 20.5 13.0 11.9 7.7 5.5 6.5 14.0 19.0 25.1 19.0 14.1 13.8 14.9 13.0 15.0 15.2 35.7 39.9 77.0 65.2 30.9 75.5 47.0 30.6 57.6 40.9 36.6 92.3 85.9 31.5 25.8 349.5 40.9 11.8 0.0 17.4 39.0 36.8 47.3 136.5 15.3 46.9 108.1 34.5 39.3 53.1 510.4 33.1 60.9 37.1 31.5 24.9 44.2 20.8 25.7 50.2 19.5 75.2 19.4 39.6 55.4 46.4 24.7 18.7 82.0 29.0 53.3 PHF23 "FLJ16355, MGC2941" ENSG00000040633 "PHD finger protein 23" Q9BUL5 17 7235028-7239722 "Disease related genes, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052410 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052410: AB_2681822" "unprognostic (1.76e-2)" "unprognostic (6.12e-2)" "unprognostic (4.72e-2)" "unprognostic (6.44e-3)" "unprognostic (1.50e-1)" "unprognostic (2.96e-2)" "unprognostic (2.41e-3)" "unprognostic (2.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.19e-1)" "unprognostic (2.67e-3)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "unprognostic (4.40e-1)" "unprognostic (1.61e-1)" "unprognostic (3.48e-2)" 13.5 29.9 16.8 17.6 20.6 6.4 14.6 13.9 18.1 16.7 28.2 15.5 22.2 16.8 18.4 18.3 24.9 15.6 19.5 17.1 18.1 15.1 26.6 30.7 13.4 20.2 19.7 11.2 22.0 15.4 14.8 15.7 21.3 11.6 18.7 13.2 13.4 14.3 18.3 15.1 13.2 21.7 17.2 11.1 21.3 14.2 16.6 16.3 36.1 18.4 15.7 24.7 19.8 15.8 14.1 15.5 17.0 7.8 9.0 17.6 7.2 18.3 28.9 33.1 21.5 21.5 22.0 12.9 25.0 27.5 30.6 26.0 15.9 13.0 27.1 15.6 26.6 21.6 17.9 30.9 20.5 25.3 27.2 25.1 20.3 19.7 17.4 34.7 9.7 32.3 30.0 19.8 26.4 17.8 32.1 28.8 13.2 22.3 6.6 35.4 13.8 16.7 19.8 31.3 13.3 12.7 23.0 16.1 13.1 32.3 10.2 10.9 34.8 17.8 14.7 28.1 20.7 17.7 11.8 26.4 27.0 19.0 15.9 30.9 12.4 12.7 13.8 24.2 16.0 23.1 17.0 7.7 13.5 15.9 6.0 13.8 12.1 12.2 17.6 8.6 14.1 10.3 12.7 14.9 9.0 7.8 15.5 10.0 7.2 16.8 20.6 13.9 18.1 18.1 15.1 19.7 11.2 11.6 16.3 6.0 8.6 11.8 18.1 74.8 11.8 13.7 15.3 6.7 9.1 21.0 5.9 27.6 33.2 33.9 15.8 25.1 18.0 0.0 18.6 18.0 27.7 20.4 17.3 11.9 31.6 15.9 17.9 17.8 17.0 16.2 23.0 18.9 32.1 40.5 16.6 15.1 31.0 25.9 16.3 22.4 8.4 38.8 40.1 27.7 18.5 72.8 64.2 15.2 15.5 25.0 PHF5A "bK223H9.2, INI, MGC1346, Rds3, SAP14b, SF3b14b, SF3B7" ENSG00000100410 "PHD finger protein 5A" Q7RTV0 22 41459717-41468725 "Predicted intracellular proteins, Transcription factors" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028885 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA028885: AB_10602079" "unprognostic (4.38e-2)" "unprognostic (3.58e-1)" "unprognostic (2.12e-3)" "unprognostic (2.64e-2)" "unprognostic (1.07e-1)" "unprognostic (2.10e-2)" "prognostic unfavorable (3.02e-8)" "unprognostic (3.39e-3)" "unprognostic (3.97e-3)" "unprognostic (4.46e-2)" "unprognostic (6.95e-3)" "unprognostic (2.12e-1)" "unprognostic (5.25e-3)" "unprognostic (4.11e-2)" "unprognostic (1.75e-1)" "unprognostic (1.67e-1)" "unprognostic (6.91e-2)" 24.5 20.8 21.4 21.4 24.9 47.6 27.8 21.3 27.3 20.7 24.0 27.6 18.2 22.0 24.4 26.8 28.8 22.2 21.9 18.3 22.0 20.8 26.1 28.9 20.0 30.9 32.4 23.8 21.9 25.9 18.1 24.5 29.7 23.0 20.1 29.0 21.5 22.4 20.0 32.4 25.3 26.9 22.3 29.5 27.1 24.8 27.3 28.8 38.0 23.4 30.4 38.4 21.3 22.8 33.8 34.2 39.5 33.5 30.4 35.0 40.0 21.8 15.9 27.2 17.9 20.1 15.3 18.9 22.5 18.3 29.4 24.9 21.6 13.1 31.7 13.1 16.6 20.7 17.0 36.8 26.6 33.4 19.5 38.3 19.7 24.0 25.0 21.0 51.5 15.7 14.6 20.8 23.2 29.0 12.3 20.7 22.8 26.2 20.4 21.1 29.3 41.6 34.3 27.2 60.8 23.4 31.6 24.2 22.2 19.4 17.4 13.4 11.3 24.6 16.3 24.2 20.0 13.1 26.8 14.1 15.8 27.5 12.5 26.9 16.9 29.6 53.3 15.1 22.6 16.6 21.4 33.5 38.9 27.0 30.8 35.0 33.8 31.2 33.6 34.2 30.4 30.9 30.1 39.5 30.4 28.4 28.8 32.5 40.0 21.4 24.9 21.3 27.3 22.0 20.8 32.4 23.8 23.0 28.8 20.8 11.5 67.5 63.0 68.6 23.0 9.7 35.7 20.1 7.9 10.4 3.9 79.5 39.7 49.1 6.3 40.0 29.3 46.7 48.8 96.5 39.8 40.0 33.4 19.2 51.8 12.7 14.5 31.9 30.2 8.9 39.1 48.0 32.1 76.7 29.2 30.1 53.9 31.6 39.3 31.5 20.3 97.0 45.3 54.3 80.0 80.0 91.3 58.6 39.3 89.1 PHOX2B "NBPhox, Phox2b, PMX2B" ENSG00000109132 "Paired like homeobox 2b" Q99453 4 41744082-41748970 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 14.5;brain: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 99 "pons and medulla: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 91 "SH-SY5Y: 53.6" "Region enriched" "Detected in single" 17 "pons and medulla: 5.9" "Region enriched" "Detected in single" 27 "pons and medulla: 2.0" "HPA074325, HPA074941" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA074325: AB_2686678, HPA074941: AB_2732272" "unprognostic (1.01e-1)" "unprognostic (2.47e-1)" "unprognostic (5.27e-2)" 0.0 14.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 24.8 0.2 1.4 0.8 0.0 0.0 0.0 0.0 3.2 0.5 0.4 0.0 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 53.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIMREG "CATS, FAM64A, FLJ10156, FLJ10491, RCS1" ENSG00000129195 "PICALM interacting mitotic regulator" Q9BSJ6 17 6444415-6451469 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 27.3" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 50.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA043783, HPA049934" Uncertain Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA043783: AB_2678669, HPA049934: AB_2680959" "unprognostic (5.32e-3)" "unprognostic (1.14e-2)" "unprognostic (2.33e-1)" "unprognostic (4.37e-3)" "unprognostic (1.46e-1)" "unprognostic (1.24e-2)" "unprognostic (6.55e-3)" "unprognostic (1.23e-3)" "unprognostic (1.80e-1)" "unprognostic (5.88e-2)" "unprognostic (1.47e-3)" "unprognostic (1.50e-2)" "unprognostic (0.00e+0)" "unprognostic (8.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 1.9 4.5 1.2 1.6 1.1 3.1 2.2 1.0 0.8 1.3 4.7 0.6 0.4 4.3 1.6 1.7 6.0 0.3 2.5 1.6 0.5 0.5 0.8 0.9 2.1 1.7 0.6 0.4 1.6 0.4 0.0 1.0 0.9 1.2 0.8 6.2 0.4 1.3 0.4 0.4 3.7 4.5 2.7 1.0 9.5 1.8 1.0 0.4 27.3 0.4 3.9 3.6 2.3 2.0 0.4 0.0 0.8 0.4 3.3 1.5 1.2 12.6 17.1 50.8 22.8 0.4 1.5 3.9 14.9 9.2 24.5 16.6 10.1 5.5 0.0 6.0 12.1 12.1 9.3 25.6 6.6 13.2 19.5 10.2 0.0 10.2 12.2 0.0 0.5 15.5 0.8 0.4 10.1 3.9 2.3 7.7 11.3 3.0 7.2 15.3 9.1 2.7 0.1 22.2 10.2 11.2 22.7 20.4 8.9 4.0 1.9 11.6 16.3 12.9 13.4 12.6 6.4 6.2 1.2 3.6 19.2 15.6 11.3 24.3 2.6 9.2 0.0 7.5 6.2 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.3 0.0 0.4 0.2 0.7 0.8 3.3 0.4 0.0 1.3 1.2 1.2 1.1 1.0 0.7 0.5 0.5 0.6 0.4 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PIN1 dod ENSG00000127445 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 1" Q13526 19 9835257-9849682 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 88.2" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 571.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004528, CAB009326, HPA068650, HPA070887" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 30000 Nucleoplasm Cytosol "CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: AB_2686014, HPA070887: " "unprognostic (2.54e-1)" "unprognostic (6.14e-3)" "unprognostic (6.50e-2)" "unprognostic (4.36e-2)" "unprognostic (1.71e-2)" "unprognostic (6.50e-3)" "unprognostic (1.90e-1)" "unprognostic (2.86e-2)" "unprognostic (2.67e-1)" "unprognostic (7.23e-3)" "prognostic favorable (3.25e-4)" "unprognostic (9.43e-2)" "prognostic favorable (7.80e-5)" "unprognostic (2.20e-2)" "unprognostic (2.56e-1)" "unprognostic (3.13e-2)" "unprognostic (1.21e-2)" 24.5 36.3 40.0 18.7 38.8 25.6 9.3 27.4 66.0 9.2 15.8 18.1 8.5 22.9 14.0 8.3 11.3 16.4 10.1 25.9 38.0 35.2 17.4 14.5 13.2 14.8 38.7 37.2 13.9 21.1 9.5 13.6 13.3 57.3 23.2 6.5 14.1 21.3 15.7 50.2 10.2 21.7 11.1 19.6 15.4 19.6 24.8 15.0 19.7 9.9 8.1 9.3 11.1 9.7 36.4 72.8 88.2 44.9 40.7 53.8 46.2 26.2 24.1 18.0 16.7 6.3 5.6 10.6 19.7 8.5 14.7 14.2 22.3 8.4 16.3 31.4 7.3 15.3 13.5 12.4 11.9 4.7 34.7 52.6 42.4 29.6 19.2 10.3 19.7 24.9 7.7 8.0 9.5 4.5 11.0 11.9 29.3 19.1 24.8 8.8 18.4 29.9 77.2 17.2 11.0 37.1 27.4 18.7 27.3 10.5 12.9 22.7 26.7 19.0 9.5 22.0 7.7 12.2 23.7 20.1 20.4 16.3 31.5 31.5 32.1 30.1 21.9 21.7 25.3 25.0 52.2 43.4 88.2 42.0 44.9 39.2 35.6 41.5 42.1 39.7 36.4 33.1 37.2 26.8 40.7 41.7 72.8 53.8 46.2 40.0 38.8 27.4 66.0 38.0 35.2 38.7 37.2 57.3 15.0 26.8 21.5 49.1 53.7 42.8 68.5 65.3 43.3 56.2 14.8 59.3 11.8 107.3 139.3 95.7 197.0 54.9 69.5 46.7 95.4 80.4 81.4 55.2 63.4 41.4 123.0 57.2 95.8 47.3 50.0 571.0 83.4 67.4 118.1 174.1 57.9 60.8 85.6 73.7 122.0 109.4 50.6 64.7 97.1 136.8 72.0 57.6 46.0 94.4 62.6 47.8 PITX2 "ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS" ENSG00000164093 "Paired like homeodomain 2" Q99697 4 110617423-110642123 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 30.4;retina: 53.5;skeletal muscle: 28.8" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 12.7;Cytotrophoblasts: 5.5;Enterocytes: 6.5;Extravillous trophoblasts: 5.4;Hofbauer cells: 6.6;Spermatogonia: 5.6;Syncytiotrophoblasts: 8.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 16 "hypothalamus: 2.1;midbrain: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 18.1;HEK 293: 8.0;LHCN-M2: 18.6;RH-30: 15.7" "Region enhanced" "Detected in single" "hypothalamus: 9.8" "Region enhanced" "Detected in single" "hypothalamus: 5.1" "HPA050074, HPA062728" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA050074: AB_2681005, HPA062728: AB_2684851" "unprognostic (1.08e-1)" "unprognostic (1.23e-2)" "unprognostic (9.29e-2)" "unprognostic (9.24e-2)" "unprognostic (1.68e-1)" "unprognostic (1.14e-2)" "unprognostic (9.61e-4)" "unprognostic (3.22e-2)" "unprognostic (1.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.16e-1)" "unprognostic (2.77e-1)" "unprognostic (1.11e-15)" "unprognostic (6.97e-3)" "unprognostic (1.43e-1)" "unprognostic (5.98e-2)" "unprognostic (9.91e-2)" 0.6 0.1 0.0 18.6 0.0 0.1 0.3 0.0 0.1 1.1 3.0 0.0 0.3 0.1 0.1 1.3 2.7 0.2 1.1 3.5 0.0 2.1 0.3 0.1 0.1 0.1 1.1 0.0 0.1 0.5 0.1 12.5 30.4 0.0 8.3 0.3 53.5 9.3 0.2 28.8 0.9 3.4 15.9 0.0 0.1 0.5 0.3 0.0 0.0 0.1 16.8 0.4 19.4 5.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 1.9 0.0 0.7 1.9 1.6 3.0 0.6 0.3 2.0 1.5 18.1 0.0 0.0 3.9 3.7 2.4 0.3 0.1 0.0 1.1 0.0 8.0 0.0 1.4 0.0 6.7 0.0 3.8 2.1 0.1 0.3 0.0 0.6 0.0 2.0 0.5 0.0 18.6 0.5 2.0 0.0 0.3 0.0 0.3 0.0 15.7 0.0 0.3 2.5 0.0 0.0 1.4 2.5 0.2 0.3 0.1 0.0 0.0 2.5 5.9 0.0 2.9 0.0 0.1 0.8 1.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 12.7 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 6.5 0.0 0.3 5.4 4.5 0.2 0.0 0.0 6.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.9 0.0 1.3 0.0 0.0 1.7 1.2 5.6 0.1 8.8 0.0 1.2 0.0 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 35.7" "Lineage enriched" "Detected in all" 8 "granulocytes: 35.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" Yes No "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: AB_2674363, HPA057913: AB_2732617" "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 21.9 20.7 12.2 21.2 13.7 33.5 27.6 25.6 16.6 28.6 39.3 12.6 15.1 22.9 20.0 20.2 28.2 17.1 13.3 16.2 10.3 8.9 15.9 15.9 26.0 16.4 13.7 8.7 27.2 18.9 24.6 29.7 20.8 13.3 19.6 23.6 14.1 19.5 25.1 15.9 17.5 49.0 17.5 12.5 18.0 15.9 12.4 16.2 29.1 20.3 14.4 13.1 21.9 22.0 4.0 3.7 35.7 4.5 1.4 3.0 1.0 23.7 9.3 18.5 11.1 12.4 14.1 12.0 14.1 13.0 15.8 16.5 9.9 17.1 9.4 16.8 13.4 19.5 18.8 18.0 10.7 21.7 3.3 13.1 6.9 19.4 8.4 10.9 6.8 2.1 11.6 11.1 12.4 15.0 12.6 18.0 7.5 11.5 6.9 17.0 4.8 7.8 5.9 9.3 9.0 10.9 7.5 28.2 3.8 14.0 46.8 9.0 5.9 21.1 12.2 18.1 14.6 9.1 6.2 16.8 13.5 12.1 17.2 14.7 3.8 3.2 6.4 5.6 6.7 5.0 4.9 4.5 6.8 2.6 2.5 2.3 3.3 2.3 2.4 2.1 4.0 3.0 2.6 35.7 1.4 3.2 3.7 1.8 1.0 12.2 13.7 25.6 16.6 10.3 8.9 13.7 8.7 13.3 16.2 38.7 52.6 24.5 42.6 42.9 83.6 41.1 40.8 45.5 39.8 66.3 84.4 37.5 10.0 51.4 2.1 51.2 79.8 70.0 52.5 29.4 35.1 52.3 15.1 32.6 20.4 62.0 42.5 51.0 34.3 2.9 50.3 29.0 30.4 41.5 55.9 64.3 62.0 87.7 45.3 22.4 151.6 38.8 29.8 35.8 18.8 45.8 31.2 21.0 50.9 118.4 PKNOX2 ENSG00000165495 "PBX/knotted 1 homeobox 2" Q96KN3 11 125164687-125433389 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 28.7;Melanocytes: 8.5;Peritubular cells: 16.6" "Cancer enhanced" "Detected in many" "melanoma: 8.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 27.2;AN3-CA: 6.8;hTEC/SVTERT24-B: 5.4;LHCN-M2: 8.0;SK-MEL-30: 5.4;WM-115: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028867, CAB034342, HPA055368, HPA066962" Supported Enhanced "Nucleoplasm,Cytokinetic bridge" NA NA Nucleoplasm "Cytokinetic bridge" "CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757" "unprognostic (2.91e-2)" "unprognostic (1.62e-1)" "unprognostic (2.10e-2)" "unprognostic (7.26e-2)" "unprognostic (9.46e-2)" "unprognostic (3.97e-2)" "unprognostic (2.41e-1)" "unprognostic (2.12e-2)" "unprognostic (1.56e-1)" "unprognostic (2.44e-2)" "unprognostic (7.66e-2)" "unprognostic (3.70e-1)" "unprognostic (4.10e-6)" "unprognostic (1.76e-3)" "unprognostic (7.11e-2)" "unprognostic (1.71e-2)" "unprognostic (6.48e-3)" 5.8 4.1 10.0 3.3 12.4 0.7 1.7 16.3 25.7 5.1 2.8 3.6 0.2 2.0 5.6 4.7 2.7 9.8 3.4 7.9 7.3 6.9 2.9 1.1 9.6 2.4 5.2 12.3 23.6 6.3 0.9 7.3 12.8 6.9 10.2 2.8 24.3 2.5 8.7 19.5 4.0 2.4 4.6 4.6 3.4 2.5 7.2 3.1 0.0 18.3 8.4 2.2 3.3 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 27.2 6.8 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.2 0.0 0.0 2.7 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 4.4 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 12.4 16.3 25.7 7.3 6.9 5.2 12.3 6.9 3.1 0.0 0.0 0.0 0.0 0.8 0.9 4.3 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.7 28.7 0.5 0.0 0.0 0.2 0.0 1.4 1.8 0.0 0.0 0.2 7.9 0.0 1.3 0.0 7.4 4.6 0.0 8.5 0.0 0.0 3.3 0.2 0.0 16.6 0.0 0.2 6.5 3.1 0.7 0.1 0.4 0.1 0.0 0.0 0.0 PLEKHA1 TAPP1 ENSG00000107679 "Pleckstrin homology domain containing A1" Q9HB21 10 122374696-122442602 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 261.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 6.9;NK-cells: 11.6;T-cells: 16.5" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 64.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002043, HPA064795" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA002043: AB_1079632, HPA064795: AB_2685354" "unprognostic (1.79e-2)" "unprognostic (3.18e-2)" "unprognostic (2.70e-1)" "unprognostic (5.44e-3)" "unprognostic (7.41e-2)" "unprognostic (1.69e-1)" "unprognostic (5.50e-2)" "unprognostic (4.07e-2)" "unprognostic (3.88e-1)" "unprognostic (2.69e-1)" "unprognostic (7.98e-2)" "unprognostic (7.63e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-1)" "unprognostic (7.42e-2)" "unprognostic (4.31e-2)" "unprognostic (5.23e-2)" 11.7 7.4 18.2 8.7 30.2 2.6 13.6 15.8 37.9 13.6 14.9 25.4 11.4 17.1 17.9 14.5 26.7 8.8 16.3 19.4 19.8 16.6 27.1 25.4 24.4 9.0 15.6 24.4 13.9 18.1 18.8 22.9 30.6 20.7 12.7 13.9 9.5 16.0 13.6 22.5 43.9 17.2 16.0 19.6 8.7 14.0 25.5 15.0 3.4 18.7 13.9 11.7 16.1 16.1 6.9 1.8 1.3 1.6 11.6 16.5 6.2 7.8 7.3 7.4 5.1 10.8 12.3 8.9 8.8 15.4 5.3 5.8 6.1 10.0 4.9 4.3 7.9 5.4 17.4 7.0 26.9 4.9 3.5 6.8 0.0 7.2 7.2 7.1 0.9 2.3 6.7 22.3 4.4 18.8 8.8 17.9 10.4 7.3 0.0 4.9 3.0 4.4 0.7 5.7 12.1 4.9 1.2 10.6 0.9 64.9 8.8 10.1 4.9 11.4 8.5 8.9 10.9 4.7 0.1 17.0 4.5 3.7 4.9 4.4 0.0 0.0 1.6 7.0 0.0 2.8 0.1 1.5 1.3 16.5 1.4 10.8 2.9 10.0 13.2 1.8 6.9 15.9 13.5 0.5 11.6 1.6 0.9 6.6 6.2 18.2 30.2 15.8 37.9 19.8 16.6 15.6 24.4 20.7 15.0 134.0 37.7 19.5 46.6 64.7 41.5 49.8 43.3 33.5 60.3 54.1 70.7 47.5 34.9 55.8 165.5 60.9 41.2 0.0 73.6 39.9 30.4 51.3 4.7 42.4 29.9 25.4 21.5 27.6 18.2 261.8 40.9 15.7 23.6 28.9 21.1 25.4 58.5 28.1 33.9 98.4 50.3 25.8 30.1 90.5 82.0 74.2 33.2 33.3 24.5 60.8 PLEKHA7 DKFZp686M22243 ENSG00000166689 "Pleckstrin homology domain containing A7" Q6IQ23 11 16777317-17014443 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 23.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "eosinophil: 6.8;MAIT T-cell: 4.5" "Group enriched" "Detected in many" 6 "granulocytes: 6.8;T-cells: 4.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.4;HaCaT: 28.7;OE19: 23.8;RT4: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038610, HPA066103" Approved Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA038610: AB_10671746, HPA066103: AB_2732738" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (3.81e-2)" "unprognostic (4.30e-2)" "unprognostic (2.51e-2)" "unprognostic (6.95e-3)" "unprognostic (2.81e-2)" "unprognostic (1.85e-2)" "unprognostic (2.65e-1)" "unprognostic (1.73e-1)" "unprognostic (2.65e-3)" "unprognostic (3.13e-2)" "prognostic favorable (1.89e-15)" "unprognostic (9.74e-2)" "unprognostic (1.17e-2)" "unprognostic (4.81e-1)" "unprognostic (2.65e-2)" 6.8 1.2 5.3 6.6 8.0 0.1 10.7 2.9 4.9 7.7 18.1 10.9 10.0 17.7 4.7 6.0 30.6 6.0 15.1 13.6 7.5 4.2 18.1 9.0 6.4 1.2 7.2 4.6 8.1 18.9 19.1 3.2 18.7 14.5 6.0 11.5 18.2 15.0 16.3 2.7 8.9 32.0 2.7 8.1 1.7 15.2 7.4 7.9 1.4 7.2 1.9 5.5 10.7 12.4 0.5 0.9 6.8 0.3 0.2 4.5 0.3 5.1 4.6 4.9 2.2 0.2 0.0 8.1 0.0 0.1 1.7 3.2 7.9 43.4 0.0 2.0 0.6 0.2 28.7 6.5 0.0 1.2 1.5 6.3 13.3 3.7 5.4 0.1 0.0 0.1 0.2 2.5 0.0 0.1 4.0 0.0 5.6 0.5 0.1 0.7 3.3 3.0 0.1 2.7 23.8 4.5 4.1 0.0 1.0 4.2 39.3 3.1 0.3 5.9 16.9 0.2 9.3 4.3 1.5 1.1 0.0 1.6 1.2 1.0 2.9 0.9 5.8 0.0 0.2 0.0 0.2 0.3 6.8 0.6 0.1 4.5 0.5 0.8 0.6 0.3 0.2 0.2 0.4 0.6 0.2 0.1 0.9 0.1 0.3 5.3 8.0 2.9 4.9 7.5 4.2 7.2 4.6 14.5 7.9 3.0 13.4 0.0 1.2 0.6 1.2 8.7 5.1 6.7 12.5 10.4 23.6 5.4 3.3 4.7 11.7 2.3 8.4 0.0 5.3 0.8 0.6 0.8 2.3 2.4 1.7 0.0 0.0 0.6 1.0 4.5 0.6 2.4 0.0 1.0 4.6 3.9 7.6 3.5 0.4 8.1 10.6 0.0 0.3 0.2 0.5 0.4 5.0 0.5 2.6 4.6 PLEKHG1 "ARHGEF41, KIAA1209" ENSG00000120278 "Pleckstrin homology and RhoGEF domain containing G1" Q9ULL1 6 150599883-150843665 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 39.7" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 43.2;Ito cells: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 28 "memory B-cell: 14.7;naive B-cell: 15.9" "Lineage enriched" "Detected in single" 29 "B-cells: 15.9" "Cell line enhanced" "Detected in many" "AF22: 12.5;HAP1: 18.4;Karpas-707: 16.4;U-698: 11.4" "Region enriched" "Detected in many" 5 "thalamus: 56.1" "Low region specificity" "Detected in all" "HPA027128, HPA027319, HPA028270" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388" "unprognostic (2.93e-1)" "unprognostic (3.44e-1)" "unprognostic (3.04e-3)" "unprognostic (2.34e-1)" "unprognostic (1.05e-1)" "unprognostic (2.80e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (2.10e-1)" "unprognostic (1.60e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (4.62e-3)" "unprognostic (3.63e-1)" "unprognostic (4.30e-2)" "unprognostic (3.83e-1)" "unprognostic (2.15e-2)" 27.5 2.2 7.3 10.6 7.3 2.3 10.0 2.4 7.1 8.3 5.8 10.1 4.8 4.8 7.8 14.1 9.6 8.9 8.1 5.9 7.7 6.7 4.5 5.1 12.1 13.5 10.5 3.0 4.7 2.8 8.2 5.1 13.9 11.1 4.1 6.2 3.4 3.5 5.4 6.4 8.9 6.0 5.7 19.6 28.9 4.5 7.3 7.7 39.7 6.0 5.8 13.3 7.4 8.5 15.9 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 12.5 0.1 0.0 0.0 8.9 0.0 0.0 0.0 0.0 6.9 3.0 4.9 4.8 0.0 1.2 1.8 18.4 1.6 0.0 7.7 2.0 0.3 0.9 0.0 0.0 0.0 1.4 0.8 4.7 0.0 0.1 0.0 7.7 4.1 0.0 16.4 0.0 0.2 1.5 0.0 0.9 4.8 0.5 0.8 0.0 0.0 3.6 8.2 0.4 0.1 0.0 2.2 1.5 1.4 0.0 0.0 7.7 0.0 1.7 0.0 3.3 0.0 0.0 11.4 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.5 14.7 0.3 0.4 0.0 15.9 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.4 7.3 7.3 2.4 7.1 7.7 6.7 10.5 3.0 11.1 7.7 0.0 3.8 8.1 0.6 3.8 0.2 1.6 2.5 5.3 3.4 7.0 0.0 4.2 3.3 2.3 2.7 43.2 4.3 0.0 1.0 1.3 9.9 0.7 0.0 3.0 0.5 0.0 5.2 39.9 6.1 1.3 0.3 0.8 5.0 8.2 9.0 8.3 6.3 10.5 0.4 2.8 0.5 0.0 2.3 1.0 0.9 3.1 2.4 3.2 4.2 2.4 PM20D2 "ACY1L2, bA63L7.3" ENSG00000146281 "Peptidase M20 domain containing 2" Q8IYS1 6 89146050-89165565 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030325, HPA030326, HPA030327" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030325: , HPA030326: AB_2673429, HPA030327: AB_10603129" "unprognostic (3.60e-2)" "unprognostic (1.40e-1)" "unprognostic (6.36e-2)" "unprognostic (3.18e-3)" "unprognostic (3.22e-2)" "unprognostic (2.73e-1)" "unprognostic (1.13e-3)" "unprognostic (8.60e-2)" "unprognostic (1.04e-1)" "unprognostic (5.86e-2)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (9.99e-2)" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (1.32e-1)" "unprognostic (1.31e-1)" 6.8 5.0 4.8 11.4 6.9 6.5 7.6 11.2 4.9 11.9 13.4 4.4 9.3 7.0 11.3 7.1 14.2 11.0 9.1 16.9 5.1 5.5 9.6 9.7 6.2 8.3 3.7 3.1 21.0 11.3 12.5 23.8 6.9 8.6 23.5 8.5 17.6 8.6 8.7 38.5 10.2 8.0 27.7 4.8 5.2 7.6 4.0 2.9 16.6 23.0 10.6 12.1 19.5 8.5 4.1 2.4 3.0 1.0 4.8 4.0 1.5 11.9 5.3 4.8 7.4 1.6 1.0 0.3 6.0 6.0 9.0 11.6 6.2 5.9 34.9 7.4 1.3 7.7 4.6 9.8 4.8 20.6 10.8 12.5 7.0 3.2 5.8 1.8 20.2 5.7 1.6 3.6 3.4 7.3 7.4 2.1 10.5 2.7 18.7 2.8 1.8 12.7 16.0 1.9 10.4 5.3 21.2 23.8 25.3 10.1 2.3 13.5 9.4 3.6 5.8 5.9 6.5 0.0 17.9 3.5 0.2 5.5 1.9 12.6 10.0 14.6 7.4 2.5 17.5 0.8 1.9 1.0 2.9 2.2 0.6 3.5 4.1 2.7 3.7 1.6 3.1 4.0 3.5 3.0 4.8 0.6 2.4 0.5 1.5 4.8 6.9 11.2 3.9 5.1 5.5 3.7 3.1 8.6 2.9 8.9 9.3 11.5 19.6 26.9 19.1 18.2 28.1 10.7 14.8 15.7 29.5 2.0 5.0 11.3 4.3 10.5 4.9 0.0 9.0 1.9 14.7 40.0 5.8 7.3 3.0 7.9 10.4 7.4 8.2 7.0 22.7 3.2 16.9 19.8 16.1 10.3 16.0 3.5 18.0 13.2 21.1 6.5 17.6 4.5 6.1 27.7 1.0 10.0 24.9 14.4 PMS2 "H_DJ0042M02.9, HNPCC4, MLH4, PMSL2" ENSG00000122512 "PMS1 homolog 2, mismatch repair system component" P54278 7 5973239-6009125 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010235, HPA066490, HPA070310" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB010235: AB_2167281, HPA066490: AB_2685677, HPA070310: AB_2686250" "unprognostic (5.13e-2)" "unprognostic (6.55e-3)" "unprognostic (1.54e-1)" "unprognostic (1.43e-3)" "unprognostic (5.14e-2)" "unprognostic (1.29e-1)" "unprognostic (7.36e-2)" "unprognostic (1.02e-1)" "unprognostic (7.43e-2)" "unprognostic (2.35e-1)" "unprognostic (1.86e-1)" "unprognostic (7.38e-2)" "prognostic favorable (1.23e-5)" "unprognostic (5.31e-2)" "unprognostic (2.01e-2)" "unprognostic (3.67e-2)" "unprognostic (2.81e-2)" 6.3 7.4 8.7 6.0 19.8 3.6 8.1 15.5 21.2 6.2 6.0 11.5 6.9 6.4 6.4 6.3 7.5 7.5 5.0 5.3 9.0 10.3 14.2 5.8 5.5 9.1 8.4 9.5 7.5 7.1 16.6 7.1 5.9 16.2 7.0 6.2 8.0 7.1 7.8 5.7 14.8 6.8 7.1 7.5 6.9 6.1 4.8 5.8 7.5 12.4 5.7 10.7 7.7 6.5 6.2 5.8 7.2 7.9 4.0 9.3 6.3 9.7 10.6 8.5 21.2 6.7 9.9 7.3 5.2 4.0 5.1 4.1 9.2 7.0 18.3 6.2 7.5 11.5 13.4 12.7 3.4 5.5 7.2 5.2 8.0 8.6 6.6 11.4 9.8 5.5 10.4 9.7 4.0 15.2 7.3 9.4 8.7 14.9 8.9 8.4 9.0 2.9 7.0 8.6 4.4 6.5 10.0 10.3 9.3 10.7 7.3 7.8 16.8 10.2 14.9 11.2 13.2 18.5 6.9 8.0 6.5 14.5 9.5 9.4 12.0 20.0 18.5 4.5 9.7 14.8 7.2 5.4 3.1 8.4 7.9 9.3 6.2 6.6 7.2 5.8 5.6 8.8 6.2 2.4 4.0 3.2 5.3 6.4 6.3 8.7 19.8 15.5 21.2 9.0 10.3 8.4 9.5 16.2 5.8 11.9 5.1 17.2 8.2 4.4 12.6 2.8 5.1 6.7 7.9 10.4 21.6 7.8 29.9 4.7 6.9 7.4 2.0 0.0 2.9 5.4 5.5 8.4 4.7 9.6 4.5 28.6 5.2 7.4 7.3 5.6 11.8 4.9 6.8 5.4 2.3 5.2 3.5 2.9 9.6 32.0 14.2 25.8 6.6 24.2 10.2 7.0 10.6 8.5 2.6 10.2 POC5 "C5orf37, FLJ35779, hPOC5, MGC120442, MGC120443, MGC120444" ENSG00000152359 "POC5 centriolar protein" Q8NA72 5 75674124-75717481 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 63.9;Late spermatids: 39.9;Rod photoreceptor cells: 37.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037509, HPA037510, HPA061521" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037509: AB_2797227, HPA037510: AB_10672349, HPA061521: AB_2797263" "unprognostic (1.33e-1)" "unprognostic (4.35e-2)" "unprognostic (1.97e-1)" "unprognostic (8.62e-2)" "unprognostic (1.26e-1)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.60e-7)" "unprognostic (1.99e-1)" "unprognostic (6.38e-2)" "unprognostic (2.97e-1)" "unprognostic (4.62e-2)" "unprognostic (6.81e-2)" "prognostic unfavorable (6.74e-5)" "unprognostic (1.02e-1)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "prognostic favorable (1.09e-4)" 8.3 8.9 9.3 9.2 17.0 12.4 13.5 12.7 11.5 9.8 7.1 10.1 6.4 6.2 10.9 12.0 6.1 12.8 6.2 5.4 8.6 8.3 9.8 6.6 8.2 14.1 13.8 8.7 16.2 7.8 8.6 6.5 10.5 16.2 9.8 9.1 10.2 6.7 7.7 5.6 8.9 8.6 10.4 13.6 15.1 7.6 25.5 11.1 27.2 8.3 5.3 14.6 8.5 8.4 15.6 15.2 20.4 9.9 14.9 18.5 7.6 9.0 7.1 11.9 11.9 5.2 4.2 8.8 8.6 5.1 15.2 11.5 10.4 8.2 12.0 16.8 4.5 20.5 8.4 10.6 8.4 11.4 12.5 6.9 7.8 5.3 5.6 7.0 9.0 15.6 4.7 8.3 11.4 19.4 5.1 6.0 12.4 7.5 22.1 7.0 10.5 14.7 11.4 5.1 2.0 6.2 9.2 9.9 14.3 6.9 4.4 9.5 10.5 8.0 4.4 9.1 6.2 8.4 10.2 2.6 5.1 11.4 8.9 17.2 13.9 28.7 17.5 7.7 11.8 12.2 7.1 9.3 20.4 13.7 9.9 12.0 13.4 14.0 14.8 13.6 15.6 14.7 14.0 8.8 14.9 7.6 15.2 18.5 7.6 9.3 17.0 12.7 11.5 8.6 8.3 13.8 8.7 16.2 11.1 6.0 12.0 8.0 2.7 2.4 12.5 3.6 5.1 21.4 5.7 7.0 11.8 5.9 8.3 6.5 63.9 5.3 2.3 23.3 6.0 6.6 3.7 1.9 2.3 1.8 5.3 9.5 4.7 6.2 3.7 39.9 5.8 5.0 3.3 1.0 4.5 4.6 4.8 2.9 6.7 4.2 37.8 6.5 3.1 29.3 15.1 2.5 3.4 7.5 4.5 1.3 POGK "BASS2, KIAA15131, KRBOX2, LST003" ENSG00000143157 "Pogo transposable element derived with KRAB domain" Q9P215 1 166839447-166856344 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007838, HPA031630, HPA075919" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA007838: AB_1079651, HPA031630: AB_10601490, HPA075919: " "unprognostic (3.48e-2)" "unprognostic (2.03e-2)" "unprognostic (4.31e-2)" "unprognostic (3.18e-3)" "unprognostic (4.20e-2)" "unprognostic (2.59e-1)" "prognostic unfavorable (5.93e-4)" "unprognostic (4.85e-1)" "unprognostic (6.09e-2)" "unprognostic (1.02e-2)" "unprognostic (2.19e-2)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (3.22e-1)" "unprognostic (9.74e-2)" "unprognostic (2.70e-1)" "unprognostic (2.11e-2)" 12.1 10.3 24.3 15.1 27.3 10.4 24.2 18.4 23.6 17.6 13.1 27.6 8.4 10.2 17.6 12.6 16.1 13.5 12.4 11.1 24.4 18.4 15.7 12.0 20.9 13.5 27.7 17.7 19.9 14.8 30.0 10.0 15.1 21.1 12.0 15.4 12.2 12.9 15.2 6.6 20.2 12.1 16.8 30.5 14.5 14.9 6.8 25.6 9.2 13.0 5.2 17.7 16.9 24.2 9.4 10.0 6.3 10.8 9.9 7.3 5.6 15.8 13.5 14.8 18.2 15.7 13.1 8.4 11.0 11.3 14.2 10.8 10.2 13.6 17.9 16.6 11.4 12.1 15.9 18.4 14.7 13.0 21.7 12.6 7.0 12.3 7.2 13.4 25.1 19.8 9.9 23.2 15.9 22.9 12.6 12.6 16.8 24.1 12.1 13.5 7.6 15.5 6.3 24.2 18.6 15.6 17.8 8.1 15.8 14.8 38.9 19.4 23.4 15.7 21.8 20.3 23.0 20.7 23.4 11.6 15.1 15.0 11.8 19.9 17.2 22.1 23.4 8.4 12.6 14.2 2.8 7.7 6.3 6.7 9.9 7.3 9.4 6.5 7.1 10.0 5.8 6.1 6.3 1.1 9.9 10.8 5.0 5.6 5.6 24.3 27.3 18.4 23.6 24.4 18.4 27.7 17.7 21.1 25.6 50.6 15.0 10.2 22.1 19.5 30.6 7.9 15.3 12.0 23.9 12.2 9.8 9.2 1.7 15.3 2.2 16.8 7.4 0.0 13.9 10.1 12.1 19.9 23.1 12.1 14.0 46.1 8.6 12.3 18.1 0.7 10.0 16.1 8.5 10.0 12.1 14.5 12.4 14.0 17.0 7.4 27.0 12.9 13.4 0.9 2.1 21.0 7.6 7.5 15.2 25.1 POGZ "KIAA0461, ZNF280E, ZNF635m" ENSG00000143442 "Pogo transposable element derived with ZNF domain" Q7Z3K3 1 151402724-151459465 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division" DNA-binding "Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006800, HPA008781" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006800: AB_1855516, HPA008781: AB_1855517" "unprognostic (2.87e-1)" "unprognostic (7.16e-2)" "unprognostic (7.47e-2)" "prognostic unfavorable (8.67e-4)" "unprognostic (2.87e-2)" "unprognostic (1.11e-2)" "unprognostic (2.30e-2)" "unprognostic (1.41e-1)" "unprognostic (7.99e-3)" "unprognostic (2.99e-1)" "unprognostic (1.00e-2)" "unprognostic (9.69e-2)" "prognostic unfavorable (3.92e-5)" "unprognostic (2.32e-1)" "unprognostic (2.92e-2)" "unprognostic (3.29e-1)" "prognostic favorable (4.40e-4)" 11.6 15.2 18.3 15.6 20.1 23.5 18.2 40.6 24.8 16.1 17.8 22.2 21.9 10.0 24.2 39.0 11.0 23.9 17.7 12.4 15.4 13.5 16.9 14.4 13.9 12.7 18.7 20.7 37.4 13.2 33.0 26.8 10.4 17.3 17.8 14.5 17.1 15.4 17.6 15.4 24.1 13.0 19.3 20.3 16.7 13.1 21.2 21.8 20.3 21.6 7.4 13.9 15.0 17.6 5.2 4.0 7.8 2.6 2.9 5.6 1.8 9.8 12.9 32.4 18.3 14.5 14.1 11.1 8.7 8.0 10.0 10.4 14.4 10.3 20.8 15.1 10.9 7.9 8.7 18.7 9.3 13.1 17.6 10.4 12.7 17.6 8.3 10.7 17.5 13.0 12.5 7.6 11.0 13.3 18.7 15.8 15.7 11.9 20.1 9.7 25.3 19.3 11.4 22.9 10.2 7.8 18.9 15.6 10.6 10.7 16.2 17.7 18.1 14.7 12.5 14.4 27.6 16.3 23.0 13.2 12.1 14.5 10.0 12.5 14.6 12.5 40.3 8.7 9.3 10.2 7.8 2.5 5.5 4.2 2.1 3.6 5.0 4.2 5.6 2.2 5.2 4.3 4.2 4.8 2.9 2.6 4.0 2.9 1.8 18.3 20.1 40.6 24.8 15.4 13.5 18.7 20.7 17.3 21.8 56.6 41.2 14.7 23.8 40.2 81.8 15.1 35.7 18.7 28.4 61.1 78.5 13.4 3.3 19.4 12.1 41.3 27.5 0.0 12.8 9.3 31.4 29.8 26.6 38.4 18.3 74.7 55.9 49.7 22.8 6.9 49.8 26.0 49.0 19.8 30.0 52.4 20.1 26.4 69.3 9.8 57.4 64.7 32.5 27.9 57.7 29.7 9.6 25.9 33.7 23.5 POLD2 ENSG00000106628 "DNA polymerase delta 2, accessory subunit" P49005 7 44114681-44124358 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 217.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026745 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA026745: AB_1855520" "unprognostic (9.09e-2)" "unprognostic (1.41e-1)" "unprognostic (9.89e-2)" "unprognostic (1.84e-3)" "unprognostic (1.55e-1)" "unprognostic (2.10e-3)" "unprognostic (1.50e-3)" "unprognostic (4.94e-3)" "unprognostic (8.17e-2)" "unprognostic (1.01e-3)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.72e-2)" "unprognostic (2.14e-1)" "unprognostic (5.18e-2)" "unprognostic (1.03e-1)" "unprognostic (4.44e-3)" 17.2 19.1 17.5 14.3 16.7 16.3 33.9 14.3 25.9 15.8 15.4 17.1 12.6 13.9 16.1 9.7 27.5 34.5 14.5 35.9 16.3 13.8 15.9 43.6 15.3 16.2 15.2 14.7 24.4 49.0 18.9 17.9 12.9 15.0 15.9 12.9 17.4 19.9 14.3 42.6 19.3 11.5 15.7 13.7 11.9 16.0 14.4 14.8 27.7 20.3 25.1 15.8 13.4 16.7 28.1 37.0 3.2 13.7 13.3 29.3 21.3 26.5 35.1 19.6 41.0 17.4 18.7 19.4 16.4 16.5 22.5 16.9 29.6 25.6 61.5 21.0 23.5 45.1 36.8 32.0 44.7 14.7 17.4 37.6 13.5 37.7 25.0 19.9 41.3 16.6 17.0 27.4 34.8 33.9 23.7 18.8 41.6 49.5 29.6 24.8 43.3 50.3 78.1 30.8 38.3 34.5 33.9 26.3 87.2 19.5 17.2 38.9 30.4 20.4 73.7 14.0 13.2 42.6 53.3 14.7 29.9 37.7 36.6 51.2 46.5 68.7 58.9 26.8 41.9 42.2 0.5 13.7 3.2 17.9 12.4 26.8 28.1 21.6 18.2 23.2 27.3 29.3 21.4 1.1 13.3 11.8 37.0 17.0 21.3 17.5 16.7 14.3 25.9 16.3 13.8 15.2 14.7 15.0 14.8 6.0 35.1 22.3 62.4 43.8 38.9 57.0 38.2 60.2 37.5 27.9 29.5 61.7 87.9 57.0 88.9 29.0 11.8 0.0 52.0 69.9 44.0 51.0 25.5 84.6 40.8 50.9 40.3 20.3 12.3 217.8 38.6 15.8 47.2 10.0 53.1 37.9 39.5 14.0 50.2 78.7 48.2 19.4 68.0 59.4 64.6 52.9 29.6 23.3 71.7 63.1 POLH "RAD30A, XP-V" ENSG00000170734 "DNA polymerase eta" Q9Y253 6 43576150-43615660 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase" "Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3;Spermatocytes: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006721, HPA026762" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA006721: AB_1847785, HPA026762: AB_10601248" "unprognostic (1.79e-1)" "unprognostic (7.29e-2)" "unprognostic (2.25e-1)" "unprognostic (7.28e-2)" "unprognostic (3.61e-1)" "unprognostic (5.11e-3)" "unprognostic (9.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.18e-1)" "unprognostic (7.75e-2)" "unprognostic (4.11e-3)" "unprognostic (2.24e-1)" "unprognostic (9.50e-2)" "unprognostic (6.73e-2)" "unprognostic (8.77e-2)" "unprognostic (7.91e-2)" "unprognostic (6.02e-2)" 7.4 9.4 7.5 9.7 10.4 4.6 7.2 10.5 10.5 8.5 8.4 12.7 8.0 5.7 9.6 7.1 11.4 7.8 6.2 6.7 5.3 4.4 7.2 7.5 9.8 16.3 8.9 8.1 7.4 13.0 7.1 9.7 5.1 7.9 6.9 10.1 8.9 8.6 5.6 9.5 11.7 7.9 11.8 6.9 9.2 7.6 24.7 6.8 22.1 9.9 6.2 18.3 8.6 8.4 8.6 4.3 4.5 2.6 6.8 7.2 3.2 20.5 4.7 6.4 9.3 9.1 15.1 15.2 22.0 6.9 12.9 14.8 5.4 3.6 22.8 5.5 8.9 3.7 5.2 6.4 13.8 16.1 11.5 4.9 6.7 13.3 15.6 6.8 11.4 9.0 10.1 17.0 10.5 5.7 5.2 12.1 7.0 10.5 13.7 16.2 6.8 10.3 3.0 1.9 15.7 3.6 11.3 6.6 5.7 4.9 15.4 7.2 2.5 7.0 5.8 3.5 7.4 8.3 5.1 16.4 11.9 11.6 5.6 11.1 12.9 8.9 41.2 5.7 6.7 12.9 4.5 2.6 4.1 7.2 2.5 6.4 7.8 6.0 5.2 2.1 8.6 5.0 5.2 2.0 6.8 1.9 4.3 7.0 3.2 7.5 10.4 10.5 10.5 5.3 4.4 8.9 8.1 7.9 6.8 11.9 5.1 4.9 2.6 4.1 6.3 2.4 2.5 5.3 7.9 3.5 9.8 1.7 5.0 2.0 7.6 2.1 2.6 23.3 0.7 2.4 2.6 2.1 0.0 2.1 1.5 0.0 5.2 0.6 1.5 6.0 3.1 1.7 1.7 2.8 2.2 2.3 1.6 2.9 2.8 1.4 8.5 0.0 3.1 17.9 5.9 2.6 1.6 2.9 3.1 2.5 POLK "DINB1, DINP, POLQ" ENSG00000122008 "DNA polymerase kappa" Q9UBT6 5 75511756-75601144 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 167.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012035, HPA057303, HPA068117, HPA069375" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA012035: AB_2668606, HPA057303: AB_2683406, HPA068117: AB_2685957, HPA069375: AB_2686131" "unprognostic (9.66e-2)" "unprognostic (5.29e-2)" "unprognostic (5.37e-2)" "unprognostic (2.70e-1)" "unprognostic (1.86e-1)" "unprognostic (1.66e-1)" "unprognostic (1.73e-2)" "unprognostic (7.76e-2)" "unprognostic (1.65e-2)" "unprognostic (6.29e-3)" "unprognostic (2.42e-1)" "unprognostic (5.93e-2)" "unprognostic (1.80e-2)" "unprognostic (9.96e-3)" "unprognostic (1.58e-1)" "unprognostic (9.64e-2)" "unprognostic (2.02e-1)" 14.7 12.7 10.1 8.6 12.9 6.3 13.4 17.0 13.4 18.1 10.7 8.8 13.6 6.3 21.3 12.1 11.7 10.5 9.5 11.4 14.1 10.5 12.6 12.3 12.2 9.2 14.1 12.9 15.5 11.1 18.5 23.9 15.2 17.2 13.9 8.1 6.5 10.2 10.5 15.2 10.3 9.2 15.4 16.9 13.1 9.0 9.8 12.4 12.1 18.8 9.3 8.9 12.7 10.2 7.0 7.5 6.0 13.3 4.6 4.5 2.5 6.4 6.6 4.1 5.3 5.5 10.9 3.5 12.3 8.8 9.6 10.0 4.2 5.2 6.6 10.2 8.1 6.3 2.5 3.8 4.2 11.6 7.3 4.5 6.0 5.8 2.0 10.4 3.9 5.0 5.1 5.3 7.7 5.3 7.7 8.0 4.4 5.3 3.9 9.1 0.5 7.5 3.1 1.5 0.7 3.9 3.2 10.6 4.6 5.8 2.2 4.2 4.6 9.3 2.5 3.3 2.9 3.6 3.7 10.1 7.1 3.6 3.3 7.0 4.6 4.1 6.0 4.7 6.1 12.1 5.7 7.1 3.4 3.3 7.9 2.9 7.0 3.7 4.0 6.1 5.4 4.5 3.0 6.0 4.6 13.3 7.5 4.1 2.5 10.1 12.9 17.0 13.4 14.1 10.5 14.1 12.9 17.2 12.4 29.8 39.4 38.7 18.4 13.1 33.6 17.1 30.6 18.7 29.6 27.9 19.6 14.0 19.9 16.1 167.0 32.1 9.2 23.3 13.7 11.0 21.7 14.6 49.8 20.9 18.7 62.0 14.3 49.7 37.8 38.8 34.8 32.2 21.9 27.9 12.4 23.5 16.5 11.5 36.0 17.0 40.7 6.5 16.5 43.4 16.6 11.3 5.6 18.5 10.6 10.5 POLN ENSG00000130997 "DNA polymerase nu" Q7Z5Q5 4 2071918-2242121 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 9.2;Spermatocytes: 17.6;Spermatogonia: 10.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035939, HPA035940" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035939: AB_2674875, HPA035940: AB_2674876" "unprognostic (8.52e-3)" "unprognostic (1.55e-1)" "unprognostic (4.87e-2)" "unprognostic (1.32e-1)" "unprognostic (2.53e-1)" "unprognostic (1.45e-2)" "unprognostic (3.46e-1)" "unprognostic (2.70e-1)" "unprognostic (5.83e-2)" "unprognostic (2.23e-1)" "unprognostic (2.02e-3)" "unprognostic (1.25e-1)" "unprognostic (1.49e-3)" "unprognostic (9.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.66e-1)" "unprognostic (1.82e-2)" 13.6 3.9 6.1 2.5 5.7 1.8 5.2 11.1 5.5 2.8 2.9 3.5 2.9 2.7 4.0 5.8 2.6 3.6 3.3 2.8 4.4 2.9 3.6 3.4 3.0 2.7 4.3 4.0 2.8 3.1 2.4 7.6 2.3 3.8 4.6 1.8 1.7 4.7 3.5 2.7 2.7 2.4 3.3 5.6 3.5 2.9 12.3 5.2 8.5 2.4 0.9 2.6 2.5 2.6 0.2 0.1 2.4 0.0 0.0 0.9 0.1 0.3 2.7 0.5 2.0 5.7 2.2 0.0 2.0 1.0 1.1 1.6 0.1 0.2 1.2 0.6 1.7 1.0 0.4 2.2 0.8 1.6 0.3 2.9 0.1 2.0 0.0 0.7 0.2 2.6 3.1 0.8 1.7 1.4 2.6 0.6 0.5 0.2 2.3 3.1 0.3 0.2 0.2 0.2 0.1 0.6 0.0 3.8 0.9 0.8 0.5 2.5 0.0 0.2 0.0 0.2 1.0 0.1 0.7 0.3 0.1 1.9 1.1 0.6 0.6 0.7 0.0 0.6 1.9 1.1 0.0 0.0 2.4 0.2 0.0 0.9 0.2 0.2 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.1 6.1 5.7 11.1 5.5 4.4 2.9 4.3 4.0 3.8 5.2 0.0 0.0 0.0 1.0 0.8 3.2 1.6 2.5 1.4 2.3 0.0 0.0 0.2 3.3 0.4 6.8 0.8 0.0 0.0 0.9 0.2 1.7 1.1 0.0 0.6 0.5 3.2 4.6 4.9 1.0 9.2 4.0 1.4 0.0 0.0 0.0 2.6 0.4 0.0 3.5 0.5 3.6 0.0 1.3 17.6 10.0 1.4 0.0 0.7 0.2 1.3 POLR1A "DKFZP586M0122, FLJ21915, RPA1, RPO1-4" ENSG00000068654 "RNA polymerase I subunit A" O95602 2 86020216-86106155 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010145, HPA031513, HPA049700" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" No No "Nucleoli fibrillar center" "Nucleoplasm, Intermediate filaments" "CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.55e-1)" "unprognostic (2.46e-2)" "unprognostic (1.32e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (3.70e-9)" "unprognostic (1.06e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.31e-2)" "unprognostic (4.56e-2)" "unprognostic (3.27e-1)" "unprognostic (2.20e-3)" "unprognostic (1.94e-1)" "prognostic unfavorable (8.41e-4)" "unprognostic (7.20e-2)" 14.3 12.9 10.1 12.4 16.5 9.7 10.3 12.2 20.3 11.1 11.0 17.4 8.3 9.4 19.5 7.4 13.5 12.3 11.7 12.7 9.0 9.2 11.5 15.1 9.4 9.6 9.0 9.4 12.6 14.3 18.2 15.9 11.4 13.8 10.7 11.8 13.9 11.2 12.5 22.5 12.3 8.6 16.0 8.0 11.2 10.4 14.9 10.9 14.0 10.3 11.4 14.2 10.9 9.6 2.6 2.6 1.8 2.5 2.0 3.8 1.2 9.4 21.6 9.6 18.5 9.5 7.6 14.0 8.7 5.8 12.6 7.8 27.0 7.5 21.7 9.3 8.9 12.2 11.0 24.7 12.9 11.2 9.0 12.8 18.7 9.2 18.1 6.7 17.7 10.1 5.8 8.1 18.6 14.5 4.8 9.7 10.1 24.7 5.5 8.6 8.4 13.1 7.5 17.5 12.7 14.3 15.8 21.1 10.2 5.6 15.5 15.0 7.8 9.6 12.8 6.9 6.9 7.5 6.2 15.4 15.3 12.1 13.0 17.5 7.8 7.5 19.0 7.9 15.3 13.4 1.8 1.5 0.2 3.0 2.5 3.8 2.0 1.5 2.5 1.8 2.6 1.4 1.8 0.7 2.0 1.9 2.6 0.7 1.2 10.1 16.5 12.2 20.3 9.0 9.2 9.0 9.4 13.8 10.9 3.0 7.8 6.1 2.9 3.8 11.5 7.8 15.3 6.7 3.4 8.7 15.7 5.7 3.3 5.9 2.4 5.7 4.2 0.0 4.0 4.4 3.8 4.3 5.8 7.2 10.2 11.1 9.2 4.9 2.8 1.5 5.8 3.1 5.0 1.8 6.1 2.9 5.0 0.0 4.9 3.0 10.1 0.0 4.7 4.2 7.5 2.4 3.2 4.4 9.0 3.7 POLR2I "hRPB14.5, RPB9" ENSG00000105258 "RNA polymerase II subunit I" P36954 19 36113710-36115346 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 926.9;Late spermatids: 1719.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035632, HPA045156" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035632: AB_2674711, HPA045156: AB_10964748" "unprognostic (1.95e-2)" "unprognostic (7.88e-3)" "unprognostic (3.54e-1)" "unprognostic (7.41e-3)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (1.24e-2)" "unprognostic (4.12e-2)" "unprognostic (7.39e-2)" "unprognostic (4.69e-3)" "unprognostic (2.86e-2)" "unprognostic (8.16e-2)" "unprognostic (1.83e-1)" "unprognostic (3.36e-2)" "unprognostic (3.84e-3)" "unprognostic (1.08e-1)" "unprognostic (1.16e-1)" 9.6 10.7 27.4 6.1 26.7 10.7 14.3 17.5 29.3 15.1 12.4 24.5 9.8 12.4 9.2 10.7 11.5 18.2 10.4 21.6 25.8 23.7 10.7 19.8 8.6 10.1 29.0 17.1 14.0 25.9 9.7 14.0 8.3 16.2 10.9 6.6 7.4 18.4 18.5 30.3 14.8 7.1 9.4 37.8 10.3 11.4 26.8 16.6 9.7 11.4 15.9 9.3 8.3 7.9 13.5 22.0 6.9 10.2 9.2 13.7 10.3 7.4 23.6 4.0 4.1 2.9 2.4 8.9 6.7 3.6 9.5 5.4 14.6 5.4 15.9 13.9 2.4 3.5 4.9 6.6 9.7 2.0 14.5 24.7 18.2 6.9 11.1 6.8 15.3 7.8 3.6 5.4 5.4 5.6 2.8 4.2 8.9 11.4 7.1 3.0 21.2 8.0 16.4 9.2 22.7 20.4 14.6 5.9 10.4 7.6 4.5 25.8 14.7 7.8 14.0 4.0 3.0 6.7 5.1 4.1 6.4 11.0 4.2 9.0 6.7 13.0 11.2 8.7 9.9 6.8 6.9 10.2 5.9 9.0 7.2 11.8 13.5 11.2 12.3 13.2 13.3 13.7 12.7 0.6 9.2 8.7 22.0 10.7 10.3 27.4 26.7 17.5 29.1 25.8 23.7 29.0 17.1 16.2 16.6 77.4 63.0 61.4 82.8 70.2 62.0 215.0 145.2 326.6 109.2 155.3 23.6 129.0 298.4 131.5 926.9 106.7 149.5 140.2 208.3 142.1 97.5 103.1 80.8 234.2 108.6 31.8 101.9 92.7 71.3 1719.1 128.9 73.2 160.3 125.4 134.4 86.3 165.9 201.5 144.9 353.5 48.4 109.9 114.1 313.9 161.1 95.2 86.8 65.0 140.6 77.0 POLR3C "RPC3, RPC62" ENSG00000186141 "RNA polymerase III subunit C" Q9BUI4 1 145824088-145842505 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 15 "Early spermatids: 260.3;Late spermatids: 416.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027508, HPA027516" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027508: AB_10600091, HPA027516: AB_10600894" "unprognostic (1.43e-2)" "unprognostic (1.70e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (6.87e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (5.48e-4)" "unprognostic (2.51e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.13e-1)" "unprognostic (1.41e-2)" "unprognostic (4.46e-1)" "prognostic unfavorable (1.85e-5)" "unprognostic (2.34e-1)" "unprognostic (4.95e-2)" "unprognostic (1.07e-2)" "unprognostic (1.38e-1)" 21.1 11.9 13.5 21.2 13.4 16.9 21.7 28.3 16.4 18.0 14.2 12.2 11.1 9.4 19.2 16.2 15.1 16.9 14.6 12.7 12.1 9.9 15.7 15.3 13.3 25.4 14.7 15.8 21.9 23.1 16.7 10.9 13.9 12.6 15.7 15.9 11.9 16.9 13.0 18.3 20.3 14.9 17.5 11.0 20.5 14.9 29.3 15.0 26.5 15.9 11.4 21.3 17.5 15.8 21.1 23.6 29.5 23.9 20.6 20.7 15.9 16.1 13.4 11.2 9.2 14.7 18.0 11.9 15.3 18.8 21.8 20.9 19.3 8.7 27.9 15.5 20.9 11.9 16.0 18.1 16.3 22.7 11.4 14.2 14.9 15.7 11.5 26.6 30.6 19.3 17.1 12.0 24.4 43.5 12.5 13.5 13.4 18.7 16.5 23.0 22.4 15.8 13.9 16.0 16.9 18.0 14.9 14.0 18.3 14.2 11.6 10.4 15.7 13.7 20.2 20.7 18.5 15.5 28.6 14.1 19.2 15.3 10.4 21.3 25.8 25.0 32.4 7.0 15.9 14.8 29.5 20.9 21.1 15.9 23.9 20.7 20.1 17.6 16.4 22.0 21.1 18.0 16.4 1.7 20.6 17.3 23.6 14.9 15.9 13.5 13.4 28.3 16.4 12.1 9.9 14.7 15.8 12.6 15.0 6.0 9.6 9.0 6.7 4.4 3.1 15.7 5.1 8.1 10.3 3.5 3.9 9.9 10.0 9.4 260.3 6.8 4.7 23.3 18.5 10.2 9.0 4.8 8.1 4.5 12.4 1.6 4.1 7.4 9.7 416.7 9.5 9.1 1.7 11.8 6.5 3.6 14.3 7.0 13.8 10.2 3.7 19.4 11.3 18.9 17.0 3.8 8.0 8.7 7.3 8.1 POLR3D "BN51T, RPC4, TSBN51" ENSG00000168495 "RNA polymerase III subunit D" P05423 8 22245104-22254600 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061331, HPA067875, HPA068461, HPA069089" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA061331: AB_2684480, HPA067875: AB_2685912, HPA068461: AB_2685993, HPA069089: AB_2686081" "unprognostic (2.33e-1)" "unprognostic (2.27e-1)" "unprognostic (9.38e-3)" "unprognostic (9.33e-3)" "unprognostic (1.24e-1)" "unprognostic (8.02e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.02e-1)" "unprognostic (2.19e-2)" "unprognostic (3.27e-1)" "unprognostic (8.03e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (9.15e-6)" "unprognostic (1.15e-1)" "unprognostic (3.13e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (2.12e-4)" 14.7 12.9 10.3 14.0 13.6 9.8 18.4 8.8 15.7 13.9 11.9 13.9 8.2 9.3 14.3 9.3 16.5 11.9 13.9 16.6 10.0 8.3 11.7 11.2 12.7 13.4 16.5 13.7 18.1 20.8 10.5 16.3 20.2 13.2 14.5 11.9 9.7 14.5 11.2 34.4 11.9 9.6 17.5 13.5 13.2 12.2 29.4 12.0 8.0 12.6 10.8 13.1 14.7 15.9 9.1 13.6 1.6 5.7 11.2 10.7 5.3 6.7 20.2 11.0 12.4 10.8 15.8 11.9 18.2 11.3 15.6 13.4 14.3 5.7 22.2 15.5 11.5 16.6 11.8 25.2 8.4 12.6 7.3 9.5 19.4 10.2 19.4 17.2 6.0 15.3 13.1 17.1 19.7 23.0 16.8 13.1 16.4 25.6 14.6 12.7 10.1 22.1 12.8 27.8 15.0 11.5 17.4 14.7 17.0 7.4 6.0 12.7 23.4 7.3 8.4 25.3 14.8 6.5 8.5 14.3 15.3 14.3 18.9 17.9 16.8 15.5 13.7 10.2 11.2 20.1 0.1 5.6 1.6 8.5 5.6 10.4 8.3 9.1 10.3 7.4 9.1 10.7 9.4 0.2 11.2 5.7 13.6 5.9 5.3 10.3 13.6 8.8 15.7 10.0 8.3 16.5 13.7 13.2 12.0 8.9 6.2 12.3 29.1 17.3 11.2 10.2 2.5 12.0 11.4 10.4 15.7 13.5 10.0 17.8 33.8 11.9 5.9 0.0 10.2 25.8 15.8 23.9 18.4 4.9 12.5 3.2 20.6 12.9 8.4 31.7 14.7 7.7 8.5 14.4 13.3 4.3 19.8 5.8 12.0 10.6 11.4 19.4 15.5 36.2 50.0 16.8 22.5 12.9 11.2 32.9 POLR3E "FLJ10509, RPC5, SIN" ENSG00000058600 "RNA polymerase III subunit E" Q9NVU0 16 22297375-22335103 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041419, HPA041477" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA041419: AB_2677468, HPA041477: AB_10796345" "unprognostic (3.09e-2)" "unprognostic (8.59e-2)" "unprognostic (8.23e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-1)" "unprognostic (7.28e-2)" "unprognostic (2.42e-2)" "unprognostic (7.73e-2)" "unprognostic (2.96e-2)" "unprognostic (1.34e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (1.74e-4)" "unprognostic (8.14e-2)" "unprognostic (1.91e-1)" "unprognostic (8.96e-2)" "unprognostic (8.19e-3)" "unprognostic (3.41e-2)" 10.8 15.8 8.9 10.4 11.1 9.8 15.5 11.7 12.9 11.7 10.7 12.0 13.0 9.7 12.4 9.3 13.1 11.1 8.5 13.9 10.9 7.0 9.5 14.0 9.5 12.7 11.1 9.8 11.0 21.2 15.7 15.8 8.9 10.7 12.7 6.6 11.8 15.0 15.2 50.7 12.7 8.9 9.2 10.0 9.5 12.4 9.6 10.7 10.4 12.3 9.1 14.0 11.4 10.4 5.9 5.7 1.9 3.8 5.3 7.2 4.8 6.6 9.3 2.7 6.7 5.3 4.0 9.2 5.4 2.8 3.6 2.5 11.7 4.7 13.8 7.1 3.8 2.5 6.4 13.3 7.5 2.9 9.1 19.0 7.0 10.1 22.3 6.5 10.9 7.8 3.9 8.3 7.7 9.4 1.7 9.1 5.8 19.9 5.6 4.1 10.8 10.9 4.5 13.7 7.4 7.9 14.3 6.0 17.7 3.7 4.0 9.9 7.4 5.1 9.5 5.2 2.3 5.5 6.3 5.7 3.6 4.1 3.1 5.9 7.6 13.5 12.7 4.1 8.4 6.7 0.0 3.3 1.9 6.5 3.8 7.2 5.9 7.2 6.8 5.7 5.1 7.0 5.8 0.3 5.3 3.1 3.3 7.2 4.8 8.9 11.1 11.7 12.9 10.9 7.0 11.1 9.8 10.7 10.7 3.0 14.3 16.6 20.1 28.8 22.8 16.2 7.6 16.0 11.4 17.4 29.5 19.3 5.0 10.9 31.0 13.1 10.9 0.0 11.0 16.4 14.4 22.7 27.6 11.1 11.5 19.1 14.5 5.5 12.3 13.9 11.5 9.4 13.5 7.2 16.4 10.6 13.0 11.5 8.5 9.1 38.3 12.9 16.5 18.4 16.2 34.6 23.7 19.2 15.0 23.8 POM121 "DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A" ENSG00000196313 "POM121 transmembrane nucleoporin" Q96HA1 7 72879365-72951440 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB003710, HPA043809, HPA049817" Approved Enhanced "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896" "unprognostic (2.33e-1)" "unprognostic (3.05e-2)" "unprognostic (9.71e-2)" "unprognostic (5.86e-3)" "unprognostic (1.70e-1)" "unprognostic (2.06e-1)" "unprognostic (1.40e-1)" "unprognostic (6.38e-2)" "unprognostic (7.07e-3)" "unprognostic (3.08e-2)" "unprognostic (3.84e-2)" "unprognostic (1.71e-1)" "unprognostic (1.85e-1)" "unprognostic (3.66e-2)" "unprognostic (2.39e-1)" "unprognostic (7.43e-3)" "unprognostic (2.40e-1)" 19.4 15.2 14.5 16.0 17.7 35.0 14.4 25.9 22.0 13.1 16.6 16.0 14.2 19.5 17.9 14.8 15.8 15.8 14.9 11.8 11.7 10.0 14.0 16.6 13.3 18.7 10.8 12.7 18.6 23.3 14.9 20.6 15.4 13.4 18.6 11.4 20.2 17.4 11.7 18.4 17.0 19.1 12.1 12.7 19.0 16.3 17.3 13.5 24.5 19.5 15.2 22.3 15.8 14.5 3.7 4.3 3.7 3.6 4.5 5.2 2.6 17.1 12.6 15.7 35.3 8.5 7.0 13.1 12.3 10.5 12.3 10.7 22.2 10.9 23.7 4.0 10.6 13.7 13.2 15.6 11.9 13.8 20.5 31.1 17.7 12.6 14.7 8.7 36.6 22.6 9.2 8.5 16.3 15.0 8.0 9.1 13.8 48.4 17.8 12.0 13.2 21.8 23.3 16.5 9.6 15.3 20.0 12.3 20.0 6.2 15.1 22.5 19.8 10.8 20.8 11.0 11.0 17.3 19.3 12.8 22.1 13.6 17.4 24.6 21.4 19.8 34.4 12.9 23.5 21.8 0.1 2.3 3.7 5.2 1.4 3.0 3.0 3.3 3.8 2.6 3.7 3.0 4.3 2.6 4.5 3.6 4.3 1.7 2.6 14.5 17.7 25.9 22.0 11.7 10.0 10.8 12.7 13.4 13.5 35.7 28.2 12.7 8.8 22.3 31.1 4.4 25.5 17.4 20.5 17.4 92.3 14.5 5.0 10.8 6.8 14.2 16.9 23.3 14.7 10.9 16.5 15.7 16.1 20.3 13.8 38.1 17.2 17.8 15.8 4.2 13.8 18.3 18.6 7.2 19.6 18.3 17.2 10.5 16.6 5.4 23.8 12.9 15.9 14.2 11.8 27.0 16.2 18.1 19.0 18.4 POU2F2 "OCT2, OTF2" ENSG00000028277 "POU class 2 homeobox 2" P09086 19 42086110-42196585 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 33.1;brain: 12.0;intestine: 10.8;lymphoid tissue: 43.1" "Cell type enhanced" "Detected in many" 13 "B-cells: 158.6;Bipolar cells: 50.4;Kupffer cells: 98.2;Macrophages: 80.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 33.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.5;Daudi: 39.0;hTEC/SVTERT24-B: 15.3;U-266/70: 27.1;U-266/84: 26.2;U-698: 30.9;U-87 MG: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002513, HPA049056, HPA062096, HPA064404, HPA073998" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB002513: AB_442118, HPA049056: AB_2732550, HPA062096: AB_2684681, HPA064404: AB_2685259, HPA073998: " "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-2)" "unprognostic (8.89e-2)" "unprognostic (6.77e-2)" "unprognostic (1.44e-2)" "unprognostic (1.62e-2)" "unprognostic (3.34e-1)" "unprognostic (8.39e-2)" "unprognostic (2.09e-1)" "unprognostic (1.52e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (7.57e-11)" "unprognostic (2.31e-1)" "unprognostic (1.76e-1)" "unprognostic (2.61e-2)" "unprognostic (1.54e-1)" 1.9 2.0 5.6 43.1 7.4 4.8 1.2 12.0 5.7 0.9 3.2 2.5 0.0 2.1 0.9 1.7 1.4 1.5 2.3 4.8 5.7 5.9 1.6 1.4 3.1 31.4 6.8 1.5 0.7 1.6 0.4 2.1 2.5 6.6 2.5 2.1 1.4 2.1 2.3 0.7 1.2 10.8 1.9 6.5 22.7 3.1 6.0 6.2 1.9 1.3 0.6 30.0 4.3 1.0 13.9 8.0 1.7 33.1 0.6 2.7 4.5 0.3 0.5 0.6 0.0 0.0 1.0 0.2 2.8 18.5 1.8 3.6 0.1 0.5 39.0 1.0 1.0 0.3 0.3 0.2 3.0 8.3 0.1 0.1 0.9 0.1 0.0 0.2 0.3 0.8 0.8 0.6 15.3 1.0 0.1 1.1 0.8 0.4 9.0 0.4 0.3 0.1 2.0 0.1 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.6 0.3 0.1 0.2 0.3 0.2 0.0 4.9 1.5 7.9 0.8 0.0 0.3 27.1 26.2 30.9 15.0 1.0 1.0 1.0 10.7 0.1 1.2 19.3 1.1 11.0 1.8 1.6 8.0 13.9 0.9 1.3 1.7 0.6 33.1 1.3 2.7 4.5 5.6 7.4 12.0 5.7 5.7 5.9 6.8 1.5 6.6 6.2 0.0 9.5 158.6 6.7 6.9 50.4 2.2 5.1 1.4 3.4 0.0 5.9 0.7 0.0 0.9 12.2 1.4 2.7 0.0 2.5 0.8 2.0 2.9 5.8 0.8 41.8 1.6 9.1 4.9 98.2 7.7 0.9 80.0 8.5 1.8 1.1 1.7 2.5 0.0 0.4 0.5 6.9 0.0 2.4 31.0 7.0 7.8 3.1 17.5 0.7 4.7 POU2F3 "Epoc-1, OCT11, PLA-1, Skn-1a" ENSG00000137709 "POU class 2 homeobox 3" Q9UKI9 11 120236640-120319944 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 18.5;Pancreatic endocrine cells: 12.7;Suprabasal keratinocytes: 33.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.2;EFO-21: 2.7;SK-BR-3: 5.3;T-47d: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019652, HPA073468" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear bodies, Plasma membrane, Cytosol" "HPA019652: AB_1855585, HPA073468: " "unprognostic (1.75e-1)" "unprognostic (2.12e-2)" "unprognostic (6.37e-2)" "unprognostic (2.41e-4)" "unprognostic (2.60e-1)" "unprognostic (4.46e-3)" "unprognostic (8.56e-3)" "unprognostic (9.34e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.69e-3)" "unprognostic (1.70e-1)" "prognostic favorable (8.14e-4)" "unprognostic (1.45e-1)" 0.2 0.2 0.1 0.2 0.1 0.0 1.6 0.1 0.1 1.2 0.9 0.0 36.5 0.7 0.4 1.2 2.5 0.3 0.4 0.2 0.1 0.1 0.3 0.2 1.6 0.4 0.1 0.0 0.2 0.3 6.4 1.3 4.4 0.1 1.1 0.1 0.0 1.1 13.2 0.1 38.2 1.0 0.2 0.1 0.2 0.4 0.6 0.0 0.4 4.5 4.8 2.2 0.7 2.6 1.0 0.7 2.1 0.5 0.9 0.6 0.2 2.5 0.0 0.0 0.2 0.0 0.0 0.8 0.3 0.6 0.0 0.0 0.1 7.2 0.3 2.7 0.0 0.1 1.3 0.0 0.4 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.7 0.4 0.2 0.0 0.1 0.0 1.4 0.0 0.1 0.1 0.2 0.3 0.1 0.6 0.0 0.0 0.1 0.0 1.9 0.5 0.1 0.1 5.3 0.0 0.9 9.7 0.4 0.8 0.0 0.2 0.4 0.1 0.1 0.1 0.0 1.1 0.2 0.1 1.4 0.4 0.5 0.5 0.3 0.5 0.5 0.6 0.4 0.1 1.0 0.6 0.6 2.1 0.9 0.5 0.7 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 5.1 0.0 9.0 18.5 0.0 0.8 0.0 1.4 2.3 10.4 0.0 1.2 0.0 3.6 1.7 0.0 0.3 0.0 1.2 0.2 0.2 5.0 0.0 0.4 0.1 0.0 2.9 0.0 0.0 3.8 0.0 0.0 5.0 0.0 0.0 0.2 12.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 33.0 6.6 0.0 0.5 10.1 POU3F1 "OCT6, OTF6, SCIP" ENSG00000185668 "POU class 3 homeobox 1" Q03052 1 38044611-38046794 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 10.5;skin 1: 31.0" "Cell type enhanced" "Detected in some" 15 "Basal keratinocytes: 24.3;Cone photoreceptor cells: 21.6;Muller glia cells: 14.6;Rod photoreceptor cells: 19.3;Suprabasal keratinocytes: 48.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.1;HDLM-2: 19.2;NTERA-2: 5.3;SCLC-21H: 3.8;SK-MEL-30: 15.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 7.0;cerebral cortex: 3.5;hippocampal formation: 9.7" "HPA055980, HPA073824" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055980: AB_2682995, HPA073824: AB_2686635" "unprognostic (9.99e-2)" "unprognostic (1.63e-1)" "unprognostic (1.69e-1)" "unprognostic (1.43e-2)" "unprognostic (7.46e-3)" "unprognostic (1.96e-2)" "unprognostic (1.33e-2)" "unprognostic (2.56e-1)" "unprognostic (1.11e-1)" "unprognostic (3.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.40e-1)" "unprognostic (4.61e-4)" "unprognostic (2.79e-2)" "unprognostic (1.97e-1)" "unprognostic (3.61e-2)" "unprognostic (2.67e-3)" 0.8 2.1 4.0 0.9 10.5 0.7 0.8 1.2 6.8 0.6 0.7 1.1 0.0 0.6 0.7 0.8 3.4 0.7 0.7 0.7 7.7 0.9 0.7 0.6 0.6 1.7 3.9 2.9 0.7 0.8 0.6 0.0 0.6 1.4 3.6 0.6 1.6 0.6 0.7 1.3 31.0 0.7 2.5 0.6 0.7 0.7 1.5 2.6 0.0 0.7 1.3 1.7 1.5 0.4 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 11.1 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 19.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.1 0.0 0.7 3.8 0.0 0.0 0.0 15.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.0 10.5 1.2 6.8 7.7 0.9 3.9 2.9 1.4 2.6 0.0 0.0 0.0 1.7 24.3 7.4 4.3 0.0 0.0 0.0 0.0 21.6 0.1 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.1 0.9 0.8 0.0 0.0 0.2 1.6 1.7 0.0 0.0 0.0 0.3 0.0 6.8 0.0 0.6 14.6 0.0 0.0 0.0 0.0 19.3 0.0 2.0 0.2 1.7 48.8 0.1 0.0 0.4 2.1 POU3F3 "BRN1, OTF8" ENSG00000198914 "POU class 3 homeobox 3" P20264 2 104855511-104858574 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "brain: 18.9;epididymis: 27.2;kidney: 23.7;seminal vesicle: 12.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 55.8;Distal tubular cells: 23.2" "Group enriched" "Detected in some" 6 "glioma: 21.5;renal cancer: 24.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 27.6;AN3-CA: 26.4;HEK 293: 10.2;RPTEC TERT1: 31.4;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052792, HPA056039, HPA067151" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790" "unprognostic (3.05e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (4.26e-5)" "unprognostic (9.66e-2)" "unprognostic (1.97e-1)" "unprognostic (4.69e-1)" "unprognostic (1.16e-1)" "unprognostic (7.28e-2)" "unprognostic (1.15e-3)" "unprognostic (7.15e-2)" 0.2 0.2 9.0 0.1 8.6 0.0 0.1 4.3 18.9 0.0 0.3 0.0 0.0 27.2 0.0 0.0 0.0 0.0 9.9 6.0 23.7 0.0 0.0 0.1 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.1 0.0 0.5 0.0 0.0 10.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.9 0.2 0.3 0.2 0.0 0.0 0.0 27.6 26.4 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.9 0.6 0.0 31.4 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.8 1.0 0.0 0.0 0.0 55.8 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PPARA "hPPAR, NR1C1, PPAR" ENSG00000186951 "Peroxisome proliferator activated receptor alpha" Q07869 22 46150521-46243756 "FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 93.5;Hepatocytes: 134.7;Rod photoreceptor cells: 152.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 12.1;plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;granulocytes: 12.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058901, HPA067049, CAB075701" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB075701: , HPA058901: AB_2683849, HPA067049: AB_2685770" "unprognostic (1.96e-1)" "unprognostic (2.19e-1)" "unprognostic (1.02e-1)" "unprognostic (4.76e-2)" "unprognostic (3.94e-3)" "unprognostic (4.30e-2)" "unprognostic (1.24e-1)" "unprognostic (4.94e-2)" "unprognostic (2.95e-1)" "unprognostic (5.52e-3)" "unprognostic (4.50e-2)" "unprognostic (1.01e-1)" "prognostic favorable (4.39e-9)" "unprognostic (4.84e-2)" "unprognostic (2.76e-1)" "unprognostic (1.23e-1)" "unprognostic (3.18e-2)" 5.7 6.6 5.8 6.0 6.2 4.2 6.9 2.6 4.5 3.8 11.8 5.9 9.9 13.9 4.8 6.6 6.3 3.9 9.1 19.6 5.1 4.1 17.8 30.9 3.8 3.4 6.1 4.9 9.1 13.4 6.6 3.5 3.1 7.8 6.2 7.1 13.5 8.1 8.2 17.1 5.8 19.7 5.0 4.7 3.5 5.7 2.7 7.1 1.3 5.4 10.4 4.8 7.3 12.3 1.5 3.8 12.1 1.4 0.9 1.5 0.3 6.9 1.7 2.2 7.7 12.4 8.0 4.9 6.1 12.1 6.6 6.8 3.4 3.4 2.5 3.1 14.1 6.0 3.1 6.5 8.0 5.9 7.2 8.3 7.7 4.4 7.1 7.7 5.3 13.3 6.3 6.4 4.8 11.1 5.6 1.4 5.7 2.8 5.8 6.1 1.8 6.0 1.9 0.3 5.8 1.7 7.1 8.0 3.2 4.5 4.1 2.2 6.6 2.3 2.2 7.7 3.2 2.5 4.1 2.3 6.8 7.4 6.2 2.6 5.9 3.4 1.0 10.7 6.0 2.1 1.7 1.0 12.1 1.4 1.4 1.2 1.0 0.7 0.7 0.7 1.5 0.8 0.6 0.8 0.9 0.8 3.8 1.5 0.3 5.8 6.2 2.6 4.5 5.1 4.1 6.1 4.9 7.8 7.1 3.0 9.9 5.2 13.1 20.7 14.7 84.0 25.5 2.7 7.9 7.0 58.9 6.8 8.3 7.2 0.4 16.1 66.1 93.5 14.3 5.4 13.0 13.9 4.7 134.7 7.4 4.8 19.1 20.9 22.5 0.4 18.1 9.6 3.3 11.8 34.6 15.2 11.6 24.6 28.3 36.9 152.6 6.5 14.4 0.7 1.7 29.9 2.5 7.5 31.6 17.9 PPARG "NR1C3, PPARG1, PPARG2, PPARgamma" ENSG00000132170 "Peroxisome proliferator activated receptor gamma" P37231 3 12287368-12434356 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Diabetes mellitus, Disease mutation, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 97.6;breast: 102.1" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 90.9;Extravillous trophoblasts: 187.1;Urothelial cells: 210.8" "Cancer enhanced" "Detected in all" "urothelial cancer: 33.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.8;intermediate monocyte: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 47.9;ASC TERT1: 27.3;BEWO: 56.5;CAPAN-2: 25.2;HSkMC: 28.1;RT4: 34.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB004282, HPA051239, HPA063663" Approved Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081" "unprognostic (7.35e-3)" "unprognostic (3.27e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-2)" "unprognostic (2.41e-2)" "unprognostic (5.27e-3)" "prognostic unfavorable (3.41e-5)" "unprognostic (9.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (2.77e-1)" "prognostic favorable (1.59e-8)" "unprognostic (1.51e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-3)" "prognostic favorable (5.52e-5)" 97.6 1.6 1.9 17.1 1.2 0.7 102.1 1.5 1.3 3.1 24.9 0.8 2.1 7.5 3.5 2.2 2.8 2.4 8.7 12.5 1.4 0.9 6.7 5.9 24.8 11.4 1.1 0.9 6.7 1.2 2.8 0.3 26.8 0.9 10.4 13.9 1.1 5.8 1.5 5.0 2.7 9.6 7.4 1.2 7.0 11.9 3.5 0.6 0.9 6.2 4.3 2.1 30.2 14.1 0.0 0.4 0.0 2.3 0.0 0.7 0.3 9.7 8.7 0.0 0.0 47.9 27.3 56.5 0.9 10.5 1.3 0.5 1.8 25.2 0.0 0.0 0.9 17.1 4.0 3.5 0.1 0.2 23.5 4.9 0.0 1.9 2.3 12.8 0.0 0.0 28.1 2.3 2.4 9.1 5.0 0.1 0.2 0.0 0.0 2.0 2.5 0.0 0.1 0.1 22.7 25.2 0.0 0.0 0.0 7.2 34.5 0.0 0.2 4.1 1.5 0.5 1.7 0.0 7.8 7.9 1.8 2.6 1.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.0 1.8 0.0 0.0 2.3 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.3 1.9 1.2 1.5 1.3 1.4 0.9 1.1 0.9 0.9 0.6 3.0 7.4 0.0 33.7 0.9 0.5 5.2 2.5 2.7 3.4 5.2 0.0 90.9 1.7 0.1 2.6 17.7 47.1 0.0 0.6 187.1 4.3 35.2 9.2 3.8 46.3 0.0 8.1 19.6 14.5 0.8 3.7 8.6 3.3 2.8 20.5 0.5 10.2 42.1 0.0 11.3 0.0 12.9 5.7 7.9 21.8 1.0 74.4 1.3 16.6 210.8 PPHLN1 ENSG00000134283 "Periphilin 1" Q8NEY8 12 42238447-42459715 "Predicted intracellular proteins" "Keratinization, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 85.8" "Low region specificity" "Detected in all" "HPA038902, HPA038903" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA038902: AB_10674844, HPA038903: AB_2676263" "unprognostic (4.06e-2)" "unprognostic (1.66e-1)" "unprognostic (6.51e-2)" "unprognostic (2.61e-2)" "unprognostic (1.80e-1)" "unprognostic (7.92e-2)" "prognostic unfavorable (1.28e-7)" "unprognostic (2.85e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-2)" "unprognostic (1.58e-1)" "unprognostic (4.42e-3)" "prognostic unfavorable (5.06e-5)" "unprognostic (3.16e-1)" "unprognostic (3.08e-1)" "unprognostic (3.22e-3)" "unprognostic (2.04e-2)" 25.6 32.4 29.0 37.2 34.2 37.6 27.8 43.0 32.2 24.3 23.7 18.9 27.7 19.2 35.3 27.7 27.0 25.3 24.5 29.0 25.6 28.7 25.2 25.2 23.0 44.3 23.8 35.0 30.6 21.3 20.7 39.9 24.2 26.3 22.6 27.1 21.6 31.1 24.9 32.0 26.1 26.9 28.3 24.6 30.5 23.1 48.4 24.9 51.4 23.1 28.6 47.2 28.1 25.3 25.0 24.1 23.1 14.5 23.7 33.2 12.2 14.7 13.8 16.4 13.6 14.8 16.5 14.5 17.4 19.8 18.3 15.2 22.2 18.7 25.2 22.1 18.5 8.6 13.8 16.8 18.2 22.6 21.6 17.5 39.4 14.2 20.1 15.6 46.4 22.8 19.6 18.7 14.5 14.0 20.9 22.8 22.2 19.2 19.5 20.0 11.3 26.0 28.0 14.2 40.5 13.7 22.2 18.7 23.1 28.5 13.1 11.6 17.1 15.3 12.4 14.9 16.3 18.9 23.3 15.7 10.7 19.1 10.3 14.9 22.5 31.3 40.6 18.1 85.8 7.0 21.0 12.8 23.1 19.3 14.5 23.2 25.0 24.7 25.9 24.1 21.1 22.7 22.6 8.3 23.7 13.4 22.9 33.2 12.2 29.0 34.2 43.0 32.2 25.6 28.7 23.8 35.0 26.3 24.9 38.7 47.5 78.2 56.2 67.3 59.8 29.5 45.9 54.9 54.6 40.1 27.5 73.8 31.5 53.2 175.7 43.2 30.4 23.3 59.6 62.8 45.5 38.3 54.4 29.8 46.7 35.0 32.3 38.1 37.1 48.4 54.1 61.7 60.8 100.0 34.6 43.3 55.2 38.6 49.1 39.8 57.0 51.8 37.6 123.1 54.7 51.7 37.0 76.2 39.2 43.7 PPIL2 "CYC4, Cyp-60, UBOX7" ENSG00000100023 "Peptidylprolyl isomerase like 2" Q13356 22 21666009-21700015 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "K-562: 71.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035344, HPA055637" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035344: AB_10672863, HPA055637: AB_2682869" "unprognostic (1.97e-3)" "unprognostic (3.61e-2)" "unprognostic (2.70e-2)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (2.90e-3)" "unprognostic (5.16e-3)" "unprognostic (3.77e-2)" "unprognostic (9.46e-2)" "unprognostic (1.54e-1)" "unprognostic (2.33e-2)" "unprognostic (1.89e-2)" "unprognostic (2.45e-3)" "unprognostic (5.46e-2)" "unprognostic (5.39e-2)" "unprognostic (5.39e-2)" "unprognostic (1.54e-3)" 15.0 21.5 19.4 20.9 24.6 16.6 13.5 24.1 30.9 17.7 17.4 25.3 19.1 18.6 21.8 17.0 22.3 15.7 16.5 20.0 17.2 17.1 21.2 20.3 14.6 23.7 15.6 20.9 16.6 31.4 23.6 30.2 31.4 19.0 19.5 17.6 23.6 22.0 16.5 25.5 17.5 19.1 15.2 15.0 21.3 19.5 18.4 17.6 32.8 27.0 13.6 33.5 17.4 16.2 8.7 11.7 4.8 17.3 12.8 13.2 9.1 6.6 6.9 8.1 8.5 8.3 7.1 7.3 8.7 6.2 10.7 9.2 7.0 4.4 11.5 5.3 9.7 5.4 9.8 10.8 7.5 6.4 7.1 11.1 10.7 6.9 8.3 6.0 16.9 10.1 7.7 6.8 7.6 5.8 6.5 9.2 7.3 71.2 8.3 7.6 10.4 7.6 4.6 7.8 12.4 4.3 9.8 12.0 2.3 5.4 6.7 12.7 6.9 7.9 12.7 2.9 5.0 9.1 5.7 11.1 6.7 11.0 7.9 5.5 9.6 7.0 8.7 7.6 6.4 8.1 1.0 8.6 4.7 9.5 13.9 11.4 7.0 11.1 12.0 11.7 8.7 9.8 8.9 4.8 12.8 17.3 11.1 13.2 9.1 19.4 24.6 24.1 30.9 17.2 17.1 15.6 20.9 19.0 17.6 8.9 25.6 20.6 7.3 2.9 22.7 4.0 30.6 6.7 17.0 14.0 31.4 13.2 11.6 10.6 57.9 5.4 16.9 0.0 14.6 12.4 5.7 12.9 16.2 16.6 13.2 17.5 10.9 11.1 24.4 67.5 11.2 14.4 1.7 10.0 20.5 12.3 15.0 17.3 12.7 7.0 29.8 0.0 4.4 18.6 16.3 5.0 18.5 15.9 18.4 10.3 PPIL4 ENSG00000131013 "Peptidylprolyl isomerase like 4" Q8WUA2 6 149504733-149546038 "Enzymes, Predicted intracellular proteins" "Isomerase, RNA-binding, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031599, HPA031600" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031599: AB_2673950, HPA031600: AB_10600928" "unprognostic (6.12e-2)" "unprognostic (4.90e-2)" "unprognostic (3.85e-2)" "unprognostic (8.42e-2)" "unprognostic (7.53e-2)" "unprognostic (6.36e-3)" "unprognostic (2.91e-3)" "unprognostic (2.22e-1)" "unprognostic (4.22e-2)" "unprognostic (1.09e-1)" "unprognostic (2.38e-1)" "unprognostic (4.62e-2)" "unprognostic (3.88e-2)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" "unprognostic (8.50e-2)" "unprognostic (7.94e-2)" 20.0 20.1 20.6 15.0 35.5 30.6 21.2 35.1 27.8 24.0 15.3 19.7 10.1 14.1 21.1 27.2 15.7 18.0 19.8 18.3 21.3 15.6 18.8 23.0 17.9 15.7 20.9 18.0 32.9 16.0 20.8 36.6 22.6 23.9 20.5 16.8 15.7 18.2 16.7 14.8 15.4 16.0 20.0 22.7 17.6 16.0 15.9 19.4 27.0 26.8 8.2 16.8 22.0 19.2 21.4 16.6 24.9 17.8 28.7 24.6 14.8 11.1 6.0 21.0 17.3 12.5 16.4 19.6 22.0 21.0 24.1 25.7 12.6 11.4 11.8 15.2 16.9 14.4 10.1 16.0 8.4 38.3 17.1 15.1 13.0 13.2 21.6 19.7 23.6 11.1 12.8 14.4 24.6 20.6 13.5 13.1 8.6 28.3 7.1 18.7 11.9 13.4 20.3 16.6 11.2 9.5 18.2 19.4 5.9 18.3 8.5 12.4 9.5 26.2 11.5 15.0 15.2 13.5 17.2 15.3 16.0 12.5 28.3 20.9 9.4 4.8 18.5 13.5 19.0 23.0 24.9 16.1 18.1 14.7 17.8 20.4 21.4 19.5 16.9 16.6 16.6 24.6 18.7 13.4 28.7 16.1 16.2 20.7 14.8 20.6 35.5 35.1 27.8 21.3 15.6 20.9 18.0 23.9 19.4 62.5 64.3 22.6 54.3 43.4 44.2 33.3 17.8 80.3 61.4 43.6 7.9 43.1 36.5 34.7 17.2 37.3 15.2 0.0 23.1 37.9 55.5 27.1 73.0 18.7 31.8 27.0 22.3 30.7 21.3 9.6 57.2 29.9 38.8 47.7 19.7 40.0 26.4 22.9 52.6 27.5 35.5 51.8 68.4 58.2 53.4 39.5 54.6 41.5 20.0 32.7 PPM1G "PP2CG, PP2Cgamma" ENSG00000115241 "Protein phosphatase, Mg2+/Mn2+ dependent 1G" O15355 2 27381194-27409687 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 93.3" "Cell type enhanced" "Detected in all" 17 "Early spermatids: 1236.5;Late spermatids: 2467.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035530, HPA035531" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035530: AB_10670021, HPA035531: AB_10610283" "unprognostic (7.50e-2)" "unprognostic (8.89e-2)" "unprognostic (1.53e-1)" "unprognostic (1.02e-1)" "unprognostic (2.27e-1)" "unprognostic (4.15e-2)" "prognostic unfavorable (3.14e-7)" "unprognostic (9.36e-3)" "unprognostic (7.73e-2)" "prognostic favorable (6.08e-5)" "unprognostic (3.74e-2)" "unprognostic (1.23e-1)" "unprognostic (7.46e-3)" "unprognostic (1.06e-2)" "unprognostic (5.33e-2)" "unprognostic (1.78e-1)" "unprognostic (7.83e-2)" 12.7 17.0 9.9 19.9 9.2 19.4 30.2 10.9 19.3 17.9 14.6 9.1 16.9 12.1 26.8 12.5 19.4 19.2 17.7 13.6 8.8 7.6 12.6 18.6 14.7 20.2 9.4 8.0 13.4 18.6 13.8 13.2 11.4 8.7 10.2 16.4 9.1 16.4 18.7 24.1 10.9 12.2 14.9 6.7 14.7 14.1 93.3 8.4 25.8 14.1 19.1 22.5 25.2 17.3 20.2 40.3 24.5 29.1 22.7 38.3 19.0 50.9 42.1 30.9 23.7 19.7 16.1 28.5 31.8 20.9 38.2 30.7 64.8 27.0 60.2 23.4 22.5 32.5 27.9 51.9 35.7 34.4 25.1 42.2 58.6 30.7 68.4 17.8 57.8 24.8 17.4 20.7 38.9 31.4 18.2 36.5 29.9 49.0 18.7 28.9 45.6 42.9 62.8 44.9 35.4 30.4 44.4 64.8 31.6 25.8 35.6 41.6 47.1 28.5 31.6 22.8 25.6 17.5 19.0 29.3 28.6 34.6 25.0 48.2 40.8 45.7 95.2 22.4 47.4 21.4 22.1 17.8 24.5 26.9 22.3 26.5 20.2 28.7 27.9 28.5 18.0 21.7 22.4 9.1 22.7 29.1 40.3 38.3 19.0 9.9 9.2 10.9 19.3 8.8 7.6 9.4 8.0 8.7 8.4 59.6 43.5 61.1 65.0 72.0 42.0 33.6 50.9 61.6 66.0 66.3 27.5 71.4 28.2 97.8 1236.5 66.3 54.6 23.3 120.2 139.9 42.7 66.0 58.8 37.8 76.1 46.1 77.4 35.6 49.4 2467.5 65.0 65.1 23.6 147.9 59.6 64.9 122.3 42.1 66.8 48.3 34.6 45.3 45.8 594.3 323.3 70.4 44.4 79.7 83.2 121.2 PPP1R10 "CAT53, FB19, p99, PNUTS" ENSG00000204569 "Protein phosphatase 1 regulatory subunit 10" Q96QC0 6 30600400-30618612 "Predicted intracellular proteins" "DNA-binding, Protein phosphatase inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025501, HPA047248, HPA056756" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227" "unprognostic (1.68e-1)" "prognostic favorable (4.84e-4)" "unprognostic (1.21e-1)" "unprognostic (9.31e-3)" "unprognostic (6.31e-2)" "unprognostic (9.57e-3)" "unprognostic (2.02e-1)" "unprognostic (1.36e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "prognostic favorable (9.74e-5)" "unprognostic (2.72e-1)" "unprognostic (8.02e-3)" "unprognostic (5.90e-2)" "unprognostic (1.76e-1)" "unprognostic (2.89e-1)" "unprognostic (3.74e-2)" 11.5 19.1 10.8 19.6 12.6 5.2 17.4 18.8 16.2 20.4 13.0 24.2 17.0 12.6 14.7 13.0 14.7 15.2 16.4 9.7 15.9 10.3 14.0 20.4 14.6 14.1 14.5 12.4 16.0 21.6 28.8 17.9 10.1 10.4 14.9 15.5 19.6 12.8 21.0 14.1 12.8 13.0 15.4 14.1 17.4 15.6 21.6 11.8 33.5 16.6 12.5 17.0 14.7 13.2 4.8 6.1 6.2 5.4 1.8 5.7 3.5 5.4 6.8 8.7 7.1 7.9 5.4 4.6 5.4 7.0 7.9 6.6 7.3 3.4 5.3 4.0 4.6 7.1 8.5 10.2 10.1 6.0 5.8 5.5 6.6 5.9 3.5 8.1 5.8 6.5 6.4 5.9 6.9 14.4 6.2 7.1 10.5 6.1 6.7 6.9 6.8 7.3 4.9 4.4 4.7 4.8 7.7 9.0 10.3 7.9 6.8 12.1 5.3 7.1 6.8 6.1 7.1 6.8 7.1 4.4 6.1 5.3 6.7 4.4 12.4 6.7 5.8 5.7 6.7 5.3 6.2 5.1 5.6 5.3 4.5 5.7 4.8 3.7 4.3 5.6 4.0 3.5 3.9 6.2 1.8 5.4 6.1 3.9 3.5 10.8 12.6 18.8 16.2 15.9 10.3 14.5 12.4 10.4 11.8 29.8 32.3 50.6 46.1 62.0 63.4 50.4 25.5 45.5 28.4 26.2 123.7 37.8 29.9 22.0 27.0 59.5 73.1 0.0 20.0 22.1 35.9 41.1 42.8 30.7 28.6 33.4 68.5 38.6 27.8 7.7 42.8 51.6 35.4 33.3 69.9 54.1 26.0 52.6 28.3 33.7 94.6 32.3 49.7 44.2 23.8 68.1 74.0 50.1 58.1 29.5 PPP1R26 KIAA0649 ENSG00000196422 "Protein phosphatase 1 regulatory subunit 26" Q5T8A7 9 135479079-135488893 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044686, HPA063817" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044686: AB_10795987, HPA063817: " "unprognostic (1.79e-1)" "unprognostic (8.80e-3)" "prognostic unfavorable (3.98e-4)" "prognostic favorable (9.91e-4)" "unprognostic (2.67e-1)" "unprognostic (1.21e-1)" "unprognostic (1.09e-1)" "unprognostic (8.79e-2)" "unprognostic (1.50e-1)" "unprognostic (2.38e-1)" "prognostic favorable (6.93e-4)" "unprognostic (9.23e-2)" "prognostic favorable (6.20e-13)" "unprognostic (4.46e-3)" "unprognostic (8.31e-2)" "unprognostic (3.94e-1)" "unprognostic (2.07e-3)" 5.2 6.2 13.8 3.0 10.1 1.0 8.4 3.0 18.2 6.0 6.4 6.9 12.4 7.9 5.0 6.4 5.1 9.0 8.1 11.3 13.2 10.2 8.1 6.6 8.9 2.1 8.3 9.6 7.5 12.5 22.9 11.9 5.4 9.1 7.4 4.4 8.9 13.3 10.8 6.9 4.0 8.0 8.1 5.7 4.7 11.4 6.1 7.3 1.1 8.2 2.8 4.5 7.4 3.7 0.6 1.7 3.0 1.3 2.6 0.6 0.4 6.7 10.2 5.5 5.6 2.3 2.0 0.0 3.7 5.1 5.1 3.4 9.9 11.8 0.0 7.1 3.6 13.0 25.3 5.0 4.8 1.7 0.3 5.6 0.1 15.4 7.3 5.5 3.3 12.6 1.4 9.0 2.5 6.3 5.6 3.2 0.0 6.7 0.0 2.9 15.4 0.1 1.0 8.0 13.9 14.1 0.0 9.6 11.2 4.9 9.1 8.4 12.4 6.6 9.3 6.9 4.5 7.1 3.0 3.8 1.9 8.6 9.1 4.2 5.2 12.3 0.2 4.0 0.6 4.8 0.0 1.3 3.0 0.4 0.4 0.0 0.6 0.2 0.0 1.7 0.4 0.0 0.0 0.3 2.6 0.6 0.3 0.6 0.4 13.8 10.1 3.0 18.2 13.2 10.2 8.3 9.6 9.1 7.3 3.0 4.8 0.0 2.0 1.9 10.1 7.3 17.8 2.7 2.3 7.0 7.9 0.4 5.0 5.2 0.2 2.3 5.2 0.0 2.9 0.7 2.3 4.1 2.3 4.9 4.8 1.6 6.3 4.3 2.4 0.0 1.1 1.1 3.3 0.0 9.7 7.2 6.1 7.0 1.8 3.9 7.7 0.0 1.7 0.3 3.6 1.5 0.2 0.0 6.5 2.3 PPP1R8 "ard-1, ARD1, NIPP-1, NIPP1, PRO2047" ENSG00000117751 "Protein phosphatase 1 regulatory subunit 8" Q12972 1 27830778-27851676 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein phosphatase inhibitor, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027406, HPA027417, HPA027452" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA027406: AB_1854488, HPA027417: AB_1854489, HPA027452: AB_1854490" "unprognostic (5.61e-2)" "unprognostic (2.55e-1)" "unprognostic (4.42e-3)" "unprognostic (3.76e-2)" "unprognostic (2.00e-2)" "unprognostic (9.09e-3)" "prognostic unfavorable (2.19e-5)" "unprognostic (4.82e-2)" "unprognostic (2.14e-3)" "unprognostic (2.20e-1)" "unprognostic (3.16e-2)" "unprognostic (9.16e-2)" "unprognostic (6.26e-2)" "unprognostic (8.08e-2)" "unprognostic (2.91e-2)" "unprognostic (4.86e-2)" "unprognostic (2.58e-2)" 18.0 14.5 28.6 15.5 37.0 23.2 19.4 23.1 29.7 18.9 16.0 18.2 12.0 13.3 24.0 15.6 19.6 19.4 14.6 16.2 23.4 17.7 13.9 14.8 17.6 28.6 24.6 25.7 24.6 18.5 14.2 18.9 17.4 24.4 15.3 18.0 11.7 15.1 19.5 17.8 17.8 15.1 21.8 24.6 16.9 14.3 21.4 25.6 20.7 17.9 9.4 24.6 18.6 16.0 11.9 9.7 17.0 11.4 14.0 16.5 14.9 21.1 15.0 32.7 21.2 20.6 21.6 18.8 22.8 24.0 39.1 31.7 16.8 24.4 30.3 16.1 25.9 15.2 19.1 38.4 21.3 28.4 25.4 23.4 39.5 20.4 24.7 20.8 36.3 28.1 18.8 23.3 35.4 31.7 17.6 23.1 26.0 33.4 20.7 23.2 13.8 39.6 21.4 40.4 18.7 17.5 32.5 27.1 28.8 21.0 19.5 22.9 20.9 28.0 21.9 27.0 17.5 19.2 22.9 19.0 19.3 17.6 30.2 21.1 19.2 29.3 38.3 18.8 47.4 24.6 17.0 10.0 9.1 14.0 10.0 16.5 11.6 11.6 15.8 9.7 11.9 12.8 12.1 5.9 14.0 11.4 7.3 11.4 14.9 28.6 37.0 23.1 29.7 23.4 17.7 24.6 25.7 24.4 25.6 14.9 7.7 28.1 17.4 15.3 22.6 11.5 7.6 18.7 20.5 5.2 2.0 41.6 26.6 24.8 26.4 14.6 12.6 0.0 22.4 34.1 19.0 13.0 25.4 15.8 23.1 7.9 11.1 20.3 14.3 18.7 22.2 16.9 10.1 40.5 14.5 19.8 24.7 16.1 15.9 19.9 13.9 25.8 16.4 27.9 40.2 12.3 36.7 24.5 15.3 17.4 PPP3CA "CALN, CALNA, CNA1, PPP2B" ENSG00000138814 "Protein phosphatase 3 catalytic subunit alpha" Q08209 4 101023409-101348278 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase, Protein phosphatase" "Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.8" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 7 "prostate cancer: 98.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012778, CAB018581" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 35000 Nucleoplasm Cytosol "CAB018581: AB_2168324, HPA012778: AB_1855660" "unprognostic (6.66e-2)" "unprognostic (1.96e-1)" "unprognostic (3.40e-1)" "unprognostic (1.36e-1)" "unprognostic (1.56e-1)" "unprognostic (7.81e-2)" "unprognostic (1.77e-2)" "unprognostic (1.08e-1)" "unprognostic (7.87e-2)" "unprognostic (3.49e-3)" "prognostic unfavorable (3.82e-4)" "unprognostic (3.38e-2)" "unprognostic (2.51e-2)" "unprognostic (5.12e-2)" "unprognostic (1.98e-1)" "unprognostic (1.84e-2)" "unprognostic (5.74e-2)" 12.2 9.2 22.7 7.4 71.8 7.7 10.6 42.1 52.4 9.4 9.5 4.8 9.8 5.8 6.2 6.9 7.4 7.2 6.8 4.3 36.0 13.5 5.8 8.4 10.0 6.7 10.1 22.1 9.6 4.7 7.0 4.2 6.6 11.9 34.6 8.4 2.6 10.4 21.1 23.7 11.4 6.4 7.9 7.5 6.9 11.0 5.3 13.0 3.8 6.8 6.8 8.9 8.4 6.8 27.7 18.3 44.3 14.9 22.3 15.5 6.6 19.4 13.8 3.8 7.5 21.6 16.4 7.4 21.5 19.8 8.7 9.2 8.0 24.4 9.3 9.0 19.4 10.8 9.8 13.9 28.6 14.8 22.7 6.4 14.7 19.8 10.2 15.9 23.6 7.5 17.0 15.0 19.0 21.8 16.6 16.3 6.0 5.7 25.6 13.9 23.4 4.9 17.7 6.4 22.5 9.0 9.0 35.0 10.7 8.4 15.4 30.4 11.5 17.7 15.2 10.3 5.5 13.6 13.5 19.0 20.6 23.5 18.8 14.2 12.0 12.2 16.4 11.4 13.4 5.5 24.6 11.8 24.8 13.6 11.4 15.5 27.7 12.9 13.1 9.9 23.4 6.2 12.3 44.3 22.3 14.9 18.3 8.6 6.6 22.7 71.8 42.1 51.5 36.0 13.5 10.1 22.1 11.9 13.0 71.5 48.8 59.1 33.3 149.9 74.7 24.1 33.1 32.1 20.5 29.6 37.3 28.9 28.2 18.2 1.8 105.6 33.9 0.0 27.3 76.5 53.9 157.6 33.6 37.0 32.1 17.5 122.2 43.6 52.2 4.7 60.1 49.5 87.7 44.1 39.6 19.3 41.1 107.8 57.3 31.7 81.9 12.9 39.4 7.2 22.1 150.4 23.0 55.4 39.9 32.0 PPP4R2 ENSG00000163605 "Protein phosphatase 4 regulatory subunit 2" Q9NY27 3 72996785-73069199 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034695, HPA039837, HPA073758" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA034695: AB_10671231, HPA039837: AB_2676707, HPA073758: AB_2686632" "unprognostic (4.60e-2)" "unprognostic (2.75e-1)" "unprognostic (3.98e-3)" "unprognostic (5.62e-2)" "unprognostic (8.86e-2)" "unprognostic (4.64e-2)" "unprognostic (2.38e-1)" "unprognostic (1.95e-1)" "unprognostic (1.11e-1)" "unprognostic (2.13e-3)" "unprognostic (1.87e-2)" "unprognostic (2.86e-3)" "unprognostic (1.67e-2)" "unprognostic (4.63e-2)" "unprognostic (1.71e-1)" "unprognostic (1.23e-1)" "unprognostic (3.35e-1)" 16.7 19.6 18.3 17.2 25.9 57.7 17.7 18.0 23.4 19.7 17.5 15.7 10.7 16.1 18.0 13.2 15.9 18.7 15.6 24.5 18.6 14.2 15.8 34.0 17.6 15.8 30.8 14.8 24.0 15.1 21.0 20.2 28.5 20.5 14.3 16.2 13.4 16.1 12.0 27.2 12.1 18.1 15.9 20.8 17.1 14.0 17.0 25.8 28.4 17.1 9.8 16.5 14.4 18.8 7.1 14.3 17.7 4.7 8.5 13.6 3.2 12.6 14.8 31.7 19.3 17.0 15.0 19.2 25.3 17.9 23.1 24.2 21.6 15.2 23.7 14.8 15.2 22.0 9.0 24.6 14.1 30.0 36.1 9.2 26.9 16.7 25.5 18.6 39.0 28.1 16.1 21.0 27.8 22.8 16.1 16.4 24.5 23.7 27.4 19.0 18.3 32.4 17.4 29.1 18.8 12.3 30.5 17.9 22.0 19.4 33.8 7.6 18.9 29.5 19.5 23.4 24.1 17.8 22.2 17.9 20.8 25.0 23.8 21.5 17.1 35.0 46.9 14.6 30.2 23.2 5.4 4.7 10.7 10.6 2.6 11.7 5.5 10.9 10.9 4.0 7.1 9.6 8.7 17.7 8.5 4.1 14.3 13.6 3.2 18.3 25.9 18.0 23.4 18.6 14.2 30.8 14.8 20.5 25.8 53.6 23.0 41.6 103.2 104.1 49.6 47.9 48.4 57.6 52.4 26.2 13.7 62.2 16.6 53.0 36.6 47.4 48.4 46.7 46.6 59.6 54.0 103.0 29.0 63.5 37.8 47.7 51.6 33.2 36.2 6.8 49.5 45.3 54.0 37.9 52.8 50.0 57.3 56.9 45.6 38.3 34.0 38.8 45.8 101.1 66.9 95.4 115.7 31.6 45.2 114.6 PPP6R3 "C11orf23, DKFZp781E17107, DKFZp781E2374, DKFZp781O2362, FLJ11058, FLJ43065, KIAA1558, MGC125711, MGC125712, PP6R3, SAP190, SAPL, SAPLa, SAPS3" ENSG00000110075 "Protein phosphatase 6 regulatory subunit 3" Q5H9R7 11 68460731-68615334 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017183, HPA038467, HPA038468" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "CAB017183: , HPA038467: AB_2676029, HPA038468: AB_2676030" "unprognostic (9.46e-3)" "unprognostic (1.45e-1)" "unprognostic (4.62e-2)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (6.19e-2)" "unprognostic (1.97e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (3.33e-2)" "unprognostic (1.02e-1)" "unprognostic (2.38e-2)" "unprognostic (2.20e-3)" "unprognostic (3.29e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (1.54e-2)" "unprognostic (6.43e-2)" 33.0 29.8 16.7 25.7 24.1 36.5 26.8 35.7 25.8 33.2 29.6 27.9 24.9 21.5 43.8 24.3 29.9 26.6 24.6 27.5 17.3 16.5 28.8 28.2 27.9 26.8 25.0 18.5 36.4 23.8 49.0 48.1 40.0 23.7 28.3 27.5 28.2 28.2 29.2 46.4 25.8 31.5 35.5 24.3 31.1 27.7 28.2 24.0 45.5 39.2 34.8 31.8 34.3 26.9 14.8 15.0 16.9 16.7 11.7 17.7 7.1 24.4 29.0 30.1 21.0 16.1 16.4 23.3 21.5 20.9 25.0 23.0 50.3 24.9 28.2 21.2 20.0 26.4 23.2 33.0 24.3 33.2 27.3 13.9 32.6 29.5 16.9 15.4 30.9 29.2 16.2 16.4 25.7 27.9 14.1 22.8 22.7 27.5 21.1 17.8 32.8 31.0 23.9 15.0 48.5 17.2 29.2 41.0 27.4 16.7 35.6 17.0 20.3 30.5 24.2 44.3 26.2 35.9 16.6 22.6 24.7 23.4 26.2 18.2 16.7 23.2 37.1 17.9 13.7 26.2 14.6 11.5 14.4 14.7 15.2 14.0 14.1 15.6 14.4 7.4 14.8 17.7 16.1 16.9 11.7 16.7 15.0 15.0 7.1 16.7 24.1 35.7 25.8 17.3 16.5 25.0 18.5 23.7 24.0 41.7 36.5 27.5 21.7 29.5 48.6 33.5 28.1 24.1 38.7 26.2 53.0 16.9 13.3 13.4 59.6 29.4 28.0 23.3 14.3 14.1 23.1 34.0 26.6 21.2 15.0 25.4 29.2 29.4 18.4 17.8 28.7 25.2 20.3 10.8 26.5 31.9 19.2 28.3 29.7 13.5 49.0 19.4 28.1 27.7 29.7 31.0 27.5 26.6 23.4 35.3 PPRC1 "KIAA0595, MGC74642, PRC" ENSG00000148840 "Peroxisome proliferator-activated receptor gamma, coactivator-related 1" Q5VV67 10 102132994-102150331 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 39.4;Suprabasal keratinocytes: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038511, HPA057571" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038511: AB_10672521, HPA057571: AB_2683472" "unprognostic (2.27e-1)" "unprognostic (7.66e-2)" "unprognostic (2.35e-2)" "unprognostic (4.77e-2)" "unprognostic (1.63e-1)" "unprognostic (4.96e-2)" "unprognostic (4.29e-3)" "unprognostic (6.31e-2)" "unprognostic (3.95e-2)" "unprognostic (1.26e-1)" "unprognostic (2.33e-1)" "unprognostic (2.86e-1)" "prognostic unfavorable (6.71e-7)" "unprognostic (8.65e-2)" "unprognostic (4.22e-1)" "unprognostic (1.12e-1)" "unprognostic (4.93e-2)" 18.9 12.0 10.0 20.2 12.3 18.1 14.2 13.1 12.2 13.4 15.6 9.5 9.7 9.1 17.4 10.1 18.4 16.2 14.2 14.4 9.3 6.1 10.3 18.0 18.9 14.2 15.0 7.8 25.4 35.6 13.5 13.1 15.3 10.4 14.2 9.8 10.0 12.6 9.7 32.8 19.6 11.3 17.0 9.7 14.7 14.8 11.5 11.4 13.2 12.2 15.9 19.3 14.2 15.4 4.0 4.6 0.3 2.4 7.6 4.6 2.2 13.3 20.0 12.3 24.6 11.0 11.3 15.8 12.0 16.2 17.3 14.4 22.4 15.4 29.2 10.1 18.0 10.9 25.2 25.0 23.8 15.3 11.9 19.5 27.7 14.3 21.5 14.8 21.8 12.1 15.0 21.4 20.2 38.5 11.5 10.7 12.0 20.6 17.3 13.6 22.9 17.4 30.5 21.1 12.7 11.9 24.4 17.5 12.4 14.8 13.3 8.5 12.4 10.2 11.4 14.3 12.4 18.4 11.5 11.7 13.8 17.5 14.0 26.9 14.5 10.2 26.3 15.6 27.4 6.9 0.0 2.1 0.3 3.6 2.4 4.6 3.1 2.8 4.4 4.6 4.0 3.3 4.1 0.1 7.6 2.3 1.9 1.7 2.2 10.0 12.3 13.1 12.2 9.3 6.1 15.0 7.8 10.4 11.4 26.8 10.4 12.2 29.1 39.4 4.5 7.4 5.1 2.7 12.5 5.2 3.9 6.7 1.7 7.4 0.7 10.5 3.3 0.0 8.3 10.5 11.3 19.5 10.4 7.3 7.7 1.6 8.1 8.6 3.5 1.8 5.8 8.5 8.5 2.8 9.1 2.0 10.6 5.8 6.0 2.2 3.4 6.5 17.6 6.4 11.8 38.0 4.2 5.3 8.1 30.1 PRKDC "DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, p350, XRCC7" ENSG00000253729 "Protein kinase, DNA-activated, catalytic polypeptide" P78527 8 47773108-47960183 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, Ribosome biogenesis" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005167, HPA035174" Supported Enhanced Nucleoplasm NA NA 1100000 Nucleoplasm "CAB005167: AB_2172845, HPA035174: AB_2674504" "unprognostic (3.14e-2)" "unprognostic (3.02e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (8.95e-2)" "unprognostic (1.34e-1)" "unprognostic (7.70e-3)" "unprognostic (5.74e-2)" "unprognostic (1.12e-2)" "unprognostic (1.60e-2)" "unprognostic (7.76e-3)" "unprognostic (7.77e-2)" "unprognostic (2.84e-2)" "unprognostic (2.32e-1)" "unprognostic (2.20e-1)" "unprognostic (6.76e-3)" "unprognostic (2.15e-2)" 21.3 20.5 16.0 22.3 22.0 27.4 30.2 16.5 23.1 19.6 20.6 17.3 18.1 12.0 26.2 14.5 27.4 24.4 13.0 21.1 20.8 15.2 16.7 18.4 17.0 33.6 16.6 18.2 24.6 23.8 33.4 29.4 20.5 17.3 17.9 20.3 17.8 17.9 17.8 34.0 23.9 18.4 27.0 20.3 24.4 19.1 20.5 15.9 44.4 20.8 15.9 27.9 21.3 19.1 17.0 13.9 7.1 11.5 11.5 11.3 2.3 32.9 28.2 27.5 26.1 17.1 18.2 11.6 14.0 13.8 19.8 19.5 18.4 10.9 31.5 12.2 17.2 14.7 18.8 36.3 19.2 31.0 6.9 22.5 61.8 25.4 22.5 7.4 23.5 12.9 13.1 6.3 31.1 32.7 7.6 20.3 21.9 41.1 13.3 21.8 15.5 33.1 19.4 30.2 23.1 8.6 16.2 21.6 11.1 9.9 28.4 13.8 17.5 43.3 14.1 13.6 17.7 20.2 16.2 23.5 25.9 22.0 20.4 28.1 11.6 14.8 45.3 14.6 26.7 20.9 6.7 8.1 3.5 8.7 6.3 10.9 12.6 10.8 8.8 5.9 17.0 11.3 10.3 7.1 11.5 11.5 13.9 7.4 2.3 16.0 22.0 16.5 23.1 20.8 15.2 16.6 18.2 17.3 15.9 35.7 26.0 39.5 30.4 34.1 100.6 65.8 25.5 52.2 39.8 40.1 117.8 48.3 14.9 34.6 26.1 40.5 10.5 0.0 30.9 53.5 37.0 37.2 43.9 39.8 32.1 98.5 24.8 33.7 41.6 10.8 52.6 32.7 18.6 29.7 26.8 69.1 30.3 14.0 65.4 18.7 102.0 51.8 28.8 106.0 117.5 35.5 27.6 38.3 45.0 27.8 PRMT7 "FLJ10640, KIAA1933" ENSG00000132600 "Protein arginine methyltransferase 7" Q9NVM4 16 68310974-68358563 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044241 Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "HPA044241: AB_2678869" "unprognostic (9.33e-2)" "unprognostic (5.33e-2)" "unprognostic (1.52e-1)" "prognostic favorable (2.31e-5)" "unprognostic (2.92e-2)" "unprognostic (1.95e-1)" "unprognostic (4.12e-2)" "unprognostic (1.22e-1)" "unprognostic (3.74e-1)" "unprognostic (1.19e-1)" "unprognostic (4.74e-3)" "unprognostic (3.09e-2)" "unprognostic (7.72e-2)" "unprognostic (1.75e-1)" "unprognostic (9.23e-2)" "unprognostic (3.57e-1)" "unprognostic (1.31e-1)" 14.8 14.4 15.6 12.7 22.0 11.1 12.9 29.4 20.5 11.4 11.7 20.2 13.9 7.0 18.9 11.9 12.7 18.1 9.3 23.1 14.4 13.1 9.5 12.2 9.7 17.0 11.2 18.7 21.9 14.8 12.0 14.0 11.4 13.3 12.8 7.6 20.8 17.3 16.2 34.0 16.9 9.9 18.5 11.6 12.4 9.9 17.0 13.1 24.4 11.1 12.0 14.9 13.3 10.4 10.8 26.2 9.9 8.5 18.6 18.1 11.5 10.2 16.7 8.0 20.0 7.6 7.2 26.7 10.3 5.6 13.1 10.9 42.3 10.3 21.9 17.4 8.7 4.8 13.4 11.3 10.4 7.3 7.8 16.9 6.5 18.8 19.1 5.5 11.9 10.2 8.0 4.5 10.8 10.2 8.1 7.8 11.4 15.4 1.2 7.1 17.2 14.7 18.5 13.1 10.3 11.4 19.8 11.7 14.8 6.1 9.4 10.9 8.5 34.5 8.7 7.0 6.8 14.5 11.9 9.3 9.3 8.3 11.1 9.2 6.7 12.4 22.5 11.8 12.8 9.6 9.9 7.0 5.9 15.8 8.5 18.1 10.1 10.6 13.9 10.2 10.8 16.1 14.1 0.8 18.6 7.7 26.2 11.7 11.5 15.6 22.0 29.4 20.5 14.4 13.1 11.2 18.7 13.3 13.1 17.9 11.7 10.4 7.4 6.2 20.5 11.8 15.3 14.7 9.1 8.7 51.1 21.8 5.0 11.0 3.4 6.8 24.9 0.0 14.4 6.5 8.0 6.2 6.9 7.5 10.2 28.6 12.7 6.7 5.9 3.2 10.9 8.3 8.5 4.6 27.0 9.4 15.1 26.9 12.4 6.8 16.4 12.9 5.7 6.3 20.0 5.3 9.7 15.2 23.3 9.3 PROB1 C5orf65 ENSG00000228672 "Proline rich basic protein 1" E7EW31 5 139390592-139395713 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 37.7" "Cell type enhanced" "Detected in some" 26 "Cardiomyocytes: 25.4;Ito cells: 4.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.1;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "HDLM-2: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA053354, HPA060103" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053354: , HPA060103: AB_2684205" "unprognostic (4.14e-2)" "prognostic favorable (9.26e-4)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (3.53e-2)" "unprognostic (9.27e-3)" "unprognostic (4.72e-2)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "unprognostic (3.21e-2)" "unprognostic (4.84e-4)" "unprognostic (7.10e-2)" "unprognostic (1.75e-2)" "unprognostic (9.05e-2)" "unprognostic (3.62e-2)" "unprognostic (5.89e-2)" "unprognostic (8.24e-2)" 0.6 1.6 0.7 0.3 0.8 0.0 0.3 0.0 0.3 0.3 0.3 0.6 0.5 0.1 0.3 0.7 0.1 6.6 0.7 0.6 0.7 0.0 0.0 0.4 0.5 0.0 0.0 1.8 0.8 0.2 1.3 0.0 0.7 0.6 37.7 0.0 0.8 0.1 0.2 0.3 0.6 0.0 0.1 0.1 0.3 0.1 0.5 1.1 0.0 0.1 0.0 1.1 0.0 0.6 0.4 0.1 0.1 0.0 0.2 0.2 0.5 0.1 0.5 0.5 2.0 1.3 3.0 0.5 1.6 0.0 0.3 0.2 0.0 0.1 48.1 0.6 0.7 1.2 0.2 1.3 0.0 1.6 0.4 0.4 1.2 0.3 0.4 0.1 2.0 0.2 3.0 1.7 0.5 2.5 1.2 0.6 0.3 1.2 7.7 0.2 5.8 0.1 0.0 0.6 0.3 2.8 3.0 0.1 0.7 1.1 1.6 0.2 0.1 0.1 0.1 0.2 0.4 0.8 4.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.1 1.1 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.2 0.0 0.0 0.0 0.2 0.5 0.4 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.3 0.2 0.0 1.1 1.4 0.0 6.5 1.7 0.1 0.3 0.0 2.2 0.0 0.2 0.3 PROX1 ENSG00000117707 "Prospero homeobox 1" Q92786 1 213983181-214041502 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 72.4" "Cell type enhanced" "Detected in many" 17 "Bipolar cells: 195.1;Hepatocytes: 270.2;Horizontal cells: 494.2" "Cancer enhanced" "Detected in many" "liver cancer: 15.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Cell line enhanced" "Detected in some" "Hep G2: 16.0;RH-30: 8.5;SH-SY5Y: 41.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000842, HPA001030, HPA027298" Enhanced Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: " "unprognostic (3.07e-1)" "unprognostic (5.98e-2)" "unprognostic (1.06e-3)" "unprognostic (3.42e-1)" "unprognostic (7.71e-2)" "unprognostic (1.39e-1)" "unprognostic (1.45e-2)" "unprognostic (6.59e-2)" "unprognostic (1.85e-2)" "unprognostic (2.31e-1)" "unprognostic (3.29e-3)" "unprognostic (6.64e-2)" "unprognostic (4.56e-6)" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (6.71e-4)" "unprognostic (1.05e-1)" 2.3 9.6 3.7 2.1 8.1 1.0 2.9 14.0 5.8 1.8 3.0 13.1 0.3 2.7 1.9 2.0 1.5 3.0 2.6 13.1 6.2 4.1 5.4 72.4 2.0 13.5 8.4 4.3 7.3 13.9 1.0 11.4 1.3 5.5 1.4 3.2 2.4 1.1 1.3 4.1 1.5 3.1 1.7 9.6 14.9 2.8 5.9 9.2 0.0 7.5 0.6 1.5 1.6 2.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.1 1.2 0.0 0.0 0.0 0.5 0.3 0.0 16.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.8 1.2 2.8 0.0 0.2 0.0 0.2 0.0 0.8 1.0 0.7 0.0 8.5 1.2 0.1 0.2 1.2 41.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.3 0.1 0.5 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 8.1 14.0 5.8 6.2 4.1 8.4 4.3 5.5 9.2 0.0 2.9 0.0 1.0 5.3 195.1 97.2 84.1 1.4 2.3 8.7 2.0 0.0 13.3 17.3 37.5 17.8 2.6 0.0 2.4 0.1 6.7 2.3 0.0 270.2 0.7 494.2 64.2 4.9 4.5 5.9 1.1 1.1 10.1 0.0 15.2 38.7 5.2 79.3 1.1 0.3 8.6 0.0 2.7 0.2 0.1 4.0 0.0 0.0 8.0 0.6 PRPF3 "hPrp3, Prp3, RP18, SNRNP90" ENSG00000117360 "Pre-mRNA processing factor 3" O43395 1 150321476-150353195 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027226, HPA067116" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027226: AB_1855770, HPA067116: AB_2685783" "unprognostic (2.75e-1)" "unprognostic (3.00e-1)" "unprognostic (2.20e-1)" "unprognostic (2.77e-1)" "unprognostic (1.78e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.59e-5)" "unprognostic (7.89e-2)" "unprognostic (7.13e-3)" "unprognostic (1.04e-2)" "unprognostic (1.42e-1)" "unprognostic (1.04e-2)" "prognostic unfavorable (3.19e-5)" "unprognostic (6.77e-3)" "unprognostic (1.65e-1)" "unprognostic (1.24e-1)" "unprognostic (7.78e-3)" 21.9 18.6 22.1 28.6 24.0 38.4 23.3 37.8 27.5 21.2 20.0 25.6 27.8 16.7 35.7 27.9 18.6 21.5 17.4 17.3 18.9 12.3 17.6 19.7 20.9 26.2 19.6 19.5 32.7 17.4 22.5 41.9 23.5 17.0 22.0 20.3 27.7 18.9 23.2 19.2 21.6 20.1 22.5 23.6 26.8 16.2 18.9 24.0 27.6 27.7 18.1 27.3 20.7 20.9 13.2 9.3 12.4 19.1 9.9 15.6 7.7 16.0 17.4 17.7 11.3 11.9 13.0 24.1 16.8 11.8 26.1 18.1 13.3 15.1 21.3 11.3 13.7 24.4 19.0 32.0 11.8 23.5 10.6 14.8 18.4 25.3 12.6 11.9 22.6 11.9 9.4 16.4 22.2 19.2 12.4 15.8 14.4 21.8 12.9 18.5 23.9 18.5 19.7 25.4 41.4 15.8 27.0 14.4 14.0 10.7 9.7 15.3 13.5 14.1 16.6 12.7 25.0 19.7 54.5 12.5 16.4 12.7 13.8 27.6 12.4 22.2 23.9 10.9 20.5 17.0 6.9 8.6 12.4 15.6 11.4 15.0 13.2 11.3 10.1 9.3 10.2 11.7 12.1 5.2 9.9 19.1 7.5 8.5 7.7 22.1 24.0 37.8 27.5 18.9 12.3 19.6 19.5 17.0 24.0 32.8 22.6 8.6 11.5 10.4 29.6 10.9 5.1 22.7 21.6 10.4 17.7 13.9 11.6 12.9 7.7 17.9 12.4 0.0 10.1 13.5 9.9 9.7 22.0 8.9 10.6 30.2 2.4 12.9 9.1 3.2 18.7 11.2 10.1 11.8 13.3 29.6 11.0 8.6 17.3 4.4 42.9 12.9 14.1 41.1 14.0 8.8 16.7 14.9 10.1 8.8 PRPF38A "FLJ14936, Prp38" ENSG00000134748 "Pre-mRNA processing factor 38A" Q8NAV1 1 52404564-52420839 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053099, HPA058407" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053099: AB_2682044, HPA058407: AB_2683709" "unprognostic (1.29e-1)" "unprognostic (6.12e-2)" "prognostic favorable (7.16e-4)" "unprognostic (1.34e-2)" "unprognostic (8.40e-2)" "unprognostic (2.15e-3)" "prognostic unfavorable (3.83e-5)" "unprognostic (3.83e-2)" "unprognostic (7.84e-3)" "unprognostic (7.06e-2)" "unprognostic (1.62e-1)" "unprognostic (9.69e-2)" "prognostic unfavorable (7.41e-5)" "unprognostic (6.54e-3)" "unprognostic (3.35e-1)" "unprognostic (1.89e-1)" "unprognostic (2.82e-1)" 13.5 13.2 21.5 16.9 19.2 25.4 20.6 30.5 18.5 17.3 17.2 20.7 12.9 12.9 22.1 16.0 15.0 18.0 11.3 11.5 19.1 16.8 15.4 12.1 15.1 22.1 20.3 14.0 28.1 12.6 19.2 19.9 15.9 16.6 17.6 19.1 17.2 13.4 15.1 10.0 17.4 16.2 14.5 19.3 17.8 12.9 18.8 22.1 36.4 19.3 13.7 22.1 14.1 20.1 9.1 9.7 12.5 8.8 13.3 15.3 6.6 8.3 4.1 14.7 7.0 5.9 5.8 8.8 5.7 3.9 9.5 9.2 7.5 4.2 17.3 6.0 3.9 7.4 6.2 20.9 6.2 12.4 9.4 16.0 23.2 15.4 7.7 7.2 25.8 8.6 4.4 5.6 10.4 10.1 7.2 8.0 12.6 21.3 4.5 5.6 4.7 19.9 15.5 18.1 8.9 9.7 19.6 22.3 14.5 8.4 5.0 9.8 12.0 11.6 9.6 11.2 10.4 6.7 21.0 6.2 5.4 8.1 8.0 11.2 8.7 12.4 17.5 8.0 22.6 6.8 12.5 7.5 10.5 9.8 8.8 13.3 9.1 11.0 11.8 9.7 8.5 15.3 11.6 6.0 13.3 8.6 5.4 10.7 6.6 21.5 19.2 30.5 18.5 19.1 16.8 20.3 14.0 16.6 22.1 38.7 27.2 33.7 76.8 47.2 31.2 23.5 15.3 17.4 30.7 15.7 88.4 53.1 29.9 28.6 65.9 47.2 52.0 23.3 25.7 65.9 30.1 36.9 57.8 15.5 35.1 23.8 34.3 22.7 35.1 11.0 23.9 30.8 28.7 23.4 38.6 45.7 21.8 45.6 31.5 26.9 42.6 51.8 41.1 111.6 55.6 48.9 86.5 62.3 47.3 64.1 PRPF8 "hPrp8, Prp8, PRPC8, RP13, SNRNP220" ENSG00000174231 "Pre-mRNA processing factor 8" Q6P2Q9 17 1650629-1684882 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Cancer-related genes, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 237.6;Rod photoreceptor cells: 234.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009941, CAB015457" Supported Enhanced Nucleoplasm NA NA 240000 Nucleoplasm "CAB009941: AB_2171185, CAB015457: AB_831685" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (2.76e-2)" "unprognostic (3.13e-2)" "unprognostic (1.56e-1)" "unprognostic (4.94e-2)" "unprognostic (6.58e-2)" "unprognostic (1.56e-1)" "unprognostic (4.19e-2)" "unprognostic (1.77e-1)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (2.45e-3)" "unprognostic (2.00e-1)" "unprognostic (2.66e-1)" "unprognostic (1.16e-1)" "unprognostic (1.23e-1)" 30.0 37.4 23.1 25.7 40.3 39.0 26.2 43.1 57.2 31.2 28.0 36.5 29.5 19.4 35.6 28.4 29.4 35.4 28.1 34.0 22.2 24.3 23.3 35.5 27.9 30.7 21.3 23.9 47.7 25.9 66.5 45.4 31.1 32.5 30.7 27.2 45.1 30.5 33.1 46.3 30.7 27.5 36.3 17.9 34.1 26.4 45.9 19.6 63.4 30.9 22.2 41.2 32.2 27.9 14.5 20.1 10.0 12.3 10.1 17.1 5.4 18.7 41.0 24.7 20.0 21.4 16.8 19.9 14.1 18.0 27.6 22.4 38.0 9.3 27.6 15.0 25.3 21.4 26.2 60.2 24.2 31.9 17.4 38.7 21.9 35.6 32.5 12.5 25.9 24.4 15.9 15.5 35.6 24.9 14.3 24.2 19.6 21.6 22.0 19.8 20.5 18.7 32.4 17.0 16.2 15.2 36.7 14.1 13.2 10.6 20.9 12.7 19.1 28.4 10.3 13.9 21.6 15.2 17.4 22.3 16.9 14.5 25.7 32.1 8.0 8.3 19.5 14.0 18.8 20.8 10.0 6.5 6.7 15.7 8.9 17.1 13.3 14.7 15.7 9.7 14.5 13.0 16.4 7.1 10.1 12.3 20.1 14.8 5.4 23.1 40.3 43.1 57.2 22.2 24.3 21.3 23.9 32.5 19.6 56.6 70.5 44.4 25.5 26.8 124.9 33.1 56.0 34.8 56.9 45.4 237.6 37.8 6.6 32.2 9.5 43.6 40.3 23.3 35.2 22.6 31.1 25.8 50.8 34.2 34.2 68.3 35.1 36.8 40.3 8.9 67.9 32.5 18.6 38.7 37.2 56.5 35.5 37.6 49.1 15.8 234.7 71.1 36.0 74.1 83.3 24.3 33.1 38.7 42.3 27.4 PRR14 MGC3121 ENSG00000156858 "Proline rich 14" Q9BWN1 16 30650717-30656440 "Predicted intracellular proteins" Myogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052022, HPA060265, HPA075914" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052022: AB_2681698, HPA060265: AB_2684236, HPA075914: " "unprognostic (1.57e-1)" "prognostic favorable (8.19e-5)" "unprognostic (3.74e-3)" "unprognostic (1.42e-2)" "unprognostic (5.18e-2)" "unprognostic (5.44e-2)" "unprognostic (5.28e-3)" "unprognostic (1.42e-2)" "unprognostic (5.75e-2)" "unprognostic (1.82e-2)" "unprognostic (1.61e-2)" "unprognostic (5.69e-2)" "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (4.54e-1)" "unprognostic (9.10e-2)" "unprognostic (2.31e-3)" 17.7 13.8 15.1 18.2 14.1 24.4 16.1 27.4 17.2 19.5 18.8 19.2 16.4 19.3 21.7 11.1 18.1 17.2 16.7 10.1 14.5 9.1 16.5 15.1 15.8 18.9 16.4 7.8 18.2 19.6 18.6 15.3 13.9 10.6 17.8 9.8 14.8 22.1 22.6 13.6 24.5 18.4 15.6 13.6 23.4 23.2 9.3 13.7 31.2 17.7 10.0 19.3 16.4 19.6 8.8 5.8 18.1 8.2 6.1 8.4 4.5 8.7 10.9 9.2 7.1 8.1 5.6 6.2 9.3 5.3 9.2 8.3 5.0 7.3 15.1 8.0 5.6 4.6 8.9 7.1 10.3 2.7 21.4 20.8 8.7 11.2 9.9 11.5 7.2 20.9 5.3 11.0 6.0 5.5 9.8 11.3 4.0 11.3 9.9 4.8 21.8 16.3 12.5 2.9 5.1 5.8 12.3 4.2 20.7 5.3 3.7 7.0 16.5 3.6 12.7 8.2 1.9 15.5 4.1 8.2 7.9 8.8 7.3 9.3 23.2 14.7 9.0 5.3 15.8 6.9 8.6 4.9 17.8 8.4 4.8 6.4 6.3 6.9 8.4 4.6 8.8 6.4 6.5 18.1 6.1 8.2 5.8 8.2 4.5 15.1 14.1 27.4 17.2 14.5 9.1 16.4 7.8 10.6 13.7 8.9 7.2 15.2 22.4 20.3 13.4 5.0 25.5 6.7 5.7 12.2 13.7 12.9 13.3 19.0 5.3 18.6 21.3 0.0 19.2 12.8 16.3 19.2 11.5 9.0 16.1 1.6 12.1 19.6 12.7 1.8 17.8 17.0 8.5 37.9 14.8 12.0 18.0 14.0 19.8 11.8 12.8 19.4 20.8 17.0 22.6 20.1 11.8 24.9 16.6 14.9 PSIP1 "DFS70, LEDGF, p52, p75, PSIP2" ENSG00000164985 "PC4 and SFRS1 interacting protein 1" O75475 9 15464066-15511019 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 273.8;Spermatogonia: 282.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 132.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013718, HPA019697" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013718: , HPA019697: AB_1852779" "unprognostic (8.54e-2)" "unprognostic (3.70e-2)" "unprognostic (1.31e-1)" "unprognostic (3.29e-2)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (2.89e-3)" "unprognostic (5.10e-2)" "unprognostic (5.93e-2)" "unprognostic (2.53e-2)" "unprognostic (6.49e-3)" "unprognostic (5.49e-2)" "unprognostic (6.98e-2)" "unprognostic (2.04e-1)" "unprognostic (2.99e-1)" "unprognostic (7.14e-2)" "unprognostic (1.39e-1)" 15.1 20.3 42.7 20.8 48.8 24.9 12.2 65.3 49.4 22.6 16.1 19.0 11.5 10.8 27.9 18.2 12.9 20.0 14.9 16.0 38.7 42.7 16.1 10.5 15.6 35.4 34.1 30.2 43.6 8.1 18.8 24.9 18.7 32.4 18.3 15.3 12.3 9.0 21.1 16.3 12.3 14.2 21.3 37.7 24.6 12.5 37.2 29.3 70.4 18.1 6.5 31.9 17.0 16.1 11.4 2.6 8.5 4.3 8.0 16.4 1.9 17.9 11.9 40.7 29.8 8.8 10.7 9.1 21.7 15.5 19.5 23.3 5.0 9.3 38.3 5.0 11.4 10.9 5.0 25.3 11.7 28.3 25.1 15.3 132.4 31.3 9.3 10.7 15.4 14.7 8.9 3.4 16.3 12.0 19.5 17.0 18.1 21.8 21.3 12.6 6.5 31.9 38.4 63.1 0.4 18.6 29.8 22.2 7.7 10.9 6.3 25.9 28.5 19.4 8.6 10.1 26.5 8.6 20.8 12.0 14.2 14.4 10.6 20.5 9.1 12.8 34.5 11.4 15.6 8.1 8.5 2.1 4.2 5.5 1.6 6.7 8.4 11.0 7.6 2.4 11.4 16.4 10.1 7.2 8.0 4.3 2.6 9.8 1.9 42.7 48.8 65.3 46.6 38.7 42.7 34.1 30.2 32.4 29.3 50.6 32.2 51.9 42.9 28.3 223.7 37.1 20.4 58.9 36.4 45.4 62.8 99.5 53.0 8.4 62.0 69.9 10.7 46.7 7.5 66.4 50.7 20.2 15.0 16.3 26.7 130.3 36.5 55.3 27.7 44.5 116.5 31.1 38.8 43.3 27.2 149.7 3.6 23.2 126.2 41.8 252.4 122.9 61.2 273.8 282.5 18.4 34.6 73.4 41.7 15.4 PSMA1 "HC2, MGC14542, MGC14575, MGC14751, MGC1667, MGC21459, MGC22853, MGC23915, NU, PROS30" ENSG00000129084 "Proteasome subunit alpha 1" P25786 11 14504874-14643635 "Enzymes, Predicted intracellular proteins" Immunity "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB033765, HPA037646, HPA043891" Supported Enhanced Nucleoplasm NA NA 27000000 Nucleoplasm "CAB033765: AB_2253026, HPA037646: AB_10670386, HPA043891: AB_2678718" "unprognostic (1.72e-2)" "unprognostic (4.97e-2)" "unprognostic (7.33e-2)" "unprognostic (4.74e-2)" "unprognostic (7.52e-2)" "unprognostic (6.66e-3)" "prognostic unfavorable (3.79e-5)" "unprognostic (3.28e-3)" "unprognostic (7.44e-2)" "unprognostic (3.43e-3)" "unprognostic (8.27e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (4.03e-11)" "unprognostic (1.93e-1)" "unprognostic (1.69e-1)" "unprognostic (4.66e-2)" "unprognostic (1.23e-2)" 46.6 46.3 33.7 36.0 40.2 45.7 39.0 28.3 42.7 33.4 35.5 23.1 37.4 37.3 42.1 43.1 43.7 33.0 32.2 55.4 31.7 34.1 47.8 61.0 38.8 42.3 32.0 32.4 34.0 35.6 28.2 39.4 55.2 36.9 35.6 42.4 32.9 34.9 37.1 86.6 35.3 42.7 39.0 26.7 45.8 37.3 31.6 25.9 53.0 45.5 62.8 42.2 41.5 31.7 24.2 55.4 20.9 42.3 30.5 35.7 45.2 67.4 47.7 40.0 47.9 39.9 40.2 33.4 39.9 52.5 60.9 50.1 41.3 85.2 59.0 44.2 42.1 55.8 50.9 45.6 49.5 57.7 57.3 67.7 36.8 31.7 48.7 52.4 61.0 48.1 38.9 29.5 33.0 69.2 44.5 59.5 47.6 69.0 49.8 54.1 44.7 55.5 45.9 33.4 57.6 71.2 37.6 59.3 36.7 52.9 47.9 33.0 20.8 42.5 47.7 35.6 43.1 28.4 37.3 47.0 39.9 37.5 69.8 48.7 21.8 58.3 52.8 59.0 48.6 50.9 20.9 42.3 11.0 24.3 31.1 32.3 24.2 28.3 27.2 55.4 20.6 25.7 25.0 9.4 30.5 29.4 31.3 35.7 45.2 33.7 40.2 28.3 42.7 31.7 34.1 32.0 32.4 36.9 25.9 77.4 91.8 78.9 188.2 127.0 44.8 0.0 73.9 65.6 95.5 83.7 17.7 398.7 217.2 193.4 40.4 121.2 89.1 70.0 203.0 301.8 137.7 149.4 72.1 111.7 261.1 54.0 38.6 87.8 164.2 23.5 107.9 156.0 136.7 273.3 81.1 94.3 195.2 111.4 119.9 182.7 40.0 84.1 135.9 126.7 65.4 132.7 524.5 142.0 111.1 217.3 PSMB2 HC7-I ENSG00000126067 "Proteasome subunit beta 2" P49721 1 35599544-35641844 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026322, HPA026324" Approved Enhanced Nucleoplasm NA NA 15000000 Nucleoplasm "HPA026322: AB_1855821, HPA026324: AB_1855822" "unprognostic (3.54e-2)" "unprognostic (8.53e-2)" "unprognostic (1.63e-3)" "unprognostic (6.93e-2)" "unprognostic (6.41e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.49e-7)" "unprognostic (2.81e-2)" "unprognostic (5.23e-2)" "unprognostic (3.34e-3)" "unprognostic (7.87e-2)" "unprognostic (4.45e-1)" "prognostic unfavorable (2.80e-6)" "unprognostic (1.65e-1)" "unprognostic (2.83e-1)" "unprognostic (3.77e-2)" "unprognostic (2.93e-2)" 26.5 30.5 29.4 28.0 35.1 37.2 25.3 20.1 50.9 23.2 26.1 35.9 15.4 27.5 27.8 25.0 30.4 26.5 20.7 23.8 30.6 33.4 27.9 63.8 24.6 30.4 30.6 24.8 22.7 24.6 22.0 21.8 37.5 32.6 23.1 27.8 22.8 23.0 24.9 54.7 28.2 27.0 28.7 32.5 29.3 22.8 23.5 21.5 42.8 22.7 29.1 34.0 23.9 22.4 24.6 30.2 19.4 35.3 25.1 28.1 25.4 40.9 25.7 28.1 19.1 14.9 17.9 35.5 19.4 22.9 40.1 32.7 30.4 49.3 40.9 45.7 22.9 24.5 25.5 36.1 32.2 33.8 33.3 33.5 37.1 28.1 29.7 26.9 38.9 21.9 19.5 20.4 47.9 23.2 16.4 31.5 33.9 44.2 23.4 25.8 18.8 50.6 29.1 37.5 18.2 27.4 31.4 28.6 28.8 27.8 22.2 24.9 18.3 22.3 21.1 30.1 33.5 15.5 17.7 21.6 20.1 23.7 18.9 45.9 20.2 32.4 41.5 29.7 41.0 34.8 17.4 27.0 19.4 23.1 33.0 23.4 24.6 23.1 24.2 29.7 19.3 16.7 20.9 9.7 25.1 35.3 30.2 28.1 25.4 29.4 35.1 20.1 50.9 30.6 33.4 30.6 24.8 32.6 21.5 59.6 61.8 70.7 120.5 98.8 48.7 51.8 71.4 68.3 47.8 62.8 15.7 342.2 122.7 240.6 77.0 88.7 69.5 23.3 197.3 290.1 75.1 97.6 33.6 136.0 195.7 55.6 94.4 84.7 99.4 12.8 93.2 93.1 72.6 231.8 76.2 58.8 222.8 74.6 85.9 183.0 36.4 90.5 72.1 168.5 124.8 97.5 369.7 82.8 96.1 159.8 PSMB7 ENSG00000136930 "Proteasome subunit beta 7" Q99436 9 124353466-124415444 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052408, HPA054902" Supported Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No No 2700000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA052408: AB_2681820, HPA054902: AB_2682635" "unprognostic (7.75e-2)" "unprognostic (1.83e-2)" "unprognostic (1.27e-1)" "unprognostic (3.64e-3)" "unprognostic (2.83e-1)" "unprognostic (1.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.24e-3)" "unprognostic (9.03e-2)" "unprognostic (3.60e-1)" "unprognostic (2.99e-1)" "unprognostic (1.78e-1)" "unprognostic (1.26e-2)" "unprognostic (1.67e-1)" "unprognostic (3.45e-1)" "unprognostic (1.93e-3)" "unprognostic (3.98e-2)" 36.9 56.9 51.0 32.8 55.1 53.4 41.9 33.7 52.7 26.6 33.3 34.0 27.9 32.5 33.6 52.1 41.9 32.6 29.2 59.6 44.5 41.3 53.7 87.1 27.0 33.6 43.6 46.9 32.7 67.1 38.5 24.1 53.2 47.3 28.8 37.1 31.1 48.2 26.9 76.7 48.7 32.2 31.4 39.9 28.6 33.1 50.3 36.5 48.2 32.7 67.7 39.5 32.3 30.8 53.4 67.9 45.2 62.7 53.6 66.2 69.0 52.6 64.4 44.1 53.3 31.2 37.2 63.6 51.3 70.8 74.4 51.4 84.6 51.6 60.1 41.5 48.0 73.5 75.4 54.9 54.3 68.4 57.8 47.4 37.7 102.4 70.2 70.5 74.7 37.6 44.5 48.0 77.5 77.7 57.5 62.4 54.6 76.8 42.8 57.4 91.7 53.5 50.2 65.2 80.2 92.2 47.4 65.8 70.2 52.6 34.5 52.1 42.3 48.8 62.5 76.0 45.2 72.1 32.9 49.4 48.2 38.9 61.4 76.8 46.5 130.1 60.7 80.6 46.1 67.6 40.4 61.7 45.2 41.8 62.7 45.0 53.4 48.1 46.1 67.9 47.5 46.3 44.9 27.3 53.6 58.4 57.8 66.2 69.0 51.0 55.1 33.7 52.7 44.5 41.3 43.6 46.9 47.3 36.5 71.5 73.0 111.6 140.8 172.4 37.7 121.6 112.1 101.7 62.6 66.3 21.6 382.0 280.2 281.6 279.3 121.5 147.6 46.7 340.4 299.5 140.7 127.9 102.7 222.4 205.6 31.8 135.5 87.8 123.1 322.3 128.9 128.4 189.0 172.3 121.7 86.0 308.8 129.0 117.8 341.8 43.4 84.1 126.0 246.2 184.2 191.3 408.7 106.6 146.6 177.4 PSMC1 "p56, S4" ENSG00000100764 "Proteasome 26S subunit, ATPase 1" P62191 14 90256495-90275429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 178.0" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 478.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000872, HPA016885" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 46000 "Nucleoplasm, Cytosol" "HPA000872: AB_1079705, HPA016885: " "unprognostic (4.10e-1)" "unprognostic (9.70e-2)" "unprognostic (8.17e-2)" "unprognostic (1.29e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (1.23e-2)" "unprognostic (1.00e-2)" "unprognostic (1.58e-1)" "unprognostic (1.03e-3)" "unprognostic (1.12e-2)" "unprognostic (1.10e-2)" "unprognostic (1.14e-2)" "unprognostic (1.28e-1)" "unprognostic (1.03e-1)" "unprognostic (2.85e-1)" "unprognostic (1.11e-2)" 23.7 21.6 28.2 16.7 26.6 26.9 24.6 17.1 39.1 18.4 21.0 11.8 14.3 12.7 23.7 27.9 23.4 18.0 13.7 34.5 37.8 19.1 22.8 29.7 17.9 16.2 19.8 29.3 16.1 20.4 21.8 15.9 25.3 37.2 19.0 23.0 12.1 18.9 22.8 178.0 22.9 17.2 23.2 31.3 19.3 20.0 42.1 15.6 14.4 18.0 29.2 25.4 23.3 17.2 21.4 37.7 57.0 38.1 28.7 36.4 37.8 32.4 30.9 35.5 37.0 31.2 28.7 37.4 31.5 44.2 69.7 52.6 28.5 36.7 27.7 48.2 38.1 32.0 33.8 43.4 36.8 81.7 33.1 19.0 21.7 20.7 24.4 27.0 32.9 29.1 25.7 29.2 45.3 33.4 29.2 41.9 30.9 30.6 16.7 47.8 61.7 24.4 42.9 31.3 42.0 38.3 29.4 46.0 22.6 39.2 33.9 37.4 25.0 25.7 67.0 26.3 30.8 42.1 29.1 31.7 26.9 24.0 28.8 45.5 29.0 45.7 41.1 38.9 30.0 40.9 30.9 37.6 57.0 26.6 34.1 26.2 21.4 27.5 27.2 37.7 20.7 25.3 24.8 41.7 28.7 38.1 26.4 36.4 37.8 28.2 26.6 17.1 39.1 37.8 19.1 19.8 29.3 37.2 15.6 95.3 66.7 41.0 73.5 57.8 47.2 33.6 99.3 137.9 116.0 52.4 49.1 265.6 101.2 136.5 478.8 81.7 77.7 46.7 171.7 144.5 72.1 66.8 95.8 167.6 133.3 74.7 54.8 77.3 91.6 350.7 70.8 81.8 64.1 188.4 56.4 79.4 161.0 64.3 77.1 126.3 54.1 84.1 75.2 77.1 45.5 43.8 392.6 74.6 66.8 81.4 PSMD3 "P58, Rpn3, S3, TSTA2" ENSG00000108344 "Proteasome 26S subunit, non-ATPase 3" O43242 17 39980797-39997960 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 227.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 141.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017038, HPA048972" Approved Enhanced Nucleoplasm,Cytosol No No 380000 Nucleoplasm Cytosol "CAB017038: , HPA048972: AB_2680579" "unprognostic (3.44e-2)" "unprognostic (3.10e-1)" "unprognostic (2.22e-2)" "unprognostic (5.21e-2)" "unprognostic (7.87e-2)" "unprognostic (8.36e-3)" "unprognostic (5.75e-3)" "unprognostic (7.46e-2)" "unprognostic (6.19e-2)" "unprognostic (1.61e-1)" "unprognostic (6.89e-2)" "unprognostic (4.42e-2)" "prognostic unfavorable (4.47e-7)" "unprognostic (1.54e-1)" "unprognostic (1.32e-1)" "unprognostic (2.85e-2)" "unprognostic (7.45e-2)" 25.1 27.7 20.0 25.0 26.1 22.0 21.3 30.0 40.3 22.5 28.1 22.4 16.8 23.2 26.8 21.2 27.7 22.7 23.7 36.1 20.6 21.4 23.8 54.4 20.8 22.3 19.2 23.7 24.0 23.6 28.1 20.8 33.8 24.5 23.2 25.4 21.4 22.5 21.9 93.2 33.2 23.5 24.7 17.6 26.9 21.1 19.9 17.5 35.7 24.3 39.2 26.3 20.7 21.2 15.6 24.3 14.4 17.0 13.1 17.7 12.0 32.7 40.9 22.5 32.3 18.4 11.9 26.8 24.2 25.2 43.7 34.0 33.8 28.3 39.5 61.0 25.9 29.3 51.5 39.9 31.6 29.6 39.7 44.5 22.8 21.0 33.4 16.7 30.7 25.6 15.8 27.0 46.2 20.3 14.7 24.6 27.7 46.5 24.7 20.2 23.9 47.5 21.1 31.2 21.3 24.3 35.0 31.3 37.0 21.8 22.2 29.7 22.5 23.1 141.9 19.9 28.6 31.9 26.6 21.9 18.9 33.5 27.9 43.2 26.9 34.1 44.0 29.0 23.2 30.5 6.6 16.8 14.4 15.1 17.0 15.1 14.4 14.6 17.7 24.3 15.6 13.7 16.5 5.5 13.1 14.3 16.7 12.6 12.0 20.0 26.1 30.0 40.3 20.6 21.4 19.2 23.7 24.5 17.5 41.7 37.3 61.7 49.4 41.4 70.1 17.3 15.3 16.0 29.6 15.7 19.6 147.2 39.7 91.3 204.0 32.3 72.1 23.3 91.5 109.0 44.2 48.0 24.3 44.4 86.1 57.2 25.3 27.0 23.7 35.1 58.1 39.1 62.4 73.1 44.9 81.4 81.7 58.8 50.9 43.1 47.4 25.8 47.6 47.1 57.9 39.0 227.2 36.2 61.2 47.1 PSMD4 "AF, AF-1, Rpn10, S5A" ENSG00000159352 "Proteasome 26S subunit, non-ATPase 4" P55036 1 151254703-151267479 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038807, HPA039252, CAB047300" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418" "unprognostic (3.83e-2)" "unprognostic (7.89e-2)" "unprognostic (6.86e-3)" "unprognostic (1.70e-1)" "unprognostic (2.63e-1)" "unprognostic (2.89e-2)" "unprognostic (1.79e-3)" "unprognostic (2.16e-1)" "unprognostic (2.81e-1)" "unprognostic (2.61e-2)" "unprognostic (7.57e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (6.66e-10)" "unprognostic (9.80e-2)" "unprognostic (6.60e-2)" "unprognostic (2.03e-2)" "unprognostic (3.91e-1)" 27.5 28.0 44.3 24.4 46.4 25.5 29.9 25.7 50.4 21.9 28.6 28.3 16.5 22.7 25.1 41.5 26.7 31.4 21.8 38.7 37.5 36.8 25.3 44.7 20.2 28.2 47.5 44.8 26.7 27.7 27.4 19.3 30.0 43.2 23.0 28.1 24.3 25.6 31.2 86.7 28.0 20.5 39.3 29.6 26.3 25.8 35.9 29.1 23.1 23.7 25.7 36.2 28.0 19.8 62.7 65.1 111.6 76.0 54.2 74.2 88.2 42.3 51.0 37.7 30.8 41.1 30.5 41.1 28.7 35.3 45.9 36.7 66.7 48.5 34.4 70.6 40.5 31.8 44.4 48.4 43.4 39.3 56.1 42.2 33.6 43.5 68.7 45.4 39.4 39.2 33.0 36.1 52.4 48.5 34.5 40.0 38.7 52.2 43.8 38.4 124.8 36.2 48.0 71.6 65.6 51.6 30.8 36.7 62.1 45.0 36.3 29.6 50.5 31.9 46.9 38.0 58.2 49.0 78.0 35.1 22.9 36.0 28.1 49.0 52.5 65.1 73.4 38.0 37.2 41.7 59.6 71.5 111.6 43.0 76.0 48.4 62.7 50.5 47.3 65.1 61.1 46.4 46.0 95.8 54.2 75.5 39.2 74.2 88.2 44.3 46.4 25.7 50.4 37.5 36.8 47.5 44.8 43.2 29.1 53.6 55.8 113.9 90.7 78.8 48.8 216.6 79.0 80.3 42.1 57.6 25.5 289.4 142.6 149.2 182.3 103.4 106.2 93.5 163.0 189.2 97.9 84.2 80.9 96.2 163.2 31.8 80.8 69.3 92.1 179.3 97.5 96.7 99.5 354.3 71.9 58.4 143.7 95.1 92.6 161.4 44.8 116.4 130.8 169.8 77.8 75.7 346.7 94.7 97.0 85.8 PSMD7 "MOV34, P40, Rpn8, S12" ENSG00000103035 "Proteasome 26S subunit, non-ATPase 7" P51665 16 74296775-74306288 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 498.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019379, HPA049824, HPA056069" Enhanced Enhanced Nucleoplasm NA NA 340000 Nucleoplasm "CAB019379: , HPA049824: AB_2680899, HPA056069: AB_2683025" "unprognostic (4.75e-3)" "unprognostic (1.30e-1)" "unprognostic (2.84e-2)" "unprognostic (6.95e-2)" "unprognostic (7.62e-2)" "prognostic unfavorable (6.64e-5)" "prognostic unfavorable (7.71e-6)" "unprognostic (1.97e-2)" "unprognostic (6.51e-2)" "unprognostic (1.91e-2)" "unprognostic (9.34e-3)" "unprognostic (1.34e-2)" "unprognostic (2.52e-2)" "unprognostic (5.06e-3)" "unprognostic (7.04e-2)" "unprognostic (2.12e-1)" "unprognostic (1.86e-2)" 26.5 30.3 23.6 20.8 32.8 45.7 21.7 21.7 34.4 17.7 26.6 22.4 17.0 19.8 24.3 26.1 31.5 16.9 17.6 59.0 22.0 21.7 25.0 47.8 20.3 23.5 24.9 22.9 17.1 18.8 23.2 17.4 44.1 36.1 30.3 28.3 16.7 22.8 27.1 88.8 30.6 22.3 26.4 25.1 27.1 21.8 20.3 22.4 30.7 18.2 34.4 28.4 34.6 22.3 50.3 71.0 64.7 60.8 44.6 56.5 58.1 27.2 45.4 33.7 17.2 24.4 25.3 42.6 38.4 32.4 47.3 43.9 60.1 38.0 37.4 42.7 31.1 20.9 35.4 26.9 34.8 42.3 22.1 29.6 28.9 35.3 45.8 32.2 46.7 49.3 23.2 35.1 42.6 42.8 21.1 41.4 23.7 42.7 16.6 30.1 67.6 26.8 44.2 36.6 27.9 22.8 38.8 21.8 49.7 25.0 41.2 21.5 24.3 37.3 14.0 22.0 26.9 29.7 32.2 37.5 28.4 23.8 30.9 28.7 35.6 45.7 109.0 38.7 34.2 29.3 45.6 58.4 64.7 49.8 60.8 48.5 50.3 49.7 52.0 71.0 36.1 48.7 49.9 34.8 44.6 60.2 59.6 56.5 58.1 23.6 32.8 21.7 34.4 22.0 21.7 24.9 22.9 36.1 22.4 62.5 54.4 81.1 136.0 92.7 50.9 45.6 63.7 85.6 83.0 43.6 7.9 286.0 68.0 118.6 92.9 69.2 93.5 70.0 165.2 180.6 80.2 157.1 101.6 127.1 167.8 54.0 82.1 71.8 72.2 15.2 52.3 110.5 94.5 141.5 71.9 64.7 136.6 87.7 61.5 80.1 48.3 90.5 77.3 113.4 94.9 113.0 498.5 82.8 82.9 180.5 PSME3 "Ki, PA28-gamma, PA28G, REG-GAMMA" ENSG00000131467 "Proteasome activator subunit 3" P61289 17 42824385-42843758 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 225.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008388, HPA012510" Supported Enhanced Nucleoplasm NA NA 260000 Nucleoplasm "CAB008388: AB_592552, HPA012510: AB_1855752" "unprognostic (4.22e-2)" "unprognostic (2.38e-2)" "unprognostic (1.63e-3)" "unprognostic (2.65e-1)" "unprognostic (1.36e-1)" "unprognostic (8.30e-3)" "prognostic unfavorable (5.41e-5)" "unprognostic (6.02e-3)" "unprognostic (2.30e-1)" "unprognostic (1.26e-2)" "unprognostic (1.89e-2)" "unprognostic (2.41e-1)" "unprognostic (5.17e-2)" "unprognostic (4.09e-2)" "unprognostic (1.17e-1)" "unprognostic (5.41e-3)" "unprognostic (1.02e-1)" 29.8 32.4 31.7 27.8 37.6 28.2 25.9 22.7 52.7 25.3 28.6 25.3 16.7 26.3 28.4 18.8 44.9 24.8 22.1 32.1 24.8 25.9 47.9 48.5 24.8 32.5 28.7 28.3 27.1 31.0 38.1 21.3 31.3 34.9 23.9 32.0 26.8 29.2 27.5 49.7 32.3 30.1 28.9 21.0 32.8 30.5 32.7 20.4 34.5 29.7 20.4 39.5 31.1 24.8 26.2 38.0 50.4 43.3 32.4 32.3 38.4 39.0 64.8 29.8 31.7 27.3 27.9 40.6 44.9 34.2 62.0 43.8 54.0 29.7 60.0 35.2 38.7 33.8 35.3 48.2 47.4 72.9 30.7 48.3 32.0 33.8 38.6 30.9 70.3 37.1 27.3 32.6 46.8 46.9 17.6 37.9 32.5 62.6 21.4 41.9 22.7 66.0 24.5 44.1 56.4 35.4 43.5 54.3 47.8 32.8 55.4 37.4 38.3 27.4 23.0 34.7 46.2 53.2 30.3 36.5 48.7 34.1 40.2 65.2 33.5 51.6 75.8 34.3 40.6 49.6 22.9 38.2 35.0 30.1 43.3 32.3 26.2 24.8 28.9 38.0 24.1 23.1 26.1 50.4 32.4 35.2 21.3 28.9 38.4 31.7 37.6 22.7 52.7 24.8 25.9 28.7 28.3 34.9 20.4 17.9 22.9 26.1 27.0 26.9 12.0 31.9 25.5 17.4 18.2 27.9 13.7 38.0 23.2 57.0 225.1 19.7 27.4 0.0 45.8 61.2 19.5 29.4 21.9 24.5 43.4 12.7 23.7 17.2 29.8 99.0 14.4 20.8 15.1 42.3 22.2 16.0 52.4 20.9 18.7 37.0 18.5 19.4 21.9 30.2 45.8 41.3 63.7 17.0 27.9 49.5 PSMG1 "c21-LRP, DSCR2, LRPC21, PAC1" ENSG00000183527 "Proteasome assembly chaperone 1" O95456 21 39174769-39183851 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 67.3" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 408.1;Spermatocytes: 226.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057193, HPA070225" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No "Nucleoplasm, Golgi apparatus, Cytosol" "HPA057193: AB_2683363, HPA070225: AB_2686236" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" "unprognostic (1.27e-1)" "unprognostic (2.34e-1)" "unprognostic (2.10e-1)" "unprognostic (9.38e-2)" "unprognostic (5.06e-3)" "unprognostic (2.02e-1)" "unprognostic (1.66e-2)" "unprognostic (5.09e-2)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (2.84e-1)" "unprognostic (8.98e-2)" "unprognostic (1.32e-2)" "unprognostic (4.17e-3)" 7.0 11.0 8.2 8.7 8.0 15.1 6.9 7.7 13.1 7.0 10.2 4.7 5.2 9.2 8.2 9.2 12.5 6.9 9.4 7.6 7.5 8.9 11.7 21.4 6.1 8.1 6.9 10.2 7.9 21.5 5.1 10.0 7.5 8.5 5.7 10.0 7.3 8.0 5.2 13.0 7.0 8.4 8.3 7.1 7.0 7.1 67.3 4.6 7.8 10.6 10.4 7.6 6.7 7.4 11.4 11.5 7.3 7.9 6.7 14.9 7.9 27.1 8.9 6.5 8.9 3.2 3.7 17.3 15.0 6.6 11.8 7.6 16.3 7.1 29.4 8.0 4.2 10.5 7.8 10.2 8.0 7.7 12.6 16.1 55.6 13.8 21.1 5.8 26.4 11.1 5.1 6.0 12.5 12.6 2.6 6.2 12.8 40.9 16.9 7.0 14.4 16.2 14.3 22.4 10.4 13.9 26.5 8.1 29.9 4.9 8.1 20.7 6.1 18.9 10.7 14.9 1.2 10.1 13.3 7.0 13.6 4.7 18.2 21.2 13.0 20.5 25.5 11.5 44.7 10.4 7.3 6.4 3.5 10.6 7.8 12.2 11.4 14.9 12.2 11.5 9.0 11.9 10.4 0.5 6.7 7.9 10.5 12.6 7.9 8.2 8.0 7.7 13.1 7.5 8.9 6.9 10.2 8.5 4.6 6.0 18.3 19.9 34.3 120.8 14.8 21.8 22.9 12.0 29.6 19.2 3.9 93.4 56.3 35.1 408.1 22.4 14.4 0.0 43.3 92.9 37.1 22.6 34.7 28.1 51.9 7.9 28.7 19.6 18.1 33.7 29.4 26.6 43.9 26.2 40.2 9.4 31.9 21.0 31.1 76.3 16.1 25.8 31.9 226.4 91.0 85.4 45.5 20.3 50.8 26.7 PSPC1 "FLJ10955, PSP1" ENSG00000121390 "Paraspeckle component 1" Q8WXF1 13 19674752-19783019 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 143.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038904 Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "HPA038904: AB_10673291" "unprognostic (2.13e-3)" "unprognostic (3.48e-1)" "unprognostic (1.52e-2)" "unprognostic (1.25e-1)" "unprognostic (4.14e-3)" "unprognostic (2.14e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.13e-3)" "unprognostic (9.57e-2)" "unprognostic (1.09e-1)" "unprognostic (1.69e-3)" "unprognostic (3.04e-3)" "unprognostic (2.92e-1)" "unprognostic (3.69e-2)" "unprognostic (8.61e-2)" "prognostic favorable (1.46e-4)" "unprognostic (7.72e-2)" 10.6 14.6 17.8 14.1 18.7 45.0 16.8 24.6 24.7 13.9 15.0 15.3 11.7 12.6 16.0 23.3 15.6 17.1 12.8 11.4 18.9 19.8 13.1 9.2 10.2 19.0 14.6 18.4 16.3 11.2 8.4 23.6 25.7 15.9 11.9 16.4 17.6 11.4 9.4 20.3 14.7 13.1 15.0 12.2 13.8 12.3 23.9 13.6 27.5 12.9 10.7 21.2 12.3 10.9 18.2 17.8 14.8 18.7 9.6 18.2 12.1 18.4 7.7 18.1 9.0 7.5 8.0 23.5 9.9 13.1 18.8 17.1 25.4 10.7 24.7 10.7 10.5 9.8 9.4 20.9 12.0 19.7 10.6 10.2 28.2 5.5 30.9 14.7 20.3 18.1 12.2 2.5 11.4 12.8 7.4 16.0 24.5 15.3 10.1 16.4 20.0 23.7 19.8 25.3 10.2 10.2 16.3 18.1 12.8 19.3 28.0 16.7 8.6 13.5 22.9 8.6 18.1 13.3 21.4 9.4 11.4 10.9 10.8 9.4 8.8 5.2 42.6 5.2 12.2 13.5 10.6 18.1 11.0 10.2 18.7 11.1 18.2 13.7 9.4 16.6 18.0 13.8 10.4 14.8 9.6 13.5 17.8 18.2 12.1 17.8 18.7 24.6 24.7 18.9 19.8 14.6 18.4 15.9 13.6 17.9 25.6 35.9 21.3 29.7 39.8 24.2 20.4 24.1 15.9 15.7 55.0 59.0 18.3 25.3 13.9 22.2 14.0 0.0 29.7 85.2 25.3 15.0 9.2 9.4 23.6 28.6 24.2 25.2 29.3 17.3 29.1 21.8 18.6 46.9 18.6 25.3 21.5 20.1 25.1 19.5 66.0 32.3 30.3 143.2 73.9 29.7 67.3 30.5 23.2 22.7 PTMA TMSA ENSG00000187514 "Prothymosin alpha" P06454 2 231706895-231713541 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047183 Approved Enhanced Nucleoplasm,Cytosol No Yes 610000 Nucleoplasm Cytosol "HPA047183: AB_2679972" "unprognostic (1.49e-3)" "prognostic favorable (6.56e-4)" "unprognostic (3.73e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (5.99e-2)" "unprognostic (1.56e-2)" "unprognostic (3.72e-3)" "unprognostic (2.35e-3)" "unprognostic (9.24e-2)" "prognostic unfavorable (1.99e-7)" "unprognostic (5.54e-2)" "unprognostic (6.07e-2)" "unprognostic (3.81e-3)" "unprognostic (8.64e-3)" 72.8 37.7 60.0 78.4 65.2 161.4 76.1 38.2 64.2 75.0 80.9 53.9 33.9 56.3 84.8 59.9 83.7 66.7 47.2 38.7 66.3 48.3 67.3 73.5 63.5 104.0 68.7 59.6 80.5 79.5 31.3 97.9 59.1 54.2 50.0 82.7 42.2 55.5 53.4 60.6 92.5 62.8 58.4 86.6 90.1 69.2 113.9 67.2 127.5 73.4 50.4 118.6 70.0 69.9 189.1 134.7 114.4 126.9 117.0 167.3 255.0 99.6 59.9 85.5 76.2 26.0 34.7 87.8 68.1 57.2 59.5 62.5 58.0 116.9 157.9 78.1 53.1 41.2 52.8 120.2 83.9 75.7 125.1 94.5 203.5 49.5 93.6 32.3 230.8 87.1 50.3 31.5 52.7 43.6 56.8 97.0 129.0 118.2 67.2 51.9 142.5 324.2 314.8 128.7 99.1 50.0 223.4 60.9 107.3 72.8 89.1 174.5 107.4 78.2 78.3 59.4 70.5 59.0 183.6 72.0 50.2 89.1 61.3 73.1 81.5 40.1 316.2 34.3 141.6 80.4 114.4 113.6 75.3 99.1 114.0 143.5 189.1 143.8 120.6 126.3 160.4 160.6 134.8 23.1 117.0 126.9 134.7 167.3 255.0 60.0 65.2 38.2 64.2 66.3 48.3 68.7 59.6 54.2 67.2 902.2 1420.8 3111.4 3331.5 6879.8 692.5 258.3 1666.3 1917.9 1803.9 2156.5 276.9 2179.3 3208.0 2815.5 89.5 3767.9 1421.2 1752.0 3609.4 4317.6 3273.0 2682.0 2759.5 1209.1 2876.6 767.5 1629.9 1539.5 3031.9 138.7 1209.6 4164.5 3499.0 2458.1 2866.2 2213.1 3219.9 1988.5 1320.3 2161.4 753.7 1895.0 6501.7 798.6 2809.8 6944.4 2286.6 2724.1 3072.9 3503.3 PTPA "PPP2R4, PR53" ENSG00000119383 "Protein phosphatase 2 phosphatase activator" Q15257 9 129110950-129148946 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 50.6;Cytotrophoblasts: 42.8;Distal tubular cells: 46.4;Ductal cells: 58.5;Exocrine glandular cells: 54.1;Hofbauer cells: 45.3;Pancreatic endocrine cells: 49.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005695, CAB022068, CAB035999" Approved Enhanced Nucleoplasm,Cytosol NA NA 4800000 Nucleoplasm Cytosol "CAB022068: , CAB035999: , HPA005695: AB_1855658" "unprognostic (4.97e-2)" "unprognostic (1.70e-2)" "unprognostic (1.13e-2)" "prognostic favorable (6.50e-5)" "unprognostic (1.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.65e-2)" "unprognostic (6.44e-3)" "unprognostic (2.22e-1)" "unprognostic (1.15e-2)" "unprognostic (3.20e-2)" "unprognostic (1.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.92e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" 16.5 35.1 41.6 19.8 41.2 18.1 23.9 32.0 74.2 27.5 27.4 27.2 30.1 18.3 26.7 26.0 31.8 30.1 28.7 42.1 38.0 32.4 32.6 41.0 22.1 19.8 30.8 35.5 23.2 22.4 55.0 22.5 21.4 37.0 33.4 21.7 20.8 36.0 41.5 110.7 27.2 18.8 35.3 21.9 24.4 23.8 62.4 17.6 23.7 27.2 37.0 21.3 22.1 23.9 12.6 19.2 7.8 15.5 17.7 18.4 14.9 24.3 43.2 26.6 49.3 18.0 22.1 26.6 25.5 28.9 35.0 24.5 23.1 30.1 25.4 19.3 43.2 39.8 39.7 27.8 31.4 30.2 45.0 15.2 15.7 45.7 21.9 53.6 27.0 34.1 26.5 31.0 25.6 24.4 53.1 35.6 26.6 23.2 28.2 29.4 63.2 24.6 16.7 41.9 66.2 43.0 24.6 24.6 46.6 36.7 30.6 28.9 20.4 51.6 53.3 31.9 26.4 56.5 11.8 26.1 29.1 26.3 30.0 35.9 25.8 65.9 22.9 35.8 17.7 40.1 5.8 15.5 7.8 18.4 15.5 17.6 9.6 14.0 16.4 19.2 12.6 13.1 13.1 5.4 17.7 14.4 13.8 14.0 14.9 41.6 41.2 32.0 74.2 38.0 32.4 30.8 35.5 37.0 17.6 3.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 50.6 0.0 42.8 46.4 58.5 0.0 0.0 0.0 0.0 54.1 37.3 0.0 0.0 8.1 0.0 45.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 37.9 0.0 0.0 49.9 0.0 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 PTPDC1 "FLJ37312, PTP9Q22" ENSG00000158079 "Protein tyrosine phosphatase domain containing 1" A2A3K4 9 94030794-94109856 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.3" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0" "Group enriched" "Detected in many" 5 "B-cells: 1.1;T-cells: 2.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016747, HPA026832" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA016747: AB_1855908, HPA026832: AB_10602917" "unprognostic (3.99e-2)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (4.91e-2)" "unprognostic (1.94e-1)" "unprognostic (3.64e-2)" "unprognostic (1.90e-3)" "unprognostic (4.71e-1)" "unprognostic (2.43e-1)" "unprognostic (2.56e-1)" "unprognostic (3.49e-2)" "unprognostic (3.55e-2)" "unprognostic (2.48e-2)" "unprognostic (2.45e-2)" "unprognostic (2.17e-1)" "unprognostic (1.28e-1)" "unprognostic (2.61e-2)" 7.0 12.0 7.6 4.4 32.3 1.5 6.4 4.7 16.4 4.7 4.9 25.3 1.4 3.1 6.2 4.9 4.4 4.4 4.7 10.0 12.1 6.9 5.1 2.4 6.8 3.7 13.9 8.9 6.3 12.2 6.8 8.9 3.7 19.9 5.6 5.9 4.1 4.3 4.4 7.0 6.2 3.6 8.3 20.5 3.0 7.1 15.0 13.0 1.6 5.1 1.3 3.9 4.9 3.6 1.1 0.3 0.0 0.2 0.0 2.0 0.1 6.1 2.7 4.9 6.3 6.1 8.5 6.5 4.5 3.2 4.6 3.9 2.6 5.2 5.2 3.1 3.4 10.6 4.9 5.0 2.9 4.5 7.0 1.4 1.2 7.2 2.8 8.0 1.4 4.0 8.4 10.5 7.0 9.8 2.8 4.9 8.6 3.0 0.0 8.6 3.3 5.2 2.2 3.4 5.0 5.1 5.6 9.7 0.0 2.6 1.5 4.3 5.5 6.2 5.8 9.7 6.8 3.1 2.5 6.9 6.2 3.8 9.5 5.4 7.6 8.4 0.7 4.6 2.5 8.6 0.0 0.2 0.0 0.1 0.0 0.1 0.4 1.1 0.0 0.3 1.1 2.0 0.7 0.0 0.0 0.2 0.2 0.0 0.1 7.6 32.3 4.7 16.4 12.1 6.9 13.9 8.9 19.9 13.0 0.0 7.7 1.9 2.6 4.2 10.5 8.4 2.5 1.4 1.2 5.2 9.8 0.3 3.3 2.9 8.0 5.7 0.9 0.0 2.5 1.6 5.0 1.9 5.7 0.8 2.7 4.8 3.4 6.2 0.3 3.8 3.4 2.7 3.3 0.0 2.4 2.3 5.0 1.1 13.4 1.0 9.8 19.4 4.8 12.0 15.9 3.8 0.2 2.5 2.3 1.7 PUF60 "FIR, RoBPI, SIAHBP1" ENSG00000179950 "Poly(U) binding splicing factor 60" Q9UHX1 8 143816344-143829859 "Disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 73.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045733, HPA052096, HPA059714" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045733: AB_10960503, HPA052096: AB_2681722, HPA059714: AB_2684110" "unprognostic (3.49e-2)" "unprognostic (8.78e-2)" "unprognostic (2.66e-1)" "unprognostic (4.05e-2)" "unprognostic (1.81e-2)" "unprognostic (3.47e-2)" "unprognostic (1.51e-2)" "unprognostic (4.34e-3)" "unprognostic (2.64e-2)" "unprognostic (1.07e-2)" "unprognostic (1.75e-1)" "unprognostic (5.45e-2)" "unprognostic (2.36e-2)" "unprognostic (2.64e-2)" "unprognostic (7.00e-2)" "unprognostic (2.28e-2)" "unprognostic (3.42e-2)" 35.4 21.1 28.5 19.1 29.5 51.1 20.8 22.8 40.0 19.5 28.4 37.3 16.7 41.2 25.6 21.3 23.8 30.8 23.8 26.7 29.8 25.5 21.7 34.4 18.0 28.7 29.9 30.9 23.9 24.4 13.3 21.6 33.0 24.3 22.8 11.2 22.8 39.1 31.4 47.5 36.6 23.8 21.0 29.4 26.2 28.5 28.9 27.9 28.7 23.2 24.2 21.9 20.2 21.3 40.9 42.9 28.3 44.6 41.4 50.9 53.3 21.2 49.5 7.5 7.2 4.0 3.6 12.4 17.1 6.3 16.5 16.7 21.6 24.1 18.6 16.3 13.4 12.8 18.8 20.3 21.2 0.9 20.4 32.7 23.9 26.2 22.8 14.7 7.8 16.8 10.1 13.3 21.7 6.7 4.8 15.9 20.8 19.3 8.3 4.9 73.0 35.7 5.3 18.6 13.7 44.1 19.4 10.3 19.6 4.6 21.1 14.5 17.2 21.8 9.3 17.5 2.0 26.4 3.6 18.1 17.0 41.3 20.1 22.1 15.5 21.8 24.5 17.1 11.6 16.4 24.1 37.9 28.3 45.6 43.3 50.9 38.6 38.3 45.2 42.9 40.9 35.8 41.7 21.1 41.4 44.6 26.2 44.9 53.3 28.5 29.5 22.8 40.0 29.8 25.5 29.9 30.9 24.3 27.9 35.7 45.6 62.1 84.0 95.7 56.5 52.6 38.2 66.9 47.8 27.9 27.5 127.5 77.9 88.5 14.8 59.5 85.2 0.0 78.5 109.1 67.7 50.1 55.3 71.2 88.1 41.3 64.2 39.3 46.1 34.6 59.2 57.1 86.0 133.5 53.5 174.2 79.1 97.9 55.5 90.1 46.1 64.7 74.1 92.1 123.9 93.6 145.0 64.0 69.8 74.0 PWWP2B "bA432J24.1, FLJ46823, PWWP2" ENSG00000171813 "PWWP domain containing 2B" Q6NUJ5 10 132397168-132417863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 29.8;MCF7: 22.5;SK-BR-3: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038056, HPA038502, HPA078118" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038056: AB_10697093, HPA038502: AB_2676048, HPA078118: " "unprognostic (2.28e-1)" "unprognostic (5.47e-2)" "unprognostic (1.11e-2)" "unprognostic (1.30e-2)" "unprognostic (5.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.67e-2)" "unprognostic (8.82e-2)" "unprognostic (2.66e-1)" "unprognostic (2.40e-1)" "unprognostic (1.33e-1)" "unprognostic (2.00e-1)" "prognostic favorable (5.75e-4)" "unprognostic (4.77e-2)" "unprognostic (1.46e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-2)" 7.3 14.1 5.1 4.2 14.7 3.0 6.6 1.8 13.4 5.1 10.0 2.0 9.0 6.4 4.3 3.3 8.9 5.1 8.4 3.8 6.4 4.3 4.1 2.3 5.5 3.7 4.1 6.9 4.7 23.4 8.9 6.3 12.6 4.3 5.5 3.3 5.1 14.0 5.9 19.5 6.2 5.7 5.4 1.1 14.9 14.7 6.5 7.1 2.1 5.7 4.8 6.9 5.8 4.5 4.9 2.1 3.7 7.2 7.2 2.0 1.0 10.9 6.7 0.8 4.3 0.6 0.5 29.8 1.3 1.3 0.8 0.7 2.9 6.5 0.0 4.6 0.8 1.7 11.8 1.2 1.6 0.1 8.1 3.3 1.3 5.9 2.8 3.2 3.6 4.9 0.4 4.2 0.4 1.2 0.7 0.6 1.5 2.1 0.9 0.5 22.5 0.1 13.6 1.3 4.3 4.9 2.6 0.0 2.5 0.3 8.3 5.5 6.8 0.8 17.4 3.4 0.9 5.3 8.9 2.2 0.4 2.4 2.1 0.9 0.2 0.1 2.3 2.7 3.3 0.8 0.0 2.4 3.7 2.0 5.0 1.6 1.5 1.1 1.3 2.1 4.9 0.9 0.8 0.4 7.2 7.2 1.3 0.0 1.0 5.1 14.7 1.8 13.4 6.4 4.3 4.1 6.9 4.3 7.1 20.8 11.2 11.2 12.6 15.7 5.9 4.9 12.7 22.7 5.7 8.7 7.9 27.4 11.6 13.6 28.6 8.5 17.3 0.0 18.8 44.1 7.2 13.6 2.3 1.1 11.5 14.3 24.3 12.3 10.5 53.6 3.4 7.7 13.5 3.6 29.5 1.9 10.0 23.0 2.1 1.3 11.8 0.0 2.4 0.9 0.9 17.8 44.3 2.5 18.4 25.5 QRICH1 FLJ20259 ENSG00000198218 "Glutamine rich 1" Q2TAL8 3 49029707-49094363 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037677, HPA037678" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037677: AB_10671883, HPA037678: AB_2675603" "unprognostic (2.38e-2)" "unprognostic (2.05e-1)" "unprognostic (8.29e-2)" "unprognostic (1.67e-1)" "unprognostic (2.41e-1)" "unprognostic (3.14e-2)" "unprognostic (2.77e-3)" "unprognostic (6.94e-2)" "unprognostic (2.82e-2)" "prognostic favorable (7.46e-4)" "unprognostic (1.12e-1)" "unprognostic (1.40e-2)" "unprognostic (2.17e-3)" "unprognostic (5.06e-2)" "unprognostic (3.84e-1)" "unprognostic (1.76e-1)" "unprognostic (1.06e-1)" 28.9 27.6 20.4 23.6 26.8 43.1 27.8 38.9 35.0 26.2 23.3 27.0 21.2 21.0 30.7 22.0 28.4 26.7 23.7 21.5 20.9 16.7 20.3 22.1 26.0 30.3 17.8 22.1 30.5 23.3 30.7 27.3 32.1 23.6 22.6 21.4 28.4 26.4 26.0 32.3 34.1 30.0 24.6 15.9 35.2 25.8 53.9 21.8 40.3 25.9 20.2 37.1 28.1 23.6 15.5 16.0 15.9 26.0 15.8 20.1 11.1 18.6 17.9 35.6 16.4 23.4 22.5 22.2 21.1 27.7 35.4 32.3 19.5 23.7 29.9 13.6 27.5 28.6 14.9 32.6 29.5 30.8 25.6 19.6 29.3 24.8 16.1 21.1 25.5 33.8 25.5 22.5 35.4 22.7 21.6 27.4 27.6 19.8 27.4 24.0 13.8 37.1 17.5 29.1 19.6 22.5 18.6 18.6 24.7 22.1 29.1 13.6 27.4 24.0 22.4 17.4 29.4 20.0 28.9 23.8 23.2 26.4 20.5 30.1 24.7 28.7 36.2 21.2 24.6 26.5 14.0 13.2 15.9 16.8 16.5 19.9 15.4 16.2 18.6 16.0 15.5 17.5 20.1 9.9 15.8 26.0 11.4 16.6 11.1 20.4 26.8 38.9 35.0 20.9 16.7 17.8 22.1 23.6 21.8 8.9 13.9 26.2 11.9 19.7 13.5 17.6 17.8 12.0 17.0 19.2 21.6 22.0 1.7 13.7 8.6 15.8 13.1 0.0 11.9 22.9 14.2 14.3 16.1 18.7 17.0 11.1 24.9 18.4 24.3 7.9 20.8 21.5 11.8 17.2 21.2 10.6 16.0 7.0 29.0 9.7 17.1 6.5 17.0 40.7 25.1 19.7 30.8 18.4 16.9 13.5 RABGGTA PTAR3 ENSG00000100949 "Rab geranylgeranyltransferase alpha subunit" Q92696 14 24265538-24271739 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043488 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043488: AB_10794887" "unprognostic (2.00e-1)" "unprognostic (8.37e-2)" "unprognostic (2.61e-3)" "unprognostic (1.13e-1)" "unprognostic (8.34e-2)" "unprognostic (1.39e-1)" "unprognostic (2.78e-1)" "unprognostic (5.78e-2)" "unprognostic (3.89e-2)" "unprognostic (7.11e-2)" "unprognostic (3.12e-2)" "unprognostic (1.12e-1)" "prognostic favorable (5.44e-4)" "unprognostic (1.77e-1)" "unprognostic (1.84e-1)" "prognostic favorable (1.51e-4)" "unprognostic (2.01e-1)" 6.9 9.9 8.6 7.1 9.4 8.7 7.5 9.4 16.2 8.2 9.8 8.4 13.6 7.2 6.4 11.6 37.2 12.3 8.1 10.9 6.9 8.0 12.5 15.0 10.6 10.7 7.7 8.5 8.0 16.4 15.7 10.2 14.1 10.6 8.0 8.0 7.2 12.8 9.2 11.1 13.3 12.1 6.9 6.1 11.5 9.4 11.3 7.0 7.3 9.4 20.3 18.2 8.4 11.4 6.5 12.7 6.7 16.8 6.9 6.3 6.3 3.5 6.0 2.3 3.2 3.8 7.0 12.8 5.4 5.2 8.8 7.6 6.1 5.3 5.5 4.0 6.6 3.5 7.1 2.9 12.5 3.5 7.0 7.3 3.2 5.1 21.0 7.2 6.7 12.2 7.4 14.3 4.3 5.8 5.0 7.3 6.1 2.8 4.3 6.8 15.6 3.6 5.0 1.4 5.2 8.8 3.1 2.2 3.8 8.0 6.9 6.3 3.7 4.1 8.4 4.4 3.6 4.2 4.8 5.3 4.1 3.1 1.9 2.9 5.8 4.4 3.5 2.9 4.3 6.4 3.1 10.0 6.7 5.9 16.8 5.1 6.5 5.7 5.1 12.7 4.2 5.0 4.4 2.6 6.9 12.4 4.0 6.3 6.3 8.6 9.4 9.4 16.2 6.9 8.0 7.7 8.5 10.6 7.0 8.9 12.3 17.9 17.1 15.8 6.9 10.1 25.5 12.0 9.1 5.2 5.9 32.5 13.3 22.0 2.6 7.4 21.7 0.0 23.8 25.8 10.7 12.8 35.7 5.9 24.6 11.1 12.6 7.4 15.6 5.6 8.3 17.3 15.1 18.0 13.1 8.2 28.8 21.0 6.7 18.0 4.1 6.5 12.8 3.0 24.9 10.8 47.9 18.7 15.8 17.4 RACGAP1 MgcRacGAP ENSG00000161800 "Rac GTPase activating protein 1" Q9H0H5 12 49976923-50033136 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 46.7;Extravillous trophoblasts: 40.9;Spermatocytes: 65.3;Spermatogonia: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025859, HPA039427, HPA043912" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728" "prognostic unfavorable (1.51e-4)" "unprognostic (1.91e-1)" "unprognostic (3.74e-3)" "unprognostic (1.53e-2)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "prognostic unfavorable (1.86e-6)" "unprognostic (1.15e-3)" "unprognostic (3.07e-3)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.12e-6)" "unprognostic (5.56e-2)" "prognostic unfavorable (3.98e-8)" "unprognostic (3.13e-2)" "unprognostic (4.94e-1)" "unprognostic (6.16e-2)" "unprognostic (2.15e-1)" 3.7 2.6 4.9 10.0 11.3 21.0 4.2 6.3 7.8 4.2 10.1 4.7 1.5 6.5 3.3 1.9 17.7 2.7 4.0 2.7 4.8 4.5 5.9 2.8 5.6 13.7 7.8 5.0 2.5 2.0 3.3 1.4 8.4 5.4 2.4 11.9 2.0 4.7 2.1 3.8 8.7 7.5 7.6 5.9 5.9 6.8 29.4 6.6 40.9 2.4 8.7 17.8 6.0 6.5 6.3 2.2 16.5 3.5 8.8 14.8 4.8 44.6 40.8 32.5 20.8 6.0 7.2 27.8 47.4 22.8 49.7 34.0 40.7 34.2 24.8 21.2 25.1 24.3 30.3 32.4 22.0 53.0 47.5 20.4 31.9 40.4 13.3 2.2 33.6 26.4 3.9 4.1 33.7 26.9 14.6 16.8 22.7 23.0 38.1 46.4 31.3 27.7 16.8 23.2 25.3 27.0 26.4 39.8 18.2 13.2 22.3 27.4 23.7 38.7 24.6 13.1 17.3 47.8 15.2 15.3 32.9 29.7 21.0 34.1 20.2 49.9 29.4 16.6 23.0 19.2 16.5 2.6 3.9 5.7 3.5 4.9 6.3 6.9 7.8 2.2 3.9 4.2 5.5 0.5 8.8 1.9 1.5 14.8 4.8 4.9 11.3 6.3 7.8 4.8 4.5 7.8 5.0 5.4 6.6 6.0 5.4 8.5 2.4 11.4 1.6 1.2 2.5 2.7 3.4 5.2 3.9 6.2 16.6 1.5 9.3 1.7 1.5 46.7 1.8 40.9 4.1 2.1 2.3 1.8 11.4 1.6 0.0 6.2 11.7 11.4 1.4 8.0 1.7 3.6 2.6 1.7 1.6 0.0 3.5 1.9 0.7 12.9 2.8 65.3 40.1 11.3 7.2 4.4 4.1 1.1 RAD17 "CCYC, RAD17Sp, Rad24" ENSG00000152942 "RAD17 checkpoint clamp loader component" O75943 5 69369293-69414801 "Predicted intracellular proteins" "Cell cycle, DNA damage" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 97.3;Spermatocytes: 125.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004551, HPA005448" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004551: AB_628195, HPA005448: AB_1079738" "unprognostic (1.25e-1)" "unprognostic (1.46e-1)" "unprognostic (3.28e-3)" "unprognostic (2.21e-1)" "unprognostic (2.30e-1)" "unprognostic (6.04e-2)" "unprognostic (7.75e-3)" "unprognostic (6.09e-2)" "unprognostic (1.66e-2)" "unprognostic (2.42e-2)" "unprognostic (1.59e-2)" "unprognostic (5.74e-2)" "prognostic favorable (5.79e-6)" "unprognostic (1.02e-1)" "unprognostic (1.92e-1)" "unprognostic (3.09e-1)" "unprognostic (2.24e-2)" 11.8 12.6 10.6 15.3 15.3 9.3 16.5 13.9 14.2 11.0 10.9 12.3 13.7 7.0 12.9 12.2 10.0 9.9 7.8 11.5 11.1 12.8 18.6 16.1 13.2 24.6 11.6 10.7 11.7 18.3 15.1 32.0 12.9 14.7 12.2 13.3 10.0 12.8 18.8 15.7 9.6 11.9 10.5 13.4 14.5 11.6 37.7 11.6 17.0 15.1 10.0 17.0 10.5 13.6 10.5 4.4 4.9 3.6 7.6 7.5 3.1 7.6 3.4 10.7 12.6 0.0 0.1 13.1 7.6 9.6 10.4 14.8 8.1 8.4 33.8 8.3 4.4 20.9 3.6 10.6 4.4 16.2 0.0 5.8 8.2 8.3 8.1 12.9 0.2 10.8 7.6 7.4 7.7 7.6 0.0 9.0 8.9 7.9 10.3 13.1 0.0 15.0 5.6 6.6 3.2 4.3 13.1 9.8 7.5 12.5 7.0 11.2 7.9 7.0 2.2 0.3 11.9 10.4 10.1 2.7 0.0 9.5 4.8 4.9 13.3 20.5 11.5 10.7 16.1 6.9 1.4 3.0 4.9 6.0 3.6 5.7 10.5 5.4 6.4 4.4 7.2 7.5 6.3 1.2 7.6 1.7 2.2 7.2 3.1 10.6 15.3 13.9 14.2 11.1 12.8 11.6 10.7 14.7 11.6 29.8 13.2 13.4 4.7 4.8 17.0 29.6 15.3 44.2 27.3 5.2 19.6 15.1 21.6 10.9 97.3 7.1 8.1 0.0 11.2 14.1 10.3 7.8 29.0 9.7 8.9 6.4 14.6 13.5 10.7 61.1 13.3 11.4 5.0 10.8 9.8 18.3 10.4 7.0 10.3 17.0 44.8 6.5 8.0 125.0 69.7 5.1 11.8 11.4 11.1 4.3 RAD18 RNF73 ENSG00000070950 "RAD18, E3 ubiquitin protein ligase" Q9NS91 3 8775402-8963773 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006716, HPA006724, HPA008752" Supported Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (4.45e-2)" "unprognostic (1.25e-3)" "unprognostic (2.73e-2)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.01e-1)" "unprognostic (9.76e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (3.73e-4)" "prognostic unfavorable (3.65e-5)" "unprognostic (1.97e-2)" "unprognostic (1.51e-1)" "unprognostic (7.92e-2)" "unprognostic (1.89e-2)" 6.2 5.7 7.4 5.6 12.7 7.9 9.5 16.4 11.4 5.5 6.6 3.9 5.4 17.7 6.5 3.7 7.6 4.9 5.6 4.4 4.7 3.3 4.3 5.7 5.9 7.6 8.4 6.9 7.1 4.2 3.4 6.9 6.9 5.7 7.4 9.0 3.5 7.5 3.5 3.7 8.5 10.5 6.0 7.8 8.5 5.1 9.5 9.8 16.6 6.7 4.7 7.5 6.1 6.8 3.7 6.3 8.7 3.0 4.3 5.5 1.5 9.9 9.4 7.9 4.7 2.0 4.2 9.7 15.8 5.4 15.2 10.5 8.6 6.4 12.3 3.0 8.9 8.9 3.5 8.3 8.2 15.6 7.6 10.5 10.4 9.5 5.1 1.2 13.7 9.0 1.6 3.0 15.0 10.2 4.1 4.9 10.5 11.1 12.2 13.3 11.5 13.9 9.8 11.0 7.9 17.4 11.1 8.8 9.7 4.4 7.7 3.3 7.5 7.0 6.8 5.1 6.5 7.0 6.1 4.0 12.7 6.9 10.7 13.5 6.2 9.4 26.7 9.3 15.3 9.3 7.4 2.7 8.7 3.0 3.0 5.5 3.7 4.0 5.2 3.4 3.7 4.3 3.2 1.2 4.3 1.8 6.3 5.0 1.5 7.4 12.7 16.4 11.4 4.7 3.3 8.4 6.9 5.7 9.8 14.9 9.8 8.2 5.8 9.8 5.1 2.0 5.1 4.0 9.1 3.5 2.0 6.6 1.7 6.5 3.3 4.2 3.8 0.0 7.1 10.7 4.3 7.0 12.8 2.9 5.9 3.2 1.7 4.9 3.7 2.1 3.7 4.6 3.3 7.2 5.0 2.8 7.9 5.8 2.5 2.4 2.2 6.5 4.7 15.5 13.6 10.3 5.6 4.6 5.2 2.7 RAD21 "hHR21, KIAA0078, SCC1" ENSG00000164754 "RAD21 cohesin complex component" O60216 8 116845935-116874866 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Activator, Developmental protein, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020044, CAB022065" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB022065: , HPA020044: AB_1856035" "unprognostic (7.85e-2)" "unprognostic (4.92e-1)" "unprognostic (3.05e-1)" "unprognostic (5.43e-3)" "unprognostic (9.56e-2)" "unprognostic (3.50e-1)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.86e-3)" "unprognostic (8.99e-2)" "unprognostic (8.80e-2)" "unprognostic (5.58e-3)" "unprognostic (3.56e-2)" "unprognostic (4.40e-2)" "unprognostic (2.00e-1)" "unprognostic (1.82e-1)" "unprognostic (1.39e-1)" "unprognostic (1.95e-1)" 31.6 40.9 48.2 30.5 52.2 78.5 37.7 58.8 55.3 24.2 36.3 37.5 21.5 24.8 30.5 25.3 32.1 23.1 22.0 37.8 45.6 44.1 30.5 27.9 29.6 49.2 54.3 35.4 33.5 18.2 29.1 30.0 38.9 45.5 26.5 37.3 19.0 25.3 31.0 37.8 24.0 26.0 33.4 49.7 31.2 31.5 37.6 56.2 58.3 41.9 20.9 50.4 37.1 36.0 8.7 5.4 17.9 7.1 8.0 25.4 6.2 41.6 20.5 40.2 22.5 20.2 17.5 18.0 29.0 27.5 32.2 29.8 16.8 39.3 61.6 16.0 20.6 17.2 23.3 34.2 18.7 37.8 81.7 21.9 62.8 25.2 21.3 12.7 20.1 37.0 14.9 15.4 18.8 22.8 21.3 25.1 89.9 25.2 86.3 27.7 25.1 92.1 11.9 23.6 53.8 25.9 33.8 29.2 30.9 19.2 24.5 50.8 26.2 30.4 82.1 19.6 22.0 34.4 24.9 18.4 22.8 33.4 23.8 30.3 45.7 52.5 55.5 19.5 29.0 27.2 17.2 4.5 15.5 11.0 5.3 11.2 8.7 12.9 13.0 5.4 8.3 13.5 13.0 17.9 8.0 7.1 4.5 25.4 6.2 48.2 52.2 58.8 55.3 45.6 44.1 54.3 35.4 45.5 56.2 238.2 123.7 70.9 67.0 84.9 73.4 149.3 48.4 87.0 138.8 52.4 29.5 106.6 36.5 47.5 247.8 88.8 56.4 70.0 38.8 119.7 73.7 80.6 143.9 61.8 58.9 63.5 81.0 64.4 91.5 303.2 107.9 82.3 65.8 97.4 62.9 99.6 49.1 57.5 100.0 50.1 60.7 71.1 54.7 31.6 81.6 87.8 95.1 93.8 69.2 65.3 RAD23A "HHR23A, MGC111083" ENSG00000179262 "RAD23 homolog A, nucleotide excision repair protein" P54725 19 12945855-12953642 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 225.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026418, HPA053901, HPA057003, HPA065599" Approved Enhanced Nucleoplasm,Cytosol NA NA 3100000 Nucleoplasm Cytosol "HPA026418: AB_2732430, HPA053901: AB_2682300, HPA057003: AB_2683309, HPA065599: AB_2685516" "unprognostic (2.09e-1)" "unprognostic (1.58e-3)" "unprognostic (1.23e-3)" "unprognostic (7.90e-3)" "unprognostic (1.45e-1)" "unprognostic (1.48e-1)" "unprognostic (3.78e-3)" "unprognostic (3.57e-3)" "unprognostic (3.13e-1)" "unprognostic (3.12e-3)" "unprognostic (1.09e-1)" "unprognostic (4.08e-2)" "unprognostic (2.09e-3)" "unprognostic (2.32e-3)" "unprognostic (9.99e-2)" "unprognostic (8.56e-2)" "unprognostic (6.59e-3)" 19.6 15.2 19.1 13.4 17.7 19.9 16.0 15.1 25.3 12.9 18.0 14.6 10.7 13.6 15.3 14.3 19.9 17.7 13.6 34.3 16.6 16.0 13.2 24.5 14.2 14.1 15.4 15.6 17.1 21.1 14.0 12.3 17.3 15.5 15.1 10.7 12.6 18.6 15.8 225.3 19.8 11.9 16.5 15.4 15.7 14.9 19.1 12.5 14.6 17.2 37.7 13.8 20.7 17.0 29.5 30.0 22.7 35.6 26.5 32.1 22.5 31.6 11.7 13.6 14.0 22.6 26.0 22.8 15.5 31.2 36.9 33.6 13.1 22.9 27.0 35.8 23.3 24.9 24.6 18.6 32.2 14.0 38.1 23.6 10.9 15.2 12.6 44.1 23.5 32.0 26.5 48.4 26.6 51.0 22.0 25.3 42.9 27.9 24.9 33.2 31.0 29.2 29.1 18.6 28.7 29.1 15.5 14.1 43.9 28.7 12.7 25.2 19.8 17.2 31.3 34.3 10.4 24.4 40.8 19.8 53.1 14.2 63.0 47.3 36.0 30.2 19.7 43.7 44.5 43.6 10.4 27.9 22.7 29.7 35.6 32.1 29.2 25.3 25.1 23.4 29.5 24.6 27.8 3.9 26.5 34.9 30.0 27.0 22.5 19.1 17.7 15.1 25.3 16.6 16.0 15.4 15.6 15.5 12.5 80.4 45.1 117.4 151.7 107.0 47.8 58.9 99.3 85.6 69.4 52.4 19.6 181.0 140.9 124.8 141.7 106.7 99.7 397.1 165.8 204.0 114.4 158.2 108.6 79.1 154.6 49.3 83.8 66.9 72.2 22.4 109.6 119.4 135.0 233.6 105.8 52.4 156.1 119.3 107.1 115.4 44.7 109.9 155.2 223.5 168.2 128.1 204.7 114.9 143.0 156.7 RAD54L "hHR54, hRAD54, RAD54A" ENSG00000085999 "RAD54 like" Q92698 1 46247688-46278473 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 41.9;testis: 56.6" "Cell type enhanced" "Detected in some" 11 "Extravillous trophoblasts: 7.8;granulocytes: 4.6;Spermatocytes: 8.0;Spermatogonia: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 4.1" "Lineage enriched" "Detected in single" 4 "T-cells: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA028954, HPA051537" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA028954: AB_2672840, HPA051537: AB_2681525" "unprognostic (2.12e-2)" "prognostic favorable (6.67e-4)" "unprognostic (5.12e-2)" "unprognostic (5.36e-3)" "unprognostic (3.24e-1)" "unprognostic (1.08e-2)" "unprognostic (9.75e-6)" "unprognostic (3.91e-2)" "unprognostic (2.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.77e-4)" "unprognostic (5.58e-2)" "unprognostic (1.11e-16)" "unprognostic (6.76e-3)" "unprognostic (1.66e-1)" "unprognostic (2.67e-1)" "unprognostic (1.74e-1)" 1.9 0.6 1.5 12.9 4.7 9.4 1.3 3.0 1.9 1.1 4.8 0.7 0.5 2.8 1.2 2.1 5.2 0.3 1.2 1.5 1.8 1.5 1.4 0.5 1.5 6.0 1.9 0.7 0.8 1.4 0.6 0.5 4.2 0.9 1.1 5.8 0.6 1.4 1.0 1.4 3.0 3.6 1.8 3.2 4.1 1.7 56.6 0.6 41.9 1.7 3.8 9.6 1.0 1.7 0.5 0.3 0.0 0.1 0.9 4.1 0.7 9.0 6.8 20.5 12.5 1.5 1.0 19.1 10.7 4.7 18.1 18.6 14.5 6.0 17.8 8.2 4.5 16.5 9.4 18.9 6.0 16.0 9.7 19.1 21.8 18.2 14.4 0.0 21.8 12.8 0.6 0.5 18.0 5.3 3.0 5.6 20.7 15.6 18.2 9.9 8.6 27.1 24.2 18.3 8.0 11.2 21.7 11.4 7.8 4.4 7.8 9.8 7.0 7.8 10.8 2.6 17.4 3.8 15.9 2.4 19.5 11.6 10.0 18.0 7.7 4.4 19.2 5.2 14.5 7.8 0.0 0.1 0.0 1.2 0.1 0.2 0.5 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.9 0.1 0.0 4.1 0.7 1.5 4.7 3.0 1.9 1.8 1.5 1.9 0.7 0.9 0.6 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 1.8 0.1 0.2 0.0 0.0 7.8 0.4 0.3 4.6 0.0 2.2 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.0 4.2 0.3 1.4 0.0 1.2 0.4 RAI1 "DKFZP434A139, KIAA1820, MGC12824, SMCR, SMS" ENSG00000108557 "Retinoic acid induced 1" Q7Z5J4 17 17681473-17811453 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023898, HPA054906" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA023898: AB_10971089, HPA054906: AB_2682637" "unprognostic (7.57e-2)" "unprognostic (3.83e-2)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (1.94e-2)" "unprognostic (3.85e-2)" "unprognostic (3.02e-3)" "unprognostic (1.30e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (2.61e-2)" "unprognostic (5.29e-2)" "unprognostic (4.20e-2)" "unprognostic (6.97e-2)" "unprognostic (1.35e-1)" "unprognostic (1.50e-2)" "unprognostic (8.28e-2)" 8.0 13.8 13.8 12.6 17.6 8.1 10.1 21.5 22.9 18.1 12.2 14.2 13.3 11.3 17.8 11.8 12.1 20.3 16.8 13.6 11.3 11.9 10.3 5.8 11.2 9.7 11.1 11.3 17.3 17.2 22.4 19.6 8.4 11.3 17.7 5.4 23.3 24.0 18.2 8.2 19.1 9.5 16.7 6.6 18.5 16.6 8.8 15.7 10.4 15.6 7.7 11.2 19.6 30.0 1.0 3.0 0.7 1.2 2.8 1.0 0.7 15.7 21.4 13.6 11.2 1.8 3.8 2.3 5.4 5.9 4.6 4.5 11.1 6.7 5.1 7.5 7.0 3.9 18.6 4.7 10.8 1.9 5.0 10.6 9.3 12.9 5.6 6.1 3.7 5.9 4.3 5.3 4.1 6.2 5.4 5.6 6.5 3.9 4.1 2.3 14.1 7.8 3.6 0.9 8.2 6.3 18.4 10.6 7.2 3.8 18.9 9.5 16.9 8.6 7.6 17.6 16.4 10.2 4.7 10.7 7.3 9.4 11.6 7.6 3.7 0.8 3.2 7.1 4.6 19.8 0.0 1.0 0.7 0.8 0.8 0.5 0.1 0.4 0.6 0.5 1.0 0.3 1.0 0.1 2.8 1.2 3.0 0.0 0.7 13.8 17.6 21.5 22.9 11.3 11.9 11.1 11.3 11.3 15.7 11.9 28.1 1.9 9.0 10.8 24.9 3.6 10.2 1.4 11.4 14.0 21.6 0.1 0.0 13.7 2.5 7.8 2.4 0.0 8.0 0.5 8.8 11.5 13.9 5.6 2.1 22.3 10.9 14.1 2.2 3.1 6.4 6.3 8.5 2.8 6.9 5.8 9.6 0.0 5.6 1.8 12.0 6.5 6.4 1.4 12.4 7.8 0.3 2.9 6.3 11.1 RALY "HNRPCL2, P542" ENSG00000125970 "RALY heterogeneous nuclear ribonucleoprotein" Q9UKM9 20 33993646-34108308 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040971, HPA043614" Enhanced Enhanced Nucleoplasm,Vesicles NA NA 12000 Nucleoplasm Vesicles "HPA040971: AB_2677230, HPA043614: AB_2678581" "unprognostic (2.06e-1)" "unprognostic (9.54e-3)" "unprognostic (3.72e-2)" "unprognostic (2.28e-1)" "unprognostic (4.68e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.60e-4)" "unprognostic (3.06e-1)" "unprognostic (1.27e-1)" "unprognostic (3.66e-1)" "unprognostic (4.20e-2)" "unprognostic (8.59e-2)" "unprognostic (3.29e-2)" "unprognostic (2.88e-2)" "unprognostic (8.61e-3)" "unprognostic (1.64e-2)" "unprognostic (8.80e-2)" 37.7 23.4 26.3 39.9 30.7 65.2 55.4 22.4 33.9 35.0 43.7 37.6 35.1 41.9 36.4 31.0 41.6 35.2 38.9 51.9 27.3 24.4 39.3 30.3 40.9 53.9 33.0 23.4 38.3 38.5 21.9 20.7 41.9 26.5 34.9 34.9 32.0 38.7 32.7 62.0 39.8 48.8 41.7 40.9 40.4 36.0 56.8 28.9 76.0 76.7 43.6 42.6 33.5 49.7 30.8 40.9 61.6 54.1 54.1 48.4 40.4 37.0 25.6 41.5 31.6 18.6 19.8 33.6 25.9 21.6 34.8 30.1 68.9 33.6 29.2 38.2 21.6 44.6 41.7 19.5 40.5 19.8 19.1 20.2 69.1 15.1 68.8 25.8 35.6 35.3 21.0 24.7 25.8 26.5 26.4 33.8 37.7 28.6 50.1 22.2 35.8 88.6 57.5 21.4 44.5 49.5 52.5 56.7 39.7 21.2 23.5 39.6 44.3 43.3 41.5 58.9 21.5 42.3 38.0 26.5 72.1 43.7 35.0 32.4 50.1 42.0 52.0 36.2 27.0 33.0 32.9 32.4 61.6 44.3 39.9 33.1 30.8 40.1 48.4 40.9 30.7 35.6 33.6 52.9 54.1 54.1 33.8 42.0 40.4 26.3 30.7 22.4 33.9 27.3 24.4 33.0 23.4 26.5 28.9 50.6 54.9 87.2 97.9 70.3 18.7 53.7 58.6 25.4 27.3 52.4 17.7 128.1 107.8 136.9 27.6 80.9 214.0 70.0 140.3 190.7 86.4 99.8 59.9 32.8 138.7 7.9 89.2 68.2 94.3 35.9 60.7 107.6 109.6 188.4 118.3 48.1 145.4 157.8 58.4 84.7 21.3 109.9 97.1 67.3 96.5 70.6 143.4 124.9 145.1 145.7 RALYL HNRPCL3 ENSG00000184672 "RALY RNA binding protein like" Q86SE5 8 84182787-84921844 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 25.6;brain: 54.9;kidney: 23.5" "Cell type enhanced" "Detected in some" 24 "Bipolar cells: 38.5;Distal tubular cells: 150.9;Horizontal cells: 31.8;Muller glia cells: 33.3" "Cancer enhanced" "Detected in single" "glioma: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 26.8" "Low region specificity" "Detected in all" "HPA055868, HPA059112" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055868: AB_2682950, HPA059112: AB_2683908" "unprognostic (1.13e-5)" "unprognostic (1.62e-1)" "unprognostic (7.48e-2)" "unprognostic (1.36e-1)" "unprognostic (5.04e-2)" "unprognostic (1.25e-2)" "unprognostic (1.74e-1)" "unprognostic (4.82e-5)" "unprognostic (2.74e-2)" "unprognostic (2.52e-1)" 1.1 25.6 14.0 1.1 23.0 1.2 1.1 54.9 38.2 0.9 1.3 1.1 0.0 1.4 1.1 1.8 0.9 1.7 7.1 3.7 14.9 22.6 23.5 1.3 1.1 1.0 14.7 20.0 1.0 3.7 1.0 7.6 2.4 9.8 1.2 1.5 0.4 1.1 3.4 1.1 1.2 1.8 1.1 4.6 3.8 1.6 1.4 3.5 0.0 1.1 0.0 1.0 1.0 0.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 26.8 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 14.0 23.0 54.9 23.0 14.9 22.6 14.7 20.0 9.8 3.5 0.0 0.0 0.0 0.0 0.0 38.5 4.4 22.9 0.0 0.0 7.0 2.0 0.0 150.9 0.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 31.8 1.7 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 33.3 0.1 0.0 0.0 14.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAN "ARA24, Gsp1, TC4" ENSG00000132341 "RAN, member RAS oncogene family" P62826 12 130871879-130877678 "Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Host-virus interaction, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA063353 Enhanced Nucleoplasm No No 2100000 Nucleoplasm "HPA063353: " "unprognostic (2.22e-2)" "unprognostic (5.16e-2)" "unprognostic (2.30e-2)" "unprognostic (3.34e-2)" "unprognostic (1.75e-1)" "unprognostic (3.39e-3)" "prognostic unfavorable (9.99e-8)" "unprognostic (2.81e-3)" "unprognostic (1.28e-1)" "unprognostic (5.41e-3)" "unprognostic (2.76e-2)" "prognostic unfavorable (7.86e-5)" "prognostic unfavorable (1.46e-7)" "unprognostic (6.55e-2)" "unprognostic (2.79e-1)" "unprognostic (4.62e-1)" "unprognostic (3.16e-2)" 52.3 68.3 46.9 75.7 62.7 80.6 53.4 42.1 62.6 38.1 61.9 32.5 41.4 41.7 47.9 59.9 96.4 44.0 36.1 55.2 53.9 59.7 52.6 65.9 50.1 90.3 48.9 61.0 46.9 51.3 31.8 43.8 57.0 50.8 37.0 65.6 28.6 43.7 40.2 84.2 45.5 45.1 59.6 42.1 60.1 47.8 87.2 31.0 84.8 51.7 89.6 108.3 44.7 49.5 94.1 69.3 34.3 62.3 60.5 96.5 110.2 97.8 134.7 116.7 67.5 53.7 66.3 90.1 129.3 67.8 126.1 87.2 144.7 104.3 161.8 87.4 92.9 79.3 63.5 169.6 134.3 137.0 54.2 133.5 95.0 102.8 146.3 65.7 164.3 81.9 62.1 84.0 108.7 158.0 84.2 121.8 116.3 140.0 48.2 123.7 120.3 160.2 198.5 136.9 101.7 215.5 125.3 100.2 90.7 117.6 171.0 107.1 65.5 74.8 67.6 90.7 100.9 133.2 119.1 84.2 72.9 111.4 73.9 120.3 67.4 109.7 227.3 74.9 101.7 101.2 29.6 51.5 34.3 69.6 62.3 84.7 94.1 95.5 79.9 69.3 78.5 87.0 82.5 10.7 60.5 58.0 65.7 96.5 110.2 46.9 62.7 42.1 62.6 53.9 59.7 48.9 61.0 50.8 31.0 169.7 129.5 266.6 518.3 564.3 160.2 103.4 160.5 183.4 197.9 160.5 35.3 577.4 328.3 654.2 67.6 212.9 137.7 233.6 391.9 1042.2 424.8 302.9 190.4 172.1 550.1 131.9 193.7 150.4 155.0 125.0 197.6 285.4 315.5 519.4 219.7 197.5 494.0 152.6 217.1 304.7 106.2 161.7 425.8 567.1 580.4 478.1 512.7 322.1 399.9 542.5 RANBP3 ENSG00000031823 "RAN binding protein 3" Q9H6Z4 19 5916139-5978142 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043375, HPA043389" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043375: AB_10959889, HPA043389: AB_10963696" "unprognostic (1.81e-1)" "unprognostic (1.18e-3)" "unprognostic (3.61e-1)" "prognostic favorable (1.22e-5)" "unprognostic (4.24e-2)" "unprognostic (1.42e-3)" "unprognostic (5.44e-2)" "unprognostic (3.90e-2)" "unprognostic (3.58e-1)" "unprognostic (1.08e-1)" "prognostic favorable (4.14e-4)" "unprognostic (2.27e-1)" "unprognostic (3.80e-2)" "unprognostic (2.91e-1)" "unprognostic (5.15e-2)" "prognostic favorable (8.14e-4)" "unprognostic (1.06e-2)" 19.5 30.2 24.8 25.2 31.5 20.9 18.6 38.2 40.9 21.2 29.8 31.6 18.3 24.7 28.2 16.5 23.4 23.9 20.3 30.8 25.0 26.5 19.3 24.6 21.9 26.7 24.3 21.2 29.2 33.1 22.4 26.1 22.3 28.8 25.6 14.2 30.1 27.9 28.0 33.9 21.2 25.1 27.9 25.0 24.9 24.9 36.7 28.0 33.5 21.9 14.7 27.7 28.0 20.9 20.7 21.3 25.0 21.4 14.9 28.7 20.1 30.2 21.3 18.1 20.2 13.7 13.9 12.9 19.4 18.3 22.7 24.7 26.9 10.7 28.6 21.8 15.0 14.3 18.9 16.1 18.9 14.0 29.2 26.3 15.3 16.7 31.9 14.9 22.4 22.6 13.6 13.1 14.2 16.2 10.6 16.5 15.7 27.7 27.1 12.8 12.7 37.2 10.9 33.2 13.2 27.0 27.6 17.4 26.0 14.7 23.5 20.0 22.5 17.2 18.2 17.1 11.1 13.9 17.0 17.1 19.2 14.1 33.5 28.4 28.1 28.3 24.6 24.3 28.2 23.6 13.2 20.8 25.0 22.7 21.4 23.3 17.0 22.0 22.7 21.3 20.7 19.6 25.1 24.0 14.9 20.6 20.2 28.7 20.1 24.8 31.5 38.2 40.9 25.0 26.5 24.3 21.2 28.8 28.0 23.8 18.7 17.9 17.1 10.9 15.9 13.3 17.8 20.1 13.6 7.0 23.6 23.8 36.5 25.9 39.7 15.2 15.8 23.3 18.2 26.3 16.4 14.7 17.3 9.5 21.6 22.3 12.7 6.7 14.3 57.9 15.5 17.0 20.3 44.1 14.6 18.9 18.6 10.5 23.3 14.7 16.8 19.4 13.7 51.1 37.9 10.3 29.6 21.7 13.3 20.9 RARB "HAP, NR1B2, RRB2" ENSG00000077092 "Retinoic acid receptor beta" P10826 3 25174332-25597932 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets, Microphthalmia, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 39.1" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 17.9;Cone photoreceptor cells: 23.6;Ito cells: 20.3;Muller glia cells: 27.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 22.6" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 7.0;HEK 293: 7.9;hTERT-RPE1: 41.7;WM-115: 18.1" "Region enriched" "Detected in many" 9 "basal ganglia: 97.9" "Low region specificity" "Detected in all" "CAB002617, HPA004174" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002617: , HPA004174: AB_1079744" "unprognostic (2.04e-2)" "unprognostic (3.53e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (2.70e-2)" "unprognostic (2.43e-1)" "unprognostic (4.71e-2)" "unprognostic (1.62e-1)" "unprognostic (2.86e-1)" "prognostic favorable (3.43e-5)" "unprognostic (9.24e-3)" "unprognostic (2.28e-1)" "unprognostic (9.99e-2)" "unprognostic (6.56e-3)" 3.9 7.1 2.4 2.3 22.6 0.0 6.8 1.5 9.1 13.4 6.0 2.2 6.8 1.7 14.4 7.5 8.1 6.2 5.3 13.6 2.6 2.2 17.5 6.2 5.6 5.6 2.0 3.7 12.2 1.5 12.8 18.9 13.9 3.2 13.0 2.3 39.1 13.7 11.8 2.5 1.4 2.4 14.7 4.6 7.7 4.8 1.7 4.8 0.0 10.0 2.9 4.6 12.1 10.2 1.0 0.4 0.1 0.6 0.1 0.8 0.0 0.0 0.9 0.6 3.1 7.0 1.8 0.0 0.8 0.4 0.0 0.3 0.1 0.0 0.0 0.1 1.2 0.1 0.2 0.0 0.1 0.0 0.0 7.9 0.0 0.0 0.5 0.1 0.1 0.0 3.7 0.0 0.0 0.0 41.7 6.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 4.2 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.5 0.0 1.1 3.4 0.1 0.0 0.0 2.8 0.1 18.1 0.0 0.6 0.0 0.8 0.1 0.3 0.3 0.5 0.5 0.4 1.0 0.6 0.8 0.1 0.1 0.1 0.4 0.0 0.0 2.4 22.6 1.5 9.1 2.6 2.2 2.0 3.7 3.2 4.8 0.0 0.3 0.0 17.9 0.1 4.2 9.3 7.6 6.7 12.5 10.4 23.6 0.1 0.0 1.4 1.3 3.8 0.0 0.0 0.8 0.1 3.1 5.5 0.0 2.0 0.3 4.8 0.0 20.3 4.1 0.4 0.0 0.0 0.0 0.0 0.0 27.5 1.1 0.0 0.0 0.5 6.1 0.0 9.2 0.2 1.1 0.1 0.2 0.0 0.0 7.1 RBBP4 "lin-53, NURF55, RbAp48" ENSG00000162521 "RB binding protein 4, chromatin remodeling factor" Q09028 1 32651142-32686211 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006264, HPA060710, HPA060724" Supported Enhanced Nucleoplasm NA NA 27000 Nucleoplasm "CAB006264: AB_425651, HPA060710: AB_2684347, HPA060724: AB_2684350" "unprognostic (1.18e-3)" "unprognostic (1.79e-3)" "unprognostic (2.96e-3)" "unprognostic (1.82e-2)" "prognostic favorable (9.23e-4)" "unprognostic (1.62e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (1.24e-2)" "prognostic unfavorable (6.45e-4)" "unprognostic (1.57e-2)" "unprognostic (1.30e-1)" "unprognostic (2.69e-1)" "unprognostic (1.36e-3)" "unprognostic (3.05e-2)" "unprognostic (1.51e-1)" "unprognostic (2.29e-1)" "unprognostic (1.88e-2)" 23.8 33.6 28.2 34.3 27.8 23.4 29.1 30.5 35.1 32.2 24.1 32.0 42.3 20.5 36.0 29.2 26.0 35.4 21.3 24.0 27.9 24.8 25.2 25.4 23.0 43.9 30.6 29.0 37.6 31.3 27.0 32.9 26.2 26.9 24.2 35.5 31.2 30.1 43.1 31.8 24.9 26.8 32.6 26.9 27.6 28.8 53.4 31.4 73.3 35.8 20.5 65.2 32.5 26.6 33.7 45.4 26.7 39.4 33.1 32.4 48.4 15.6 13.7 39.2 28.6 12.1 11.5 15.9 11.9 10.4 24.4 23.8 19.6 32.2 47.5 13.2 14.1 14.1 10.1 42.9 12.4 26.3 18.5 20.6 44.3 27.7 25.7 17.5 41.8 19.2 12.6 15.8 18.4 12.0 19.0 18.0 32.9 31.1 34.1 20.8 10.9 53.5 13.1 43.6 15.5 16.0 52.0 41.3 41.2 17.1 33.5 37.5 22.3 28.2 10.1 19.3 40.4 17.3 19.3 14.9 14.8 15.1 18.7 16.0 27.0 28.3 53.3 17.7 33.8 22.7 26.4 38.8 26.7 31.1 39.4 32.4 33.7 29.7 31.4 45.4 26.6 26.7 28.8 10.2 33.1 35.3 38.3 30.3 48.4 28.2 27.8 30.5 35.1 27.9 24.8 30.6 29.0 26.9 31.4 38.7 41.4 104.6 60.7 63.4 104.9 19.4 79.0 50.9 46.6 69.8 135.5 102.1 71.3 72.0 18.9 58.2 40.2 23.3 50.7 69.8 69.6 53.3 47.4 69.1 71.5 100.1 93.2 70.6 73.4 13.7 73.6 63.2 47.2 72.1 69.7 74.5 62.2 28.8 83.1 53.7 104.1 97.0 47.5 120.2 77.3 67.8 71.5 85.3 75.6 47.1 RBBP7 RbAp46 ENSG00000102054 "RB binding protein 7, chromatin remodeling factor" Q16576 X 16839283-16870414 "Predicted intracellular proteins" "DNA replication, Transcription, Transcription regulation" "Chaperone, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 376.6;Syncytiotrophoblasts: 445.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037084, HPA060710, HPA060724" Supported Enhanced Nucleoplasm NA NA 25000 Nucleoplasm "CAB037084: AB_477448, HPA060710: AB_2684347, HPA060724: AB_2684350" "unprognostic (5.18e-1)" "unprognostic (3.29e-2)" "unprognostic (6.68e-3)" "unprognostic (1.09e-2)" "unprognostic (8.85e-2)" "unprognostic (2.39e-1)" "prognostic unfavorable (5.55e-4)" "unprognostic (3.64e-1)" "unprognostic (1.87e-2)" "unprognostic (3.00e-2)" "unprognostic (7.82e-2)" "unprognostic (1.10e-1)" "unprognostic (6.07e-2)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "prognostic favorable (2.43e-4)" "unprognostic (5.65e-2)" 16.0 81.2 16.6 21.1 26.7 20.3 15.5 13.3 16.2 34.6 22.8 15.3 103.2 13.1 32.3 77.3 20.9 24.5 19.7 36.2 15.1 13.1 17.3 18.5 14.3 19.7 13.7 15.5 41.6 19.0 47.8 16.0 28.7 12.2 26.2 18.1 16.5 19.0 87.6 78.2 16.4 17.9 25.9 15.9 16.0 23.5 31.6 13.6 30.8 18.1 18.2 24.5 24.3 18.5 36.6 29.4 23.7 41.2 32.8 37.7 27.3 54.1 40.3 30.7 40.4 19.3 22.8 19.5 27.0 27.1 39.8 45.1 23.6 35.9 59.9 41.5 26.1 45.8 28.7 54.7 40.1 52.8 33.9 75.1 25.3 49.0 28.0 16.4 38.2 30.7 17.7 14.8 45.8 33.6 25.6 39.8 25.3 25.3 32.0 31.4 36.4 42.7 35.4 34.5 26.2 37.5 37.5 56.5 70.7 28.9 36.5 28.6 21.2 50.9 24.5 23.9 45.1 81.3 23.2 18.3 19.2 19.7 50.6 29.9 22.4 32.0 78.7 24.7 25.8 23.3 16.6 18.3 23.7 36.4 31.3 34.8 36.6 30.4 37.7 25.4 31.0 32.2 35.9 7.4 32.8 41.2 29.4 27.9 27.3 16.6 26.7 13.3 16.2 15.1 13.1 13.7 15.5 12.2 13.6 47.6 54.2 48.2 88.5 66.4 28.9 94.0 30.6 84.3 85.3 52.4 27.5 376.6 66.3 71.3 10.8 45.8 40.0 0.0 65.2 134.7 86.4 63.3 56.6 33.9 93.5 23.8 58.3 39.9 27.6 22.8 105.3 44.7 79.2 75.7 53.5 73.6 61.9 31.6 176.0 51.2 38.7 135.8 87.2 52.9 107.5 53.3 445.1 67.8 67.4 67.3 RBFOX1 "A2BP1, FOX-1, HRNBP1" ENSG00000078328 "RNA binding fox-1 homolog 1" Q9NWB1 16 5239802-7713338 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 57.2;heart muscle: 17.6;skeletal muscle: 67.6" "Cell type enriched" "Detected in some" 11 "Cardiomyocytes: 81.4" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 15 "RH-30: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040809, HPA066746, HPA075862" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" No No Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA040809: AB_10796228, HPA066746: , HPA075862: " "unprognostic (3.75e-3)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (5.19e-3)" "unprognostic (8.82e-5)" "unprognostic (5.02e-1)" "unprognostic (3.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.43e-2)" "unprognostic (3.24e-2)" "unprognostic (2.23e-1)" "unprognostic (5.00e-2)" "unprognostic (2.28e-1)" 1.2 2.4 19.9 1.5 33.0 1.6 1.3 31.5 57.2 1.4 1.9 1.9 0.0 1.3 1.3 5.0 2.0 2.2 1.3 17.6 16.4 6.7 1.5 1.3 1.2 1.2 3.7 21.7 1.4 1.3 1.2 0.5 1.3 13.5 2.6 1.7 0.0 1.7 4.9 67.6 1.5 1.4 1.2 3.5 1.2 1.4 1.7 5.6 0.0 1.3 9.7 1.2 1.5 0.3 1.7 0.7 3.1 0.7 1.2 1.4 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 25.1 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.0 2.4 0.6 2.0 1.1 0.3 0.7 1.0 0.9 0.8 0.3 1.7 1.4 1.0 3.1 1.2 0.7 0.7 1.0 0.0 19.9 33.0 31.5 34.3 16.4 6.7 3.7 21.7 13.5 5.6 0.0 0.3 0.0 0.0 0.0 2.3 81.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 1.1 0.0 1.7 1.0 0.4 7.1 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.0 RBL1 "cp107, p107, PRB1" ENSG00000080839 "RB transcriptional corepressor like 1" P28749 20 36996349-37095995 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 14.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA054962, HPA056525" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054962: AB_2682652, HPA056525: AB_2683165" "unprognostic (1.97e-1)" "unprognostic (2.47e-2)" "unprognostic (1.30e-2)" "unprognostic (3.70e-3)" "unprognostic (2.13e-1)" "unprognostic (1.51e-1)" "unprognostic (6.25e-5)" "unprognostic (6.91e-2)" "unprognostic (7.19e-3)" "unprognostic (1.20e-1)" "unprognostic (4.49e-3)" "unprognostic (3.23e-2)" "prognostic unfavorable (2.52e-6)" "unprognostic (3.15e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-2)" "unprognostic (1.26e-1)" 5.0 4.3 4.9 12.3 7.1 20.4 4.8 16.6 7.8 5.1 5.6 5.5 5.9 4.0 8.1 3.0 7.7 4.4 3.6 4.0 4.0 3.6 3.3 3.0 4.5 11.1 6.5 2.2 7.8 6.0 5.9 5.9 8.3 5.7 4.4 6.1 5.3 4.8 2.7 10.2 5.3 5.9 5.9 7.1 6.9 4.6 8.2 5.5 19.6 5.3 6.1 11.4 4.7 7.1 5.0 5.1 2.2 1.9 3.6 7.4 1.6 12.2 7.9 10.0 6.7 2.5 3.4 6.4 14.3 6.4 12.4 12.9 8.4 6.9 13.7 4.1 5.9 7.3 12.1 8.9 9.2 20.7 4.7 4.8 13.5 9.5 7.1 1.5 17.3 9.4 1.6 1.3 16.3 5.8 2.1 6.9 9.1 9.8 13.3 7.0 5.2 16.1 5.7 2.9 6.2 7.8 10.5 29.8 10.4 2.8 6.1 2.4 6.0 15.6 9.0 4.1 3.3 5.8 12.5 4.5 21.9 8.4 20.0 12.4 4.4 7.8 13.9 15.7 12.2 10.8 1.4 1.2 2.2 5.0 1.4 4.2 5.0 5.6 4.5 2.2 3.9 6.0 4.8 0.6 3.6 1.9 5.1 7.4 1.6 4.9 7.1 16.6 7.8 4.0 3.6 6.5 2.2 5.7 5.5 6.0 14.1 9.2 1.4 2.2 5.2 2.4 0.0 1.4 10.3 0.0 2.0 4.7 0.0 1.3 1.3 2.1 0.8 0.0 1.0 4.2 2.5 0.6 8.1 1.0 4.0 3.2 1.2 1.8 2.8 0.2 2.0 3.2 1.7 4.6 1.1 4.0 1.1 2.8 2.8 0.6 12.8 6.5 1.2 8.7 6.6 1.1 3.2 5.4 2.3 0.7 RBM12 "HRIHFB2091, KIAA0765, SWAN" ENSG00000244462 "RNA binding motif protein 12" Q9NTZ6 20 35648925-35664956 "Disease related genes, Predicted intracellular proteins" RNA-binding "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043258, HPA043621" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043258: AB_2678395, HPA043621: AB_2678584" "unprognostic (8.94e-2)" "unprognostic (2.39e-1)" "unprognostic (1.04e-3)" "unprognostic (7.57e-2)" "unprognostic (1.04e-1)" "unprognostic (4.19e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (7.96e-2)" "unprognostic (8.56e-2)" "unprognostic (1.28e-1)" "unprognostic (7.47e-2)" "unprognostic (3.34e-2)" "unprognostic (3.67e-1)" "unprognostic (3.29e-1)" "unprognostic (4.44e-1)" "unprognostic (3.92e-1)" "unprognostic (6.87e-2)" 23.3 26.1 18.6 26.6 20.6 22.5 23.1 28.1 19.9 26.7 20.8 19.3 21.2 17.5 31.1 21.3 27.9 29.4 22.4 21.1 17.8 12.5 19.5 18.7 23.8 32.2 17.7 20.0 39.5 18.9 24.4 25.7 31.4 15.6 22.7 21.6 22.1 25.6 18.6 24.4 22.1 25.7 25.2 15.4 28.5 21.7 20.6 18.6 52.8 29.3 21.9 37.6 28.0 22.8 15.1 14.9 9.9 13.8 11.5 17.3 11.7 25.1 16.9 36.4 22.2 8.9 17.7 22.4 14.0 16.6 19.7 19.5 23.4 17.8 45.5 15.7 28.1 20.6 17.9 43.0 35.9 25.3 21.5 15.5 38.1 16.8 15.6 15.4 41.3 20.5 25.2 18.6 22.6 15.1 12.7 21.9 24.8 36.2 22.1 17.2 18.5 49.0 11.7 26.4 16.4 17.5 30.0 44.8 22.2 14.3 41.6 19.3 25.0 25.0 19.7 18.8 31.3 25.4 15.3 30.8 16.7 24.7 16.3 20.7 24.0 26.0 48.2 14.6 16.2 21.6 6.0 11.9 9.9 14.8 13.8 17.3 15.1 13.1 17.0 14.9 14.4 14.0 12.1 9.2 11.5 11.1 9.6 12.0 11.7 18.6 20.6 28.1 19.9 17.8 12.5 17.7 20.0 15.6 18.6 23.8 20.8 19.8 17.7 26.3 14.7 19.0 22.9 24.1 18.2 3.5 25.5 18.2 1.7 13.5 3.2 15.7 13.7 0.0 15.3 15.3 17.9 15.2 25.5 11.9 15.6 7.9 23.6 22.1 23.9 3.6 13.6 19.9 15.1 14.4 21.7 11.6 16.5 14.0 15.6 10.2 13.9 6.5 18.6 15.7 14.9 25.7 14.6 20.3 18.5 23.8 RBM15 "OTT, OTT1" ENSG00000162775 "RNA binding motif protein 15" Q96T37 1 110338506-110346681 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015201, HPA019824, HPA049642" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB015201: , HPA019824: AB_1856113, HPA049642: AB_2680839" "unprognostic (1.70e-1)" "unprognostic (1.63e-1)" "unprognostic (9.39e-2)" "unprognostic (7.57e-3)" "unprognostic (2.43e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (7.61e-4)" "unprognostic (1.13e-1)" "unprognostic (1.84e-2)" "unprognostic (4.91e-2)" "unprognostic (9.67e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (1.37e-4)" "prognostic favorable (7.97e-4)" "unprognostic (2.88e-1)" "unprognostic (2.46e-2)" "unprognostic (2.12e-1)" 8.5 7.6 6.3 12.2 7.6 48.7 7.9 18.6 8.3 6.6 8.8 7.6 8.3 7.3 8.5 7.2 8.0 7.3 6.6 8.8 5.2 4.3 6.3 11.0 10.5 13.7 8.3 6.0 8.6 7.5 7.1 8.1 7.1 5.9 5.7 5.7 8.1 7.4 6.4 17.2 7.2 11.3 5.5 5.0 12.5 8.3 14.0 7.9 21.8 7.0 5.3 13.4 6.5 8.6 10.5 4.8 9.8 6.9 5.0 9.9 5.5 7.1 7.8 7.0 7.2 4.5 4.7 11.1 3.8 5.0 6.0 7.9 9.5 6.5 13.5 6.1 4.3 4.9 10.1 11.0 9.5 8.9 14.0 10.1 10.9 11.8 6.9 6.2 11.8 11.6 4.3 6.6 8.3 7.8 3.1 6.3 10.3 15.4 23.7 6.0 7.3 10.6 9.3 15.0 6.3 4.4 12.6 10.6 9.2 4.9 7.2 8.5 4.3 8.3 10.5 8.0 7.9 7.2 14.3 4.4 5.7 10.4 6.2 6.9 18.3 9.2 29.3 8.6 12.0 7.1 8.2 6.9 9.4 7.0 6.0 9.9 10.5 7.7 6.0 4.8 10.0 6.8 8.2 9.8 5.0 6.4 4.7 7.5 5.5 6.3 7.6 18.6 8.3 5.2 4.3 8.3 6.0 5.9 7.9 6.0 3.0 15.3 8.2 29.5 5.4 10.8 7.6 9.4 2.3 3.5 13.7 7.6 0.0 3.4 6.2 9.8 7.5 0.0 3.1 6.2 8.9 8.6 28.8 13.5 5.6 0.0 9.2 10.4 5.7 4.1 3.7 5.5 8.5 1.8 8.4 5.6 4.2 2.9 4.9 3.3 7.1 0.0 13.3 24.4 14.5 29.5 3.9 12.5 7.6 6.7 RBM15B "HUMAGCGB, OTT3" ENSG00000259956 "RNA binding motif protein 15B" Q8NDT2 3 51391268-51397908 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036645, HPA058136" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036645: AB_10671965, HPA058136: AB_2683618" "unprognostic (2.65e-3)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (1.39e-1)" "unprognostic (5.29e-1)" "unprognostic (5.28e-2)" "unprognostic (3.13e-3)" "unprognostic (1.70e-1)" "unprognostic (5.25e-2)" "unprognostic (3.11e-1)" "unprognostic (3.39e-1)" "unprognostic (3.01e-2)" "prognostic favorable (1.84e-5)" "unprognostic (1.35e-1)" "unprognostic (1.69e-1)" "unprognostic (1.89e-1)" "unprognostic (3.84e-1)" 8.6 3.8 4.9 5.6 6.3 5.2 7.1 4.4 9.0 8.0 7.5 6.1 6.3 5.9 7.4 6.5 8.4 7.2 10.1 5.6 5.2 4.8 9.4 6.7 11.6 4.9 4.1 9.3 9.8 9.2 3.3 7.3 4.1 8.3 7.1 5.1 7.2 7.0 4.9 9.9 9.3 7.4 2.2 7.8 6.4 9.1 4.1 23.0 8.2 5.4 7.3 6.8 9.3 4.5 4.9 1.5 5.7 3.4 5.0 3.1 10.9 9.8 22.9 23.8 20.7 16.2 14.0 10.2 19.1 16.4 13.6 12.1 8.0 15.9 8.5 18.4 18.1 10.2 13.1 18.4 7.9 12.7 10.2 13.7 15.3 10.3 12.1 17.8 7.8 17.6 22.9 15.0 17.9 17.9 16.9 26.2 10.2 10.8 14.0 11.7 31.0 11.3 18.2 10.1 15.4 11.1 10.1 13.5 14.6 26.6 14.9 21.4 13.2 17.6 11.7 15.9 13.9 21.2 15.2 16.8 14.7 14.1 19.2 16.0 14.4 17.7 13.7 14.4 17.8 0.0 4.1 1.5 4.0 5.7 4.4 2.4 5.0 4.2 4.5 4.5 5.0 3.1 0.8 3.4 5.3 4.9 2.3 3.1 3.0 4.8 10.7 31.2 22.6 18.0 15.1 5.1 8.1 7.9 14.0 9.8 13.5 10.0 18.2 18.6 17.5 15.0 23.3 19.7 17.7 12.1 26.3 4.7 18.3 15.9 14.3 12.1 12.3 26.2 8.6 14.7 10.5 6.8 4.6 19.4 12.3 25.8 8.6 14.2 14.3 12.9 25.8 18.7 11.4 6.4 24.6 16.5 11.7 20.8 29.3 RBM18 MGC2734 ENSG00000119446 "RNA binding motif protein 18" Q96H35 9 122237624-122264839 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057281, HPA077955" Uncertain Enhanced "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA057281: AB_2683394, HPA077955: " "unprognostic (1.75e-2)" "unprognostic (7.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (2.52e-3)" "unprognostic (1.08e-1)" "unprognostic (9.39e-3)" "unprognostic (7.27e-3)" "unprognostic (2.79e-2)" "unprognostic (1.45e-1)" "unprognostic (8.51e-2)" "prognostic favorable (8.00e-7)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" 12.8 14.8 16.5 9.1 16.5 15.1 24.6 18.1 20.3 14.4 13.4 10.5 13.7 10.4 13.6 16.2 11.8 11.6 11.7 27.2 16.7 18.6 17.3 12.2 10.7 10.9 17.8 13.2 15.1 13.7 16.0 18.2 16.2 16.3 17.2 12.6 8.2 12.6 13.9 29.4 10.1 10.8 13.2 16.0 12.4 12.3 7.6 15.0 11.9 15.3 13.5 11.1 13.0 14.4 8.7 9.5 16.0 13.0 7.7 10.0 8.2 5.8 6.1 8.4 9.2 12.4 15.4 7.3 13.3 10.9 9.1 8.5 7.0 5.8 10.2 5.8 8.6 10.1 13.7 13.1 13.8 11.5 10.4 5.9 7.6 10.2 5.9 14.0 15.1 10.5 13.1 15.7 9.6 19.6 9.2 13.1 8.3 10.4 8.0 13.6 6.3 7.8 9.3 6.5 19.8 10.2 7.0 17.4 13.8 12.7 6.6 17.6 9.3 10.0 14.1 15.0 6.9 8.2 8.6 7.2 8.6 4.9 13.7 13.0 11.7 21.5 8.5 14.1 9.4 10.2 6.8 9.2 16.0 10.0 10.5 9.6 8.7 8.9 9.7 9.5 6.0 9.3 9.7 9.7 7.7 13.0 6.9 9.1 8.2 16.5 16.5 18.1 20.3 16.7 18.6 17.8 13.2 16.3 15.0 29.8 10.9 16.7 9.8 19.3 11.8 46.6 7.6 17.4 13.6 24.4 2.0 28.1 23.2 20.9 61.1 24.8 12.3 0.0 14.0 35.6 16.0 18.9 17.3 13.7 24.5 3.2 18.9 13.5 21.4 54.6 12.4 16.2 18.6 10.0 16.7 15.8 18.5 13.9 15.9 18.9 11.6 19.4 23.1 10.1 19.4 22.6 47.6 17.3 13.6 14.1 RBM22 "Cwc2, FLJ10290, fSAP47, ZC3H16" ENSG00000086589 "RNA binding motif protein 22" Q9NW64 5 150690794-150701107 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001634 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA001634: AB_1079746" "unprognostic (1.94e-1)" "unprognostic (1.17e-3)" "unprognostic (6.86e-3)" "unprognostic (1.00e-2)" "unprognostic (1.49e-1)" "unprognostic (3.04e-2)" "prognostic unfavorable (5.50e-6)" "unprognostic (7.08e-2)" "unprognostic (2.51e-1)" "unprognostic (4.58e-2)" "unprognostic (8.71e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (7.29e-2)" "unprognostic (2.37e-1)" "unprognostic (7.82e-2)" "unprognostic (9.87e-3)" 26.2 17.5 20.3 16.3 26.3 50.1 21.2 29.4 29.5 20.6 20.1 37.4 16.7 17.4 28.0 18.5 18.8 23.8 20.5 18.5 19.7 19.1 20.0 18.8 20.5 23.5 25.7 16.9 29.2 19.6 21.5 18.0 37.8 23.5 20.9 21.5 19.1 18.3 19.2 30.4 21.5 19.1 19.7 28.0 23.0 17.8 13.5 24.6 38.6 23.8 16.3 27.6 20.3 19.2 25.8 24.9 36.3 28.8 28.4 26.7 20.8 14.9 16.3 25.1 29.2 17.0 16.0 35.5 15.3 17.6 31.0 35.1 26.4 22.2 22.2 24.5 15.0 29.4 15.8 32.5 28.2 32.4 24.6 25.7 17.6 16.2 11.1 16.4 31.1 20.8 13.3 22.5 25.7 16.9 13.6 21.8 18.3 18.6 22.4 19.3 17.4 28.7 20.7 15.0 18.4 17.2 29.4 20.7 19.7 15.3 15.4 23.6 17.9 17.2 28.6 28.2 15.7 29.7 27.9 14.4 25.0 19.8 10.9 27.9 20.8 23.4 32.0 19.7 28.4 18.7 17.6 20.8 33.5 24.4 24.9 26.7 25.8 22.6 22.7 24.9 25.3 24.6 22.9 36.3 28.4 28.8 13.3 24.2 20.8 20.3 26.3 29.4 29.5 19.7 19.1 25.7 16.9 23.5 24.6 26.8 26.2 37.5 47.4 23.1 34.3 26.9 28.1 28.1 39.8 15.7 23.6 46.8 21.6 29.7 5.0 41.2 27.1 0.0 29.8 38.5 28.7 21.3 62.3 15.1 38.1 28.6 24.9 27.0 25.1 2.6 40.0 33.7 21.9 45.9 27.2 34.4 23.2 35.1 42.8 16.5 16.9 32.3 29.3 21.3 28.8 19.1 60.8 45.7 30.2 34.3 RBM24 "dJ259A10.1, FLJ30829, RNPC6" ENSG00000112183 "RNA binding motif protein 24" Q9BX46 6 17281346-17293875 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 41.0;skeletal muscle: 153.8;tongue: 37.3" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 165.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enhanced" "Detected in many" "LHCN-M2: 29.0;RH-30: 29.8;T-47d: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA066927, HPA067231" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA066927: AB_2685750, HPA067231: AB_2685808" "unprognostic (9.05e-3)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.67e-3)" "unprognostic (1.53e-1)" "unprognostic (4.54e-4)" "unprognostic (3.34e-2)" "unprognostic (1.33e-2)" "unprognostic (2.97e-3)" "unprognostic (3.38e-2)" "unprognostic (2.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.45e-1)" "unprognostic (1.16e-2)" "unprognostic (3.06e-2)" "unprognostic (1.08e-2)" "unprognostic (2.33e-4)" 3.4 0.2 1.4 0.9 2.2 0.1 1.1 0.3 1.9 7.0 2.7 0.1 3.0 0.5 9.7 7.3 3.4 7.8 1.7 41.0 1.5 1.7 0.3 0.4 0.4 0.2 0.5 1.1 2.1 0.2 0.1 1.8 0.2 0.3 3.6 2.4 1.6 2.5 2.2 153.8 0.4 1.2 9.3 0.5 0.4 0.8 1.3 0.1 0.1 1.4 37.3 1.9 5.1 2.9 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.7 4.5 6.0 0.0 0.0 0.0 0.0 9.1 3.3 6.2 6.6 0.0 0.5 0.0 2.9 6.5 9.8 0.0 5.6 0.2 11.3 0.0 0.2 0.0 0.5 3.1 0.2 0.0 0.5 3.3 0.0 1.2 0.2 8.0 0.7 0.0 0.0 0.0 29.0 1.3 0.0 0.0 2.0 0.0 0.7 0.0 29.8 0.0 0.0 0.0 3.9 0.4 0.0 0.0 0.1 4.9 13.9 0.2 0.0 2.1 5.0 0.0 7.8 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.2 0.3 1.9 1.5 1.7 0.5 1.1 0.3 0.1 0.0 0.0 0.0 0.2 1.0 1.6 165.8 0.0 20.1 2.3 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 9.2 0.8 0.2 1.1 0.0 0.2 1.6 4.6 0.0 0.0 1.0 0.0 0.0 1.7 0.0 3.9 0.6 0.2 0.0 0.7 0.1 0.0 6.5 16.2 0.3 7.7 0.9 0.7 0.0 1.5 0.1 RBM3 IS1-RNPL ENSG00000102317 "RNA binding motif protein 3" P98179 X 48574449-48579066 "Predicted intracellular proteins" "Stress response" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Exocrine glandular cells: 1250.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003624, CAB062559" Enhanced Enhanced Nucleoplasm NA NA 24000 Nucleoplasm "CAB062559: AB_2665621, HPA003624: AB_10602123" "unprognostic (1.07e-2)" "unprognostic (1.14e-3)" "prognostic favorable (3.07e-7)" "unprognostic (1.65e-3)" "unprognostic (2.87e-1)" "unprognostic (4.05e-2)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (9.37e-2)" "unprognostic (1.63e-2)" "unprognostic (2.65e-2)" "unprognostic (2.02e-2)" "unprognostic (6.18e-2)" "unprognostic (1.10e-1)" "unprognostic (5.05e-2)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 71.2 25.5 12.6 43.0 13.9 59.0 52.2 16.4 22.5 44.7 32.7 20.9 16.4 23.9 38.5 58.2 46.4 32.9 36.4 44.8 12.2 12.3 53.5 32.9 36.8 115.8 15.0 15.2 38.6 43.2 15.2 19.1 62.2 30.5 21.0 36.0 43.4 39.7 25.0 59.1 56.2 37.8 33.0 23.6 48.4 27.2 27.2 7.4 73.6 24.0 76.8 67.6 46.4 30.1 32.9 56.5 6.4 44.2 29.9 31.8 45.7 20.2 28.4 30.9 32.3 7.7 40.7 19.3 26.4 46.1 66.0 46.1 28.5 53.7 41.8 8.4 53.4 12.9 17.7 26.9 36.0 52.9 38.8 35.7 21.0 46.5 25.4 28.2 57.6 42.9 31.4 25.7 22.2 21.5 8.5 58.5 22.3 11.7 32.5 45.6 34.2 47.8 31.5 17.0 5.4 40.0 46.2 31.6 31.7 28.4 33.7 12.3 30.5 26.4 34.7 28.8 15.5 45.9 57.3 78.8 21.6 35.0 74.7 43.9 16.1 17.6 47.0 32.4 34.6 43.9 5.8 38.4 6.2 27.0 44.2 31.8 32.9 27.6 26.7 56.5 20.5 28.2 27.4 6.4 29.9 37.5 39.1 28.6 45.7 12.6 13.9 16.4 22.5 12.2 12.3 15.0 15.2 30.5 7.4 154.9 140.4 318.0 135.2 461.5 60.5 71.4 114.7 91.0 153.6 50.6 45.2 435.3 149.2 258.9 4.9 222.6 136.8 70.0 1250.6 594.7 406.0 86.3 255.6 72.3 381.7 39.7 237.4 173.7 454.7 10.5 227.6 401.8 496.0 551.0 243.6 125.2 635.6 224.5 138.6 113.6 76.3 129.4 465.6 25.6 174.8 443.8 409.2 335.1 293.7 176.9 RBM48 "C7orf64, DKFZp564O0523, HSPC304" ENSG00000127993 "RNA binding motif protein 48" Q5RL73 7 92528773-92538005 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021777, HPA025306" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021777: AB_1845763, HPA025306: AB_1845764" "unprognostic (2.79e-2)" "unprognostic (2.15e-1)" "unprognostic (2.12e-1)" "unprognostic (1.30e-2)" "unprognostic (2.81e-2)" "unprognostic (5.04e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (2.86e-2)" "unprognostic (2.37e-2)" "unprognostic (3.22e-1)" "unprognostic (1.59e-3)" "unprognostic (3.38e-2)" "unprognostic (1.72e-1)" "unprognostic (6.51e-2)" "unprognostic (7.79e-2)" "unprognostic (2.43e-2)" "unprognostic (8.04e-2)" 11.1 13.0 23.9 10.8 36.0 24.6 14.1 28.3 34.2 11.7 9.0 18.4 7.1 10.3 12.0 12.4 9.9 10.9 8.9 12.1 22.8 15.2 12.4 10.5 9.9 17.1 42.4 15.1 17.0 10.6 11.1 18.3 10.6 20.7 11.5 11.0 9.0 13.0 8.9 16.5 10.8 10.7 9.7 28.0 14.5 9.8 12.5 36.9 13.6 14.5 6.6 13.9 10.2 10.1 20.1 10.6 37.5 12.1 18.1 25.8 14.0 7.5 5.6 9.7 15.2 11.9 12.4 7.6 9.1 9.4 12.1 11.5 6.5 10.4 10.8 16.5 7.7 15.2 7.8 9.9 7.3 13.5 12.2 12.2 8.5 12.2 7.4 10.1 14.9 10.2 9.5 14.4 11.9 12.7 13.9 12.1 14.1 16.8 19.2 11.2 8.9 19.2 15.2 8.6 10.8 9.4 8.9 8.5 14.6 9.6 7.3 11.5 16.2 9.1 17.6 12.7 13.3 5.5 14.7 6.2 17.1 9.3 13.5 13.0 11.4 15.1 18.5 8.1 13.1 15.6 37.5 10.1 21.0 18.5 12.1 20.2 20.1 20.3 18.9 9.7 18.5 25.8 22.1 13.4 18.1 9.9 10.6 18.3 14.0 23.9 36.0 28.3 34.2 22.8 15.2 42.4 15.1 20.7 36.9 11.9 6.9 15.6 11.1 7.6 12.2 14.6 5.1 9.4 11.4 3.5 0.0 8.8 6.6 6.9 6.1 9.3 5.8 23.3 5.2 4.8 8.7 8.9 29.0 3.8 5.4 11.1 0.0 4.9 6.5 5.7 5.5 8.9 5.0 8.2 3.8 12.5 4.1 6.6 6.0 7.4 12.5 12.9 8.3 21.2 15.6 9.9 12.8 14.1 5.2 10.3 RBM5 "H37, LUCA15" ENSG00000003756 "RNA binding motif protein 5" P52756 3 50088908-50119021 "Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017335, HPA018011" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA017335: AB_1856134, HPA018011: AB_1856135" "unprognostic (4.11e-3)" "unprognostic (1.19e-1)" "unprognostic (6.12e-2)" "unprognostic (4.00e-2)" "unprognostic (2.07e-1)" "unprognostic (2.61e-3)" "prognostic unfavorable (9.77e-4)" "prognostic favorable (6.46e-4)" "unprognostic (1.16e-2)" "unprognostic (2.85e-1)" "prognostic favorable (7.58e-4)" "unprognostic (5.58e-2)" "unprognostic (1.49e-2)" "unprognostic (1.93e-1)" "unprognostic (1.58e-1)" "unprognostic (2.41e-1)" "unprognostic (3.89e-3)" 33.8 25.9 34.1 43.7 37.8 37.7 37.0 51.2 38.9 38.5 33.1 47.7 41.3 25.1 53.2 45.9 28.9 40.5 27.6 28.5 31.1 25.0 30.4 26.9 30.3 41.2 38.1 38.4 63.5 36.3 37.7 58.6 40.3 30.3 41.5 33.5 40.4 35.7 37.9 45.9 54.5 34.7 37.9 41.1 47.0 30.9 36.4 39.5 41.4 42.0 28.5 45.5 31.8 36.6 14.3 12.2 29.6 14.4 14.0 20.1 10.3 9.7 12.1 43.8 19.0 18.3 26.7 10.3 29.8 18.0 22.2 15.7 12.1 11.3 23.0 10.3 19.4 21.9 8.6 29.6 14.4 23.9 21.4 10.8 28.9 41.2 10.8 22.7 26.4 23.4 23.7 16.4 24.1 23.8 38.3 23.5 23.7 19.7 15.5 20.8 8.7 26.8 17.9 15.7 16.7 13.8 14.6 19.2 11.8 16.1 49.1 6.3 14.6 24.5 10.7 14.8 31.2 9.9 25.4 26.6 14.8 15.5 20.4 17.2 21.5 31.4 24.4 11.0 16.2 17.0 29.6 14.0 18.5 17.5 14.4 16.6 13.7 15.8 18.1 12.2 14.3 20.1 15.8 26.1 14.0 14.0 9.3 18.4 10.3 34.1 37.8 51.2 38.9 31.1 25.0 38.1 38.4 30.3 39.5 65.5 105.1 31.8 36.7 28.4 88.7 39.5 17.8 100.4 86.4 36.6 172.8 40.3 10.0 22.5 120.2 50.7 39.5 0.0 18.1 21.2 40.9 41.1 64.9 37.6 27.8 89.0 70.6 55.3 39.9 150.2 59.5 45.4 42.2 37.9 45.1 49.6 24.7 36.8 54.5 7.6 131.6 32.3 43.2 48.9 34.1 29.6 68.3 55.8 33.6 34.9 RBM7 ENSG00000076053 "RNA binding motif protein 7" Q9Y580 11 114400030-114414203 "Predicted intracellular proteins" Meiosis RNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 146.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA013993, HPA048003" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA013993: AB_1856137, HPA048003: AB_2680231" "unprognostic (2.90e-3)" "unprognostic (8.21e-3)" "prognostic favorable (6.14e-4)" "unprognostic (1.03e-2)" "unprognostic (1.43e-1)" "unprognostic (2.58e-2)" "unprognostic (1.93e-2)" "unprognostic (2.89e-1)" "unprognostic (9.38e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (1.05e-1)" "unprognostic (3.62e-2)" "unprognostic (5.49e-2)" "unprognostic (4.74e-2)" "unprognostic (1.84e-1)" "unprognostic (8.30e-2)" 21.6 13.0 11.4 12.9 14.9 39.9 20.2 15.1 13.0 19.9 17.2 11.9 8.4 11.0 20.2 13.9 19.2 18.2 15.4 13.9 12.1 7.3 14.7 28.6 18.2 18.7 15.5 8.7 26.3 14.9 14.4 17.7 23.8 11.9 20.9 16.8 8.4 18.1 12.1 17.2 13.9 17.7 18.7 15.8 20.0 16.6 16.7 16.1 22.0 21.5 12.5 15.8 24.3 20.5 13.4 15.4 36.2 16.5 17.5 18.6 12.7 12.8 8.6 11.3 10.7 14.8 20.1 12.4 21.1 28.6 24.8 28.7 18.7 29.1 15.5 29.5 19.6 22.8 11.7 13.7 15.4 32.6 14.3 7.5 18.5 9.8 15.4 25.1 12.1 12.9 19.9 20.6 20.7 29.2 22.3 22.0 12.9 18.0 2.9 19.1 3.7 14.1 12.4 14.1 12.1 14.3 11.1 20.6 14.8 20.7 14.3 9.2 8.8 18.3 8.6 9.6 22.4 8.4 8.3 19.7 7.5 17.7 9.5 22.1 7.6 7.8 13.7 5.3 21.5 12.7 36.2 16.2 18.2 13.0 16.5 18.6 13.4 14.0 12.3 15.4 11.9 17.5 15.0 15.6 17.5 16.0 14.8 14.9 12.7 11.4 14.9 15.1 13.0 12.1 7.3 15.5 8.7 11.9 16.1 14.9 18.8 43.6 71.5 59.9 11.2 12.8 10.2 24.1 19.4 27.9 11.8 43.4 56.3 42.2 146.5 38.3 29.0 0.0 30.7 67.9 54.3 61.6 39.3 23.2 27.3 7.9 45.5 34.4 25.7 16.1 29.1 22.4 40.5 31.5 26.8 21.6 37.8 33.2 15.9 28.4 11.6 0.0 60.8 29.2 15.2 60.0 77.2 40.5 34.3 73.7 RCOR1 "COREST, KIAA0071, RCOR" ENSG00000089902 "REST corepressor 1" Q9UKL0 14 102592661-102730576 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 102.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001956, HPA049327, HPA054241" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB001956: , HPA049327: AB_2680715, HPA054241: AB_2682426" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.17e-1)" "unprognostic (4.01e-3)" "unprognostic (1.25e-1)" "unprognostic (2.18e-1)" "unprognostic (9.96e-3)" "unprognostic (1.72e-2)" "unprognostic (1.87e-2)" "unprognostic (4.98e-2)" "unprognostic (1.46e-2)" "unprognostic (6.05e-3)" "unprognostic (7.23e-2)" "unprognostic (1.39e-1)" "unprognostic (2.02e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (3.72e-4)" 8.0 5.9 4.2 15.2 4.5 25.2 6.2 8.8 4.4 9.8 14.6 3.8 9.7 7.0 9.7 9.7 16.4 5.8 10.4 6.0 4.4 4.4 5.3 6.0 15.1 8.1 4.1 2.6 7.3 5.3 8.9 6.0 12.5 3.6 7.1 6.7 6.3 8.5 7.6 11.2 9.5 16.1 6.5 4.5 8.6 7.9 18.4 3.8 21.2 5.4 10.4 12.9 8.7 10.3 0.8 2.8 7.0 3.1 1.3 1.1 0.9 10.5 9.9 8.9 9.8 7.2 10.0 18.9 10.9 7.8 10.3 9.8 9.0 12.9 11.9 9.0 9.5 5.2 16.7 13.4 7.8 15.5 5.0 4.9 22.1 9.0 8.8 9.8 21.9 20.0 7.0 12.3 9.0 14.0 11.1 11.2 11.3 17.5 9.1 10.3 17.2 13.6 14.8 4.4 11.7 17.1 35.1 9.0 5.3 12.5 13.1 11.6 7.2 24.5 11.3 7.0 11.7 15.5 17.4 12.1 7.2 5.4 22.7 7.1 6.7 8.1 12.8 8.6 16.1 7.5 4.9 2.7 3.7 0.4 2.9 0.6 0.7 0.7 1.1 2.8 0.8 0.6 0.7 7.0 1.3 3.1 1.1 1.0 0.9 4.2 4.5 8.8 4.4 4.4 4.4 4.1 2.6 3.6 3.8 44.7 30.7 22.9 21.2 51.2 7.5 15.9 5.1 12.0 23.9 3.5 2.0 24.5 5.0 5.7 4.2 11.8 21.2 0.0 6.4 16.3 18.3 23.4 24.2 10.9 13.2 9.5 20.2 12.3 35.2 4.0 22.5 28.9 23.6 1.8 16.0 10.0 12.7 13.3 19.8 6.9 5.1 0.0 20.6 22.4 18.5 102.9 36.0 13.8 18.0 56.9 RCOR3 FLJ10876 ENSG00000117625 "REST corepressor 3" Q9P2K3 1 211258377-211316385 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007413, HPA007621, HPA071997" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA007413: AB_1079796, HPA007621: , HPA071997: AB_2732193" "unprognostic (2.39e-2)" "unprognostic (1.23e-1)" "unprognostic (9.35e-2)" "unprognostic (3.07e-2)" "prognostic favorable (1.35e-5)" "unprognostic (4.02e-3)" "unprognostic (2.28e-2)" "prognostic favorable (5.75e-5)" "unprognostic (2.04e-1)" "unprognostic (1.27e-1)" "unprognostic (5.12e-2)" "unprognostic (9.86e-2)" "unprognostic (1.03e-2)" "unprognostic (3.62e-2)" "unprognostic (1.82e-1)" "unprognostic (3.95e-1)" "unprognostic (3.56e-3)" 15.1 15.0 17.2 14.9 19.6 25.8 18.9 33.7 21.7 17.3 16.2 17.3 26.8 11.8 19.1 21.9 13.5 16.0 17.1 20.8 16.3 14.4 15.7 13.5 15.8 15.3 18.8 20.8 27.5 18.2 21.4 23.8 14.1 18.6 23.7 13.4 17.3 18.0 35.5 55.3 17.7 16.5 23.6 18.1 17.5 14.4 31.4 21.3 20.6 30.0 16.4 13.4 17.9 16.3 10.0 9.5 27.3 8.5 11.8 10.7 5.4 9.9 7.8 15.9 8.9 13.8 12.9 17.7 11.3 11.3 12.8 13.3 7.6 13.0 14.6 7.9 14.5 9.0 15.0 12.7 11.2 10.0 14.9 7.5 13.3 14.0 10.1 15.5 20.1 12.9 14.3 10.6 13.9 17.2 14.1 7.9 14.5 13.8 18.3 18.5 6.6 10.3 11.6 17.4 6.8 9.6 11.3 30.8 16.7 10.6 17.2 10.2 22.2 29.0 15.1 21.1 15.7 18.9 14.4 10.8 11.4 13.0 14.7 12.7 16.2 10.6 18.3 9.5 12.0 10.0 15.3 8.1 27.3 6.0 7.5 7.9 10.0 6.5 6.2 8.5 8.0 10.7 7.6 13.7 11.8 8.5 9.5 7.6 5.4 17.2 19.6 33.7 21.7 16.3 14.4 18.8 20.8 18.6 21.3 35.7 41.5 10.2 9.5 12.9 43.2 61.3 28.1 25.4 29.6 14.0 33.4 21.6 18.3 8.4 51.5 15.5 17.7 0.0 13.4 12.4 17.2 13.2 18.5 18.7 17.5 22.3 32.8 20.9 20.2 93.2 20.8 21.1 21.9 17.2 17.5 25.7 9.1 16.7 25.5 19.9 49.5 0.0 20.2 56.9 31.5 14.8 21.3 17.5 16.9 7.6 RDH14 "PAN2, SDR7C4" ENSG00000240857 "Retinol dehydrogenase 14" Q9HBH5 2 18554723-18560680 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056686, HPA078577" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA056686: AB_2683209, HPA078577: " "unprognostic (5.79e-2)" "unprognostic (3.96e-2)" "unprognostic (1.64e-1)" "unprognostic (7.03e-2)" "unprognostic (1.99e-2)" "unprognostic (8.71e-3)" "unprognostic (1.11e-2)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (8.83e-3)" "unprognostic (6.41e-2)" "unprognostic (1.92e-1)" "unprognostic (1.82e-1)" "unprognostic (8.98e-2)" "unprognostic (1.58e-2)" "unprognostic (4.32e-2)" "unprognostic (3.69e-2)" 13.8 16.2 10.7 8.7 14.3 5.1 14.0 14.2 15.4 11.3 14.1 11.0 9.6 12.7 16.2 14.3 16.0 12.7 11.0 29.0 12.2 10.4 23.0 22.1 12.5 14.6 11.7 9.0 11.7 21.0 23.5 13.5 14.2 13.2 20.7 12.0 10.6 13.8 13.1 27.8 9.9 16.3 22.9 10.3 15.4 15.9 11.1 8.8 17.4 18.1 13.6 10.7 18.1 17.9 9.9 7.6 7.2 2.0 3.7 7.6 1.6 18.6 5.9 5.0 4.1 15.1 16.1 16.8 11.4 11.7 10.3 10.3 4.6 9.7 18.4 6.8 6.8 13.4 10.2 7.2 13.3 12.1 10.2 19.8 7.2 6.5 13.8 12.9 8.7 9.8 12.2 13.6 10.0 15.7 14.5 9.5 7.5 12.8 6.3 16.9 6.0 7.5 15.4 13.5 14.3 16.9 11.0 13.6 7.9 20.2 12.2 7.7 13.4 6.2 13.7 16.2 10.9 6.8 5.0 9.5 14.7 9.1 11.6 13.5 17.9 14.7 13.7 10.5 6.0 11.5 1.7 1.8 7.2 4.4 2.0 7.6 7.4 5.1 6.3 2.3 9.9 7.3 6.0 0.8 3.7 1.9 7.6 5.8 1.6 10.7 14.3 14.2 15.4 12.2 10.4 11.7 9.0 13.2 8.8 14.9 10.9 21.4 26.0 21.8 22.4 43.0 22.9 2.7 6.8 15.7 5.9 40.0 26.6 32.8 16.1 17.9 14.0 0.0 30.8 42.8 33.7 31.0 12.7 26.8 21.0 14.3 12.7 17.2 15.1 9.4 61.9 14.8 21.9 22.6 27.1 25.0 23.9 32.3 42.1 30.5 18.0 32.3 30.7 71.9 28.2 16.3 38.2 17.5 29.8 23.7 RECQL "RecQ1, RecQL1" ENSG00000004700 "RecQ like helicase" P46063 12 21468911-21501669 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009743, HPA030960, HPA064259" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009743: AB_655306, HPA030960: AB_10794912, HPA064259: AB_2685230" "unprognostic (9.70e-3)" "unprognostic (2.55e-2)" "unprognostic (1.86e-2)" "unprognostic (6.25e-3)" "unprognostic (2.47e-1)" "unprognostic (1.39e-1)" "unprognostic (8.97e-3)" "unprognostic (1.89e-3)" "unprognostic (8.74e-2)" "prognostic unfavorable (3.15e-4)" "unprognostic (3.77e-3)" "unprognostic (3.78e-2)" "unprognostic (2.85e-1)" "unprognostic (1.27e-1)" "unprognostic (1.09e-1)" "unprognostic (2.99e-1)" "unprognostic (3.69e-2)" 32.7 15.8 10.0 22.0 12.7 10.8 18.2 10.9 11.2 18.0 16.3 9.4 11.0 7.5 19.8 14.4 18.7 14.6 14.1 17.9 11.2 7.2 19.6 18.0 19.5 25.7 15.3 7.6 16.0 11.9 8.0 14.8 17.1 12.0 14.0 12.7 6.7 13.1 12.4 15.0 12.4 15.5 20.5 19.5 34.0 12.9 10.8 13.0 27.4 17.4 14.3 25.0 22.6 13.0 19.3 15.2 11.3 20.7 23.1 28.0 13.8 17.2 17.5 13.3 9.8 26.9 33.8 15.4 33.3 28.2 21.5 25.2 19.1 14.4 20.7 12.9 22.7 27.3 12.6 14.2 16.6 30.7 34.6 9.4 25.3 19.4 8.1 10.4 17.5 19.1 18.8 8.6 30.5 22.4 19.8 24.1 14.6 8.8 10.1 28.3 8.4 19.1 20.4 22.1 5.3 11.9 15.8 53.9 16.0 8.3 11.9 3.6 10.6 24.9 6.7 17.5 48.0 17.0 11.2 32.5 30.3 19.7 26.5 30.9 4.1 12.2 45.4 25.6 10.3 22.2 9.3 11.8 11.3 21.9 20.7 21.3 19.3 20.5 21.0 15.2 16.0 13.6 18.8 5.5 23.1 18.8 11.6 28.0 13.8 10.0 12.7 10.9 11.2 11.2 7.2 15.3 7.6 12.0 13.0 20.8 19.7 38.7 12.7 20.9 10.9 7.3 12.7 30.8 25.0 14.0 13.7 9.7 8.3 16.8 0.5 36.0 3.2 0.0 21.6 23.8 30.7 7.0 50.8 11.9 25.0 14.3 9.4 28.3 30.7 2.0 20.4 35.9 28.7 49.5 6.0 17.7 24.4 5.5 35.3 9.5 10.9 12.9 25.8 6.0 8.1 37.5 3.0 41.7 6.9 8.2 RECQL4 RecQ4 ENSG00000160957 "RecQ like helicase 4" 8 144511288-144517845 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.0;lymphoid tissue: 18.9" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 7.1;Spermatocytes: 12.6;Spermatogonia: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 14 "B-cells: 1.9;monocytes: 1.0;T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB017800, HPA025821" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB017800: , HPA025821: AB_1856168" "unprognostic (5.92e-2)" "unprognostic (1.86e-1)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (9.17e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (1.91e-4)" "unprognostic (1.12e-2)" "unprognostic (4.12e-2)" "unprognostic (7.53e-2)" "unprognostic (2.65e-2)" "unprognostic (4.26e-2)" "unprognostic (1.12e-3)" "unprognostic (8.82e-3)" "unprognostic (1.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.34e-1)" 2.0 1.6 2.6 12.3 5.6 21.0 2.8 11.5 3.7 1.8 4.3 1.5 1.6 5.6 2.5 4.9 9.4 1.5 1.9 1.9 2.3 1.7 1.6 1.9 1.6 5.9 1.5 2.2 1.9 3.5 0.3 2.4 2.7 2.2 7.7 1.5 1.4 5.4 0.9 2.1 9.4 4.8 1.1 1.7 4.7 3.0 18.1 1.8 18.9 2.5 5.3 8.0 1.6 1.8 1.9 0.1 0.0 1.0 0.0 1.6 0.2 10.4 18.7 8.7 18.4 0.5 0.9 15.3 10.6 1.9 7.9 6.6 18.4 15.5 7.1 7.1 1.7 4.6 12.7 5.8 4.5 2.2 12.5 22.0 25.7 32.0 13.7 0.1 6.5 21.5 1.1 0.6 8.8 1.8 1.1 2.2 14.6 25.5 9.3 2.7 32.4 23.7 17.7 6.1 8.7 22.4 24.9 6.9 11.9 2.1 11.3 17.3 10.4 14.4 12.1 3.7 2.5 14.7 14.4 2.9 12.8 38.7 15.3 19.5 5.2 5.4 12.1 7.3 20.2 12.8 0.0 0.1 0.0 1.1 1.0 0.0 1.9 0.5 1.1 0.1 0.0 0.9 1.6 0.0 0.0 0.0 0.1 0.0 0.2 2.6 5.6 11.5 3.7 2.3 1.7 1.5 2.2 2.2 1.8 0.0 0.0 2.2 0.4 1.3 2.5 1.6 2.5 0.0 0.0 0.0 3.9 1.2 0.0 0.4 3.1 0.0 0.4 0.0 0.4 7.1 0.8 0.5 0.0 0.6 3.0 0.0 0.0 0.0 0.3 6.2 1.1 0.6 0.0 0.0 1.4 0.2 0.3 0.0 1.4 0.3 1.6 0.0 0.4 12.6 21.1 0.9 1.3 0.0 3.1 0.4 RFC1 "A1, MHCBFB, PO-GA, RFC140" ENSG00000035928 "Replication factor C subunit 1" P35251 4 39287456-39366375 "Plasma proteins, Predicted intracellular proteins" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" Neuropathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009520, HPA046116, HPA069306" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009520: AB_2178317, HPA046116: AB_2679544, HPA069306: AB_2686115" "unprognostic (8.23e-2)" "unprognostic (2.30e-1)" "prognostic favorable (4.43e-5)" "unprognostic (4.15e-2)" "unprognostic (4.08e-2)" "unprognostic (3.38e-2)" "unprognostic (7.48e-2)" "unprognostic (3.30e-1)" "unprognostic (4.70e-2)" "unprognostic (2.47e-1)" "unprognostic (4.17e-2)" "unprognostic (4.14e-2)" "unprognostic (1.62e-3)" "unprognostic (4.48e-2)" "unprognostic (1.31e-1)" "unprognostic (5.41e-2)" "unprognostic (1.47e-2)" 18.7 24.0 20.2 22.5 24.9 26.8 21.2 19.9 22.7 23.8 17.8 17.1 20.3 12.5 20.7 19.0 19.4 15.8 11.9 15.4 17.9 14.6 23.4 24.9 17.2 26.3 29.0 22.7 26.2 34.1 41.3 30.7 17.6 23.5 20.1 14.5 10.5 17.4 18.9 13.5 17.8 16.0 21.0 32.7 21.6 17.1 12.4 28.9 33.6 22.3 14.6 27.3 25.3 17.4 15.3 13.0 6.4 8.1 10.8 13.5 4.7 15.8 7.2 20.5 16.7 9.9 12.6 10.5 18.4 16.8 18.9 22.5 13.9 16.2 39.2 12.5 12.3 20.3 7.7 18.8 16.0 30.5 7.0 12.8 17.5 13.8 12.7 12.0 24.5 11.7 9.6 12.9 19.1 21.4 15.1 14.6 19.6 17.3 8.3 14.3 6.4 35.9 15.8 12.5 9.9 9.2 28.6 37.4 12.3 8.2 11.1 14.4 14.0 10.8 4.3 13.9 13.4 11.3 13.8 11.1 15.6 19.3 14.4 23.3 11.9 16.1 37.3 12.8 25.7 15.5 6.4 8.1 3.2 13.2 6.2 9.6 12.4 11.4 11.2 6.2 15.3 13.5 11.9 3.7 10.8 7.4 13.0 9.9 4.7 20.2 24.9 19.9 22.7 17.9 14.6 29.0 22.7 23.5 28.9 59.6 101.9 40.2 33.4 18.3 67.9 62.9 30.6 45.5 48.9 54.1 56.9 32.4 61.3 47.2 30.3 54.6 23.3 23.3 57.3 45.5 31.2 43.3 24.4 70.3 26.9 81.0 28.8 55.9 42.4 22.0 75.9 33.8 15.1 37.9 46.9 81.0 46.5 31.6 86.3 63.9 74.7 58.2 24.5 40.8 69.2 18.6 26.9 55.4 43.2 40.9 RFC4 "A1, RFC37" ENSG00000163918 "Replication factor C subunit 4" P35249 3 186789880-186807058 "Plasma proteins, Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 48.3;Spermatocytes: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004557, HPA049123, HPA058507" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736" "unprognostic (2.45e-1)" "prognostic favorable (7.41e-5)" "unprognostic (2.84e-1)" "unprognostic (1.81e-3)" "unprognostic (1.03e-1)" "unprognostic (6.69e-3)" "prognostic unfavorable (6.75e-7)" "unprognostic (5.29e-3)" "unprognostic (1.15e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (7.38e-4)" "unprognostic (5.92e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (1.80e-2)" "unprognostic (4.98e-1)" "unprognostic (6.15e-2)" "unprognostic (2.16e-1)" 7.1 6.9 11.5 14.1 16.0 26.8 10.5 28.0 13.9 8.8 11.6 5.3 5.8 8.2 11.8 7.3 13.0 10.2 7.6 8.0 8.6 6.2 8.2 9.3 6.6 22.1 14.5 9.8 12.7 11.9 6.5 9.0 11.0 12.5 7.3 16.1 5.9 8.1 5.8 8.1 8.7 11.8 13.6 8.4 15.6 9.8 20.3 12.8 28.6 6.4 11.0 25.2 8.3 8.5 11.2 7.7 7.4 10.3 7.0 16.5 6.2 34.8 12.0 28.5 18.2 4.1 4.5 22.5 16.9 10.7 27.0 29.9 17.9 16.7 25.2 39.3 8.1 25.9 18.4 25.1 16.5 33.3 38.0 22.1 25.9 18.4 18.2 3.2 27.3 17.4 3.8 6.0 18.5 14.5 6.0 9.0 39.5 20.1 35.9 18.4 16.6 34.3 25.6 25.2 31.2 16.4 27.2 24.5 34.6 9.7 13.0 27.9 13.9 21.1 23.3 19.1 22.4 39.6 26.2 4.1 16.4 20.7 27.4 50.4 20.1 44.4 83.9 14.4 30.1 21.5 0.0 2.2 7.4 9.8 3.3 9.4 10.6 9.7 10.1 3.9 11.2 9.8 8.9 0.4 7.0 10.3 7.7 16.5 6.2 11.5 16.0 28.0 13.9 8.6 6.2 14.5 9.8 12.5 12.8 0.0 2.1 20.1 13.1 5.4 17.0 6.9 10.2 9.4 7.9 10.4 0.0 26.7 5.0 9.4 18.6 4.5 2.0 23.3 14.4 48.3 5.1 4.1 8.1 2.9 20.0 7.9 1.2 6.7 2.1 7.9 9.8 5.2 1.7 15.4 4.2 12.4 7.9 3.5 7.4 6.7 14.0 6.5 10.3 67.9 38.7 2.6 9.4 8.6 11.5 3.1 RFWD3 "FANCW, FLJ10520, RNF201" ENSG00000168411 "Ring finger and WD repeat domain 3" Q6PCD5 16 74621394-74666881 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 46.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048258, HPA075649" Approved Enhanced Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA048258: AB_2680332, HPA075649: AB_2686761" "unprognostic (4.79e-2)" "unprognostic (6.45e-3)" "unprognostic (6.35e-2)" "unprognostic (6.61e-2)" "unprognostic (2.73e-1)" "unprognostic (1.97e-1)" "unprognostic (1.11e-3)" "unprognostic (5.04e-2)" "unprognostic (3.64e-2)" "unprognostic (1.01e-1)" "unprognostic (4.03e-3)" "unprognostic (2.53e-3)" "unprognostic (1.73e-3)" "unprognostic (2.84e-1)" "unprognostic (4.31e-1)" "unprognostic (5.74e-2)" "unprognostic (3.29e-1)" 7.3 5.2 4.2 12.2 6.1 33.9 7.8 7.8 5.6 7.4 6.7 8.4 8.4 5.5 9.7 10.0 12.8 6.3 5.5 5.4 3.9 3.7 6.5 5.6 6.5 12.0 6.1 4.8 7.7 9.6 8.5 7.5 11.5 5.3 6.5 8.1 7.2 8.0 8.4 4.5 11.6 7.8 5.6 4.8 9.7 6.2 35.1 7.2 40.5 7.0 7.5 18.0 7.2 8.6 9.3 7.1 13.8 10.9 9.1 11.7 6.5 14.1 18.2 13.8 10.0 2.9 4.0 15.5 12.8 9.9 20.5 17.9 23.7 14.9 19.8 10.5 10.0 10.3 17.1 22.4 13.3 25.2 6.2 13.4 17.5 14.8 13.3 2.5 17.6 18.3 2.8 4.2 25.8 16.0 5.3 8.7 16.9 26.4 8.9 15.4 22.6 25.6 16.1 27.1 8.3 8.8 39.9 9.3 17.4 7.3 15.1 10.2 10.9 20.6 7.3 9.1 13.0 13.4 15.0 8.4 15.0 14.4 8.4 16.1 12.1 22.4 59.4 10.7 13.6 18.2 13.8 6.8 9.9 9.3 6.3 10.2 7.8 7.7 8.6 7.1 9.3 11.7 8.1 7.7 9.1 10.9 5.5 10.9 6.5 4.2 6.1 7.8 5.6 3.9 3.7 6.1 4.8 5.3 7.2 0.0 5.1 11.2 5.0 9.6 5.8 2.4 2.5 2.7 5.7 1.8 9.8 9.1 10.0 5.6 4.2 5.2 4.2 23.3 6.6 6.6 4.8 9.2 4.6 6.4 7.6 3.2 9.1 10.4 13.7 5.4 3.4 6.1 15.1 3.6 8.3 3.5 8.2 0.0 3.9 3.4 6.8 6.5 5.6 46.5 30.6 8.2 6.3 7.5 7.3 12.0 RFX1 EF-C ENSG00000132005 "Regulatory factor X1" P22670 19 13961538-14007039 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 122.1;Late spermatids: 79.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048722, HPA052966" Approved Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA048722: AB_2680500, HPA052966: " "unprognostic (6.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.55e-3)" "unprognostic (2.63e-1)" "unprognostic (5.45e-2)" "prognostic favorable (2.42e-4)" "unprognostic (2.62e-1)" "unprognostic (1.71e-1)" "unprognostic (2.88e-1)" "unprognostic (1.61e-2)" "prognostic favorable (4.92e-4)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.83e-2)" "unprognostic (2.96e-1)" "unprognostic (1.50e-1)" "unprognostic (1.56e-2)" 7.4 7.4 13.1 8.7 13.1 9.8 7.0 36.2 19.3 10.3 6.0 6.2 10.2 10.6 8.0 4.6 8.0 8.5 6.3 7.0 11.7 5.9 7.9 8.6 7.0 7.2 8.6 9.5 10.2 12.5 11.9 18.9 8.0 9.5 8.5 3.1 9.8 12.7 12.4 11.0 7.0 9.2 4.4 6.8 12.0 11.2 21.0 10.8 11.6 10.9 3.4 9.3 6.8 13.6 3.9 3.5 10.8 3.5 3.4 2.0 1.1 6.2 6.3 3.4 4.1 2.1 2.6 10.3 3.5 2.3 4.0 3.5 6.5 6.3 3.5 7.0 1.8 3.5 8.2 2.5 2.5 1.4 3.5 14.1 4.0 7.1 5.8 3.9 4.1 8.6 1.9 2.7 3.6 2.1 3.6 3.2 3.1 10.2 4.0 2.1 9.5 7.4 8.9 7.7 3.4 9.7 6.5 3.5 5.0 4.0 3.4 14.2 7.5 6.0 5.3 4.8 1.9 5.6 4.3 3.7 7.1 5.8 7.7 5.9 9.4 4.2 2.4 5.6 4.0 6.2 0.7 3.5 1.6 1.4 1.1 1.3 2.9 1.6 1.5 1.7 3.9 1.7 2.0 10.8 3.4 2.0 3.5 1.0 1.1 13.1 13.1 36.2 19.3 11.7 5.9 8.6 9.5 9.5 10.8 14.9 9.9 15.9 8.0 4.9 27.9 7.7 5.1 1.4 12.5 21.0 33.4 8.2 8.3 8.7 122.1 9.8 14.9 0.0 8.4 10.4 9.6 6.2 11.5 14.4 9.2 22.3 16.0 13.5 17.5 79.7 23.9 8.5 1.7 3.6 14.5 13.8 9.3 12.5 26.2 6.7 47.6 12.9 6.1 31.2 17.5 6.6 15.9 15.3 12.7 5.6 RFXANK "ANKRA1, BLS, F14150_1, MGC138628, RFX-B" ENSG00000064490 "Regulatory factor X associated ankyrin containing protein" O14593 19 19192229-19201869 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049157, HPA053330" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049157: AB_2680658, HPA053330: AB_2682114" "unprognostic (3.16e-2)" "unprognostic (6.39e-3)" "unprognostic (1.47e-2)" "unprognostic (1.22e-1)" "unprognostic (5.23e-2)" "unprognostic (4.46e-2)" "unprognostic (1.25e-3)" "unprognostic (3.40e-2)" "unprognostic (3.89e-1)" "unprognostic (1.57e-1)" "unprognostic (2.71e-1)" "unprognostic (1.97e-1)" "unprognostic (1.31e-2)" "unprognostic (3.62e-2)" "unprognostic (3.52e-1)" "unprognostic (2.73e-2)" "unprognostic (2.04e-3)" 16.2 11.0 15.8 19.5 17.8 28.4 15.6 7.6 15.3 19.5 20.1 14.9 17.4 16.9 16.6 20.3 21.8 25.3 12.8 17.7 14.3 12.7 19.0 11.3 14.3 22.5 16.0 10.1 18.8 17.9 12.2 14.0 21.9 13.6 17.7 9.0 16.1 27.0 22.4 32.0 18.7 15.3 11.9 13.0 26.5 16.7 8.5 9.3 49.6 36.6 21.8 23.4 15.1 13.8 25.1 31.7 28.4 18.2 18.3 23.3 15.7 18.6 11.7 8.3 16.6 2.9 8.2 20.9 9.3 9.8 16.0 15.9 9.7 39.1 18.4 23.9 9.6 6.8 13.9 7.1 18.4 7.1 12.6 11.1 14.6 11.9 14.1 30.5 20.8 31.1 15.6 10.9 14.0 10.3 9.8 15.9 18.3 29.1 21.0 8.7 37.4 27.1 27.7 10.0 19.7 26.6 23.0 8.5 32.0 13.2 13.1 6.9 14.4 9.7 12.4 22.8 5.8 17.9 42.6 15.5 8.8 9.3 20.7 14.9 24.3 26.3 27.3 12.7 26.0 16.7 20.5 17.7 28.4 15.1 18.2 12.6 23.6 16.9 16.3 20.0 25.1 17.1 16.5 7.6 18.3 13.3 31.7 23.3 15.7 15.8 17.8 7.6 15.3 14.3 12.7 16.0 10.1 13.6 9.3 29.8 34.6 34.2 28.5 19.6 7.8 3.3 25.5 41.5 14.8 29.6 2.0 50.0 64.6 40.6 4.0 26.3 43.3 23.3 49.9 50.7 21.3 23.9 32.2 13.6 54.2 14.3 35.7 31.3 48.3 7.6 28.1 33.6 20.3 68.5 37.0 24.1 47.4 36.8 18.0 53.8 10.1 38.8 25.9 5.2 17.2 21.5 38.1 28.0 39.4 21.3 RHOXF1 "OTEX, PEPP1" ENSG00000101883 "Rhox homeobox family member 1" Q8NHV9 X 120109053-120115937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 8.1;brain: 9.2;testis: 27.8" "Cell type enriched" "Detected in some" 39 "Spermatogonia: 154.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 9.2" "Cell type enriched" "Detected in some" 6 "T-reg: 8.1" "Lineage enriched" "Detected in single" 30 "T-cells: 8.1" "Cell line enhanced" "Detected in some" "HDLM-2: 3.2;HEK 293: 3.9;NB-4: 2.8" "HPA052560, HPA056506" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA052560: , HPA056506: AB_2683157" "unprognostic (5.03e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (2.31e-2)" "unprognostic (8.65e-2)" "unprognostic (1.07e-3)" "unprognostic (2.46e-1)" "unprognostic (3.15e-1)" "unprognostic (3.89e-1)" "unprognostic (2.15e-1)" "unprognostic (7.50e-4)" "unprognostic (1.97e-1)" "unprognostic (5.85e-4)" "unprognostic (3.00e-1)" "unprognostic (7.96e-2)" "unprognostic (2.26e-1)" "unprognostic (1.73e-3)" 2.8 0.5 0.9 0.5 1.1 0.3 0.9 9.2 1.7 0.5 0.7 0.5 0.5 0.2 0.5 0.5 0.5 1.5 0.5 0.5 0.8 2.4 0.8 0.5 0.5 0.6 0.8 0.5 2.2 0.5 0.8 0.9 1.1 0.5 0.5 0.1 0.5 0.8 0.6 0.5 2.4 0.5 0.5 0.5 0.5 0.2 27.8 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.1 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 3.2 3.9 0.4 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.2 8.1 0.0 0.9 1.1 9.2 1.7 0.8 2.4 0.8 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 2.7 0.0 0.0 3.9 0.1 1.7 0.1 1.0 0.1 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.0 0.1 0.8 0.0 0.0 1.4 0.0 1.3 0.0 0.0 2.9 154.2 0.3 0.0 0.0 0.1 0.0 RNASEH2A "AGS4, RNASEHI, RNHIA, RNHL" ENSG00000104889 "Ribonuclease H2 subunit A" O75792 19 12806556-12815201 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 44.8" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 97.8;Spermatocytes: 51.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042692 Enhanced Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA042692: AB_10793981" "unprognostic (6.74e-2)" "prognostic favorable (1.18e-4)" "prognostic favorable (6.18e-4)" "unprognostic (2.24e-1)" "unprognostic (2.62e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (8.72e-5)" "unprognostic (8.48e-2)" "unprognostic (9.33e-2)" "prognostic favorable (1.22e-4)" "unprognostic (3.80e-3)" "unprognostic (8.71e-2)" "prognostic unfavorable (6.29e-6)" "unprognostic (3.40e-3)" "unprognostic (4.35e-2)" "unprognostic (5.35e-2)" "unprognostic (8.60e-2)" 6.5 5.5 6.4 11.4 10.6 21.9 6.6 11.0 7.5 6.8 6.6 9.2 1.6 8.6 6.8 4.4 14.1 6.0 5.7 5.1 6.7 4.8 8.7 5.9 5.5 9.2 10.6 5.8 7.3 7.0 6.2 4.1 11.8 6.1 5.3 5.7 5.5 8.8 4.3 7.1 13.4 7.1 4.4 7.8 12.0 7.4 14.1 8.4 44.8 8.6 13.4 17.4 6.0 8.0 11.3 7.8 7.1 6.8 12.9 8.6 5.0 14.9 11.3 6.8 6.8 1.0 1.9 8.4 7.0 2.9 10.5 12.1 8.9 5.7 16.0 10.5 1.6 5.9 8.9 5.6 6.9 5.8 8.7 15.1 7.7 12.0 6.8 0.8 7.0 7.1 1.0 1.7 8.8 3.2 2.0 4.0 13.1 10.6 4.8 5.0 25.7 12.9 7.0 6.8 5.6 19.7 13.9 9.9 11.5 2.6 5.9 14.2 8.3 7.5 2.8 3.2 3.1 7.4 4.4 3.8 12.5 6.3 17.7 11.5 11.6 12.8 12.7 7.4 11.3 10.0 7.1 6.8 6.4 8.6 6.6 7.0 9.8 7.0 6.1 4.2 11.3 6.6 6.5 6.8 12.9 5.9 7.8 5.5 5.0 6.4 10.6 11.0 7.5 6.7 4.8 10.6 5.8 6.1 8.4 0.0 1.6 10.4 15.3 12.5 15.9 2.4 10.2 4.0 1.2 0.0 3.9 40.3 0.0 3.9 12.7 4.9 4.6 0.0 5.4 97.8 9.3 6.6 3.5 3.4 41.5 7.9 8.1 10.4 10.3 15.1 7.8 11.9 11.8 6.4 7.7 10.1 1.9 7.0 4.6 0.8 11.2 6.5 11.3 51.9 45.0 11.5 19.0 12.5 19.0 7.3 RNASEH2B "AGS2, DLEU8, FLJ11712" ENSG00000136104 "Ribonuclease H2 subunit B" Q5TBB1 13 50909678-51024120 "Disease related genes, Predicted intracellular proteins" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 120.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 68.3;REH: 57.1;THP-1: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040084, HPA041469" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040084: AB_10697714, HPA041469: AB_2677496" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (2.80e-2)" "unprognostic (3.20e-1)" "unprognostic (2.59e-1)" "unprognostic (1.16e-1)" "unprognostic (8.33e-2)" "unprognostic (2.79e-2)" "unprognostic (2.50e-2)" "unprognostic (9.63e-3)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "prognostic unfavorable (2.54e-8)" "unprognostic (1.05e-1)" "unprognostic (3.13e-1)" "unprognostic (1.39e-2)" "unprognostic (3.34e-1)" 11.9 10.5 11.3 20.2 14.1 28.3 10.9 11.3 10.9 14.0 15.2 9.4 12.9 8.9 20.0 12.6 11.6 15.8 11.6 14.7 10.0 8.8 9.1 7.9 14.3 25.7 11.8 9.9 14.0 18.0 6.3 12.0 10.6 8.5 15.4 12.4 9.6 12.7 12.9 15.8 8.5 13.9 15.5 10.0 18.5 11.5 16.4 11.3 120.1 15.8 11.0 20.4 15.1 12.2 34.2 31.3 5.5 13.9 12.0 34.5 16.9 7.9 6.6 3.6 7.2 4.8 9.5 8.6 5.7 6.6 8.3 7.0 8.6 12.4 22.8 3.7 5.9 8.0 7.7 11.3 5.3 10.0 8.3 9.2 20.4 4.6 5.0 6.5 37.3 13.5 3.8 6.7 7.3 6.5 7.6 7.3 48.0 11.3 10.9 11.3 3.8 68.3 50.7 11.6 17.3 5.2 57.1 10.6 15.3 6.3 4.7 8.0 11.7 6.9 2.5 7.3 4.8 3.9 51.0 5.2 7.5 6.2 8.8 12.7 14.6 9.6 27.0 1.9 27.9 8.7 0.9 12.6 5.5 11.1 13.9 12.7 34.2 22.1 18.2 18.2 29.0 19.9 18.5 2.1 12.0 11.9 31.3 34.5 16.9 11.3 14.1 11.3 10.9 10.0 8.8 11.8 9.9 8.5 11.3 35.7 22.1 62.1 24.8 16.7 12.9 43.5 20.4 53.5 28.4 15.7 5.9 29.9 24.9 37.0 45.2 13.9 8.1 23.3 44.0 45.2 22.6 20.1 50.8 13.1 86.8 1.6 11.6 16.5 44.7 31.5 25.6 35.6 15.1 89.2 18.7 8.1 26.5 3.5 28.0 22.5 4.7 12.9 24.2 70.7 39.5 18.3 15.0 48.4 36.3 22.0 RNF168 FLJ35794 ENSG00000163961 "Ring finger protein 168" Q8IYW5 3 196468783-196503768 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 199.9;Late spermatids: 360.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046109 Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA046109: AB_2679540" "unprognostic (6.15e-3)" "prognostic favorable (8.21e-4)" "unprognostic (3.11e-1)" "unprognostic (1.11e-2)" "unprognostic (4.22e-1)" "unprognostic (5.04e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (6.81e-3)" "unprognostic (5.30e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (8.31e-4)" "unprognostic (4.83e-3)" "unprognostic (2.80e-3)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (1.95e-2)" "unprognostic (6.65e-2)" 20.8 9.3 8.9 10.7 11.1 31.6 18.7 21.1 13.0 13.6 11.2 10.7 12.3 11.1 13.9 8.5 14.3 10.1 10.9 12.0 10.2 10.2 7.5 18.8 14.3 12.0 13.8 11.0 14.6 9.2 12.0 8.1 9.9 15.3 10.1 10.8 9.1 11.0 13.6 20.8 20.1 10.1 12.9 10.5 11.7 10.7 18.4 13.4 17.6 9.6 13.9 15.2 14.7 17.1 6.2 5.8 21.8 10.0 7.7 11.6 5.7 12.5 5.0 9.0 11.8 8.4 6.1 12.9 7.7 4.9 5.2 8.2 9.8 6.2 13.3 17.8 6.4 7.3 12.8 12.6 9.2 8.0 6.3 6.2 25.2 12.7 12.1 4.4 7.7 6.3 6.1 3.5 8.1 7.2 3.7 7.5 11.0 7.5 14.0 5.2 21.2 25.5 4.6 10.7 6.8 6.5 11.5 10.5 10.8 4.4 17.4 7.5 7.6 8.7 10.7 6.6 7.0 16.2 6.9 7.4 9.0 7.1 9.5 10.1 12.0 11.2 20.2 8.8 9.4 7.1 21.8 6.6 7.5 11.6 7.1 10.4 5.7 9.8 8.3 5.8 6.2 8.7 9.1 7.3 7.7 10.0 5.5 6.2 5.7 8.9 11.1 21.1 13.0 10.2 10.2 13.8 11.0 15.3 13.4 14.9 29.1 17.1 44.2 89.0 35.1 19.7 12.7 18.7 19.4 14.0 56.9 11.4 14.9 11.9 199.9 29.2 13.6 0.0 7.9 20.7 33.6 23.5 49.6 25.8 15.9 14.3 13.8 17.2 29.0 360.7 18.7 39.0 25.3 37.9 16.0 13.4 8.6 14.4 19.4 8.4 39.6 12.9 35.0 11.1 67.5 110.7 8.9 46.0 18.6 50.5 RNF169 KIAA1991 ENSG00000166439 "Ring finger protein 169" Q8NCN4 11 74748868-74842413 "Enzymes, Predicted intracellular proteins" "DNA damage, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038505, HPA046138, HPA047952" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Nucleoli, Nucleoli rim, Cytosol" "HPA038505: , HPA046138: AB_2679553, HPA047952: " "unprognostic (1.71e-1)" "unprognostic (4.18e-2)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (3.86e-2)" "unprognostic (3.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-1)" "unprognostic (6.47e-2)" "prognostic unfavorable (8.04e-4)" "unprognostic (2.76e-1)" "unprognostic (1.46e-1)" "unprognostic (3.23e-1)" "unprognostic (2.34e-1)" "unprognostic (9.55e-3)" "unprognostic (1.21e-1)" 12.3 7.0 12.0 11.6 14.0 23.1 12.0 22.6 15.6 13.1 11.2 12.2 6.3 7.4 14.2 8.2 20.6 10.7 10.8 9.2 12.6 5.9 8.9 9.3 16.9 11.3 15.4 9.1 14.6 10.7 17.5 10.4 8.6 13.9 10.5 10.0 8.4 12.4 8.8 15.0 14.1 10.3 14.2 10.1 12.6 10.3 7.2 14.9 12.6 11.5 7.4 12.5 13.1 15.8 0.6 0.8 5.0 1.9 1.2 1.6 0.6 8.3 6.4 7.8 7.6 5.0 6.8 3.1 6.5 6.2 7.3 6.4 10.7 6.3 14.9 6.7 7.8 5.0 8.1 10.4 7.8 9.6 7.4 6.7 10.3 11.8 4.2 5.8 5.4 8.6 6.2 6.2 8.3 19.0 8.2 11.8 10.2 9.1 12.0 7.3 7.0 9.3 9.8 3.0 10.6 4.2 8.7 18.5 8.1 4.7 8.7 3.5 6.3 8.8 6.7 14.2 6.5 8.4 7.0 7.8 12.2 10.3 7.6 5.8 8.7 4.5 17.7 2.4 6.0 7.0 2.8 1.9 1.5 1.6 1.1 1.2 0.3 1.5 0.9 0.8 0.6 1.1 0.9 5.0 1.2 1.0 0.8 1.2 0.6 12.0 14.0 22.6 15.6 12.6 5.9 15.4 9.1 13.9 14.9 8.9 10.7 13.0 26.3 17.6 51.9 2.8 2.5 5.3 7.9 3.5 49.1 5.0 5.0 8.8 2.2 11.7 6.7 0.0 9.5 5.0 9.3 37.6 6.9 11.0 7.6 35.0 11.5 8.6 10.7 2.2 6.9 9.2 10.1 1.8 7.8 33.2 9.1 5.8 9.9 9.1 32.5 25.8 15.1 10.4 10.9 16.3 6.8 16.6 9.7 39.6 RNF2 "BAP-1, BAP1, DING, HIPI3, RING1B, RING2" ENSG00000121481 "Ring finger protein 2" Q99496 1 185045364-185102608 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 78.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026803 Uncertain Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA026803: AB_10602086" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-1)" "unprognostic (1.35e-3)" "unprognostic (1.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.08e-5)" "unprognostic (5.85e-2)" "unprognostic (3.56e-3)" "unprognostic (1.62e-2)" "unprognostic (2.01e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (1.94e-7)" "unprognostic (2.08e-1)" "unprognostic (5.51e-2)" "unprognostic (9.89e-3)" "unprognostic (2.52e-1)" 17.8 15.0 14.3 13.9 12.4 15.3 29.7 15.6 23.6 16.6 12.0 7.8 20.7 10.4 16.2 12.6 15.2 11.5 13.1 12.0 16.0 13.1 13.7 11.1 16.7 20.7 9.4 10.4 19.9 15.0 12.3 26.5 28.4 11.4 13.2 13.5 10.1 17.3 20.6 13.1 12.5 9.8 14.8 11.2 16.2 12.2 27.8 9.4 17.2 15.1 11.5 16.1 17.6 16.9 14.7 19.9 20.6 22.1 17.4 19.4 12.0 13.8 7.6 28.2 11.2 8.0 13.7 26.8 9.8 12.4 15.5 12.5 12.1 23.1 4.1 12.3 12.0 10.5 4.9 19.3 14.2 18.9 12.1 10.1 22.3 4.7 10.6 11.8 22.8 12.6 12.9 8.7 12.7 16.3 12.6 15.6 14.4 17.6 9.9 11.2 8.6 19.7 6.7 37.8 11.7 4.2 22.6 17.5 3.9 11.7 9.8 8.3 14.3 6.8 4.1 19.9 32.0 8.7 12.2 11.0 11.2 14.5 10.6 12.4 16.4 10.6 15.4 7.0 10.8 12.5 19.3 17.0 20.6 13.5 21.1 19.4 14.6 12.5 12.6 19.9 14.7 12.8 12.6 7.9 17.4 22.1 10.0 13.2 12.0 14.3 12.4 15.6 23.6 16.0 13.1 9.4 10.4 11.4 9.4 3.0 5.4 10.8 18.7 20.6 9.2 5.9 7.6 5.3 3.4 8.7 3.9 22.5 19.9 10.5 4.8 17.9 4.0 0.0 11.1 42.7 21.1 12.7 12.7 7.3 17.9 6.4 28.4 21.5 20.3 5.2 8.9 21.4 20.3 28.9 10.4 8.5 10.4 11.5 11.0 10.6 5.9 0.0 12.1 29.9 78.0 17.8 23.8 15.0 11.5 33.6 RNF20 "BRE1, BRE1A, FLJ11189, FLJ20382, hBRE1, KAIA2779" ENSG00000155827 "Ring finger protein 20" Q5VTR2 9 101533851-101563344 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012478, HPA051773" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB012478: , HPA051773: AB_2681604" "unprognostic (7.02e-2)" "unprognostic (2.21e-1)" "unprognostic (9.04e-2)" "unprognostic (2.03e-1)" "unprognostic (3.12e-2)" "unprognostic (1.68e-1)" "unprognostic (1.41e-2)" "unprognostic (2.90e-1)" "unprognostic (2.01e-1)" "unprognostic (5.47e-2)" "unprognostic (7.27e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.64e-6)" "unprognostic (2.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.32e-1)" "unprognostic (9.54e-3)" 16.4 17.1 24.6 17.0 24.9 12.1 17.7 24.4 26.3 18.6 16.4 27.7 15.9 10.1 18.3 18.7 20.4 19.1 13.2 24.1 22.3 22.1 20.5 14.4 14.9 15.5 25.2 20.7 21.1 19.5 31.5 23.1 15.1 30.0 21.6 16.1 16.8 16.2 17.7 32.0 16.3 12.5 23.6 28.8 17.0 13.9 28.2 25.8 21.2 22.0 15.3 18.6 21.1 19.0 13.0 12.5 21.0 23.5 13.8 18.6 10.4 9.7 24.8 14.3 15.7 17.7 14.0 12.2 17.0 13.7 17.1 15.0 15.0 10.4 21.6 9.2 13.1 14.3 24.8 16.6 14.5 17.6 22.5 7.7 11.5 22.7 15.0 13.0 19.8 13.9 13.7 15.6 15.1 19.6 12.9 10.0 8.0 10.9 12.8 18.5 12.7 15.4 5.3 31.6 22.0 12.6 14.9 49.6 10.7 7.0 9.4 15.3 19.3 24.1 12.9 14.0 15.0 11.6 9.4 14.1 15.9 16.0 11.3 14.3 13.9 42.7 11.8 14.0 7.5 19.2 21.0 12.7 19.1 18.6 17.5 14.0 13.0 15.4 13.9 12.5 11.2 16.2 14.9 13.9 13.8 23.5 7.9 11.9 10.4 24.6 24.9 24.4 26.3 22.3 22.1 25.2 20.7 30.0 25.8 23.8 24.5 7.5 8.1 5.7 29.1 42.4 10.2 33.5 26.1 21.0 5.9 13.6 5.0 14.3 26.2 11.3 12.2 0.0 12.1 9.6 11.5 7.2 20.9 16.8 14.4 41.3 23.6 7.4 23.8 15.2 16.7 20.0 10.1 27.9 10.7 27.6 10.2 15.3 22.3 9.1 23.0 32.3 14.4 24.7 15.8 5.1 6.4 16.0 12.0 5.4 RNF208 DKFZP761H1710 ENSG00000212864 "Ring finger protein 208" Q9H0X6 9 137220247-137221581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 21.6;Horizontal cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 12.4;MCF7: 29.7;REH: 23.9;RPMI-8226: 13.2;T-47d: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021256, HPA021429" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021256: AB_1844331, HPA021429: AB_2180654" "unprognostic (2.97e-1)" "unprognostic (7.37e-2)" "unprognostic (1.46e-2)" "unprognostic (6.33e-3)" "unprognostic (9.99e-2)" "unprognostic (2.10e-3)" "unprognostic (3.52e-3)" "unprognostic (1.50e-1)" "unprognostic (9.51e-2)" "unprognostic (2.95e-2)" "unprognostic (8.42e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.12e-8)" "unprognostic (3.41e-1)" "unprognostic (1.69e-1)" "unprognostic (7.66e-2)" "unprognostic (3.40e-2)" 3.7 7.1 17.3 1.2 13.3 0.7 4.3 10.1 27.4 1.9 1.7 1.5 1.2 2.0 1.7 2.7 4.6 3.4 1.2 6.2 18.1 10.8 3.7 8.1 1.8 3.4 9.4 4.6 1.5 8.8 5.7 3.0 1.2 3.5 4.0 0.6 1.8 11.4 5.5 13.2 6.6 2.4 1.2 3.3 1.8 3.4 3.1 2.1 1.2 2.1 3.2 1.2 2.1 1.3 0.6 0.0 0.8 0.7 0.0 1.2 0.8 0.8 1.5 1.1 1.8 0.7 0.1 3.2 0.4 0.6 0.7 0.7 4.5 2.8 0.4 2.3 0.5 0.1 2.3 2.5 0.1 0.1 1.1 0.9 3.1 5.2 12.4 2.4 0.6 1.1 0.5 0.8 0.7 0.3 2.8 0.7 4.6 4.4 0.2 0.3 29.7 1.6 1.4 1.3 2.9 3.3 23.9 0.2 13.2 0.8 0.1 3.0 10.6 0.3 0.9 0.6 0.6 10.7 2.3 0.3 0.5 0.7 1.1 0.0 0.4 0.4 0.1 1.4 0.2 0.6 0.0 0.4 0.2 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.8 17.3 13.3 10.1 27.4 18.1 10.8 9.4 4.6 3.5 2.1 6.0 2.1 1.5 1.1 0.3 8.2 8.2 5.1 4.0 0.0 7.0 11.8 0.2 21.6 3.9 0.5 1.4 4.0 0.0 1.9 0.2 0.9 1.6 0.0 6.8 1.1 15.9 7.5 1.3 0.3 0.5 1.1 0.0 1.7 1.8 3.9 5.5 3.5 4.2 3.2 8.8 3.2 0.0 0.9 1.7 2.2 1.6 0.2 0.8 3.3 0.7 RP9 PAP-1 ENSG00000164610 "RP9, pre-mRNA splicing factor" Q8TA86 7 33094797-33109401 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031523, HPA050778" Uncertain Enhanced Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA031523: AB_10603235, HPA050778: AB_2681233" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (1.07e-2)" "unprognostic (1.82e-1)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "prognostic unfavorable (2.58e-4)" "unprognostic (6.71e-2)" "unprognostic (6.22e-2)" "unprognostic (7.53e-2)" "unprognostic (7.03e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.65e-5)" "unprognostic (4.19e-2)" "unprognostic (2.63e-2)" "unprognostic (2.70e-1)" "unprognostic (1.61e-1)" 10.1 13.8 11.7 9.4 16.0 20.7 14.9 17.1 16.0 10.9 12.2 13.0 7.0 10.3 14.6 18.8 8.1 10.0 10.7 19.2 11.1 10.1 11.4 11.5 9.7 19.4 17.4 8.6 14.2 16.9 10.4 14.2 11.7 11.0 14.0 11.8 12.8 15.0 14.4 34.7 10.7 12.5 15.7 11.8 17.2 10.5 15.2 12.6 13.6 15.6 9.0 18.2 13.4 16.0 34.1 11.7 8.1 5.0 5.9 8.4 3.3 9.9 14.3 15.1 17.2 9.6 9.0 7.2 12.7 10.9 14.7 11.8 12.7 7.3 12.6 8.4 10.5 18.1 10.0 18.3 10.9 19.0 5.7 11.4 9.2 11.3 11.8 16.9 12.3 6.5 9.0 10.3 16.7 33.1 12.0 12.0 13.5 16.5 11.6 14.7 20.6 13.2 33.8 12.7 13.3 10.3 13.3 13.1 8.4 10.6 9.6 14.6 20.0 8.9 20.0 21.7 18.7 10.5 17.1 9.6 14.6 20.5 12.9 20.6 18.9 17.1 25.1 10.3 17.6 28.2 6.4 5.0 8.1 6.6 3.6 6.1 22.0 7.0 7.4 5.3 34.1 8.4 7.8 0.9 5.9 4.6 11.7 5.9 3.3 11.7 16.0 17.1 16.0 11.1 10.1 17.4 8.6 11.0 12.6 11.9 8.5 17.4 13.8 18.7 16.3 32.5 12.7 10.7 11.4 14.0 13.7 16.9 18.3 14.1 3.5 21.7 10.5 0.0 13.7 16.3 19.4 11.5 3.5 15.1 16.0 7.9 9.8 14.7 7.6 2.7 16.7 9.9 21.9 9.0 16.4 15.8 13.4 5.8 15.2 13.5 12.9 25.8 20.2 33.0 48.0 15.7 8.7 11.8 18.0 10.7 RPA1 "HSSB, REPA1, RF-A, RP-A, RPA70" ENSG00000132383 "Replication protein A1" P27694 17 1829702-1900082 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004563, HPA006914, HPA046497" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004563: AB_628224, HPA006914: AB_1856410, HPA046497: AB_2679675" "unprognostic (1.84e-1)" "unprognostic (1.47e-2)" "unprognostic (7.38e-2)" "unprognostic (1.01e-1)" "unprognostic (7.53e-2)" "unprognostic (6.58e-3)" "prognostic unfavorable (9.00e-9)" "unprognostic (9.59e-2)" "unprognostic (2.20e-1)" "unprognostic (2.69e-1)" "unprognostic (6.03e-3)" "unprognostic (1.75e-2)" "unprognostic (3.37e-2)" "unprognostic (2.19e-1)" "unprognostic (6.57e-2)" "unprognostic (2.62e-1)" "unprognostic (4.52e-2)" 19.8 18.9 17.5 22.2 18.6 15.7 19.6 21.0 19.2 20.1 21.2 17.0 26.7 15.9 23.7 20.1 23.8 23.2 20.6 27.6 15.0 15.6 13.3 15.2 19.2 27.6 19.6 19.8 28.8 17.8 18.8 15.7 15.2 15.0 20.2 16.5 20.9 22.9 23.3 46.1 23.6 18.6 21.7 15.0 18.7 17.0 13.9 17.5 36.7 21.1 24.4 33.1 23.6 19.1 24.6 14.5 23.9 19.7 34.2 27.1 25.2 27.7 28.6 26.0 23.9 13.1 13.3 29.1 22.9 14.3 30.5 31.9 40.4 12.9 39.2 21.6 14.5 11.9 25.9 32.2 19.6 34.4 25.6 37.9 23.7 35.4 16.8 8.7 17.4 21.1 10.8 12.9 30.0 13.2 10.8 22.0 25.3 22.4 22.6 21.3 16.0 37.5 11.2 19.9 19.7 16.7 52.2 13.9 21.3 13.5 19.3 11.2 17.5 32.5 11.5 20.2 19.6 23.4 13.7 17.0 20.7 18.1 24.0 34.6 6.3 16.4 22.6 14.8 27.5 25.8 16.7 11.3 23.9 25.9 16.2 26.3 24.6 27.1 25.7 13.8 15.4 26.8 24.3 5.5 34.2 19.7 14.5 25.0 25.2 17.5 18.6 21.0 19.2 15.0 15.6 19.6 19.8 15.0 17.5 8.9 14.3 22.9 13.7 26.3 17.6 18.2 28.1 18.7 11.4 38.4 3.9 55.5 5.0 16.5 15.8 20.1 15.1 46.7 17.4 61.3 22.4 11.7 33.4 20.3 39.8 35.0 15.0 26.4 37.7 27.5 30.0 18.4 27.0 41.5 20.4 34.7 13.6 3.5 32.5 8.5 17.6 0.0 22.7 13.1 21.4 25.5 36.4 25.5 18.1 8.5 RPA2 ENSG00000117748 "Replication protein A2" P15927 1 27891524-27914746 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatogonia: 183.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016538, HPA026306, HPA026309" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572" "unprognostic (2.59e-1)" "prognostic favorable (4.33e-4)" "unprognostic (8.98e-2)" "unprognostic (6.89e-2)" "unprognostic (1.04e-1)" "prognostic favorable (8.12e-4)" "unprognostic (4.29e-3)" "unprognostic (2.03e-2)" "unprognostic (8.62e-3)" "unprognostic (1.68e-1)" "unprognostic (1.58e-2)" "unprognostic (2.31e-1)" "unprognostic (3.59e-2)" "unprognostic (9.13e-2)" "unprognostic (2.30e-1)" "unprognostic (2.18e-3)" "unprognostic (2.82e-2)" 18.6 17.1 33.6 24.3 38.8 20.5 26.6 23.6 30.5 20.0 15.4 17.2 17.6 9.9 19.5 26.3 18.7 28.8 19.2 22.5 31.4 22.1 19.5 18.4 19.3 37.1 22.0 26.7 32.6 15.3 16.4 27.0 17.2 25.4 17.2 19.0 18.0 16.2 19.8 45.0 22.6 16.8 18.6 22.1 28.4 15.3 34.6 27.7 25.4 30.7 17.2 37.9 20.3 17.1 46.2 31.5 48.4 18.1 49.3 55.9 65.9 13.2 12.6 21.2 16.0 14.4 13.4 12.9 24.6 16.7 31.5 27.4 17.9 16.4 33.7 15.8 9.7 11.3 12.3 30.0 13.9 30.8 25.0 27.8 39.2 17.1 15.4 7.3 52.0 27.6 5.7 7.8 30.4 15.7 9.8 13.6 30.6 40.9 29.4 18.2 13.4 37.0 22.7 41.6 26.0 27.1 24.7 31.5 15.7 11.3 14.4 18.1 17.6 27.2 11.0 21.5 17.6 11.3 15.4 8.7 7.8 16.9 42.1 16.1 23.9 53.2 29.3 19.3 46.1 14.0 42.8 18.1 48.4 51.6 14.0 55.9 46.2 48.8 47.3 20.4 39.0 55.8 53.9 18.1 49.3 18.1 31.5 42.5 65.9 33.6 38.8 23.6 30.5 31.4 22.1 22.0 26.7 25.4 27.7 20.8 14.9 53.6 28.2 18.7 26.4 26.0 28.1 30.8 25.0 21.0 2.0 71.3 29.9 26.8 35.0 27.8 9.3 23.3 18.1 52.7 29.0 16.7 60.0 13.5 44.9 7.9 13.3 26.4 35.6 17.1 38.3 36.5 35.4 118.2 13.1 96.8 21.4 7.0 43.5 17.7 30.1 32.3 27.8 118.9 183.5 19.6 46.6 91.4 17.8 15.7 RPL27 L27 ENSG00000131469 "Ribosomal protein L27" P61353 17 42998273-43002959 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Cancer-related genes, Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002649 Approved Enhanced Nucleoplasm,Nucleoli NA NA 30000 Nucleoli Nucleoplasm "HPA002649: AB_1079840" "unprognostic (8.53e-3)" "unprognostic (7.15e-2)" "unprognostic (3.97e-2)" "unprognostic (2.81e-2)" "unprognostic (4.99e-2)" "unprognostic (4.31e-2)" "unprognostic (1.91e-3)" "unprognostic (7.32e-2)" "unprognostic (9.17e-2)" "unprognostic (1.19e-1)" "unprognostic (5.12e-2)" "unprognostic (3.86e-1)" "prognostic unfavorable (7.80e-8)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "unprognostic (2.70e-1)" "unprognostic (1.14e-1)" 78.4 66.9 61.7 82.2 45.7 150.0 148.7 63.1 82.7 75.1 76.8 27.2 65.4 48.8 74.8 80.1 91.9 64.9 80.8 120.6 46.2 38.5 76.2 121.7 109.5 222.2 49.2 49.0 123.7 185.0 17.2 44.1 81.0 48.3 65.3 55.0 43.8 119.1 78.5 127.5 113.8 61.9 82.4 43.6 84.4 69.7 40.3 28.8 72.6 70.5 153.8 78.5 86.1 80.9 178.5 152.7 44.2 99.0 111.4 184.7 216.0 114.1 144.8 88.7 128.4 157.1 233.0 143.3 133.0 109.3 143.0 102.6 205.0 89.9 216.5 113.2 104.6 77.6 100.2 101.6 169.8 137.6 100.2 241.7 85.0 121.4 216.7 193.9 244.1 89.5 219.6 145.5 96.5 123.8 146.7 118.5 114.9 158.0 134.0 132.0 111.6 203.2 206.9 134.3 132.4 92.7 142.6 249.8 244.5 120.8 154.3 99.8 110.2 52.2 103.0 211.8 125.8 173.2 258.0 133.7 106.6 105.6 130.2 195.6 117.1 188.5 211.9 95.8 151.7 108.6 44.2 99.0 29.5 106.6 87.9 150.2 178.5 159.0 124.5 118.6 168.3 184.7 159.1 20.4 111.4 67.3 152.7 112.5 216.0 61.7 45.7 63.1 82.7 46.2 38.5 49.2 49.0 48.3 28.8 681.9 960.2 2744.7 1731.4 2247.5 123.8 670.7 1245.8 627.7 1104.4 492.0 84.4 1811.7 1268.3 1382.3 339.9 1526.1 906.3 700.8 2626.7 2977.9 1476.5 1638.9 947.9 1517.2 1848.2 62.0 876.6 1298.9 2145.4 659.2 2254.1 2398.0 1353.0 2460.8 1687.2 280.7 2397.9 1157.3 1202.8 1660.9 156.7 853.7 1593.4 457.6 394.4 2946.9 1827.2 1797.0 2037.9 2132.8 RPS6KA4 "MSK2, RSK-B" ENSG00000162302 "Ribosomal protein S6 kinase A4" O75676 11 64359148-64372215 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Inflammatory response, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 12.6" "Lineage enriched" "Detected in many" 4 "dendritic cells: 12.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008649, HPA023225" Approved Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "CAB008649: AB_1619460, HPA023225: AB_1854144" "unprognostic (2.30e-1)" "unprognostic (7.05e-2)" "unprognostic (2.03e-1)" "unprognostic (4.07e-2)" "unprognostic (2.40e-1)" "unprognostic (7.47e-2)" "prognostic unfavorable (8.17e-4)" "prognostic unfavorable (9.27e-4)" "unprognostic (2.45e-1)" "unprognostic (9.03e-2)" "unprognostic (1.41e-2)" "unprognostic (3.06e-3)" "unprognostic (1.98e-2)" "unprognostic (3.93e-3)" "unprognostic (5.25e-2)" "unprognostic (1.09e-1)" "unprognostic (2.85e-1)" 14.9 9.1 13.3 15.7 17.1 13.2 7.6 37.6 22.7 7.7 12.4 13.1 5.8 14.0 11.0 6.9 18.5 8.1 10.5 7.8 10.9 10.1 8.7 9.6 10.9 15.0 16.7 9.9 6.5 9.2 5.7 4.7 16.6 9.8 8.3 8.4 10.0 10.9 8.9 16.3 17.3 15.4 9.8 11.5 22.2 18.3 3.3 13.5 7.6 6.7 16.7 16.4 9.7 8.8 0.5 12.6 1.4 3.0 0.3 1.0 2.1 28.1 15.8 2.3 5.7 5.1 4.8 32.6 15.0 7.9 11.8 5.8 15.6 14.8 2.9 17.5 8.6 15.0 26.1 2.7 12.2 5.8 8.9 5.3 6.6 13.5 7.9 5.1 6.7 12.4 4.7 11.5 10.0 8.2 4.2 7.1 5.4 2.7 4.1 5.9 25.8 6.0 10.5 2.5 10.9 33.3 11.8 9.4 9.4 8.1 13.0 3.4 2.7 15.5 9.5 13.0 3.4 11.1 8.3 14.1 16.1 20.2 29.0 13.3 4.9 3.8 2.9 10.6 7.7 8.1 1.1 3.0 1.4 0.9 2.4 1.0 0.5 0.7 0.7 2.7 0.4 0.4 0.4 0.2 0.3 1.4 12.6 0.6 2.1 13.3 17.1 37.6 22.7 10.9 10.1 16.7 9.9 9.8 13.5 3.0 4.0 5.7 4.6 10.8 6.3 11.8 5.1 0.0 1.2 3.5 3.9 60.8 5.0 13.7 0.2 7.4 17.0 0.0 21.8 31.5 9.1 7.1 19.5 6.4 26.9 7.9 8.1 11.6 29.2 0.7 10.3 15.3 8.5 12.6 11.6 3.1 40.7 10.7 6.3 7.3 2.0 0.0 9.2 0.7 7.2 9.4 39.0 8.7 13.9 8.5 RPS6KA5 "MSK1, RLPK" ENSG00000100784 "Ribosomal protein S6 kinase A5" O75582 14 90847862-91060636 "Enzymes, Predicted intracellular proteins" "Inflammatory response, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "granulocytes: 86.9;Syncytiotrophoblasts: 93.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 30.1;SK-BR-3: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001274, HPA001780, CAB025458" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB025458: , HPA001274: AB_1079417, HPA001780: AB_2666432" "unprognostic (3.05e-2)" "unprognostic (2.19e-3)" "unprognostic (4.27e-4)" "unprognostic (1.98e-3)" "unprognostic (4.79e-2)" "unprognostic (4.20e-4)" "unprognostic (3.70e-2)" "unprognostic (5.80e-4)" "unprognostic (6.70e-2)" "unprognostic (8.39e-2)" "unprognostic (1.84e-1)" "unprognostic (1.97e-1)" "unprognostic (1.38e-4)" "unprognostic (5.73e-3)" "unprognostic (1.07e-1)" "unprognostic (2.42e-1)" "unprognostic (1.75e-1)" 4.9 2.4 8.3 13.0 21.6 5.8 16.3 32.9 12.2 7.0 11.0 12.0 4.2 9.3 11.8 2.6 11.9 8.9 6.7 6.1 9.0 7.9 4.5 4.1 6.1 7.3 12.8 9.7 10.2 4.9 12.0 6.9 14.9 11.0 8.0 11.7 2.8 8.7 9.9 14.3 6.6 9.8 19.4 17.1 7.4 9.8 5.2 13.7 4.8 8.6 7.8 7.7 11.6 7.3 5.8 2.5 20.0 3.2 8.4 7.1 2.2 1.2 1.7 2.0 1.3 0.0 0.4 8.7 0.7 1.1 2.3 3.4 0.9 2.3 5.9 2.5 2.2 1.6 3.8 1.7 1.7 4.8 0.9 3.1 5.9 1.7 0.2 0.0 5.8 30.1 0.5 3.6 1.4 1.1 0.5 2.5 4.1 0.6 6.7 2.3 2.5 1.8 2.9 0.6 3.7 2.7 3.2 9.6 3.0 2.5 2.2 10.1 3.2 2.5 15.1 8.5 1.8 2.9 1.9 0.5 0.7 1.3 0.6 2.9 2.9 2.8 5.1 1.4 4.3 9.5 10.5 2.7 7.8 3.6 2.1 5.9 4.4 4.8 3.5 2.5 5.8 5.6 3.0 20.0 8.4 3.2 1.0 7.1 2.2 8.3 21.6 32.9 12.2 9.0 7.9 12.8 9.7 11.0 13.7 17.9 27.4 40.7 37.9 35.8 29.4 14.1 12.7 37.5 29.6 7.0 15.7 31.0 0.0 8.9 5.5 19.6 27.6 0.0 4.6 4.7 13.2 25.2 86.9 6.8 6.4 25.4 15.6 14.1 16.1 2.1 13.0 16.9 18.6 2.8 17.9 12.9 3.0 11.5 11.0 2.8 29.2 12.9 27.6 13.1 23.7 40.5 93.5 39.5 18.8 42.3 RRM2B p53R2 ENSG00000048392 "Ribonucleotide reductase regulatory TP53 inducible subunit M2B" Q7LG56 8 102204502-102239118 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, DNA replication" Oxidoreductase "Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006854, HPA028812" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB006854: , HPA028812: AB_10602246" "unprognostic (7.76e-3)" "unprognostic (4.14e-2)" "unprognostic (9.41e-3)" "unprognostic (3.41e-1)" "unprognostic (1.13e-2)" "unprognostic (1.28e-1)" "unprognostic (5.51e-2)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (9.40e-2)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (1.70e-2)" "unprognostic (4.32e-1)" "unprognostic (1.47e-1)" "unprognostic (2.52e-1)" "unprognostic (7.17e-2)" 11.8 18.6 11.7 11.5 11.4 4.3 9.3 8.5 13.5 9.5 10.1 9.8 9.5 10.2 8.2 10.8 8.0 9.7 8.2 11.3 17.5 12.8 17.5 15.1 15.8 12.6 14.9 10.6 9.7 9.5 34.7 24.8 11.6 23.1 11.2 11.1 7.7 9.7 10.9 34.6 7.4 7.6 8.2 26.1 10.6 7.1 6.6 9.4 6.3 37.1 8.1 13.1 10.7 7.0 7.4 6.2 18.3 8.4 3.0 3.3 2.8 5.6 10.0 11.9 7.0 16.8 16.2 9.4 13.0 15.8 7.0 8.2 3.5 4.5 35.8 12.3 14.3 7.1 2.1 5.7 13.2 9.9 5.8 6.2 9.0 4.2 7.5 13.6 2.7 19.2 20.5 24.9 7.7 11.8 16.7 19.6 6.2 6.6 5.5 22.4 5.5 4.7 5.2 6.6 6.1 7.4 3.0 4.8 7.2 16.3 6.4 3.0 5.9 6.8 3.6 7.7 31.0 9.7 6.2 14.9 10.9 21.1 7.5 3.5 5.8 5.3 32.6 16.0 4.2 11.5 10.0 5.1 5.3 2.2 4.5 3.3 5.6 2.0 2.8 6.2 7.4 2.3 2.5 18.3 3.0 8.4 1.8 1.4 2.8 11.7 11.4 8.5 13.5 17.5 12.8 14.9 10.6 23.1 9.4 53.6 24.0 7.2 8.1 17.2 13.1 17.9 20.4 38.8 25.0 38.4 13.7 11.2 21.6 6.2 1.6 16.4 6.4 0.0 7.0 4.9 10.4 10.8 10.5 20.3 11.1 9.5 28.3 18.4 21.8 1.1 13.3 17.8 16.9 7.2 10.3 23.6 5.5 7.0 13.8 18.1 14.7 6.5 10.8 8.2 10.0 16.2 4.0 12.8 11.7 5.4 RRP1B "KIAA0179, Nnp1, PPP1R136, RRP1" ENSG00000160208 "Ribosomal RNA processing 1B" Q14684 21 43659548-43696079 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 123.7;Early spermatids: 195.5;Late spermatids: 173.7;Rod photoreceptor cells: 138.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA017893, HPA020324" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA017893: AB_1852274, HPA020324: AB_1852276" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (4.03e-1)" "unprognostic (1.32e-3)" "unprognostic (1.24e-1)" "unprognostic (1.92e-2)" "unprognostic (2.03e-2)" "unprognostic (7.19e-2)" "unprognostic (1.98e-2)" "unprognostic (5.55e-3)" "unprognostic (1.08e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.95e-9)" "unprognostic (1.45e-1)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (4.24e-2)" 12.7 10.3 10.7 20.0 13.7 7.6 14.5 13.9 12.5 13.1 11.1 11.5 9.4 9.5 16.1 9.2 15.7 14.0 12.2 8.4 9.5 8.6 7.5 17.7 10.4 22.8 13.1 7.5 20.0 20.6 11.8 11.4 8.4 10.3 11.3 10.9 15.0 13.9 12.8 21.6 14.1 11.1 12.9 9.9 16.9 11.8 32.5 12.6 25.6 9.6 12.6 20.5 13.5 14.1 6.0 3.2 2.1 2.7 5.8 9.8 5.3 16.9 10.0 10.7 16.1 7.0 7.5 8.8 8.9 6.4 9.9 8.2 22.7 7.4 33.2 5.9 7.0 11.5 7.6 26.4 15.4 11.8 11.1 21.0 19.6 11.6 14.2 9.7 30.5 7.8 7.7 9.9 11.9 13.8 6.1 11.0 14.4 30.6 9.8 8.7 8.8 24.2 9.3 36.5 11.0 11.2 32.0 10.8 23.2 7.2 8.1 21.3 11.4 16.8 12.4 12.4 4.1 8.1 9.6 9.8 3.1 9.7 8.1 16.2 13.3 16.9 39.7 9.7 33.0 10.0 2.1 2.6 0.7 7.2 2.7 8.5 6.0 9.1 8.6 3.2 5.3 8.6 9.8 0.1 5.8 2.3 2.6 7.0 5.3 10.7 13.7 13.9 12.5 9.5 8.6 13.1 7.5 10.3 12.6 29.8 16.0 22.1 12.1 20.3 28.9 10.4 12.7 21.4 28.4 5.2 123.7 6.5 1.7 12.9 195.5 15.9 4.7 0.0 13.7 13.6 13.6 12.0 33.7 16.6 16.5 23.8 5.2 11.1 11.9 173.7 20.8 11.6 8.5 11.8 8.5 14.7 16.6 0.0 25.1 9.5 138.2 0.0 16.0 24.0 34.2 27.7 3.7 27.3 13.8 12.2 RRP36 "C6orf153, dJ20C7.4" ENSG00000124541 "Ribosomal RNA processing 36" Q96EU6 6 43021645-43034156 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029904, HPA029905" Uncertain Enhanced Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA029904: AB_10611817, HPA029905: AB_2673244" "unprognostic (1.76e-1)" "unprognostic (4.47e-1)" "unprognostic (3.78e-2)" "unprognostic (1.46e-2)" "unprognostic (3.25e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (2.61e-1)" "unprognostic (6.83e-2)" "unprognostic (1.32e-3)" "unprognostic (1.39e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (3.53e-1)" "unprognostic (1.63e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-2)" 25.0 29.7 21.0 24.9 27.2 23.3 57.7 18.0 42.1 21.3 22.4 16.0 24.9 19.4 23.8 24.7 31.9 20.6 20.1 31.3 22.7 21.4 25.2 32.7 24.1 46.5 21.1 28.0 17.3 37.4 37.0 28.8 23.4 27.3 24.6 23.8 19.5 23.5 36.4 61.9 28.4 21.4 28.3 28.5 29.4 25.7 23.9 15.8 25.0 22.6 30.9 31.8 23.7 28.2 6.5 9.7 4.0 4.6 3.1 7.7 1.2 39.4 22.3 22.2 32.4 24.0 22.5 18.7 31.3 28.4 40.2 39.5 40.5 17.3 18.3 25.6 32.6 29.5 21.2 37.1 38.0 44.5 23.1 37.8 29.4 24.8 43.2 27.9 24.4 22.9 22.7 23.3 48.0 20.6 14.4 32.6 16.6 35.5 20.0 37.2 41.6 29.3 26.7 24.6 70.7 23.2 27.7 21.9 21.1 24.6 37.4 28.5 25.0 23.1 21.2 35.8 21.8 29.2 30.1 26.2 37.2 28.3 24.4 49.1 18.8 28.2 48.9 16.2 30.9 34.5 3.9 3.6 3.1 5.9 4.6 4.7 6.5 4.2 7.0 3.7 2.6 3.9 7.7 4.0 3.1 3.6 9.7 2.1 1.2 21.0 27.2 18.0 42.1 22.7 21.4 21.1 28.0 27.3 15.8 0.0 14.1 20.6 9.5 11.8 15.3 13.7 28.1 8.1 12.5 19.2 15.7 25.9 11.6 31.6 8.6 11.3 10.5 0.0 38.9 36.9 13.2 13.1 5.8 34.3 25.3 17.5 13.4 22.1 14.3 18.5 10.9 13.4 13.5 28.9 11.3 25.1 32.5 7.0 17.7 16.1 17.2 6.5 12.0 7.6 10.2 16.3 28.1 10.0 12.8 12.1 RSF1 "HBXAP, p325, RSF-1, XAP8" ENSG00000048649 "Remodeling and spacing factor 1" Q96T23 11 77659996-77821017 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022626, HPA046129, HPA057547, HPA064567" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB022626: , HPA046129: AB_2679550, HPA057547: AB_2683462, HPA064567: AB_2685289" "unprognostic (2.67e-1)" "unprognostic (2.02e-1)" "unprognostic (2.39e-1)" "unprognostic (4.35e-3)" "unprognostic (5.00e-3)" "unprognostic (5.57e-2)" "unprognostic (1.23e-2)" "unprognostic (2.46e-1)" "unprognostic (7.33e-3)" "unprognostic (2.35e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (6.19e-2)" "prognostic favorable (5.94e-4)" "unprognostic (1.71e-1)" "unprognostic (2.22e-1)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" 15.9 20.1 20.4 19.5 23.5 21.1 14.4 32.3 20.0 19.0 14.2 11.0 15.2 8.7 19.3 14.6 13.4 14.1 15.7 13.1 18.7 17.2 14.0 10.9 15.6 13.2 16.2 15.3 26.0 15.6 25.3 27.3 16.9 18.7 16.3 12.0 8.1 13.4 21.3 15.7 13.5 12.7 16.7 15.8 16.2 12.5 21.1 21.8 22.4 21.1 8.4 12.3 21.3 25.8 21.7 18.5 27.7 15.7 13.6 17.1 4.0 10.5 7.1 24.8 13.2 8.4 10.7 9.3 12.5 12.3 10.3 12.7 18.7 14.8 18.0 13.4 8.7 15.9 11.1 14.5 9.3 19.3 12.8 6.5 16.9 10.1 5.0 8.1 16.0 12.1 8.9 7.1 14.0 22.6 12.0 12.9 6.0 27.5 17.1 11.8 7.2 11.2 9.0 14.4 12.7 9.8 18.8 43.1 11.7 5.4 13.8 15.0 15.2 19.2 7.6 7.5 13.5 13.6 8.0 16.1 18.2 15.8 28.4 8.9 10.3 13.2 41.5 4.8 10.9 13.6 21.3 10.7 17.8 17.1 9.9 11.7 18.2 10.3 10.7 8.1 21.7 14.3 14.2 27.7 13.6 15.7 18.5 9.6 4.0 20.4 23.5 32.3 20.0 18.7 17.2 16.2 15.3 18.7 21.8 110.2 97.4 50.0 60.3 80.4 120.3 86.5 48.4 78.9 81.9 69.8 70.7 51.8 39.7 63.9 69.5 87.9 40.1 70.0 48.5 44.1 80.8 77.0 91.4 37.7 39.8 138.2 82.1 72.4 47.5 29.1 117.3 58.4 54.0 85.6 57.6 115.2 62.7 57.7 111.0 31.1 94.9 103.5 72.1 96.0 109.4 73.4 56.4 77.8 54.2 72.5 RSL24D1 "C15orf15, HRP-L30-iso, L30, RPL24, RPL24L" ENSG00000137876 "Ribosomal L24 domain containing 1" Q9UHA3 15 55180806-55197067 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062724, HPA063392" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA062724: AB_2684850, HPA063392: AB_2685002" "unprognostic (3.40e-2)" "unprognostic (3.00e-1)" "unprognostic (3.83e-1)" "unprognostic (7.28e-2)" "unprognostic (3.80e-2)" "unprognostic (1.07e-3)" "unprognostic (6.71e-3)" "unprognostic (1.15e-1)" "unprognostic (6.56e-3)" "unprognostic (1.34e-1)" "unprognostic (6.19e-3)" "unprognostic (7.22e-2)" "unprognostic (1.13e-1)" "unprognostic (4.44e-1)" "unprognostic (4.54e-2)" "unprognostic (4.95e-1)" "unprognostic (2.41e-1)" 27.7 24.3 26.7 23.4 28.8 76.1 47.8 35.7 29.9 40.6 32.2 10.0 25.6 18.1 34.5 26.6 34.2 26.4 21.4 25.3 25.1 25.3 24.3 26.7 27.0 35.8 25.4 25.8 54.7 37.8 15.0 23.2 22.4 24.1 44.3 20.5 11.2 25.8 21.3 47.2 19.3 21.1 50.4 27.5 28.6 28.8 24.2 20.6 39.5 43.1 36.9 27.4 61.9 49.6 29.1 27.0 11.4 24.1 22.7 45.1 47.7 16.1 16.4 18.1 23.7 14.2 26.8 14.7 17.1 19.2 14.4 18.4 15.7 9.9 50.4 15.5 12.3 14.1 19.8 23.8 19.8 19.4 24.5 14.8 25.8 13.2 19.5 32.8 48.5 16.9 22.7 42.0 14.4 41.9 23.3 17.8 37.9 48.6 36.6 16.7 16.5 26.5 42.8 22.3 33.1 14.8 21.2 22.7 75.9 21.6 15.0 25.7 30.8 7.9 22.3 55.4 15.0 21.4 71.8 12.4 11.9 13.9 13.8 24.4 35.3 53.9 50.1 18.5 48.1 19.9 11.4 23.8 11.4 19.6 23.4 31.1 29.1 29.5 24.3 27.0 22.5 45.1 34.0 6.0 22.7 24.1 21.1 32.4 47.7 26.7 28.8 35.7 29.9 25.1 25.3 25.4 25.8 24.1 20.6 92.3 65.6 256.3 349.8 515.7 83.5 63.5 89.2 77.6 80.8 80.3 21.6 138.6 242.1 170.0 67.8 119.6 46.1 70.0 234.1 222.4 198.3 186.8 150.0 57.1 128.0 14.3 134.4 79.8 196.0 28.6 188.4 183.5 269.9 194.8 102.0 68.6 201.1 134.0 140.4 191.4 51.1 155.2 258.6 71.0 148.8 456.4 145.9 187.5 118.2 292.9 RTCA "RPC, RTC1, RTCD1" ENSG00000137996 "RNA 3'-terminal phosphate cyclase" O00442 1 100266207-100292769 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027982, HPA027990, HPA028151, HPA028331" Uncertain Enhanced Nucleoplasm NA NA 8700 Nucleoplasm "HPA027982: AB_10601769, HPA027990: AB_2672452, HPA028151: AB_10602099, HPA028331: " "unprognostic (4.79e-2)" "unprognostic (1.17e-2)" "unprognostic (3.97e-2)" "unprognostic (3.82e-2)" "unprognostic (6.76e-2)" "unprognostic (4.12e-2)" "prognostic unfavorable (2.76e-5)" "unprognostic (9.55e-3)" "unprognostic (3.64e-2)" "unprognostic (1.12e-2)" "unprognostic (2.46e-1)" "unprognostic (8.09e-3)" "unprognostic (3.74e-3)" "unprognostic (2.10e-2)" "unprognostic (1.44e-1)" "unprognostic (3.59e-1)" "unprognostic (2.94e-2)" 20.9 25.0 19.4 17.8 24.9 25.5 20.0 22.6 31.7 14.7 22.9 20.3 19.9 31.7 14.2 26.0 27.0 13.4 19.9 25.5 20.0 21.0 31.7 23.0 16.1 21.8 21.5 20.7 13.3 27.7 21.1 17.2 21.2 33.1 20.9 22.2 14.1 18.5 17.4 35.4 14.6 37.8 15.4 20.5 24.2 21.8 12.2 12.4 25.0 18.3 20.2 20.8 18.7 17.5 9.6 8.0 8.2 19.6 11.0 20.1 7.7 22.0 11.4 11.3 15.2 14.3 23.3 30.9 26.2 12.8 17.1 14.8 18.6 11.1 22.6 19.9 16.6 21.1 11.2 13.8 12.4 20.7 22.6 11.5 14.9 13.0 23.4 22.1 27.1 23.6 18.9 19.6 22.3 29.9 17.0 21.2 16.5 25.6 34.5 25.8 7.3 13.9 21.1 17.3 15.7 22.1 10.0 20.2 9.9 21.0 18.1 9.1 11.4 16.9 24.5 35.8 18.5 5.3 34.8 18.4 16.2 11.3 25.2 31.4 20.0 20.1 18.1 34.0 23.6 9.6 8.2 9.1 7.5 10.8 11.3 13.8 9.6 10.0 12.8 8.0 7.1 9.3 10.5 4.4 11.0 19.6 7.6 20.1 7.7 19.4 24.9 22.6 31.7 20.0 21.0 21.5 20.7 33.1 12.4 6.0 14.4 26.1 13.0 12.0 22.2 49.6 7.6 13.4 10.3 17.4 11.8 48.9 21.6 37.0 11.5 17.5 35.4 0.0 30.2 65.3 13.9 14.2 12.7 15.3 69.5 20.6 18.5 22.7 41.9 6.4 17.8 28.9 15.1 50.5 26.6 20.6 46.7 37.1 12.0 49.6 26.8 6.5 12.3 27.2 14.7 12.8 38.8 32.0 29.7 15.7 RUNX1 "AML1, AMLCR1, CBFA2, PEBP2A2" ENSG00000159216 "Runt related transcription factor 1" Q01196 21 34787801-36004667 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 54.3;lymphoid tissue: 58.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 61.2;HMC-1: 36.9;JURKAT: 56.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA004176, HPA037912" Enhanced Enhanced Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "HPA004176: AB_1078412, HPA037912: AB_2675733" "unprognostic (4.06e-3)" "unprognostic (2.35e-2)" "unprognostic (1.42e-2)" "unprognostic (1.52e-1)" "unprognostic (5.15e-3)" "unprognostic (2.62e-1)" "unprognostic (5.87e-2)" "unprognostic (1.15e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-3)" "unprognostic (2.33e-2)" "unprognostic (3.47e-2)" "prognostic unfavorable (3.44e-15)" "unprognostic (1.48e-1)" "unprognostic (1.50e-1)" "unprognostic (6.17e-2)" "unprognostic (5.47e-2)" 11.5 3.2 5.2 14.8 7.3 29.8 54.3 1.0 4.3 12.5 4.7 3.8 4.0 3.8 2.9 7.4 6.5 4.6 12.4 7.6 6.1 2.0 4.2 6.7 17.9 13.9 8.5 1.1 6.5 5.8 1.6 5.5 6.4 6.0 9.9 5.1 3.5 29.8 8.8 14.4 8.3 5.1 6.8 12.3 10.6 12.7 2.9 6.6 58.6 4.6 5.7 14.2 11.0 9.1 3.2 3.4 17.0 3.9 1.3 4.8 2.0 12.2 0.9 0.0 0.0 3.2 4.1 8.1 6.9 7.1 3.9 2.9 0.6 9.4 6.1 0.4 6.1 6.5 11.1 0.7 8.3 5.6 9.3 0.9 61.2 2.4 2.8 5.9 7.0 36.9 8.0 5.0 11.8 11.7 5.4 2.2 56.6 4.1 3.5 8.2 2.6 28.5 11.2 0.5 6.7 3.6 28.9 21.4 3.7 5.2 4.9 0.3 0.0 7.2 1.8 2.5 1.8 3.7 16.6 9.1 6.4 8.3 9.5 10.4 11.8 4.8 5.7 8.0 15.5 9.3 17.0 3.2 6.3 3.4 1.4 3.3 3.2 3.1 3.2 0.9 3.1 4.8 3.8 3.5 1.3 3.9 3.4 4.0 2.0 5.2 7.3 1.0 4.3 6.1 2.0 8.5 1.1 6.0 6.6 50.6 30.7 14.5 44.6 37.0 2.1 2.2 38.2 56.2 39.8 19.2 0.0 0.8 1.7 35.7 16.8 5.8 12.0 0.0 24.4 19.6 25.7 45.4 16.3 4.3 57.2 0.0 5.8 4.9 79.5 21.7 4.4 63.0 27.0 31.5 10.8 0.5 63.1 12.7 4.2 1.2 0.6 0.0 31.5 23.0 24.9 17.7 2.1 37.4 14.4 53.7 RUNX2 "AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1" ENSG00000124813 "Runt related transcription factor 2" Q13950 6 45328157-45664349 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 67.7;monocytes: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 16.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 18.6;Karpas-707: 29.1;RH-30: 24.3;U-698: 25.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB008374, HPA022040, CAB062561, CAB068226, HPA070715" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: " "unprognostic (1.49e-1)" "unprognostic (8.90e-3)" "unprognostic (3.99e-2)" "unprognostic (2.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-1)" "unprognostic (1.23e-1)" "unprognostic (3.70e-2)" "unprognostic (3.18e-1)" "prognostic unfavorable (3.97e-9)" "prognostic unfavorable (2.24e-4)" "unprognostic (5.52e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (6.66e-5)" 3.7 2.1 4.9 13.7 7.0 15.5 5.7 1.0 7.2 13.5 6.0 5.6 7.4 4.1 3.5 2.3 3.4 2.4 6.8 1.8 7.4 3.5 3.9 1.8 5.3 8.6 6.3 3.4 5.0 1.9 1.3 3.8 3.3 7.2 9.5 7.8 5.4 19.8 14.9 2.2 4.9 10.8 3.4 10.5 6.6 6.0 2.1 7.3 6.5 4.2 4.5 11.7 7.3 8.9 0.1 11.4 5.3 0.6 16.0 10.2 0.7 1.6 0.5 0.3 0.0 1.5 4.0 0.0 1.5 3.6 5.1 7.2 0.0 0.9 0.0 1.8 2.1 2.3 2.0 0.0 1.4 9.4 6.1 0.7 0.0 1.1 0.0 8.0 6.3 0.0 10.8 1.1 4.5 5.1 18.6 0.0 2.5 0.0 29.1 9.1 0.4 0.2 11.0 0.3 1.4 0.2 0.0 24.3 0.0 5.0 3.2 0.0 0.0 1.1 0.0 1.8 4.5 1.7 0.5 0.2 5.2 4.2 8.0 5.5 9.2 0.0 25.4 5.9 2.4 2.3 5.3 0.6 3.2 1.2 0.1 10.2 0.1 2.8 3.2 1.8 0.1 0.5 1.5 4.8 16.0 0.1 11.4 2.3 0.7 4.9 7.0 1.0 7.2 7.4 3.5 6.3 3.4 7.2 7.3 0.0 2.4 3.7 14.8 2.5 0.0 1.7 0.0 4.0 4.5 3.5 0.0 0.0 0.0 0.6 67.7 0.3 0.0 0.0 0.2 0.0 2.7 15.7 2.3 0.5 3.8 0.0 0.0 1.8 4.5 13.2 1.1 7.9 6.8 20.8 0.7 0.0 0.4 0.0 2.1 2.2 0.0 6.5 2.5 0.9 0.4 1.4 0.1 17.3 0.0 18.2 SAE1 "AOS1, FLJ3091, Sua1" ENSG00000142230 "SUMO1 activating enzyme subunit 1" Q9UBE0 19 47113274-47210636 "Predicted intracellular proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041906, HPA043552" Supported Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041906: AB_2677735, HPA043552: AB_2678548" "unprognostic (9.69e-3)" "unprognostic (1.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.68e-1)" "unprognostic (1.37e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (5.49e-8)" "unprognostic (9.86e-2)" "unprognostic (1.62e-2)" "unprognostic (1.58e-1)" "unprognostic (1.93e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.15e-5)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.27e-1)" 20.1 17.8 26.7 22.8 30.5 24.0 18.6 21.9 45.9 23.6 50.1 17.6 21.6 14.0 30.2 13.1 27.5 21.3 17.1 22.5 21.2 23.9 14.6 16.0 19.2 30.6 20.4 34.6 19.0 14.4 28.0 13.9 26.8 24.3 20.2 27.3 20.9 15.7 28.6 24.1 19.0 20.1 38.5 15.9 25.8 30.5 60.2 16.2 32.7 37.5 17.2 37.5 33.0 25.8 19.1 22.3 22.8 19.0 35.2 41.3 29.4 36.2 39.8 62.5 29.8 21.5 25.3 21.2 44.9 39.2 50.7 62.0 34.2 24.2 43.7 17.7 36.0 26.9 17.3 64.0 28.3 55.2 36.6 46.5 42.5 26.9 39.0 23.7 47.0 26.5 18.8 14.6 27.7 29.9 20.0 48.5 31.5 50.5 22.1 47.8 29.1 30.8 129.8 31.2 39.3 21.3 48.5 41.9 17.9 22.7 43.0 24.7 27.2 46.0 31.7 27.1 35.8 25.9 28.7 25.2 26.7 30.7 17.5 48.2 27.6 80.2 62.1 18.8 39.1 39.0 22.8 19.0 10.4 23.0 16.9 24.8 19.1 29.0 23.2 22.3 15.7 41.3 31.3 7.9 35.2 11.3 15.0 33.5 29.4 26.7 30.5 21.9 45.9 21.2 23.9 20.4 34.6 24.3 16.2 8.9 16.0 34.0 28.7 22.8 17.8 18.6 7.6 4.0 10.3 12.2 5.9 57.7 10.0 35.8 11.1 31.4 10.5 23.3 30.4 80.2 33.8 28.6 15.0 17.4 48.9 19.1 18.5 20.3 19.0 12.8 14.4 20.0 43.9 71.3 22.5 18.0 30.8 14.4 17.7 11.5 15.0 51.8 35.6 95.2 109.0 21.5 48.1 33.2 28.3 25.8 SAFB "HET, SAFB1" ENSG00000160633 "Scaffold attachment factor B" Q15424 19 5623035-5668478 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001969, HPA016832, HPA020076" Supported Enhanced Nucleoplasm,Midbody NA NA Nucleoplasm Midbody "CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624" "unprognostic (2.41e-2)" "unprognostic (8.18e-3)" "unprognostic (6.66e-2)" "unprognostic (3.81e-3)" "unprognostic (6.50e-2)" "unprognostic (7.82e-2)" "unprognostic (1.62e-3)" "unprognostic (9.31e-2)" "unprognostic (5.76e-2)" "unprognostic (4.85e-2)" "prognostic favorable (9.75e-5)" "unprognostic (3.25e-2)" "unprognostic (3.53e-3)" "unprognostic (3.14e-2)" "unprognostic (2.67e-2)" "unprognostic (4.07e-1)" "prognostic favorable (1.70e-4)" 28.7 27.6 26.4 34.8 32.5 50.7 26.2 50.8 36.0 28.9 29.7 34.3 18.6 31.0 32.1 17.3 26.6 25.8 22.6 26.9 28.2 25.8 23.8 29.0 27.1 38.0 31.5 26.2 35.0 29.2 31.2 35.0 35.5 28.1 27.5 20.5 21.4 31.1 28.8 53.6 35.5 31.0 27.8 31.4 39.1 28.4 30.3 32.1 61.4 26.3 19.5 31.3 30.7 45.6 32.8 31.6 48.4 42.3 31.2 37.5 30.5 27.5 24.4 29.8 19.1 13.2 11.9 34.1 20.7 13.5 17.7 15.0 36.6 15.9 44.8 16.5 10.3 14.9 26.0 28.6 17.0 18.7 30.2 28.0 32.9 22.5 34.2 12.5 40.4 29.1 10.6 15.8 15.8 16.9 12.7 14.0 19.7 45.6 23.0 13.5 24.5 42.5 32.0 39.6 19.0 24.4 42.8 32.6 31.0 13.8 23.2 27.4 23.6 23.3 18.8 21.2 17.9 17.4 21.9 21.5 18.1 22.3 22.1 31.8 37.4 31.9 41.0 17.4 33.6 23.9 35.0 28.4 48.4 36.2 28.4 36.7 32.8 36.0 35.2 31.6 32.2 37.5 36.0 30.6 31.2 42.3 26.6 34.5 30.5 26.4 32.5 50.8 36.0 28.2 25.8 31.5 26.2 28.1 32.1 29.8 16.0 30.4 40.5 58.3 38.8 35.0 10.2 85.6 50.0 15.7 33.4 43.6 21.6 36.0 5.2 35.2 30.0 0.0 30.2 47.2 40.1 31.6 48.6 24.5 32.8 47.7 28.6 23.4 21.9 4.5 33.1 39.9 28.7 50.5 36.7 29.9 28.1 28.8 24.4 22.4 44.2 19.4 47.0 78.8 82.8 57.1 52.3 44.7 34.5 34.2 SAGE1 "CT14, SAGE" ENSG00000181433 "Sarcoma antigen 1" Q9NXZ1 X 135889205-135913061 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 10.9" "Cell type enriched" "Detected in single" 26 "Spermatogonia: 8.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 15.1;K-562: 10.9;Karpas-707: 18.8;U-2 OS: 5.3;U-266/70: 6.6;U-266/84: 16.4" "HPA003033, HPA003208" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA003033: AB_1079865, HPA003208: AB_1079863" "unprognostic (1.11e-1)" "unprognostic (5.26e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (2.37e-1)" "unprognostic (7.12e-4)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 6.6 16.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 SALL4 "dJ1112F19.1, ZNF797" ENSG00000101115 "Spalt like transcription factor 4" Q9UJQ4 20 51782331-51802520 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "parathyroid gland: 8.8;testis: 11.7;thyroid gland: 8.6" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 25.4" "Cancer enriched" "Detected in many" 11 "testis cancer: 22.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "NK-cell: 6.3" "Lineage enriched" "Detected in single" 9 "NK-cells: 6.3" "Cell line enhanced" "Detected in some" "AF22: 13.1;AN3-CA: 9.1;BEWO: 17.5;NTERA-2: 31.5;SiHa: 8.0;SuSa: 22.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015291, HPA015791" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "HPA015291: AB_1856548, HPA015791: AB_1856547" "unprognostic (1.30e-1)" "unprognostic (2.35e-2)" "unprognostic (1.11e-1)" "unprognostic (1.09e-3)" "unprognostic (3.55e-2)" "unprognostic (7.43e-2)" "unprognostic (3.63e-2)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (9.23e-2)" "unprognostic (2.50e-2)" "unprognostic (2.39e-2)" "unprognostic (2.42e-8)" "unprognostic (5.90e-3)" "unprognostic (1.82e-1)" "unprognostic (5.00e-5)" "unprognostic (7.41e-2)" 0.3 0.4 0.3 0.3 0.9 1.2 0.3 0.8 0.9 0.4 0.7 0.3 2.2 0.1 0.3 0.8 0.3 0.2 0.3 0.3 0.3 0.1 0.5 1.9 0.3 0.3 0.3 0.3 0.3 4.6 8.8 0.6 0.3 0.9 3.1 0.2 4.5 2.2 0.4 0.3 0.3 0.7 0.3 0.3 0.8 0.3 11.7 0.3 0.3 8.6 0.3 0.3 0.9 0.3 0.1 0.1 0.6 0.1 6.3 0.2 0.0 0.0 0.8 13.1 9.1 0.0 0.0 17.5 0.0 0.1 0.0 0.1 4.5 0.1 0.0 0.1 0.1 0.1 2.2 0.1 0.0 0.1 0.2 0.0 0.0 3.0 0.2 0.1 0.0 1.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 31.5 0.1 0.2 1.2 0.0 0.0 0.0 0.2 3.0 1.6 8.0 0.0 0.7 22.0 0.0 0.5 0.0 0.5 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.6 6.3 0.1 0.1 0.0 0.0 0.3 0.9 0.8 0.9 0.3 0.1 0.3 0.3 0.9 0.3 0.0 1.3 0.0 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.2 0.0 0.4 1.1 0.0 0.0 0.2 25.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.5 1.7 0.0 0.0 0.0 0.0 1.0 SAP30BP "HCNGP, HTRG, HTRP" ENSG00000161526 "SAP30 binding protein" Q9UHR5 17 75667116-75708062 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042382, HPA052943" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042382: AB_10793881, HPA052943: AB_2681995" "unprognostic (6.92e-2)" "unprognostic (8.56e-3)" "unprognostic (1.20e-1)" "unprognostic (5.34e-3)" "unprognostic (2.95e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (4.71e-5)" "unprognostic (1.53e-2)" "unprognostic (2.15e-1)" "unprognostic (8.32e-3)" "unprognostic (1.03e-2)" "unprognostic (3.31e-3)" "prognostic unfavorable (1.98e-4)" "unprognostic (1.31e-1)" "unprognostic (1.88e-1)" "unprognostic (6.06e-2)" "unprognostic (6.58e-2)" 19.2 18.4 28.7 21.7 27.6 28.6 22.1 25.2 31.2 25.3 22.6 39.0 15.4 17.2 25.7 26.5 22.0 22.8 22.0 22.3 29.5 24.9 19.3 23.1 19.6 24.3 29.6 23.9 23.9 21.0 29.2 21.1 25.4 24.7 22.3 22.4 22.6 31.8 26.6 31.2 19.3 19.2 24.5 31.7 24.3 20.1 21.6 25.0 26.1 20.4 15.6 31.0 25.4 21.0 21.3 29.9 21.6 21.4 22.6 25.8 20.1 13.0 15.7 13.2 12.3 13.1 13.8 14.6 13.9 15.4 26.1 27.3 14.4 11.0 14.2 7.5 13.3 24.1 10.2 15.7 15.6 26.9 5.0 17.9 11.1 11.4 15.4 12.9 11.7 9.8 12.9 14.3 20.0 21.3 14.8 36.0 15.1 13.2 11.3 20.6 13.7 19.0 9.8 10.9 19.1 18.6 12.4 19.7 10.7 22.1 11.2 8.9 15.2 12.8 12.7 14.5 21.0 20.4 10.0 13.4 22.8 14.0 10.0 18.4 8.2 3.2 16.8 15.4 8.7 18.2 13.6 21.4 21.2 23.7 17.5 25.8 20.9 21.9 24.2 18.1 21.3 21.7 22.5 21.6 22.6 20.0 29.9 23.0 20.1 28.7 27.6 25.2 31.2 29.5 24.9 29.6 23.9 24.7 25.0 50.6 60.8 45.5 99.7 44.0 18.7 43.6 22.9 76.3 79.6 21.0 11.8 51.1 58.0 63.1 43.1 62.4 47.7 23.3 63.6 54.6 56.3 38.2 74.1 31.8 50.3 9.5 34.4 45.4 38.7 69.2 41.1 51.7 54.0 68.5 33.6 59.7 77.0 45.6 32.5 35.4 14.4 64.7 61.4 29.6 29.0 39.6 80.3 65.0 24.9 96.7 SCAF11 "CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP" ENSG00000139218 "SR-related CTD associated factor 11" Q99590 12 45919131-45992120 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038862, HPA045456, HPA046345" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA038862: AB_10672830, HPA045456: AB_2679331, HPA046345: AB_2679630" "unprognostic (2.83e-2)" "unprognostic (4.10e-2)" "unprognostic (2.01e-1)" "unprognostic (5.88e-2)" "unprognostic (1.19e-1)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (9.00e-2)" "unprognostic (1.37e-2)" "unprognostic (1.30e-2)" "unprognostic (4.10e-2)" "unprognostic (2.15e-2)" "unprognostic (6.30e-3)" "unprognostic (1.68e-1)" "unprognostic (2.76e-1)" "unprognostic (4.30e-2)" "unprognostic (4.13e-2)" 34.4 17.0 17.5 34.1 19.5 46.1 25.8 19.1 17.9 29.0 24.5 12.4 29.0 17.0 25.1 25.9 25.8 21.0 21.1 33.6 15.8 16.6 27.9 32.2 27.8 29.9 19.2 12.5 31.7 21.3 32.7 26.8 23.0 20.6 26.5 21.4 15.3 24.3 31.0 35.4 24.1 30.7 25.5 21.7 38.1 17.4 22.7 20.6 42.3 27.8 21.9 28.6 29.1 33.9 18.4 19.2 32.8 13.6 12.9 15.3 7.9 15.1 13.8 17.1 14.2 11.8 16.2 15.9 17.9 14.6 15.5 11.3 49.4 16.7 31.8 20.2 19.0 9.2 15.0 17.5 14.4 17.7 17.4 11.8 29.6 18.3 12.9 9.3 31.0 20.0 13.4 15.5 13.3 20.2 17.9 15.9 13.9 22.6 17.5 19.5 14.3 23.2 17.3 13.3 0.2 18.8 18.9 23.0 16.0 14.7 19.4 9.9 10.1 19.8 17.0 9.6 14.2 15.8 33.6 19.7 16.0 13.2 12.0 9.5 12.7 9.4 52.0 13.5 66.8 6.1 20.9 13.0 17.3 14.7 12.5 13.3 17.7 13.9 14.1 9.8 18.4 15.3 13.7 32.8 12.9 13.6 19.2 12.4 7.9 17.5 19.5 19.1 17.9 15.8 16.6 19.2 12.5 20.6 20.6 163.8 142.7 110.7 106.1 114.1 130.0 160.2 84.1 199.4 167.2 75.0 119.8 73.3 46.4 103.3 42.7 114.7 93.2 23.3 93.9 58.9 105.3 100.7 213.0 117.3 96.4 101.7 99.3 118.4 141.0 26.6 112.8 152.3 64.1 130.8 108.9 103.7 84.4 88.0 97.6 67.1 187.2 122.9 106.1 130.4 56.4 105.3 51.0 110.7 86.0 129.0 SCAF4 "DKFZp434E098, KIAA1172, SFRS15, SRA4" ENSG00000156304 "SR-related CTD associated factor 4" O95104 21 31671033-31732075 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018319, HPA018668, HPA021504, HPA028807" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA018319: AB_1856784, HPA018668: AB_1856783, HPA021504: AB_1856785, HPA028807: AB_10602927" "unprognostic (9.18e-2)" "unprognostic (1.17e-1)" "unprognostic (9.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (3.99e-3)" "unprognostic (4.31e-1)" "unprognostic (2.19e-1)" "unprognostic (2.66e-2)" "unprognostic (3.28e-1)" "unprognostic (6.11e-2)" "unprognostic (1.85e-3)" "unprognostic (2.87e-1)" "unprognostic (7.65e-3)" "unprognostic (1.10e-1)" "unprognostic (2.16e-3)" 18.8 14.9 15.1 32.7 16.3 19.0 18.4 24.0 21.4 19.9 23.2 20.3 12.9 19.4 21.6 17.6 22.3 16.8 22.3 15.4 13.2 11.5 14.0 22.5 19.0 27.1 15.3 11.9 23.9 18.5 23.7 18.1 20.3 14.3 17.6 16.8 17.1 18.4 19.3 23.3 24.2 21.9 16.1 13.3 23.7 17.9 25.6 14.6 44.2 16.5 12.8 26.4 18.9 20.4 14.1 12.0 12.7 13.2 9.6 12.8 8.4 14.0 9.4 18.9 13.7 10.2 7.9 12.9 10.5 11.1 11.1 10.4 17.9 10.2 28.9 6.4 10.2 12.2 8.8 20.5 10.2 12.3 12.9 12.2 23.0 7.3 14.9 11.8 24.5 9.7 8.7 11.6 14.9 12.8 7.1 9.7 11.6 30.4 15.1 9.2 18.9 26.0 17.9 24.3 13.8 8.1 25.8 21.1 9.5 7.7 11.1 13.0 14.1 16.1 12.5 9.1 10.9 9.6 16.5 11.2 11.6 11.2 11.1 10.6 9.8 9.0 33.4 8.3 19.8 10.8 8.2 9.4 12.7 12.8 13.2 12.8 14.1 7.5 12.1 12.0 14.0 8.8 9.5 5.0 9.6 11.4 8.4 6.6 8.4 15.1 16.3 24.0 21.4 13.2 11.5 15.3 11.9 14.3 14.6 6.0 9.7 35.8 31.3 41.4 22.2 7.9 15.3 20.1 12.5 10.4 23.6 14.1 3.3 14.7 7.8 15.8 31.5 23.3 12.1 13.5 20.6 25.6 11.5 19.8 13.5 20.6 19.0 18.4 19.1 2.0 20.4 14.9 32.1 16.2 16.7 15.3 14.7 18.4 13.4 5.0 22.8 12.9 17.5 20.9 22.2 35.9 15.8 20.0 19.6 28.7 SCAF8 "KIAA1116, RBM16" ENSG00000213079 "SR-related CTD associated factor 8" Q9UPN6 6 154733325-154834244 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035601, HPA035602" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035601: AB_2674698, HPA035602: AB_10673220" "unprognostic (4.60e-3)" "unprognostic (3.67e-2)" "unprognostic (7.90e-3)" "unprognostic (2.50e-2)" "unprognostic (6.18e-2)" "unprognostic (1.13e-1)" "unprognostic (1.01e-2)" "unprognostic (3.41e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (6.61e-4)" "unprognostic (3.65e-1)" "unprognostic (2.08e-1)" "unprognostic (9.08e-2)" "unprognostic (2.66e-1)" "unprognostic (1.52e-1)" "unprognostic (2.42e-1)" "unprognostic (1.11e-1)" 27.9 19.1 17.4 32.0 19.1 36.1 27.5 28.1 22.2 30.0 23.4 18.2 20.8 14.2 28.3 21.6 18.5 25.1 21.9 19.3 16.9 13.4 19.8 17.6 19.6 23.5 16.2 15.1 32.6 20.0 33.6 24.1 23.8 14.8 24.4 20.7 17.9 21.9 30.1 28.5 26.9 21.2 23.8 14.3 21.7 19.9 25.4 20.2 42.6 24.7 20.1 22.8 26.1 32.9 5.4 3.3 3.8 6.7 6.1 7.5 2.6 8.5 8.4 24.9 15.0 16.8 17.3 15.3 14.1 19.9 18.7 19.0 13.1 8.7 26.9 11.5 16.2 16.6 11.7 21.9 18.6 25.1 11.7 11.0 24.1 9.1 16.0 19.5 22.2 16.2 18.6 19.8 16.3 25.6 14.5 15.8 11.9 27.9 16.4 17.1 15.6 23.7 15.1 17.3 13.2 6.3 22.8 13.6 14.5 15.8 15.8 15.4 18.0 14.7 19.4 10.7 18.7 12.7 25.9 14.4 10.7 13.0 13.8 14.2 15.4 11.3 29.8 13.3 13.9 16.5 1.2 2.8 3.5 6.0 3.9 5.8 4.8 6.2 5.9 3.3 5.4 6.3 5.6 3.8 6.1 6.7 3.2 7.5 2.6 17.4 19.1 28.1 22.2 16.9 13.4 16.2 15.1 14.8 20.2 23.8 18.6 14.1 10.3 11.2 17.7 31.1 7.6 13.4 9.1 12.2 23.6 9.2 1.7 9.3 2.7 13.5 12.2 0.0 10.2 7.4 13.5 10.4 33.5 10.4 11.2 12.7 12.5 19.6 25.1 4.2 15.3 11.4 10.1 6.4 13.9 14.8 11.9 8.6 11.7 5.3 18.6 25.8 8.2 21.4 22.4 9.4 8.9 10.0 13.6 12.8 SCRIB "KIAA0147, SCRB1, Vartul" ENSG00000180900 "Scribbled planar cell polarity protein" Q14160 8 143790920-143815379 "Disease related genes, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015463, CAB022081, HPA023557, HPA064312" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Rods & Rings" "CAB015463: AB_2238926, CAB022081: , HPA023557: AB_2671238, HPA064312: AB_2685242" "unprognostic (1.24e-1)" "unprognostic (1.94e-2)" "unprognostic (7.78e-2)" "unprognostic (8.95e-2)" "unprognostic (3.77e-1)" "unprognostic (3.96e-2)" "unprognostic (1.14e-3)" "unprognostic (1.86e-2)" "unprognostic (2.46e-1)" "unprognostic (2.56e-1)" "unprognostic (8.22e-2)" "unprognostic (1.87e-1)" "unprognostic (2.16e-3)" "unprognostic (3.46e-3)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (1.83e-1)" 13.0 6.1 15.1 10.8 12.2 9.4 15.9 10.1 13.9 15.1 18.4 17.5 9.8 14.8 9.4 5.9 36.6 11.6 11.9 8.0 12.2 7.7 10.2 13.6 11.5 12.9 13.5 12.8 10.9 17.2 11.2 9.6 9.5 11.8 10.9 7.6 7.5 22.9 11.2 36.8 33.3 16.3 11.2 9.7 11.2 17.0 10.1 16.4 14.0 9.1 11.9 9.6 11.6 17.8 0.6 0.5 0.2 0.4 0.2 1.5 0.6 18.6 15.1 6.9 8.8 2.5 3.3 11.7 10.5 3.0 4.9 4.1 6.6 12.2 7.4 12.8 3.1 2.8 19.5 3.7 14.1 0.9 8.2 20.8 10.3 13.0 11.6 5.7 4.3 5.8 2.8 13.7 4.7 4.1 2.2 5.3 8.1 13.0 2.6 3.7 37.2 11.1 9.2 5.2 11.6 19.2 13.4 6.4 8.2 2.5 18.8 15.1 11.1 11.9 13.1 11.1 2.2 16.5 10.3 10.2 5.4 22.4 9.5 14.7 9.3 9.1 7.5 5.5 4.3 8.4 0.1 0.1 0.1 0.6 0.4 1.5 0.6 0.4 1.2 0.5 0.4 0.4 0.4 0.2 0.2 0.1 0.2 0.4 0.6 15.1 12.2 10.1 13.9 12.2 7.7 13.5 12.8 11.8 16.4 0.0 6.9 6.9 4.2 7.6 11.1 10.8 15.3 1.4 1.2 14.0 13.7 8.9 3.3 7.5 1.2 6.0 18.4 23.3 8.1 5.3 5.1 8.0 0.0 7.5 5.5 4.8 13.3 4.3 6.3 0.4 8.3 4.6 8.5 4.6 19.5 11.9 9.9 20.1 9.2 4.3 14.0 12.9 4.2 7.9 9.2 9.4 4.2 5.1 19.5 5.9 SEL1L3 KIAA0746 ENSG00000091490 "SEL1L family member 3" Q68CR1 4 25747427-25863760 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 48.0" "Cell type enhanced" "Detected in many" 4 "Mucus-secreting cells: 74.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 45.9" "Group enriched" "Detected in many" 5 "memory B-cell: 20.8;naive B-cell: 20.8;plasmacytoid DC: 17.9" "Group enriched" "Detected in many" 4 "B-cells: 20.8;dendritic cells: 17.9" "Cell line enhanced" "Detected in many" "Daudi: 65.9;OE19: 49.9;U-698: 43.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 191.0" "HPA040045, HPA058792" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040045: AB_10796116, HPA058792: AB_2683822" "unprognostic (1.01e-2)" "unprognostic (2.03e-1)" "unprognostic (3.06e-3)" "unprognostic (1.44e-2)" "unprognostic (2.43e-3)" "unprognostic (1.80e-1)" "unprognostic (1.26e-2)" "unprognostic (1.39e-1)" "unprognostic (5.33e-2)" "unprognostic (7.24e-2)" "unprognostic (1.11e-1)" "unprognostic (5.11e-1)" "unprognostic (4.77e-2)" "unprognostic (7.21e-3)" "unprognostic (1.32e-1)" "unprognostic (2.28e-2)" "prognostic favorable (4.33e-4)" 5.4 3.3 4.0 36.3 5.6 2.3 3.8 45.9 6.4 13.7 19.3 1.5 1.5 19.3 2.2 18.1 6.2 3.6 22.0 2.4 3.3 2.8 6.9 3.6 14.3 27.7 2.1 1.7 3.1 48.0 10.9 2.9 13.7 3.0 4.2 16.7 12.9 23.1 1.0 1.3 1.7 30.3 3.4 2.1 33.5 24.6 2.2 1.1 2.8 12.5 3.8 46.7 14.8 2.2 20.8 17.9 0.4 0.1 3.7 4.3 1.4 4.8 5.3 3.9 1.3 0.6 0.8 0.6 2.4 6.6 1.8 6.0 3.3 22.7 65.9 11.7 16.6 15.9 3.1 2.9 10.5 2.5 3.5 1.7 0.7 8.8 4.5 17.1 9.0 0.4 1.3 8.5 6.6 2.6 7.5 24.8 1.3 4.3 0.0 1.3 3.7 0.0 0.6 11.4 49.9 4.7 0.3 21.7 9.1 14.5 16.4 9.8 1.9 16.1 0.2 1.6 5.7 0.8 11.2 10.8 0.1 7.9 0.1 6.9 0.4 0.1 43.0 30.0 3.8 4.5 0.4 0.1 0.0 2.8 0.0 3.4 20.8 3.5 3.1 0.7 20.8 1.5 2.4 0.3 3.7 0.1 17.9 4.3 1.4 4.0 5.6 45.9 6.4 3.3 2.8 2.1 1.7 3.0 1.1 11.9 29.0 65.6 3.0 0.8 2.1 1.2 63.7 8.1 55.7 3.5 0.0 23.3 0.0 64.6 46.5 8.4 31.3 23.3 28.5 1.3 1.5 12.0 2.3 1.7 4.6 0.0 11.1 13.5 16.0 58.1 1.4 6.4 8.5 15.4 74.5 32.9 37.4 24.6 0.4 9.7 29.0 0.0 1.4 0.6 2.4 1.4 13.7 26.1 35.6 4.2 SENP1 ENSG00000079387 "SUMO1/sentrin specific peptidase 1" Q9P0U3 12 48042898-48106308 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.2" "Cell type enhanced" "Detected in many" 10 "Spermatocytes: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011765, HPA046491" Supported "Nucleoplasm,Focal adhesion sites" NA NA Nucleoplasm "Focal adhesion sites" "HPA011765: AB_1079907, HPA046491: AB_2679672" "unprognostic (2.66e-2)" "unprognostic (6.51e-2)" "unprognostic (3.14e-1)" "unprognostic (5.69e-2)" "unprognostic (2.83e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.72e-5)" "unprognostic (6.48e-2)" "unprognostic (2.44e-3)" "unprognostic (8.20e-3)" "unprognostic (2.57e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.37e-4)" "unprognostic (7.61e-2)" "unprognostic (3.02e-1)" "unprognostic (1.01e-1)" "unprognostic (1.28e-1)" 5.7 3.3 3.0 9.0 4.0 8.4 5.2 5.3 3.2 5.5 4.9 3.8 3.5 3.4 6.2 4.3 5.7 5.2 3.8 3.6 2.7 3.3 3.8 3.9 4.3 7.3 3.0 2.3 6.2 4.4 6.1 11.4 8.1 3.0 4.4 4.7 5.1 20.0 4.7 6.8 6.6 4.5 5.8 4.3 6.4 4.5 60.2 3.6 15.0 5.2 4.8 8.3 5.7 6.3 5.3 3.8 7.1 2.6 3.8 5.5 2.3 7.1 9.2 11.5 8.6 3.4 5.1 8.5 7.7 8.6 13.2 10.8 11.3 11.6 19.4 6.7 7.0 5.2 7.0 14.2 6.8 13.5 17.6 6.4 17.0 8.9 5.4 5.7 15.8 11.5 4.1 5.6 11.9 10.6 5.9 6.9 13.2 14.9 9.3 6.8 5.7 19.7 5.0 10.5 4.9 7.0 18.7 12.1 9.5 3.6 8.8 12.1 8.3 11.1 6.8 4.5 6.8 10.7 7.6 6.3 11.2 10.1 6.5 8.1 9.6 15.5 19.0 6.9 36.8 5.1 2.0 1.8 7.1 4.3 2.6 5.5 2.4 4.2 3.9 3.3 5.3 3.6 4.1 3.8 3.8 2.0 3.8 5.0 2.3 3.0 4.0 5.3 3.2 2.7 3.3 3.0 2.3 3.0 3.6 8.9 6.2 5.6 4.2 3.3 8.2 2.1 7.6 5.3 10.3 3.5 3.9 3.1 3.3 3.0 10.2 6.3 2.5 0.0 5.6 2.8 3.7 3.6 5.8 6.6 3.8 14.3 3.4 7.4 10.0 3.3 5.8 4.8 1.7 5.4 3.7 4.8 4.5 2.0 6.3 3.4 8.3 0.0 3.1 64.4 24.9 5.4 2.3 4.4 3.6 3.0 SERGEF "DelGEF, Gnefr" ENSG00000129158 "Secretion regulating guanine nucleotide exchange factor" Q9UGK8 11 17788048-18013162 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 115.8;Late spermatids: 197.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037811, HPA037812, HPA074086" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037811: AB_10672726, HPA037812: AB_2675680, HPA074086: AB_2686658" "unprognostic (2.67e-2)" "unprognostic (7.15e-2)" "unprognostic (7.00e-2)" "unprognostic (9.04e-3)" "prognostic unfavorable (5.67e-4)" "unprognostic (6.94e-2)" "unprognostic (1.30e-3)" "unprognostic (1.87e-1)" "unprognostic (3.69e-2)" "unprognostic (1.70e-1)" "unprognostic (3.74e-3)" "unprognostic (5.56e-2)" "unprognostic (4.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.43e-1)" "unprognostic (1.24e-2)" "unprognostic (5.82e-2)" 8.2 14.2 30.1 7.5 22.3 4.7 15.2 24.4 31.4 13.1 10.7 9.5 4.3 6.1 11.8 17.7 9.6 13.9 10.3 9.9 28.6 24.1 15.6 12.3 10.0 8.0 27.9 18.1 26.1 17.4 17.7 19.3 4.8 23.0 13.6 11.5 10.1 12.3 17.1 11.8 11.1 6.2 14.4 10.4 7.6 10.1 3.9 10.7 7.8 25.3 8.8 11.8 9.5 15.6 15.4 14.4 8.9 11.8 11.3 22.0 14.1 6.4 7.4 7.1 13.3 12.3 12.7 4.3 5.1 11.6 6.0 7.9 5.3 2.1 5.8 6.7 6.5 17.4 8.4 25.1 16.5 5.2 12.7 20.4 8.9 6.8 21.9 13.8 7.8 10.3 11.4 18.1 2.9 12.9 18.7 6.5 13.2 5.4 11.2 9.2 10.0 7.6 17.1 5.4 21.9 8.9 11.0 7.8 6.4 14.6 9.7 16.6 3.9 9.6 9.6 9.7 15.0 4.5 7.4 3.3 6.3 7.3 8.2 6.1 7.7 9.3 7.5 9.7 9.1 6.0 7.2 11.8 8.9 21.1 9.3 17.4 15.4 21.3 16.0 14.4 11.1 21.7 19.2 1.2 11.3 9.4 5.9 22.0 14.1 30.1 22.3 24.4 31.4 28.6 24.1 27.9 18.1 23.0 10.7 6.0 5.0 11.3 18.7 23.6 13.1 10.4 10.2 5.3 7.9 10.4 2.0 6.2 33.2 14.7 115.8 11.3 7.9 0.0 21.5 10.6 11.8 15.5 13.9 12.3 12.5 11.1 46.6 7.4 15.5 197.3 18.1 11.9 20.3 10.8 13.0 15.2 13.8 7.0 20.1 30.0 8.2 6.5 20.0 6.2 5.6 17.7 2.6 20.6 12.4 17.2 SET "2PP2A, IPP2A2, PHAPII" ENSG00000119335 "SET nuclear proto-oncogene" Q01105 9 128683424-128696400 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, DNA-binding" "Cancer-related genes, Disease mutation, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005232, HPA063683" Supported Enhanced "Nucleoplasm,Lipid droplets" NA NA 880000 Nucleoplasm "Lipid droplets" "CAB005232: AB_2185634, HPA063683: AB_2685088" "unprognostic (1.92e-1)" "unprognostic (2.22e-1)" "unprognostic (2.31e-1)" "unprognostic (3.77e-1)" "unprognostic (7.15e-2)" "unprognostic (4.37e-3)" "prognostic unfavorable (9.41e-7)" "unprognostic (2.00e-2)" "unprognostic (1.88e-2)" "unprognostic (3.62e-1)" "unprognostic (3.78e-2)" "unprognostic (3.27e-2)" "unprognostic (1.29e-1)" "unprognostic (7.57e-2)" "unprognostic (1.91e-1)" "unprognostic (2.09e-1)" "unprognostic (1.54e-2)" 47.2 49.7 66.5 59.3 65.8 71.8 56.5 64.2 61.2 54.4 51.3 55.3 45.6 40.1 64.8 33.1 71.6 51.6 48.9 81.6 63.6 57.3 51.7 57.8 51.2 91.1 65.4 56.1 76.5 61.3 55.0 38.7 65.4 47.3 59.2 56.4 36.3 52.1 46.9 76.3 53.6 45.7 59.0 73.5 62.8 46.8 34.8 58.6 152.9 69.1 46.2 92.7 74.4 84.1 72.2 66.4 43.2 56.5 78.8 77.9 69.7 51.4 58.8 84.6 66.9 25.2 39.6 78.0 42.5 47.1 61.5 42.4 80.7 63.2 133.1 36.0 43.7 48.1 96.5 124.9 63.9 70.3 60.7 53.2 76.6 91.4 65.6 56.5 139.7 50.2 33.0 50.1 52.3 105.0 49.5 57.5 71.6 148.6 54.0 50.3 86.8 117.0 51.6 141.2 78.7 62.6 107.0 105.1 107.8 47.4 58.1 86.2 54.1 93.6 62.9 50.8 62.8 78.4 43.6 55.0 72.7 54.5 44.8 70.3 42.5 122.1 158.5 34.6 74.5 69.2 34.5 53.9 43.2 58.9 56.5 72.1 72.2 67.9 62.8 52.7 66.3 65.8 77.9 35.4 78.8 45.6 66.4 52.3 69.7 66.5 65.8 64.2 61.2 63.6 57.3 65.4 56.1 47.3 58.6 113.2 124.3 265.7 328.1 598.4 174.9 190.6 209.0 89.7 129.7 186.7 41.2 273.8 330.0 223.2 30.8 200.0 100.9 93.5 188.0 401.9 250.8 373.4 128.3 164.3 210.2 117.6 245.8 160.2 212.7 25.3 151.8 217.3 310.4 235.4 230.5 205.1 229.0 108.7 163.0 257.3 97.8 129.4 279.5 127.7 287.7 613.8 263.1 219.3 275.8 519.4 SETD1B "KIAA1076, KMT2G, Set1B" ENSG00000139718 "SET domain containing 1B" Q9UPS6 12 121804180-121832584 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021667, HPA059412" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021667: AB_1856753, HPA059412: AB_2684006" "unprognostic (1.69e-1)" "unprognostic (2.38e-2)" "unprognostic (6.32e-2)" "unprognostic (3.51e-1)" "unprognostic (2.06e-1)" "unprognostic (2.75e-2)" "unprognostic (5.32e-2)" "unprognostic (1.35e-1)" "unprognostic (1.28e-2)" "unprognostic (5.65e-2)" "unprognostic (1.59e-2)" "unprognostic (1.75e-1)" "unprognostic (7.33e-2)" "unprognostic (1.55e-1)" "unprognostic (1.28e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" 13.8 9.6 9.3 16.8 9.4 22.7 18.1 22.0 11.1 19.6 25.0 7.4 16.0 13.0 27.2 14.8 15.8 21.1 18.2 10.0 8.9 4.6 10.1 10.9 10.9 11.9 5.4 7.4 17.4 14.3 12.1 11.9 12.2 7.1 16.5 6.8 14.4 15.9 31.1 12.9 11.8 15.3 14.7 5.4 14.4 17.8 9.1 7.3 31.1 14.7 8.9 14.7 22.8 14.4 1.3 2.1 3.9 2.0 1.0 2.1 0.8 6.0 12.1 6.4 10.5 6.0 4.1 9.7 5.7 4.7 4.6 2.6 6.8 3.7 4.5 5.3 6.4 2.7 9.5 7.4 4.6 2.6 7.9 9.0 13.9 15.0 5.8 5.1 12.6 11.9 5.0 5.4 6.2 4.9 5.2 4.8 9.0 14.2 3.2 3.1 14.3 18.0 16.7 8.9 2.9 7.4 14.1 4.2 6.4 4.1 12.7 7.9 6.0 13.0 8.7 4.7 4.8 10.8 10.9 8.0 6.5 8.1 9.2 6.3 6.3 3.2 2.7 5.4 7.9 7.4 3.9 0.9 2.0 1.9 2.0 1.3 1.2 1.3 1.8 0.7 1.3 2.1 1.3 3.8 1.0 0.8 2.1 1.3 0.8 9.3 9.4 22.0 11.1 8.9 4.6 5.4 7.4 7.1 7.3 3.0 5.3 2.4 3.2 10.4 12.0 8.3 7.6 0.0 6.8 5.2 7.9 6.5 0.0 4.5 7.5 9.3 5.5 0.0 6.2 5.9 7.4 6.7 3.5 11.9 5.7 11.1 7.0 12.9 21.6 14.4 10.6 5.6 1.7 1.0 7.3 5.3 5.7 9.5 9.6 3.0 8.4 6.5 7.2 12.5 1.0 11.3 11.0 8.5 6.7 6.5 SETD5 FLJ10707 ENSG00000168137 "SET domain containing 5" Q9C0A6 3 9397615-9479240 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Autism, Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017093, HPA035574" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB017093: , HPA035574: AB_2674681" "unprognostic (6.46e-2)" "unprognostic (1.64e-1)" "unprognostic (3.44e-1)" "unprognostic (1.13e-1)" "unprognostic (1.22e-1)" "unprognostic (7.99e-2)" "prognostic unfavorable (6.21e-4)" "unprognostic (5.52e-2)" "unprognostic (2.29e-1)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (4.04e-2)" "prognostic unfavorable (4.27e-4)" "unprognostic (6.65e-2)" "unprognostic (1.67e-1)" "unprognostic (4.04e-2)" "unprognostic (5.15e-3)" 18.9 21.9 33.1 18.2 29.1 13.2 40.9 58.0 38.9 21.7 20.7 15.4 22.1 14.0 24.0 27.0 20.7 22.0 18.4 18.3 29.6 13.8 15.4 22.1 26.5 29.8 23.0 30.1 29.7 22.7 25.6 31.4 23.0 25.1 20.6 20.4 16.7 22.3 22.7 16.6 29.0 19.8 24.1 22.8 22.5 18.7 21.3 26.6 21.0 25.9 14.8 24.2 20.4 37.5 3.7 4.0 4.7 2.0 4.3 4.1 1.0 9.9 12.0 24.7 11.2 14.6 15.2 59.0 9.8 13.3 14.3 16.5 11.9 12.4 21.7 5.9 14.3 12.6 8.3 23.0 13.0 15.8 15.3 11.4 21.2 20.2 11.0 14.9 16.2 14.1 14.7 21.2 21.6 25.7 14.8 15.1 15.4 20.8 14.3 12.2 14.6 14.3 13.5 18.7 7.6 9.7 16.6 19.5 9.6 11.2 16.1 9.9 15.4 14.3 11.8 8.9 23.0 15.8 11.9 17.9 15.1 17.3 8.1 11.7 10.4 13.0 36.2 10.8 11.7 14.1 2.3 2.0 1.7 3.8 1.2 2.5 3.4 2.5 4.1 1.3 3.7 2.4 2.2 4.7 4.3 1.4 4.0 1.0 1.0 33.1 29.1 58.0 38.9 29.6 13.8 23.0 30.1 25.1 26.6 38.7 45.3 34.4 46.5 83.5 109.6 20.7 48.4 56.2 59.1 40.1 108.0 31.2 3.3 31.7 6.2 57.1 35.1 0.0 29.5 33.8 55.5 67.5 46.2 41.4 21.1 52.4 60.0 57.1 28.8 7.5 61.9 31.1 42.2 30.7 47.0 38.4 36.6 45.6 50.5 9.8 62.8 12.9 58.0 37.5 39.3 79.9 47.9 50.7 42.2 63.9 SF3A1 "Prp21, PRPF21, SAP114, SF3a120" ENSG00000099995 "Splicing factor 3a subunit 1" Q15459 22 30331988-30356947 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000690, HPA030083" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" NA NA 19000 "Nucleoplasm, Nuclear speckles" "HPA000690: AB_1079933, HPA030083: AB_10602183" "unprognostic (8.61e-2)" "unprognostic (1.60e-1)" "unprognostic (3.21e-2)" "unprognostic (7.54e-2)" "unprognostic (5.06e-3)" "unprognostic (1.79e-1)" "unprognostic (5.54e-3)" "unprognostic (3.30e-1)" "unprognostic (3.83e-1)" "unprognostic (2.59e-1)" "unprognostic (2.58e-1)" "unprognostic (3.26e-1)" "prognostic favorable (1.16e-4)" "unprognostic (2.25e-1)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" "unprognostic (1.13e-1)" 32.6 30.2 23.3 37.3 25.6 44.6 35.0 33.6 37.3 29.2 26.4 24.8 27.7 26.1 36.3 23.0 32.2 29.4 30.7 26.2 21.5 16.6 24.9 29.7 28.5 48.2 23.5 26.1 45.7 31.4 44.4 27.2 25.9 19.6 27.2 24.5 29.7 31.8 33.1 45.5 36.3 29.5 27.6 18.7 34.6 29.1 78.4 25.7 50.9 32.9 26.6 34.9 32.7 42.6 13.2 10.6 16.2 13.7 12.1 16.6 8.3 26.4 18.6 25.6 24.8 15.2 13.7 30.6 21.0 13.4 22.9 17.1 24.6 17.7 33.1 14.5 14.8 18.1 25.5 32.4 22.3 25.2 30.0 28.4 30.9 23.1 20.1 13.8 61.9 34.4 13.7 15.8 28.9 23.6 13.0 16.4 18.0 34.1 34.7 16.6 15.2 30.1 14.1 42.3 20.4 15.6 43.0 32.1 26.8 13.1 29.4 26.6 24.3 26.7 16.3 24.2 17.8 19.9 20.4 22.9 29.4 26.2 20.9 38.7 26.9 32.4 33.5 22.6 23.0 30.2 7.6 9.8 15.0 13.5 11.3 13.7 12.8 13.5 14.4 10.6 13.2 15.3 13.7 16.2 12.1 13.7 6.4 16.6 8.3 23.3 25.6 33.6 37.3 21.5 16.6 23.5 26.1 19.6 25.7 53.6 60.9 28.0 23.1 23.2 17.9 26.6 35.7 48.2 37.5 29.6 15.7 28.2 14.9 22.6 85.6 29.2 25.3 46.7 25.3 33.8 23.4 23.0 50.8 23.6 34.7 25.4 24.1 28.3 35.7 91.2 32.5 26.1 16.9 63.1 29.8 24.6 24.5 31.6 35.3 14.6 17.4 45.3 23.9 54.7 41.0 23.8 28.9 30.5 28.2 22.2 SF3B5 "MGC3133, SF3b10, Ysf3" ENSG00000169976 "Splicing factor 3b subunit 5" Q9BWJ5 6 144094881-144095573 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054408 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054408: AB_2682479" "unprognostic (1.22e-1)" "unprognostic (7.12e-2)" "unprognostic (4.54e-2)" "unprognostic (6.86e-2)" "unprognostic (1.42e-1)" "unprognostic (3.08e-2)" "unprognostic (1.07e-3)" "unprognostic (1.74e-1)" "unprognostic (6.47e-3)" "unprognostic (1.43e-1)" "unprognostic (1.33e-3)" "unprognostic (2.47e-1)" "unprognostic (3.61e-2)" "unprognostic (1.92e-1)" "unprognostic (2.77e-1)" "unprognostic (1.90e-2)" "unprognostic (1.49e-1)" 31.0 52.5 32.9 34.0 37.2 76.6 41.7 18.6 35.8 36.9 42.6 23.8 45.3 33.1 34.5 42.6 46.9 47.1 39.8 47.7 32.0 31.1 54.4 84.8 30.3 62.4 32.5 26.0 40.9 100.7 22.3 48.4 31.3 28.0 32.1 40.6 26.5 43.1 60.4 47.4 39.8 40.3 33.2 30.6 38.7 33.9 47.3 24.7 56.7 47.7 63.7 43.4 35.3 30.2 42.7 76.4 38.4 80.7 38.6 48.6 68.5 22.6 30.8 35.4 65.4 41.6 47.4 21.1 23.6 39.8 48.6 55.7 32.6 20.8 37.9 42.5 38.3 47.2 27.0 40.6 54.2 34.4 39.1 57.3 41.3 27.5 71.6 40.0 80.4 26.6 48.3 73.3 53.3 53.4 31.5 58.8 52.5 52.9 55.4 43.5 80.5 51.9 72.6 22.7 35.7 37.3 32.4 46.4 38.3 52.8 20.5 48.7 30.8 32.9 40.4 43.9 18.7 29.3 49.5 31.7 25.0 34.2 44.7 50.9 41.7 50.2 35.6 40.5 67.6 30.8 30.6 80.7 38.4 38.4 56.1 47.2 42.7 43.6 45.2 68.8 39.1 43.5 43.3 21.6 38.6 49.8 76.4 48.6 68.5 32.9 37.2 18.6 35.8 32.0 31.1 32.5 26.0 28.0 24.7 83.4 145.5 165.3 123.3 240.9 44.9 77.9 196.1 116.4 94.4 116.9 11.8 202.6 388.0 204.2 171.0 134.9 248.1 210.2 274.2 179.7 208.8 158.9 174.4 239.5 289.2 41.3 257.0 153.4 220.2 84.0 124.8 193.2 239.6 242.5 242.8 104.3 226.1 234.4 102.2 429.7 46.6 103.5 144.3 82.1 55.6 283.4 172.7 200.5 251.5 180.0 SFMBT1 "DKFZp434L243, RU1, SFMBT" ENSG00000163935 "Scm like with four mbt domains 1" Q9UHJ3 3 52903572-53046750 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 30.2" "Cell type enhanced" "Detected in many" 10 "Spermatocytes: 123.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036152, HPA064564" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036152: AB_2674972, HPA064564: AB_2685288" "unprognostic (2.78e-2)" "unprognostic (9.96e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (1.69e-1)" "unprognostic (2.71e-2)" "unprognostic (1.28e-2)" "unprognostic (9.39e-2)" "unprognostic (6.79e-2)" "unprognostic (3.55e-2)" "unprognostic (2.36e-1)" "unprognostic (2.57e-2)" "unprognostic (3.57e-3)" "unprognostic (7.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.19e-2)" "unprognostic (3.55e-2)" 3.1 2.4 5.1 7.0 3.7 5.5 6.8 10.5 5.8 3.2 4.9 3.1 2.7 3.1 2.8 5.2 4.9 3.7 3.8 4.8 4.1 2.4 4.5 6.3 7.3 6.3 2.6 4.3 2.4 11.8 15.1 12.0 3.1 3.1 4.6 5.4 2.9 4.6 2.1 17.7 4.8 4.4 4.1 4.1 5.9 4.2 30.2 2.4 3.9 5.1 2.7 5.6 3.2 12.9 8.2 0.9 10.9 2.1 3.6 5.3 2.4 15.3 4.2 6.9 12.4 1.5 1.1 14.0 3.4 3.2 10.3 12.8 8.6 13.3 7.9 4.0 2.1 11.3 1.3 6.8 4.3 12.5 14.3 4.3 6.6 8.9 3.8 2.4 10.4 6.9 1.0 6.3 7.0 4.8 1.1 1.8 9.1 2.2 11.9 3.4 4.8 6.5 4.2 3.6 5.9 4.5 5.9 6.3 4.4 1.4 16.6 8.1 5.1 14.5 6.0 7.3 0.8 3.9 9.7 1.1 4.6 10.4 7.9 10.4 5.7 19.9 16.9 4.2 4.3 7.7 2.0 2.1 10.9 3.4 1.1 4.5 8.2 5.2 3.1 0.9 6.9 4.8 5.3 3.8 3.6 1.1 0.9 2.5 2.4 5.1 3.7 10.5 5.8 4.1 2.4 2.6 4.3 3.1 2.4 8.9 6.5 14.7 7.5 10.3 13.3 13.7 12.7 13.4 6.8 1.8 43.2 8.8 6.6 6.0 33.8 4.5 6.2 23.3 11.7 8.3 4.2 7.6 9.2 12.4 5.6 7.9 5.8 3.7 5.3 43.6 2.0 5.4 0.0 4.6 8.5 6.0 8.6 8.6 7.1 6.9 21.2 6.5 5.9 123.8 23.2 7.5 4.5 12.5 10.6 4.2 SFPQ "PPP1R140, PSF" ENSG00000116560 "Splicing factor proline and glutamine rich" P23246 1 35176378-35193148 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009886, HPA047513, HPA054689" Enhanced Enhanced Nucleoplasm NA NA 280000 Nucleoplasm "CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574" "prognostic favorable (9.56e-5)" "unprognostic (1.01e-1)" "unprognostic (1.02e-3)" "unprognostic (1.99e-1)" "unprognostic (5.53e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (7.91e-13)" "unprognostic (3.10e-1)" "unprognostic (4.00e-3)" "unprognostic (3.85e-2)" "unprognostic (2.20e-2)" "unprognostic (8.03e-3)" "unprognostic (1.25e-3)" "unprognostic (1.16e-2)" "unprognostic (3.97e-3)" "unprognostic (3.07e-1)" "unprognostic (3.77e-3)" 40.5 35.7 31.5 39.4 31.4 122.5 48.3 53.0 38.5 39.0 31.4 37.8 32.9 30.0 45.3 36.5 45.5 43.0 28.1 34.0 29.1 24.6 36.4 34.2 47.6 48.8 26.3 32.6 59.9 40.2 45.8 46.3 35.5 31.9 35.5 38.0 35.7 39.6 38.0 44.9 42.9 34.1 36.5 32.8 42.4 35.5 37.5 32.9 95.2 35.3 24.1 60.6 35.9 38.6 6.9 11.2 4.4 8.8 4.9 8.9 3.3 36.4 30.5 53.2 30.1 13.1 19.7 49.9 20.0 20.3 34.2 25.0 33.1 26.4 66.6 27.8 23.1 21.4 33.4 57.8 39.1 46.6 35.5 38.4 50.0 32.9 39.3 17.7 52.0 29.8 15.7 15.2 29.6 14.4 15.2 29.7 35.3 56.5 31.8 33.2 31.7 60.8 44.6 63.4 22.0 29.5 61.9 36.1 43.3 33.0 44.3 38.4 42.7 28.8 22.5 28.9 38.9 26.3 37.1 31.6 27.4 40.3 17.9 42.7 36.5 31.0 67.8 19.5 34.5 38.9 2.6 6.5 4.4 7.7 8.8 8.9 6.2 7.6 6.1 5.8 6.9 7.2 7.9 3.4 4.9 6.4 11.2 8.2 3.3 31.5 31.4 53.0 38.5 29.1 24.6 26.3 32.6 31.9 32.9 157.8 233.8 123.2 218.3 317.6 223.2 127.3 68.8 123.1 187.7 104.7 180.6 178.4 69.6 106.2 101.7 173.0 92.7 46.7 119.2 185.7 204.4 133.7 151.3 95.2 121.1 162.1 210.6 114.8 123.3 250.0 132.3 139.5 133.3 108.2 106.4 182.5 126.2 101.2 109.6 66.5 219.0 51.8 200.9 192.3 171.1 286.1 255.5 127.5 133.5 143.0 SGO1 "NY-BR-85, SGOL1" ENSG00000129810 "Shugoshin 1" Q5FBB7 3 20160593-20186292 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 40.1" "Cell type enhanced" "Detected in some" 27 "Cytotrophoblasts: 5.4;Extravillous trophoblasts: 33.5;Hofbauer cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA035501, HPA069302, HPA069857" Enhanced Enhanced Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214" "unprognostic (6.87e-3)" "unprognostic (5.01e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-3)" "unprognostic (2.51e-2)" "unprognostic (4.10e-2)" "unprognostic (2.55e-6)" "unprognostic (9.49e-3)" "unprognostic (2.45e-2)" "unprognostic (3.69e-2)" "unprognostic (1.65e-4)" "unprognostic (1.52e-2)" "unprognostic (0.00e+0)" "unprognostic (2.29e-2)" "unprognostic (4.95e-2)" "unprognostic (4.14e-1)" "unprognostic (1.64e-1)" 0.6 0.6 0.4 9.1 0.4 8.9 1.0 0.4 1.5 0.9 3.4 0.3 0.6 2.7 0.8 0.5 4.0 0.3 1.7 0.4 0.3 0.4 0.8 1.0 0.9 6.9 0.4 0.1 0.5 0.5 0.0 0.4 3.7 0.2 0.6 3.5 0.1 1.0 0.1 0.3 1.1 3.4 0.8 0.4 4.9 1.5 8.6 0.2 40.1 0.5 2.4 7.4 1.2 1.5 9.0 4.5 8.3 0.2 0.3 2.7 0.6 9.5 10.9 14.9 9.1 0.7 1.3 10.1 10.3 5.3 15.0 16.5 7.7 11.8 14.6 5.2 4.2 10.6 5.6 14.0 5.7 19.0 18.6 9.3 16.6 7.5 6.1 0.1 15.1 14.3 0.1 0.4 16.5 7.0 2.1 8.9 17.4 14.2 26.2 12.4 9.4 23.7 8.5 15.8 10.2 8.3 15.2 19.1 8.5 3.8 7.0 7.4 7.8 11.4 14.1 6.8 11.6 9.1 10.6 2.4 11.4 13.7 10.2 20.5 11.3 26.2 17.0 6.2 15.3 17.1 8.3 0.1 1.5 0.3 0.2 0.1 8.6 0.7 0.8 0.4 9.0 0.2 0.4 1.6 0.3 0.2 4.5 2.7 0.6 0.4 0.4 0.4 1.5 0.3 0.4 0.4 0.1 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 5.4 0.0 1.1 0.0 0.0 0.0 0.0 1.6 33.5 0.0 0.0 1.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 SGO2 "FLJ25211, SGOL2, TRIPIN" ENSG00000163535 "Shugoshin 2" Q562F6 2 200510008-200583782 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 12.6;lymphoid tissue: 25.7;testis: 27.9" "Group enriched" "Detected in many" 4 "Ciliated cells: 14.7;Club cells: 11.4;Extravillous trophoblasts: 24.6;granulocytes: 10.5;Hofbauer cells: 11.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035163, HPA040817" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA035163: AB_10602397, HPA040817: AB_2677149" "unprognostic (3.43e-1)" "unprognostic (1.70e-1)" "unprognostic (7.06e-3)" "unprognostic (6.71e-3)" "unprognostic (1.90e-1)" "unprognostic (1.77e-1)" "unprognostic (7.55e-6)" "unprognostic (1.12e-2)" "unprognostic (1.98e-3)" "unprognostic (4.87e-2)" "unprognostic (1.37e-4)" "unprognostic (9.49e-2)" "unprognostic (8.07e-9)" "unprognostic (5.21e-2)" "unprognostic (5.43e-2)" "unprognostic (9.86e-2)" "unprognostic (2.02e-1)" 5.3 1.7 1.5 8.6 2.3 5.3 3.5 4.0 3.1 1.6 2.7 0.7 0.3 2.1 1.6 1.0 3.7 1.6 1.3 1.4 1.9 1.5 1.8 1.0 1.9 6.5 2.7 3.7 2.2 1.2 1.1 0.9 2.2 3.2 1.4 2.9 0.1 1.7 1.5 1.0 2.0 2.8 1.7 3.5 3.9 1.7 27.9 2.3 25.7 1.5 4.1 7.0 2.0 1.8 3.8 2.1 12.6 1.9 2.4 4.2 1.4 15.7 7.4 17.9 8.0 2.4 3.9 11.1 18.1 7.6 15.6 15.7 11.4 10.7 10.3 8.5 8.6 16.5 11.8 15.7 9.4 26.7 20.6 7.8 19.4 10.7 8.1 0.7 20.2 15.7 1.5 1.1 15.7 8.1 3.8 13.8 14.7 14.9 15.2 29.5 7.0 16.2 8.3 12.7 11.2 18.5 12.8 23.6 9.4 6.5 6.2 10.5 7.2 13.3 6.5 7.9 15.1 6.9 11.9 8.3 16.4 16.3 15.0 15.8 6.9 14.4 22.4 10.3 13.6 23.4 12.6 1.8 5.1 2.8 1.7 1.9 3.0 3.2 2.8 1.0 3.8 2.4 3.0 1.3 2.4 1.9 2.1 4.2 1.4 1.5 2.3 4.0 3.1 1.9 1.5 2.7 3.7 3.2 2.3 3.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 14.7 11.4 0.0 0.0 3.2 3.3 3.1 0.0 0.0 0.0 0.0 2.3 24.6 0.0 0.0 10.5 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.8 0.0 0.0 2.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 SH3BP5 Sab ENSG00000131370 "SH3 domain binding protein 5" O60239 3 15254853-15341368 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 199.4;Extravillous trophoblasts: 335.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 94.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036445, HPA057988" Uncertain Enhanced "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA036445: AB_10670106, HPA057988: AB_2683572" "unprognostic (1.28e-3)" "unprognostic (2.99e-2)" "unprognostic (9.50e-2)" "unprognostic (6.97e-2)" "unprognostic (4.68e-2)" "unprognostic (1.56e-2)" "unprognostic (7.74e-2)" "unprognostic (7.81e-3)" "unprognostic (4.80e-2)" "unprognostic (4.09e-2)" "unprognostic (2.76e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (8.17e-4)" "unprognostic (4.76e-2)" "unprognostic (3.06e-2)" "unprognostic (4.34e-2)" "unprognostic (2.03e-1)" 38.6 72.5 12.7 20.0 13.4 29.9 35.7 34.8 22.3 30.5 12.7 20.7 42.0 7.5 33.9 20.4 11.9 32.2 29.0 9.6 17.2 11.2 19.6 9.9 38.8 25.1 13.0 18.9 49.6 7.1 30.0 14.7 19.5 15.1 13.5 4.9 12.4 22.4 45.1 61.7 10.1 10.3 21.0 19.0 14.8 7.2 17.0 10.8 9.3 20.8 7.7 18.9 25.3 44.3 13.3 4.8 8.0 3.9 13.0 28.9 9.5 7.4 3.7 1.7 3.5 16.1 13.6 94.1 4.1 2.7 2.2 2.8 2.4 3.4 6.2 1.7 10.8 4.7 0.9 0.8 3.5 1.9 4.8 3.4 4.2 16.9 0.4 6.1 1.1 2.1 10.9 2.6 10.2 2.2 10.6 31.4 8.1 4.6 2.1 3.0 26.6 14.8 6.9 3.7 0.9 5.6 0.2 8.4 28.1 2.7 12.4 4.2 2.2 5.6 5.1 5.9 7.2 4.6 3.1 24.1 6.0 8.4 5.7 3.1 0.8 1.7 4.3 11.5 4.1 8.1 3.5 3.9 4.5 28.9 1.3 9.1 10.9 13.7 19.9 4.8 13.3 7.5 9.8 8.0 13.0 2.1 2.2 5.7 9.5 12.7 13.4 34.8 19.2 17.2 11.2 13.0 18.9 15.1 10.8 0.0 18.9 87.1 5.5 15.0 40.9 0.5 7.6 6.7 17.0 64.6 13.7 9.5 3.3 2.9 199.4 71.8 1.4 0.0 7.7 335.6 62.1 6.6 2.3 5.1 28.9 62.0 2.4 138.1 68.8 76.3 45.5 65.1 32.1 17.2 1.8 4.7 3.6 0.0 111.4 22.1 45.9 6.5 7.7 2.1 3.0 10.7 144.9 40.5 0.9 8.1 SH3RF2 "FLJ23654, Hepp1, POSHER, PPP1R39, RNF158" ENSG00000156463 "SH3 domain containing ring finger 2" Q8TEC5 5 145936579-146081791 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Protein phosphatase inhibitor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 40.8" "Cell type enriched" "Detected in many" 5 "Late spermatids: 7204.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basal ganglia: 11.5;cerebral cortex: 2.9" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "dendritic cells: 1.4;T-cells: 1.6" "Cell line enhanced" "Detected in many" "CACO-2: 34.6;GAMG: 15.3;hTERT-RPE1: 17.2" "Region enriched" "Detected in single" 14 "basal ganglia: 23.9" "Region enhanced" "Detected in some" "basal ganglia: 14.5" "HPA035903, HPA058119" Uncertain Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA035903: AB_10696515, HPA058119: AB_2683611" "unprognostic (8.90e-3)" "unprognostic (2.00e-3)" "unprognostic (5.11e-3)" "unprognostic (1.66e-2)" "unprognostic (1.45e-3)" "unprognostic (1.47e-2)" "unprognostic (9.96e-3)" "unprognostic (8.22e-2)" "unprognostic (3.92e-1)" "unprognostic (7.37e-3)" "unprognostic (2.44e-3)" "unprognostic (1.66e-1)" "unprognostic (2.98e-2)" "unprognostic (5.21e-2)" "unprognostic (1.46e-1)" "unprognostic (2.64e-2)" "unprognostic (4.13e-3)" 2.6 0.6 1.2 6.2 11.5 0.0 2.9 0.2 2.9 6.4 19.1 0.4 0.4 9.2 2.9 2.2 22.2 3.6 40.8 23.5 0.8 0.3 0.8 4.6 1.9 0.0 0.3 1.1 1.0 14.3 0.0 3.3 0.3 0.1 2.2 8.5 0.9 16.9 1.0 21.7 33.1 21.4 1.2 0.5 0.2 11.9 6.4 0.6 0.6 3.8 19.6 16.1 0.9 10.0 0.0 1.4 0.3 0.1 0.0 1.6 0.3 10.2 2.8 0.1 0.6 0.0 0.0 0.0 0.1 0.8 2.1 0.8 34.6 9.5 0.0 5.4 0.4 15.3 9.5 0.0 11.2 2.0 0.1 0.1 0.0 4.1 4.6 0.6 0.0 0.0 0.1 6.0 3.2 7.6 17.2 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.8 8.5 0.7 0.0 0.1 0.0 4.4 1.0 0.0 0.0 0.6 0.2 0.2 0.5 3.3 0.0 4.9 0.4 8.9 0.7 3.3 0.0 0.0 0.0 5.5 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 1.6 0.7 1.4 0.0 0.0 1.5 0.2 0.0 0.1 0.0 0.8 0.3 1.2 11.5 0.2 2.9 0.8 0.3 0.3 1.1 0.1 0.6 14.9 2.9 0.0 4.5 48.9 0.6 414.9 2.5 2.7 2.3 1.8 0.0 0.0 0.0 6.5 1412.5 1.5 27.7 0.0 7.6 0.0 0.5 1.3 1.1 8.3 0.2 0.0 1.2 0.6 0.0 7204.3 23.9 0.0 8.5 1.0 12.2 1.9 13.6 17.5 32.5 0.6 0.0 12.9 1.4 32.0 16.2 43.7 0.0 0.0 27.1 6.4 SHOX "GCFX, PHOG, SHOXY, SS" ENSG00000185960 "Short stature homeobox" O15266 X 624344-659411 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.3;breast: 13.9" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 1.4" "Not detected" "Not detected" "Region enhanced" "Detected in some" "pons and medulla: 6.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "BJ: 19.5;BJ hTERT+: 9.0" "HPA035141, HPA060931" Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA035141: AB_2674489, HPA060931: AB_2684388" "unprognostic (7.51e-3)" "unprognostic (1.99e-1)" "unprognostic (3.08e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-1)" "unprognostic (6.82e-2)" "unprognostic (2.45e-2)" "unprognostic (2.34e-1)" "unprognostic (9.24e-2)" "unprognostic (9.95e-2)" "unprognostic (5.67e-6)" "unprognostic (1.99e-1)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.38e-1)" 3.8 1.0 0.3 0.7 0.3 3.0 13.9 1.8 0.8 0.3 0.4 0.2 0.2 1.4 0.3 0.6 0.3 0.4 0.4 0.4 0.7 0.3 0.3 0.3 0.3 0.6 0.3 1.4 0.3 0.9 0.0 0.3 4.8 6.3 0.8 0.3 0.2 1.4 0.2 2.8 1.4 1.0 0.2 0.4 1.6 0.4 0.4 0.2 0.2 0.5 0.2 0.2 0.3 0.3 2.2 1.9 5.5 1.8 2.5 1.5 0.8 0.1 0.2 0.1 0.2 0.2 0.1 3.2 19.5 9.0 2.9 3.2 0.3 0.3 0.3 0.1 0.4 0.8 0.3 0.2 0.0 1.0 0.2 0.1 0.1 1.3 0.1 0.1 0.1 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.8 0.1 0.2 0.1 0.2 0.1 0.0 0.4 0.1 0.3 0.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.6 0.0 0.1 0.3 0.2 0.1 0.1 0.9 0.1 0.3 0.1 0.2 0.1 5.5 1.8 1.8 1.4 1.1 1.5 1.6 1.1 1.2 0.5 2.2 1.5 1.5 5.2 2.5 1.5 1.9 1.0 0.8 0.3 0.3 1.8 0.4 0.7 0.3 0.3 1.4 6.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 SIK3 "FLJ12240, KIAA0999, L19, QSK" ENSG00000160584 "SIK family kinase 3" 11 116843402-117098437 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 106.0;Late spermatids: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045245, HPA048161" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045245: AB_2679270, HPA048161: AB_2680293" "unprognostic (3.19e-2)" "unprognostic (3.31e-1)" "unprognostic (2.78e-2)" "unprognostic (8.21e-2)" "unprognostic (1.31e-1)" "unprognostic (2.30e-2)" "unprognostic (2.73e-1)" "unprognostic (2.33e-2)" "unprognostic (7.63e-2)" "unprognostic (2.46e-2)" "unprognostic (1.28e-3)" "unprognostic (1.89e-1)" "prognostic favorable (1.12e-5)" "unprognostic (1.82e-1)" "unprognostic (6.85e-2)" "unprognostic (1.02e-2)" "unprognostic (3.28e-2)" 13.0 12.2 24.7 13.8 36.9 14.3 13.5 24.0 34.4 13.5 16.6 40.5 10.4 10.9 18.6 9.9 13.7 16.6 12.8 16.0 23.7 16.2 13.9 17.6 13.7 11.9 25.8 24.4 22.4 19.5 29.4 18.4 16.3 23.9 11.4 11.7 10.6 11.7 15.6 16.9 11.3 14.0 18.4 17.2 14.2 14.5 26.0 38.0 10.4 22.1 6.9 12.9 14.5 12.9 2.4 1.7 3.9 3.7 1.6 1.8 0.7 7.9 6.1 9.7 10.2 8.4 9.1 15.6 6.0 10.9 4.8 5.4 14.8 9.2 9.4 9.9 11.1 10.6 12.5 8.0 8.7 6.7 25.8 5.1 21.1 6.7 9.1 7.8 7.5 8.3 10.0 5.1 10.2 16.5 6.1 6.4 6.3 10.1 7.0 6.5 2.7 6.7 8.1 5.4 5.4 4.5 8.7 5.6 7.4 6.6 1.5 9.5 7.6 16.3 7.2 3.2 7.8 4.7 8.0 7.3 5.9 7.5 9.8 6.0 5.0 3.6 12.0 5.5 12.4 7.9 3.9 1.1 0.0 1.0 1.5 1.8 0.4 0.9 0.4 1.7 2.4 0.3 0.1 2.6 1.6 3.7 0.1 0.1 0.7 24.7 36.9 24.0 32.2 23.7 16.2 25.8 24.4 23.9 38.0 8.9 26.1 22.2 23.4 23.6 42.8 19.3 12.7 18.7 15.9 5.2 106.0 7.4 5.0 6.7 76.2 16.5 9.7 0.0 6.4 2.6 20.8 17.6 17.3 18.4 6.8 44.5 16.6 14.1 21.4 130.5 9.5 18.7 15.1 4.6 12.0 47.3 7.9 8.6 13.4 5.6 64.0 0.0 20.6 20.4 11.3 21.2 24.8 25.9 10.3 24.3 SIMC1 "C5orf25, FLJ44216, OOMA1, PLEIAD" ENSG00000170085 "SUMO interacting motifs containing 1" Q8NDZ2 5 176238367-176345991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 29.3;testis: 41.5" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037889, HPA037890" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA037889: AB_2675720, HPA037890: AB_2675721" "unprognostic (1.15e-1)" "unprognostic (9.97e-2)" "unprognostic (3.81e-3)" "prognostic unfavorable (2.32e-6)" "prognostic unfavorable (1.59e-4)" "unprognostic (7.20e-2)" "unprognostic (5.59e-2)" "unprognostic (2.75e-1)" "unprognostic (1.97e-3)" "unprognostic (1.60e-1)" "unprognostic (1.21e-2)" "unprognostic (1.74e-1)" "unprognostic (2.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-1)" "unprognostic (3.59e-2)" "unprognostic (9.20e-2)" 3.1 15.1 5.4 5.0 3.9 2.0 3.3 10.2 5.4 7.5 4.5 2.0 2.9 3.9 8.0 6.8 3.1 9.3 5.3 2.0 6.2 4.4 1.8 5.1 3.1 3.5 2.5 3.0 29.3 3.4 4.2 7.6 3.3 3.4 6.1 4.9 4.0 3.8 4.7 5.5 2.3 5.1 6.2 3.0 5.5 5.1 41.5 3.7 4.5 2.1 2.7 3.4 4.4 5.4 7.1 8.1 10.5 5.3 10.8 6.3 3.5 1.8 5.0 16.3 13.0 8.5 8.4 8.2 6.9 6.8 7.2 9.0 17.5 5.4 0.0 8.6 8.0 14.8 1.7 17.6 12.3 9.0 3.1 13.1 8.8 3.3 2.2 19.1 9.6 6.8 5.6 5.1 4.8 8.7 5.3 6.7 3.2 22.0 8.5 8.5 8.6 9.4 7.6 5.9 2.3 5.5 14.0 10.8 12.1 4.8 3.7 10.7 11.6 7.6 1.1 6.6 5.9 4.4 18.4 4.7 8.8 4.7 8.0 5.9 2.1 2.4 13.8 3.5 6.4 5.0 7.0 5.3 10.5 5.2 5.2 6.3 7.1 6.3 4.0 8.1 6.9 5.3 4.1 0.7 10.8 4.0 3.9 4.1 3.5 5.4 3.9 10.2 5.4 6.2 4.4 2.5 3.0 3.4 3.7 8.9 3.5 2.7 4.8 2.6 15.3 3.1 2.5 2.7 3.4 1.8 3.9 0.2 1.7 3.2 27.6 2.1 5.3 0.0 3.2 2.1 4.3 3.7 0.0 7.5 2.0 17.5 12.7 4.9 4.1 9.8 27.6 2.8 5.0 4.6 9.3 5.8 4.1 7.0 32.5 2.1 4.5 32.3 5.3 64.2 24.7 2.3 0.7 5.0 8.9 2.6 SIN3A "DKFZP434K2235, KIAA0700" ENSG00000169375 "SIN3 transcription regulator family member A" Q96ST3 15 75369379-75455842 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004506, HPA047213, HPA062123" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689" "unprognostic (1.94e-1)" "unprognostic (1.38e-1)" "unprognostic (1.48e-1)" "unprognostic (1.27e-1)" "unprognostic (1.99e-1)" "unprognostic (2.90e-1)" "unprognostic (4.74e-2)" "unprognostic (1.91e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "unprognostic (8.52e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-3)" "unprognostic (7.33e-2)" "unprognostic (2.19e-1)" "unprognostic (1.33e-1)" "unprognostic (3.52e-1)" 21.0 15.4 14.0 19.4 18.5 31.6 20.4 26.3 15.5 26.3 20.2 19.9 15.3 11.8 26.6 16.8 17.7 22.1 15.9 13.4 14.2 11.8 13.6 13.9 17.4 20.7 13.0 14.2 27.6 19.8 23.4 16.8 17.2 13.0 22.9 14.3 23.0 17.6 20.5 18.2 23.5 17.9 24.5 12.8 20.3 16.8 28.5 15.1 48.7 24.0 12.8 26.9 26.0 19.0 9.8 6.5 9.3 8.3 9.7 12.7 6.3 12.9 26.9 24.1 15.8 12.0 12.7 13.9 9.7 15.2 14.4 15.5 14.8 17.7 28.3 10.2 14.4 19.7 23.3 34.9 14.7 15.8 22.8 18.1 26.7 20.5 11.6 9.1 25.3 22.9 15.4 11.4 16.7 17.5 14.9 12.9 20.3 21.0 31.6 11.6 15.1 24.8 16.3 23.4 17.3 11.3 25.1 31.9 17.4 10.3 23.9 19.1 19.0 24.1 10.8 13.5 24.2 16.4 20.1 11.2 17.9 24.2 11.8 14.4 21.8 34.0 30.1 10.6 25.9 9.9 3.3 4.8 6.9 8.5 4.8 12.7 9.3 10.8 10.7 6.5 9.8 11.1 9.5 9.3 9.7 8.3 4.4 9.5 6.3 14.0 18.5 26.3 15.5 14.2 11.8 13.0 14.2 13.0 15.1 32.8 26.7 28.9 21.6 34.9 19.3 12.6 17.8 29.4 31.8 26.2 29.5 18.2 5.0 13.3 6.8 23.9 11.8 0.0 11.0 9.1 23.6 23.5 29.9 14.3 11.4 19.1 16.6 26.4 23.0 3.1 21.3 20.0 10.1 12.6 17.1 17.2 12.3 15.0 19.1 8.4 31.7 12.9 17.6 37.7 41.7 46.4 18.3 22.3 15.9 16.6 SKAP2 "RA70, SAPS, SCAP2, SKAP-HOM, SKAP55R" ENSG00000005020 "Src kinase associated phosphoprotein 2" O75563 7 26667062-26995239 "Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 255.1;Kupffer cells: 178.5;Late spermatids: 271.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005560, HPA024045" Enhanced Supported Nucleoplasm,Cytosol NA NA 3200000 Nucleoplasm Cytosol "HPA005560: AB_2667360, HPA024045: AB_2671416" "unprognostic (8.52e-2)" "unprognostic (5.57e-2)" "unprognostic (3.76e-1)" "unprognostic (5.62e-2)" "unprognostic (7.91e-3)" "unprognostic (1.30e-1)" "unprognostic (1.07e-3)" "unprognostic (4.15e-3)" "unprognostic (1.82e-1)" "unprognostic (1.41e-2)" "unprognostic (1.26e-2)" "unprognostic (3.80e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-1)" "unprognostic (1.12e-1)" "unprognostic (3.51e-2)" 20.8 22.5 11.5 29.4 12.9 12.8 28.5 6.0 12.8 7.7 15.3 7.6 11.0 10.5 5.2 15.4 14.0 9.4 9.6 12.6 9.5 12.1 20.4 7.8 31.6 36.4 12.0 8.9 13.3 6.1 25.1 10.9 5.3 15.5 10.2 15.0 2.5 5.8 9.8 8.3 8.6 16.5 21.1 42.6 31.8 11.7 10.1 11.5 6.4 6.1 1.9 19.3 19.3 28.1 9.9 12.3 37.3 18.0 8.3 5.1 6.7 11.7 6.2 0.6 15.5 2.9 2.4 3.8 4.8 7.2 2.4 6.0 4.9 47.4 9.1 21.1 9.0 17.5 6.3 8.5 4.9 5.0 5.1 13.7 10.0 1.8 6.5 3.9 18.4 35.4 10.6 4.6 6.9 9.5 0.4 14.4 0.0 5.3 4.7 9.4 2.2 0.0 9.3 0.5 10.5 6.1 11.9 1.5 0.7 29.3 9.2 7.7 0.2 8.7 4.7 6.3 3.7 6.5 9.7 21.0 4.0 0.1 13.3 4.9 7.5 9.5 15.9 9.5 23.9 15.2 8.2 12.6 19.4 3.7 15.0 5.1 9.9 2.1 3.0 9.6 8.0 0.5 2.9 37.3 8.3 18.0 12.3 3.5 6.7 11.5 12.9 6.0 12.8 9.5 12.1 12.0 8.9 15.5 11.5 17.9 29.9 77.3 32.3 23.6 12.3 4.7 5.1 14.7 9.1 22.7 11.8 11.1 54.7 7.9 255.1 35.8 46.2 23.3 20.3 18.4 9.5 16.9 50.9 8.3 82.6 4.8 41.3 90.9 178.5 271.4 8.3 120.8 18.6 28.9 64.6 13.0 15.8 31.6 10.3 65.3 12.7 0.0 12.0 19.9 34.3 37.9 15.6 34.8 45.4 27.2 SLTM "FLJ13213, Met" ENSG00000137776 "SAFB like transcription modulator" Q9NWH9 15 58879045-58933653 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040256, HPA040381" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA040256: AB_10674990, HPA040381: AB_2676953" "unprognostic (2.36e-1)" "unprognostic (6.56e-2)" "unprognostic (2.23e-1)" "unprognostic (1.81e-1)" "unprognostic (2.52e-3)" "unprognostic (9.65e-2)" "unprognostic (1.00e-1)" "unprognostic (2.48e-1)" "unprognostic (2.82e-3)" "unprognostic (3.44e-1)" "unprognostic (2.09e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (7.09e-2)" "unprognostic (3.69e-1)" "unprognostic (5.71e-2)" "unprognostic (3.24e-3)" 32.1 20.2 26.1 37.1 27.6 46.9 35.9 38.0 28.8 32.6 28.2 25.9 27.6 27.4 27.4 25.2 35.3 25.0 25.6 24.6 27.2 24.2 29.5 32.1 25.9 35.9 34.1 29.3 29.0 22.4 40.0 40.9 38.2 32.4 26.6 30.5 20.6 38.1 45.6 39.4 32.0 29.2 29.0 34.3 38.2 34.9 24.4 34.6 50.5 32.9 30.5 38.8 31.3 32.8 31.2 32.4 32.6 21.1 27.2 29.8 12.5 27.5 30.3 26.7 13.5 18.3 13.9 22.6 20.1 23.4 18.5 18.1 20.9 16.7 52.0 18.8 18.3 20.3 24.8 26.4 22.8 25.9 33.3 17.2 37.7 31.7 15.8 16.0 29.6 29.2 12.9 22.9 19.6 16.5 11.4 17.1 24.2 33.4 30.3 21.4 19.8 29.4 22.9 29.9 16.5 14.8 22.7 24.4 25.0 22.5 36.0 22.0 19.0 20.8 20.4 20.3 31.0 16.3 32.4 17.7 22.7 33.2 24.7 26.7 21.4 42.2 37.8 18.0 36.6 22.6 32.6 18.9 25.6 29.2 18.0 29.8 31.2 23.4 24.8 18.6 27.6 25.7 23.0 26.9 27.2 21.1 32.4 20.9 12.5 26.1 27.6 38.0 28.8 27.2 24.2 34.1 29.3 32.4 34.6 142.9 158.5 113.0 87.4 86.1 111.1 98.2 50.9 128.5 149.0 101.2 92.3 60.3 66.3 78.9 82.2 77.3 62.6 23.3 101.1 133.7 70.3 79.3 113.5 93.5 57.0 112.8 70.4 49.1 81.2 88.7 80.0 95.3 74.2 90.2 65.9 83.4 100.5 58.8 83.1 61.8 133.5 71.1 74.5 165.4 68.0 91.5 94.1 94.8 69.0 108.9 SMARCA5 "hISWI, hSNF2H, ISWI" ENSG00000153147 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5" O60264 4 143513463-143557486 "Predicted intracellular proteins, Transcription factors" "Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 285.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005227, HPA008751, HPA074181" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "CAB005227: AB_2191863, HPA008751: AB_1857268, HPA074181: " "unprognostic (9.21e-3)" "unprognostic (7.99e-2)" "unprognostic (4.99e-3)" "unprognostic (8.03e-2)" "unprognostic (8.96e-2)" "unprognostic (3.47e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.85e-2)" "unprognostic (8.84e-2)" "unprognostic (1.99e-1)" "unprognostic (4.19e-2)" "unprognostic (1.32e-1)" "unprognostic (1.87e-2)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (4.20e-2)" "unprognostic (1.82e-1)" 21.0 39.5 24.7 24.8 32.6 34.5 21.9 26.9 29.2 24.0 23.8 27.7 24.6 17.9 27.3 26.3 19.8 23.0 23.8 29.8 25.0 25.1 21.1 21.0 33.3 29.5 30.2 26.5 29.4 24.6 33.1 33.3 27.7 29.6 23.1 22.5 16.3 22.0 25.7 24.6 14.7 22.6 22.9 34.6 28.6 22.8 37.8 32.8 44.3 28.5 15.1 29.7 25.6 23.7 11.7 13.2 15.4 19.4 15.6 16.3 10.6 11.9 9.4 34.6 21.7 20.3 14.7 20.7 15.2 18.1 22.1 18.8 16.0 16.8 32.4 10.5 12.9 8.9 9.5 31.6 14.2 21.5 21.5 11.2 24.2 13.9 13.1 15.0 29.9 14.3 12.9 10.3 15.7 13.5 13.0 17.1 16.6 21.8 20.5 14.4 10.7 34.8 10.4 28.1 20.0 13.5 38.7 22.2 10.5 17.3 14.6 27.7 23.5 19.8 14.0 17.5 27.1 10.1 14.0 18.2 14.7 11.3 15.3 14.9 22.6 27.0 39.4 11.5 25.1 14.9 5.0 10.7 15.4 13.9 12.7 16.3 11.7 14.2 15.0 13.2 11.5 14.9 14.7 9.7 15.6 19.4 10.1 16.1 10.6 24.7 32.6 26.9 29.2 25.0 25.1 30.2 26.5 29.6 32.8 285.9 217.7 44.0 61.8 41.2 94.8 89.1 28.1 137.9 128.5 41.8 60.9 60.5 33.2 66.8 37.7 52.0 32.2 0.0 53.1 58.4 45.4 47.0 98.4 21.7 39.5 81.0 76.6 36.2 50.0 18.9 55.8 51.0 28.7 101.0 33.6 83.9 56.1 32.8 58.4 29.3 110.5 51.8 54.2 117.2 123.0 35.8 85.4 55.4 37.9 62.6 SMARCAD1 "DKFZP762K2015, ETL1, KIAA1122" ENSG00000163104 "SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1" Q9H4L7 4 94207611-94291292 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016737 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA016737: AB_1857271" "unprognostic (5.01e-2)" "unprognostic (5.83e-2)" "unprognostic (2.59e-3)" "unprognostic (1.23e-1)" "unprognostic (8.41e-3)" "unprognostic (9.08e-3)" "prognostic unfavorable (3.22e-5)" "unprognostic (2.45e-1)" "unprognostic (3.49e-3)" "unprognostic (3.55e-1)" "unprognostic (2.57e-2)" "unprognostic (7.72e-2)" "unprognostic (2.99e-2)" "unprognostic (1.43e-1)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "unprognostic (3.20e-3)" 12.8 15.4 15.4 22.2 14.6 8.6 20.1 26.7 25.1 15.4 13.6 9.4 14.4 12.6 19.6 17.5 17.2 16.5 13.9 12.9 13.6 14.7 16.6 14.9 21.6 22.8 17.6 11.1 20.8 15.0 17.2 33.0 18.3 14.9 15.4 16.5 10.2 14.9 20.9 11.8 26.5 13.9 15.6 17.9 17.6 13.9 15.3 16.2 42.0 20.2 11.4 17.8 16.0 15.9 5.5 4.3 3.5 3.0 7.5 6.2 2.7 7.4 9.7 30.1 19.7 8.7 14.3 15.6 13.3 12.5 11.1 10.7 8.7 12.2 19.2 9.2 11.4 10.1 6.5 21.2 11.2 16.1 14.7 9.6 13.8 10.5 13.3 12.6 20.1 14.8 14.6 9.3 13.8 17.8 13.8 17.3 16.8 22.8 8.0 16.8 5.9 34.2 10.7 20.9 9.4 4.8 19.9 17.2 9.8 13.0 9.1 17.7 26.2 10.2 17.2 14.6 19.3 8.8 13.6 16.3 14.5 15.5 8.9 10.1 11.3 16.9 23.0 13.6 10.8 17.9 3.5 2.5 0.3 4.6 3.0 4.8 5.5 5.1 4.9 4.3 4.2 5.5 6.2 0.0 7.5 2.9 3.7 4.1 2.7 15.4 14.6 26.7 25.1 13.6 14.7 17.6 11.1 14.9 16.2 11.9 9.9 6.0 5.4 10.4 19.7 12.3 5.1 37.5 34.2 8.7 15.7 11.2 1.7 10.8 1.7 14.3 5.0 0.0 8.7 9.4 10.1 5.8 22.1 11.0 9.3 17.5 8.6 11.1 14.0 1.8 13.3 12.3 3.3 7.2 12.6 9.4 12.3 8.2 17.3 12.7 18.1 6.5 7.2 26.5 34.0 8.4 8.0 16.2 10.9 3.8 SMARCC1 "BAF155, CRACC1, Rsc8, SRG3" ENSG00000173473 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1" Q92922 3 47585272-47782106 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011576, CAB016336, HPA024352, HPA026853" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB011576: AB_2191988, CAB016336: AB_671095, HPA024352: AB_1857274, HPA026853: AB_10603030" "unprognostic (3.47e-1)" "unprognostic (1.65e-1)" "prognostic favorable (3.34e-4)" "unprognostic (2.54e-1)" "unprognostic (1.83e-2)" "unprognostic (3.70e-2)" "prognostic unfavorable (3.37e-4)" "unprognostic (1.33e-2)" "unprognostic (4.28e-3)" "unprognostic (6.92e-2)" "unprognostic (5.53e-2)" "unprognostic (2.78e-2)" "unprognostic (1.66e-2)" "unprognostic (7.99e-2)" "unprognostic (3.84e-1)" "unprognostic (2.31e-2)" "unprognostic (2.45e-1)" 16.5 9.3 14.5 22.6 18.9 16.7 21.8 16.5 17.2 19.3 22.4 19.6 13.1 13.3 20.0 15.2 21.8 12.5 16.4 10.3 13.9 11.3 18.7 15.6 13.6 18.6 18.1 11.3 18.7 25.6 16.4 15.1 28.0 11.7 22.1 20.8 14.5 18.9 16.9 19.8 24.3 17.8 32.6 16.1 18.7 16.6 18.7 18.3 45.0 21.1 12.8 27.7 24.9 27.0 8.2 4.7 4.3 5.4 4.0 8.1 3.9 14.5 7.7 32.4 25.1 7.2 12.5 21.8 11.6 10.9 15.1 15.4 13.8 15.5 34.0 9.4 14.6 8.8 12.5 30.4 18.0 22.2 16.2 18.1 33.3 13.3 18.7 10.9 30.4 15.4 10.4 16.0 17.0 18.9 11.3 17.6 22.9 27.9 11.6 16.2 10.8 39.6 15.9 42.7 14.1 11.9 17.8 18.8 29.9 16.2 19.1 14.5 29.1 18.1 17.7 12.9 23.7 15.4 28.5 14.1 10.1 14.4 11.4 18.9 14.2 18.1 40.6 7.4 28.9 14.2 4.0 3.5 3.4 6.2 5.4 5.6 8.2 6.7 8.1 4.4 6.3 6.4 7.5 4.3 4.0 3.8 4.7 6.3 3.9 14.5 18.9 16.5 17.2 13.9 11.3 18.1 11.3 11.7 18.3 38.7 41.6 33.7 45.3 47.2 27.1 26.6 35.7 33.5 69.4 54.1 35.3 65.8 11.6 61.0 86.4 27.0 20.0 23.3 40.5 94.1 27.3 55.4 23.2 35.0 26.8 19.1 87.9 19.6 24.2 81.6 23.6 30.7 21.9 56.9 60.1 17.9 53.5 20.1 26.9 30.5 30.1 38.8 29.3 55.9 92.0 58.3 60.6 30.5 59.9 48.2 SMARCC2 "BAF170, CRACC2, Rsc8" ENSG00000139613 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2" Q8TAQ2 12 56162983-56189567 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004321, HPA021213, HPA061788" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004321: AB_2286337, HPA021213: AB_1857275, HPA061788: AB_2684608" "unprognostic (7.51e-2)" "unprognostic (1.08e-2)" "unprognostic (9.31e-2)" "unprognostic (4.93e-2)" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (1.43e-2)" "unprognostic (1.83e-1)" "unprognostic (1.71e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-1)" "unprognostic (1.04e-1)" "unprognostic (2.46e-1)" "unprognostic (1.35e-1)" "unprognostic (2.45e-1)" "unprognostic (6.74e-2)" "unprognostic (8.79e-2)" 25.0 22.2 34.5 17.4 36.5 15.7 22.5 43.7 40.7 24.9 20.4 29.9 17.1 21.5 29.1 16.6 18.2 25.5 18.6 19.0 35.0 22.7 19.8 14.1 21.6 20.9 29.2 24.2 38.4 21.8 36.1 21.1 19.9 27.5 24.6 19.0 26.7 26.1 28.2 32.3 26.8 21.7 27.2 22.6 23.4 20.6 17.7 32.1 21.3 30.2 13.2 23.2 27.5 22.7 8.8 7.0 19.0 12.2 6.2 12.7 9.6 19.6 30.4 32.5 23.4 20.2 21.2 13.5 17.6 18.9 21.3 20.7 17.5 24.7 28.6 17.0 20.5 20.0 22.9 20.9 17.8 19.3 21.8 19.5 45.4 20.6 11.0 10.9 21.3 33.8 19.7 13.4 20.1 10.2 38.5 26.9 22.3 25.8 24.0 19.6 20.6 36.0 19.2 11.0 15.7 20.8 21.4 26.0 22.4 15.9 25.8 24.0 24.9 29.9 20.9 8.1 17.7 35.3 19.0 23.0 18.2 22.3 16.2 12.9 22.8 16.6 20.0 18.9 14.3 19.3 13.7 7.6 19.0 11.9 10.0 12.7 8.6 8.4 8.4 7.0 8.8 6.2 7.8 6.6 6.2 12.2 5.0 8.2 9.6 34.5 36.5 43.7 40.7 35.0 22.7 29.2 24.2 27.5 32.1 62.5 38.7 25.3 36.7 18.2 55.0 23.4 20.4 29.4 47.8 40.1 37.3 16.4 6.6 21.2 1.3 30.1 17.6 0.0 15.7 10.2 22.4 27.0 61.4 14.3 14.3 36.5 21.8 26.4 15.9 2.8 63.9 18.0 18.6 33.3 19.9 50.0 18.7 17.3 51.9 14.2 58.8 19.4 28.4 43.6 29.4 19.7 11.1 32.4 19.9 32.5 SMARCD2 "BAF60B, CRACD2, PRO2451, Rsc6p" ENSG00000108604 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2" Q92925 17 63832081-63843065 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059934, HPA061348" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059934: AB_2684170, HPA061348: AB_2684486" "unprognostic (1.70e-1)" "unprognostic (2.17e-2)" "unprognostic (8.04e-2)" "unprognostic (3.84e-2)" "unprognostic (1.59e-1)" "unprognostic (2.00e-2)" "unprognostic (7.84e-2)" "unprognostic (4.79e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.75e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (1.81e-2)" "unprognostic (1.26e-1)" "unprognostic (1.79e-3)" "unprognostic (6.80e-2)" 22.0 25.0 6.9 23.1 11.5 21.2 25.6 29.0 12.5 21.7 24.6 14.3 36.5 17.8 17.2 25.8 30.7 22.7 25.9 13.4 8.6 5.3 16.0 21.3 20.1 26.5 15.8 8.9 18.0 42.5 17.3 16.1 33.2 10.1 24.2 18.0 15.0 42.9 30.2 11.1 36.3 25.6 22.1 8.9 26.1 26.4 17.7 13.6 40.6 23.3 23.7 28.0 23.7 22.5 11.0 14.5 13.0 11.6 9.1 13.6 6.7 26.2 17.2 4.6 20.8 29.1 47.6 26.0 9.8 14.7 21.7 14.2 20.1 15.2 30.4 5.7 17.7 8.9 18.0 14.9 22.6 13.7 8.1 35.7 20.7 7.0 29.5 23.9 24.3 23.1 37.0 28.3 11.6 10.3 12.9 17.8 22.4 16.3 18.5 12.9 63.6 38.5 26.1 10.7 42.2 19.7 39.4 16.1 35.1 15.7 20.0 17.4 30.9 12.3 50.9 21.1 15.2 47.0 24.3 11.7 13.8 8.3 12.6 16.9 21.7 16.1 20.6 10.8 24.2 10.0 5.4 11.6 10.6 11.5 10.0 7.6 8.8 12.9 12.3 14.5 11.0 8.6 11.6 13.0 9.1 11.5 12.9 13.6 6.7 6.9 11.5 29.0 12.5 8.6 5.3 15.8 8.9 10.1 13.6 26.8 46.8 21.8 16.6 20.4 10.3 5.0 25.5 22.7 27.3 15.7 5.9 43.2 3.3 14.5 0.8 14.6 27.6 0.0 17.0 34.6 23.0 18.1 13.9 72.9 19.3 11.1 31.8 22.1 34.0 2.4 45.8 19.0 13.5 16.2 38.9 16.7 17.7 31.5 29.0 10.0 11.6 32.3 15.0 13.4 17.9 27.1 44.3 13.8 36.8 16.2 SMARCD3 "BAF60C, CRACD3, Rsc6p" ENSG00000082014 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3" Q6STE5 7 151238764-151277896 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 75.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 59.6;Peritubular cells: 83.1;Sertoli cells: 64.7;Smooth muscle cells: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 8.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.6;granulocytes: 3.1;monocytes: 8.8" "Cell line enhanced" "Detected in many" "AN3-CA: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063955, HPA065517" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063955: AB_2685159, HPA065517: AB_2685500" "unprognostic (1.23e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (5.50e-4)" "unprognostic (4.38e-3)" "unprognostic (4.67e-1)" "unprognostic (1.41e-3)" "unprognostic (2.24e-2)" "unprognostic (3.52e-2)" "unprognostic (1.63e-1)" "unprognostic (3.50e-1)" "unprognostic (2.08e-3)" "unprognostic (9.18e-2)" "unprognostic (1.02e-1)" "unprognostic (2.05e-3)" "unprognostic (1.34e-1)" "unprognostic (3.35e-3)" "unprognostic (1.29e-1)" 9.7 16.0 34.2 4.0 40.3 4.9 9.8 25.4 36.8 12.9 5.6 7.8 7.9 2.9 8.6 11.4 6.7 14.5 10.7 38.5 22.2 24.7 4.9 2.0 8.3 4.0 18.7 18.8 19.2 7.5 6.8 14.7 4.6 13.3 10.8 3.6 7.6 6.6 18.1 75.2 5.7 3.4 10.0 14.1 4.3 4.8 9.0 11.6 0.0 7.4 9.5 2.5 10.1 4.8 0.2 2.6 3.1 8.8 0.0 0.8 2.1 0.3 2.8 9.4 33.3 15.0 6.7 0.7 6.1 6.2 3.6 2.1 2.1 1.9 3.6 2.2 9.6 1.4 0.6 7.5 0.6 1.4 1.1 4.6 0.0 1.9 0.6 12.9 0.1 6.1 15.9 0.8 1.2 0.1 15.7 0.7 9.3 7.2 1.2 19.0 3.8 0.6 4.7 2.9 0.9 1.2 0.2 14.8 0.1 3.2 0.0 5.4 11.0 5.8 1.0 4.4 1.5 0.8 9.3 1.1 2.3 3.7 7.1 2.0 7.9 0.0 3.0 6.6 8.2 10.3 0.6 8.8 0.0 0.2 1.9 0.1 0.2 0.8 0.0 2.6 0.0 0.5 0.8 3.1 0.0 0.4 0.0 0.7 2.1 34.2 40.3 25.4 27.9 22.2 24.7 18.7 18.8 13.3 11.6 6.0 20.8 0.0 31.9 9.5 12.7 59.6 17.8 6.7 5.7 10.4 3.9 0.4 26.6 14.9 1.8 4.7 0.0 0.0 2.1 0.2 19.3 7.3 2.3 0.4 3.4 11.1 3.4 2.5 17.1 8.9 46.9 6.4 6.8 1.0 0.0 23.4 4.3 0.0 83.1 1.7 4.6 64.7 51.5 1.7 9.5 4.1 0.9 0.9 0.0 8.1 SMC1A "DXS423E, KIAA0178, SB1.8, SMC1L1, Smcb" ENSG00000072501 "Structural maintenance of chromosomes 1A" Q14683 X 53374149-53422728 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005499, CAB025404" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB025404: , HPA005499: AB_1080028" "unprognostic (2.00e-1)" "unprognostic (1.52e-1)" "unprognostic (4.00e-2)" "unprognostic (5.76e-2)" "unprognostic (1.04e-1)" "unprognostic (9.89e-2)" "unprognostic (1.29e-3)" "unprognostic (1.89e-1)" "unprognostic (9.80e-3)" "unprognostic (9.49e-2)" "unprognostic (4.48e-2)" "unprognostic (6.55e-2)" "unprognostic (2.58e-1)" "unprognostic (4.18e-3)" "unprognostic (6.28e-2)" "unprognostic (2.89e-1)" "unprognostic (9.39e-2)" 20.6 14.1 14.6 24.2 28.2 24.6 16.2 33.6 21.7 19.9 18.2 22.0 10.5 16.2 27.5 10.0 22.4 21.7 12.5 16.2 16.8 10.8 19.2 23.5 15.4 30.2 25.2 13.0 21.8 17.2 31.0 18.4 19.5 18.0 13.4 17.3 12.5 16.8 12.9 24.3 16.2 19.7 21.7 21.3 20.1 17.5 10.4 25.8 38.3 16.8 11.1 25.7 22.0 21.3 14.3 15.5 13.7 18.7 15.6 17.8 10.6 28.3 31.8 25.3 21.5 9.3 10.4 14.2 17.2 11.3 21.8 17.7 18.8 16.5 27.7 14.7 11.4 30.1 21.7 45.0 24.8 24.4 23.7 52.5 24.2 36.9 13.1 3.8 34.1 34.8 5.8 6.4 24.4 14.9 5.6 18.8 18.3 35.5 17.9 17.0 17.2 30.7 10.3 37.5 12.3 17.0 33.0 43.6 25.5 9.2 18.7 26.9 22.7 44.9 22.1 9.5 34.6 23.8 13.9 10.5 18.6 19.7 18.3 16.6 11.7 19.8 25.7 10.6 38.8 18.1 6.1 13.8 13.7 17.8 18.7 17.0 12.2 12.0 15.6 15.5 14.3 14.2 10.9 9.4 15.6 17.4 12.9 8.8 10.6 14.6 28.2 33.6 21.7 16.8 10.8 25.2 13.0 18.0 25.8 41.7 29.9 35.6 26.7 21.4 44.7 48.0 30.6 56.2 61.4 19.2 25.5 30.6 6.6 27.7 8.7 31.0 31.4 23.3 23.5 52.5 23.8 28.7 33.6 48.7 42.3 57.2 19.1 19.6 33.4 5.8 35.1 40.8 21.9 37.9 35.3 40.8 26.4 14.0 33.9 20.3 44.9 38.8 37.0 17.9 54.6 21.3 40.5 27.7 41.7 25.8 SMCR8 FLJ34716 ENSG00000176994 "Smith-Magenis syndrome chromosome region, candidate 8" Q8TEV9 17 18315310-18328055 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021557, HPA024646" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021557: AB_1857283, HPA024646: AB_1857284" "unprognostic (1.69e-1)" "unprognostic (2.25e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.07e-1)" "unprognostic (4.34e-3)" "unprognostic (2.11e-3)" "unprognostic (3.02e-2)" "unprognostic (3.18e-1)" "unprognostic (1.48e-2)" "unprognostic (5.09e-3)" "unprognostic (7.11e-2)" "prognostic favorable (1.35e-4)" "unprognostic (9.41e-3)" "unprognostic (4.35e-2)" "unprognostic (1.55e-2)" "unprognostic (9.27e-2)" 10.4 10.0 6.1 11.1 11.4 25.0 10.5 13.9 15.8 8.7 8.5 11.2 10.6 8.0 12.2 6.9 10.4 9.1 7.8 7.3 7.2 6.3 9.6 7.9 10.7 12.4 6.7 5.7 10.8 9.6 14.0 17.1 11.6 9.3 9.7 9.3 12.0 13.6 7.9 13.3 10.4 13.0 7.9 7.1 16.1 10.9 8.8 8.8 15.8 9.5 4.7 15.8 12.5 10.9 1.1 1.2 5.2 2.2 1.1 1.2 0.9 5.8 8.1 4.1 4.7 5.8 3.9 7.5 4.2 5.6 7.4 7.2 12.4 2.5 3.4 3.2 5.1 8.4 7.8 8.0 4.9 6.9 7.0 6.8 6.4 8.1 3.5 6.2 2.5 15.9 4.9 6.4 8.5 5.4 4.9 5.3 5.0 5.3 3.3 4.4 3.5 4.2 3.7 3.9 7.5 3.4 4.7 10.5 5.4 3.4 6.7 2.2 5.0 4.7 6.1 9.0 22.6 12.4 5.1 5.2 4.3 5.2 11.1 5.5 5.0 5.6 1.8 5.9 4.0 4.3 5.2 1.7 1.5 1.0 1.2 0.9 1.1 0.8 1.1 1.2 0.8 1.2 1.1 2.1 1.1 2.2 1.0 0.7 0.9 6.1 11.4 13.9 15.8 7.2 6.3 6.7 5.7 9.3 8.8 6.0 11.2 3.2 2.9 0.3 7.2 2.8 5.1 4.0 10.3 10.4 2.0 3.2 0.0 4.4 2.9 4.5 4.3 0.0 4.7 2.5 3.0 4.9 8.1 4.9 7.5 6.4 3.5 11.1 15.5 1.5 3.7 8.3 0.0 7.2 8.7 2.7 5.5 3.5 3.9 5.7 6.0 0.0 2.8 6.7 7.0 0.5 5.0 5.0 6.3 5.7 SMNDC1 "SMNR, SPF30, TDRD16C" ENSG00000119953 "Survival motor neuron domain containing 1" O75940 10 110290730-110304951 "Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061214, HPA070666" Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA061214: AB_2684451, HPA070666: " "unprognostic (4.65e-2)" "unprognostic (1.68e-2)" "unprognostic (2.64e-1)" "unprognostic (3.07e-2)" "unprognostic (3.63e-3)" "unprognostic (5.03e-3)" "prognostic unfavorable (8.08e-6)" "unprognostic (3.16e-3)" "unprognostic (1.21e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (7.20e-4)" "unprognostic (2.68e-3)" "unprognostic (6.88e-3)" "unprognostic (1.35e-1)" "unprognostic (2.82e-1)" "unprognostic (1.80e-1)" "unprognostic (2.00e-1)" 21.3 18.0 16.7 20.0 17.5 38.3 26.6 24.0 20.1 19.0 18.1 17.5 13.5 13.9 23.6 13.1 24.1 18.4 16.7 19.4 15.0 15.4 19.3 20.8 23.5 32.7 15.0 14.4 23.4 15.3 18.0 24.3 25.2 16.5 18.0 16.1 19.6 18.0 17.4 34.3 19.0 16.6 21.3 22.7 21.8 17.0 19.8 16.9 30.0 18.9 14.9 24.7 25.4 22.4 6.2 9.2 17.4 9.7 6.3 8.7 4.5 15.6 11.9 17.5 20.1 13.6 16.3 13.0 18.1 19.0 24.2 24.9 15.3 19.4 22.2 11.8 11.3 13.9 17.0 25.7 12.5 27.3 12.5 13.8 22.2 10.2 17.8 16.3 24.3 21.4 12.6 13.4 19.2 32.4 18.0 13.3 12.9 19.9 20.8 18.6 7.4 25.9 23.7 19.5 12.1 8.3 22.5 35.1 11.6 13.5 11.3 8.8 11.8 11.8 10.0 20.7 15.8 12.3 14.0 14.5 14.2 16.2 13.0 23.0 17.2 17.8 33.7 14.2 34.2 10.9 5.7 9.6 14.7 6.1 9.7 7.5 6.2 7.9 7.6 9.2 5.5 7.1 6.8 17.4 6.3 9.7 5.5 8.7 4.5 16.7 17.5 24.0 20.1 15.0 15.4 15.0 14.4 16.5 16.9 26.8 29.6 33.5 33.3 61.8 25.5 19.0 10.2 34.8 29.6 10.4 19.6 28.1 28.2 21.0 5.4 32.3 18.8 23.3 15.6 27.2 32.9 39.7 57.7 21.2 28.0 31.8 17.9 21.5 34.0 3.8 27.0 39.8 33.7 40.5 14.8 22.3 19.3 17.3 20.8 26.9 30.6 19.4 28.8 44.1 36.1 72.9 38.6 30.5 17.4 60.1 SNAPC1 "PTFgamma, SNAP43" ENSG00000023608 "Small nuclear RNA activating complex polypeptide 1" Q16533 14 61762357-61796428 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 120.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 41.4;hTERT-HME1: 41.6;U-2 OS: 55.1;U-251 MG: 38.0" "Low region specificity" "Detected in all" "HPA067076, HPA072276" Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA067076: AB_2732757, HPA072276: AB_2732199" "unprognostic (7.40e-2)" "unprognostic (5.04e-2)" "unprognostic (3.09e-2)" "unprognostic (1.11e-1)" "unprognostic (2.94e-1)" "unprognostic (8.55e-2)" "unprognostic (1.68e-3)" "unprognostic (1.88e-1)" "unprognostic (4.01e-2)" "unprognostic (5.18e-2)" "unprognostic (1.58e-1)" "unprognostic (1.99e-1)" "unprognostic (2.47e-3)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.10e-1)" "unprognostic (2.26e-1)" 9.9 12.3 7.5 8.6 10.3 7.0 8.4 12.1 8.0 14.4 6.8 5.6 11.6 4.9 10.3 15.8 9.2 8.7 10.4 11.2 7.8 7.6 8.7 7.0 10.5 9.7 11.8 5.4 12.1 5.0 8.8 27.2 11.3 14.2 10.3 4.2 5.7 7.2 19.8 5.6 8.7 5.2 6.9 14.5 9.5 5.4 24.9 9.4 9.1 9.8 8.2 8.9 17.4 14.3 12.0 9.3 7.5 7.0 9.6 13.1 5.1 14.6 2.8 2.8 6.0 3.2 3.7 3.4 12.4 8.3 14.3 8.5 1.0 3.0 3.0 16.6 5.2 41.4 4.6 2.8 3.7 23.6 3.3 2.0 1.8 1.5 2.0 8.4 1.9 4.0 3.5 2.5 12.0 41.6 5.6 5.4 4.2 2.0 2.8 13.6 1.8 4.6 3.0 2.7 1.6 9.5 3.5 7.5 1.1 11.7 2.3 2.0 4.9 8.2 1.4 9.8 3.7 2.9 3.0 8.3 15.8 55.1 10.2 38.0 1.8 1.9 2.7 10.7 2.4 9.3 7.5 7.0 5.8 6.4 5.9 8.3 12.0 8.1 5.5 7.0 12.0 13.1 8.5 7.1 9.6 4.9 9.3 8.7 5.1 7.5 10.3 12.1 8.0 7.8 7.6 11.8 5.4 14.2 9.4 32.8 16.5 17.9 48.3 84.6 10.6 18.8 5.1 57.6 28.4 27.9 2.0 14.9 6.6 20.7 35.6 28.5 4.0 0.0 14.0 21.4 31.0 23.1 40.5 5.8 15.6 7.9 4.1 27.6 12.6 8.2 20.4 19.5 16.9 13.6 4.5 42.6 16.7 0.0 19.1 8.2 11.7 19.4 30.3 120.2 67.0 56.3 4.7 15.2 6.4 22.2 SNRNP70 "RNPU1Z, RPU1, Snp1, SNRP70, U1-70K" ENSG00000104852 "Small nuclear ribonucleoprotein U1 subunit 70" P08621 19 49085419-49108605 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001718, HPA042050, HPA043516" Supported Enhanced Nucleoplasm NA NA 30000 Nucleoplasm "CAB001718: , HPA042050: AB_2677821, HPA043516: AB_2678523" "unprognostic (2.22e-3)" "unprognostic (5.27e-2)" "unprognostic (9.13e-3)" "unprognostic (1.05e-1)" "unprognostic (6.66e-2)" "unprognostic (2.58e-2)" "unprognostic (4.01e-3)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-1)" "prognostic favorable (4.59e-5)" "unprognostic (3.63e-3)" "prognostic unfavorable (6.12e-5)" "unprognostic (5.18e-3)" "unprognostic (6.87e-2)" "unprognostic (3.03e-1)" "prognostic favorable (5.35e-5)" 46.9 46.5 50.1 65.8 57.0 51.9 29.8 89.6 73.1 36.7 36.2 40.5 46.5 45.8 44.0 38.8 38.9 34.0 35.4 33.3 46.5 34.6 30.6 35.0 29.3 47.6 53.8 49.0 43.3 36.1 37.8 41.8 34.3 43.4 43.0 27.3 26.6 42.7 52.7 73.5 48.1 44.6 28.5 41.5 45.6 45.2 30.5 58.1 34.9 39.8 25.6 37.3 26.9 35.0 5.3 3.2 3.2 3.7 7.9 3.9 1.2 34.5 40.0 28.1 20.1 11.5 7.1 34.5 26.8 16.5 28.1 24.2 24.3 20.4 42.3 25.9 17.3 23.4 30.9 34.8 25.3 20.8 27.7 92.8 38.6 20.1 27.6 6.0 41.7 26.0 9.9 7.0 20.0 13.6 12.7 20.9 20.2 39.5 13.1 16.7 29.9 43.0 66.6 35.6 18.6 34.6 50.0 27.9 24.7 17.1 21.6 24.2 28.7 33.6 18.9 17.8 19.3 20.0 25.1 31.1 20.6 38.7 18.0 42.9 34.9 29.4 51.5 17.4 27.2 19.3 1.5 3.7 3.2 3.6 2.5 2.1 5.3 2.3 1.5 3.2 3.5 3.9 2.3 1.7 7.9 1.9 2.8 2.4 1.2 50.1 57.0 89.6 73.1 46.5 34.6 53.8 49.0 43.4 58.1 17.9 62.4 92.3 143.3 123.9 97.6 25.0 56.0 36.1 47.8 71.5 84.4 155.8 39.7 97.0 14.1 68.1 71.8 23.3 90.8 176.6 99.6 110.3 53.2 72.3 109.6 108.1 113.3 63.3 61.9 12.5 120.6 80.2 65.8 77.5 97.3 96.3 92.5 74.8 104.0 62.4 104.8 122.9 97.6 108.5 89.7 114.3 147.5 77.8 98.4 135.5 SNRPC "U1-C, Yhc1" ENSG00000124562 "Small nuclear ribonucleoprotein polypeptide C" P09234 6 34757406-34773794 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034338, HPA042419, HPA055490" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034338: AB_2295245, HPA042419: AB_2677989, HPA055490: AB_2682833" "unprognostic (1.84e-1)" "unprognostic (3.73e-2)" "unprognostic (1.59e-1)" "unprognostic (2.32e-3)" "unprognostic (1.45e-1)" "unprognostic (3.93e-2)" "prognostic unfavorable (5.65e-4)" "unprognostic (1.48e-2)" "unprognostic (6.16e-2)" "unprognostic (1.16e-3)" "unprognostic (7.71e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (8.20e-5)" "unprognostic (4.39e-2)" "unprognostic (8.64e-2)" "unprognostic (1.52e-1)" "unprognostic (2.62e-2)" 20.9 24.6 28.3 25.5 29.5 56.2 23.5 19.0 26.7 20.3 28.2 19.0 26.9 26.6 28.5 33.7 28.1 32.1 31.6 56.8 24.4 22.4 26.7 34.9 25.3 36.3 27.4 28.3 26.3 62.5 18.5 19.5 27.1 23.8 22.9 24.3 19.7 30.6 26.5 54.9 20.7 27.3 25.0 29.3 28.6 25.5 66.6 26.3 39.8 36.9 47.2 33.7 24.1 21.0 58.6 53.4 32.6 56.7 38.4 58.3 55.5 47.4 29.4 38.7 50.4 21.0 20.5 29.8 27.2 30.0 54.6 46.2 50.6 18.8 53.4 36.5 33.8 38.2 22.9 58.2 40.7 44.5 35.6 61.4 41.2 25.1 69.7 36.5 52.3 26.3 25.3 39.7 55.4 39.5 21.7 34.5 52.2 66.1 31.2 39.3 39.8 62.6 86.6 42.2 70.8 35.9 43.4 32.7 51.3 35.2 20.3 48.0 34.4 24.4 25.2 59.6 26.2 38.7 79.3 22.9 33.6 39.4 27.3 66.2 34.7 90.1 75.1 15.2 91.7 56.9 26.8 43.8 32.6 35.3 50.1 40.4 58.6 43.5 40.4 50.3 51.0 47.4 43.0 7.9 38.4 56.7 53.4 58.3 55.5 28.3 29.5 19.0 26.7 24.4 22.4 27.4 28.3 23.8 26.3 113.2 104.2 62.5 63.3 39.0 23.7 207.1 84.1 131.2 119.4 64.6 23.6 209.0 160.8 134.3 96.2 66.7 54.9 23.3 135.8 171.0 97.6 66.3 77.5 85.5 197.4 27.0 87.2 63.8 66.9 49.1 51.2 87.8 60.8 201.0 86.3 68.5 129.0 73.7 39.3 158.4 33.1 64.7 62.8 146.4 108.6 39.1 94.7 91.6 100.0 62.6 SNW1 "Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1" ENSG00000100603 "SNW domain containing 1" Q13573 14 77717599-77761207 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 252.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002457, CAB009931, HPA017370" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339" "unprognostic (1.24e-3)" "unprognostic (2.02e-1)" "unprognostic (2.40e-1)" "unprognostic (6.43e-2)" "unprognostic (3.04e-1)" "unprognostic (4.27e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.07e-1)" "unprognostic (8.09e-3)" "unprognostic (2.88e-2)" "unprognostic (3.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.67e-1)" "unprognostic (2.47e-1)" "unprognostic (1.55e-1)" "unprognostic (4.45e-3)" "unprognostic (1.22e-2)" 30.5 23.4 20.3 24.0 24.8 59.5 28.3 32.1 26.2 26.1 27.6 29.6 21.5 24.6 32.5 24.3 29.1 25.4 20.5 26.3 20.6 18.3 23.5 25.3 24.8 31.5 23.9 26.7 32.1 26.5 19.8 31.6 32.3 26.8 29.8 24.9 22.3 23.4 17.6 41.8 33.3 30.7 30.8 23.7 32.3 24.2 36.3 24.3 37.5 34.1 24.2 30.4 33.0 25.0 32.5 38.2 47.8 44.1 47.6 47.1 35.5 39.3 29.1 30.0 31.8 24.7 27.9 34.9 27.1 23.9 29.8 27.6 28.9 36.2 38.5 24.8 20.1 22.7 38.8 35.9 25.7 40.7 30.6 28.4 31.1 26.3 28.9 35.5 21.7 36.9 21.4 34.5 27.0 37.4 32.5 28.9 37.0 44.4 28.9 22.8 40.3 38.6 36.9 33.5 44.5 39.3 41.8 38.8 26.4 27.7 36.5 32.3 34.9 37.3 33.0 37.3 32.2 47.3 41.8 30.6 32.8 37.5 29.5 32.3 28.7 40.6 42.8 29.7 35.0 36.1 42.0 38.0 47.8 32.1 40.6 36.0 30.9 36.2 36.3 38.2 32.5 38.3 36.0 36.1 47.6 44.1 22.7 47.1 35.5 20.3 24.8 32.1 26.2 20.6 18.3 23.9 26.7 26.8 24.3 86.4 43.0 62.2 66.5 50.3 55.1 46.0 43.3 109.7 79.6 50.6 33.4 68.5 64.6 65.3 25.3 65.0 31.6 46.7 61.0 83.4 54.9 37.6 88.0 26.6 66.2 36.5 41.9 45.4 48.4 16.5 72.2 71.0 37.1 92.0 37.1 67.4 58.2 45.0 69.6 39.6 63.7 64.7 69.5 252.6 138.5 47.4 91.2 73.9 40.5 62.2 SOX12 SOX22 ENSG00000177732 "SRY-box 12" O15370 20 325595-330224 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 53.0;Cone photoreceptor cells: 39.3;Horizontal cells: 30.2;Rod photoreceptor cells: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "B-cells: 1.8;dendritic cells: 1.5;T-cells: 1.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055052, HPA061627" Enhanced Nucleoplasm No No Nucleoplasm "HPA055052: AB_2682685, HPA061627: AB_2684571" "unprognostic (1.02e-1)" "unprognostic (1.33e-2)" "unprognostic (1.18e-3)" "unprognostic (1.30e-3)" "unprognostic (1.81e-3)" "unprognostic (8.80e-2)" "prognostic unfavorable (6.64e-5)" "unprognostic (1.90e-1)" "unprognostic (1.49e-3)" "unprognostic (3.55e-1)" "unprognostic (5.02e-3)" "unprognostic (4.66e-1)" "unprognostic (3.12e-3)" "unprognostic (7.91e-2)" "unprognostic (1.55e-1)" "unprognostic (8.36e-2)" "unprognostic (2.20e-2)" 5.2 7.4 11.0 4.9 10.2 5.4 10.3 27.5 14.1 8.2 7.8 10.1 11.0 4.1 10.9 11.3 5.8 10.2 5.2 6.8 10.9 8.8 8.3 4.7 5.3 5.1 11.3 5.7 14.6 12.6 7.7 7.0 5.0 8.4 8.7 3.0 7.8 8.8 13.8 2.3 9.0 4.8 8.5 6.9 7.6 5.0 8.2 10.9 12.1 8.2 2.0 3.8 7.8 9.0 1.8 1.5 0.3 0.2 0.2 1.3 0.2 3.7 13.2 12.9 8.7 6.3 4.6 3.9 5.2 4.5 4.7 4.7 2.6 3.9 8.4 4.0 6.0 9.9 4.4 9.4 1.7 2.7 4.2 6.5 5.4 5.1 26.3 8.1 7.4 1.4 6.3 5.4 4.0 1.6 7.8 6.2 5.8 12.7 4.4 3.0 9.1 2.5 18.3 21.1 2.1 17.4 13.2 3.3 6.8 6.7 0.4 15.9 18.5 3.5 15.3 19.2 5.6 14.5 10.4 7.0 18.4 18.3 0.5 4.5 12.8 13.4 8.7 3.4 7.4 3.5 0.3 0.2 0.3 0.5 0.1 0.2 1.7 0.6 0.8 0.2 1.8 1.3 1.1 0.1 0.2 0.0 1.5 0.8 0.2 11.0 10.2 27.5 10.7 10.9 8.8 11.3 5.7 8.4 10.9 0.0 2.7 0.8 2.1 3.1 53.0 11.0 5.1 1.4 1.2 7.0 39.3 1.2 13.3 1.1 0.6 3.8 1.1 0.0 0.3 0.4 4.3 2.6 0.0 4.7 1.8 30.2 8.7 8.6 1.9 1.7 9.5 0.7 5.0 0.0 4.0 8.3 0.4 0.0 11.7 4.8 37.2 0.0 5.7 0.9 7.0 1.0 0.6 2.1 3.7 0.3 SOX13 "ICA12, MGC117216, Sox-13" ENSG00000143842 "SRY-box 13" Q9UN79 1 204073115-204127743 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.1" "Group enriched" "Detected in many" 6 "NK-cells: 4.1;T-cells: 2.6" "Cell line enhanced" "Detected in many" "BEWO: 24.0;SK-BR-3: 50.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051790, HPA054843" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051790: AB_2681610, HPA054843: AB_2682622" "unprognostic (4.88e-3)" "unprognostic (6.01e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (4.74e-2)" "unprognostic (2.65e-1)" "unprognostic (3.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.27e-2)" "unprognostic (2.75e-1)" "unprognostic (2.95e-1)" "unprognostic (1.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.48e-3)" "unprognostic (1.04e-1)" "unprognostic (8.20e-2)" "unprognostic (7.98e-2)" "unprognostic (1.92e-1)" 22.2 10.7 11.0 6.9 8.6 0.8 18.4 9.2 9.9 37.0 17.2 14.4 16.1 13.5 30.3 12.4 10.9 22.3 16.4 9.7 11.0 6.9 19.0 12.3 20.5 4.3 13.7 7.0 13.5 12.8 34.2 5.6 27.3 14.3 23.5 8.3 13.7 13.1 18.7 14.2 9.9 16.8 18.2 12.1 8.4 8.2 8.7 13.3 0.1 10.4 7.5 7.0 19.5 19.2 0.0 0.0 0.5 0.0 4.1 2.6 0.3 8.5 5.5 11.9 0.8 11.4 3.4 24.0 3.3 2.0 5.3 3.3 4.6 6.4 0.0 11.0 2.1 1.4 13.9 4.5 4.3 2.5 3.9 2.2 0.0 3.7 5.1 2.6 0.0 5.0 3.5 2.2 3.3 2.9 2.6 7.6 0.1 0.0 0.0 1.1 10.5 0.0 0.0 15.7 13.9 6.7 0.1 4.0 5.2 4.0 19.8 1.8 0.9 3.4 50.1 15.0 11.1 22.3 1.0 4.4 1.2 3.2 5.1 2.3 0.0 0.0 0.0 1.9 0.1 3.1 0.2 0.0 0.5 2.5 0.0 2.6 0.0 1.2 1.4 0.0 0.0 0.0 1.0 0.3 4.1 0.0 0.0 0.0 0.3 11.0 8.6 9.2 9.9 11.0 6.9 13.7 7.0 14.3 13.3 6.0 11.4 0.8 7.9 1.9 0.5 24.3 10.2 1.4 4.5 8.7 0.0 4.3 1.7 2.7 8.5 12.7 12.6 0.0 1.3 5.0 5.0 6.6 16.2 5.9 1.2 0.0 7.5 8.0 0.0 20.2 19.2 0.7 1.7 0.0 5.5 6.3 2.9 7.6 18.4 3.5 0.9 38.8 15.5 0.2 0.7 1.4 1.6 1.9 5.4 5.7 SOX15 "SOX20, SOX26, SOX27" ENSG00000129194 "SRY-box 15" O60248 17 7588178-7590170 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 185.8;Suprabasal keratinocytes: 148.4;Urothelial cells: 76.9" "Cancer enhanced" "Detected in many" "testis cancer: 67.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 7.1;non-classical monocyte: 10.8" "Lineage enriched" "Detected in many" 4 "monocytes: 10.8" "Group enriched" "Detected in some" 7 "A-431: 41.8;HaCaT: 47.0;HBEC3-KT: 18.8;hTCEpi: 18.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA067196, HPA074049" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles" Yes NA Nucleoplasm "Nucleoli, Golgi apparatus, Vesicles" "HPA067196: AB_2685802, HPA074049: AB_2686656" "unprognostic (5.79e-3)" "unprognostic (6.65e-2)" "unprognostic (1.40e-2)" "unprognostic (2.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.60e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (5.00e-2)" "unprognostic (8.50e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (8.61e-3)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.95e-2)" "unprognostic (2.97e-1)" 1.0 0.8 4.6 1.0 4.1 2.1 1.3 7.2 5.0 7.5 2.6 1.1 1.0 0.7 4.4 1.7 62.7 3.7 1.0 2.9 3.1 4.1 1.3 1.0 1.5 1.0 2.6 1.0 7.0 1.0 0.1 2.0 2.0 3.5 4.1 0.6 1.4 3.4 7.0 1.9 30.0 1.0 1.6 1.4 1.0 0.7 1.3 1.0 1.8 1.0 59.0 38.7 3.6 7.8 0.0 2.4 0.2 10.8 0.0 0.0 0.5 41.8 1.0 0.6 0.3 0.0 0.1 3.2 0.5 0.1 0.3 0.6 0.8 0.2 0.1 0.4 0.0 0.1 47.0 0.0 18.8 0.1 1.1 1.3 0.1 0.5 0.1 0.0 0.1 0.9 0.0 18.6 0.2 4.2 1.3 0.0 0.8 0.9 0.3 0.0 0.3 0.2 0.5 1.3 0.1 0.2 0.5 0.6 0.3 0.8 0.2 0.3 0.7 0.5 0.1 0.2 1.9 0.3 0.3 0.5 0.4 0.8 0.5 1.4 0.3 0.5 0.6 1.5 0.6 1.1 0.2 2.4 0.0 0.0 7.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 10.8 1.2 0.0 0.5 4.6 4.1 7.2 4.4 3.1 4.1 2.6 1.0 3.5 1.0 0.0 0.0 0.0 39.1 185.8 11.0 2.8 0.0 10.7 5.7 1.8 13.7 0.3 1.7 0.0 0.1 1.6 0.2 0.0 0.4 1.5 6.1 15.1 0.0 0.0 0.4 9.5 1.2 1.8 2.7 0.6 29.1 1.1 25.3 1.8 0.0 33.2 0.3 0.0 34.6 0.0 6.2 32.3 8.9 0.4 8.7 148.4 0.9 0.0 0.2 76.9 SOX2 ENSG00000181449 "SRY-box 2" P48431 3 181711924-181714436 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 80.1" "Cell type enriched" "Detected in some" 9 "Muller glia cells: 455.6" "Cancer enhanced" "Detected in many" "glioma: 136.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 68.9;HAP1: 29.3;NTERA-2: 56.2;U-251 MG: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045725, HPA062851, HPA071379, CAB079745" Enhanced Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: " "unprognostic (1.80e-2)" "unprognostic (3.18e-3)" "unprognostic (5.69e-2)" "unprognostic (6.96e-2)" "unprognostic (2.74e-3)" "unprognostic (1.60e-1)" "unprognostic (1.79e-2)" "unprognostic (4.48e-3)" "unprognostic (1.71e-1)" "unprognostic (4.38e-3)" "unprognostic (1.83e-1)" "unprognostic (7.68e-2)" "unprognostic (3.81e-9)" "unprognostic (1.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.12e-2)" 1.8 2.5 30.3 2.0 25.8 1.5 1.6 13.9 80.1 1.8 2.3 24.3 0.0 2.0 1.5 1.8 15.9 5.0 1.8 1.7 36.0 19.2 1.5 1.5 3.4 1.5 19.4 18.5 1.7 1.6 1.5 5.8 1.5 18.6 3.9 2.0 1.0 6.3 1.9 1.6 1.8 2.3 1.7 18.4 1.6 9.7 3.0 22.4 0.0 1.5 2.1 6.9 2.3 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 68.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 29.3 0.7 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 56.2 2.9 0.1 0.0 0.1 0.0 7.6 0.1 0.1 0.3 0.0 0.0 0.0 11.9 0.4 0.0 0.0 0.0 1.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 25.8 13.9 20.0 36.0 19.2 19.4 18.5 18.6 22.4 0.0 5.9 0.0 41.2 0.2 3.5 0.4 0.0 52.2 38.7 3.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 4.9 1.1 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.6 0.2 3.3 0.0 0.0 455.6 0.0 0.0 0.0 0.0 8.2 0.0 0.1 1.5 0.2 0.4 0.2 0.0 0.0 7.0 SOX3 PHP ENSG00000134595 "SRY-box 3" P41225 X 140502985-140505116 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 18.2;testis: 12.4" "Cell type enriched" "Detected in single" 8 "Muller glia cells: 4.3" "Cancer enhanced" "Detected in some" "glioma: 2.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.8;HEK 293: 8.3;NTERA-2: 18.6;SuSa: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054720, HPA075003" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054720: AB_2682584, HPA075003: AB_2686727" "unprognostic (6.04e-2)" "unprognostic (3.75e-1)" "unprognostic (8.62e-3)" "unprognostic (8.03e-2)" "unprognostic (1.57e-1)" "unprognostic (5.27e-3)" 0.3 0.5 2.6 0.3 2.7 0.3 0.3 0.6 2.6 1.5 0.3 5.0 0.0 0.3 0.6 0.3 0.3 18.2 0.3 0.3 2.2 5.0 0.3 0.3 0.3 0.3 2.0 1.8 4.7 0.3 0.4 3.2 0.3 3.6 0.3 0.3 0.5 0.3 0.3 0.4 0.3 0.3 0.3 2.3 0.3 0.3 12.4 0.6 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.7 0.6 2.6 2.2 5.0 2.0 1.8 3.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 SOX8 ENSG00000005513 "SRY-box 8" P57073 16 981808-986979 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 64.9" "Cell type enriched" "Detected in some" 22 "Muller glia cells: 120.0" "Cancer enriched" "Detected in many" 6 "glioma: 46.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.2;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 23 "T-cells: 2.2" "Cell line enriched" "Detected in some" 5 "RH-30: 51.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041640, HPA058665" Enhanced Nucleoplasm No NA Nucleoplasm "HPA041640: AB_10964357, HPA058665: AB_2683792" "unprognostic (1.40e-2)" "unprognostic (2.56e-3)" "unprognostic (1.59e-1)" "unprognostic (3.10e-2)" "unprognostic (4.58e-2)" "unprognostic (7.16e-3)" "unprognostic (6.05e-3)" "unprognostic (3.01e-2)" "unprognostic (2.53e-1)" "unprognostic (1.16e-1)" "unprognostic (4.53e-3)" "unprognostic (4.46e-2)" "unprognostic (1.20e-3)" "unprognostic (8.50e-2)" "unprognostic (6.18e-2)" "unprognostic (5.47e-1)" "unprognostic (9.09e-2)" 1.6 1.5 18.4 1.8 25.1 1.0 2.5 3.2 64.9 1.2 1.4 20.9 0.0 1.1 1.1 1.1 1.2 1.1 1.5 1.8 22.6 14.5 1.0 1.0 1.0 2.7 26.5 5.4 1.0 1.5 1.0 0.1 1.4 12.0 1.3 1.5 0.9 8.6 1.4 1.3 1.3 1.2 1.2 27.1 1.8 1.7 1.9 30.4 0.0 1.1 0.0 3.1 1.1 0.3 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.3 1.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.5 0.7 0.1 0.0 51.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.2 18.4 25.1 3.2 11.8 22.6 14.5 26.5 5.4 12.0 30.4 0.0 0.0 0.0 0.4 0.3 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.2 0.1 2.1 1.4 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 3.1 0.0 1.7 1.0 0.0 120.0 0.1 0.0 1.8 0.0 5.3 0.0 0.8 0.0 4.3 0.9 0.0 0.0 0.0 0.1 SOX9 "CMD1, CMPD1, SRA1" ENSG00000125398 "SRY-box 9" P48436 17 72121020-72126420 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 63.4" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 178.3;Muller glia cells: 170.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 28.5;Hep G2: 34.1;OE19: 26.3;U-251 MG: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001758, CAB022456, CAB068240" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB022456: , CAB068240: AB_2665670, HPA001758: AB_1080067" "unprognostic (6.92e-2)" "unprognostic (1.73e-2)" "unprognostic (4.47e-3)" "unprognostic (4.43e-2)" "unprognostic (2.55e-2)" "unprognostic (7.96e-3)" "unprognostic (4.32e-3)" "prognostic unfavorable (2.07e-4)" "unprognostic (4.87e-2)" "unprognostic (3.31e-1)" "unprognostic (8.92e-3)" "unprognostic (1.21e-1)" "unprognostic (3.26e-3)" "unprognostic (2.77e-3)" "unprognostic (1.15e-1)" "unprognostic (8.88e-2)" "unprognostic (1.21e-2)" 3.1 2.6 32.2 4.3 31.6 1.1 23.4 20.3 32.4 7.4 14.6 28.4 8.1 16.6 3.5 1.9 7.7 7.4 11.7 9.5 35.5 15.7 11.7 3.9 3.4 1.9 14.6 13.7 1.2 31.9 1.2 7.0 1.4 21.3 21.7 15.7 12.9 63.4 14.4 3.0 13.1 12.9 2.1 15.6 1.3 35.2 25.2 20.2 0.0 17.8 5.3 5.0 1.9 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 6.9 14.3 28.5 1.4 0.4 0.0 1.7 1.5 3.0 1.6 9.6 14.8 0.0 1.1 0.4 16.2 11.2 0.0 6.7 2.8 0.0 0.9 0.0 1.5 34.1 0.1 0.0 0.0 0.2 0.6 3.5 3.3 17.4 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.5 26.3 10.6 0.0 11.6 0.1 12.9 0.7 0.7 0.7 1.4 1.7 0.0 8.1 6.1 0.1 0.0 5.9 15.9 3.1 23.5 0.0 0.0 0.0 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.2 31.6 20.3 26.7 35.5 15.7 14.6 13.7 21.3 20.2 11.9 3.5 2.2 77.1 49.2 1.4 13.8 178.3 26.8 20.5 34.9 0.0 0.2 6.6 53.5 3.4 1.4 28.2 0.0 41.0 0.0 3.8 85.0 4.6 3.9 0.2 0.0 57.4 0.0 0.0 7.1 4.0 2.6 11.8 1.8 90.5 170.2 39.9 21.0 0.4 46.9 6.5 6.5 6.2 12.5 1.5 15.6 0.1 0.5 78.3 71.8 SP1 ENSG00000185591 "Sp1 transcription factor" P08047 12 53380176-53416446 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000330, HPA001853, HPA012292" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000330: AB_2171049, HPA001853: AB_1080069, HPA012292: AB_1857394" "unprognostic (1.12e-1)" "unprognostic (8.52e-3)" "unprognostic (6.11e-2)" "unprognostic (1.24e-1)" "unprognostic (2.03e-1)" "unprognostic (4.64e-3)" "unprognostic (1.08e-2)" "unprognostic (2.53e-1)" "unprognostic (1.01e-1)" "unprognostic (2.66e-2)" "prognostic unfavorable (1.43e-4)" "unprognostic (6.38e-2)" "unprognostic (5.14e-2)" "unprognostic (4.05e-2)" "unprognostic (1.37e-1)" "unprognostic (4.77e-2)" "unprognostic (2.12e-2)" 20.7 18.1 8.8 13.9 14.2 17.0 20.1 30.0 14.7 20.9 21.9 17.5 19.3 19.6 25.4 21.2 35.0 20.4 18.7 12.1 14.1 6.8 31.3 14.1 17.6 14.2 18.3 9.7 22.5 17.9 19.0 11.3 19.5 14.4 16.2 20.1 21.5 25.8 19.5 22.0 25.8 30.0 18.4 21.0 19.0 18.8 22.4 15.2 25.8 16.6 17.3 26.6 25.1 21.6 2.7 3.0 11.2 4.2 1.7 2.8 1.4 17.7 19.5 22.4 16.3 18.0 20.8 17.8 12.9 16.6 15.8 14.6 16.2 35.6 24.1 17.1 14.7 10.2 25.8 25.7 17.4 17.7 18.4 14.9 21.2 24.7 8.8 12.6 19.3 18.0 22.0 18.2 16.2 31.6 28.7 16.2 19.3 20.3 35.0 11.6 25.4 28.8 14.8 12.4 13.7 14.7 20.5 21.6 14.3 12.5 32.2 11.8 15.8 26.1 21.9 13.2 18.4 27.5 20.8 15.7 18.6 17.4 13.9 13.7 12.1 13.8 24.1 14.3 16.1 14.9 4.5 4.2 2.5 2.2 2.7 2.8 2.3 2.2 2.1 2.4 2.7 2.4 2.6 11.2 1.7 3.1 3.0 1.6 1.4 8.8 14.2 30.0 14.7 14.1 6.8 18.3 9.7 14.4 15.2 20.8 12.9 13.5 18.3 21.2 11.0 6.7 35.7 12.0 21.6 29.6 7.9 13.5 5.0 15.2 44.6 19.7 33.8 23.3 11.9 13.5 16.5 21.7 5.8 25.9 16.0 15.9 12.1 28.8 37.1 35.5 25.3 17.2 8.5 9.0 29.3 20.6 15.6 17.3 24.4 18.4 9.7 12.9 17.0 27.9 22.6 27.4 17.8 13.1 23.4 40.6 SP2 KIAA0048 ENSG00000167182 "Sp2 transcription factor" Q02086 17 47896150-47928957 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003357, CAB010245" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB010245: AB_2121523, HPA003357: AB_1080070" "unprognostic (1.23e-1)" "unprognostic (1.66e-2)" "unprognostic (6.30e-3)" "unprognostic (5.85e-2)" "unprognostic (1.18e-1)" "unprognostic (6.91e-2)" "unprognostic (5.66e-2)" "unprognostic (2.46e-1)" "unprognostic (6.46e-2)" "unprognostic (2.52e-1)" "unprognostic (1.44e-1)" "unprognostic (5.39e-2)" "prognostic favorable (1.82e-5)" "unprognostic (5.34e-3)" "unprognostic (4.28e-2)" "unprognostic (3.37e-2)" "unprognostic (8.66e-2)" 18.8 15.0 16.9 21.9 20.5 19.1 21.0 28.5 23.4 17.3 16.3 26.9 12.5 16.9 20.5 16.2 19.9 18.3 14.9 20.2 13.8 11.8 17.2 13.3 17.4 22.3 14.1 13.0 20.5 19.7 31.0 14.5 21.4 18.5 16.2 15.8 26.9 18.7 18.2 30.2 19.2 20.8 16.6 17.6 22.2 16.5 23.2 16.3 31.9 21.7 16.0 28.3 18.9 18.0 8.3 6.3 14.3 9.3 12.7 11.5 7.8 16.5 19.2 13.2 11.1 6.5 6.1 12.6 9.8 7.2 10.2 9.2 20.9 8.4 14.4 8.8 12.8 10.3 12.8 9.2 8.5 10.7 20.9 12.9 14.6 12.9 10.8 6.1 13.0 17.3 8.8 10.1 11.9 11.3 7.2 9.6 13.4 15.8 24.6 9.8 22.5 32.1 8.2 5.9 15.0 12.8 14.6 18.1 9.0 7.1 26.9 13.2 15.8 8.5 9.1 9.7 8.5 13.1 12.4 15.8 17.9 9.6 12.4 15.0 21.9 24.2 12.9 9.7 8.8 14.4 14.3 8.0 12.1 11.5 9.3 10.1 7.0 8.8 10.7 6.3 8.3 10.2 10.3 14.3 12.7 8.1 6.1 8.8 7.8 16.9 20.5 28.5 23.4 13.8 11.8 14.1 13.0 18.5 16.3 8.9 21.6 8.3 13.7 5.6 8.4 8.3 2.5 12.0 5.7 10.4 0.0 9.2 13.3 5.9 7.9 10.0 7.7 0.0 6.7 7.7 6.0 10.4 12.7 5.8 7.8 11.1 15.0 5.5 8.5 7.5 9.8 9.2 8.5 7.2 8.9 11.3 5.4 11.5 3.2 5.9 5.9 6.5 7.8 9.1 7.2 6.6 17.2 12.5 7.3 14.5 SP4 "HF1B, MGC130008, MGC130009, SPR-1" ENSG00000105866 "Sp4 transcription factor" Q02446 7 21428034-21514822 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010246, HPA040395" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB010246: AB_2194481, HPA040395: AB_2676959" "unprognostic (1.57e-1)" "unprognostic (1.09e-1)" "unprognostic (6.04e-2)" "unprognostic (8.28e-2)" "unprognostic (9.14e-2)" "unprognostic (8.51e-2)" "unprognostic (1.09e-2)" "unprognostic (7.85e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (3.15e-3)" "unprognostic (1.89e-1)" "unprognostic (6.04e-3)" "unprognostic (2.26e-1)" "unprognostic (1.65e-1)" "unprognostic (6.18e-2)" "unprognostic (7.80e-3)" 5.8 4.7 7.9 8.9 11.0 10.2 6.3 25.9 9.5 8.6 4.4 6.4 3.8 3.1 9.2 5.8 4.1 7.8 4.6 6.5 8.3 6.1 5.4 3.4 6.0 11.7 8.6 6.9 19.8 5.2 17.1 11.8 3.7 6.7 7.3 4.3 6.0 5.0 5.7 10.5 5.0 5.6 5.3 6.8 9.1 4.9 6.0 10.0 27.0 13.1 4.8 11.2 6.8 6.3 5.4 1.5 7.2 1.8 3.5 8.3 3.1 2.2 1.7 5.1 8.1 1.5 1.0 1.5 2.3 1.7 2.7 3.7 3.5 2.7 9.2 1.4 1.5 7.2 2.8 7.5 2.2 5.3 2.7 2.8 4.8 3.3 1.5 1.1 4.0 5.7 1.1 1.9 2.9 3.3 1.4 5.4 6.7 6.0 7.0 2.2 1.0 9.3 2.9 12.3 4.3 2.1 20.9 8.7 3.3 0.9 1.6 6.6 8.2 5.3 2.4 1.8 5.1 2.6 2.9 2.3 4.4 5.5 2.7 4.2 9.3 7.3 14.4 2.5 6.4 6.1 4.3 0.8 7.2 6.8 0.9 8.3 3.7 6.4 6.6 0.9 5.4 7.6 7.1 1.9 3.5 1.8 1.5 7.6 3.1 7.9 11.0 25.9 9.5 8.3 6.1 8.6 6.9 6.7 10.0 3.0 7.0 5.0 11.4 11.2 15.9 7.6 10.2 1.4 7.9 0.0 7.9 1.0 0.0 1.7 5.5 5.8 1.1 0.0 1.8 1.0 6.1 7.1 4.7 4.0 1.5 17.5 10.3 11.6 6.5 4.1 5.2 5.9 6.8 2.8 1.8 9.8 1.4 8.6 6.3 1.4 18.8 0.0 4.1 7.9 8.3 9.7 1.3 14.6 2.8 4.3 SPATA13 "ARHGEF29, FLJ31208" ENSG00000182957 "Spermatogenesis associated 13" Q96N96 13 23979805-24307074 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "granulocytes: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 19.6;HDLM-2: 26.4" "HPA040185, HPA041208" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040185: AB_10795521, HPA041208: AB_10794193" "unprognostic (8.80e-2)" "unprognostic (9.32e-3)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (4.35e-1)" "unprognostic (2.66e-3)" "unprognostic (6.23e-2)" "unprognostic (1.82e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" "unprognostic (2.00e-2)" "unprognostic (2.76e-3)" "unprognostic (9.15e-3)" "unprognostic (1.78e-1)" "unprognostic (4.21e-1)" "prognostic favorable (1.16e-4)" 5.5 11.8 14.7 13.9 23.7 21.4 11.8 5.5 15.2 9.2 8.8 33.7 10.9 9.4 7.8 11.9 3.2 8.2 9.8 6.4 15.3 10.5 13.1 17.8 15.3 16.8 27.9 7.4 12.1 29.7 6.1 8.3 13.7 17.7 12.1 10.2 7.5 6.8 9.8 2.4 6.3 11.5 6.2 25.7 47.8 13.8 5.2 27.2 11.9 10.7 3.1 12.8 6.5 4.5 1.2 2.5 19.3 4.7 9.6 17.7 5.8 1.8 2.9 15.3 1.9 0.5 1.3 0.6 4.5 19.6 2.3 2.0 3.7 7.7 11.7 2.4 4.1 1.2 3.4 4.3 1.3 5.9 26.4 5.2 2.8 2.2 4.3 0.7 4.5 2.2 1.7 0.2 2.5 1.4 2.0 3.8 6.3 0.0 9.9 2.4 6.4 8.2 1.5 5.0 12.4 3.8 7.2 5.9 6.2 10.4 5.8 5.6 4.3 0.9 9.7 8.7 3.5 1.4 2.6 4.4 3.0 2.4 0.2 3.2 2.3 0.0 0.0 2.6 4.3 14.4 2.4 3.1 0.0 17.3 4.0 13.5 1.2 14.7 17.7 2.2 1.0 15.6 16.0 19.3 9.6 4.7 2.5 13.8 5.8 14.7 23.7 5.5 15.2 15.3 10.5 27.9 7.4 17.7 27.2 3.0 25.8 4.5 1.9 4.7 0.7 3.6 0.0 45.5 27.3 14.0 0.0 1.0 3.3 16.3 8.1 18.2 21.2 0.0 13.6 11.9 11.0 26.3 66.1 0.0 10.1 0.0 31.0 0.0 0.0 5.1 6.9 13.4 5.0 1.0 24.3 20.0 17.3 31.7 7.1 4.7 0.5 0.0 7.1 1.9 1.9 5.4 18.7 13.1 22.8 7.8 SPEN "KIAA0929, MINT, RBM15C, SHARP" ENSG00000065526 "Spen family transcriptional repressor" Q96T58 1 15847864-15940460 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Notch signaling pathway, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015825, HPA050257" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015825: AB_1856823, HPA050257: AB_2681065" "unprognostic (3.91e-1)" "unprognostic (1.74e-1)" "unprognostic (3.76e-1)" "unprognostic (2.04e-1)" "unprognostic (1.48e-1)" "unprognostic (3.06e-2)" "unprognostic (6.93e-3)" "unprognostic (2.26e-1)" "unprognostic (4.26e-2)" "unprognostic (4.88e-3)" "unprognostic (1.71e-1)" "unprognostic (5.98e-2)" "unprognostic (1.06e-3)" "unprognostic (1.49e-1)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (1.83e-1)" 18.2 11.2 18.2 18.2 22.2 27.2 17.3 38.2 25.9 18.5 13.4 20.7 17.7 11.9 19.0 12.7 16.7 19.4 11.8 13.5 17.6 11.5 14.4 13.2 17.8 16.6 23.4 17.5 31.2 23.9 35.1 17.5 16.2 19.0 14.9 13.3 11.6 16.2 16.2 24.0 22.8 16.0 15.1 22.0 16.5 13.7 13.6 23.3 18.3 20.1 8.7 18.0 17.1 41.9 5.0 2.7 7.7 2.4 1.3 1.7 0.6 12.7 10.8 13.5 10.1 13.6 8.3 7.3 6.6 8.7 7.2 6.1 9.8 10.0 18.0 7.9 13.0 8.5 18.5 12.7 11.8 11.6 16.2 35.2 22.6 9.6 6.2 6.1 18.5 10.8 6.1 8.5 10.7 15.6 6.8 8.2 13.8 23.5 18.6 5.8 7.1 15.3 7.3 6.1 7.4 8.3 14.8 13.2 11.1 4.0 11.5 10.5 10.6 18.6 9.1 7.9 6.4 3.2 9.1 14.7 6.6 8.2 12.8 9.4 11.2 7.3 20.6 6.5 15.0 9.2 7.7 1.5 0.9 1.6 2.4 1.3 1.8 1.7 1.4 0.7 5.0 0.9 1.3 4.2 1.3 1.2 2.7 1.1 0.6 18.2 22.2 38.2 25.9 17.6 11.5 23.4 17.5 19.0 23.3 74.5 74.0 31.3 47.9 93.0 64.6 48.1 20.4 38.8 66.0 5.2 49.1 10.9 3.3 16.9 3.4 55.5 30.7 23.3 15.0 12.0 46.5 43.4 59.1 26.3 13.3 90.6 30.4 13.5 30.8 3.6 25.3 30.1 20.3 25.2 24.4 29.6 18.0 23.2 33.6 6.5 54.5 19.4 54.6 34.9 51.9 88.8 13.2 20.2 18.7 49.2 SPTY2D1 "DKFZp686I068, FLJ39441, Spt2" ENSG00000179119 "SPT2 chromatin protein domain containing 1" Q68D10 11 18606401-18634791 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039372, HPA040177, HPA047957" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224" "unprognostic (8.43e-2)" "unprognostic (1.50e-1)" "unprognostic (8.62e-2)" "unprognostic (2.16e-1)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.51e-2)" "unprognostic (5.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.59e-4)" "unprognostic (2.03e-1)" "prognostic favorable (2.07e-4)" "unprognostic (1.33e-2)" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (3.33e-1)" 14.0 12.7 6.2 9.7 9.2 33.6 11.9 10.9 10.9 13.7 10.9 6.9 9.9 8.3 11.9 8.6 15.5 12.5 12.2 9.9 5.8 6.5 14.9 25.1 9.7 8.7 6.0 6.8 16.7 16.9 13.6 14.0 15.3 8.5 12.5 9.7 7.9 13.3 13.9 16.3 12.5 13.7 9.3 7.6 15.0 11.0 7.1 5.5 17.7 12.8 8.0 13.3 12.5 11.8 2.7 3.4 7.8 5.7 7.3 8.7 3.3 8.2 8.1 6.5 9.1 10.9 11.4 10.0 12.2 13.4 10.2 12.3 7.2 3.6 18.5 6.9 11.5 8.0 8.6 10.8 9.6 14.7 9.7 10.1 7.4 4.9 6.6 10.5 15.6 14.8 9.4 10.0 6.5 13.3 7.4 11.2 11.1 10.3 29.5 11.3 8.9 10.4 6.2 5.9 16.2 9.1 9.6 18.1 7.9 10.7 11.9 6.3 8.9 10.9 12.7 8.5 8.9 7.9 6.7 9.8 10.0 8.5 19.4 7.4 10.3 12.7 14.5 11.9 8.7 8.4 7.8 4.1 5.8 5.7 5.7 8.7 2.6 5.6 5.7 3.4 2.7 5.2 5.6 6.0 7.3 5.4 2.9 6.0 3.3 6.2 9.2 10.9 10.9 5.8 6.5 6.0 6.8 8.5 5.5 23.8 45.0 23.8 18.6 49.6 12.8 23.6 12.7 61.6 34.2 26.2 9.8 12.3 14.9 21.5 1.6 21.9 22.7 0.0 21.7 19.7 31.0 20.1 56.6 25.6 14.3 11.1 42.5 21.5 27.0 1.7 17.5 31.7 15.1 13.6 24.2 13.8 21.6 22.1 13.1 12.6 11.2 32.3 23.0 10.7 14.2 58.1 23.0 35.5 18.6 29.3 SREK1 "DKFZp564B176, SFRS12, SRrp508, SRrp86" ENSG00000153914 "Splicing regulatory glutamic acid and lysine rich protein 1" Q8WXA9 5 66139971-66183615 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037673, HPA037674, HPA059332" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA037673: AB_2675598, HPA037674: AB_10671376, HPA059332: AB_2683983" "unprognostic (1.38e-1)" "unprognostic (2.51e-1)" "unprognostic (6.16e-2)" "unprognostic (1.52e-1)" "unprognostic (9.40e-2)" "prognostic favorable (2.54e-4)" "unprognostic (1.29e-2)" "unprognostic (7.67e-2)" "unprognostic (5.66e-3)" "unprognostic (2.19e-1)" "unprognostic (2.66e-2)" "unprognostic (5.48e-2)" "prognostic unfavorable (5.77e-4)" "unprognostic (1.63e-1)" "unprognostic (3.08e-1)" "unprognostic (6.76e-2)" "unprognostic (6.69e-2)" 11.1 13.4 12.8 15.6 14.5 38.0 16.3 24.2 14.7 12.9 10.1 8.9 17.3 10.9 18.5 15.9 9.6 13.6 10.6 8.2 12.4 13.3 10.6 10.5 12.5 12.7 11.1 12.0 12.2 14.3 23.4 30.3 12.2 11.4 12.2 10.7 11.9 12.4 16.5 11.9 20.2 12.6 13.7 11.3 14.9 11.0 11.0 11.4 19.5 14.3 9.8 9.5 10.6 10.5 6.5 6.0 8.5 5.6 7.7 6.0 2.8 5.1 6.3 8.9 5.3 4.2 7.9 8.8 6.0 3.5 3.3 3.5 9.3 6.0 7.7 7.7 4.6 4.4 6.9 4.5 6.0 5.8 5.4 10.2 7.3 16.2 6.8 3.7 6.6 8.6 4.6 6.0 4.0 4.5 6.9 5.2 4.5 6.6 5.6 3.5 5.0 6.9 15.5 4.7 2.1 3.2 9.3 4.1 5.5 5.7 9.3 10.5 7.1 5.7 2.7 4.9 6.9 6.8 8.6 5.5 5.3 3.2 7.2 6.1 6.0 4.1 8.7 5.2 10.7 5.7 8.5 5.6 5.2 5.0 3.9 5.4 6.2 4.7 6.0 4.2 6.5 5.6 5.6 4.1 7.7 3.7 6.0 4.4 2.8 12.8 14.5 24.2 13.8 12.4 13.3 11.1 12.0 11.4 11.4 86.4 149.8 64.8 77.1 58.6 59.7 64.9 66.2 132.5 117.2 43.6 110.0 73.9 31.5 45.7 31.9 85.0 41.6 70.0 48.3 73.9 67.2 73.1 94.7 57.6 44.0 63.5 74.7 58.3 48.5 44.8 77.3 55.5 40.5 37.9 43.9 86.7 44.4 37.0 72.2 27.8 96.5 45.3 63.8 65.4 57.5 60.6 100.9 61.0 47.2 68.6 SRRT "ARS2, Asr2, serrate" ENSG00000087087 "Serrate, RNA effector molecule" Q9BXP5 7 100875111-100888664 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 199.7;Late spermatids: 241.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042858, HPA058379" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042858: AB_2678201, HPA058379: AB_2683697" "unprognostic (5.83e-2)" "unprognostic (3.72e-3)" "unprognostic (5.89e-2)" "unprognostic (1.77e-1)" "unprognostic (1.45e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (1.90e-5)" "unprognostic (4.36e-2)" "unprognostic (4.99e-3)" "unprognostic (2.35e-2)" "unprognostic (4.25e-3)" "unprognostic (2.74e-2)" "prognostic unfavorable (1.01e-6)" "unprognostic (6.30e-3)" "unprognostic (2.77e-2)" "unprognostic (9.98e-2)" "unprognostic (1.10e-3)" 18.8 25.2 23.0 32.4 26.7 62.8 22.0 43.4 28.2 25.5 20.7 27.6 37.6 24.3 25.9 27.9 26.5 23.0 22.3 19.3 26.0 15.5 24.2 29.6 20.2 36.5 26.7 20.0 31.6 25.7 26.4 32.6 25.2 24.1 30.8 17.2 23.5 32.4 39.1 23.8 44.2 24.3 18.8 17.4 31.8 22.4 67.6 28.9 39.9 27.9 24.3 32.6 18.9 26.2 10.4 9.9 13.2 14.9 6.1 26.1 12.3 24.9 30.0 31.3 30.2 13.4 9.6 28.9 27.8 14.2 28.8 24.8 39.1 28.4 41.7 19.2 20.3 21.4 23.8 37.6 25.0 14.5 36.8 30.8 39.6 34.6 32.1 12.1 51.1 67.9 14.3 9.8 25.6 7.2 13.1 15.6 25.6 34.6 34.0 19.8 43.4 47.1 56.3 32.0 21.6 26.4 44.2 23.9 25.1 18.4 27.7 24.7 23.9 27.4 34.3 18.0 16.7 21.5 31.4 23.5 32.6 31.3 27.4 37.5 21.5 30.6 44.3 18.1 34.2 30.5 4.6 9.2 13.2 19.7 14.9 12.3 8.4 12.9 26.1 9.9 10.4 11.3 15.9 6.8 6.1 10.4 9.0 6.2 12.3 23.0 26.7 43.4 28.2 26.0 15.5 26.7 20.0 24.1 28.9 23.8 51.7 19.3 25.8 34.2 21.3 19.7 15.3 38.8 48.9 15.7 13.7 32.7 6.6 21.3 199.7 19.9 14.2 23.3 27.6 41.8 23.3 18.3 25.5 11.4 23.3 25.4 31.6 9.8 10.5 241.6 31.4 23.9 15.1 29.7 17.9 26.9 21.0 14.4 26.2 9.9 45.7 19.4 29.9 83.4 63.9 38.0 45.3 29.9 26.2 17.0 SRSF5 "HRS, SFRS5, SRP40" ENSG00000100650 "Serine and arginine rich splicing factor 5" Q13243 14 69726900-69772005 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043484, HPA056523" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA043484: AB_10797143, HPA056523: AB_2683164" "unprognostic (2.08e-3)" "prognostic favorable (7.91e-4)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.30e-3)" "unprognostic (1.07e-3)" "unprognostic (2.37e-2)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (1.00e-2)" 66.6 60.1 67.1 60.9 74.4 131.5 70.3 111.7 88.8 54.3 63.3 67.8 77.1 42.6 71.3 74.6 66.3 79.3 50.1 48.5 66.2 43.0 40.5 60.8 69.4 63.3 86.4 62.1 76.6 41.0 56.4 124.8 59.2 74.0 59.0 54.7 69.2 68.5 75.6 76.0 78.1 74.1 59.7 68.6 66.5 62.0 35.3 75.6 47.8 70.8 52.3 69.1 69.6 55.8 41.2 37.4 60.8 45.1 30.8 38.2 24.4 70.0 20.5 50.2 22.6 31.0 26.9 27.9 33.8 36.4 27.6 29.3 25.7 45.0 72.6 17.9 45.8 28.4 33.5 38.0 48.3 32.6 62.0 20.9 54.7 54.9 28.1 36.1 51.0 41.5 55.7 30.8 31.8 34.1 41.5 38.2 63.2 38.0 43.3 17.1 56.9 58.6 34.6 29.4 55.3 18.9 50.3 23.9 27.9 35.1 86.3 26.2 37.4 57.3 34.8 43.6 31.4 37.9 43.0 47.2 16.2 43.4 17.6 31.6 42.1 27.5 117.5 38.1 43.5 22.2 39.0 24.1 37.2 37.3 43.4 38.2 41.2 33.2 33.4 26.2 40.6 33.2 31.5 60.8 30.8 45.1 37.4 27.4 24.4 67.1 74.4 111.7 88.8 66.2 43.0 86.4 62.1 74.0 75.6 235.2 245.0 272.6 618.6 122.6 370.2 163.3 193.6 401.5 253.6 174.5 225.8 335.9 271.9 173.3 146.9 251.5 417.9 163.5 148.9 193.0 195.8 288.7 459.5 204.3 193.9 357.6 290.6 219.1 193.0 84.2 319.9 251.8 126.5 254.3 249.3 292.6 182.8 399.8 251.0 172.0 307.5 271.7 240.9 175.1 136.3 127.2 626.6 371.3 207.8 495.2 SRSF7 "9G8, AAG3, HSSG1, RBM37, SFRS7, ZCCHC20, ZCRB2" ENSG00000115875 "Serine and arginine rich splicing factor 7" Q16629 2 38743599-38751494 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043850, HPA056926" Supported Enhanced Nucleoplasm NA NA 1400000 Nucleoplasm "HPA043850: AB_10964495, HPA056926: AB_2683277" "unprognostic (2.74e-1)" "unprognostic (1.53e-3)" "unprognostic (1.24e-1)" "unprognostic (1.56e-1)" "unprognostic (1.86e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.90e-5)" "unprognostic (3.24e-2)" "unprognostic (2.53e-2)" "unprognostic (2.61e-1)" "unprognostic (3.75e-1)" "unprognostic (4.44e-3)" "prognostic unfavorable (3.18e-8)" "unprognostic (1.02e-2)" "unprognostic (1.87e-1)" "unprognostic (1.72e-1)" "unprognostic (3.07e-3)" 42.2 32.2 32.8 51.1 37.3 76.7 39.2 34.7 38.9 26.8 37.2 21.4 34.8 20.4 34.1 27.3 50.2 36.9 25.9 29.8 26.9 24.6 25.1 34.9 34.3 45.5 37.5 23.8 31.7 38.2 20.4 50.4 34.3 32.8 27.4 37.2 25.0 32.8 32.4 31.7 26.2 37.7 36.6 33.4 34.8 38.8 35.9 33.0 44.1 26.1 38.6 59.2 28.2 40.7 20.9 47.6 8.8 33.4 20.8 22.9 22.3 44.4 38.7 52.0 33.5 16.0 12.7 36.8 38.1 16.4 38.4 31.0 45.6 34.3 72.7 26.1 24.7 35.7 25.1 65.4 46.6 46.3 45.2 40.9 43.8 27.7 46.5 13.6 53.7 31.9 7.5 15.9 26.4 51.1 16.1 31.8 30.4 63.2 29.1 32.5 49.5 68.0 47.6 56.8 51.9 35.5 60.4 43.6 41.2 28.5 43.2 35.7 34.7 36.4 32.2 25.5 34.2 29.4 49.1 27.4 23.3 36.5 19.9 53.0 32.1 48.1 108.6 27.7 56.4 32.0 6.4 23.1 8.8 21.3 33.4 22.9 20.9 16.4 21.0 47.6 14.1 18.6 21.1 2.3 20.8 19.6 28.6 17.4 22.3 32.8 37.3 34.7 38.9 26.9 24.6 37.5 23.8 32.8 33.0 74.5 215.1 214.9 400.1 230.6 113.1 58.5 71.4 103.1 134.2 61.1 111.9 262.6 132.6 156.5 100.6 205.2 175.7 93.5 114.8 395.5 179.8 170.8 309.8 83.0 212.6 114.4 170.8 124.0 110.1 27.4 128.3 171.7 145.1 221.8 114.8 196.9 126.7 138.2 103.3 87.8 205.4 116.4 213.8 249.3 306.4 212.9 209.3 335.6 161.8 319.7 SSBP2 HSPC116 ENSG00000145687 "Single stranded DNA binding protein 2" P81877 5 81413021-81751797 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 89.9" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 139.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 38.3;MOLT-4: 35.5;REH: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020834, HPA068605, HPA071780" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB020834: , HPA068605: AB_2732116, HPA071780: " "unprognostic (4.62e-2)" "unprognostic (1.96e-3)" "unprognostic (1.12e-1)" "unprognostic (1.46e-2)" "unprognostic (1.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.30e-1)" "unprognostic (6.54e-2)" "unprognostic (1.56e-1)" "unprognostic (7.78e-3)" "unprognostic (2.36e-3)" "unprognostic (6.01e-2)" "unprognostic (1.01e-2)" "unprognostic (3.04e-3)" "unprognostic (6.56e-2)" "unprognostic (9.81e-2)" "unprognostic (4.39e-3)" 18.9 11.5 16.3 11.1 24.3 11.0 20.0 49.8 21.3 26.5 18.8 13.6 11.1 5.2 27.0 27.2 21.3 26.4 14.2 26.3 16.1 22.8 10.3 3.2 11.3 15.4 19.9 16.2 33.1 8.7 42.4 31.0 11.7 20.9 16.1 11.7 20.0 14.6 19.5 16.3 19.6 10.3 26.1 20.6 8.9 13.6 6.9 21.5 89.9 12.8 11.7 19.9 19.0 18.5 16.2 8.1 26.2 12.2 25.6 15.2 7.9 1.0 1.9 24.2 13.7 14.0 21.3 1.5 5.0 4.6 4.7 4.9 0.0 2.0 16.7 0.3 5.9 2.3 0.1 6.6 2.7 4.6 7.1 2.8 3.5 4.1 0.0 7.9 1.7 9.3 21.8 23.5 0.8 4.5 10.2 2.0 38.3 2.2 8.2 5.0 2.3 35.5 2.8 3.3 0.0 1.0 53.5 5.5 12.7 2.4 0.9 12.6 11.4 5.3 5.9 1.8 10.2 8.7 4.9 1.3 1.8 3.0 3.5 1.3 8.7 6.7 28.0 6.2 3.1 1.2 20.7 8.6 26.2 2.4 7.6 3.8 9.9 7.7 4.3 8.1 16.2 15.2 5.3 12.5 25.6 12.2 2.6 3.4 7.9 16.3 24.3 49.8 21.3 16.1 22.8 19.9 16.2 20.9 21.5 8.9 18.1 15.4 39.3 31.0 60.9 38.4 7.6 29.4 33.0 27.9 25.5 5.9 14.9 10.5 5.4 19.6 2.3 0.0 8.8 2.8 30.8 11.9 24.3 1.6 16.4 39.7 14.5 18.4 15.4 3.4 35.1 18.7 33.7 5.4 4.7 139.7 6.3 10.2 45.6 4.1 43.9 51.8 68.0 6.3 20.3 31.7 6.2 14.4 3.5 26.4 ST6GALNAC3 SIAT7C ENSG00000184005 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3" Q8NDV1 1 76074719-76634601 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 23 "Endothelial cells: 21.6;Ito cells: 57.1;Kupffer cells: 11.7;Muller glia cells: 11.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 18.6;HUVEC TERT2: 23.6;SK-MEL-30: 32.2;TIME: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054566, HPA055399" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054566: AB_2682526, HPA055399: AB_2682806" "unprognostic (7.85e-2)" "unprognostic (1.78e-1)" "unprognostic (2.99e-2)" "unprognostic (2.70e-4)" "unprognostic (2.76e-2)" "unprognostic (2.21e-2)" "unprognostic (6.55e-3)" "unprognostic (7.31e-2)" "unprognostic (2.14e-1)" "unprognostic (4.57e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (9.97e-4)" "unprognostic (3.33e-4)" "unprognostic (5.44e-2)" "unprognostic (1.92e-1)" "unprognostic (3.44e-4)" 20.7 2.9 7.0 3.6 13.0 5.3 13.9 3.8 9.7 4.3 4.0 13.4 2.0 1.8 10.7 2.1 3.8 4.2 4.7 7.8 8.8 6.0 14.9 3.9 7.5 5.1 16.3 3.6 4.7 2.2 12.6 4.3 5.7 12.9 2.5 4.7 2.8 2.3 3.5 3.3 1.9 2.7 8.3 19.0 3.0 3.0 1.2 12.5 0.0 23.2 1.5 1.7 5.5 5.2 5.9 3.0 5.2 8.3 0.4 1.9 2.6 0.1 0.0 18.6 0.0 0.3 0.0 0.0 0.0 2.2 0.3 0.2 6.0 0.0 0.3 1.2 0.1 1.2 0.0 0.0 0.2 0.1 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.5 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 1.4 0.0 0.9 0.8 0.0 0.0 0.0 1.4 4.6 0.0 0.0 32.2 4.5 0.0 0.1 10.4 0.1 1.5 0.0 1.7 0.0 0.0 0.0 0.0 4.2 2.8 0.0 8.3 3.7 0.0 2.9 0.0 3.3 0.5 0.8 3.0 5.9 1.9 1.9 5.2 0.4 5.3 0.0 0.0 2.6 7.0 13.0 3.8 9.7 8.8 6.0 16.3 3.6 12.9 12.5 3.0 1.0 1.3 0.1 0.2 3.0 1.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.4 0.8 0.0 0.0 57.1 11.7 0.4 0.0 1.5 5.0 0.0 0.3 11.0 0.2 3.2 0.0 0.0 0.5 0.0 0.3 0.2 0.4 0.4 0.1 0.0 0.0 0.1 STAC3 MGC2793 ENSG00000185482 "SH3 and cysteine rich domain 3" Q96MF2 12 57243453-57251193 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "skeletal muscle: 222.7;tongue: 107.8" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 36.5;Kupffer cells: 32.7;Macrophages: 17.2;monocytes: 16.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "intermediate monocyte: 8.0" "Group enriched" "Detected in many" 6 "dendritic cells: 4.9;monocytes: 8.0" "Cell line enriched" "Detected in some" 23 "RH-30: 230.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA039285, HPA039527" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039285: AB_2676427, HPA039527: AB_10673424" "unprognostic (6.16e-2)" "prognostic favorable (2.01e-4)" "prognostic unfavorable (7.10e-4)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" "unprognostic (5.25e-2)" "unprognostic (1.62e-1)" "unprognostic (1.19e-1)" "unprognostic (2.05e-2)" "unprognostic (1.31e-1)" "unprognostic (9.12e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (7.11e-6)" "unprognostic (4.58e-2)" "unprognostic (3.36e-1)" "unprognostic (2.09e-1)" "unprognostic (1.14e-3)" 3.7 0.2 0.1 0.6 0.1 1.6 0.2 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 10.3 3.2 0.2 0.1 0.1 0.1 0.1 0.2 0.4 0.6 0.7 0.2 0.0 0.1 0.1 0.4 0.2 0.2 0.0 2.3 0.2 0.1 5.4 0.0 222.7 0.2 0.3 0.1 0.3 1.1 0.1 1.2 0.0 0.1 1.2 107.8 3.8 0.1 0.1 1.1 4.9 0.5 8.0 0.0 0.3 1.8 0.0 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 2.7 0.0 0.0 0.0 1.6 9.8 1.0 0.1 0.0 0.0 0.1 0.0 0.6 0.2 0.2 0.7 0.5 0.1 3.5 0.0 0.0 0.1 1.2 230.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 4.7 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.9 0.1 3.2 0.0 0.0 6.1 0.5 0.0 8.0 0.1 1.1 0.0 0.3 4.9 0.5 0.0 0.1 0.3 0.0 4.0 1.4 0.3 1.8 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 1.1 0.5 0.4 1.3 6.4 0.2 2.5 1.4 0.0 0.0 2.0 0.9 0.0 0.8 9.3 0.0 1.1 0.0 0.9 0.5 0.9 0.6 5.7 0.6 36.5 1.6 2.4 2.5 32.7 7.6 1.1 17.2 0.0 16.2 1.1 2.2 1.0 0.0 0.7 0.5 1.9 0.0 0.3 2.4 1.1 0.3 1.1 1.3 1.1 0.3 STAG1 "SA-1, SA1, SCC3A" ENSG00000118007 "Stromal antigen 1" Q8WVM7 3 136336233-136752403 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035015, HPA058653" Supported Enhanced "Nucleoplasm,Nuclear bodies" No No Nucleoplasm "Nuclear bodies" "HPA035015: AB_10603117, HPA058653: AB_2683787" "unprognostic (1.82e-1)" "unprognostic (1.11e-2)" "unprognostic (1.41e-1)" "unprognostic (5.37e-2)" "unprognostic (4.05e-2)" "unprognostic (1.92e-1)" "unprognostic (4.62e-2)" "unprognostic (5.26e-2)" "unprognostic (1.74e-1)" "unprognostic (7.22e-3)" "unprognostic (1.29e-2)" "unprognostic (1.71e-1)" "unprognostic (5.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.58e-1)" "unprognostic (5.97e-2)" "unprognostic (2.83e-2)" 26.0 10.9 13.3 12.9 15.6 12.9 17.9 46.5 14.3 24.8 14.9 11.2 12.0 9.1 21.3 10.8 12.8 16.8 10.5 12.3 12.9 7.4 12.0 10.2 13.3 12.9 14.0 7.2 22.6 13.8 17.3 20.4 20.5 14.3 16.3 14.3 13.0 14.5 14.0 20.8 17.2 12.7 16.8 9.5 14.5 12.2 9.5 18.9 29.7 15.6 11.7 18.6 17.0 29.0 8.9 6.7 13.2 4.8 8.0 7.4 2.9 17.6 9.2 15.5 13.3 11.7 20.4 8.3 19.9 25.5 18.7 17.8 15.6 7.8 13.8 12.6 20.6 15.1 12.3 16.7 9.0 25.6 16.9 7.8 14.7 13.4 8.6 8.9 25.6 14.9 12.8 10.3 13.7 15.4 10.9 14.5 15.1 9.4 28.0 11.8 15.1 16.8 8.3 10.1 12.2 7.3 15.1 16.9 18.4 10.2 12.7 7.6 12.2 21.3 8.5 8.9 8.4 12.1 10.9 12.1 21.6 15.8 19.2 17.5 20.9 14.3 31.4 13.3 8.8 13.8 4.8 4.4 6.5 7.0 4.6 7.4 8.9 5.9 6.3 4.1 7.3 6.7 5.2 13.2 8.0 4.8 6.7 6.9 2.9 13.3 15.6 46.5 14.3 12.9 7.4 14.0 7.2 14.3 18.9 23.8 21.6 31.2 28.0 35.5 41.8 8.9 12.7 16.0 29.6 15.7 37.3 24.5 10.0 17.5 1.9 25.1 29.0 23.3 19.2 22.1 23.6 19.6 21.9 17.8 15.8 27.0 18.0 32.5 14.6 2.3 45.8 19.5 15.1 24.4 23.3 29.1 21.6 17.3 30.4 8.4 65.9 25.8 27.2 32.7 43.2 32.0 26.5 27.7 21.2 21.7 STAT1 "ISGF-3, STAT91" ENSG00000115415 "Signal transducer and activator of transcription 1" P42224 2 190964358-191020960 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 90.5;BJ hTERT+ SV40 Large T+ RasG12V: 101.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000931, HPA000982, CAB004049" Approved Enhanced Nucleoplasm,Cytosol NA NA 22000 "Nucleoplasm, Cytosol" "CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099" "unprognostic (6.90e-2)" "unprognostic (6.47e-2)" "unprognostic (4.27e-2)" "unprognostic (2.47e-2)" "unprognostic (2.51e-1)" "unprognostic (2.91e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-2)" "unprognostic (1.35e-1)" "prognostic favorable (1.75e-4)" "prognostic unfavorable (4.23e-4)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.22e-5)" "unprognostic (2.43e-1)" "unprognostic (4.17e-2)" "unprognostic (3.35e-3)" "unprognostic (3.93e-2)" 27.9 27.2 17.4 47.8 17.8 19.5 20.4 15.0 21.7 21.0 19.8 14.9 17.5 22.7 17.1 27.4 23.3 14.5 29.0 25.5 15.6 22.2 34.9 35.7 29.4 57.9 16.9 18.8 24.3 18.7 20.0 24.0 24.3 23.6 23.6 20.3 17.9 47.5 18.0 20.1 17.4 24.6 24.8 21.8 49.0 24.2 13.5 10.4 58.7 36.2 18.5 30.2 29.3 16.5 10.8 16.2 55.0 47.1 22.7 54.1 44.6 8.9 9.6 4.5 7.5 19.9 26.9 14.6 13.7 41.9 90.5 101.9 15.2 10.4 3.7 8.7 29.3 30.1 7.6 5.1 10.9 18.0 30.7 4.2 16.6 7.6 8.9 13.8 8.5 10.4 17.8 7.0 16.7 5.9 9.9 10.8 6.5 9.0 22.0 16.6 7.3 6.4 10.8 6.3 5.8 15.8 5.4 12.4 4.5 11.9 11.2 6.3 6.1 16.1 6.2 41.9 6.7 6.4 10.6 9.5 18.0 10.6 15.5 8.8 37.4 54.8 3.5 13.7 7.3 8.3 13.0 36.9 27.0 14.7 47.1 19.9 10.8 35.1 21.0 16.2 8.6 35.8 26.0 55.0 22.7 27.6 7.4 54.1 44.6 17.4 17.8 15.0 21.7 15.6 22.2 16.9 18.8 23.6 10.4 68.5 26.4 26.1 13.6 19.7 12.8 39.2 48.4 49.5 50.0 50.6 23.6 11.6 6.6 40.3 8.8 23.9 22.2 0.0 32.6 47.9 29.1 25.0 50.7 45.1 91.4 3.2 20.2 25.8 63.7 2.6 20.1 70.4 16.9 25.2 23.9 14.3 30.0 22.8 28.0 36.2 16.5 38.8 21.7 18.5 24.5 27.4 7.0 25.4 27.4 24.1 STAT5A "MGF, STAT5" ENSG00000126561 "Signal transducer and activator of transcription 5A" P42229 17 42287547-42311943 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Lactation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 43.3;Peritubular cells: 38.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 25.8;HEL: 39.1;HMC-1: 22.8;K-562: 65.1;MOLT-4: 47.2;NB-4: 18.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB003860, HPA027873, HPA042128, HPA049883, HPA051156" Approved Enhanced Nucleoplasm,Cytosol NA NA 140000 "Nucleoplasm, Cytosol" "CAB003860: AB_562347, HPA027873: AB_10603893, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366" "prognostic favorable (5.87e-4)" "unprognostic (3.09e-3)" "unprognostic (2.31e-2)" "unprognostic (1.76e-1)" "unprognostic (1.43e-1)" "unprognostic (3.41e-3)" "unprognostic (2.15e-1)" "unprognostic (6.22e-2)" "unprognostic (3.33e-1)" "unprognostic (6.82e-3)" "unprognostic (2.76e-1)" "unprognostic (2.11e-1)" "unprognostic (3.85e-2)" "unprognostic (5.74e-2)" "unprognostic (1.90e-2)" "unprognostic (1.98e-1)" "unprognostic (5.49e-3)" 44.0 21.5 3.6 16.5 8.1 30.0 24.1 3.4 4.0 12.6 12.8 6.3 10.5 5.1 11.0 11.4 11.6 9.6 15.3 9.8 3.9 4.7 8.9 5.5 12.8 26.7 9.1 3.2 15.6 8.3 1.9 7.0 11.3 6.1 13.9 5.8 11.9 11.9 11.7 18.3 9.7 11.6 13.6 7.4 17.3 7.9 8.5 6.1 21.9 8.6 9.1 17.0 19.9 20.2 7.2 15.0 15.2 18.5 14.3 16.2 8.8 1.1 1.3 0.1 0.0 9.3 4.5 0.0 0.5 2.0 1.0 0.6 0.1 1.0 0.0 2.4 2.1 0.0 0.0 0.2 0.0 0.3 25.8 0.0 39.1 2.9 0.3 3.8 3.3 22.8 10.4 0.7 0.4 0.5 0.0 3.1 0.9 65.1 0.0 0.5 0.1 47.2 18.6 0.3 0.6 0.0 1.1 0.3 3.3 0.3 0.7 0.1 0.0 2.3 1.2 4.3 0.3 0.7 4.2 1.7 2.4 0.6 1.1 0.0 0.0 0.0 0.0 0.2 6.4 0.6 6.8 11.8 5.9 9.1 15.1 12.8 7.2 15.8 13.2 15.0 6.7 16.2 13.0 15.2 14.3 18.5 5.7 11.2 8.8 3.6 8.1 3.4 4.0 3.9 4.7 9.1 3.2 6.1 6.1 0.0 11.7 17.9 3.4 6.5 1.5 20.2 5.1 5.3 2.3 5.2 0.0 1.2 5.0 4.9 0.3 21.8 3.8 0.0 11.8 2.1 15.5 6.7 22.0 2.6 19.4 0.0 0.0 5.5 19.7 2.1 30.2 22.7 8.5 43.3 4.2 5.1 8.2 7.0 38.5 8.4 0.3 6.5 18.7 0.0 0.7 6.8 1.1 19.1 6.2 4.1 STX6 ENSG00000135823 "Syntaxin 6" O43752 1 180972712-181023121 "Plasma proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038557, HPA038558" Approved Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA038557: AB_2676082, HPA038558: AB_10672716" "unprognostic (1.11e-2)" "unprognostic (3.22e-2)" "unprognostic (1.47e-1)" "unprognostic (9.09e-3)" "unprognostic (2.23e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.12e-1)" "unprognostic (6.12e-2)" "unprognostic (4.48e-3)" "unprognostic (4.18e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (1.93e-8)" "unprognostic (2.59e-1)" "unprognostic (1.59e-1)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" 12.2 10.4 17.6 14.1 18.9 2.9 12.4 21.7 25.5 13.4 10.4 15.5 7.2 9.8 11.3 10.7 22.2 10.3 9.6 8.1 18.6 13.2 11.6 6.5 15.3 12.7 18.5 13.1 11.5 5.5 9.2 6.8 15.0 16.1 10.1 11.1 6.4 10.7 9.6 5.7 16.5 9.9 11.8 15.0 11.6 10.5 7.3 20.0 14.1 15.3 7.3 17.8 16.3 15.6 1.7 5.1 5.9 3.6 0.4 3.2 1.4 9.8 11.1 11.0 14.6 11.6 13.7 18.6 12.7 16.4 10.0 8.6 10.3 9.9 10.0 17.6 13.9 6.3 17.7 9.9 22.4 11.8 7.2 7.3 6.7 8.4 10.0 11.5 9.5 8.7 12.4 20.6 16.9 17.5 18.1 20.2 9.4 12.2 7.1 13.3 14.2 9.1 9.0 17.1 12.4 5.6 8.0 13.4 14.4 11.9 24.8 15.6 16.6 13.3 25.7 13.9 19.7 15.6 8.7 16.6 13.9 7.3 12.9 10.1 12.1 6.7 7.3 6.8 9.4 8.1 5.9 3.6 4.5 1.8 2.9 1.9 1.7 2.6 2.7 5.1 1.7 3.2 2.4 3.4 0.4 2.5 1.7 3.2 1.4 17.6 18.9 21.7 19.1 18.6 13.2 18.5 13.1 16.1 20.0 14.9 15.2 3.7 16.3 43.5 11.7 5.6 0.0 13.4 11.4 17.4 5.9 22.0 10.0 9.1 6.4 22.4 7.8 0.0 8.5 21.8 11.5 17.4 11.5 4.3 24.6 7.9 22.4 11.1 21.9 8.0 7.8 30.2 6.8 19.0 12.7 6.0 11.1 14.0 12.4 6.7 10.1 6.5 13.3 4.7 14.5 33.0 17.2 13.3 9.8 18.7 SUGP1 "DKFZp434E2216, F23858, RBP, SF4" ENSG00000105705 "SURP and G-patch domain containing 1" Q8IWZ8 19 19276018-19320844 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 83.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004890 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA004890: AB_1079935" "unprognostic (1.08e-1)" "unprognostic (4.51e-3)" "unprognostic (5.21e-2)" "unprognostic (9.88e-2)" "unprognostic (1.87e-1)" "unprognostic (7.34e-3)" "unprognostic (1.67e-2)" "unprognostic (4.90e-3)" "unprognostic (2.14e-2)" "unprognostic (1.26e-1)" "unprognostic (1.37e-3)" "unprognostic (4.25e-2)" "unprognostic (3.52e-2)" "unprognostic (2.06e-3)" "unprognostic (5.51e-2)" "unprognostic (1.50e-2)" "unprognostic (3.42e-3)" 6.8 8.2 14.8 9.2 13.4 5.6 7.0 16.4 17.0 7.3 8.6 9.1 7.8 9.7 9.0 6.9 9.2 8.3 7.1 11.2 12.1 8.7 8.6 8.6 8.3 7.9 11.0 9.1 7.1 10.5 9.0 8.1 6.4 10.3 8.4 6.6 8.2 11.2 8.7 19.7 7.4 8.5 8.5 10.8 8.1 8.7 20.2 10.9 9.8 6.5 6.8 8.8 8.6 6.2 12.9 14.1 14.1 21.9 15.8 17.0 14.4 12.0 2.5 5.9 7.2 5.9 5.7 15.4 8.6 11.4 12.3 8.9 5.6 9.0 11.8 11.8 11.3 7.7 8.3 6.6 10.0 6.0 8.3 5.5 9.8 3.1 4.0 6.9 6.8 10.6 10.9 4.8 10.7 4.5 6.2 8.8 9.0 12.6 6.3 10.1 9.6 17.1 10.4 12.6 12.1 7.8 14.3 8.8 13.5 9.0 5.1 10.1 13.1 8.4 7.1 14.1 6.6 8.1 12.6 14.1 8.8 9.1 11.3 10.5 11.2 11.1 13.6 11.0 9.1 10.9 7.8 14.1 14.1 16.2 16.8 12.6 12.9 12.7 17.0 14.1 11.9 11.9 12.6 12.8 15.8 21.9 13.0 12.4 14.4 14.8 13.4 16.4 17.0 12.1 8.7 11.0 9.1 10.3 10.9 14.9 16.0 8.8 6.7 4.1 11.0 18.7 12.7 6.7 14.8 14.0 3.9 15.8 14.9 12.9 33.1 9.0 13.3 0.0 12.4 11.5 6.1 3.0 9.2 7.3 12.4 1.6 9.2 6.7 6.3 83.0 10.3 10.8 10.1 22.6 9.1 13.8 11.3 11.2 11.7 13.6 7.6 6.5 9.2 27.8 16.4 5.0 14.1 12.8 9.4 3.1 SUGP2 "KIAA0365, SFRS14" ENSG00000064607 "SURP and G-patch domain containing 2" Q8IX01 19 18990888-19034023 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 170.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041557, HPA061111" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA041557: AB_10794301, HPA061111: AB_2684432" "unprognostic (1.35e-1)" "unprognostic (2.94e-1)" "unprognostic (3.59e-2)" "unprognostic (1.13e-1)" "unprognostic (1.85e-1)" "unprognostic (1.91e-3)" "prognostic unfavorable (3.21e-4)" "unprognostic (1.94e-2)" "unprognostic (4.60e-2)" "unprognostic (3.28e-1)" "unprognostic (4.41e-3)" "unprognostic (2.29e-2)" "unprognostic (1.00e-1)" "unprognostic (1.17e-2)" "unprognostic (1.51e-1)" "unprognostic (5.11e-2)" "unprognostic (3.60e-2)" 7.8 13.9 27.2 11.8 27.0 24.5 9.9 36.0 34.4 9.0 10.1 15.4 10.8 11.8 14.8 15.0 7.8 13.5 9.0 18.2 23.0 17.0 9.9 7.4 9.4 15.0 16.8 24.2 13.8 9.1 13.3 22.8 9.8 16.0 16.1 11.7 14.5 14.1 11.9 19.5 12.2 10.6 11.2 15.1 13.9 11.4 56.5 16.9 11.0 19.0 6.7 13.6 10.7 9.7 4.3 4.1 5.3 3.2 9.0 4.7 1.7 12.9 12.3 31.6 22.7 14.8 14.7 15.9 16.3 12.2 19.0 16.4 8.0 11.5 25.6 13.5 12.9 22.5 9.6 25.6 9.8 17.4 9.0 23.1 16.1 18.2 10.4 10.7 13.5 16.3 15.2 10.5 11.6 9.5 25.5 9.9 20.1 24.3 18.5 20.5 10.9 15.8 25.5 16.3 15.2 18.1 15.9 16.2 14.2 9.7 13.1 35.1 14.4 14.3 10.1 7.1 25.4 10.5 12.7 10.8 18.8 11.4 21.8 19.0 23.6 17.9 19.0 18.9 21.4 19.7 5.3 3.1 2.4 4.7 3.2 2.5 2.5 2.9 2.7 3.1 4.3 2.7 3.2 2.8 9.0 2.8 4.1 2.7 1.7 27.2 27.0 36.0 34.4 23.0 17.0 16.8 24.2 16.0 16.9 38.7 39.7 19.0 19.9 15.7 80.7 31.9 17.8 41.5 39.8 26.2 88.4 13.2 8.3 14.7 63.8 22.6 13.7 0.0 9.3 8.6 20.8 23.4 25.5 24.6 19.8 100.1 39.9 27.6 18.0 97.3 37.4 23.8 11.8 16.2 21.7 49.8 15.7 24.3 35.3 7.8 102.0 51.8 15.7 170.1 42.8 16.4 6.3 26.1 24.1 20.2 SUMO3 "SMT3A, SMT3H1" ENSG00000184900 "Small ubiquitin-like modifier 3" P55854 21 44805617-44818779 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "monocytes: 368.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012180, HPA042123, HPA048064" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB012180: AB_304041, HPA042123: AB_2677860, HPA048064: AB_2680244" "unprognostic (2.77e-2)" "unprognostic (2.52e-1)" "unprognostic (5.79e-2)" "prognostic unfavorable (7.88e-5)" "unprognostic (1.96e-1)" "unprognostic (1.21e-1)" "unprognostic (6.81e-2)" "unprognostic (7.13e-2)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (2.09e-2)" "unprognostic (7.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.00e-2)" "unprognostic (1.62e-1)" "unprognostic (7.50e-2)" "unprognostic (1.80e-2)" 32.2 23.8 37.4 17.7 43.8 50.0 25.0 31.6 43.4 26.9 28.0 17.5 19.4 24.0 21.7 23.9 23.4 22.1 21.9 36.6 27.6 38.7 24.4 29.2 26.2 32.0 30.8 29.0 26.3 26.2 14.6 15.6 21.7 26.6 21.8 15.5 30.6 28.3 30.2 62.4 18.9 28.9 17.4 19.7 28.2 27.7 17.3 17.3 23.9 26.1 18.4 20.8 22.5 20.3 23.8 46.0 14.0 35.7 18.5 27.6 38.4 45.6 18.5 17.4 7.2 20.2 23.4 18.2 31.9 35.0 45.2 36.3 27.5 18.2 16.2 50.6 29.7 21.4 9.1 15.0 24.8 11.1 22.4 22.6 66.4 13.2 21.8 22.1 37.4 32.9 26.4 23.6 26.4 15.1 10.4 18.3 34.0 37.9 27.0 18.1 58.8 31.8 25.9 41.4 30.1 37.1 37.1 1.5 36.1 11.8 17.8 17.0 32.8 28.5 21.0 22.1 4.8 28.2 26.9 36.0 13.5 29.7 28.8 32.8 33.5 46.8 40.9 12.2 51.3 18.7 0.6 34.6 14.0 23.5 35.7 23.9 23.8 22.8 22.8 37.5 21.5 27.6 24.8 4.1 18.5 32.0 46.0 24.7 38.4 37.4 43.8 31.6 43.4 27.6 38.7 30.8 29.0 26.6 17.3 59.6 47.4 74.9 104.6 85.3 68.8 55.4 53.5 20.1 38.7 90.7 19.6 109.8 140.9 91.8 47.0 107.9 85.0 46.7 98.1 85.9 94.3 117.4 28.9 88.9 177.5 58.8 56.7 85.3 119.6 80.4 66.7 155.6 92.8 368.9 80.7 78.5 112.8 93.7 68.2 95.9 44.8 58.2 77.3 58.8 72.0 68.1 114.0 79.9 86.4 112.9 SUPT5H "FLJ34157, SPT5, SPT5H" ENSG00000196235 "SPT5 homolog, DSIF elongation factor subunit" O00267 19 39436156-39476670 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029273, CAB034370" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034370: AB_2196394, HPA029273: AB_10603896" "unprognostic (3.96e-2)" "unprognostic (3.51e-1)" "unprognostic (1.32e-2)" "unprognostic (5.53e-3)" "unprognostic (4.19e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (7.00e-5)" "unprognostic (7.30e-2)" "unprognostic (4.35e-1)" "unprognostic (1.68e-2)" "unprognostic (1.94e-2)" "unprognostic (6.42e-2)" "unprognostic (1.37e-3)" "unprognostic (1.74e-1)" "unprognostic (2.68e-1)" "unprognostic (3.32e-1)" "unprognostic (2.38e-1)" 27.7 26.2 39.4 28.9 41.0 64.2 23.5 46.8 50.7 26.2 29.2 34.2 21.0 27.7 33.0 22.3 24.2 26.9 26.7 27.8 34.9 28.6 22.6 28.4 25.5 32.9 28.7 42.3 39.8 34.2 39.3 42.9 26.3 31.3 27.8 21.7 25.7 37.6 27.5 55.9 27.7 29.7 24.4 34.4 30.1 27.9 77.8 37.2 22.2 30.1 17.5 27.9 30.3 31.1 10.8 23.4 25.9 12.2 8.2 8.0 6.9 33.5 54.4 20.1 20.1 19.2 13.5 17.1 29.3 18.6 17.7 19.7 35.5 21.0 40.9 27.7 27.2 14.7 13.2 26.9 19.2 13.9 40.0 26.4 45.8 26.0 21.6 17.5 37.2 31.3 21.5 14.5 22.5 23.2 19.5 16.8 36.2 34.4 21.2 17.4 34.1 27.3 11.3 25.1 28.2 13.8 27.8 29.6 20.8 18.3 55.8 19.1 26.0 34.5 27.6 18.8 17.9 16.8 20.3 35.8 18.0 21.0 22.4 37.3 35.0 56.8 50.4 22.1 21.5 22.1 18.5 12.2 9.6 8.0 6.5 8.0 10.8 5.6 6.5 5.8 8.7 6.4 5.1 25.9 8.2 8.2 23.4 6.0 6.9 39.4 41.0 46.8 50.7 34.9 28.6 28.7 42.3 31.3 37.2 41.7 79.1 45.9 20.1 45.8 45.3 52.6 30.6 68.3 56.9 41.8 80.5 32.5 11.6 31.8 50.0 42.9 54.2 23.3 30.4 37.8 29.7 29.1 44.0 52.8 32.5 46.1 85.6 32.5 25.7 57.1 41.7 36.3 38.8 35.1 48.8 26.7 41.7 38.2 38.9 18.8 55.7 19.4 32.0 67.0 46.5 43.3 45.2 48.4 40.2 24.7 SURF2 ENSG00000148291 "Surfeit 2" Q15527 9 133356552-133361169 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.1" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 358.5;Late spermatids: 675.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 43.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044340, HPA052213, HPA059710" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044340: AB_2678900, HPA052213: AB_2681763, HPA059710: " "unprognostic (1.53e-1)" "unprognostic (6.10e-3)" "unprognostic (1.24e-3)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (6.27e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (1.85e-1)" "unprognostic (5.46e-3)" "unprognostic (8.28e-2)" "unprognostic (1.07e-3)" "unprognostic (1.09e-2)" "unprognostic (3.15e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" 8.3 9.2 15.8 9.0 13.2 8.2 10.7 13.1 14.5 5.7 8.8 7.4 10.8 13.2 6.4 12.0 11.0 10.7 11.2 8.9 13.4 11.0 14.3 12.0 6.5 12.1 13.1 8.7 9.0 17.5 7.1 11.3 5.9 10.3 7.7 5.7 7.7 14.2 8.8 11.5 14.8 11.4 6.9 9.4 8.6 9.3 50.1 6.6 10.6 10.1 14.9 9.8 6.5 8.3 17.5 15.6 13.1 16.2 13.2 26.9 14.1 7.2 12.5 5.3 6.5 3.8 3.0 11.1 3.7 3.3 5.9 3.1 17.1 6.0 7.2 5.4 2.4 5.1 19.9 8.3 9.0 2.7 6.9 11.5 5.7 14.3 6.3 7.7 9.3 4.3 3.6 10.7 8.4 12.4 2.1 2.7 8.9 9.0 5.0 4.0 43.6 9.6 6.2 16.6 17.4 24.2 10.7 7.9 16.9 5.0 8.3 19.7 9.9 8.2 13.8 11.0 3.4 14.7 4.4 5.1 9.0 9.1 9.2 13.1 6.2 12.3 7.8 5.7 5.6 9.0 13.1 16.2 12.0 17.8 16.2 23.1 15.6 21.9 20.2 13.8 17.5 20.8 19.7 7.1 13.2 11.6 15.6 26.9 14.1 15.8 13.2 13.1 14.5 13.4 11.0 13.1 8.7 10.3 6.6 11.9 7.8 21.6 25.7 74.8 17.9 12.4 45.9 48.2 17.0 21.0 2.0 33.0 89.5 56.4 358.5 19.4 48.7 0.0 70.1 21.0 22.4 21.1 9.2 21.5 25.8 12.7 35.1 20.3 25.9 675.3 24.2 22.4 40.5 27.9 17.1 13.2 50.2 28.1 23.0 64.0 18.9 64.7 32.0 140.5 86.5 77.0 21.4 26.1 23.8 17.8 TAF13 "TAF2K, TAFII18" ENSG00000197780 "TATA-box binding protein associated factor 13" Q15543 1 109062486-109076002 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044492 Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA044492: AB_10962871" "unprognostic (8.54e-2)" "unprognostic (2.02e-2)" "unprognostic (2.82e-2)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.74e-6)" "unprognostic (1.73e-2)" "unprognostic (2.18e-1)" "prognostic favorable (2.42e-5)" "unprognostic (1.85e-1)" "unprognostic (6.78e-2)" "unprognostic (2.43e-1)" "unprognostic (2.11e-2)" "unprognostic (1.91e-1)" "unprognostic (7.61e-3)" "unprognostic (7.22e-3)" 23.5 13.4 24.6 14.3 23.4 27.7 14.7 14.0 33.7 18.0 16.6 19.5 15.3 10.0 13.9 14.7 22.1 9.9 18.0 19.2 25.3 26.9 22.3 21.0 11.5 8.6 32.2 22.6 6.6 15.9 14.6 21.2 21.0 35.8 16.9 18.2 7.7 14.5 11.7 40.9 13.0 12.8 22.2 36.1 7.7 14.0 10.3 20.7 4.1 18.2 16.6 14.8 16.4 11.0 1.3 3.0 7.9 4.6 0.5 2.3 0.8 20.6 5.4 8.3 12.1 24.0 22.5 13.8 49.1 20.8 20.0 20.3 8.6 4.7 7.9 18.8 32.6 11.9 8.7 14.6 17.7 30.2 13.5 3.3 7.9 13.2 8.9 19.0 13.9 12.1 20.0 21.3 33.5 18.3 10.8 17.1 7.3 15.1 7.7 27.0 11.9 7.3 3.8 16.6 9.6 11.3 5.7 15.0 3.1 23.6 18.0 8.7 10.8 24.1 15.6 17.7 15.5 5.3 9.9 22.3 33.1 12.6 23.3 26.8 9.4 23.7 10.6 35.2 7.4 49.1 2.6 4.6 3.7 1.7 3.3 1.5 1.2 1.1 1.7 1.5 1.3 1.1 1.6 7.9 0.5 2.8 3.0 2.3 0.8 24.6 23.4 14.0 33.7 25.3 26.9 32.2 22.6 35.8 20.7 17.9 21.1 8.2 9.3 62.4 4.5 57.2 10.2 16.0 26.1 7.0 0.0 15.5 11.6 14.4 29.0 19.7 31.6 23.3 18.1 26.6 20.6 18.8 13.9 35.8 16.4 6.4 30.6 24.5 29.7 2.9 8.6 18.4 13.5 12.6 26.1 10.8 24.9 20.1 12.0 26.2 7.5 6.5 26.2 9.8 15.7 72.0 45.9 7.7 10.5 25.9 TAF15 "hTAFII68, Npl3, RBP56, TAF2N" ENSG00000270647 "TATA-box binding protein associated factor 15" Q92804 17 35713791-35864615 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052059, HPA063647" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052059: AB_2681711, HPA063647: AB_2685072" "unprognostic (1.26e-1)" "unprognostic (2.66e-3)" "unprognostic (1.10e-1)" "unprognostic (1.63e-2)" "unprognostic (1.82e-1)" "unprognostic (1.27e-1)" "unprognostic (8.48e-3)" "unprognostic (4.75e-2)" "unprognostic (8.06e-3)" "unprognostic (2.08e-2)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (1.79e-2)" "unprognostic (1.39e-2)" "unprognostic (5.41e-2)" "unprognostic (3.35e-2)" "unprognostic (2.99e-1)" 14.0 12.9 12.7 15.3 16.2 13.9 11.0 13.7 14.1 10.5 11.7 15.0 13.2 12.7 10.2 11.0 12.6 8.0 11.5 13.1 11.8 9.8 15.0 8.9 19.4 14.7 8.3 10.7 11.3 14.6 18.1 11.1 11.1 11.4 10.1 9.2 9.8 15.3 26.9 14.7 13.4 17.5 15.9 12.7 11.0 11.3 15.5 21.1 9.4 12.8 15.8 12.0 9.8 3.7 3.2 3.8 3.6 4.7 7.2 2.2 29.2 48.1 25.7 24.9 20.6 11.7 16.9 33.4 11.4 15.3 15.0 32.2 21.2 58.2 24.1 21.6 18.3 31.1 34.1 33.7 22.0 16.4 44.7 33.5 34.9 33.7 20.4 54.0 22.5 18.6 17.7 23.1 36.3 17.7 20.6 36.2 31.4 24.1 17.2 34.9 58.8 13.1 15.9 27.3 13.8 35.1 38.3 21.8 19.3 52.6 19.5 19.2 41.6 12.6 13.2 31.4 29.5 18.6 27.7 11.8 25.8 16.9 40.1 22.8 27.8 42.4 23.3 26.7 19.3 3.8 3.5 3.5 4.9 3.4 7.2 3.0 3.5 3.8 2.5 3.7 3.3 3.7 2.0 4.7 3.6 3.2 3.9 2.2 14.9 50.3 37.4 49.0 32.1 54.1 35.5 43.3 50.9 64.8 57.6 39.3 72.7 3.3 35.9 4.6 49.6 37.7 46.7 25.7 39.3 25.9 36.3 54.3 53.9 37.4 57.2 47.1 33.2 42.9 8.9 28.4 36.7 32.1 34.3 49.4 55.6 28.8 28.1 38.2 26.6 42.8 45.3 31.9 60.1 72.8 32.5 65.2 42.4 50.6 42.6 TAF4 "TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135" ENSG00000130699 "TATA-box binding protein associated factor 4" O00268 20 61953469-62065810 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008599, CAB031484" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB031484: AB_671207, HPA008599: AB_1080183" "unprognostic (3.38e-2)" "unprognostic (1.21e-2)" "unprognostic (1.38e-1)" "unprognostic (6.29e-2)" "unprognostic (3.14e-1)" "unprognostic (9.67e-2)" "prognostic unfavorable (3.31e-4)" "unprognostic (2.16e-1)" "unprognostic (1.91e-1)" "unprognostic (2.74e-1)" "unprognostic (3.34e-1)" "unprognostic (1.00e-3)" "unprognostic (4.39e-3)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (3.92e-2)" "unprognostic (9.99e-2)" 7.7 11.4 8.5 7.8 9.5 9.8 6.2 16.5 9.6 8.9 9.8 8.5 4.2 10.1 8.5 3.8 7.6 7.0 7.0 4.9 7.7 4.5 6.6 8.9 6.2 7.1 9.6 6.0 16.7 12.4 4.3 6.4 6.8 6.4 6.8 4.6 6.4 6.6 7.6 13.2 7.7 10.4 6.8 5.8 9.7 10.9 17.9 8.7 16.5 6.8 4.3 5.8 7.7 9.9 0.1 0.2 2.7 0.6 0.0 1.4 0.2 5.6 5.3 3.2 3.6 1.5 1.1 6.4 2.8 1.2 4.7 2.5 17.6 4.7 4.6 7.2 1.5 3.5 7.3 2.8 3.3 2.0 3.9 4.1 10.5 5.8 8.1 1.6 5.0 9.5 0.8 3.0 2.1 2.2 1.3 1.8 5.7 8.5 4.1 0.8 6.0 14.0 6.1 4.7 4.0 7.5 13.0 7.3 4.8 1.5 5.2 5.4 4.7 8.5 9.1 2.9 2.4 5.5 6.1 2.3 6.0 8.8 6.0 5.1 5.7 5.3 7.2 3.5 3.0 4.1 0.0 0.6 0.7 0.1 0.2 0.0 0.0 0.3 0.4 0.2 0.1 0.3 0.5 2.7 0.0 0.1 0.1 1.4 0.2 8.5 9.5 16.5 9.6 7.7 4.5 9.6 6.0 6.4 8.7 6.0 16.0 5.6 2.8 6.8 6.2 6.7 5.1 8.1 3.4 5.2 2.0 5.1 0.0 5.1 12.7 4.5 6.8 0.0 3.3 4.2 5.9 5.8 1.1 10.0 4.9 14.3 3.5 5.5 10.7 4.2 8.6 6.1 3.3 1.8 10.9 3.9 5.0 10.5 9.9 4.7 8.6 6.5 8.1 8.9 12.5 8.4 7.0 3.8 9.5 5.6 TAF8 "FLJ32821, TAF(II)43, TBN" ENSG00000137413 "TATA-box binding protein associated factor 8" Q7Z7C8 6 42050513-42087461 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031730, HPA031731, HPA031734" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031730: AB_2674016, HPA031731: AB_2674017, HPA031734: AB_10603994" "unprognostic (7.41e-2)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (3.46e-3)" "unprognostic (3.08e-1)" "unprognostic (2.23e-2)" "unprognostic (2.46e-1)" "unprognostic (3.53e-1)" "unprognostic (2.01e-3)" "unprognostic (6.74e-2)" "unprognostic (8.22e-2)" "unprognostic (1.44e-1)" "unprognostic (8.49e-2)" "unprognostic (1.36e-1)" "unprognostic (1.67e-1)" "unprognostic (2.42e-2)" "unprognostic (2.26e-2)" 24.7 17.4 11.9 17.1 13.2 25.5 17.4 9.6 15.1 15.6 19.0 15.2 21.4 14.9 16.1 17.6 15.6 11.4 12.1 22.8 11.5 9.9 18.7 14.1 16.2 19.9 15.0 13.2 13.8 14.0 22.3 12.3 19.1 12.4 15.6 13.3 16.4 16.4 19.6 25.5 12.8 14.1 14.7 12.2 20.6 17.2 18.9 12.2 36.0 24.3 11.2 20.1 16.7 15.6 15.4 19.8 19.7 24.6 8.4 13.2 7.3 9.5 10.5 8.7 9.7 9.8 9.1 8.0 4.5 7.8 11.9 12.4 17.9 5.8 14.7 9.7 6.5 12.2 7.2 14.1 9.5 9.3 12.7 13.6 18.5 12.6 8.8 12.1 10.7 13.6 12.4 7.6 8.5 10.8 6.0 13.2 18.3 22.8 15.5 6.6 12.7 9.8 16.3 5.4 25.5 4.9 20.2 10.3 11.2 10.5 7.9 9.0 8.0 8.2 6.4 9.1 7.5 9.7 13.2 12.3 10.7 11.2 4.9 9.1 13.5 13.1 31.1 4.9 11.9 6.0 13.4 12.1 19.7 13.2 12.8 9.3 14.1 12.0 10.3 13.0 15.4 12.5 12.1 15.2 8.4 24.6 19.8 10.1 7.3 11.9 13.2 9.6 15.1 11.5 9.9 15.0 13.2 12.4 12.2 17.9 22.6 10.4 11.0 6.3 15.6 24.5 15.3 9.4 19.4 10.4 29.5 19.6 26.6 8.9 8.2 15.8 9.2 0.0 8.4 6.8 10.4 12.4 18.5 7.4 11.5 20.6 8.6 7.4 14.2 13.8 13.8 10.9 6.8 12.6 11.1 11.7 7.4 7.0 11.0 12.9 23.1 12.9 10.8 7.9 14.5 7.3 18.0 12.8 9.0 11.5 TAF9 "AD-004, CGI-137, MGC1603, MGC3647, MGC5067, TAF2G, TAFII31, TAFII32, TAFIID32" ENSG00000273841 "TATA-box binding protein associated factor 9" Q16594 5 69364743-69370013 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 444.4;Late spermatids: 626.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028930, HPA053429, HPA058961, HPA072658" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA028930: AB_2672832, HPA053429: AB_2682148, HPA058961: AB_2683863, HPA072658: " "unprognostic (1.25e-3)" "unprognostic (9.52e-2)" "unprognostic (1.76e-3)" "unprognostic (8.38e-3)" "unprognostic (5.40e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (1.48e-5)" "unprognostic (1.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.66e-1)" "unprognostic (9.45e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (9.20e-4)" "unprognostic (2.58e-1)" "unprognostic (1.97e-1)" "unprognostic (3.02e-2)" "unprognostic (1.79e-1)" 11.3 7.2 6.8 5.5 8.4 16.6 8.8 6.5 9.5 6.7 8.0 4.0 6.3 6.3 5.9 10.0 10.9 5.1 5.7 9.2 5.6 11.5 18.0 6.5 8.2 6.8 6.2 7.3 7.4 4.4 10.8 8.6 9.4 7.1 9.1 4.4 5.2 5.2 11.0 5.3 9.7 6.9 5.7 8.7 6.1 30.1 6.8 10.2 9.8 9.8 9.8 7.8 5.0 24.9 21.8 29.8 28.8 14.9 25.0 31.2 16.9 17.8 11.4 19.1 18.2 23.9 29.8 16.9 25.4 28.4 38.0 18.9 20.8 23.0 12.7 24.2 53.7 12.5 15.2 33.9 37.3 10.4 18.8 18.8 29.7 23.8 44.5 18.5 27.3 28.2 22.5 19.6 44.0 19.9 22.9 21.0 18.8 18.4 26.7 23.3 20.9 29.0 13.6 6.4 14.0 13.6 18.9 26.0 24.1 18.6 18.9 13.5 16.0 9.8 29.2 19.8 15.5 27.3 16.0 11.0 16.8 11.7 27.8 17.1 20.5 28.9 16.1 22.5 12.6 28.4 28.8 29.8 14.9 26.1 22.4 24.9 22.2 18.3 21.8 19.7 25.0 21.4 4.5 14.9 20.6 13.5 23.2 31.2 17.9 30.6 51.1 138.1 154.5 21.2 61.3 43.3 33.5 31.8 22.7 13.7 101.8 76.3 62.8 444.4 55.3 36.5 23.3 69.7 133.9 64.7 69.2 37.0 41.2 94.4 19.1 29.6 34.4 40.6 626.5 60.4 60.8 94.5 53.3 53.5 24.2 76.7 31.6 32.2 66.6 33.1 32.3 93.7 328.5 65.8 142.7 87.4 36.2 61.0 135.9 TAL1 "bHLHa17, SCL, TCL5" ENSG00000162367 "TAL bHLH transcription factor 1, erythroid differentiation factor" P17542 1 47216290-47232220 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 33.1" "Cell type enhanced" "Detected in some" 22 "Endothelial cells: 18.0;Erythroid cells: 93.5;granulocytes: 35.8;Ito cells: 30.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.2;neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.2" "Cell line enhanced" "Detected in some" "HEL: 52.8;HMC-1: 25.4;HUVEC TERT2: 11.0;JURKAT: 21.1;K-562: 16.5;TIME: 12.0" "Region enriched" "Detected in some" 5 "midbrain: 17.1" "Low region specificity" "Detected in many" "CAB017805, HPA047866, HPA073983" Approved Enhanced Nucleoplasm Yes NA Nucleoplasm "CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246" "unprognostic (2.63e-1)" "unprognostic (2.62e-2)" "unprognostic (1.22e-1)" "unprognostic (2.40e-2)" "unprognostic (1.59e-1)" "unprognostic (8.80e-3)" "unprognostic (3.95e-3)" "unprognostic (1.33e-1)" "unprognostic (4.15e-2)" "unprognostic (1.99e-2)" "unprognostic (5.42e-3)" "unprognostic (3.68e-1)" "unprognostic (1.02e-2)" "unprognostic (2.76e-2)" "unprognostic (2.19e-1)" "unprognostic (1.51e-1)" "unprognostic (1.18e-2)" 9.1 2.7 7.0 1.8 5.7 33.1 7.1 1.6 6.9 3.3 2.4 12.0 2.3 1.6 3.7 3.3 2.5 4.1 4.2 3.9 8.8 3.5 4.5 2.4 14.6 2.2 11.1 4.4 1.5 1.3 2.2 2.1 9.8 7.3 2.4 2.4 2.1 1.4 3.0 3.1 2.0 3.3 4.4 9.4 8.5 2.1 1.8 9.2 0.0 6.7 4.1 1.5 2.5 5.5 0.3 0.1 3.2 0.3 0.4 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 52.8 0.0 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 11.0 21.1 16.5 0.0 0.0 0.0 8.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.3 0.4 0.1 1.2 0.4 0.1 0.1 0.1 2.2 7.0 5.7 1.6 6.9 8.8 3.5 11.1 4.4 7.3 9.2 0.0 0.0 0.0 0.0 0.8 0.0 1.7 2.5 0.0 2.3 1.8 0.0 0.1 0.0 0.0 4.8 18.0 0.0 93.5 0.0 0.1 0.9 0.0 35.8 0.0 7.9 0.0 0.0 30.7 2.1 10.2 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.4 0.9 0.0 0.0 0.0 0.0 TARDBP "ALS10, TDP-43" ENSG00000120948 "TAR DNA binding protein" Q13148 1 11012344-11026420 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003703, HPA017284" Supported Enhanced Nucleoplasm NA Yes 13000 Nucleoplasm "CAB003703: AB_425904, HPA017284: AB_1857775" "unprognostic (3.72e-3)" "prognostic favorable (1.15e-5)" "unprognostic (1.06e-1)" "unprognostic (1.22e-1)" "unprognostic (8.52e-2)" "unprognostic (4.10e-2)" "prognostic unfavorable (1.20e-7)" "unprognostic (1.06e-1)" "unprognostic (3.41e-3)" "unprognostic (4.75e-3)" "unprognostic (2.24e-1)" "unprognostic (2.54e-2)" "unprognostic (2.27e-3)" "unprognostic (2.27e-1)" "unprognostic (1.87e-1)" "unprognostic (2.86e-1)" "unprognostic (2.71e-2)" 36.1 38.1 52.3 43.3 62.9 31.7 42.8 86.2 61.8 38.7 39.8 47.6 37.5 39.8 45.8 47.2 47.8 37.9 32.4 40.8 49.5 36.7 39.3 48.3 40.2 52.8 59.0 45.2 53.0 39.1 60.2 68.1 44.2 46.5 43.3 52.9 38.4 41.7 45.3 57.1 43.0 43.4 50.5 44.7 46.1 38.1 34.5 62.6 52.2 46.7 38.0 63.5 38.1 47.9 29.4 31.7 16.5 24.8 33.6 31.1 17.0 52.6 36.2 62.1 31.8 33.7 28.4 36.7 36.2 32.0 59.6 44.6 42.7 38.9 70.2 26.6 40.2 35.0 37.8 75.2 42.1 78.6 37.6 36.3 53.2 60.1 56.7 27.6 63.7 35.4 23.1 47.9 41.8 34.3 33.5 42.2 27.7 68.3 39.6 50.4 42.5 46.6 51.7 49.5 50.5 32.4 55.3 49.8 44.6 42.9 39.0 42.4 35.0 49.3 39.1 27.9 47.4 39.1 45.0 38.5 40.0 47.0 32.9 52.0 29.6 36.5 74.3 26.2 64.1 42.4 16.3 19.6 16.5 25.4 24.8 31.1 29.4 26.0 24.6 31.7 21.2 25.9 27.7 7.9 33.6 23.6 22.2 26.8 17.0 52.3 62.9 86.2 61.8 49.5 36.7 59.0 45.2 46.5 62.6 29.8 67.3 58.2 67.5 101.8 36.2 65.0 33.1 64.3 60.3 27.9 27.5 55.0 28.2 39.9 5.6 56.1 37.9 46.7 47.0 69.3 45.5 61.8 39.5 45.1 43.8 35.0 63.7 35.6 47.5 7.8 43.7 40.0 33.7 38.7 45.1 35.8 42.4 31.6 48.4 33.2 37.8 32.3 50.6 50.2 31.1 100.1 61.4 41.7 47.8 60.0 TBK1 NAK ENSG00000183735 "TANK binding kinase 1" Q9UHD2 12 64451880-64502108 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045797, HPA060211" Uncertain Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA045797: AB_2679457, HPA060211: AB_2684222" "unprognostic (4.73e-2)" "unprognostic (8.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.90e-1)" "unprognostic (1.94e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.30e-4)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.48e-4)" "unprognostic (1.69e-1)" "unprognostic (2.54e-2)" "unprognostic (1.24e-2)" "prognostic unfavorable (4.20e-6)" "unprognostic (4.35e-2)" "unprognostic (1.30e-1)" "unprognostic (1.26e-2)" "unprognostic (9.56e-3)" 19.1 23.3 13.7 16.8 17.1 32.3 19.1 17.8 20.5 14.9 18.3 10.0 14.1 18.0 17.0 15.1 15.3 13.8 15.6 11.7 14.7 15.6 15.4 20.8 17.8 18.3 20.2 13.6 15.6 11.1 13.1 27.2 40.6 21.1 16.3 12.9 10.1 15.0 18.3 24.8 12.1 21.4 17.2 18.8 24.6 14.5 27.9 16.9 3.4 13.3 12.6 16.7 18.4 19.6 9.7 8.2 22.5 11.9 16.3 11.8 5.9 13.4 15.4 8.8 12.8 15.8 16.0 19.4 14.7 21.5 13.9 13.2 8.7 8.2 18.8 12.8 15.9 20.1 12.7 11.3 12.4 16.4 17.3 10.8 20.2 11.2 12.0 17.3 20.6 25.2 12.0 11.3 13.9 13.4 24.1 18.5 7.2 15.4 27.4 17.9 16.4 0.6 16.1 17.6 12.3 9.0 9.6 9.8 18.1 15.1 24.4 7.4 10.7 19.4 20.0 14.3 15.3 20.4 15.0 17.1 12.5 12.1 10.0 14.4 17.4 30.2 18.3 15.8 11.4 16.1 22.5 7.3 16.6 11.0 11.9 11.8 9.7 8.0 11.0 8.2 7.6 2.8 7.1 15.1 16.3 10.6 1.9 9.5 5.9 13.7 17.1 17.8 20.5 14.7 15.6 20.2 13.6 21.1 16.9 17.9 15.6 14.7 23.9 9.7 18.4 10.0 7.6 18.7 19.4 21.0 9.8 24.9 10.0 17.0 24.8 24.1 10.7 0.0 20.6 24.3 13.6 35.1 41.6 14.3 18.1 17.5 16.6 16.5 19.0 20.1 17.8 26.2 13.5 27.9 8.0 13.0 14.3 10.2 19.4 11.6 15.8 25.8 17.8 49.9 12.9 13.0 77.5 25.8 9.3 32.4 TBPL1 "STUD, TLF, TLP, TRF2" ENSG00000028839 "TATA-box binding protein like 1" P62380 6 133952170-133990432 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.2" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 221.6;Spermatocytes: 178.1;Syncytiotrophoblasts: 204.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071810, HPA071813" Enhanced Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA071810: AB_2686451, HPA071813: AB_2686452" "unprognostic (2.21e-3)" "unprognostic (1.95e-2)" "unprognostic (5.11e-2)" "unprognostic (6.67e-3)" "prognostic favorable (7.22e-4)" "unprognostic (5.16e-3)" "prognostic unfavorable (7.91e-5)" "unprognostic (1.19e-1)" "unprognostic (3.94e-2)" "unprognostic (4.66e-2)" "prognostic favorable (7.23e-4)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.14e-4)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.82e-1)" "unprognostic (8.16e-2)" 7.1 7.7 10.8 8.9 11.7 19.3 12.2 16.4 16.6 7.3 7.3 5.2 7.8 8.1 7.9 5.6 7.1 8.5 7.4 7.9 15.9 14.2 5.7 8.5 6.6 12.0 10.0 11.8 8.3 6.0 4.7 8.2 9.2 11.1 8.0 9.3 4.6 5.7 9.2 4.4 5.9 7.7 7.2 8.5 7.6 7.2 71.2 8.0 11.7 10.7 5.0 10.2 9.2 12.0 27.8 14.7 43.1 14.9 21.1 30.8 25.3 6.3 7.8 17.9 11.6 13.7 14.2 10.1 12.1 12.8 16.2 21.3 9.1 5.1 19.8 8.3 9.6 18.0 8.4 11.4 13.0 19.6 15.1 14.2 34.8 4.7 10.0 13.9 18.2 13.6 8.7 13.3 18.1 19.6 12.3 15.3 17.5 50.2 13.6 11.5 14.5 15.2 10.9 20.0 9.3 10.2 10.6 10.8 7.6 9.5 5.7 23.3 23.2 7.1 9.4 14.9 15.6 4.3 7.3 13.8 9.3 13.5 20.5 13.2 11.0 11.9 12.9 15.6 11.9 11.1 43.1 13.7 32.7 28.5 13.8 30.8 27.8 24.1 29.9 12.4 25.0 23.4 27.3 31.4 21.1 14.9 14.7 24.6 25.3 10.8 11.7 16.4 16.6 15.9 14.2 10.0 11.8 11.1 8.0 6.0 12.6 23.3 25.8 62.8 20.7 9.2 20.4 12.0 7.9 7.0 17.7 36.2 24.9 25.0 221.6 33.3 12.0 0.0 22.1 57.3 32.7 32.8 40.3 8.9 21.4 14.3 68.1 17.2 16.7 29.8 19.5 20.0 30.4 19.0 22.4 12.3 24.3 21.0 17.3 18.9 9.4 19.4 34.0 178.1 63.9 57.5 204.8 47.3 23.6 36.7 TBRG1 "FLJ14621, NIAM, TB-5" ENSG00000154144 "Transforming growth factor beta regulator 1" Q3YBR2 11 124622836-124635398 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055645, HPA068022" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055645: AB_2682873, HPA068022: AB_2685942" "unprognostic (1.64e-2)" "unprognostic (3.24e-2)" "unprognostic (7.81e-2)" "unprognostic (1.37e-2)" "unprognostic (9.21e-2)" "unprognostic (3.66e-1)" "unprognostic (1.03e-1)" "unprognostic (4.58e-2)" "unprognostic (1.18e-3)" "unprognostic (1.52e-1)" "unprognostic (7.40e-2)" "unprognostic (3.72e-3)" "unprognostic (1.78e-1)" "unprognostic (1.70e-1)" "unprognostic (1.22e-1)" "unprognostic (3.83e-1)" "unprognostic (7.13e-3)" 13.3 16.0 13.8 15.9 24.8 7.9 9.8 10.3 33.1 9.2 10.9 13.6 8.0 18.7 10.2 14.4 11.0 8.8 11.8 8.7 12.8 9.3 12.9 17.5 14.0 17.1 15.3 18.0 9.4 17.2 11.4 12.7 12.2 15.8 12.9 15.3 8.3 12.1 10.7 18.9 16.0 17.3 9.5 12.2 19.0 15.2 7.4 16.5 7.6 13.4 6.6 16.3 10.8 9.3 24.2 17.7 25.5 19.5 11.1 22.6 9.3 4.9 4.1 4.7 4.2 8.6 6.4 4.4 9.6 5.9 3.2 3.4 7.0 4.1 6.2 5.9 6.6 7.7 8.5 5.5 7.1 5.5 4.3 5.1 24.1 2.1 5.6 7.7 11.5 23.1 6.5 12.7 4.4 6.4 4.9 5.3 6.6 9.2 6.2 7.8 2.5 4.9 9.5 5.8 12.2 6.4 3.2 5.7 3.6 5.6 5.3 3.2 4.9 4.3 6.0 5.7 4.7 9.1 6.8 10.0 8.4 2.7 5.3 5.6 4.7 5.4 6.8 4.4 11.0 5.4 20.5 19.5 25.5 20.4 17.6 15.6 22.5 20.9 17.3 11.5 24.2 22.6 18.0 24.9 11.1 15.5 17.7 19.5 9.3 13.8 24.8 10.3 33.1 12.8 9.3 15.3 18.0 15.8 16.5 41.7 50.4 29.8 40.9 41.0 19.1 20.6 35.7 34.8 46.6 22.7 11.8 28.8 44.7 33.4 41.8 42.9 45.1 23.3 41.6 24.3 42.1 68.1 68.3 58.7 32.8 28.6 27.2 28.3 39.1 4.3 35.1 58.3 32.1 33.3 38.1 26.2 46.7 42.1 31.5 48.0 18.7 25.8 39.2 28.1 22.3 42.0 40.4 49.6 30.4 63.5 TCEAL1 "p21, pp21, SIIR, WEX9" ENSG00000172465 "Transcription elongation factor A like 1" Q15170 X 103628704-103630953 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Leydig cells: 262.6;Peritubular cells: 364.5;Sertoli cells: 148.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057345, HPA060384, HPA076762" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA057345: , HPA060384: AB_2732648, HPA076762: " "unprognostic (1.98e-2)" "unprognostic (2.53e-2)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (1.99e-1)" "unprognostic (5.30e-2)" "unprognostic (1.38e-1)" "unprognostic (5.60e-3)" "unprognostic (6.09e-2)" "unprognostic (2.03e-2)" "unprognostic (9.85e-3)" "unprognostic (6.54e-2)" "unprognostic (4.80e-2)" "unprognostic (2.62e-1)" "unprognostic (2.56e-1)" "unprognostic (5.56e-2)" "unprognostic (8.76e-2)" 10.5 24.7 23.8 9.1 20.8 4.2 19.5 19.9 45.1 29.6 17.1 5.5 29.7 7.3 45.8 20.2 18.4 32.1 17.6 13.5 27.0 18.6 10.6 7.5 10.1 7.8 12.2 25.3 59.1 9.0 13.5 11.2 8.5 19.9 25.4 8.4 6.1 6.4 40.3 22.4 8.1 8.7 49.2 23.5 9.3 13.3 9.3 13.2 3.1 15.5 10.5 4.7 33.9 24.7 18.3 16.6 11.3 8.4 13.4 14.7 8.2 9.5 9.2 5.2 7.2 22.7 15.7 7.0 13.6 13.7 13.3 14.5 4.0 9.5 4.4 14.1 17.5 20.2 9.6 8.7 7.2 9.9 0.0 10.8 6.0 12.9 7.8 10.2 0.0 9.1 19.2 14.0 10.2 5.7 22.1 13.6 5.1 2.2 2.5 26.6 10.5 5.2 0.1 1.7 8.5 15.0 5.4 16.9 0.0 18.3 9.5 7.2 6.1 13.8 6.6 14.9 4.0 6.1 5.6 10.8 9.7 3.5 22.6 6.9 2.5 7.9 0.1 12.7 0.0 9.6 11.3 8.4 0.5 10.4 5.7 14.7 18.3 9.4 8.6 16.6 16.1 12.5 14.3 0.9 13.4 2.3 13.0 8.0 8.2 23.8 20.8 19.9 45.1 27.0 18.6 12.2 25.3 19.9 13.2 14.9 24.5 11.9 44.6 26.4 19.2 25.8 30.6 56.2 44.3 24.4 2.0 27.4 48.0 19.4 1.6 35.2 7.3 0.0 21.7 28.5 38.1 16.0 25.5 17.1 30.3 20.6 26.5 36.8 17.8 4.2 262.6 22.6 18.6 24.4 13.1 29.3 11.5 18.2 364.5 39.9 12.0 148.8 69.3 3.9 7.5 18.6 6.1 17.1 18.1 10.2 TCERG1 "CA150, TAF2S, Urn1" ENSG00000113649 "Transcription elongation regulator 1" O14776 5 146447311-146511961 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064854, HPA069752, HPA069808" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064854: AB_2685370, HPA069752: AB_2686190, HPA069808: AB_2686204" "unprognostic (2.73e-1)" "unprognostic (5.11e-2)" "unprognostic (1.27e-3)" "unprognostic (8.58e-2)" "unprognostic (1.32e-1)" "unprognostic (9.32e-2)" "prognostic unfavorable (5.34e-5)" "unprognostic (1.07e-1)" "unprognostic (3.38e-2)" "unprognostic (2.13e-2)" "unprognostic (2.41e-1)" "unprognostic (1.35e-3)" "prognostic unfavorable (4.70e-11)" "unprognostic (1.52e-2)" "unprognostic (7.76e-2)" "unprognostic (3.98e-2)" "unprognostic (1.24e-3)" 15.7 12.1 16.8 20.9 28.1 34.2 16.7 36.3 22.7 14.2 15.3 13.7 10.1 15.3 19.6 13.9 18.6 17.5 14.8 14.5 16.3 12.7 10.7 10.0 14.7 23.8 12.4 19.1 20.5 12.6 14.4 18.5 17.8 17.2 15.0 16.4 13.0 16.1 19.0 34.9 19.0 15.2 17.5 12.7 16.6 16.8 19.5 14.9 21.9 14.7 14.9 23.9 18.7 16.5 6.5 10.5 2.6 11.6 10.5 8.3 5.8 19.4 14.5 22.5 15.3 6.2 9.8 28.3 14.8 12.0 16.5 19.6 23.3 20.8 33.6 11.1 12.0 11.9 17.5 27.1 18.6 25.3 19.8 21.8 22.2 16.3 14.1 6.6 32.7 17.4 6.8 11.0 15.9 17.5 9.2 14.6 28.7 25.8 12.4 12.6 13.9 28.5 18.5 22.2 11.2 16.5 28.0 26.4 22.4 10.4 15.4 14.6 18.0 16.4 17.6 10.8 14.2 18.6 16.5 16.1 14.4 17.0 12.2 22.8 12.9 14.3 45.3 13.5 28.0 16.1 1.0 6.4 2.6 6.7 9.6 7.9 6.5 7.8 8.3 10.5 6.0 8.2 8.1 0.5 10.5 11.6 5.4 6.9 5.8 16.8 28.1 36.3 22.7 16.3 12.7 12.4 19.1 17.2 14.9 50.6 36.7 36.9 37.7 40.0 54.0 32.3 17.8 40.2 43.3 22.7 58.9 41.0 1.7 22.8 2.2 28.7 13.8 23.3 28.9 50.1 36.0 30.8 35.9 16.6 26.8 33.4 27.1 23.9 27.2 4.1 26.4 26.8 23.6 23.4 32.9 21.2 32.4 24.6 23.0 5.5 36.8 19.4 33.0 77.9 60.0 40.0 36.7 24.9 41.3 51.5 TCF3 "bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, VDIR" ENSG00000071564 "Transcription factor 3" P15923 19 1609290-1652605 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 76.6;REH: 76.2;U-698: 96.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018351, HPA049808, HPA062476" Approved Enhanced Nucleoplasm No No Nucleoplasm "CAB018351: AB_675504, HPA049808: AB_2680892, HPA062476: AB_2684775" "unprognostic (8.82e-2)" "unprognostic (4.74e-2)" "unprognostic (1.26e-2)" "unprognostic (1.25e-1)" "unprognostic (1.91e-2)" "unprognostic (8.25e-3)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.07e-2)" "unprognostic (7.99e-2)" "unprognostic (2.35e-1)" "unprognostic (2.42e-1)" "unprognostic (9.29e-3)" "prognostic unfavorable (1.53e-4)" "unprognostic (4.87e-3)" "unprognostic (1.88e-1)" "unprognostic (3.07e-1)" "unprognostic (8.05e-2)" 13.0 8.8 12.8 31.6 9.8 33.2 17.4 8.3 11.9 15.5 16.2 11.9 9.4 18.1 16.6 11.3 16.7 12.1 19.0 9.4 11.2 6.2 11.9 8.9 13.2 42.0 10.7 6.0 18.2 13.5 6.3 13.9 10.8 11.0 17.1 9.7 12.4 13.6 6.9 11.2 16.7 23.0 8.8 10.4 33.1 14.9 36.0 11.2 63.2 15.9 11.6 38.0 15.2 13.9 11.3 12.1 2.9 2.8 2.3 4.2 1.6 15.9 8.2 22.6 20.3 3.2 8.6 10.1 9.9 7.8 11.4 10.1 16.2 12.6 76.6 11.3 8.1 2.1 16.6 13.8 10.8 6.7 46.4 9.2 7.2 10.3 17.6 7.4 17.6 10.1 5.5 12.5 8.9 6.9 10.2 13.7 28.5 29.6 26.6 7.2 28.2 48.6 17.1 31.4 9.7 8.6 76.2 10.4 17.3 7.7 14.1 21.6 30.3 9.4 9.3 11.5 8.8 11.8 31.4 16.4 15.0 17.8 18.5 16.9 64.8 31.6 96.6 9.8 22.5 13.4 2.9 1.3 0.9 3.5 1.4 3.7 10.8 2.2 3.2 2.7 11.3 3.2 4.2 0.4 2.3 2.8 12.1 2.1 1.6 12.8 9.8 8.3 11.9 11.2 6.2 10.7 6.0 11.0 11.2 6.0 7.8 26.7 4.5 12.4 10.7 8.9 2.5 0.0 10.3 1.8 25.5 3.4 1.7 9.4 6.7 9.5 13.5 0.0 5.9 7.4 11.5 8.0 6.9 3.9 6.7 4.8 15.5 8.6 7.2 3.9 12.7 6.5 10.1 5.4 13.0 9.0 14.7 14.0 9.6 4.5 13.6 19.4 10.5 3.7 15.8 11.5 2.4 8.6 18.4 6.7 TCF7 TCF-1 ENSG00000081059 "Transcription factor 7" P36402 5 134114711-134151865 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 326.1" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 68.7;Rod photoreceptor cells: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "MAIT T-cell: 10.3;memory CD4 T-cell: 17.8;memory CD8 T-cell: 10.4;naive CD4 T-cell: 35.8;naive CD8 T-cell: 21.8;NK-cell: 14.2" "Group enriched" "Detected in many" 19 "NK-cells: 14.2;T-cells: 35.8" "Cell line enriched" "Detected in many" 6 "MOLT-4: 170.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB019403, HPA058863, HPA070505" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB019403: AB_2199302, HPA058863: AB_2683837, HPA070505: AB_2686275" "unprognostic (3.63e-3)" "unprognostic (1.98e-3)" "unprognostic (1.03e-1)" "unprognostic (5.08e-3)" "unprognostic (1.70e-1)" "unprognostic (6.74e-2)" "unprognostic (1.12e-1)" "unprognostic (6.38e-2)" "unprognostic (2.31e-1)" "unprognostic (1.65e-1)" "unprognostic (5.35e-2)" "unprognostic (2.32e-1)" "unprognostic (3.04e-1)" "unprognostic (1.50e-2)" "unprognostic (2.33e-2)" "unprognostic (1.90e-1)" "unprognostic (4.10e-2)" 1.8 3.6 1.3 21.8 1.5 5.2 3.1 0.9 1.2 2.1 3.3 2.5 2.2 5.6 1.4 16.3 2.7 16.1 2.6 1.6 1.5 1.2 2.7 3.7 4.0 41.8 1.3 1.0 2.5 7.2 0.2 6.1 1.4 4.7 2.9 2.3 3.6 7.9 1.8 0.9 2.9 15.1 0.9 3.3 14.4 3.7 2.4 1.1 326.1 4.4 2.2 32.5 3.3 1.5 1.2 0.1 1.0 0.1 14.2 35.8 6.9 0.0 1.0 1.1 3.9 0.5 2.1 1.5 0.3 0.5 0.1 0.1 8.0 2.5 0.0 1.9 1.7 4.3 0.1 1.7 0.4 0.0 0.3 1.7 0.0 1.1 6.0 0.0 0.0 0.2 0.1 0.0 1.6 0.0 0.7 0.2 29.0 1.0 0.0 0.1 0.0 170.0 0.1 1.2 2.5 1.4 0.2 0.0 0.1 0.4 0.1 0.4 3.4 0.8 0.2 0.2 0.9 0.2 0.9 0.2 11.0 0.0 5.0 0.3 0.1 0.0 0.0 5.8 0.0 0.5 0.7 0.1 1.0 4.4 0.0 10.3 1.2 17.8 10.4 0.0 0.4 35.8 21.8 0.7 14.2 0.0 0.1 2.1 6.9 1.3 1.5 0.9 1.2 1.5 1.2 1.3 1.0 4.7 1.1 3.0 3.4 22.9 24.6 14.0 27.8 2.7 10.2 1.4 0.0 3.5 68.7 20.0 0.0 5.8 2.4 4.7 21.4 0.0 8.9 23.4 10.8 11.6 20.7 3.2 6.4 9.5 12.1 6.7 5.2 1.7 5.8 4.9 10.1 9.0 12.7 8.3 15.8 17.3 4.2 0.8 53.0 0.0 16.9 3.9 9.4 9.9 25.1 47.5 14.4 12.3 TCL1A TCL1 ENSG00000100721 "T cell leukemia/lymphoma 1A" P56279 14 95709967-95714196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "blood: 179.4;lymphoid tissue: 63.7" "Group enriched" "Detected in some" 5 "B-cells: 166.3;Spermatogonia: 48.5" "Cancer enriched" "Detected in many" 18 "testis cancer: 64.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 381 "memory B-cell: 45.6;naive B-cell: 179.4;plasmacytoid DC: 79.8" "Group enriched" "Detected in many" 487 "B-cells: 179.4;dendritic cells: 79.8" "Group enriched" "Detected in some" 157 "Daudi: 71.1;REH: 92.4;U-698: 94.4" "Not detected" "Not detected" "CAB004045, HPA016604" Enhanced Enhanced "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB004045: AB_2179419, HPA016604: AB_1857859" "unprognostic (1.27e-3)" "unprognostic (3.12e-4)" "unprognostic (2.61e-4)" "unprognostic (2.01e-2)" "unprognostic (1.27e-1)" "unprognostic (4.75e-4)" "unprognostic (7.70e-2)" "unprognostic (9.67e-3)" "unprognostic (1.03e-1)" "unprognostic (3.35e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-2)" "unprognostic (2.64e-2)" "unprognostic (1.87e-1)" "unprognostic (3.94e-1)" "unprognostic (2.06e-1)" "unprognostic (4.55e-1)" 0.4 0.2 0.2 53.4 0.2 4.8 0.3 0.2 0.2 0.2 0.9 0.0 0.2 0.0 0.3 0.0 0.8 0.3 0.6 0.3 0.2 0.2 1.1 0.4 3.2 63.7 0.2 0.0 0.3 0.2 0.0 0.2 0.6 0.0 0.4 0.2 0.1 2.9 0.0 0.2 0.2 10.4 0.1 0.2 33.5 0.5 5.3 0.0 4.7 0.8 1.2 53.6 3.6 0.3 179.4 79.8 0.2 0.1 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.5 94.4 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 45.6 0.0 0.0 0.1 179.4 0.1 0.0 0.2 0.0 0.1 79.8 0.0 6.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 2.2 166.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 20.6 48.5 0.0 0.0 0.0 0.0 0.0 TDRD3 FLJ21007 ENSG00000083544 "Tudor domain containing 3" Q9H7E2 13 60396457-60573878 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "granulocytes: 143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034925, HPA067153" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB034925: AB_2240523, HPA067153: AB_2732759" "unprognostic (8.52e-2)" "unprognostic (3.19e-1)" "unprognostic (2.23e-1)" "prognostic favorable (2.77e-4)" "unprognostic (5.21e-2)" "unprognostic (2.62e-1)" "unprognostic (7.37e-2)" "unprognostic (5.79e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-1)" "unprognostic (6.18e-3)" "unprognostic (9.62e-2)" "unprognostic (9.95e-2)" "unprognostic (3.68e-2)" "unprognostic (4.40e-2)" "unprognostic (1.27e-3)" 13.7 12.0 13.0 10.3 14.7 6.9 16.9 13.8 14.2 16.7 17.2 11.7 14.2 12.9 15.2 14.2 16.5 14.4 12.7 16.7 12.9 10.6 16.2 13.5 16.9 11.3 13.5 14.8 20.6 21.3 15.3 15.4 12.4 17.7 15.5 15.5 11.1 12.5 14.8 42.4 15.2 16.7 19.0 16.8 12.9 14.8 15.9 15.0 18.7 16.9 18.6 12.1 19.0 15.4 3.8 7.2 2.3 3.5 3.0 6.9 2.1 4.4 4.9 10.9 25.4 4.4 9.5 6.5 5.1 5.8 6.0 3.9 3.2 7.4 10.9 2.1 7.5 5.1 6.3 8.9 7.5 6.5 8.2 6.8 20.3 9.4 6.2 8.5 14.2 10.6 6.4 10.7 3.5 10.6 12.5 8.1 9.0 4.5 6.7 6.5 4.8 12.7 7.4 8.3 16.1 3.8 6.8 5.3 7.2 8.2 5.9 9.7 11.6 7.4 9.0 18.5 7.8 4.6 6.2 6.8 3.8 3.9 4.3 5.6 13.3 11.5 9.4 3.6 7.4 11.7 0.5 2.3 2.3 5.5 3.5 3.8 3.8 6.2 6.2 3.3 2.7 5.2 6.4 0.1 3.0 2.5 7.2 6.9 2.1 13.0 14.7 13.8 14.2 12.9 10.6 13.5 14.8 17.7 15.0 20.8 28.8 13.4 9.0 7.0 29.0 40.4 5.1 33.5 25.0 10.4 51.1 7.3 18.3 11.5 16.8 12.8 9.3 0.0 15.4 8.8 8.3 6.1 143.8 7.2 6.3 19.1 16.7 8.0 9.4 17.0 17.5 11.6 18.6 8.2 13.8 13.4 9.6 15.3 17.3 9.9 28.8 6.5 7.5 33.9 15.5 5.8 5.6 13.8 13.8 6.3 TEAD1 "AA, TCF13, TEF-1" ENSG00000187079 "TEA domain transcription factor 1" P28347 11 12674591-12944483 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057339, HPA062471" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA057339: AB_2683413, HPA062471: AB_2684773" "unprognostic (1.00e-1)" "unprognostic (2.53e-2)" "unprognostic (8.84e-2)" "unprognostic (9.93e-3)" "unprognostic (2.05e-2)" "unprognostic (4.50e-1)" "unprognostic (1.50e-1)" "unprognostic (1.75e-1)" "unprognostic (1.43e-1)" "unprognostic (4.40e-3)" "unprognostic (8.39e-2)" "unprognostic (4.76e-2)" "unprognostic (1.41e-2)" "unprognostic (7.08e-3)" "unprognostic (2.52e-1)" "unprognostic (3.14e-1)" "unprognostic (2.18e-2)" 16.3 6.6 8.2 6.7 6.6 0.0 23.5 7.8 7.7 13.6 12.6 7.3 9.5 4.1 14.1 7.9 16.4 11.4 10.9 16.5 10.6 4.2 13.1 8.4 8.2 1.9 8.0 4.9 12.1 8.6 25.2 18.5 17.5 7.9 13.9 6.7 11.9 8.8 10.4 41.4 7.5 7.3 21.4 7.2 4.1 9.1 5.9 8.2 0.2 9.6 12.8 5.0 22.2 20.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 22.0 21.9 16.7 19.4 18.4 19.2 28.7 30.4 23.3 23.5 21.9 20.4 19.4 0.1 8.3 36.0 10.4 12.7 19.2 11.4 36.9 0.0 7.5 0.0 36.9 6.3 17.3 0.0 1.7 16.5 5.8 17.1 21.4 18.3 4.7 1.4 9.7 0.0 33.0 4.2 0.0 0.1 6.2 4.5 8.7 0.1 22.6 10.8 15.4 14.1 9.2 10.9 32.1 14.9 18.7 23.6 7.3 1.4 10.4 34.2 27.3 28.1 20.6 3.2 6.6 4.0 13.4 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 6.6 7.8 7.7 10.6 4.2 8.0 4.9 7.9 8.2 83.4 14.2 0.8 28.4 88.3 12.7 55.4 33.1 56.2 40.9 47.1 11.8 18.1 1.7 14.0 5.7 23.3 7.0 0.0 10.9 45.4 42.9 45.8 0.0 35.5 3.2 1.6 44.9 20.9 2.4 5.6 21.9 2.5 23.6 0.0 10.4 29.8 25.0 7.0 22.6 24.5 18.8 6.5 34.0 3.2 26.9 47.9 10.3 0.0 8.7 49.8 TEAD2 "ETF, TEF-4, TEF4" ENSG00000074219 "TEA domain transcription factor 2" Q15562 19 49340595-49362457 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 45.7;Early spermatids: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory B-cell: 4.1;naive B-cell: 5.2" "Lineage enriched" "Detected in single" 27 "B-cells: 5.2" "Cell line enhanced" "Detected in many" "AF22: 42.8;AN3-CA: 46.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066292, HPA069963" Supported Nucleoplasm NA NA Nucleoplasm "HPA066292: AB_2685651, HPA069963: AB_2686222" "unprognostic (2.69e-2)" "unprognostic (1.08e-1)" "unprognostic (2.09e-1)" "unprognostic (1.03e-2)" "unprognostic (8.58e-3)" "unprognostic (4.39e-1)" "prognostic unfavorable (8.66e-4)" "unprognostic (2.91e-1)" "unprognostic (4.47e-3)" "unprognostic (1.11e-1)" "unprognostic (3.96e-3)" "unprognostic (1.24e-1)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" "unprognostic (1.08e-1)" "unprognostic (1.31e-1)" "unprognostic (6.78e-2)" 17.6 8.1 4.5 9.3 4.3 0.0 19.5 2.1 3.4 21.7 21.6 3.9 11.6 3.9 20.2 12.4 12.8 14.4 12.8 25.6 4.1 1.5 11.3 18.3 19.9 8.7 5.6 1.8 25.2 18.1 4.9 4.5 10.5 5.2 19.0 6.3 19.0 10.0 13.6 6.1 4.8 8.1 21.8 7.5 11.8 14.7 10.9 3.2 1.8 9.5 8.9 5.1 16.3 26.4 5.2 0.0 0.0 0.1 0.0 0.1 0.1 3.7 8.8 42.8 46.3 4.6 6.8 7.6 7.0 7.5 8.1 9.5 0.7 2.1 0.3 9.4 11.9 4.1 4.3 11.7 2.4 4.5 0.0 5.4 0.0 8.4 5.8 8.0 0.0 0.1 8.0 5.6 5.5 2.7 16.1 28.8 0.0 6.5 0.0 11.3 4.7 0.0 0.0 14.4 10.8 11.3 0.0 12.9 0.0 7.4 0.0 0.0 26.0 11.8 1.7 3.1 15.3 12.7 1.0 16.9 14.7 9.1 3.1 0.5 0.0 0.0 1.4 0.5 0.1 5.7 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 4.3 2.1 3.4 4.1 1.5 5.6 1.8 5.2 3.2 3.0 2.7 0.0 5.0 3.0 0.0 0.8 7.6 1.4 3.4 12.2 0.0 0.7 1.7 45.7 59.6 26.5 0.0 0.0 22.7 19.4 13.2 6.2 0.0 2.0 0.6 0.0 6.8 18.4 1.2 22.0 14.1 0.6 5.0 0.0 4.5 7.8 25.8 3.5 20.8 0.0 0.4 32.3 24.5 2.5 1.5 1.4 1.0 0.0 5.2 2.4 TERF2 "TRBF2, TRF2" ENSG00000132604 "Telomeric repeat binding factor 2" Q15554 16 69355561-69408571 "Predicted intracellular proteins" "Cell cycle" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001907, HPA002735, CAB010451" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB010451: AB_2201333, HPA001907: AB_1080246, HPA002735: AB_1857898" "unprognostic (2.61e-2)" "unprognostic (2.61e-2)" "unprognostic (3.05e-1)" "unprognostic (1.60e-1)" "unprognostic (1.54e-1)" "unprognostic (1.13e-2)" "unprognostic (6.07e-2)" "unprognostic (3.45e-2)" "unprognostic (3.42e-1)" "unprognostic (1.64e-1)" "unprognostic (1.07e-1)" "unprognostic (1.23e-1)" "unprognostic (1.00e-1)" "unprognostic (5.79e-2)" "unprognostic (2.92e-1)" "unprognostic (2.00e-2)" "unprognostic (1.04e-1)" 15.6 14.9 22.1 18.2 24.4 16.1 14.1 32.2 30.0 16.2 15.2 20.0 13.3 13.4 19.2 16.4 15.3 16.1 14.0 14.7 21.2 22.1 13.2 14.9 12.6 32.6 19.6 21.6 20.5 22.2 26.9 13.4 15.8 17.1 15.5 15.0 14.5 12.0 15.3 28.9 15.3 13.6 19.6 17.3 14.9 12.6 15.8 16.5 23.0 16.9 9.6 42.2 17.2 21.5 15.2 5.4 11.2 4.1 4.9 7.5 2.9 8.2 13.5 12.2 12.2 11.6 8.6 10.4 8.4 10.6 20.1 15.6 12.2 11.3 37.9 11.5 10.3 7.2 13.4 14.8 10.3 18.9 7.1 11.7 10.9 7.1 11.1 9.9 10.8 9.2 8.8 10.5 16.0 19.6 9.0 13.8 15.1 20.6 5.5 12.9 11.2 21.4 13.9 14.0 9.1 6.5 30.0 8.1 21.8 8.6 6.1 13.8 10.8 28.0 6.4 7.5 11.5 12.1 12.6 8.4 12.6 11.1 8.6 10.0 14.8 15.4 47.8 10.9 9.8 12.1 11.2 4.1 4.5 6.8 3.4 5.1 15.2 6.8 5.9 4.1 8.7 7.5 7.5 4.7 4.9 3.5 5.4 5.2 2.9 22.1 24.4 32.2 30.0 21.2 22.1 19.6 21.6 17.1 16.5 14.9 12.2 20.8 10.2 11.1 23.2 13.5 10.2 8.1 4.5 8.7 17.7 6.7 1.7 4.5 25.7 16.5 10.2 0.0 6.6 6.5 8.5 11.9 13.9 16.6 10.3 42.9 9.8 14.7 15.4 16.2 8.6 10.1 3.3 2.8 10.0 17.6 7.0 7.0 13.4 7.0 12.8 19.4 10.8 7.7 12.0 11.3 7.0 8.7 10.0 11.2 TESK2 ENSG00000070759 "Testis-specific kinase 2" Q96S53 1 45343883-45491166 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 13.1;RT4: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027257, HPA063869" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027257: AB_10602477, HPA063869: AB_2685137" "unprognostic (2.95e-1)" "prognostic favorable (2.22e-4)" "unprognostic (3.90e-2)" "unprognostic (5.04e-3)" "unprognostic (6.03e-2)" "unprognostic (1.87e-3)" "unprognostic (3.22e-2)" "unprognostic (1.43e-2)" "unprognostic (5.15e-2)" "unprognostic (2.96e-1)" "unprognostic (2.28e-1)" "unprognostic (2.86e-1)" "unprognostic (4.36e-2)" "unprognostic (2.49e-2)" "unprognostic (1.13e-1)" "unprognostic (4.37e-2)" "unprognostic (2.01e-1)" 5.5 3.3 6.1 5.9 17.4 12.6 9.6 7.8 12.6 7.7 8.4 25.7 4.0 11.9 4.7 5.7 9.1 4.1 3.9 5.8 9.6 5.1 3.5 9.7 5.5 6.0 19.2 4.7 14.4 4.6 6.7 4.1 8.3 13.2 22.1 10.1 7.6 11.2 5.7 10.1 17.1 14.8 4.4 18.7 6.3 5.6 11.7 14.8 4.2 5.1 3.2 7.2 8.2 9.7 7.5 2.0 15.9 5.9 1.1 3.7 2.6 1.6 0.0 0.8 0.0 3.2 1.7 13.1 0.6 4.3 1.9 3.2 3.6 1.5 5.3 0.6 1.6 4.9 2.0 3.4 2.7 1.5 3.7 4.3 3.6 1.8 2.7 1.7 1.2 9.9 1.8 2.9 2.1 3.0 2.9 1.5 7.1 0.6 10.9 1.3 0.6 3.0 2.4 3.4 1.5 1.5 4.4 0.1 1.4 1.7 12.8 0.3 1.4 3.4 6.4 12.2 8.1 10.0 1.5 0.0 0.2 2.0 1.6 1.1 7.2 4.2 1.0 1.0 0.0 0.8 9.4 3.8 10.6 2.4 2.8 1.7 7.5 2.2 1.6 2.0 5.7 3.7 2.1 15.9 1.1 5.9 1.1 1.5 2.6 6.1 17.4 7.8 12.6 9.6 5.1 19.2 4.7 13.2 14.8 0.0 3.2 2.4 6.5 6.9 2.3 1.1 5.1 1.4 3.4 0.0 13.7 6.5 0.0 1.0 18.1 2.9 12.4 0.0 2.3 2.5 2.2 12.9 6.9 5.5 5.9 0.0 4.1 1.3 4.6 5.2 2.6 4.5 3.3 2.8 5.3 1.1 1.0 7.4 1.8 0.6 2.8 6.5 4.7 26.8 5.7 7.4 12.4 4.4 4.9 7.3 TFAP2A "AP-2, AP2TF, TFAP2" ENSG00000137203 "Transcription factor AP-2 alpha" P05549 6 10393186-10419659 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 130.5;retina: 48.1" "Cell type enhanced" "Detected in many" 17 "Cytotrophoblasts: 245.7;Extravillous trophoblasts: 224.5;Syncytiotrophoblasts: 585.5" "Cancer enhanced" "Detected in many" "melanoma: 45.6" "Region enhanced" "Detected in single" "cerebellum: 2.2" "Cell type enriched" "Detected in single" 10 "myeloid DC: 1.0" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.0" "Cell line enhanced" "Detected in many" "AN3-CA: 28.0;HDLM-2: 31.3;hTCEpi: 30.2;SuSa: 31.6" "Region enhanced" "Detected in single" "cerebellum: 4.3" "Region enhanced" "Detected in single" "cerebellum: 8.6" "CAB000326, HPA056871" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000326: AB_667767, HPA056871: AB_2683262" "unprognostic (5.97e-2)" "unprognostic (2.18e-1)" "unprognostic (1.31e-2)" "unprognostic (1.14e-1)" "unprognostic (3.87e-2)" "unprognostic (1.27e-1)" "unprognostic (7.62e-5)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.45e-1)" "unprognostic (2.76e-2)" "unprognostic (3.33e-3)" "unprognostic (2.82e-1)" "unprognostic (1.40e-11)" "unprognostic (1.46e-2)" "unprognostic (2.14e-1)" "unprognostic (1.72e-4)" "unprognostic (2.25e-2)" 0.4 0.3 0.3 0.0 0.3 0.0 19.0 2.2 0.5 4.4 0.8 0.0 18.7 0.2 0.5 17.8 18.3 0.4 1.7 0.7 0.3 0.2 6.4 0.2 0.5 0.1 0.2 0.2 0.3 0.3 0.0 0.4 130.5 0.6 5.8 0.2 48.1 19.4 26.7 0.2 36.0 0.4 0.1 0.4 0.2 0.7 1.6 0.0 0.1 0.4 16.6 9.9 2.4 9.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 16.3 6.3 0.0 28.0 0.1 0.0 6.0 12.1 9.3 9.9 9.8 0.6 6.1 0.9 1.6 3.5 5.7 17.5 1.5 20.7 9.5 31.3 15.8 0.1 14.8 0.0 0.0 0.4 0.4 0.0 30.2 0.0 22.0 5.6 0.0 0.3 0.9 0.0 0.1 3.6 0.0 5.1 0.1 1.0 7.8 1.7 1.5 0.6 5.6 6.6 4.1 0.1 14.9 26.2 23.8 31.6 17.3 0.5 0.0 3.0 0.8 2.1 7.6 0.0 1.4 0.2 1.6 0.5 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 2.2 0.3 0.3 0.2 0.2 0.2 0.6 0.0 0.0 0.0 0.0 37.5 116.1 3.1 2.2 0.0 8.1 15.9 29.6 2.0 245.7 6.6 2.0 4.6 0.8 0.0 0.0 0.3 224.5 5.3 38.8 0.0 0.0 17.7 76.3 1.2 0.0 0.0 2.1 0.6 0.2 118.1 0.0 0.5 2.4 2.2 0.0 0.0 0.2 4.2 0.0 2.1 3.9 11.8 120.9 585.5 0.0 0.4 39.3 TGIF2 ENSG00000118707 "TGFB induced factor homeobox 2" Q9GZN2 20 36573488-36593950 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053786, HPA064522" Enhanced Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA053786: AB_2682261, HPA064522: " "unprognostic (1.42e-2)" "unprognostic (8.27e-2)" "unprognostic (2.80e-1)" "unprognostic (2.10e-3)" "unprognostic (4.50e-2)" "unprognostic (2.10e-1)" "unprognostic (7.19e-2)" "unprognostic (4.88e-2)" "unprognostic (2.70e-2)" "unprognostic (1.77e-1)" "unprognostic (6.73e-2)" "unprognostic (1.51e-1)" "unprognostic (3.75e-2)" "unprognostic (8.53e-2)" "unprognostic (1.22e-1)" "unprognostic (8.79e-3)" "unprognostic (1.14e-2)" 14.0 6.1 2.8 20.0 3.1 4.1 7.8 1.3 3.5 13.7 8.8 4.0 3.5 3.2 23.7 7.9 6.8 18.0 10.2 7.6 2.7 2.5 9.2 13.2 13.7 16.6 4.4 1.6 17.9 33.3 10.5 3.4 9.1 3.9 9.3 3.7 12.1 14.9 5.7 4.1 5.6 8.1 13.7 3.2 20.3 7.0 16.9 2.8 26.7 12.9 6.9 22.1 10.0 7.2 8.2 7.7 14.7 5.4 4.2 7.6 3.8 7.0 1.7 20.3 23.0 3.0 2.7 7.4 4.0 4.7 9.7 7.3 10.4 9.0 19.0 10.7 3.9 4.4 7.3 16.5 10.5 9.5 8.9 5.9 23.8 4.1 13.7 4.6 10.0 5.8 4.3 7.0 2.0 7.6 8.8 9.6 9.2 11.4 11.7 4.7 10.0 17.0 19.2 17.0 10.3 5.1 14.7 24.3 10.3 6.4 4.7 6.1 18.1 1.3 10.8 10.1 17.0 12.9 22.5 6.9 1.5 6.4 0.1 7.6 13.4 5.0 17.9 0.1 12.1 7.6 14.7 5.4 1.7 4.8 4.9 5.2 8.2 4.4 4.9 7.4 6.5 7.6 6.3 2.2 4.2 3.4 7.7 4.2 3.8 2.8 3.1 1.3 3.5 2.7 2.5 4.4 1.6 3.9 2.8 8.9 9.1 6.5 26.2 39.6 0.1 11.2 12.7 5.3 9.1 7.0 2.0 5.2 6.6 16.4 2.0 14.3 0.0 0.0 6.7 1.0 16.9 15.0 16.1 5.9 8.7 0.0 6.3 11.6 7.0 1.9 5.8 8.8 13.5 7.2 2.6 7.2 13.3 6.2 7.1 6.1 1.9 6.5 15.6 2.3 25.6 22.2 7.6 12.8 3.3 13.9 TGOLN2 "TGN38, TGN46, TGN48, TGN51, TTGN2" ENSG00000152291 "Trans-golgi network protein 2" O43493 2 85318020-85328425 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB011489, HPA012609, HPA012723" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" NA NA 9800000 "Golgi apparatus" Nucleoplasm "CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975" "unprognostic (3.03e-2)" "unprognostic (1.82e-2)" "unprognostic (2.35e-1)" "unprognostic (4.39e-2)" "unprognostic (3.90e-2)" "unprognostic (2.66e-1)" "unprognostic (5.50e-3)" "unprognostic (2.49e-1)" "unprognostic (2.98e-1)" "unprognostic (1.52e-2)" "unprognostic (5.19e-2)" "unprognostic (2.72e-2)" "unprognostic (6.30e-2)" "unprognostic (2.83e-2)" "unprognostic (3.22e-2)" "unprognostic (2.04e-2)" "unprognostic (5.37e-2)" 40.0 40.7 34.3 38.4 38.0 55.6 36.5 51.7 43.1 33.3 50.0 38.7 31.5 53.2 41.2 31.1 23.9 33.3 44.9 43.2 31.9 34.4 59.6 66.2 44.1 37.4 35.4 36.7 36.1 34.4 39.5 21.8 50.4 35.8 34.0 50.1 26.9 38.9 36.5 23.7 23.7 63.1 36.0 40.3 47.1 36.8 22.3 33.2 31.8 44.8 17.0 37.7 39.9 32.9 9.4 14.9 34.2 34.1 8.6 12.3 22.7 11.3 29.4 12.5 16.5 30.2 31.7 29.2 34.6 40.4 23.5 18.9 24.5 34.5 14.3 27.4 47.8 32.3 18.6 9.0 16.9 39.1 23.3 9.0 20.4 10.4 26.3 16.4 39.5 47.4 23.4 10.8 30.4 18.4 36.6 34.0 12.1 11.8 23.5 34.7 10.3 12.7 20.1 11.1 25.4 12.0 13.5 46.0 10.5 25.3 17.9 11.8 9.8 30.2 22.8 20.0 15.4 12.7 17.8 36.0 50.5 18.8 38.1 41.4 15.3 19.7 13.9 37.4 30.7 32.9 17.6 27.5 23.5 12.3 26.9 9.6 9.4 9.2 8.3 14.9 9.1 9.6 9.1 34.2 8.6 34.1 5.6 7.2 22.7 34.3 38.0 51.7 43.1 31.9 34.4 35.4 36.7 35.8 33.2 95.3 89.8 56.6 49.3 34.0 49.1 62.0 180.9 111.1 77.3 171.0 37.3 50.3 8.3 79.9 4.7 71.6 170.0 0.0 81.2 69.6 67.3 78.0 151.6 221.1 103.3 197.0 86.0 81.6 146.0 5.6 45.8 116.6 57.3 39.7 94.6 52.5 79.1 98.9 65.0 89.4 34.5 64.7 48.7 22.3 32.7 30.6 37.3 74.8 88.0 60.7 THAP8 FLJ32891 ENSG00000161277 "THAP domain containing 8" Q8NA92 19 36034985-36054762 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 19.3;Spermatogonia: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA064056, HPA070139" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064056: AB_2685184, HPA070139: AB_2686230" "unprognostic (1.33e-3)" "unprognostic (2.24e-1)" "unprognostic (8.03e-2)" "unprognostic (1.08e-2)" "unprognostic (3.10e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (9.01e-3)" "unprognostic (3.94e-1)" "unprognostic (1.27e-1)" "prognostic favorable (3.19e-4)" "unprognostic (2.50e-1)" "unprognostic (2.10e-2)" "unprognostic (9.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.48e-2)" "unprognostic (2.48e-1)" 4.6 5.3 9.1 3.9 10.3 1.3 3.3 6.0 8.7 5.7 11.2 10.1 3.9 4.9 6.4 6.3 5.2 6.8 6.5 4.8 6.5 6.6 5.4 5.6 4.6 4.3 8.5 8.1 6.3 3.4 5.6 6.1 6.4 9.9 5.6 4.1 3.6 5.7 7.5 12.7 8.5 5.0 7.5 9.0 5.0 4.8 15.8 13.3 10.1 5.2 2.6 3.5 7.8 5.0 5.9 6.2 10.4 9.3 7.0 8.4 5.3 2.5 7.9 3.9 3.3 10.5 6.6 2.8 2.3 4.1 4.6 7.6 3.5 2.0 3.8 8.1 3.6 4.7 1.3 2.3 2.9 1.7 2.9 1.9 2.4 2.0 4.0 12.0 1.1 2.3 5.5 4.5 3.1 1.8 5.5 2.3 7.4 2.2 4.7 4.7 4.9 3.1 3.1 3.6 4.8 2.9 3.0 1.3 3.6 3.9 2.4 6.9 5.2 4.0 3.3 2.4 5.5 3.5 1.7 1.5 6.5 4.2 3.4 1.8 3.9 3.3 2.7 6.9 2.3 3.9 10.4 8.6 9.5 7.2 9.3 8.1 5.9 7.5 7.2 6.2 4.9 6.1 8.4 4.0 7.0 8.0 6.2 7.0 5.3 9.1 10.3 6.0 8.7 6.5 6.6 8.5 8.1 9.9 13.3 3.0 3.0 2.7 1.0 1.0 2.1 3.1 5.1 0.0 2.3 7.0 2.0 9.3 1.7 4.0 1.8 1.6 2.6 0.0 0.5 4.0 3.3 0.9 5.7 2.9 13.5 3.2 6.3 2.5 5.1 3.9 1.7 1.8 1.7 5.4 1.3 4.3 3.7 1.5 3.9 7.4 2.2 0.0 2.5 19.3 19.8 1.9 8.8 3.2 2.3 1.0 THOC3 "MGC5469, TEX1" ENSG00000051596 "THO complex 3" Q96J01 5 175917873-176034680 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.4" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 149.1;Spermatocytes: 102.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042764, HPA044009, HPA045071" Approved Enhanced Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "HPA042764: AB_10965055, HPA044009: AB_10959603, HPA045071: AB_10959461" "unprognostic (1.13e-1)" "unprognostic (1.44e-1)" "unprognostic (1.85e-3)" "unprognostic (6.48e-3)" "unprognostic (8.60e-2)" "unprognostic (3.57e-2)" "unprognostic (3.06e-3)" "unprognostic (2.02e-2)" "unprognostic (3.41e-2)" "unprognostic (1.11e-2)" "unprognostic (1.04e-1)" "unprognostic (4.04e-2)" "unprognostic (8.80e-3)" "unprognostic (3.20e-1)" "unprognostic (2.86e-1)" "unprognostic (3.16e-2)" "unprognostic (2.91e-1)" 2.3 3.5 8.5 2.3 5.8 8.3 6.0 12.5 6.4 4.7 7.3 3.0 3.4 20.0 21.5 4.0 1.6 1.7 8.5 3.2 4.4 6.0 2.8 7.3 2.6 5.3 3.4 0.4 3.7 4.5 3.8 5.9 5.5 4.1 2.6 7.2 4.1 3.0 2.0 4.3 4.5 11.9 5.1 12.5 5.1 7.6 24.0 13.9 4.7 10.5 12.6 41.4 19.2 22.3 12.5 13.3 29.1 12.8 11.5 48.6 13.5 12.6 29.9 34.8 17.7 18.3 29.2 19.6 7.7 32.3 19.3 20.2 57.5 31.6 20.0 29.5 15.7 12.4 19.2 4.2 25.7 14.2 9.7 24.5 25.7 13.0 6.7 16.4 27.5 23.8 13.2 18.8 26.9 17.3 15.8 11.4 22.3 45.8 30.2 16.9 30.4 21.3 16.8 25.8 14.9 28.0 13.7 13.8 20.2 15.6 23.6 12.5 10.3 11.8 15.9 24.1 6.6 11.6 17.5 7.7 25.0 8.0 4.4 9.0 4.7 13.7 10.5 16.5 16.5 28.3 16.8 13.9 24.0 34.9 21.9 1.3 12.6 9.4 12.9 41.4 19.2 11.9 7.5 18.0 23.9 39.5 12.1 3.1 7.6 8.1 5.7 24.4 9.8 43.8 34.9 21.6 149.1 14.1 7.8 46.7 16.8 69.7 17.4 13.6 11.5 19.0 21.6 6.4 16.1 16.5 9.9 84.4 13.6 13.4 8.5 15.4 15.9 7.8 19.7 7.0 18.0 35.5 10.9 19.4 18.4 102.0 45.3 35.8 16.7 23.5 28.5 21.7 TJP3 ZO-3 ENSG00000105289 "Tight junction protein 3" O95049 19 3708109-3750813 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.0" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 259.3;Enterocytes: 138.3;Paneth cells: 101.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "gdT-cell: 2.0;MAIT T-cell: 6.2;memory CD4 T-cell: 4.8;memory CD8 T-cell: 3.8;naive CD4 T-cell: 5.3;naive CD8 T-cell: 1.9;T-reg: 5.5" "Lineage enriched" "Detected in many" 6 "T-cells: 6.2" "Cell line enhanced" "Detected in some" "BEWO: 22.2;CAPAN-2: 22.3;MCF7: 9.8;OE19: 17.4;SK-BR-3: 13.0;T-47d: 27.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB013244, HPA046863, HPA053337" Enhanced Enhanced "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB013244: AB_2533257, HPA046863: AB_2679845, HPA053337: AB_2682118" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (2.80e-1)" "prognostic favorable (1.83e-6)" "unprognostic (2.78e-1)" "prognostic favorable (9.52e-4)" "unprognostic (1.30e-1)" "unprognostic (1.25e-1)" "unprognostic (2.52e-1)" "unprognostic (6.52e-2)" "unprognostic (2.15e-2)" "unprognostic (1.78e-1)" "prognostic favorable (9.36e-8)" "unprognostic (8.58e-3)" "unprognostic (5.03e-2)" "unprognostic (1.31e-1)" "unprognostic (4.62e-3)" 0.2 0.0 0.3 8.4 0.4 0.0 3.6 0.2 0.3 3.3 34.9 0.7 15.0 23.0 0.7 5.0 16.0 7.9 22.8 0.6 0.5 0.1 4.4 8.0 10.1 0.6 0.2 0.2 2.2 5.9 2.0 1.6 2.7 1.1 2.6 7.7 1.6 26.1 20.5 0.4 4.3 47.0 0.6 0.2 0.4 15.2 1.4 0.2 0.6 5.5 2.6 8.3 4.5 3.4 1.0 0.0 0.0 0.0 0.0 6.2 1.7 0.1 3.3 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 6.5 22.3 4.0 0.6 0.0 0.0 5.2 0.3 0.0 0.0 0.2 0.1 0.0 0.5 1.6 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 9.8 0.0 0.1 0.4 17.4 0.1 0.0 0.0 2.9 0.7 3.4 0.1 0.1 0.8 13.0 0.0 1.7 27.4 0.1 0.0 0.0 0.5 0.0 0.0 0.8 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 6.2 0.7 4.8 3.8 0.0 1.0 5.3 1.9 0.0 0.0 0.0 0.0 5.5 1.7 0.3 0.4 0.2 0.3 0.5 0.1 0.2 0.2 1.1 0.2 8.9 10.7 0.0 6.7 0.0 0.0 0.8 30.6 34.8 12.5 29.6 0.0 26.9 16.6 16.8 259.3 0.0 138.3 0.0 21.0 3.5 0.2 4.8 4.6 4.9 2.4 0.0 12.0 0.0 0.0 10.7 1.7 0.1 3.3 0.0 40.6 0.0 16.7 101.7 1.1 5.1 0.0 0.0 0.2 2.1 3.3 0.1 33.6 1.5 46.1 23.1 TKT ENSG00000163931 Transketolase P29401 3 53224707-53256052 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 216.3" "Cell type enhanced" "Detected in all" 5 "Kupffer cells: 587.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "classical monocyte: 63.0;eosinophil: 41.5;intermediate monocyte: 31.0;myeloid DC: 32.5;neutrophil: 60.1;non-classical monocyte: 35.5" "Group enriched" "Detected in all" 8 "dendritic cells: 32.5;granulocytes: 60.1;monocytes: 63.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029480, HPA029481" Enhanced Enhanced Nucleoplasm NA NA 190000000 Nucleoplasm "HPA029480: AB_10599307, HPA029481: AB_10601895" "unprognostic (5.05e-2)" "unprognostic (3.34e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-2)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (7.21e-6)" "unprognostic (6.78e-2)" "unprognostic (1.70e-1)" "unprognostic (4.73e-2)" "unprognostic (3.06e-3)" "unprognostic (1.36e-2)" "unprognostic (2.08e-1)" "unprognostic (2.99e-1)" "unprognostic (1.07e-1)" "unprognostic (3.29e-1)" "unprognostic (9.90e-3)" 53.6 37.0 21.2 24.1 26.0 216.3 70.1 18.1 24.3 19.0 24.3 21.1 9.9 31.8 16.9 9.5 60.4 21.8 36.5 15.3 19.4 23.0 51.9 27.4 50.1 45.6 33.4 16.0 35.2 69.9 22.5 16.9 29.8 28.7 25.2 19.6 17.5 21.0 21.6 5.2 16.8 22.5 34.5 28.2 45.6 24.5 10.8 23.3 44.8 67.7 37.9 25.1 58.2 57.3 6.8 32.5 60.1 63.0 4.7 5.7 37.6 31.4 159.3 22.8 25.3 50.9 62.2 46.6 21.3 37.0 37.0 35.4 44.0 81.1 39.6 10.3 31.1 71.5 45.6 39.5 80.3 11.0 13.2 21.9 26.4 111.4 66.0 62.3 32.2 17.8 45.0 46.2 44.2 22.8 101.2 46.5 33.7 18.7 17.3 15.0 38.5 33.6 36.1 77.4 61.4 38.5 20.3 10.4 73.6 57.8 53.5 14.8 11.0 39.7 63.6 38.3 72.9 19.8 44.6 34.8 11.4 17.7 33.7 40.7 10.0 18.7 23.7 25.0 32.7 21.2 7.0 63.0 41.5 3.0 31.0 3.8 6.8 4.4 3.4 32.5 3.5 4.6 3.4 60.1 4.7 35.5 5.5 5.7 37.6 21.2 26.0 18.1 24.3 19.4 23.0 33.4 16.0 28.7 23.3 125.0 107.1 122.7 318.5 70.5 32.5 12.0 68.8 60.2 69.4 59.3 27.5 317.9 68.0 167.6 5.0 48.1 125.0 23.3 233.6 204.0 47.6 102.3 61.2 73.1 233.2 35.0 50.5 56.4 587.5 2.7 145.6 247.7 72.6 160.5 113.7 78.1 222.7 69.1 100.4 170.5 36.1 51.8 72.1 14.1 21.1 58.6 345.9 84.1 213.7 357.0 TLX3 "HOX11L2, RNX" ENSG00000164438 "T cell leukemia homeobox 3" O43711 5 171309284-171312134 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "brain: 46.6" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 5.2" "Cancer enhanced" "Detected in some" "cervical cancer: 1.7" "Region enriched" "Detected in some" 22 "cerebellum: 46.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 24.6" "Region enriched" "Detected in single" 7 "cerebellum: 2.5" "Region enriched" "Detected in some" 10 "cerebellum: 48.1" "HPA030504, HPA060957, HPA069359" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130" "unprognostic (3.52e-2)" "unprognostic (2.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.11e-1)" "unprognostic (9.80e-2)" "unprognostic (2.76e-2)" "unprognostic (4.48e-2)" 0.4 0.5 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 24.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 TMA16 "C4orf43, FLJ11184" ENSG00000198498 "Translation machinery associated 16 homolog" Q96EY4 4 163494442-163520539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041571, HPA052688" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA041571: AB_10794381, HPA052688: AB_2681916" "unprognostic (6.02e-2)" "unprognostic (1.19e-1)" "unprognostic (4.63e-2)" "unprognostic (1.18e-1)" "unprognostic (4.00e-1)" "unprognostic (2.92e-3)" "prognostic unfavorable (2.70e-5)" "prognostic unfavorable (4.40e-4)" "unprognostic (2.30e-3)" "unprognostic (1.33e-2)" "unprognostic (1.17e-3)" "unprognostic (2.69e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (6.98e-2)" "unprognostic (2.30e-1)" "unprognostic (1.40e-2)" "unprognostic (2.56e-2)" 16.1 13.1 7.1 25.3 9.6 10.2 16.0 8.9 11.5 17.5 11.5 8.9 11.8 9.4 18.5 17.7 16.1 12.8 13.5 12.0 8.7 7.4 13.5 16.8 10.2 22.1 7.6 8.8 16.0 19.3 7.2 12.4 12.6 9.9 11.6 11.0 8.8 16.9 12.2 17.2 15.1 9.8 13.1 11.1 21.1 13.0 30.0 8.5 28.2 10.6 15.0 18.3 15.6 13.5 21.4 28.2 3.3 21.9 13.5 14.0 7.4 15.7 8.3 13.4 12.2 5.6 9.6 13.8 18.5 9.3 10.1 8.6 8.0 21.6 35.0 7.7 9.8 8.3 8.0 15.6 13.2 12.8 18.0 13.4 48.8 7.9 12.7 12.4 38.5 15.2 6.2 12.0 8.5 10.7 8.4 11.0 11.3 17.1 25.7 11.0 14.2 23.1 20.0 14.9 8.6 12.2 22.1 12.7 22.1 8.0 7.8 7.8 11.5 11.7 15.7 13.8 8.9 9.4 15.0 19.3 8.1 15.3 7.7 19.5 18.7 24.0 40.7 16.0 20.5 24.2 3.3 14.5 1.3 7.7 21.9 11.4 21.4 14.0 9.9 16.5 19.9 13.2 11.1 0.5 13.5 17.7 28.2 11.5 7.4 7.1 9.6 8.9 11.5 8.7 7.4 7.6 8.8 9.9 8.5 20.8 28.2 49.6 29.7 29.2 13.2 32.7 50.9 14.7 27.3 31.4 3.9 47.8 54.7 39.8 141.5 25.9 10.6 23.3 60.9 76.4 30.6 17.5 27.8 47.0 32.6 14.3 29.3 38.6 33.4 132.5 51.5 37.8 25.3 35.1 34.4 14.7 45.8 28.1 30.1 37.2 13.4 38.8 30.6 59.7 38.5 34.6 25.5 21.7 37.6 23.0 TMEM92 FLJ33318 ENSG00000167105 "Transmembrane protein 92" Q6UXU6 17 50271406-50281485 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 74.7" "Cell type enhanced" "Detected in many" 15 "Pancreatic endocrine cells: 31.5;Urothelial cells: 92.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 21 "neutrophil: 5.5" "Lineage enriched" "Detected in single" 21 "granulocytes: 5.5" "Cell line enhanced" "Detected in some" "A549: 9.1;CACO-2: 15.5;CAPAN-2: 14.8;EFO-21: 30.9;OE19: 17.9;SuSa: 20.9" "Low region specificity" "Detected in all" "HPA063009, HPA069820" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063009: AB_2684921, HPA069820: AB_2686208" "unprognostic (3.54e-3)" "unprognostic (2.39e-2)" "unprognostic (9.85e-2)" "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "prognostic unfavorable (8.35e-4)" "unprognostic (4.37e-3)" "unprognostic (2.45e-2)" "unprognostic (1.11e-1)" "unprognostic (4.39e-1)" "unprognostic (3.88e-3)" "unprognostic (2.97e-2)" "prognostic unfavorable (1.14e-6)" "unprognostic (3.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (7.81e-2)" 0.2 0.1 0.3 1.9 0.3 0.4 0.3 0.3 0.3 3.3 27.9 0.3 0.1 23.3 1.2 0.3 1.0 0.7 11.7 0.1 0.8 0.3 0.4 10.2 6.1 0.1 0.3 0.2 2.4 1.2 0.0 0.1 0.3 0.9 1.2 1.8 1.1 4.3 1.2 0.1 0.2 74.7 0.4 0.4 0.3 17.9 0.5 0.3 0.1 0.1 0.4 1.6 2.2 3.7 0.1 0.2 5.5 0.1 0.0 0.0 0.0 0.9 9.1 0.2 0.0 0.0 0.4 2.0 0.2 0.3 0.0 0.0 15.5 14.8 0.0 30.9 0.6 3.5 0.0 0.2 1.7 0.0 2.4 0.1 0.0 0.9 1.5 0.1 0.1 0.1 0.1 1.7 0.1 0.5 1.4 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.2 3.4 17.9 4.0 0.2 0.0 3.8 3.3 0.0 0.0 0.0 0.0 0.1 0.0 20.9 1.9 0.5 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.1 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.3 0.8 0.3 0.3 0.2 0.9 0.3 3.0 17.1 0.0 6.4 0.5 0.0 0.1 22.9 2.7 1.2 7.0 0.0 0.0 0.0 6.2 0.0 0.0 8.0 0.0 17.8 1.2 1.0 16.8 0.0 11.3 0.4 0.0 5.2 1.8 0.3 0.0 0.0 0.0 0.0 1.8 20.4 0.0 31.5 16.4 0.0 0.0 0.0 0.0 0.1 0.1 1.7 0.9 0.0 0.0 14.9 92.2 TNFAIP8 "GG2-1, MDC-3.13, SCC-S2" ENSG00000145779 "TNF alpha induced protein 8" O95379 5 119268692-119399688 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 73.4;lymphoid tissue: 83.1" "Cell type enhanced" "Detected in many" 6 "granulocytes: 208.8;monocytes: 266.9;Syncytiotrophoblasts: 244.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 44.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA054434, HPA057089" Uncertain Enhanced Nucleoplasm No Yes 270000 Nucleoplasm "HPA054434: AB_2682487, HPA057089: AB_2683331" "prognostic favorable (2.45e-4)" "unprognostic (6.06e-2)" "unprognostic (9.81e-2)" "unprognostic (1.57e-1)" "unprognostic (6.32e-2)" "unprognostic (1.08e-1)" "unprognostic (2.86e-3)" "unprognostic (4.92e-1)" "unprognostic (1.55e-1)" "unprognostic (4.45e-2)" "unprognostic (5.81e-3)" "unprognostic (4.47e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.88e-3)" "unprognostic (1.64e-1)" "unprognostic (1.73e-2)" 21.1 2.1 1.6 49.9 3.0 17.8 18.9 1.5 1.7 11.3 8.0 1.6 4.7 4.3 9.7 9.2 15.0 4.6 9.7 8.5 1.8 1.7 8.7 8.4 22.0 71.3 2.9 1.8 4.2 12.5 5.2 1.7 36.1 12.2 11.8 5.5 4.2 13.7 5.8 2.2 14.4 21.4 6.9 3.6 37.5 13.1 4.7 2.2 83.1 9.3 8.6 41.1 12.7 12.8 50.3 25.2 73.4 19.7 19.7 54.4 36.5 7.5 5.3 2.8 4.6 6.1 5.1 26.0 4.2 11.4 3.2 6.6 2.9 8.8 14.2 1.3 4.7 5.1 10.8 2.3 12.8 4.5 15.5 4.9 22.5 11.9 4.9 2.9 27.1 25.0 5.7 12.1 9.6 4.6 6.2 4.3 28.3 8.7 44.5 4.4 2.9 23.0 35.4 4.3 4.4 2.5 7.0 12.6 20.6 12.8 15.2 1.5 2.2 15.8 3.1 1.5 9.7 2.7 31.0 2.1 5.8 2.2 4.0 4.9 21.9 24.0 28.6 6.7 29.0 3.4 73.4 18.6 55.3 22.6 19.7 43.9 50.3 45.5 33.2 25.2 44.2 54.4 34.9 10.6 19.7 14.8 12.1 34.8 36.5 1.6 3.0 1.5 1.7 1.8 1.7 2.9 1.8 12.2 2.2 8.9 16.0 115.2 57.1 142.5 0.1 8.9 15.3 48.2 25.0 17.4 0.0 133.6 14.9 46.4 1.9 18.9 1.3 0.0 87.0 135.2 42.9 45.5 208.8 0.5 45.7 0.0 1.2 6.2 52.3 1.1 2.0 76.8 35.4 266.9 7.6 3.9 105.8 2.9 1.8 11.0 0.5 45.3 34.0 0.4 14.9 104.3 244.7 119.6 3.8 58.5 TNIP2 "ABIN-2, FLIP1, KLIP, MGC4289" ENSG00000168884 "TNFAIP3 interacting protein 2" Q8NFZ5 4 2741648-2756376 "Predicted intracellular proteins" "Apoptosis, Inflammatory response, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020818, HPA049886, HPA063197" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020818: , HPA049886: AB_2680934, HPA063197: AB_2684960" "unprognostic (1.22e-1)" "unprognostic (2.09e-1)" "unprognostic (2.44e-1)" "prognostic favorable (1.13e-4)" "unprognostic (3.64e-1)" "unprognostic (9.87e-2)" "unprognostic (4.36e-2)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.77e-1)" "unprognostic (2.47e-2)" "unprognostic (8.34e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.94e-5)" "unprognostic (3.00e-1)" "unprognostic (7.23e-2)" "unprognostic (1.97e-3)" "unprognostic (4.02e-3)" 16.7 10.3 7.8 14.5 14.0 18.9 32.5 3.4 12.4 9.8 26.4 7.3 7.1 16.4 11.9 10.1 14.5 9.6 13.7 26.6 7.4 6.5 23.4 16.6 16.0 17.9 11.2 4.7 12.3 24.2 3.5 11.4 15.3 12.4 13.6 10.1 9.7 10.7 13.5 21.9 10.5 37.2 23.9 12.2 17.8 15.3 11.7 11.1 8.1 14.2 12.3 18.2 15.1 33.7 9.8 7.3 20.9 11.8 4.4 11.2 4.7 12.2 16.7 5.3 8.0 17.0 11.7 23.0 13.4 12.0 12.5 12.2 19.1 19.9 11.2 15.2 14.6 28.1 8.1 9.5 15.4 7.4 8.7 11.9 13.4 9.9 21.1 21.2 10.9 17.0 15.1 14.0 13.8 12.5 9.7 17.8 10.3 13.6 15.9 8.6 25.4 14.3 27.0 13.9 18.3 28.6 9.5 8.1 5.8 13.4 13.8 8.0 9.0 10.4 10.9 14.7 9.6 12.0 16.1 20.6 9.7 10.7 15.1 20.5 16.5 11.2 8.1 17.7 19.8 10.4 6.4 7.2 20.9 6.7 11.2 7.2 7.8 10.2 11.2 7.3 9.8 8.4 7.0 7.1 4.4 11.8 3.4 10.2 4.7 7.8 14.0 3.4 12.4 7.4 6.5 11.2 4.7 12.4 11.1 6.0 9.8 20.6 45.8 54.5 2.1 12.0 5.1 6.7 11.4 14.0 2.0 44.9 11.6 51.5 2.1 31.7 65.3 0.0 52.5 89.5 32.8 52.4 12.7 14.9 31.4 0.0 18.4 28.8 18.9 5.4 19.8 35.5 25.3 104.6 33.4 10.0 53.3 52.6 16.6 33.2 6.5 19.4 37.0 15.8 60.0 69.1 80.0 34.8 32.9 71.1 TOE1 hCaf1z ENSG00000132773 "Target of EGR1, exonuclease" Q96GM8 1 45339670-45343975 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053775, HPA069119" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA053775: AB_2682259, HPA069119: AB_2686090" "unprognostic (7.20e-2)" "unprognostic (1.20e-1)" "unprognostic (7.15e-3)" "unprognostic (1.90e-2)" "unprognostic (3.33e-1)" "prognostic favorable (9.05e-4)" "prognostic unfavorable (6.12e-9)" "unprognostic (4.67e-2)" "unprognostic (4.84e-2)" "unprognostic (2.37e-2)" "unprognostic (6.03e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (2.71e-4)" "prognostic favorable (9.98e-4)" "unprognostic (1.81e-1)" "unprognostic (1.41e-2)" "unprognostic (2.08e-1)" 7.4 9.2 8.9 8.0 10.6 9.7 8.1 11.6 9.4 7.4 8.9 8.7 11.2 9.8 10.8 11.0 8.3 8.9 8.7 7.5 6.4 5.6 7.1 7.9 9.4 8.7 5.1 7.4 9.4 7.4 10.8 7.8 8.2 7.7 8.8 9.2 10.0 9.9 7.7 4.3 6.9 9.4 10.0 9.4 11.0 9.4 18.7 5.0 14.6 10.3 6.1 8.8 9.1 7.3 8.7 6.0 13.8 6.8 3.2 9.6 4.7 8.2 4.5 6.4 7.6 3.8 3.1 11.5 6.7 6.0 12.4 11.8 5.6 4.4 14.5 6.8 7.9 11.0 7.5 10.0 11.6 8.7 9.2 8.2 15.3 8.8 6.2 3.3 9.2 8.4 4.5 2.0 12.5 8.0 4.3 9.9 12.0 12.0 8.0 8.5 6.4 16.4 7.8 14.2 9.2 6.2 11.8 11.3 6.3 4.9 11.0 6.8 7.0 6.8 17.5 13.0 11.0 4.4 14.7 6.7 5.3 11.2 9.6 11.9 5.7 7.6 9.2 7.9 12.1 6.8 13.8 5.7 5.7 7.9 6.8 9.6 6.2 7.7 8.4 5.5 8.7 6.9 8.3 0.8 3.2 5.9 6.0 8.5 4.7 8.9 10.6 11.6 9.4 6.4 5.6 5.1 7.4 7.7 5.0 6.0 3.7 9.5 5.0 1.5 9.9 1.4 7.6 4.0 9.1 7.0 11.8 33.5 6.6 4.8 8.9 9.0 6.7 0.0 5.5 10.3 5.2 5.5 11.5 4.5 8.0 7.9 2.9 7.4 3.5 6.5 6.4 4.9 3.3 13.6 5.9 12.3 2.8 10.5 6.0 5.8 17.6 12.9 7.2 31.0 18.1 1.3 19.0 7.0 5.7 3.7 TOP2B ENSG00000077097 "DNA topoisomerase II beta" Q02880 3 25597905-25664907 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "Autism spectrum disorder, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 106.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004601, HPA024120, HPA050441" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127" "unprognostic (2.90e-2)" "unprognostic (5.17e-2)" "unprognostic (7.21e-3)" "unprognostic (2.42e-1)" "unprognostic (1.60e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.86e-7)" "unprognostic (7.86e-2)" "unprognostic (1.89e-1)" "unprognostic (2.84e-1)" "unprognostic (7.14e-2)" "unprognostic (1.08e-1)" "prognostic favorable (2.43e-4)" "unprognostic (1.01e-1)" "unprognostic (1.59e-1)" "unprognostic (1.49e-1)" "unprognostic (7.93e-2)" 19.3 18.8 23.4 23.1 29.7 26.5 21.1 48.4 33.5 24.1 22.4 21.1 18.9 17.1 29.6 25.6 21.1 20.6 20.7 22.7 22.0 19.9 20.3 18.4 17.7 28.2 21.0 28.5 26.8 17.2 43.0 21.6 22.3 26.4 24.7 20.8 17.6 21.3 22.3 31.3 20.9 19.3 24.4 23.4 24.6 20.1 11.3 22.7 60.2 28.3 20.7 27.3 34.8 21.5 5.5 5.6 5.3 4.6 7.8 7.2 2.2 10.7 11.1 24.6 30.1 8.2 10.4 9.8 10.4 13.4 9.7 10.6 5.7 8.5 33.3 7.3 15.0 6.0 9.1 20.3 11.6 16.3 15.9 10.9 50.4 13.8 9.5 5.8 39.4 27.0 7.4 5.8 10.8 9.5 9.8 15.7 22.8 16.9 16.4 12.4 11.9 25.5 9.7 18.6 7.2 8.5 106.6 13.8 15.4 8.7 37.9 12.4 21.5 15.5 11.1 9.5 14.8 11.5 35.3 15.0 13.5 10.5 10.7 11.1 25.4 14.4 35.3 8.8 29.5 8.9 4.2 2.9 5.3 6.3 3.3 6.9 4.3 6.1 6.4 4.3 5.5 7.2 6.4 2.0 7.8 4.6 5.6 4.4 2.2 23.4 29.7 48.4 33.5 22.0 19.9 21.0 28.5 26.4 22.7 59.6 57.9 25.1 36.1 34.8 53.5 109.0 43.3 34.8 40.9 24.4 53.0 41.2 11.6 29.3 2.9 32.2 17.7 23.3 28.8 20.8 35.0 47.5 31.4 33.5 23.1 57.2 57.0 21.5 40.9 4.8 36.2 38.8 21.9 21.6 32.6 46.4 32.0 17.5 31.5 21.9 89.3 32.3 36.7 66.2 27.0 33.0 39.0 45.0 37.9 57.7 TOPBP1 "KIAA0259, TOP2BP1" ENSG00000163781 "DNA topoisomerase II binding protein 1" Q92547 3 133598175-133662380 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 79.9;Spermatocytes: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022451, HPA036738, HPA036739" Approved Supported Nucleoplasm No No Nucleoplasm "CAB022451: , HPA036738: AB_2675280, HPA036739: AB_2675281" "unprognostic (7.72e-2)" "unprognostic (8.54e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.05e-1)" "unprognostic (3.05e-2)" "prognostic unfavorable (4.66e-5)" "unprognostic (8.03e-2)" "unprognostic (3.98e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (1.88e-4)" "unprognostic (2.74e-3)" "unprognostic (8.65e-3)" "unprognostic (7.97e-2)" "unprognostic (2.52e-1)" "unprognostic (7.64e-2)" "unprognostic (1.60e-1)" 13.0 8.2 9.7 16.1 11.7 32.9 17.2 14.4 13.8 9.6 10.8 5.4 8.2 9.7 11.5 10.3 15.0 9.7 8.8 12.1 9.2 7.8 7.4 8.6 10.2 21.3 8.8 9.2 11.0 12.6 10.0 9.8 14.0 10.7 9.5 14.0 5.1 12.0 7.2 10.8 13.6 13.0 11.0 13.1 18.9 10.9 24.6 8.8 38.0 10.3 11.5 20.9 11.0 11.1 2.8 3.1 6.1 2.7 3.0 4.4 1.2 16.0 10.0 16.3 13.2 3.1 4.1 12.2 12.5 10.0 15.5 20.1 13.9 10.2 29.1 11.1 9.1 18.8 18.7 23.4 8.3 24.0 17.6 10.4 27.3 14.5 8.5 3.0 29.1 21.6 4.8 5.2 15.2 9.1 5.8 10.6 17.3 16.9 20.9 12.2 11.0 28.5 15.5 13.4 18.4 8.5 19.3 20.3 21.2 5.5 11.1 15.5 17.2 15.4 8.5 12.9 16.6 14.2 27.2 7.3 16.4 14.9 16.6 13.7 12.6 18.9 56.1 9.7 15.6 14.4 4.6 2.0 6.1 2.2 2.7 3.3 2.8 2.3 2.2 2.0 1.9 2.2 2.3 2.4 3.0 1.5 3.1 4.4 1.2 9.7 11.7 14.4 13.8 9.2 7.8 8.8 9.2 10.7 8.8 20.8 24.5 14.2 6.9 11.0 14.7 7.9 15.3 12.0 30.7 10.4 2.0 15.8 8.3 9.3 56.8 13.2 6.5 23.3 11.5 18.3 8.0 7.5 7.0 8.6 9.8 3.2 6.9 7.4 11.9 79.9 9.5 14.0 8.5 20.8 10.1 10.4 11.7 10.5 9.2 5.0 8.5 12.9 5.2 68.9 51.3 10.0 11.7 13.8 12.4 8.8 TOX3 "CAGF9, TNRC9" ENSG00000103460 "TOX high mobility group box family member 3" O15405 16 52438005-52547802 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 18.7" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 40.8;Intestinal endocrine cells: 59.2;Muller glia cells: 158.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 20.0;HAP1: 9.8;Hep G2: 8.7;OE19: 10.4;RT4: 38.0;SCLC-21H: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040240, HPA040376" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040240: , HPA040376: AB_10795522" "unprognostic (1.14e-2)" "unprognostic (9.75e-3)" "unprognostic (9.08e-3)" "unprognostic (3.32e-2)" "unprognostic (3.50e-1)" "unprognostic (2.31e-1)" "unprognostic (4.74e-3)" "unprognostic (1.28e-1)" "unprognostic (2.00e-1)" "unprognostic (2.94e-2)" "unprognostic (2.59e-1)" "unprognostic (4.60e-3)" "prognostic favorable (3.08e-12)" "unprognostic (1.19e-1)" "unprognostic (1.31e-1)" "prognostic favorable (3.95e-4)" 0.7 3.1 7.1 5.0 4.7 0.0 3.9 0.6 6.0 7.0 13.5 6.0 0.2 9.4 1.3 9.2 0.9 3.0 14.8 0.2 3.2 5.3 9.5 5.8 2.7 0.1 5.4 3.6 1.0 7.8 0.0 5.8 0.3 5.1 1.8 15.1 2.7 11.0 0.7 0.3 1.1 13.5 0.9 7.0 0.2 18.7 0.7 4.7 0.0 0.2 0.3 2.1 7.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 1.7 0.0 0.1 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 10.4 0.0 0.0 3.4 0.1 4.7 38.0 13.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 4.7 0.6 4.3 3.2 5.3 5.4 3.6 5.1 4.7 6.0 5.1 0.0 0.2 0.9 2.6 0.6 40.8 17.4 6.8 33.2 0.0 0.0 3.3 1.4 2.5 0.0 22.3 0.0 4.4 0.0 0.3 13.0 0.0 4.9 0.1 38.1 59.2 1.3 0.0 0.8 0.6 0.1 0.0 0.0 31.7 158.0 9.8 8.6 0.0 8.6 1.5 0.0 0.3 0.0 0.7 0.3 0.0 0.0 28.7 1.1 TP53 "LFS1, p53" ENSG00000141510 "Tumor protein p53" P04637 17 7661779-7687550 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 102.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, HPA051244: AB_2681403, HPA063532: " "unprognostic (2.29e-2)" "unprognostic (8.83e-3)" "unprognostic (1.26e-2)" "prognostic favorable (1.35e-4)" "unprognostic (9.95e-2)" "unprognostic (4.00e-2)" "unprognostic (2.79e-3)" "unprognostic (4.99e-2)" "unprognostic (2.75e-2)" "unprognostic (2.55e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (1.86e-3)" "unprognostic (7.89e-3)" "unprognostic (8.05e-2)" "unprognostic (2.74e-1)" "unprognostic (1.08e-1)" 18.5 11.1 6.0 28.6 6.8 9.0 17.5 2.5 7.3 18.5 14.6 6.8 8.3 9.7 20.3 15.0 25.3 16.7 22.6 8.1 5.0 3.8 10.6 20.8 11.2 26.0 6.6 3.1 33.8 13.8 4.9 6.0 22.8 6.9 16.5 14.5 9.9 15.3 16.1 12.5 24.6 14.0 12.8 6.2 24.2 12.0 14.1 6.9 102.6 13.2 23.5 31.2 16.9 15.0 15.2 19.6 2.2 14.1 11.0 11.3 8.2 19.4 36.0 19.7 14.2 9.2 11.0 20.8 7.0 15.8 19.4 24.6 1.0 10.0 45.8 31.9 13.8 18.9 43.0 28.5 19.3 18.2 10.2 19.1 18.5 20.2 17.1 27.7 0.4 9.6 13.9 22.5 9.4 26.1 11.2 19.0 6.2 0.9 1.8 9.9 34.6 31.1 22.7 19.8 2.5 0.7 60.4 13.9 15.9 14.5 21.6 11.7 20.3 23.1 15.6 5.9 10.2 27.0 1.7 24.6 23.3 7.7 0.3 11.8 12.1 8.8 19.7 6.0 2.4 19.6 0.8 13.3 2.2 9.1 14.1 11.1 15.2 9.4 10.2 19.6 14.5 9.9 10.8 1.7 11.0 11.9 17.9 11.3 8.2 6.0 6.8 2.5 6.4 5.0 3.8 6.6 3.1 6.9 6.9 8.9 10.9 24.4 8.9 25.4 2.3 2.0 22.9 8.1 12.5 19.2 0.0 30.5 8.3 19.1 7.8 19.6 10.2 0.0 15.7 35.3 17.1 11.3 1.1 16.1 21.7 0.0 29.6 20.3 27.8 2.1 21.3 14.4 11.8 15.4 37.2 6.1 19.5 0.0 15.9 6.5 2.2 12.9 20.1 0.5 4.2 28.7 18.8 15.7 50.6 7.4 TP63 "EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L" ENSG00000073282 "Tumor protein p63" Q9H3D4 3 189631416-189897279 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 83.2;skin 1: 54.2" "Group enriched" "Detected in many" 12 "Basal keratinocytes: 244.6;Suprabasal keratinocytes: 247.4" "Group enriched" "Detected in many" 11 "cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HaCaT: 23.8;HBEC3-KT: 45.6;hTCEpi: 34.6;hTERT-HME1: 33.1;RT4: 50.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000083, HPA006288, HPA006289, HPA007009, HPA007010" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336" "prognostic favorable (1.07e-4)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" "unprognostic (3.02e-1)" "unprognostic (4.38e-2)" "unprognostic (3.50e-1)" "unprognostic (1.29e-1)" "unprognostic (5.17e-2)" "unprognostic (2.78e-1)" "unprognostic (5.37e-2)" "unprognostic (2.09e-3)" "unprognostic (1.54e-1)" "unprognostic (1.87e-5)" "unprognostic (1.86e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (2.74e-3)" 2.9 0.1 0.2 0.7 0.1 0.0 7.2 0.1 0.2 9.5 0.1 0.1 5.7 0.0 0.3 8.0 33.7 0.3 0.0 0.2 0.1 0.1 0.4 0.1 1.2 0.2 0.1 0.2 0.1 0.1 0.0 0.3 7.8 0.8 9.6 0.0 0.3 9.0 7.8 83.2 54.2 0.1 2.7 0.6 0.1 0.1 1.2 0.0 9.0 0.4 36.7 26.1 9.6 19.2 3.7 1.3 3.0 0.9 1.2 1.2 0.2 0.6 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 23.8 0.0 45.6 0.0 0.3 0.0 0.5 0.3 0.1 0.0 0.0 0.1 0.0 34.6 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 50.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 0.3 0.1 0.0 0.2 2.0 0.4 1.1 0.9 0.5 0.7 3.7 1.2 1.0 0.4 1.7 0.8 0.7 3.0 1.2 0.9 1.3 0.8 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.8 0.0 0.0 4.0 0.0 20.4 244.6 0.0 0.6 0.0 1.4 5.7 0.0 0.0 18.7 0.0 0.2 0.7 0.3 0.0 0.0 0.2 1.8 1.0 2.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.5 1.0 0.0 0.0 1.2 0.0 1.1 0.0 0.0 0.0 0.5 0.3 2.6 247.4 7.4 0.0 0.0 10.1 TRA2B "Htra2-beta, PPP1R156, SFRS10" ENSG00000136527 "Transformer 2 beta homolog" P62995 3 185915906-185938136 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011692, HPA063597, HPA064972" Supported Enhanced Nucleoplasm,Cytosol NA NA 40000 Nucleoplasm Cytosol "CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396" "unprognostic (9.37e-2)" "unprognostic (1.42e-2)" "unprognostic (1.22e-2)" "unprognostic (7.58e-3)" "unprognostic (1.48e-1)" "unprognostic (2.10e-2)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.92e-1)" "unprognostic (2.65e-3)" "prognostic favorable (2.15e-4)" "unprognostic (1.07e-1)" "unprognostic (3.22e-3)" "unprognostic (1.71e-3)" "unprognostic (1.28e-2)" "unprognostic (2.64e-1)" "unprognostic (4.38e-1)" "unprognostic (4.36e-2)" 36.2 38.0 34.9 52.5 32.4 34.5 34.1 29.8 29.1 30.5 39.5 20.3 31.7 22.4 37.8 32.3 36.5 27.1 31.0 26.4 29.9 30.1 33.0 37.1 27.1 36.9 29.8 21.9 28.9 31.0 28.6 31.3 38.0 20.9 31.6 27.5 26.1 26.6 32.3 50.8 22.7 24.9 35.7 27.1 31.9 28.7 38.4 25.1 57.2 29.6 47.3 42.8 34.0 50.3 34.5 37.0 30.7 21.0 20.6 25.0 10.7 31.8 13.1 33.0 16.8 9.6 7.6 18.2 25.8 16.7 28.5 22.6 21.1 16.8 30.8 31.1 13.2 19.7 20.8 36.1 25.1 33.6 25.9 22.9 28.8 11.9 28.0 12.8 30.5 23.3 7.3 12.5 16.8 16.3 9.2 21.8 15.4 27.5 19.7 21.8 16.7 75.5 44.3 49.2 31.1 20.5 45.9 26.6 35.9 27.7 13.9 24.5 24.4 17.0 24.0 30.4 17.7 24.2 33.9 12.4 19.3 25.3 16.1 38.8 36.3 88.4 57.5 19.9 35.5 30.4 30.7 21.0 16.1 20.2 17.1 18.1 31.7 19.8 18.7 18.3 34.5 25.0 22.7 22.1 20.6 18.6 37.0 18.5 10.7 34.9 32.4 29.8 29.1 29.9 30.1 29.8 21.9 20.9 25.1 59.6 114.4 168.3 155.0 229.4 101.5 57.6 104.4 62.9 102.4 66.3 184.6 157.7 61.3 105.4 125.7 154.8 106.8 233.6 94.8 196.4 163.4 151.8 191.8 78.1 151.9 68.3 218.4 179.9 244.9 31.1 118.2 213.7 128.2 216.4 142.0 89.2 85.0 121.0 110.3 42.8 196.4 103.5 173.1 132.6 147.0 227.8 179.8 202.0 165.8 133.4 TRERF1 "BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132" ENSG00000124496 "Transcriptional regulating factor 1" Q96PN7 6 42224931-42452051 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 20.8;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 55.1" "Low region specificity" "Detected in all" "HPA027771, HPA051273, HPA059943" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA027771: AB_2672381, HPA051273: AB_2681416, HPA059943: AB_2684173" "unprognostic (5.85e-3)" "unprognostic (4.38e-2)" "unprognostic (2.39e-1)" "unprognostic (3.28e-3)" "unprognostic (6.64e-2)" "unprognostic (3.92e-3)" "unprognostic (1.19e-1)" "unprognostic (1.58e-2)" "unprognostic (2.05e-4)" "unprognostic (2.67e-1)" "unprognostic (1.16e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (3.67e-5)" "unprognostic (8.60e-2)" "unprognostic (5.39e-2)" "unprognostic (6.05e-2)" "unprognostic (2.78e-2)" 4.9 8.7 9.3 7.7 8.7 16.7 4.0 18.1 10.8 12.0 5.1 2.9 9.7 4.2 10.0 4.0 12.6 7.2 6.9 2.8 4.5 3.9 5.2 1.4 4.0 9.2 2.5 4.7 10.2 2.5 7.5 9.3 3.4 3.5 8.8 4.7 7.3 3.7 5.2 1.3 8.4 6.6 8.6 4.9 9.0 5.6 11.2 4.8 23.4 3.3 3.6 12.7 13.3 11.0 0.4 1.4 8.1 1.1 2.7 3.0 1.1 5.2 3.6 4.1 5.2 1.9 4.3 5.8 4.0 6.4 4.6 3.8 0.0 2.8 4.9 0.8 6.0 6.3 6.3 5.2 4.9 3.7 55.1 0.4 5.2 3.0 0.0 1.3 9.6 16.9 1.7 6.9 4.1 1.6 4.1 0.0 3.3 0.0 1.6 2.0 1.1 2.4 16.4 4.5 3.8 3.8 4.5 0.3 1.8 2.7 6.5 3.3 1.7 2.4 0.0 0.4 2.3 2.3 13.1 1.7 2.6 3.0 4.2 1.1 0.6 3.5 5.3 1.7 8.8 0.0 2.1 1.1 8.1 3.0 0.4 2.9 0.4 2.2 2.7 1.4 0.0 1.9 2.0 3.8 2.7 0.2 1.2 2.1 1.1 9.3 8.7 18.1 10.8 4.5 3.9 2.5 4.7 3.5 4.8 3.0 2.2 0.8 2.6 7.3 10.8 1.6 2.5 4.0 5.7 5.2 0.0 2.7 0.0 1.3 2.3 3.8 2.3 0.0 0.9 0.7 7.0 1.7 11.5 0.0 2.7 7.9 2.9 8.0 4.4 2.0 13.0 5.8 3.3 1.8 1.9 4.9 0.9 2.9 20.8 0.2 0.5 25.8 4.4 2.4 6.1 6.5 1.0 7.0 2.8 3.4 TRIM11 "BIA1, RNF92" ENSG00000154370 "Tripartite motif containing 11" Q96F44 1 228393673-228406840 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 105.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028541, HPA043879" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028541: AB_10600833, HPA043879: AB_2678711" "unprognostic (1.73e-1)" "unprognostic (9.73e-3)" "unprognostic (5.48e-3)" "unprognostic (7.73e-2)" "unprognostic (3.27e-1)" "unprognostic (2.33e-1)" "prognostic unfavorable (7.42e-5)" "unprognostic (1.08e-1)" "unprognostic (9.74e-2)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (3.15e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (3.40e-2)" "unprognostic (4.89e-2)" "unprognostic (2.04e-1)" "unprognostic (1.22e-2)" 8.8 9.2 8.9 13.8 16.5 33.2 23.8 45.2 11.5 8.7 11.2 6.4 15.1 10.1 8.7 10.6 13.3 9.4 13.9 6.9 9.2 8.5 7.7 7.1 27.5 18.6 9.0 8.0 9.0 11.9 8.5 7.2 9.4 7.1 10.5 9.7 6.0 14.4 18.2 5.0 12.5 11.8 8.6 6.0 16.5 12.6 9.5 7.8 20.0 9.0 9.7 13.1 9.5 24.3 6.4 6.9 10.0 11.4 9.4 11.8 5.4 13.9 13.2 7.1 9.7 5.4 4.4 33.6 9.1 6.1 10.6 8.5 16.1 12.2 10.5 10.2 6.1 7.0 22.7 8.6 8.8 4.5 11.6 20.6 8.7 12.2 8.6 14.6 10.9 13.2 6.0 14.0 11.0 5.5 5.4 5.2 17.2 19.7 13.5 5.4 9.0 13.2 17.2 18.1 11.8 11.7 13.0 6.4 12.6 6.9 17.1 11.9 21.8 7.6 21.6 12.0 3.0 15.3 18.3 5.8 6.8 9.5 15.7 18.8 13.9 9.2 9.2 8.4 8.8 10.6 6.1 6.9 8.3 9.6 8.2 10.2 5.8 10.7 11.8 6.9 6.4 6.3 8.4 10.0 9.4 11.4 5.5 9.8 5.4 8.9 16.5 45.2 11.5 9.2 8.5 9.0 8.0 7.1 7.8 3.0 7.2 3.9 12.3 14.1 12.6 2.8 7.6 4.0 7.9 1.8 2.0 13.8 14.9 13.0 105.9 8.3 22.7 0.0 9.7 12.0 7.0 15.1 5.7 4.9 10.0 4.8 13.8 6.7 10.0 12.4 8.9 9.7 5.0 25.2 16.1 8.1 14.3 17.3 7.1 6.3 1.7 6.5 9.7 5.5 11.8 16.9 47.9 24.9 13.4 22.9 TRIM24 "hTIF1, RNF82, TIF1, Tif1a" ENSG00000122779 "Tripartite motif containing 24" O15164 7 138460334-138589993 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 43.3;HMC-1: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043495, HPA061717" Approved Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA043495: AB_10962915, HPA061717: AB_2684592" "unprognostic (2.40e-1)" "unprognostic (9.52e-3)" "unprognostic (2.23e-1)" "unprognostic (3.96e-2)" "unprognostic (1.20e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.94e-4)" "prognostic favorable (6.57e-4)" "unprognostic (4.01e-2)" "unprognostic (8.93e-2)" "unprognostic (2.53e-1)" "unprognostic (2.02e-1)" "unprognostic (4.62e-2)" "unprognostic (1.62e-1)" "unprognostic (2.25e-2)" "unprognostic (5.54e-2)" "unprognostic (6.34e-2)" 10.3 31.4 10.4 11.2 10.6 8.8 8.8 8.5 10.7 9.4 9.2 14.6 5.7 9.4 9.0 8.5 11.3 7.0 10.3 9.7 8.4 8.5 9.6 21.5 10.7 8.5 10.5 8.0 29.9 11.6 20.7 7.3 13.5 8.4 13.6 9.1 7.5 10.1 7.1 16.0 9.8 14.1 9.4 8.0 8.5 10.8 24.1 11.3 34.8 8.8 9.2 8.9 11.3 11.2 1.3 1.9 3.7 2.5 2.2 2.7 0.8 4.2 5.2 43.3 12.5 2.9 2.7 3.3 3.9 4.2 3.1 3.0 8.2 3.9 8.1 3.9 3.8 6.4 2.3 21.0 3.3 4.6 6.2 5.2 17.9 3.9 25.2 3.9 13.9 58.5 2.4 3.5 2.6 4.1 2.2 7.3 4.5 20.2 5.0 3.7 8.2 23.7 12.6 16.5 22.1 4.7 18.8 5.1 6.8 6.9 12.6 9.0 20.5 7.3 6.6 2.1 15.7 4.5 9.2 3.1 3.6 3.0 6.3 5.4 4.6 5.0 13.8 6.0 9.2 5.2 1.1 2.3 3.6 2.2 2.5 0.4 0.9 1.9 1.2 1.9 1.3 1.8 2.0 3.7 2.2 1.1 1.4 2.7 0.8 10.4 10.6 8.5 9.7 8.4 8.5 10.5 8.0 8.4 11.3 47.6 42.2 4.5 11.6 12.4 13.3 38.8 15.3 17.4 20.5 7.0 15.7 25.9 5.0 6.3 45.5 13.2 8.0 0.0 10.6 11.7 11.8 10.1 38.3 28.4 9.2 38.1 9.7 14.1 11.2 28.3 13.0 12.4 13.5 4.6 8.2 28.0 10.1 9.3 15.2 7.7 20.8 12.9 9.9 43.1 8.5 10.3 18.5 10.2 15.5 12.2 TRIM28 "KAP1, PPP1R157, RNF96, TF1B, TIF1B" ENSG00000130726 "Tripartite motif containing 28" Q13263 19 58544091-58550722 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 221.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010066, HPA064033" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA 140000 Nucleoplasm "CAB010066: AB_2209905, HPA064033: AB_2685179" "unprognostic (2.76e-1)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (1.85e-6)" "unprognostic (1.20e-2)" "unprognostic (2.10e-2)" "unprognostic (2.66e-1)" "unprognostic (4.92e-3)" "unprognostic (9.28e-2)" "unprognostic (2.47e-2)" "unprognostic (4.67e-2)" "unprognostic (7.34e-2)" "unprognostic (4.22e-1)" "unprognostic (3.28e-2)" 24.2 26.4 17.9 40.1 20.6 52.2 30.6 34.5 26.3 46.7 36.5 26.2 26.2 26.8 43.3 30.0 34.1 34.5 38.5 28.4 18.5 16.4 27.3 42.3 29.5 38.1 29.2 22.7 69.3 47.0 30.7 25.7 45.6 22.8 37.6 18.5 21.5 31.8 32.4 56.5 41.2 27.5 38.4 17.9 34.9 32.9 48.1 23.1 119.9 50.6 33.5 33.5 34.0 46.4 13.7 14.6 5.0 7.6 16.0 16.9 6.3 36.5 78.7 42.3 31.2 18.5 14.2 47.2 24.0 21.8 23.5 18.0 54.8 30.8 40.2 15.9 20.7 43.6 25.1 47.8 34.6 15.4 20.6 221.1 69.2 35.7 43.6 19.7 43.9 44.5 19.2 19.3 30.0 23.5 19.8 21.9 47.6 33.6 22.7 21.6 54.1 61.3 54.1 29.6 37.7 50.7 58.2 25.6 43.2 21.0 60.7 42.4 33.2 25.1 32.7 13.4 13.1 22.4 42.7 20.2 55.3 21.9 12.0 43.0 29.3 47.7 45.0 25.0 32.8 35.0 1.3 7.1 5.0 8.9 7.6 11.6 11.5 12.8 12.3 9.0 13.7 16.9 15.1 3.8 16.0 4.9 14.6 8.2 6.3 17.9 20.6 34.5 26.3 18.5 16.4 29.2 22.7 22.8 23.1 11.9 15.2 37.3 46.8 57.1 60.0 8.4 40.8 8.1 17.0 31.4 25.5 50.7 19.9 38.6 75.8 40.5 45.0 0.0 47.9 51.6 41.1 44.2 21.8 31.0 40.2 52.4 62.0 26.4 32.9 81.1 60.9 36.2 27.0 29.7 61.8 50.0 49.3 45.6 38.9 32.1 31.8 58.2 46.4 124.7 74.6 53.1 46.9 30.5 58.1 39.7 TRIM65 ENSG00000141569 "Tripartite motif containing 65" Q6PJ69 17 75880335-75897003 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021575, HPA021578, HPA064820" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: AB_2685359" "unprognostic (1.82e-1)" "unprognostic (1.47e-1)" "unprognostic (3.47e-2)" "unprognostic (1.36e-1)" "unprognostic (1.96e-1)" "unprognostic (1.36e-2)" "prognostic unfavorable (4.74e-6)" "unprognostic (5.36e-2)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (5.82e-2)" "unprognostic (6.00e-3)" "prognostic unfavorable (1.82e-5)" "unprognostic (2.86e-3)" "unprognostic (7.18e-2)" "unprognostic (4.24e-3)" "unprognostic (7.50e-3)" 15.5 8.2 12.8 12.1 20.0 10.8 13.6 26.7 16.6 15.7 12.7 17.6 11.9 13.9 15.7 9.3 14.0 14.4 12.9 11.0 16.5 12.3 11.3 8.2 13.3 14.6 22.4 8.1 17.7 15.7 14.9 12.7 8.1 16.1 12.4 12.0 15.8 14.7 15.2 16.5 21.6 12.8 13.0 11.4 17.2 12.7 5.4 21.3 11.7 13.1 11.0 14.8 12.7 15.4 5.3 3.4 4.4 3.0 5.2 5.9 1.6 13.6 14.8 5.3 14.9 9.8 13.6 2.6 5.5 7.3 9.3 6.9 5.3 11.7 14.7 4.0 5.8 10.5 9.5 11.1 12.3 4.0 6.6 19.8 11.9 13.5 7.9 10.4 12.5 12.7 9.8 9.8 6.2 10.0 6.6 20.5 18.5 18.2 14.8 5.6 14.7 22.6 20.1 12.2 13.3 12.3 21.1 7.1 23.2 6.8 5.1 11.9 11.4 8.7 13.3 14.6 6.8 15.8 15.1 11.0 19.5 9.0 8.7 10.2 12.5 4.6 3.8 12.4 20.2 8.3 2.8 3.0 4.4 5.2 2.7 5.9 4.1 3.9 5.3 2.7 5.3 4.3 4.2 3.1 5.2 1.5 3.4 3.5 1.6 12.8 20.0 26.7 16.6 16.5 12.3 22.4 8.1 16.1 21.3 6.0 4.5 7.6 5.3 2.6 15.0 3.4 5.1 1.4 3.4 8.7 11.8 0.7 1.7 3.3 0.3 5.2 2.3 23.3 3.0 3.0 4.1 4.2 6.9 3.2 8.0 4.8 0.0 6.2 5.6 0.0 12.7 7.9 8.5 1.0 6.9 7.1 4.7 2.9 8.9 4.0 12.2 0.0 3.8 0.5 2.5 3.1 0.5 5.0 4.8 2.5 TRIM8 "GERP, RNF27" ENSG00000171206 "Tripartite motif containing 8" Q9BZR9 10 102642310-102660680 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023560, HPA023561" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA023560: AB_10600414, HPA023561: AB_10601861" "unprognostic (4.32e-2)" "unprognostic (6.90e-2)" "unprognostic (3.02e-3)" "unprognostic (1.45e-1)" "unprognostic (1.78e-1)" "unprognostic (5.03e-1)" "unprognostic (3.82e-2)" "unprognostic (1.03e-1)" "unprognostic (2.15e-3)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (1.52e-1)" "unprognostic (9.55e-2)" "unprognostic (1.48e-1)" "unprognostic (3.12e-2)" "unprognostic (8.34e-2)" "unprognostic (1.36e-2)" 31.7 18.4 26.1 23.9 25.2 17.0 18.0 26.1 31.6 31.8 19.5 22.9 15.4 15.8 18.0 14.3 17.8 21.6 19.8 25.0 23.2 18.0 27.2 21.9 23.0 25.4 20.1 20.0 19.3 35.9 24.7 14.7 17.5 16.3 17.4 8.1 19.4 28.5 18.5 34.8 14.6 23.7 13.6 15.7 22.5 21.2 11.7 21.9 48.3 26.6 14.5 30.3 21.4 15.9 9.0 11.9 17.8 5.3 5.5 7.2 3.9 26.9 6.3 6.3 10.2 6.9 14.1 5.8 9.7 19.7 10.5 8.5 11.4 32.6 8.7 26.0 21.5 4.6 9.9 4.2 13.0 8.7 8.8 8.2 21.9 5.3 26.0 17.6 4.9 8.8 16.1 7.2 23.1 13.7 35.0 14.0 4.5 4.1 13.1 8.2 17.5 9.3 16.4 3.4 9.8 12.9 4.6 14.1 4.3 12.5 19.0 3.8 7.4 5.3 6.6 12.8 7.4 18.8 9.8 25.9 14.2 6.3 7.9 21.7 11.9 7.8 5.0 21.6 12.3 3.6 10.7 4.8 2.6 6.8 4.4 6.7 9.0 7.2 5.3 4.1 7.0 6.4 5.5 17.8 5.5 5.3 11.9 6.9 3.9 26.1 25.2 26.1 31.6 23.2 18.0 20.1 20.0 16.3 21.9 53.6 64.6 14.3 12.5 27.9 37.2 34.1 33.1 37.5 36.4 83.7 7.9 10.3 34.9 50.3 0.9 21.5 18.8 0.0 39.1 2.9 23.8 18.6 8.1 24.1 21.7 27.0 20.7 26.4 31.7 0.4 28.7 27.1 16.9 46.9 30.1 22.7 48.9 17.5 32.2 40.0 14.3 12.9 24.3 2.3 5.3 19.9 9.2 17.5 20.4 18.7 TRMT6 "CGI-09, GCD10, Gcd10p, MGC5029" ENSG00000089195 "TRNA methyltransferase 6" Q9UJA5 20 5937235-5950558 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatogonia: 110.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047032, HPA050408" Approved Enhanced "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA047032: AB_2679911, HPA050408: AB_2681117" "unprognostic (1.78e-1)" "unprognostic (4.51e-2)" "unprognostic (1.65e-1)" "unprognostic (4.26e-2)" "unprognostic (2.11e-1)" "unprognostic (6.81e-2)" "prognostic unfavorable (4.70e-12)" "unprognostic (5.37e-2)" "unprognostic (3.53e-2)" "unprognostic (1.14e-1)" "unprognostic (6.27e-2)" "unprognostic (1.22e-1)" "unprognostic (7.65e-3)" "unprognostic (2.52e-2)" "unprognostic (1.76e-1)" "unprognostic (3.87e-3)" "unprognostic (4.96e-2)" 10.5 12.9 10.5 11.3 12.1 20.6 8.5 15.0 10.5 7.3 7.4 5.7 47.8 5.1 9.1 7.9 11.9 7.9 5.6 13.2 8.4 9.5 10.2 10.1 7.2 13.2 8.3 11.8 9.6 9.6 9.8 13.9 9.4 13.6 7.2 8.2 5.1 8.2 33.9 24.4 9.9 8.6 8.0 8.2 12.2 7.5 15.5 7.9 10.3 8.7 10.6 12.7 8.8 7.9 9.2 17.8 5.9 8.7 13.9 11.6 7.1 25.5 12.6 8.5 13.0 4.8 6.2 11.9 12.3 6.3 12.1 10.1 16.6 11.3 30.5 6.4 6.8 15.8 19.6 17.0 19.6 20.2 6.3 11.9 25.1 5.8 14.8 9.5 23.0 6.6 6.2 10.3 21.5 16.2 4.1 5.1 11.9 15.1 9.5 13.8 7.1 23.9 12.5 19.2 16.5 15.9 15.9 16.9 16.7 8.2 16.3 16.6 25.7 15.0 19.4 19.7 8.5 10.3 11.2 5.0 14.3 13.4 13.2 24.7 15.5 29.9 35.7 6.3 19.0 14.0 2.0 7.9 5.9 9.6 8.7 11.0 9.2 10.8 11.6 17.8 8.2 11.2 11.6 0.8 13.9 7.6 8.1 11.3 7.1 10.5 12.1 15.0 10.5 8.4 9.5 8.3 11.8 13.6 7.9 6.0 16.9 15.9 15.9 19.1 17.7 21.3 12.7 34.8 34.2 27.9 9.8 23.4 29.9 18.1 3.0 15.3 3.9 0.0 26.5 20.1 12.3 14.0 34.6 16.3 15.9 25.4 13.2 3.7 13.2 6.3 10.6 27.0 16.9 9.0 8.2 12.2 17.8 7.0 6.7 17.9 9.8 12.9 20.5 59.7 110.3 21.0 24.5 17.5 9.9 14.2 TSEN2 "MGC2776, SEN2, SEN2L" ENSG00000154743 "TRNA splicing endonuclease subunit 2" Q8NCE0 3 12484432-12539623 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" Lyase "Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 41.2;Rod photoreceptor cells: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027120, HPA027125, HPA027268" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347" "unprognostic (5.58e-2)" "unprognostic (4.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.71e-2)" "unprognostic (9.59e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (1.42e-1)" "unprognostic (5.66e-2)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "unprognostic (6.15e-2)" "unprognostic (1.41e-2)" "unprognostic (6.99e-2)" "unprognostic (4.90e-2)" "unprognostic (6.06e-2)" "prognostic favorable (3.49e-4)" 8.8 10.6 9.7 8.8 19.1 6.7 10.9 16.5 14.0 10.4 9.8 12.7 8.4 5.8 14.0 9.9 7.9 12.8 10.3 14.3 10.5 12.3 9.8 7.3 7.3 10.9 11.5 7.6 18.0 11.9 14.3 15.3 4.9 10.2 10.5 10.9 13.5 7.2 13.1 16.7 15.3 6.1 12.3 12.3 6.1 8.5 11.3 9.1 9.9 12.5 9.6 8.1 8.6 8.3 8.5 7.1 2.6 4.2 5.0 13.7 5.6 7.8 13.7 7.4 9.6 12.5 13.3 17.0 7.4 6.6 8.0 5.8 7.7 8.4 9.4 5.2 6.0 9.5 7.3 12.3 12.7 9.1 7.4 15.2 10.3 18.3 7.9 9.6 16.2 4.0 11.5 14.8 14.5 17.8 5.9 6.4 13.8 15.3 5.2 9.2 14.8 12.4 7.4 10.4 22.2 16.5 9.4 5.1 18.9 11.9 8.1 4.8 8.4 6.9 6.2 5.8 5.3 11.2 11.3 5.7 5.1 5.0 6.9 11.5 4.9 12.5 11.8 6.8 16.4 6.3 2.4 4.2 0.3 6.4 4.2 10.9 8.5 9.8 7.4 5.9 8.3 13.7 11.7 2.6 5.0 3.6 7.1 3.5 5.6 9.7 19.1 16.5 14.0 10.5 12.3 11.5 7.6 10.2 9.1 3.0 3.5 10.9 9.7 2.6 27.2 6.2 15.3 9.4 2.3 10.4 41.2 7.4 1.7 4.9 1.3 5.6 2.6 0.0 3.7 3.2 3.8 5.0 4.7 5.5 4.1 9.5 4.1 3.1 4.0 2.1 8.3 3.2 3.3 1.0 4.7 8.7 3.5 3.5 9.6 5.0 33.9 6.5 5.1 10.3 19.3 4.3 1.6 5.7 8.2 8.0 TSHZ3 "KIAA1474, TSH3, ZNF537" ENSG00000121297 "Teashirt zinc finger homeobox 3" Q63HK5 19 31274945-31349547 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 18.6;Ito cells: 19.6;Leydig cells: 16.4;Peritubular cells: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.9" "Group enriched" "Detected in many" 35 "granulocytes: 4.9;monocytes: 2.2;T-cells: 3.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 13.0;RH-30: 26.7;U-138 MG: 18.9;U-87 MG: 12.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebral cortex: 20.4;hippocampal formation: 16.8" "HPA008834, HPA071010" Approved Enhanced "Nucleoplasm,Plasma membrane" No No Nucleoplasm "Plasma membrane" "HPA008834: AB_1080731, HPA071010: " "unprognostic (2.56e-1)" "unprognostic (3.88e-1)" "unprognostic (4.56e-2)" "unprognostic (3.66e-1)" "unprognostic (1.66e-3)" "unprognostic (4.07e-2)" "unprognostic (1.67e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (3.58e-3)" "unprognostic (2.23e-1)" "unprognostic (3.91e-2)" "prognostic unfavorable (2.92e-4)" "unprognostic (8.76e-3)" "unprognostic (8.22e-2)" "unprognostic (1.91e-2)" "unprognostic (1.73e-3)" 5.7 3.3 4.4 4.0 6.6 1.0 5.2 1.1 17.3 13.0 11.6 0.7 2.4 2.5 19.4 8.5 5.6 9.5 11.5 4.6 3.3 2.0 2.8 1.3 4.9 1.2 1.6 8.0 28.0 1.5 1.1 7.2 4.8 2.8 9.5 3.7 4.9 2.8 8.9 1.6 2.5 4.3 16.4 3.3 4.5 6.1 3.3 1.2 0.0 8.5 1.7 0.7 11.1 11.4 0.0 0.0 4.9 2.2 0.0 3.2 0.7 0.0 1.1 0.4 0.0 5.9 13.0 0.0 3.4 4.9 2.1 3.8 0.0 0.7 0.0 0.0 8.4 4.4 0.5 1.5 3.1 4.7 0.0 1.3 0.0 0.0 0.0 11.4 2.8 5.3 7.6 2.8 7.8 3.9 0.0 0.0 2.5 0.0 0.0 9.8 0.5 0.0 0.0 0.5 0.0 0.0 3.3 26.7 0.0 0.0 0.0 0.0 8.1 0.0 0.0 2.6 2.7 0.0 2.0 0.0 18.9 6.0 2.1 4.8 0.0 0.0 0.0 12.2 4.9 0.5 0.0 2.2 0.0 3.2 0.8 0.1 0.0 0.9 1.0 0.0 0.0 0.3 0.8 4.9 0.0 0.4 0.0 0.7 0.7 4.4 6.6 1.1 17.3 3.3 2.0 1.6 8.0 2.8 1.2 3.0 0.6 0.0 6.8 4.2 13.9 1.6 0.0 1.4 6.8 3.5 0.0 0.3 0.0 0.3 0.1 6.7 0.0 0.0 0.6 0.2 18.6 3.3 1.1 0.0 9.1 15.9 0.0 19.6 11.6 0.0 16.4 6.1 5.0 0.0 0.0 0.2 0.5 0.0 27.6 0.0 0.1 0.0 10.3 0.0 5.0 1.5 0.7 0.5 0.0 2.4 TSNAX TRAX ENSG00000116918 "Translin associated factor X" Q99598 1 231528653-231566524 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA024613, HPA031054, HPA031055, CAB034263" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 100000 Nucleoplasm "Golgi apparatus, Cytosol" "CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314" "unprognostic (6.28e-3)" "unprognostic (5.48e-2)" "unprognostic (1.62e-1)" "unprognostic (1.12e-1)" "unprognostic (5.55e-2)" "unprognostic (2.27e-1)" "unprognostic (2.96e-2)" "unprognostic (2.05e-1)" "unprognostic (1.22e-1)" "unprognostic (2.42e-3)" "unprognostic (4.51e-2)" "unprognostic (1.91e-1)" "unprognostic (2.16e-1)" "unprognostic (1.27e-1)" "unprognostic (4.98e-2)" "unprognostic (6.52e-3)" "unprognostic (2.70e-2)" 27.4 29.9 23.9 17.1 26.7 12.0 23.4 28.0 33.1 19.7 16.2 21.9 17.2 15.8 20.0 24.6 18.0 16.4 16.7 22.7 25.1 23.9 29.1 23.0 18.4 22.6 22.1 22.1 18.6 14.6 32.3 36.0 18.3 28.5 21.3 18.0 19.6 17.5 19.9 52.5 20.6 14.8 18.9 28.2 24.0 15.5 17.5 24.4 24.5 26.7 25.4 22.0 19.1 17.3 10.0 11.7 54.6 17.5 18.7 13.5 11.0 11.0 9.1 13.9 11.4 10.3 12.7 15.8 12.6 19.1 16.2 14.0 7.8 15.6 15.6 21.3 13.7 6.0 12.1 11.0 11.4 21.1 13.9 19.2 15.0 9.4 10.3 14.2 24.7 31.9 15.5 12.6 15.6 12.1 10.2 11.7 11.4 24.2 11.1 21.9 4.5 15.9 12.1 20.5 9.3 11.1 15.8 15.3 21.1 18.1 12.8 13.3 25.6 13.1 16.7 42.4 5.9 24.3 42.0 10.9 11.2 10.2 22.4 22.6 18.9 24.9 17.4 18.3 19.6 30.6 54.6 11.2 29.2 11.4 13.5 10.8 10.0 12.3 11.2 11.7 9.9 13.2 12.7 11.4 18.7 17.5 6.8 13.5 11.0 23.9 26.7 28.0 33.1 25.1 23.9 22.1 22.1 28.5 24.4 26.8 32.9 25.4 17.9 38.9 58.2 20.9 38.2 26.8 17.0 40.1 27.5 39.1 46.4 25.0 7.5 33.3 20.5 46.7 27.1 39.0 28.8 14.4 75.1 26.0 42.6 62.0 27.7 27.6 51.1 7.5 31.1 45.0 25.3 37.9 29.8 64.5 23.0 23.4 33.9 36.6 45.9 38.8 35.6 28.1 70.9 44.9 30.3 35.8 22.4 12.2 TSPAN2 "FLJ12082, TSN2, TSPAN-2" ENSG00000134198 "Tetraspanin 2" O60636 1 115048011-115089500 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 44.6" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 22.5;Intestinal endocrine cells: 37.7;Smooth muscle cells: 20.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "pons and medulla: 11.9" "Cell type enhanced" "Detected in many" "neutrophil: 35.0" "Group enriched" "Detected in many" 4 "granulocytes: 35.0;NK-cells: 25.9" "Cell line enhanced" "Detected in many" "EFO-21: 35.1;hTERT-RPE1: 9.8;U-937: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015640, HPA073306" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015640: AB_1858405, HPA073306: " "unprognostic (4.56e-2)" "unprognostic (6.86e-2)" "unprognostic (2.60e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (1.57e-3)" "unprognostic (1.64e-1)" "unprognostic (9.73e-6)" "unprognostic (6.06e-3)" "unprognostic (3.07e-2)" "unprognostic (4.74e-2)" "unprognostic (7.66e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (8.48e-7)" "unprognostic (5.40e-2)" "unprognostic (1.59e-1)" "unprognostic (1.48e-3)" "unprognostic (7.80e-3)" 3.7 0.6 1.1 4.7 2.5 9.6 3.2 0.9 2.0 20.1 31.0 1.5 8.9 2.5 30.6 6.9 12.3 14.2 10.6 6.1 1.1 2.6 4.0 0.6 3.0 1.5 1.9 1.9 6.5 2.0 6.4 2.0 1.5 11.9 15.2 6.2 1.9 2.2 15.7 2.0 1.6 7.0 44.6 1.6 2.2 10.0 4.4 0.8 2.6 4.0 4.9 0.9 25.4 7.0 0.2 1.2 35.0 2.9 25.9 7.4 3.8 8.5 0.1 0.7 0.0 0.0 0.1 0.0 1.4 0.5 1.4 2.2 1.7 5.2 0.0 35.1 1.9 1.9 1.2 1.1 0.0 1.5 1.7 0.7 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 9.8 0.0 6.9 0.0 0.5 0.0 0.4 4.6 0.7 8.0 1.7 0.9 0.0 0.5 0.0 0.2 3.2 1.8 2.9 2.1 0.9 0.1 4.9 0.1 0.3 0.1 0.1 3.4 0.2 8.0 7.3 0.2 0.0 0.0 15.4 3.8 27.8 2.9 16.6 5.9 0.0 1.9 0.2 7.0 7.4 1.2 0.1 1.2 6.0 35.0 25.9 0.0 1.2 0.9 3.8 1.1 2.5 0.9 2.0 1.1 2.6 1.9 1.9 11.9 0.8 0.0 1.1 0.0 22.5 7.1 0.2 9.2 0.0 10.7 2.3 10.4 0.0 0.1 0.0 16.3 10.8 15.0 0.0 0.0 2.2 3.1 3.1 10.9 0.0 0.0 0.6 0.0 37.7 5.5 0.8 2.7 0.6 0.9 3.3 0.0 0.8 0.0 7.7 0.0 2.8 1.0 0.4 6.5 20.2 0.1 0.9 2.4 0.2 5.0 1.0 9.2 TUBD1 "FLJ12709, TUBD" ENSG00000108423 "Tubulin delta 1" Q9UJT1 17 59859482-59892945 "FDA approved drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004609, HPA023980, HPA027090" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457" "unprognostic (1.92e-1)" "unprognostic (5.95e-2)" "prognostic favorable (2.04e-4)" "unprognostic (1.39e-1)" "unprognostic (1.32e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (2.86e-2)" "unprognostic (8.87e-3)" "unprognostic (1.02e-1)" "unprognostic (1.77e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (6.06e-4)" "unprognostic (4.97e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-1)" "unprognostic (8.83e-2)" 8.7 8.0 9.3 8.1 13.8 6.8 12.4 19.9 12.2 12.3 11.2 13.5 16.6 6.7 13.6 16.4 18.2 10.0 8.3 8.4 8.9 7.2 8.5 9.3 8.8 10.2 16.1 8.5 16.3 13.2 10.4 18.7 7.2 12.3 12.3 8.2 11.7 11.4 12.2 9.9 11.6 7.5 9.3 13.4 9.3 9.6 9.2 16.4 16.2 15.5 10.3 13.8 14.1 13.0 10.1 8.8 14.1 7.6 8.1 17.6 6.9 6.0 8.3 6.5 6.8 3.7 2.6 5.5 4.7 2.8 6.3 5.2 9.0 3.9 5.5 8.1 1.1 4.3 5.1 9.1 2.8 6.0 3.2 11.1 6.4 7.0 10.6 2.0 3.8 3.5 1.4 4.5 5.4 2.0 2.2 4.9 5.5 13.8 3.8 2.1 42.9 7.8 4.4 5.7 6.7 3.7 8.4 9.6 8.6 2.4 2.8 6.1 3.7 3.4 2.7 3.2 8.2 6.4 3.7 1.5 4.5 10.1 3.1 5.1 4.5 6.8 8.4 2.1 4.3 4.0 5.6 7.6 14.1 10.9 5.0 12.4 10.1 13.5 11.5 5.2 8.6 17.6 14.2 8.2 8.1 5.3 8.8 14.1 6.9 9.3 13.8 19.9 12.2 8.9 7.2 16.1 8.5 12.3 16.4 11.9 45.1 5.4 12.7 14.0 7.1 4.8 7.6 12.0 20.5 3.5 5.9 5.1 10.0 4.6 1.3 7.7 2.6 0.0 4.2 6.5 8.2 11.1 10.5 3.2 3.5 3.2 9.9 6.7 4.8 0.4 5.2 6.2 6.8 3.6 5.5 7.7 3.3 4.9 7.8 3.1 7.7 6.5 10.3 11.4 28.1 14.8 3.3 13.6 5.4 5.7 TWISTNB ENSG00000105849 "TWIST neighbor" Q3B726 7 19695462-19709087 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019071, HPA022416" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA019071: AB_1858465, HPA022416: AB_1858466" "unprognostic (5.66e-3)" "unprognostic (3.43e-3)" "unprognostic (2.38e-1)" "unprognostic (1.25e-1)" "unprognostic (3.98e-3)" "unprognostic (1.85e-2)" "prognostic unfavorable (1.85e-4)" "unprognostic (1.16e-1)" "unprognostic (5.87e-2)" "unprognostic (2.03e-1)" "unprognostic (5.02e-2)" "unprognostic (4.93e-2)" "unprognostic (6.16e-2)" "unprognostic (1.23e-1)" "unprognostic (9.06e-2)" "unprognostic (4.95e-3)" "unprognostic (2.96e-1)" 16.4 13.9 11.5 13.6 17.6 21.5 15.8 13.2 20.8 16.1 14.0 9.9 12.3 8.5 20.4 9.4 14.8 14.3 9.7 14.6 13.5 12.5 13.3 15.9 9.9 16.6 13.1 11.7 17.5 12.6 15.4 12.0 16.4 13.5 15.3 11.0 6.4 11.4 14.5 25.5 13.8 11.4 22.7 13.4 17.7 12.4 10.8 11.3 20.8 13.6 14.1 18.8 20.2 14.4 10.8 7.7 3.5 5.0 14.6 11.6 5.0 11.7 9.0 6.6 9.9 7.8 9.6 5.2 6.8 5.1 8.0 9.3 7.3 10.4 13.2 19.9 8.4 10.1 10.7 13.5 12.7 14.9 4.1 10.4 12.2 7.2 5.6 11.9 24.9 8.9 8.7 9.0 8.7 10.5 5.4 13.0 9.3 18.8 11.9 11.4 4.3 13.7 23.3 17.3 12.3 10.2 11.2 11.5 13.9 13.1 6.1 4.8 7.3 6.2 16.9 8.4 11.4 6.8 22.4 10.8 16.6 8.9 15.3 16.4 15.3 9.4 33.6 11.2 37.5 24.2 3.5 3.9 1.1 7.2 5.0 10.8 10.8 8.6 9.5 6.0 10.4 10.0 11.6 0.3 14.6 4.7 7.7 7.8 5.0 11.5 17.6 13.2 20.8 13.5 12.5 13.1 11.7 13.5 11.3 14.9 23.5 21.4 59.8 110.2 25.7 20.1 10.2 24.1 37.5 8.7 11.8 32.6 36.5 21.9 4.1 30.8 6.3 23.3 23.7 26.9 40.3 29.1 118.6 27.1 30.4 31.8 23.4 29.4 15.2 2.5 29.7 41.4 59.1 25.2 16.5 19.0 19.5 14.0 32.9 24.5 12.1 19.4 57.7 25.0 44.7 125.0 13.8 37.3 21.5 43.6 TXN TRX ENSG00000136810 Thioredoxin P10599 9 110243811-110256640 "Plasma proteins, Predicted intracellular proteins" "Electron transport, Transcription, Transcription regulation, Transport" Activator Allergen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 447.3" "Cell type enriched" "Detected in all" 10 "monocytes: 27271.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 127.1;granulocytes: 104.5" "Cell line enhanced" "Detected in all" "OE19: 265.0" "Low region specificity" "Detected in all" "CAB008678, HPA047478, HPA055752" Enhanced Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 25000000 "Nucleoplasm, Cytosol" "CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907" "unprognostic (2.12e-2)" "unprognostic (1.27e-1)" "unprognostic (9.77e-2)" "prognostic favorable (3.40e-6)" "unprognostic (1.80e-2)" "unprognostic (2.13e-2)" "unprognostic (5.52e-3)" "unprognostic (1.37e-2)" "unprognostic (1.75e-1)" "unprognostic (3.36e-2)" "unprognostic (5.93e-3)" "unprognostic (1.66e-1)" "unprognostic (4.96e-3)" "unprognostic (7.80e-2)" "unprognostic (8.55e-2)" "unprognostic (2.99e-2)" "unprognostic (8.51e-2)" 23.6 16.7 26.6 18.2 16.9 35.8 25.9 10.8 19.7 30.8 57.9 7.7 17.5 40.7 15.5 20.4 162.3 27.5 22.2 11.7 20.9 19.0 65.8 69.4 39.0 19.4 21.3 14.1 18.2 22.0 5.3 8.0 41.2 28.7 15.5 50.6 8.0 50.2 16.3 16.0 26.3 58.9 21.9 17.6 19.8 26.3 9.2 7.0 40.0 18.9 447.3 82.0 31.3 27.1 12.8 127.1 104.5 25.1 14.2 26.0 18.8 45.9 63.1 17.1 18.8 43.2 56.3 25.2 55.9 52.2 39.0 29.7 40.9 55.4 40.9 24.0 51.6 85.4 103.8 24.3 74.5 38.3 60.7 54.1 20.5 59.2 70.8 49.4 50.9 62.7 39.9 49.1 57.0 43.2 36.3 34.2 26.1 34.5 39.4 53.3 37.2 42.3 76.4 36.4 265.0 77.0 17.8 58.0 47.6 49.8 32.6 37.2 13.3 60.3 49.0 37.9 34.4 47.0 35.2 41.0 40.2 26.0 75.4 69.2 20.0 56.4 34.8 58.3 44.4 55.8 32.2 25.1 104.5 14.5 15.1 13.9 12.8 20.5 17.4 37.1 5.6 7.7 11.5 99.7 14.2 9.6 127.1 26.0 18.8 26.6 16.9 10.8 19.7 20.9 19.0 21.3 14.1 28.7 7.0 363.3 237.5 189.1 832.3 1158.8 34.8 96.1 504.4 436.3 374.2 249.5 19.6 560.0 824.0 1017.1 20.9 327.5 1162.8 233.6 1150.3 840.4 409.8 774.5 261.1 685.2 516.6 27.0 534.8 206.2 278.9 11.1 373.3 793.2 723.7 27271.2 934.3 40.9 1608.6 1292.8 268.3 2636.4 24.8 142.3 563.4 10.6 70.3 1303.3 391.5 213.2 1478.0 1356.2 TXNRD3 "TGR, TR2, TRXR3" ENSG00000197763 "Thioredoxin reductase 3" Q86VQ6 3 126607052-126655155 "Enzymes, Predicted intracellular proteins" "Differentiation, Electron transport, Spermatogenesis, Transport" "Developmental protein, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.8" "Cell type enhanced" "Detected in many" 13 "Spermatocytes: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.0" "Lineage enriched" "Detected in single" 4 "T-cells: 4.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020802, HPA036109" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020802: , HPA036109: AB_2674945" "unprognostic (1.41e-1)" "unprognostic (1.55e-2)" "unprognostic (3.92e-1)" "prognostic unfavorable (3.35e-4)" "unprognostic (3.90e-1)" "unprognostic (2.96e-1)" "unprognostic (3.01e-1)" "unprognostic (3.39e-2)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.86e-4)" "unprognostic (3.14e-1)" "prognostic favorable (2.72e-4)" "unprognostic (5.94e-2)" "unprognostic (1.74e-1)" "unprognostic (1.03e-2)" "unprognostic (2.51e-1)" 5.4 5.9 4.9 2.4 4.7 0.9 7.2 5.5 5.7 7.3 4.2 4.6 5.5 1.6 8.3 7.1 6.4 4.7 5.2 4.9 4.0 2.9 6.7 10.0 7.0 5.2 4.6 3.5 8.8 7.1 12.3 8.5 3.3 7.0 5.2 3.6 6.4 5.7 5.1 7.3 4.8 2.6 8.1 5.1 3.3 4.9 27.8 5.8 5.0 7.4 3.6 2.1 6.6 5.3 0.3 0.7 0.5 0.9 0.9 4.0 0.3 14.0 3.6 4.6 7.2 8.5 13.0 2.3 6.2 5.6 5.1 7.2 6.4 7.9 0.0 7.9 8.5 3.1 5.6 5.7 6.4 6.5 0.0 4.2 1.6 3.3 4.9 7.4 5.7 0.5 11.9 5.6 1.7 11.8 7.0 3.7 4.6 3.4 0.0 8.2 10.1 1.2 3.1 6.5 3.8 2.7 0.4 4.0 2.3 5.4 7.0 8.0 4.9 17.8 5.2 9.0 3.7 7.2 2.2 6.1 6.3 1.5 8.5 2.9 3.7 1.6 0.0 3.4 2.0 5.3 0.0 0.9 0.5 0.5 0.8 0.1 0.0 0.2 0.6 0.7 0.3 4.0 1.3 0.0 0.9 0.2 0.0 0.0 0.3 4.9 4.7 5.5 5.7 4.0 2.9 4.6 3.5 7.0 5.8 3.0 7.4 0.0 4.8 0.9 1.9 3.6 5.1 2.7 3.4 3.5 2.0 7.5 3.3 4.3 15.1 1.5 0.0 0.0 3.4 4.6 3.7 2.1 5.7 7.3 2.6 0.0 4.1 1.3 0.3 2.9 4.4 0.3 0.0 0.0 2.3 2.3 3.9 0.0 8.1 2.8 0.5 0.0 2.7 54.7 15.3 0.5 6.1 0.0 1.5 2.5 U2AF1 "RN, RNU2AF1, U2AF35, U2AFBP" ENSG00000160201 "U2 small nuclear RNA auxiliary factor 1" Q01081 21 43092956-43107587 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Basal keratinocytes: 437.9;Melanocytes: 192.3;Suprabasal keratinocytes: 379.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044833, HPA052083" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044833: AB_10960990, HPA052083: AB_2681720" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (5.98e-2)" "unprognostic (2.87e-2)" "unprognostic (1.36e-1)" "unprognostic (8.06e-2)" "unprognostic (2.76e-2)" "unprognostic (4.29e-4)" "unprognostic (4.81e-4)" "unprognostic (3.42e-2)" "unprognostic (2.31e-3)" "unprognostic (8.85e-2)" "unprognostic (2.14e-6)" "unprognostic (1.08e-1)" "unprognostic (1.40e-2)" "unprognostic (1.72e-1)" "unprognostic (1.26e-2)" 20.0 15.1 20.8 19.2 21.1 48.5 61.0 25.6 20.8 16.1 21.5 9.7 12.3 17.6 28.8 26.5 19.3 27.6 17.1 19.5 19.7 15.8 14.6 17.1 35.2 33.5 25.7 2.9 22.1 48.3 15.3 27.8 21.2 20.8 23.9 13.7 9.6 44.5 19.8 33.0 16.6 20.4 38.7 23.9 21.0 17.5 33.9 22.7 20.6 27.3 26.5 20.0 22.9 31.7 58.4 82.8 81.2 54.1 33.1 55.5 53.8 25.3 27.8 15.1 11.4 8.9 6.4 35.5 22.0 15.3 18.0 16.1 64.6 9.3 43.4 12.0 14.3 24.7 12.4 31.6 23.4 9.3 34.0 71.5 70.2 14.2 24.3 21.7 30.2 17.3 8.8 14.4 29.1 18.6 6.5 14.8 26.6 38.5 19.6 12.5 47.7 24.9 33.5 32.1 21.7 32.1 41.2 14.6 21.8 12.0 10.7 23.0 17.6 23.6 14.3 11.7 4.3 17.4 17.6 18.5 15.0 20.4 13.5 23.0 26.3 30.9 35.9 14.4 55.6 23.1 48.4 52.6 50.9 42.2 52.5 41.4 55.9 46.4 42.1 54.1 58.4 46.4 44.8 81.2 33.1 54.1 82.8 55.5 53.8 20.8 21.1 25.6 20.8 19.7 15.8 25.7 2.9 20.8 22.7 17.9 17.8 8.9 29.0 437.9 21.8 2.8 7.6 21.4 27.3 1.8 41.2 16.3 1.7 4.5 1.9 22.2 22.9 0.0 5.1 15.6 26.8 31.7 26.7 17.8 19.6 17.5 17.5 28.8 21.4 2.0 17.0 27.1 192.3 2.8 16.7 13.0 4.0 17.5 21.2 2.8 59.6 6.5 29.2 14.4 17.7 379.0 19.9 20.0 22.2 30.1 U2AF2 U2AF65 ENSG00000063244 "U2 small nuclear RNA auxiliary factor 2" P26368 19 55654146-55674715 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010910, HPA041943, HPA043562" Supported Supported Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "CAB010910: AB_262122, HPA041943: AB_2677760, HPA043562: AB_2678555" "unprognostic (2.37e-1)" "unprognostic (2.22e-1)" "unprognostic (3.12e-1)" "unprognostic (9.60e-2)" "unprognostic (6.94e-2)" "unprognostic (4.01e-2)" "prognostic unfavorable (1.54e-6)" "unprognostic (9.46e-2)" "unprognostic (1.36e-2)" "unprognostic (8.00e-2)" "unprognostic (3.33e-2)" "unprognostic (4.25e-3)" "unprognostic (2.19e-2)" "unprognostic (4.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.14e-1)" "unprognostic (3.08e-2)" 32.1 39.3 40.0 51.9 40.0 68.2 34.1 53.4 44.1 39.6 43.7 41.2 37.0 46.2 45.0 32.5 47.9 43.6 35.4 33.8 35.0 29.4 36.5 39.1 35.6 59.6 41.1 33.7 51.4 38.3 37.7 48.1 42.9 31.5 36.8 29.7 35.9 36.4 39.5 33.3 42.7 43.0 34.7 32.4 58.1 37.4 104.4 41.4 68.4 42.0 34.0 50.4 36.3 42.9 3.0 4.1 5.5 4.0 1.4 3.0 1.7 44.2 72.7 44.5 36.5 21.1 21.4 48.0 35.9 33.8 61.8 60.2 42.2 42.2 53.6 29.2 30.4 30.6 36.3 55.2 50.0 27.5 40.3 92.3 44.9 32.5 38.7 34.3 51.0 51.5 29.1 30.3 46.1 30.5 23.2 35.5 36.3 53.5 34.6 31.2 41.6 70.8 44.9 49.0 38.3 57.9 77.3 28.7 42.8 33.9 51.9 52.9 41.1 39.4 37.3 22.7 26.0 36.4 54.0 30.3 54.4 39.5 25.0 75.8 31.5 42.6 63.6 24.2 50.6 46.2 0.2 2.6 2.2 3.0 4.0 2.6 2.1 2.7 2.4 2.4 3.0 2.2 2.0 5.5 1.4 2.6 4.1 2.9 1.7 40.0 40.0 53.4 44.1 35.0 29.4 41.1 33.7 31.5 41.4 3.0 7.8 30.2 34.6 40.3 39.4 2.0 28.1 2.7 10.3 26.2 29.5 50.4 16.6 27.1 3.6 25.3 37.1 0.0 20.6 50.3 29.4 26.5 34.5 24.6 32.5 33.4 43.7 25.2 23.2 5.2 41.1 28.1 18.6 39.7 38.5 23.8 24.5 21.0 32.2 19.6 49.8 0.0 31.7 23.3 28.8 34.4 60.1 33.7 38.2 39.4 UBA6 "FLJ10808, UBE1L2" ENSG00000033178 "Ubiquitin like modifier activating enzyme 6" A0AVT1 4 67612652-67701179 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 126.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037001 Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA037001: AB_10672787" "unprognostic (2.52e-1)" "unprognostic (4.89e-2)" "unprognostic (3.97e-3)" "unprognostic (2.81e-1)" "unprognostic (3.67e-2)" "unprognostic (4.92e-2)" "unprognostic (3.55e-3)" "unprognostic (6.06e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-2)" "unprognostic (3.38e-2)" "unprognostic (5.30e-2)" "prognostic unfavorable (7.01e-5)" "unprognostic (2.35e-1)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.05e-3)" 16.8 12.6 14.1 14.1 16.6 22.7 13.0 18.0 16.0 17.0 10.5 14.6 7.0 12.2 16.7 10.0 20.5 9.9 12.4 9.5 12.0 12.0 10.2 16.4 14.5 17.3 18.7 11.2 14.3 10.9 17.4 44.8 18.5 17.7 12.7 13.2 7.5 13.7 10.4 10.1 12.6 15.3 13.4 20.7 16.9 13.9 14.6 18.6 27.1 12.3 13.3 19.9 15.7 19.5 5.6 5.1 9.3 4.0 9.7 5.8 1.9 15.1 8.5 14.1 11.0 7.0 8.2 9.5 31.4 12.3 14.4 16.9 8.9 20.5 19.2 11.2 12.9 14.7 9.0 14.5 15.6 21.8 22.1 4.0 12.3 15.0 8.3 6.0 21.6 9.5 5.9 5.0 18.6 11.3 9.9 12.7 9.9 29.2 11.4 17.0 5.7 22.4 4.9 8.3 10.8 10.3 13.3 28.9 7.1 11.8 17.2 6.9 8.7 17.7 12.6 5.9 12.3 8.4 5.8 18.3 13.4 15.1 10.8 13.7 8.2 6.4 19.4 23.8 6.0 12.8 9.3 3.0 4.6 4.4 3.9 4.8 5.6 5.1 5.8 3.7 5.2 3.9 4.5 2.2 9.7 4.0 5.1 4.2 1.9 14.1 16.6 18.0 16.0 12.0 12.0 18.7 11.2 17.7 18.6 23.8 20.8 33.8 52.9 62.3 46.2 14.4 12.7 25.4 20.5 15.7 51.1 22.4 3.3 21.4 1.4 34.4 21.2 0.0 14.8 12.9 28.2 64.5 30.1 17.3 20.5 31.8 31.0 17.8 27.9 4.0 19.8 35.3 23.6 33.3 24.7 19.8 36.7 21.0 18.7 10.2 42.3 19.4 23.0 37.9 35.1 40.4 49.2 29.9 19.6 126.8 UBE2M "hUbc12, UBC12" ENSG00000130725 "Ubiquitin conjugating enzyme E2 M" P61081 19 58555712-58558960 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 134.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004993, HPA054551, HPA057800" Approved Enhanced "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531" "unprognostic (1.42e-1)" "unprognostic (1.99e-1)" "unprognostic (1.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.35e-2)" "unprognostic (1.77e-1)" "unprognostic (1.17e-3)" "unprognostic (3.90e-3)" "unprognostic (4.86e-2)" "unprognostic (1.09e-2)" "unprognostic (3.05e-3)" "unprognostic (1.96e-1)" "unprognostic (1.81e-1)" "unprognostic (8.63e-3)" "unprognostic (1.76e-1)" "unprognostic (5.85e-2)" "unprognostic (8.42e-3)" 18.1 26.0 51.8 16.3 38.9 32.1 13.6 28.4 52.4 15.2 20.4 17.0 20.5 17.8 17.3 19.6 24.9 19.3 17.4 43.2 35.1 33.9 19.6 19.1 16.5 18.1 32.1 30.5 19.4 20.2 25.9 22.8 32.0 26.4 18.4 16.7 15.0 20.9 22.6 61.9 19.2 15.9 19.2 19.8 18.5 17.9 31.8 16.1 32.7 22.2 21.2 19.9 18.2 23.5 3.8 7.6 10.9 4.3 1.8 3.8 2.1 21.5 39.3 19.9 18.9 10.6 12.7 14.5 22.5 19.8 16.3 14.1 23.7 16.8 22.7 17.0 15.9 32.7 14.1 22.1 22.2 12.3 25.8 134.3 33.0 25.3 15.4 26.0 29.8 26.2 13.6 17.4 24.8 29.5 17.9 19.6 21.5 16.0 28.7 21.6 22.1 23.8 27.1 12.6 25.2 34.4 22.2 16.6 29.2 18.8 27.2 35.1 28.7 19.5 23.9 21.0 7.6 14.3 27.4 14.6 51.1 10.4 16.0 39.8 34.8 52.5 24.3 32.5 26.5 33.3 6.8 4.3 4.1 3.5 2.8 2.7 3.4 3.8 3.7 3.1 3.8 3.7 2.5 10.9 1.8 2.7 7.6 3.1 2.1 51.8 38.9 28.4 52.4 35.1 33.9 32.1 30.5 26.4 16.1 6.0 15.4 10.4 28.7 35.8 101.5 34.7 17.8 12.0 6.8 17.4 19.6 18.8 6.6 15.3 18.8 19.0 45.1 23.3 26.0 17.2 20.9 42.6 19.6 28.7 30.5 103.3 39.5 20.3 27.6 27.8 16.1 18.1 33.7 11.8 28.6 85.9 31.9 25.4 13.1 25.9 58.3 25.8 25.5 26.4 7.9 49.7 43.8 15.2 31.9 47.5 UBE2V1 "CROC-1, CROC1, UBE2V, UEV-1, UEV1A" ENSG00000244687 "Ubiquitin conjugating enzyme E2 V1" Q13404 20 50081124-50115959 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 76.3;Club cells: 55.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA052535, HPA053186" Enhanced Nucleoplasm NA NA 4000000 Nucleoplasm "HPA052535: AB_2681863, HPA053186: AB_2682073" "unprognostic (1.39e-1)" "unprognostic (3.13e-3)" "unprognostic (1.52e-1)" "unprognostic (1.01e-3)" "unprognostic (2.16e-1)" "unprognostic (2.00e-2)" "unprognostic (2.81e-3)" "unprognostic (4.35e-2)" "unprognostic (3.48e-2)" "unprognostic (5.32e-2)" "unprognostic (2.02e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (4.58e-5)" "unprognostic (2.58e-2)" "unprognostic (1.95e-1)" "unprognostic (1.31e-1)" "unprognostic (1.01e-1)" 35.2 35.3 44.9 31.7 52.4 25.6 29.7 36.9 61.7 27.4 37.7 33.8 19.3 34.2 29.1 32.7 43.6 27.4 28.7 38.1 37.5 39.3 39.2 61.8 34.1 36.8 36.4 33.3 37.2 60.8 36.7 23.2 45.9 44.7 30.3 37.3 38.7 38.6 35.0 46.0 37.8 40.1 43.7 29.0 40.2 33.3 23.2 23.2 35.0 30.2 32.0 50.7 49.0 31.7 37.4 40.1 33.9 39.1 54.2 57.4 70.2 29.8 18.7 35.3 21.1 29.0 50.0 19.6 34.0 33.6 72.4 34.9 93.2 22.5 29.1 31.5 44.0 31.5 26.5 25.8 46.6 63.1 20.3 16.3 28.4 14.0 41.2 26.2 34.6 23.1 39.8 28.1 35.6 23.7 40.9 48.8 24.1 35.4 17.7 40.4 20.1 31.1 27.5 24.6 40.0 33.1 17.2 40.3 26.5 49.9 21.5 20.7 25.0 34.6 60.5 25.6 36.9 23.2 31.4 42.3 40.2 37.2 34.0 27.3 17.6 22.6 23.6 43.8 18.1 27.8 25.5 39.1 33.9 56.6 38.5 57.4 37.4 47.0 53.9 40.1 31.0 48.3 52.4 13.8 54.2 33.0 31.6 44.4 70.2 44.9 52.4 36.9 61.7 37.5 39.3 36.4 33.3 44.7 23.2 47.6 19.1 17.1 2.6 5.3 4.5 6.9 12.7 76.3 55.7 10.4 5.9 5.2 19.9 9.5 14.5 6.3 7.4 0.0 9.7 4.6 4.1 2.1 33.7 11.0 6.1 0.0 9.8 16.5 20.0 15.2 7.2 7.7 8.5 19.8 4.2 3.0 15.6 7.0 4.6 12.6 4.9 6.5 5.0 10.3 6.4 7.4 5.9 10.2 4.3 3.5 UBN2 "FLJ25778, KIAA2030" ENSG00000157741 "Ubinuclein 2" Q6ZU65 7 139230356-139308236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 109.8;Late spermatids: 132.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 9.0;NK-cell: 3.4" "Group enriched" "Detected in many" 5 "granulocytes: 9.0;NK-cells: 3.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019743, HPA020122, HPA020124" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA019743: AB_1848851, HPA020122: AB_1848847, HPA020124: AB_2212202" "unprognostic (1.96e-1)" "unprognostic (2.49e-1)" "unprognostic (2.48e-2)" "unprognostic (1.44e-2)" "unprognostic (2.41e-1)" "prognostic favorable (4.49e-4)" "unprognostic (1.24e-3)" "unprognostic (1.22e-2)" "unprognostic (1.30e-3)" "unprognostic (9.88e-2)" "unprognostic (1.65e-1)" "unprognostic (4.96e-2)" "unprognostic (3.65e-2)" "unprognostic (4.54e-3)" "unprognostic (2.95e-1)" "unprognostic (2.91e-2)" "unprognostic (1.05e-2)" 5.4 7.8 11.9 5.3 13.0 10.4 9.7 20.8 13.7 7.6 5.9 8.7 12.6 5.0 10.0 14.1 7.0 7.3 5.7 5.8 11.5 6.9 6.3 7.0 6.0 5.1 10.2 7.6 11.5 10.7 10.5 16.9 6.2 8.6 8.2 6.9 8.1 8.1 12.7 11.1 18.6 5.9 7.9 8.4 6.3 6.3 25.5 9.7 6.9 10.4 3.1 5.2 6.4 13.6 1.2 1.2 9.0 1.0 3.4 0.8 0.1 3.9 3.7 6.1 7.6 4.9 4.5 4.7 2.3 3.4 2.1 2.5 4.5 3.9 6.7 4.3 2.8 5.2 3.7 7.8 1.9 3.7 3.4 4.5 5.0 6.7 4.9 2.8 9.7 3.9 3.1 5.5 2.7 4.4 3.8 4.0 3.6 11.6 5.2 2.7 6.0 7.0 11.3 8.7 4.0 2.7 4.0 5.7 4.7 2.9 2.9 10.1 7.3 7.0 4.9 3.3 6.0 3.1 6.5 4.5 2.6 3.0 3.8 2.9 6.0 6.6 11.8 4.2 5.9 3.8 9.0 1.0 0.1 0.5 0.5 0.4 1.0 0.5 0.6 0.3 1.2 0.8 0.5 1.0 3.4 0.4 1.2 0.3 0.1 11.9 13.0 20.8 13.7 11.5 6.9 10.2 7.6 8.6 9.7 6.0 20.5 7.1 15.7 20.7 52.5 24.3 15.3 29.4 15.9 21.0 88.4 7.1 6.6 6.4 109.8 13.8 13.1 23.3 6.1 7.6 17.4 29.6 11.5 16.8 6.2 42.9 22.4 16.5 14.0 132.0 20.8 13.4 8.5 4.6 16.7 25.5 8.4 14.7 20.1 7.9 57.3 19.4 21.5 26.9 30.1 25.2 12.2 8.7 12.1 18.6 UBXN7 "KIAA0794, UBXD7" ENSG00000163960 "UBX domain protein 7" O94888 3 196347662-196432474 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048441, HPA049442" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA048441: AB_2680394, HPA049442: AB_2680769" "unprognostic (8.36e-3)" "unprognostic (4.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-3)" "unprognostic (1.05e-1)" "unprognostic (6.64e-2)" "unprognostic (5.12e-3)" "unprognostic (1.49e-1)" "unprognostic (9.60e-2)" "unprognostic (6.45e-2)" "unprognostic (2.11e-2)" "unprognostic (2.91e-2)" "unprognostic (2.52e-2)" "unprognostic (1.78e-1)" "unprognostic (3.40e-1)" "unprognostic (7.58e-2)" "unprognostic (1.32e-1)" 13.8 12.7 14.0 11.2 17.6 29.9 13.3 30.4 16.3 14.5 13.1 19.2 13.5 9.0 17.3 14.3 13.4 14.4 9.9 9.6 15.6 12.1 11.4 10.4 13.3 13.3 16.3 12.9 21.4 12.9 23.1 23.4 14.9 16.2 12.4 11.5 11.4 12.8 13.3 10.3 17.5 12.9 13.4 14.0 13.5 10.8 17.9 19.0 24.7 13.2 6.7 13.6 13.9 17.2 9.6 6.3 10.4 6.5 7.6 9.5 2.8 15.1 4.4 18.9 10.0 9.9 17.5 7.9 12.7 8.4 7.3 6.7 12.4 6.6 14.1 26.1 8.5 9.7 12.3 14.1 7.6 13.6 5.8 8.7 22.7 10.3 6.7 7.6 11.2 7.3 10.4 8.6 10.2 12.8 13.1 11.7 10.4 10.7 9.9 8.5 6.6 11.7 6.1 11.0 6.3 6.1 13.6 14.2 9.6 6.0 6.4 12.9 9.7 19.7 5.7 10.1 15.8 15.3 9.6 14.7 8.5 7.5 7.5 13.5 13.5 18.5 20.7 7.7 13.3 6.1 10.2 5.9 8.9 6.1 4.9 5.8 9.6 5.4 4.0 6.3 7.5 9.5 8.3 10.4 7.6 6.5 2.9 8.7 2.8 14.0 17.6 30.4 16.3 15.6 12.1 16.3 12.9 16.2 19.0 41.7 16.8 11.7 12.6 42.0 34.6 16.1 15.3 25.4 23.9 19.2 66.8 14.0 5.0 9.9 30.5 22.2 11.2 0.0 8.7 8.8 21.7 21.2 8.1 10.5 11.1 30.2 44.6 21.5 20.6 19.6 27.6 19.9 21.9 15.4 16.7 21.5 10.8 8.6 26.5 9.4 45.6 32.3 20.8 29.8 21.3 47.8 15.8 27.3 15.5 14.1 UHRF2 "MGC33463, NIRF, RNF107, TDRD23, URF2" ENSG00000147854 "Ubiquitin like with PHD and ring finger domains 2" Q96PU4 9 6413151-6507054 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026633, HPA026697" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA026633: AB_2732431, HPA026697: AB_2732432" "unprognostic (1.08e-1)" "unprognostic (1.13e-1)" "unprognostic (1.52e-1)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (8.40e-2)" "unprognostic (4.35e-3)" "unprognostic (4.12e-2)" "unprognostic (1.53e-1)" "unprognostic (4.17e-2)" "unprognostic (1.73e-1)" "unprognostic (5.69e-3)" "unprognostic (2.14e-2)" "unprognostic (6.21e-2)" "unprognostic (8.77e-2)" "unprognostic (7.42e-2)" "unprognostic (1.50e-1)" 14.1 12.9 10.6 25.4 12.2 49.1 19.0 24.8 11.8 18.6 15.6 12.7 17.6 7.9 17.5 15.1 13.3 12.0 11.9 11.3 10.2 10.6 10.1 9.8 13.5 19.3 12.3 10.5 18.9 14.5 12.7 12.7 14.6 11.4 19.3 12.0 10.7 13.0 16.4 15.7 11.0 12.0 17.1 12.2 14.1 11.6 10.6 14.8 40.3 15.2 10.2 19.8 18.7 18.2 5.1 2.5 7.5 1.4 1.2 3.6 1.2 6.7 7.7 11.1 4.7 9.1 13.2 8.1 15.6 9.6 9.8 17.2 4.9 4.9 10.3 3.4 7.7 9.1 4.4 10.2 9.1 15.0 18.7 4.7 18.0 15.0 7.8 7.5 8.4 6.1 5.9 5.9 7.6 18.8 18.8 38.2 10.6 1.7 10.1 23.1 2.3 14.1 32.7 4.3 9.9 5.7 16.0 5.1 3.6 7.3 4.6 10.0 3.9 6.7 4.5 9.7 14.1 5.6 16.9 32.2 10.5 3.8 4.3 13.0 2.7 8.0 12.1 5.1 7.4 4.1 7.5 1.1 4.3 2.3 0.9 1.7 3.5 3.6 1.8 0.7 5.1 2.3 3.0 1.3 1.2 1.4 2.5 3.5 1.2 10.6 12.2 24.8 11.8 10.2 10.6 12.3 10.5 11.4 14.8 6.0 11.8 25.0 9.7 19.2 22.6 42.0 5.1 5.3 9.1 12.2 29.5 10.8 1.7 5.1 16.0 20.4 8.1 23.3 3.4 8.5 12.4 13.9 17.3 11.3 9.2 27.0 6.8 15.4 11.7 5.9 17.8 11.0 20.3 6.4 12.4 6.7 6.0 12.9 13.8 5.1 34.9 12.9 13.7 37.2 17.2 16.7 4.9 13.8 11.3 7.1 UPP1 "UDRPASE, UP, UPASE, UPP" ENSG00000183696 "Uridine phosphorylase 1" Q16831 7 48088628-48108733 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 206.2;Macrophages: 205.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 26.4;hTERT-HME1: 103.9;SK-MEL-30: 24.1;WM-115: 23.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054040, HPA055394" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "HPA054040: AB_2682352, HPA055394: AB_2682805" "unprognostic (1.16e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (5.96e-2)" "unprognostic (1.01e-1)" "unprognostic (3.21e-3)" "unprognostic (6.36e-2)" "unprognostic (1.78e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.81e-2)" "unprognostic (1.91e-1)" "unprognostic (1.53e-1)" "unprognostic (2.59e-1)" "unprognostic (1.52e-3)" "unprognostic (2.95e-2)" "unprognostic (1.30e-1)" "unprognostic (1.30e-1)" "unprognostic (1.39e-1)" 16.7 8.4 2.8 12.6 4.2 17.6 7.1 5.7 3.8 10.3 8.0 1.7 2.1 7.5 2.8 4.2 37.7 3.3 8.5 7.0 2.3 3.3 12.4 9.1 18.3 17.4 5.8 1.4 2.9 5.8 2.4 5.0 28.9 5.5 3.0 7.6 2.9 7.5 2.1 5.1 2.0 9.7 5.2 3.9 13.9 2.5 1.8 4.8 1.2 6.2 34.0 19.4 7.9 19.6 0.6 8.2 15.7 22.0 5.7 19.7 16.0 6.5 7.9 0.8 1.6 2.7 1.2 8.1 3.2 4.5 4.1 5.1 3.3 3.2 0.0 1.2 2.6 26.4 4.6 1.5 13.1 2.7 1.3 1.4 0.2 1.9 1.3 2.4 0.2 0.5 1.6 6.4 1.9 103.9 1.9 2.7 0.2 0.4 3.9 2.2 0.7 0.0 1.1 3.1 1.1 6.9 0.0 1.7 1.7 9.5 3.4 0.7 0.7 3.3 0.9 24.1 8.9 0.8 0.2 3.8 9.7 8.3 2.6 8.2 7.5 10.0 1.1 9.8 1.0 23.6 15.7 22.0 15.1 19.7 16.7 12.5 0.2 12.6 13.5 8.2 0.6 13.0 12.0 9.1 5.7 15.9 0.7 11.2 16.0 2.8 4.2 5.7 3.8 2.3 3.3 5.8 1.4 5.5 4.8 17.9 64.1 14.6 17.3 41.6 27.8 10.4 22.9 8.1 13.6 10.4 31.4 6.0 59.7 36.9 0.6 58.5 53.1 0.0 35.8 206.2 39.5 10.1 24.4 15.1 111.9 15.9 12.5 78.5 137.0 1.5 4.9 205.8 82.7 43.3 11.6 13.5 73.7 52.6 2.1 15.4 28.8 6.5 33.0 0.0 3.0 26.1 65.8 46.7 13.3 29.6 USF1 "bHLHb11, MLTFI, UEF" ENSG00000158773 "Upstream transcription factor 1" P22415 1 161039251-161045977 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001480, HPA036233, HPA036535" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB001480: AB_2213986, HPA036233: AB_2675012, HPA036535: AB_2675178" "unprognostic (3.66e-2)" "unprognostic (2.79e-2)" "unprognostic (9.12e-3)" "unprognostic (2.17e-1)" "unprognostic (9.40e-2)" "prognostic favorable (8.70e-4)" "unprognostic (1.59e-3)" "unprognostic (2.94e-2)" "unprognostic (3.57e-1)" "unprognostic (1.03e-3)" "unprognostic (3.05e-1)" "unprognostic (2.44e-2)" "prognostic unfavorable (6.01e-12)" "unprognostic (1.24e-3)" "unprognostic (3.29e-1)" "unprognostic (4.08e-1)" "prognostic favorable (1.95e-5)" 15.4 17.0 21.6 16.9 24.4 14.3 13.8 31.0 27.6 15.2 17.6 15.6 15.6 17.7 15.1 15.5 12.6 17.1 16.2 17.4 21.6 22.1 15.2 19.1 16.7 23.8 19.7 19.4 17.2 9.8 19.0 12.3 17.3 17.1 14.4 18.0 14.7 13.8 19.0 27.4 14.6 17.8 18.0 18.3 26.7 13.7 8.5 18.7 21.9 16.1 13.5 30.3 18.5 13.8 3.9 5.7 8.6 4.7 2.0 4.0 2.0 8.2 12.6 15.1 17.5 20.4 11.7 20.3 7.0 15.1 21.8 17.0 8.8 10.5 10.7 14.8 11.5 9.5 10.4 17.8 11.0 12.3 9.9 10.5 9.2 10.5 9.2 11.9 12.8 12.9 9.5 11.1 15.7 12.8 13.9 20.3 18.4 15.1 11.6 13.6 9.7 19.7 14.0 31.1 18.1 16.5 17.2 11.8 13.0 10.8 13.3 8.5 16.4 12.7 16.5 8.8 22.8 13.7 41.8 11.9 10.9 6.9 6.6 11.2 9.8 12.4 17.0 9.4 12.5 8.3 4.7 4.7 2.7 4.0 4.5 2.4 3.4 2.5 2.9 5.4 3.9 2.7 2.6 8.6 2.0 4.2 5.7 2.7 2.0 21.6 24.4 31.0 27.6 21.6 22.1 19.7 19.4 17.1 18.7 6.0 8.6 3.2 0.6 2.1 3.6 0.7 0.0 8.1 2.3 3.5 2.0 1.9 1.7 1.6 0.3 1.9 6.3 0.0 1.2 3.3 1.8 1.0 10.5 0.4 2.8 4.8 2.9 0.0 1.9 0.0 0.3 3.2 5.0 2.8 2.7 2.0 2.1 7.0 0.0 2.5 3.4 6.5 1.4 0.5 0.4 1.6 2.9 4.6 3.2 1.3 USF2 "bHLHb12, FIP" ENSG00000105698 "Upstream transcription factor 2, c-fos interacting" Q15853 19 35268978-35279821 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029764, HPA046567" Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA029764: AB_2673190, HPA046567: AB_2679702" "unprognostic (6.10e-3)" "unprognostic (2.27e-1)" "unprognostic (1.06e-2)" "unprognostic (5.03e-3)" "unprognostic (4.60e-2)" "unprognostic (1.72e-1)" "unprognostic (2.45e-1)" "unprognostic (2.87e-1)" "unprognostic (2.10e-1)" "unprognostic (7.07e-2)" "prognostic favorable (5.12e-5)" "unprognostic (7.75e-2)" "unprognostic (8.12e-2)" "unprognostic (7.47e-2)" "unprognostic (5.75e-2)" "unprognostic (6.90e-2)" "prognostic favorable (3.28e-4)" 40.6 48.6 50.9 42.7 56.8 52.8 53.0 52.5 60.5 23.4 26.2 41.2 25.9 36.5 26.3 23.4 25.8 23.6 23.1 52.6 50.8 35.5 22.1 47.9 29.1 48.8 48.6 43.6 54.1 41.8 34.9 36.4 22.1 40.2 22.5 19.7 31.7 34.0 21.6 108.9 35.1 35.8 24.4 48.5 42.9 30.6 13.0 51.2 22.7 29.9 24.9 32.5 26.8 35.6 7.1 27.3 17.8 5.8 5.8 7.2 3.7 38.7 39.0 20.4 19.2 35.2 18.0 19.1 21.0 25.0 19.1 14.5 18.1 20.1 37.2 33.7 17.9 20.9 11.8 18.8 16.4 10.0 62.5 29.0 22.1 23.4 29.0 21.4 36.9 38.1 15.6 23.2 12.5 19.5 33.3 13.0 25.0 26.5 55.8 15.0 44.4 40.4 14.7 16.9 35.8 13.2 39.7 25.9 35.1 15.9 24.8 34.4 26.1 39.1 42.6 70.6 18.6 17.2 29.7 21.9 32.5 21.9 21.3 28.2 56.2 56.2 40.4 30.1 23.6 42.3 17.8 4.7 5.7 3.9 5.8 4.8 5.6 4.0 5.1 7.1 7.1 3.6 3.5 4.2 5.8 3.5 27.3 7.2 3.7 50.9 56.8 52.5 60.5 50.8 35.5 48.6 43.6 40.2 51.2 6.0 19.0 63.3 21.7 21.1 61.7 62.0 20.4 5.3 9.1 29.6 31.4 20.0 48.0 27.2 0.6 27.9 41.8 0.0 49.5 31.8 22.8 23.4 19.7 42.9 101.1 89.0 50.1 31.3 52.2 2.4 29.7 43.7 25.3 34.3 33.1 60.1 34.5 36.6 29.4 35.6 44.7 12.9 29.9 9.5 10.4 21.7 14.6 39.9 28.2 27.4 VCP "CDC48, IBMPFD, p97, TERA" ENSG00000165280 "Valosin containing protein" P55072 9 35056064-35073249 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway" Hydrolase "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 452.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005593, HPA012728, HPA012814" Supported Enhanced Nucleoplasm,Cytosol No No 110000000 "Nucleoplasm, Cytosol" "CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.15e-2)" "prognostic favorable (7.30e-4)" "unprognostic (5.78e-2)" "unprognostic (1.87e-1)" "unprognostic (2.52e-3)" "unprognostic (1.13e-2)" "unprognostic (3.82e-2)" "unprognostic (1.81e-2)" "unprognostic (2.19e-2)" "unprognostic (3.24e-1)" "prognostic favorable (9.63e-7)" "unprognostic (1.83e-2)" "unprognostic (1.16e-1)" "unprognostic (3.93e-1)" "unprognostic (9.11e-2)" 33.7 43.6 19.6 30.3 21.8 30.8 31.4 19.4 31.0 32.2 25.7 22.7 32.9 22.2 30.5 34.0 40.0 24.7 33.8 69.6 20.0 23.4 30.1 63.4 27.6 42.7 23.1 21.1 25.0 34.9 44.5 29.0 46.3 26.3 33.4 26.5 21.2 30.7 34.1 80.4 29.2 26.3 29.2 23.0 37.8 28.9 25.6 18.2 43.3 32.1 42.2 35.7 31.5 26.5 25.9 29.4 43.4 30.6 23.0 32.1 34.4 36.0 41.2 28.4 15.3 34.3 24.2 21.7 33.6 38.1 50.3 37.2 27.5 14.9 28.6 29.5 41.7 44.2 17.4 42.3 40.1 43.6 30.7 24.5 19.9 39.0 37.6 26.7 22.3 26.6 27.6 27.0 43.6 19.5 21.1 54.4 13.1 20.6 20.8 40.2 25.4 21.8 53.7 37.0 18.7 39.4 19.4 22.1 17.7 39.3 25.8 15.5 19.5 20.3 23.0 10.2 36.9 18.5 15.9 44.5 20.2 26.1 17.9 29.5 10.6 22.4 24.5 33.1 16.1 25.8 43.4 24.5 31.9 24.7 27.2 23.8 25.9 23.6 24.8 29.4 21.1 17.7 18.5 28.4 23.0 30.6 18.9 32.1 34.4 19.6 21.8 19.4 31.0 20.0 23.4 23.1 21.1 26.3 18.2 74.5 72.0 80.5 100.9 68.5 80.1 178.9 43.3 71.0 68.2 52.4 111.9 240.5 63.0 177.8 24.1 121.1 90.3 23.3 162.4 147.5 81.6 98.2 61.1 102.4 116.5 69.9 80.8 122.8 57.9 36.5 77.6 66.7 72.6 234.4 63.9 87.7 195.1 56.3 81.7 89.3 82.6 135.8 82.4 127.7 117.9 79.3 452.1 76.6 57.1 105.3 VEZF1 "DB1, ZNF161" ENSG00000136451 "Vascular endothelial zinc finger 1" Q14119 17 57971547-57988259 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027520, HPA048315" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027520: AB_10602680, HPA048315: AB_2680353" "unprognostic (7.24e-2)" "unprognostic (3.18e-1)" "prognostic favorable (6.14e-5)" "unprognostic (2.12e-2)" "unprognostic (3.85e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (6.46e-4)" "unprognostic (2.71e-2)" "unprognostic (1.65e-1)" "unprognostic (4.72e-2)" "unprognostic (4.97e-2)" "unprognostic (5.15e-2)" "unprognostic (3.28e-3)" "unprognostic (1.45e-1)" "unprognostic (7.67e-2)" "unprognostic (8.67e-2)" "unprognostic (3.03e-2)" 18.3 26.6 21.2 18.6 29.2 38.6 27.9 24.0 24.2 27.4 31.2 32.4 21.4 15.9 34.0 16.9 21.1 32.4 20.3 24.1 23.6 14.5 23.8 13.4 23.6 21.2 32.2 16.4 28.7 22.6 19.8 26.1 21.2 24.6 26.2 19.2 22.6 23.5 26.1 51.7 13.5 21.2 29.7 21.6 20.6 22.4 16.5 37.2 39.8 31.3 19.6 15.6 29.7 36.4 13.9 17.5 26.2 26.0 25.3 18.2 11.9 19.3 22.0 42.3 14.7 10.9 15.5 14.7 16.1 23.4 20.3 18.5 10.5 20.6 10.0 27.5 17.9 18.8 11.2 16.9 18.4 27.7 28.0 13.2 18.5 17.4 12.4 13.8 16.2 16.6 11.0 23.1 13.1 25.0 28.5 19.6 13.7 13.8 14.0 20.6 7.4 26.2 8.8 14.5 17.3 25.8 20.1 33.1 7.7 12.5 18.5 17.6 33.1 15.7 7.2 23.6 18.5 41.2 16.7 19.2 28.8 29.3 17.8 26.1 14.6 11.5 15.4 20.0 14.4 36.6 21.6 13.8 26.2 17.0 17.1 17.5 12.0 14.0 18.2 16.5 13.9 17.8 15.8 24.1 25.3 26.0 17.5 13.1 11.9 21.2 29.2 24.0 24.2 23.6 14.5 32.2 16.4 24.6 37.2 77.4 48.7 19.9 33.3 32.2 65.0 85.3 40.8 66.9 51.2 24.4 62.8 14.1 21.6 30.9 18.8 40.5 18.7 0.0 31.8 14.2 34.8 46.0 54.4 17.8 19.0 31.8 47.0 34.4 37.2 28.5 33.4 41.5 40.5 19.8 30.2 41.2 25.1 21.0 26.2 23.7 61.8 51.8 39.1 37.7 21.3 18.3 16.6 23.0 23.5 32.0 VHL VHL1 ENSG00000134086 "Von Hippel-Lindau tumor suppressor" P40337 3 10141008-10152220 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Congenital erythrocytosis, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 54.7" "CAB005430, HPA031631, HPA031632" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB005430: AB_2241850, HPA031631: AB_2673968, HPA031632: AB_2673969" "prognostic unfavorable (9.02e-5)" "unprognostic (1.10e-1)" "unprognostic (4.46e-3)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (3.55e-1)" "unprognostic (3.03e-2)" "unprognostic (4.36e-2)" "unprognostic (5.82e-3)" "unprognostic (1.81e-2)" "unprognostic (2.51e-1)" "prognostic favorable (7.84e-4)" "unprognostic (1.46e-1)" "unprognostic (2.92e-2)" "unprognostic (1.28e-3)" 13.8 17.4 18.1 29.2 18.4 24.3 15.4 25.8 21.4 13.3 19.8 19.3 14.5 15.9 15.1 13.6 16.4 14.3 18.9 10.5 17.1 18.5 13.7 16.3 14.6 27.9 13.5 12.3 15.2 22.5 13.8 14.6 18.8 12.8 15.1 16.6 12.5 21.8 13.7 14.8 14.0 22.3 13.4 17.0 22.6 16.2 17.9 11.2 39.2 16.9 11.5 29.3 15.4 19.1 5.4 3.9 8.0 4.1 4.4 4.3 1.7 6.8 6.6 14.6 8.9 13.6 10.5 54.7 6.1 8.7 7.8 9.2 7.8 8.6 24.3 8.3 8.2 11.0 5.9 13.5 8.5 9.6 11.6 12.2 18.9 10.8 10.7 12.9 16.6 15.2 10.6 9.7 10.3 13.0 10.4 8.9 15.3 16.8 18.5 7.6 12.4 15.8 12.2 9.8 7.4 8.5 20.1 12.9 12.2 9.5 17.8 5.5 18.3 12.8 6.8 7.3 9.2 13.4 21.1 7.7 7.7 10.4 7.2 9.5 13.2 26.9 38.8 8.6 20.0 7.0 2.6 4.1 3.3 3.8 2.5 3.6 4.1 2.9 4.3 3.9 5.4 2.5 2.7 8.0 4.4 3.2 2.4 3.1 1.7 18.1 18.4 25.8 21.4 17.1 18.5 13.5 12.3 12.8 11.2 11.9 12.2 25.5 15.5 13.1 15.6 5.0 20.4 5.3 5.7 15.7 17.7 13.9 6.6 9.9 7.6 12.1 10.5 0.0 4.5 15.8 9.5 19.0 4.7 12.3 12.9 17.5 13.8 17.2 20.2 6.1 13.0 18.5 11.8 15.4 9.3 10.4 8.5 9.3 10.6 7.3 13.9 6.5 6.2 14.4 25.6 17.9 14.4 17.5 10.7 19.5 VWA5A "BCSC-1, LOH11CR2A" ENSG00000110002 "Von Willebrand factor A domain containing 5A" O00534 11 124115362-124147721 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 15 "granulocytes: 538.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 25.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 28.2;HEL: 20.3;HHSteC: 15.8;HUVEC TERT2: 18.7;RPTEC TERT1: 20.6" "Low region specificity" "Detected in all" "HPA037813, HPA037814, HPA061500" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542" "unprognostic (2.69e-1)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (6.48e-2)" "unprognostic (8.49e-3)" "unprognostic (2.48e-1)" "unprognostic (8.18e-2)" "unprognostic (4.88e-2)" "unprognostic (1.18e-1)" "unprognostic (5.15e-2)" "unprognostic (4.53e-2)" "unprognostic (2.38e-2)" "prognostic favorable (1.55e-5)" "unprognostic (4.54e-2)" "unprognostic (7.21e-2)" "unprognostic (2.16e-1)" "unprognostic (4.65e-1)" 14.8 20.2 13.8 7.5 13.4 1.6 16.0 2.3 9.3 15.5 23.9 7.5 10.0 16.7 16.6 17.0 12.6 9.9 19.9 6.5 14.1 24.6 16.0 4.3 19.4 6.8 12.5 6.6 9.6 15.3 5.5 34.2 25.9 15.2 22.5 28.4 10.3 31.2 13.2 3.0 17.9 24.0 13.6 15.0 6.0 17.8 6.3 7.6 3.9 13.7 7.1 9.8 14.9 11.8 4.5 4.8 25.6 5.3 4.3 7.5 3.6 0.0 0.2 3.6 0.2 3.9 3.6 1.3 0.5 0.2 0.3 0.1 0.2 28.2 0.0 3.5 0.6 4.9 0.1 0.7 6.4 0.0 9.6 0.0 20.3 5.1 0.6 15.8 0.2 9.5 10.7 0.7 0.6 2.1 1.4 18.7 2.7 1.1 3.5 1.1 0.1 0.4 0.3 5.7 0.0 0.7 0.0 12.6 0.1 20.6 0.2 3.2 0.3 0.5 0.2 1.0 8.7 2.5 0.9 0.5 0.1 2.7 0.1 0.0 1.3 1.1 0.0 11.7 0.4 0.2 25.6 4.8 0.5 2.9 3.3 0.7 4.5 3.2 1.7 4.8 2.3 4.1 2.6 0.3 4.3 5.3 2.6 7.5 3.6 13.8 13.4 2.3 9.3 14.1 24.6 12.5 6.6 15.2 7.6 8.9 36.5 0.8 11.6 15.2 2.9 2.4 7.6 25.4 14.8 31.4 2.0 7.8 8.3 19.7 32.8 3.6 25.8 0.0 25.0 2.1 7.8 8.4 538.2 2.4 29.2 30.2 14.5 1.8 5.6 3.6 2.6 6.0 5.0 2.8 22.5 12.0 20.8 17.3 0.4 11.5 1.1 0.0 3.8 0.2 2.3 10.9 1.6 4.9 22.5 14.0 WAC "BM-016, FLJ31290, MGC10753, PRO1741, Wwp4" ENSG00000095787 "WW domain containing adaptor with coiled-coil" Q9BTA9 10 28532493-28623112 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036528, HPA042609, HPA074604" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036528: AB_10670839, HPA042609: AB_2678076, HPA074604: " "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.80e-1)" "unprognostic (4.53e-2)" "unprognostic (2.19e-2)" "prognostic unfavorable (9.27e-6)" "unprognostic (1.40e-1)" "unprognostic (1.44e-1)" "unprognostic (3.60e-1)" "unprognostic (2.07e-1)" "unprognostic (2.90e-1)" "unprognostic (1.82e-2)" "unprognostic (1.23e-1)" "unprognostic (3.13e-2)" "unprognostic (6.63e-2)" "unprognostic (1.36e-1)" 30.6 25.2 36.5 29.8 40.9 59.3 30.4 83.3 46.0 30.4 36.5 27.8 26.9 24.9 33.3 30.6 29.0 28.3 25.9 40.8 37.4 31.6 32.2 28.7 29.4 32.9 36.4 35.5 39.6 33.8 41.8 44.2 34.8 35.4 32.3 28.8 21.2 27.0 31.7 31.8 28.9 27.5 36.4 38.1 33.5 27.3 28.1 41.0 30.1 36.5 18.3 36.6 40.3 78.9 15.0 14.9 19.9 20.6 23.0 17.6 9.7 31.3 20.1 41.3 25.2 34.1 32.9 29.1 30.5 24.2 35.8 41.1 28.5 35.1 41.8 22.1 28.1 28.2 30.6 33.5 23.0 39.6 42.9 27.7 44.3 22.5 22.3 39.8 21.5 34.8 28.3 44.3 39.2 34.7 35.4 31.5 33.7 39.0 39.0 29.8 24.2 47.7 18.9 23.9 24.4 10.4 34.6 57.0 28.0 25.6 18.3 41.5 31.2 25.3 33.6 45.9 34.6 25.5 34.5 26.1 22.8 28.3 24.6 26.9 21.1 18.7 45.4 24.1 41.0 20.0 14.6 12.1 12.4 14.6 20.6 17.6 15.0 13.2 16.8 14.9 13.6 15.0 13.6 19.9 23.0 15.9 11.3 14.2 9.7 36.5 40.9 83.3 46.0 37.4 31.6 36.4 35.5 35.4 41.0 86.4 62.7 75.1 84.6 156.4 108.3 98.2 58.6 34.8 55.7 38.4 90.3 50.1 26.6 39.8 80.4 72.4 67.2 0.0 40.9 51.4 74.3 94.2 54.3 51.3 46.5 101.7 66.7 68.2 99.9 76.5 76.8 83.5 72.6 38.7 70.0 65.8 47.1 63.3 77.8 50.0 84.7 58.2 80.8 79.1 54.1 160.8 82.8 82.8 62.6 118.0 WASHC4 "KIAA1033, SWIP" ENSG00000136051 "WASH complex subunit 4" Q2M389 12 105107324-105169134 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 41.8;Hofbauer cells: 44.7;monocytes: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045666, HPA046737" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045666: AB_2679411, HPA046737: AB_2679778" "unprognostic (2.68e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (4.85e-2)" "unprognostic (2.76e-1)" "unprognostic (1.10e-1)" "unprognostic (4.41e-1)" "unprognostic (9.79e-3)" "unprognostic (1.32e-2)" "unprognostic (3.14e-2)" "unprognostic (1.24e-2)" "unprognostic (1.81e-1)" "unprognostic (1.49e-2)" "unprognostic (2.96e-1)" "unprognostic (4.61e-2)" "unprognostic (1.87e-1)" "unprognostic (1.03e-1)" "unprognostic (3.86e-2)" 26.2 22.1 14.4 22.8 18.1 16.0 20.2 14.8 16.8 20.8 16.2 16.4 21.1 11.5 22.3 18.0 15.9 15.3 18.2 13.3 14.3 11.9 25.6 28.5 19.4 31.5 18.7 11.9 21.7 19.6 20.7 30.1 23.8 24.0 18.5 14.8 14.6 17.5 18.0 18.0 24.3 21.9 18.2 22.1 36.5 14.3 9.9 17.4 21.3 17.9 12.2 29.8 16.7 18.9 11.4 7.9 11.0 20.9 5.3 3.6 4.3 10.0 12.2 10.9 7.9 25.6 25.5 13.0 15.6 18.1 18.4 17.0 8.6 5.8 22.7 8.7 26.2 11.8 9.4 9.2 9.6 14.8 8.2 7.0 4.6 11.3 7.1 17.2 12.9 9.0 20.4 11.3 16.6 13.4 19.7 29.7 8.1 9.2 8.1 19.9 5.1 7.2 13.4 13.1 7.1 10.2 13.7 14.8 7.1 24.4 11.8 7.0 8.8 16.2 11.5 16.0 14.4 8.5 13.9 36.1 22.3 6.1 14.1 10.2 10.6 10.0 18.4 15.7 11.4 22.3 9.9 10.2 5.9 2.1 12.4 3.1 11.4 3.4 2.8 7.9 9.0 3.6 3.4 11.0 5.3 20.9 4.0 2.3 4.3 14.4 18.1 14.8 16.8 14.3 11.9 18.7 11.9 24.0 17.4 32.8 18.7 0.0 0.0 0.0 0.0 0.0 0.0 32.1 21.6 41.8 0.0 19.1 16.6 22.0 0.0 0.0 0.0 0.0 19.0 23.9 0.0 0.0 24.4 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 46.9 0.0 0.0 22.7 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 WASHC5 "KIAA0196, SPG8" ENSG00000164961 "WASH complex subunit 5" Q12768 8 125024260-125091840 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 17.5;Exocrine glandular cells: 14.9;Hofbauer cells: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034216, CAB034219, HPA064649, HPA070916" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034216: AB_2234159, CAB034219: AB_2130519, HPA064649: AB_2685312, HPA070916: AB_2686322" "unprognostic (1.98e-3)" "unprognostic (3.75e-2)" "unprognostic (8.40e-2)" "unprognostic (3.89e-3)" "unprognostic (2.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (6.74e-5)" "unprognostic (2.54e-2)" "unprognostic (3.54e-1)" "unprognostic (5.69e-2)" "unprognostic (9.10e-3)" "unprognostic (1.53e-1)" "unprognostic (9.39e-3)" "unprognostic (5.95e-2)" "unprognostic (2.17e-1)" "unprognostic (1.62e-1)" "unprognostic (2.33e-2)" 21.7 28.1 16.7 17.3 25.1 18.5 20.1 17.1 23.7 18.7 18.2 38.0 13.0 17.9 22.2 16.5 19.6 15.8 18.0 17.1 16.9 15.2 23.2 18.2 16.8 23.0 22.8 16.4 16.5 17.1 25.9 26.4 22.0 28.7 18.3 20.7 17.9 22.6 17.3 23.1 18.6 16.8 20.7 24.5 19.6 18.3 9.3 22.5 25.0 23.9 17.8 20.6 20.4 16.0 8.4 16.0 9.7 21.5 13.5 13.5 9.6 15.7 18.6 10.2 12.5 23.3 25.0 6.7 16.9 26.1 18.0 19.2 6.9 17.1 14.1 12.1 22.1 10.5 12.4 16.6 15.5 23.7 18.6 9.3 19.0 11.5 9.0 22.7 5.8 19.3 24.8 10.3 14.8 13.0 13.8 20.6 12.5 10.9 14.6 21.8 34.4 17.2 4.6 9.7 26.5 18.9 11.7 9.2 14.4 13.7 19.8 5.4 10.8 19.8 44.8 15.7 11.1 19.3 10.1 17.9 9.8 21.8 16.2 15.0 13.1 12.0 12.7 26.0 11.0 13.6 7.7 13.7 9.7 11.8 16.8 12.5 8.4 11.3 11.9 16.0 8.1 9.1 12.5 4.8 13.5 21.5 5.8 13.5 9.6 16.7 25.1 17.1 23.7 16.9 15.2 22.8 16.4 28.7 22.5 3.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 8.1 9.1 10.4 0.0 11.0 5.0 10.4 0.0 0.0 0.0 0.0 14.9 8.8 0.0 0.0 8.1 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 10.0 0.0 0.0 12.8 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 WBP11 "NPWBP, PPP1R165, SIPP1" ENSG00000084463 "WW domain binding protein 11" Q9Y2W2 12 14784579-14803540 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039710, HPA040037, HPA046403, HPA049126" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039710: AB_2676638, HPA040037: AB_10796115, HPA046403: AB_2679654, HPA049126: AB_2680644" "unprognostic (4.40e-2)" "unprognostic (1.58e-1)" "unprognostic (4.16e-2)" "unprognostic (1.39e-2)" "unprognostic (1.55e-1)" "unprognostic (4.15e-2)" "prognostic unfavorable (9.40e-4)" "unprognostic (5.67e-3)" "unprognostic (3.30e-2)" "unprognostic (2.68e-1)" "unprognostic (9.69e-2)" "unprognostic (1.68e-1)" "unprognostic (2.96e-3)" "unprognostic (6.11e-2)" "unprognostic (3.07e-1)" "unprognostic (1.94e-1)" "unprognostic (4.09e-2)" 27.0 30.8 32.7 22.8 40.7 59.5 25.9 25.6 34.2 21.4 21.9 28.8 10.7 17.5 27.5 20.5 23.4 27.3 19.3 32.9 28.1 25.3 23.5 25.1 25.4 27.3 24.0 29.7 29.4 23.1 29.7 21.8 28.2 29.3 25.1 24.9 23.0 23.2 21.6 46.7 28.7 23.1 24.6 29.1 31.1 23.6 39.2 25.8 25.7 26.5 20.4 30.6 26.4 20.9 15.4 11.4 10.5 16.7 15.9 19.8 11.3 16.2 14.6 17.3 32.9 11.6 11.1 31.2 13.4 11.3 20.5 20.7 26.4 20.2 20.3 8.7 12.1 17.6 13.5 26.6 17.7 25.3 35.9 17.8 29.6 16.1 16.0 11.6 27.6 16.3 10.8 14.1 22.9 17.2 11.2 16.3 19.3 18.8 10.8 16.2 15.7 25.7 14.8 55.6 11.3 9.3 22.0 27.4 12.7 14.7 22.4 9.2 18.8 17.9 15.0 14.1 43.1 8.0 18.3 12.0 14.3 22.0 12.6 22.9 9.5 13.2 37.4 15.0 13.8 19.0 9.5 12.1 10.5 17.2 16.7 18.9 15.4 16.6 17.3 11.4 13.8 19.8 17.9 7.4 15.9 16.5 8.2 17.2 11.3 32.7 40.7 25.6 34.2 28.1 25.3 24.0 29.7 29.3 25.8 53.6 55.4 61.2 69.4 48.8 41.1 94.8 61.1 100.4 67.1 34.9 45.2 49.7 36.5 51.5 59.9 46.9 28.6 70.0 51.9 78.0 44.6 45.4 101.8 36.5 41.5 41.3 37.9 44.2 29.8 44.4 42.0 44.2 33.7 132.6 33.1 45.0 42.9 17.5 30.8 39.1 49.6 58.2 50.2 136.2 151.1 48.7 63.5 59.6 38.4 55.9 WDHD1 "AND-1, CHTF4, CTF4" ENSG00000198554 "WD repeat and HMG-box DNA binding protein 1" O75717 14 54938950-55027105 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.1" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 10.6;Spermatogonia: 20.5" "Cancer enhanced" "Detected in all" "testis cancer: 23.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000632, HPA001122" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000632: , HPA001122: AB_1080589" "unprognostic (1.88e-1)" "unprognostic (1.21e-1)" "unprognostic (1.98e-2)" "unprognostic (2.25e-3)" "unprognostic (1.20e-1)" "unprognostic (6.85e-3)" "unprognostic (2.33e-4)" "unprognostic (5.52e-3)" "unprognostic (7.28e-3)" "unprognostic (8.05e-3)" "prognostic unfavorable (9.24e-4)" "unprognostic (5.11e-2)" "unprognostic (2.67e-4)" "unprognostic (8.31e-3)" "unprognostic (1.50e-1)" "unprognostic (3.49e-2)" "unprognostic (2.36e-2)" 5.0 2.8 6.3 6.6 7.5 10.8 3.8 7.2 4.6 3.7 4.9 2.7 0.6 3.2 4.2 2.9 7.0 4.0 2.3 2.3 3.2 2.3 2.8 2.1 2.9 8.9 3.3 2.5 4.1 2.0 3.0 1.9 6.0 4.4 2.1 7.3 2.6 3.0 2.2 2.0 4.5 3.6 4.6 2.8 4.6 2.8 8.8 3.5 21.1 2.1 6.4 11.2 3.6 4.3 4.8 1.8 4.3 0.9 4.3 4.6 1.6 16.0 10.4 20.6 9.0 2.0 4.9 12.0 15.6 6.7 12.6 15.5 6.9 10.8 18.4 8.0 4.4 9.1 13.7 30.6 9.0 26.6 12.3 5.3 12.1 10.1 6.6 0.8 22.8 9.3 2.5 1.6 15.6 6.1 3.0 8.2 12.0 15.1 9.3 12.1 8.9 21.4 4.5 16.3 8.6 10.8 20.1 29.6 7.1 3.6 10.8 12.0 8.4 16.6 4.2 5.4 15.7 11.3 4.6 5.3 16.1 19.1 11.7 13.2 2.8 5.7 24.6 7.3 11.3 12.6 4.3 0.8 1.4 2.3 0.6 3.2 3.0 2.7 3.3 1.4 4.8 3.3 4.6 1.2 4.3 0.9 1.8 3.9 1.6 6.3 7.5 7.2 4.6 3.2 2.3 3.3 2.5 4.4 3.5 0.0 1.3 2.9 1.5 3.4 2.1 1.5 0.0 4.0 5.7 3.5 0.0 5.8 0.0 1.8 0.5 1.0 0.5 0.0 0.9 8.0 3.1 0.5 0.0 0.8 3.4 3.2 0.0 1.3 1.6 0.8 0.0 2.0 1.7 1.8 2.5 1.5 1.0 0.0 2.8 1.9 3.3 0.0 3.3 10.6 20.5 2.0 2.2 0.0 3.1 0.9 WDR26 "FLJ21016, GID7" ENSG00000162923 "WD repeat domain 26" Q9H7D7 1 224385143-224437033 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 63.9" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 178.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028538, HPA028539, HPA061094" Enhanced Enhanced Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427" "unprognostic (4.09e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.31e-2)" "unprognostic (6.67e-2)" "unprognostic (2.27e-1)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (8.42e-2)" "unprognostic (6.32e-2)" "unprognostic (5.59e-2)" "unprognostic (4.18e-1)" "prognostic unfavorable (3.31e-6)" "unprognostic (8.40e-3)" "unprognostic (4.00e-1)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" 8.2 7.2 6.7 6.7 6.7 18.5 7.2 8.2 7.3 7.8 7.0 6.7 6.7 4.0 6.8 9.3 13.0 5.9 7.0 7.5 6.7 5.0 6.7 9.3 9.0 7.2 6.7 6.7 7.0 6.9 9.2 6.7 8.7 6.7 7.0 6.7 6.7 7.2 6.7 15.2 9.9 6.7 7.1 6.7 10.2 6.3 63.9 6.7 6.7 7.0 6.7 7.4 6.7 8.3 1.5 2.1 8.3 3.9 2.7 2.7 1.3 11.9 6.2 19.3 8.9 25.8 29.4 13.9 17.6 28.8 16.1 15.2 9.8 13.6 14.2 17.7 28.3 6.2 10.9 11.3 15.1 26.5 11.1 12.9 9.8 8.1 9.2 28.1 10.2 17.2 27.3 21.9 17.0 16.1 26.7 26.8 8.7 12.9 14.7 21.1 6.6 10.5 9.9 18.6 12.4 7.2 9.7 20.2 11.2 19.6 12.1 7.0 17.9 20.0 27.1 21.5 21.1 31.1 16.8 28.1 13.8 6.3 12.9 21.1 15.7 7.5 9.7 15.7 7.3 17.0 4.1 1.9 3.3 2.7 2.4 1.5 1.5 1.9 2.1 1.8 1.4 1.4 2.1 8.3 2.7 3.9 2.1 1.6 1.3 6.7 6.7 8.2 6.7 6.7 5.0 6.7 6.7 6.7 6.7 98.3 43.8 19.4 25.3 99.0 23.8 42.4 45.9 41.5 50.0 33.2 29.5 23.4 5.0 19.2 178.7 37.6 21.6 0.0 20.3 11.8 51.5 39.3 46.2 31.0 44.5 36.5 34.0 44.2 119.9 79.7 34.2 49.8 43.9 12.6 40.3 16.9 26.6 25.9 26.5 17.0 22.9 19.4 41.9 36.4 24.6 107.0 57.1 31.6 23.8 59.3 WDR27 MGC43690 ENSG00000184465 "WD repeat domain 27" A2RRH5 6 169457212-169702048 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037497, HPA037498" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037497: AB_10671503, HPA037498: AB_2675509" "unprognostic (2.10e-1)" "unprognostic (8.66e-3)" "unprognostic (1.32e-1)" "unprognostic (1.78e-2)" "unprognostic (8.59e-2)" "unprognostic (1.98e-3)" "unprognostic (3.81e-3)" "unprognostic (2.59e-2)" "unprognostic (1.83e-1)" "unprognostic (8.63e-2)" "unprognostic (2.43e-2)" "unprognostic (3.62e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (3.15e-2)" "unprognostic (2.19e-1)" "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" 6.7 8.0 8.6 11.8 9.2 7.0 9.3 10.1 10.9 9.9 7.9 10.3 7.1 8.1 17.2 10.2 8.9 13.4 8.1 5.0 6.1 4.1 7.2 6.3 6.6 8.2 5.9 5.1 18.2 8.5 8.4 9.9 5.9 7.2 9.2 6.3 8.4 11.2 5.9 5.9 7.5 8.6 9.1 4.7 7.8 7.7 21.5 8.6 7.6 12.7 4.2 9.0 10.2 10.8 4.7 2.1 1.5 1.1 0.7 6.0 1.2 4.4 6.3 15.8 8.9 4.7 6.2 7.9 6.1 1.5 2.9 4.5 8.4 6.6 4.5 4.7 1.9 6.3 9.1 5.0 4.3 4.5 6.0 8.9 8.5 11.3 5.4 3.4 4.7 1.3 6.1 3.8 3.9 4.6 7.5 5.8 9.2 19.8 9.3 4.8 6.7 3.0 11.7 7.4 4.8 5.5 7.9 5.5 6.6 3.7 4.0 9.0 10.8 5.0 3.6 3.8 5.6 4.4 8.0 5.6 4.3 5.4 6.3 7.1 8.8 3.5 10.0 5.3 9.3 7.4 0.2 1.1 1.5 1.9 0.7 3.2 2.1 2.0 2.5 1.1 4.7 6.0 1.7 0.5 0.7 0.5 2.1 1.2 1.2 8.6 9.2 10.1 10.9 6.1 4.1 5.9 5.1 7.2 8.6 8.9 3.8 5.6 5.1 1.9 12.7 3.2 7.6 14.7 3.4 12.2 5.9 4.2 0.0 2.2 21.5 5.8 3.3 0.0 1.3 2.3 4.5 3.7 3.5 3.9 1.9 20.6 4.1 11.1 1.3 6.8 7.5 2.5 3.3 1.0 4.2 7.0 1.7 5.1 9.2 1.3 13.8 0.0 2.7 14.9 9.4 1.0 1.6 4.4 6.0 4.7 WDR3 "DIP2, FLJ12796, UTP12" ENSG00000065183 "WD repeat domain 3" Q9UNX4 1 117929720-117966542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027509, HPA054354, HPA072915" Enhanced Nucleoplasm,Nucleoli No No Nucleoli Nucleoplasm "HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: " "unprognostic (6.77e-2)" "unprognostic (4.53e-3)" "unprognostic (1.50e-1)" "unprognostic (2.46e-3)" "unprognostic (1.91e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (8.82e-4)" "unprognostic (8.90e-3)" "unprognostic (7.47e-2)" "unprognostic (5.29e-2)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (8.65e-2)" 12.5 13.5 7.7 10.6 10.7 3.3 12.2 8.4 9.7 10.5 7.7 6.8 9.7 7.3 12.6 6.5 13.3 10.5 4.6 8.7 7.1 6.4 8.5 14.8 7.3 15.5 6.9 6.2 12.1 21.4 16.3 14.8 8.4 8.3 8.4 10.8 6.6 9.8 8.1 25.4 10.5 6.8 11.7 6.2 8.5 9.3 14.9 6.9 15.2 11.1 9.5 15.2 10.2 9.1 8.7 11.9 0.5 6.6 7.9 12.4 6.3 15.2 9.7 9.7 14.8 10.6 8.7 11.2 10.7 7.0 12.5 11.0 10.2 5.1 18.1 14.7 7.9 8.0 10.3 24.1 12.3 19.9 14.9 12.5 17.0 10.4 8.2 8.7 31.8 9.0 8.5 8.9 15.8 24.0 7.4 11.9 12.8 20.7 8.9 10.9 8.8 15.1 7.3 35.0 13.4 15.6 14.5 33.7 13.8 6.2 10.2 15.0 13.7 12.2 15.1 17.3 14.1 6.0 13.3 10.5 9.4 15.0 17.1 23.9 13.1 15.3 28.4 13.8 20.6 24.2 0.1 6.0 0.5 8.8 6.1 11.4 8.7 8.0 10.3 11.9 7.9 12.4 11.3 0.5 7.9 6.6 6.6 10.7 6.3 7.7 10.7 8.4 9.7 7.1 6.4 6.9 6.2 8.3 6.9 8.9 11.0 9.2 10.8 18.5 9.6 14.0 5.1 25.4 33.0 7.0 5.9 9.2 8.3 8.4 28.6 11.7 2.7 0.0 11.8 7.5 9.5 8.9 15.1 25.5 7.2 14.3 3.5 11.6 6.3 34.2 11.5 7.4 10.1 2.8 5.1 6.5 10.6 3.5 11.0 6.0 6.4 12.9 14.6 25.9 60.1 19.6 4.2 5.7 9.4 7.7 WDR33 "FLJ11294, NET14, WDC146" ENSG00000136709 "WD repeat domain 33" Q9C0J8 2 127701022-127811187 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026897, HPA046527" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA026897: AB_1858803, HPA046527: AB_2679686" "unprognostic (1.26e-1)" "unprognostic (7.22e-2)" "unprognostic (1.50e-1)" "unprognostic (1.79e-2)" "unprognostic (6.63e-2)" "unprognostic (8.32e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (1.01e-1)" "unprognostic (1.66e-2)" "unprognostic (8.13e-2)" "unprognostic (5.72e-3)" "unprognostic (1.61e-1)" "unprognostic (6.60e-2)" "unprognostic (3.64e-1)" "unprognostic (2.04e-1)" "unprognostic (9.85e-2)" "unprognostic (1.03e-2)" 19.8 19.2 18.1 22.5 22.5 18.8 21.7 51.4 24.3 20.9 19.8 22.0 22.8 18.2 32.2 19.0 20.6 18.6 17.9 16.8 17.7 16.5 22.3 32.3 18.5 25.0 19.4 14.5 29.2 21.8 26.4 41.8 20.9 22.0 21.9 19.5 24.4 25.3 17.4 22.0 27.8 21.3 21.0 22.2 28.1 18.0 24.5 20.8 39.5 25.2 16.6 30.5 21.5 22.4 24.4 21.6 26.7 18.3 25.9 26.3 14.4 18.5 10.5 18.4 14.9 10.9 11.4 19.1 17.0 13.6 18.0 17.1 24.4 14.3 23.6 18.9 11.2 16.6 15.2 20.7 14.4 23.7 21.6 12.4 22.7 13.4 26.0 12.3 27.3 17.0 11.1 15.3 17.2 14.7 12.9 15.3 21.4 18.8 21.2 12.6 11.7 28.3 20.0 22.3 12.1 12.0 19.9 18.6 18.7 10.3 24.2 17.2 13.4 15.2 14.1 12.0 18.1 10.9 16.0 14.2 14.2 20.8 15.8 14.5 20.7 31.6 45.0 11.6 10.9 13.2 21.2 16.7 26.7 21.5 18.3 21.9 24.4 21.9 20.6 21.6 23.0 23.3 22.1 11.4 25.9 18.2 15.8 26.3 14.4 18.1 22.5 51.4 24.3 17.7 16.5 19.4 14.5 22.0 20.8 32.8 38.9 53.6 65.1 97.7 50.6 43.7 50.9 26.8 25.0 34.9 60.9 70.6 39.7 41.7 25.0 53.7 27.8 46.7 39.3 76.0 51.5 42.9 63.5 58.0 43.8 57.2 37.8 42.4 42.9 17.6 46.6 47.4 72.6 84.8 34.6 30.4 34.6 31.7 47.4 42.1 55.4 45.3 50.9 89.8 72.4 101.3 92.5 69.8 38.3 50.3 WDR55 "FLJ20195, FLJ21702" ENSG00000120314 "WD repeat domain 55" Q9H6Y2 5 140664676-140674124 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043470, HPA048143, HPA075133" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: " "prognostic unfavorable (1.51e-4)" "unprognostic (1.35e-1)" "unprognostic (7.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (8.88e-6)" "unprognostic (9.96e-2)" "unprognostic (2.78e-1)" "unprognostic (3.05e-1)" "unprognostic (4.00e-2)" "unprognostic (1.02e-2)" "unprognostic (1.19e-3)" "unprognostic (1.37e-1)" "unprognostic (2.14e-1)" "unprognostic (3.70e-1)" "unprognostic (2.51e-2)" 17.9 12.4 7.6 17.8 8.8 18.1 12.9 13.0 12.7 9.5 16.6 11.4 16.9 14.9 12.0 11.0 18.8 10.9 20.2 9.6 7.7 9.1 15.3 29.9 12.7 15.0 12.6 8.5 12.0 16.2 11.4 13.2 13.9 10.6 12.8 17.5 8.9 16.7 14.8 18.2 15.8 20.8 11.1 8.9 18.8 14.9 8.0 8.5 12.5 12.0 14.0 21.4 13.5 11.0 10.4 11.3 10.4 18.9 11.3 14.3 10.2 7.9 10.9 5.3 21.3 8.3 6.7 14.9 7.9 9.8 8.5 9.7 18.7 10.9 7.5 10.7 10.3 15.3 9.9 7.2 13.9 6.6 6.9 5.9 8.5 9.0 7.6 8.0 8.9 16.1 7.9 8.1 11.6 6.2 5.8 9.0 8.4 5.9 5.9 9.3 11.3 8.2 8.0 5.6 11.4 9.6 7.0 7.7 7.0 10.1 12.0 5.2 7.0 10.9 31.9 12.1 6.8 22.6 9.6 8.0 11.1 5.8 12.7 10.7 9.8 7.6 5.9 14.3 11.9 6.5 6.9 11.7 8.6 13.9 18.9 14.3 10.4 12.9 11.8 11.3 8.8 10.5 10.7 10.4 11.3 15.4 8.4 14.1 10.2 7.6 8.8 13.0 12.7 7.7 9.1 12.6 8.5 10.6 8.5 8.9 18.4 22.6 8.8 12.9 12.9 4.5 5.1 17.4 18.2 17.4 11.8 19.4 18.3 17.5 20.3 9.5 24.1 0.0 24.4 36.3 12.9 11.7 19.6 13.5 18.9 22.3 14.3 8.6 12.4 6.8 8.9 18.9 8.5 26.2 17.8 5.6 23.0 28.1 7.1 15.6 7.8 12.9 12.3 7.1 9.6 11.7 19.5 20.0 19.8 12.9 WDR61 REC14 ENSG00000140395 "WD repeat domain 61" Q9GZS3 15 78277835-78299794 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039932, HPA040065" Enhanced Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039932: AB_10796336, HPA040065: AB_10793926" "unprognostic (1.08e-1)" "unprognostic (1.85e-2)" "unprognostic (8.91e-2)" "unprognostic (1.07e-1)" "unprognostic (2.09e-1)" "unprognostic (3.36e-1)" "unprognostic (2.44e-1)" "unprognostic (1.60e-1)" "unprognostic (3.05e-1)" "unprognostic (2.74e-3)" "unprognostic (4.21e-1)" "unprognostic (5.72e-2)" "prognostic favorable (2.03e-10)" "unprognostic (1.04e-1)" "unprognostic (3.13e-1)" "unprognostic (3.18e-1)" "unprognostic (1.09e-2)" 23.8 34.3 23.5 17.2 31.2 29.6 34.5 25.2 32.1 24.3 22.0 27.6 22.7 20.3 24.2 69.4 25.9 27.4 19.6 23.1 23.7 28.2 34.2 28.2 22.4 18.7 26.8 23.1 20.7 30.7 22.4 37.7 27.7 30.8 27.4 25.7 24.9 28.1 23.1 26.3 29.9 18.5 23.6 27.8 18.6 20.9 38.5 20.9 26.9 32.5 30.1 24.6 19.1 20.3 21.9 45.2 11.1 32.4 22.7 25.2 28.7 9.4 24.0 19.0 19.5 18.8 17.3 14.3 14.4 16.2 18.3 18.1 22.9 17.2 18.1 18.0 16.4 29.2 20.1 40.2 17.4 15.2 11.7 31.5 14.6 22.2 22.1 16.4 22.5 16.4 13.3 13.4 7.1 6.1 13.0 20.6 19.0 26.7 20.4 23.9 29.5 19.7 21.9 14.0 23.7 19.3 18.3 14.4 22.1 21.3 29.3 26.5 14.4 19.7 22.2 78.5 20.1 14.2 31.1 12.4 14.4 17.0 10.3 24.8 17.6 26.4 25.7 20.9 36.6 28.6 11.1 31.6 10.5 21.5 32.4 23.2 21.9 21.6 22.3 45.2 16.9 23.0 25.2 2.6 22.7 26.3 24.2 23.5 28.7 23.5 31.2 25.2 32.1 23.7 28.2 26.8 23.1 30.8 20.9 32.8 43.1 20.1 47.2 43.6 50.0 23.2 30.6 62.9 22.7 36.6 45.2 87.6 106.1 52.5 15.9 38.7 22.6 23.3 48.6 62.8 54.1 49.6 46.2 41.4 58.3 41.3 22.4 45.4 29.1 10.0 46.3 46.3 55.6 48.7 33.3 72.9 38.7 28.1 47.7 102.6 46.0 6.5 49.5 95.0 66.6 51.3 77.2 35.9 50.2 41.4 WEE2 FLJ16107 ENSG00000214102 "WEE1 homolog 2" P0C1S8 7 141708353-141731271 "Enzymes, Predicted intracellular proteins" Meiosis "Kinase, Transferase, Tyrosine-protein kinase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 21 "Distal tubular cells: 1.7;Proximal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CACO-2: 8.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA027418, HPA054280" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027418: AB_10603144, HPA054280: " "unprognostic (6.35e-2)" "unprognostic (1.47e-1)" "unprognostic (1.89e-1)" "unprognostic (3.18e-1)" "unprognostic (2.33e-1)" "unprognostic (4.00e-2)" "unprognostic (2.90e-1)" "unprognostic (1.97e-2)" "unprognostic (3.23e-2)" "unprognostic (3.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.76e-2)" "unprognostic (1.73e-1)" "unprognostic (3.25e-2)" "unprognostic (2.66e-1)" "unprognostic (6.07e-2)" "unprognostic (2.88e-3)" 0.6 0.1 0.5 0.3 1.0 0.0 0.4 0.8 0.6 0.6 0.1 0.0 0.7 0.0 1.3 0.7 1.6 1.3 0.5 0.6 1.3 0.1 0.3 1.6 0.6 1.2 1.1 0.0 1.0 0.0 0.3 0.0 0.9 0.0 0.7 2.8 0.4 0.0 0.8 0.4 0.8 1.3 2.0 0.0 0.5 0.3 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.2 0.4 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.4 0.1 0.1 0.0 0.3 1.0 0.3 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.3 0.5 1.6 1.2 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.0 0.2 0.1 1.7 1.1 0.5 0.0 0.4 0.7 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.4 0.6 0.0 0.1 0.1 0.6 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WIZ ZNF803 ENSG00000011451 "Widely interspaced zinc finger motifs" O95785 19 15419980-15449951 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022923, HPA023774" Supported Enhanced Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA022923: AB_1858845, HPA023774: AB_2671308" "unprognostic (3.50e-2)" "unprognostic (3.91e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (5.12e-5)" "unprognostic (1.05e-1)" "unprognostic (4.96e-3)" "unprognostic (9.73e-3)" "unprognostic (3.00e-1)" "unprognostic (2.24e-2)" "unprognostic (4.69e-2)" "unprognostic (7.46e-2)" "unprognostic (5.47e-2)" "unprognostic (2.65e-1)" "unprognostic (4.27e-2)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (2.11e-1)" 28.0 17.5 27.6 18.3 21.6 13.6 20.9 15.8 24.4 17.5 17.3 12.8 18.0 18.2 25.2 12.0 16.3 16.3 15.3 17.3 23.0 11.4 13.8 18.4 13.5 17.5 14.1 19.0 21.6 26.9 14.3 10.9 13.7 13.7 17.4 7.7 12.4 21.9 23.1 24.4 21.5 16.8 16.5 11.9 18.0 15.6 40.9 15.8 18.6 13.3 14.6 12.1 19.3 21.4 2.0 1.5 0.7 3.6 2.5 1.2 0.5 13.5 9.3 13.4 17.0 19.3 7.9 10.9 14.2 7.0 11.9 8.2 8.2 25.5 11.3 23.5 12.9 7.2 11.6 7.3 10.0 2.9 8.8 12.5 8.2 7.2 6.4 12.3 9.4 12.3 14.0 13.2 8.6 9.4 7.4 10.7 8.9 12.8 9.7 8.0 27.6 17.1 8.7 18.1 13.3 22.2 16.0 6.1 11.4 7.7 10.6 18.3 23.3 12.5 11.4 9.2 4.8 12.5 8.9 17.2 27.3 10.8 21.4 18.1 14.4 8.6 12.2 11.4 11.4 18.4 0.0 1.4 0.0 1.2 1.2 1.0 0.5 0.8 1.2 1.0 2.0 1.0 1.0 0.7 2.5 3.6 1.5 0.8 0.5 27.6 21.6 15.8 24.4 23.0 11.4 14.1 19.0 13.7 15.8 11.9 5.8 8.5 5.5 14.1 8.8 9.1 12.7 0.0 3.4 12.2 0.0 6.1 3.3 12.3 6.3 13.5 5.0 0.0 17.1 8.3 9.9 8.6 1.1 13.2 6.7 6.4 6.4 13.5 10.2 6.4 14.7 7.1 6.8 5.4 9.5 7.1 16.5 0.0 18.0 4.7 7.5 12.9 10.8 27.2 26.0 17.8 6.2 4.4 10.5 11.8 WT1 "AWT1, GUD, NPHS4, WAGR, WIT-2" ENSG00000184937 "Wilms tumor 1" P19544 11 32387775-32435630 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 69.0;fallopian tube: 34.5;ovary: 53.4" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 19.2;Late spermatids: 5.9;Leydig cells: 7.8;Sertoli cells: 6.5" "Cancer enriched" "Detected in many" 14 "ovarian cancer: 55.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 13.5;HMC-1: 17.4;K-562: 12.2;NB-4: 32.6;THP-1: 15.6" "Region enhanced" "Detected in single" "pons and medulla: 0.5" "Not detected" "Not detected" "CAB000327, HPA035717, HPA053848" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: AB_2682279" "unprognostic (3.09e-3)" "unprognostic (9.97e-4)" "unprognostic (3.32e-1)" "unprognostic (8.24e-3)" "unprognostic (5.20e-2)" "unprognostic (1.98e-3)" "unprognostic (2.94e-2)" "unprognostic (1.59e-2)" "unprognostic (1.23e-2)" "unprognostic (4.15e-2)" "unprognostic (1.86e-2)" "unprognostic (1.36e-1)" "unprognostic (1.31e-10)" "unprognostic (2.65e-3)" "unprognostic (1.87e-1)" "unprognostic (1.96e-3)" "unprognostic (1.30e-2)" 10.3 0.0 0.2 1.8 0.6 0.0 0.2 0.2 0.5 20.3 1.5 0.2 3.7 0.0 69.0 9.3 0.4 34.5 0.8 2.1 0.9 0.0 5.3 0.2 0.8 0.5 0.2 0.2 53.4 0.2 0.0 0.2 6.9 0.3 0.9 0.0 0.2 0.2 4.2 0.2 0.0 0.4 23.7 0.2 14.6 0.0 24.5 0.2 0.2 0.3 0.2 0.2 1.3 4.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.1 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.0 4.7 13.5 0.0 1.2 3.8 9.0 17.4 0.0 0.0 2.8 0.0 0.0 0.0 2.8 12.2 0.1 2.7 0.0 7.9 32.6 0.7 0.0 3.8 1.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.8 15.6 0.1 0.0 2.4 0.0 0.3 0.0 0.0 0.0 0.1 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.6 0.2 0.5 0.9 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 19.2 0.0 0.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.3 0.0 0.0 2.5 0.0 5.9 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 0.0 6.5 0.0 1.9 0.9 0.0 0.7 0.0 0.0 0.1 XPC "RAD4, XPCC" ENSG00000154767 "XPC complex subunit, DNA damage recognition and repair factor" Q01831 3 14145147-14178783 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009932, HPA035707, HPA069673" Supported Enhanced "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167" "unprognostic (7.46e-2)" "unprognostic (2.52e-2)" "unprognostic (4.50e-2)" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (2.54e-2)" "unprognostic (1.97e-1)" "unprognostic (5.65e-2)" "unprognostic (1.50e-1)" "unprognostic (7.13e-3)" "unprognostic (4.39e-2)" "unprognostic (2.07e-1)" "prognostic favorable (4.14e-7)" "unprognostic (1.59e-1)" "unprognostic (7.88e-2)" "unprognostic (7.62e-2)" "prognostic favorable (2.46e-4)" 20.2 17.1 14.2 24.0 30.2 8.4 21.4 16.1 19.3 22.3 18.9 20.8 27.5 18.0 24.6 18.3 16.9 24.9 25.1 12.4 16.2 14.4 24.6 23.4 19.9 21.1 33.4 15.2 35.0 20.9 35.4 26.7 28.0 22.1 20.9 15.9 16.7 17.6 30.3 22.4 30.5 23.6 17.7 22.6 23.3 15.9 12.9 30.6 18.5 25.7 12.4 20.8 22.4 22.3 10.9 7.0 34.6 8.8 8.8 12.2 6.1 4.5 11.6 13.1 8.4 19.7 13.6 44.5 11.3 32.3 10.9 8.5 4.2 5.4 15.1 5.0 13.7 5.1 5.7 8.6 18.0 9.0 6.1 7.4 8.0 12.3 7.8 17.5 6.0 15.3 19.3 21.4 14.5 29.1 12.8 12.9 6.9 11.0 8.2 12.1 9.5 4.9 5.7 7.8 7.4 7.9 6.3 5.9 12.1 13.8 13.5 2.8 10.2 12.3 10.2 8.1 21.5 10.7 4.9 20.2 4.2 11.5 6.4 5.2 18.9 13.7 8.9 10.1 7.0 15.2 12.0 8.2 9.4 9.8 6.3 9.6 10.7 11.2 9.6 7.0 10.9 12.2 8.7 34.6 8.8 8.8 6.7 9.2 6.1 14.2 30.2 16.1 19.3 16.2 14.4 33.4 15.2 22.1 30.6 56.6 54.6 22.2 18.7 12.2 33.8 11.2 33.1 84.3 73.9 15.7 37.3 34.0 29.9 16.3 1.9 24.9 12.3 46.7 16.9 17.1 16.4 15.5 44.1 30.4 16.2 25.4 15.6 22.1 24.3 1.8 28.4 28.4 8.5 38.7 12.2 29.9 15.2 14.8 26.5 34.1 50.6 25.8 18.0 22.7 57.3 9.7 26.8 34.6 13.3 8.7 XPO1 "CRM1, emb" ENSG00000082898 "Exportin 1" O14980 2 61477849-61538626 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Transport" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010184, HPA042933" Supported Enhanced "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA 170000 "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "CAB010184: AB_2215817, HPA042933: AB_2678229" "unprognostic (7.34e-2)" "unprognostic (7.04e-2)" "unprognostic (6.37e-2)" "unprognostic (1.67e-2)" "unprognostic (5.61e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.84e-1)" "unprognostic (1.99e-3)" "unprognostic (4.43e-1)" "unprognostic (3.53e-3)" "unprognostic (4.90e-2)" "prognostic unfavorable (3.74e-4)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (2.43e-1)" "unprognostic (5.55e-2)" 20.7 27.9 36.1 28.1 39.6 21.6 35.1 41.5 36.3 28.2 23.2 19.5 26.0 16.5 35.7 35.3 26.1 36.0 20.3 20.1 33.0 19.2 19.5 22.2 22.0 34.5 42.0 19.5 45.0 34.6 33.4 27.6 30.8 33.6 25.8 24.5 18.0 20.2 29.9 34.9 29.8 25.0 28.4 32.1 24.5 21.9 32.1 39.3 51.1 28.2 16.4 35.7 26.0 57.8 6.1 5.4 12.6 5.1 6.2 5.1 2.5 39.4 35.3 47.9 35.9 21.7 29.2 35.3 43.7 28.2 46.0 39.4 46.9 29.7 57.9 30.6 29.9 46.8 33.5 73.0 30.3 67.7 35.3 26.9 57.0 36.3 29.3 15.7 57.4 39.0 16.4 22.7 36.3 39.6 34.9 37.5 29.2 65.7 33.8 42.3 20.8 47.7 25.2 55.7 47.2 27.1 42.8 54.7 35.2 20.9 30.0 38.3 20.4 42.5 35.9 21.3 50.4 29.4 28.4 25.0 43.2 49.1 35.1 42.9 27.5 45.3 84.0 26.8 49.3 38.9 12.6 5.1 5.8 5.1 5.0 4.7 4.3 3.6 4.5 3.9 6.1 4.3 3.7 12.4 6.2 3.2 5.4 3.2 2.5 36.1 39.6 41.5 36.3 33.0 19.2 42.0 19.5 33.6 39.3 38.7 36.3 31.8 27.6 46.2 69.7 57.0 43.3 46.8 28.4 29.6 90.3 46.3 11.6 24.4 3.2 40.7 19.3 70.0 22.5 42.3 40.9 34.4 40.5 48.0 49.4 68.3 43.4 42.4 46.3 8.0 31.1 53.2 35.4 49.5 31.2 34.0 26.3 17.5 29.0 20.8 102.5 19.4 43.7 64.6 88.2 49.7 25.2 42.9 37.6 38.3 XPO5 KIAA1291 ENSG00000124571 "Exportin 5" Q9HAV4 6 43522330-43576075 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, RNA-mediated gene silencing, Transport" "RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 27.2;Spermatogonia: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012357, HPA018402, HPA023959, HPA029909" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB012357: , HPA018402: AB_1848330, HPA023959: AB_1848331, HPA029909: AB_10611245" "unprognostic (6.98e-2)" "unprognostic (4.34e-2)" "unprognostic (5.13e-2)" "prognostic unfavorable (4.94e-7)" "unprognostic (6.16e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (3.98e-8)" "unprognostic (4.78e-1)" "unprognostic (4.72e-3)" "unprognostic (1.72e-1)" "unprognostic (4.86e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-2)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (9.48e-2)" "unprognostic (5.66e-3)" 11.5 12.2 9.5 10.8 14.0 9.0 10.8 14.6 15.4 9.6 8.8 11.5 8.3 7.8 12.0 12.0 16.7 9.8 7.5 8.9 8.0 7.3 10.0 13.1 9.4 10.0 9.5 8.0 11.9 19.7 17.7 16.1 9.5 9.4 10.5 11.5 9.7 12.9 10.6 14.9 15.3 8.6 12.3 8.0 9.9 11.2 42.3 9.7 18.3 16.7 8.5 13.7 10.5 10.4 3.7 5.9 3.6 11.7 8.4 6.8 4.4 15.6 9.4 15.7 31.6 8.2 6.9 14.6 8.2 5.8 16.2 11.8 25.8 5.5 21.3 10.7 7.8 15.3 13.5 26.1 11.9 18.3 15.4 20.7 20.6 11.3 18.7 11.8 22.7 11.0 5.0 12.4 17.0 26.6 5.8 11.5 15.3 44.1 16.8 10.9 19.2 17.1 11.3 16.8 43.1 9.6 18.7 16.7 15.9 9.3 12.3 32.5 13.4 11.4 10.5 14.6 14.4 12.1 18.3 9.6 12.0 14.3 11.4 17.2 10.7 11.7 41.9 4.3 19.9 12.8 0.0 5.0 3.6 6.3 6.4 5.8 3.7 5.6 6.8 5.9 3.4 4.5 5.9 0.5 8.4 11.7 1.8 5.5 4.4 9.5 14.0 14.6 15.4 8.0 7.3 9.5 8.0 9.4 9.7 6.0 3.5 3.0 4.4 7.9 10.8 5.4 2.5 5.3 1.2 10.4 7.9 4.2 1.7 6.5 9.2 4.5 3.3 0.0 6.6 5.6 6.4 6.0 11.5 4.0 5.5 20.6 13.8 1.8 6.5 10.2 3.7 4.0 1.7 2.8 6.6 4.1 6.4 0.0 7.8 4.2 13.7 0.0 4.4 27.2 26.3 6.1 3.7 3.2 6.4 5.2 XPOT XPO3 ENSG00000184575 "Exportin for tRNA" O43592 12 64404350-64451127 "Predicted intracellular proteins, Transporters" Transport "RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Muller glia cells: 71.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048067, HPA057602" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA048067: AB_2680246, HPA057602: AB_2683481" "unprognostic (4.53e-3)" "unprognostic (7.20e-2)" "unprognostic (1.38e-1)" "unprognostic (3.78e-3)" "unprognostic (1.01e-2)" "unprognostic (3.14e-1)" "prognostic unfavorable (1.81e-7)" "unprognostic (1.50e-2)" "unprognostic (2.22e-2)" "unprognostic (1.50e-1)" "unprognostic (2.16e-2)" "unprognostic (8.87e-2)" "prognostic unfavorable (2.41e-12)" "unprognostic (2.72e-1)" "unprognostic (3.68e-1)" "unprognostic (5.20e-2)" "prognostic unfavorable (5.79e-4)" 19.3 19.4 20.7 19.3 22.8 26.9 29.9 17.9 21.7 16.9 12.4 18.7 13.2 10.5 16.1 19.8 21.3 12.5 12.6 12.7 19.0 19.4 14.7 35.7 18.3 18.9 22.4 15.5 17.3 30.1 21.4 18.5 18.6 23.5 15.3 14.7 15.8 21.3 13.7 15.6 17.3 11.6 16.7 21.7 14.5 14.7 17.9 21.3 18.2 48.7 14.1 21.4 15.8 27.8 7.9 10.2 10.1 7.5 11.1 14.7 6.5 17.8 12.4 12.6 15.8 19.0 20.3 23.1 23.9 20.1 16.1 14.7 12.3 6.1 36.3 17.1 30.1 17.2 13.5 23.9 18.4 23.4 22.6 12.6 20.2 11.6 10.7 33.7 37.1 18.3 14.4 47.5 17.9 55.3 20.9 14.2 27.2 33.5 72.9 17.0 21.9 20.4 14.7 24.0 12.6 22.2 16.3 15.2 27.1 8.8 10.5 14.1 16.5 14.0 16.1 34.6 12.8 28.6 37.0 14.9 12.7 12.8 18.2 18.7 45.9 35.2 28.1 28.1 29.0 20.4 5.8 7.5 10.1 10.9 7.5 14.7 7.9 12.4 11.3 10.2 5.3 11.4 9.6 2.3 11.1 6.7 3.5 10.3 6.5 20.7 22.8 17.9 21.2 19.0 19.4 22.4 15.5 23.5 21.3 11.9 7.8 10.7 12.2 17.4 16.4 9.8 12.7 5.3 11.4 14.0 11.8 21.2 14.9 8.8 3.3 16.7 5.4 23.3 11.0 17.4 18.5 18.0 24.3 28.2 12.9 12.7 10.9 24.5 21.3 4.1 18.7 12.1 20.3 3.6 10.9 71.1 13.5 3.5 19.1 11.3 21.2 12.9 19.6 11.8 12.7 19.6 14.2 15.0 12.7 12.8 XRCC1 RCC ENSG00000073050 "X-ray repair cross complementing 1" P18887 19 43543040-43580473 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005427, HPA006717" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB005427: AB_2215661, HPA006717: AB_1858896" "unprognostic (1.10e-2)" "unprognostic (3.51e-3)" "unprognostic (4.59e-1)" "unprognostic (2.81e-2)" "unprognostic (4.08e-1)" "unprognostic (2.68e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (5.07e-2)" "unprognostic (3.12e-1)" "unprognostic (7.51e-2)" "unprognostic (3.00e-2)" "unprognostic (9.54e-2)" "unprognostic (1.07e-1)" "unprognostic (2.28e-1)" "unprognostic (9.34e-3)" "unprognostic (2.20e-2)" "unprognostic (5.69e-2)" 16.6 17.5 20.8 18.7 22.4 22.4 16.9 23.6 22.7 20.3 17.4 19.2 18.0 13.6 23.8 18.9 20.2 24.9 16.9 15.7 16.5 16.3 16.3 10.4 16.3 22.8 15.8 21.1 34.2 22.1 19.4 32.0 19.7 15.7 16.7 12.6 21.8 16.4 19.2 18.8 20.4 14.2 18.8 15.3 19.5 17.2 25.0 17.9 38.9 21.5 12.0 21.6 18.1 17.2 14.2 13.6 20.3 14.2 10.6 17.7 12.9 25.6 21.1 25.0 22.3 12.2 11.5 13.3 14.4 16.3 19.0 20.8 13.2 18.7 19.3 18.3 12.7 18.8 13.3 14.9 16.5 11.3 21.3 15.4 24.7 20.6 15.3 12.3 13.9 21.5 13.3 11.4 24.0 12.1 23.2 17.1 22.9 15.5 19.7 16.8 21.2 28.7 25.1 7.8 20.0 9.3 24.2 15.6 11.1 16.2 20.5 20.7 13.1 17.9 17.5 8.6 13.5 16.5 34.1 9.6 25.2 19.7 7.5 17.9 21.7 20.9 14.2 20.4 12.6 27.3 20.3 14.2 16.8 12.9 13.4 14.6 14.2 16.1 17.7 13.6 12.6 14.0 12.8 16.3 10.6 8.3 10.5 16.2 12.9 20.8 22.4 23.6 22.7 16.5 16.3 15.8 21.1 15.7 17.9 14.9 9.8 9.7 6.8 5.5 11.0 7.4 2.5 48.2 11.4 7.0 5.9 25.8 16.6 12.7 22.1 9.0 7.3 0.0 10.1 16.2 11.7 4.1 19.6 4.9 18.6 4.8 13.1 9.2 19.5 13.6 9.5 11.8 13.5 14.4 13.0 7.3 11.2 8.6 12.0 11.8 11.3 6.5 8.3 19.0 12.9 6.1 16.7 17.5 13.3 2.4 XRCC3 ENSG00000126215 "X-ray repair cross complementing 3" O43542 14 103697609-103715504 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 30.3" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 6.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062422, HPA068953" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA062422: AB_2684757, HPA068953: AB_2686062" "unprognostic (2.52e-2)" "unprognostic (1.81e-3)" "unprognostic (6.75e-2)" "unprognostic (4.01e-2)" "unprognostic (4.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.53e-4)" "unprognostic (2.93e-2)" "unprognostic (4.67e-2)" "unprognostic (1.58e-2)" "unprognostic (4.46e-2)" "unprognostic (2.53e-2)" "unprognostic (3.52e-7)" "unprognostic (1.27e-1)" "unprognostic (1.57e-1)" "unprognostic (8.84e-2)" "unprognostic (3.72e-2)" 5.4 3.3 8.1 15.1 7.3 22.0 5.4 11.3 8.0 5.5 5.8 6.5 4.6 5.4 6.4 5.1 8.5 6.1 5.3 4.4 6.9 2.6 4.1 3.8 6.0 11.1 7.3 5.4 7.0 7.8 2.1 4.4 5.6 6.8 7.7 6.2 5.3 11.1 2.9 8.9 30.3 7.0 2.3 5.3 13.5 6.8 10.1 5.0 17.6 5.6 6.7 14.2 5.3 9.0 4.5 2.0 3.0 3.3 2.5 3.9 3.6 12.7 23.3 12.8 15.9 1.1 3.3 23.3 14.1 4.7 20.0 21.6 12.9 20.5 20.3 12.2 2.9 15.9 20.4 14.0 21.0 12.3 12.5 14.5 19.8 11.4 11.9 2.0 17.7 12.9 2.5 2.1 17.6 11.2 4.2 8.1 20.7 12.2 12.5 10.3 27.8 30.7 14.0 11.0 18.7 16.6 25.0 18.5 8.0 4.4 17.6 12.7 10.5 16.6 9.0 5.8 7.4 14.2 13.9 7.0 10.4 12.2 33.0 15.4 10.7 9.7 25.2 6.5 14.7 15.9 2.6 1.6 3.0 3.8 3.3 3.9 4.5 3.3 3.2 2.0 4.0 3.3 2.2 1.2 2.5 2.5 1.4 2.5 3.6 8.1 7.3 11.3 8.0 6.9 2.6 7.3 5.4 6.8 5.0 0.0 0.0 1.9 2.1 1.3 1.5 0.2 2.5 1.4 3.4 0.0 2.0 6.8 1.7 1.4 0.4 0.9 2.0 0.0 1.6 4.5 0.4 1.4 0.0 0.4 3.8 3.2 1.2 0.0 0.0 1.5 0.3 1.5 0.0 1.8 5.0 1.3 1.4 3.5 1.1 0.0 2.1 0.0 0.9 3.4 5.7 1.1 2.6 0.0 5.0 0.7 XRCC4 ENSG00000152422 "X-ray repair cross complementing 4" Q13426 5 83077498-83353787 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Pancreatic endocrine cells: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 37.1" "Low region specificity" "Detected in all" "HPA006801, HPA051538" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006801: AB_1858899, HPA051538: AB_2681526" "prognostic unfavorable (1.80e-5)" "unprognostic (3.05e-2)" "unprognostic (5.12e-2)" "unprognostic (3.91e-3)" "unprognostic (1.55e-1)" "unprognostic (1.69e-1)" "unprognostic (1.44e-3)" "unprognostic (2.23e-2)" "unprognostic (2.19e-2)" "unprognostic (5.77e-2)" "unprognostic (2.38e-2)" "unprognostic (8.24e-2)" "unprognostic (4.46e-2)" "unprognostic (1.79e-1)" "unprognostic (1.97e-1)" "unprognostic (2.34e-1)" "unprognostic (6.91e-2)" 8.8 9.4 8.1 12.9 10.1 5.9 9.4 4.8 10.2 5.3 9.1 7.2 5.4 11.4 8.3 7.7 10.1 6.2 8.1 13.0 8.5 6.6 12.2 8.1 7.6 11.7 8.7 5.8 5.8 4.9 4.0 9.5 11.3 11.5 6.3 8.8 3.7 7.2 7.1 5.3 5.7 15.4 5.9 9.5 14.6 6.4 12.5 8.8 20.6 7.4 9.7 12.9 8.7 5.8 7.4 10.3 12.3 19.1 11.5 7.0 6.8 8.6 6.9 8.4 7.5 4.8 7.0 8.0 8.3 6.9 9.2 10.8 5.8 12.9 12.4 6.2 6.6 13.2 7.6 5.6 18.8 15.2 5.7 7.0 6.4 5.2 7.3 3.2 7.1 10.4 4.8 8.6 11.9 6.7 9.4 7.3 8.2 4.6 5.8 10.5 7.0 13.0 9.2 4.7 5.3 10.2 10.9 37.1 12.4 8.5 4.0 5.5 7.1 5.2 3.9 10.5 7.4 7.9 11.6 4.5 5.0 10.7 5.3 11.0 4.7 6.9 15.3 9.0 12.9 8.0 12.1 13.5 9.2 4.7 19.1 4.9 7.4 5.2 5.2 10.3 6.3 7.0 5.6 12.3 11.5 17.8 7.6 5.6 6.8 8.1 10.1 4.8 10.2 8.5 6.6 8.7 5.8 11.5 8.8 14.9 5.6 12.8 11.2 4.7 4.3 12.3 5.1 10.7 12.5 5.2 0.0 15.8 13.3 15.0 7.8 7.5 6.8 0.0 24.8 33.3 10.1 4.9 10.4 4.9 17.2 1.6 0.0 11.6 20.2 3.6 7.2 25.5 8.5 14.4 6.9 7.5 43.1 4.9 6.7 16.5 3.8 0.0 7.2 24.9 25.3 3.9 10.0 10.9 5.2 8.4 XRCC5 "KARP-1, KU80, Ku86, KUB2" ENSG00000079246 "X-ray repair cross complementing 5" P13010 2 216107464-216206303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004468, HPA025813, HPA064685" Supported Enhanced Nucleoplasm NA NA 140000 Nucleoplasm "CAB004468: AB_672929, HPA025813: AB_1858901, HPA064685: AB_2685322" "unprognostic (4.23e-2)" "unprognostic (1.75e-1)" "unprognostic (9.07e-3)" "unprognostic (3.44e-3)" "unprognostic (2.44e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (2.10e-7)" "unprognostic (4.42e-3)" "unprognostic (1.38e-1)" "unprognostic (1.06e-1)" "unprognostic (3.38e-3)" "unprognostic (1.96e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-1)" "unprognostic (2.88e-2)" "unprognostic (3.58e-2)" "unprognostic (6.01e-2)" 53.7 47.6 35.2 47.0 56.8 47.0 56.6 47.0 59.7 51.2 44.3 45.2 39.5 39.5 62.9 43.8 61.1 51.7 41.2 43.7 38.6 36.4 62.4 67.1 43.8 56.2 41.8 45.2 58.7 46.7 63.0 56.1 54.3 58.3 46.0 53.5 36.1 49.4 47.9 65.0 54.7 46.5 49.7 44.2 60.5 47.9 36.9 38.0 112.4 64.2 55.6 65.5 56.5 47.7 38.6 51.5 60.9 61.3 50.4 54.0 82.3 38.8 33.0 74.1 39.6 32.9 37.8 44.8 46.3 47.9 53.5 57.7 70.8 38.7 37.6 37.8 40.4 46.9 34.8 72.8 56.1 82.6 35.8 50.1 81.6 52.2 66.1 40.9 72.6 40.0 34.4 30.0 62.8 27.5 38.3 63.1 46.5 51.5 34.4 69.7 37.4 81.1 36.7 86.1 39.4 29.5 71.4 65.5 31.1 57.6 44.3 65.0 54.8 37.2 27.6 33.3 78.1 33.9 54.5 45.4 50.4 42.4 32.9 52.3 41.7 50.5 84.0 39.2 57.0 49.4 60.9 51.5 51.8 50.2 54.0 54.0 38.6 49.1 50.9 51.5 37.5 49.9 49.8 59.4 50.4 61.3 31.4 49.3 82.3 35.2 56.8 47.0 59.7 38.6 36.4 41.8 45.2 58.3 38.0 98.3 108.3 82.7 152.6 101.0 129.3 138.8 101.9 165.9 152.4 96.0 43.2 176.4 82.9 239.3 65.8 131.5 70.4 70.0 206.2 196.4 122.7 101.3 140.1 177.3 138.8 84.2 128.0 77.3 91.0 17.1 94.0 132.7 65.8 380.5 79.8 130.6 194.7 63.1 121.6 110.9 102.9 109.9 137.9 221.2 164.2 105.1 138.4 124.6 99.6 138.1 XRCC6 "D22S671, D22S731, G22P1, KU70, ML8" ENSG00000196419 "X-ray repair cross complementing 6" P12956 22 41621119-41664048 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase, Lyase, Multifunctional enzyme" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004254, HPA047549, HPA062226" Enhanced Enhanced Nucleoplasm No No 24000 Nucleoplasm "CAB004254: AB_628453, HPA047549: AB_2680085, HPA062226: AB_2684716" "unprognostic (5.55e-2)" "unprognostic (2.39e-2)" "unprognostic (1.82e-3)" "unprognostic (2.39e-1)" "unprognostic (2.47e-2)" "unprognostic (9.17e-2)" "unprognostic (1.16e-3)" "unprognostic (2.32e-2)" "unprognostic (2.21e-1)" "unprognostic (2.11e-1)" "unprognostic (1.89e-2)" "unprognostic (1.33e-1)" "unprognostic (2.06e-3)" "unprognostic (1.22e-1)" "unprognostic (2.28e-1)" "unprognostic (4.77e-2)" "unprognostic (7.95e-2)" 49.2 67.9 44.4 47.8 54.3 62.3 49.7 44.5 57.5 51.2 51.3 39.5 44.1 44.7 59.9 41.0 68.6 52.4 35.2 63.0 59.3 39.2 50.1 61.6 48.1 66.9 37.2 50.6 61.5 44.0 48.4 53.1 63.5 51.5 46.1 56.4 39.7 59.2 52.1 100.9 58.6 46.9 58.2 68.4 54.4 50.8 113.6 34.2 83.8 49.5 59.2 70.9 51.4 50.1 51.9 63.7 42.7 57.0 46.6 62.6 96.7 62.2 45.0 62.6 54.5 38.2 34.1 49.4 45.4 54.7 95.6 78.9 66.0 39.5 100.5 38.2 55.1 43.0 46.9 86.5 56.9 96.4 55.9 108.6 53.9 55.1 65.4 34.6 127.2 62.4 30.8 39.3 59.7 32.9 38.4 59.4 43.8 52.6 42.7 61.5 68.6 66.1 47.5 57.5 132.4 53.3 75.7 65.9 79.8 54.0 46.7 29.2 20.9 73.9 39.4 52.4 49.3 45.3 51.5 41.9 47.8 66.5 42.0 59.6 42.4 74.0 102.5 44.8 50.5 56.4 24.5 50.1 42.7 51.1 57.0 53.5 51.9 56.8 55.8 63.7 48.2 62.6 55.8 13.5 46.6 55.5 37.7 61.8 96.7 44.4 54.3 44.5 57.5 59.3 39.2 37.2 50.6 51.5 34.2 89.3 116.9 114.6 165.5 110.1 101.4 76.4 96.8 104.4 113.7 78.5 58.9 380.2 140.9 149.3 68.8 107.6 88.2 46.7 159.8 266.0 133.6 98.3 115.6 92.4 150.7 82.6 94.6 71.8 90.4 42.8 117.3 120.1 84.4 217.4 92.7 138.2 128.0 107.8 119.2 113.5 75.0 161.7 129.7 482.0 292.1 89.3 302.9 130.7 133.6 112.7 XRN2 ENSG00000088930 "5'-3' exoribonuclease 2" Q9H0D6 20 21303304-21389827 "Predicted intracellular proteins" "mRNA processing, Transcription, Transcription regulation, Transcription termination" "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047118, HPA050485" Supported Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA047118: AB_2679941, HPA050485: AB_2681141" "unprognostic (9.38e-2)" "unprognostic (4.70e-2)" "unprognostic (2.07e-2)" "unprognostic (3.09e-2)" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.54e-5)" "unprognostic (7.26e-2)" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (1.09e-2)" "unprognostic (1.40e-1)" "unprognostic (1.99e-3)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (1.63e-2)" "unprognostic (1.31e-1)" 42.9 35.1 12.5 24.5 17.7 38.3 30.4 18.0 16.4 26.8 22.8 18.6 23.3 14.4 38.6 25.2 22.1 30.6 21.8 19.3 13.7 10.3 31.4 35.3 27.5 33.4 17.4 12.1 32.1 26.4 30.0 35.3 26.5 15.9 25.7 20.1 19.1 27.6 25.0 36.8 23.0 21.6 24.1 18.6 40.9 23.2 27.4 18.3 41.1 31.3 20.4 30.6 33.1 21.7 16.0 30.6 35.0 33.9 21.7 24.6 23.8 27.4 32.7 36.1 27.6 27.0 33.3 35.8 25.3 33.1 33.8 39.5 21.8 31.6 27.1 15.1 26.5 46.1 32.7 40.6 42.6 43.5 12.2 20.5 35.0 12.3 41.1 23.8 31.4 30.5 31.5 21.6 37.2 32.7 30.2 29.0 26.1 28.0 23.3 31.3 21.5 46.2 20.8 28.1 26.8 22.1 34.0 61.4 23.1 28.8 29.2 28.0 36.4 29.5 36.4 27.1 29.2 20.4 37.5 26.7 34.0 25.5 7.7 31.9 20.6 26.4 29.1 13.1 14.7 25.6 15.1 33.9 23.8 18.6 27.2 24.6 16.0 20.4 20.2 30.6 15.1 21.8 21.0 35.0 21.7 32.7 13.2 24.0 23.8 12.5 17.7 18.0 16.4 13.7 10.3 17.4 12.1 15.9 18.3 56.6 105.5 63.6 78.1 56.4 39.0 48.7 53.5 108.4 109.2 38.4 39.3 93.9 23.2 104.4 113.2 77.5 32.5 0.0 104.1 85.7 61.2 59.6 79.9 61.8 93.6 47.7 57.1 43.0 136.4 16.3 53.5 87.6 57.3 76.7 45.4 69.3 88.3 45.9 52.3 62.6 44.7 58.2 72.1 99.1 113.5 58.7 88.0 62.3 54.7 73.2 ZBED8 "Buster3, C5orf54" ENSG00000221886 "Zinc finger BED-type containing 8" Q8IZ13 5 160393148-160400097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 9.4;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045445, HPA055817" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045445: AB_10959608, HPA055817: AB_2682933" "unprognostic (1.51e-1)" "unprognostic (2.06e-1)" "unprognostic (1.20e-1)" "unprognostic (8.40e-2)" "unprognostic (7.04e-3)" "unprognostic (7.50e-2)" "unprognostic (1.47e-5)" "unprognostic (6.52e-2)" "unprognostic (1.05e-2)" "unprognostic (5.65e-2)" "prognostic favorable (3.72e-4)" "unprognostic (1.16e-1)" "unprognostic (7.44e-2)" "unprognostic (9.74e-2)" "unprognostic (9.25e-2)" "unprognostic (2.50e-1)" "unprognostic (9.96e-3)" 3.6 8.1 10.4 1.9 12.4 0.6 6.7 20.1 8.8 11.1 6.3 9.9 5.2 2.9 10.5 13.5 3.8 9.4 4.4 6.8 7.9 6.6 6.7 2.5 4.2 2.5 14.2 6.4 18.8 4.4 6.3 21.7 7.6 9.7 8.3 3.5 5.6 7.9 10.3 4.1 4.8 2.8 8.2 9.5 3.6 4.6 7.0 12.5 2.1 9.5 1.5 3.1 5.5 9.0 0.8 2.9 1.1 3.1 3.3 2.4 1.6 5.5 4.4 10.9 9.5 8.7 6.4 4.5 4.8 4.5 5.9 8.9 3.9 4.4 4.6 9.2 1.6 13.9 6.0 6.2 2.8 7.9 4.7 6.2 2.9 6.4 5.0 3.3 1.9 3.7 2.5 5.9 4.3 2.9 5.4 3.0 3.9 2.0 4.4 6.2 2.2 1.7 3.1 2.6 2.3 4.7 2.3 12.6 3.0 2.7 1.6 11.2 3.8 6.3 1.8 5.2 4.5 4.2 1.9 2.1 8.8 5.9 2.7 3.9 4.0 6.8 1.1 6.3 2.8 8.6 0.0 2.4 1.1 2.4 1.9 1.4 0.8 2.2 1.7 2.9 0.6 1.7 1.3 0.3 3.3 3.1 2.6 0.0 1.6 10.4 12.4 20.1 8.8 7.9 6.6 14.2 6.4 9.7 12.5 0.0 0.3 0.0 0.7 0.0 4.6 2.4 0.0 9.4 1.2 1.8 2.0 3.5 1.7 1.1 0.8 1.5 0.0 0.0 0.4 1.2 0.9 0.8 0.0 0.0 1.2 3.2 0.0 0.6 1.2 0.0 6.1 0.0 0.0 1.8 0.6 5.8 0.7 0.0 5.3 1.0 3.9 12.9 0.5 1.6 4.9 0.0 1.1 0.0 0.6 0.3 ZBTB10 "FLJ12752, RINZF" ENSG00000205189 "Zinc finger and BTB domain containing 10" Q96DT7 8 80485619-80526265 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021554, HPA050569" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021554: AB_1858937, HPA050569: AB_2681179" "unprognostic (7.97e-2)" "unprognostic (3.53e-1)" "unprognostic (2.26e-1)" "unprognostic (6.67e-2)" "unprognostic (9.28e-2)" "unprognostic (8.97e-3)" "unprognostic (1.29e-2)" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" "unprognostic (4.86e-1)" "unprognostic (3.66e-2)" "unprognostic (2.15e-1)" "prognostic favorable (3.52e-4)" "unprognostic (4.65e-3)" "unprognostic (2.40e-1)" "unprognostic (7.15e-2)" "unprognostic (2.63e-2)" 12.4 8.2 6.3 8.4 6.8 21.3 14.1 13.5 8.0 11.3 6.9 6.1 8.6 2.0 14.5 9.1 5.7 12.2 7.4 9.0 5.6 5.3 10.7 18.4 11.5 9.7 7.5 3.3 18.8 16.2 9.4 7.2 22.8 6.4 17.6 8.0 7.9 8.7 6.8 17.3 3.8 4.3 14.0 7.6 6.6 6.6 12.1 6.3 14.6 10.3 7.5 4.1 19.2 13.4 2.1 3.6 0.6 0.8 2.0 1.5 0.2 0.0 2.4 12.5 6.3 5.5 4.2 16.9 2.2 0.0 1.8 1.8 5.2 1.9 7.1 6.5 3.4 5.4 0.6 9.7 3.0 2.1 0.0 15.9 3.7 1.6 4.1 3.2 1.3 1.7 4.0 2.9 2.2 6.3 1.5 4.5 6.1 3.3 14.1 1.5 3.8 7.0 3.2 3.1 0.7 3.8 8.2 6.8 2.4 5.2 7.1 7.3 8.6 2.9 28.6 8.4 14.9 5.4 5.1 5.7 4.3 8.1 0.0 2.0 4.2 2.0 8.1 1.6 0.0 5.3 0.6 0.2 0.0 0.8 0.3 0.9 1.1 0.7 0.9 0.7 2.1 1.5 1.4 0.0 2.0 0.8 3.6 0.0 0.2 6.3 6.8 13.5 5.5 5.6 5.3 7.5 3.3 6.4 6.3 23.8 14.2 14.3 11.0 25.2 12.9 29.0 17.8 22.7 14.8 12.2 15.7 30.3 3.3 11.0 53.3 23.8 20.6 0.0 6.0 31.5 26.2 72.3 9.2 28.4 11.2 30.2 58.0 12.9 14.8 24.7 17.8 11.5 47.2 15.4 32.3 19.3 8.4 5.8 19.8 11.1 8.2 25.8 36.5 14.4 10.6 11.0 88.0 17.9 29.2 10.7 ZBTB11 "ZNF-U69274, ZNF913" ENSG00000066422 "Zinc finger and BTB domain containing 11" O95625 3 101648889-101677495 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015328, HPA024138" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015328: AB_1858938, HPA024138: AB_1858939" "unprognostic (3.25e-3)" "unprognostic (9.62e-2)" "unprognostic (4.92e-2)" "prognostic unfavorable (7.49e-4)" "unprognostic (2.86e-2)" "unprognostic (7.04e-2)" "unprognostic (1.17e-3)" "unprognostic (4.77e-1)" "unprognostic (6.65e-3)" "unprognostic (1.75e-1)" "unprognostic (1.41e-1)" "unprognostic (1.45e-2)" "unprognostic (5.64e-2)" "unprognostic (2.91e-1)" "unprognostic (1.89e-1)" "unprognostic (5.90e-2)" "unprognostic (2.09e-1)" 11.6 11.0 14.8 14.8 16.5 44.0 13.7 21.9 16.0 14.1 11.9 8.5 8.4 11.4 13.6 10.4 14.1 10.9 10.5 9.1 12.3 12.4 10.5 12.9 14.2 16.6 11.2 12.9 15.0 16.4 19.1 14.3 14.2 14.3 13.0 10.8 7.1 15.2 13.2 16.2 16.6 12.7 12.3 13.5 16.6 11.7 13.7 13.6 28.7 13.6 10.2 16.4 14.4 22.3 6.8 8.0 9.6 11.6 5.2 9.0 4.6 9.8 11.0 7.3 9.7 11.4 11.2 12.8 9.7 9.4 8.8 9.7 9.9 6.8 11.9 7.9 7.2 8.1 12.2 10.8 10.8 15.8 12.4 7.7 26.5 10.2 9.1 8.8 18.6 9.7 9.0 14.0 8.1 18.9 8.0 8.6 13.8 15.1 14.6 9.4 12.0 16.3 8.3 6.9 10.4 16.3 13.4 11.4 14.4 8.2 11.7 21.4 7.9 12.5 10.3 12.8 4.8 13.1 10.2 9.8 13.6 10.1 5.6 9.6 16.8 13.9 22.3 8.5 12.3 9.6 9.6 6.3 7.0 6.8 8.2 9.0 5.4 5.8 7.5 8.0 6.8 6.8 5.6 4.3 5.2 11.6 4.8 6.3 4.6 14.8 16.5 21.9 16.0 12.3 12.4 11.2 12.9 14.3 13.6 29.8 14.4 13.7 18.0 41.2 12.0 10.8 12.7 24.1 26.1 1.8 31.4 8.2 0.0 5.5 2.6 16.7 9.1 0.0 4.8 6.6 21.6 14.6 8.1 8.9 6.8 20.6 19.4 15.4 25.9 2.3 7.8 20.4 18.6 8.2 10.2 11.7 6.7 3.5 13.4 4.8 22.8 6.5 16.2 16.1 19.3 42.9 14.1 22.4 9.5 20.4 ZBTB12 "C6orf46, D6S59E, G10, NG35" ENSG00000204366 "Zinc finger and BTB domain containing 12" Q9Y330 6 31899607-31901992 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 20 "Cardiomyocytes: 3.9;Horizontal cells: 3.2;Rod photoreceptor cells: 1.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047161, HPA070639" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA047161: AB_2679962, HPA070639: " "unprognostic (2.05e-1)" "unprognostic (3.15e-2)" "unprognostic (3.77e-1)" "unprognostic (2.93e-1)" "unprognostic (1.24e-1)" "unprognostic (8.92e-2)" "unprognostic (1.26e-3)" "unprognostic (1.55e-1)" "unprognostic (5.22e-2)" "unprognostic (8.16e-2)" "unprognostic (2.58e-1)" "unprognostic (5.41e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.87e-1)" "unprognostic (2.11e-1)" "unprognostic (6.39e-2)" "unprognostic (8.98e-3)" 2.2 3.2 5.0 3.4 4.6 1.8 3.0 4.5 5.5 5.3 2.7 7.4 5.7 4.8 5.7 2.3 2.9 5.3 2.6 2.8 5.5 3.6 1.6 1.4 2.2 2.5 8.6 2.9 7.4 2.2 2.5 2.1 2.3 4.0 6.5 1.2 3.2 4.5 2.4 3.3 1.8 3.7 7.3 4.7 3.2 3.3 2.4 9.9 3.5 6.5 1.8 1.6 4.4 6.7 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.0 2.7 6.2 5.4 1.2 1.4 0.5 1.1 1.1 2.2 1.6 2.1 2.9 2.7 2.6 1.3 4.3 0.7 3.1 2.1 0.9 7.1 8.5 2.3 0.0 4.2 2.2 8.8 4.2 1.2 0.8 0.9 1.7 3.1 0.1 3.1 2.6 1.6 1.3 2.8 4.5 6.3 6.4 1.5 1.0 9.9 1.3 0.0 1.3 1.6 3.4 11.4 1.1 0.6 3.1 1.5 0.0 2.7 0.9 3.4 1.1 1.5 0.1 2.3 8.3 2.8 1.5 0.9 3.5 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.0 4.6 4.5 5.1 5.5 3.6 8.6 2.9 4.0 9.9 0.0 0.0 0.0 0.0 0.0 0.8 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ZBTB20 "DKFZp566F123, DPZF, ODA-8S, ZNF288" ENSG00000181722 "Zinc finger and BTB domain containing 20" Q9HC78 3 114314501-115147271 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.6" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 279.2;Early spermatids: 317.2" "Cancer enhanced" "Detected in some" "stomach cancer: 1.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015551, HPA016815" Approved Enhanced "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA015551: AB_2669217, HPA016815: AB_1858947" "unprognostic (1.79e-1)" "unprognostic (1.50e-2)" "unprognostic (5.51e-2)" "unprognostic (2.33e-3)" "unprognostic (5.72e-3)" "unprognostic (3.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (7.51e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-3)" "unprognostic (6.94e-2)" "unprognostic (1.41e-1)" "unprognostic (7.83e-3)" "unprognostic (1.81e-1)" 10.7 7.3 6.3 2.9 12.3 4.0 6.2 17.3 9.3 7.2 4.2 10.8 5.3 1.7 6.6 17.4 3.5 4.9 4.3 6.1 9.7 5.2 9.8 9.8 4.4 3.3 14.9 3.7 12.7 5.9 5.3 26.1 2.2 11.5 10.0 2.7 7.9 5.4 9.2 12.1 4.4 4.0 7.5 19.2 4.4 3.9 44.6 14.2 2.1 9.1 8.1 3.3 5.2 5.0 18.2 4.3 7.8 3.6 4.1 7.7 2.7 2.3 4.4 1.7 4.2 6.3 2.8 0.0 1.8 3.9 1.1 0.9 2.5 0.8 0.6 6.1 4.6 1.5 0.1 6.1 1.0 1.1 0.5 0.1 0.6 2.1 1.9 1.5 0.3 0.0 2.7 0.3 2.5 0.8 3.9 1.3 0.5 0.1 1.0 6.4 0.0 0.3 0.2 0.4 0.0 0.2 0.2 5.1 0.0 4.3 0.0 0.4 1.0 0.8 0.0 1.3 0.2 0.0 0.5 7.2 1.6 5.5 0.3 2.7 1.6 0.0 0.3 2.6 0.4 2.0 7.8 1.4 5.1 6.1 2.0 4.2 18.2 6.0 5.6 1.6 10.7 7.7 6.6 3.1 4.1 3.6 4.3 2.8 2.7 6.3 12.3 17.3 9.3 9.7 5.2 14.9 3.7 11.5 14.2 148.9 92.8 51.6 33.4 22.9 70.0 42.8 101.9 45.5 35.2 279.2 56.9 0.2 41.4 165.4 317.2 68.7 13.9 0.0 71.6 0.5 90.0 35.5 79.6 95.2 3.8 76.3 30.5 49.7 16.5 71.3 97.8 22.0 30.4 34.3 15.3 183.7 101.7 11.4 113.5 147.9 113.2 84.1 55.2 6.6 4.3 16.2 0.5 36.3 16.6 21.7 ZBTB21 "KIAA1227, ZNF295" ENSG00000173276 "Zinc finger and BTB domain containing 21" Q9ULJ3 21 41986831-42010387 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 53.2;Suprabasal keratinocytes: 55.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024655, HPA031757, HPA031758" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA024655: AB_1859171, HPA031757: AB_2674031, HPA031758: AB_2674032" "unprognostic (1.16e-2)" "unprognostic (3.51e-2)" "unprognostic (8.79e-2)" "unprognostic (1.79e-1)" "unprognostic (5.88e-2)" "unprognostic (4.61e-2)" "unprognostic (6.03e-3)" "unprognostic (2.19e-2)" "unprognostic (2.67e-1)" "unprognostic (6.21e-3)" "unprognostic (2.67e-2)" "unprognostic (4.59e-2)" "unprognostic (1.35e-3)" "unprognostic (1.81e-2)" "unprognostic (3.45e-1)" "unprognostic (1.63e-3)" "unprognostic (4.02e-1)" 13.1 41.0 11.0 6.8 12.9 39.2 11.8 11.5 14.4 10.3 7.5 8.3 7.4 4.9 15.4 9.2 8.0 11.4 13.8 9.4 9.6 7.3 8.0 19.6 10.3 5.8 8.3 6.2 19.6 10.7 20.9 11.7 18.3 8.8 9.6 6.2 6.8 8.5 8.6 5.3 13.8 7.6 9.9 8.9 8.7 8.9 13.1 10.4 10.1 12.1 6.4 7.1 10.7 14.5 4.9 5.0 5.0 6.2 1.3 5.9 2.4 6.5 5.2 5.1 5.8 7.3 5.7 5.0 6.1 8.8 5.9 9.0 6.2 3.3 11.7 2.8 6.1 10.6 5.0 7.5 4.3 9.6 6.1 7.4 1.3 5.3 3.7 5.6 4.5 2.8 3.2 9.3 8.2 10.8 2.6 3.3 6.4 7.6 20.4 4.1 9.6 12.2 2.2 5.1 4.8 6.5 5.2 5.8 13.6 2.6 5.3 7.3 4.3 8.5 12.8 5.9 2.7 4.5 2.1 3.7 8.7 4.9 6.0 6.0 32.6 28.5 11.0 11.4 7.6 5.6 0.2 4.9 2.4 3.7 6.0 4.2 4.9 4.0 2.9 5.0 4.5 5.9 4.3 5.0 1.3 6.2 4.3 2.6 2.4 11.0 12.9 11.5 14.4 9.6 7.3 8.3 6.2 8.8 10.4 6.0 37.9 18.5 32.4 53.2 12.5 3.7 2.5 16.0 15.9 7.0 2.0 5.7 10.0 4.7 11.1 17.4 4.9 0.0 4.3 4.2 27.2 23.1 16.1 17.8 5.5 30.2 4.1 9.2 7.6 4.1 3.7 12.2 33.7 5.4 8.7 9.4 3.7 6.0 9.9 4.4 13.6 6.5 19.6 15.2 11.1 55.3 8.1 10.7 5.1 16.2 ZBTB25 "C14orf51, KUP, ZNF46" ENSG00000089775 "Zinc finger and BTB domain containing 25" P24278 14 64449106-64505213 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054699 Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054699: AB_2682579" "unprognostic (1.13e-2)" "unprognostic (1.86e-1)" "unprognostic (1.16e-1)" "unprognostic (1.64e-2)" "unprognostic (1.82e-2)" "unprognostic (1.11e-3)" "unprognostic (5.32e-3)" "unprognostic (4.21e-2)" "unprognostic (2.26e-1)" "unprognostic (7.33e-2)" "unprognostic (1.70e-3)" "unprognostic (2.48e-1)" "prognostic unfavorable (3.56e-6)" "unprognostic (3.29e-2)" "unprognostic (1.05e-1)" "unprognostic (4.62e-2)" "unprognostic (1.04e-1)" 12.1 12.0 16.5 18.4 19.2 14.6 18.1 17.1 15.2 12.3 12.6 13.9 7.7 8.1 13.3 18.8 8.3 14.6 11.9 20.0 13.0 10.8 10.1 12.4 12.5 28.0 15.4 12.9 16.3 12.9 18.1 18.6 9.5 14.7 12.9 11.3 13.2 9.0 12.8 19.2 15.9 14.1 13.2 18.5 17.0 11.1 11.5 18.1 31.8 19.2 7.8 22.7 20.0 14.0 6.4 2.9 2.8 2.4 6.3 11.5 6.3 15.1 6.7 4.5 4.5 6.5 8.1 8.8 2.6 4.7 4.3 5.7 3.2 10.6 11.3 3.1 4.3 5.5 14.0 4.4 4.4 5.3 11.7 1.4 2.6 10.0 1.4 7.4 1.8 6.0 10.3 4.3 4.3 8.5 9.3 3.9 10.9 1.5 18.7 5.1 6.5 6.4 2.7 2.3 5.4 7.0 4.9 4.8 4.8 5.0 7.2 4.3 4.7 5.6 4.3 3.5 4.3 5.4 1.4 4.2 6.0 9.1 2.8 4.0 16.5 3.8 5.2 8.9 2.3 4.4 2.8 2.4 1.5 6.9 1.6 9.0 6.4 9.7 6.6 1.6 4.3 11.5 11.2 2.6 6.3 1.3 2.9 8.3 6.3 16.5 19.2 17.1 15.2 13.0 10.8 15.4 12.9 14.7 18.1 6.0 8.8 17.7 6.8 7.0 17.8 16.1 7.6 13.4 5.7 7.0 17.7 6.4 8.3 6.5 44.5 7.7 1.8 0.0 5.7 8.0 5.6 6.6 5.8 8.9 9.5 7.9 3.4 7.4 8.2 36.7 12.4 11.3 16.9 4.6 2.7 8.6 6.0 3.2 10.3 5.8 21.2 0.0 7.2 10.7 11.7 7.3 3.3 24.9 3.9 4.7 ZBTB33 "kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348" ENSG00000177485 "Zinc finger and BTB domain containing 33" Q86T24 X 120250752-120258398 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000755, CAB001980, HPA005732" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166" "unprognostic (9.14e-3)" "unprognostic (1.45e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.47e-2)" "unprognostic (6.13e-2)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (4.51e-2)" "unprognostic (5.08e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (6.44e-2)" "unprognostic (2.59e-2)" 15.4 10.4 12.8 9.3 15.5 20.2 18.0 16.3 13.9 9.6 8.5 11.6 9.1 9.1 7.7 11.5 14.9 10.0 9.0 6.0 12.6 15.0 8.0 22.5 10.7 14.0 13.4 11.6 12.2 11.6 17.7 15.5 10.2 16.7 10.5 7.9 6.2 15.0 10.0 9.5 21.6 10.2 6.0 18.6 12.7 9.9 6.9 14.8 29.3 17.4 5.3 14.6 10.3 9.7 3.4 8.9 14.2 8.9 5.1 7.2 5.2 9.3 10.4 14.2 12.9 11.2 12.8 16.7 7.2 9.7 8.5 10.5 6.3 8.2 13.7 13.8 7.3 11.3 14.4 22.4 11.4 10.8 15.1 16.1 14.3 15.8 8.5 8.5 14.2 16.3 9.1 13.9 8.6 12.8 12.1 14.4 13.8 9.2 16.0 10.4 11.2 13.3 9.3 17.3 14.0 11.3 15.1 10.8 21.8 8.6 16.7 26.0 11.0 15.3 15.1 17.0 11.1 8.1 20.1 14.1 6.8 5.0 10.1 12.8 9.0 9.1 17.4 9.5 20.4 8.4 14.2 6.1 7.7 4.4 8.9 7.2 3.4 5.6 5.5 8.9 3.3 7.1 4.8 1.2 5.1 5.6 8.5 4.9 5.2 12.8 15.5 16.3 13.9 12.6 15.0 13.4 11.6 16.7 14.8 14.9 6.5 4.2 6.8 11.3 4.3 4.5 10.2 12.0 15.9 1.8 0.0 6.6 1.7 4.9 0.1 6.9 4.6 23.3 5.8 6.9 5.4 6.9 0.0 16.6 6.8 3.2 8.1 8.0 9.9 0.0 4.0 9.8 3.3 10.0 7.8 6.5 6.4 5.7 2.5 2.8 1.4 6.5 3.1 2.9 11.7 11.4 7.8 9.6 6.5 10.1 ZBTB38 "CIBZ, FLJ35036, PPP1R171, ZNF921" ENSG00000177311 "Zinc finger and BTB domain containing 38" Q8NAP3 3 141324213-141449792 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 52.0;RPMI-8226: 75.3;U-266/70: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014865, HPA059378" Enhanced Nucleoplasm No No Nucleoplasm "HPA014865: AB_2732412, HPA059378: AB_2683998" "unprognostic (1.78e-1)" "unprognostic (3.18e-1)" "unprognostic (2.97e-3)" "unprognostic (1.93e-1)" "unprognostic (2.78e-1)" "unprognostic (2.84e-2)" "unprognostic (4.01e-2)" "unprognostic (7.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.38e-1)" "unprognostic (2.01e-3)" "unprognostic (4.53e-1)" "unprognostic (5.07e-3)" "unprognostic (1.04e-1)" "unprognostic (1.83e-1)" "unprognostic (1.29e-2)" "unprognostic (1.04e-1)" 18.4 27.6 19.6 16.3 26.5 5.4 20.2 50.9 30.1 28.0 23.2 11.6 15.5 14.9 36.1 11.1 14.4 20.1 25.4 21.7 16.3 12.5 18.8 13.2 20.1 16.7 17.6 21.0 21.3 17.3 43.5 21.8 19.9 18.3 19.7 21.9 13.4 22.8 21.3 56.7 11.1 20.4 30.1 18.7 11.8 17.1 17.4 20.1 2.6 20.3 9.4 19.5 25.7 24.5 11.4 5.1 13.6 5.3 14.8 17.8 6.7 10.7 16.0 1.9 3.8 17.2 16.3 2.5 17.4 21.0 16.9 24.7 8.3 6.3 0.3 7.2 15.1 13.2 3.1 2.1 14.7 38.7 10.4 3.0 3.0 15.3 4.8 19.3 0.2 4.5 12.2 8.7 17.9 36.4 27.7 12.9 0.3 3.2 52.0 19.1 1.1 0.2 0.6 1.9 3.0 2.0 0.2 5.5 75.3 10.9 6.7 0.7 2.7 25.5 2.5 9.2 3.4 5.2 2.7 31.0 13.8 3.5 26.8 8.1 51.9 30.2 3.8 23.7 0.3 7.6 13.6 3.4 9.4 17.8 5.3 13.3 11.4 11.7 17.7 5.1 5.1 9.1 14.7 4.0 14.8 4.2 2.5 15.3 6.7 19.6 26.5 50.9 30.1 16.3 12.5 17.6 21.0 18.3 20.1 71.5 54.7 23.8 31.7 18.1 86.6 104.9 66.2 48.2 69.4 55.8 70.7 27.6 24.9 35.6 201.9 74.9 41.3 0.0 27.8 12.6 45.6 45.5 64.9 27.0 27.6 133.5 34.5 48.5 19.7 97.7 65.3 39.9 37.1 95.6 43.1 55.0 48.7 28.8 96.9 39.2 66.4 116.4 91.0 7.2 10.0 16.3 104.5 67.8 69.1 34.1 ZBTB7B "c-Krox, hcKrox, ZBTB15, ZFP67, ZNF857B" ENSG00000160685 "Zinc finger and BTB domain containing 7B" O15156 1 155002630-155018522 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 54.0" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 141.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006811, HPA025820" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006811: AB_1859046, HPA025820: AB_1859045" "unprognostic (5.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.45e-1)" "unprognostic (4.36e-2)" "unprognostic (2.43e-1)" "unprognostic (4.95e-3)" "unprognostic (9.55e-2)" "unprognostic (1.41e-1)" "unprognostic (3.72e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.46e-2)" "unprognostic (5.35e-2)" "unprognostic (1.11e-2)" "unprognostic (1.82e-1)" "unprognostic (1.61e-1)" "unprognostic (1.53e-2)" 9.4 11.1 3.0 8.8 4.7 11.6 11.1 4.0 4.9 9.5 33.7 11.3 22.3 27.3 5.4 4.5 29.1 5.9 13.2 6.4 4.3 2.1 9.3 19.1 10.5 6.3 8.0 4.3 6.2 18.2 5.1 6.4 11.3 5.9 9.9 8.1 9.6 19.1 18.6 11.8 33.3 54.0 5.4 5.6 10.3 11.2 3.8 7.3 1.8 14.3 11.2 16.0 8.6 12.4 2.0 2.3 5.7 3.4 1.5 2.5 4.3 7.5 13.5 1.2 4.1 6.2 3.5 16.6 5.2 6.2 5.5 6.4 9.0 11.0 3.3 9.4 5.8 4.3 11.5 3.8 7.3 1.1 18.0 4.3 5.5 22.5 6.0 9.1 4.2 15.2 4.6 26.2 7.5 9.3 7.4 4.3 0.5 7.8 15.3 3.1 14.3 0.1 9.4 4.1 12.1 11.2 3.1 0.9 20.7 8.2 7.9 7.7 7.9 10.0 26.8 4.2 5.3 16.7 14.1 3.6 3.6 6.3 7.0 4.3 18.2 11.1 3.5 8.3 14.0 4.0 0.9 3.2 2.9 1.5 3.4 0.5 1.6 2.0 0.9 2.3 2.0 1.7 0.5 5.7 1.5 2.9 0.2 2.5 4.3 3.0 4.7 4.0 4.9 4.3 2.1 8.0 4.3 5.9 7.3 8.9 0.0 4.7 8.4 31.3 14.0 1.4 20.4 0.0 1.2 5.2 2.0 9.2 10.0 11.9 2.2 4.1 141.0 0.0 13.0 12.8 5.6 21.8 5.7 23.7 12.7 15.9 6.4 4.9 30.8 5.6 8.3 16.2 15.1 6.4 27.3 5.1 14.5 48.0 6.7 8.9 9.8 0.0 6.3 0.4 1.2 46.9 23.0 7.4 33.0 16.9 ZC3H4 "C19orf7, KIAA1064" ENSG00000130749 "Zinc finger CCCH-type containing 4" Q9UPT8 19 47064187-47113752 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040934, HPA041068" Supported Enhanced Nucleoplasm,Cytosol NA NA 8500 Nucleoplasm Cytosol "HPA040934: AB_10795495, HPA041068: AB_10796567" "unprognostic (8.02e-3)" "unprognostic (3.68e-3)" "unprognostic (3.11e-2)" "unprognostic (1.91e-1)" "unprognostic (3.17e-1)" "unprognostic (7.04e-3)" "unprognostic (9.37e-2)" "unprognostic (1.28e-1)" "unprognostic (3.03e-1)" "unprognostic (2.93e-1)" "unprognostic (1.68e-2)" "unprognostic (1.53e-1)" "unprognostic (9.14e-2)" "unprognostic (3.00e-3)" "unprognostic (1.19e-1)" "unprognostic (5.90e-2)" "prognostic favorable (2.23e-4)" 12.0 8.2 8.6 14.5 16.9 8.5 18.2 25.6 13.9 8.9 9.6 14.7 9.8 11.5 12.8 6.0 11.8 10.4 6.5 8.2 9.3 7.6 9.2 10.9 19.9 14.1 16.5 5.2 14.6 12.5 10.4 45.4 15.4 13.9 9.7 7.2 10.8 11.8 10.4 14.1 13.5 11.5 8.5 26.0 16.0 11.5 14.5 12.4 17.5 10.5 9.3 11.5 10.3 24.0 5.2 6.8 6.2 3.7 5.2 5.6 1.2 8.8 13.8 8.6 12.2 4.8 3.0 8.8 7.1 4.0 6.7 4.5 9.8 9.9 18.7 5.3 4.8 4.1 15.4 3.8 10.1 4.3 11.5 6.1 13.3 8.4 7.4 4.2 12.6 14.2 5.1 2.8 6.2 4.9 3.6 5.4 11.6 12.8 7.1 4.3 15.4 14.2 21.3 12.8 6.0 4.7 22.4 7.4 8.4 5.0 14.5 10.5 14.9 10.8 9.1 5.3 4.4 9.5 10.2 9.5 9.1 8.9 5.8 9.9 9.3 7.5 16.7 7.1 10.3 12.9 4.6 2.2 3.2 5.5 3.7 5.6 5.2 4.9 5.5 2.9 5.1 4.3 4.8 6.2 5.2 3.5 6.8 3.1 1.2 8.6 16.9 25.6 13.9 9.3 7.6 16.5 5.2 13.9 12.4 3.0 13.3 13.6 5.5 19.8 24.1 11.2 25.5 12.0 12.5 19.2 13.7 5.7 8.3 9.9 11.9 13.0 15.8 23.3 10.1 5.8 13.5 7.5 11.6 11.9 10.9 15.9 18.4 17.2 27.8 5.4 15.5 14.8 6.8 13.6 20.6 17.4 10.3 16.7 9.2 7.0 23.0 6.5 10.2 13.0 9.2 19.6 7.2 14.4 14.9 6.7 ZCCHC8 DKFZp434E2220 ENSG00000033030 "Zinc finger CCHC-type containing 8" Q6NZY4 12 122471600-122501073 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cone photoreceptor cells: 117.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037483, HPA037484" Supported Enhanced Nucleoplasm NA NA 130000 Nucleoplasm "HPA037483: AB_10671502, HPA037484: AB_10672485" "unprognostic (1.96e-3)" "unprognostic (8.48e-2)" "unprognostic (5.55e-2)" "unprognostic (5.24e-2)" "unprognostic (2.44e-1)" "unprognostic (6.30e-3)" "unprognostic (1.33e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (7.40e-4)" "unprognostic (1.03e-1)" "unprognostic (6.95e-2)" "unprognostic (4.78e-2)" "prognostic unfavorable (5.36e-4)" "unprognostic (8.86e-2)" "unprognostic (2.88e-1)" "unprognostic (2.55e-2)" "unprognostic (1.48e-2)" 13.6 11.9 12.8 15.0 14.2 44.3 13.9 25.5 17.6 15.8 11.7 9.6 19.3 11.1 16.0 10.9 14.3 13.7 9.5 9.0 11.7 6.3 10.6 14.0 11.9 12.2 12.4 7.2 17.3 16.4 14.2 21.8 13.2 9.9 13.3 10.9 10.4 13.6 15.1 21.7 14.9 13.9 14.0 12.8 14.5 13.8 14.5 14.4 19.5 15.8 10.5 17.3 14.6 13.3 10.5 6.8 9.0 8.8 10.0 12.5 5.4 11.6 11.5 17.1 17.6 7.5 10.4 21.8 14.0 9.6 18.8 14.5 10.9 10.1 21.4 9.5 6.0 10.2 14.4 19.1 8.9 16.0 17.3 11.0 13.2 12.7 9.7 18.1 22.7 14.3 8.3 13.5 11.8 16.3 15.5 10.0 20.3 19.1 12.9 9.1 7.5 16.2 17.5 15.4 8.7 13.1 17.9 14.1 16.7 9.1 6.7 12.0 12.9 16.5 8.6 19.0 17.6 15.7 17.2 10.1 11.8 11.6 10.3 14.0 13.8 8.0 28.4 6.2 14.1 6.8 9.0 7.2 4.7 8.9 8.6 8.9 10.5 9.9 10.6 6.8 9.4 11.0 9.0 5.7 10.0 8.8 6.6 12.5 5.4 12.8 14.2 25.5 17.6 11.7 6.3 12.4 7.2 9.9 14.4 29.8 16.9 24.1 26.0 18.2 28.5 8.1 20.4 18.7 37.5 8.7 117.8 14.9 1.7 9.8 63.3 15.8 12.7 23.3 8.3 14.2 15.5 18.3 18.5 13.4 11.2 14.3 18.8 10.4 12.3 37.2 13.8 18.1 15.1 17.2 14.0 16.4 12.1 11.5 13.8 5.7 66.5 6.5 17.5 31.1 11.9 22.5 27.0 17.0 14.0 19.2 ZHX2 KIAA0854 ENSG00000178764 "Zinc fingers and homeoboxes 2" Q9Y6X8 8 122781394-122974512 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 24.1;REH: 25.8;U-698: 24.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006769, HPA006996" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006769: AB_10669919, HPA006996: AB_10670555" "unprognostic (8.28e-2)" "unprognostic (3.80e-3)" "unprognostic (6.48e-2)" "unprognostic (6.90e-2)" "unprognostic (8.19e-3)" "unprognostic (3.61e-2)" "unprognostic (2.03e-2)" "unprognostic (2.68e-2)" "unprognostic (1.35e-1)" "unprognostic (4.80e-2)" "unprognostic (2.25e-1)" "unprognostic (1.36e-1)" "unprognostic (7.29e-2)" "unprognostic (2.03e-2)" "unprognostic (1.70e-1)" "unprognostic (7.61e-3)" "unprognostic (3.04e-1)" 11.3 12.4 14.6 26.2 14.8 7.1 12.7 11.1 16.2 15.1 8.2 22.2 9.8 6.0 15.8 10.6 10.8 17.7 13.9 16.3 16.0 9.8 9.7 15.9 13.2 26.8 19.3 10.3 31.5 20.3 10.1 13.5 7.1 12.4 16.9 7.7 12.7 13.4 15.2 31.1 9.3 11.7 13.6 14.3 15.9 8.3 5.2 20.0 17.9 15.3 10.9 24.7 17.7 11.3 12.2 5.4 9.6 1.9 6.9 7.5 3.2 2.6 1.3 7.7 1.5 3.8 1.2 0.0 1.6 5.1 1.8 2.4 0.3 8.9 24.1 6.7 5.3 1.4 2.2 5.1 3.1 2.0 10.8 3.4 11.2 1.7 8.5 4.1 2.7 3.5 3.3 3.7 1.7 9.1 8.7 2.0 4.4 0.4 8.5 2.1 7.6 2.5 2.4 4.2 1.4 1.8 25.8 4.2 1.9 8.5 6.8 3.3 1.9 6.5 19.2 3.2 5.4 3.3 6.0 3.5 1.4 3.7 1.7 3.4 2.2 0.0 24.7 1.4 2.1 2.3 9.6 1.0 5.2 6.9 1.3 7.2 12.2 5.0 6.7 1.2 11.0 7.5 5.9 5.1 6.9 1.9 5.4 5.1 3.2 14.6 14.8 11.1 12.8 16.0 9.8 19.3 10.3 12.4 20.0 6.0 2.9 16.4 4.3 4.8 2.4 8.9 12.7 2.7 1.2 8.7 0.0 0.4 3.3 9.4 7.5 6.7 3.1 0.0 5.5 0.2 7.8 11.8 8.1 9.9 1.7 4.8 4.1 7.4 5.4 1.9 9.8 2.5 10.1 5.4 4.8 12.8 7.0 3.5 18.4 3.7 0.7 0.0 18.1 0.5 0.1 7.8 1.1 15.2 3.4 7.8 ZMYM3 "DXS6673E, KIAA0385, MYM, ZNF198L2, ZNF261" ENSG00000147130 "Zinc finger MYM-type containing 3" Q14202 X 71239624-71255146 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003211, HPA075255" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003211: AB_1080661, HPA075255: AB_2732287" "unprognostic (2.17e-1)" "unprognostic (1.73e-1)" "unprognostic (1.31e-1)" "unprognostic (7.69e-3)" "unprognostic (2.03e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (5.18e-4)" "unprognostic (5.03e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-2)" "unprognostic (4.07e-2)" "unprognostic (1.17e-1)" "unprognostic (2.93e-1)" "unprognostic (2.73e-1)" "unprognostic (5.50e-2)" "unprognostic (4.42e-2)" "unprognostic (1.30e-3)" 7.3 23.7 22.5 7.9 20.6 6.2 7.9 16.6 22.7 10.8 10.4 13.6 10.3 7.0 14.0 19.2 8.0 19.8 11.3 9.3 19.5 14.6 10.6 9.6 10.8 10.9 16.8 20.6 36.8 8.2 15.3 14.4 7.8 14.0 14.3 8.0 10.5 11.2 18.0 9.5 11.1 8.8 14.8 14.1 12.1 9.0 15.9 17.3 13.9 12.6 6.4 10.4 11.9 10.0 9.4 13.5 6.8 7.3 6.0 6.8 5.0 7.1 13.1 31.8 16.8 9.3 9.4 8.1 6.6 9.9 14.3 13.5 14.4 10.8 18.0 16.5 11.8 13.0 6.7 27.1 10.0 10.9 6.0 14.5 15.7 11.6 12.8 4.3 14.6 9.8 11.0 5.8 10.4 6.5 25.6 12.0 14.6 18.0 10.0 10.5 11.8 17.5 18.7 31.6 8.8 11.5 22.0 9.7 13.3 10.6 8.7 15.2 10.5 11.2 7.0 6.5 24.2 10.3 9.6 9.2 7.1 13.2 10.3 5.9 9.1 5.4 15.4 8.6 20.0 7.8 6.8 7.3 5.6 6.1 6.3 6.8 9.4 6.8 5.6 6.4 9.0 6.0 5.9 0.5 6.0 5.1 13.5 6.3 5.0 22.5 20.6 16.6 22.7 19.5 14.6 16.8 20.6 14.0 17.3 11.9 11.0 1.7 2.2 3.4 12.7 7.3 7.6 2.7 15.9 29.6 9.8 6.9 1.7 5.6 1.0 7.2 3.9 0.0 7.7 5.0 5.1 1.7 2.3 13.1 8.3 12.7 4.6 5.5 11.1 3.1 12.7 6.3 3.3 12.6 8.2 11.6 6.5 10.2 21.9 11.8 7.1 6.5 4.4 1.4 3.6 3.3 3.5 4.3 8.2 1.3 ZNF131 "pHZ-10, ZBTB35" ENSG00000172262 "Zinc finger protein 131" P52739 5 43065176-43192021 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007023, HPA027748, HPA074630" Approved Enhanced "Nucleoplasm,Intermediate filaments" No No Nucleoplasm "Intermediate filaments" "HPA007023: AB_2667726, HPA027748: AB_2672374, HPA074630: AB_2686705" "unprognostic (1.23e-1)" "unprognostic (8.24e-2)" "unprognostic (4.70e-2)" "unprognostic (7.97e-2)" "unprognostic (8.84e-2)" "unprognostic (7.18e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (2.52e-1)" "unprognostic (2.98e-3)" "unprognostic (1.94e-2)" "unprognostic (5.83e-2)" "unprognostic (8.07e-2)" "unprognostic (2.09e-2)" "unprognostic (1.47e-2)" "unprognostic (2.76e-1)" "unprognostic (3.11e-3)" "unprognostic (1.46e-2)" 16.0 14.3 15.0 18.6 16.7 24.3 20.3 24.8 18.5 18.9 13.0 10.6 10.3 10.0 19.3 10.3 15.3 13.4 13.3 10.8 15.1 13.0 12.3 14.8 12.6 21.6 12.8 14.6 21.6 16.1 13.9 17.3 20.0 14.2 13.9 13.8 8.1 11.9 16.0 16.5 18.2 12.9 16.5 11.9 16.1 12.5 31.0 13.0 27.2 15.5 15.3 17.2 15.5 18.0 13.0 8.9 7.9 7.1 11.7 18.3 7.4 10.5 6.5 14.2 18.8 13.5 9.3 12.0 14.0 11.5 14.0 11.9 10.1 9.5 21.4 11.5 9.4 13.1 7.6 16.7 8.9 19.9 10.4 14.8 13.2 37.4 7.5 12.4 22.8 10.8 8.4 17.0 10.3 16.9 10.0 10.6 16.8 16.8 23.0 15.9 10.3 22.3 28.8 9.4 9.9 10.8 14.8 21.6 16.7 11.8 10.4 8.8 12.9 35.9 17.4 18.0 10.0 9.7 21.8 7.9 17.7 16.4 9.0 13.1 9.3 13.1 24.5 9.3 30.1 11.7 7.9 6.1 4.1 15.0 7.1 15.3 10.1 14.9 14.5 8.9 13.0 18.3 14.6 3.1 11.7 4.8 8.5 10.8 7.4 15.0 16.7 24.8 18.5 15.1 13.0 12.8 14.6 14.2 13.0 20.8 18.7 38.9 47.9 44.1 49.5 17.3 15.3 17.4 18.2 8.7 49.1 22.3 26.6 12.1 29.7 27.5 27.7 0.0 10.3 21.3 29.8 30.2 23.1 10.9 14.4 36.5 30.0 23.9 22.5 12.8 19.0 31.2 20.3 22.6 19.5 24.0 13.8 24.6 19.8 9.8 60.6 25.8 37.3 81.7 71.0 57.2 21.3 41.7 27.6 33.9 ZNF207 ENSG00000010244 "Zinc finger protein 207" O43670 17 32350117-32381886 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017013, HPA063908" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA017013: AB_1859124, HPA063908: AB_2685149" "unprognostic (8.40e-3)" "unprognostic (1.84e-1)" "prognostic favorable (2.81e-4)" "unprognostic (7.57e-2)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.30e-8)" "unprognostic (2.68e-1)" "unprognostic (4.75e-3)" "unprognostic (8.53e-2)" "unprognostic (5.18e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.17e-8)" "unprognostic (1.28e-2)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" 41.0 36.7 29.7 42.6 29.9 101.0 37.1 51.0 35.2 40.1 33.2 39.1 31.0 26.9 44.3 37.5 61.0 35.4 29.5 32.5 25.8 24.4 33.3 33.7 40.3 45.6 35.4 25.5 43.9 31.3 38.4 53.1 52.5 28.4 32.5 41.3 37.7 42.1 31.4 42.4 39.7 34.9 39.0 41.4 41.8 34.7 32.7 33.8 74.9 35.6 46.5 60.4 42.0 43.1 28.3 45.7 39.6 39.1 36.9 38.8 35.6 37.8 46.6 50.5 28.4 27.1 29.3 40.5 38.0 53.6 54.1 48.7 44.3 36.3 52.2 29.4 46.6 42.0 39.2 65.1 46.0 61.2 26.8 43.6 53.5 42.7 45.5 28.4 67.7 49.2 33.8 27.7 37.9 21.2 30.5 49.9 26.6 54.2 40.3 51.8 34.6 54.1 31.8 43.5 36.3 26.6 48.7 45.3 48.7 44.6 74.1 35.4 39.5 35.7 26.3 33.5 45.2 47.5 40.3 35.2 30.6 36.4 31.0 51.3 34.5 51.1 83.4 26.1 32.2 47.3 39.6 34.2 34.3 33.0 38.4 34.1 28.3 30.4 30.3 45.7 22.1 25.7 29.3 17.7 36.9 39.1 21.6 38.8 35.6 29.7 29.9 51.0 35.2 25.8 24.4 35.4 25.5 28.4 33.8 74.5 102.5 74.9 153.6 132.7 131.5 29.5 58.6 99.0 149.0 61.1 212.1 105.3 46.4 78.7 38.1 90.4 96.3 46.7 92.1 139.6 97.2 143.7 71.8 51.6 86.8 95.3 111.3 88.4 95.4 18.3 99.2 106.7 52.3 121.8 73.1 61.6 105.4 86.5 91.9 39.8 151.1 122.9 93.9 117.2 108.3 129.7 149.4 101.5 89.7 220.0 ZNF22 "HKR-T1, KOX15, Zfp422, ZNF422" ENSG00000165512 "Zinc finger protein 22" P17026 10 45000475-45005326 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA016736, HPA054893" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA016736: AB_1859133, HPA054893: AB_2682632" "unprognostic (2.87e-2)" "unprognostic (1.10e-1)" "unprognostic (2.65e-1)" "unprognostic (5.77e-2)" "unprognostic (3.50e-3)" "unprognostic (3.42e-2)" "unprognostic (4.77e-2)" "unprognostic (2.01e-1)" "unprognostic (1.01e-3)" "unprognostic (9.31e-3)" "unprognostic (2.94e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.11e-5)" "prognostic unfavorable (8.06e-4)" "unprognostic (1.39e-1)" "unprognostic (9.96e-2)" "unprognostic (4.58e-2)" 28.5 7.9 15.3 14.5 14.0 12.4 38.6 13.5 13.7 15.7 12.1 9.9 14.7 10.8 18.0 14.0 11.4 15.1 10.5 14.7 14.2 13.0 17.0 22.8 14.1 19.9 14.9 10.2 21.6 29.2 5.5 11.1 22.6 13.6 18.1 12.5 10.2 12.9 11.9 14.0 6.2 13.1 13.9 15.6 17.8 12.4 9.0 14.5 40.1 25.4 11.7 19.1 12.2 12.1 19.8 24.7 13.4 10.9 25.2 25.2 13.6 11.5 1.8 16.2 10.0 8.6 6.2 0.1 5.4 11.1 13.9 15.1 6.4 9.7 11.9 8.9 8.0 3.1 1.9 15.5 5.7 19.8 7.4 0.2 12.4 3.0 0.0 18.0 24.0 4.3 11.0 8.4 5.7 0.2 0.1 21.9 32.6 16.2 21.6 10.9 0.3 44.6 36.3 9.7 6.6 3.2 32.9 22.5 16.8 10.8 9.7 15.7 13.5 4.9 9.9 8.0 15.5 2.1 24.1 12.1 10.2 18.8 7.1 18.1 12.4 12.1 11.4 6.5 0.9 10.8 8.0 10.9 13.4 21.0 10.3 25.2 16.0 13.7 21.6 14.3 19.8 18.9 23.1 1.1 25.2 6.5 24.7 7.7 13.6 15.3 14.0 13.5 13.7 14.2 13.0 14.9 10.2 13.6 14.5 26.8 20.6 39.5 55.7 17.1 32.7 8.9 53.5 41.5 30.7 31.4 9.8 60.0 48.0 50.3 2.7 58.3 4.5 46.7 37.4 50.1 50.3 45.8 31.3 47.9 42.0 36.5 38.4 77.3 24.7 2.4 41.1 26.9 18.6 74.9 34.1 47.6 36.1 10.5 48.1 37.2 30.4 32.3 36.2 37.5 34.5 11.5 44.5 30.5 34.2 25.9 ZNF281 ZBP-99 ENSG00000162702 "Zinc finger protein 281" Q9Y2X9 1 200404940-200410056 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051228 Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051228: AB_2681396" "unprognostic (3.13e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.50e-1)" "unprognostic (8.99e-3)" "unprognostic (1.23e-1)" "unprognostic (5.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" "unprognostic (3.71e-3)" "unprognostic (8.30e-2)" "unprognostic (3.69e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (2.60e-5)" "unprognostic (1.26e-2)" "unprognostic (4.86e-1)" "unprognostic (6.19e-2)" "unprognostic (1.83e-1)" 8.4 5.7 8.8 11.4 18.3 31.2 8.8 22.4 13.1 8.5 7.9 9.1 4.0 6.2 8.8 4.6 4.6 6.8 11.3 5.2 10.5 9.2 8.1 22.9 9.1 11.4 17.3 8.1 6.7 7.6 7.0 8.7 10.3 12.0 6.1 5.0 4.1 6.4 5.1 7.8 3.1 7.3 9.8 11.2 11.4 7.5 10.0 19.9 19.9 5.9 4.8 12.3 8.8 10.2 7.1 5.3 24.5 5.4 4.7 9.3 2.2 11.0 10.8 15.1 7.0 6.0 8.3 13.2 11.6 18.3 11.7 11.1 10.6 8.7 15.9 6.9 13.2 13.7 7.5 16.2 10.8 14.0 17.1 9.9 12.7 8.2 10.9 6.6 11.6 7.3 8.0 12.1 12.6 13.8 14.9 10.5 8.7 18.3 2.6 11.8 5.2 11.9 7.3 35.1 3.4 9.8 11.3 10.5 9.5 12.0 5.6 5.3 14.1 11.5 7.7 10.1 24.8 15.4 8.5 14.2 21.9 16.4 5.0 12.3 9.9 9.6 20.4 11.6 9.2 11.6 8.4 5.1 18.4 6.6 5.4 6.7 7.1 5.7 6.9 5.1 6.5 9.3 8.1 24.5 4.7 4.9 5.3 6.7 2.2 8.8 18.3 22.4 13.1 10.5 9.2 17.3 8.1 12.0 19.9 59.6 29.3 27.2 21.7 42.7 47.6 12.9 30.6 17.4 23.9 26.2 27.5 11.5 11.6 18.9 2.1 26.6 10.7 23.3 9.2 25.2 20.8 19.3 5.8 62.2 18.0 17.5 25.7 28.3 42.5 0.9 9.2 21.8 21.9 16.2 10.4 17.4 14.8 13.1 7.4 15.8 32.4 12.9 20.8 46.8 38.7 19.8 10.3 27.4 10.6 13.6 ZNF300 ENSG00000145908 "Zinc finger protein 300" Q96RE9 5 150894392-150904983 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 7.0;Spermatocytes: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 3.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.2;HeLa: 18.9" "HPA028975, HPA051777" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" NA NA Nucleoplasm "Nucleoli, Nucleoli rim, Nuclear bodies" "HPA028975: AB_2672851, HPA051777: AB_2681606" "unprognostic (5.06e-2)" "unprognostic (1.05e-2)" "unprognostic (8.41e-2)" "unprognostic (2.31e-1)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (1.15e-1)" "unprognostic (6.23e-3)" "unprognostic (4.21e-2)" "unprognostic (3.23e-1)" "unprognostic (8.62e-2)" "unprognostic (6.85e-3)" "prognostic unfavorable (3.21e-6)" "unprognostic (3.62e-3)" "unprognostic (2.99e-1)" "unprognostic (3.46e-1)" "unprognostic (1.50e-2)" 4.5 1.3 4.8 4.0 12.0 3.6 7.2 12.5 6.4 7.4 4.3 5.4 4.1 4.1 11.7 5.3 7.5 5.4 5.4 4.0 7.5 3.2 7.3 1.5 3.0 4.4 8.2 2.4 16.6 7.3 1.0 7.3 2.4 7.4 7.0 4.4 3.6 3.8 3.9 1.5 6.9 5.8 6.4 9.2 5.1 7.1 14.9 9.1 1.5 9.3 2.7 4.4 5.5 6.2 3.8 1.2 1.1 1.5 1.7 1.0 0.8 1.2 2.8 17.2 0.0 1.5 3.6 0.0 4.2 3.3 3.7 5.4 1.4 2.1 0.0 3.7 3.5 11.2 2.5 0.0 9.7 5.8 0.0 5.6 0.0 18.9 2.2 3.1 0.1 0.0 5.5 3.0 7.7 9.1 5.3 6.3 0.1 0.0 9.2 3.7 0.0 0.0 0.8 16.5 0.0 0.0 0.0 2.5 4.9 2.7 3.1 9.7 16.1 9.9 8.6 5.7 10.9 5.7 0.0 2.7 5.0 2.1 3.6 7.6 0.3 0.1 0.0 0.5 0.1 10.3 0.0 0.6 1.1 0.7 1.5 0.1 0.9 1.0 0.0 1.2 3.8 0.7 0.4 0.2 1.7 0.1 0.1 0.0 0.8 4.8 12.0 12.5 6.4 7.5 3.2 8.2 2.4 7.4 9.1 0.0 0.3 0.0 2.5 1.3 3.6 0.4 0.0 0.0 2.3 7.0 0.0 0.7 1.7 2.1 1.3 2.1 0.4 0.0 1.4 1.9 3.0 2.0 0.0 0.2 0.4 0.0 2.9 0.6 0.6 0.5 2.3 0.7 0.0 1.8 0.7 3.9 1.4 0.0 1.1 1.1 4.6 6.5 1.7 6.6 3.8 1.9 0.7 1.3 1.2 2.6 ZNF317 ENSG00000130803 "Zinc finger protein 317" Q96PQ6 19 9140380-9163424 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042075, HPA048625" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042075: AB_10796471, HPA048625: AB_2680464" "unprognostic (3.81e-1)" "unprognostic (3.11e-2)" "unprognostic (3.90e-1)" "unprognostic (1.63e-1)" "unprognostic (2.98e-2)" "unprognostic (6.07e-3)" "unprognostic (7.70e-2)" "unprognostic (6.17e-2)" "unprognostic (3.89e-2)" "unprognostic (1.72e-2)" "unprognostic (1.18e-1)" "unprognostic (1.14e-1)" "unprognostic (1.67e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-1)" "unprognostic (3.36e-1)" "unprognostic (2.42e-3)" 14.6 17.2 18.4 22.8 19.4 36.1 30.3 22.0 24.1 15.6 17.2 22.1 12.4 17.9 19.4 19.5 17.8 17.2 16.9 13.1 18.3 16.1 17.5 20.5 17.1 22.2 19.7 15.2 18.8 21.5 22.0 19.9 14.5 14.6 18.2 17.1 17.9 15.3 18.5 14.3 22.0 17.8 16.9 17.0 25.7 18.0 8.7 19.4 27.0 17.0 11.2 23.4 16.2 15.5 19.0 14.4 14.5 15.0 21.7 20.9 12.9 8.6 7.4 8.1 10.8 8.1 7.9 7.0 7.3 11.4 10.0 12.2 8.3 4.6 14.7 9.4 7.5 11.9 8.8 13.2 12.3 13.1 12.1 17.8 12.8 6.7 9.2 11.1 13.5 13.4 9.4 16.8 11.4 19.9 8.7 8.7 13.2 12.0 17.1 10.0 7.2 17.0 43.6 15.1 9.2 15.9 12.1 10.2 11.8 8.7 14.7 14.0 9.6 10.1 9.0 11.3 7.3 6.7 14.4 7.7 7.1 6.5 16.1 9.6 21.6 20.6 16.7 6.9 12.0 9.1 13.9 14.1 14.5 13.6 15.0 20.9 19.0 17.9 15.4 14.4 16.0 17.1 18.5 8.8 21.7 11.9 13.2 20.8 12.9 18.4 19.4 22.0 24.1 18.3 16.1 19.7 15.2 14.6 19.4 8.9 12.0 9.8 6.8 6.5 6.5 5.9 12.7 12.0 12.5 5.2 5.9 4.4 3.3 4.6 0.6 7.1 5.7 0.0 5.5 4.3 5.2 7.0 12.8 9.8 7.0 7.9 6.9 5.5 12.7 1.3 3.4 9.5 5.0 3.6 7.2 4.0 6.8 3.5 3.5 7.7 4.8 0.0 5.2 2.1 1.1 5.6 9.2 13.8 9.2 8.9 ZNF326 "FLJ20403, ZAN75, Zfp326, ZIRD" ENSG00000162664 "Zinc finger protein 326" Q5BKZ1 1 89995112-90035531 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Bipolar cells: 134.9;Cone photoreceptor cells: 351.5;Rod photoreceptor cells: 448.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028450, HPA028461, HPA028466" Supported Enhanced "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA028450: AB_2672616, HPA028461: AB_10601777, HPA028466: AB_10601677" "prognostic favorable (9.46e-4)" "unprognostic (2.45e-1)" "unprognostic (7.25e-3)" "unprognostic (1.09e-1)" "unprognostic (5.28e-3)" "unprognostic (1.67e-2)" "unprognostic (8.61e-3)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (3.17e-2)" "unprognostic (3.66e-2)" "unprognostic (1.33e-2)" "unprognostic (2.62e-2)" "unprognostic (8.59e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-1)" "prognostic favorable (2.84e-4)" 12.7 13.4 18.4 12.7 27.8 45.2 17.7 20.2 18.5 11.8 14.1 23.2 16.3 18.5 18.3 17.1 17.5 11.9 13.9 12.5 19.2 15.2 13.4 15.2 11.5 15.3 26.1 14.1 21.8 20.2 14.4 18.0 14.5 22.8 13.3 20.7 23.9 15.7 9.4 19.2 14.5 18.9 17.8 31.3 11.0 14.6 10.6 27.8 17.3 14.1 10.5 15.1 11.9 17.2 6.8 8.4 3.6 6.1 7.8 4.3 2.2 17.2 15.8 24.6 11.7 11.0 5.2 26.0 17.5 6.8 14.5 9.1 14.6 12.6 21.6 12.5 9.0 16.0 15.6 25.6 11.4 20.0 12.6 12.3 19.5 15.4 13.3 3.7 22.9 9.6 4.6 5.4 14.4 9.2 10.2 8.4 10.1 26.0 9.4 11.7 8.2 23.6 13.0 23.1 14.6 18.0 16.8 24.9 5.8 12.0 19.4 21.6 14.0 20.1 18.7 8.5 18.2 10.3 6.0 11.4 17.1 17.2 14.4 17.3 8.0 7.9 21.6 4.1 18.1 10.9 2.1 5.1 3.6 4.0 6.1 3.2 4.2 3.2 3.4 4.0 6.8 3.2 4.3 2.5 7.8 4.6 8.4 2.8 2.2 18.4 27.8 20.2 18.5 19.2 15.2 26.1 14.1 22.8 27.8 20.8 44.0 32.0 53.5 57.9 134.9 34.4 15.3 45.5 44.3 22.7 351.5 36.5 16.6 45.3 3.4 38.7 63.7 0.0 48.0 73.0 29.8 46.9 48.7 28.0 22.6 65.2 67.4 24.5 16.4 4.2 40.0 32.7 37.1 46.9 33.4 49.5 37.7 66.6 31.8 14.7 448.1 25.8 38.7 58.0 40.9 39.5 41.3 22.4 36.2 68.1 ZNF335 "bA465L10.2, NIF-1" ENSG00000198026 "Zinc finger protein 335" Q9H4Z2 20 45948653-45972172 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063999, HPA071230" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063999: AB_2685170, HPA071230: AB_2686369" "unprognostic (1.50e-1)" "unprognostic (8.05e-2)" "unprognostic (8.29e-3)" "unprognostic (7.85e-2)" "unprognostic (1.35e-2)" "prognostic favorable (4.48e-4)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.74e-2)" "unprognostic (1.01e-1)" "unprognostic (7.91e-2)" "unprognostic (1.30e-3)" "prognostic unfavorable (7.04e-4)" "prognostic unfavorable (2.77e-5)" "unprognostic (4.10e-1)" "unprognostic (1.94e-1)" "unprognostic (2.44e-1)" "unprognostic (2.88e-3)" 10.5 8.3 12.0 12.2 13.6 28.8 10.7 17.9 15.7 10.5 10.3 9.7 4.0 11.5 14.2 5.2 11.2 12.3 8.2 7.0 10.7 5.0 8.6 7.8 10.4 15.0 8.1 11.6 15.2 10.5 13.2 10.4 13.7 8.2 10.7 6.7 8.4 12.0 9.2 12.3 22.9 13.5 7.9 7.6 13.9 10.6 16.5 10.1 19.4 14.9 8.8 12.0 11.4 9.5 3.7 3.6 5.0 4.5 8.9 7.3 3.5 9.1 9.3 8.3 9.0 4.4 5.6 17.7 8.2 5.7 8.2 5.9 20.1 10.3 11.0 12.2 8.0 7.5 13.2 8.0 12.3 3.7 7.5 10.9 9.1 13.6 10.6 6.9 11.8 15.6 9.0 10.5 10.7 7.7 5.9 7.0 11.6 8.6 14.8 5.6 18.6 13.9 11.5 5.7 6.2 15.4 11.5 5.5 9.2 7.2 14.4 8.4 7.4 12.2 17.2 8.6 5.2 13.0 9.8 7.3 17.7 7.7 11.2 11.1 17.3 8.8 11.4 14.3 7.4 9.7 2.4 3.5 5.0 7.3 4.5 3.7 3.3 3.6 4.9 3.6 3.7 3.1 3.4 3.6 8.9 3.6 2.5 3.6 3.5 12.0 13.6 17.9 15.7 10.7 5.0 8.1 11.6 8.2 10.1 11.9 15.9 11.8 11.4 16.7 17.4 2.8 2.5 1.4 4.5 1.8 25.5 7.2 0.0 3.9 22.2 8.3 13.7 0.0 5.1 7.0 7.8 9.9 6.9 5.7 5.3 12.7 20.6 7.4 6.4 17.7 6.9 10.2 8.5 2.8 9.2 5.8 6.6 10.5 4.9 1.9 11.1 0.0 8.6 3.7 8.3 19.6 10.0 16.2 9.1 11.4 ZNF34 KOX32 ENSG00000196378 "Zinc finger protein 34" Q8IZ26 8 144773114-144787345 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA053925, HPA060755, HPA066805" Uncertain Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA053925: AB_2682311, HPA060755: AB_2684354, HPA066805: AB_2685725" "unprognostic (2.54e-1)" "unprognostic (3.50e-1)" "unprognostic (5.01e-2)" "unprognostic (7.60e-2)" "unprognostic (1.98e-1)" "unprognostic (1.67e-2)" "unprognostic (3.26e-2)" "unprognostic (3.54e-2)" "unprognostic (2.85e-2)" "unprognostic (1.40e-2)" "unprognostic (9.84e-3)" "unprognostic (1.46e-1)" "unprognostic (3.46e-3)" "unprognostic (5.80e-2)" "unprognostic (2.09e-3)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" 9.0 5.7 12.3 4.1 11.5 4.6 8.6 28.5 14.4 10.0 9.4 12.6 7.8 3.6 10.0 8.0 6.3 10.4 6.6 7.5 13.4 7.8 6.4 6.5 7.5 5.8 17.2 13.8 17.0 7.8 12.5 11.5 7.6 12.2 8.7 6.0 8.3 5.6 12.7 5.9 8.0 5.4 10.7 11.8 6.0 5.9 7.1 16.0 4.1 11.1 1.8 4.7 8.7 7.8 7.2 10.4 12.7 15.2 5.5 8.5 5.0 3.0 5.3 8.9 6.6 7.6 7.4 2.4 2.9 6.2 7.3 6.1 1.2 5.1 5.0 5.5 7.3 4.2 3.1 5.1 5.8 5.5 4.9 4.3 9.6 8.2 4.0 6.9 2.5 5.0 7.9 6.8 5.8 11.9 7.5 4.9 3.2 6.4 4.1 6.3 7.8 5.5 3.9 6.4 7.1 5.6 5.0 3.6 6.0 4.1 3.1 8.4 6.3 6.7 4.7 4.5 5.9 5.3 3.2 3.5 6.7 5.9 5.6 5.6 5.1 1.7 5.7 4.9 4.1 8.0 8.1 7.0 12.7 7.4 6.4 6.5 6.8 6.9 8.5 10.4 7.2 4.9 7.4 1.0 5.5 15.2 4.9 5.4 5.0 12.3 11.5 28.5 14.4 13.4 7.8 17.2 13.8 12.2 16.0 6.0 3.2 0.9 1.5 3.3 7.1 2.0 0.0 1.4 4.5 0.0 0.0 2.2 5.0 2.7 6.0 4.9 1.3 0.0 1.2 2.1 3.3 1.5 4.7 2.4 1.6 12.7 0.0 3.7 1.9 5.5 6.6 3.1 3.3 12.6 1.9 5.4 1.2 1.9 4.6 1.4 8.7 6.5 4.7 9.3 6.3 4.3 1.9 4.1 2.3 0.7 ZNF394 "FLJ12298, ZKSCAN14, ZSCAN46" ENSG00000160908 "Zinc finger protein 394" Q53GI3 7 99486519-99500324 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051421, HPA054639" Uncertain Enhanced Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA051421: AB_2681479, HPA054639: AB_2682553" "prognostic favorable (3.56e-4)" "unprognostic (1.62e-1)" "unprognostic (2.83e-3)" "unprognostic (2.60e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.11e-4)" "unprognostic (3.62e-2)" "unprognostic (4.14e-1)" "unprognostic (6.28e-2)" "unprognostic (2.45e-1)" "unprognostic (1.59e-1)" "unprognostic (4.70e-2)" "unprognostic (7.47e-2)" "unprognostic (3.42e-1)" "prognostic favorable (1.09e-4)" 11.3 8.3 10.0 11.5 11.8 77.5 12.2 16.4 13.2 10.8 10.9 11.7 8.8 10.7 11.0 7.7 12.2 11.2 9.3 10.4 7.9 6.2 9.4 9.5 12.6 12.2 11.2 6.6 14.3 12.0 7.9 16.2 8.4 9.7 13.0 9.1 10.1 10.1 9.0 14.8 13.6 13.5 9.1 9.1 19.1 10.9 9.5 11.0 15.6 11.4 8.8 17.5 11.9 11.6 17.6 22.3 31.6 17.0 24.3 29.3 17.0 7.8 7.8 5.3 11.1 8.2 5.6 10.5 6.7 8.9 7.8 7.6 8.2 8.7 9.4 9.7 6.9 11.0 7.6 7.1 8.5 7.7 6.8 9.4 9.2 9.3 9.0 6.6 13.1 16.1 7.4 7.4 7.6 8.1 5.8 8.9 8.4 13.2 18.7 7.1 14.7 13.5 21.5 11.8 9.8 9.4 7.7 5.8 16.3 8.4 11.2 6.3 13.1 7.8 19.0 12.6 13.5 4.9 16.3 9.3 9.5 9.5 13.6 8.3 15.4 16.1 15.2 6.7 13.3 9.9 31.6 14.3 24.1 23.1 17.0 24.2 17.6 23.6 25.0 15.6 17.2 29.3 23.1 26.3 24.3 16.7 22.3 25.2 17.0 10.0 11.8 16.4 13.2 7.9 6.2 11.2 6.6 9.7 11.0 14.9 22.4 32.0 29.5 31.6 8.1 7.0 2.5 20.1 11.4 10.4 11.8 13.3 14.9 13.3 5.6 16.9 25.5 0.0 12.4 14.8 17.4 23.7 57.7 10.5 16.3 14.3 20.0 12.9 22.1 1.1 14.4 20.8 27.0 15.4 14.7 12.4 14.1 18.6 12.7 9.5 10.6 12.9 17.0 42.5 30.3 31.0 24.8 44.5 15.8 52.9 ZNF423 "Ebfaz, JBTS19, KIAA0760, NPHP14, OAZ, Roaz, Zfp104" ENSG00000102935 "Zinc finger protein 423" Q2M1K9 16 49487524-49857919 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Late spermatids: 47.7;Leydig cells: 25.6;Peritubular cells: 51.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "NK-cell: 1.6" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.6" "Cell line enhanced" "Detected in some" "AF22: 24.7;NTERA-2: 12.6;REH: 10.7;SCLC-21H: 13.4;SH-SY5Y: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015258, HPA065820" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015258: , HPA065820: AB_2685563" "unprognostic (2.81e-1)" "unprognostic (1.18e-1)" "unprognostic (1.19e-1)" "unprognostic (2.68e-1)" "unprognostic (2.86e-1)" "unprognostic (8.65e-3)" "unprognostic (3.37e-2)" "unprognostic (4.84e-2)" "unprognostic (1.14e-1)" "unprognostic (2.77e-1)" "unprognostic (9.13e-2)" "unprognostic (8.97e-2)" "unprognostic (1.22e-1)" "unprognostic (6.64e-3)" "unprognostic (8.25e-2)" "unprognostic (2.92e-2)" "unprognostic (5.84e-2)" 10.8 4.1 10.3 3.0 8.8 0.9 7.3 9.1 9.0 14.3 4.8 7.7 6.8 2.2 10.0 9.4 6.7 14.0 9.3 9.1 8.8 9.5 1.9 1.5 6.7 3.7 8.6 7.2 13.6 4.2 5.3 4.7 5.8 7.5 12.2 4.0 14.5 4.0 13.8 28.7 2.4 3.3 9.3 5.6 2.2 2.6 7.1 7.7 0.0 4.9 11.0 2.2 5.3 7.1 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 24.7 1.3 2.0 0.3 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.7 0.2 0.0 1.6 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.8 0.2 12.6 0.0 0.0 10.7 0.0 0.0 0.0 0.7 13.4 40.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.4 7.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 10.3 8.8 9.1 8.8 8.8 9.5 8.6 7.2 7.5 7.7 0.0 0.0 0.0 0.2 2.4 8.0 2.8 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.2 14.5 9.1 0.4 0.0 0.2 0.6 10.8 0.1 0.0 0.8 0.6 0.0 0.0 12.9 0.3 47.7 25.6 0.2 1.7 0.0 1.3 7.5 0.2 0.0 51.2 0.0 1.0 0.0 6.4 0.5 0.6 1.5 0.2 0.0 0.4 0.0 ZNF432 KIAA0798 ENSG00000256087 "Zinc finger protein 432" O94892 19 52031379-52095738 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 25.4;Rod photoreceptor cells: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA052082, HPA060274, HPA065606" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052082: AB_2681719, HPA060274: AB_2684238, HPA065606: AB_2685518" "unprognostic (1.62e-1)" "unprognostic (2.34e-1)" "unprognostic (1.92e-1)" "unprognostic (7.04e-3)" "unprognostic (1.08e-2)" "unprognostic (2.41e-3)" "unprognostic (3.19e-2)" "unprognostic (2.56e-1)" "unprognostic (6.92e-2)" "unprognostic (1.83e-1)" "unprognostic (3.14e-2)" "unprognostic (5.49e-3)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (1.90e-1)" "prognostic favorable (4.11e-5)" 8.6 9.8 8.4 5.9 12.5 9.4 9.6 11.0 9.1 14.3 5.9 4.5 6.4 6.4 8.3 12.8 7.2 7.9 5.2 7.0 9.8 5.9 10.1 4.3 6.0 5.6 7.8 7.3 10.8 19.0 8.5 15.5 6.3 8.8 17.4 6.2 7.3 7.5 6.9 4.2 9.7 8.6 6.4 10.8 8.3 6.9 9.3 11.2 8.9 14.0 4.2 5.6 8.2 7.2 5.6 3.0 4.1 4.1 2.5 5.7 2.9 4.3 3.6 9.0 13.2 5.5 6.8 3.0 4.9 4.2 3.8 6.3 2.9 2.6 3.2 1.7 5.6 4.2 3.2 4.5 5.1 6.5 3.1 11.3 8.8 8.2 5.4 2.6 0.0 8.2 7.4 3.6 5.3 7.6 7.2 5.1 3.6 2.6 13.2 7.0 2.3 8.8 5.1 3.3 2.2 5.7 4.4 8.9 4.8 5.4 19.5 5.2 4.9 7.7 4.2 2.6 6.2 4.0 3.9 6.5 3.6 5.1 3.6 5.0 6.6 9.0 6.9 6.8 0.8 6.0 2.7 3.6 4.1 5.1 4.1 3.6 5.6 3.1 3.4 3.0 4.9 5.7 4.0 3.8 2.5 2.1 2.3 3.7 2.9 8.4 12.5 11.0 9.1 9.8 5.9 7.8 7.3 8.8 11.2 14.9 10.6 2.4 2.9 1.8 9.5 5.2 2.5 13.4 18.2 8.7 15.7 2.1 3.3 2.7 12.2 4.1 2.1 0.0 1.4 5.1 3.7 3.8 11.6 0.8 2.0 25.4 9.8 4.3 4.6 9.0 3.4 2.5 3.3 2.8 4.6 6.2 1.4 5.1 4.2 2.2 29.8 6.5 3.3 8.0 7.5 1.9 4.1 3.2 3.0 2.1 ZNF444 "EZF2, FLJ11137, ZSCAN17" ENSG00000167685 "Zinc finger protein 444" Q8N0Y2 19 56132599-56160893 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056895, HPA065203" Approved Enhanced Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA056895: AB_2683267, HPA065203: AB_2685431" "unprognostic (1.58e-1)" "unprognostic (3.34e-1)" "unprognostic (5.00e-2)" "unprognostic (1.23e-2)" "unprognostic (1.26e-1)" "unprognostic (4.57e-2)" "unprognostic (1.32e-2)" "unprognostic (2.01e-2)" "unprognostic (1.56e-1)" "unprognostic (7.29e-2)" "unprognostic (1.35e-3)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.61e-4)" "unprognostic (4.70e-2)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "prognostic favorable (1.87e-4)" 9.4 13.4 15.0 7.1 21.0 3.7 8.3 14.9 20.1 9.0 14.8 12.8 14.3 13.6 10.5 9.9 6.6 11.9 11.2 10.5 13.5 13.3 9.9 37.4 10.9 6.1 12.3 11.0 12.5 25.3 8.5 12.2 12.5 8.0 14.3 5.3 10.4 14.1 25.6 17.2 11.5 11.3 7.5 10.3 8.6 17.2 9.2 10.4 28.1 16.6 2.8 8.2 10.4 6.8 4.3 3.5 3.5 1.7 3.7 7.1 1.8 4.7 9.1 8.4 7.3 3.6 3.7 5.5 6.1 4.0 5.2 5.7 10.0 5.4 8.4 5.4 3.5 2.6 4.4 5.2 4.1 2.2 7.3 51.5 8.2 6.1 18.0 5.9 3.6 7.7 4.3 3.8 4.2 3.3 7.9 4.6 10.5 10.6 3.7 3.6 6.2 11.8 10.3 9.1 9.5 16.7 13.8 5.4 4.4 5.7 4.4 9.0 12.4 3.1 10.3 4.5 4.8 10.2 6.7 6.0 9.4 8.1 2.0 6.6 9.1 7.7 6.3 5.9 5.0 6.1 3.1 1.7 3.5 4.1 1.4 4.5 2.0 6.9 6.9 2.1 4.3 7.1 4.6 0.2 3.7 1.0 3.5 4.2 1.8 15.0 21.0 14.9 20.1 13.5 13.3 12.3 11.0 8.0 10.4 3.0 14.9 10.2 14.2 2.7 16.7 11.4 33.1 13.4 9.1 10.4 7.9 16.2 8.3 23.1 26.9 15.8 12.8 0.0 19.3 7.9 9.2 13.8 10.3 34.7 9.4 19.1 28.2 19.6 5.3 28.6 11.2 3.9 15.1 19.8 24.4 16.6 21.0 10.5 11.3 18.8 13.6 25.8 13.2 10.4 19.8 4.5 10.4 13.1 19.3 8.9 ZNF500 "KIAA0557, ZKSCAN18, ZSCAN50" ENSG00000103199 "Zinc finger protein 500" O60304 16 4748239-4767624 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA035498, HPA057963" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035498: AB_10602356, HPA057963: AB_2683565" "unprognostic (3.83e-2)" "unprognostic (5.50e-2)" "unprognostic (2.57e-1)" "unprognostic (1.06e-1)" "unprognostic (3.17e-1)" "unprognostic (3.61e-3)" "unprognostic (8.72e-3)" "unprognostic (7.77e-3)" "unprognostic (1.45e-2)" "unprognostic (1.28e-2)" "unprognostic (8.04e-3)" "unprognostic (4.07e-2)" "unprognostic (1.10e-2)" "prognostic favorable (3.41e-4)" "unprognostic (8.98e-2)" "unprognostic (6.89e-2)" "unprognostic (3.19e-2)" 8.1 6.4 10.2 9.4 7.5 5.9 8.1 13.8 11.4 10.3 8.0 11.7 11.5 8.4 12.2 10.9 6.2 8.9 10.4 6.0 6.2 5.1 6.0 5.2 7.2 12.5 6.6 9.4 13.9 8.5 9.1 8.0 6.7 6.6 9.3 5.3 10.6 11.3 14.9 7.5 8.5 7.5 7.5 5.4 11.4 7.7 7.2 8.4 9.9 9.2 7.1 8.3 9.2 8.4 5.3 6.5 3.4 2.5 3.0 4.9 2.1 2.0 8.4 2.8 7.3 3.3 3.0 12.8 6.1 6.8 7.6 5.2 3.7 4.0 4.4 5.3 3.3 2.8 4.7 5.8 3.2 5.6 3.2 8.8 3.6 10.6 5.0 4.7 2.5 4.0 3.5 7.8 3.4 6.5 7.5 4.3 5.6 5.3 7.0 3.0 4.6 5.2 4.4 3.6 1.6 3.0 9.3 6.7 8.7 2.5 2.4 10.4 6.8 5.2 7.9 2.3 2.0 5.1 4.1 4.8 7.2 5.5 8.0 2.9 6.7 4.5 3.9 2.2 2.1 4.5 2.3 2.5 3.4 3.9 2.4 3.3 4.9 2.5 3.0 1.4 5.3 4.2 4.9 2.9 3.0 1.7 6.5 3.9 2.1 10.2 7.5 13.8 11.4 6.2 5.1 6.6 9.4 6.6 8.4 11.9 2.4 8.9 2.6 2.2 16.8 4.8 2.5 5.3 2.3 7.0 23.6 4.9 1.7 3.8 6.8 4.9 4.9 0.0 2.7 3.8 3.6 4.3 6.9 4.0 2.7 17.5 8.1 9.2 3.3 1.3 10.6 3.1 1.7 9.0 4.9 12.1 2.9 0.0 10.6 2.2 20.5 0.0 4.1 12.6 8.3 1.9 3.8 5.7 5.2 1.6 ZNF512B "GM632, MGC149845, MGC149846" ENSG00000196700 "Zinc finger protein 512B" Q96KM6 20 63956702-63969865 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 20.1;Cone photoreceptor cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006688, HPA008731" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006688: AB_10963053, HPA008731: " "unprognostic (7.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.40e-3)" "unprognostic (7.19e-3)" "unprognostic (2.33e-1)" "unprognostic (1.84e-1)" "unprognostic (5.30e-3)" "unprognostic (2.38e-2)" "unprognostic (3.04e-1)" "unprognostic (1.13e-1)" "unprognostic (6.99e-3)" "unprognostic (5.03e-3)" "unprognostic (2.12e-1)" "unprognostic (7.72e-2)" "unprognostic (5.52e-2)" "unprognostic (1.95e-3)" "unprognostic (3.72e-2)" 7.5 8.2 11.0 6.3 13.3 6.2 5.6 14.3 16.7 7.4 3.6 9.9 6.1 5.3 9.3 9.0 10.1 8.5 7.5 8.3 11.0 8.5 9.6 18.5 7.1 7.0 8.8 10.5 11.3 14.4 13.6 10.3 10.4 8.4 8.5 1.7 9.9 15.5 10.5 11.2 14.3 5.8 7.8 6.4 9.3 8.5 8.8 6.5 6.2 10.7 5.8 8.8 6.2 6.7 0.6 0.4 0.0 0.1 1.4 1.1 0.3 5.4 9.2 10.4 11.0 4.6 3.4 9.5 7.9 6.2 23.8 7.8 17.9 9.2 3.6 19.4 6.8 4.4 7.0 7.8 11.7 5.7 5.8 11.2 8.8 12.9 17.0 7.4 4.7 10.6 7.2 9.7 8.2 4.7 6.3 7.3 16.2 12.2 5.5 4.7 13.0 23.0 10.3 7.2 7.0 12.1 10.6 0.9 10.7 4.3 9.2 15.2 8.9 6.5 10.8 5.2 5.2 22.7 11.5 10.2 22.9 3.5 5.7 6.7 13.2 6.3 10.0 8.2 0.0 9.7 0.0 0.1 0.0 1.1 0.0 0.1 0.1 1.0 0.1 0.4 0.6 1.1 1.0 0.0 1.4 0.0 0.4 0.0 0.3 11.0 13.3 14.3 16.7 11.0 8.5 8.8 10.5 8.4 6.5 3.0 6.4 3.2 2.9 4.7 20.1 1.7 7.6 1.4 5.7 1.8 21.6 6.2 1.7 3.2 0.1 3.0 0.3 0.0 5.2 2.6 4.5 2.5 0.0 15.3 3.2 12.7 5.8 8.6 1.3 1.0 6.1 0.7 5.0 1.8 0.5 8.0 2.8 0.0 6.3 4.1 10.5 0.0 3.4 3.0 4.8 6.0 4.2 2.9 1.3 2.4 ZNF554 FLJ34817 ENSG00000172006 "Zinc finger protein 554" Q86TJ5 19 2819874-2835773 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060247, HPA063358" Uncertain Enhanced Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA060247: AB_2684230, HPA063358: AB_2684995" "unprognostic (3.81e-1)" "unprognostic (1.89e-3)" "unprognostic (1.84e-1)" "unprognostic (3.58e-3)" "unprognostic (5.05e-2)" "unprognostic (7.36e-5)" "unprognostic (1.65e-1)" "prognostic favorable (9.31e-4)" "unprognostic (1.82e-1)" "unprognostic (3.37e-3)" "prognostic favorable (4.69e-4)" "unprognostic (1.57e-1)" "prognostic favorable (1.99e-5)" "unprognostic (1.75e-1)" "unprognostic (9.91e-3)" "unprognostic (1.79e-2)" "prognostic favorable (5.00e-4)" 4.1 4.4 7.9 2.0 9.1 1.9 5.1 12.2 14.1 6.0 4.6 7.7 5.6 6.1 6.8 4.5 4.0 6.4 5.6 7.3 8.2 8.4 6.6 8.6 5.0 3.9 6.2 6.9 8.2 5.0 9.8 8.4 25.9 6.0 5.7 4.3 7.7 7.6 5.4 8.9 7.4 4.7 5.6 4.2 3.7 4.2 4.0 6.5 5.1 7.9 4.7 6.0 4.5 4.1 2.3 3.6 0.6 0.6 1.8 1.8 0.7 3.7 0.1 3.3 3.6 2.3 3.0 4.2 2.4 2.6 5.0 2.3 0.3 1.0 3.5 2.3 1.9 3.8 1.8 0.3 1.9 0.7 0.0 1.7 1.0 1.2 1.5 1.8 0.5 0.8 2.4 4.4 1.4 2.0 3.0 0.4 4.4 3.6 2.0 1.6 0.7 1.7 0.4 1.6 1.2 1.1 1.9 2.2 0.9 3.2 3.0 3.0 5.4 2.7 0.5 4.0 4.2 1.4 1.8 0.0 0.4 1.0 1.4 0.9 6.6 7.3 0.7 1.9 1.7 1.0 0.2 0.3 0.6 0.4 0.1 1.5 0.8 0.7 0.9 0.0 2.3 1.8 0.3 0.2 1.8 0.6 3.6 0.3 0.7 7.9 9.1 12.2 11.2 8.2 8.4 6.2 6.9 6.0 6.5 11.9 15.1 0.9 2.6 1.1 4.1 2.8 2.5 8.1 6.8 0.0 7.9 1.9 3.3 2.0 0.4 2.5 3.8 0.0 1.2 1.0 2.0 2.5 0.0 1.9 1.3 3.2 3.5 2.5 1.0 0.2 2.8 2.0 0.0 1.0 1.7 4.6 1.7 0.0 2.5 2.1 4.7 0.0 1.5 4.4 10.4 1.3 7.3 4.5 2.2 1.5 ZNF560 FLJ31986 ENSG00000198028 "Zinc finger protein 560" Q96MR9 19 9466507-9498607 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 21.1" "Cell type enriched" "Detected in some" 4 "Early spermatids: 48.7" "Cancer enriched" "Detected in some" 7 "testis cancer: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.8;SuSa: 8.8" "HPA045439, HPA074438" Enhanced "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA045439: AB_2732520, HPA074438: " "unprognostic (4.43e-3)" "unprognostic (8.91e-2)" "unprognostic (9.85e-3)" "unprognostic (2.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.29e-1)" "unprognostic (1.04e-1)" "unprognostic (1.39e-1)" "unprognostic (6.57e-3)" "unprognostic (6.33e-5)" "unprognostic (5.60e-2)" "unprognostic (2.32e-1)" "unprognostic (9.15e-3)" "unprognostic (1.65e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.4 2.6 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 21.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.8 2.4 0.0 1.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 1.0 17.9 0.0 0.0 1.3 0.0 4.4 2.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 11.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.0 8.3 0.0 0.0 0.0 0.0 0.0 ZNF593 ZT86 ENSG00000142684 "Zinc finger protein 593" O00488 1 26169871-26170873 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 59.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054363, HPA059387" Supported Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA054363: AB_2682462, HPA059387: AB_2684001" "unprognostic (1.23e-2)" "unprognostic (8.97e-2)" "unprognostic (7.13e-2)" "unprognostic (7.42e-2)" "unprognostic (9.37e-2)" "unprognostic (5.92e-2)" "unprognostic (1.63e-2)" "unprognostic (8.96e-2)" "unprognostic (5.06e-1)" "unprognostic (1.76e-2)" "unprognostic (1.78e-1)" "unprognostic (1.08e-1)" "unprognostic (4.46e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" "unprognostic (4.79e-2)" 11.7 11.5 9.4 10.7 9.4 15.7 18.3 7.2 12.1 9.0 11.7 7.0 12.1 11.4 8.7 9.0 10.9 8.4 11.3 14.5 8.9 10.0 13.5 30.8 7.7 16.8 10.0 7.0 11.6 36.2 9.7 9.3 12.7 10.9 10.4 5.8 5.9 15.9 12.0 59.3 9.8 11.0 6.5 7.3 13.0 15.2 9.3 8.3 5.4 15.1 17.2 9.2 10.6 10.1 23.5 26.8 0.7 25.0 16.1 21.7 14.1 20.1 11.1 3.8 13.4 3.7 4.9 20.2 9.0 4.6 10.5 10.1 17.0 12.2 23.6 16.6 5.6 8.4 13.2 12.9 11.7 3.8 14.1 41.4 16.0 9.1 25.7 16.1 22.1 14.1 8.8 11.5 11.6 12.2 4.4 8.8 5.8 24.0 9.1 6.2 15.4 9.0 41.1 15.1 19.5 39.5 11.3 6.7 23.8 7.5 8.9 10.1 11.0 10.9 27.4 34.2 3.3 11.3 12.5 9.1 10.1 11.9 21.1 16.8 18.0 18.2 25.5 11.8 45.9 12.9 0.1 15.7 0.2 14.2 25.0 13.3 23.5 20.1 14.0 21.7 22.7 15.0 14.3 0.7 16.1 25.0 26.8 21.7 14.1 9.4 9.4 7.2 12.1 8.9 10.0 10.0 7.0 10.9 8.3 11.9 63.0 48.3 137.4 152.1 16.6 5.9 58.6 21.4 40.9 57.6 2.0 93.3 87.9 89.4 5.0 36.0 55.3 23.3 126.2 135.2 54.6 99.4 51.7 184.5 69.6 3.2 105.3 38.6 55.7 10.0 30.0 42.5 47.2 47.7 71.1 18.5 122.6 60.4 21.9 148.8 11.7 12.9 55.6 33.0 56.3 147.0 186.2 28.8 68.1 152.9 ZNF594 KIAA1871 ENSG00000180626 "Zinc finger protein 594" Q96JF6 17 5179536-5191883 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 14.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA060283, HPA067178, HPA069360, HPA074493, HPA077596" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA060283: AB_2732645, HPA067178: AB_2685796, HPA069360: AB_2732131, HPA074493: , HPA077596: " "unprognostic (6.67e-2)" "unprognostic (1.07e-2)" "unprognostic (6.93e-2)" "unprognostic (7.92e-3)" "unprognostic (1.11e-1)" "unprognostic (8.24e-3)" "unprognostic (3.36e-2)" "unprognostic (1.32e-1)" "unprognostic (6.67e-2)" "unprognostic (1.86e-1)" "unprognostic (1.33e-5)" "unprognostic (4.09e-3)" "unprognostic (1.08e-1)" "unprognostic (1.08e-1)" "unprognostic (4.99e-1)" "unprognostic (5.21e-2)" "unprognostic (6.59e-2)" 4.0 6.2 11.8 8.4 11.2 1.3 8.8 13.8 13.4 7.5 6.3 8.0 5.3 3.1 9.3 8.4 4.2 8.3 4.2 4.9 8.9 5.9 6.7 3.8 4.1 10.1 13.6 6.6 19.8 6.0 15.3 15.9 5.8 9.2 9.6 5.1 6.0 6.5 10.2 6.7 3.8 6.8 6.0 8.3 8.4 5.2 7.8 11.1 11.9 10.2 2.1 10.2 6.6 5.6 5.9 4.5 1.1 1.0 2.4 5.2 1.0 5.5 2.5 10.7 8.3 1.7 1.9 8.9 3.8 1.9 6.8 6.5 7.0 2.0 12.6 6.0 3.0 5.0 6.2 6.8 0.2 8.7 6.7 6.9 4.1 8.8 3.5 2.4 0.0 4.1 1.4 1.1 4.0 0.0 1.8 0.7 7.5 1.6 3.2 2.3 5.3 3.4 1.7 4.8 0.9 3.4 7.3 9.0 1.7 1.9 1.5 6.3 8.4 2.9 1.5 5.7 4.9 3.4 3.0 0.1 0.1 3.8 3.4 2.7 2.1 4.1 3.0 0.6 0.0 4.1 0.4 0.8 1.1 3.2 1.0 2.3 3.5 3.3 2.9 1.0 5.9 5.2 3.4 0.4 2.4 0.9 4.5 4.4 1.0 11.8 11.2 13.8 13.4 8.9 5.9 13.6 6.6 9.2 11.1 6.0 3.8 1.4 1.2 1.0 9.4 4.2 7.6 6.7 4.5 5.2 5.9 1.0 6.6 1.3 0.6 1.0 0.0 0.0 1.0 0.6 0.9 0.8 3.5 0.8 0.8 14.3 1.2 3.7 2.2 2.6 3.1 0.0 0.0 1.8 0.9 8.2 0.7 1.1 2.5 0.6 9.8 0.0 1.0 2.3 3.8 0.3 0.2 0.8 1.2 0.4 ZNF609 KIAA0295 ENSG00000180357 "Zinc finger protein 609" O15014 15 64460742-64686068 "Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 133.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040742, HPA040832" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040742: AB_10963581, HPA040832: AB_10960400" "unprognostic (2.09e-1)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (2.61e-1)" "unprognostic (3.11e-2)" "unprognostic (5.02e-2)" "unprognostic (7.21e-2)" "unprognostic (9.51e-2)" "unprognostic (2.17e-1)" "unprognostic (1.22e-1)" "unprognostic (1.37e-2)" "unprognostic (2.28e-1)" 11.1 11.2 14.5 14.5 12.6 7.3 11.4 17.1 15.1 17.9 14.2 16.2 19.1 12.1 18.7 8.4 10.2 15.7 14.0 10.9 12.3 10.4 9.1 10.2 13.9 11.3 10.9 11.0 29.9 11.6 18.1 11.6 16.3 10.9 15.2 11.4 14.6 12.6 22.8 9.2 11.9 11.2 16.1 12.7 12.9 11.4 28.9 13.6 21.4 12.4 4.5 12.1 15.6 28.4 1.2 2.8 3.2 1.7 4.0 3.0 0.5 6.1 15.6 16.9 6.4 6.5 8.3 5.8 8.1 10.8 10.2 10.3 9.6 9.8 10.6 6.8 9.5 13.9 13.2 24.7 11.1 10.7 12.3 5.3 19.4 9.0 4.7 12.0 11.1 13.0 8.4 10.2 10.6 21.0 14.8 18.8 9.1 30.4 6.9 8.3 5.6 8.6 4.7 12.8 8.3 4.4 7.9 15.4 5.5 7.4 11.1 13.7 10.5 11.0 12.6 7.5 16.9 6.2 7.8 18.7 9.5 15.2 4.9 10.0 7.7 8.7 9.6 5.9 12.2 7.7 3.2 1.7 1.9 2.3 0.7 1.6 0.7 1.3 1.6 0.6 1.2 3.0 3.0 2.1 4.0 0.8 2.8 0.8 0.5 14.5 12.6 17.1 15.1 12.3 10.4 10.9 11.0 10.9 13.6 11.9 20.1 6.1 13.9 16.0 28.1 18.3 17.8 30.8 25.0 17.4 133.5 12.7 3.3 12.3 17.2 14.4 9.9 0.0 12.8 11.9 12.1 18.2 9.3 11.6 8.7 42.9 17.9 17.8 23.1 9.6 16.7 11.6 13.5 9.0 10.8 19.5 11.6 11.5 13.1 3.1 56.5 19.4 9.2 31.7 14.0 15.2 26.1 13.3 10.5 15.6 ZNF638 "MGC26130, NP220, ZFML, Zfp638" ENSG00000075292 "Zinc finger protein 638" Q14966 2 71276561-71435069 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036784, HPA057395" Supported Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA036784: AB_10672478, HPA057395: AB_2683426" "unprognostic (2.58e-2)" "unprognostic (3.15e-1)" "unprognostic (7.57e-2)" "unprognostic (1.26e-3)" "unprognostic (2.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-2)" "unprognostic (5.68e-3)" "unprognostic (2.31e-2)" "unprognostic (1.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.32e-1)" "unprognostic (2.66e-3)" "unprognostic (3.28e-1)" "unprognostic (7.68e-2)" "unprognostic (1.93e-2)" "prognostic favorable (8.73e-5)" 20.7 19.1 22.4 14.9 26.0 18.7 19.8 51.3 25.5 19.8 19.7 23.4 13.0 11.3 26.0 14.8 17.3 20.1 14.3 16.0 20.1 11.9 18.7 22.9 16.4 16.9 25.4 19.9 31.1 15.4 28.9 46.7 16.9 23.9 17.2 14.7 14.1 20.6 15.5 33.2 16.9 15.8 18.4 22.7 16.0 17.3 21.0 29.7 26.0 22.5 11.2 16.1 26.6 17.8 14.8 10.2 32.4 12.8 11.8 14.1 6.0 14.8 21.5 33.1 15.4 19.5 21.4 25.5 17.0 19.8 14.5 13.1 20.5 14.6 24.5 15.9 15.5 22.7 12.6 30.7 17.5 21.2 24.9 17.1 32.2 23.5 18.6 16.9 29.4 21.9 13.6 17.1 15.6 29.1 20.8 22.3 16.6 32.2 14.5 21.1 14.9 20.7 21.7 28.6 22.4 13.8 17.7 50.1 17.1 15.5 22.8 25.5 16.8 21.0 14.8 21.5 34.5 13.8 18.2 22.8 18.0 26.3 13.3 17.1 11.9 18.3 24.3 15.1 19.3 19.5 32.4 10.1 18.7 11.4 9.5 10.6 14.5 10.6 10.4 7.9 14.8 14.1 10.3 17.1 11.8 12.8 10.2 8.9 6.0 22.4 26.0 51.3 25.5 20.1 11.9 25.4 19.9 23.9 29.7 62.5 96.8 21.9 49.0 28.2 107.5 95.4 33.1 95.0 67.1 38.4 115.8 33.4 16.6 33.6 9.1 50.4 34.1 0.0 35.4 23.2 45.8 52.3 76.3 39.4 28.2 63.5 36.9 35.0 35.3 11.0 69.6 45.7 21.9 49.5 31.9 69.1 35.4 26.0 60.1 17.0 107.8 32.3 40.0 110.7 64.1 26.5 42.0 42.7 33.6 45.0 ZNF672 FLJ22301 ENSG00000171161 "Zinc finger protein 672" Q499Z4 1 248838210-248849517 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055779, HPA062506" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA055779: AB_2682917, HPA062506: AB_2684786" "unprognostic (1.64e-2)" "unprognostic (3.45e-2)" "unprognostic (8.96e-2)" "unprognostic (2.92e-2)" "unprognostic (2.50e-1)" "unprognostic (9.54e-3)" "unprognostic (7.42e-3)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (2.40e-2)" "prognostic favorable (7.51e-4)" "unprognostic (9.03e-2)" "unprognostic (1.16e-2)" "unprognostic (1.99e-2)" "unprognostic (2.69e-1)" "unprognostic (8.35e-3)" "prognostic favorable (1.79e-5)" 11.3 12.5 11.1 16.4 13.6 15.1 12.1 18.6 15.3 10.2 13.0 17.3 15.0 13.8 12.1 10.7 15.9 11.3 13.3 20.1 11.4 10.2 14.8 27.5 13.6 16.7 14.1 7.5 12.0 14.1 20.4 14.1 16.1 12.4 18.7 11.1 15.1 24.1 14.8 46.6 13.3 16.8 11.3 11.2 16.0 12.7 12.4 14.5 28.1 21.7 21.0 17.3 14.5 10.4 14.5 20.8 9.6 13.4 10.5 8.0 10.3 10.2 11.7 9.6 10.7 5.4 3.8 18.1 9.8 5.3 6.9 7.6 6.4 10.8 11.6 10.1 6.4 5.4 10.1 5.2 7.2 4.6 16.8 2.9 17.7 10.8 8.6 7.0 7.7 13.7 4.2 6.0 9.2 6.6 5.7 6.5 8.0 21.5 9.7 4.9 7.4 13.6 7.7 11.0 11.8 19.9 25.7 9.1 9.1 7.2 8.5 14.1 12.4 8.7 13.3 8.6 6.0 7.7 15.8 5.5 9.8 5.8 6.5 19.8 29.1 10.9 6.8 9.1 13.6 8.0 7.6 13.3 9.6 8.0 13.4 6.7 10.8 5.7 7.9 20.8 14.5 6.3 5.6 8.1 10.5 12.4 11.7 6.5 10.3 11.1 13.6 18.6 15.3 11.4 10.2 14.1 7.5 12.4 14.5 3.0 17.5 21.4 22.4 11.6 21.0 16.9 7.6 5.3 4.5 15.7 11.8 28.2 18.3 16.4 6.2 12.1 18.8 0.0 9.4 16.4 10.8 20.5 28.7 14.8 15.4 9.5 17.3 5.5 15.2 8.9 5.2 14.1 11.8 12.6 16.6 19.2 12.1 17.3 5.3 13.5 30.2 6.5 9.9 22.9 13.6 12.8 59.6 13.8 15.2 19.9 ZNF687 KIAA1441 ENSG00000143373 "Zinc finger protein 687" Q8N1G0 1 151281618-151292180 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 13.1;neutrophil: 9.6" "Group enriched" "Detected in many" 6 "granulocytes: 13.1;monocytes: 4.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021193, HPA023948" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021193: AB_1859415, HPA023948: AB_2671380" "unprognostic (2.23e-1)" "unprognostic (3.25e-1)" "unprognostic (2.93e-2)" "unprognostic (9.64e-3)" "unprognostic (2.44e-2)" "unprognostic (7.82e-2)" "unprognostic (2.62e-2)" "unprognostic (1.56e-1)" "unprognostic (1.39e-1)" "unprognostic (9.91e-2)" "unprognostic (8.69e-3)" "unprognostic (2.10e-1)" "unprognostic (5.82e-3)" "unprognostic (1.36e-1)" "unprognostic (1.41e-1)" "unprognostic (8.54e-2)" "unprognostic (7.99e-2)" 9.8 13.6 9.9 10.7 11.4 36.1 10.6 16.1 21.0 13.6 17.3 17.1 10.9 11.7 13.5 12.9 12.9 13.2 12.8 10.0 9.2 9.7 13.0 14.4 10.2 14.8 9.4 10.7 16.6 21.4 23.0 16.4 13.5 10.6 13.3 8.1 17.6 16.2 13.3 12.5 14.1 15.2 11.4 9.6 17.9 12.5 22.5 9.8 19.6 14.0 8.3 15.4 13.9 9.9 1.3 0.9 13.1 4.1 0.5 0.9 1.0 9.4 14.3 13.2 8.0 7.4 6.3 18.3 5.3 8.4 8.9 8.9 11.2 12.4 8.1 13.1 7.7 9.6 14.7 11.5 9.8 4.0 12.0 12.6 7.7 11.5 12.7 8.2 8.7 11.3 9.9 10.0 7.4 7.9 7.9 5.9 9.1 12.0 14.4 4.9 28.1 12.2 10.5 17.9 12.2 10.8 10.9 10.8 14.7 7.4 13.9 12.3 19.6 13.2 15.6 12.7 12.9 20.6 19.0 5.7 7.1 8.3 9.2 7.6 18.0 15.1 19.8 9.1 5.9 9.0 0.4 1.8 13.1 0.6 2.2 0.7 1.1 0.6 0.6 0.9 1.3 0.8 0.9 9.6 0.5 4.1 0.8 0.4 1.0 9.9 11.4 16.1 21.0 9.2 9.7 9.4 10.7 10.6 9.8 3.0 5.8 1.9 3.0 4.1 6.4 1.2 7.6 1.4 1.2 1.8 9.8 5.7 3.3 5.1 1.6 2.5 5.9 0.0 5.1 4.2 4.1 3.5 0.0 4.0 4.5 7.9 2.4 4.3 3.8 2.1 5.8 4.3 0.0 5.4 6.5 6.1 6.4 2.9 6.7 3.3 10.6 12.9 2.2 8.6 8.6 3.0 7.9 3.3 7.5 4.1 ZNF692 "AREBP, FLJ20531, Zfp692" ENSG00000171163 "Zinc finger protein 692" Q9BU19 1 248850006-248859144 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059337, HPA062792" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA059337: AB_2683984, HPA062792: AB_2684869" "unprognostic (4.86e-2)" "unprognostic (9.51e-2)" "unprognostic (1.64e-3)" "unprognostic (1.05e-2)" "unprognostic (1.90e-1)" "unprognostic (6.72e-3)" "unprognostic (2.85e-3)" "unprognostic (5.66e-3)" "unprognostic (1.25e-1)" "unprognostic (4.50e-2)" "prognostic favorable (4.09e-4)" "unprognostic (5.65e-3)" "prognostic unfavorable (7.72e-9)" "unprognostic (5.32e-2)" "unprognostic (2.07e-2)" "unprognostic (1.59e-1)" "prognostic favorable (8.35e-5)" 5.6 8.7 15.3 7.9 25.0 11.1 10.7 27.7 22.3 11.6 8.1 16.5 17.8 8.3 13.6 15.1 9.7 13.1 9.4 7.4 20.1 11.6 9.7 8.6 6.9 9.8 30.4 14.3 17.2 12.2 18.4 13.8 8.1 21.2 14.9 7.0 7.7 21.9 11.1 11.5 19.6 8.9 9.2 18.3 10.0 8.7 22.9 25.7 6.6 11.3 9.2 7.8 9.1 8.8 4.6 4.4 4.8 2.1 10.6 6.4 2.8 4.8 5.1 4.3 10.7 3.7 1.9 18.7 4.1 1.4 4.7 3.0 5.8 7.0 6.0 8.5 2.0 1.9 7.0 6.5 6.2 3.4 8.9 4.4 7.1 10.9 1.6 2.8 7.9 5.7 2.4 8.0 4.8 12.8 4.7 4.3 8.0 14.6 4.4 2.1 3.4 4.0 16.3 8.8 12.4 11.1 13.7 2.8 12.0 9.0 3.6 8.5 6.3 4.5 7.8 8.4 1.7 9.5 13.0 3.0 2.1 3.5 2.3 5.6 12.4 7.8 3.8 4.6 10.5 3.5 0.0 2.1 1.9 5.7 1.6 4.9 4.6 4.5 6.0 4.4 3.8 6.4 4.6 4.8 10.6 1.4 3.5 4.7 2.8 15.3 25.0 27.7 22.3 20.1 11.6 30.4 14.3 21.2 25.7 8.9 7.5 8.0 10.6 8.5 14.0 3.0 10.2 8.1 2.3 10.4 21.6 10.2 5.0 6.3 8.0 6.3 8.8 23.3 3.4 9.1 6.6 13.7 5.7 5.9 5.7 11.1 7.9 1.8 6.9 5.8 9.5 5.4 15.1 6.4 9.4 8.4 6.1 5.8 6.7 3.1 13.8 0.0 4.9 31.1 15.6 6.9 5.1 10.2 11.7 8.5 ZNF771 DSC43 ENSG00000179965 "Zinc finger protein 771" Q7L3S4 16 30407297-30431108 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 27.0;REH: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030730, HPA046672, HPA059398" Uncertain Enhanced Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA030730: AB_2673583, HPA046672: AB_2679745, HPA059398: AB_2684002" "unprognostic (8.21e-2)" "unprognostic (1.61e-1)" "unprognostic (9.21e-2)" "unprognostic (2.41e-1)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.16e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-2)" "unprognostic (3.12e-5)" "unprognostic (3.53e-2)" "unprognostic (3.44e-2)" "unprognostic (1.63e-1)" "unprognostic (2.38e-1)" "unprognostic (2.57e-1)" "unprognostic (9.99e-3)" 6.6 6.7 15.3 5.0 14.5 4.0 5.3 10.7 18.3 6.6 6.1 4.9 6.6 4.5 10.4 7.2 4.6 7.5 6.1 4.6 13.4 10.6 9.2 8.6 4.1 3.3 8.8 16.9 10.8 7.3 8.1 6.2 2.4 8.8 10.1 5.4 4.0 4.9 12.3 18.2 6.1 4.3 9.6 5.1 3.6 4.8 3.7 8.1 1.9 5.4 3.5 4.2 6.8 5.6 6.6 3.7 1.9 2.5 1.8 6.2 2.7 3.1 3.6 5.0 4.1 7.2 3.0 3.8 4.7 2.3 3.0 3.1 1.6 1.6 3.8 8.0 2.3 3.7 2.4 5.2 2.1 3.1 1.3 27.0 3.2 2.4 4.8 3.7 1.6 3.8 4.6 1.6 3.7 2.3 3.1 3.0 4.0 7.7 2.3 2.5 5.7 3.8 5.2 4.0 1.9 2.9 17.3 3.7 2.4 1.7 1.3 7.9 5.0 2.5 2.2 3.0 2.7 2.9 1.8 2.7 5.0 6.0 2.9 3.3 3.5 3.7 1.9 3.3 3.5 3.2 1.0 1.1 0.7 3.6 2.5 4.9 2.7 4.3 4.2 2.8 6.6 6.2 3.7 1.9 1.8 0.5 3.7 4.4 2.7 15.3 14.5 10.7 18.3 13.4 10.6 8.8 16.9 8.8 8.1 3.0 0.3 2.2 10.4 4.5 11.2 6.3 15.3 0.0 1.2 5.2 9.8 4.8 28.2 6.4 1.3 5.8 5.3 0.0 3.7 2.6 9.4 8.8 1.1 16.3 2.9 11.1 4.1 14.7 0.6 1.5 23.3 2.8 5.0 1.0 8.1 15.1 3.6 4.2 28.0 23.6 7.1 12.9 8.9 1.1 1.6 5.8 3.0 3.9 9.8 3.4 ZNF789 ENSG00000198556 "Zinc finger protein 789" Q5FWF6 7 99472841-99503650 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029500, HPA050793" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029500: AB_10603009, HPA050793: AB_2681240" "unprognostic (6.84e-3)" "unprognostic (5.75e-2)" "unprognostic (5.71e-2)" "unprognostic (2.49e-2)" "unprognostic (3.08e-1)" "unprognostic (2.90e-2)" "unprognostic (1.25e-3)" "unprognostic (4.38e-3)" "unprognostic (5.16e-2)" "unprognostic (1.56e-1)" "prognostic favorable (7.14e-4)" "unprognostic (1.58e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (6.63e-2)" "unprognostic (2.03e-1)" "unprognostic (8.33e-2)" "prognostic favorable (5.31e-6)" 6.1 5.5 11.0 15.9 10.0 11.6 9.2 31.9 14.4 6.1 9.2 9.2 11.0 15.1 10.9 12.8 5.0 7.8 6.6 4.0 10.0 8.5 9.0 8.1 6.5 10.5 6.8 9.8 8.9 7.8 6.3 13.3 4.6 7.6 16.4 12.5 14.8 10.3 13.8 8.9 13.3 12.6 8.5 8.6 11.2 8.4 17.6 8.1 8.4 9.3 4.8 10.1 4.1 5.6 3.9 14.2 2.0 1.6 4.1 7.0 2.1 11.2 3.8 6.2 11.2 1.8 2.1 8.6 5.8 2.2 3.5 7.7 6.4 7.7 8.6 4.9 2.6 4.1 5.7 3.5 3.3 4.9 3.9 6.0 6.5 10.6 10.8 3.1 4.4 14.9 2.3 3.0 7.5 3.3 2.3 3.7 11.1 9.7 8.4 3.2 10.7 5.3 11.9 6.3 5.3 6.0 7.0 5.9 9.0 4.6 3.5 6.2 6.8 4.1 11.2 6.5 3.7 3.0 7.0 6.9 6.7 8.2 10.0 5.6 5.1 7.0 10.8 10.6 8.0 7.2 2.0 1.6 1.5 2.7 1.1 2.9 2.7 3.4 2.9 5.6 3.9 7.0 4.2 0.4 4.1 1.4 14.2 5.3 2.1 11.0 10.0 31.9 14.4 10.0 8.5 6.8 9.8 7.6 8.1 0.0 4.6 4.2 3.8 4.8 17.5 1.7 2.5 6.7 4.5 1.8 13.7 4.0 1.7 3.6 21.1 5.6 4.7 23.3 4.8 3.0 3.4 2.5 3.5 2.9 5.6 6.4 5.2 0.6 4.4 6.4 3.1 6.6 6.8 2.8 5.1 10.9 3.5 4.5 4.2 3.4 13.5 0.0 4.2 10.6 3.8 4.5 1.8 4.8 5.6 3.0 ZNF830 "CCDC16, MGC20398, OMCG1" ENSG00000198783 "Zinc finger protein 830" Q96NB3 17 34961530-34963775 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024754, HPA027211" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA024754: AB_1859464, HPA027211: AB_1859465" "unprognostic (2.87e-1)" "unprognostic (3.86e-2)" "unprognostic (2.47e-1)" "unprognostic (1.45e-1)" "unprognostic (1.14e-1)" "unprognostic (8.70e-2)" "unprognostic (2.37e-2)" "unprognostic (6.39e-2)" "unprognostic (6.39e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.01e-4)" "unprognostic (2.01e-2)" "unprognostic (5.63e-2)" "unprognostic (1.55e-1)" "unprognostic (8.22e-2)" "unprognostic (8.63e-2)" 11.7 11.5 14.2 13.8 17.6 15.4 13.6 26.9 20.0 15.1 13.9 14.0 9.7 13.4 16.1 11.4 14.1 14.8 12.6 9.2 13.1 10.5 12.9 15.7 10.8 19.6 20.5 11.3 21.4 20.2 11.2 12.5 16.9 18.7 13.4 10.3 10.7 12.7 11.4 11.2 13.0 16.6 17.9 11.9 24.1 13.7 15.0 16.3 20.6 17.5 9.6 17.9 12.9 12.0 10.1 9.8 26.7 8.3 10.1 19.3 8.1 5.7 11.2 10.1 9.4 10.9 8.4 7.0 7.0 7.1 9.2 9.2 8.4 7.8 10.4 6.5 6.8 9.6 13.5 10.8 6.4 10.4 6.2 14.7 12.2 11.0 10.4 11.1 18.2 17.5 8.2 15.0 7.7 15.1 9.3 8.3 12.9 17.5 15.4 8.3 4.3 16.5 20.5 6.7 7.7 5.5 11.2 13.8 13.7 8.5 7.8 12.1 10.3 6.8 4.3 10.9 10.3 9.9 20.0 8.6 9.8 7.1 7.1 12.1 17.1 13.0 14.0 8.4 9.8 8.7 14.6 8.3 26.7 11.9 8.2 11.7 9.2 12.6 12.8 9.1 10.1 19.3 15.2 8.1 10.1 5.7 9.8 11.1 8.1 14.2 17.6 26.9 20.0 13.1 10.5 20.5 11.3 18.7 16.3 35.7 24.2 16.6 37.9 21.3 19.4 6.7 20.4 14.7 35.2 12.2 13.7 20.5 29.9 16.2 3.2 16.9 20.3 0.0 11.5 14.6 19.2 21.3 16.2 9.6 12.7 9.5 17.7 13.5 9.4 2.0 24.7 16.0 20.3 11.8 15.4 19.3 12.1 24.6 25.8 16.5 28.7 25.8 20.2 40.6 45.4 21.1 22.3 29.4 17.6 32.7 ZRANB2 "ZIS, ZIS1, ZIS2, ZNF265" ENSG00000132485 "Zinc finger RANBP2-type containing 2" O95218 1 71063291-71081297 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053960, HPA061949, HPA063298" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA053960: AB_2682323, HPA061949: AB_2684645, HPA063298: AB_2684979" "unprognostic (2.10e-1)" "unprognostic (7.54e-2)" "unprognostic (4.15e-3)" "unprognostic (8.11e-2)" "unprognostic (1.04e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (7.29e-5)" "unprognostic (4.25e-3)" "unprognostic (1.24e-2)" "unprognostic (7.79e-2)" "unprognostic (4.54e-2)" "prognostic unfavorable (5.70e-4)" "prognostic unfavorable (1.57e-8)" "unprognostic (3.96e-2)" "unprognostic (8.51e-2)" "unprognostic (1.40e-1)" "unprognostic (1.84e-3)" 26.4 27.4 39.8 31.1 42.2 35.1 34.4 54.1 48.6 39.3 28.8 19.6 33.3 23.4 48.3 45.6 20.2 30.6 20.3 27.5 33.5 30.6 20.1 19.5 26.7 37.8 34.1 40.5 39.5 23.9 23.1 77.5 24.6 32.0 30.5 29.3 17.5 25.1 33.2 54.4 27.9 24.9 35.1 42.2 26.2 23.6 31.6 38.0 40.0 32.8 24.3 30.9 32.8 25.6 31.4 34.0 32.1 16.3 20.9 30.8 13.8 23.7 8.6 35.6 20.5 13.9 24.0 20.3 29.1 16.0 25.6 32.7 16.1 15.4 49.3 25.8 17.9 24.1 15.0 30.1 18.1 38.4 34.8 21.7 42.8 33.8 13.4 20.7 46.6 17.5 18.2 22.7 24.9 21.5 29.0 21.5 25.5 44.7 26.4 19.5 8.1 38.1 15.1 36.3 14.2 16.9 43.4 26.6 28.9 16.5 20.3 26.5 16.8 24.8 16.7 24.8 19.4 20.5 20.5 28.8 18.9 18.1 14.8 28.7 21.8 27.0 54.2 27.9 43.5 26.5 32.1 16.3 14.2 22.2 15.0 25.1 30.6 23.6 21.3 12.4 31.4 30.8 24.2 14.6 20.9 14.8 34.0 22.0 13.8 39.8 42.2 54.1 48.6 33.5 30.6 34.1 40.5 32.0 38.0 92.3 128.7 70.6 66.5 45.0 171.8 89.9 58.6 91.0 72.8 47.1 121.7 45.9 41.4 45.1 111.6 51.1 53.4 23.3 58.7 46.6 56.3 44.1 84.4 36.4 38.8 201.8 70.2 51.0 27.2 20.7 171.7 52.0 45.5 50.5 41.0 144.1 55.6 45.6 108.5 30.6 205.0 116.4 59.5 149.3 96.0 40.7 53.1 60.9 36.0 49.3 ZSCAN26 "SRE-ZBP, ZNF187" ENSG00000197062 "Zinc finger and SCAN domain containing 26" Q16670 6 28267010-28278224 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027521 Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA027521: AB_2672314" "unprognostic (1.07e-1)" "unprognostic (4.10e-1)" "unprognostic (1.95e-1)" "unprognostic (3.31e-2)" "unprognostic (1.38e-3)" "unprognostic (4.60e-3)" "prognostic unfavorable (7.81e-5)" "unprognostic (1.00e-2)" "unprognostic (1.16e-2)" "unprognostic (1.04e-2)" "unprognostic (2.49e-3)" "unprognostic (9.01e-2)" "prognostic unfavorable (6.79e-5)" "unprognostic (4.45e-2)" "unprognostic (1.44e-1)" "unprognostic (3.10e-1)" "prognostic favorable (1.68e-4)" 4.4 5.4 7.4 4.8 10.5 2.5 8.3 17.7 11.4 8.4 4.3 10.5 7.3 4.2 10.5 7.4 4.9 7.9 6.7 6.3 8.1 5.1 3.6 5.2 4.9 7.3 11.5 18.7 4.0 8.9 7.8 4.6 9.6 7.7 5.0 5.7 4.5 10.7 6.4 4.9 4.4 8.9 6.6 7.6 4.9 2.9 9.6 4.0 7.6 2.0 6.1 5.8 4.6 15.2 9.6 10.7 6.2 16.1 16.3 9.6 5.6 4.8 13.7 11.7 14.9 14.3 3.1 11.2 11.2 14.8 15.3 3.5 4.1 3.2 17.4 7.1 11.1 4.3 6.3 8.2 16.3 6.8 6.8 8.5 6.7 7.5 10.3 7.0 5.5 11.9 7.8 11.3 10.3 19.1 14.9 5.0 7.0 6.8 11.6 4.7 7.4 9.6 4.0 3.0 7.3 7.5 11.9 5.4 12.5 5.8 9.9 7.7 6.9 2.9 9.3 11.6 4.8 4.8 9.7 11.9 8.7 4.2 13.6 7.2 9.6 6.2 4.3 7.9 10.3 10.5 6.2 10.7 13.4 4.8 15.8 13.4 13.1 14.4 9.6 15.2 16.3 13.5 4.4 16.1 4.0 4.5 11.8 9.6 0.0 3.5 10.4 2.8 0.0 8.6 8.7 0.0 2.7 11.4 0.0 3.9 3.8 3.3 4.2 3.2 6.8 2.6 0.0 4.4 2.7 3.5 3.0 5.8 1.5 5.0 1.6 6.4 4.3 5.0 1.7 8.3 1.9 0.0 1.0 2.3 11.7 3.0 4.0 12.4 4.9 9.7 19.4 2.7 5.5 8.1 0.0 1.1 7.5 2.7 0.9 ZWINT "KNTC2AP, SIP30, Zwint1" ENSG00000122952 "ZW10 interacting kinetochore protein" O95229 10 56357228-56361275 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.6;testis: 37.1" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 87.4;Late spermatids: 149.1;Spermatocytes: 124.1;Spermatogonia: 125.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 15.2" "Lineage enriched" "Detected in many" 5 "T-cells: 15.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA005757, HPA022264" Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No Yes "Nucleoplasm, Nuclear bodies" Cytosol "HPA005757: AB_10600224, HPA022264: AB_10600995" "unprognostic (5.59e-2)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (9.38e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.77e-8)" "unprognostic (6.36e-3)" "unprognostic (5.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.58e-3)" "unprognostic (1.86e-2)" "prognostic unfavorable (3.72e-12)" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (5.47e-2)" "unprognostic (3.46e-1)" 1.7 3.5 3.4 14.6 3.1 18.4 3.0 0.9 2.8 3.3 9.4 1.3 2.1 6.8 2.0 4.5 14.1 1.1 6.3 1.6 2.7 1.8 4.6 2.9 2.6 12.8 2.4 3.4 1.7 2.8 2.8 1.9 7.3 1.9 1.8 11.8 1.5 4.2 1.4 0.9 5.2 8.8 3.1 2.5 9.0 6.2 37.1 0.7 35.6 1.9 12.7 17.2 3.1 4.6 1.6 1.3 0.6 2.6 2.9 15.2 3.0 39.9 31.8 22.7 25.2 1.6 2.3 18.5 29.5 22.3 35.7 32.5 56.2 24.0 20.6 11.3 10.1 16.7 20.6 31.8 22.2 33.3 52.3 16.6 20.5 25.6 26.0 0.1 33.8 27.6 1.1 1.4 33.2 13.7 4.4 17.9 27.7 27.7 25.3 31.3 32.3 29.8 21.4 16.1 27.5 39.3 30.5 44.1 11.0 11.1 17.9 21.1 12.9 27.9 63.5 7.4 13.7 41.1 33.1 9.7 15.6 40.3 16.1 45.1 22.3 10.7 35.8 22.1 42.6 19.6 0.0 0.7 0.6 2.2 2.6 0.3 1.6 5.3 3.6 1.3 0.3 6.4 3.6 0.0 2.9 2.0 1.0 15.2 3.0 3.4 3.1 0.9 2.8 2.7 1.8 2.4 3.4 1.9 0.7 3.0 1.7 4.5 4.8 16.4 1.3 0.8 5.1 1.4 3.4 5.2 0.0 36.2 0.0 9.4 58.5 2.3 7.0 46.7 11.7 87.4 2.8 1.3 0.0 3.4 41.1 0.0 0.0 9.8 8.3 149.1 4.6 7.4 6.8 2.8 11.6 1.2 6.7 11.8 2.5 4.6 1.1 0.0 0.9 124.1 125.8 7.2 19.3 7.9 22.7 2.0